PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gheiratmand, L; Brasseur, A; Zhou, Q; He, CY				Gheiratmand, Ladan; Brasseur, Anais; Zhou, Qing; He, Cynthia Y.			Biochemical Characterization of the Bi-lobe Reveals a Continuous Structural Network Linking the Bi-lobe to Other Single-copied Organelles in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL BODY MOVEMENTS; CELL-CYCLE; MONOCLONAL-ANTIBODIES; GENOME SEGREGATION; PARAFLAGELLAR ROD; MITOCHONDRIAL-DNA; GOLGI DUPLICATION; FLAGELLAR POCKET; DIVISION; PROTEIN	Trypanosoma brucei, a unicellular parasite, contains several single-copied organelles that duplicate and segregate in a highly coordinated fashion during the cell cycle. In the procyclic stage, a bi-lobed structure is found adjacent to the single ER exit site and Golgi apparatus, forming both stable and dynamic association with other cytoskeletal components including the basal bodies that seed the flagellum and the flagellar pocket collar that is critical for flagellar pocket biogenesis. To further understand the bi-lobe and its association with adjacent organelles, we performed proteomic analyses on the immunoisolated bi-lobe complex. Candidate proteins were localized to the flagellar pocket, the basal bodies, a tripartite attachment complex linking the basal bodies to the kinetoplast, and a segment of microtubule quartet linking the flagellar pocket collar and bi-lobe to the basal bodies. These results supported an extensive connection among the single-copied organelles in T. brucei, a strategy employed by the parasite for orderly organelle assembly and inheritance during the cell cycle.	[Gheiratmand, Ladan; Brasseur, Anais; Zhou, Qing; He, Cynthia Y.] Natl Univ Singapore, Ctr BioImaging Sci, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	He, CY (corresponding author), Natl Univ Singapore, Ctr BioImaging Sci, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbshyc@nus.edu.sg	He, Cynthia/H-9789-2012; Zhou, Qing/A-8296-2019; Zhou, Qing/I-6223-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960	Singapore National Research Foundation; A*STAR SINGA fellowship	Singapore National Research Foundation(National Research Foundation, Singapore); A*STAR SINGA fellowship(Agency for Science Technology & Research (A*STAR))	This work was supported by the Singapore National Research Foundation.; A recipient of the A*STAR SINGA fellowship.	Absalon S, 2008, J CELL SCI, V121, P3704, DOI 10.1242/jcs.035626; Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Bangs JD, 2011, MOL MICROBIOL, V82, P1433, DOI 10.1111/j.1365-2958.2011.07900.x; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chan SW, 2005, GENE, V353, P189, DOI 10.1016/j.gene.2005.04.025; Dougherty GW, 2005, CELL MOTIL CYTOSKEL, V62, P141, DOI 10.1002/cm.20093; Esson HJ, 2012, EUKARYOT CELL, V11, P761, DOI 10.1128/EC.05287-11; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Fagarasanu A, 2010, NAT REV MOL CELL BIO, V11, P644, DOI 10.1038/nrm2960; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Ikeda KN, 2012, J CELL SCI, V125, P3173, DOI 10.1242/jcs.101162; Imoto Y, 2011, J ELECTRON MICROSC, V60, pS117, DOI 10.1093/jmicro/dfr034; ISMACH R, 1989, J PROTOZOOL, V36, P617, DOI 10.1111/j.1550-7408.1989.tb01105.x; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Lacomble S, 2010, J CELL SCI, V123, P2884, DOI 10.1242/jcs.074161; Lowe M, 2007, NAT REV MOL CELL BIO, V8, P429, DOI 10.1038/nrm2179; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; Ochsenreiter T, 2008, MOL CELL BIOL, V28, P5595, DOI 10.1128/MCB.00637-08; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Portman N, 2012, PARASITOLOGY, V139, P1168, DOI 10.1017/S0031182012000443; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; Sheahan MB, 2007, J INTEGR PLANT BIOL, V49, P1208, DOI 10.1111/j.1672-9072.2007.00523.x; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; VICKERMAN K, 1969, J CELL SCI, V5, P163; Wang ZF, 2002, EMBO J, V21, P4998, DOI 10.1093/emboj/cdf482; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Zhao Z, 2008, EMBO J, V27, P143, DOI 10.1038/sj.emboj.7601956; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660	45	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3489	3499		10.1074/jbc.M112.417428	http://dx.doi.org/10.1074/jbc.M112.417428			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235159	Green Published, hybrid			2022-12-25	WOS:000314397900054
J	Mendelson, K; Zygmunt, T; Torres-Vazquez, J; Evans, T; Hla, T				Mendelson, Karen; Zygmunt, Tomasz; Torres-Vazquez, Jesus; Evans, Todd; Hla, Timothy			Sphingosine 1-Phosphate Receptor Signaling Regulates Proper Embryonic Vascular Patterning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; GENOME DUPLICATION; PROGENITOR CELLS; SPHINGOSINE-1-PHOSPHATE; ZEBRAFISH; MIGRATION; ANGIOGENESIS; METABOLISM; CADHERIN; BLOOD	Sphingosine 1-phosphate (S1P) binds G-protein-coupled receptors (S1P(1-5)) to regulate a multitude of physiological effects, especially those in the vascular and immune systems. S1P receptors in the vascular system have been characterized primarily in mammals. Here, we report that the S1P receptors and metabolic enzymes are conserved in the genome of zebrafish Danio rerio. Bioinformatic analysis identified seven S1P receptor-like sequences in the zebrafish genome, including duplicated orthologs of receptors 3 and 5. Sphingolipidomic analysis detected erythrocyte and plasma S1P as well as high plasma ceramides and sphingosine. Morpholino-mediated knockdown of s1pr1 causes global and pericardial edema, loss of blood circulation, and vascular defects characterized by both reduced vascularization in intersegmental vessels, decreased proliferation of intersegmental and axial vessels, and hypersprouting in the caudal vein plexus. The s1pr2 gene was previously characterized as a regulator of cell migration and heart development, but its role in angiogenesis is not known. However, when expression of both s1pr1 and s1pr2 is suppressed, severely reduced vascular development of the intersegmental vessels was observed with doses of the s1pr1 morpholino that alone did not cause any discernible vascular defects, suggesting that s1pr1 and s1pr2 function cooperatively to regulate vascular development in zebrafish. Similarly, the S1P transporter, spns2, also cooperated with s1pr1. We propose that extracellular S1P acts through vascular S1P receptors to regulate vascular development.	[Mendelson, Karen; Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Ctr Vasc Biol, Dept Pathol & Lab Med, New York, NY 10021 USA; [Evans, Todd] Cornell Univ, Dept Surg, Weill Cornell Med Coll, New York, NY 10021 USA; [Zygmunt, Tomasz; Torres-Vazquez, Jesus] NYU, Sch Med, Dept Cell Biol,Skirball Inst, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA	Cornell University; Cornell University; New York University	Evans, T (corresponding author), Cornell Univ, Dept Surg, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10021 USA.	tre2003@med.cornell.edu; tih2002@med.cornell.edu	; Hla, Timothy/G-5873-2012	Torres-Vazquez, Jesus/0000-0002-3808-3978; Hla, Timothy/0000-0001-8355-4065	National Institutes of Health from the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; National Institutes of Health COBRE Grant from the Lipidomics Core, South Carolina Lipidomics and Pathobiology [P20 RR017677]; National Institutes of Health from NHLBI [T32HL083824, HL092263-01A1, HL056182, HL111400, HL67330, HL89934, HL70694]; Office of the Director of the National Institutes of Health through NCRR [C06 RR018823]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083824, R01HL089934, R37HL067330, R37HL056182, P01HL070694, R01HL067330, R01HL056182, R01HL111400, R01HL092263] Funding Source: NIH RePORTER	National Institutes of Health from the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; National Institutes of Health COBRE Grant from the Lipidomics Core, South Carolina Lipidomics and Pathobiology; National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of the Director of the National Institutes of Health through NCRR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Sphingolipid measurements were supported by National Institutes of Health Grant P30 CA138313 from the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina and by National Institutes of Health COBRE Grant P20 RR017677 from the Lipidomics Core, South Carolina Lipidomics and Pathobiology.; This work was supported, in whole or in part, by National Institutes of Health Grants T32HL083824 (to K. M.), HL092263-01A1 (to J. T.-V.), HL056182, and HL111400 (to T. E.), and HL67330, HL89934, and HL70694 (to T. H.) from NHLBI and Grant C06 RR018823 from Office of the Director of the National Institutes of Health through NCRR.	Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Choi J, 2011, DEVELOPMENT, V138, P1173, DOI 10.1242/dev.054049; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hla T, 2005, PROSTAG OTH LIPID M, V77, P197, DOI 10.1016/j.prostaglandins.2005.06.008; HLA T, 1990, J BIOL CHEM, V265, P9308; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Im DS, 2001, BIOCHEMISTRY-US, V40, P14053, DOI 10.1021/bi011606i; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kai M, 2008, DEVELOPMENT, V135, P3043, DOI 10.1242/dev.020396; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu CH, 1997, GENOMICS, V43, P15, DOI 10.1006/geno.1997.4759; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Malek RL, 2001, J BIOL CHEM, V276, P5692, DOI 10.1074/jbc.M003964200; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Matsui Takaaki, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS77, DOI 10.1038/ncpcardio0764; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pedroso GL, 2012, JOVE-J VIS EXP, DOI 10.3791/3865; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; SCHMELZ EM, 1994, J NUTR, V124, P702, DOI 10.1093/jn/124.5.702; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tobia C, 2012, ARTERIOSCL THROM VAS, V32, pE104, DOI 10.1161/ATVBAHA.112.250035; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007	42	58	60	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2143	2156		10.1074/jbc.M112.427344	http://dx.doi.org/10.1074/jbc.M112.427344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229546	Green Published, hybrid			2022-12-25	WOS:000314211500005
J	Dong, Z; Di, H; Dai, W; Liang, JY; Pan, MY; Zhang, MJ; Zhou, ZB; Li, Z; Liu, RZ; Yu, SY				Dong, Zhao; Di, Hai; Dai, Wei; Liang, Jingyao; Pan, Meiyan; Zhang, Mingjie; Zhou, Zhibin; Li, Zheng; Liu, Ruozhuo; Yu, Shengyuan			Application of ICHD-II Criteria in a Headache Clinic of China	PLOS ONE			English	Article							CLUSTER HEADACHE; UNITED-STATES; PREVALENCE; MIGRAINE; CLASSIFICATION; DISORDERS; FREQUENCY; FEATURES; PROFILE; BURDEN	Background: China has the huge map and the largest population in the world. Previous studies on the prevalence and classification of headaches were conducted based on the general population, however, similar studies among the Chinese outpatient population are scarce. This study aimed to analyze the characteristics of 1843 headache patients enrolled in a North China headache clinic of the General Hospital for Chinese People's Liberation Army from October 2011 to May 2012, with the International Classification of Headache Disorders, 2nd Edition (ICHD-II). Methods and Results: Personal interviews were carried out and a detailed questionnaire was used to collect medical records including age, sex and headache characteristics. Patients came from 28 regions of China with the median age of 40.9 (9-80) years and the female/male ratio of 1.67/1. The primary headaches (78.4%) were classified as the following: migraine (39.1%), tension-type headache (32.5%), trigeminal autonomic cephalalgias (5.3%) and other primary headache (1.5%). Among the rest patients, 12.9% were secondary headaches, 5.9% were cranial neuralgias and 2.5% were unspecified or not elsewhere classified. Fourteen point nine percent (275/1843) were given an additional diagnosis of chronic daily headache, including medication-overuse headache (MOH, 49.5%), chronic tension-type headache (CTTH, 32.7%) and chronic migraine (CM, 13.5%). The visual analogue scale (VAS) score of TTH with MOH was significantly higher than that of CTTH (6.8 +/- 2.0 vs 5.6 +/- 2.0, P<0.001). The similar result was also observed in VAS score between migraine with MOH and CM (8.0 +/- 1.5 vs 7.0 +/- 1.5, P = 0.004). The peak age at onset of TTH for male and female were both in the 3rd decade of life. However, the age distribution at onset of migraine shows an obvious sex difference, i.e. the 2nd decade for females and the 1st decade for males. Conclusions/Significance: This study revealed the characteristics of the headache clinic outpatients in a tertiary hospital of North China that migraine is the most common diagnosis. Furthermore, most headaches in this patient population can be classified using ICHD-II criteria.	[Dong, Zhao; Di, Hai; Dai, Wei; Liang, Jingyao; Pan, Meiyan; Zhang, Mingjie; Zhou, Zhibin; Li, Zheng; Liu, Ruozhuo; Yu, Shengyuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Int Headache Ctr, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Yu, SY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Int Headache Ctr, Beijing, Peoples R China.	yusy1963@126.com	Dai, Wei/AFV-9133-2022	Dai, Wei/0000-0002-7015-2531; Zhang, Mingjie/0000-0002-3519-1746	National Science Foundation Committee (NSFC) in China [30970417, 81171058]	National Science Foundation Committee (NSFC) in China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Science Foundation Committee (NSFC) in China (no. 30970417 and no. 81171058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakravarty A, 2003, CEPHALALGIA, V23, P348, DOI 10.1046/j.1468-2982.2003.00514.x; Couch JR, 2011, CURR TREAT OPTION NE, V13, P41, DOI 10.1007/s11940-010-0104-7; De Diego EV, 2005, CEPHALALGIA, V25, P184, DOI 10.1111/j.1468-2982.2004.00820.x; Dermitzakis EV, 2010, J HEADACHE PAIN, V11, P123, DOI 10.1007/s10194-009-0178-3; Felicio AC, 2006, ARQ NEURO-PSIQUIAT, V64, P41, DOI 10.1590/S0004-282X2006000100009; Friedman BW, 2007, ANN EMERG MED, V49, P409, DOI 10.1016/j.annemergmed.2006.11.004; Gesztelyi G, 2004, EUR J NEUROL, V11, P389, DOI 10.1111/j.1468-1331.2004.00800.x; Goldstein JN, 2006, CEPHALALGIA, V26, P684, DOI 10.1111/j.1468-2982.2006.01093.x; Guerrero AL, 2011, HEADACHE, V51, P226, DOI 10.1111/j.1526-4610.2010.01828.x; Imai N, 2011, CEPHALALGIA, V31, P628, DOI 10.1177/0333102410391486; Lin KH, 2004, CEPHALALGIA, V24, P631, DOI 10.1111/j.1468-2982.2003.00721.x; Lu SR, 2001, CEPHALALGIA, V21, P980, DOI 10.1046/j.1468-2982.2001.00294.x; Murtaza M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005827; Okumura Toshikatsu, 2010, Asia Pac Fam Med, V9, P10, DOI 10.1186/1447-056X-9-10; Ondo WG, 2004, CEPHALALGIA, V24, P60, DOI 10.1111/j.1468-2982.2004.00641.x; Relja Giuliano, 2005, J Headache Pain, V6, P298; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Scher AI, 2003, PAIN, V106, P81, DOI 10.1016/S0304-3959(03)00293-8; Silberstein SD, 2000, CURR OPIN NEUROL, V13, P277, DOI 10.1097/00019052-200006000-00008; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; Wang SJ, 2008, HEADACHE, V48, P1356, DOI 10.1111/j.1526-4610.2008.01088.x; Wang YF, 2011, J HEADACHE PAIN, V12, P561, DOI 10.1007/s10194-011-0360-2; Yu SY, 2012, HEADACHE, V52, P582, DOI 10.1111/j.1526-4610.2011.02061.x	24	30	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50898	10.1371/journal.pone.0050898	http://dx.doi.org/10.1371/journal.pone.0050898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239993	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800029
J	Chafai, M; Corbani, M; Guillon, G; Desarmenien, MG				Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.			Vasopressin Inhibits LTP in the CA2 Mouse Hippocampal Area	PLOS ONE			English	Article							V-1B RECEPTOR ANTAGONIST; LONG-TERM POTENTIATION; RAT-BRAIN; 1B RECEPTOR; PERFORANT PATH; AVP ANTAGONIST; BINDING-SITES; DENTATE GYRUS; KNOCKOUT MICE; V1B RECEPTOR	Growing evidence points to vasopressin (AVP) as a social behavior regulator modulating various memory processes and involved in pathologies such as mood disorders, anxiety and depression. Accordingly, AVP antagonists are actually envisaged as putative treatments. However, the underlying mechanisms are poorly characterized, in particular the influence of AVP on cellular or synaptic activities in limbic brain areas involved in social behavior. In the present study, we investigated AVP action on the synapse between the entorhinal cortex and CA2 hippocampal pyramidal neurons, by using both field potential and whole-cell recordings in mice brain acute slices. Short application (1 min) of AVP transiently reduced the synaptic response, only following induction of long-term potentiation (LTP) by high frequency stimulation (HFS) of afferent fibers. The basal synaptic response, measured in the absence of HFS, was not affected. The Schaffer collateral-CA1 synapse was not affected by AVP, even after LTP, while the Schaffer collateral-CA2 synapse was inhibited. Although investigated only recently, this CA2 hippocampal area appears to have a distinctive circuitry and a peculiar role in controlling episodic memory. Accordingly, AVP action on LTP-increased synaptic responses in this limbic structure may contribute to the role of this neuropeptide in controlling memory and social behavior.	[Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.] CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France; [Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.] INSERM, U661, Montpellier, France; [Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.] Univ Montpellier I, UMR 5203, Montpellier, France; [Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.] Univ Montpellier 2, UMR 5203, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Desarmenien, MG (corresponding author), CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France.	michel.desarmenien@igf.cnrs.fr			CNRS; INSERM; Agence Nationale de la Recherche [ANR-09-MNPS-031-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS, INSERM and Agence Nationale de la Recherche (ANR-09-MNPS-031-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; BARBERIS C, 1993, ANN NY ACAD SCI, V689, P475, DOI 10.1111/j.1749-6632.1993.tb55573.x; Bartesaghi R, 2004, HIPPOCAMPUS, V14, P948, DOI 10.1002/hipo.20011; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Caldwell HK, 2008, PROG BRAIN RES, V170, P65, DOI 10.1016/S0079-6123(08)00406-8; CHEN C, 1993, HIPPOCAMPUS, V3, P193, DOI 10.1002/hipo.450030211; Chevaleyre V, 2000, J NEUROSCI, V20, P5813, DOI 10.1523/JNEUROSCI.20-15-05813.2000; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Corbani M, 2011, J MED CHEM, V54, P2864, DOI 10.1021/jm1016208; DeVito LM, 2009, J NEUROSCI, V29, P2676, DOI 10.1523/JNEUROSCI.5488-08.2009; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dubrovsky B, 2003, BRAIN RES BULL, V59, P467, DOI 10.1016/S0361-9230(02)00961-9; Egashira N, 2004, NEUROSCI LETT, V356, P195, DOI 10.1016/j.neulet.2003.11.050; Frank E, 2008, EUR J PHARMACOL, V583, P226, DOI 10.1016/j.ejphar.2007.11.063; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hernando F, 2001, ENDOCRINOLOGY, V142, P1659, DOI 10.1210/en.142.4.1659; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; JOHNSON AE, 1993, BRAIN RES, V622, P9, DOI 10.1016/0006-8993(93)90795-O; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; Mercer A, 2010, HIPPOCAMPUS; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Piskorowski RA, 2012, CELL MOL LIFE SCI, V69, P75, DOI 10.1007/s00018-011-0769-4; Raggenbass M, 2008, EUR J PHARMACOL, V583, P243, DOI 10.1016/j.ejphar.2007.11.074; Rood BD, 2011, J COMP NEUROL, V519, P2434, DOI 10.1002/cne.22635; Sakurai E, 1998, JPN J PHARMACOL, V77, P103, DOI 10.1254/jjp.77.103; Serradeil-Le Gal C, 2002, J PHARMACOL EXP THER, V300, P1122; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; Surget A, 2008, EUR J PHARMACOL, V583, P340, DOI 10.1016/j.ejphar.2007.11.065; TIBERIIS BE, 1983, NEUROPEPTIDES, V4, P65, DOI 10.1016/0143-4179(83)90010-0; Tobin V, 2006, EUR J NEUROSCI, V24, P400, DOI 10.1111/j.1460-9568.2006.04935.x; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; Van Wimersma Greidanus TB, 1980, ACTA PSYCHIAT BELG, V80, P721; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; Young WS, 2006, NEUROSCIENCE, V143, P1031, DOI 10.1016/j.neuroscience.2006.08.040; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	42	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49708	10.1371/journal.pone.0049708	http://dx.doi.org/10.1371/journal.pone.0049708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236353	Green Submitted, gold, Green Published			2022-12-25	WOS:000312064100005
J	Medina-Roldan, E; Bardgett, RD				Medina-Roldan, Eduardo; Bardgett, Richard D.			Inter-Specific Competition, but Not Different Soil Microbial Communities, Affects N Chemical Forms Uptake by Competing Graminoids of Upland Grasslands	PLOS ONE			English	Article							ORGANIC NITROGEN RELEVANCE; INORGANIC CARBON UPTAKE; EXTRACTION METHOD; PLANT UPTAKE; NICHE COMPLEMENTARITY; NARDUS-STRICTA; AMINO-ACIDS; ECOSYSTEM; DIVERSITY; ISOTOPES	Evidence that plants differ in their ability to take up both organic (ON) and inorganic (IN) forms of nitrogen (N) has increased ecologists' interest on resource-based plant competition. However, whether plant uptake of IN and ON responds to differences in soil microbial community composition and/or functioning has not yet been explored, despite soil microbes playing a key role in N cycling. Here, we report results from a competition experiment testing the hypothesis that soil microbial communities differing in metabolic activity as a result of long-term differences to grazing exposure could modify N uptake of Eriophorum vaginatum L. and Nardus stricta L. These graminoids co-occur on nutrient-poor, mountain grasslands where E. vaginatum decreases and N. stricta increases in response to long-term grazing. We inoculated sterilised soil with soil microbial communities from continuously grazed and ungrazed grasslands and planted soils with both E. vaginatum and N. stricta, and then tracked uptake of isotopically labelled NH4+ (IN) and glycine (ON) into plant tissues. The metabolically different microbial communities had no effect on N uptake by either of the graminoids, which might suggest functional equivalence of soil microbes in their impacts on plant N uptake. Consistent with its dominance in soils with greater concentrations of ON relative to IN in the soluble N pool, Eriophorum vaginatum took up more glycine than N. stricta. Nardus stricta reduced the glycine proportion taken up by E. vaginatum, thus increasing niche overlap in N usage between these species. Local abundances of these species in mountain grasslands are principally controlled by grazing and soil moisture, although our results suggest that changes in the relative availability of ON to IN can also play a role. Our results also suggest that coexistence of these species in mountain grasslands is likely based on non-equilibrium mechanisms such as disturbance and/or soil heterogeneity.	[Medina-Roldan, Eduardo; Bardgett, Richard D.] Univ Lancaster, Soil & Ecosyst Ecol Lab, Lancaster Environm Ctr, Lancaster, England	Lancaster University	Medina-Roldan, E (corresponding author), Xian Jiaotong Liverpool Univ, Dept Environm Sci, Suzhou Ind Pk, Suzhou, Peoples R China.	educamero@googlemail.com			National Council of Science and Technology in Mexico, CONACYT; Natural Environment Research Council [ceh010010] Funding Source: researchfish	National Council of Science and Technology in Mexico, CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the National Council of Science and Technology in Mexico, CONACYT (www.conacyt.gob.mx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUARGHUB SM, 1988, NEW PHYTOL, V108, P433, DOI 10.1111/j.1469-8137.1988.tb04184.x; [Anonymous], 2010, R LANG ENV STAT COMP; Ashton IW, 2008, OECOLOGIA, V156, P625, DOI 10.1007/s00442-008-1006-1; Ashton IW, 2010, ECOLOGY, V91, P3252, DOI 10.1890/09-1849.1; Bardgett RD, 1997, SOIL BIOL BIOCHEM, V29, P1285, DOI 10.1016/S0038-0717(97)00019-9; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; Dunn RM, 2006, PLANT SOIL, V289, P321, DOI 10.1007/s11104-006-9142-z; EDGELL MCR, 1971, J ECOL, V59, P189, DOI 10.2307/2258461; Farrell M, 2011, SOIL BIOL BIOCHEM, V43, P835, DOI 10.1016/j.soilbio.2010.12.022; FISHER TR, 1979, LIMNOL OCEANOGR, V24, P593, DOI 10.4319/lo.1979.24.3.0593; Frank DA, 2003, OECOLOGIA, V137, P603, DOI 10.1007/s00442-003-1385-2; GRANT SA, 1985, J APPL ECOL, V22, P739, DOI 10.2307/2403226; Griffiths BS, 2001, SOIL BIOL BIOCHEM, V33, P1713, DOI 10.1016/S0038-0717(01)00094-3; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Harrison KA, 2008, SOIL BIOL BIOCHEM, V40, P228, DOI 10.1016/j.soilbio.2007.08.004; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Hartley SE, 1999, J ECOL, V87, P330, DOI 10.1046/j.1365-2745.1999.00353.x; HAVILL DC, 1974, NEW PHYTOL, V73, P1221, DOI 10.1111/j.1469-8137.1974.tb02151.x; Hill PW, 2011, NAT CLIM CHANGE, V1, P50, DOI [10.1038/nclimate1060, 10.1038/NCLIMATE1060]; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Lipson DA, 1999, ECOLOGY, V80, P1623; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Medina-Roldan E, 2012, OECOLOGIA, V170, P159, DOI 10.1007/s00442-012-2287-y; Medina-Roldan E, 2012, AGR ECOSYST ENVIRON, V149, P118, DOI 10.1016/j.agee.2011.12.012; Medina-Roldan E, 2011, PLANT SOIL, V344, P377, DOI 10.1007/s11104-011-0756-4; Miller AE, 2007, ECOLOGY, V88, P1832, DOI 10.1890/06-0946.1; Nasholm T, 2009, SOIL BIOL BIOCHEM, V41, P1588, DOI 10.1016/j.soilbio.2009.05.001; Nasholm T, 2000, ECOLOGY, V81, P1155, DOI 10.1890/0012-9658(2000)081[1155:UOONIT]2.0.CO;2; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Rasmussen J, 2009, SOIL BIOL BIOCHEM, V41, P1586, DOI 10.1016/j.soilbio.2009.03.006; RATCLIFFE DA, 1959, J ECOL, V47, P371, DOI 10.2307/2257373; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Rodwell, 1992, BRIT PLANT COMMUNITI, V3; SALONIUS PO, 1967, PLANT SOIL, V27, P239, DOI 10.1007/BF01373392; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Sorensen LI, 2008, SOIL BIOL BIOCHEM, V40, P2891, DOI 10.1016/j.soilbio.2008.08.009; SPARLING GP, 1990, SOIL BIOL BIOCHEM, V22, P301, DOI 10.1016/0038-0717(90)90104-8; Streeter TC, 2000, RAPID COMMUN MASS SP, V14, P1351, DOI 10.1002/1097-0231(20000815)14:15<1351::AID-RCM23>3.3.CO;2-0; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; WEIN RW, 1973, J ECOL, V61, P601, DOI 10.2307/2259047; WELCH D, 1986, J APPL ECOL, V23, P1047, DOI 10.2307/2403954; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x	51	4	4	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51193	10.1371/journal.pone.0051193	http://dx.doi.org/10.1371/journal.pone.0051193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236451	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100079
J	Spuler, M; Rosenstiel, W; Bogdan, M				Spueler, Martin; Rosenstiel, Wolfgang; Bogdan, Martin			Online Adaptation of a c-VEP Brain-Computer Interface(BCI) Based on Error-Related Potentials and Unsupervised Learning	PLOS ONE			English	Article								The goal of a Brain-Computer Interface (BCI) is to control a computer by pure brain activity. Recently, BCIs based on code-modulated visual evoked potentials (c-VEPs) have shown great potential to establish high-performance communication. In this paper we present a c-VEP BCI that uses online adaptation of the classifier to reduce calibration time and increase performance. We compare two different approaches for online adaptation of the system: an unsupervised method and a method that uses the detection of error-related potentials. Both approaches were tested in an online study, in which an average accuracy of 96% was achieved with adaptation based on error-related potentials. This accuracy corresponds to an average information transfer rate of 144 bit/min, which is the highest bitrate reported so far for a non-invasive BCI. In a free-spelling mode, the subjects were able to write with an average of 21.3 error-free letters per minute, which shows the feasibility of the BCI system in a normal-use scenario. In addition we show that a calibration of the BCI system solely based on the detection of error-related potentials is possible, without knowing the true class labels.	[Spueler, Martin; Rosenstiel, Wolfgang; Bogdan, Martin] Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Tubingen, Germany; [Bogdan, Martin] Univ Leipzig, Leipzig, Germany	Eberhard Karls University of Tubingen; Leipzig University	Spuler, M (corresponding author), Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Tubingen, Germany.	spueler@informatik.uni-tuebingen.de			ERC [227632]; German Federal Ministry of Education and Research (BMBF) [UTu 01 GQ 0831]	ERC(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was partly funded by the ERC (Grant 227632, BCCI) and the German Federal Ministry of Education and Research (BMBF, BFNT F*T, Grant UTu 01 GQ 0831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Blankertz B, 2002, LECT NOTES COMPUT SC, V2415, P1137; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dal Seno B, 2010, IEEE T NEUR SYS REH, V18, P20, DOI 10.1109/TNSRE.2009.2032642; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Ferrez PW, 2008, IEEE T BIO-MED ENG, V55, P923, DOI 10.1109/TBME.2007.908083; Golomb S. W., 1982, SHIFT REGISTER SEQUE; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Llera A, 2011, NEURAL NETWORKS, V24, P1120, DOI 10.1016/j.neunet.2011.05.006; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Spuler M, 2012, CLIN NEUROPHYSIOL, V123, P1328, DOI 10.1016/j.clinph.2011.11.082; Spuler M, 2012, P 20 EUR S ART NEUR, P103, DOI [10.13140/2.1.2186.7526, DOI 10.13140/2.1.2186.7526]; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Sutter EE, 1984, P IEEE S BIOS, P85; Urbina MH, 2007, P 3 C COMM GAZ INT C, P65; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Wilson JA, 2010, IEEE T BIO-MED ENG, V57, P1785, DOI 10.1109/TBME.2010.2047259; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Zhang D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016010	24	119	120	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51077	10.1371/journal.pone.0051077	http://dx.doi.org/10.1371/journal.pone.0051077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236433	Green Submitted, gold, Green Published			2022-12-25	WOS:000312064100062
J	Gifford, JL; Ishida, H; Vogel, HJ				Gifford, Jessica L.; Ishida, Hiroaki; Vogel, Hans J.			Structural Characterization of the Interaction of Human Lactoferrin with Calmodulin	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; NF-KAPPA-B; NEUTROPHIL LACTOFERRIN; PROTEIN-KINASE; BINDING DOMAIN; PROTEOLYTIC FRAGMENTS; NUCLEAR-LOCALIZATION; CROSS-SATURATION; GENE DELIVERY; ACTIVATION	Lactoferrin (Lf) is an 80 kDa, iron (Fe3+)-binding immunoregulatory glycoprotein secreted into most exocrine fluids, found in high concentrations in colostrum and milk, and released from neutrophil secondary granules at sites of infection and inflammation. In a number of cell types, Lf is internalized through receptor-mediated endocytosis and targeted to the nucleus where it has been demonstrated to act as a transcriptional trans-activator. Here we characterize human Lf's interaction with calmodulin (CaM), a ubiquitous, 17 kDa regulatory calcium (Ca2+)-binding protein localized in the cytoplasm and nucleus of activated cells. Due to the size of this intermolecular complex (similar to 100 kDa), TROSY-based NMR techniques were employed to structurally characterize Ca2+-CaM when bound to intact apo-Lf. Both CaM's backbone amides and the epsilon-methyl group of key methionine residues were used as probes in chemical shift perturbation and cross-saturation experiments to define the binding interface of apo-Lf on Ca2+-CaM. Unlike the collapsed conformation through which Ca2+-CaM binds the CaM-binding domains of its classical targets, Ca2+-CaM assumes an extended structure when bound to apo-Lf. Apo-Lf appears to interact predominantly with the C-terminal lobe of Ca2+-CaM, enabling the N-terminal lobe to potentially bind another target. Our use of intact apo-Lf has made possible the identification of a secondary interaction interface, removed from CaM's primary binding domain. Secondary interfaces play a key role in the target's response to CaM binding, highlighting the importance of studying intact complexes. This solution-based approach can be applied to study other regulatory calcium-binding EF-hand proteins in intact intermolecular complexes. Citation: Gifford JL, Ishida H, Vogel HJ (2012) Structural Characterization of the Interaction of Human Lactoferrin with Calmodulin. PLoS ONE 7(12): e51026. doi:10.1371/journal.pone.0051026	[Gifford, Jessica L.; Ishida, Hiroaki; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Canadian Institute of Health Research; National Science and Engineering Research Council; Alberta Ingenuity Fund as well as a Killam Fellowship; Alberta Heritage Foundation for Medical Research Scientist	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Fund as well as a Killam Fellowship; Alberta Heritage Foundation for Medical Research Scientist(Alberta Heritage Foundation for Medical Research)	This work is supported by an operating grant from the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). JLG was the recipient of postgraduate scholarships from the National Science and Engineering Research Council and Alberta Ingenuity Fund as well as a Killam Fellowship. HJV is an Alberta Heritage Foundation for Medical Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Actor JK, 2009, CURR PHARM DESIGN, V15, P1956, DOI 10.2174/138161209788453202; ANDERSSON A, 1983, BIOCHEMISTRY-US, V22, P2309, DOI 10.1021/bi00279a001; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Ashida K, 2004, BIOMETALS, V17, P311, DOI 10.1023/B:BIOM.0000027710.13543.3f; Baker HM, 2012, BIOCHEM CELL BIOL, V90, P320, DOI [10.1139/O11-071, 10.1139/o11-071]; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAYNES RD, 1986, SCAND J HAEMATOL, V36, P79; Bertini I, 2007, J AM CHEM SOC, V129, P12786, DOI 10.1021/ja0726613; Britigan BE, 2001, J IMMUNOL, V167, P2921, DOI 10.4049/jimmunol.167.5.2921; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; DAVIDSON LA, 1987, ACTA PAEDIATR SCAND, V76, P733, DOI 10.1111/j.1651-2227.1987.tb10557.x; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; De la Rosa G, 2008, J IMMUNOL, V180, P6868, DOI 10.4049/jimmunol.180.10.6868; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELILLO A, 1992, FEBS LETT, V298, P195, DOI 10.1016/0014-5793(92)80055-L; Dhennin-Duthille I, 2000, J CELL BIOCHEM, V79, P583, DOI 10.1002/1097-4644(20001215)79:4<583::AID-JCB70>3.0.CO;2-9; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Edwards RA, 1998, BIOCHEM J, V331, P149, DOI 10.1042/bj3310149; Elass E, 2002, INFECT IMMUN, V70, P1860, DOI 10.1128/IAI.70.4.1860-1866.2002; ElassRochard E, 1995, BIOCHEM J, V312, P839, DOI 10.1042/bj3120839; Elfinger M, 2007, BIOMATERIALS, V28, P3448, DOI 10.1016/j.biomaterials.2007.04.011; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; Fischer R, 2006, BIOCHEM CELL BIOL, V84, P303, DOI 10.1139/O06-058; Florian P, 2012, BIOCHEM CELL BIOL, V90, P449, DOI [10.1139/O11-090, 10.1139/o11-090]; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; GARRE C, 1992, J CELL PHYSIOL, V153, P477, DOI 10.1002/jcp.1041530306; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gifford JL, 2012, J BIOL CHEM, V287, P26513, DOI 10.1074/jbc.M112.373373; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; HE JL, 1995, NATURE, V373, P721, DOI 10.1038/373721a0; He SH, 2003, BIOCHEM PHARMACOL, V65, P1007, DOI 10.1016/S0006-2952(02)01651-9; Hellermann GR, 1997, J BIOL CHEM, V272, P12030, DOI 10.1074/jbc.272.18.12030; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Huang RQ, 2008, BIOMATERIALS, V29, P238, DOI 10.1016/j.biomaterials.2007.09.024; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Ishida H, 2009, J BIOL CHEM, V284, P28292, DOI 10.1074/jbc.M109.025080; Jain NU, 2004, J MOL BIOL, V343, P1379, DOI 10.1016/j.jmb.2004.08.103; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim CW, 2012, FEBS LETT, V586, P229, DOI 10.1016/j.febslet.2011.12.011; Koster S, 2011, J BIOL CHEM, V286, P40954, DOI 10.1074/jbc.M111.286906; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, pR23; Legrand D, 1997, BIOCHEM J, V327, P841, DOI 10.1042/bj3270841; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Legrand D, 2006, BIOCHEM CELL BIOL, V84, P282, DOI 10.1139/O06-045; Legrand D, 2010, BIOMETALS, V23, P365, DOI 10.1007/s10534-010-9297-1; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Liao YL, 2012, BIOCHEM CELL BIOL, V90, P476, DOI [10.1139/o11-075, 10.1139/O11-075]; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; Lopez V, 2008, BIOCH J; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Mariller C, 2012, BIOCHEM CELL BIOL, V90, P307, DOI [10.1139/O11-070, 10.1139/o11-070]; Medvedeva MV, 1996, BIOCHEM J, V315, P1021, DOI 10.1042/bj3151021; Nagulapalli M, 2012, STRUCTURE, V20, P522, DOI 10.1016/j.str.2012.01.021; Oh SM, 2007, J IMMUNOL, V179, P5686, DOI 10.4049/jimmunol.179.9.5686; Oh SM, 2004, ONCOGENE, V23, P8282, DOI 10.1038/sj.onc.1208021; Oh SM, 2001, J BIOL CHEM, V276, P42575, DOI 10.1074/jbc.M107724200; Penco S, 2001, BIOTECHNOL APPL BIOC, V34, P151, DOI 10.1042/BA20010038; Puddu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022504; Puddu P, 2009, BIOCHIMIE, V91, P11, DOI 10.1016/j.biochi.2008.05.005; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Sabatucci A, 2007, J MOL BIOL, V371, P1038, DOI 10.1016/j.jmb.2007.05.089; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Senkovich O, 2007, J MOL BIOL, V370, P701, DOI 10.1016/j.jmb.2007.04.075; Shi QY, 2008, BIOPHYS CHEM, V138, P138, DOI 10.1016/j.bpc.2008.09.012; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Shuman CF, 2006, J MOL BIOL, V358, P870, DOI 10.1016/j.jmb.2006.02.017; Siebert PD, 1997, P NATL ACAD SCI USA, V94, P2198, DOI 10.1073/pnas.94.6.2198; Son KN, 2002, BIOCHEM BIOPH RES CO, V290, P236, DOI 10.1006/bbrc.2001.6181; Spadaro M, 2008, FASEB J, V22, P2747, DOI 10.1096/fj.07-098038; SU ZH, 1994, J BIOL CHEM, V269, P16761; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; Suzuki YA, 2008, BIOCHEMISTRY-US, V47, P10915, DOI 10.1021/bi8012164; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; TEUWISSEN B, 1974, EUR J BIOCHEM, V42, P411, DOI 10.1111/j.1432-1033.1974.tb03354.x; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Van Lierop JE, 2002, J BIOL CHEM, V277, P6550, DOI 10.1074/jbc.M111404200; Vogel HJ, 2012, BIOCHEM CELL BIOL, V90, P233, DOI [10.1139/O2012-016, 10.1139/o2012-016]; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; WALSH M, 1977, J BIOL CHEM, V252, P7440; WARD PP, 1992, BIO-TECHNOL, V10, P784, DOI 10.1038/nbt0792-784; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yamniuk AP, 2007, PLANT SIGNAL BEHAV, V2, P354, DOI 10.4161/psb.2.5.4155; Yamniuk AP, 2009, MOL IMMUNOL, V46, P2395, DOI 10.1016/j.molimm.2009.04.024; Yamniuk AP, 2009, BIOPHYS J, V96, P1495, DOI 10.1016/j.bpj.2008.10.060; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; Yuan T, 2001, BIOPOLYMERS, V58, P50, DOI 10.1002/1097-0282(200101)58:1<50::AID-BIP60>3.0.CO;2-S; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546	108	16	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51026	10.1371/journal.pone.0051026	http://dx.doi.org/10.1371/journal.pone.0051026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236421	Green Published, gold, Green Submitted			2022-12-25	WOS:000312589700027
J	Said, RS; Nada, AS; El-Demerdash, E				Said, Riham S.; Nada, Ahmed S.; El-Demerdash, Ebtehal			Sodium Selenite Improves Folliculogenesis in Radiation-Induced Ovarian Failure: A Mechanistic Approach	PLOS ONE			English	Article							GRANULOSA-CELLS; IN-VITRO; GLUTATHIONE-PEROXIDASE; FERTILITY PRESERVATION; ANTIOXIDANT DEFENSE; INDUCED APOPTOSIS; FOLLICULAR-FLUID; RATS; TISSUES; DAMAGE	Radiotherapy is a major factor contributing to female infertility by inducing premature ovarian failure (POF). Therefore, the need for an effective radioprotective agent is evident. The present study investigated the mechanism of potential radioprotective effect of sodium selenite on radiation-induced ovarian failure and whether sodium selenite can stimulate invivo follicular development in experimental rats. Immature female Sprague-Dawely rats were either exposed to gammaradiation (3.2 Gy, LD20), once and/or treated with sodium selenite (0.5 mg/kg), once daily for one week before irradiation. Follicular and oocyte development, apoptotic markers, proliferation marker as well as oxidative stress markers were assessed 24-h after irradiation. In addition, fertility assessment was performed after female rats became completely mature at two months of age. Sodium selenite significantly enhanced follicular development as compared to the irradiated group. Sodium selenite significantly reversed the oxidative stress effects of radiation that was evidenced by increasing in lipid peroxide level and decreasing in glutathione level, and glutathione peroxidase (GPx) activity. Assessment of apoptosis and cell proliferation markers revealed that caspase 3 and cytochrome c expressions markedly-increased, whereas, PCNA expression markedly-decreased in the irradiated group; in contrast, sodium selenite treatment prevented these alterations. Histopathological examination further confirmed the radioprotective efficacy of sodium selenite and its in-vivo effect on ovarian follicles' maturation. In conclusion, sodium selenite showed a radioprotective effect and improved folliculogenesis through increasing ovarian granulosa cells proliferation, estradiol and FSH secretion, and GPx activity, whilst decreasing lipid peroxidation and oxidative stress, leading to inhibition of the apoptosis pathway through decreasing the expressions of caspase 3 and cytochrome c. Citation: Said RS, Nada AS, El-Demerdash E (2012) Sodium Selenite Improves Folliculogenesis in Radiation-Induced Ovarian Failure: A Mechanistic Approach. PLoS ONE 7(12): e50928. doi:10.1371/journal.pone.0050928	[El-Demerdash, Ebtehal] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Said, Riham S.; Nada, Ahmed S.] Atom Energy Author, Natl Ctr Radiat Res & Technol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA); National Center for Radiation Research & Technology	El-Demerdash, E (corresponding author), Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	ebtehal_dm@yahoo.com	El-Demerdash, Ebtehal/ABE-6729-2020; Said, Riham/AAR-1943-2021					Abedelahi A, 2008, J ASSIST REPROD GEN, V25, P483, DOI 10.1007/s10815-008-9252-z; Abedelahi A, 2010, HUM REPROD, V25, P977, DOI 10.1093/humrep/deq002; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Amsterdam A, 1997, ENDOCR REV, V18, P435, DOI 10.1210/er.18.4.435; Andersen CY, 2012, FUTURE ONCOL, V8, P595, DOI [10.2217/fon.12.47, 10.2217/FON.12.47]; ATAYA KM, 1985, CANCER RES, V45, P3651; Barrington JW, 1996, BRIT J OBSTET GYNAEC, V103, P130, DOI 10.1111/j.1471-0528.1996.tb09663.x; Basini G, 2000, DOMEST ANIM ENDOCRIN, V18, P1, DOI 10.1016/S0739-7240(99)00059-4; Bath LE, 1999, BRIT J OBSTET GYNAEC, V106, P1265, DOI 10.1111/j.1471-0528.1999.tb08180.x; Bedaiwy MA, 2004, FERTIL STERIL, V82, P593, DOI 10.1016/j.fertnstert.2004.02.121; Beltran-Garcia MJ, 2000, CONTRACEPTION, V61, P99, DOI 10.1016/S0010-7824(00)00085-8; Borek C, 2004, J NUTR, V134, p3207S, DOI 10.1093/jn/134.11.3207S; BRAW RH, 1980, J REPROD FERTIL, V59, P267, DOI 10.1530/jrf.0.0590267; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Cadet J, 2004, J ENVIRON PATHOL TOX, V23, P33, DOI 10.1615/JEnvPathToxOncol.v23.i1.30; Cassano E, 1999, CELL PHYSIOL BIOCHEM, V9, P106, DOI 10.1159/000016307; CEKAN E, 1985, ACTA RADIOL ONCOL, V24, P267, DOI 10.3109/02841868509134399; Chattopadhyay S, 2003, TOXICOL SCI, V75, P412, DOI 10.1093/toxsci/kfg194; CLEMENS JA, 1977, ACTA ENDOCRINOL-COP, V85, P18; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; COULAM CB, 1982, FERTIL STERIL, V38, P645; DAMEWOOD MD, 1986, FERTIL STERIL, V45, P443; DJUJIC IS, 1992, BIOL TRACE ELEM RES, V33, P197, DOI 10.1007/BF02784023; Pontual MLD, 2007, J APPL ORAL SCI, V15, P162, DOI 10.1590/S1678-77572007000300003; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; England K, 2005, REDOX REP, V10, P237, DOI 10.1179/135100005X70224; Esterbauer H, 1996, PATHOL BIOL, V44, P25; Feinendegen LE, 2002, HUM EXP TOXICOL, V21, P85, DOI 10.1191/0960327102ht216oa; Fraunholz I, 2008, STRAHLENTHER ONKOL, V184, P411, DOI 10.1007/s00066-008-1867-6; Gopee NV, 2004, TOXICOL SCI, V78, P204, DOI 10.1093/toxsci/kfh072; Imam SZ, 2000, BRAIN RES, V855, P186, DOI 10.1016/S0006-8993(99)02249-0; Jancar N, 2007, J ASSIST REPROD GEN, V24, P91, DOI 10.1007/s10815-006-9103-8; Kamat JP, 2000, J ETHNOPHARMACOL, V71, P425, DOI 10.1016/S0378-8741(00)00176-8; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Lee Young-Keun, 1998, Arhiv za Higijenu Rada i Toksikologiju, V49, P147; MANDL AM, 1959, PROC R SOC SER B-BIO, V150, P53, DOI 10.1098/rspb.1959.0007; Markstrom E, 2002, REPRODUCTION, V123, P23, DOI 10.1530/rep.0.1230023; Mutlu-Turkoglu U, 2000, LIFE SCI, V66, P1905, DOI 10.1016/S0024-3205(00)00516-6; Navarro J, 1997, FREE RADICAL BIO MED, V22, P1203, DOI 10.1016/S0891-5849(96)00554-0; Naziroglu M, 2004, TOXICOLOGY, V195, P221, DOI 10.1016/j.tox.2003.10.012; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Ognjanovic BI, 2008, PHYSIOL RES, V57, P403, DOI 10.33549/physiolres.931197; OKTAY K, 1995, BIOL REPROD, V53, P295, DOI 10.1095/biolreprod53.2.295; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PASZKOWSKI T, 1995, CLIN CHIM ACTA, V236, P173, DOI 10.1016/0009-8981(95)98130-9; Patil S R, 1998, Indian J Physiol Pharmacol, V42, P503; RABINOVICI J, 1990, ENDOCR REV, V11, P532, DOI 10.1210/edrv-11-4-532; Schueller P, 2004, ANTICANCER RES, V24, P2913; Shinomiya N, 2001, J CELL MOL MED, V5, P240, DOI 10.1111/j.1582-4934.2001.tb00158.x; Skillern A, 2008, SEX DEV, V2, P228, DOI 10.1159/000152039; Sonmezer M, 2008, CURR OPIN ENDOCRINOL, V15, P514, DOI 10.1097/MED.0b013e32831a46fc; Tian JQ, 2010, INT J RADIAT ONCOL, V78, P230, DOI 10.1016/j.ijrobp.2010.03.006; Tsunoda M, 2000, ARCH ENVIRON CON TOX, V39, P32, DOI 10.1007/s002440010076; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; VIJAYAN E, 1978, NEUROENDOCRINOLOGY, V25, P150, DOI 10.1159/000122737; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WEISS JF, 1992, ADV SPACE RES-SERIES, V12, P223, DOI 10.1016/0273-1177(92)90112-B; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yacobi K, 2004, ENDOCRINOLOGY, V145, P1943, DOI 10.1210/en.2003-1395; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Zeng HW, 2002, J NUTR, V132, P674, DOI 10.1093/jn/132.4.674; Zhang JY, 2006, BIOTECHNOL BIOENG, V95, P1188, DOI 10.1002/bit.21081	64	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50928	10.1371/journal.pone.0050928	http://dx.doi.org/10.1371/journal.pone.0050928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236409	Green Submitted, Green Published, gold			2022-12-25	WOS:000312589700022
J	Harms, R; Morsey, B; Boyer, CW; Fox, HS; Sarvetnick, N				Harms, Robert; Morsey, Brenda; Boyer, Craig W.; Fox, Howard S.; Sarvetnick, Nora			Methamphetamine Administration Targets Multiple Immune Subsets and Induces Phenotypic Alterations Suggestive of Immunosuppression	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MOUSE NK CELLS; T-CELLS; VIRUS-INFECTION; ACTIVATION; MONOCYTES; RISK; AMPHETAMINE; MOLECULE; HIV	Methamphetamine (Meth) is a widely abused stimulant and its users are at increased risk for multiple infectious diseases. To determine the impact of meth on the immune system, we utilized a murine model that simulates the process of meth consumption in a typical addict. Our phenotypic analysis of leukocytes from this dose escalation model revealed that meth affected key immune subsets. Meth administration led to a decrease in abundance of natural killer (NK) cells and the remaining NK cells possessed a phenotype suggesting reduced responsiveness. Dendritic cells (DCs) and Gr-1(high) monocytes/macrophages were also decreased in abundance while Gr-1(low) monocytes/macrophages appear to show signs of perturbation. CD4 and CD8 T cell subsets were affected by methamphetamine, both showing a reduction in antigen-experienced subsets. CD4 T cells also exhibited signs of activation, with increased expression of CD150 on CD226-expressing cells and an expansion of KLRG1(+), FoxP3(-) cells. These results exhibit that meth has the ability to disrupt immune homeostasis and impact key subsets of leukocytes which may leave users more vulnerable to pathogens.	[Harms, Robert; Boyer, Craig W.; Sarvetnick, Nora] Univ Nebraska Med Ctr, Dept Surgery Transplant, Omaha, NE USA; [Morsey, Brenda; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Sarvetnick, Nora] Univ Nebraska Med Ctr, Regenerat Med Project, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Harms, R (corresponding author), Univ Nebraska Med Ctr, Dept Surgery Transplant, Omaha, NE USA.	rharms@unmc.edu		Fox, Howard/0000-0003-2032-374X	NIH from the National Institute on Drug Abuse [RO1:345160-2058101]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032513] Funding Source: NIH RePORTER	NIH from the National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by NIH RO1:345160-2058101 from the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Bonell CP, 2010, INT J DRUG POLICY, V21, P244, DOI 10.1016/j.drugpo.2009.07.002; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brouwer KC, 2006, SUBST USE MISUSE, V41, P707, DOI 10.1080/10826080500411478; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cohen AL, 2007, EMERG INFECT DIS, V13, P1707, DOI 10.3201/eid1311.070148; Corsi Karen F, 2008, Curr Drug Abuse Rev, V1, P292; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P217, DOI 10.1080/09595230801956538; Denoeud J, 2011, J LEUKOCYTE BIOL, V89, P195, DOI 10.1189/jlb.0610351; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Forrest DW, 2010, J URBAN HEALTH, V87, P480, DOI 10.1007/s11524-009-9422-z; Freeman P, 2011, ARCH PEDIAT ADOL MED, V165, P736, DOI 10.1001/archpediatrics.2011.118; GAGNON L, 1992, TOXICOL LETT, V63, P313, DOI 10.1016/0378-4274(92)90093-Y; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzales R, 2006, J SUBST ABUSE TREAT, V31, P195, DOI 10.1016/j.jsat.2006.04.006; Gonzales R, 2010, ANNU REV PUBL HEALTH, V31, P385, DOI 10.1146/annurev.publhealth.012809.103600; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Henning G, 2001, EUR J IMMUNOL, V31, P2741, DOI 10.1002/1521-4141(200109)31:9<2741::AID-IMMU2741>3.0.CO;2-6; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HOUSE RV, 1994, IMMUNOPHARM IMMUNOT, V16, P1, DOI 10.3109/08923979409029897; Howie D, 2002, BLOOD, V100, P2899, DOI 10.1182/blood-2002-02-0445; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Hutin YJF, 2000, AM J EPIDEMIOL, V152, P186, DOI 10.1093/aje/152.2.186; In SW, 2005, J TOXICOL ENV HEAL A, V68, P2133, DOI 10.1080/15287390500177156; In SW, 2004, J TOXICOL ENV HEAL A, V67, P1923, DOI 10.1080/15287390490514589; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Iwasa M, 1996, INT J LEGAL MED, V109, P23, DOI 10.1007/BF01369597; Kirkos WC, 2008, CAN MED ASSOC J, V178, P1655, DOI 10.1503/cmaj.071299; KOJIMA T, 1986, FORENSIC SCI INT, V31, P93, DOI 10.1016/0379-0738(86)90193-3; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Marcenaro E, 2011, IMMUNOTHERAPY-UK, V3, P1075, DOI [10.2217/IMT.11.99, 10.2217/imt.11.99]; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Marshall BDL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-20; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; Mau MK, 2009, VASC HEALTH RISK MAN, V5, P45; Mcketin R, 2008, DRUG ALCOHOL REV, V27, P220, DOI 10.1080/09595230801923710; NAGATA T, 1990, FORENSIC SCI INT, V48, P39, DOI 10.1016/0379-0738(90)90270-9; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nicosia N, 2009, THE ECONOMIC COST OF; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Peltzer K, 2010, SUBST USE MISUSE, V45, P2221, DOI 10.3109/10826084.2010.481594; Peng YF, 2009, J IMMUNOL, V182, P2777, DOI 10.4049/jimmunol.0803172; Potula R, 2010, J IMMUNOL, V185, P2867, DOI 10.4049/jimmunol.0903691; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Saito M, 2005, EXPERIMENTAL ANIMALS, V55, P477; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sato Y, 2000, Nihon Hoigaku Zasshi, V54, P420; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sheridan J, 2009, J PSYCHOACTIVE DRUGS, V41, P11, DOI 10.1080/02791072.2009.10400670; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Tsujimura K, 2006, IMMUNOL LETT, V106, P48, DOI 10.1016/j.imlet.2006.04.006; Vogt TM, 2006, ADDICTION, V101, P726, DOI 10.1111/j.1360-0443.2006.01407.x; Volkow ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015269; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wey SP, 2008, TOXICOL LETT, V181, P157, DOI 10.1016/j.toxlet.2008.07.015; Wiede F, 2009, J LEUKOCYTE BIOL, V85, P108, DOI 10.1189/jlb.0107018; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Ye L, 2008, J VIRAL HEPATITIS, V15, P261, DOI 10.1111/j.1365-2893.2007.00940.x; Yu QL, 2002, INT IMMUNOPHARMACOL, V2, P951, DOI 10.1016/S1567-5769(02)00047-4	77	45	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49897	10.1371/journal.pone.0049897	http://dx.doi.org/10.1371/journal.pone.0049897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227154	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200016
J	Spellicy, CJ; Northrup, H; Fletcher, JM; Cirino, PT; Dennis, M; Morrison, AC; Martinez, CA; Au, KS				Spellicy, Catherine J.; Northrup, Hope; Fletcher, Jack M.; Cirino, Paul T.; Dennis, Maureen; Morrison, Alanna C.; Martinez, Carla A.; Au, Kit Sing			Folate Metabolism Gene 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Is Associated with ADHD in Myelomeningocele Patients	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; NEURAL-TUBE DEFECTS; SPINA-BIFIDA; FOLIC-ACID; CHILDHOOD LEUKEMIA; ATTENTION; CHILDREN; POLYMORPHISMS; VITAMIN-B-12; PREVALENCE	The objective of this study was to examine the relation between the 5, 10-methylenetetrahydrofolate reductase (MTHFR) gene and behaviors related to attention-deficit/hyperactivity disorder (ADHD) in individuals with myelomeningocele. The rationale for the study was twofold: folate metabolizing genes, (e.g. MTHFR), are important not only in the etiology of neural tube defects but are also critical to cognitive function; and individuals with myelomeningocele have an elevated incidence of ADHD. Here, we tested 478 individuals with myelomeningocele for attention-deficit hyperactivity disorder behavior using the Swanson Nolan Achenbach Pelham-IV ADHD rating scale. Myelomeningocele participants in this group for whom DNAs were available were genotyped for seven single nucleotide polymorphisms (SNPs) in the MTHFR gene. The SNPs were evaluated for an association with manifestation of the ADHD phenotype in children with myelomeningocele. The data show that 28.7% of myelomeningocele participants exhibit rating scale elevations consistent with ADHD; of these 70.1% had scores consistent with the predominantly inattentive subtype. In addition, we also show a positive association between the SNP rs4846049 in the 39-untranslated region of the MTHFR gene and the attention-deficit hyperactivity disorder phenotype in myelomeningocele participants. These results lend further support to the finding that behavior related to ADHD is more prevalent in patients with myelomeningocele than in the general population. These data also indicate the potential importance of the MTHFR gene in the etiology of the ADHD phenotype.	[Spellicy, Catherine J.; Northrup, Hope; Au, Kit Sing] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Univ Texas Med Sch Houston, Houston, TX USA; [Northrup, Hope] Shriners Hosp Children, Houston, TX USA; [Fletcher, Jack M.; Cirino, Paul T.] Univ Houston, Dept Psychol, Houston, TX USA; [Cirino, Paul T.] Univ Houston, TIMES, Houston, TX USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX USA; [Martinez, Carla A.] Texas Tech Univ Hlth Sci Ctr, Dept Obstet & Gynecol, El Paso, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Texas Tech University System; Texas Tech University Health Science Center	Au, KS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Univ Texas Med Sch Houston, Houston, TX USA.	Kit-Sing.Au@uth.tmc.edu	fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020	Cirino, Paul T./0000-0002-9587-0388; Morrison, Alanna/0000-0001-6381-4296; Au, Kit Sing/0000-0002-2694-5833	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P01-HD35946]; Shriners Hospital for Children [8580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035946] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Shriners Hospital for Children; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Grant sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) P01-HD35946 (HN, JMF, PTC, DM, ACM, KSA); Shriners Hospital for Children #8580 (KSA, HN). The content is solely the responsibility of the authors and does not necessarily represent the official views of Shriners Hospital for Children, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agiopian A, 2011, AM J MED GENET A, V9999, P1; Ammerman RT, 1998, J CLIN PSYCHOL MED S, V5, P449, DOI 10.1023/A:1026211028595; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Bussing R, 2008, ASSESSMENT, V15, P317, DOI 10.1177/1073191107313888; Canfield MA, 2009, PAEDIATR PERINAT EP, V23, P41, DOI 10.1111/j.1365-3016.2008.00975.x; CDC, 2010, VIT HLTH STAT 10; Chen BH, 2008, BIRTH DEFECTS RES A, V82, P547, DOI 10.1002/bdra.20466; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; Davidson CM, 2008, REPROD SCI, V15, P51, DOI 10.1177/1933719107309590; de Lau LML, 2009, J NEUROL NEUROSUR PS, V80, P149, DOI 10.1136/jnnp.2008.149286; de Lau LML, 2007, AM J CLIN NUTR, V86, P728, DOI 10.1093/ajcn/86.3.728; Dennis M, 2006, J INT NEUROPSYCH SOC, V12, P285, DOI 10.1017/S1355617706060371; Dennis M, 2005, NEUROPSYCHOLOGIA, V43, P976, DOI 10.1016/j.neuropsychologia.2004.08.012; Dennis M, 2008, J INT NEUROPSYCH SOC, V14, P673, DOI 10.1017/S1355617708080983; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Ergul E, 2012, GENET TEST MOL BIOMA, V16, P67, DOI 10.1089/gtmb.2011.0062; GIRALT J, 1992, INT J RADIAT ONCOL, V24, P49, DOI 10.1016/0360-3016(92)91020-N; Gokcen C, 2011, INT J MED SCI, V8, P523, DOI 10.7150/ijms.8.523; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Harris MJ, 2009, BIRTH DEFECTS RES A, V85, P331, DOI 10.1002/bdra.20552; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Koturbash I, 2013, MOL CARCINOGEN, V52, P318, DOI 10.1002/mc.21861; Krull KR, 2008, J PEDIATR-US, V152, P101, DOI 10.1016/j.jpeds.2007.05.047; Kuznetsova AY, 2008, J COMPUT NEUROSCI, V24, P314, DOI 10.1007/s10827-007-0057-3; Lakhan SE, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-2; MALOUF R, 2008, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD004514; MARIA BL, 1993, CAN J NEUROL SCI, V20, P199; Martinez D, 2009, AM J OBSTET GYNECOL, V201, pel; Moretti P, 2008, J AUTISM DEV DISORD, V38, P1170, DOI 10.1007/s10803-007-0492-z; MORGAN DJR, 1995, POSTGRAD MED J, V71, P17, DOI 10.1136/pgmj.71.831.17; Morris MS, 2001, AM J CLIN NUTR, V73, P927; NINDS NIH, 2007, SPIN BIF FACT SHEET; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sen A, 2009, INDIAN PEDIATR, V46, P849; Swartwout MAD, 2008, NEUROPSYCHOLOGY, V22, P765, DOI 10.1037/a0013373; Tangney CC, 2009, NEUROLOGY, V72, P361, DOI 10.1212/01.wnl.0000341272.48617.b0; Trembath D, 1999, TERATOLOGY, V59, P331, DOI 10.1002/(SICI)1096-9926(199905)59:5<331::AID-TERA4>3.0.CO;2-L; van der Linden IJM, 2006, P NUTR SOC, V65, P204, DOI 10.1079/PNS2006495; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; WALD N, 1991, LANCET, V338, P131; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wu C, 2012, NUTR METAB CARDIOVAS, V28; Zhao R, 2001, J NEUROCHEM, V78, P788, DOI 10.1046/j.1471-4159.2001.00471.x	46	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51330	10.1371/journal.pone.0051330	http://dx.doi.org/10.1371/journal.pone.0051330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227261	gold, Green Published			2022-12-25	WOS:000312588200120
J	Zhong, SF; Monakhov, M; Mok, HP; Tong, T; Lai, PS; Chew, SH; Ebstein, RP				Zhong, Songfa; Monakhov, Mikhail; Mok, Helen P.; Tong, Terry; Lai, Poh San; Chew, Soo Hong; Ebstein, Richard P.			U-Shaped Relation between Plasma Oxytocin Levels and Behavior in the Trust Game	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; VASOPRESSIN; HUMANS; RISK; RECIPROCITY; DISORDER; AVERSION; HORMESIS; RELEASE; BINDING	Trust underpins much of social and economic exchanges across human societies. In experimental economics, the Trust Game has served as the workhorse for the study of trust in a controlled incentivized setting. Recent evidence using intranasal drug administration, aka 'sniffing', suggests that oxytocin (OT) can function as a social hormone facilitating trust and other affiliative behaviors. Here we hypothesized that baseline plasma OT is a biomarker that partially predicts the degree of trust and trustworthiness observed in the trust game. Using a large sample of 1,158 participants, we observed a significant U-shaped relationship between plasma OT with the level of trust, and marginally with the level of trustworthiness, especially among males. Specifically, subjects with more extreme levels of plasma OT were more likely to be trusting as well as trustworthy than those with moderate levels of plasma OT. Our results contribute to a deeper understanding of the biological basis of human trust and underscore the usefulness of peripheral plasma OT measures in characterizing human social behavior.	[Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Zhong, Songfa; Monakhov, Mikhail; Chew, Soo Hong] Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore; [Mok, Helen P.; Tong, Terry] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117595, Singapore; [Lai, Poh San] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Chew, Soo Hong] Natl Univ Singapore, Dept Finance, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Ebstein, RP (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.	rpebstein@gmail.com	Zhong, Songfa Z/I-4718-2016; Mikhail, Monakhov/J-5899-2016	Mikhail, Monakhov/0000-0003-0285-2293; Chew, Soo Hong/0000-0003-1245-0909; Ebstein, Richard/0000-0002-3626-541X	Ministry of Education at Singapore; AXA research foundation; Templeton foundation	Ministry of Education at Singapore(Ministry of Education, Singapore); AXA research foundation(AXA Research Fund); Templeton foundation	This study has been financial supports from Ministry of Education at Singapore (http://www.moe.gov.sg/; Tier 2: Biological Economics and Decision Making), AXA research foundation (http://www.axa-research.org/; Biology of Decision Making under Risk) and the Templeton foundation (http://www.templeton.org/; Genes, God and Generosity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JA, 2008, EXPT EC, P1; Aimone JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017725; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; [Anonymous], OXYTOCIN ELISA KIT I; Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Backstrom T, 2011, NEUROSCIENCE, V191, P46, DOI 10.1016/j.neuroscience.2011.03.061; Bales KL, 2004, DEV PSYCHOBIOL, V44, P123, DOI 10.1002/dev.10165; Bartz J, 2010, SOC COGN AFFECT NEUR; Bartz JA, 2011, TRENDS COGNITIVE SCI; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bick J, 2010, DEV PSYCHOBIOL, V52, P100, DOI 10.1002/dev.20411; Biederman J, 2004, INT J NEUROPSYCHOPH, V7, P77, DOI 10.1017/S1461145703003973; Boccia MM, 1998, NEUROBIOL LEARN MEM, V69, P136, DOI 10.1006/nlme.1997.3817; Bohnet I, 2008, AM ECON REV, V98, P294, DOI 10.1257/aer.98.1.294; BURBACH JPH, 1983, EUR J PHARMACOL, V94, P125, DOI 10.1016/0014-2999(83)90449-1; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P453, DOI 10.1080/10408440802004007; Camerer C, 2003, BEHAV GAME THEORY EX, Vxv; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Carter CS, 2006, BEHAV BRAIN RES; Coleman James S., 1988, AM J SOCIOL, V94, P95, DOI DOI 10.1086/228943; Conlisk J, 2011, J EC BEHAV ORG; Cox JC, 2004, GAME ECON BEHAV, V46, P260, DOI 10.1016/S0899-8256(03)00119-2; Croson R, 1999, AM ECON REV, V89, P386, DOI 10.1257/aer.89.2.386; Danalache BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013643; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; De Dreu CKW, 2011, PSYCHONEUROENDOCRINO; Domes G, 2006, BIOL PSYCHIAT; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Gambetta D, 1988, TRUST MAKING BREAKIN, P217; Gneezy U, 1997, Q J ECON, V112, P631, DOI 10.1162/003355397555217; Gordon I, 2010, BIOL PSYCHIAT, V68, P377, DOI 10.1016/j.biopsych.2010.02.005; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Guastella AJ, 2009, BIOL PSYCHIAT; Holt-Lunstad J, 2011, PSYCHONEUROENDOCRINO; Houser D, 2010, J ECON BEHAV ORGAN, V74, P72, DOI 10.1016/j.jebo.2010.01.002; Kastin AJ, 2008, CRIT REV TOXICOL, V38, P629, DOI 10.1080/10408440802026372; Kelemenova S, 2010, PSYCHIAT GENET, V20, P137, DOI 10.1097/YPG.0b013e32833a1eb3; Keri S, 2011, PHYSIOL BEHAV, V102, P221, DOI 10.1016/j.physbeh.2010.11.011; Kok BE, 2010, BIOL PSYCHOL, V85, P432, DOI 10.1016/j.biopsycho.2010.09.005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee AG, 2011, BIOL LETTERS, V7, P584, DOI 10.1098/rsbl.2011.0107; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Luhmann N., 1979, TRUST POWER; Michopoulos V, 2011, HORM BEHAV, V59, P528, DOI 10.1016/j.yhbeh.2011.02.002; Misztal BA, 1996, TRUST MODERN SOC SEA; Momose K, 1998, PEPTIDES, V19, P1739, DOI 10.1016/S0196-9781(98)00131-4; Opacka-Juffry J, 2011, STRESS; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Razzoli M, 2003, HORM BEHAV, V43, P549, DOI 10.1016/S0018-506X(03)00064-3; Smeltzer MD, 2006, NEUROSCI LETT, V394, P146, DOI 10.1016/j.neulet.2005.10.019; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Szeto A, 2011, PSYCHOSOMATIC MED; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Uhl-Bronner S, 2005, NEUROSCIENCE, V135, P147, DOI 10.1016/j.neuroscience.2005.05.025; Van Ijzendoorn MH, 2011, PSYCHONEUROENDOCRINO; Wayner MJ, 2001, PEPTIDES, V22, P1403, DOI 10.1016/S0196-9781(01)00475-2; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zak PJ, 2001, ECON J, V111, P295, DOI 10.1111/1468-0297.00609	63	53	54	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51095	10.1371/journal.pone.0051095	http://dx.doi.org/10.1371/journal.pone.0051095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227239	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200099
J	Mann, CD; Bastianpillai, C; Neal, CP; Masood, MM; Jones, DJL; Teichert, F; Singh, R; Karpova, E; Berry, DP; Manson, MM				Mann, Christopher D.; Bastianpillai, Christopher; Neal, Christopher P.; Masood, Muhammad M.; Jones, Donald J. L.; Teichert, Friederike; Singh, Rajinder; Karpova, Elena; Berry, David P.; Manson, Margaret M.			Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; HUMAN LUNG CANCERS; SIGNALING PATHWAY; OVARIAN-CANCER; JAGGED1 EXPRESSION; DOWN-REGULATION; APOPTOSIS; TRANSFORMATION	In order to achieve a better outcome for pancreatic cancer patients, reliable biomarkers are required which allow for improved diagnosis. These may emanate from a more detailed molecular understanding of the aggressive nature of this disease. Having previously reported that Notch3 activation appeared to be associated with more aggressive disease, we have now examined components of this pathway (Notch1, Notch3, Notch4, HES-1, HEY-1) in more detail in resectable (n = 42) and non-resectable (n = 50) tumours compared to uninvolved pancreas. All three Notch family members were significantly elevated in tumour tissue, compared to uninvolved pancreas, with expression maintained within matched lymph node metastases. Furthermore, significantly higher nuclear expression of Notch1, -3 and -4, HES-1, and HEY-1 (all p <= 0.001) was noted in locally advanced and metastatic tumours compared to resectable cancers. In survival analyses, nuclear Notch3 and HEY-1 expression were significantly associated with reduced overall and disease-free survival following tumour resection with curative intent, with nuclear HEY-1 maintaining independent prognostic significance for both outcomes on multivariate analysis. These data further support a central role for Notch signalling in pancreatic cancer and suggest that nuclear expression of Notch3 and its target gene, HEY-1, merit validation in biomarker panels for diagnosis, prognosis and treatment efficacy. A peptide fragment of Notch3 was detected in plasma from patients with inoperable pancreatic cancer, but due to wide inter-individual variation, mean levels were not significantly different compared to age-matched controls.	[Mann, Christopher D.; Bastianpillai, Christopher; Neal, Christopher P.; Masood, Muhammad M.; Jones, Donald J. L.; Teichert, Friederike; Singh, Rajinder; Karpova, Elena; Berry, David P.; Manson, Margaret M.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England	University of Leicester	Manson, MM (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England.	mmm2@le.ac.uk	Singh, Raj/A-5398-2011; Jones, Donald/Y-6803-2019; Singh, Raj/HDN-1244-2022	Jones, Donald/0000-0001-6583-870X; 	Royal College of Surgeons, England; Pathological Society; CR-UK/DoH Leicester Experimental Cancer Medicine Centre; Hope Against Cancer; Cancer Prevention Research Trust	Royal College of Surgeons, England; Pathological Society; CR-UK/DoH Leicester Experimental Cancer Medicine Centre; Hope Against Cancer; Cancer Prevention Research Trust	This study was funded by a Royal College of Surgeons, England, fellowship to CDM, the Pathological Society (sponsored student CB), CR-UK/DoH Leicester Experimental Cancer Medicine Centre (FT, EK, M. Manson), Hope Against Cancer (M. Manson) and the Cancer Prevention Research Trust (M. Manson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Beatus P, 1999, DEVELOPMENT, V126, P3925; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Doucas H, 2008, J SURG ONCOL, V97, P63, DOI 10.1002/jso.20894; Garcea G, 2005, EUR J CANCER, V41, P2213, DOI 10.1016/j.ejca.2005.04.044; Gungor C, 2011, CANCER RES, V71, P5009, DOI 10.1158/0008-5472.CAN-11-0036; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Jubb AM, 2010, AM J PATHOL, V176, P2019, DOI 10.2353/ajpath.2010.090908; Jung SG, 2010, CANCER SCI, V101, P1977, DOI 10.1111/j.1349-7006.2010.01641.x; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kim JW, 2005, P NATL ACAD SCI USA, V102, P14308, DOI 10.1073/pnas.0501600102; Konishi J, 2010, ONCOGENE, V29, P589, DOI 10.1038/onc.2009.366; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Lin JT, 2010, ANN SURG ONCOL, V17, P2976, DOI 10.1245/s10434-010-1118-9; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Shi TP, 2008, J UROLOGY, V180, P361, DOI 10.1016/j.juro.2008.02.037; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Wu KR, 2011, JPN J CLIN ONCOL, V41, P411, DOI 10.1093/jjco/hyq205; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579	42	51	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51119	10.1371/journal.pone.0051119	http://dx.doi.org/10.1371/journal.pone.0051119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226563	Green Published, Green Submitted, gold			2022-12-25	WOS:000312108500046
J	Viel, JF; Studer, JM; Ottignon, Y; Hirsch, JP				Viel, Jean-Francois; Studer, Jean-Marie; Ottignon, Yves; Hirsch, Jean-Pierre		Franche-Comte Polyp Surveillance S	Predictors of Colorectal Polyp Recurrence after the First Polypectomy in Private Practice Settings: A Cohort Study	PLOS ONE			English	Article							SURVEILLANCE COLONOSCOPY; SCREENING COLONOSCOPY; COMMUNITY PRACTICE; NATIONAL-SURVEY; GUIDELINES; ADENOMAS; CANCER; RISK; PHYSICIANS; NEOPLASMS	Background: Supplementary observational data in the community setting are required to better assess the predictors of colorectal polyp recurrence and the effectiveness of colonoscopy surveillance under real circumstances. Aim: The goal of this study was to identify patient characteristics and polyp features at baseline colonoscopy that are associated with the recurrence of colorectal polyps (including hyperplastic polyps) among patients consulting private practice physicians. Patients and Methods: This cohort study was conducted from March 2004 to December 2010 in 26 private gastroenterology practices (France). It included 1023 patients with a first-time diagnosis of histologically confirmed polyp removed during a diagnostic or screening colonoscopy. At enrollment, interviews were conducted to obtain data on socio-demographic variables and risk factors. Pathology reports were reviewed to abstract data on polyp features at baseline colonoscopy. Colorectal polyps diagnosed at the surveillance colonoscopy were considered as end points. The time to event was analyzed with an accelerated failure time model assuming a Weibull distribution. Results: Among the 1023 patients with colorectal polyp at baseline, 553 underwent a surveillance colonoscopy. The mean time interval from baseline colonoscopy to first surveillance examination was 3.42 (standard deviation, 1.45) years. The recurrence rates were 50.5% and 32.9% for all polyps and adenomas, respectively. In multivariate models, the number of polyps at baseline was the only significant predictor for both polyp recurrence (hazard ratio [HR] 1.19, 95% CI 1.06 to 1.33), and adenoma recurrence (HR 1.17, 95% CI 1.03 to 1.34). Conclusion: The efficacy of surveillance colonoscopy in community gastroenterology practice compared favorably with academic settings. This study provides further evidence that the number of initial colorectal polyps is useful for predicting the risk of polyp recurrence, even in the community setting. Citation: Viel J-F, Studer J-M, Ottignon Y, Hirsch J-P, Franche-Comte Polyp Surveillance Study Group (2012) Predictors of Colorectal Polyp Recurrence after the First Polypectomy in Private Practice Settings: A Cohort Study. PLoS ONE 7(12): e50990. doi: 10.1371/journal.pone.0050990	[Viel, Jean-Francois] Univ Hosp, Dept Epidemiol & Publ Hlth, Rennes, France	CHU Rennes	Viel, JF (corresponding author), Univ Hosp, Dept Epidemiol & Publ Hlth, Rennes, France.	jean-francois.viel@univ-rennes1.fr	Viel, Jean-Francois/K-2224-2015	Viel, Jean-Francois/0000-0002-6716-7468	French Ministry of Health; National League Against Cancer; 4 Departmental Leagues against Cancer (Montbeliard, Vesoul, Lons le Saulnier, Besancon); French National Cancer Institute	French Ministry of Health; National League Against Cancer(Ligue nationale contre le cancer); 4 Departmental Leagues against Cancer (Montbeliard, Vesoul, Lons le Saulnier, Besancon); French National Cancer Institute(Institut National du Cancer (INCA) France)	This work was supported by grants from the French Ministry of Health, the National League Against Cancer, 4 Departmental Leagues against Cancer (Montbeliard, Vesoul, Lons le Saulnier, Besancon) and the French National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi C, 2009, ENDOSCOPY, V41, P209, DOI 10.1055/s-0028-1119646; Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Bonithon-Kopp C, 2004, DIS COLON RECTUM, V47, P323, DOI 10.1007/s10350-003-0054-1; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Brueckl WM, 2006, WORLD J GASTROENTERO, V12, P7313, DOI 10.3748/wjg.v12.i45.7313; Chung SJ, 2011, GUT, V60, P1537, DOI 10.1136/gut.2010.232876; Gao F, 2009, COLORECTAL DIS, V11, P893, DOI 10.1111/j.1463-1318.2008.01746.x; Huang YL, 2010, J GASTROENTEROL, V45, P838, DOI 10.1007/s00535-010-0227-3; Jacobs ET, 2009, AM J EPIDEMIOL, V169, P657, DOI 10.1093/aje/kwn401; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Nusko G, 2008, INT J COLORECTAL DIS, V23, P1065, DOI 10.1007/s00384-008-0508-y; Paskett ED, 2005, CANCER CAUSE CONTROL, V16, P1021, DOI 10.1007/s10552-005-0298-2; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Ransohoff DF, 2011, DIGEST DIS SCI, V56, P2623, DOI 10.1007/s10620-011-1791-y; Reid ME, 2003, CANCER EPIDEM BIOMAR, V12, P1006; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schoen RE, 2003, AM J GASTROENTEROL, V98, P1237, DOI 10.1016/S0002-9270(03)00271-5; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301	27	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50990	10.1371/journal.pone.0050990	http://dx.doi.org/10.1371/journal.pone.0050990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226555	Green Submitted, gold, Green Published			2022-12-25	WOS:000312104700030
J	Jung, M; Lord, MS; Cheng, B; Lyons, JG; Alkhouri, H; Hughes, JM; McCarthy, SJ; Iozzo, RV; Whitelock, JM				Jung, MoonSun; Lord, Megan S.; Cheng, Bill; Lyons, J. Guy; Alkhouri, Hatem; Hughes, J. Margaret; McCarthy, Simon J.; Iozzo, Renato V.; Whitelock, John M.			Mast Cells Produce Novel Shorter Forms of Perlecan That Contain Functional Endorepellin A ROLE IN ANGIOGENESIS AND WOUND HEALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CHONDROITIN SULFATE-E; HEPARAN-SULFATE; SERGLYCIN PROTEOGLYCAN; MONOCLONAL-ANTIBODY; ANGIOSTATIC MODULE; CORE PROTEIN; DOMAIN V; FRAGMENT; GENE	Mast cells are derived from hematopoietic progenitors that are known to migrate to and reside within connective and mucosal tissues, where they differentiate and respond to various stimuli by releasing pro-inflammatory mediators, including histamine, growth factors, and proteases. This study demonstrated that primary human mast cells as well as the rat and human mast cell lines, RBL-2H3 and HMC-1, produce the heparan sulfate proteoglycan, perlecan, with a molecular mass of 640 kDa as well as smaller molecular mass species of 300 and 130 kDa. Utilizing domain-specific antibodies coupled with N-terminal sequencing, it was confirmed that both forms contained the C-terminal module of the protein core known as endorepellin, which were generated by mast cell-derived proteases. Domain-specific RT-PCR experiments demonstrated that transcripts corresponding to domains I and V, including endorepellin, were present; however, mRNA transcripts corresponding to regions of domain III were not present, suggesting that these cells were capable of producing spliced forms of the protein core. Fractions from mast cell cultures that were enriched for these fragments were shown to bind endothelial cells via the alpha(2)beta(1) integrin and stimulate the migration of cells in "scratch assays," both activities of which were inhibited by incubation with either anti-endorepellin or anti-perlecan antibodies. This study shows for the first time that mast cells secrete and process the extracellular proteoglycan perlecan into fragments containing the endorepellin C-terminal region that regulate angiogenesis and matrix turnover, which are both key events in wound healing.	[Whitelock, John M.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia; [Lyons, J. Guy] Univ Sydney, Discipline Dermatol, Bosch Inst, Sydney Canc Ctr, Sydney, NSW 2006, Australia; [Alkhouri, Hatem; Hughes, J. Margaret] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [McCarthy, Simon J.] HemCon Med Technol Inc, Portland, OR 97223 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	University of New South Wales Sydney; University of Sydney; University of Sydney; Jefferson University; Jefferson University	Whitelock, JM (corresponding author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.	j.whitelock@unsw.edu.au	Lyons, Guy/B-1319-2012; Cheng, Bill/M-8387-2013; Alkhouri, Hatem/AAG-3390-2021; Lord, Megan/D-4673-2013; Iozzo, Renato/AAS-1980-2020	Lyons, Guy/0000-0002-4835-4663; Alkhouri, Hatem/0000-0002-5569-704X; Lord, Megan/0000-0002-0506-9811; Whitelock, John/0000-0003-1835-802X; Cheng, Bill/0000-0002-0692-4349; Iozzo, Renato/0000-0002-5908-5112	Australian Research Council under the Linkage Project [LP0776293]; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA047282] Funding Source: NIH RePORTER	Australian Research Council under the Linkage Project(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by partial funding from the Australian Research Council under the Linkage Project (Grant LP0776293).	Alkhouri H, 2011, ALLERGY, V66, P1231, DOI 10.1111/j.1398-9995.2011.02616.x; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; CATERSON B, 1983, J BIOL CHEM, V258, P8848; Chang JW, 2008, PROTEOM CLIN APPL, V2, P23, DOI 10.1002/prca.200780049; Chuang CY, 2010, BIOCHEMISTRY-US, V49, P5524, DOI 10.1021/bi1005199; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COUCHMAN JR, 1995, J HISTOCHEM CYTOCHEM, V43, P955, DOI 10.1177/43.9.7543915; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; GILEAD L, 1987, IMMUNOLOGY, V62, P23; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; GOTO T, 1984, AM REV RESPIR DIS, V130, P797; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; HAWKINS RA, 1985, ANN INTERN MED, V102, P182, DOI 10.7326/0003-4819-102-2-182; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; Joseph SJ, 1996, DEVELOPMENT, V122, P3443; KATZ HR, 1986, J BIOL CHEM, V261, P3393; Knox S, 2001, PROTEOMICS, V1, P1534, DOI 10.1002/1615-9861(200111)1:12<1534::AID-PROT1534>3.0.CO;2-A; Knox S, 2002, J BIOL CHEM, V277, P14657, DOI 10.1074/jbc.M111826200; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Lundquist EA, 1996, DEVELOPMENT, V122, P1601; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Mullen GP, 1999, MOL BIOL CELL, V10, P3205, DOI 10.1091/mbc.10.10.3205; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Ng MFY, 2010, INT WOUND J, V7, P55, DOI 10.1111/j.1742-481X.2009.00651.x; NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x; Oda O, 1996, CLIN CHIM ACTA, V255, P119, DOI 10.1016/0009-8981(96)06395-4; Parker TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033714; Passante E, 2009, INFLAMM RES, V58, P611, DOI [10.1007/s00011-009-0028-4, 10.1007/s00011-009-0644-z]; Patel VN, 2007, DEVELOPMENT, V134, P4177, DOI 10.1242/dev.011171; Samoszuk M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-121; SELDIN DC, 1985, J BIOL CHEM, V260, P1131; Skold CM, 2001, INFLAMMATION, V25, P47, DOI 10.1023/A:1007075628316; Smith SML, 2007, ARCH BIOCHEM BIOPHYS, V468, P244, DOI 10.1016/j.abb.2007.10.006; Soulez M, 2012, CIRC RES, V110, P94, DOI 10.1161/CIRCRESAHA.111.250431; Soulez M, 2010, STEM CELLS, V28, P810, DOI 10.1002/stem.403; Spartz AK, 2004, MOL CELL BIOL, V24, P6811, DOI 10.1128/MCB.24.15.6811-6823.2004; Spike CA, 2001, MOL CELL BIOL, V21, P4985, DOI 10.1128/MCB.21.15.4985-4995.2001; STEVENS RL, 1988, J BIOL CHEM, V263, P7287; Tapanadechopone P, 1999, BIOCHEM BIOPH RES CO, V265, P680, DOI 10.1006/bbrc.1999.1714; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; THOMPSON HL, 1988, J IMMUNOL, V140, P2708; THOMPSON HL, 1991, J CLIN INVEST, V87, P619, DOI 10.1172/JCI115038; West L, 2006, J ORTHOP RES, V24, P1317, DOI 10.1002/jor.20160; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200	59	51	51	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3289	3304		10.1074/jbc.M112.387811	http://dx.doi.org/10.1074/jbc.M112.387811			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235151	Green Published, hybrid			2022-12-25	WOS:000314397900035
J	Pan, JA; Fan, YJ; Gandhirajan, RK; Madesh, M; Zong, WX				Pan, Ji-An; Fan, Yongjun; Gandhirajan, Rajesh Kumar; Madesh, Muniswamy; Zong, Wei-Xing			Hyperactivation of the Mammalian Degenerin MDEG Promotes Caspase-8 Activation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CAENORHABDITIS-ELEGANS; CELL-DEATH; C-ELEGANS; NEURONAL DEGENERATION; 26S PROTEASOME; CYTOCHROME-C; NA+ CHANNEL; AUTOPHAGY; CALCIUM	Intracellular calcium overload plays a critical role in numerous pathological syndromes such as heart failure, brain ischemia, and stroke. Hyperactivation of the acid-sensing ion channels including degenerin/epithelial amiloride-sensitive sodium (DEG/ENaC) channels has been shown to elevate intracellular calcium and cause subsequent neuronal cell death that is independent of the canonical Egl-1/Ced-9/Ced-4/Ced-3 apoptotic pathway in Caenorhabditis elegans. In mammalian cells, hyperactivation of the DEG/ENaC channels can also lead to cell death, although the underlying mechanism remains largely unknown. Here, we use a tetracycline-inducible system to express the hyperactivation mutant of a mammalian DEG/ENaC channel protein, MDEG G430F, in murine kidney epithelial cells deficient in the key mitochondrial apoptotic proteins Bax and Bak. Remarkably, expression of MDEG G430F induces increased intracellular calcium, reactive oxygen species (ROS) production, and cell death. The MDEG G430F-induced cell death is blocked by the intracellular calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (acetoxymethyl ester), ROS scavengers, and the caspase inhibitor z-VAD-fmk (where z and fmk are benzyloxycarbonyl and fluoromethyl ketone). Mechanistically, the intracellular calcium overload and ROS increase lead to the inhibition of proteasomal and autophagic protein degradation, which promotes the accumulation of protein aggregates containing caspase-8 and subsequent caspase-8 activation. As protein aggregation upon the inhibition of proteasomal and autophagic degradation pathways is mediated by the ubiquitin-binding protein SQSTM1/p62 and the autophagy-related protein LC3, silencing of p62 and LC3 protects cells from MDEG G430F-induced cell death. Our results uncover a new mechanism of caspase-8-mediated apoptosis induced by intracellular calcium overload that is dependent on the autophagy-related proteins LC3 and p62 upon hyperactivation of DEG/ENaC channels.	[Pan, Ji-An; Fan, Yongjun; Zong, Wei-Xing] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Gandhirajan, Rajesh Kumar; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140 USA; [Gandhirajan, Rajesh Kumar; Madesh, Muniswamy] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Zong, WX (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	wzong@notes.cc.sunysb.edu		Gandhirajan, Rajesh/0000-0002-0039-771X	National Institutes of Health [CA129536, GM097355, HL086699]; NATIONAL CANCER INSTITUTE [R01CA129536] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129536 and GM097355 (to W. X. Z) and HL086699 (to M. M.).	Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dou ZX, 2010, J CELL BIOL, V191, P827, DOI 10.1083/jcb.201006056; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Harr MW, 2010, AUTOPHAGY, V6, P912, DOI 10.4161/auto.6.7.13290; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; KAWAHARA H, 1994, DEV BIOL, V166, P623, DOI 10.1006/dbio.1994.1342; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lam D, 2008, MOL BIOL CELL, V19, P691, DOI 10.1091/mbc.E07-08-0823; Li Minghua, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P156; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Toth ML, 2007, J CELL SCI, V120, P1134, DOI 10.1242/jcs.03401; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Ullman E, 2011, MOL CELL BIOL, V31, P2902, DOI 10.1128/MCB.05452-11; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wei MC, 2000, GENE DEV, V14, P2060; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	42	24	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2952	2963		10.1074/jbc.M112.441063	http://dx.doi.org/10.1074/jbc.M112.441063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239879	Green Published, hybrid			2022-12-25	WOS:000314397900006
J	Che-Castaldo, JP; Neel, MC				Che-Castaldo, Judy P.; Neel, Maile C.			Testing Surrogacy Assumptions: Can Threatened and Endangered Plants Be Grouped by Biological Similarity and Abundances?	PLOS ONE			English	Article							REGRESSION TREES; SPECIES RICHNESS; LIFE-HISTORY; CONSERVATION; EXTINCTION; BIRDS; BIODIVERSITY; CLASSIFICATION; COMPLEMENTARITY; INDICATORS	There is renewed interest in implementing surrogate species approaches in conservation planning due to the large number of species in need of management but limited resources and data. One type of surrogate approach involves selection of one or a few species to represent a larger group of species requiring similar management actions, so that protection and persistence of the selected species would result in conservation of the group of species. However, among the criticisms of surrogate approaches is the need to test underlying assumptions, which remain rarely examined. In this study, we tested one of the fundamental assumptions underlying use of surrogate species in recovery planning: that there exist groups of threatened and endangered species that are sufficiently similar to warrant similar management or recovery criteria. Using a comprehensive database of all plant species listed under the U.S. Endangered Species Act and tree-based random forest analysis, we found no evidence of species groups based on a set of distributional and biological traits or by abundances and patterns of decline. Our results suggested that application of surrogate approaches for endangered species recovery would be unjustified. Thus, conservation planning focused on individual species and their patterns of decline will likely be required to recover listed species.	[Che-Castaldo, Judy P.; Neel, Maile C.] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Neel, Maile C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Che-Castaldo, JP (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	jchecastaldo@sesync.org			Strategic Environmental Research and Development Program of the US Department of Defense [SI-1475]	Strategic Environmental Research and Development Program of the US Department of Defense	Funding was provided by the Strategic Environmental Research and Development Program of the US Department of Defense (http://www.serdp.org/), project number SI-1475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bevill RL, 1999, CONSERV BIOL, V13, P493, DOI 10.1046/j.1523-1739.1999.97369.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks T, 2001, OSTRICH, P3; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Caro T, 2005, CONSERV BIOL, V19, P1821, DOI 10.1111/j.1523-1739.2005.00251.x; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Chase MK, 2000, CONSERV BIOL, V14, P474, DOI 10.1046/j.1523-1739.2000.98312.x; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Cushman SA, 2010, CONSERV BIOL, V24, P830, DOI 10.1111/j.1523-1739.2009.01396.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Elphick CS, 2001, CONSERV BIOL, V15, P1285, DOI 10.1046/j.1523-1739.2001.00356.x; Faith D. P., 1996, Biodiversity Letters, V3, P18, DOI 10.2307/2999706; Favreau JM, 2006, BIODIVERS CONSERV, V15, P3949, DOI 10.1007/s10531-005-2631-1; Fenneman N.M., 1946, PHYSIOGRAPHIC DIVISI; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Fleishman E, 2001, ECOL APPL, V11, P1489, DOI 10.1890/1051-0761(2001)011[1489:EVOAMF]2.0.CO;2; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; Gladstone W, 2002, BIOL CONSERV, V104, P211, DOI 10.1016/S0006-3207(01)00167-7; Inhaber H., 1976, ENV INDICES; Kesler DC, 2007, BIOL CONSERV, V136, P520, DOI 10.1016/j.biocon.2006.12.023; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Leidner AK, 2011, CONSERV BIOL, V25, P716, DOI 10.1111/j.1523-1739.2011.01689.x; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Lindenmayer DB, 2011, ECOSYSTEMS, V14, P47, DOI 10.1007/s10021-010-9394-6; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Murphy DD, 2011, CONSERV BIOL, V25, P873, DOI 10.1111/j.1523-1739.2011.01711.x; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Murray BR, 2002, EVOL ECOL RES, V4, P937; Neel MC, 2012, BIOSCIENCE, V62, P646, DOI 10.1525/bio.2012.62.7.7; Neel MC, CONSERVATIO IN PRESS; Neel MC, 2008, CONSERVATION BIOL EV, P283; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Noon Barry R., 2008, P51; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Noss RF., 1997, SCI CONSERVATION PLA; Pearman PB, 2011, BIOL CONSERV, V144, P866, DOI 10.1016/j.biocon.2010.11.020; R Development Core Team, 2012, LANG ENV STAT COMP; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; SAETERSDAL M, 1993, BIOL CONSERV, V65, P121, DOI 10.1016/0006-3207(93)90441-3; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718; Scott TA, 2000, ENVIRON MANAGE, V26, pS37; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Sodhi NS, 2008, DIVERS DISTRIB, V14, P1, DOI 10.1111/j.1472-4642.2007.00398.x; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; TEAR TH, 1993, SCIENCE, V262, P976, DOI 10.1126/science.262.5136.976; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; U. S. Fish & Wildlife Service, 2012, DRAFT GUID SEL SPEC; Vamosi JC, 2005, DIVERS DISTRIB, V11, P25, DOI 10.1111/j.1366-9516.2005.00119.x; Virolainen KM, 2000, P ROY SOC B-BIOL SCI, V267, P1143, DOI 10.1098/rspb.2000.1120; Wiens JA, 2008, BIOSCIENCE, V58, P241, DOI 10.1641/B580310; WILCOX B. A., 1984, NATL PARKS CONSERVAT, P18, DOI DOI 10.13140/2.1.4879.2322; Williams PH, 2000, ANIM CONSERV, V3, P249, DOI 10.1111/j.1469-1795.2000.tb00110.x; Zeigler SL, CONSERVATION B UNPUB	65	7	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51659	10.1371/journal.pone.0051659	http://dx.doi.org/10.1371/journal.pone.0051659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240051	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800087
J	Dong, YY; Wang, JX; Fu, HH; Zhou, GQ; Shi, MM; Gao, HC				Dong, Yangyang; Wang, Jixuan; Fu, Huihui; Zhou, Guangqi; Shi, Miaomiao; Gao, Haichun			A Crp-Dependent Two-Component System Regulates Nitrate and Nitrite Respiration in Shewanella oneidensis	PLOS ONE			English	Article							REDUCTASE OPERON EXPRESSION; ESCHERICHIA-COLI K-12; ANAEROBIC RESPIRATION; FNR PROTEIN; NARX; PROMOTERS; TRANSPORT; NRFA; IDENTIFICATION; REASSESSMENT	We have previously illustrated the nitrate/nitrite respiratory pathway of Shewanella oneidensis, which is renowned for its remarkable versatility in respiration. Here we investigated the systems regulating the pathway with a reliable approach which enables characterization of mutants impaired in nitrate/nitrite respiration by guaranteeing biomass. The S. oneidensis genome encodes an Escherichia coli NarQ/NarX homolog SO3981 and two E. coli NarP/NarL homologs SO1860 and SO3982. Results of physiological characterization and mutational analyses demonstrated that S. oneidensis possesses a single two-component system (TCS) for regulation of nitrate/nitrite respiration, consisting of the sensor kinase SO3981(NarQ) and the response regulator SO3982(NarP). The TCS directly controls the transcription of nap and nrfA (genes encoding nitrate and nitrite reductases, respectively) but regulates the former less tightly than the latter. Additionally, phosphorylation at residue 57 of SO3982 is essential for its DNA-binding capacity. At the global control level, Crp is found to regulate expression of narQP as well as nap and nrfA. In contrast to NarP-NarQ, Crp is more essential for nap rather than nrfA.	[Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/AFU-4588-2022; Gao, Haichun/A-2160-2014	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Major State Basic Research Development Program (973 Program) [2010CB833803]; National Natural Science Foundation of China [30870032]; Natural Science Foundation of Zhejiang province [R3110096]; Major Program of Science and Technology Department of Zhejiang [2009C12061]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Major Program of Science and Technology Department of Zhejiang	This research was supported by Major State Basic Research Development Program (973 Program: 2010CB833803), National Natural Science Foundation of China (30870032), Natural Science Foundation of Zhejiang province (R3110096), and Major Program of Science and Technology Department of Zhejiang (2009C12061) to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraquet C, 2009, MOL MICROBIOL, V73, P278, DOI 10.1111/j.1365-2958.2009.06770.x; Binnenkade L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023440; Browning DF, 2004, MOL MICROBIOL, V53, P203, DOI 10.1111/j.1365-2958.2004.04104.x; Browning DF, 2002, MOL MICROBIOL, V43, P687, DOI 10.1046/j.1365-2958.2002.02776.x; Charania MA, 2009, J BACTERIOL, V191, P4298, DOI 10.1128/JB.01829-08; Chen Y, 2011, ISME J, V5, P843, DOI 10.1038/ismej.2010.182; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; Cruz-Garcia C, 2007, J BACTERIOL, V189, P656, DOI 10.1128/JB.01194-06; Cruz-Garcia C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-64; Darwin AJ, 1998, J BACTERIOL, V180, P4192, DOI 10.1128/JB.180.16.4192-4198.1998; DARWIN AJ, 1995, J BACTERIOL, V177, P3865, DOI 10.1128/jb.177.13.3865-3869.1995; Elias DA, 2008, ARCH MICROBIOL, V189, P313, DOI 10.1007/s00203-007-0321-y; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gao HC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002983; Gon S, 2002, J BACTERIOL, V184, P1262, DOI 10.1128/JB.184.5.1262-1269.2002; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Jepson BJN, 2006, BIOCHEM SOC T, V34, P122, DOI 10.1042/BST0340122; Lamberg KE, 2000, MOL MICROBIOL, V38, P817, DOI 10.1046/j.1365-2958.2000.02172.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Liang YL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015295, 10.1371/journal.pone.0012860]; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Maier TM, 2001, J BACTERIOL, V183, P4918, DOI 10.1128/JB.183.16.4918-4926.2001; Melville SB, 1996, P NATL ACAD SCI USA, V93, P1226, DOI 10.1073/pnas.93.3.1226; Miller JH., 1972, EXPT MOL GENETICS; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Noriega CE, 2010, MOL MICROBIOL, V75, P394, DOI 10.1111/j.1365-2958.2009.06987.x; RABIN RS, 1992, P NATL ACAD SCI USA, V89, P8419, DOI 10.1073/pnas.89.18.8419; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; Saffarini DA, 2003, J BACTERIOL, V185, P3668, DOI 10.1128/JB.185.12.3668-3671.2003; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Simon J, 2001, EUR J BIOCHEM, V268, P5776, DOI 10.1046/j.0014-2956.2001.02520.x; Simpson PJL, 2010, MICROBIOL-SGM, V156, P302, DOI 10.1099/mic.0.034421-0; Stewart V, 2003, J BACTERIOL, V185, P5862, DOI 10.1128/JB.185.19.5862-5870.2003; Stewart V, 2003, BIOCHEM SOC T, V31, P1; Stewart V, 2009, J BACTERIOL, V191, P996, DOI 10.1128/JB.00873-08; TRAGESER M, 1990, MOL MICROBIOL, V4, P21, DOI 10.1111/j.1365-2958.1990.tb02011.x; TuAnh NH, 2010, P NATL ACAD SCI USA, V107, P21140, DOI 10.1073/pnas.1013081107; Wang HN, 2000, J BACTERIOL, V182, P5813, DOI 10.1128/JB.182.20.5813-5822.2000; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701	46	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51643	10.1371/journal.pone.0051643	http://dx.doi.org/10.1371/journal.pone.0051643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240049	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800085
J	Domaica, CI; Fuertes, MB; Uriarte, I; Girart, MV; Sardanons, J; Comas, DI; Di Giovanni, D; Gaillard, MI; Bezrodnik, L; Zwirner, NW				Ines Domaica, Carolina; Beatriz Fuertes, Mercedes; Uriarte, Ignacio; Victoria Girart, Maria; Sardanons, Jessica; Ileana Comas, Dorina; Di Giovanni, Daniela; Isabel Gaillard, Maria; Bezrodnik, Liliana; Walter Zwirner, Norberto			Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development	PLOS ONE			English	Article							HUMAN NK CELLS; DENDRITIC CELLS; ADAPTIVE IMMUNITY; L-SELECTIN; DIFFERENTIATION; SUBSET; DEFICIENCY; ACTIVATION; EXPRESSION; INNATE	Two populations of human natural killer (NK) cells can be identified in peripheral blood. The majority are CD3(-)CD56(dim) cells while the minority exhibits a CD3(-)CD56(bright) phenotype. In vitro evidence indicates that CD56(bright) cells are precursors of CD56(dim) cells, but in vivo evidence is lacking. Here, we studied NK cells from a patient that suffered from a melanoma and opportunistic fungal infection during childhood. The patient exhibited a stable phenotype characterized by a reduction in the frequency of peripheral blood CD3(-)CD56(dim) NK cells, accompanied by an overt increase in the frequency and absolute number of CD3(-)CD56(bright) cells. These NK cells exhibited similar expression of perforin, CD57 and CD158, the major activating receptors CD16, NKp46, NKG2D, DNAM-1, and 2B4, as well as the inhibitory receptor CD94/NKG2A, on both CD56(bright) and CD56(dim) NK cells as healthy controls. Also, both NK cell subpopulations produced IFN-gamma upon stimulation with cytokines, and CD3(-)CD56(dim) NK cells degranulated in response to cytokines or K562 cells. However, upon stimulation with cytokines, a substantial fraction of CD56(dim) cells failed to up-regulate CD57 and CD158, showed a reduction in the percentage of CD16(+) cells, and CD56(bright) cells did not down-regulate CD62L, suggesting that CD56(dim) cells could not acquire a terminally differentiated phenotype and that CD56(bright) cells exhibit a maturation defect that might result in a potential altered migration pattern. These observations, support the notion that NK cells of this patient display a maturation/activation defect that precludes the generation of mature NK cells at a normal rate accompanied by CD56(dim) NK cells that cannot completely acquire a terminally differentiated phenotype. Thus, our results provide evidence that support the concept that in vivo CD56(bright) NK cells differentiate into CD56(dim) NK cells, and contribute to further understand human NK cell ontogeny.	[Ines Domaica, Carolina; Beatriz Fuertes, Mercedes; Victoria Girart, Maria; Walter Zwirner, Norberto] Consejo Nacl Invest Cient & Tecn CONICET, Lab Fisiopatol Inmunidad Innata, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina; [Beatriz Fuertes, Mercedes] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, RA-1428 Buenos Aires, DF, Argentina; [Uriarte, Ignacio; Sardanons, Jessica; Ileana Comas, Dorina; Di Giovanni, Daniela; Isabel Gaillard, Maria; Bezrodnik, Liliana] Hosp Ninos Dr Ricardo Gutierrez, Unidad Inmunol, Buenos Aires, DF, Argentina; [Walter Zwirner, Norberto] Univ Buenos Aires, Fac Med, Dept Microbiol Parasitol & Inmunol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; University of Buenos Aires	Zwirner, NW (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Lab Fisiopatol Inmunidad Innata, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina.	nzwirner@ibyme.conicet.gov.ar	Zwirner, Norberto/AAI-8961-2020; Comas, David/D-5382-2014	Comas, David/0000-0002-5075-0956; Domaica, Carolina Ines/0000-0001-9596-4889; Fuertes, Mercedes Beatriz/0000-0002-2734-1468; Zwirner, Norberto/0000-0001-7098-359X	National Agency for Promotion of Science and Technology from Argentina (ANPCYT); University of Buenos Aires (UBA); Bunge & Born Foundation	National Agency for Promotion of Science and Technology from Argentina (ANPCYT); University of Buenos Aires (UBA)(University of Buenos Aires); Bunge & Born Foundation	This work was supported by grants from the National Agency for Promotion of Science and Technology from Argentina (ANPCYT) and the University of Buenos Aires (UBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.I.D. was a postdoctoral fellow of CONICET and currently holds a postdoctoral fellowship of the Bunge & Born Foundation. M. B. F., L. B. and N.W.Z. are members of the Researcher Career of CONICET.	Allan DSJ, 2010, EUR J IMMUNOL, V40, P2289, DOI 10.1002/eji.200939910; Barcelos W, 2008, SCAND J IMMUNOL, V68, P92, DOI 10.1111/j.1365-3083.2008.02116.x; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dulphy N, 2008, J IMMUNOL, V181, P2227, DOI 10.4049/jimmunol.181.3.2227; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Frey M, 1998, J IMMUNOL, V161, P400; Gineau L, 2012, J CLIN INVEST, V122, P821, DOI 10.1172/JCI61014; Hughes CR, 2012, J CLIN INVEST, V122, P814, DOI 10.1172/JCI60224; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Li ZQ, 2005, J IMMUNOL, V174, P5187, DOI 10.4049/jimmunol.174.9.5187; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Moldovan I, 1999, IMMUNOL LETT, V68, P125, DOI 10.1016/S0165-2478(99)00041-3; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Villa-Forte A, 2008, ARTHRITIS RHEUM-US, V58, P2579, DOI 10.1002/art.23675; Vitale C, 2005, MOL IMMUNOL, V42, P405, DOI 10.1016/j.molimm.2004.07.019; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; Warren HS, 1996, J IMMUNOL, V156, P3254; Zimmer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001033; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	35	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51677	10.1371/journal.pone.0051677	http://dx.doi.org/10.1371/journal.pone.0051677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240056	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800092
J	Robles, VM; Marechal, JD; Bahloul, A; Sari, MA; Mahy, JP; Golinelli-Pimpaneau, B				Munoz Robles, Victor; Marechal, Jean-Didier; Bahloul, Amel; Sari, Marie-Agnes; Mahy, Jean-Pierre; Golinelli-Pimpaneau, Beatrice			Crystal Structure of Two Anti-Porphyrin Antibodies with Peroxidase Activity	PLOS ONE			English	Article							OBTAINING ARTIFICIAL HEMOPROTEINS; X-RAY STRUCTURES; CATALYTIC ANTIBODIES; 3-DIMENSIONAL STRUCTURES; IRON PORPHYRINS; PEPTIDE-EPITOPE; METAL-ION; COMPLEXES; AFFINITY; HEMOABZYMES	We report the crystal structures at 2.05 and 2.45 angstrom resolution of two antibodies, 13G10 and 14H7, directed against an iron(III)-alpha alpha alpha beta-carboxyphenylporphyrin, which display some peroxidase activity. Although these two antibodies differ by only one amino acid in their variable lambda-light chain and display 86% sequence identity in their variable heavy chain, their complementary determining regions (CDR) CDRH1 and CDRH3 adopt very different conformations. The presence of Met or Leu residues at positions preceding residue H101 in CDRH3 in 13G10 and 14H7, respectively, yields to shallow combining sites pockets with different shapes that are mainly hydrophobic. The hapten and other carboxyphenyl-derivatized iron(III)-porphyrins have been modeled in the active sites of both antibodies using protein ligand docking with the program GOLD. The hapten is maintained in the antibody pockets of 13G10 and 14H7 by a strong network of hydrogen bonds with two or three carboxylates of the carboxyphenyl substituents of the porphyrin, respectively, as well as numerous stacking and van der Waals interactions with the very hydrophobic CDRH3. However, no amino acid residue was found to chelate the iron. Modeling also allows us to rationalize the recognition of alternative porphyrinic cofactors by the 13G10 and 14H7 antibodies and the effect of imidazole binding on the peroxidase activity of the 13G10/porphyrin complexes. Citation: Munoz Robles V, Marechal J-D, Bahloul A, Sari M-A, Mahy J-P, et al. (2012) Crystal Structure of Two Anti-Porphyrin Antibodies with Peroxidase Activity. PLoS ONE 7(12): e51128. doi:10.1371/journal.pone.0051128	[Munoz Robles, Victor; Marechal, Jean-Didier] Univ Autonoma Barcelona, Dept Quim, E-08193 Barcelona, Spain; [Bahloul, Amel; Golinelli-Pimpaneau, Beatrice] Ctr Rech Gif, CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Sari, Marie-Agnes] Univ Paris 05, CNRS, Lab Chim & Biochim Pharmacol & Toxicol, Paris, France; [Mahy, Jean-Pierre] Univ Paris 11, CNRS, Inst Chim Mol & Mat Orsay, Lab Chim Biorgan & Bioinorgan, F-91405 Orsay, France	Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Golinelli-Pimpaneau, B (corresponding author), Coll France, CNRS, Lab Chim Proc Biol, F-75231 Paris, France.	beatrice.golinelli@college-de-france.fr	Maréchal, Jean-Didier P/A-8936-2012; Golinelli, Beatrice/ABB-8347-2021; Muñoz Robles, Victor/K-3004-2012; Mahy, Jean-Pierre/AAQ-3621-2020	Maréchal, Jean-Didier P/0000-0002-8344-9043; Golinelli, Beatrice/0000-0001-8248-4704; Mahy, Jean-Pierre/0000-0001-6502-7923; BAHLOUL, Amel/0000-0001-7042-4616	Centre National de la Recherche Scientifique (Programme Physique et Chimie du Vivant); Spanish "Ministerio de Ciencia e Innovacion" [CTQ2008-06866-C02-01]; Generalitat de Catalunya [2009SGR68]	Centre National de la Recherche Scientifique (Programme Physique et Chimie du Vivant); Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Financial support was provided to B.G.-P. and J.-P.M. by the Centre National de la Recherche Scientifique (Programme Physique et Chimie du Vivant) and to J.-D.M. and V. M. by the Spanish "Ministerio de Ciencia e Innovacion" through projects CTQ2008-06866-C02-01 and consolider- ingenio 2010 and by the Generalitat de Catalunya through project 2009SGR68. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BRITTON D, 1972, ACTA CRYSTALL A-CRYS, V28, P296, DOI 10.1107/S0567739472000786; Chang S, 2005, MOL IMMUNOL, V42, P1293, DOI 10.1016/j.molimm.2004.12.008; Charbonnier JB, 1997, BIOCHIMIE, V79, P653, DOI 10.1016/S0300-9084(97)83498-0; COCHRAN AG, 1990, SCIENCE, V249, P781, DOI 10.1126/science.2389144; COCHRAN AG, 1990, J AM CHEM SOC, V112, P9414, DOI 10.1021/ja00181a065; Corneillie TM, 2003, J AM CHEM SOC, V125, P15039, DOI 10.1021/ja037236y; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; De Lauzon S, 1998, EUR J BIOCHEM, V257, P121, DOI 10.1046/j.1432-1327.1998.2570121.x; de Lauzon S, 1999, FEBS LETT, V443, P229, DOI 10.1016/S0014-5793(98)01703-7; de Lauzon S, 2002, EUR J BIOCHEM, V269, P470, DOI 10.1046/j.0014-2956.2001.02670.x; Debler EW, 2007, J MOL BIOL, V368, P1392, DOI 10.1016/j.jmb.2007.02.081; DEMONTELLANO PRO, 1992, ANNU REV PHARMACOL, V32, P89, DOI 10.1146/annurev.pharmtox.32.1.89; Dokurno P, 1998, J MOL BIOL, V284, P713, DOI 10.1006/jmbi.1998.2209; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Eigenbrot C, 2003, J MOL BIOL, V331, P433, DOI 10.1016/S0022-2836(03)00735-6; EISEN HN, 1985, ANNU REV IMMUNOL, V3, P337, DOI 10.1146/annurev.iy.03.040185.002005; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; FENG Y, 1995, ANN NY ACAD SCI, V750, P271, DOI 10.1111/j.1749-6632.1995.tb19964.x; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Ganesh K, 2011, FASEB J, V25, P1123, DOI 10.1096/fj.11-0402ufm; Golinelli-Pimpaneau B, 2000, P NATL ACAD SCI USA, V97, P9892, DOI 10.1073/pnas.97.18.9892; Golinelli-Pimpaneau B, 2005, ACTA CRYSTALLOGR D, V61, P472, DOI 10.1107/S0907444905003331; Golinelli-Pimpaneau B, 2002, J IMMUNOL METHODS, V269, P157, DOI 10.1016/S0022-1759(02)00240-5; Golinelli-Pimpaneau B, 2000, CURR OPIN STRUC BIOL, V10, P697, DOI 10.1016/S0959-440X(00)00157-3; Golinelli-Pimpaneau B, 2006, J BIOL CHEM, V281, P23969, DOI 10.1074/jbc.M602184200; Goswami RK, 2009, BIOORG MED CHEM LETT, V19, P3821, DOI 10.1016/j.bmcl.2009.04.041; Guddat LW, 2000, J MOL BIOL, V302, P853, DOI 10.1006/jmbi.2000.4083; GUDDAT LW, 1994, J MOL BIOL, V236, P247, DOI 10.1006/jmbi.1994.1133; Hamdane D, 2009, ACTA CRYSTALLOGR D, V65, P388, DOI 10.1107/S0907444909003382; Harada A, 1997, INORG CHEM, V36, P6099, DOI 10.1021/ic9610849; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hart-Davis J, 1998, J AM CHEM SOC, V120, P12524, DOI 10.1021/ja981805y; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI [10.1063/1.448800, 10.1063/1.448799]; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Hosomi N, 2005, J BIOSCI BIOENG, V99, P222, DOI 10.1263/jbb.99.222; HsiehWilson LC, 1996, P NATL ACAD SCI USA, V93, P5363, DOI 10.1073/pnas.93.11.5363; JONES ST, 1991, BIO-TECHNOL, V9, P579; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabat EA, 1991, SEQUENCES PROTEINS I; KawamuraKonishi Y, 1996, J BIOCHEM-TOKYO, V119, P857; Khan T, 2012, J IMMUNOL, V188, P1819, DOI 10.4049/jimmunol.1102701; Kohda K, 1997, FEBS LETT, V407, P280, DOI 10.1016/S0014-5793(97)00338-4; Larsen NA, 2002, ACTA CRYSTALLOGR D, V58, P2055, DOI 10.1107/S0907444902017420; Larsen NA, 2004, BIOCHEMISTRY-US, V43, P8067, DOI 10.1021/bi049495l; Le KHD, 2010, J MOL BIOL, V400, P518, DOI 10.1016/j.jmb.2010.05.035; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee JE, 2008, J MOL BIOL, V375, P202, DOI 10.1016/j.jmb.2007.10.017; LOVE RA, 1993, BIOCHEMISTRY-US, V32, P10950, DOI 10.1021/bi00092a004; Mahy JP, 2009, BIOCHIMIE, V91, P1321, DOI 10.1016/j.biochi.2009.03.002; Mahy JP, 1998, APPL BIOCHEM BIOTECH, V75, P103, DOI 10.1007/BF02787712; Mansuy D., 1994, CYTOCHROME P450 MODE, P99; Marnett Lawrence J., 1995, P49; MILLETT F, 1995, J BIOENERG BIOMEMBR, V27, P341, DOI 10.1007/BF02110103; MIZUTANI R, 1995, J MOL BIOL, V254, P208, DOI 10.1006/jmbi.1995.0612; Monnet C, 2002, J MOL BIOL, V315, P699, DOI 10.1006/jmbi.2001.5284; Robles VM, 2011, FARADAY DISCUSS, V148, P137, DOI 10.1039/c004578k; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nimri S, 1999, J AM CHEM SOC, V121, P8978, DOI 10.1021/ja990314q; Nogi T, 2008, PROTEIN SCI, V17, P2120, DOI 10.1110/ps.038299.108; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quilez R, 1996, FEBS LETT, V395, P73, DOI 10.1016/0014-5793(96)01006-X; Ricoux R, 2004, EUR J BIOCHEM, V271, P1277, DOI 10.1111/j.1432-1033.2004.04032.x; Ricoux R, 2002, J PROTEIN CHEM, V21, P473, DOI 10.1023/A:1021351120772; Ricoux R, 2002, J IMMUNOL METHODS, V269, P39, DOI 10.1016/S0022-1759(02)00223-5; Ricoux R, 2008, BIOCONJUGATE CHEM, V19, P899, DOI 10.1021/bc700435a; Rietjens IMCM, 1996, J BIOL INORG CHEM, V1, P372, DOI 10.1007/s007750050068; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Romesberg FE, 1998, BIOCHEMISTRY-US, V37, P14404, DOI 10.1021/bi981578c; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVITSKY AP, 1994, APPL BIOCHEM BIOTECH, V47, P317, DOI 10.1007/BF02787943; SCHAEFER WH, 1985, BIOCHEMISTRY-US, V24, P3254, DOI 10.1021/bi00334a027; Seebeck B, 2008, PROTEINS, V71, P1237, DOI 10.1002/prot.21818; Shinde S, 2012, J BIOL INORG CHEM, V17, P557, DOI 10.1007/s00775-012-0876-1; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Stevenson JD, 2000, NAT PROD REP, V17, P535, DOI 10.1039/b006389o; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; TAKAGI M, 1995, FEBS LETT, V375, P273, DOI 10.1016/0014-5793(95)01224-3; Tanaka F, 2002, J IMMUNOL METHODS, V269, P67, DOI 10.1016/S0022-1759(02)00225-9; Thayer MM, 1999, J MOL BIOL, V291, P329, DOI 10.1006/jmbi.1999.2960; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; Wentworth P, 2001, CELL BIOCHEM BIOPHYS, V35, P63, DOI 10.1385/CBB:35:1:63; Xu Y, 2004, BIOORGAN MED CHEM, V12, P5247, DOI 10.1016/j.bmc.2004.03.077; Yin J, 2004, J AM CHEM SOC, V126, P3006, DOI 10.1021/ja039198o; Yin J, 2003, P NATL ACAD SCI USA, V100, P856, DOI 10.1073/pnas.0235873100; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Yin J, 2001, BIOCHEMISTRY-US, V40, P10764, DOI 10.1021/bi010536c; Yuhasz SC, 1995, MOL IMMUNOL, V32, P1143, DOI 10.1016/0161-5890(95)00063-1; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200	99	9	9	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51128	10.1371/journal.pone.0051128	http://dx.doi.org/10.1371/journal.pone.0051128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240001	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800037
J	Traby, L; Kollars, M; Eischer, L; Eichinger, S; Kyrle, PA				Traby, Ludwig; Kollars, Marietta; Eischer, Lisbeth; Eichinger, Sabine; Kyrle, Paul A.			Prediction of Recurrent Venous Thromboembolism by Clot Lysis Time: A Prospective Cohort Study	PLOS ONE			English	Article							RISK; THROMBOSIS; HYPOFIBRINOLYSIS	Venous thromboembolism (VTE) is a chronic disease, which tends to recur. Whether an abnormal fibrinolytic system is associated with an increased risk of VTE is unclear. We assessed the relationship between fibrinolytic capacity (reflected by clot lysis time [CLT]) and risk of recurrent VTE. We followed 704 patients (378 women; mean age 48 yrs) with a first unprovoked VTE for an average of 46 months after anticoagulation withdrawal. Patients with natural coagulation inhibitor deficiency, lupus anticoagulant, cancer, homozygosity for factor V Leiden or prothrombin mutation, or requirement for indefinite anticoagulation were excluded. Study endpoint was symptomatic recurrent VTE. For measurement of CLT, a tissue factor-induced clot was lysed by adding tissue-type plasminogen activator. Time between clot formation and lysis was determined by measuring the turbidity. 135 (19%) patients had recurrent VTE. For each increase in CLT of 10 minutes, the crude relative risk (RR) of recurrence was 1.13 (95% CI 1.02-1.25; p = 0.02) and was 1.08 (95% CI 0.98-1.20; p = 0.13) after adjustment for age and sex. For women only, the adjusted RR was 1.14 (95% CI, 0.91-1.42, p = 0.22) for each increase in CLT of 10 minutes. CLT values in the 4th quartile of the female patient population, as compared to values in the 1st quartile, conferred a risk of recurrence of 3.28 (95% CI, 1.07-10.05; p = 0.04). No association between CLT and recurrence risk was found in men. Hypofibrinolysis as assessed by CLT confers a moderate increase in the risk of recurrent VTE. A weak association between CLT and risk of recurrence was found in women only.	[Traby, Ludwig; Kollars, Marietta; Eischer, Lisbeth; Eichinger, Sabine; Kyrle, Paul A.] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Eichinger, Sabine; Kyrle, Paul A.] Karl Landsteiner Inst Clin Thrombosis Res, Vienna, Austria	Medical University of Vienna	Kyrle, PA (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.	paul.kyrle@meduniwien.ac.at	Traby, Ludwig/ABC-2338-2020	Traby, Ludwig/0000-0003-2861-5771	Osterreichische Nationalbank; Medizinisch-Wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien	Osterreichische Nationalbank; Medizinisch-Wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien(Austrian Science Fund (FWF))	This work was supported by grants of the Osterreichische Nationalbank and the Medizinisch-Wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien. Both institutions are non-commercial and do not have a potential competing interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Crowther MA, 2001, THROMB HAEMOSTASIS, V85, P390; Eichinger S, 2004, BLOOD, V103, P3773, DOI 10.1182/blood-2003-10-3422; Eichinger S, 2008, CLIN CHEM, V54, P2042, DOI 10.1373/clinchem.2008.112243; Kalbfleisch J. D., 1980, WILEY SERIES PROBABI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; KORNINGER C, 1984, THROMB HAEMOSTASIS, V52, P127; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Kyrle PA, 2010, LANCET, V376, P2032, DOI 10.1016/S0140-6736(10)60962-2; Meltzer ME, 2010, J THROMB HAEMOST, V8, P605, DOI 10.1111/j.1538-7836.2009.03715.x; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Schulman S, 1996, THROMB HAEMOSTASIS, V75, P607	14	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51447	10.1371/journal.pone.0051447	http://dx.doi.org/10.1371/journal.pone.0051447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240024	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800060
J	Acosta, C; McMullan, S; Djouhri, L; Gao, LL; Watkins, R; Berry, C; Dempsey, K; Lawson, SN				Acosta, Cristian; McMullan, Simon; Djouhri, Laiche; Gao, Linlin; Watkins, Roger; Berry, Carol; Dempsey, Katherine; Lawson, Sally N.			HCN1 and HCN2 in Rat DRG Neurons: Levels in Nociceptors and Non-Nociceptors, NT3-Dependence and Influence of CFA-Induced Skin Inflammation on HCN2 and NT3 Expression	PLOS ONE			English	Article							ROOT GANGLION NEURONS; ACTIVATED PACEMAKER CHANNELS; PRIMARY AFFERENT NEURONS; PRIMARY SENSORY NEURONS; NUCLEOTIDE-GATED CHANNELS; MESSENGER-RNA EXPRESSION; MUSCLE-SPINDLE AFFERENTS; ACTION-POTENTIAL SHAPE; C-FIBER NOCICEPTORS; GUINEA-PIG	I-h, which influences neuronal excitability, has recently been measured in vivo in sensory neuron subtypes in dorsal root ganglia (DRGs). However, expression levels of HCN (hyperpolarization-activated cyclic nucleotide-gated) channel proteins that underlie I-h were unknown. We therefore examined immunostaining of the most abundant isoforms in DRGs, HCN1 and HCN2 in these neuron subtypes. This immunostaining was cytoplasmic and membrane-associated (ring). Ring-staining for both isoforms was in neurofilament-rich A-fiber neurons, but not in small neurofilament-poor C-fiber neurons, although some C-neurons showed cytoplasmic HCN2 staining. We recorded intracellularly from DRG neurons in vivo, determined their sensory properties (nociceptive or low-threshold-mechanoreceptive, LTM) and conduction velocities (CVs). We then injected fluorescent dye enabling subsequent immunostaining. For each dye-injected neuron, ring- and cytoplasmic-immunointensities were determined relative to maximum ring-immunointensity. Both HCN1- and HCN2-ring-immuno-intensities were positively correlated with CV in both nociceptors and LTMs; they were high in A beta-nociceptors and A alpha/beta-LTMs. High HCN1 and HCN2 levels in A alpha/beta-neurons may, via I-h, influence normal non-painful (e. g. touch and proprioceptive) sensations as well as nociception and pain. HCN2-, not HCN1-, ring-intensities were higher in muscle spindle afferents (MSAs) than in all other neurons. The previously reported very high I-h in MSAs may relate to their very high HCN2. In normal C-nociceptors, low HCN1 and HCN2 were consistent with their low/undetectable I-h. In some C-LTMs HCN2-intensities were higher than in C-nociceptors. Together, HCN1 and HCN2 expressions reflect previously reported I-h magnitudes and properties in neuronal subgroups, suggesting these isoforms underlie I-h in DRG neurons. Expression of both isoforms was NT3-dependent in cultured DRG neurons. HCN2-immunostaining in small neurons increased 1 day after cutaneous inflammation (CFA-induced) and recovered by 4 days. This could contribute to acute inflammatory pain. HCN2-immunostaining in large neurons decreased 4 days after CFA, when NT3 was decreased in the DRG. Thus HCN2-expression control differs between large and small neurons.	[Acosta, Cristian; Gao, Linlin; Watkins, Roger; Berry, Carol; Dempsey, Katherine; Lawson, Sally N.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [McMullan, Simon] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Djouhri, Laiche] King Faisal Univ, Dept Biomed Sci, Fac Med, Al Hasa, Saudi Arabia; [Gao, Linlin] Huazhong Univ Sci & Technol, Dept Physiol, Tongji Med Sch, Wuhan 430074, Peoples R China	University of Bristol; Macquarie University; King Faisal University; Huazhong University of Science & Technology	Lawson, SN (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	Sally.Lawson@bristol.ac.uk		McMullan, Simon/0000-0002-9854-1029; Acosta, Cristian/0000-0001-9333-5843	Wellcome Trust UK [WT82508MA]; China Scholarship Council; University of Bristol; MRC [G0700420] Funding Source: UKRI; Medical Research Council [G0700420] Funding Source: researchfish	Wellcome Trust UK(Wellcome Trust); China Scholarship Council(China Scholarship Council); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust UK (WT82508MA). LG was supported by Overseas Research Scholarship, China Scholarship Council and a postgraduate scholarship from The University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta C, 2008, J NEUROSCI RES, V86, P1077, DOI 10.1002/jnr.21565; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Cho HJ, 2009, NEUROSCIENCE, V162, P453, DOI 10.1016/j.neuroscience.2009.04.063; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Djouhri L, 1999, J PHYSIOL-LONDON, V520, P565, DOI 10.1111/j.1469-7793.1999.t01-1-00565.x; Djouhri L, 2001, NEUROSCIENCE, V108, P479, DOI 10.1016/S0306-4522(01)00423-7; Djouhri L, 2012, PAIN; Doan TN, 2004, J NEUROSCI, V24, P3335, DOI 10.1523/JNEUROSCI.5156-03.2004; Emery E.C., 2012, TRENDS PHARM SCI; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Fang X, 2002, J NEUROSCI, V22, P7425; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; Gao LL, 2012, J PHYSIOL-LONDON, V590, P4691, DOI 10.1113/jphysiol.2012.238485; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Han W, 2002, CIRC RES, V91, P790, DOI 10.1161/01.RES.0000039534.18114.D9; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hogan QH, 2008, BRAIN RES, V1207, P102, DOI 10.1016/j.brainres.2008.02.066; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kouranova EV, 2008, NEUROSCIENCE, V153, P1008, DOI 10.1016/j.neuroscience.2008.03.032; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Li HY, 2011, MOL VIS, V17, P3314; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; McMahon Stephen B, 2004, Novartis Found Symp, V261, P68; Michels G, 2008, CARDIOVASC RES, V78, P466, DOI 10.1093/cvr/cvn032; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Morris NP, 2004, BRAIN RES, V1006, P74, DOI 10.1016/j.brainres.2004.01.062; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Oakley RA, 1997, J NEUROSCI, V17, P4262; Pannese E, 2002, INT REV CYTOL, V220, P1; Parekh A, 2010, J PHYSIOL-LONDON, V588, P4131, DOI 10.1113/jphysiol.2010.196386; PERL ER, 1968, J PHYSIOL-LONDON, V197, P593, DOI 10.1113/jphysiol.1968.sp008576; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; SCROGGS RS, 1994, J NEUROPHYSIOL, V71, P271, DOI 10.1152/jn.1994.71.1.271; Simeone TA, 2005, J PHYSIOL-LONDON, V568, P371, DOI 10.1113/jphysiol.2005.093161; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Tu HY, 2004, J NEUROSCI RES, V76, P713, DOI 10.1002/jnr.20109; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; Villiere V, 1996, J NEUROPHYSIOL, V76, P1924, DOI 10.1152/jn.1996.76.3.1924; Watanabe M, 2000, NEUROSCI LETT, V282, P61, DOI 10.1016/S0304-3940(00)00842-9; Weng X, 2012, PAIN; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Zhou XF, 1998, NEUROSCIENCE, V86, P1155, DOI 10.1016/S0306-4522(98)00076-1	64	55	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50442	10.1371/journal.pone.0050442	http://dx.doi.org/10.1371/journal.pone.0050442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236374	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100017
J	Chaudhuri, N; Jary, H; Lea, S; Khan, N; Piddock, KC; Dockrell, DH; Donaldson, K; Duffin, R; Singh, D; Parker, LC; Sabroe, I				Chaudhuri, Nazia; Jary, Hannah; Lea, Simon; Khan, Naimat; Piddock, Katie C.; Dockrell, David H.; Donaldson, Ken; Duffin, Rodger; Singh, Dave; Parker, Lisa C.; Sabroe, Ian			Diesel Exhaust Particle Exposure In Vitro Alters Monocyte Differentiation and Function	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; PARTICULATE AIR-POLLUTION; ALVEOLAR MACROPHAGES; INFLAMMATORY RESPONSES; CIGARETTE-SMOKE; HEALTHY HUMANS; LIPOPOLYSACCHARIDE; CHEMICALS; RELEASE	Air pollution by diesel exhaust particles is associated with elevated mortality and increased hospital admissions in individuals with respiratory diseases such as asthma and chronic obstructive pulmonary disease. During active inflammation monocytes are recruited to the airways and can replace resident alveolar macrophages. We therefore investigated whether chronic fourteen day exposure to low concentrations of diesel exhaust particles can alter the phenotype and function of monocytes from healthy individuals and those with chronic obstructive pulmonary disease. Monocytes were purified from the blood of healthy individuals and people with a diagnosis of chronic obstructive pulmonary disease. Monocyte-derived macrophages were generated in the presence or absence of diesel exhaust particles and their phenotypes studied through investigation of their lifespan, cytokine generation in response to Toll like receptor agonists and heat killed bacteria, and expression of surface markers. Chronic fourteen day exposure of monocyte-derived macrophages to concentrations of diesel exhaust particles >10 mu g/ml caused mitochondrial and lysosomal dysfunction, and a gradual loss of cells over time both in healthy and chronic obstructive pulmonary disease individuals. Chronic exposure to lower concentrations of diesel exhaust particles impaired CXCL8 cytokine responses to lipopolysaccharide and heat killed E. coli, and this phenotype was associated with a reduction in CD14 and CD11b expression. Chronic diesel exhaust particle exposure may therefore alter both numbers and function of lung macrophages differentiating from locally recruited monocytes in the lungs of healthy people and patients with chronic obstructive pulmonary disease.	[Chaudhuri, Nazia; Jary, Hannah; Piddock, Katie C.; Dockrell, David H.; Parker, Lisa C.; Sabroe, Ian] Univ Sheffield, Sch Med & Biomed Sci, Acad Unit Resp Med, Sheffield, S Yorkshire, England; [Lea, Simon; Khan, Naimat; Singh, Dave] Univ Hosp S Manchester NHS Trust, Educ & Res Ctr, Manchester, Lancs, England; [Donaldson, Ken; Duffin, Rodger] Univ Edinburgh, Queens Med Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Sheffield; Wythenshawe Hospital NHS Foundation Trust; University of Edinburgh	Sabroe, I (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Acad Unit Resp Med, Sheffield, S Yorkshire, England.	i.sabroe@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Singh, Dave/AAH-4342-2020; Lea, Simon/U-3590-2019; Sabroe, Ian/I-5981-2013; Chaudhuri, Nazia/J-4517-2019	Singh, Dave/0000-0001-8918-7075; Sabroe, Ian/0000-0001-9750-8975; Chaudhuri, Nazia/0000-0003-3325-6996; Duffin, Rodger/0000-0002-3425-9745; Dockrell, David/0000-0002-2718-4861	Sheffield Hospital Charitable trust [7887]; MRC [G0901697] Funding Source: UKRI; Medical Research Council [G0901697] Funding Source: researchfish	Sheffield Hospital Charitable trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is supported by the Sheffield Hospital Charitable trust 7887. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Atkinson RW, 1999, EUR RESPIR J, V13, P257, DOI 10.1183/09031936.99.13225799; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Becker S, 2002, TOXICOL IN VITRO, V16, P209, DOI 10.1016/S0887-2333(02)00015-2; Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904; Chaudhuri N, 2010, AM J PHYSIOL-LUNG C, V299, pL263, DOI 10.1152/ajplung.00297.2009; Ciccone G, 1998, OCCUP ENVIRON MED, V55, P771, DOI 10.1136/oem.55.11.771; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Goto Y, 2004, AM J RESP CRIT CARE, V170, P891, DOI 10.1164/rccm.200402-235OC; HASLETT C, 1985, AM J PATHOL, V119, P101; Hiura TS, 1999, J IMMUNOL, V163, P5582; Hiura TS, 2000, J IMMUNOL, V165, P2703, DOI 10.4049/jimmunol.165.5.2703; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Ishii H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-87; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Li N, 2002, J IMMUNOL, V169, P4531, DOI 10.4049/jimmunol.169.8.4531; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Mazzarella G, 2007, RESP MED, V101, P1155, DOI 10.1016/j.rmed.2006.11.011; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Morris GE, 2006, FASEB J, V20, P2153, DOI 10.1096/fj.06-5910fje; Nordenhall C, 2001, EUR RESPIR J, V17, P909, DOI 10.1183/09031936.01.17509090; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Saito Y, 2002, EXP LUNG RES, V28, P201, DOI 10.1080/019021402753570509; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Sapey E, 2009, J CLIN IMMUNOL, V29, P508, DOI 10.1007/s10875-009-9286-8; SCHWARTZ J, 1993, AM REV RESPIR DIS, V147, P826, DOI 10.1164/ajrccm/147.4.826; Stenfors N, 2004, EUR RESPIR J, V23, P82, DOI 10.1183/09031936.03.00004603; Takizawa H, 2004, CURR OPIN ALLERGY CL, V4, P355, DOI 10.1097/00130832-200410000-00005; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Webster SJ, 2010, J IMMUNOL, V185, P2968, DOI 10.4049/jimmunol.1000805; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766	36	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51107	10.1371/journal.pone.0051107	http://dx.doi.org/10.1371/journal.pone.0051107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236439	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000312064100068
J	Cossarizza, A; Bertoncelli, L; Nemes, E; Lugli, E; Pinti, M; Nasi, M; De Biasi, S; Gibellini, L; Montagna, JP; Vecchia, M; Manzini, L; Meschiari, M; Borghi, V; Guaraldi, G; Mussini, C				Cossarizza, Andrea; Bertoncelli, Linda; Nemes, Elisa; Lugli, Enrico; Pinti, Marcello; Nasi, Milena; De Biasi, Sara; Gibellini, Lara; Montagna, Jonas P.; Vecchia, Marco; Manzini, Lisa; Meschiari, Marianna; Borghi, Vanni; Guaraldi, Giovanni; Mussini, Cristina			T Cell Activation but Not Polyfunctionality after Primary HIV Infection Predicts Control of Viral Load and Length of the Time without Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; GASTROINTESTINAL-TRACT; TREATMENT INTERRUPTION; FUNCTIONAL PROFILE; TYPE-1 INFECTION; LYMPHOCYTES; RESPONSES	Objective: Immune changes occurring after primary HIV infection (PHI) have a pivotal relevance. Our objective was to characterize the polyfunctionality of immune response triggered by PHI, and to characterize immune activation and regulatory T cells, correlating such features to disease progression. Patients and Methods: We followed 11 patients experiencing PHI for 4 years. By polychromatic flow cytometry, we studied every month, for the first 6 months, T lymphocyte polyfunctionality after cell stimulation with peptides derived from HIV-1 gag and nef. Tregs were identified by flow cytometry, and T cell activation studied by CD38 and HLA-DR expression. Results: An increase of anti-gag and anti-nef CD8+ specific T cells was observed 3 months after PHI; however, truly polyfunctional T cells, also able to produce IL-2, were never found. No gross changes in Tregs were present. T lymphocyte activation was maximal 1 and 2 months after PHI, and significantly decreased in the following period. The level of activation two months after PHI was strictly correlated to the plasma viral load 1 year after infection, and significantly influenced the length of period without therapy. Indeed, 80% of patients with less than the median value of activated CD8+ (15.5%) or CD4+ (0.9%) T cells remained free of therapy for >46 months, while all patients over the median value had to start treatment within 26 months. Conclusions: T cell activation after PHI, more than T cell polyfunctionality or Tregs, is a predictive marker for the control of viral load and for the time required to start treatment. Citation: Cossarizza A, Bertoncelli L, Nemes E, Lugli E, Pinti M, et al. (2012) T Cell Activation but Not Polyfunctionality after Primary HIV Infection Predicts Control of Viral Load and Length of the Time without Therapy. PLoS ONE 7(12): e50728. doi:10.1371/journal.pone.0050728	[Cossarizza, Andrea; Bertoncelli, Linda; Nemes, Elisa; Lugli, Enrico; Nasi, Milena; De Biasi, Sara; Gibellini, Lara; Montagna, Jonas P.; Vecchia, Marco; Manzini, Lisa; Meschiari, Marianna; Mussini, Cristina] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Modena, Italy; [Pinti, Marcello] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Borghi, Vanni; Guaraldi, Giovanni; Mussini, Cristina] Azienda Osped Univ Policlin Modena, Infect Dis Clin, Modena, Italy; [Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Mother Child & Adult, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia	Cossarizza, A (corresponding author), Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Modena, Italy.	andrea.cossarizza@unimore.it	Nasi, Milena/J-4425-2016; Meschiari, Marianna/AAC-1916-2022; Guaraldi, Giovanni/J-9467-2018; Pinti, Marcello/C-9351-2015; De Biasi, Sara/AAB-7520-2019; Mussini, Cristina/K-8672-2016; Lugli, Enrico/AAB-7933-2019	Nasi, Milena/0000-0003-3079-8001; Meschiari, Marianna/0000-0002-1254-9995; Pinti, Marcello/0000-0001-9118-1262; De Biasi, Sara/0000-0002-3217-9821; Mussini, Cristina/0000-0002-6615-4198; Lugli, Enrico/0000-0002-1964-7678; Cossarizza, Andrea/0000-0002-5381-1558; Gray, Clive/0000-0002-9293-901X; Vecchia, Marco/0000-0002-6660-2448; Guaraldi, Giovanni/0000-0002-5724-3914	"Programma Nazionale di Ricerca sull'AIDS - Istituto Superiore di Sanita'', Rome, Italy [40H71]	"Programma Nazionale di Ricerca sull'AIDS - Istituto Superiore di Sanita'', Rome, Italy	This study was partially supported by "Programma Nazionale di Ricerca sull'AIDS 2009-2010 - Istituto Superiore di Sanita'', Rome, Italy (grant 40H71 to AC). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Al-Harthi L, 2007, CLIN IMMUNOL, V125, P299, DOI 10.1016/j.clim.2007.08.011; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Barbieri D, 1998, NEUROCHEM INT, V32, P493, DOI 10.1016/S0197-0186(97)00129-0; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bosinger SE, 2011, CURR OPIN HIV AIDS, V6, P411, DOI 10.1097/COH.0b013e3283499cf6; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Cossarizza A, 2004, JAIDS-J ACQ IMM DEF, V35, P213, DOI 10.1097/00126334-200403010-00001; Cossarizza A, 1999, EXP CELL RES, V247, P304, DOI 10.1006/excr.1999.4387; COSSARIZZA A, 1995, AIDS, V9, P547, DOI 10.1097/00002030-199506000-00003; Cossarizza A, 1997, AIDS, V11, P19, DOI 10.1097/00002030-199701000-00004; COSSARIZZA A, 1995, J INFECT DIS, V172, P105, DOI 10.1093/infdis/172.1.105; Cossarizza A, 2000, AIDS, V14, P345, DOI 10.1097/00002030-200003100-00007; Cossarizza A, 2011, MITOCHONDRION, V11, P750, DOI 10.1016/j.mito.2011.06.005; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Lugli E, 2007, CYTOM PART A, V71A, P334, DOI 10.1002/cyto.a.20387; Maenetje P, 2010, J IMMUNOL, V184, P4926, DOI 10.4049/jimmunol.0903771; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Moreno-Fernandez ME, 2012, J VIROL, V86, P10262, DOI 10.1128/JVI.00993-12; Nemes E, 2006, AIDS, V20, P2021, DOI 10.1097/01.aids.0000247575.41622.b1; Nemes E, 2011, AIDS, V25, P1443, DOI 10.1097/QAD.0b013e328347b5e2; Nemes E, 2010, AIDS, V24, P947, DOI 10.1097/QAD.0b013e328337b144; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Ortiz AM, 2011, J CLIN INVEST, V121, P4433, DOI 10.1172/JCI46023; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Pinti M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.47; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Rizzardi GP, 2002, J CLIN INVEST, V109, P681, DOI 10.1172/JCI200214522; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Tran TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003305; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	48	19	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50728	10.1371/journal.pone.0050728	http://dx.doi.org/10.1371/journal.pone.0050728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236388	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100030
J	Estopinal, CB; van Dijk, JH; Sitali, S; Stewart, H; Davidson, MA; Spurrier, J; Vermund, SH				Estopinal, Christopher B.; van Dijk, Janneke H.; Sitali, Stanley; Stewart, Hannah; Davidson, Mario A.; Spurrier, John; Vermund, Sten H.			Availability of Volunteer-Led Home-Based Care System and Baseline Factors as Predictors of Clinical Outcomes in HIV-Infected Patients in Rural Zambia	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; ADHERENCE; MORTALITY; SUPPORT	Background: We assessed the impact of home-based care (HBC) for HIV+ patients, comparing outcomes between two groups of Zambians receiving antiretroviral therapy (ART) who lived in villages with and without HBC teams. Methods: We conducted a retrospective cohort study using medical charts from Macha Mission Hospital, a hospital providing HIV care in Zambia's rural Southern Province. Date of birth, date of ART initiation, place of residence, sex, body mass index (BMI), CD4+ cell count, and hemoglobin (Hgb) were abstracted. Logistic regression was used to test our hypothesis that HBC was associated with treatment outcomes. Results: Of 655 patients, 523 (80%) were eligible and included in the study. There were 428 patients (82%) with favorable outcomes (alive and on ART) and 95 patients (18%) with unfavorable outcomes (died, lost to follow-up, or stopped treatment). A minority of the 523 eligible patients (n = 84, 16%) lived in villages with HBC available. Living in a village with HBC was not significantly associated with treatment outcomes; 80% of patients in a village with HBC had favorable outcomes, compared to 82% of patients in a village without HBC (P = 0.6 by chi(2)). In bivariable analysis, lower BMI (P < 0.001), low CD4+ cell count (P = 0.02), low Hgb concentration (P = 0.02), and older age at ART initiation (P = 0.047) were associated with unfavorable outcomes. In multivariable analysis, low BMI remained associated with unfavorable outcomes (P, 0.001). Conclusions: We did not find that living in a village with HBC available was associated with improved treatment outcomes. We speculate that the ART clinic's rigorous treatment preparation before ART initiation and continuous adherence counseling during ART create a motivated group of patients whose outcomes did not improve with additional HBC support. An alternative explanation is that the quality of the HBC program is suboptimal.	[Estopinal, Christopher B.; Davidson, Mario A.; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [van Dijk, Janneke H.; Stewart, Hannah] Macha Res Trust, Macha, Zambia; [Sitali, Stanley; Spurrier, John] Macha Mission Hosp, Macha, Zambia	Vanderbilt University	Estopinal, CB (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	chris.estopinal@vanderbilt.edu	Vermund, Sten/AAD-3592-2020; Davidson, Mario/AAX-1102-2021	Vermund, Sten/0000-0001-7289-8698; 	Vanderbilt University Emphasis program; Vanderbilt-Meharry Framework Program for Global Health (Fogarty International Center, NIH) [R25TW007766]; FOGARTY INTERNATIONAL CENTER [R25TW007766] Funding Source: NIH RePORTER	Vanderbilt University Emphasis program; Vanderbilt-Meharry Framework Program for Global Health (Fogarty International Center, NIH); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Vanderbilt University Emphasis program and the Vanderbilt-Meharry Framework Program for Global Health (Fogarty International Center, NIH grant #R25TW007766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AW, 2010, GLOB HLTH ACTION, V3; Berrien VM, 2004, AIDS PATIENT CARE ST, V18, P355, DOI 10.1089/1087291041444078; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Carlucci JG, 2008, JAIDS-J ACQ IMM DEF, V47, P615, DOI 10.1097/QAI.0b013e318165dc25; CSO/Macro, 2009, ZAMB DEM HLTH SURV 2; Denny CC, 2008, JAMA-J AM MED ASSOC, V300, P2048, DOI 10.1001/jama.2008.556; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gordis L, 2004, EPIDEMIOLOGY, P226; Gostin LO, 2010, JAMA-J AM MED ASSOC, V304, P789, DOI 10.1001/jama.2010.1164; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Heimburger DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010687; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Johnson BA, 2004, J NATL MED ASSOC, V96, P496; Kabore I, 2010, AIDS PATIENT CARE ST, V24, P581, DOI 10.1089/apc.2009.0307; Lehmann U, 2007, COMMUNITY HLTH WORKE, P41; Miles MS, 2003, NURS RES, V52, P350, DOI 10.1097/00006199-200311000-00002; Ndaba-Mbata R D, 2000, Int Nurs Rev, V47, P218, DOI 10.1046/j.1466-7657.2000.00023.x; Olang'o CO, 2010, HEALTH POLICY, V97, P232, DOI 10.1016/j.healthpol.2010.05.004; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tuboi SH, 2005, JAIDS-J ACQ IMM DEF, V40, P324, DOI 10.1097/01.qai.0000182627.28595.01; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNDP, 2010, UN DEV PROGR HUM DEP; United Nations Development Programme (UNDP), 2010, HUM DEV REP 2010 20; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; Williams AB, 2006, JAIDS-J ACQ IMM DEF, V42, P314, DOI 10.1097/01.qai.0000221681.60187.88; World Health Organization, 2006, ANT THER HIV INF AD; Wouters E, 2008, AIDS, V22, P2545, DOI 10.1097/QAD.0b013e32831c5562; Wube M, 2010, J PAIN SYMPTOM MANAG, V40, P6, DOI 10.1016/j.jpainsymman.2010.04.003; Young T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005417.pub2; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	31	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49564	10.1371/journal.pone.0049564	http://dx.doi.org/10.1371/journal.pone.0049564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236351	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100004
J	Jourdain, P; Boss, D; Rappaz, B; Moratal, C; Hernandez, MC; Depeursinge, C; Magistretti, PJ; Marquet, P				Jourdain, Pascal; Boss, Daniel; Rappaz, Benjamin; Moratal, Corinne; Hernandez, Maria-Clemencia; Depeursinge, Christian; Magistretti, Pierre Julius; Marquet, Pierre			Simultaneous Optical Recording in Multiple Cells by Digital Holographic Microscopy of Chloride Current Associated to Activation of the Ligand-Gated Chloride Channel GABA(A) Receptor	PLOS ONE			English	Article							K-CL COTRANSPORTER; PHASE MICROSCOPY; LIVING CELLS; ACID; EXPRESSION; CONTRAST; GLYCINE; NEURONS; BRAIN; NKCC1	Chloride channels represent a group of targets for major clinical indications. However, molecular screening for chloride channel modulators has proven to be difficult and time-consuming as approaches essentially rely on the use of fluorescent dyes or invasive patch-clamp techniques which do not lend themselves to the screening of large sets of compounds. To address this problem, we have developed a non-invasive optical method, based on digital holographic microcopy (DHM), allowing monitoring of ion channel activity without using any electrode or fluorescent dye. To illustrate this approach, GABA(A) mediated chloride currents have been monitored with DHM. Practically, we show that DHM can non-invasively provide the quantitative determination of transmembrane chloride fluxes mediated by the activation of chloride channels associated with GABA(A) receptors. Indeed through an original algorithm, chloride currents elicited by application of appropriate agonists of the GABA(A) receptor can be derived from the quantitative phase signal recorded with DHM. Finally, chloride currents can be determined and pharmacologically characterized non-invasively simultaneously on a large cellular sampling by DHM.	[Jourdain, Pascal; Boss, Daniel; Rappaz, Benjamin; Moratal, Corinne; Magistretti, Pierre Julius; Marquet, Pierre] Ecole Polytech Fed Lausanne, Brain & Mind Inst, Lausanne, Switzerland; [Hernandez, Maria-Clemencia] Hoffmann La Roche AG, Basel, Switzerland; [Depeursinge, Christian] Ecole Polytech Fed Lausanne, Inst Appl Opt, Lausanne, Switzerland; [Magistretti, Pierre Julius; Marquet, Pierre] Univ Lausanne Hosp, Ctr Psychiat, Dept Neurosci, Prilly, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Roche Holding; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Jourdain, P (corresponding author), Ecole Polytech Fed Lausanne, Brain & Mind Inst, Lausanne, Switzerland.	pascal.jourdain@epfl.ch; pierre.marquet@chuv.ch	Rappaz, Benjamin/C-1881-2014	Rappaz, Benjamin/0000-0002-8744-600X; Magistretti, Pierre Julius/0000-0002-6678-320X	CTI/KTI [9389.1]; Swiss National Science Foundation (SNSF) [CR3213_132993]	CTI/KTI; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This research has been funded by the CTI/KTI project (http://www.kti.admin.ch/index.html?lang=en) #9389.1 and by the Swiss National Science Foundation (SNSF; http://www.snf.ch/E/Pages/default.aspx) grant no CR3213_132993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARER R, 1953, NATURE, V172, P1097, DOI 10.1038/1721097a0; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Bowery NG, 2006, BRIT J PHARMACOL, V147, pS109, DOI 10.1038/sj.bjp.0706443; Carl D, 2004, APPL OPTICS, V43, P6536, DOI 10.1364/AO.43.006536; Colomb T, 2006, J OPT SOC AM A, V23, P3177, DOI 10.1364/JOSAA.23.003177; Cuche E, 1999, APPL OPTICS, V38, P6994, DOI 10.1364/AO.38.006994; Curl CL, 2004, CLIN EXP PHARMACOL P, V31, P896, DOI 10.1111/j.1440-1681.2004.04100.x; Depeursinge C, 2007, P ANN INT IEEE EMBS, P6244; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; HAMILTON BJ, 1993, NEUROSCI LETT, V153, P206, DOI 10.1016/0304-3940(93)90323-D; Helix N, 2003, J MEMBRANE BIOL, V196, P83, DOI 10.1007/s00232-003-0627-x; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Loscher W, 2012, NEUROPHARMACOLOGY; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; Maksay G, 2001, NEUROSCI LETT, V311, P169, DOI 10.1016/S0304-3940(01)02163-2; MALHERBE P, 1990, J NEUROSCI, V10, P2330; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Pavillon N, 2010, J BIOPHOTONICS, V3, P432, DOI 10.1002/jbio.201000018; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rappaz B, 2008, CYTOM PART A, V73A, P895, DOI 10.1002/cyto.a.20605; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696	31	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51041	10.1371/journal.pone.0051041	http://dx.doi.org/10.1371/journal.pone.0051041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236427	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100057
J	McNally, B; Willette, M; Ye, F; Partida-Sanchez, S; Flano, E				McNally, Beth; Willette, Meredith; Ye, Fang; Partida-Sanchez, Santiago; Flano, Emilio			Intranasal Administration of dsRNA Analog Poly(I:C) Induces Interferon-alpha Receptor-Dependent Accumulation of Antigen Experienced T Cells in the Airways	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; VACCINE PROTECTS; VIRUS REPLICATION; MICE; RECOGNITION; RESPONSES; IMMUNITY; DIFFERENTIATION; ACTIVATION	Polyriboinosinic-polyribocytoidylic acid (pIC), a synthetic dsRNA, acts as an adjuvant that boosts immune responses and protection. Intranasal (IN) administration of pIC has recently been used to adjuvant influenza virus vaccines; however, the effects of IN pIC administration on pulmonary T cell responses remain unclear. Here we show that a single IN administered dose of dsRNA into mice induced local Th1 chemokine production in the lungs and airways, and generated a biphasic and sustained migration of T lymphocytes to the airways. Furthermore, IN pIC-induced chemokine production and T cell recruitment to the airways were interferon-alpha receptor (IFNAR) signaling dependent. The effect of dsRNA on T cell recruitment to the airways was also dependent on the presence of high molecular weight (HMW) pIC, as a low molecular weight (LMW) pIC preparation known to only interact with TLR3 did not elicit the same effect on T cell migration to the airways, suggesting that the observed effects were dependent upon dsRNA recognition by multiple pattern recognition receptors (PPRs). IN pIC was additionally capable of stimulating low levels of T cell proliferation in the draining lymph nodes approximately 4-6 days after treatment that preceded a small population of de-novo T cells found in the airways by day 10. Taken together, these results demonstrate that the adjuvant effect of IN pIC that results in enhanced T cell proliferation and sustained T cell recruitment to the airways requires multiple PRRs and IFNAR signaling.	[McNally, Beth; Willette, Meredith; Ye, Fang; Flano, Emilio] Res Inst Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH 43205 USA; [Partida-Sanchez, Santiago] Res Inst Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH USA; [Partida-Sanchez, Santiago; Flano, Emilio] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Flano, E (corresponding author), Res Inst Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH 43205 USA.	Emilio.flano@nationwidechildrens.org	Flano, Emilio/E-3066-2011; Partida-Sanchez, Santiago/B-7523-2008	Partida-Sanchez, Santiago/0000-0003-2996-9440	NIH [AI082962, AI059603]; Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059603, U01AI082962, R01AI059603, R01AI092117] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants AI082962 and AI059603 and by The Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2001, AM J PATHOL, V158, P1703, DOI 10.1016/S0002-9440(10)64126-0; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Atmar RL, 2007, VACCINE, V25, P5367, DOI 10.1016/j.vaccine.2007.05.002; Avraamides G, 2007, J INTERF CYTOK RES, V27, P291, DOI 10.1089/jir.2006.0107; Avril T, 2009, J IMMUNOTHER, V32, P353, DOI 10.1097/CJI.0b013e31819d29bf; Barnard Dale L., 2006, Antiviral Chemistry & Chemotherapy, V17, P275; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Durand V, 2006, VACCINE, V24, pS22, DOI 10.1016/j.vaccine.2005.01.115; Shen EX, 2007, CELL MOL IMMUNOL, V4, P113; Flano E, 2009, CURR PROTOC CELL BIO; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2007, MICROBES INFECT, V9, P1333, DOI 10.1016/j.micinf.2007.06.007; Ichinohe T, 2010, J MED VIROL, V82, P1754, DOI 10.1002/jmv.21824; Ichinohe T, 2009, VACCINE, V27, P6276, DOI 10.1016/j.vaccine.2009.04.074; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lau YF, 2009, VACCINE, V27, P1354, DOI 10.1016/j.vaccine.2008.12.048; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Ngoi SM, 2008, J IMMUNOL, V181, P7670, DOI 10.4049/jimmunol.181.11.7670; Salaun B, 2009, VACCINE, V27, P1841, DOI 10.1016/j.vaccine.2009.01.044; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Starkhammar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032110; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Tough DF, 2012, IMMUNOL CELL BIOL; Wareing MD, 2003, VACCINE, V21, P3097, DOI 10.1016/S0264-410X(03)00262-7; Wiesel M, 2012, EUR J IMMUNOL, V42, P320, DOI 10.1002/eji.201142091; Wiesel M, 2011, J IMMUNOL, V186, P754, DOI 10.4049/jimmunol.1003166; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048	42	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51351	10.1371/journal.pone.0051351	http://dx.doi.org/10.1371/journal.pone.0051351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236482	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100103
J	Sargeant, DP; Gryk, MR; Maciejewski, MW; Thapar, V; Kundeti, V; Rajasekaran, S; Romero, P; Dunker, K; Li, SC; Kaneko, T; Schiller, MR				Sargeant, David P.; Gryk, Michael R.; Maciejewski, Mark W.; Thapar, Vishal; Kundeti, Vamsi; Rajasekaran, Sanguthevar; Romero, Pedro; Dunker, Keith; Li, Shun-Cheng; Kaneko, Tomonori; Schiller, Martin R.			Secondary Structure, a Missing Component of Sequence-Based Minimotif Definitions	PLOS ONE			English	Article							POLYPROLINE-II HELICES; RAMAN OPTICAL-ACTIVITY; PROLINE-RICH PEPTIDES; PROTEIN DATA-BANK; RESIDUAL STRUCTURE; SH3 DOMAIN; DENATURED-STATE; CRYSTAL-STRUCTURE; LINEAR MOTIFS; ALPHA-HELIX	Minimotifs are short contiguous segments of proteins that have a known biological function. The hundreds of thousands of minimotifs discovered thus far are an important part of the theoretical understanding of the specificity of protein-protein interactions, posttranslational modifications, and signal transduction that occur in cells. However, a longstanding problem is that the different abstractions of the sequence definitions do not accurately capture the specificity, despite decades of effort by many labs. We present evidence that structure is an essential component of minimotif specificity, yet is not used in minimotif definitions. Our analysis of several known minimotifs as case studies, analysis of occurrences of minimotifs in structured and disordered regions of proteins, and review of the literature support a new model for minimotif definitions that includes sequence, structure, and function.	[Sargeant, David P.; Schiller, Martin R.] Univ Nevada Las Vegas, Sch Life Sci, Las Vegas, NV 89119 USA; [Gryk, Michael R.; Maciejewski, Mark W.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT USA; [Thapar, Vishal; Kundeti, Vamsi; Rajasekaran, Sanguthevar] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA; [Romero, Pedro; Dunker, Keith] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Li, Shun-Cheng; Kaneko, Tomonori] Univ Western Ontario, Dept Biochem, London, ON, Canada	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Connecticut; University of Connecticut; Indiana University System; Indiana University Bloomington; Western University (University of Western Ontario)	Schiller, MR (corresponding author), Univ Nevada Las Vegas, Sch Life Sci, Las Vegas, NV 89119 USA.	Martin.Schiller@unlv.edu	Romero, Pedro R/D-4110-2018	Romero, Pedro R/0000-0002-6995-5193; Kaneko, Tomonori/0000-0001-5448-9639; Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [GM079689, LM010101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by National Institutes of Health grants GM079689 and LM010101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Adler MJ, 2011, CURR TOP MICROBIOL, V348, P1, DOI 10.1007/82_2010_91; ADZHUBEI AA, 1994, PROTEIN SCI, V3, P2395, DOI 10.1002/pro.5560031223; ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Alix Alain J. P., 2001, Journal de la Societe de Biologie, V195, P181; AUNE KC, 1967, J BIOL CHEM, V242, P4486; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; Bourguet E, 2003, BIOORG MED CHEM LETT, V13, P1561, DOI 10.1016/S0960-894X(03)00181-1; Bowler BE, 2007, MOL BIOSYST, V3, P88, DOI 10.1039/b611895j; BRAKCH N, 1993, BIOCHEMISTRY-US, V32, P4925, DOI 10.1021/bi00069a029; BRAKCH N, 1993, EUR J BIOCHEM, V216, P39, DOI 10.1111/j.1432-1033.1993.tb18114.x; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; CALLAHAN JF, 1992, J MED CHEM, V35, P3970, DOI 10.1021/jm00099a027; Ceol A, 2007, NUCLEIC ACIDS RES, V35, pD557, DOI 10.1093/nar/gkl961; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Chica C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006052; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Chugh J, 2008, BIOPHYS CHEM, V137, P13, DOI 10.1016/j.bpc.2008.06.005; Cobos ES, 2004, J MOL BIOL, V342, P355, DOI 10.1016/j.jmb.2004.06.078; Cortajarena AL, 2008, J MOL BIOL, V382, P203, DOI 10.1016/j.jmb.2008.07.005; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Creighton CJ, 2006, BIOORG MED CHEM LETT, V16, P3971, DOI 10.1016/j.bmcl.2006.05.020; Crisma M, 2002, BIOPOLYMERS, V64, P236, DOI 10.1002/bip.10178; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dunker A K, 1998, Pac Symp Biocomput, P473; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Edwards RJ, 2012, MOL BIOSYST, V8, P282, DOI 10.1039/c1mb05212h; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Finnegan ML, 2010, J MOL BIOL, V403, P495, DOI 10.1016/j.jmb.2010.09.004; Fisher MJ, 1997, J MED CHEM, V40, P2085, DOI 10.1021/jm9701076; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gmeiner WH, 2001, CELL BIOCHEM BIOPHYS, V35, P115, DOI 10.1385/CBB:35:2:115; Hagarman A, 2011, CHEM-EUR J, V17, P6789, DOI 10.1002/chem.201100016; Harkiolaki M, 2009, STRUCTURE, V17, P809, DOI 10.1016/j.str.2009.03.017; Higo J, 2001, PROTEIN SCI, V10, P1160, DOI 10.1110/ps.44901; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; HOOG SS, 1995, J MED CHEM, V38, P3246, DOI 10.1021/jm00017a008; Hugo W, 2010, BIOINFORMATICS, V26, P1036, DOI 10.1093/bioinformatics/btq065; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JOHNSON WC, 1993, BIOCHEMISTRY-US, V32, P268, DOI 10.1021/bi00052a034; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karvounis G, 2004, J CHEM PHYS, V121, P4925, DOI 10.1063/1.1780152; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Kolano C, 2006, NATURE, V444, P469, DOI 10.1038/nature05352; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOSHLAND DE, 1958, FED PROC, V17, P1145; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lazarus Robert A., 1993, Current Opinion in Biotechnology, V4, P438, DOI 10.1016/0958-1669(93)90009-L; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Li H, 2008, J BIOL CHEM, V283, P27165, DOI 10.1074/jbc.M803892200; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; MATTHEWS CR, 1975, BIOCHEMISTRY-US, V14, P4532, DOI 10.1021/bi00691a031; MAYO KH, 1991, BIOCHEMISTRY-US, V30, P8251, DOI 10.1021/bi00247a022; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; Mi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045589; Mi T, 2012, NUCLEIC ACIDS RES, V40, pD252, DOI 10.1093/nar/gkr1189; MONSALVE RI, 1990, FEBS LETT, V263, P209, DOI 10.1016/0014-5793(90)81375-X; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Moroy G, 2009, PROTEINS, V76, P461, DOI 10.1002/prot.22361; Morton CJ, 1996, STRUCTURE, V4, P705, DOI 10.1016/S0969-2126(96)00076-7; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neira JL, 1999, J MOL BIOL, V285, P627, DOI 10.1006/jmbi.1998.2365; NEWLANDER KA, 1993, J MED CHEM, V36, P2321, DOI 10.1021/jm00068a008; Newman RA, 2008, PROTEINS, V71, P1792, DOI 10.1002/prot.21861; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; Nioche P, 2002, J MOL BIOL, V315, P1167, DOI 10.1006/jmbi.2001.5299; O'Shea J Conor, 2002, Expert Opin Pharmacother, V3, P1199; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Paz A, 2008, BIOPHYS J, V95, P1928, DOI 10.1529/biophysj.107.126995; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Rajasekaran S, 2010, ALGORITHMS COMPUTATI, P261; Rajasekaran S, 2011, PROTEINS, V79, P153, DOI 10.1002/prot.22868; Rajasekaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012276; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Skelton NJ, 2001, BIOCHEMISTRY-US, V40, P8487, DOI 10.1021/bi0103866; Smith LJ, 1996, FOLD DES, V1, pR95, DOI 10.1016/S1359-0278(96)00046-6; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Tompa P, 2003, J MOL STRUC-THEOCHEM, V666, P361, DOI 10.1016/j.theochem.2003.08.047; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Vanhee P, 2011, NUCLEIC ACIDS RES, V39, pD435, DOI 10.1093/nar/gkq972; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Vyas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-328; Vyas J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-360; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Willighagen E, 2007, NATURE PRECEEDINGS; Wilson G, 1996, BIOCHEMISTRY-US, V35, P12518, DOI 10.1021/bi961314v; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Yamada T, 1996, FEBS LETT, V387, P11, DOI 10.1016/0014-5793(96)00409-7; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816; Yoon MK, 2009, PROTEIN SCI, V18, P337, DOI 10.1002/pro.34; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhu F, 2008, PROTEINS, V70, P823, DOI 10.1002/prot.21593; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	123	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49957	10.1371/journal.pone.0049957	http://dx.doi.org/10.1371/journal.pone.0049957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236358	gold, Green Published, Green Submitted			2022-12-25	WOS:000312064100009
J	Liu, PW; Chen, MF; Tsai, APY; Lee, TJF				Liu, Po-Wen; Chen, Mei-Fang; Tsai, Andy Po-Yi; Lee, Tony J. F.			STAT1 Mediates Oroxylin A Inhibition of iNOS and Pro-Inflammatory Cytokines Expression in Microglial BV-2 Cells	PLOS ONE			English	Article							NITRIC-OXIDE-SYNTHASE; FACTOR-KAPPA-B; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); ACTIVATED MACROPHAGES; MEMORY IMPAIRMENT; GENE-EXPRESSION; UP-REGULATION; LIPOPOLYSACCHARIDE; MECHANISMS; DISEASE	Microglia-mediated inflammation is implicated in pathogenesis of neurodegenerative diseases. Oroxylin A, a flavonoid isolated from Scutellariae baicalensis, has been shown to ameliorate microglia activation-mediated neurodegeneration in vivo. The molecular mechanism underlying the inhibitory effects of oroxylin A on microglia activation, however, remains unknown. In the present study, effects of oroxylin A co-treated with lipopolysaccharide (LPS, 100 ng/ml) on LPS-induced activation of cultured microglial BV-2 cells were examined. Nitric oxide (NO) production was determined by Greiss method. Expression of inducible nitric oxide synthase (iNOS), interleukin (IL)-1 beta and IL-6 was assessed using real-time RT-PCR or Western blot analysis. Furthermore, activation of the nuclear factor kappa B (NF kappa B) and the signal transducer and activator of transcription 1 (STAT1) was examined by Western blot analysis and transcription factor DNA-binding activity assay. Our results indicated that oroxylin A (10-100 mu M) in a concentration-dependent manner inhibited LPS-induced NO production via blocking iNOS expression at both mRNA and protein levels without affecting the degradation rate of iNOS mRNA. Moreover, oroxylin A significantly attenuated LPS-induced late expression (20 hours after LPS challenge) of IL-1 beta and IL-6. Furthermore, oroxylin A significantly suppressed LPS-induced JAK2-mediated STAT1 phosphorylation without affecting LPS-induced NF kappa B-p65 nuclear translocation or NF kappa B-p65 DNA-binding activity. This is consistent with the finding that AG490, a specific JAK2 inhibitor, significantly inhibited LPS-induced STAT1 phosphorylation with almost completely diminished iNOS expression. These results suggest that oroxylin A, via suppressing STAT1 phosphorylation, inhibits LPS-induced expression of pro-inflammatory genes in BV-2 microglial cells. Citation: Liu P-W, Chen M-F, Tsai AP-Y, Lee TJF (2012) STAT1 Mediates Oroxylin A Inhibition of iNOS and Pro-Inflammatory Cytokines Expression in Microglial BV-2 Cells. PLoS ONE 7(12): e50363. doi:10.1371/journal.pone.0050363	[Liu, Po-Wen; Tsai, Andy Po-Yi; Lee, Tony J. F.] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan; [Lee, Tony J. F.] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Chen, Mei-Fang; Lee, Tony J. F.] Tzu Chi Univ, Coll Life Sci, Ctr Vasc Med, Hualien, Taiwan; [Chen, Mei-Fang] Buddhist Tzu Chi Gen Hosp, Dept Res, Hualien, Taiwan; [Chen, Mei-Fang] Tzu Chi Coll Technol, Hualien, Taiwan; [Lee, Tony J. F.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Tzu Chi University; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University of Science & Technology; Southern Illinois University System; Southern Illinois University	Lee, TJF (corresponding author), Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan.	tlee@mail.tcu.edu.tw	Tsai, Andy/AAP-2963-2021; TSAI, ANDY/AAT-2711-2021	Tsai, Andy/0000-0001-6400-544X; 	Tzu Chi University [TCIRP 95005-01, TCIRP 95005-02, TCIRP 98005-01, TCIRP 98005-02, TCRPP99006]; National Science Council of Taiwan [NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC-99-2320-B-320-008, NSC-99-2120-M-259001, NSC 100-2320-B-320-007-MY2]; Tzu Chi Foundation	Tzu Chi University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi Foundation	This study was supported by Tzu Chi University (Grants TCIRP 95005-01, TCIRP 95005-02, TCIRP 98005-01, TCIRP 98005-02, and TCRPP99006), National Science Council of Taiwan (NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC-99-2320-B-320-008, NSC-99-2120-M-259001, and NSC 100-2320-B-320-007-MY2), and Tzu Chi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beck KF, 1996, FEBS LETT, V394, P263, DOI 10.1016/0014-5793(96)00966-0; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Chang LC, 2008, BIOCHEM PHARMACOL, V76, P507, DOI 10.1016/j.bcp.2008.06.002; Chen YC, 2000, BIOCHEM PHARMACOL, V59, P1445, DOI 10.1016/S0006-2952(00)00255-0; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Gao HM, 2003, FASEB J, V17, P1957, DOI 10.1096/fj.03-0203fje; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hammermann R, 2000, MOL PHARMACOL, V58, P1294, DOI 10.1124/mol.58.6.1294; Ichikawa T, 2009, J ETHNOPHARMACOL, V125, P145, DOI 10.1016/j.jep.2009.05.032; Jacobs AT, 2001, J BIOL CHEM, V276, P47950, DOI 10.1074/jbc.M106639200; Kim DH, 2008, NEUROPHARMACOLOGY, V55, P639, DOI 10.1016/j.neuropharm.2008.05.019; Kim DH, 2006, PHARMACOL BIOCHEM BE, V85, P658, DOI 10.1016/j.pbb.2006.10.025; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Liberatore GT, 1999, NAT MED, V5, P1403; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Pautz A, 2009, J BIOL CHEM, V284, P2755, DOI 10.1074/jbc.M809314200; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Pham TAN, 2012, BIOORG MED CHEM LETT, V22, P2534, DOI 10.1016/j.bmcl.2012.01.135; Possel H, 2000, GLIA, V32, P51, DOI 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Salonen T, 2006, BRIT J PHARMACOL, V147, P790, DOI 10.1038/sj.bjp.0706672; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Sareila O, 2008, J PHARMACOL EXP THER, V324, P858, DOI 10.1124/jpet.107.129114; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Takeuchi H, 2006, NEUROBIOL DIS, V22, P33, DOI 10.1016/j.nbd.2005.09.014; Tedeschi E, 2004, MOL PHARMACOL, V65, P111, DOI 10.1124/mol.65.1.111; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wang MJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-99; Won JS, 2004, FREE RADICAL BIO MED, V37, P1834, DOI 10.1016/j.freeradbiomed.2004.08.017	40	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50363	10.1371/journal.pone.0050363	http://dx.doi.org/10.1371/journal.pone.0050363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236370	gold, Green Submitted, Green Published			2022-12-25	WOS:000312589700012
J	Colombi, CE; Fernandez, E; Currie, BS; Alcober, OA; Martinez, R; Correa, G				Colombi, Carina E.; Fernandez, Eliana; Currie, Brian S.; Alcober, Oscar A.; Martinez, Ricardo; Correa, Gustavo			Large-Diameter Burrows of the Triassic Ischigualasto Basin, NW Argentina: Paleoecological and Paleoenvironmental Implications	PLOS ONE			English	Article							BEAUFORT-GROUP; TETRAPOD BURROWS; EARLY EVOLUTION; KAROO BASIN; DINOSAUR; CYNODONT; ORIGIN; RECORD; SAUROPODOMORPHA; EUCYNODONTIA	Large-diameter ichnofossils comprising three morphotypes have been identified in the Upper Triassic Ischigualasto and Los Colorados formations of northwestern Argentina. These burrows add to the global record of the early appearance of fossorial behavior during early Mesozoic time. Morphotypes 1 and 2 are characterized by a network of tunnels and shafts that can be assigned to tetrapod burrows given similarities with previously described forms. However, differences in diameter, overall morphology, and stratigraphic occurrence allow their independent classification. Morphotype 3 forms a complex network of straight branches that intersect at oblique angles. Their calcareous composition and surface morphology indicate these structures have a composite biogenic origin likely developed due to combined plant/animal interactions. The association of Morphotypes 1 and 2 with fluvial overbank lithologies deposited under an extremely seasonal arid climate confirms interpretations that the early appearance of burrowing behavior was employed by vertebrates in response to both temperature and moisture-stress associated with seasonally or perpetually dry Pangean paleoclimates. Comparisons of burrow morphology and biomechanical attributes of the abundant paleovertebrate fauna preserved in both formations permit interpretations regarding the possible burrow architects for Morphotypes 1 and 2. In the case of the Morphotype 1, the burrow constructor could be one of the small carnivorous cynodonts, Ecteninion or Probelesodon. Assigning an architect for Morphotype 2 is more problematic due to mismatches between the observed burrow morphology and the size of the known Los Colorados vertebrates. Citation: Colombi CE, Fernandez E, Currie BS, Alcober OA, Martinez R, et al. (2012) Large-Diameter Burrows of the Triassic Ischigualasto Basin, NW Argentina: Paleoecological and Paleoenvironmental Implications. PLoS ONE 7(12): e50662. doi:10.1371/journal.pone.0050662	[Colombi, Carina E.; Correa, Gustavo] Consejo Nacl Invest Cient & Tecn, San Juan, Argentina; [Colombi, Carina E.; Fernandez, Eliana; Alcober, Oscar A.; Martinez, Ricardo; Correa, Gustavo] Univ Nacl San Juan, Inst & Museo Ciencias Nat, Dept Paleontol Vertebrados, San Juan, Argentina; [Currie, Brian S.] Miami Univ, Dept Geol, Oxford, OH 45056 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Juan; University System of Ohio; Miami University	Colombi, CE (corresponding author), Consejo Nacl Invest Cient & Tecn, San Juan, Argentina.	ccolombi@unsj.edu.ar		Colombi, Carina/0000-0003-0192-9455; Correa, Gustavo Alejandro/0000-0002-9799-9644; Currie, Brian/0000-0002-5759-3914	Instituto y Museo de Ciencias Naturales	Instituto y Museo de Ciencias Naturales	We thank the Instituto y Museo de Ciencias Naturales for their support at all stages of research. We also thank the field crews of the 2005 and 2006 Ischigualasto Basin fieldwork. We are indebted to Kay Behrensmeyer for her significant field discussion. We thank Ameghiniana for the permission to reproduce original figures under a Creative Commons Attribution Licence.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Alcober O, 1997, J VERTEBR PALEONTOL, V17, P548, DOI 10.1080/02724634.1997.10011001; Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; ANDERSEN DC, 1982, AM NAT, V119, P18, DOI 10.1086/283887; Arcucci AB, 2004, GEOBIOS-LYON, V37, P557, DOI 10.1016/j.geobios.2003.04.008; Arcucci AB, 2003, AMEGHINIANA, V40, P217; Bonaparte, 1971, P 2 IUGS GONDW S, P665; BONAPARTE J F, 1982, Journal of Vertebrate Paleontology, V2, P362; Bonaparte J.F., 1994, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" e Instituto Nacional de Investigacion de las Ciencias Naturales Paleontologia, V5, P1; BONAPARTE J F, 1978, Ameghiniana, V15, P327; Bonaparte J. F., 1963, Acta Geologica Lilloana, V4, P111; Bonaparte J. F., 1962, Publ Mus Cienc nat Mar del Plata, V1, P135; Bonaparte J.F., 1981, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" y Instituto Nacional de Investigacion de las Ciencias Naturales Palaeontologia, V3, P55; Bonaparte J.F, 1970, P PAP 2 GONDW S S AF, P665; Bonaparte J.F, 1980, ACT 2 C ARG PAL, V1, P123; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Bonaparte JF, 1978, OPERA LILLOANAO, V26, P596; Bonaparte JF, 1997, TRIASICO SL RIOJA; Bonaparte JF, 1969, IUGS C MAR PLATA MAR, V1967, P283; BONAPARTE JF, 1971, OPERA LILLOANA, V22, P87; Bordy EM, 2011, LETHAIA, V44, P33, DOI 10.1111/j.1502-3931.2010.00223.x; Desojo JB, 2009, PALAEONTOL Z, V83, P499, DOI 10.1007/s12542-009-0032-6; Casamiquela R. M., 1960, Rev Asoc pal argent, V2, P3; Casamiquela R. M., 1967, Ameghiniana, V5, P47; Casselli A, 2001, REV ASOC GEOL ARGENT, V56, P173; Colombi CE, 2011, REV BRAS PALEONTOLOG, V14, P39, DOI 10.4072/rbp.2011.1.04; Colombi CE, 2008, AMEGHINIANA, V45, P795; Colombi CE, 2008, PALAIOS, V23, P778, DOI 10.2110/palo.2007.p07-101r; Colombi GE, 2011, 4 C LAT PAL VERT AM; COX CB, 1965, PHILOS T ROY SOC B, V248, P457, DOI 10.1098/rstb.1965.0005; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Damiani R, 2003, P ROY SOC B-BIOL SCI, V270, P1747, DOI 10.1098/rspb.2003.2427; Davenport J., 1992, ANIMAL LIFE LOW TEMP; Delany M.J., 1979, ECOLOGY AFRICAN MAMM; Dentzien-Dias Paula C., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P585; Desojo JB, 2003, REV GEOL CHILE, V30, P53; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Groenewald GH, 2001, PALAIOS, V16, P148, DOI 10.2307/3515526; Hasiotis Stephen T., 2007, P196, DOI 10.1016/B978-044452949-7/50138-8; Hasiotis Stephen T., 2004, Ichnos, V11, P103, DOI 10.1080/10420940490428760; Hasiotis Stephen T., 1993, Ichnos, V2, P291; Krapovickas V, 2012, LETHAIA; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P3341, DOI 10.1029/JD094iD03p03341; Laundre J.W., 1989, Northwestern Naturalist, V70, P18, DOI 10.2307/3536924; Lopez Gamundi O.R., 1994, GEOL S AMER, V1984, P281, DOI DOI 10.1130/MEM184-P281; Martin AJ, 2009, CRETACEOUS RES, V30, P1223, DOI 10.1016/j.cretres.2009.06.003; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinelli AG, 2007, J VERTEBR PALEONTOL, V27, P442, DOI 10.1671/0272-4634(2007)27[442:OCMETF]2.0.CO;2; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P271, DOI 10.1080/02724634.1996.10011314; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P285, DOI 10.1080/02724634.1996.10011315; Milana J.P., 1994, REV ASOC GEOL ARGENT, V49, P217; Miller MF, 2001, PALAIOS, V16, P218, DOI 10.2307/3515601; Modesto SP, 2010, PALAIOS, V25, P274, DOI 10.2110/palo.2009.p09-077r; PARRISH JT, 1993, J GEOL, V101, P215, DOI 10.1086/648217; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Reichman O.J., 1990, Current Mammalogy, V2, P197; Reig O. A., 1963, Ameghiniana, V3, P3; Reig OA., 1959, REV ASOC GEOL ARGENT, V13, P257; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; ROMER A. S., 1954, BREVIORA MUS COMP ZOOL [HARVARD], V30, P1; ROUGIER GW, 1995, SCIENCE, V268, P855, DOI 10.1126/science.268.5212.855; Santi-Malnis P, 2011, LATINMAG LETT, V1, P1; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sidor CA, 2008, J VERTEBR PALEONTOL, V28, P277, DOI 10.1671/0272-4634(2008)28[277:TBFTTO]2.0.CO;2; SILL W D, 1970, Ameghiniana, V7, P341; SILL W D, 1974, Bulletin of the Museum of Comparative Zoology, V146, P317; SIMMS MJ, 1990, J GEOL SOC LONDON, V147, P321, DOI 10.1144/gsjgs.147.2.0321; SIMMS MJ, 1989, GEOLOGY, V17, P265, DOI 10.1130/0091-7613(1989)017<0265:SOCCAE>2.3.CO;2; Small BJ, 2002, ZOOL J LINN SOC-LOND, V136, P97, DOI 10.1046/j.1096-3642.2002.00028.x; Smith RMH, 1996, PALAEONTOLOGY, V39, P289; SMITH RMH, 1987, PALAEOGEOGR PALAEOCL, V60, P155, DOI 10.1016/0031-0182(87)90030-7; Smith Roger M. H., 1995, Palaeontologia Africana, V32, P45; Stipanicic PN, 1979, GEOLOGIA REGIONAL AR, P503; Tabor NJ, 2006, GEOL SOC AM SPEC PAP, P17, DOI 10.1130/2006.2416(02); Talanda M, 2011, PALAIOS, V26, P99, DOI 10.2110/palo.2010.p10-024r; Tanner LH, 2004, EARTH-SCI REV, V65, P103, DOI 10.1016/S0012-8252(03)00082-5; Tanner LH, 2009, VOLUMINA JURASSICA, V6, P99; Trotteyn MJ, 2012, J VERTEBR PALEONTOL, V32, P485, DOI 10.1080/02724634.2012.645975; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; Voigt S, 2011, PALAIOS, V26, P555, DOI 10.2110/palo.2011.p11-014r; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; Willmer P., 2000, ENV PHYSL ANIMALS	85	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50662	10.1371/journal.pone.0050662	http://dx.doi.org/10.1371/journal.pone.0050662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227195	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200055
J	Helfer, JL; White, ER; Christie, BR				Helfer, Jennifer L.; White, Emily R.; Christie, Brian R.			Enhanced Deficits in Long-Term Potentiation in the Adult Dentate Gyrus with 2nd Trimester Ethanol Consumption	PLOS ONE			English	Article							PRENATAL PROTEIN-MALNUTRITION; FETAL ALCOHOL SYNDROME; DECARBOXYLASE IMMUNOREACTIVE CELLS; BINDING-SITE DENSITY; BRAIN GROWTH SPURT; HIPPOCAMPAL-FORMATION; POSTNATAL EXPOSURE; RAT HIPPOCAMPUS; EARLY UNDERNUTRITION; SYNAPTIC PLASTICITY	Ethanol exposure during pregnancy can cause structural and functional changes in the brain that can impair cognitive capacity. The hippocampal formation, an area of the brain strongly linked with learning and memory, is particularly vulnerable to the teratogenic effects of ethanol. In the present experiments we sought to determine if the functional effects of developmental ethanol exposure could be linked to ethanol exposure during any single trimester-equivalent. Ethanol exposure during the 1st or 3rd trimester-equivalent produced only minor changes in synaptic plasticity in adult offspring. In contrast, ethanol exposure during the 2nd trimester equivalent resulted in a pronounced decrease in long-term potentiation, indicating that the timing of exposure influences the severity of the deficit. Together, the results from these experiments demonstrate long-lasting alterations in synaptic plasticity as the result of developmental ethanol exposure and dependent on the timing of exposure. Furthermore, these results allude to neural circuit malfunction within the hippocampal formation, perhaps relating to the learning and memory deficits observed in individuals with fetal alcohol spectrum disorders.	[Helfer, Jennifer L.; White, Emily R.; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Helfer, Jennifer L.; Christie, Brian R.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [White, Emily R.; Christie, Brian R.] Univ Victoria, Grad Program Neurosci, Victoria, BC, Canada; [Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Christie, Brian R.] Univ British Columbia, Grad Program Neurosci, Vancouver, BC V5Z 1M9, Canada; [Christie, Brian R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Victoria; University of Victoria; University of Victoria; University of British Columbia; University of British Columbia; University of British Columbia	Christie, BR (corresponding author), Univ Victoria, Div Med Sci, Victoria, BC, Canada.	brain64@uvic.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; Helfer, Jennifer/0000-0002-3769-0602	Candian Institute for Health Research (CIHR)	Candian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this work was supplied by the Candian Institute for Health Research (CIHR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Altman J., 1975, HIPPOCAMPUS STRUCTUR, P95, DOI [10.1007/978-1-4684-2976-3_5, DOI 10.1007/978-1-4684-2976-3_5]; ANGEVINE JB, 1965, EXP NEUROL, VS, P1; AUSTIN KB, 1986, DEV BRAIN RES, V29, P267, DOI 10.1016/0165-3806(86)90102-1; BARNES DE, 1981, DEV BRAIN RES, V1, P333, DOI 10.1016/0165-3806(81)90071-7; BAYER SA, 1975, EXP NEUROL, V48, P167, DOI 10.1016/0014-4886(75)90231-9; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Bellinger FP, 1999, SYNAPSE, V31, P51, DOI 10.1002/(SICI)1098-2396(199901)31:1<51::AID-SYN7>3.0.CO;2-O; Bronzino JD, 1997, EXP NEUROL, V148, P317, DOI 10.1006/exnr.1997.6653; Byrnes ML, 2004, NEUROTOXICOL TERATOL, V26, P543, DOI 10.1016/j.ntt.2004.04.005; Ceranik K, 1999, EUR J NEUROSCI, V11, P4278, DOI 10.1046/j.1460-9568.1999.00860.x; Christie BR, 2005, EUR J NEUROSCI, V21, P1719, DOI 10.1111/j.1460-9568.2005.04004.x; CLARREN SK, 1978, J PEDIATR-US, V92, P64, DOI 10.1016/S0022-3476(78)80072-9; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Costa ET, 2000, J BIOL CHEM, V275, P38268, DOI 10.1074/jbc.M004136200; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; Datta S, 2000, J SLEEP RES, V9, P71, DOI 10.1046/j.1365-2869.2000.00179.x; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; DEBASSIO WA, 1994, BRAIN RES BULL, V35, P57, DOI 10.1016/0361-9230(94)90216-X; Debassio WA, 1996, BRAIN RES BULL, V41, P379, DOI 10.1016/S0361-9230(96)00214-6; DiazGranados JL, 1997, ALCOHOL CLIN EXP RES, V21, P874, DOI 10.1097/00000374-199708000-00016; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; DREOSTI IE, 1993, ANN NY ACAD SCI, V678, P193; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Fisher H, 1997, ALCOHOL, V14, P199, DOI 10.1016/S0741-8329(97)83140-0; FISHER SE, 1988, ALCOHOL CLIN EXP RES, V12, P417, DOI 10.1111/j.1530-0277.1988.tb00219.x; Gloria L, 1997, AM J GASTROENTEROL, V92, P485; Goodlett CR, 1998, NEUROTOXICOL TERATOL, V20, P285, DOI 10.1016/S0892-0362(97)00102-5; Goodlett CR, 1997, NEUROTOXICOL TERATOL, V19, P435, DOI 10.1016/S0892-0362(97)00062-7; GREEN PHR, 1983, CLIN GASTROENTEROL, V12, P563; Guerri C, 2009, ALCOHOL ALCOHOLISM, V44, P108, DOI 10.1093/alcalc/agn105; HALL JL, 1994, PSYCHOBIOLOGY, V22, P181; Helfer JL, 2009, BRAIN RES, V1294, P1, DOI 10.1016/j.brainres.2009.07.090; Helfer JL, 2009, J COMP NEUROL, V514, P259, DOI 10.1002/cne.22018; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; JORDAN TC, 1983, BEHAV NEUROSCI, V97, P319, DOI 10.1037/0735-7044.97.2.319; JORDAN TC, 1982, RES EXP MED, V180, P201, DOI 10.1007/BF01852291; KOTCH LE, 1992, INT J DEV NEUROSCI, V10, P273, DOI 10.1016/0736-5748(92)90016-S; KOTKOSKIE LA, 1988, ALCOHOL CLIN EXP RES, V12, P831, DOI 10.1111/j.1530-0277.1988.tb01355.x; Krahl SE, 1999, ALCOHOL, V17, P125, DOI 10.1016/S0741-8329(98)00043-3; Kuhn HG, 2011, EUR J NEUROSCI, V33, P1115, DOI 10.1111/j.1460-9568.2011.07610.x; Kumada T, 2006, J NEUROSCI, V26, P742, DOI 10.1523/JNEUROSCI.4478-05.2006; Maier SE, 1996, PHARMACOL BIOCHEM BE, V55, P521, DOI 10.1016/S0091-3057(96)00282-1; Maier SE, 2001, ALCOHOL RES HEALTH, V25, P168; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; MCGIVERN RF, 1993, ALCOHOL CLIN EXP RES, V17, P1215, DOI 10.1111/j.1530-0277.1993.tb05232.x; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MIDDAUGH LD, 1991, ALCOHOL CLIN EXP RES, V15, P919, DOI 10.1111/j.1530-0277.1991.tb05189.x; MILLER MW, 1995, ALCOHOL CLIN EXP RES, V19, P1359, DOI 10.1111/j.1530-0277.1995.tb01625.x; MILLER MW, 1993, ALCOHOL CLIN EXP RES, V17, P304, DOI 10.1111/j.1530-0277.1993.tb00768.x; MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878; Miller MW, 1995, ALCOHOL CLIN EXP RES, V19, P1500, DOI 10.1111/j.1530-0277.1995.tb01014.x; Morgane PJ, 2002, NEUROSCI BIOBEHAV R, V26, P471, DOI 10.1016/S0149-7634(02)00012-X; Nixon K, 2004, ALCOHOL CLIN EXP RES, V28, P105, DOI 10.1097/01.ALC.0000106311.88523.7B; Palmer AA, 2008, BRAIN RES, V1237, P62, DOI 10.1016/j.brainres.2008.07.089; RAO GA, 1987, HEPATOLOGY, V7, P416, DOI 10.1002/hep.1840070248; Richardson DP, 2002, EUR J NEUROSCI, V16, P1593, DOI 10.1046/j.1460-9568.2002.02214.x; River C, 2012, SPRAGUE DAWLEY RATS; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Rotta LN, 2003, NEUROCHEM RES, V28, P1181, DOI 10.1023/A:1024272227219; Rubert G, 2006, J NEUROSCI RES, V84, P483, DOI 10.1002/jnr.20963; SAVAGE DD, 1992, ALCOHOL, V9, P37, DOI 10.1016/0741-8329(92)90007-W; SAVAGE DD, 1991, ALCOHOL, V8, P193, DOI 10.1016/0741-8329(91)90806-8; SCHENKER S, 1990, J LAB CLIN MED, V116, P106; SERESS L, 1977, ANAT EMBRYOL, V151, P335, DOI 10.1007/BF00318935; Seress L, 2007, PROG BRAIN RES, V163, P23; Shultz PL, 1999, BEHAV PHARMACOL, V10, P379, DOI 10.1097/00008877-199907000-00005; Sliwowska JH, 2008, PSYCHONEUROENDOCRINO, V33, P1111, DOI 10.1016/j.psyneuen.2008.05.001; SMART JL, 1990, UPSALA J MED SCI, P21; SORIANO E, 1989, J COMP NEUROL, V281, P603, DOI 10.1002/cne.902810409; SORIANO E, 1989, J COMP NEUROL, V281, P586, DOI 10.1002/cne.902810408; Stratton K., 1996, FETAL ALCOHOL SYNDRO; STREISSGUTH AP, 1994, DRUG ALCOHOL DEPEN, V36, P89, DOI 10.1016/0376-8716(94)90090-6; Sulik KK, 2005, EXP BIOL MED, V230, P366, DOI 10.1177/15353702-0323006-04; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Sutherland RJ, 1997, HIPPOCAMPUS, V7, P232, DOI 10.1002/(SICI)1098-1063(1997)7:2<232::AID-HIPO9>3.0.CO;2-O; SWARTZWELDER HS, 1988, ALCOHOL, V5, P121, DOI 10.1016/0741-8329(88)90008-0; TAN SE, 1990, ALCOHOL, V7, P507, DOI 10.1016/0741-8329(90)90040-J; Tateno M, 2004, ALCOHOL CLIN EXP RES, V28, p134S, DOI 10.1097/01.ALC.0000133538.40841.36; Titterness AK, 2012, HIPPOCAMPUS, V22, P69, DOI 10.1002/hipo.20849; TONKISS J, 1990, BEHAV BRAIN RES, V40, P95, DOI 10.1016/0166-4328(90)90002-V; TONKISS J, 1990, PHYSIOL BEHAV, V48, P73, DOI 10.1016/0031-9384(90)90263-4; Tran TD, 2003, NEUROTOXICOL TERATOL, V25, P519, DOI 10.1016/S0892-0362(03)00074-6; Varaschin RK, 2010, J PHARMACOL EXP THER, V334, P191, DOI 10.1124/jpet.109.165027; WEST JR, 1984, CIBA F SYMP, V105, P8; Young CL, 2008, NEUROBIOL DIS, V31, P355, DOI 10.1016/j.nbd.2008.05.009	87	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51344	10.1371/journal.pone.0051344	http://dx.doi.org/10.1371/journal.pone.0051344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227262	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200121
J	Kajitani, N; Hisaoka-Nakashima, K; Morioka, N; Okada-Tsuchioka, M; Kaneko, M; Kasai, M; Shibasaki, C; Nakata, Y; Takebayashi, M				Kajitani, Naoto; Hisaoka-Nakashima, Kazue; Morioka, Norimitsu; Okada-Tsuchioka, Mami; Kaneko, Masahiro; Kasai, Miho; Shibasaki, Chiyo; Nakata, Yoshihiro; Takebayashi, Minoru			Antidepressant Acts on Astrocytes Leading to an Increase in the Expression of Neurotrophic/Growth Factors: Differential Regulation of FGF-2 by Noradrenaline	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CULTURED RAT ASTROCYTES; HIPPOCAMPAL-NEURONS; MAJOR DEPRESSION; MESSENGER-RNA; GLIAL-CELLS; TRANSCRIPTIONAL REGULATION; KINASE ACTIVATION; ASTROGLIAL CELLS; BRAIN	Recently, multiple neurotrophic/growth factors have been proposed to play an important role in the therapeutic action of antidepressants. In this study, we prepared astrocyte-and neuron-enriched cultures from the neonatal rat cortex, and examined the changes in neurotrophic/growth factor expression by antidepressant treatment using real-time PCR. Treatment with amitriptyline (a tricyclic antidepressant) significantly increased the expression of fibroblast growth factor-2 (FGF-2), brain-derived neurotrophic factor, vascular endothelial growth factor and glial cell line-derived neurotrophic factor mRNA with a different time course in astrocyte cultures, but not in neuron-enriched cultures. Only the expression of FGF-2 was higher in astrocyte cultures than in neuron-enriched cultures. We focused on the FGF-2 production in astrocytes. Several different classes of antidepressants, but not non-antidepressants, also induced FGF-2 mRNA expression. Noradrenaline (NA) is known to induce FGF-2 expression in astrocyte cultures, as with antidepressants. Therefore, we also assessed the mechanism of NA-induced FGF-2 expression, in comparison to amitriptyline. NA increased the FGF-2 mRNA expression via alpha 1 and beta-adrenergic receptors; however, the amitriptyline-induced FGF-2 mRNA expression was not mediated via these adrenergic receptors. Furthermore, the amitriptyline-induced FGF-2 mRNA expression was completely blocked by cycloheximide (an inhibitor of protein synthesis), while the NA-induced FGF-2 mRNA was not. These data suggest that the regulation of FGF-2 mRNA expression by amitriptyline was distinct from that by NA. Taken together, antidepressant-stimulated astrocytes may therefore be important mediators that produce several neurotrophic/growth factors, especially FGF-2, through a monoamine-independent and a de novo protein synthesis-dependent mechanism.	[Kajitani, Naoto; Okada-Tsuchioka, Mami; Shibasaki, Chiyo; Takebayashi, Minoru] Natl Hosp Org NHO Kure Med Ctr, Div Psychiat & Neurosci, Inst Clin Res, Kure, Hiroshima, Japan; [Kajitani, Naoto; Okada-Tsuchioka, Mami; Shibasaki, Chiyo; Takebayashi, Minoru] Chugoku Canc Ctr, Kure, Hiroshima, Japan; [Kajitani, Naoto; Hisaoka-Nakashima, Kazue; Morioka, Norimitsu; Kaneko, Masahiro; Kasai, Miho; Nakata, Yoshihiro] Hiroshima Univ, Dept Pharmacol, Grad Sch Biomed Sci, Hiroshima, Japan; [Shibasaki, Chiyo; Takebayashi, Minoru] Natl Hosp Org NHO Kure Med Ctr, Dept Psychiat, Kure, Hiroshima, Japan	Hiroshima University	Takebayashi, M (corresponding author), Natl Hosp Org NHO Kure Med Ctr, Div Psychiat & Neurosci, Inst Clin Res, Kure, Hiroshima, Japan.	mtakebayashi@kure-nh.go.jp	Morioka, Norimitsu/J-3165-2019	Morioka, Norimitsu/0000-0001-9148-4167; Kajitani, Naoto/0000-0001-7245-9206	JSPS KAKENHI [23591686, 23790297, 24006852]; Pharmacological Research Foundation, Tokyo; SENSHIN Medical Research Foundation, Osaka; Grants-in-Aid for Scientific Research [12J06852] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo); SENSHIN Medical Research Foundation, Osaka; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Number 23591686, 23790297, 24006852 and by the Pharmacological Research Foundation, Tokyo and by a grant from SENSHIN Medical Research Foundation, Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, PSYCHOPHARMACOLOGY, V216, P75, DOI 10.1007/s00213-011-2190-y; Audigier S, 2008, RNA, V14, P1852, DOI 10.1261/rna.790608; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bachis A, 2008, NEUROPHARMACOLOGY, V55, P1114, DOI 10.1016/j.neuropharm.2008.07.014; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; BAUMANN P, 1984, PSYCHOPHARMACOLOGY, V84, P489, DOI 10.1007/BF00431455; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen FH, 2010, HIPPOCAMPUS, V20, P1376, DOI 10.1002/hipo.20718; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; CHEN Y, 1995, BRAIN RES BULL, V38, P153, DOI 10.1016/0361-9230(95)00082-P; Czeh B., 2012, EUR NEUROPSYCHOPHARM; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Elsayed M, 2012, BIOL PSYCHIAT, V72, P258, DOI 10.1016/j.biopsych.2012.03.003; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Fuchikami M, 2009, INT J NEUROPSYCHOPH, V12, P73, DOI 10.1017/S1461145708008997; FURUKAWA S, 1987, BIOCHEM BIOPH RES CO, V147, P1048, DOI 10.1016/S0006-291X(87)80176-6; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Iwata M, 2011, HIPPOCAMPUS, V21, P877, DOI 10.1002/hipo.20803; Jarosik J, 2011, RESTOR NEUROL NEUROS, V29, P153, DOI 10.3233/RNN-2011-0588; Juric DM, 2006, BRAIN RES, V1108, P54, DOI 10.1016/j.brainres.2006.06.008; Kim Y, 2011, PROG NEURO-PSYCHOPH, V35, P1026, DOI 10.1016/j.pnpbp.2011.02.012; Krzan M, 2001, J NEUROSCI RES, V64, P261, DOI 10.1002/jnr.1074; Li AJ, 2002, EUR J NEUROSCI, V16, P1313, DOI 10.1046/j.1460-9568.2002.02193.x; Liu Q, 2009, EUR NEUROPSYCHOPHARM, V19, P796, DOI 10.1016/j.euroneuro.2009.06.010; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Mallei A, 2002, MOL PHARMACOL, V61, P1017, DOI 10.1124/mol.61.5.1017; Mercier G, 2004, J MOL NEUROSCI, V24, P207, DOI 10.1385/JMN:24:2:207; MIYAKE K, 1990, J PHARM SCI, V79, P288, DOI 10.1002/jps.2600790403; Moffett J, 1998, MOL BIOL CELL, V9, P2269, DOI 10.1091/mbc.9.8.2269; Morishima T, 2008, NEUROSCI RES, V61, P18, DOI 10.1016/j.neures.2008.01.005; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Nelson AD, 2006, MOL CELL NEUROSCI, V33, P29, DOI 10.1016/j.mcn.2006.06.003; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Numakawa T, 2002, J BIOL CHEM, V277, P6520, DOI 10.1074/jbc.M109139200; O'Donnell JM, 2011, GOODMAN GILMANS PHAR, V12th, P397; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290; Overstreet DH, 2010, PHARMACOL BIOCHEM BE, V94, P553, DOI 10.1016/j.pbb.2009.11.010; Pav M, 2008, PHYSIOL RES, V57, P151, DOI 10.33549/physiolres.930990; PROUTY RW, 1990, J FORENSIC SCI, V35, P243; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Riva MA, 1996, MOL PHARMACOL, V49, P699; Sergent-Tanguy S, 2006, J NEUROSCI RES, V83, P1515, DOI 10.1002/jnr.20846; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Shinozaki Y, 2005, GLIA, V49, P288, DOI 10.1002/glia.20118; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Sugimoto T, 2011, NEUROSCIENCE, V185, P1, DOI 10.1016/j.neuroscience.2011.04.024; Takebayashi M, 2009, RECENT DEV DEPRESSIO, P125; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Yan M, 2011, NEUROCHEM INT, V58, P549, DOI 10.1016/j.neuint.2011.01.013; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004	63	65	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51197	10.1371/journal.pone.0051197	http://dx.doi.org/10.1371/journal.pone.0051197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227251	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200110
J	Morano, M; Colella, D; Rutigliano, I; Fiore, P; Pettoello-Mantovani, M; Campanozzi, A				Morano, Milena; Colella, Dario; Rutigliano, Irene; Fiore, Pietro; Pettoello-Mantovani, Massimo; Campanozzi, Angelo			Changes in Actual and Perceived Physical Abilities in Clinically Obese Children: A 9-Month Multi-Component Intervention Study	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; MOTOR-PERFORMANCE; SELF-PERCEPTION; BODY-IMAGE; OVERWEIGHT; ADOLESCENTS; HEALTH; EXERCISE; FITNESS	Objectives: (1) To examine relationships among changes in physical activity, physical fitness and some psychosocial determinants of activity behavior in a clinical sample of obese children involved in a multi-component program; (2) to investigate the causal relationship over time between physical activity and one of its strongest correlates (i.e. perceived physical ability). Methods: Self-reported physical activity and health-related fitness tests were administered before and after a 9-month intervention in 24 boys and 20 girls aged 8 to 11 years. Individuals' perceptions of strength, speed and agility were assessed using the Perceived Physical Ability Scale, while body image was measured using Collins' Child Figure Drawings. Results: Findings showed that body mass index, physical activity, performances on throwing and weight-bearing tasks, perceived physical ability and body image significantly improved after treatment among obese children. Gender differences were found in the correlational analyses, showing a link between actual and perceived physical abilities in boys, but not in girls. For the specific measurement interval of this study, perception of physical ability was an antecedent and not a potential consequence of physical activity. Conclusions: Results indicate that a multi-component activity program not based merely on a dose-effect approach enhances adherence of the participants and has the potential to increase the lifelong exercise skills of obese children. Rather than focusing entirely on diet and weight loss, findings support the inclusion of interventions directed toward improving perceived physical ability that is predictive of subsequent physical activity.	[Morano, Milena; Colella, Dario] Univ Foggia, Dept Biomed Sci Motor Act & Sport Sci, Foggia, Italy; [Fiore, Pietro] Univ Foggia, Dept Med Sci, Phys Med & Rehabil Unit, Foggia, Italy; Univ Foggia, Phys Med & Rehabil Unit, Foggia, Italy	University of Foggia; University of Foggia; University of Foggia	Morano, M (corresponding author), Univ Foggia, Dept Biomed Sci Motor Act & Sport Sci, Foggia, Italy.	milenamorano@gmail.com	Rutigliano, Irene/AAB-3458-2021; Campanozzi, Angelo/AAR-6227-2020; Morano, Milena/GNH-4072-2022; MANTOVANI, Massimo PETTOELLO/AAC-1990-2019	Campanozzi, Angelo/0000-0002-3489-2524; Morano, Milena/0000-0003-2574-6055; MANTOVANI, Massimo PETTOELLO/0000-0002-0688-1131; Rutigliano, Irene/0000-0003-3217-5393; FIORE, PIETRO/0000-0001-5621-2393	Italian Ministry of Education, University and Research [2009PMTYTP]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This study was funded by the Italian Ministry of Education, University and Research in the framework of the Projects of Relevant National Interest (PRIN 2009), according to the Italian Ministerial Decree No. 404/Recognised of 14 July 2011 (2009PMTYTP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, YOUTH PHYS ACTIVITY; [Anonymous], 2007, FITNESSGRAM ACTIVITY; Atlantis E, 2006, INT J OBESITY, V30, P1027, DOI 10.1038/sj.ijo.0803286; Bandura A, 1997, SELF EFFICACY EXERCI; Barnett LM, 2011, MED SCI SPORT EXER, V43, P898, DOI 10.1249/MSS.0b013e3181fdfadd; Barnett LM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-40; Bortoli L, 1997, PERCEPT MOTOR SKILL, V85, P187, DOI 10.2466/pms.1997.85.1.187; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; Chen LJ, 2010, WOMEN STUD INT FORUM, V33, P234, DOI 10.1016/j.wsif.2010.01.003; Cliff DP, 2010, OBES REV, V11, P516, DOI 10.1111/j.1467-789X.2009.00625.x; Cohen J., 2003, APPL MULTIPLE REGRES; Colella D, 2009, PERCEPT MOTOR SKILL, V108, P209, DOI 10.2466/PMS.108.1.209-218; COLLINS ME, 1991, INT J EAT DISORDER, V10, P199, DOI 10.1002/1098-108X(199103)10:2&lt;199::AID-EAT2260100209&gt;3.0.CO;2-D; *COMM EXP SPORTS R, 1993, HDB EUR TESTS PHYS F; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Crocker PRE, 2000, J SPORT SCI, V18, P383, DOI 10.1080/02640410050074313; CURETON KJ, 1995, MED SCI SPORT EXER, V27, P445; Deforche B, 2004, PATIENT EDUC COUNS, V55, P407, DOI 10.1016/j.pec.2003.07.012; Fulton JE, 2004, SPORTS MED, V34, P581, DOI 10.2165/00007256-200434090-00003; Goldfield GS, 2007, J PEDIATR PSYCHOL, V32, P783, DOI 10.1093/jpepsy/jsm017; Harter S, 1985, MANUAL SELF PERCEPTI; Hopkins W.G., 2002, SCALE MAGNITUDES EFF; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Kessler R. C., 1981, LINEAR PANEL ANAL MO; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Martin KA, 2004, BODY IMAGE HDB THEOR, P414; Moller NC, 2007, SCAND J MED SCI SPOR, V17, P331, DOI 10.1111/j.1600-0838.2006.00583.x; Morano M, 2011, SCAND J MED SCI SPOR, V21, P465, DOI 10.1111/j.1600-0838.2009.01068.x; Morrow JR., 2005, MEASUREMENT EVOLUTIO, V3rd, P416; Norton K, 1996, ANTHROPOMETRICA, V1, P25; O'Dea JA, 2005, HEALTH EDUC, V105, P11, DOI 10.1108/09654280510572277; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Reilly JJ, 2005, BEST PRACT RES CL EN, V19, P327, DOI 10.1016/j.beem.2005.04.002; Rowland T.W., 2005, CHILDRENS EXERCISE P; Siri W., 1961, TECHNIQUES MEASURING, P223; Spinelli A., 2009, 0924 ISTISAN; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Sung RYT, 2005, EUR J CLIN NUTR, V59, P101, DOI 10.1038/sj.ejcn.1602044; Tanaka C., 2006, BODY IMAGE NEW RES, P243; Taris T. W., 2000, PRIMER LONGITUDINAL; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Watts K, 2005, SPORTS MED, V35, P375, DOI 10.2165/00007256-200535050-00002	44	16	16	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50782	10.1371/journal.pone.0050782	http://dx.doi.org/10.1371/journal.pone.0050782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23239985	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200068
J	Wang, HY; Fan, LS; Wei, JC; Weng, YJ; Zhou, L; Shi, Y; Zhou, WJ; Ma, D; Wang, CY				Wang, Hongyan; Fan, Liangsheng; Wei, Juncheng; Weng, Yanjie; Zhou, Li; Shi, Ying; Zhou, Wenjuan; Ma, Ding; Wang, Changyu			Akt Mediates Metastasis-Associated Gene 1 (MTA1) Regulating the Expression of E-cadherin and Promoting the Invasiveness of Prostate Cancer Cells (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							EPITHELIAL-MESENCHYMAL TRANSITION; PI3K-AKT PATHWAY; MESSENGER-RNA; PROTEIN; REPRESSION; ADHESION; LINES; EMT; ACTIVATION; MIGRATION	Human metastasis-associated gene 1 (MTA1) is highly associated with the metastasis of prostate cancer; however, the molecular functions of MTA1 that facilitate metastasis remain unclear. In this study, we demonstrate that the silencing of MTA1 by siRNA treatment results in the upregulation of E-cadherin expression by the phosphorylation of AKT (p-AKT) and decreases the invasiveness of prostate cancer cells. We show that MTA1 is expressed in over 90% of prostate cancer tissues, especially metastatic prostate cancer tissue, comparing to non-expression in normal prostate tissue. RT-PCR analysis and Western blot assay showed that MTA1 expression is significantly higher in highly metastatic prostate cancer PC-3M-1E8 cells (1E8) than in poorly metastatic prostate cancer PC-3M-2B4 cells (2B4). Silencing MTA1 expression by siRNA treatment in 1E8 cells increased the cellular malignant characters, including the cellular adhesive ability, decreased the cellular invasive ability and changed the polarity of cellular cytoskeleton. 1E8 cells over-expressing MTA1 had a reduced expression of E-cadherin, while 1E8 cells treated with MTA1 siRNA had a higher expression of E-cadherin. The expression of phosphorylated AKT (p-AKT) or the inhibition of p-AKT by wortmannin treatment (100 nM) significantly altered the function of MTA1 in the regulation of E-cadherin expression. Alterations in E-cadherin expression changed the role of p-AKT in cellular malignant characters. All of these results demonstrate that MTA1 plays an important role in controlling the malignant transformation of prostate cancer cells through the p-AKT/E-cadherin pathway. This study also provides a new mechanistic role for MTA1 in the regulation of prostate cancer metastasis.	[Wang, Hongyan; Fan, Liangsheng; Weng, Yanjie; Shi, Ying; Zhou, Wenjuan; Ma, Ding; Wang, Changyu] Huazhong Univ Sci & Technol, Canc Biol Res Ctr, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China; [Wei, Juncheng; Ma, Ding; Wang, Changyu] Huazhong Univ Sci & Technol, Dept Gynecol Oncol, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China; [Wang, Hongyan] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Zhou, Li] Tianjin Cent Hosp Obstet & Gynecol, Tianjin, Peoples R China; [Fan, Liangsheng] Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Shandong University; Guangzhou Medical University	Wang, CY (corresponding author), Huazhong Univ Sci & Technol, Canc Biol Res Ctr, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China.	dma@tjh.tjmu.edu.cn; tjwcy@yahoo.com.cn	shi, zhensheng/GXN-3967-2022		National Natural Science Foundation of China [30973184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (30973184)(www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzumanyan A, 2012, ONCOGENE, V31, P563, DOI 10.1038/onc.2011.255; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Dannenmann C, 2008, CANCER BIOL THER, V7, P1462, DOI 10.4161/cbt.7.9.6427; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Geng Li, 2008, Open Biochem J, V2, P100, DOI 10.2174/1874091X00802010100; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Grille SJ, 2003, CANCER RES, V63, P2172; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hofer MD, 2004, CANCER RES, V64, P825, DOI 10.1158/0008-5472.CAN-03-2755; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Kumar R, 2003, CELL, V113, P142, DOI 10.1016/S0092-8674(03)00274-5; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pakala SB, 2011, ONCOGENE, V30, P2230, DOI 10.1038/onc.2010.608; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; Qian HL, 2005, CLIN EXP METASTAS, V22, P653, DOI 10.1007/s10585-006-9005-2; Radaelli E, 2009, FUTURE ONCOL, V5, P1113, DOI [10.2217/fon.09.93, 10.2217/FON.09.93]; Rao YM, 2011, J HUAZHONG U SCI-MED, V31, P1, DOI 10.1007/s11596-011-0141-9; Sasaki H, 2001, CANCER LETT, V174, P159, DOI 10.1016/S0304-3835(01)00704-2; Shimul S, 2010, J CANC SCI THER, V2, P114; Simpson A, 2001, GENE, V273, P29, DOI 10.1016/S0378-1119(01)00563-7; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Toh Y, 2004, INT J CANCER, V110, P362, DOI 10.1002/ijc.20154; TOH Y, 1994, J BIOL CHEM, V269, P22958; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Tong D, 2007, ONCOL RES, V16, P465, DOI 10.3727/096504007783338322; Wu MFF, 2007, PROTEOMICS, V7, P1973, DOI 10.1002/pmic.200600643; Yan W, 2009, BIOCHEM BIOPH RES CO, V382, P631, DOI 10.1016/j.bbrc.2009.03.088; Yang WH, 2008, CLIN CANCER RES, V14, P5494, DOI 10.1158/1078-0432.CCR-08-0233; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	49	30	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e46888	10.1371/journal.pone.0046888	http://dx.doi.org/10.1371/journal.pone.0046888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227138	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200001
J	Yahata, K; Treeck, M; Culleton, R; Gilberger, TW; Kaneko, O				Yahata, Kazuhide; Treeck, Moritz; Culleton, Richard; Gilberger, Tim-Wolf; Kaneko, Osamu			Time-Lapse Imaging of Red Blood Cell Invasion by the Rodent Malaria Parasite Plasmodium yoelii	PLOS ONE			English	Article							MEMBRANE ANTIGEN 1; FALCIPARUM MEROZOITES; MOVING JUNCTION; PROTEIN; TRANSFECTION; ERYTHROCYTE; TRANSFORMATION; TOXOPLASMA; MATURATION; VIRULENCE	In order to propagate within the mammalian host, malaria parasites must invade red blood cells (RBCs). This process offers a window of opportunity in which to target the parasite with drugs or vaccines. However, most of the studies relating to RBC invasion have analyzed the molecular interactions of parasite proteins with host cells under static conditions, and the dynamics of these interactions remain largely unstudied. Time-lapse imaging of RBC invasion is a powerful technique to investigate cell invasion and has been reported for Plasmodium knowlesi and Plasmodium falciparum. However, experimental modification of genetic loci is laborious and time consuming for these species. We have established a system of time-lapse imaging for the rodent malaria parasite Plasmodium yoelii, for which modification of genetic loci is quicker and simpler. We compared the kinetics of RBC invasion by P. yoelii with that of P. falciparum and found that the overall kinetics during invasion were similar, with some exceptions. The most striking of these differences is that, following egress from the RBC, the shape of P. yoelii merozoites gradually changes from flat elongated ovals to spherical bodies, a process taking about 60 sec. During this period merozoites were able to attach to and deform the RBC membrane, but were not able to reorient and invade. We propose that this morphological change of P. yoelii merozoites may be related to the secretion or activation of invasion-related proteins. Thus the P. yoelii merozoite appears to be an excellent model to analyze the molecular dynamics of RBC invasion, particularly during the morphological transition phase, which could serve as an expanded window that cannot be observed in P. falciparum.	[Yahata, Kazuhide; Culleton, Richard; Kaneko, Osamu] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan; [Yahata, Kazuhide; Culleton, Richard; Kaneko, Osamu] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan; [Treeck, Moritz; Gilberger, Tim-Wolf] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Hamburg, Germany; [Treeck, Moritz] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Culleton, Richard] Nagasaki Univ, Inst Trop Med NEKKEN, Malaria Unit, Nagasaki 852, Japan; [Gilberger, Tim-Wolf] McMaster Univ, MG DeGroote Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada	Nagasaki University; Nagasaki University; Bernhard Nocht Institut fur Tropenmedizin; Stanford University; Nagasaki University; McMaster University	Yahata, K (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan.	kyahata@nagasaki-u.ac.jp; okaneko@nagasaki-u.ac.jp	Treeck, Moritz/O-6662-2017; Treeck, Moritz/X-8007-2019; Treeck, Moritz/Q-9078-2019; Culleton, Richard/H-8327-2014	Treeck, Moritz/0000-0002-9727-6657; Treeck, Moritz/0000-0002-9727-6657; Culleton, Richard/0000-0001-8808-5771; Gilberger, Tim-Wolf/0000-0002-7965-8272	Japan Society for the Promotion of Science (JSPS)-German Research Foundation (DFG) Joint Research Program [09035811-000063]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22790397, 24590509, 22390079]	Japan Society for the Promotion of Science (JSPS)-German Research Foundation (DFG) Joint Research Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This project was supported by a Japan Society for the Promotion of Science (JSPS)-German Research Foundation (DFG) Joint Research Program 09035811-000063 (OK). This work was also supported in part by Grants-in-Aids for Scientific Research 22790397 (KY), 24590509 (KY) and 22390079 (OK), and the Global COE Program, Nagasaki University, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; BANNISTER LH, 1995, ANN TROP MED PARASIT, V89, P105, DOI 10.1080/00034983.1995.11812940; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Child MA, 2010, MOL MICROBIOL, V78, P187, DOI 10.1111/j.1365-2958.2010.07324.x; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Kendric RK, 1978, RODENT MALARIA, P85; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Li J, 2011, P NATL ACAD SCI USA, V108, pE374, DOI 10.1073/pnas.1102261108; Liu J, 2010, BLOOD, V115, P2021, DOI 10.1182/blood-2009-08-241182; Mota MM, 2001, MOL BIOCHEM PARASIT, V113, P271, DOI 10.1016/S0166-6851(01)00228-6; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Otsuki H, 2009, P NATL ACAD SCI USA, V106, P7167, DOI 10.1073/pnas.0811313106; PETERSON MG, 1989, MOL CELL BIOL, V9, P3151, DOI 10.1128/MCB.9.7.3151; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Spence PJ, 2011, NAT PROTOC, V6, P553, DOI 10.1038/nprot.2011.313; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173, DOI 10.1080/00034983.1975.11686998; YOELI M, 1974, SCIENCE, V184, P572, DOI 10.1126/science.184.4136.572	34	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50780	10.1371/journal.pone.0050780	http://dx.doi.org/10.1371/journal.pone.0050780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227208	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200067
J	Pelosi, E; Castelli, G; Martin-Padura, I; Bordoni, V; Santoro, S; Conigliaro, A; Cerio, AM; De Santis Puzzonia, M; Marighetti, P; Biffoni, M; Alonzi, T; Amicone, L; Alcalay, M; Bertolini, F; Testa, U; Tripodi, M				Pelosi, Elvira; Castelli, Germana; Martin-Padura, Ines; Bordoni, Veronica; Santoro, Simona; Conigliaro, Alice; Cerio, Anna Maria; De Santis Puzzonia, Marco; Marighetti, Paola; Biffoni, Mauro; Alonzi, Tonino; Amicone, Laura; Alcalay, Myriam; Bertolini, Francesco; Testa, Ugo; Tripodi, Marco			Human Haemato-Endothelial Precursors: Cord Blood CD34+ Cells Produce Haemogenic Endothelium	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIUM; PROGENITOR CELLS; MESODERMAL CELLS; HEMANGIOBLAST; GENERATION; DIFFERENTIATION; LINEAGES; IDENTIFICATION; TRANSITION	Embryologic and genetic evidence suggest a common origin of haematopoietic and endothelial lineages. In the murine embryo, recent studies indicate the presence of haemogenic endothelium and of a common haemato-endothelial precursor, the haemangioblast. Conversely, so far, little evidence supports the presence of haemogenic endothelium and haemangioblasts in later stages of development. Our studies indicate that human cord blood haematopoietic progenitors (CD34+45+144-), triggered by murine hepatocyte conditioned medium, differentiate into adherent proliferating endothelial precursors (CD144+CD105+CD146+CD31+CD45-) capable of functioning as haemogenic endothelium. These cells, proven to give rise to functional vasculature in vivo, if further instructed by haematopoietic growth factors, first switch to transitional CD144+45+ cells and then to haematopoietic cells. These results highlight the plasticity of haemato-endhothelial precursors in human post-natal life. Furthermore, these studies may provide highly enriched populations of human post-fetal haemogenic endothelium, paving the way for innovative projects at a basic and possibly clinical level.	[Pelosi, Elvira; Castelli, Germana; Santoro, Simona; Cerio, Anna Maria; Biffoni, Mauro; Testa, Ugo] Ist Super Sanita, Dept Haematol Oncol & Mol Med, I-00161 Rome, Italy; [Bordoni, Veronica; Alonzi, Tonino; Tripodi, Marco] IRCCS, L Spallanzani Natl Inst Infect Dis, Rome, Italy; [Conigliaro, Alice; De Santis Puzzonia, Marco; Amicone, Laura; Tripodi, Marco] Univ Roma La Sapienza, Ist Pasteur Cenci Bolognetti, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy; [Martin-Padura, Ines; Marighetti, Paola; Bertolini, Francesco] European Inst Oncol, Dept Med, Lab Haematol Oncol, Milan, Italy; [Alcalay, Myriam] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Alcalay, Myriam] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	Istituto Superiore di Sanita (ISS); IRCCS Lazzaro Spallanzani; Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of Milan	Pelosi, E (corresponding author), Ist Super Sanita, Dept Haematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	elvira.pelosi@iss.it; tripodi@bce.uniroma1.it	pelosi, elvira/J-7298-2016; Alcalay, Myriam/AAB-4300-2019; De Santis Puzzonia, Marco/J-3611-2016; bordoni, veronica/K-8614-2016; Tripodi, Marco/ABO-1160-2022; Testa, Ugo/J-6472-2016; Conigliaro, Alice/J-8717-2016; Biffoni, Mauro/J-8318-2016; Tripodi, Marco/F-1143-2011; bertolini, francesco/AAC-9780-2019; Conigliaro, Alice/L-5590-2019; Alcalay, Myriam/B-3182-2016; castelli, germana/J-7244-2016	pelosi, elvira/0000-0002-3043-6249; Alcalay, Myriam/0000-0002-5558-4272; bordoni, veronica/0000-0002-1747-2245; Tripodi, Marco/0000-0001-6135-971X; Testa, Ugo/0000-0001-7900-8942; Conigliaro, Alice/0000-0002-3037-835X; Biffoni, Mauro/0000-0002-1304-9060; Tripodi, Marco/0000-0001-6135-971X; bertolini, francesco/0000-0001-5660-3255; Conigliaro, Alice/0000-0002-3037-835X; Alcalay, Myriam/0000-0002-5558-4272; Amicone, Laura/0000-0002-3487-5740; De Santis Puzzonia, Marco/0000-0001-5691-1733; castelli, germana/0000-0002-3593-1230	Ministero della Salute (The Italian Ministry of Health), Rome, Italy [RF2006-411189]; Associazione Italiana per la Ricerca sul Cancro (AIRC) (The Italian Association for Cancer Research), Milan, Italy; MIUR, Ministero Universita e Ricerca Scientifica (The Ministry of Education, University and Research), Tavola Valdese OPM	Ministero della Salute (The Italian Ministry of Health), Rome, Italy; Associazione Italiana per la Ricerca sul Cancro (AIRC) (The Italian Association for Cancer Research), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); MIUR, Ministero Universita e Ricerca Scientifica (The Ministry of Education, University and Research), Tavola Valdese OPM(Ministry of Education, Universities and Research (MIUR))	Funding: Ministero della Salute (The Italian Ministry of Health), Rome, Italy (RF2006-411189); Associazione Italiana per la Ricerca sul Cancro (AIRC) (The Italian Association for Cancer Research), Milan, Italy; MIUR, Ministero Universita e Ricerca Scientifica (The Ministry of Education, University and Research), Tavola Valdese OPM., Regione Lazio Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1998, HEPATOLOGY, V28, P1645, DOI 10.1002/hep.510280626; Baker CD, 2009, AM J RESP CRIT CARE, V180, P454, DOI 10.1164/rccm.200901-0115OC; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bordoni V, 2004, HEPATOLOGY, V39, P1508, DOI 10.1002/hep.20234; Bordoni V, 2007, HEPATOLOGY, V45, P1218, DOI 10.1002/hep.21568; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Choi JH, 2009, LIFE SCI, V85, P39, DOI 10.1016/j.lfs.2009.04.008; Choi K, 1998, DEVELOPMENT, V125, P725; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dieterlen-Lievre F, 2009, CELL STEM CELL, V4, P189, DOI 10.1016/j.stem.2009.02.006; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Liu ZJ, 2011, BLOOD, V117, P4106, DOI 10.1182/blood-2010-07-293092; MAHESHWARI RK, 1991, J CELL PHYSIOL, V146, P164, DOI 10.1002/jcp.1041460121; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Robb L, 1998, BIOESSAYS, V20, P611, DOI 10.1002/(SICI)1521-1878(199808)20:8<611::AID-BIES3>3.0.CO;2-L; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Wu X, 2007, STEM CELLS, V25, P2770, DOI 10.1634/stemcells.2006-0783; Xiong JW, 2008, DEV DYNAM, V237, P1218, DOI 10.1002/dvdy.21542; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	32	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51109	10.1371/journal.pone.0051109	http://dx.doi.org/10.1371/journal.pone.0051109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226561	gold, Green Published, Green Submitted			2022-12-25	WOS:000312108500044
J	Amacher, JF; Cushing, PR; Bahl, CD; Beck, T; Madden, DR				Amacher, Jeanine F.; Cushing, Patrick R.; Bahl, Christopher D.; Beck, Tobias; Madden, Dean R.			Stereochemical Determinants of C-terminal Specificity in PDZ Peptide-binding Domains A NOVEL CONTRIBUTION OF THE CARBOXYLATE- BINDING LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; STRUCTURAL BASIS; WIDE PREDICTION; RECOGNITION; AFFINITY; NETWORKS; PARTNERS; FEATURES; COMPLEX; MOTIFS	PDZ (PSD-95/Dlg/ZO-1) binding domains often serve as cellular traffic engineers, controlling the localization and activity of a wide variety of binding partners. As a result, they play important roles in both physiological and pathological processes. However, PDZ binding specificities overlap, allowing multiple PDZ proteins to mediate distinct effects on shared binding partners. For example, several PDZ domains bind the cystic fibrosis (CF) transmembrane conductance regulator (CFTR), an epithelial ion channel mutated in CF. Among these binding partners, the CFTR-associated ligand (CAL) facilitates post-maturational degradation of the channel and is thus a potential therapeutic target. Using iterative optimization, we previously developed a selective CAL inhibitor peptide (iCAL36). Here, we investigate the stereochemical basis of iCAL36 specificity. The crystal structure of iCAL36 in complex with the CAL PDZ domain reveals stereochemical interactions distributed along the peptide-binding cleft, despite the apparent degeneracy of the CAL binding motif. A critical selectivity determinant that distinguishes CAL from other CFTR-binding PDZ domains is the accommodation of an isoleucine residue at the C-terminal position (P-0), a characteristic shared with the Tax-interacting protein-1. Comparison of the structures of these two PDZ domains in complex with ligands containing P-0 Leu or Ile residues reveals two distinct modes of accommodation for beta-branched C-terminal side chains. Access to each mode is controlled by distinct residues in the carboxylate-binding loop. These studies provide new insights into the primary sequence determinants of binding motifs, which in turn control the scope and evolution of PDZ interactomes.	Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Beck, Tobias] Univ Gottingen, Dept Struct Chem, D-37077 Gottingen, Germany	Dartmouth College; University of Gottingen	Madden, DR (corresponding author), 7200 Vail Bldg, Hanover, NH 03755 USA.	drm0001@dartmouth.edu	Beck, Tobias/K-3738-2014; Bahl, Christopher D/B-9410-2016	Beck, Tobias/0000-0001-7398-3982; Bahl, Christopher D/0000-0002-3652-3693	National Institutes of Health [R01-DK075309, T32-GM008704, T32-DK007301, P20-RR018787, P20-GM103413]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075309, T32DK007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704, P20GM103413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK075309 (to D. R. M.) and Training Grants T32-GM008704 (to J. F. A.) and T32-DK007301 (to P. R. C.), Institutional Development Awards P20-RR018787 and P20-GM103413 to the Dartmouth Lung Biology Center of Biomedical Research Excellence, Cystic Fibrosis Foundation Grant RDP STANTO11R0, and a Hitchcock Foundation Program Project Grant.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; Amacher JF, 2011, ACTA CRYSTALLOGR F, V67, P600, DOI 10.1107/S1744309111009985; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Babault N, 2011, STRUCTURE, V19, P1518, DOI 10.1016/j.str.2011.07.007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Beck T, 2008, ACTA CRYSTALLOGR E, V64, pO1286, DOI 10.1107/S1600536808017741; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chimura T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-300; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Edwards RJ, 2012, MOL BIOSYST, V8, P282, DOI 10.1039/c1mb05212h; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Feng J, 1998, PDB VALIDATION SERVE; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko T, 2011, TRENDS BIOCHEM SCI, V36, P183, DOI 10.1016/j.tibs.2010.12.001; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kaufmann K, 2011, J MOL MODEL, V17, P315, DOI 10.1007/s00894-010-0725-5; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002510; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee HJ, 2009, ANGEW CHEM INT EDIT, V48, P6448, DOI 10.1002/anie.200902981; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025528; Li X, 2006, PROTEIN SCI, V15, P2149, DOI 10.1110/ps.062087506; Madden D. R., 1992, THESIS HARVARD U CAM; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obenauer John C, 2004, Methods Mol Biol, V261, P445; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Piserchio A, 2005, BIOCHEMISTRY-US, V44, P16158, DOI 10.1021/bi0516475; Piserchio A, 2004, CHEM BIOL, V11, P469, DOI 10.1016/j.chembiol.2004.03.013; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; Ponting CP, 1997, PROTEIN SCI, V6, P464; Roberts KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002477; Sakarya O, 2010, MOL BIOL EVOL, V27, P1058, DOI 10.1093/molbev/msp311; SHELDRICK G, 1991, XPREP SPACE GROUP DE; Sheldrick G. M., 2004, SADABS; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shepherd TR, 2010, J MOL BIOL, V398, P730, DOI 10.1016/j.jmb.2010.03.047; Shoulders MD, 2010, P NATL ACAD SCI USA, V107, P559, DOI 10.1073/pnas.0909592107; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Thomas J, 2009, PROTEINS, V76, P911, DOI 10.1002/prot.22398; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vouilleme L, 2010, ANGEW CHEM INT EDIT, V49, P9912, DOI 10.1002/anie.201005575; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yaffe Michael B, 2006, Sci STKE, V2006, ppe28, DOI 10.1126/stke.3402006pe28; Yan XJ, 2009, J MOL BIOL, V392, P967, DOI 10.1016/j.jmb.2009.07.060; Zaslavsky E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012787; Zhang JX, 2008, J MOL BIOL, V384, P255, DOI 10.1016/j.jmb.2008.09.034	73	22	23	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5114	5126		10.1074/jbc.M112.401588	http://dx.doi.org/10.1074/jbc.M112.401588			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23243314	hybrid, Green Published			2022-12-25	WOS:000315340400059
J	Errami, Y; Naura, AS; Kim, H; Ju, JH; Suzuki, Y; El-Bahrawy, AH; Ghonim, MA; Hemeida, RA; Mansy, MS; Zhang, JH; Xu, M; Smulson, ME; Brim, H; Boulares, AH				Errami, Youssef; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Suzuki, Yasuhiro; El-Bahrawy, Ali H.; Ghonim, Mohamed A.; Hemeida, Ramadan A.; Mansy, Moselhy S.; Zhang, Jianhua; Xu, Ming; Smulson, Mark E.; Brim, Hassan; Boulares, A. Hamid			Apoptotic DNA Fragmentation May Be a Cooperative Activity between Caspase-activated Deoxyribonuclease and the Poly(ADP-ribose) Polymerase-regulated DNAS1L3, an Endoplasmic Reticulum-localized Endonuclease That Translocates to the Nucleus during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN CONDENSATION; CELLS; ROLES; THYMOCYTES; CLEAVAGE; IDENTIFICATION; DFF40/CAD; PROTEASES; DNASE1L3; CA2+	Caspase-activated DNase (CAD) is the most favorable candidate for chromatin degradation during apoptosis. Ca2+-dependent endonucleases are equally important in internucleosomal DNA fragmentation (INDF), including the PARP-1-regulated DNAS1L3. Despite the elaborate work on these endonucleases, the question of whether these enzymes cooperate during INDF was not addressed. Here, we show a lack of correlation between INDF and CAD expression levels and inactivation by cleavage of its inhibitor (ICAD) during apoptosis. The cells that failed to induce INDF accumulated large amounts of 50-kb breaks, which is suggestive of incomplete chromatin processing. Similarly, INDF was blocked by Ca2+ chelation without a block in ICAD cleavage or caspase-3 activation, which is consistent with the involvement of CAD in 50-kb DNA fragmentation and its Ca2+ independence. However, DNAS1L3 expression in INDF-deficient cells promoted INDF during apoptosis and was blocked by Ca2+ chelation. Interestingly, expression of DNAS1L3 in ICAD-deficient cells failed to promote tumor necrosis factor alpha-induced INDF but required the coexpression of ICAD. These results suggest a cooperative activity between CAD and DNAS1L3 to accomplish INDF. In HT-29 cells, endogenous DNAS1L3 localized to the endoplasmic reticulum (ER) and translocated to the nucleus upon apoptosis induction but prior to INDF manifestation, making it the first reported Ca2+-dependent endonuclease to migrate from the ER to the nucleus. The nuclear accumulation of DNAS1L3, but not its exit out of the ER, required the activity of cysteine and serine proteases. Interestingly, the endonuclease accumulated in the cytosol upon inhibition of serine, but not cysteine, proteases. These results exemplify the complexity of chromatin degradation during apoptosis.	[Errami, Youssef; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; El-Bahrawy, Ali H.; Ghonim, Mohamed A.; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Stanley Scott Canc Ctr, New Orleans, LA 70112 USA; [Errami, Youssef; Suzuki, Yasuhiro; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Naura, Amarjit S.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; [El-Bahrawy, Ali H.; Hemeida, Ramadan A.] Al Azhar Univ, Dept Pharmacol & Toxicol, Assiut 71515, Egypt; [Ghonim, Mohamed A.; Mansy, Moselhy S.] Al Azhar Univ, Fac Pharm, Cairo 11787, Egypt; [Zhang, Jianhua] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; [Smulson, Mark E.] Georgetown Univ, Sch Med, Dept Biochem, Washington, DC 20057 USA; [Brim, Hassan] Howard Univ, Dept Pathol, Washington, DC 20059 USA; [Brim, Hassan] Howard Univ, Ctr Canc, Washington, DC 20059 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Al Azhar University; University of Alabama System; University of Alabama Birmingham; University of Chicago; Georgetown University; Howard University; Howard University	Boulares, AH (corresponding author), 533 Bolivar St, New Orleans, LA 70112 USA.	hboulr@lsuhsc.edu	Ghonim, Mohamed A./AAT-3339-2021; Ghonim, Mohamed A./L-4757-2016	Ghonim, Mohamed A./0000-0001-9404-2698; Ghonim, Mohamed A./0000-0001-9404-2698; Zhang, Jianhua/0000-0002-2128-9574; Errami, Youssef/0000-0002-0432-4331; El-Bahrawy, Ali/0000-0001-6116-0428	National Institutes of Health Grant [HL072889]; American Cancer Society Grant [RSG-116608]; Louisiana Cancer Research Consortium (New Orleans, LA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Grant(American Cancer Society); Louisiana Cancer Research Consortium (New Orleans, LA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL072889. This work was also supported by American Cancer Society Grant RSG-116608 and by funds from the Louisiana Cancer Research Consortium (New Orleans, LA) (to H. B.).	Boulares AH, 2004, BASIC CLIN PHARMACOL, V94, P19; Boulares AH, 2002, CANCER RES, V62, P4439; Boulares AH, 2002, BIOCHEM BIOPH RES CO, V290, P796, DOI 10.1006/bbrc.2001.6280; Boulares AH, 2002, J BIOL CHEM, V277, P372, DOI 10.1074/jbc.M107738200; Boulares AH, 2001, J BIOL CHEM, V276, P38185; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu QY, 1998, BIOCHEMISTRY-US, V37, P10134, DOI 10.1021/bi9800597; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Los M, 2000, BIOCHEMISTRY-US, V39, P7365, DOI 10.1021/bi000158w; Moffitt KL, 2007, BIOCHEM SOC T, V35, P559, DOI 10.1042/BST0350559; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Napirei M, 2005, BIOCHEM J, V389, P355, DOI 10.1042/BJ20042124; Napirei M, 2009, FEBS J, V276, P1059, DOI 10.1111/j.1742-4658.2008.06849.x; O'Connell AR, 2006, BIOCHEM BIOPH RES CO, V345, P608, DOI 10.1016/j.bbrc.2006.04.147; Shiokawa D, 2005, BIOCHEM J, V392, P511, DOI 10.1042/BJ20051114; Shiokawa D, 2003, BIOCHEM J, V376, P377, DOI 10.1042/BJ20030820; SHIOKAWA D, 1994, EUR J BIOCHEM, V226, P23, DOI 10.1111/j.1432-1033.1994.tb20022.x; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Takahashi K, 1999, INT J RADIAT BIOL, V75, P1099, DOI 10.1080/095530099139566; Trbovich AM, 1998, CELL DEATH DIFFER, V5, P38, DOI 10.1038/sj.cdd.4400299; Urbano A, 1998, J BIOL CHEM, V273, P34820, DOI 10.1074/jbc.273.52.34820; WALKER PR, 1991, CANCER RES, V51, P1078; Widlak P, 2001, MOL CELL BIOCHEM, V218, P125, DOI 10.1023/A:1007231822086; Widlak P, 2000, ACTA BIOCHIM POL, V47, P1037; Yakovlev AG, 2000, J BIOL CHEM, V275, P21302, DOI 10.1074/jbc.M001087200; Yakovlev AG, 2001, MOL MED, V7, P205, DOI 10.1007/BF03401955; Yakovlev AG, 1999, NUCLEIC ACIDS RES, V27, P1999, DOI 10.1093/nar/27.9.1999; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang JH, 2000, BIOCHEM BIOPH RES CO, V274, P225, DOI 10.1006/bbrc.2000.3122; Zhang M, 2001, APOPTOSIS, V6, P291, DOI 10.1023/A:1011387509290	35	51	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3460	3468		10.1074/jbc.M112.423061	http://dx.doi.org/10.1074/jbc.M112.423061			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23229555	Green Published, hybrid			2022-12-25	WOS:000314397900050
J	Ripple, MO; Kim, N; Springett, R				Ripple, Maureen O.; Kim, Namjoon; Springett, Roger			Acute Mitochondrial Inhibition by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK) 1/2 Inhibitors Regulates Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; COMPLEX-I; CANCER; PATHWAY; GROWTH; RAS; DIFFERENTIATION; EXPRESSION; NADH; PHOSPHORYLATION	The Ras-MEK1/2-ERK1/2 kinase signaling pathway regulates proliferation, survival, and differentiation and, because it is often aberrant in tumors, is a popular target for small molecule inhibition. A novel metabolic analysis that measures the real-time oxidation state of NAD(H) and the hemes of the electron transport chain and oxygen consumption within intact, living cells found that structurally distinct MEK1/2 inhibitors had an immediate, dose-dependent effect on mitochondrial metabolism. The inhibitors U0126, MIIC and PD98059 caused NAD(H) reduction, heme oxidation, and decreased oxygen consumption, characteristic of complex I inhibition. PD198306, an orally active MEK1/2 inhibitor, acted as an uncoupler. Each MEK1/2 inhibitor depleted phosphorylated ERK1/2 and inhibited proliferation, but the most robust antiproliferative effects always correlated with the metabolic failure which followed mitochondrial inhibition rather than inhibition of MEK1/2. This warrants rethinking the role of ERK1/2 in proliferation and emphasizes the importance of mitochondrial function in this process.	[Ripple, Maureen O.; Kim, Namjoon; Springett, Roger] Geisel Sch Med Dartmouth, Dept Radiol, Hanover, NH 03755 USA	Dartmouth College	Ripple, MO (corresponding author), Geisel Sch Med Dartmouth, Dept Radiol, HB 7786, Hanover, NH 03755 USA.	maureen.ripple@dartmouth.edu	Springett, Roger/P-2274-2019		National Institutes of Health [5R21RR25803, R01NS054298]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R21RR25803 and R01NS054298.	Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Beloueche-Babari M, 2005, CANCER RES, V65, P3356, DOI 10.1158/0008-5472.CAN-03-2981; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Bost F, 1997, J BIOL CHEM, V272, P33422, DOI 10.1074/jbc.272.52.33422; Brose MS, 2002, CANCER RES, V62, P6997; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; COLLINS SJ, 1987, BLOOD, V70, P1233; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; HALLER T, 1994, ANAL BIOCHEM, V218, P338, DOI 10.1006/abio.1994.1188; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hollis VS, 2003, BBA-BIOENERGETICS, V1607, P191, DOI 10.1016/j.bbabio.2003.09.012; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Kim N, 2012, BIOPHYS J, V102, P1194, DOI 10.1016/j.bpj.2012.02.003; Kim N, 2011, BBA-BIOENERGETICS, V1807, P779, DOI 10.1016/j.bbabio.2011.03.008; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; Osborne JK, 2012, CELL RES, V22, P14, DOI 10.1038/cr.2011.193; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Papa S, 2002, J BIOENERG BIOMEMBR, V34, P1, DOI 10.1023/A:1013863018115; Paz C, 2009, METHOD ENZYMOL, V457, P169, DOI 10.1016/S0076-6879(09)05010-1; Ripple MO, 2005, BREAST CANCER RES TR, V93, P177, DOI 10.1007/s10549-005-4794-6; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schilling B, 2005, MOL CELL PROTEOMICS, V4, P84, DOI 10.1074/mcp.M400143-MCP200; Sebolt-Leopold JS, 2008, CLIN CANCER RES, V14, P3651, DOI 10.1158/1078-0432.CCR-08-0333; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; SteinlechnerMaran R, 1996, AM J PHYSIOL-CELL PH, V271, pC2053, DOI 10.1152/ajpcell.1996.271.6.C2053; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; YU L, 1987, J BIOL CHEM, V262, P1137	41	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2933	2940		10.1074/jbc.M112.430082	http://dx.doi.org/10.1074/jbc.M112.430082			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235157	Green Published, hybrid			2022-12-25	WOS:000314397900004
J	Lambertucci, AC; Lambertucci, RH; Hirabara, SM; Curi, R; Moriscot, AS; Alba-Loureiro, TC; Guimaraes-Ferreira, L; Levada-Pires, AC; Vasconcelos, DAA; Sellitti, DF; Pithon-Curi, TC				Lambertucci, Adriana C.; Lambertucci, Rafael H.; Hirabara, Sandro M.; Curi, Rui; Moriscot, Anselmo S.; Alba-Loureiro, Tatiana C.; Guimaraes-Ferreira, Lucas; Levada-Pires, Adriana C.; Vasconcelos, Diogo A. A.; Sellitti, Donald F.; Pithon-Curi, Tania C.			Glutamine Supplementation Stimulates Protein-Synthetic and Inhibits Protein-Degradative Signaling Pathways in Skeletal Muscle of Diabetic Rats	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; AMINO-ACIDS; UBIQUITIN LIGASES; LEUCINE; ATROPHY; METABOLISM; ACTIVATION; EXPRESSION; ATROGIN-1	In this study, we investigated the effect of glutamine (Gln) supplementation on the signaling pathways regulating protein synthesis and protein degradation in the skeletal muscle of rats with streptozotocin (STZ)-induced diabetes. The expression levels of key regulatory proteins in the synthetic pathways (Akt, mTOR, GSK3 and 4E-BP1) and the degradation pathways (MuRF-1 and MAFbx) were determined using real-time PCR and Western blotting in four groups of male Wistar rats; 1) control, non-supplemented with glutamine; 2) control, supplemented with glutamine; 3) diabetic, non-supplemented with glutamine; and 4) diabetic, supplemented with glutamine. Diabetes was induced by the intravenous injection of 65 mg/kg bw STZ in citrate buffer (pH 4.2); the non-diabetic controls received only citrate buffer. After 48 hours, diabetes was confirmed in the STZ-treated animals by the determination of blood glucose levels above 200 mg/dL. Starting on that day, a solution of 1 g/kg bw Gln in phosphate buffered saline (PBS) was administered daily via gavage for 15 days to groups 2 and 4. Groups 1 and 3 received only PBS for the same duration. The rats were euthanized, and the soleus muscles were removed and homogenized in extraction buffer for the subsequent measurement of protein and mRNA levels. The results demonstrated a significant decrease in the muscle Gln content in the diabetic rats, and this level increased toward the control value in the diabetic rats receiving Gln. In addition, the diabetic rats exhibited a reduced mRNA expression of regulatory proteins in the protein synthesis pathway and increased expression of those associated with protein degradation. A reduction in the skeletal muscle mass in the diabetic rats was observed and was alleviated partially with Gln supplementation. The data suggest that glutamine supplementation is potentially useful for slowing the progression of muscle atrophy in patients with diabetes.	[Lambertucci, Adriana C.; Lambertucci, Rafael H.; Hirabara, Sandro M.; Levada-Pires, Adriana C.; Pithon-Curi, Tania C.] Univ Cruzeiro Sul, Postgrad Program Human Movement Sci, Inst Phys Act Sci & Sports, Sao Paulo, Brazil; [Lambertucci, Rafael H.; Curi, Rui; Alba-Loureiro, Tatiana C.; Vasconcelos, Diogo A. A.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Moriscot, Anselmo S.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol & Dev, Sao Paulo, Brazil; [Guimaraes-Ferreira, Lucas] Univ Fed Espirito Santo, Ctr Phys Educ & Sports, Vitoria, ES, Brazil; [Sellitti, Donald F.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	Universidade Cruzeiro do Sul; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Espirito Santo; Uniformed Services University of the Health Sciences - USA	Pithon-Curi, TC (corresponding author), Univ Cruzeiro Sul, Postgrad Program Human Movement Sci, Inst Phys Act Sci & Sports, Sao Paulo, Brazil.	tcuri@icb.usp.br	Lambertucci, Rafael H/C-6975-2012; Curi, Rui/C-9351-2012; Moriscot, Anselmo S./C-4506-2012; Hirabara, Sandro Massao/C-4014-2012; Loureiro, Tatiana C Alba/U-9436-2018; Loureiro, Tatiana/C-6712-2012; Pithon-Curi, Tania Cristina/AAB-9436-2021; Pires, Adriana Cristina Levada/AAC-9783-2021; Guimarães-Ferreira, Lucas/B-1137-2011	Lambertucci, Rafael H/0000-0001-8532-2639; Moriscot, Anselmo S./0000-0003-3098-4613; Hirabara, Sandro Massao/0000-0002-7392-0444; Guimarães-Ferreira, Lucas/0000-0002-2970-7355; PITHON-CURI, TANIA CRISTINA/0000-0002-9714-9105	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; Curi R, 2007, FRONT BIOSCI-LANDMRK, V12, P344, DOI 10.2741/2068; Dokken BB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1188, DOI 10.1152/ajpendo.00547.2004; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kimball Scot R, 2004, Nutr Metab (Lond), V1, P3, DOI 10.1186/1743-7075-1-3; Lagranha CJ, 2004, MED SCI SPORT EXER, V36, P210, DOI 10.1249/01.MSS.0000113490.98089.B1; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Medeiros C, 2011, J CELL PHYSIOL, V226, P666, DOI 10.1002/jcp.22387; Newsholme P, 2011, FRONT BIOSCI-LANDMRK, V16, P315, DOI 10.2741/3690; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; O'Neill ED, 2010, AGE, V32, P209, DOI 10.1007/s11357-009-9125-0; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Peters SJ, 2011, ONCOL REP, V26, P247, DOI 10.3892/or.2011.1269; Pithon-Curi TC, 2003, AM J PHYSIOL-CELL PH, V284, pC1355, DOI 10.1152/ajpcell.00224.2002; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Semiz S, 2002, MOL CELL BIOCHEM, V231, P23, DOI 10.1023/A:1014437019586; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Vary TC, 2007, J NUTR, V137, P2074, DOI 10.1093/jn/137.9.2074; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; WINDMUELLER HG, 1974, J BIOL CHEM, V249, P5070; Wolfe RR, 2002, J NUTR, V132, p3219S, DOI 10.1093/jn/131.10.3219S; Wu M, 2010, J CELL PHYSL, V226, P29; Xi PB, 2011, FRONT BIOSCI-LANDMRK, V16, P578, DOI 10.2741/3707	40	33	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50390	10.1371/journal.pone.0050390	http://dx.doi.org/10.1371/journal.pone.0050390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239980	Green Published, gold			2022-12-25	WOS:000312290800018
J	Leal, MDC; Pincini, A; Tornillo, G; Fiorito, E; Bisaro, B; Di Luca, E; Turco, E; Defilippi, P; Cabodi, S				Leal, Maria del Pilar Camacho; Pincini, Alessandra; Tornillo, Giusy; Fiorito, Elisa; Bisaro, Brigitte; Di Luca, Elisa; Turco, Emilia; Defilippi, Paola; Cabodi, Sara			p130Cas Over-Expression Impairs Mammary Branching Morphogenesis in Response to Estrogen and EGF	PLOS ONE			English	Article							RECEPTOR-ALPHA; BREAST-CANCER; CELL-DEATH; GLAND; ACTIVATION; SRC; GROWTH; AMPHIREGULIN; ASSOCIATION; MAINTENANCE	p130Cas adaptor protein regulates basic processes such as cell cycle control, survival and migration. p130Cas over-expression has been related to mammary gland transformation, however the in vivo consequences of p130Cas over-expression during mammary gland morphogenesis are not known. In ex vivo mammary explants from MMTV-p130Cas transgenic mice, we show that p130Cas impairs the functional interplay between Epidermal Growth Factor Receptor (EGFR) and Estrogen Receptor (ER) during mammary gland development. Indeed, we demonstrate that p130Cas over-expression upon the concomitant stimulation with EGF and estrogen (E2) severely impairs mammary morphogenesis giving rise to enlarged multicellular spherical structures with altered architecture and absence of the central lumen. These filled acinar structures are characterized by increased cell survival and proliferation and by a strong activation of Erk1/2 MAPKs and Akt. Interestingly, antagonizing the ER activity is sufficient to re-establish branching morphogenesis and normal Erk1/2 MAPK activity. Overall, these results indicate that high levels of p130Cas expression profoundly affect mammary morphogenesis by altering epithelial architecture, survival and unbalancing Erk1/2 MAPKs activation in response to growth factors and hormones. These results suggest that alteration of morphogenetic pathways due to p130Cas over-expression might prime mammary epithelium to tumorigenesis.	[Leal, Maria del Pilar Camacho; Pincini, Alessandra; Tornillo, Giusy; Fiorito, Elisa; Bisaro, Brigitte; Di Luca, Elisa; Turco, Emilia; Defilippi, Paola; Cabodi, Sara] Univ Turin, Dept Genet Biol & Biochem, MBC, Turin, Italy; [Fiorito, Elisa] Nordic EMBL Partnership, Ctr Mol Med Norway NCMM, Oslo, Norway	University of Turin	Cabodi, S (corresponding author), Univ Turin, Dept Genet Biol & Biochem, MBC, Turin, Italy.	sara.cabodi@unito.it	Tornillo, Giusy/AAZ-8165-2020; DEFILIPPI, Paola/L-2232-2014; De Luca, Elisa/L-2491-2017	Tornillo, Giusy/0000-0002-3934-3567; Migliaccio, Antimo/0000-0002-4197-2055; De Luca, Elisa/0000-0001-9849-0703; Cabodi, Sara/0000-0003-1248-6549; Defilippi, Paola/0000-0001-6427-4906	Associazione Italiana Ricerca sul Cancro (AIRC) [IG2008, IG2011]; Fondazione Ricerca Italiana sul cancro (FIRC) fellowships; Progetto Sanita Finalizzata; Piattaforma per la ricerca su cellule staminali (PiSTEM); Ministero Italiano Universita e Ricerca (FIRB Giovani)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Ricerca Italiana sul cancro (FIRC) fellowships(Fondazione AIRC per la ricerca sul cancro); Progetto Sanita Finalizzata; Piattaforma per la ricerca su cellule staminali (PiSTEM); Ministero Italiano Universita e Ricerca (FIRB Giovani)	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) (Grant IG2008 and IG2011), Ministero Italiano Universita e Ricerca (FIRB Giovani 2008), Piattaforma per la ricerca su cellule staminali (PiSTEM), Progetto Sanita Finalizzata. G. Tornillo and B. Bisaro are supported by Fondazione Ricerca Italiana sul cancro (FIRC) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Auricchio F, 2008, STEROIDS, V73, P880, DOI 10.1016/j.steroids.2008.01.023; Blatchford DR, 1999, J CELL PHYSIOL, V181, P304, DOI 10.1002/(SICI)1097-4652(199911)181:2<304::AID-JCP12>3.0.CO;2-5; Boonyaratanakornkit V, STEROIDS, V76, P877; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Hynes NE, COLD SPRING HARB PER, V2; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; LaMarca HL, 2008, ENDOCRINOLOGY, V149, P4317, DOI 10.1210/en.2008-0450; Lee YR, 2005, BIOCHEM BIOPH RES CO, V336, P1221, DOI 10.1016/j.bbrc.2005.08.256; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Marino M, 2006, STEROIDS, V71, P298, DOI 10.1016/j.steroids.2005.09.011; Migliaccio A, 2010, MOL CELL ENDOCRINOL, V327, P19, DOI 10.1016/j.mce.2010.06.014; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Reginato MJ, 2006, J MAMMARY GLAND BIOL, V11, P205, DOI 10.1007/s10911-006-9030-4; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Sebastian J, 1998, CELL GROWTH DIFFER, V9, P777; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Tian J, 2012, J CLIN INVEST, V122, P192, DOI 10.1172/JCI42204; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tornillo G, 2011, EUR J CELL BIOL, V90, P237, DOI 10.1016/j.ejcb.2010.09.002; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49817	10.1371/journal.pone.0049817	http://dx.doi.org/10.1371/journal.pone.0049817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239970	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000312290800008
J	Rosowski, EE; Saeij, JPJ				Rosowski, Emily E.; Saeij, Jeroen P. J.			Toxoplasma gondii Clonal Strains All Inhibit STAT1 Transcriptional Activity but Polymorphic Effectors Differentially Modulate IFN gamma Induced Gene Expression and STAT1 Phosphorylation	PLOS ONE			English	Article							INTERFERON-GAMMA; MURINE MACROPHAGES; NITRIC-OXIDE; ANTIGEN PRESENTATION; CELL-LINE; INFECTION; MECHANISMS; RESPONSES; ALPHA; MICE	Host defense against the parasite Toxoplasma gondii requires the cytokine interferon-gamma (IFN gamma). However, Toxoplasma inhibits the host cell transcriptional response to IFN gamma, which is thought to allow the parasite to establish a chronic infection. It is not known whether all strains of Toxoplasma block IFN gamma-responsive transcription equally and whether this inhibition occurs solely through the modulation of STAT1 activity or whether other transcription factors are involved. We find that strains from three North American/European clonal lineages of Toxoplasma, types I, II, and III, can differentially modulate specific aspects of IFN gamma signaling through the polymorphic effector proteins ROP16 and GRA15. STAT1 tyrosine phosphorylation is activated in the absence of IFN gamma by the Toxoplasma kinase ROP16, but this ROP16-activated STAT1 is not transcriptionally active. Many genes induced by STAT1 can also be controlled by other transcription factors and therefore using these genes as specific readouts to determine Toxoplasma inhibition of STAT1 activity might be inappropriate. Indeed, GRA15 and ROP16 modulate the expression of subsets of IFN gamma responsive genes through activation of the NF-kappa B/IRF1 and STAT3/6 transcription factors, respectively. However, using a stable STAT1-specific reporter cell line we show that strains from the type I, II, and III clonal lineages equally inhibit STAT1 transcriptional activity. Furthermore, all three of the clonal lineages significantly inhibit global IFN gamma induced gene expression.	[Rosowski, Emily E.; Saeij, Jeroen P. J.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Saeij, JPJ (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	jsaeij@mit.edu	Rosowski, Emily E./U-9654-2019	Rosowski, Emily E./0000-0002-6761-1098; Saeij, Jeroen/0000-0003-0289-7109	National Institutes of Health [R01-AI080621]; American Heart Association [0835099N]; pre-doctoral grant in the Biological Sciences [5-T32- GM007287-33]; Cleo and Paul Schimmel Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); pre-doctoral grant in the Biological Sciences; Cleo and Paul Schimmel Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J. Saeij was supported by National Institutes of Health R01-AI080621 and by a Scientist Development Grant from the American Heart Association (0835099N). E. Rosowski was supported by a pre-doctoral grant in the Biological Sciences (5-T32- GM007287-33) and the Cleo and Paul Schimmel Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baus D, 2009, LEUKEMIA, V23, P1885, DOI 10.1038/leu.2009.103; Boyle JP, 2007, EXP PARASITOL, V116, P302, DOI 10.1016/j.exppara.2007.01.010; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Hebenstreit D, 2003, J IMMUNOL, V171, P5901, DOI 10.4049/jimmunol.171.11.5901; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kim SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06; Koshy AA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002825; Lang C, 2006, MICROBES INFECT, V8, P1994, DOI 10.1016/j.micinf.2006.02.031; Leng J, 2009, J IMMUNOL, V182, P489, DOI 10.4049/jimmunol.182.1.489; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; Liesenfeld O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020568; Luder CGK, 1998, CLIN EXP IMMUNOL, V112, P308; Luder CGK, 2003, J NEUROIMMUNOL, V134, P12, DOI 10.1016/S0165-5728(02)00320-X; Luder CGK, 2001, EUR J IMMUNOL, V31, P1475, DOI 10.1002/1521-4141(200105)31:5&lt;1475::AID-IMMU1475&gt;3.0.CO;2-C; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Ohmori Y, 1997, J IMMUNOL, V159, P5474; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Robinson CM, 2006, CYTOKINE, V35, P53, DOI 10.1016/j.cyto.2006.07.007; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Rozenfeld C, 2005, AM J PATHOL, V167, P1021, DOI 10.1016/S0002-9440(10)61191-1; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Wang YX, 2011, BIOCHEM BIOPH RES CO, V410, P549, DOI 10.1016/j.bbrc.2011.06.022; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yang TH, 1996, MICROBIOL IMMUNOL, V40, P443, DOI 10.1111/j.1348-0421.1996.tb01091.x; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zimmermann S, 2006, J IMMUNOL, V176, P1840, DOI 10.4049/jimmunol.176.3.1840	44	52	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51448	10.1371/journal.pone.0051448	http://dx.doi.org/10.1371/journal.pone.0051448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240025	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800061
J	Jaerve, A; Kruse, F; Malik, K; Hartung, HP; Muller, HW				Jaerve, Anne; Kruse, Fabian; Malik, Katharina; Hartung, Hans-Peter; Mueller, Hans Werner			Age-Dependent Modulation of Cortical Transcriptomes in Spinal Cord Injury and Repair	PLOS ONE			English	Article							CORTICOSPINAL MOTOR-NEURONS; NEUROTROPHIC FACTOR CNTF; NEURITE OUTGROWTH; AXON REGENERATION; NERVOUS-SYSTEM; DM-GRASP; COMPLEMENT; PROTEIN; BRAIN; GENE	Both injury and aging of the central nervous system reportedly produce profound changes in gene expression. Therefore, aging may interfere with the success of therapeutic interventions which were tailored for young patients. Using genome-scale transcriptional profiling, we identified distinct age-dependent expression profiles in rat sensorimotor cortex during acute, subacute and chronic phases of spinal cord injury (SCI). Aging affects the cortical transcriptomes triggered by transection of the corticospinal tract as there was only a small overlap between the significantly lesion-regulated genes in both age groups. Over-representation analysis of the lesion-regulated genes revealed that, in addition to biological processes in common, such as lipid metabolism, others, such as activation of complement cascade, were specific for aged animals. When a recently developed treatment to suppress fibrotic scarring (anti-scarring treatment AST) was applied to the injured spinal cord of aged (22 months) and young (2 months) rats, we found that the cortical gene expression in old rats was modulated to resemble regeneration-associated profiles of young animals including the up-regulation of known repair promoting growth and transcription factors at 35 dpo. In combination with recent immunohistochemical findings demonstrating regenerative axon growth upon AST in aged animals, the present investigation on the level of gene expression strongly supports the feasibility of a successful AST therapy in elderly patients.	[Jaerve, Anne; Kruse, Fabian; Malik, Katharina; Hartung, Hans-Peter; Mueller, Hans Werner] Univ Dusseldorf, Fac Med, Dept Neurol, Mol Neurobiol Lab, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Muller, HW (corresponding author), Univ Dusseldorf, Fac Med, Dept Neurol, Mol Neurobiol Lab, D-40225 Dusseldorf, Germany.	hanswerner.mueller@uni-duesseldorf.de		Jarve, Anne/0000-0003-2096-0706	German Research Council Deutsche Forschungsgemeinschaft DFG [SFB 590/TPC2]; German Research Council Deutsche Forschungsgemeinschaft DFG (Research Training Group) [1033]; Aging Research Foundation, Dusseldorf, Germany	German Research Council Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); German Research Council Deutsche Forschungsgemeinschaft DFG (Research Training Group); Aging Research Foundation, Dusseldorf, Germany	This work was supported by the German Research Council Deutsche Forschungsgemeinschaft DFG (SFB 590/TPC2 and Research Training Group 1033) and by the Aging Research Foundation, Dusseldorf, Germany. The authors declare: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023764; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Bloch J, 2011, J COMP NEUROL, V519, P775, DOI 10.1002/cne.22547; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Chrast R, 2004, NEUROCHEM INT, V45, P353, DOI 10.1016/j.neuint.2003.069.011; Cox S, 2004, BRAIN RES, V1010, P55, DOI 10.1016/j.brainres.2004.02.068; DALE SM, 1995, EXP NEUROL, V135, P67, DOI 10.1006/exnr.1995.1066; Dauth S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-74; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; Dutta R, 2007, BRAIN, V130, P2566, DOI 10.1093/brain/awm206; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Gillis J, 2010, NAT PROTOC, V5, P1148, DOI 10.1038/nprot.2010.78; Hao HP, 2007, J NEUROSCI RES, V85, P2196, DOI 10.1002/jnr.21357; He YD, 2011, ACTA NEUROCHIR SUPPL, V111, P133, DOI 10.1007/978-3-7091-0693-8_22; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; Jaerve A, 2011, EXP NEUROL, V231, P284, DOI 10.1016/j.expneurol.2011.07.002; Junger H, 1998, NEUROREPORT, V9, P3749, DOI 10.1097/00001756-199811160-00033; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Kriebel M, 2012, INT J BIOCH IN PRESS; Kruse F., 2008, NEURAL DEGENERATION, P61; Kruse F, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00026; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Martin-Villalba A, 1998, MOL BRAIN RES, V62, P158, DOI 10.1016/S0169-328X(98)00239-3; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; National Spinal Cord Injury Statistical Center, FACTS FIG GLANC; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; PASINETTI GM, 1992, EXP NEUROL, V118, P117, DOI 10.1016/0014-4886(92)90028-O; Petcu EB, 2008, GERONTOLOGY, V54, P6, DOI 10.1159/000112845; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Shimokawara T, 2002, NEUROPATHOLOGY, V22, P261, DOI 10.1046/j.1440-1789.2002.00463.x; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Tsai MJ, 2007, J NEUROSCI RES, V85, P2950, DOI 10.1002/jnr.21395; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2007, CURR OPIN BIOTECH, V18, P355, DOI 10.1016/j.copbio.2007.07.004	51	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49812	10.1371/journal.pone.0049812	http://dx.doi.org/10.1371/journal.pone.0049812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236355	gold, Green Published, Green Submitted			2022-12-25	WOS:000312064100007
J	Forel, JM; Chiche, L; Thomas, G; Mancini, J; Farnarier, C; Cognet, C; Guervilly, C; Daumas, A; Vely, F; Xeridat, F; Vivier, E; Papazian, L				Forel, Jean-Marie; Chiche, Laurent; Thomas, Guillemette; Mancini, Julien; Farnarier, Catherine; Cognet, Celine; Guervilly, Christophe; Daumas, Aurelie; Vely, Frederic; Xeridat, Francois; Vivier, Eric; Papazian, Laurent			Phenotype and Functions of Natural Killer Cells in Critically-Ill Septic Patients	PLOS ONE			English	Article							HUMAN NK CELLS; INFLAMMATORY RESPONSE; IN-VITRO; GAMMA PRODUCTION; IFN-GAMMA; SEPSIS; CYTOKINE; LYMPHOCYTES; INNATE; INTERFERON	Rationale: Natural killer cells, as a major source of interferon-gamma, contribute to the amplification of the inflammatory response as well as to mortality during severe sepsis in animal models. Objective: We studied the phenotype and functions of circulating NK cells in critically-ill septic patients. Methods: Blood samples were taken <48 hours after admission from 42 ICU patients with severe sepsis (n = 15) or septic shock (n = 14) (Sepsis group), non-septic SIRS (n = 13) (SIRS group), as well as 21 healthy controls. The immuno-phenotype and functions of NK cells were studied by flow cytometry. Results: The absolute number of peripheral blood CD3-CD56(+) NK cells was similarly reduced in all groups of ICU patients, but with a normal percentage of NK cells. When NK cell cytotoxicity was evaluated with degranulation assays (CD107 expression), no difference was observed between Sepsis patients and healthy controls. Under antibody-dependent cell cytotoxicity (ADCC) conditions, SIRS patients exhibited increased CD107 surface expression on NK cells (62.9[61.3-70]%) compared to healthy controls (43.5[32.1-53.1]%) or Sepsis patients (49.2[37.3-62.9]%) (p = 0.002). Compared to healthy (10.2[6.3-13.1]%), reduced interferon-gamma production by NK cells (K562 stimulation) was observed in Sepsis group (6.2[2.2-9.9]%, p<0.01), and especially in patients with septic shock. Conversely, SIRS patients exhibited increased interferon-gamma production (42.9[30.1-54.7]%) compared to Sepsis patients (18.4[11.7-35.7]%, p<0.01) or healthy controls (26.8[19.3-44.9]%, p = 0.09) in ADCC condition. Conclusions: Extensive monitoring of the NK-cell phenotype and function in critically-ill septic patients revealed early decreased NK-cell function with impaired interferon-gamma production. These results may aid future NK-based immuno-interventions.	[Forel, Jean-Marie; Chiche, Laurent; Thomas, Guillemette; Guervilly, Christophe; Daumas, Aurelie; Xeridat, Francois; Papazian, Laurent] Hop Nord Marseille, APHM, Marseille, France; [Forel, Jean-Marie; Papazian, Laurent] Aix Marseille Univ, Fac Med, URMITE UMR CNRS 7278, Marseille, France; [Chiche, Laurent; Thomas, Guillemette; Vivier, Eric] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM U, CNRS UMR7280, Marseille, France; [Chiche, Laurent; Thomas, Guillemette; Farnarier, Catherine; Cognet, Celine; Vely, Frederic; Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, Immunol Lab, Marseille, France; [Mancini, Julien] Hop La Timone, Serv Sante Publ, APHM, Marseille, France; [Mancini, Julien] Aix Marseille Univ, UMR912, INSERM, IRD, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Chiche, L (corresponding author), Hop Nord Marseille, APHM, Marseille, France.	laurent.chiche@ap-hm.fr	DAUMAS, Aurélie/AAK-3672-2020; Vivier, Eric/F-8939-2010; guervilly, christophe/C-1083-2016; Vély, Frédéric/HHM-3894-2022; Mancini, Julien/G-6263-2011	Vivier, Eric/0000-0001-7022-8287; Mancini, Julien/0000-0001-9500-8598; Guervilly, Christophe/0000-0001-9066-6591; Vely, Frederic/0000-0002-1682-0949	Assistance Publique Hopitaux de Marseille (Appel d'Offre Recherche Clinique); Societe de Reanimation de Langue Francaise (SRLF)	Assistance Publique Hopitaux de Marseille (Appel d'Offre Recherche Clinique); Societe de Reanimation de Langue Francaise (SRLF)	This work was supported by the Assistance Publique Hopitaux de Marseille (Appel d'Offre Recherche Clinique) and by a grant from the Societe de Reanimation de Langue Francaise (SRLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Andaluz-Ojeda D, 2011, CRIT CARE, V15, DOI 10.1186/cc10501; Andre Pascale, 2008, V415, P291, DOI 10.1007/978-1-59745-570-1_17; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Badgwell B, 2002, SURGERY, V132, P205, DOI 10.1067/msy.2002.125311; BENDER BS, 1988, CLIN EXP IMMUNOL, V71, P120; BLAZAR BA, 1986, J CLIN IMMUNOL, V6, P26, DOI 10.1007/BF00915361; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Carson WE, 1999, J IMMUNOL, V162, P4943; Cavaillon JM, 2006, J ENDOTOXIN RES, V12, P151, DOI 10.1179/096805106X102246; Chiche L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/986491; de Pablo R, 2012, CRIT CARE, V16, DOI 10.1186/cc11204; Emoto M, 2002, J IMMUNOL, V169, P1426, DOI 10.4049/jimmunol.169.3.1426; Etogo AO, 2008, J IMMUNOL, V180, P6334, DOI 10.4049/jimmunol.180.9.6334; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fumeaux T, 2002, AM J RESP CRIT CARE, V166, P1475, DOI 10.1164/rccm.200203-217OC; Giamarellos-Bourboulis EJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5111; Gogos C, 2010, CRIT CARE, V14, DOI 10.1186/cc9031; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; HEREMANS H, 1994, EUR J IMMUNOL, V24, P1155, DOI 10.1002/eji.1830240522; Holub M, 2003, CLIN MICROBIOL INFEC, V9, P202, DOI 10.1046/j.1469-0691.2003.00518.x; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kerr AR, 2005, MICROBES INFECT, V7, P845, DOI 10.1016/j.micinf.2005.02.011; KLIMPEL GR, 1986, CLIN EXP IMMUNOL, V66, P384; Lopez-Botet M, 2004, TISSUE ANTIGENS, V63, P195, DOI 10.1111/j.1399-0039.2004.00210.x; MATURANA P, 1991, J CRIT CARE, V6, P42, DOI 10.1016/0883-9441(91)90032-O; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; PUENTE J, 1993, INT J CLIN PHARM TH, V31, P271; Rayhane N, 1999, J ENDOTOXIN RES, V5, P319, DOI 10.1179/096805199101531895; Schroder M, 2003, J IMMUNOL, V170, P5260, DOI 10.4049/jimmunol.170.10.5260; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Souza-Fonseca-Guimaraes F, 2012, J IMMUNOL; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; STEIN MD, 1984, CELL IMMUNOL, V86, P551, DOI 10.1016/0008-8749(84)90412-X; Takabayashi A, 2003, WORLD J SURG, V27, P659, DOI 10.1007/s00268-003-6926-7; Venet F, 2010, SHOCK, V34, P358, DOI 10.1097/SHK.0b013e3181dc0977; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; von Muller L, 2007, J INFECT DIS, V196, P1288, DOI 10.1086/522429; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Yu JH, 2006, IMMUNITY, V24, P575, DOI 10.1016/j.immuni.2006.03.016	48	50	60	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50446	10.1371/journal.pone.0050446	http://dx.doi.org/10.1371/journal.pone.0050446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236375	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700015
J	Sindhurakar, A; Bradley, NS				Sindhurakar, Anil; Bradley, Nina S.			Light Accelerates Morphogenesis and Acquisition of Interlimb Stepping in Chick Embryos	PLOS ONE			English	Article							CELL-PROLIFERATION; LOCOMOTOR BEHAVIOR; KINEMATIC ANALYSIS; LEG MOVEMENTS; MOTOR OUTPUT; MUSCLE; GROWTH; PATTERNS; HINDLIMB; PINEAL	Chicks are bipedal precocious vertebrates that achieve adaptive locomotor skill within hours after hatching. Development of limb movement has been extensively studied in the chicken embryo, but few studies have focused on the preparations leading to precocious locomotor skill. Chicks typically hatch after 21 days of incubation, and recent studies provided evidence that the neural circuits for intralimb control of stepping are established between embryonic days (E) 18-20. It has also been shown that variations in light exposure during embryogenesis can accelerate or delay the onset of hatching and walking by 1 to 2 days. Our earlier work revealed that despite these differences in time to hatch, chicks incubated in different light conditions achieved similar locomotor skill on the day of hatching. Results suggested to us that light exposure during incubation may have accelerated development of locomotor circuits in register with earlier hatching. Thus, in this study, embryos were incubated in 1 of 3 light conditions to determine if development of interlimb coordination at a common time point, 19 days of incubation, varied with light exposure during embryogenesis. Leg muscle activity was recorded bilaterally and burst analyses were performed for sequences of spontaneous locomotor-related activity in one or more ankle muscles to quantify the extent of interlimb coordination in ovo. We report findings indicating that the extent of interlimb coordination varied with light exposure, and left-right alternating steps were a more reliable attribute of interlimb coordination for embryos incubated in constant bright light. We provide evidence that morphological development of the leg varied with light exposure. Based on these findings, we propose that light can accelerate the development of interlimb coordination in register with earlier hatching. Our results lead us to further propose that alternating left-right stepping is the default pattern of interlimb coordination produced by locomotor circuits during embryogenesis. Citation: Sindhurakar A, Bradley NS (2012) Light Accelerates Morphogenesis and Acquisition of Interlimb Stepping in Chick Embryos. PLoS ONE 7(12): e51348. doi:10.1371/journal.pone.0051348	[Bradley, Nina S.] Univ So Calif, Ostrow Sch Dent, Los Angeles, CA 90089 USA; [Sindhurakar, Anil] Burke Cornell Med Res Inst, White Plains, NY USA	University of Southern California	Bradley, NS (corresponding author), Univ So Calif, Ostrow Sch Dent, Los Angeles, CA 90089 USA.	nbradley@usc.edu	Bradley, Nina/F-8830-2014	Bradley, Nina/0000-0002-9674-4834	NIH National Institute of Child Health and Human Development [R01 HD-053367]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053367] Funding Source: NIH RePORTER	NIH National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the NIH National Institute of Child Health and Human Development grant R01 HD-053367 awarded to N.S. Bradley. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASAKA K, 1995, BRAIN RES, V692, P283, DOI 10.1016/0006-8993(95)00643-5; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Arendt J., 1995, MELATONIN MAMMALIAN; Batchelet E., 1981, CIRCULAR STAT BIOL, V1st; BEKOFF A, 1979, J EXP BIOL, V83, P1; BEKOFF A, 1982, J COMP PHYSIOL, V145, P497, DOI 10.1007/BF00612815; BEKOFF A, 1975, P NATL ACAD SCI USA, V72, P1245, DOI 10.1073/pnas.72.4.1245; BEKOFF A, 1976, BRAIN RES, V106, P271, DOI 10.1016/0006-8993(76)91025-8; BEKOFF A, 1980, J EXP ZOOL, V214, P173, DOI 10.1002/jez.1402140207; BEKOFF A, 1978, DEV BEHAVIOR COMP EV, P19; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; Bradley NS, 2008, J NEUROPHYSIOL, V99, P1733, DOI 10.1152/jn.01393.2007; Bradley NS, 2003, J NEUROPHYSIOL, V90, P1408, DOI 10.1152/jn.00393.2003; BRADLEY NS, 1990, DEV PSYCHOBIOL, V23, P763, DOI 10.1002/dev.420230802; Branchereau P, 2000, BRAIN RES BULL, V53, P711, DOI 10.1016/S0361-9230(00)00403-2; CALVO J, 1978, ACTA ANAT, V101, P289, DOI 10.1159/000144980; CHAMBERS SH, 1995, EXP BRAIN RES, V103, P218; COLEMAN MA, 1976, POULTRY SCI, V55, P2483, DOI 10.3382/ps.0552483; Cooper CB, 2011, FUNCT ECOL, V25, P769, DOI 10.1111/j.1365-2435.2011.01847.x; Csernus VJ, 2007, GEN COMP ENDOCR, V152, P148, DOI 10.1016/j.ygcen.2007.01.008; Danilova N, 2004, FASEB J, V18, P751, DOI 10.1096/fj.03-0544fje; Fairchild BD, 2000, POULTRY SCI, V79, P1627, DOI 10.1093/ps/79.11.1627; Ghatpande A, 1995, CELL MOL BIOL RES, V41, P613; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Halevy O, 2006, AM J PHYSIOL-REG I, V290, pR1062, DOI 10.1152/ajpregu.00378.2005; Halevy O, 1998, COMP BIOCHEM PHYS A, V120, P317, DOI 10.1016/S1095-6433(98)10032-6; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; HAMBURGE.V, 1965, J EXP ZOOL, V159, P1, DOI 10.1002/jez.1401590102; HAMBURGER V, 1963, Q REV BIOL, V38, P342, DOI 10.1086/403941; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMBURGER V, 1963, DEV BIOL, V7, P533, DOI 10.1016/0012-1606(63)90140-4; Hill WL, 2004, DEV PSYCHOBIOL, V45, P174, DOI 10.1002/dev.20021; ISAKSON ST, 1970, COMP BIOCHEM PHYSIOL, V35, P229, DOI 10.1016/0010-406X(70)90925-4; JACOBSON RD, 1982, J NEUROPHYSIOL, V48, P238, DOI 10.1152/jn.1982.48.1.238; Johnston RM, 1996, J COMP PHYSIOL A, V179, P169, DOI 10.1007/BF00222784; JOHNSTON RM, 1992, J EXP BIOL, V171, P43; KARU TI, 1987, NUOVO CIMENTO D, V9, P1245, DOI 10.1007/BF02454725; LAUBER JK, 1975, COMP BIOCHEM PHYS A, V51, P903, DOI 10.1016/0300-9629(75)90073-0; Liu WJ, 2010, ANAT REC, V293, P1315, DOI 10.1002/ar.21174; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Muir GD, 1998, EXP BRAIN RES, V122, P275, DOI 10.1007/s002210050515; Okabayashi N, 2003, BRAIN RES, V990, P231, DOI 10.1016/S0006-8993(03)03531-5; Pang MYC, 2003, J NEUROPHYSIOL, V90, P2731, DOI 10.1152/jn.00407.2003; PROVINE RR, 1980, DEV PSYCHOBIOL, V13, P151, DOI 10.1002/dev.420130207; Robinson SR, 2005, DEV PSYCHOBIOL, V47, P328, DOI 10.1002/dev.20103; Ryu YU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006111; Shafey TM, 2004, BRIT POULTRY SCI, V45, P223, DOI 10.1080/00071660410001715821; SHUTZE JV, 1962, NATURE, V196, P594, DOI 10.1038/196594a0; SIEGEL PB, 1969, COMP BIOCHEM PHYSIOL, V28, P753, DOI 10.1016/0010-406X(69)92108-2; SIEGEL S, 1988, NONPARAMETERIC STAT; Sindhurakar A, 2010, DEV PSYCHOBIOL, V52, P802, DOI 10.1002/dev.20476; STEHOUWER DJ, 1984, DEV PSYCHOBIOL, V17, P217, DOI 10.1002/dev.420170303; Stein PSG, 2004, J NEUROPHYSIOL, V91, P2380, DOI 10.1152/jn.01184.2003; VALCAVI R, 1993, CLIN ENDOCRINOL, V39, P193, DOI 10.1111/j.1365-2265.1993.tb01773.x; Wai MSM, 2006, MICROSC RES TECHNIQ, V69, P99, DOI 10.1002/jemt.20279; Whelan PJ, 2003, J PHYSIOL-LONDON, V553, P695, DOI 10.1113/jphysiol.2003.046219	58	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51348	10.1371/journal.pone.0051348	http://dx.doi.org/10.1371/journal.pone.0051348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236480	gold, Green Published, Green Submitted			2022-12-25	WOS:000312589700037
J	de Vries, FT; Bloem, J; Quirk, H; Stevens, CJ; Bol, R; Bardgett, RD				de Vries, Franciska T.; Bloem, Jaap; Quirk, Helen; Stevens, Carly J.; Bol, Roland; Bardgett, Richard D.			Extensive Management Promotes Plant and Microbial Nitrogen Retention in Temperate Grassland	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SPECIES RICHNESS; BIOMASS RATIOS; SOIL MICROBES; FUNGAL; BACTERIAL; TRAITS; ABUNDANCE; VEGETATION; LINKAGES	Leaching losses of nitrogen (N) from soil and atmospheric N deposition have led to widespread changes in plant community and microbial community composition, but our knowledge of the factors that determine ecosystem N retention is limited. A common feature of extensively managed, species-rich grasslands is that they have fungal-dominated microbial communities, which might reduce soil N losses and increase ecosystem N retention, which is pivotal for pollution mitigation and sustainable food production. However, the mechanisms that underpin improved N retention in extensively managed, species-rich grasslands are unclear. We combined a landscape-scale field study and glasshouse experiment to test how grassland management affects plant and soil N retention. Specifically, we hypothesised that extensively managed, species-rich grasslands of high conservation value would have lower N loss and greater N retention than intensively managed, species-poor grasslands, and that this would be due to a greater immobilisation of N by a more fungal-dominated microbial community. In the field study, we found that extensively managed, species-rich grasslands had lower N leaching losses. Soil inorganic N availability decreased with increasing abundance of fungi relative to bacteria, although the best predictor of soil N leaching was the C/N ratio of aboveground plant biomass. In the associated glasshouse experiment we found that retention of added N-15 was greater in extensively than in intensively managed grasslands, which was attributed to a combination of greater root uptake and microbial immobilisation of N-15 in the former, and that microbial immobilisation increased with increasing biomass and abundance of fungi. These findings show that grassland management affects mechanisms of N retention in soil through changes in root and microbial uptake of N. Moreover, they support the notion that microbial communities might be the key to improved N retention through tightening linkages between plants and microbes and reducing N availability.	[de Vries, Franciska T.; Quirk, Helen; Stevens, Carly J.; Bardgett, Richard D.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Bloem, Jaap] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands; [Bol, Roland] Forschungszentrum Julich, Inst Bio & Geosci, IBG Agrosphere 3, D-52425 Julich, Germany	Lancaster University; Wageningen University & Research; Helmholtz Association; Research Center Julich	de Vries, FT (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	f.devries@lancaster.ac.uk	Bol, Roland/H-9324-2013; de Vries, Franciska/AAD-5760-2021; de Vries, Franciska T/D-3041-2009	Bol, Roland/0000-0003-3015-7706; de Vries, Franciska/0000-0002-6822-8883; de Vries, Franciska T/0000-0002-6822-8883; Stevens, Carly/0000-0002-2390-1763	EU; research program KB IV "Innovative scientific research for sustainable green and blue environment''; Netherlands Ministry of Economic Affairs, Agriculture and Innovation; Leverhulme Early Career fellowship; Natural Environment Research Council [ceh010010] Funding Source: researchfish	EU(European Commission); research program KB IV "Innovative scientific research for sustainable green and blue environment''; Netherlands Ministry of Economic Affairs, Agriculture and Innovation(Ministry of Economic Affairs, Netherlands); Leverhulme Early Career fellowship(Leverhulme Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was part of the EU 7th Framework funded SOILSERVICE project, led by Katarina Hedlund. The contribution of Wageningen University and Research Centre was supported by the research program KB IV "Innovative scientific research for sustainable green and blue environment'' funded by the Netherlands Ministry of Economic Affairs, Agriculture and Innovation. CJS is funded by a Leverhulme Early Career fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CR, 1998, SOIL BIOL BIOCHEM, V30, P767, DOI 10.1016/S0038-0717(97)00168-5; BAKKEN LR, 1983, APPL ENVIRON MICROB, V45, P1188, DOI 10.1128/AEM.45.4.1188-1195.1983; BARDGETT RD, 1993, AGR ECOSYST ENVIRON, V45, P25, DOI 10.1016/0167-8809(93)90057-V; Bardgett RD, 2003, ECOLOGY, V84, P1277, DOI 10.1890/0012-9658(2003)084[1277:SMCEWP]2.0.CO;2; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; Bloem J., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P861; BLOEM J, 1995, APPL ENVIRON MICROB, V61, P926, DOI 10.1128/AEM.61.3.926-936.1995; Bradley K, 2006, SOIL BIOL BIOCHEM, V38, P1583, DOI 10.1016/j.soilbio.2005.11.011; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; COLEMAN DC, 1983, ADV ECOL RES, V13, P1, DOI 10.1016/S0065-2504(08)60107-5; Crawley M.J., 2007, R BOOK; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; de Vries FT, 2007, SOIL BIOL BIOCHEM, V39, P1620, DOI 10.1016/j.soilbio.2007.01.013; de Vries FT, 2006, SOIL BIOL BIOCHEM, V38, P2092, DOI 10.1016/j.soilbio.2006.01.008; de Vries FT, 2012, FRONT ECOL ENVIRON, V10, P425, DOI 10.1890/110162; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; de Vries FT, 2012, NAT CLIM CHANGE, V2, P276, DOI [10.1038/nclimate1368, 10.1038/NCLIMATE1368]; de Vries FT, 2011, SOIL BIOL BIOCHEM, V43, P997, DOI 10.1016/j.soilbio.2011.01.016; de Vries FT, 2009, FEMS MICROBIOL ECOL, V67, P389, DOI 10.1111/j.1574-6941.2008.00643.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Donnison LM, 2000, SOIL BIOL BIOCHEM, V32, P253, DOI 10.1016/S0038-0717(99)00159-5; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Frey SD, 2003, SOIL BIOL BIOCHEM, V35, P1001, DOI 10.1016/S0038-0717(03)00155-X; FRY JC, 1990, METHOD MICROBIOL, V22, P41; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gordon H, 2008, SOIL BIOL BIOCHEM, V40, P302, DOI 10.1016/j.soilbio.2007.08.008; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Harrison KA, 2010, J ECOL, V98, P384, DOI 10.1111/j.1365-2745.2009.01614.x; Helgason BL, 2009, SOIL SCI SOC AM J, V73, P120, DOI 10.2136/sssaj2007.0392; Hopkins DW, 2011, EUR J SOIL SCI, V62, P95, DOI 10.1111/j.1365-2389.2010.01320.x; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Johnson D, 2005, PLANT SOIL, V271, P157, DOI 10.1007/s11104-004-2267-z; Kennedy N, 2005, MICROB ECOL, V50, P463, DOI 10.1007/s00248-005-0256-2; Laughlin DC, 2011, J ECOL, V99, P1091, DOI 10.1111/j.1365-2745.2011.01856.x; Lu M, 2011, NEW PHYTOL, V189, P1040, DOI 10.1111/j.1469-8137.2010.03563.x; Nilsson LO, 2007, OECOLOGIA, V153, P375, DOI 10.1007/s00442-007-0735-x; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; Pinheiro J, 2000, MIXED EFFECTS MODELS; Postma-Blaauw MB, 2010, ECOLOGY, V91, P460, DOI 10.1890/09-0666.1; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Raciti SM, 2008, ECOL APPL, V18, P1615, DOI 10.1890/07-1062.1; Ramirez KS, 2012, GLOB CHANGE BIOL, pn/a; Rodwell JS, 1992, BRITISH PLANT COMMUN, V3; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Smith RS, 2008, J APPL ECOL, V45, P670, DOI 10.1111/j.1365-2664.2007.01425.x; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Thiet RK, 2006, SOIL BIOL BIOCHEM, V38, P837, DOI 10.1016/j.soilbio.2005.07.010; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2010, ECOLOGY, V91, P1163, DOI 10.1890/09-0336.1; van der Heijden MGA, 2009, J ECOL, V97, P1139, DOI 10.1111/j.1365-2745.2009.01570.x; VANVEEN JA, 1979, APPL ENVIRON MICROB, V37, P686, DOI 10.1128/AEM.37.4.686-692.1979; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Zelles L, 1997, SOIL BIOL BIOCHEM, V29, P1325, DOI 10.1016/S0038-0717(97)00062-X; Zogg GP, 2000, ECOLOGY, V81, P1858, DOI 10.1890/0012-9658(2000)081[1858:MIATRO]2.0.CO;2	65	83	83	2	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51201	10.1371/journal.pone.0051201	http://dx.doi.org/10.1371/journal.pone.0051201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227252	Green Published, Green Accepted, gold			2022-12-25	WOS:000312588200111
J	Kapczynski, A; Park, C; Sampat, B				Kapczynski, Amy; Park, Chan; Sampat, Bhaven			Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of "Secondary'' Pharmaceutical Patents	PLOS ONE			English	Article							LIFE	Background: While there has been much discussion by policymakers and stakeholders about the effects of "secondary patents'' on the pharmaceutical industry, there is no empirical evidence on their prevalence or determinants. Characterizing the landscape of secondary patents is important in light of recent court decisions in the U.S. that may make them more difficult to obtain, and for developing countries considering restrictions on secondary patents. Methodology/Principal Findings: We read the claims of the 1304 Orange Book listed patents on all new molecular entities approved in the U.S. between 1988 and 2005, and coded the patents as including chemical compound claims (claims covering the active molecule itself) and/or one of several types of secondary claims. We distinguish between patents with any secondary claims, and those with only secondary claims and no chemical compound claims ("independent'' secondary patents). We find that secondary claims are common in the pharmaceutical industry. We also show that independent secondary patents tend to be filed and issued later than chemical compound patents, and are also more likely to be filed after the drug is approved. When present, independent formulation patents add an average of 6.5 years of patent life (95% C.I.: 5.9 to 7.3 years), independent method of use patents add 7.4 years (95% C.I.: 6.4 to 8.4 years), and independent patents on polymorphs, isomers, prodrug, ester, and/or salt claims add 6.3 years (95% C.I.: 5.3 to 7.3 years). We also provide evidence that late-filed independent secondary patents are more common for higher sales drugs. Conclusions/Significance: Policies and court decisions affecting secondary patenting are likely to have a significant impact on the pharmaceutical industry. Secondary patents provide substantial additional patent life in the pharmaceutical industry, at least nominally. Evidence that they are also more common for best-selling drugs is consistent with accounts of active "life cycle management'' or "evergreening'' of patent portfolios in the industry.	[Sampat, Bhaven] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA; [Kapczynski, Amy] Yale Univ, Yale Law Sch, New Haven, CT USA; [Park, Chan] Med Patent Pool, Geneva, Switzerland	Columbia University; Yale University	Sampat, B (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.	bns3@columbia.edu						Agency for Healthcare Research and Quality, 1996, MEDICAL EXPENDITURE; Amin T, 2012, HEALTH AFFAIR, V31, P2286, DOI 10.1377/hlthaff.2012.0107; Burdon M., 2003, J MED MARK, V3, P226, DOI DOI 10.1057/PALGRAVE.JMM.5040125; CAVES RE, 1991, BROOKINGS PAP ECO AC, P1; Cheng J, 2008, COLUMBIA LAW REV, V108, P1471; Cohen Wesley M., 2000, WORKING PAPER NO 755; Correa C. M., 2007, GUIDELINES FOR THE E; Eisenberg Rebecca S., 2008, LEWIS CLARK L REV, V12, P375; European Commission, 2009, PHARMACEUTICAL SECTO; Federal Trade Commission, 2002, GENERIC DRUG ENTRY P; Furrow ME, 2008, FOOD DRUG LAW J, V63, P275; Gorlin DL, 2008, FOOD DRUG LAW J, V63, P823; Grabowski HG, 2000, INT J TECHNOL MANAGE, V19, P98, DOI 10.1504/IJTM.2000.002803; Grubb PW, 2010, PATENTS FOR CHEMICAL; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hemphill CS, 2011, J EMPIR LEGAL STUD, V8, P613, DOI 10.1111/j.1740-1461.2011.01235.x; Jaffe A, 2006, INNOVATION AND ITS D; Kapczynski A, 2009, CALIF LAW REV, V97, P1571; LEVIN RC, 1987, BROOKINGS PAP ECO AC, P783; MANSFIELD E, 1986, MANAGE SCI, V32, P173, DOI 10.1287/mnsc.32.2.173; OECD, 2004, PATENTS INNOVATION A; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Park C, 2008, DEFINING THE CONCEPT; Park C, 2010, THE IMPLEMENTATION O; Rathod S, 2010, EVER GREENING A STAT, V7, P227; Scherer F.M., 2009, J TELECOMM HIGH TECH, V7, P167; US Food and Drug Administration, ORANGE BOOK APPROVED; USPTO, CASSIS BIB DVD	28	66	68	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49470	10.1371/journal.pone.0049470	http://dx.doi.org/10.1371/journal.pone.0049470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227141	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200004
J	Krivokharchenko, A; Karmenyan, A; Sarkisov, O; Bader, M; Chiou, A; Shakhbazyan, A				Krivokharchenko, Alexander; Karmenyan, Artashes; Sarkisov, Oleg; Bader, Michael; Chiou, Arthur; Shakhbazyan, Avetik			Laser Fusion of Mouse Embryonic Cells and Intra-Embryonic Fusion of Blastomeres without Affecting the Embryo Integrity	PLOS ONE			English	Article							ELECTRIC-FIELD; IN-VITRO; POLYETHYLENE-GLYCOL; BLASTOCYSTS; ELECTROFUSION	Manipulation with early mammalian embryos is the one of the most important approach to study preimplantation development. Artificial cell fusion is a research tool for various biotechnological experiments. However, the existing methods have various disadvantages, first of them impossibility to fuse selected cells within multicellular structures like mammalian preimplantation embryos. In our experiments we have successfully used high repetition rate picosecond near infrared laser beam for fusion of pairs of oocytes and oocytes with blastomeres. Fused cells looked morphologically normal and keep their ability for further divisions in vitro. We also fused two or three blastomeres inside four-cell mouse embryos. The presence of one, two or three nuclei in different blastomeres of the same early preimplantation mouse embryo was confirmed under UV-light after staining of DNA with the vital dye Hoechst-33342. The most of established embryos demonstrated high viability and developed in vitro to the blastocyst stage. We demonstrated for the first time the use of laser beam for the fusion of various embryonic cells of different size and of two or three blastomeres inside of four-cell mouse embryos without affecting the embryo's integrity and viability. These embryos with blastomeres of various ploidy maybe unique model for numerous purposes. Thus, we propose laser optical manipulation as a new tool for investigation of fundamental mechanisms of mammalian development.	[Karmenyan, Artashes; Chiou, Arthur] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Krivokharchenko, Alexander; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Sarkisov, Oleg; Shakhbazyan, Avetik] Russian Acad Sci, NN Semenov Chem Phys Inst, Moscow, Russia; [Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Shakhbazyan, Avetik] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Moscow Region, Russia	National Yang Ming Chiao Tung University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences; National Yang Ming Chiao Tung University; Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Karmenyan, A (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan.	artashes@ym.edu.tw	Bader, Michael/K-2124-2013; Karmenyan, Artashes/U-3697-2019	Bader, Michael/0000-0003-4780-4164	DFG [KR 3719/1-1, KR 3719/2-1]; Russian Foundation for Basic Research; Taiwan National Science Consulate [NSC 99-2923-B-010-003-MY2, NSC 10-04-92001-NNC_a]	DFG(German Research Foundation (DFG)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Taiwan National Science Consulate	A Krivokharchenko was supported by the grant of DFG(KR 3719/1-1 & KR 3719/2-1). This work was supported by a joint grant between the Russian Foundation for Basic Research and Taiwan National Science Consulate NSC 99-2923-B-010-003-MY2 and NSC 10-04-92001-NNC_a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG H, 1982, BIOELECTROCH BIOENER, V9, P223, DOI 10.1016/0302-4598(82)80178-5; Curnow EC, 2000, MOL REPROD DEV, V56, P372, DOI 10.1002/1098-2795(200007)56:3&lt;372::AID-MRD7&gt;3.0.CO;2-W; EGLITIS MA, 1980, J EXP ZOOL, V213, P309, DOI 10.1002/jez.1402130222; Karmenyan AV, 2009, MOL REPROD DEV, V76, P975, DOI 10.1002/mrd.21045; Kohli V, 2009, WIRES NANOMED NANOBI, V1, P11, DOI 10.1002/wnan.29; Krivokharchenko A, 2003, BIOL REPROD, V68, P829, DOI 10.1095/biolreprod.102.006494; Krivokharchenko A, 2002, MOL REPROD DEV, V61, P460, DOI 10.1002/mrd.90001; KUBIAK JZ, 1985, EXP CELL RES, V157, P561, DOI 10.1016/0014-4827(85)90143-0; Kuetemeyer K, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3609818; Kuetemeyer K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463012; NAGY A, 1990, DEVELOPMENT, V110, P815; ONEILL GT, 1990, CYTOGENET CELL GENET, V53, P191, DOI 10.1159/000132928; OZIL JP, 1986, J EMBRYOL EXP MORPH, V96, P211; Popova E, 2011, HUM REPROD, V26, P662, DOI 10.1093/humrep/deq379; Prather RS, 1996, MOL REPROD DEV, V45, P38, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;38::AID-MRD5&gt;3.0.CO;2-T; Shakhbazyan A K, 2009, Dokl Biol Sci, V429, P587; SPINDLE A, 1981, EXP CELL RES, V131, P465, DOI 10.1016/0014-4827(81)90259-7; STEUBING RW, 1991, CYTOMETRY, V12, P505, DOI 10.1002/cyto.990120607; WIEGAND R, 1987, J CELL SCI, V88, P145	19	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50029	10.1371/journal.pone.0050029	http://dx.doi.org/10.1371/journal.pone.0050029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227157	Green Published, Green Accepted, gold			2022-12-25	WOS:000312588200019
J	Liniger, M; Summerfield, A; Ruggli, N				Liniger, Matthias; Summerfield, Artur; Ruggli, Nicolas			MDA5 Can Be Exploited as Efficacious Genetic Adjuvant for DNA Vaccination against Lethal H5N1 Influenza Virus Infection in Chickens	PLOS ONE			English	Article							RIG-I; INNATE IMMUNITY; ADAPTER PROTEIN; IFN-BETA; VACCINES; RESPONSES; CELLS; RECEPTORS; RECOGNITION; STRATEGIES	Chickens lack the retinoic acid-inducible gene I (RIG-I) and sense avian influenza virus (AIV) infections by means of the melanoma differentiation-associated gene 5 product (chMDA5). Plasmid-driven expression of the N-terminal half of chMDA5 containing the caspase activation and recruitment domains [chMDA5(1-483)] triggers interferon-beta responses in chicken cells. We hypothesized that mimicking virus infection by chMDA5(1-483) expression may enhance vaccine-induced adaptive immunity. In order to test this, the potential genetic adjuvant properties of chMDA5(1-483) were evaluated in vivo in combination with a suboptimal quantity of a plasmid DNA vaccine expressing haemagglutinin (HA) of H5N1 AIV. Co-administration of the HA plasmid with plasmid DNA for chMDA5(1-483) expression resulted in approximately 10-fold higher HA-specific antibody responses than injection of the HA plasmid mixed with empty vector DNA as control. Accordingly, compared with HA DNA vaccination alone, the chMDA5(1-483)-adjuvanted HA DNA vaccine mediated enhanced protection against a lethal H5N1 challenge infection in chickens, with reduced clinical signs and cloacal virus shedding. These data demonstrate that innate immune activation by expression of signaling domains of RIG-I-like receptors can be exploited to enhance vaccine efficacy.	[Liniger, Matthias; Summerfield, Artur; Ruggli, Nicolas] Inst Virol & Immunoprophylaxis, Res Dept, Mittelhausern, Switzerland		Ruggli, N (corresponding author), Inst Virol & Immunoprophylaxis, Res Dept, Mittelhausern, Switzerland.	nicolas.ruggli@ivi.admin.ch	Summerfield, Artur/K-2105-2016; Summerfield, Artur/H-6025-2019	Summerfield, Artur/0000-0001-8292-4634; Summerfield, Artur/0000-0001-8292-4634; Ruggli, Nicolas/0000-0002-7679-6290	Swiss Federal Veterinary Office [1.07.09]; EU [044220]	Swiss Federal Veterinary Office; EU(European Commission)	This work was funded by the Swiss Federal Veterinary Office (grant number 1.07.09; www.bvet.admin.ch) and by the EU FP6 project FUPATH (grant number 044220; cordis.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041332; Gasparini R, 2012, EXPERT REV VACCINES, V11, P145, DOI [10.1586/erv.11.170, 10.1586/ERV.11.170]; Heegaard PMH, 2011, ARCH VIROL, V156, P183, DOI 10.1007/s00705-010-0863-1; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Johnston D, 2007, CANCER IMMUNOL IMMUN, V56, P1133, DOI 10.1007/s00262-006-0262-3; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kobiyama K, 2009, J IMMUNOL, V182, P1593, DOI 10.4049/jimmunol.182.3.1593; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Krenn BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018577; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kumar Sachin, 2010, Recent Pat Biotechnol, V4, P235, DOI 10.2174/187220810793611473; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; Liniger M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-7; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Lladser A, 2011, MOL THER, V19, P594, DOI 10.1038/mt.2010.268; Luke JM, 2011, J VIROL, V85, P1370, DOI 10.1128/JVI.01250-10; Luo MC, 2011, VACCINE, V29, P2561, DOI 10.1016/j.vaccine.2011.01.060; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moser M, 2010, VACCINE, V28, pC2, DOI 10.1016/j.vaccine.2010.07.022; Moulin HR, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-6; Mueller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009097; Ocana-Macchi M, 2009, J VIROL, V83, P12947, DOI 10.1128/JVI.00468-09; Olive C, 2012, EXPERT REV VACCINES, V11, P237, DOI [10.1586/erv.11.189, 10.1586/ERV.11.189]; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Rao SS, 2009, POULTRY SCI, V88, P860, DOI 10.3382/ps.2008-00360; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Schwartz JA, 2011, J VIROL, V85, P4602, DOI 10.1128/JVI.02491-10; Schwarz H, 2004, J INTERF CYTOK RES, V24, P179, DOI 10.1089/107999004322917025; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Soda K, 2008, JPN J VET RES, V55, P93; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Steel J, 2011, BIODRUGS, V25, P285, DOI 10.2165/11593870-000000000-00000; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Stevceva L, 2000, GENES IMMUN, V1, P308, DOI 10.1038/sj.gene.6363680; Tovey MG, 2010, METHODS MOL BIOL, V626, P287, DOI 10.1007/978-1-60761-585-9_19; Tritto E, 2009, VACCINE, V27, P3331, DOI 10.1016/j.vaccine.2009.01.084; Veits J, 2008, VACCINE, V26, P1688, DOI 10.1016/j.vaccine.2008.01.016; Vemula SV, 2010, EXPERT OPIN BIOL TH, V10, P1469, DOI 10.1517/14712598.2010.519332; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; Yang SG, 2009, VACCINE, V27, P7451, DOI 10.1016/j.vaccine.2009.05.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	60	27	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49952	10.1371/journal.pone.0049952	http://dx.doi.org/10.1371/journal.pone.0049952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227156	Green Published, gold			2022-12-25	WOS:000312588200018
J	Liu, SC; Hsu, CJ; Chen, HT; Tsou, HK; Chuang, SM; Tang, CH				Liu, Shan-Chi; Hsu, Chin-Jung; Chen, Hsien-Te; Tsou, Hsi-Kai; Chuang, Show-Mei; Tang, Chih-Hsin			CTGF Increases IL-6 Expression in Human Synovial Fibroblasts through Integrin-Dependent Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR; RHEUMATOID-ARTHRITIS; INTERLEUKIN-6 IL-6; CELL; OSTEOARTHRITIS; RECEPTOR; STRESS; GENE; PROGRESSION	Background: Connective tissue growth factor (CTGF; also known as CCN2) is an inflammatory mediator, and shows elevated levels in regions of severe injury and inflammatory diseases. CTGF is abundantly expressed in osteoarthritis (OA). However, the relationship between CTGF and IL-6 in OA synovial fibroblasts (OASFs) is mostly unknown. Methodology/Principal Findings: OASFs showed significant expression of CTGF, and expression was higher than in normal SFs. OASFs stimulation with CTGF induced concentration-dependent increases in IL-6 expression. CTGF mediated IL-6 production was attenuated by alpha v beta 5 integrin neutralized antibody and apoptosis signal-regulating kinase 1 (ASK1) shRNA. Pretreatment with p38 inhibitor (SB203580), JNK inhibitor (SP600125), AP-1 inhibitors (Curcumin and Tanshinone IIA), and NF-kappa B inhibitors (PDTC and TPCK) also inhibited the potentiating action of CTGF. CTGF-mediated increase of NF-kappa B and AP-1 luciferase activity was inhibited by SB203580 and SP600125 or ASK1 shRNA or p38 and JNK mutant. Conclusions/Significance: Our results suggest that CTGF increased IL-6 production in OASFs via the avb5 integrin, ASK1, p38/JNK, and AP-1/NF-kappa B signaling pathways.	[Liu, Shan-Chi; Chuang, Show-Mei] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Hsu, Chin-Jung; Chen, Hsien-Te] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Hsu, Chin-Jung; Chen, Hsien-Te] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Chen, Hsien-Te; Tsou, Hsi-Kai] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan; [Tsou, Hsi-Kai] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Tsou, Hsi-Kai] Jen Teh Jr Coll Med Nursing & Management, Ctr Gen Educ, Miaoli, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Feng Chia University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan	Chuang, SM (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.	smchuang@dragon.nchu.edu.tw; chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352; Chuang, Show-Mei/0000-0003-2986-0736	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, 100-2320-B-039-028-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3; 100-2320-B-039-028-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2008, RHEUMATOLOGY, V47, pV8, DOI 10.1093/rheumatology/ken278; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Ayral X, 2005, OSTEOARTHR CARTILAGE, V13, P361, DOI 10.1016/j.joca.2005.01.005; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Coluet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI 10.1016/j.drudis.2009.07.012; Davidson ENB, 2006, ARTHRITIS RHEUM-US, V54, P1653, DOI 10.1002/art.21795; Dhar A., 2010, Experimental Oncology, V32, P2; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; GRAEVE L, 1993, CLIN INVESTIGATOR, V71, P664; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Grimble RF, 1998, NUTRITION, V14, P634, DOI 10.1016/S0899-9007(98)00010-0; Hahm ER, 2002, CANCER LETT, V184, P89, DOI 10.1016/S0304-3835(02)00170-2; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Omoto S, 2004, OSTEOARTHR CARTILAGE, V12, P771, DOI 10.1016/j.joca.2004.06.009; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Persson E, 2005, BONE, V37, P513, DOI 10.1016/j.bone.2005.04.043; Pozgan U, 2010, BIOL CHEM, V391, P571, DOI 10.1515/BC.2010.035; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Tan TW, 2009, J CELL BIOCHEM, V107, P345, DOI 10.1002/jcb.22132; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Uson J, 1997, J RHEUMATOL, V24, P2069; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang YC, 2003, ANAL BIOCHEM, V319, P206, DOI 10.1016/S0003-2697(03)00330-0; Wright AA, 2009, ARTHRIT RHEUM-ARTHR, V61, P925, DOI 10.1002/art.24641; Yokota K, 2006, J RHEUMATOL, V33, P463; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790	39	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51097	10.1371/journal.pone.0051097	http://dx.doi.org/10.1371/journal.pone.0051097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227240	gold, Green Submitted, Green Published			2022-12-25	WOS:000323179700001
J	Smith, KE; Thatje, S				Smith, Kathryn E.; Thatje, Sven			The Secret to Successful Deep-Sea Invasion: Does Low Temperature Hold the Key?	PLOS ONE			English	Article							NEOGASTROPOD BUCCINUM-UNDATUM; CLIMATE-CHANGE; PRESSURE TOLERANCES; HYDROSTATIC-PRESSURE; REPRODUCTIVE-CYCLE; DIVERSITY GRADIENT; SPECIES-DIVERSITY; WATER; DISPERSAL; LARVAL	There is a general consensus that today's deep-sea biodiversity has largely resulted from recurrent invasions and speciations occurring through homogenous waters during periods of the Phanerozoic eon. Migrations likely continue today, primarily via isothermal water columns, such as those typical of Polar Regions, but the necessary ecological and physiological adaptations behind them are poorly understood. In an evolutionary context, understanding the adaptations, which allow for colonisation to high-pressure environments, may enable us to predict future events. In this investigation, we examine pressure tolerance during development, in the shallow-water neogastropod Buccinum undatum using thermally acclimated egg masses from temperate and sub-polar regions across the species range. Fossil records indicate neogastropods to have a deep-water origin, suggesting shallow-water species may be likely candidates for re-emergence into the deep sea. Our results show population level differences in physiological thresholds, which indicate low temperature acclimation to increase pressure tolerance. These findings imply this species is capable of deep-sea penetration through isothermal water columns prevailing at high latitudes. This study gives new insight into the fundamentals behind past and future colonisation events. Such knowledge is instrumental to understand better how changes in climate envelopes affect the distribution and radiation of species along latitudinal as well as bathymetric temperature gradients.	[Smith, Kathryn E.; Thatje, Sven] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Smith, KE (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	kathryn.smith@noc.soton.ac.uk	Smith, Kathryn/G-5257-2014	Smith, Kathryn/0000-0002-7240-1490	Total Foundation [Abyss2100)]; Malacological Society of London	Total Foundation(Total SA); Malacological Society of London	This work was made possible through a grant (Abyss2100) from the Total Foundation to Sven Thatje and from the Malacological Society of London to Kathryn Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaina N, 2012, MAR BIOL, V159, P1871, DOI 10.1007/s00227-012-1975-9; Allan EL, 2006, J EXP MAR BIOL ECOL, V337, P103, DOI 10.1016/j.jembe.2006.06.006; Anger K, 2003, MAR ECOL PROG SER, V253, P243, DOI 10.3354/meps253243; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Aquino-Souza R, 2008, J MAR BIOL ASSOC UK, V88, P453, DOI 10.1017/S0025315408001148; Balny C, 1997, COMP BIOCHEM PHYS A, V116, P299, DOI 10.1016/S0300-9629(96)00355-6; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Benitez-Villalobos F, 2006, MAR ECOL PROG SER, V314, P109; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Brown A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028562; Cancino JM, 2011, J MAR BIOL ASSOC UK, V91, P727, DOI 10.1017/S0025315410001335; Casadei M. A., 1997, HIGH PRESSURE RES BI, P281; Casadei MA, 2002, APPL ENVIRON MICROB, V68, P5965, DOI 10.1128/AEM.68.12.5965-5972.2002; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; CLARKE A, 1993, FUNCT ECOL, V7, P139, DOI 10.2307/2389880; Culver SJ, 2000, DEEP-SEA RES PT I, V47, P259, DOI 10.1016/S0967-0637(99)00055-2; DASARO CN, 1970, B MAR SCI, V20, P414; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Drinkwater Kenneth F., 2004, Journal of Northwest Atlantic Fishery Science, V34, P85, DOI 10.2960/J.v34.m545; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Fretter V, 1985, J MOLLUS STUD, P435; Hall S, 2009, J BIOGEOGR, V36, P2125, DOI 10.1111/j.1365-2699.2009.02153.x; Hancock D, 1967, WHELKS; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; JABLONSKI D, 1986, B MAR SCI, V39, P565; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; JABLONSKI D, 1991, SCIENCE, V252, P1831, DOI 10.1126/science.252.5014.1831; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; KIDEYS AE, 1993, J MAR BIOL ASSOC UK, V73, P391, DOI 10.1017/S002531540003294X; Kiel S, 2012, GEOLOGY, V40, P839, DOI 10.1130/G33300.1; Kiel S, 2010, GEOLOGY, V38, P955, DOI 10.1130/G31282.1; Macpherson E, 2003, BIOL J LINN SOC, V80, P437, DOI 10.1046/j.1095-8312.2003.00256.x; MARTEL A, 1986, J EXP MAR BIOL ECOL, V96, P27, DOI 10.1016/0022-0981(86)90011-0; Martell KA, 2002, J MOLLUS STUD, V68, P45, DOI 10.1093/mollus/68.1.45; Mestre NC, 2009, P ROY SOC B-BIOL SCI, V276, P717, DOI 10.1098/rspb.2008.1376; Morel GM, 2004, FISH RES, V68, P283, DOI 10.1016/j.fishres.2003.11.010; Nasution S, 2004, AQUACULT INT, V12, P509, DOI 10.1007/s10499-004-5745-7; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Oliphant A, 2011, J EXP BIOL, V214, P1109, DOI 10.1242/jeb.048058; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pradillon Florence, 2007, Reviews in Environmental Science and Bio/Technology, V6, P181, DOI 10.1007/s11157-006-9111-2; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rex MA, 2000, P NATL ACAD SCI USA, V97, P4082, DOI 10.1073/pnas.050589497; Rosenberg G, 2009, MALACOLOG 4 1 1 DATA; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; Smith KE, 2013, HELGOLAND MAR RES, V67, P109, DOI 10.1007/s10152-012-0308-1; Smith KE, J SEA RES IN PRESS; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thatje S, 2010, J EXP MAR BIOL ECOL, V390, P22, DOI 10.1016/j.jembe.2010.04.028; Thomas E, 1996, GEOLOGY, V24, P355, DOI 10.1130/0091-7613(1996)024<0355:CDSBFT>2.3.CO;2; Tokuda G, 2006, BIOL LETTERS, V2, P257, DOI 10.1098/rsbl.2005.0420; Tyler PA, 1998, DEEP-SEA RES PT II, V45, P253, DOI 10.1016/S0967-0645(97)00091-X; Tyler PA, 2000, MAR ECOL PROG SER, V192, P173, DOI 10.3354/meps192173; Valentinsson D, 2002, MAR BIOL, V140, P1139, DOI 10.1007/s00227-002-0793-x; Weiss M, 2009, J EXP MAR BIOL ECOL, V376, P48, DOI 10.1016/j.jembe.2009.06.002; Weiss M, 2009, J MAR BIOL ASSOC UK, V89, P753, DOI 10.1017/S0025315409003269; WILSON GD, 1980, J NAT HIST, V14, P215, DOI 10.1080/00222938000770201; Young CM, 1997, MAR ECOL PROG SER, V154, P197, DOI 10.3354/meps154197; ZINSMEISTER WJ, 1984, SCIENCE, V224, P281, DOI 10.1126/science.224.4646.281; Zippay ML, 2010, MAR BIOL, V157, P707, DOI 10.1007/s00227-009-1354-3	71	93	97	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51219	10.1371/journal.pone.0051219	http://dx.doi.org/10.1371/journal.pone.0051219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227254	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200113
J	Fois, G; Weimer, M; Busch, T; Felder, ET; Oswald, F; von Wichert, G; Seufferlein, T; Dietl, P; Felder, E				Fois, Giorgio; Weimer, Michael; Busch, Tobias; Felder, Erika T.; Oswald, Franz; von Wichert, Goetz; Seufferlein, Thomas; Dietl, Paul; Felder, Edward			Effects of keratin phosphorylation on the mechanical properties of keratin filaments in living cells	FASEB JOURNAL			English	Article						mechanical stress; tension; cytoskeleton; cytoarchitecture	INTERMEDIATE-FILAMENTS; MARKER PROTEIN; NETWORK; STRAIN; ACTIN; CYCLE	Keratin filaments impart resilience against mechanical extension of the cell. Despite the pathophysiological relevance of this function, very little is known about the mechanical properties of intermediate filaments in living cells and how these properties are modulated. We used keratin mutants that mimic or abrogate phosphorylation of keratin 8-serine(431) and keratin 18-serine(52) and investigated their effect on keratin tortuousness after cell stretch release in squamous cell carcinoma cells. Cells transfected with the wild-type keratins were used as controls. We can show that keratin dephosphorylation alters the stretch response of keratin in living cells since keratin tortuousness was abolished when phosphorylation of keratin18-serine(52) was abrogated. Additional experiments demonstrate that keratin tortuousness is not simply caused by a plastic overextension of keratin filaments because tortuousness is reversible and requires an intact actin-myosin system. The role of actin in this process remains unclear, but we suggest anchorage of keratin filaments to actin during stretch that leads to buckling on stretch release. Dephosphorylated keratin18-serine(52) might strengthen the recoil force of keratin filaments and hence explain the abolished buckling. The almost exclusive immunolabeling for phosphorylated keratin18-serine(52) in the cell periphery points at a particular role of the peripheral keratin network in this regard.-Fois, G., Weimer, M., Busch, T., Felder, E. T., Oswald, F., von Wichert, G., Seufferlein, T., Dietl, P., Felder, E. Effects of keratin phosphorylation on the mechanical properties of keratin filaments in living cells. FASEB J. 27, 1322-1329 (2013). www.fasebj.org	[Fois, Giorgio; Weimer, Michael; Felder, Erika T.; Dietl, Paul; Felder, Edward] Univ Ulm, Inst Gen Physiol, D-89081 Ulm, Germany; [Busch, Tobias; Oswald, Franz; von Wichert, Goetz; Seufferlein, Thomas] Univ Med Ctr Ulm, Ctr Internal Med, Dept Internal Med 1, Ulm, Germany	Ulm University; Ulm University	Felder, E (corresponding author), Univ Ulm, Inst Gen Physiol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	edward.felder@uni-ulm.de	Seufferlein, Thomas TW/P-7147-2018; Oswald, Franz/AAO-9584-2020; Fois, Giorgio/AAD-5657-2022	Fois, Giorgio/0000-0001-5414-1149	Deutsche Forschungsgemeinschaft [DI 1402/1-1, DI1402/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Technical assistance by the entire team of the EM-core facility of the University of Ulm and in particular Eberhard Schmid is gratefully acknowledged. The authors also thank Michael Beil for his fruitful comments and helpful discussion. This work was supported by the Deutsche Forschungsgemeinschaft, grants DI 1402/1-1 and DI1402/3-1 (to P.D.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Busch T, 2012, J CELL SCI, V125, P2148, DOI 10.1242/jcs.080127; CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0; Felder E, 2008, AM J PHYSIOL-LUNG C, V295, pL849, DOI 10.1152/ajplung.00503.2007; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fuchs J, 2010, NAT METHODS, V7, P627, DOI [10.1038/NMETH.1477, 10.1038/nmeth.1477]; Fudge D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002327; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Gerstmair A, 2009, J APPL PHYSIOL, V107, P613, DOI 10.1152/japplphysiol.00012.2009; Green KJ, 2005, ADV PROTEIN CHEM, V70, P143, DOI 10.1016/S0065-3233(04)70006-6; Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030; Harada H, 1998, J ORAL PATHOL MED, V27, P11; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Miklavc P, 2012, J CELL SCI, V125, P2765, DOI 10.1242/jcs.105262; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Qin Z, 2010, J BIOMECH, V43, P15, DOI 10.1016/j.jbiomech.2009.09.004; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; SAUK JJ, 1984, J CELL BIOL, V99, P1590, DOI 10.1083/jcb.99.5.1590; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Strnad P, 2002, J CELL SCI, V115, P4133, DOI 10.1242/jcs.00096; Strnad P, 2001, CELL TISSUE RES, V306, P277, DOI 10.1007/s004410100455; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Woll S, 2005, EUR J CELL BIOL, V84, P311, DOI 10.1016/j.ejcb.2004.12.004	36	22	24	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1322	1329		10.1096/fj.12-215632	http://dx.doi.org/10.1096/fj.12-215632			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23241311				2022-12-25	WOS:000316940800005
J	Flach, RJR; Matevossian, A; Akie, TE; Negrin, KA; Paul, MT; Czech, MP				Flach, Rachel J. Roth; Matevossian, Anouch; Akie, Thomas E.; Negrin, Kimberly A.; Paul, Marina T.; Czech, Michael P.			beta(3)-Adrenergic Receptor Stimulation Induces E-Selectin-mediated Adipose Tissue Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; P-SELECTIN; ENDOTHELIAL-CELLS; DEFICIENT MICE; INSULIN; OBESITY; ACTIVATION; AGONIST; PROTEIN; WHITE	Inflammation induced by wound healing or infection activates local vascular endothelial cells to mediate leukocyte rolling, adhesion, and extravasation by up-regulation of leukocyte adhesion molecules such as E-selectin and P-selectin. Obesity-associated adipose tissue inflammation has been suggested to cause insulin resistance, but weight loss and lipolysis also promote adipose tissue immune responses. While leukocyte-endothelial interactions are required for obesity-induced inflammation of adipose tissue, it is not known whether lipolysis-induced inflammation requires activation of endothelial cells. Here, we show that beta(3)-adrenergic receptor stimulation by CL 316,243 promotes adipose tissue neutrophil infiltration in wild type and P-selectin-null mice but not in E-selectin-null mice. Increased expression of adipose tissue cytokines IL-1 beta, CCL2, and TNF-alpha in response to CL 316,243 administration is also dependent upon E-selectin but not P-selectin. In contrast, fasting increases adipose-resident macrophages but not neutrophils, and does not activate adipose-resident endothelium. Thus, two models of lipolysis-induced inflammation induce distinct immune cell populations within adipose tissue and exhibit distinct dependences on endothelial activation. Importantly, our results indicate that beta(3)-adrenergic stimulation acts through up-regulation of E-selectin in adipose tissue endothelial cells to induce neutrophil infiltration.	[Flach, Rachel J. Roth; Matevossian, Anouch; Akie, Thomas E.; Negrin, Kimberly A.; Paul, Marina T.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Suite 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu			National Institutes of Health [DK030898]; International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research; NIH [5T32HD007312-25]; American Heart Association [AHA 11POST704009]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant DK030898 and a grant from the International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research (to M. P. C.), NIH Training Grant 5T32HD007312-25, and American Heart Association postdoctoral fellowship AHA 11POST704009 (to R. J. R. F.), and support for core facilities by the UMASS Diabetes and Endocrinology Research Center (DK032520).	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Asterholm IW, 2012, J LIPID RES, V53, P1254, DOI 10.1194/jlr.M021725; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; deSouza CJ, 1997, DIABETES, V46, P1257, DOI 10.2337/diabetes.46.8.1257; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Giri H, 2012, ARTERIOSCL THROM VAS, V32, P1943, DOI 10.1161/ATVBAHA.111.239251; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Jung U, 1999, J IMMUNOL, V162, P6755; Karmann K, 1996, J EXP MED, V184, P173, DOI 10.1084/jem.184.1.173; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li GL, 2009, ENDOCRINOLOGY, V150, P3475, DOI 10.1210/en.2009-0172; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Ringseis R, 2010, PROSTAG LEUKOTR ESS, V82, P189, DOI 10.1016/j.plefa.2010.02.022; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Russo HM, 2010, CIRC RES, V107, P388, DOI 10.1161/CIRCRESAHA.110.218651; Sato C, 2011, DIABETES, V60, P189, DOI 10.2337/db09-1894; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sengenes C, 2007, J INTERN MED, V262, P415, DOI 10.1111/j.1365-2796.2007.01853.x; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	48	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2882	2892		10.1074/jbc.M112.412346	http://dx.doi.org/10.1074/jbc.M112.412346			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23235150	Green Published, hybrid			2022-12-25	WOS:000314211500070
J	Salcedo-Sicilia, L; Granell, S; Jovic, M; Sicart, A; Mato, E; Johannes, L; Balla, T; Egea, G				Salcedo-Sicilia, Laia; Granell, Susana; Jovic, Marko; Sicart, Adria; Mato, Eugenia; Johannes, Ludger; Balla, Tamas; Egea, Gustavo			beta III Spectrin Regulates the Structural Integrity and the Secretory Protein Transport of the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; ATAXIA TYPE 5; RETROGRADE TRANSPORT; MEMBRANE SKELETON; ANKYRIN; IDENTIFICATION; BINDING; DYNEIN; PHOSPHOINOSITIDES; TRAFFICKING	A spectrin-based cytoskeleton is associated with endomembranes, including the Golgi complex and cytoplasmic vesicles, but its role remains poorly understood. Using new generated antibodies to specific peptide sequences of the human beta III spectrin, we here show its distribution in the Golgi complex, where it is enriched in the trans-Golgi and trans-Golgi network. The use of a drug-inducible enzymatic assay that depletes the Golgi-associated pool of PI4P as well as the expression of PH domains of Golgi proteins that specifically recognize this phosphoinositide both displaced beta III spectrin from the Golgi. However, the interference with actin dynamics using actin toxins did not affect the localization of beta III spectrin to Golgi membranes. Depletion of beta III spectrin using siRNA technology and the microinjection of anti-beta III spectrin antibodies into the cytoplasm lead to the fragmentation of the Golgi. At ultrastructural level, Golgi fragments showed swollen distal Golgi cisternae and vesicular structures. Using a variety of protein transport assays, we show that the endoplasmic reticulum-to-Golgi and post-Golgi protein transports were impaired in beta III spectrin-depleted cells. However, the internalization of the Shiga toxin subunit B to the endoplasmic reticulum was unaffected. We state that beta III spectrin constitutes a major skeletal component of distal Golgi compartments, where it is necessary to maintain its structural integrity and secretory activity, and unlike actin, PI4P appears to be highly relevant for the association of beta III spectrin the Golgi complex.	[Salcedo-Sicilia, Laia; Granell, Susana; Sicart, Adria; Mato, Eugenia; Egea, Gustavo] Univ Barcelona, Fac Med, Dept Biol Cel Lular Immunol & Neurociencies, Barcelona 08036, Spain; [Jovic, Marko; Balla, Tamas] NICHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD USA; [Johannes, Ludger] Inst Curie, Ctr Rech, Traff Signaling & Delivery Grp, F-75005 Paris, France; [Johannes, Ludger] CNRS, UMR144, F-75700 Paris, France; [Mato, Eugenia] Hosp Santa Creu & Sant Pau, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Barcelona 08025, Spain; [Egea, Gustavo] Inst Invest Biomed August Pi & Sunyer Nanociencia, Barcelona 08036, Spain	University of Barcelona; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Hospital of Santa Creu i Sant Pau; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Egea, G (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cel Lular Immunol & Neurociencies, C Casanova 143, Barcelona 08036, Spain.	gegea@ub.edu	Egea, Gustavo/I-2394-2014; Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019	Egea, Gustavo/0000-0001-5242-150X; Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Balla, Tamas/0000-0002-9077-3335; Jovic, Marko/0000-0002-0310-7730	intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; Ministry of Science and Innovation; University of Barcelona; Generalitat de Catalunya;  [BFU2009-07186]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Barcelona; Generalitat de Catalunya(Generalitat de Catalunya); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant BFU2009-07186 (to G. E,) and by the intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (to M. J. and T. B.); Recipient of a FPI predoctoral fellowship from Ministry of Science and Innovation.; Recipient of a fellowship from the University of Barcelona.; Recipient of a Beatriu de Pinos postdoctoral contract from the Generalitat de Catalunya.	Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Beck KA, 1998, BBA-MOL CELL RES, V1404, P153, DOI 10.1016/S0167-4889(98)00054-8; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; Beck KA, 1997, J CELL SCI, V110, P1239; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Clarkson YL, 2010, HUM MOL GENET, V19, P3634, DOI 10.1093/hmg/ddq279; Colon-Franco JM, 2011, J CELL SCI, V124, P3118, DOI 10.1242/jcs.083725; D'Angelo Giovanni, 2012, Subcell Biochem, V59, P255, DOI 10.1007/978-94-007-3015-1_8; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; De Matteis MA, 2000, J CELL SCI, V113, P2331; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Holappa K, 2004, FEBS LETT, V564, P97, DOI 10.1016/S0014-5793(04)00315-1; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1998, INT REV CYTOL, V182, P69, DOI 10.1016/S0074-7696(08)62168-3; Holleran EA, 1998, TRENDS CELL BIOL, V8, P26, DOI 10.1016/S0962-8924(97)01195-1; Hui N., 1998, CELL BIOL LAB HDB, V2; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kang QZ, 2009, J CELL SCI, V122, P1091, DOI 10.1242/jcs.039644; Kepes F, 2005, INT REV CYTOL, V242, P55; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Percival JM, 2004, MOL BIOL CELL, V15, P268, DOI 10.1091/mbc.e03-03-0176; Perkins EM, 2010, J NEUROSCI, V30, P4857, DOI 10.1523/JNEUROSCI.6065-09.2010; Siddhanta A, 2003, J BIOL CHEM, V278, P1957, DOI 10.1074/jbc.M209137200; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Stankewich MC, 2010, P NATL ACAD SCI USA, V107, P6022, DOI 10.1073/pnas.1001522107; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Watabe H, 2008, J INVEST DERMATOL, V128, P162, DOI 10.1038/sj.jid.5701019; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063	48	17	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2157	2166		10.1074/jbc.M112.406462	http://dx.doi.org/10.1074/jbc.M112.406462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233669	Green Published, hybrid			2022-12-25	WOS:000314211500006
J	Muller, K; Bouyer, D; Schnittger, A; Kermode, AR				Mueller, Kerstin; Bouyer, Daniel; Schnittger, Arp; Kermode, Allison R.			Evolutionarily Conserved Histone Methylation Dynamics during Seed Life-Cycle Transitions	PLOS ONE			English	Article							FLOWERING-LOCUS-C; ABSCISIC-ACID; DORMANCY MAINTENANCE; ARABIDOPSIS CVI; GENE; GERMINATION; EXPRESSION; PROTEIN; ABI3; H3	Plants have a remarkable ability to react to seasonal changes by synchronizing life-cycle transitions with environmental conditions. We addressed the question of how transcriptional re-programming occurs in response to an environmental cue that triggers the major life cycle transition from seed dormancy to germination and seedling growth. We elucidated an important mechanistic aspect of this process by following the chromatin dynamics of key regulatory genes with a focus on the two antagonistic marks, H3K4me3 and H3K27me3. Histone methylation patterns of major dormancy regulators changed during the transition to germination and seedling growth. We observed a switch from H3K4me3 and high transcription levels to silencing by the repressive H3K27me3 mark when dormancy was broken through exposure to moist chilling, underscoring that a functional PRC2 complex is necessary for this transition. Moreover, this reciprocal regulation by H3K4me3 and H3K27me3 is evolutionarily conserved from gymnosperms to angiosperms. Citation: Muller K, Bouyer D, Schnittger A, Kermode AR (2012) Evolutionarily Conserved Histone Methylation Dynamics during Seed Life-Cycle Transitions. PLoS ONE 7(12): e51532. doi:10.1371/journal.pone.0051532	[Mueller, Kerstin; Kermode, Allison R.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Bouyer, Daniel; Schnittger, Arp] CNRS, IBMP, UPR2357, Strasbourg, France	Simon Fraser University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Muller, K (corresponding author), Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada.	kermode@sfu.ca; kermode@sfu.ca	Schnittger, Arp/AAO-6920-2020; Schnittger, Arp/F-8989-2010; Bouyer, Daniel/P-5119-2016	Schnittger, Arp/0000-0001-7067-0091; Schnittger, Arp/0000-0001-7067-0091; Berger, Frederic/0000-0002-3609-8260; Bouyer, Daniel/0000-0002-7438-5551	German Research Foundation [MU 3114/1-1]; European Research Council Starting Independent Researcher Grant; Natural Sciences and Engineering Research Council of Canada Discovery grant	German Research Foundation(German Research Foundation (DFG)); European Research Council Starting Independent Researcher Grant; Natural Sciences and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors gratefully acknowledge funding from the German Research Foundation to KM (MU 3114/1-1), a European Research Council Starting Independent Researcher Grant to AS, and a Natural Sciences and Engineering Research Council of Canada Discovery grant to ARK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichinger E, 2011, PLANT CELL, V23, P1047, DOI 10.1105/tpc.111.083352; Alonso-Blanco C, 2003, GENETICS, V164, P711; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Coustham V, 2012, SCIENCE, V337, P584, DOI 10.1126/science.1221881; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; de Casas RR, 2012, NEW PHYTOL, V194, P868, DOI 10.1111/j.1469-8137.2012.04097.x; Deal RB, 2011, CURR OPIN PLANT BIOL, V14, P116, DOI 10.1016/j.pbi.2010.11.005; Feurtado JA, 2011, METHODS MOL BIOL, V773, P53, DOI 10.1007/978-1-61779-231-1_4; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Graeber K, 2010, PLANT MOL BIOL, V73, P67, DOI 10.1007/s11103-009-9583-x; He YH, 2009, MOL PLANT, V2, P554, DOI 10.1093/mp/ssp005; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; Kim DH, 2008, PLANT CELL, V20, P1260, DOI 10.1105/tpc.108.058859; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Li HC, 2005, PLANT J, V44, P1010, DOI 10.1111/j.1365-313X.2005.02602.x; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mosquna A, 2009, DEVELOPMENT, V136, P2433, DOI 10.1242/dev.035048; Quatrano RS, 2007, CURR OPIN PLANT BIOL, V10, P182, DOI 10.1016/j.pbi.2007.01.005; Ren CW, 1999, J EXP BOT, V50, P1403, DOI 10.1093/jexbot/50.337.1403; Rohde A, 2006, TRENDS PLANT SCI, V10, P418; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Rozen S, 2000, Methods Mol Biol, V132, P365; Saleh A, 2008, GENE, V423, P43, DOI 10.1016/j.gene.2008.06.022; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Sung S, 2006, J EXP BOT, V57, P3369, DOI 10.1093/jxb/erl105; Suzuki M, 2001, PLANT J, V28, P409, DOI 10.1046/j.1365-313X.2001.01165.x; Tamada Y, 2009, PLANT CELL, V21, P3257, DOI 10.1105/tpc.109.070060; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Zeng Y, 2004, PLANT MOL BIOL, V56, P731, DOI 10.1007/s11103-004-4952-y; Zeng Y, 2003, PLANT MOL BIOL, V51, P39, DOI 10.1023/A:1020762304937; Zhang XW, 2011, INT P ECON DEV RES, V4, P62; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	46	51	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51532	10.1371/journal.pone.0051532	http://dx.doi.org/10.1371/journal.pone.0051532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240039	Green Published, gold			2022-12-25	WOS:000312290800075
J	do Amaral, AM; Antoniw, J; Rudd, JJ; Hammond-Kosack, KE				do Amaral, Alexandre Morais; Antoniw, John; Rudd, Jason J.; Hammond-Kosack, Kim E.			Defining the Predicted Protein Secretome of the Fungal Wheat Leaf Pathogen Mycosphaerella graminicola	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; SEPTORIA-TRITICI; HYDROGEN-PEROXIDE; EFFECTOR PROTEINS; VIRULENCE; GENOME; PLANTA; GENE; COLLETOTRICHUM; IDENTIFICATION	The Dothideomycete fungus Mycosphaerella graminicola is the causal agent of Septoria tritici blotch, a devastating disease of wheat leaves that causes dramatic decreases in yield. Infection involves an initial extended period of symptomless intercellular colonisation prior to the development of visible necrotic disease lesions. Previous functional genomics and gene expression profiling studies have implicated the production of secreted virulence effector proteins as key facilitators of the initial symptomless growth phase. In order to identify additional candidate virulence effectors, we re-analysed and catalogued the predicted protein secretome of M. graminicola isolate IPO323, which is currently regarded as the reference strain for this species. We combined several bioinformatic approaches in order to increase the probability of identifying truly secreted proteins with either a predicted enzymatic function or an as yet unknown function. An initial secretome of 970 proteins was predicted, whilst further stringent selection criteria predicted 492 proteins. Of these, 321 possess some functional annotation, the composition of which may reflect the strictly intercellular growth habit of this pathogen, leaving 171 with no functional annotation. This analysis identified a protein family encoding secreted peroxidases/chloroperoxidases (PF01328) which is expanded within all members of the family Mycosphaerellaceae. Further analyses were done on the non-annotated proteins for size and cysteine content (effector protein hallmarks), and then by studying the distribution of homologues in 17 other sequenced Dothideomycete fungi within an overall total of 91 predicted proteomes from fungal, oomycete and nematode species. This detailed M. graminicola secretome analysis provides the basis for further functional and comparative genomics studies.	[do Amaral, Alexandre Morais] Rothamsted Res, Embrapa LabEx Programme, Harpenden, Herts, England; [do Amaral, Alexandre Morais; Antoniw, John; Rudd, Jason J.; Hammond-Kosack, Kim E.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	do Amaral, AM (corresponding author), Rothamsted Res, Embrapa LabEx Programme, Harpenden, Herts, England.	alexandre.amaral@embrapa.br		Rudd, Jason/0000-0002-4743-1401; Hammond-Kosack, kim/0000-0002-9699-485X	Embrapa LabEx Programme; Biotechnology and Biological Sciences Research Council of the UK (BBSRC) through the Institute Strategic Programme 20:20 Wheat(R); BBSRC; BBSRC [BBS/E/C/00005203] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005203] Funding Source: researchfish	Embrapa LabEx Programme(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Biotechnology and Biological Sciences Research Council of the UK (BBSRC) through the Institute Strategic Programme 20:20 Wheat(R); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AMDA is supported by the Embrapa LabEx Programme. JRR and KEHK are supported by the Biotechnology and Biological Sciences Research Council of the UK (BBSRC) through the Institute Strategic Programme 20:20 Wheat (R). JA is supported by additional BBSRC funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniw J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-447; Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Brown NA, 2010, FUNGAL BIOL-UK, V114, P555, DOI 10.1016/j.funbio.2010.04.006; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Deller S, 2011, J PLANT PHYSIOL, V168, P63, DOI 10.1016/j.jplph.2010.05.024; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Goodwin SB, 2004, PHYTOPATHOLOGY, V94, P800, DOI 10.1094/PHYTO.2004.94.8.800; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Gout L, 2006, MOL MICROBIOL, V60, P67, DOI 10.1111/j.1365-2958.2006.05076.x; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Joly DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-422; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kema GHJ, 2008, MOL PLANT MICROBE IN, V21, P1249, DOI 10.1094/MPMI-21-9-1249; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P777, DOI 10.1094/Phyto-86-777; Keon J, 2005, MOL PLANT PATHOL, V6, P527, DOI 10.1111/J.1364-3703.2005.00304.X; Keon J, 2005, FUNGAL GENET BIOL, V42, P376, DOI 10.1016/j.fgb.2004.12.005; Keon J, 2007, MOL PLANT MICROBE IN, V20, P178, DOI 10.1094/MPMI-20-2-0178; Kleemann J, 2008, MICROBIOL-SGM, V154, P1204, DOI 10.1099/mic.0.2007/014944-0; Lum G, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar001; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Motteram J, 2009, MOL PLANT MICROBE IN, V22, P790, DOI 10.1094/MPMI-22-7-0790; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Muller O, 2008, MOL GENET GENOMICS, V279, P27, DOI 10.1007/s00438-007-0291-4; Neidleman S, 1992, BIOHALOGENATION PRIN; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Quaedvlieg W, 2011, PERSOONIA, V26, P57, DOI 10.3767/003158511X571841; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Rudd JJ, 2008, PLANT PHYSIOL, V147, P802, DOI 10.1104/pp.108.119511; Rudd JJ, 2010, FUNGAL GENET BIOL, V47, P19, DOI 10.1016/j.fgb.2009.10.009; Shetty NP, 2007, NEW PHYTOL, V174, P637, DOI 10.1111/j.1469-8137.2007.02026.x; Shetty NP, 2003, PHYSIOL MOL PLANT P, V62, P333, DOI 10.1016/S0885-5765(03)00079-1; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; Stukenbrock EH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001189; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Wittenberg AHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005863	54	59	59	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49904	10.1371/journal.pone.0049904	http://dx.doi.org/10.1371/journal.pone.0049904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236356	gold, Green Published, Green Submitted			2022-12-25	WOS:000312064100008
J	Guo, JJ; Ren, W; Ding, Y; Li, AM; Jia, L; Su, DM; Liu, X; Xu, KF; Yang, T				Guo, Jianjin; Ren, Wei; Ding, Ying; Li, Aimei; Jia, Lu; Su, Dongming; Liu, Xiang; Xu, Kuanfeng; Yang, Tao			Fat Mass and Obesity Associated Gene (FTO) Expression Is Regulated Negatively by the Transcription Factor Foxa2	PLOS ONE			English	Article							LIVER DEVELOPMENT; ADULT OBESITY; CANCER-RISK; INSULIN; METAANALYSIS; CHILDHOOD; VARIANTS; HUMANS	Fat mass and obesity associated gene (FTO) is the first gene associated with body mass index (BMI) and risk for diabetes. FTO is highly expressed in the brain and pancreas, and is involved in regulating dietary intake and energy expenditure. To investigate the transcriptional regulation of FTO expression, we created 5'-deletion constructs of the FTO promoter to determine which transcription factors are most relevant to FTO expression. The presence of an activation region at -201/+34 was confirmed by luciferase activity analysis. A potential Foxa2 (called HNF-3 beta) binding site and an upstream stimulatory factor (USF)-binding site was identified in the -100 bp fragment upstream of the transcription start site (TSS). Furthermore, using mutagenesis, we identified the Foxa2 binding sequence (-26/-14) as a negative regulatory element to the activity of the human FTO promoter. The USF binding site did not affect the FTO promoter activity. Chromatin immunoprecipitation (ChIP) assays were performed to confirm Foxa2 binding to the FTO promoter. Overexpression of Foxa2 in HEK 293 cells significantly down-regulated FTO promoter activity and expression. Conversely, knockdown of Foxa2 by siRNA significantly up-regulated FTO expression. These findings suggest that Foxa2 negatively regulates the basal transcription and expression of the human FTO gene.	[Guo, Jianjin; Xu, Kuanfeng; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Ren, Wei] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Hosp 6, Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Ren, Wei] Shanghai Clin Ctr Diabet, Shanghai, Peoples R China; [Ding, Ying; Li, Aimei; Jia, Lu; Su, Dongming] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Jiangsu, Peoples R China; [Liu, Xiang] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Nanjing Medical University; Shanghai Jiao Tong University; Nanjing Medical University; Medical University of South Carolina	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn			National Natural Science Foundation of China [30971405, 81170252, 81070656]; National Basic Research Program of China [2010CB535008]; Jiangsu Province Innovation Project for Graduate Students of China [CXZZ11_0708]; China Postdoctoral Science Foundation [2012M510850]; Shanghai Postdoctoral Sustentation Fund [12R21414700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Jiangsu Province Innovation Project for Graduate Students of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Sustentation Fund	This work was supported by National Natural Science Foundation of China (30971405, 81170252, 81070656), the National Basic Research Program of China (2010CB535008, 973 Program), the Jiangsu Province Innovation Project for Graduate Students of China (CXZZ11_0708), the China Postdoctoral Science Foundation (2012M510850) and Shanghai Postdoctoral Sustentation Fund (12R21414700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Brennan P, 2009, INT J EPIDEMIOL, V38, P971, DOI 10.1093/ije/dyp162; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Kaklamani V, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-52; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016756; Mei H, 2010, HUM GENET, V128, P589, DOI 10.1007/s00439-010-0883-7; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Speakman JR, 2010, NATURE, V464, pE1, DOI 10.1038/nature08807; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047	26	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51082	10.1371/journal.pone.0051082	http://dx.doi.org/10.1371/journal.pone.0051082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236435	gold, Green Published, Green Submitted			2022-12-25	WOS:000312064100064
J	Schurmann, C; Heim, K; Schillert, A; Blankenberg, S; Carstensen, M; Dorr, M; Endlich, K; Felix, SB; Gieger, C; Grallert, H; Herder, C; Hoffmann, W; Homuth, G; Illig, T; Kruppa, J; Meitinger, T; Muller, C; Nauck, M; Peters, A; Rettig, R; Roden, M; Strauch, K; Volker, U; Volzke, H; Wahl, S; Wallaschofski, H; Wild, PS; Zeller, T; Teumer, A; Prokisch, H; Ziegler, A				Schurmann, Claudia; Heim, Katharina; Schillert, Arne; Blankenberg, Stefan; Carstensen, Maren; Doerr, Marcus; Endlich, Karlhans; Felix, Stephan B.; Gieger, Christian; Grallert, Harald; Herder, Christian; Hoffmann, Wolfgang; Homuth, Georg; Illig, Thomas; Kruppa, Jochen; Meitinger, Thomas; Mueller, Christian; Nauck, Matthias; Peters, Annette; Rettig, Rainer; Roden, Michael; Strauch, Konstantin; Voelker, Uwe; Voelzke, Henry; Wahl, Simone; Wallaschofski, Henri; Wild, Philipp S.; Zeller, Tanja; Teumer, Alexander; Prokisch, Holger; Ziegler, Andreas			Analyzing Illumina Gene Expression Microarray Data from Different Tissues: Methodological Aspects of Data Analysis in the MetaXpress Consortium	PLOS ONE			English	Article							BREAST-CANCER; GENOME BROWSER; METAANALYSIS; POPULATION; SIGNATURE; PROFILES; SURVIVAL; CLASSIFICATION; INFORMATION; HEALTH	Microarray profiling of gene expression is widely applied in molecular biology and functional genomics. Experimental and technical variations make meta-analysis of different studies challenging. In a total of 3358 samples, all from German population-based cohorts, we investigated the effect of data preprocessing and the variability due to sample processing in whole blood cell and blood monocyte gene expression data, measured on the Illumina HumanHT-12 v3 BeadChip array. Gene expression signal intensities were similar after applying the log(2) or the variance-stabilizing transformation. In all cohorts, the first principal component (PC) explained more than 95% of the total variation. Technical factors substantially influenced signal intensity values, especially the Illumina chip assignment (33-48% of the variance), the RNA amplification batch (12-24%), the RNA isolation batch (16%), and the sample storage time, in particular the time between blood donation and RNA isolation for the whole blood cell samples (2-3%), and the time between RNA isolation and amplification for the monocyte samples (2%). White blood cell composition parameters were the strongest biological factors influencing the expression signal intensities in the whole blood cell samples (3%), followed by sex (1-2%) in both sample types. Known single nucleotide polymorphisms (SNPs) were located in 38% of the analyzed probe sequences and 4% of them included common SNPs (minor allele frequency >5%). Out of the tested SNPs, 1.4% significantly modified the probe-specific expression signals (Bonferroni corrected p-value<0.05), but in almost half of these events the signal intensities were even increased despite the occurrence of the mismatch. Thus, the vast majority of SNPs within probes had no significant effect on hybridization efficiency. In summary, adjustment for a few selected technical factors greatly improved reliability of gene expression analyses. Such adjustments are particularly required for meta-analyses.	[Heim, Katharina; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Schillert, Arne; Kruppa, Jochen; Ziegler, Andreas] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Lubeck, Germany; [Blankenberg, Stefan; Mueller, Christian] Univ Herzzentrum Hamburg, Klin Allgemeine & Intervent Kardiol, Hamburg, Germany; [Blankenberg, Stefan; Zeller, Tanja] DZHK German Ctr Cardiovasc Res, Hamburg, Germany; [Carstensen, Maren; Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Doerr, Marcus; Felix, Stephan B.] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Doerr, Marcus; Felix, Stephan B.; Hoffmann, Wolfgang; Nauck, Matthias; Voelker, Uwe; Voelzke, Henry; Wallaschofski, Henri] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Endlich, Karlhans] Univ Med Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Gieger, Christian; Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Grallert, Harald; Hoffmann, Wolfgang; Illig, Thomas; Peters, Annette; Wahl, Simone] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Hoffmann, Wolfgang; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-3000 Hannover, Germany; [Meitinger, Thomas; Peters, Annette; Prokisch, Holger] DZHK German Ctr Cardiovasc Res, Munich, Germany; [Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Humangenet, Munich, Germany; [Meitinger, Thomas; Peters, Annette] Munich Heart Alliance, Munich, Germany; [Nauck, Matthias; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, Karlsburg, Germany; [Roden, Michael] Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Metab Dis, D-40225 Dusseldorf, Germany; [Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany; [Wild, Philipp S.] DZHK German Ctr Cardiovasc Res, Mainz, Germany; [Schillert, Arne; Kruppa, Jochen; Ziegler, Andreas] DZHK German Ctr Cardiovasc Res, Lubeck, Germany; [Schurmann, Claudia; Homuth, Georg; Voelker, Uwe; Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Hannover Medical School; German Centre for Cardiovascular Research; Technical University of Munich; Munich Heart Alliance; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research; Ernst Moritz Arndt Universitat Greifswald	Teumer, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany.	ateumer@uni-greifswald.de; prokisch@helmholtz-muenchen.de; ziegler@imbs.uni-luebeck.de	Meitinger, Thomas/O-1318-2015; Peters, Annette/A-6117-2011; Prokisch, Holger/N-8964-2013; Endlich, Karlhans/G-5485-2013; Roden, Michael/AAD-3843-2019; Wild, Philipp S./M-2106-2019; Teumer, Alexander/S-7438-2019; Dörr, Marcus/F-1919-2010; Schurmann, Claudia/L-1204-2016; Grallert, Harald/B-3424-2013; Ziegler, Andreas/G-4246-2012	Peters, Annette/0000-0001-6645-0985; Teumer, Alexander/0000-0002-8309-094X; Dörr, Marcus/0000-0001-7471-475X; Schurmann, Claudia/0000-0003-4158-9192; Volker, Uwe/0000-0002-5689-3448; Endlich, Karlhans/0000-0001-6052-6061; Muller, Christian/0000-0002-9449-6865; Prokisch, Holger/0000-0003-2379-6286; Ziegler, Andreas/0000-0002-8386-5397; Gieger, Christian/0000-0001-6986-9554; Meitinger, Thomas/0000-0002-8838-8403; Wild, Philipp/0000-0003-4413-9752; Zeller, Tanja/0000-0003-3379-2641; Kruppa, Jochen/0000-0001-8376-8864	BMBF (German Ministry of Education and Research); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; BMBF [03IS2061A, 03ZIK012, 0315494A, 01GS0834, BMBF 01KU0908A, ANR 09 GENO 106 01, 01KU0908A, 01KU0908B, 0315536F]; Siemens Healthcare, Erlangen; Federal State of Mecklenburg, West Pomerania; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; BMBF; State of Bavaria; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia; German Research Foundation (DFG) [RA 459/2-1]; Leibniz Association; government of Rheinland-Pfalz [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; PHILIPS Medical Systems; National Genome Network "NGFNplus" [01GS0833, 01GS0831]; Agence Nationale de la Recherche, France [BMBF 01KU0908A, ANR 09 GENO 106 01]; European Union [HEALTH-2011-278913]; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research); Siemens Healthcare, Erlangen, Germany; InterSystems GmbH; Boehringer Ingelheim; Medical Research Council [G9817803B] Funding Source: researchfish	BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; BMBF(Federal Ministry of Education & Research (BMBF)); Siemens Healthcare, Erlangen; Federal State of Mecklenburg, West Pomerania; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; BMBF(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia; German Research Foundation (DFG)(German Research Foundation (DFG)); Leibniz Association; government of Rheinland-Pfalz; Johannes Gutenberg-University of Mainz; PHILIPS Medical Systems; National Genome Network "NGFNplus"; Agence Nationale de la Recherche, France(French National Research Agency (ANR)); European Union(European Commission); DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research); Siemens Healthcare, Erlangen, Germany; InterSystems GmbH; Boehringer Ingelheim(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the BMBF (German Ministry of Education and Research, http://www.bmbf.de), the Ministry of Cultural Affairs (http://www.regierung-mv.de/cms2/Regierungsportal_prod/Regierungsportal/de/bm/) as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania (http://www.regierung-mv.de/cms2/Regierungsportal_prod/Regierungsportal/de/sm/). Analyses were supported by the "Greifswald Approach to Individualized Medicine (GANI_MED, http://www.gani-med.de/)" consortium funded by the BMBF (grant 03IS2061A). Genome-wide genotyping and expression data have been supported by the BMBF (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany (http://www.siemens.com/) and the Federal State of Mecklenburg, West Pomerania (http://www.regierung-mv.de/). The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of the Siemens AG and the Cache Campus program of the InterSystems GmbH (http://www.intersystems.com). The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (http://www.helmholtz-muenchen.de/), which is funded by the BMBF and by the State of Bavaria (http://www.bayern.de/). The German Diabetes Center is funded by the German Federal Ministry of Health (http://www.bmg.bund.de/) and the Ministry of School, Science and Research of the State of North-Rhine-Westphalia (http://www.innovation.nrw.de/). The Diabetes Cohort Study was funded by a German Research Foundation (http://www.dfg.de) project grant to W. R. (DFG; RA 459/2-1). This study was supported in part by a grant from the BMBF to the German Center for Diabetes Research (DZD e. V., http://www.dzd-ev.de/). This work was supported by the BMBF funded Systems Biology of Metabotypes grant (SysMBo#0315494A). Additional support was obtained from the BMBF (National Genome Research Network NGFNplus Atherogenomics, 01GS0834) and the Leibniz Association (http://www.wgl.de/) (WGL Pakt fur Forschung und Innovation). The Gutenberg Health Study is funded through the government of Rheinland-Pfalz (http://www.rlp.de/) ("Stiftung Rheinland Pfalz fur Innovation", contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz (http://www.uni-mainz.de/), and its contract with Boehringer Ingelheim (http://www.boehringer-ingelheim.de/) and PHILIPS Medical Systems (http://www.healthcare.philips.com/), including an unrestricted grant for the Gutenberg Health Study. Specifically, the research reported in this article was supported by the National Genome Network "NGFNplus" (http://www.ngfn.de/en/start.html) (contract 01GS0833 and 01GS0831) by the BMBF, and a joint funding grant from the BMBF, and the Agence Nationale de la Recherche, France (http://www.agence-nationale-recherche.fr/) (contract BMBF 01KU0908A and ANR 09 GENO 106 01). This work was supported in part by the European Union (http://europa.eu/) (HEALTH-2011-278913), the BMBF (grants 01KU0908A, 01KU0908B, 0315536F), and supported by the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research, http://www.bmbf.de/de/16542.php, http://www.dzhk.de) and by the BMBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following interest: They received funding from a commercial source (Siemens Healthcare, Erlangen, Germany, InterSystems GmbH, Boehringer Ingelheim, PHILIPS Medical Systems). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Co-authors Tanja Zeller and Christian Herder are PLOS ONE Editorial Board members. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Allen JD, 2011, BRIEF BIOINFORM; Arasappan D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-65; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Brannon AR, 2012, EUR UROL, V61, P258, DOI 10.1016/j.eururo.2011.10.007; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Chen LS, 2008, BIOINFORMATICS, V24, P2260, DOI 10.1093/bioinformatics/btn411; Choi H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-364; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; EYSENCK HJ, 1994, BRIT MED J, V309, P789, DOI 10.1136/bmj.309.6957.789; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fekete T, 2012, INT J CANCER, V131, P95, DOI 10.1002/ijc.26364; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gyorffy B, 2009, BREAST CANCER RES TR, V118, P433, DOI 10.1007/s10549-008-0242-8; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Martini P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-92; Miller BG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009466; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Repsilber D, 2005, METHOD INFORM MED, V44, P461, DOI 10.1055/s-0038-1633994; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Robert J, 2004, CRIT REV ONCOL HEMAT, V51, P205, DOI 10.1016/S1040-8428(04)00111-8; Roder C, 2012, NEUROSCIENCE, V201, P105, DOI 10.1016/j.neuroscience.2011.10.033; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Starling RC, 2006, J HEART LUNG TRANSPL, V25, P1389, DOI 10.1016/j.healun.2006.10.002; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wild PS, 2010, CIRC-CARDIOVASC IMAG, V3, P604, DOI 10.1161/CIRCIMAGING.109.911933; Xu QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026905; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	45	60	61	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50938	10.1371/journal.pone.0050938	http://dx.doi.org/10.1371/journal.pone.0050938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236413	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100047
J	Thomas, EC; Gunter, JH; Webster, JA; Schieber, NL; Oorschot, V; Parton, RG; Whitehead, JP				Thomas, Elaine C.; Gunter, Jennifer H.; Webster, Julie A.; Schieber, Nicole L.; Oorschot, Viola; Parton, Robert G.; Whitehead, Jonathan P.			Different Characteristics and Nucleotide Binding Properties of Inosine Monophosphate Dehydrogenase (IMPDH) Isoforms	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; CYSTATHIONINE BETA-SYNTHASE; REGULATED PROTEIN-KINASE; NUCLEIC-ACID BINDING; 5-MONOPHOSPHATE DEHYDROGENASE; MYCOPHENOLIC-ACID; 5'-MONOPHOSPHATE DEHYDROGENASE; INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; LIGAND-BINDING	We recently reported that Inosine Monophosphate Dehydrogenase (IMPDH), a rate-limiting enzyme in de novo guanine nucleotide biosynthesis, clustered into macrostructures in response to decreased nucleotide levels and that there were differences between the IMPDH isoforms, IMPDH1 and IMPDH2. We hypothesised that the Bateman domains, which are present in both isoforms and serve as energy-sensing/allosteric modules in unrelated proteins, would contribute to isoform-specific differences and that mutations situated in and around this domain in IMPDH1 which give rise to retinitis pigmentosa (RP) would compromise regulation. We employed immuno-electron microscopy to investigate the ultrastructure of IMPDH macrostructures and live-cell imaging to follow clustering of an IMPDH2-GFP chimera in real-time. Using a series of IMPDH1/IMPDH2 chimera we demonstrated that the propensity to cluster was conferred by the N-terminal 244 amino acids, which includes the Bateman domain. A protease protection assay suggested isoform-specific purine nucleotide binding characteristics, with ATP protecting IMPDH1 and AMP protecting IMPDH2, via a mechanism involving conformational changes upon nucleotide binding to the Bateman domain without affecting IMPDH catalytic activity. ATP binding to IMPDH1 was confirmed in a nucleotide binding assay. The RP-causing mutation, R224P, abolished ATP binding and nucleotide protection and this correlated with an altered propensity to cluster. Collectively these data demonstrate that (i) the isoforms are differentially regulated by AMP and ATP by a mechanism involving the Bateman domain, (ii) communication occurs between the Bateman and catalytic domains and (iii) the RP-causing mutations compromise such regulation. These findings support the idea that the IMPDH isoforms are subject to distinct regulation and that regulatory defects contribute to human disease.	[Thomas, Elaine C.; Gunter, Jennifer H.; Webster, Julie A.; Whitehead, Jonathan P.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metabol Med, Brisbane, Qld, Australia; [Webster, Julie A.; Whitehead, Jonathan P.] Mater Med Res Inst, Brisbane, Qld, Australia; [Schieber, Nicole L.; Oorschot, Viola; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland; Mater Research; University of Queensland	Thomas, EC (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	elaine.thomas@bristol.ac.uk; jwhitehead@mmri.mater.org.au	Parton, Robert G/C-5673-2009; Gunter, Jennifer H/B-8960-2016; Webster, Julie A/N-6081-2015	Parton, Robert G/0000-0002-7494-5248; Gunter, Jennifer H/0000-0003-2447-5732; Webster, Julie A/0000-0003-2879-700X; Schieber, Nicole L./0000-0002-3212-5057; Whitehead, Jonathan/0000-0003-3978-3148; Thomas, Elaine/0000-0002-9435-3653	National Health and Medical Research Council of Australia [401677, 511005, 361310]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants (401677, to JPW; 511005, to RGP) and a scholarship (361310, to ECT) from the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; CARR SF, 1993, J BIOL CHEM, V268, P27286; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; COLLART FR, 1988, J BIOL CHEM, V263, P15769; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; GLESNE DA, 1991, MOL CELL BIOL, V11, P5417, DOI 10.1128/MCB.11.11.5417; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; HAGER PW, 1995, BIOCHEM PHARMACOL, V49, P1323, DOI 10.1016/0006-2952(95)00026-V; Hnizda A, 2010, BIOCHEMISTRY-US, V49, P10526, DOI 10.1021/bi101384m; HOLMES EW, 1974, BIOCHIM BIOPHYS ACTA, V364, P209, DOI 10.1016/0005-2744(74)90006-0; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; Kozhevnikova EN, 2012, MOL CELL, V47, P133, DOI 10.1016/j.molcel.2012.04.030; Link JO, 1996, J AM CHEM SOC, V118, P2091, DOI 10.1021/ja9534056; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Mortimer SE, 2008, J BIOL CHEM, V283, P36354, DOI 10.1074/jbc.M806143200; Mortimer SE, 2005, BIOCHEM J, V390, P41, DOI 10.1042/BJ20042051; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; NATSUMEDA Y, 1990, J BIOL CHEM, V265, P5292; Nimmesgern E, 1999, PROTEIN EXPRES PURIF, V17, P282, DOI 10.1006/prep.1999.1136; Nimmesgern E, 1996, J BIOL CHEM, V271, P19421, DOI 10.1074/jbc.271.32.19421; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; OKADA M, 1983, J BIOCHEM-TOKYO, V94, P1605; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Pimkin M, 2009, J BIOL CHEM, V284, P7960, DOI 10.1074/jbc.M808541200; Risal D, 2003, CRYSTAL STR IN PRESS; Schieber NL, 2010, METHOD CELL BIOL, V96, P425, DOI 10.1016/S0091-679X(10)96018-4; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SENDA M, 1994, LIFE SCI, V54, P1917, DOI 10.1016/0024-3205(94)90150-3; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Su H, 2009, BIOCHEM BIOPH RES CO, V386, P351, DOI 10.1016/j.bbrc.2009.06.040; Whitehead JP, 2004, TRAFFIC, V5, P739, DOI 10.1111/j.1600-0854.2004.00217.x; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xu D, 2008, ARCH BIOCHEM BIOPHYS, V472, P100, DOI 10.1016/j.abb.2008.02.012; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhou X, 1997, J BIOL CHEM, V272, P21977, DOI 10.1074/jbc.272.35.21977	57	46	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51096	10.1371/journal.pone.0051096	http://dx.doi.org/10.1371/journal.pone.0051096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236438	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100067
J	Wu, DM; Lin, XC; Bernloehr, C; Hildebrandt, T; Doods, H				Wu, Dongmei; Lin, Xinchun; Bernloehr, Christian; Hildebrandt, Tobias; Doods, Henri			Effects of a Novel Bradykinin B1 Receptor Antagonist and Angiotensin II Receptor Blockade on Experimental Myocardial Infarction in Rats	PLOS ONE			English	Article							KININ B-1 RECEPTOR; CONVERTING-ENZYME-INHIBITORS; KALLIKREIN GENE-TRANSFER; HUMAN TISSUE KALLIKREIN; NECROSIS-FACTOR-ALPHA; KNOCKOUT MICE; HYPERTENSIVE-RATS; TYPE-1 RECEPTOR; UP-REGULATION; NEOVASCULARIZATION	Background: The aim of the present study was to evaluate the cardiovascular effects of the novel bradykinin B1 receptor antagonist BI-113823 following myocardial infarction (MI) and to determine whether B1 receptor blockade alters the cardiovascular effects of an angiotensin II type 1 (AT1) receptor antagonist after MI in rats. Methodology/Principal Findings: Sprague Dawley rats were subjected to permanent occlusion of the left descending coronary artery. Cardiovascular function was determined at 7 days post MI. Treatment with either B1 receptor antagonist (BI-113823) or AT1 receptor antagonist (irbesartan) alone or in combination improved post-MI cardiac function as evidenced by attenuation of elevated left ventricular end diastolic pressure (LVEDP); greater first derivative of left ventricular pressure (+/- dp/dt max), left ventricle ejection fraction, fractional shorting, and better wall motion; as we as reductions in post-MI up-regulation of matrix metalloproteinases 2 (MMP-2) and collagen III. In addition, the cardiac up-regulation of B1 receptor and AT1 receptor mRNA were markedly reduced in animals treated with BI 113823, although bradykinin B2 receptor and angiotensin 1 converting enzyme (ACE1) mRNA expression were not significantly affected by B1 receptor blockade. Conclusions/Significance: The present study demonstrates that treatment with the novel B1 receptor antagonist, BI-113823 improves post-MI cardiac function and does not influence the cardiovascular effects of AT1 receptor antagonist following MI.	[Wu, Dongmei; Lin, Xinchun] Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA; [Wu, Dongmei] Chonbuk Natl Univ, WCU Program, Dept BIN Fus Technol, Jeollabuk Do, South Korea; [Bernloehr, Christian; Hildebrandt, Tobias; Doods, Henri] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Mount Sinai Medical Center; Jeonbuk National University; Boehringer Ingelheim	Wu, DM (corresponding author), Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA.	dongmeiwu@bellsouth.net	Wu, Dongmei/I-3213-2016		Boehringer Ingelheim Pharma KG, Biberach, Germany; World Class University Program [R31-20029]; Ministry of Education, Science and Technology, Republic of Korea	Boehringer Ingelheim Pharma KG, Biberach, Germany(Boehringer Ingelheim); World Class University Program; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Boehringer Ingelheim Pharma KG, Biberach, Germany; and in part by the World Class University Program (R31-20029) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This was a collabrative research between MSMC and BI.	Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; BENY JL, 1987, REGUL PEPTIDES, V17, P181, DOI 10.1016/0167-0115(87)90061-9; Berthonneche C, 2005, CARDIOVASC DRUG THER, V19, P251, DOI 10.1007/s10557-005-3695-6; Bradham WS, 2002, CARDIOVASC RES, V53, P822, DOI 10.1016/S0008-6363(01)00503-X; Cyr M, 2001, TRANSFUSION, V41, P136, DOI 10.1046/j.1537-2995.2001.41010136.x; Doods H, 2012, PAIN PRACT, V12, P18; Emanueli C, 2004, CIRCULATION, V110, P1638, DOI 10.1161/01.CIR.0000142051.36244.83; Emanueli C, 2004, ARCH MAL COEUR VAISS, V97, P679; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Emanueli C, 2001, HYPERTENSION, V38, P136, DOI 10.1161/01.HYP.38.1.136; Erdos EG, 2010, HYPERTENSION, V55, P214, DOI 10.1161/HYPERTENSIONAHA.109.144600; Gera L, 2008, INT IMMUNOPHARMACOL, V8, P289, DOI 10.1016/j.intimp.2007.06.006; Golias Ch, 2007, Hippokratia, V11, P124; GUIMARAES JA, 1986, EUR J PHARMACOL, V130, P177, DOI 10.1016/0014-2999(86)90266-9; HASHIMOTO K, 1978, AM HEART J, V95, P619, DOI 10.1016/0002-8703(78)90304-6; Klein J, 2010, J AM SOC NEPHROL, V21, P1157, DOI 10.1681/ASN.2009090887; Krankel N, 2008, CIRC RES, V103, P1335, DOI 10.1161/CIRCRESAHA.108.179952; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Lagneux C, 2002, INT IMMUNOPHARMACOL, V2, P815, DOI 10.1016/S1567-5769(02)00022-X; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; MacNeil T, 1997, CAN J PHYSIOL PHARM, V75, P735, DOI 10.1139/cjpp-75-6-735; Madeddu P, 2000, HYPERTENSION, V35, P391, DOI 10.1161/01.HYP.35.1.391; Maestri R, 2003, HYPERTENSION, V41, P1151, DOI 10.1161/01.HYP.0000064180.55222.DF; Masutomo K, 1999, J MOL CELL CARDIOL, V31, P1607, DOI 10.1006/jmcc.1999.0997; MINSHALL RD, 1995, CIRC RES, V76, P773, DOI 10.1161/01.RES.76.5.773; Parenti A, 2001, FASEB J, V15, P1487, DOI 10.1096/fj.00-0503fje; Savvatis K, 2010, NEUROPEPTIDES, V44, P119, DOI 10.1016/j.npep.2009.11.007; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Spillmann F, 2006, REGEN MED, V1, P235, DOI 10.2217/17460751.1.2.235; Spinetti G, 2011, CIRC RES, V108, P284, DOI 10.1161/CIRCRESAHA.110.236786; Stauss H M, 1994, J Cardiovasc Risk, V1, P255; Stone OA, 2009, ARTERIOSCL THROM VAS, V29, P657, DOI 10.1161/ATVBAHA.108.182139; Su JB, 2006, CURR PHARM DESIGN, V12, P3423; Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8; Tanaka Y, 2004, HYPERTENS RES, V27, P865, DOI 10.1291/hypres.27.865; Tschope C, 2004, CARDIOVASC RES, V61, P559, DOI 10.1016/j.cardiores.2003.10.018; Tschope C, 2000, BRAZ J MED BIOL RES, V33, P701, DOI 10.1590/S0100-879X2000000600011; Vianna RMJ, 2003, BRIT J PHARMACOL, V138, P13, DOI 10.1038/sj.bjp.0704999; Wang PHM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003050; Westermann D, 2008, BIOL CHEM, V389, P713, DOI 10.1515/BC.2008.070; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; WHALLEY ET, 1983, N-S ARCH PHARMACOL, V324, P296, DOI 10.1007/BF00502627; Whitehurst RM, 1999, J APPL PHYSIOL, V86, P61, DOI 10.1152/jappl.1999.86.1.61; Wu DM, 2012, RESUSCITATION, V83, P774, DOI 10.1016/j.resuscitation.2011.11.025; Xu J, 2009, EXP PHYSIOL, V94, P322, DOI 10.1113/expphysiol.2008.045583; Yang XP, 2001, CIRC RES, V88, P1072, DOI 10.1161/hh1001.090759; Yin H, 2007, PEPTIDES, V28, P1383, DOI 10.1016/j.peptides.2007.05.010; Yokoyama T, 1997, CIRCULATION, V95, P1247	48	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51151	10.1371/journal.pone.0051151	http://dx.doi.org/10.1371/journal.pone.0051151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236443	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100071
J	Berndt, S; Blacher, S; Munaut, C; Detilleux, J; d'Hauterive, SP; Huhtaniemi, I; Evain-Brion, D; Noel, A; Fournier, T; Foidart, JM				Berndt, Sarah; Blacher, Silvia; Munaut, Carine; Detilleux, Julien; d'Hauterive, Sophie Perrier; Huhtaniemi, Ilpo; Evain-Brion, Daniele; Noel, Agnes; Fournier, Thierry; Foidart, Jean-Michel			Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-beta receptor activation	FASEB JOURNAL			English	Article						angiostimulation; mural cells; endothelial cells; placenta; choriocarcinoma	GROWTH-FACTOR-BETA; GESTATIONAL TROPHOBLASTIC DISEASES; HUMAN FETOPLACENTAL VASCULOGENESIS; VASCULAR SMOOTH-MUSCLE; INVASIVE TROPHOBLAST; CELL-PROLIFERATION; HCG-BETA; IN-VITRO; ENDOGLIN; EXPRESSION	Embryo implantation requires extensive angiogenesis at the maternal-fetal interface. Hyperglycosylated human chorionic gonadotropin (hCG-H), a trophoblast invasive signal produced by extravillous cytotrophoblasts and by choriocarcinoma, was evaluated for its angiogenic role. hCG-H was purified by HPLC from choriocarcinoma supernatant, and the glycosylation pattern was determined by 2D gel analysis. Angiogenesis models used were aortic ring assay with wild-type and LHCGR-knockout mice, endothelial and mural cell proliferation, and migration assays. The TGF-beta signaling pathway was studied by coimmunoprecipitation, competitive binding, TGF-beta reporter gene assays, and Smad immunoblotting. hCG-H displayed a potent angiogenic effect [3.2-fold increase of number of vessel intersections in wild-type aortic rings (11.406 to 36.964)]. hCG-H-induced angiostimulation was independent of the classic hCG signaling pathway since it persisted in LHCGR-knockout mice [4.73-fold increase of number of vessel intersections (10.826 to 51.288)]. Using TGF-beta signaling inhibitors, T beta-RII was identified as the hCG-H receptor responsible for its angiogenic switch. hCG-H exposure enhanced phosphorylation of Smad 2 in endothelial and mural cells and genomic activation of Smad-responsive elements. Interaction between hCG-H and T beta-RII was demonstrated by coimmunoprecipitation and binding competition with I-125-TGF-beta. This new paracrine interaction between trophoblast and endothelial cells through the hCG-H and the TGF-beta receptor complex plays a key role in angiogenesis associated with placental development and tumorigenesis.-Berndt, S., Blacher, S., Munaut, C., Detilleux, J., Perrier d'Hauterive, S., Huhtaniemi, I., Evain-Brion, D., Noel, A., Fournier, T., Foidart, J.-M. Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-beta receptor activation. FASEB J. 27, 1309-1321 (2013). www.fasebj.org	[Berndt, Sarah; Evain-Brion, Daniele; Fournier, Thierry] INSERM, UMRS 767, F-75006 Paris, France; [Berndt, Sarah; Evain-Brion, Daniele; Fournier, Thierry] Univ Paris 05, Paris, France; [Berndt, Sarah; Evain-Brion, Daniele; Fournier, Thierry] PremUP Fondat, Paris, France; [Blacher, Silvia; Munaut, Carine; Detilleux, Julien; Noel, Agnes; Foidart, Jean-Michel] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, Liege, Belgium; [d'Hauterive, Sophie Perrier] Univ Liege, Ctr Immunol, Liege, Belgium; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [d'Hauterive, Sophie Perrier; Foidart, Jean-Michel] CHR, Dept Obstet & Gynecol, Liege, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Liege; University of Liege; Imperial College London	Fournier, T (corresponding author), INSERM, U767, 4 Ave Observ, F-75006 Paris, France.	thierry.fournier@parisdescartes.fr	Munaut, Carine/K-8138-2019; Fournier, Thierry C/E-5836-2016	Noel, Agnes/0000-0002-7670-6179; Fournier, Thierry/0000-0002-7515-339X	European 7th Research Framework Programme [HEALTH-2007-2.4.1-6, LSHM-CT-2004-512040]; European Network of Excellence on Embryo Implantation Control (EMBIC); Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique (FNRS; Belgium); Fondation contre le Cancer; Fonds Speciaux Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Frederieq (University of Liege); Direction Generale des Technologies, de la Recherche et de l'Energie (DGTRE) of the Region Wallonne (NEOANGIO); Fonds Social Europeen (FSE); Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium); PremUp Fondation; Rotary Foundation	European 7th Research Framework Programme; European Network of Excellence on Embryo Implantation Control (EMBIC); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (FNRS; Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer; Fonds Speciaux Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Frederieq (University of Liege); Direction Generale des Technologies, de la Recherche et de l'Energie (DGTRE) of the Region Wallonne (NEOANGIO); Fonds Social Europeen (FSE)(European Social Fund (ESF)); Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); PremUp Fondation; Rotary Foundation	The authors thank J. Guibourdenche for the progesterone measurements and F. Olivier, P. Gavitelli, D. Gabriel-Delapierre, L. Volders, M. R. Pignon, F. Bouillenne, A. M. Matton, I. Thamm, and G. Roland for their excellent technical assistance. The authors warmly thank Dr. J. Badet for advice, protocols, and data analyses of <SUP>125</SUP>I-TGF-beta binding experiments; J. Guibourdenche for radioimmunoassay facilities at Assistance Publique-Hopitaux de Paris Cochin Hospital (Paris, France); ZenTech S. A. (Liege Science Park, Angleur, Belgium) for radioactive iodation; and Prof J. Moreau for binding experiment data analysis. This work was supported by grants from the European 7th Research Framework Programme: HEALTH-2007-2.4.1-6, MICROENVIMET; Framework Programme 6-NOE no LSHM-CT-2004-512040; the European Network of Excellence on Embryo Implantation Control (EMBIC); the Fonds de la Recherche Scientifique Medicale; the Fonds National de la Recherche Scientifique (FNRS; Belgium); the Fondation contre le Cancer; the Fonds Speciaux Recherche (University of Liege); the Centre Anticancereux pres l'Universite de Liege; the Fonds Leon Frederieq (University of Liege); the Direction Generale des Technologies, de la Recherche et de l'Energie (DGTRE) of the Region Wallonne (NEOANGIO); the Fonds Social Europeen (FSE); the Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium); the PremUp Fondation; and the Rotary Foundation.	ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Berndt S, 2006, FASEB J, V20, P2630, DOI 10.1096/fj.06-5885fje; Berndt S, 2009, J CLIN ENDOCR METAB, V94, P4567, DOI 10.1210/jc.2009-0443; Bersinger NA, 2008, FETAL DIAGN THER, V24, P74, DOI 10.1159/000132412; Birken S, 2003, CLIN CHEM, V49, P144, DOI 10.1373/49.1.144; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Butler SA, 2000, BRIT J CANCER, V82, P1553; Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Chung IB, 2000, PLACENTA, V21, P320, DOI 10.1053/plac.1999.0481; Cole LA, 2007, PLACENTA, V28, P977, DOI 10.1016/j.placenta.2007.01.011; Cole LA, 2010, PLACENTA, V31, P653, DOI 10.1016/j.placenta.2010.06.005; Cole LA, 1997, CLIN CHEM, V43, P2233; Cole LA, 2008, J REPROD MED, V53, P499; Cole LA, 2006, J REPROD MED, V51, P919; Cole LA, 2006, GYNECOL ONCOL, V102, P145, DOI 10.1016/j.ygyno.2005.12.047; Cole LA, 2006, GYNECOL ONCOL, V102, P151, DOI 10.1016/j.ygyno.2005.12.045; Cole LA, 2012, AM J CANCER RES, V2, P22; Cole LA, 2012, MOL CELL ENDOCRINOL, V349, P232, DOI 10.1016/j.mce.2011.10.029; Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; FEINBERG RF, 1994, J CLIN ENDOCR METAB, V78, P1241, DOI 10.1210/jc.78.5.1241; Fonsatti E, 2001, J CELL PHYSIOL, V188, P1, DOI 10.1002/jcp.1095; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Goumans MJ, 1999, DEVELOPMENT, V126, P3473; Guibourdenche J, 2010, J CLIN ENDOCR METAB, V95, pE240, DOI 10.1210/jc.2010-0138; Hamada AL, 2005, J CLIN ENDOCR METAB, V90, P4873, DOI 10.1210/jc.2004-2458; Handschuh K, 2007, PLACENTA, V28, P175, DOI 10.1016/j.placenta.2006.01.019; Handschuh K, 2007, ENDOCRINOLOGY, V148, P5011, DOI 10.1210/en.2007-0286; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Herrler Andreas, 2003, Reprod Biomed Online, V6, P244; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Iles RK, 2010, MOL CELL ENDOCRINOL, V329, P62, DOI 10.1016/j.mce.2010.07.014; Iles RK, 2010, MOL CELL ENDOCRINOL, V329, P1, DOI 10.1016/j.mce.2010.07.024; Ingman WV, 2002, BIOESSAYS, V24, P904, DOI 10.1002/bies.10155; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Khoo NKS, 1998, INT J CANCER, V77, P429, DOI 10.1002/(SICI)1097-0215(19980729)77:3<429::AID-IJC20>3.3.CO;2-Q; KORNYEI JL, 1993, BIOL REPROD, V49, P1149, DOI 10.1095/biolreprod49.6.1149; Kovalevskaya G, 2007, MOL CELL ENDOCRINOL, V260, P237, DOI 10.1016/j.mce.2006.02.021; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; MYOKEN Y, 1990, EXP CELL RES, V191, P299, DOI 10.1016/0014-4827(90)90018-6; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Sasaki Y, 2008, FERTIL STERIL, V89, P1781, DOI 10.1016/j.fertnstert.2007.03.010; TOTH P, 1994, J CLIN ENDOCR METAB, V79, P307, DOI 10.1210/jc.79.1.307; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zygmunt M, 2003, EUR J OBSTET GYN R B, V110, pS10, DOI 10.1016/S0301-2115(03)00168-4; Zygmunt M, 2002, J CLIN ENDOCR METAB, V87, P5290, DOI 10.1210/jc.2002-020642	54	69	74	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1309	1321		10.1096/fj.12-213686	http://dx.doi.org/10.1096/fj.12-213686			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23233533				2022-12-25	WOS:000316940800004
J	Strauss, L; Rantakari, P; Sjogren, K; Salminen, A; Lauren, E; Kallio, J; Damdimopoulou, P; Bostrom, M; Bostrom, PJ; Pakarinen, P; Zhang, FP; Kujala, P; Ohlsson, C; Makela, S; Poutanen, M				Strauss, Leena; Rantakari, Pia; Sjogren, Klara; Salminen, Anu; Lauren, Eve; Kallio, Jenny; Damdimopoulou, Pauliina; Bostrom, Minna; Bostrom, Peter J.; Pakarinen, Pirjo; Zhang, FuPing; Kujala, Paula; Ohlsson, Claes; Makela, Sari; Poutanen, Matti			Seminal vesicles and urinary bladder as sites of aromatization of androgens in men, evidenced by a CYP19A1-driven luciferase reporter mouse and human tissue specimens	FASEB JOURNAL			English	Article						aromatase; male urogenital tract; androgen regulation	CYP19 AROMATASE GENE; ESTROGEN-RECEPTOR-ALPHA; TRANSGENIC MICE; TRANSCRIPTIONAL REGULATION; PHYSIOLOGICAL-ROLE; HUMAN SPERM; ER-BETA; EXPRESSION; SPERMATOZOA; DEFICIENCY	The human CYP19A1 gene is expressed in various tissues by the use of tissue-specific promoters, whereas the rodent cyp19a1 gene is expressed mainly in the gonads and brain. We generated a transgenic mouse model containing a > 100-kb 5' region of human CYP19A1 gene connected to a luciferase reporter gene. The luciferase activity in mouse tissues mimicked the CYP19A1 gene expression pattern in humans. Interestingly, the reporter gene activity was 16 and 160 times higher in the urinary bladder and seminal vesicles, respectively, as compared with the activity in the testis. Accordingly, CYP19A1 gene and P450arom protein expression was detected in those human tissues. Moreover, the data revealed that the expression of CYP19A1 gene is driven by promoters PII, I. 4, and I. 3 in the seminal vesicles, and by promoters PII and I. 4 in the urinary bladder. Furthermore, the reporter gene expression in the seminal vesicles was androgen dependent: Castration decreased the expression similar to 20 times, and testosterone treatment restored it to the level of an intact mouse. This reporter mouse model facilitates studies of tissue-specific regulation of the human CYP19A1 gene, and our data provide evidence for seminal vesicles as important sites for estrogen production in males.-Strauss, L., Rantakari, P., Sjogren, K., Salminen, A., Lauren, E., Kallio, J., Damdimopoulou, P., Bostrom, M., Bostrom, P. J., Pakarinen, P., Zhang, F. P., Kujala, P., Ohlsson, C., Makela, S., Poutanen, M. Seminal vesicles and urinary bladder as sites of aromatization of androgens in men, evidenced by a CYP19A1-driven luciferase reporter mouse and human tissue specimens. FASEB J. 27, 1342-1350 (2013). www.fasebj.org	[Strauss, Leena; Rantakari, Pia; Salminen, Anu; Lauren, Eve; Kallio, Jenny; Pakarinen, Pirjo; Zhang, FuPing; Poutanen, Matti] Univ Turku, Dept Physiol, FIN-20520 Turku, Finland; [Strauss, Leena; Rantakari, Pia; Kallio, Jenny; Damdimopoulou, Pauliina; Pakarinen, Pirjo; Zhang, FuPing; Makela, Sari; Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, Inst Biomed, FIN-20520 Turku, Finland; [Strauss, Leena] Univ Turku, Electron Microscopy Lab, FIN-20520 Turku, Finland; [Damdimopoulou, Pauliina; Makela, Sari] Univ Turku, FIN-20520 Turku, Finland; [Sjogren, Klara; Ohlsson, Claes; Poutanen, Matti] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Bostrom, Minna; Bostrom, Peter J.] Turku Univ Hosp, Dept Surg, Div Urol, FIN-20520 Turku, Finland; [Kujala, Paula] Tampere Univ Hosp, Dept Pathol, Tampere, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Gothenburg; University of Turku; Tampere University; Tampere University Hospital	Poutanen, M (corresponding author), Univ Turku, Dept Physiol, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	matpou@utu.fi	Ohlsson, Claes/AGP-3544-2022; Strauss, Leena/AAY-8824-2021; Poutanen, Matti/I-1700-2018	Ohlsson, Claes/0000-0002-9633-2805; Poutanen, Matti/0000-0002-8953-1734; Bostrom, Peter/0000-0003-3647-0015; Makela, Sari/0000-0002-8698-4076; Rantakari, Pia/0000-0003-1638-5075; Damdimopoulou, Pauliina/0000-0001-8458-0855; Strauss, Leena/0000-0002-5682-205X; Sjogren, Klara/0000-0001-5776-7278	European Commission [PIONEER FOOD-CT-2004-513991]; Jalmari and Rauha Ahokas Foundation; Academy of Finland; Sigrid Juselius Foundation; Swedish Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); Jalmari and Rauha Ahokas Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors thank Katri Hovirinta, Heidi Liljenback, Nina Messner, Erja Mantysalo, Heli Niittymaki, Erica Nyman, Jonna Palmu, Hannele Rekola, and Charlotta Uggla for skillful technical assistance. This work was supported by the European Commission (PIONEER FOOD-CT-2004-513991), the Jalmari and Rauha Ahokas Foundation, the Academy of Finland, the Sigrid Juselius Foundation, and the Swedish Research Council.	Aapro M. S., 2003, BREAST CANC RES T S1, V80, pS13; Aapro MS, 2003, BREAST CANCER RES TR, V80, pS3; Aquila S, 2004, J CLIN ENDOCR METAB, V89, P1443, DOI 10.1210/jc.2003-031681; Aquila S, 2003, HUM REPROD, V18, P1650, DOI 10.1093/humrep/deg340; Balducci L., ONCOLOGY, V24, P741; Barnadas A, 2011, ADV THER, V28, P1045, DOI 10.1007/s12325-011-0075-4; Barnard RJ, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.12.1752; Bianco JJ, 2002, ENDOCRINOLOGY, V143, P4922, DOI 10.1210/en.2002-220493; Bouillon R, 2004, J CLIN ENDOCR METAB, V89, P6025, DOI 10.1210/jc.2004-0602; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1616, DOI 10.1210/jc.77.6.1616; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Carani C, 1997, NEW ENGL J MED, V337, P91, DOI 10.1056/NEJM199707103370204; Cavaco JEB, 2009, SYST BIOL REPROD MED, V55, P137, DOI 10.1080/19396360902855733; Chavalmane AK, 2010, J SEX MED, V7, P2698, DOI 10.1111/j.1743-6109.2010.01811.x; Chow JDY, 2009, J STEROID BIOCHEM, V115, P115, DOI 10.1016/j.jsbmb.2009.03.010; Cunha G R, 1987, Prog Clin Biol Res, V239, P251; Demura M, 2011, LUNG CANCER, V73, P289, DOI 10.1016/j.lungcan.2011.01.003; Demura M, 2008, REPROD SCI, V15, P1044, DOI 10.1177/1933719108322441; Fraser LR, 2006, HUM REPROD, V21, P1184, DOI 10.1093/humrep/dei486; Geisler J, 2011, BRIT J CANCER, V104, P1059, DOI 10.1038/bjc.2011.58; Harada N, 2001, J STEROID BIOCHEM, V79, P151, DOI 10.1016/S0960-0760(01)00153-4; Herrmann BL, 2002, J CLIN ENDOCR METAB, V87, P5476, DOI 10.1210/jc.2002-020498; Hinshelwood MM, 2000, ENDOCRINOLOGY, V141, P2050, DOI 10.1210/en.141.6.2050; IDAOMAR M, 1989, ARCH ANDROLOGY, V22, P197, DOI 10.3109/01485018908986772; JENKINS C, 1993, MOL CELL ENDOCRINOL, V97, pR1, DOI 10.1016/0303-7207(93)90227-B; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Kamat A, 2005, ENDOCRINOLOGY, V146, P2481, DOI 10.1210/en.2004-1606; Kamat A, 1999, P NATL ACAD SCI USA, V96, P4575, DOI 10.1073/pnas.96.8.4575; Luboshitzky R, 2002, INT J ANDROL, V25, P345, DOI 10.1046/j.1365-2605.2002.00376.x; Luboshitzky R, 2002, ARCH ANDROLOGY, V48, P225, DOI 10.1080/01485010252869324; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; MARTEL C, 1994, MOL CELL ENDOCRINOL, V104, P103, DOI 10.1016/0303-7207(94)90056-6; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Myers RP, 2010, CLIN ANAT, V23, P18, DOI 10.1002/ca.20895; Pradidarcheep W, 2008, AGING MALE, V11, P51, DOI 10.1080/13685530801954026; Prins GS, 2008, STEROIDS, V73, P233, DOI 10.1016/j.steroids.2007.10.013; Rivest P, 2010, TOXICOL APPL PHARM, V249, P33, DOI 10.1016/j.taap.2010.08.011; Saunders PTK, 2001, MOL HUM REPROD, V7, P227, DOI 10.1093/molehr/7.3.227; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; Streng T, 2002, J UROLOGY, V168, P298, DOI 10.1016/S0022-5347(05)64911-7; Toppari J, 2008, SEX DEV, V2, P260, DOI 10.1159/000152042; Wengstrom Y, 2008, BREAST, V17, P227, DOI 10.1016/j.breast.2007.11.001; WILSON JD, 1981, SCIENCE, V211, P1278, DOI 10.1126/science.7010602; Yague JG, 2009, ENDOCRINE, V35, P252, DOI 10.1007/s12020-008-9134-2; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhao H, 2012, ENDOCRINOLOGY, V153, P2701, DOI 10.1210/en.2011-1761; Zhao H, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-37	52	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1342	1350		10.1096/fj.12-219048	http://dx.doi.org/10.1096/fj.12-219048			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23239821				2022-12-25	WOS:000316940800007
J	Dixit, M; Kim, S; Matthews, GF; Erreger, K; Galli, A; Cobb, CE; Hustedt, EJ; Beth, AH				Dixit, Mrinalini; Kim, Sunghoon; Matthews, Gage F.; Erreger, Kevin; Galli, Aurelio; Cobb, Charles E.; Hustedt, Eric J.; Beth, Albert H.			Structural Arrangement of the Intracellular Ca2+ Binding Domains of the Cardiac Na+/Ca2+ Exchanger (NCX1.1) EFFECTS OF Ca2+ BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOLEMMAL NA+-CA2+ EXCHANGER; HUMAN VENTRICULAR MYOCYTES; SODIUM-CALCIUM EXCHANGE; CYTOPLASMIC DOMAIN; SPIN-LABELS; ELECTROSTATIC SWITCH; CA2+-BINDING DOMAIN; ERYTHROCYTE BAND-3; DYNAMIC PROPERTIES; GLOBAL ANALYSIS	The cardiac Na+/Ca2+ exchanger (NCX1.1) serves as the primary means of Ca2+ extrusion across the plasma membrane of cardiomyocytes after the rise in intracellular Ca2+ during contraction. The exchanger is regulated by binding of Ca2+ to its intracellular domain, which contains two structurally homologous Ca2+ binding domains denoted as CBD1 and CBD2. NMR and x-ray crystallographic studies have provided structures for the isolated CBD1 and CBD2 domains and have shown how Ca2+ binding affects their structures and motional dynamics. However, structural information on the entire Ca2+ binding domain, denoted CBD12, and how binding of Ca2+ alters its structure and dynamics is more limited. Site-directed spin labeling has been employed in this work to address these questions. Electron paramagnetic resonance measurements on singly labeled constructs of CBD12 have identified the regions that undergo changes in dynamics as a result of Ca2+ binding. Double electron-electron resonance (DEER) measurements on doubly labeled constructs of CBD12 have shown that the beta-sandwich regions of the CBD1 and CBD2 domains are largely insensitive to Ca2+ binding and that these two domains are widely separated at their N and C termini. Interdomain distances measured by DEER have been employed to construct structural models for CBD12 in the presence and absence of Ca2+. These models show that there is not a major change in the relative orientation of the two Ca2+ binding domains as a result of Ca2+ binding in the NCX1.1 isoform. Additional measurements have shown that there are significant changes in the dynamics of the F-G loop region of CBD2 that merit further characterization with regard to their possible involvement in regulation of NCX1.1 activity.	[Dixit, Mrinalini; Kim, Sunghoon; Matthews, Gage F.; Erreger, Kevin; Galli, Aurelio; Cobb, Charles E.; Hustedt, Eric J.; Beth, Albert H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Beth, AH (corresponding author), Vanderbilt Univ, Sch Med, 727 Light Hall, Nashville, TN 37232 USA.	al.beth@vanderbilt.edu		Matthews, Gage/0000-0002-8695-9727; kim, sunghoon/0000-0002-1570-3230	National Institutes of Health [RR019120]; NATIONAL CANCER INSTITUTE [DP1CA174419] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We greatly appreciate receiving the cDNA encoding NCX1.1 from Dr.J.Lytton, University of Calgary. Funding for the DEER instrument was provided by National Institutes of Health Grant RR019120.	Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Brandon S, 2012, J MAGN RESON, V218, P93, DOI 10.1016/j.jmr.2012.03.006; Breukels V, 2010, PROTEINS, V78, P1813, DOI 10.1002/prot.22695; Dong H, 2002, BIOPHYS J, V82, P1943, DOI 10.1016/S0006-3495(02)75543-4; Dong H, 2001, J BIOL CHEM, V276, P25919, DOI 10.1074/jbc.M103401200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Hustedt EJ, 1997, BIOPHYS J, V72, P1861, DOI 10.1016/S0006-3495(97)78832-5; Hustedt EJ, 2006, BIOPHYS J, V90, P340, DOI 10.1529/biophysj.105.068544; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pogwizd SM, 1999, CIRC RES, V85, P1009; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Ren XY, 2006, J BIOL CHEM, V281, P22808, DOI 10.1074/jbc.M604753200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Salinas RK, 2011, J BIOL CHEM, V286, P32123, DOI 10.1074/jbc.M111.249268; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Weisser-Thomas J, 2003, CARDIOVASC RES, V57, P974, DOI 10.1016/S0008-6363(02)00732-0; Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P15115, DOI 10.1021/bi050931t; Zhou Z, 2007, BIOCHEMISTRY-US, V46, P10248, DOI 10.1021/bi700948p	35	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4194	4207		10.1074/jbc.M112.423293	http://dx.doi.org/10.1074/jbc.M112.423293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23233681	Green Published, hybrid			2022-12-25	WOS:000314845000046
J	Jin, ES; Sherry, AD; Malloy, CR				Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.			Evidence for Transaldolase Activity in the Isolated Heart Supplied with [U-C-13(3)]Glycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTOSE-PHOSPHATE PATHWAY; WORKING RAT-HEART; EXTRACELLULAR GLYCEROL; OXIDATIVE STRESS; PLASMA-GLUCOSE; ACID CYCLE; GLUCONEOGENESIS; FAILURE; FLUX; METABOLISM	Studies of glycerol metabolism in the heart have largely emphasized its role in triglyceride synthesis. However, glycerol may also be oxidized in the citric acid cycle, and glycogen synthesis from glycerol has been reported in the nonmammalian myocardium. The intent of this study was to test the hypothesis that glycerol may be metabolized to glycogen in mammalian heart. Isolated rat hearts were supplied with a mixture of substrates including glucose, lactate, pyruvate, octanoate, [U-C-13(3)]glycerol, and (H2O)-H-2 to probe various metabolic pathways including glycerol oxidation, glycolysis, the pentose phosphate pathway, and carbon sources of stored glycogen. NMR analysis confirmed that glycogen production from the level of the citric acid cycle did not occur and that the glycerol contribution to oxidation in the citric acid cycle was negligible in the presence of alternative substrates. Quite unexpectedly, C-13 from [U-C-13(3)]glycerol appeared in glycogen in carbon positions 4-6 of glucosyl units but none in positions 1-3. The extent of [4,5,6-C-13(3)]glucosyl unit enrichment in glycogen was enhanced by insulin but decreased by H2O2. Given that triose phosphate isomerase is generally assumed to fully equilibrate carbon tracers in the triose pool, the marked C-13 asymmetry in glycogen can only be attributed to conversion of [U-C-13(3)]glycerol to [U-C-13(3)]dihydroxyacetone phosphate and [U-C-13(3)]glyceraldehyde 3-phosphate followed by rearrangements in the nonoxidative branch of the pentose phosphate pathway involving transaldolase that places this C-13-enriched 3-carbon unit only in the bottom half of hexose phosphate molecules contributing to glycogen.	[Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Jin, Eunsook S.; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Malloy, Craig R.] Vet Affairs N Texas Hlth Care Syst, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Jin, ES (corresponding author), Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eunsook.jin@utsouthwestern.edu	Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [K01-DK078933, RR-02584, HL-34557]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034557, R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078933, P01DK058398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported, in whole or in part, by National Institutes of Health Grants K01-DK078933 (to E. S. J.), RR-02584 (to C. R. M.), and HL-34557 (to A. D. S.).	Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Basu R, 2009, DIABETES, V58, P1539, DOI 10.2337/db08-1300; BELCH JJF, 1991, BRIT HEART J, V65, P245; Bock G, 2008, DIABETES, V57, P50, DOI 10.2337/db07-0694; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; BURNS AH, 1977, AM J PHYSIOL, V232, pE570, DOI 10.1152/ajpendo.1977.232.6.E570; Chandramouli V, 1999, AM J PHYSIOL-ENDOC M, V277, pE717, DOI 10.1152/ajpendo.1999.277.4.E717; Davis SN, 2000, J CLIN ENDOCR METAB, V85, P224, DOI 10.1210/jc.85.1.224; DRAKE AJ, 1980, CARDIOVASC RES, V14, P65, DOI 10.1093/cvr/14.2.65; Gambert S, 2005, BBA-MOL CELL BIOL L, V1736, P152, DOI 10.1016/j.bbalip.2005.08.004; Gambert S, 2007, AM J PHYSIOL-HEART C, V292, pH1600, DOI 10.1152/ajpheart.00563.2006; Goodwin GW, 2001, AM J PHYSIOL-ENDOC M, V280, pE502, DOI 10.1152/ajpendo.2001.280.3.E502; Hill MF, 1996, AM J PATHOL, V148, P291; James H M, 1985, Int J Vitam Nutr Res Suppl, V28, P29; Jin ES, 2005, AM J PHYSIOL-ENDOC M, V288, pE654, DOI 10.1152/ajpendo.00365.2004; Jin ES, 2009, AM J PHYSIOL-ENDOC M, V296, pE748, DOI 10.1152/ajpendo.90935.2008; Jones JG, 2000, ANAL BIOCHEM, V277, P121, DOI 10.1006/abio.1999.4391; Jones JG, 2008, MAGN RESON MED, V59, P423, DOI 10.1002/mrm.21451; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; LJUNGDAHL L, 1961, J BIOL CHEM, V236, P1622; MALAISSE WJ, 1990, MOL CELL BIOCHEM, V93, P153; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; Massicotte D, 2006, EUR J APPL PHYSIOL, V96, P322, DOI 10.1007/s00421-005-0058-8; Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014; PFEIFER R, 1986, BIOL CHEM H-S, V367, P1061, DOI 10.1515/bchm3.1986.367.2.1061; REMESY C, 1983, ANN NUTR METAB, V27, P57, DOI 10.1159/000176624; ROBINSON J, 1969, BIOCHEM J, V112, P449, DOI 10.1042/bj1120449; SAVINA MV, 1977, COMP BIOCHEM PHYS B, V57, P185, DOI 10.1016/0305-0491(77)90141-9; TAEGTMEYER H, 1984, BASIC RES CARDIOL, V79, P322, DOI 10.1007/BF01908033; van der Merwe MT, 2001, J CLIN ENDOCR METAB, V86, P3296, DOI 10.1210/jc.86.7.3296; van Rosendal SP, 2009, NUTR REV, V67, P690, DOI 10.1111/j.1753-4887.2009.00254.x; Verhoeven NM, 2005, J INHERIT METAB DIS, V28, P169, DOI 10.1007/s10545-005-5261-6	34	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2914	2922		10.1074/jbc.M112.409441	http://dx.doi.org/10.1074/jbc.M112.409441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235149	hybrid, Green Published			2022-12-25	WOS:000314397900002
J	Barcellos, KSA; Bigarella, CL; Wagner, MV; Vieira, KP; Lazarini, M; Langford, PR; Machado-Neto, JA; Call, SG; Staley, DM; Chung, JY; Hansen, MD; Saad, STO				Barcellos, Karin S. A.; Bigarella, Carolina L.; Wagner, Mark V.; Vieira, Karla P.; Lazarini, Mariana; Langford, Peter R.; Machado-Neto, Joao A.; Call, Steven G.; Staley, Davis M.; Chung, Jarom Y.; Hansen, Marc D.; Saad, Sara T. O.			ARHGAP21 Protein, a New Partner of alpha-Tubulin Involved in Cell-Cell Adhesion Formation and Essential for Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; E-CADHERIN; CATENIN EXPRESSION; BETA-CATENIN; MICROTUBULE; MIGRATION; MECHANISMS; SIGNALS; COMPLEX; GROWTH	Cell-cell adhesions and the cytoskeletons play important and coordinated roles in cell biology, including cell differentiation, development, and migration. Adhesion and cytoskeletal dynamics are regulated by Rho-GTPases. ARHGAP21 is a negative regulator of Rho-GTPases, particularly Cdc42. Here we assess the function ofARHGAP21in cell-cell adhesion, cell migration, and scattering. We find that ARHGAP21 is localized in the nucleus, cytoplasm, or perinuclear region but is transiently redistributed to cell-cell junctions 4 h after initiation of cell-cell adhesion. ARHGAP21 interacts with Cdc42, and decreased Cdc42 activity coincides with the appearance of ARHGAP21 at the cell-cell junctions. Cells lacking ARHGAP21 expression show weaker cell-cell adhesions, increased cell migration, and a diminished ability to undergo hepatocyte growth factor-induced epithelial-mesenchymal transition (EMT). In addition, ARHGAP21 interacts with alpha-tubulin, and it is essential for alpha-tubulin acetylation in EMT. Our findings indicate that ARHGAP21 is a Rho-GAP involved in cell-cell junction remodeling and that ARHGAP21 affects migration and EMT through alpha-tubulin interaction and acetylation.	[Barcellos, Karin S. A.; Bigarella, Carolina L.; Vieira, Karla P.; Lazarini, Mariana; Machado-Neto, Joao A.; Saad, Sara T. O.] Univ Estadual Campinas, Hemoctr, UNICAMP,Hematol & Hemotherapy Ctr, Inst Nacl Ciencia & Tecnol Sangue, Campinas, SP, Brazil; [Wagner, Mark V.; Call, Steven G.; Staley, Davis M.; Chung, Jarom Y.; Hansen, Marc D.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA	Universidade Estadual de Campinas; Brigham Young University	Saad, STO (corresponding author), Univ Estadual Campinas UNICAMP, Ctr Hematol & Hemoterapia, Hemoctr, Rua Carlos Chagas,480 Cidade Univ Zeferino Vaz, BR-13083970 Campinas, SP, Brazil.	sara@unicamp.br	Machado-Neto, João Agostinho/L-8975-2016	Machado-Neto, João Agostinho/0000-0002-2937-8109; Lazarini, Mariana/0000-0002-5030-7583	Instituto Nacional de Ciencia e Tecnologia do Sangue (INCT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brigham Young University Cancer Research Center	Instituto Nacional de Ciencia e Tecnologia do Sangue (INCT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brigham Young University Cancer Research Center	This work was supported by Instituto Nacional de Ciencia e Tecnologia do Sangue (INCT), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).; Supported by a Summer Undergraduate Research Fellowship from the Brigham Young University Cancer Research Center.	Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Bagutti C, 1998, J PATHOL, V186, P8, DOI 10.1002/(SICI)1096-9896(199809)186:1<8::AID-PATH156>3.0.CO;2-H; Basseres DS, 2002, BIOCHEM BIOPH RES CO, V294, P579; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bigarella CL, 2009, BBA-MOL CELL RES, V1793, P806, DOI 10.1016/j.bbamcr.2009.02.010; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; El-Bahrawy M, 2002, LAB INVEST, V82, P1167, DOI 10.1097/01.LAB.0000028821.41246.6A; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; HARTMANN G, 1994, J BIOL CHEM, V269, P21936; Hehnly H, 2009, MOL BIOL CELL, V20, P4303, DOI 10.1091/mbc.E09-02-0155; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; SHIOZAKI H, 1994, AM J PATHOL, V144, P667; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Sperry RB, 2010, J CELL PHYSIOL, V222, P612, DOI 10.1002/jcp.21977; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; van Leenders G, 2002, PROSTATE, V51, P98, DOI 10.1002/pros.10073; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang S, 2012, J BIOL CHEM, V287, P9804, DOI 10.1074/jbc.M111.312959; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wynshaw-Boris A, 2009, CELL, V136, P393, DOI 10.1016/j.cell.2009.01.024	44	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2179	2189		10.1074/jbc.M112.432716	http://dx.doi.org/10.1074/jbc.M112.432716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23235160	Green Published, hybrid			2022-12-25	WOS:000314211500008
J	Lee, J; Lee, J				Lee, Jihyun; Lee, Junho			Hypoxia-inducible Factor-1 (HIF-1)-independent Hypoxia Response of the Small Heat Shock Protein hsp-16.1 Gene Regulated by Chromatin-remodeling Factors in the Nematode Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-2 HOMEOSTASIS; FACTOR 1-ALPHA; OXYGEN; HIF-1; NURF; ISWI; CALCIUM; DNA; PURIFICATION; CALCINEURIN	Oxygen deprivation is accompanied by the coordinated expression of numerous hypoxia-responsive genes, many of which are controlled by hypoxia-inducible factor-1 (HIF-1). However, the cellular response to hypoxia is not likely to be mediated by HIF-1 alone, and little is known about HIF-1-independent hypoxia responses. To better establish the molecular mechanisms of HIF-1-independent hypoxia responses, we sought to characterize the molecular basis of the hypoxia response of the hsp-16.1 gene in the nematode Caenorhabditis elegans; this gene has been shown to be induced by hypoxia independently of hif-1. Using affinity purification followed by LC-MS/MS, we identified HMG-1.2 as a protein that binds to a specific promoter region under hypoxic conditions. By systematic prediction followed by validation of these interactions through RNAi, we identified the chromatin modifiers isw-1 and hda-1, histone H4, and NURF-1 chromatin-remodeling factors as new components of the hif-1-independent hypoxia response. These data suggest that the modulation of nucleosome positioning at the hsp-16.1 promoter may be important for the hypoxia response. In addition, we found that calcineurin acts independently of hif-1 to modulate the cellular response to hypoxia and that calcium ions are necessary for the induction of hsp-16.1 under hypoxic conditions.	[Lee, Jihyun; Lee, Junho] Seoul Natl Univ, Dept Biol Sci, WCU Dept Biophys & Chem Biol, Inst Mol Biol & Genet,Res Ctr Cellul, Seoul 151742, South Korea	Seoul National University (SNU)	Lee, J (corresponding author), Seoul Natl Univ, Dept Biol Sci, WCU Dept Biophys & Chem Biol, Inst Mol Biol & Genet,Res Ctr Cellul, 56-1 Gwanak Gu, Seoul 151742, South Korea.	elegans@snu.ac.kr	Lee, Junho/AAO-4706-2021		World Class University Program; Research Center for Functional Cellulomics; Korea Student Aid Foundation (KOSAF) from the Korean Government [S2-2009-000-01151-1]	World Class University Program; Research Center for Functional Cellulomics; Korea Student Aid Foundation (KOSAF) from the Korean Government	This work was supported in part by the World Class University Program and the Research Center for Functional Cellulomics.; Supported by Korea Student Aid Foundation (KOSAF) Grant S2-2009-000-01151-1 from the Korean Government.	Andersen EC, 2006, DEVELOPMENT, V133, P2695, DOI 10.1242/dev.02444; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; BUCKLER KJ, 1994, J PHYSIOL-LONDON, V476, P423, DOI 10.1113/jphysiol.1994.sp020143; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; DIXON DK, 1990, DNA CELL BIOL, V9, P177, DOI 10.1089/dna.1990.9.177; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gdula DA, 1998, GENE DEV, V12, P3206, DOI 10.1101/gad.12.20.3206; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hong M, 2004, J MOL BIOL, V344, P369, DOI 10.1016/j.jmb.2004.09.077; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Jiang LI, 1999, GENE DEV, V13, P877, DOI 10.1101/gad.13.7.877; JONES D, 1989, DNA-J MOLEC CELL BIO, V8, P481, DOI 10.1089/dna.1.1989.8.481; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee I, 2010, GENOME RES, V20, P1143, DOI 10.1101/gr.102749.109; Lehner Ben, 2008, Briefings in Functional Genomics & Proteomics, V7, P217, DOI 10.1093/bfgp/eln020; Mabon ME, 2009, GENETICS, V181, P483, DOI 10.1534/genetics.108.097188; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; STROS M, 1994, FEBS LETT, V344, P201, DOI 10.1016/0014-5793(94)00364-5; STROS M, 1990, BIOCHEM INT, V21, P891; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Von Stetina SE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-226; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zhong H, 1999, CANCER RES, V59, P5830	51	15	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1582	1589		10.1074/jbc.M112.401554	http://dx.doi.org/10.1074/jbc.M112.401554			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23229554	Green Published, hybrid			2022-12-25	WOS:000313751400014
J	Li, RH; Yu, JX; Huang, X; Cheng, H				Li, Rong-Hua; Yu, Jeffrey Xu; Huang, Xin; Cheng, Hong			A Framework of Algorithms: Computing the Bias and Prestige of Nodes in Trust Networks	PLOS ONE			English	Article								A trust network is a social network in which edges represent the trust relationship between two nodes in the network. In a trust network, a fundamental question is how to assess and compute the bias and prestige of the nodes, where the bias of a node measures the trustworthiness of a node and the prestige of a node measures the importance of the node. The larger bias of a node implies the lower trustworthiness of the node, and the larger prestige of a node implies the higher importance of the node. In this paper, we define a vector-valued contractive function to characterize the bias vector which results in a rich family of bias measurements, and we propose a framework of algorithms for computing the bias and prestige of nodes in trust networks. Based on our framework, we develop four algorithms that can calculate the bias and prestige of nodes effectively and robustly. The time and space complexities of all our algorithms are linear with respect to the size of the graph, thus our algorithms are scalable to handle large datasets. We evaluate our algorithms using five real datasets. The experimental results demonstrate the effectiveness, robustness, and scalability of our algorithms.	[Li, Rong-Hua; Yu, Jeffrey Xu; Huang, Xin; Cheng, Hong] Chinese Univ Hong Kong, Dept Syst Engn & Engn Management, Sha Tin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Li, RH (corresponding author), Chinese Univ Hong Kong, Dept Syst Engn & Engn Management, Sha Tin, Hong Kong, Peoples R China.	rhli@se.cuhk.hk.edu	Cheng, Hong/F-7228-2011; Zhou, Xiaofang/C-6169-2013; Yu, Jeffrey X/F-6005-2011	Zhou, Xiaofang/0000-0001-6343-1455; Yu, Jeffrey X/0000-0002-9738-827X	Research Grants Council of the Hong Kong SAR, China [419109, 411211]	Research Grants Council of the Hong Kong SAR, China(Hong Kong Research Grants Council)	The work was supported by grant of the Research Grants Council of the Hong Kong SAR, China Nos. 419109 and 411211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2008, INTERNATIONAL WORLD; [Anonymous], 2009, P 18 INT C WORLD WID, DOI DOI 10.1145/1526709.1526809; Apostol T.M., 1974, MATH ANAL; Bachrach Y, 2009, AUTON AGENT MULTI-AG, V19, P153, DOI 10.1007/s10458-008-9073-6; Bahmani B., 2012, P 18 ACM SIGKDD INT, P24, DOI DOI 10.1145/2339530.2339539; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brin S., 1997, TECHNICAL REPORT; Cruz FL, 2012, INFORM PROCESS MANAG, V48, P271, DOI 10.1016/j.ipm.2011.08.003; de Kerchove G, 2008, SIAM INTERNATIONAL C; Desikan PK, 2005, INCREMENTAL PAGE RAN; Granas A., 2003, FIXED POINT THEORY; Guha R., 2004, P 13 INT C WORLD WID, P403, DOI [10.1145/988672.988727, DOI 10.1145/988672.988727]; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Haveliwala TH, INTERNATIONAL WORLD; Ortega FJ, 2012, COMPUT NETW, V56, P2884, DOI 10.1016/j.comnet.2012.05.002; Jen G, 2003, INTERNATIONAL WORLD; Josang A, 2009, PROCEEDINGS OF THE 5; Josang A, 2007, DECIS SUPPORT SYST, V43, P618, DOI 10.1016/j.dss.2005.05.019; Kamvar SD, 2003, INTERNATIONAL WORLD; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Leskovec J, 2010, ACM SIGCHI CONFERENC; Li RH, 2012, ROBUST REPUTATION BA; Ma H, 2009, ACM INTERNATIONAL CO; Massa P, 2007, RECSYS 07: PROCEEDINGS OF THE 2007 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P17; Mishra A, 2011, INTERNATIONAL WORLD; Procaccia AD, 2007, GOSSIP BASED AGGREGA; Richardson M, 2003, INTERNATIONAL SEMANT; Richters O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018384; Tang J, 2012, ACM INTERNATIONAL CO; Theodorakopoulos G, 2006, IEEE J SEL AREA COMM, V24, P318, DOI 10.1109/JSAC.2005.861390; Vigna S, 2011, SPECTRAL RANKING; Zhou R, 2008, IEEE T KNOWL DATA EN, V20, P1282, DOI 10.1109/TKDE.2008.48; Zhou RF, 2007, IEEE T PARALL DISTR, V18, P460, DOI [10.1109/TPDS.2007.1021, 10.1109/TPDS.2007.1015]	34	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50843	10.1371/journal.pone.0050843	http://dx.doi.org/10.1371/journal.pone.0050843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239990	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800027
J	Luo, W; Wang, CY; Jin, LJ				Luo, Wei; Wang, Cun-Yu; Jin, Lijian			Baicalin Downregulates Porphyromonas gingivalis Lipopolysaccharide-Upregulated IL-6 and IL-8 Expression in Human Oral Keratinocytes by Negative Regulation of TLR Signaling	PLOS ONE			English	Article							NF-KAPPA-B; COLONY-STIMULATING FACTOR; PROTEIN-KINASE INHIBITOR; TOLL-LIKE RECEPTORS; CANCER CELL-LINES; GENE-EXPRESSION; LIPID-A; CUTTING EDGE; INTERLEUKIN-1 RECEPTOR; INFLAMMATORY RESPONSE	Periodontal (gum) disease is one of the main global oral health burdens and severe periodontal disease (periodontitis) is a leading cause of tooth loss in adults globally. It also increases the risk of cardiovascular disease and diabetes mellitus. Porphyromonas gingivalis lipopolysaccharide (LPS) is a key virulent attribute that significantly contributes to periodontal pathogenesis. Baicalin is a flavonoid from Scutellaria radix, an herb commonly used in traditional Chinese medicine for treating inflammatory diseases. The present study examined the modulatory effect of baicalin on P. gingivalis LPS-induced expression of IL-6 and IL-8 in human oral keratinocytes (HOKs). Cells were pre-treated with baicalin (0-80 mu M) for 24 h, and subsequently treated with P. gingivalis LPS at 10 mu g/ml with or without baicalin for 3 h. IL-6 and IL-8 transcripts and proteins were detected by real-time polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. The expression of nuclear factor-kappa B (NF-kappa B), p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) proteins was analyzed by western blot. A panel of genes related to toll-like receptor (TLR) signaling was examined by PCR array. We found that baicalin significantly downregulated P. gingivalis LPS-stimulated expression of IL-6 and IL-8, and inhibited P. gingivalis LPS-activated NF-kappa B, p38 MAPK and JNK. Furthermore, baicalin markedly downregulated P. gingivalis LPS-induced expression of genes associated with TLR signaling. In conclusion, the present study shows that baicalin may significantly downregulate P. gingivalis LPS-upregulated expression of IL-6 and IL-8 in HOKs via negative regulation of TLR signaling.	[Luo, Wei; Jin, Lijian] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of Hong Kong; University of California System; University of California Los Angeles	Jin, LJ (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	ljjin@hkucc.hku.hk		Jin, Lijian/0000-0003-4305-1337	Hong Kong Research Grants Council [HKU766909M, HKU768411M]; Modern Dental Laboratory/HKU Endowment Fund	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Modern Dental Laboratory/HKU Endowment Fund	This study was supported by the Hong Kong Research Grants Council (HKU766909M and HKU768411M to LJJ), and the Modern Dental Laboratory/HKU Endowment Fund to LJJ. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Berman KS, 2002, CLIN CANCER RES, V8, P354; Bhatavadekar NB, 2009, INT DENT J, V59, P305, DOI 10.1922/IDJ_2157Bhatavadekar04; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Cai X, 2008, J PERIODONTAL RES, V43, P14, DOI 10.1111/j.1600-0765.2007.00989.x; Campbell IK, 2011, J IMMUNOL, V186, P5468, DOI 10.4049/jimmunol.1002923; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Cao ZG, 2010, EUR J PHARMACOL, V641, P1, DOI 10.1016/j.ejphar.2010.04.042; Carayol N, 2006, J BIOL CHEM, V281, P31142, DOI 10.1074/jbc.M603417200; Carboni S, 2004, J PHARMACOL EXP THER, V310, P25, DOI 10.1124/jpet.103.064246; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; DEMETRI GD, 1991, BLOOD, V78, P2791; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dominguez C, 2005, CURR OPIN DRUG DISC, V8, P421; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Hajishengallis G, 2009, PERIODONTOL 2000, V51, P181, DOI 10.1111/j.1600-0757.2009.00304.x; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Herath TDK, 2011, J CLIN PERIODONTOL, V38, P694, DOI 10.1111/j.1600-051X.2011.01741.x; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Ikemoto S, 2000, UROLOGY, V55, P951, DOI 10.1016/S0090-4295(00)00467-2; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jin L J, 2011, Adv Dent Res, V23, P221, DOI 10.1177/0022034511402080; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; KOGA T, 1985, INFECT IMMUN, V47, P638, DOI 10.1128/IAI.47.3.638-647.1985; Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li X, 2011, J DENT RES, V90, P1062, DOI 10.1177/0022034510397194; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Macagno A, 2006, J EXP MED, V203, P1481, DOI 10.1084/jem.20060136; Maruyama M, 2009, HYBRIDOMA, V28, P431, DOI 10.1089/hyb.2009.0055; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Ogawa T, 2002, INT IMMUNOL, V14, P1325, DOI 10.1093/intimm/dxf097; Ogawa T, 2007, FRONT BIOSCI-LANDMRK, V12, P3795, DOI 10.2741/2353; Oringer RJ, 2002, J PERIODONTOL, V73, P835, DOI 10.1902/jop.2002.73.8.835; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Parahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P46, DOI 10.1128/CMR.00028-08; Park HJ, 2009, ARCH PHARM RES, V32, P583, DOI 10.1007/s12272-009-1415-7; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Preshaw PM, 2004, J CLIN PERIODONTOL, V31, P697, DOI 10.1111/j.1600-051X.2004.00558.x; Rogers JE, 2007, J PERIODONTOL, V78, P1992, DOI 10.1902/jop.2007.070101; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421; Sawada N, 2007, CLIN EXP IMMUNOL, V148, P529, DOI 10.1111/j.1365-2249.2007.03346.x; Seo T, 2012, J MICROBIOL, V50, P311, DOI 10.1007/s12275-012-2146-x; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Souza PPC, 2010, J DENT RES, V89, P802, DOI 10.1177/0022034510366898; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang GF, 2006, PHARMACOLOGY, V77, P71, DOI 10.1159/000092853; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002; Zhu GX, 2007, J ETHNOPHARMACOL, V109, P325, DOI 10.1016/j.jep.2006.08.001	77	41	46	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51008	10.1371/journal.pone.0051008	http://dx.doi.org/10.1371/journal.pone.0051008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239998	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800034
J	Raghunathan, G; Soundrarajan, N; Sokalingam, S; Yun, H; Lee, SG				Raghunathan, Govindan; Soundrarajan, Nagasundarapandian; Sokalingam, Sriram; Yun, Hyungdon; Lee, Sun-Gu			Deletional Protein Engineering Based on Stable Fold	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; SECONDARY STRUCTURE ANALYSES; SULFOLOBUS-SOLFATARICUS; NATIVE-LIKE; CRYSTAL-STRUCTURE; INCLUSION-BODIES; SEQUENCE SPACE; STABILITY; EVOLUTION; ACYLPHOSPHATASE	Diversification of protein sequence-structure space is a major concern in protein engineering. Deletion mutagenesis can generate a protein sequence-structure space different from substitution mutagenesis mediated space, but it has not been widely used in protein engineering compared to substitution mutagenesis, because it causes a relatively huge range of structural perturbations of target proteins which often inactivates the proteins. In this study, we demonstrate that, using green fluorescent protein (GFP) as a model system, the drawback of the deletional protein engineering can be overcome by employing the protein structure with high stability. The systematic dissection of N-terminal, C-terminal and internal sequences of GFPs with two different stabilities showed that GFP with high stability (s-GFP), was more tolerant to the elimination of amino acids compared to a GFP with normal stability (n-GFP). The deletion studies of s-GFP enabled us to achieve three interesting variants viz. s-DL4, s-N14, and s-C225, which could not been obtained from n-GFP. The deletion of 191-196 loop sequences led to the variant s-DL4 that was expressed predominantly as insoluble form but mostly active. The s-N14 and s-C225 are the variants without the amino acid residues involving secondary structures around N- and C-terminals of GFP fold respectively, exhibiting comparable biophysical properties of the n-GFP. Structural analysis of the variants through computational modeling study gave a few structural insights that can explain the spectral properties of the variants. Our study suggests that the protein sequence-structure space of deletion mutants can be more efficiently explored by employing the protein structure with higher stability.	[Raghunathan, Govindan; Soundrarajan, Nagasundarapandian; Sokalingam, Sriram; Lee, Sun-Gu] Pusan Natl Univ, Dept Chem Engn, Pusan, South Korea; [Yun, Hyungdon] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea	Pusan National University; Yeungnam University	Lee, SG (corresponding author), Pusan Natl Univ, Dept Chem Engn, Pusan, South Korea.	sungulee@pusan.ac.kr	Raghunathan, Govindan/T-5299-2019	Yun, Hyungdon/0000-0002-9125-975X; Raghunathan, Govindan/0000-0002-1456-0768; Soundrarajan, Nagasundarapandian/0000-0001-5239-7992	Basic Science Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2011-0021222]	Basic Science Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0021222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyadurai N, 2011, ANGEW CHEM INT EDIT, V50, P6534, DOI 10.1002/anie.201008289; Ayyadurai N, 2011, BIOCONJUGATE CHEM, V22, P551, DOI 10.1021/bc2000066; Ayyadurai N, 2009, BIOTECHNOL BIOPROC E, V14, P257, DOI [10.1007/s12257-009-0009-z, 10.1007/S12257-009-0009-Z]; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bemporad F, 2008, BBA-PROTEINS PROTEOM, V1784, P1986, DOI 10.1016/j.bbapap.2008.08.021; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2004, BIOPHYS J, V86, P2758, DOI 10.1016/S0006-3495(04)74329-5; Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101; Caetano-Anolles G, 2010, BIOESSAYS, V32, P655, DOI 10.1002/bies.201000038; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dopf J, 1996, GENE, V173, P39, DOI 10.1016/0378-1119(95)00692-3; EHRIG T, 1995, FEBS LETT, V367, P163, DOI 10.1016/0014-5793(95)00557-P; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Haglund E, 2012, J BIOL CHEM, V287, P2731, DOI 10.1074/jbc.M111.312447; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang YM, 2011, PROTEIN SCI, V20, P1775, DOI 10.1002/pro.735; Kent KP, 2009, J AM CHEM SOC, V131, P15988, DOI 10.1021/ja906303f; Leconte AM, 2010, ANGEW CHEM INT EDIT, V49, P5921, DOI 10.1002/anie.201001607; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Li YG, 2007, NAT BIOTECHNOL, V25, P1051, DOI 10.1038/nbt1333; Liu LW, 2011, J BIOL CHEM, V286, P44710, DOI 10.1074/jbc.M111.269753; Mata L, 1999, PROTEIN ENG, V12, P681, DOI 10.1093/protein/12.8.681; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Muller MM, 2010, PROTEIN SCI, V19, P1000, DOI 10.1002/pro.377; Nagasundarapandian S, 2010, CHEMBIOCHEM, V11, P2521, DOI 10.1002/cbic.201000380; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pagano K, 2010, J BIOL CHEM, V285, P14689, DOI 10.1074/jbc.M109.082156; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peternel S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-34; Plakoutsi G, 2006, STRUCTURE, V14, P993, DOI 10.1016/j.str.2006.03.014; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; PutnamEvans C, 1996, PLANT MOL BIOL, V32, P1191, DOI 10.1007/BF00041405; Sample V, 2009, CHEM SOC REV, V38, P2852, DOI 10.1039/b913033k; Santhoshkumar P, 2009, BIOCHEMISTRY-US, V48, P5066, DOI 10.1021/bi900085v; SHORTLE D, 1995, CURR OPIN BIOTECH, V6, P387, DOI 10.1016/0958-1669(95)80067-0; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Trevino RJ, 1998, J BIOL CHEM, V273, P27841, DOI 10.1074/jbc.273.43.27841; Trevino RJ, 1999, J BIOL CHEM, V274, P13938, DOI 10.1074/jbc.274.20.13938; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vamvaca K, 2011, J NEUROCHEM, V119, P389, DOI 10.1111/j.1471-4159.2011.07431.x; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	49	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51510	10.1371/journal.pone.0051510	http://dx.doi.org/10.1371/journal.pone.0051510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240034	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800070
J	Tang, W; Zhu, JJ; Su, SC; Wu, W; Liu, Q; Su, FX; Yu, FY				Tang, Wei; Zhu, Jiujun; Su, Shicheng; Wu, Wei; Liu, Qiang; Su, Fengxi; Yu, Fengyan			MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival	PLOS ONE			English	Article							PROTEIN TRANSCRIPTION FACTORS; CELL-CYCLE PROGRESSION; ONCOGENIC MICRORNA-27A; DRUG-RESISTANCE; GENE-EXPRESSION; DOWN-REGULATION; TUMOR-GROWTH; ANGIOGENESIS; ADENOCARCINOMA; PROLIFERATION	Background: MicroRNA-27a (miR-27a) is thought to be an onco-microRNA that promotes tumor growth and metastasis by downregulating ZBTB10. The potential predictive value of miR-27a was studied in breast cancer patients. Methods: The expression of miR-27a and ZBTB10 was examined in 102 breast cancer cases using in situ hybridization (ISH) and immunohistochemistry techniques and were evaluated semi-quantitatively by examining the staining index. The Correlation of miR-27a and ZBTB10 expression was analyed by Spearman Rank Correlation. The association of miR-27a and ZBTB10 expression with clinicopathological characteristics was analyzed using the chi(2) test, and their effects on patient survival were analyzed by a log-rank test and the Kaplan-Meier method. Univariate and multivariate Cox regression analyses were used to evaluate the prognostic values of miR-27a and ZBTB10. Results: miR-27a was markedly up-regulated in invasive breast cancers that expressed low levels of ZBTB10 (P<0.001). A reverse correlation between miR-27a and ZBTB10 was also observed in breast cancer tissue samples (r(s) = -0.478, P<0.001). Furthermore, the expression of miR-27a and ZBTB10 was significantly correlated with clinicopathological parameters, including tumor size, lymph node metastasis and distant metastasis (P<0.05), but not with receptor status. Patients with high miR-27a or low ZBTB10 expression tended to have significantly shorter disease-free survival times (57 months and 53 months, respectively, P,0.001) and overall survival times (58 months and 55 months, respectively, P <0.001). Univariate and multivariate analysis showed that both miR-27a and ZBTB10 were independent prognostic factors of disease-free survival in breast cancer patients (P <0.001), while only miR-27a was an independent predictor of overall survival (P <0.001). Conclusions: High miR-27a expression is associated with poor overall survival in patients with breast cancer, which suggests that miR-27a could be a valuable marker of breast cancer progression.	[Tang, Wei; Zhu, Jiujun; Su, Shicheng; Wu, Wei; Liu, Qiang; Su, Fengxi; Yu, Fengyan] Sun Yat Sen Univ, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Wei] Guangzhou Med Univ, Dept Breast Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Su, FX (corresponding author), Sun Yat Sen Univ, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	fengxisu@vip.163.com; fengyanyu_summer@163.com	ZHU, JIUJUN/GRJ-0173-2022; Liu, Qiang/HHZ-3181-2022	ZHU, JIUJUN/0000-0001-7083-0155; Liu, Qiang/0000-0002-5451-4862	Natural Science Foundation of China [30921140312, 30973396, 30830110, 30972785, 81172524]; Public Health Administration of China; Ministry of Health of China [2011ZX09102-010-02]; HuoYingdong Educational Foundation [121042]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Health Administration of China; Ministry of Health of China; HuoYingdong Educational Foundation	This work was supported by Natural Science Foundation of China grants (30921140312, 30973396, 30830110, 30972785 and 81172524), a Clinical Key Project of the Public Health Administration of China, a grant for Development of Important New Drugs from the Ministry of Health of China (2011ZX09102-010-02) and a Young Teacher grant from the HuoYingdong Educational Foundation (121042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Banerjee N, 2012, BREAST CANCER RES TR, V136, P21, DOI 10.1007/s10549-012-2224-0; Chadalapaka G, 2012, CARCINOGENESIS, V33, P886, DOI 10.1093/carcin/bgs102; Chintharlapalli S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-371; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Han BW, 2011, HUM MOL GENET, V20, P4903, DOI 10.1093/hmg/ddr428; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iyevleva AG, 2012, BREAST CANCER RES TR, V131, P1049, DOI 10.1007/s10549-011-1845-z; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Li XR, 2010, ENDOCRINOLOGY, V151, P2462, DOI 10.1210/en.2009-1150; Li ZM, 2010, GYNECOL ONCOL, V119, P125, DOI 10.1016/j.ygyno.2010.06.004; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mertens-Talcott SU, 2012, MOL CARCINOGENESIS; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang HW, 2010, DIGEST DIS SCI, V55, P2545, DOI 10.1007/s10620-009-1051-6; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zhao XH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-55	36	92	106	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51702	10.1371/journal.pone.0051702	http://dx.doi.org/10.1371/journal.pone.0051702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240057	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800093
J	Johnson, IM; Prakash, H; Prathiba, J; Raghunathan, R; Malathi, R				Johnson, Irudayam Maria; Prakash, Halan; Prathiba, Jeyaguru; Raghunathan, Raghavachary; Malathi, Raghunathan			Spectral Analysis of Naturally Occurring Methylxanthines (Theophylline, Theobromine and Caffeine) Binding with DNA	PLOS ONE			English	Article							INTERCALATOR ACRIDINE-ORANGE; ANTITUMOR-ACTIVITY; AQUEOUS-SOLUTION; NUCLEIC-ACIDS; CELLS; DERIVATIVES; INHIBITION; ADRIAMYCIN; RNA; DOXORUBICIN	Nucleic acids exist in a dynamic equilibrium with a number of molecules that constantly interact with them and regulate the cellular activities. The inherent nature of the structure and conformational integrity of these macromolecules can lead to altered biological activity through proper targeting of nucleic acids binding ligands or drug molecules. We studied the interaction of naturally occurring methylxanthines such as theophylline, theobromine and caffeine with DNA, using UV absorption and Fourier transform infrared (FTIR) spectroscopic methods, and especially monitored their binding affinity in the presence of Mg2+ and during helix-coil transitions of DNA by temperature (T-m) or pH melting profiles. The study indicates that all these molecules effectively bind to DNA in a dose dependent manner. The overall binding constants of DNA-theophylline = 3.5x10(3) M 21, DNA-theobromine = 1.1x10(3) M-1, and DNA-Caffeine = 3.8x10(3) M-1. On the other hand T-m/pH melting profiles showed 24-35% of enhanced binding activity of methylxanthines during helix-coil transitions of DNA rather than to its native double helical structure. The FTIR analysis divulged that theophylline, theobromine and caffeine interact with all the base pairs of DNA (A-T; G-C) and phosphate group through hydrogen bond (H-bond) interaction. In the presence of Mg2+, methylxanthines altered the structure of DNA from B to A-family. However, the B-family structure of DNA remained unaltered in DNA-methylxanthines complexes or in the absence of Mg2+. The spectral analyses indicated the order of binding affinity as "caffeine >= theophylline>theobromine" to the native double helical DNA, and "theophylline >= theobromine>caffeine to the denatured form of DNA and in the presence of divalent metal ions.	[Johnson, Irudayam Maria] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Prakash, Halan] Univ Madras, Natl Ctr Ultrafast Proc, Madras, Tamil Nadu, India; [Prathiba, Jeyaguru; Malathi, Raghunathan] Univ Madras, Dept Genet, Madras, Tamil Nadu, India; [Raghunathan, Raghavachary] Univ Madras, Dept Organ Chem, Chennai, Tamil Nadu, India	University of Tennessee System; University of Tennessee Health Science Center; University of Madras; University of Madras; University of Madras	Johnson, IM (corresponding author), St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA.	i_mariajohnson@yahoo.com; r_malathi@hotmail.com			CSIR-SRF; CSIR, New Delhi	CSIR-SRF(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	IMJ was a recipient of CSIR-SRF, and the financial support from CSIR, New Delhi, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Ahmad R, 2003, BIOPHYS J, V84, P2460, DOI 10.1016/S0006-3495(03)75050-4; Bedner E, 2001, CYTOMETRY, V43, P38, DOI 10.1002/1097-0320(20010101)43:1<38::AID-CYTO1017>3.0.CO;2-S; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Bravo-Cuellar A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-114; CAKE MH, 1978, EUR J BIOCHEM, V82, P97, DOI 10.1111/j.1432-1033.1978.tb12000.x; Charak S, 2012, INT J BIOL MACROMOL, V51, P406, DOI 10.1016/j.ijbiomac.2012.06.012; Chou CC, 2003, AM J VET RES, V64, P216, DOI 10.2460/ajvr.2003.64.216; Davies DB, 2001, EUR BIOPHYS J BIOPHY, V30, P354, DOI 10.1007/s002490100150; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Fredholm BB, 1999, PHARMACOL REV, V51, P83; FRITZSCHE H, 1980, BIOPHYS CHEM, V11, P109, DOI 10.1016/0301-4622(80)85013-7; FRITZSCHE H, 1980, BIOPHYS CHEM, V11, P121, DOI 10.1016/0301-4622(80)85014-9; Froehlich E, 2012, BIOMACROMOLECULES, V13, P282, DOI 10.1021/bm2016515; Gonzalez-Bosquet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014522; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043792; Johnson IM, 2005, ANAL BIOCHEM, V339, P179, DOI 10.1016/j.ab.2004.09.032; Johnson IM, 2003, J BIOMOL STRUCT DYN, V20, P687, DOI 10.1080/07391102.2003.10506885; Johnson IM, 2003, J BIOMOL STRUCT DYN, V20, P677, DOI 10.1080/07391102.2003.10506884; Johnson RM, 2009, CLIN CHIM ACTA, V400, P74, DOI 10.1016/j.cca.2008.10.006; Kakuyama A, 2001, CURR DRUG METAB, V2, P379, DOI 10.2174/1389200013338270; Kawano Y, 2012, BIOL PHARM BULL, V35, P400, DOI 10.1248/bpb.35.400; Khandelwal G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012433; Kleinstiver BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023804; Kwong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043994; Lee TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042051; Li FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029664; Lyles MB, 2002, CELL BIOL INT, V26, P145, DOI 10.1006/cbir.2001.0810; Lyles MB, 2001, J MED CHEM, V44, P4650, DOI 10.1021/jm9904708; Lyles MB, 2002, BIOPHYS CHEM, V96, P53, DOI 10.1016/S0301-4622(02)00036-4; Nafisi S, 2008, J MOL STRUCT, V875, P392, DOI 10.1016/j.molstruc.2007.05.010; Natarajan G, 1996, ANAL BIOCHEM, V237, P152, DOI 10.1006/abio.1996.0216; Nunnari G, 2005, VIROLOGY, V335, P177, DOI 10.1016/j.virol.2005.02.015; Ouameur AA, 2003, J BIOMOL STRUCT DYN, V20, P561, DOI 10.1080/07391102.2003.10506872; Sabisz M, 2008, CURR PHARM BIOTECHNO, V9, P325, DOI 10.2174/138920108785161497; SADZUKA Y, 1995, JPN J CANCER RES, V86, P594, DOI 10.1111/j.1349-7006.1995.tb02439.x; SADZUKA Y, 1995, BIOL PHARM BULL, V18, P159; SELBY CP, 1990, P NATL ACAD SCI USA, V87, P3522, DOI 10.1073/pnas.87.9.3522; Sinn B, 2010, MOL CANCER THER, V9, P480, DOI 10.1158/1535-7163.MCT-09-0498; TRAGANOS F, 1991, CANCER RES, V51, P3682; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043872; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020	42	23	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50019	10.1371/journal.pone.0050019	http://dx.doi.org/10.1371/journal.pone.0050019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236361	gold, Green Submitted, Green Published			2022-12-25	WOS:000312064100011
J	Leng, RX; Wang, W; Cen, H; Zhou, M; Feng, CC; Zhu, Y; Yang, XK; Yang, M; Zhai, Y; Li, BZ; Wang, XS; Li, R; Chen, GM; Chen, H; Pan, HF; Ye, DQ				Leng, Rui-Xue; Wang, Wei; Cen, Han; Zhou, Mo; Feng, Chen-Chen; Zhu, Yan; Yang, Xiao-Ke; Yang, Mei; Zhai, Yu; Li, Bao-Zhu; Wang, Xiao-Song; Li, Rui; Chen, Gui-Mei; Chen, Hong; Pan, Hai-Feng; Ye, Dong-Qing			Gene-Gene and Gene-Sex Epistatic Interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in Systemic Lupus Erythematosus	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; SUSCEPTIBILITY LOCI; AUTOIMMUNE-DISEASE; REVISED CRITERIA; ASSOCIATION; DIFFERENTIATION; CLASSIFICATION; POPULATION; TNFAIP3; CELLS	Several confirmed genetic susceptibility loci involved in the interferon signaling and Th17/B cell response for SLE in Chinese Han populations have been described. Available data also indicate that sex-specific genetic differences contribute to SLE susceptibility. The aim of this study was to test for gene-gene/gene-sex epistasis (interactions) in these known lupus susceptibility loci. Six single-nucleotide polymorphisms (SNPs) in MiR146a, IRF5, IKZF1, ETS1 and IL21 were genotyped by Sequenom MassArray system. A total of 1,825 subjects (858 SLE patients and 967 controls) were included in the final analysis. Epistasis was tested by additive model, multiplicative model and multifactor dimensionality reduction (MDR) method. Additive interaction analysis revealed interactions between IRF5 and IKZF1 (OR 2.26, 95% CI 1.48-3.44 [P = 1.21x10(4)]). A similar tendency was also observed between IL21 and ETS1 by parametric methods. In addition, multiple high dimensional gene-gene or gene-sex interactions (three-and four-way) were identified by MDR analysis. Our study identified novel gene-gene/gene-sex interactions in lupus. Furthermore, these findings highlight sex, interferon pathway, and Th17/B cells as important contributors to the pathogenesis of SLE.	[Leng, Rui-Xue; Wang, Wei; Cen, Han; Zhou, Mo; Feng, Chen-Chen; Zhu, Yan; Yang, Xiao-Ke; Yang, Mei; Zhai, Yu; Li, Bao-Zhu; Wang, Xiao-Song; Li, Rui; Chen, Gui-Mei; Chen, Hong; Pan, Hai-Feng; Ye, Dong-Qing] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Leng, Rui-Xue; Wang, Wei; Cen, Han; Zhou, Mo; Feng, Chen-Chen; Zhu, Yan; Yang, Xiao-Ke; Yang, Mei; Zhai, Yu; Li, Bao-Zhu; Wang, Xiao-Song; Li, Rui; Chen, Gui-Mei; Chen, Hong; Pan, Hai-Feng; Ye, Dong-Qing] Anhui Med Univ, Anhui Prov Lab Populat Hlth & Major Dis Screening, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Ye, DQ (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.	ydq@ahmu.edu.cn	Li, Bao-Zhu/GLU-3542-2022	Pan, Hai-Feng/0000-0001-6814-1553; Pan, Hai-Feng/0000-0001-8218-5747	National Natural Science Foundation of China [81102192, 30830089]; Anhui Provincial Natural Science Foundation [11040606M183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work was supported by grants from the National Natural Science Foundation of China (81102192, 30830089) and the Anhui Provincial Natural Science Foundation (11040606M183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding L, 2012, INFLAMMATION, V35, P1781, DOI 10.1007/s10753-012-9497-7; Dolff S, 2011, ARTHRITIS RES THER, V13, pR157, DOI DOI 10.1186/AR3474; Ettinger R, 2008, ANN RHEUM DIS, V67, P83, DOI 10.1136/ard.2008.098400; Eyquem S, 2004, EUR J IMMUNOL, V34, P3187, DOI 10.1002/eji.200425352; Fang CM, 2012, GENES IMMUN, V13, P421, DOI 10.1038/gene.2012.10; Fu QO, 2011, ARTHRITIS RHEUM-US, V63, P749, DOI 10.1002/art.30193; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Han SZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001757; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hu SJ, 2013, MOD RHEUMATOL, V23, P205, DOI 10.1007/s10165-012-0706-x; Hughes T, 2012, ANN RHEUM DIS, V71, P694, DOI 10.1136/annrheumdis-2011-200385; Hughes T, 2012, ARTHRITIS RHEUM-US, V64, P485, DOI 10.1002/art.33354; Hughes T, 2011, ARTHRITIS RHEUM-US, V63, P1689, DOI 10.1002/art.30320; Kariuki SN, 2008, ARTHRITIS RHEUM, V58, P2818, DOI 10.1002/art.23728; Kawasaki A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3134; Leng RX, 2011, AUTOIMMUN REV, V10, P439, DOI 10.1016/j.autrev.2011.01.007; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Motsinger Alison A., 2006, Human Genomics, V2, P318; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sawalha AH, 2008, ANN RHEUM DIS, V67, P458, DOI 10.1136/ard.2007.075424; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Su MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030694; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhou XJ, 2012, ARTHRITIS RHEUM-US, V64, P222, DOI 10.1002/art.33318	28	34	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51090	10.1371/journal.pone.0051090	http://dx.doi.org/10.1371/journal.pone.0051090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236436	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100065
J	Rateri, DL; Moorleghen, JJ; Knight, V; Balakrishnan, A; Howatt, DA; Cassis, LA; Daugherty, A				Rateri, Debra L.; Moorleghen, Jessica J.; Knight, Victoria; Balakrishnan, Anju; Howatt, Deborah A.; Cassis, Lisa A.; Daugherty, Alan			Depletion of Endothelial or Smooth Muscle Cell-Specific Angiotensin II Type 1a Receptors Does Not Influence Aortic Aneurysms or Atherosclerosis in LDL Receptor Deficient Mice	PLOS ONE			English	Article							HYPERCHOLESTEROLEMIA-INDUCED ATHEROSCLEROSIS; BONE-MARROW-TRANSPLANTATION; AMERICAN-HEART-ASSOCIATION; CHOLESTEROL-FED RABBITS; BLOOD-PRESSURE; VASCULAR-LESIONS; RENIN INHIBITION; SYSTEM; ATHEROGENESIS; INFUSION	Background: Whole body genetic deletion of AT1a receptors in mice uniformly reduces hypercholesterolemia and angiotensin II-(AngII) induced atherosclerosis and abdominal aortic aneurysms (AAAs). However, the role of AT1a receptor stimulation of principal cell types resident in the arterial wall remains undefined. Therefore, the aim of this study was to determine whether deletion of AT1a receptors in either endothelial cells or smooth muscle cells influences the development of atherosclerosis and AAAs. Methodology/Principal Findings: AT1a receptor floxed mice were developed in an LDL receptor -/- background. To generate endothelial or smooth muscle cell specific deficiency, AT1a receptor floxed mice were bred with mice expressing Cre under the control of either Tie2 or SM22, respectively. Groups of males and females were fed a saturated fat-enriched diet for 3 months to determine effects on atherosclerosis. Deletion of AT1a receptors in either endothelial or smooth muscle cells had no discernible effect on the size of atherosclerotic lesions. We also determined the effect of cell-specific AT1a receptor deficiency on atherosclerosis and AAAs using male mice fed a saturated fat-enriched diet and infused with AngII (1,000 ng/kg/min). Again, deletion of AT1a receptors in either endothelial or smooth muscle cells had no discernible effects on either AngII-induced atherosclerotic lesions or AAAs. Conclusions: Although previous studies have demonstrated whole body AT1a receptor deficiency diminishes atherosclerosis and AAAs, depletion of AT1a receptors in either endothelial or smooth muscle cells did not affect either of these vascular pathologies.	[Rateri, Debra L.; Moorleghen, Jessica J.; Knight, Victoria; Balakrishnan, Anju; Howatt, Deborah A.; Daugherty, Alan] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA; [Cassis, Lisa A.; Daugherty, Alan] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA	University of Kentucky; University of Kentucky	Daugherty, A (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA.	Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Institutes of Health [RO1 HL62846, HL80100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062846, P01HL080100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1 HL62846 and HL80100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG G, 1990, J CARDIOVASC PHARM, V15, pS65, DOI 10.1097/00005344-199000155-00010; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Benicky J, 2012, CELL MOL NEUROBIOL; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Chen XL, 1998, CIRC RES, V83, P952; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2005, METHODS, V36, P129, DOI 10.1016/j.ymeth.2004.11.008; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; DAUGHERTY A, 2009, J VIS EXP, V1291; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; Eto H, 2008, HYPERTENS RES, V31, P1631, DOI 10.1291/hypres.31.1631; Fukuda D, 2007, ARTERIOSCLER THROMB, V28, P72; Grafe M, 1997, CIRC RES, V81, P804; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gurley SB, 2011, CELL METAB, V13, P469, DOI 10.1016/j.cmet.2011.03.001; Henriques TA, 2004, ENDOCRINOLOGY, V145, P3866, DOI 10.1210/en.2003-1615; Henriques T, 2008, ARTERIOSCL THROM VAS, V28, P1251, DOI 10.1161/ATVBAHA.107.160382; Imanishi T, 2008, HYPERTENSION, V52, P563, DOI 10.1161/HYPERTENSIONAHA.108.111120; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Kato H, 2008, LAB INVEST, V88, P731, DOI 10.1038/labinvest.2008.42; Kim JA, 1996, BIOCHEM BIOPH RES CO, V226, P862, DOI 10.1006/bbrc.1996.1441; Kogai J, 2008, HYPERTENS RES, V31, P1791, DOI 10.1291/hypres.31.1791; KOWALA MC, 1994, ATHEROSCLEROSIS, V108, P61, DOI 10.1016/0021-9150(94)90037-X; Li J, 1999, ATHEROSCLEROSIS, V143, P315, DOI 10.1016/S0021-9150(98)00309-8; Li Z, 2004, HYPERTENSION, V44, P758, DOI 10.1161/01.HYP.0000145179.44166.0f; Lu Hong, 2007, V139, P77; Lu H, 2008, J CLIN INVEST, V118, P984, DOI 10.1172/JCI32970; Lu H, 2007, CURR DRUG TARGETS, V8, P1181, DOI 10.2174/138945007782403829; Lu H, 2012, CLIN SCI, V123, P531, DOI 10.1042/CS20120097; Lu H, 2012, BRIT J PHARMACOL, V165, P2000, DOI 10.1111/j.1476-5381.2011.01712.x; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nussberger J, 2008, HYPERTENSION, V51, P1306, DOI 10.1161/HYPERTENSIONAHA.108.110932; Poduri A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048462; Police SB, 2009, ARTERIOSCL THROM VAS, V29, P1458, DOI 10.1161/ATVBAHA.109.192658; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; SCHUH JR, 1993, J CLIN INVEST, V91, P1453, DOI 10.1172/JCI116350; Sparks MA, 2011, HYPERTENSION, V57, P577, DOI 10.1161/HYPERTENSIONAHA.110.165274; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Strawn WB, 2000, CIRCULATION, V101, P1586, DOI 10.1161/01.CIR.101.13.1586; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Uchida HA, 2011, ARTERIOSCL THROM VAS, V31, P2845, DOI 10.1161/ATVBAHA.111.234997; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; Wolfsgruber W, 2003, P NATL ACAD SCI USA, V100, P13519, DOI 10.1073/pnas.1936024100; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; Zhang X, 2012, CIRC RES, V110, pE73, DOI 10.1161/CIRCRESAHA.111.253880	58	41	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51483	10.1371/journal.pone.0051483	http://dx.doi.org/10.1371/journal.pone.0051483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236507	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100123
J	Scolz, M; Widlund, PO; Piazza, S; Bublik, DR; Reber, S; Peche, LY; Ciani, Y; Hubner, N; Isokane, M; Monte, M; Ellenberg, J; Hyman, AA; Schneider, C; Bird, AW				Scolz, Massimilano; Widlund, Per O.; Piazza, Silvano; Bublik, Debora Rosa; Reber, Simone; Peche, Leticia Y.; Ciani, Yari; Hubner, Nina; Isokane, Mayumi; Monte, Martin; Ellenberg, Jan; Hyman, Anthony A.; Schneider, Claudio; Bird, Alexander W.			GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration	PLOS ONE			English	Article							INTRINSICALLY DISORDERED PROTEINS; IN-VITRO; BAC TRANSGENEOMICS; CYCLE; DYNAMICS; APC; LOCALIZATION; ENDOCYTOSIS; METASTASIS; PATHWAYS	The regulation of cell migration is a highly complex process that is often compromised when cancer cells become metastatic. The microtubule cytoskeleton is necessary for cell migration, but how microtubules and microtubule-associated proteins regulate multiple pathways promoting cell migration remains unclear. Microtubule plus-end binding proteins (+TIPs) are emerging as important players in many cellular functions, including cell migration. Here we identify a +TIP, GTSE1, that promotes cell migration. GTSE1 accumulates at growing microtubule plus ends through interaction with the EB1+TIP. The EB1-dependent +TIP activity of GTSE1 is required for cell migration, as well as for microtubule-dependent disassembly of focal adhesions. GTSE1 protein levels determine the migratory capacity of both nontransformed and breast cancer cell lines. In breast cancers, increased GTSE1 expression correlates with invasive potential, tumor stage, and time to distant metastasis, suggesting that misregulation of GTSE1 expression could be associated with increased invasive potential.	[Widlund, Per O.; Reber, Simone; Hyman, Anthony A.; Bird, Alexander W.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Scolz, Massimilano; Piazza, Silvano; Bublik, Debora Rosa; Peche, Leticia Y.; Ciani, Yari; Monte, Martin; Schneider, Claudio] Interuniv Consortium Biotechnol, Lab Nazl, Trieste, Italy; [Hubner, Nina] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; [Isokane, Mayumi] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Schneider, Claudio] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	Max Planck Society; Utrecht University; Utrecht University Medical Center; European Molecular Biology Laboratory (EMBL); University of Udine	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	hyman@mpi-cbg.de; schneide@lncib.it; Alex.Bird@mpi-dortmund.mpg.de	Hyman, Tony/F-1923-2011; Hubner, Nina C/C-4298-2008; Widlund, Per/J-1238-2019; Ellenberg, Jan/I-4688-2014; Hyman, Anthony A/B-3917-2017	Hubner, Nina C/0000-0002-7864-2877; Widlund, Per/0000-0002-3645-0009; Ellenberg, Jan/0000-0001-5909-701X; Hyman, Anthony A/0000-0003-3664-154X; Monte, Martin/0000-0002-5068-563X; Peche, Leticia Yamila/0000-0002-1666-9433; Piazza, Silvano/0000-0002-7156-5434; Ciani, Yari/0000-0002-9635-2830	Italian Association for Cancer Research (AIRC) IG; AIRC Special Program Molecular Clinical Oncology "5 per mille"; Area Science Park; School of Molecular Biomedicine University of Trieste	Italian Association for Cancer Research (AIRC) IG; AIRC Special Program Molecular Clinical Oncology "5 per mille"; Area Science Park; School of Molecular Biomedicine University of Trieste	Work done in CS's lab at Laboratorio Nazionale The Interuniversity Consortium for Biotechnology has been supported by Italian Association for Cancer Research (AIRC) IG-2010 and AIRC Special Program Molecular Clinical Oncology "5 per mille". MS and LP were supported by fellowships from Area Science Park. YC is supported by a PhD Fellowship from the School of Molecular Biomedicine University of Trieste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Bublik DR, 2010, J BIOL CHEM, V285, P5274, DOI 10.1074/jbc.M109.045948; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Collavin L, 2000, FEBS LETT, V481, P57, DOI 10.1016/S0014-5793(00)01969-4; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fukui R, 2000, AM J PHYSIOL-CELL PH, V279, pC999, DOI 10.1152/ajpcell.2000.279.4.C999; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Gell C, 2011, METHODS MOL BIOL, V777, P15, DOI 10.1007/978-1-61779-252-6_2; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; IWASAKI T, 1995, INT J CANCER, V63, P282, DOI 10.1002/ijc.2910630223; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034456; Levasseur M, 2000, DEVELOPMENT, V127, P631; Li DM, 2011, BREAST CANCER RES TR, V128, P7, DOI 10.1007/s10549-011-1499-x; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; MASUYAMA JI, 1992, J IMMUNOL, V148, P1367; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Monte M, 2000, GENE, V254, P229, DOI 10.1016/S0378-1119(00)00260-2; Monte M, 2004, J BIOL CHEM, V279, P11744, DOI 10.1074/jbc.M311123200; Monte M, 2003, J BIOL CHEM, V278, P30356, DOI 10.1074/jbc.M302902200; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pagano A, 2012, BIOCHEM PHARMACOL, V84, P432, DOI 10.1016/j.bcp.2012.05.010; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Pfleger CM, 2000, GENE DEV, V14, P655; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; RATNER S, 1988, J IMMUNOL, V140, P583; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Schober JM, 2009, CANCER LETT, V284, P30, DOI 10.1016/j.canlet.2009.04.007; Sironi L, 2011, CYTOSKELETON, V68, P266, DOI 10.1002/cm.20510; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Tian T, 2011, ASIAN PAC J CANCER P, V12, P2039; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen YD, 2004, KENYON REV, V26, P1; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430	73	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51259	10.1371/journal.pone.0051259	http://dx.doi.org/10.1371/journal.pone.0051259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236459	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100084
J	Tebbenkamp, ATN; Crosby, KW; Siemienski, ZB; Brown, HH; Golde, TE; Borchelt, DR				Tebbenkamp, Andrew T. N.; Crosby, Keith W.; Siemienski, Zoe B.; Brown, Hilda H.; Golde, Todd E.; Borchelt, David R.			Analysis of Proteolytic Processes and Enzymatic Activities in the Generation of Huntingtin N-Terminal Fragments in an HEK293 Cell Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE INHIBITOR; FREE TG2576 MICE; MUTANT HUNTINGTIN; TRANSGENIC MICE; INTRANUCLEAR INCLUSIONS; CASPASE CLEAVAGE; REDUCES TOXICITY; CALPAIN CLEAVAGE; NEURONAL CELLS	Background: N-terminal fragments of mutant huntingtin (htt) that terminate between residues 90-115, termed cleavage product A or 1 (cp-A/1), form intracellular and intranuclear inclusion bodies in the brains of patients with Huntington's disease (HD). These fragments appear to be proteolytic products of the full-length protein. Here, we use an HEK293 cell culture model to investigate huntingtin proteolytic processing; previous studies of these cells have demonstrated cleavage of htt to cp-A/1 like htt fragments. Results: Recombinant N-terminal htt fragments, terminating at residue 171 (also referred to as cp-B/2 like), were efficiently cleaved to produce cp-A/1 whereas fragments representing endogenous caspase, calpain, and metalloproteinase cleavage products, terminating between residues 400-600, were inefficiently cleaved. Using cysteine-labeling techniques and antibody binding mapping, we localized the C-terminus of the cp-A/1 fragments produced by HEK293 cells to sequences minimally limited by cysteine 105 and an antibody epitope composed of residues 115-124. A combination of genetic and pharmacologic approaches to inhibit potential proteases, including gamma-secretase and calpain, proved ineffective in preventing production of cp-A/1. Conclusions: Our findings indicate that HEK293 cells express a protease that is capable of efficiently cleaving cp-B/2 like fragments of htt with normal or expanded glutamine repeats. For reasons that remain unclear, this protease cleaves longer htt fragments, with normal or expanded glutamine expansions, much less efficiently. The protease in HEK293 cells that is capable of generating a cp-A/1 like htt fragment may be a novel protease with a high preference for a cp-B/2-like htt fragment as substrate.	[Tebbenkamp, Andrew T. N.; Crosby, Keith W.; Siemienski, Zoe B.; Brown, Hilda H.; Golde, Todd E.; Borchelt, David R.] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32610 USA; [Tebbenkamp, Andrew T. N.; Crosby, Keith W.; Siemienski, Zoe B.; Brown, Hilda H.; Borchelt, David R.] Univ Florida, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32610 USA.	borchelt@mbi.ufl.edu		Tebbenkamp, Andrew/0000-0002-9015-3427	Coalition for a Cure; Huntington's Disease Society of America; SantaFe HealthCare Alzheimer's Disease Research Center	Coalition for a Cure; Huntington's Disease Society of America; SantaFe HealthCare Alzheimer's Disease Research Center	This work was supported by the Coalition for a Cure; Huntington's Disease Society of America, and the SantaFe HealthCare Alzheimer's Disease Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Dev KK, 2006, EUR J PHARMACOL, V540, P10, DOI 10.1016/j.ejphar.2006.04.011; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fauq AH, 2007, BIOORG MED CHEM LETT, V17, P6392, DOI 10.1016/j.bmcl.2007.07.062; Fortun J, 2007, NEUROBIOL DIS, V25, P252, DOI 10.1016/j.nbd.2006.09.018; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Goffredo D, 2005, PHARMACOL RES, V52, P140, DOI 10.1016/j.phrs.2005.01.006; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Inagaki R, 2008, EUR J NEUROSCI, V28, P30, DOI 10.1111/j.1460-9568.2008.06323.x; Kegel KB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-58; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lanz TA, 2005, J PHARMACOL EXP THER, V312, P399, DOI 10.1124/jpet.104.073965; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Meyer SL, 1996, BIOCHEM J, V314, P511, DOI 10.1042/bj3140511; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Sadasivan S, 2006, APOPTOSIS, V11, P1573, DOI 10.1007/s10495-006-7690-6; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P2770, DOI 10.1093/hmg/ddr176; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278	49	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50750	10.1371/journal.pone.0050750	http://dx.doi.org/10.1371/journal.pone.0050750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236391	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100033
J	Angeletti, D; Albrecht, L; Blomqvist, K; Quintana, MD; Akhter, T; Bachle, SM; Sawyer, A; Sandalova, T; Achour, A; Wahlgren, M; Moll, K				Angeletti, Davide; Albrecht, Letusa; Blomqvist, Karin; del Pilar Quintana, Maria; Akhter, Tahmina; Bachle, Susanna M.; Sawyer, Alan; Sandalova, Tatyana; Achour, Adnane; Wahlgren, Mats; Moll, Kirsten			Plasmodium falciparum Rosetting Epitopes Converge in the SD3-Loop of PfEMP1-DBL1 alpha	PLOS ONE			English	Article							VAR GENE-TRANSCRIPTION; STRUCTURAL BASIS; INFECTED ERYTHROCYTES; ANTIGENIC VARIATION; RECEPTOR-BINDING; VARIANT ANTIGEN; IN-VIVO; MALARIA; PROTEIN; PFEMP1	The ability of Plasmodium falciparum parasitized RBC (pRBC) to form rosettes with normal RBC is linked to the virulence of the parasite and RBC polymorphisms that weaken rosetting confer protection against severe malaria. The adhesin PfEMP1 mediates the binding and specific antibodies prevent sequestration in the micro-vasculature, as seen in animal models. Here we demonstrate that epitopes targeted by rosette disrupting antibodies converge in the loop of subdomain 3 (SD3) which connects the h6 and h7 alpha-helices of PfEMP1-DBL1 alpha. Both monoclonal antibodies and polyclonal IgG, that bound to epitopes in the SD3-loop, stained the surface of pRBC, disrupted rosettes and blocked direct binding of recombinant NTS-DBL1 alpha to RBC. Depletion of polyclonal IgG raised to NTS-DBL1 alpha on a SD3 loop-peptide removed the anti-rosetting activity. Immunizations with recombinant subdomain 1 (SD1), subdomain 2 (SD2) or SD3 all generated antibodies reacting with the pRBC-surface but only the sera of animals immunized with SD3 disrupted rosettes. SD3-sequences were found to segregate phylogenetically into two groups (A/B). Group A included rosetting sequences that were associated with two cysteine-residues present in the SD2-domain while group B included those with three or more cysteines. Our results suggest that the SD3 loop of PfEMP1-DBL1 alpha is an important target of anti-rosetting activity, clarifying the molecular basis of the development of variant-specific rosette disrupting antibodies.	[Angeletti, Davide; Albrecht, Letusa; Blomqvist, Karin; del Pilar Quintana, Maria; Akhter, Tahmina; Wahlgren, Mats; Moll, Kirsten] Karolinska Inst, Dept Microbiol Tumor & Cellbiol MTC, Stockholm, Sweden; [del Pilar Quintana, Maria] Univ Rosario, Fac Ciencias Nat & Matemat, Escuela Med & Ciencias Salud, Bogota, Colombia; [Bachle, Susanna M.; Sandalova, Tatyana; Achour, Adnane] Karolinska Inst, Huddinge Hosp, Dept Med, Ctr Infect Med, S-10401 Stockholm, Sweden; [Sawyer, Alan] EMBL Monoclonal Antibodies Core Facil, Monterotondo, RM, Italy	Karolinska Institutet; Universidad del Rosario; Karolinska Institutet; European Molecular Biology Laboratory (EMBL)	Wahlgren, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cellbiol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se; kirsten.moll@ki.se	Angeletti, Davide/H-7350-2019; Albrecht, Letusa/I-1837-2012	Angeletti, Davide/0000-0002-5256-1972; Albrecht, Letusa/0000-0001-6406-2057; Sandalova, Tatyana/0000-0002-7694-6420; Sawyer, Alan/0000-0001-5942-4498; Bachle, Susanna M/0000-0002-4237-0638; Achour, Adnane/0000-0003-0432-710X; Quintana, Maria del Pilar/0000-0001-6190-3324	Swedish Research Council (VR) [VR/2012-2014/521-2011-3377]; Swedish Academy of Sciences (KVA, Soderberg foundation); Karolinska Institutet-DPA; EU Network of Excellence EviMalar	Swedish Research Council (VR)(Swedish Research Council); Swedish Academy of Sciences (KVA, Soderberg foundation); Karolinska Institutet-DPA(Karolinska Institutet); EU Network of Excellence EviMalar	This work was supported by Swedish Research Council (VR) (grant number VR/2012-2014/521-2011-3377), The Swedish Academy of Sciences (KVA, Soderberg foundation), Karolinska Institutet-DPA and the EU Network of Excellence EviMalar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; [Anonymous], 2008, METHODS MALARIA RES; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barragan A, 2000, INFECT IMMUN, V68, P2971, DOI 10.1128/IAI.68.5.2971-2975.2000; Baruch DI, 2002, P NATL ACAD SCI USA, V99, P3860, DOI 10.1073/pnas.022018399; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; FANDEUR T, 1995, J EXP MED, V181, P283, DOI 10.1084/jem.181.1.283; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Hayes CN, 2008, BIOINFORMATICS, V24, P2564, DOI 10.1093/bioinformatics/btn477; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; KAUL DK, 1991, BLOOD, V78, P812; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirchgatter K, 2002, MOL MED, V8, P16, DOI 10.1007/BF03401999; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Pinto VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017942; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Siddiqui AA, 2012, INFECT IMMUN, V80, P2920, DOI 10.1128/IAI.00206-12; Singh K, 2010, J BIOL CHEM, V285, P24855, DOI 10.1074/jbc.M110.118612; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith J D, 1995, Cell, V82, P101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor HM, 2000, MOL BIOCHEM PARASIT, V105, P13, DOI 10.1016/S0166-6851(99)00159-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Treutiger CJ, 1999, EXP PARASITOL, V93, P215, DOI 10.1006/expr.1999.4454; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	59	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50758	10.1371/journal.pone.0050758	http://dx.doi.org/10.1371/journal.pone.0050758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227205	Green Published, gold, Green Accepted			2022-12-25	WOS:000312588200064
J	Maddin, HC; Jenkins, FA; Anderson, JS				Maddin, Hillary C.; Jenkins, Farish A., Jr.; Anderson, Jason S.			The Braincase of Eocaecilia micropodia (Lissamphibia, Gymnophiona) and the Origin of Caecilians	PLOS ONE			English	Article							DERMOPHIS-MEXICANUS AMPHIBIA; PALEOZOIC ANCESTRY; LIVING AMPHIBIANS; FOSSIL RECORD; SALAMANDERS; PHYLOGENY; EVOLUTION; DISSOROPHOIDEA; TEMNOSPONDYLI; SKULL	The scant fossil record of caecilians has obscured the origin and evolution of this lissamphibian group. Eocaecilia micropodia from the Lower Jurassic of North America remains the only stem-group caecilian with an almost complete skull preserved. However, this taxon has been controversial, engendering re-evaluation of traits considered to be plesiomorphic for extant caecilians. Both the validity of the placement of E. micropodia as a stem caecilian and estimates of the plesiomorphic condition of extant caecilians have been questioned. In order to address these issues, the braincase of E. micropodia was examined via micro-computed tomography. The braincase is considered to be a more reliable phylogenetic indicator than peripheral regions of the skull. These data reveal significant new information, including the possession of an ossified nasal septum, ossified anterior wall of the sphenethmoid, long anterolateral processes on the sphenethmoid, and paired olfactory nerve foramina, which are known only to occur in extant caecilians; the latter are possibly related to the evolution of the tentacle, a caecilian autapomorphy. A phylogenetic analysis that included 64 non-amniote taxa and 308 characters represents the first extensive test of the phylogenetic affinities of E. micropodia. The results place E. micropodia securely on the stem of extant caecilians, representing a clade within Temnospondyli that is the sister taxon to batrachians plus Gerobatrachus. Ancestral character state reconstruction confirms the braincase of E. micropodia to be largely representative of the plesiomorphic condition of extant caecilians. Additionally, the results refine the context within which the evolution of the caecilian form can be evaluated. The robust construction and pattern of the dermal skull of E. micropodia is interpreted as symplesiomorphic with advanced dissorophoid temnospondyls, rather than being autapomorphic in its robust construction. Together these data increase confidence in incorporating E. micropodia into discussions of caecilian evolution.	[Maddin, Hillary C.; Jenkins, Farish A., Jr.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Maddin, Hillary C.; Jenkins, Farish A., Jr.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Maddin, Hillary C.; Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	Harvard University; Harvard University; University of Calgary	Maddin, HC (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	hmaddin@fas.harvard.edu			Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship; Natural Sciences and Engineering Research Council of Canada [327756-2011]; Directorate For Geosciences [0948842] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship to HCM and Natural Sciences and Engineering Research Council of Canada Discovery Grant to JSA (327756-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson JS, 2002, J PALEONTOL, V76, P1029, DOI 10.1666/0022-3360(2002)076<1029:ROTAGP>2.0.CO;2; BADENHORST A, 1978, Annale Universiteit van Stellenbosch Serie A II (Soologie), V1, P1; BILLO R, 1987, J MORPHOL, V192, P101, DOI 10.1002/jmor.1051920203; BOLT JR, 1969, SCIENCE, V166, P888, DOI 10.1126/science.166.3907.888; Boy Juergen A., 1995, Palaeontologische Zeitschrift, V69, P429; Cannatella DC, 2009, TIMETREE LIFE, P351; Cardini A, 2008, BIOL J LINN SOC, V93, P813, DOI 10.1111/j.1095-8312.2008.01011.x; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; CARROLL ROBERT L., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V131, P161; Duellman WE., 1994, BIOL AMPHIBIANS; ESTES R, 1972, NATURE, V239, P228, DOI 10.1038/239228b0; Evans SE, 2001, PALAEONTOLOGY, V44, P259, DOI 10.1111/1475-4983.00179; Evans SE, 1996, PALAEONTOLOGY, V39, P77; Frobisch NB, 2008, J VERTEBR PALEONTOL, V28, P1015, DOI 10.1671/0272-4634-28.4.1015; Goswami Anjali, 2010, P141; Gower DJ, 2009, TIMETREE LIFE; Haas A, 2001, J MORPHOL, V247, P1, DOI 10.1002/1097-4687(200101)247:1<1::AID-JMOR1000>3.0.CO;2-3; Hecht Max K., 1997, P95; IVAKHNENKO M F, 1978, Paleontologicheskii Zhurnal, P84; JENKINS FA, 1993, NATURE, V365, P246; Jenkins Farish A. Jr., 2007, Bulletin of the Museum of Comparative Zoology, V158, P285, DOI 10.3099/0027-4100(2007)158[285:AOEMAL]2.0.CO;2; Kleinteich T, 2012, J EXP BIOL, V215, P833, DOI 10.1242/jeb.065979; Lee MSY, 2006, MOL PHYLOGENET EVOL, V40, P635, DOI 10.1016/j.ympev.2006.03.013; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Maddin Hillary C., 2012, Fieldiana-Life and Earth Sciences, V5, P59; Maddin HC, 2012, ZOOL J LINN SOC-LOND, V166, P160, DOI 10.1111/j.1096-3642.2012.00838.x; Maddin HC, 2011, J MORPHOL, V272, P850, DOI 10.1002/jmor.10953; Maddin HC, 2010, EVOL DEV, V12, P393, DOI 10.1111/j.1525-142X.2010.00426.x; Maddison WP, 2017, MESQUITE MODULAR SYS; Maisano JA, 2006, J MORPHOL, V267, P70, DOI 10.1002/jmor.10388; Muller H, 2006, J MORPHOL, V267, P968, DOI 10.1002/jmor.10454; Norris HW, 1918, J MORPHOL, V31, P487; Nussbaum R.A., 1977, Occasional Papers of the Museum of Zoology University of Michigan, VNo. 682, P1; NUSSBAUM RA, 1983, J ZOOL, V199, P545; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; RAGE J-C, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P1; Rage J-C, 2011, GEO PAL UGANDA, V4, P1; Reiss J, 1996, J HERPETOL, V30, P27, DOI 10.2307/1564703; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; SCHMIDT A, 1990, J MORPHOL, V205, P255, DOI 10.1002/jmor.1052050303; Schoch RR, 2005, J VERTEBR PALEONTOL, V25, P502, DOI 10.1671/0272-4634(2005)025[0502:TAMFTL]2.0.CO;2; Schoch RR, 2003, EVOL DEV, V5, P314, DOI 10.1046/j.1525-142X.2003.03038.x; Sigurdsen T, 2010, J VERTEBR PALEONTOL, V30, P1360, DOI 10.1080/02724634.2010.501445; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; WAKE MH, 1982, J MORPHOL, V173, P203, DOI 10.1002/jmor.1051730208; Wake MH, 2003, AMPHIBIAN BIOL, P1911; Wake TA, 1999, QUATERNARY RES, V52, P138, DOI 10.1006/qres.1999.2046; Werner Christa, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V10, P633; Wilkinson M, 1997, BIOL REV, V72, P423, DOI 10.1017/S0006323197005069; Wilkinson M, 2006, REPROD BIOL PHYLOGEN, V5, P39; Zhang P, 2005, SYST BIOL, V54, P391, DOI 10.1080/10635150590945278; ZILLES K, 1981, Z MIKROSK ANAT FORSC, V95, P943	55	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50743	10.1371/journal.pone.0050743	http://dx.doi.org/10.1371/journal.pone.0050743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227204	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200063
J	Maneshi, M; Moeller, F; Fahoum, F; Gotman, J; Grova, C				Maneshi, Mona; Moeller, Friederike; Fahoum, Firas; Gotman, Jean; Grova, Christophe			Resting-State Connectivity of the Sustained Attention Network Correlates with Disease Duration in Idiopathic Generalized Epilepsy	PLOS ONE			English	Article							JUVENILE MYOCLONIC EPILEPSY; FUNCTIONAL CONNECTIVITY; GLOBAL SIGNAL; COGNITIVE DYSFUNCTION; COMPONENT ANALYSIS; SIMULTANEOUS EEG; WAVE DISCHARGES; HUMAN BRAIN; FMRI; PERFORMANCE	Introduction: In idiopathic generalized epilepsy (IGE), a normal electroencephalogram between generalized spike and wave (GSW) discharges is believed to reflect normal brain function. However, some studies indicate that even excluding GSW-related errors, IGE patients perform poorly on sustained attention task, the deficit being worse as a function of disease duration. We hypothesized that at least in a subset of structures which are normally involved in sustained attention, resting-state functional connectivity (FC) is different in IGE patients compared to controls and that some of the changes are related to disease duration. Method: Seeds were selected based on a sustained attention study in controls. Resting-state functional magnetic resonance imaging (fMRI) data was obtained from 14 IGE patients and 14 matched controls. After physiological noise removal, the mean time-series of each seed was used as a regressor in a general linear model to detect regions that showed correlation with the seed. In patients, duration factor was defined based on epilepsy duration. Between-group differences weighted by the duration factor were evaluated with mixed-effects model. Correlation was then evaluated in IGE patients between the FC, averaged over each significant cluster, and the duration factor. Results: Eight of 18 seeds showed significant difference in FC across groups. However, only for seeds in the medial superior frontal and precentral gyri and in the medial prefrontal area, average FC taken over significant clusters showed high correlation with the duration factor. These 3 seeds showed changes in FC respectively with the premotor and superior frontal gyrus, the dorsal premotor, and the supplementary motor area plus precentral gyrus. Conclusion: Alterations of FC in IGE patients are not limited to the frontal areas. However, as indicated by specificity analysis, patients with long history of disease show changes in FC mainly within the frontal areas. Citation: Maneshi M, Moeller F, Fahoum F, Gotman J, Grova C (2012) Resting-State Connectivity of the Sustained Attention Network Correlates with Disease Duration in Idiopathic Generalized Epilepsy. PLoS ONE 7(12): e50359. doi:10.1371/journal.pone.0050359	[Maneshi, Mona; Moeller, Friederike; Fahoum, Firas; Gotman, Jean; Grova, Christophe] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Grova, Christophe] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Moeller, Friederike] Univ Kiel, Dept Neuropediat, Kiel, Germany	McGill University; McGill University; University of Kiel	Maneshi, M (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada.	mona.maneshi@mail.mcgill.ca	Fahoum, Firas/AFJ-8624-2022	Fahoum, Firas/0000-0003-2262-5530; Grova, Christophe/0000-0003-2775-9968; Moeller, Friederike/0000-0003-2434-2825	Canadian Institutes of Health Research [MOP-38079]; Fonds de Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by grant MOP-38079 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). Dr. C. Grova was supported by a salary award from Fonds de Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Archer JS, 2006, EPILEPSIA, V47, P1487, DOI 10.1111/j.1528-1167.2006.00620.x; Ballard JC, 2001, J CLIN EXP NEUROPSYC, V23, P331, DOI 10.1076/jcen.23.3.331.1188; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Benar CG, 2003, CLIN NEUROPHYSIOL, V114, P569, DOI 10.1016/S1388-2457(02)00383-8; Berman R, 2010, EPILEPSIA, V51, P2011, DOI 10.1111/j.1528-1167.2010.02652.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenfeld H, 2003, EPILEPSIA, V44, P7, DOI 10.1046/j.1528-1157.44.s.2.2.x; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; CONNERS CK, 1985, PSYCHOPHARMACOL BULL, V21, P891; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Pascalicchio TF, 2007, EPILEPSY BEHAV, V10, P263, DOI 10.1016/j.yebeh.2006.11.012; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Killory BD, 2011, NEUROIMAGE, V56, P2209, DOI 10.1016/j.neuroimage.2011.03.036; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; KOSTOPOULOS G, 1983, BRAIN RES, V278, P207, DOI 10.1016/0006-8993(83)90239-1; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; LANSDELL H, 1964, EXP NEUROL, V9, P463, DOI 10.1016/0014-4886(64)90054-8; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Lund TE, 2001, MAGNET RESON MED, V46, P628, DOI 10.1002/mrm.1238; Lund TE, 2006, NEUROIMAGE, V29, P54, DOI 10.1016/j.neuroimage.2005.07.005; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Mattson RH, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s.2.3.x; Maxwell SE, 2003, DESIGNING EXPT ANAL, DOI DOI 10.1158/2159-8290.CD-16-0040; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; MIRSKY AF, 1965, ELECTROEN CLIN NEURO, V18, P334, DOI 10.1016/0013-4694(65)90053-2; MIRSKY AF, 1960, EXP NEUROL, V2, P75, DOI 10.1016/0014-4886(60)90049-2; Mirsky AF, 2002, NEUROPSYCHOLOGY CHIL, P141; Moeller F, 2011, EPILEPSIA, V52, P515, DOI 10.1111/j.1528-1167.2010.02938.x; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; O'Muircheartaigh J, 2011, NEUROLOGY, V76, P34, DOI 10.1212/WNL.0b013e318203e93d; Ogg RJ, 2008, MAGN RESON IMAGING, V26, P504, DOI 10.1016/j.mri.2007.09.004; Perlbarg V, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/218519; Piazzini A, 2008, EPILEPSIA, V49, P657, DOI 10.1111/j.1528-1167.2007.01482.x; Savic I, 2000, EPILEPSIA, V41, P290, DOI 10.1111/j.1528-1157.2000.tb00158.x; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017294; Srivastava G, 2005, NEUROIMAGE, V24, P50, DOI 10.1016/j.neuroimage.2004.09.041; Tae WS, 2006, KOREAN J RADIOL, V7, P162, DOI 10.3348/kjr.2006.7.3.162; Tana M G, 2010, Comput Intell Neurosci, P329213, DOI 10.1155/2010/329213; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Vlooswijk MCG, 2010, LANCET NEUROL, V9, P1018, DOI 10.1016/S1474-4422(10)70180-0; Vollmar C, 2011, BRAIN, V134, P1710, DOI 10.1093/brain/awr098; Wandschneider B, 2010, NEUROLOGY, V75, P2161, DOI 10.1212/WNL.0b013e318202010a; Wang ZG, 2011, BRAIN RES, V1374, P134, DOI 10.1016/j.brainres.2010.12.034; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Woermann FG, 1999, BRAIN, V122, P2101, DOI 10.1093/brain/122.11.2101; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	67	20	20	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50359	10.1371/journal.pone.0050359	http://dx.doi.org/10.1371/journal.pone.0050359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227168	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200029
J	Song, J; Desphande, AS; Meier, TB; Tudorascu, DL; Vergun, S; Nair, VA; Biswal, BB; Meyerand, ME; Birn, RM; Bellec, P; Prabhakaran, V				Song, Jie; Desphande, Alok S.; Meier, Timothy B.; Tudorascu, Dana L.; Vergun, Svyatoslav; Nair, Veena A.; Biswal, Bharat B.; Meyerand, Mary E.; Birn, Rasmus M.; Bellec, Pierre; Prabhakaran, Vivek			Age-Related Differences in Test-Retest Reliability in Resting-State Brain Functional Connectivity	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; GLOBAL SIGNAL REGRESSION; FMRI DATA; DEFAULT NETWORK; IMAGES; MRI; ANTICORRELATIONS; SCHIZOPHRENIA; FLUCTUATIONS; OPTIMIZATION	Resting-state functional MRI (rs-fMRI) has emerged as a powerful tool for investigating brain functional connectivity (FC). Research in recent years has focused on assessing the reliability of FC across younger subjects within and between scan-sessions. Test-retest reliability in resting-state functional connectivity (RSFC) has not yet been examined in older adults. In this study, we investigated age-related differences in reliability and stability of RSFC across scans. In addition, we examined how global signal regression (GSR) affects RSFC reliability and stability. Three separate resting-state scans from 29 younger adults (18-35 yrs) and 26 older adults (55-85 yrs) were obtained from the International Consortium for Brain Mapping (ICBM) dataset made publically available as part of the 1000 Functional Connectomes project www.nitrc.org/projects/fcon_1000.92 regions of interest (ROIs) with 5 cubic mm radius, derived from the default, cingulo-opercular, fronto-parietal and sensorimotor networks, were previously defined based on a recent study. Mean time series were extracted from each of the 92 ROIs from each scan and three matrices of z-transformed correlation coefficients were created for each subject, which were then used for evaluation of multi-scan reliability and stability. The young group showed higher reliability of RSFC than the old group with GSR (p-value = 0.028) and without GSR (p-value < 0.001). Both groups showed a high degree of multi-scan stability of RSFC and no significant differences were found between groups. By comparing the test-retest reliability of RSFC with and without GSR across scans, we found significantly higher proportion of reliable connections in both groups without GSR, but decreased stability. Our results suggest that aging is associated with reduced reliability of RSFC which itself is highly stable within-subject across scans for both groups, and that GSR reduces the overall reliability but increases the stability in both age groups and could potentially alter group differences of RSFC.	[Song, Jie; Meyerand, Mary E.] Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI USA; [Desphande, Alok S.] Univ Wisconsin Madison, Dept Elec & Comp Engn, Madison, WI USA; [Meier, Timothy B.; Prabhakaran, Vivek] Univ Wisconsin Madison, Neurosci Training Program, Madison, WI USA; [Tudorascu, Dana L.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Vergun, Svyatoslav; Meyerand, Mary E.] Univ Wisconsin Madison, Dept Med Phys, Madison, WI USA; [Nair, Veena A.; Prabhakaran, Vivek] Univ Wisconsin Madison, Dept Radiol, Madison, WI USA; [Biswal, Bharat B.] Univ Med & Dent New Jersey, Dept Radiol, Newark, NJ 07103 USA; [Birn, Rasmus M.] Univ Wisconsin Madison, Dept Psychiat, Madison, WI USA; [Bellec, Pierre] Univ Montreal, Geriatr Inst, Res Ctr, Montreal, PQ, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Wisconsin System; University of Wisconsin Madison; Universite de Montreal	Song, J (corresponding author), Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI USA.	jsong46@wisc.edu	Nair, Veena A/E-4037-2013	prabhakaran, vivek/0000-0002-1974-3125; NAIR, VEENA/0000-0002-5666-3239; Bellec, Pierre/0000-0002-9111-0699	NIH-NIMH ARRA Challenge Grant [RC1MH090912]; Pilot Grant from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR) [UW ICTR NIH/UL1RR025011]; KL2 Scholar Award; NIH [5R01AG032088]; National Research Service [T32EB011434]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB011434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH090912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	NIH-NIMH ARRA Challenge Grant; Pilot Grant from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR); KL2 Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants RC1MH090912 NIH-NIMH ARRA Challenge Grant to MEM, UW ICTR NIH/UL1RR025011 Pilot Grant from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR) and KL2 Scholar Award to VP, NIH 5R01AG032088 to BBB, and National Research Service Award T32EB011434 to SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baumgartner R, 1999, MAGN RESON IMAGING, V17, P1525, DOI 10.1016/S0730-725X(99)00101-0; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Carbonell F, 2011, BRAIN CONNECT, V1, P496, DOI 10.1089/brain.2011.0065; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chen S, 2008, BRAIN RES, V1239, P141, DOI 10.1016/j.brainres.2008.08.028; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Della-Maggiore V, 2002, NEUROIMAGE, V17, P19, DOI 10.1006/nimg.2002.1113; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Meier TB, 2012, NEUROIMAGE, V60, P601, DOI 10.1016/j.neuroimage.2011.12.052; Meltzer JA, 2009, NEUROIMAGE, V47, P745, DOI 10.1016/j.neuroimage.2009.04.089; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sampat M P, 2006, Br J Radiol, V79 Spec No 2, pS134, DOI 10.1259/bjr/96723280; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	50	61	62	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49847	10.1371/journal.pone.0049847	http://dx.doi.org/10.1371/journal.pone.0049847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227153	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200015
J	Chakrapani, V; Newman, PA; Singhal, N; Jerajani, J; Shunmugam, M				Chakrapani, Venkatesan; Newman, Peter A.; Singhal, Neeti; Jerajani, Jhalak; Shunmugam, Murali			Willingness to Participate in HIV Vaccine Trials among Men Who Have Sex with Men in Chennai and Mumbai, India: A Social Ecological Approach	PLOS ONE			English	Article							RISK; BARRIERS; PERCEPTIONS; PREVENTION; MOTIVATORS; ENROLLMENT; HIV/AIDS	Background: Recruitment of low-and middle-income country volunteers from most-at-risk populations in HIV vaccine trials is essential to vaccine development. In India, men who have sex with men (MSM) are at disproportionately high risk for HIV infection and an important population for trial recruitment. Investigations of willingness to participate (WTP) in HIV vaccine trials have focused predominantly on individual-level determinants. We explored multi-level factors associated with WTP among MSM in India. Methods: We conducted 12 focus groups (n = 68) with low socioeconomic MSM in Chennai and Mumbai, and 14 key informant interviews with MSM community leaders and service providers. Focus groups/interviews were recorded, transcribed and translated into English. Two bilingual investigators conducted thematic analysis using line-by-line coding and a constant comparative method, with member-checking by community representatives. Results: Factors associated with WTP were evidenced across the social ecology of MSM-social-structural: poverty, HIV-, sexual-and gender non-conformity stigma, institutionalized discrimination and government sponsorship of trials; community-level: endorsement by MSM community leaders and organizations, and fear of within-group discrimination; interpersonal: anticipated family discord, partner rejection, having financially-dependent family members and disclosure of same-sex sexuality; and individual-level: HIV vaccine trial knowledge and misconceptions, safety concerns, altruism and preventive misconception. Conclusion: Pervasive familial, community and social-structural factors characteristic of the Indian sociocultural context may complicate individual-focused approaches to WTP and thereby constrain the effectiveness of interventions to support recruitment and retention in HIV vaccine trials. Interventions to reduce stigma and discrimination against MSM and people living with HIV, capacity-building of MSM community organizations and transparent communications tailored to the knowledge and educational level of local communities may support meaningful engagement of MSM in HIV vaccine trials. Vigilance in providing fair but not excessive compensation and healthcare benefits and in mitigating preventive misconception are warranted to support ethical conduct of trials among MSM in India.	[Newman, Peter A.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Chakrapani, Venkatesan; Shunmugam, Murali] Ctr Sexual & Hlth Res & Policy, Chennai, Tamil Nadu, India; [Chakrapani, Venkatesan; Singhal, Neeti; Jerajani, Jhalak; Shunmugam, Murali] Humsafar Trust, Mumbai, Maharashtra, India	University of Toronto	Newman, PA (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	p.newman@utoronto.ca	Swaibu, Ramadhani A/H-3164-2011; Chakrapani, Venkatesan/P-8056-2014; Newman, Peter A/P-7056-2019	Chakrapani, Venkatesan/0000-0001-9998-9135; Newman, Peter A/0000-0003-0444-5915	Canadian Institutes of Health Research; Social Sciences and Humanities Research Council; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs program(Canada Research Chairs)	This study was funded by the Canadian Institutes of Health Research, the Social Sciences and Humanities Research Council, and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashforth A, 2005, SOC DYNAMICS, V31, P285, DOI 10.1080/02533950508628716; Burt RS, 2005, BROKERAGE CLOSURE IN; Chakrapani V, 2008, CULT HEALTH SEX, V10, P313, DOI 10.1080/13691050701816714; Chakrapani V, 2007, AIDS EDUC PREV, V19, P346, DOI 10.1521/aeap.2007.19.4.346; Dhalla S, 2011, AIDS CARE, V23, P1430, DOI 10.1080/09540121.2011.555750; Dhalla S, 2011, VACCINE, V29, P5850, DOI 10.1016/j.vaccine.2011.06.055; Downs JS, 2008, VACCINE, V26, P1595, DOI 10.1016/j.vaccine.2008.01.011; Excler JL, 2008, INDIAN J MED RES, V127, P531; Fisher CB, 2010, J EMPIR RES HUM RES, V5, P65, DOI 10.1525/jer.2010.5.2.65; Guest G., 2011, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Horowitz CR, 2009, CIRCULATION, V119, P2633, DOI 10.1161/CIRCULATIONAHA.107.729863; IMF-International Monetary Fund, 2009, WORLD EC OUTL DAT; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011, GOOD PART PRACT GUID; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Mamotte N, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-3; Mills E, 2004, AIDS, V18, P2235, DOI 10.1097/00002030-200411190-00003; Moodley K, 2002, SAMJ S AFR MED J, V92, P904; National AIDS Control Organization (NACO) Department of AIDS Control Ministry of Health and Family Welfare Government of India, ANN CMIS B 2008 09; Newman PA, 2008, SEX TRANSM INFECT, V84, P434, DOI 10.1136/sti.2008.031484; Newman PA, 2011, VACCINE, V29, P451, DOI 10.1016/j.vaccine.2010.10.076; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; Newman PA, 2006, LANCET, V367, P302, DOI 10.1016/S0140-6736(06)68067-7; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Newman PA, 2009, HEALTH EDUC BEHAV, V36, P321, DOI 10.1177/1090198107305078; Nyamathi AM, 2007, AIDS BEHAV, V11, P619, DOI 10.1007/s10461-006-9173-8; Nzioka C, 1996, AIDS CARE, V8, P565, DOI 10.1080/09540129650125524; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Sahay S, 2005, VACCINE, V23, P1351, DOI 10.1016/j.vaccine.2004.09.032; Stadler J, 2003, AIDS EDUC PREV, V15, P357, DOI 10.1521/aeap.15.5.357.23823; Streefland PH, 2003, VACCINE, V21, P1304, DOI 10.1016/S0264-410X(02)00685-0; Suhadev M, 2006, INDIAN J MED RES, V124, P631; Suhadev M, 2009, AIDS RES HUM RETROV, V25, P217, DOI 10.1089/aid.2007.0312	34	32	32	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51080	10.1371/journal.pone.0051080	http://dx.doi.org/10.1371/journal.pone.0051080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	051EQ	23226560	Green Submitted, gold, Green Published			2022-12-25	WOS:000312108500043
J	Saxena, V; Ramdas, S; Ochoa, CR; Wallace, D; Bhide, P; Kohane, I				Saxena, Vishal; Ramdas, Shweta; Ochoa, Courtney Rothrock; Wallace, David; Bhide, Pradeep; Kohane, Isaac			Structural, Genetic, and Functional Signatures of Disordered Neuro-Immunological Development in Autism Spectrum Disorder	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; EXPRESSION; ASSOCIATION; SUSCEPTIBILITY; CYTOKINE; CHILDREN; BRAIN; IDENTIFICATION; PREGNANCY; PROTEINS	Background: Numerous linkage studies have been performed in pedigrees of Autism Spectrum Disorders, and these studies point to diverse loci and etiologies of autism in different pedigrees. The underlying pattern may be identified by an integrative approach, especially since ASD is a complex disorder manifested through many loci. Method: Autism spectrum disorder (ASD) was studied through two different and independent genome-scale measurement modalities. We analyzed the results of copy number variation in autism and triangulated these with linkage studies. Results: Consistently across both genome-scale measurements, the same two molecular themes emerged: immune/chemokine pathways and developmental pathways. Conclusion: Linkage studies in aggregate do indeed share a thematic consistency, one which structural analyses recapitulate with high significance. These results also show for the first time that genomic profiling of pathways using a recombination distance metric can capture pathways that are consistent with those obtained from copy number variations (CNV).	[Saxena, Vishal; Bhide, Pradeep] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Saxena, Vishal] Massachusetts Gen Hosp, Dept Med, Charlestown, MA USA; [Saxena, Vishal; Kohane, Isaac] Harvard Univ, Sch Med, Boston, MA USA; [Saxena, Vishal; Wallace, David] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Ochoa, Courtney Rothrock] Univ S Alabama Coll, Ctr Lung Biol, Mobile, AL USA; [Saxena, Vishal; Kohane, Isaac] Childrens Hosp, Dept Endocrinol, Boston, MA 02115 USA; [Ramdas, Shweta] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan	Saxena, V (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA.	vishal@mit.edu	saxena, vishal/GRJ-5665-2022; Ramdas, Shweta/J-7712-2019	Ramdas, Shweta/0000-0001-8888-4661; Bhide, Pradeep/0000-0003-4236-9415	Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes(National Institutes of Health) [P50MH94267]; Nancy Lurie Marks Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER	Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes(National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Lurie Marks Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was funded in part by Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes(National Institutes of Health P50MH94267). ISK was supported in part by the Nancy Lurie Marks Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Barrett S, 1999, AM J MED GENET, V88, P609; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; Chung WK, 1996, GENOME RES, V6, P1192, DOI 10.1101/gr.6.12.1192; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eaves LC, 2004, J AUTISM DEV DISORD, V34, P367, DOI 10.1023/B:JADD.0000037414.33270.a8; Enstrom A, 2009, BRAIN BEHAV IMMUN, V23, P389, DOI 10.1016/j.bbi.2008.12.005; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Filipovic R, 2003, DEV NEUROSCI-BASEL, V25, P279, DOI 10.1159/000072275; Filipovic R, 2008, GLIA, V56, P1, DOI 10.1002/glia.20582; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Grigorenko EL, 2008, PEDIATRICS, V122, pE438, DOI 10.1542/peds.2007-3604; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Hintzen C, 2009, ARTHRITIS RHEUM-US, V60, P1932, DOI 10.1002/art.24602; Hohlfeld R, 2007, NEUROLOGY, V68, pS58, DOI 10.1212/01.wnl.0000275234.43506.9b; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hosking MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000937; Jyonouchi H, 2002, NEUROPSYCHOBIOLOGY, V46, P76, DOI 10.1159/000065416; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee KS, 2009, CELL MOL IMMUNOL, V6, P143, DOI 10.1038/cmi.2009.20; Ma DQ, 2009, ANN HUM GENET, V73, P263, DOI 10.1111/j.1469-1809.2009.00523.x; Manousou P, 2010, CLIN EXP IMMUNOL, V162, P337, DOI 10.1111/j.1365-2249.2010.04248.x; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nawa H, 2000, MOL PSYCHIATR, V5, P594, DOI 10.1038/sj.mp.4000730; Owczarek W, 2010, CYTOKINE, V50, P181, DOI 10.1016/j.cyto.2010.02.016; Ponzio NM, 2007, ANN NY ACAD SCI, V1107, P118, DOI 10.1196/annals.1381.013; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Saxena V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl766; Strachan T, 1999, HUM MOL GENET, V2, pxxiii; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Daalen E, 2009, EUR CHILD ADOLES PSY, V18, P663, DOI 10.1007/s00787-009-0025-8; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wilkins JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-141; Yang MS, 2007, INT J DEV NEUROSCI, V25, P69, DOI 10.1016/j.ijdevneu.2006.12.002; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	47	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e48835	10.1371/journal.pone.0048835	http://dx.doi.org/10.1371/journal.pone.0048835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23239965	Green Published, gold			2022-12-25	WOS:000312108500002
J	Tran, MN; Choi, W; Wszolek, MF; Navai, N; Lee, ILC; Nitti, G; Wen, SJ; Flores, ER; Siefker-Radtke, A; Czerniak, B; Dinney, C; Barton, M; McConkey, DJ				Tran, Mai N.; Choi, Woonyoung; Wszolek, Matthew F.; Navai, Neema; Lee, I-Ling C.; Nitti, Giovanni; Wen, Sijin; Flores, Elsa R.; Siefker-Radtke, Arlene; Czerniak, Bogdan; Dinney, Colin; Barton, Michelle; McConkey, David J.			The p63 Protein Isoform Delta Np63 alpha Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells ROLE OF MIR-205	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN KERATINOCYTES; STEM-CELLS; E-CADHERIN; UROTHELIAL NEOPLASMS; CARCINOMA-CELLS; MIR-200 FAMILY; BREAST-CANCER; HOST GENES; P-CADHERIN; IN-VIVO	Epithelial-mesenchymal transition (EMT) is a physiological process that plays important roles in tumor metastasis, "stemness," and drug resistance. EMT is typically characterized by the loss of the epithelial marker E-cadherin and increased expression of EMT-associated transcriptional repressors, including ZEB1 and ZEB2. The miR-200 family and miR-205 prevent EMT through suppression of ZEB1/2. p53 has been implicated in the regulation of miR-200c, but the mechanisms controlling miR-205 expression remain elusive. Here we report that the p53 family member and p63 isoform, Delta Np63 alpha, promotes miR-205 transcription and controls EMT in human bladder cancer cells. Delta Np63 alpha, E-cadherin and miR-205 were coexpressed in a panel of bladder cancer cell lines (n = 28) and a cohort of primary bladder tumors (n = 98). Stable knockdown of Delta Np63 alpha in the "epithelial" bladder cancer cell line UM-UC6 decreased the expression of miR-205 and induced the expression of ZEB1/2, effects that were reversed by expression of exogenous miR-205. Conversely, overexpression of Delta Np63 alpha in the "mesenchymal" bladder cancer cell line UM-UC3 induced miR-205 and suppressed ZEB1/2. Delta Np63 alpha knockdown reduced the expression of the primary and mature forms of miR-205 and the miR-205 "host" gene (miR-205HG) and decreased binding of RNA Pol II to the miR-205HG promoter, inhibiting miR-205HG transcription. Finally, high miR-205 expression was associated with adverse clinical outcomes in bladder cancer patients. Together, our data demonstrate that Delta Np63 alpha-mediated expression of miR-205 contributes to the regulation of EMT in bladder cancer cells and identify miR-205 as a molecular marker of the lethal subset of human bladder cancers.	[Dinney, Colin; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77054 USA; [Siefker-Radtke, Arlene] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77054 USA; [McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA; [Flores, Elsa R.; Barton, Michelle] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77054 USA; [Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77054 USA; [Wen, Sijin] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77054 USA; [Tran, Mai N.; Nitti, Giovanni; Flores, Elsa R.; Barton, Michelle; McConkey, David J.] Univ Texas Grad Sch Biomed Sci GSBS Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	McConkey, DJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA.	dmcconke@mdanderson.org		Barton, Michelle/0000-0002-4042-1374; Wen, Sijin/0000-0002-6955-2917; Dinney, Colin/0000-0002-8969-711X; Siefker-Radtke, Arlene/0000-0002-6328-9599	MD Anderson Bladder SPORE Grant [P50 CA91846]; Cancer Center Support Grant [P30 016672]; Vietnam Education Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA160394, R01CA151489, P50CA091846] Funding Source: NIH RePORTER	MD Anderson Bladder SPORE Grant; Cancer Center Support Grant; Vietnam Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MD Anderson Bladder SPORE Grant P50 CA91846 and Cancer Center Support Grant P30 016672.; We thank the Vietnam Education Foundation for fellowship support to Mai Tran. We also thank Dr. Santosh Chauhan (Cancer Biology Department, University of Texas M.D. Anderson Cancer Center) for technical help with the ChIP experiments and Dr. Russell Braeuer (Cancer Biology Department, University of Texas M.D. Anderson Cancer Center) for help with the nuclear run-on experiments.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Blanpain C, 2007, NAT CELL BIOL, V9, P731, DOI 10.1038/ncb0707-731; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Choi W, 2012, PLOS ONE, V7, P453, DOI 10.1371/journal.pone.0030206; Chow SE, 2011, CANCER CHEMOTH PHARM, V68, P835, DOI 10.1007/s00280-010-1552-1; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gandellini P, 2012, CELL DEATH DIFFER, V19, P1750, DOI 10.1038/cdd.2012.56; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; Johansson SL, 1997, SEMIN SURG ONCOL, V13, P291; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Koga F, 2003, BRIT J CANCER, V88, P740, DOI 10.1038/sj.bjc.6600764; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marquis L, 2012, CANCER BIOL THER, V13, P477, DOI 10.4161/cbt.19590; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piovan C, 2012, MOL ONCOL, V6, P458, DOI 10.1016/j.molonc.2012.03.003; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rieger-Christ KM, 2001, HUM PATHOL, V32, P18, DOI 10.1053/hupa.2001.21140; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Roman S, 2007, AM J PHYSIOL-GASTR L, V293, pG45, DOI 10.1152/ajpgi.00583.2006; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Tsai J. H., CANC CELL, V22, P725; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Westfall MD, 2004, CARCINOGENESIS, V25, P857, DOI 10.1093/carcin/bgh148; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yugawa T, 2010, CANCER RES, V70, P4034, DOI 10.1158/0008-5472.CAN-09-4063	55	101	102	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3275	3288		10.1074/jbc.M112.408104	http://dx.doi.org/10.1074/jbc.M112.408104			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239884	Green Published, hybrid			2022-12-25	WOS:000314397900034
J	Harleton, E; Besana, A; Comas, GM; Danilo, P; Rosen, TS; Argenziano, M; Rosen, MR; Robinson, RB; Feinmark, SJ				Harleton, Erin; Besana, Alessandra; Comas, George M.; Danilo, Peter, Jr.; Rosen, Tove S.; Argenziano, Michael; Rosen, Michael R.; Robinson, Richard B.; Feinmark, Steven J.			Ability to Induce Atrial Fibrillation in the Peri-operative Period Is Associated with Phosphorylation-dependent Inhibition of TWIK Protein-related Acid-sensitive Potassium Channel 1 (TASK-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; MYOCARDIAL-ISCHEMIA-REPERFUSION; K+ CHANNEL; VENTRICULAR-FIBRILLATION; PAF-ANTAGONIST; ARRHYTHMIAS; REPOLARIZATION; INFLAMMATION; NEUTROPHILS; PERFUSION	Peri-operative atrial fibrillation (peri-op AF) is a common complication following thoracic surgery. This arrhythmia is thought to be triggered by an inflammatory response and can be reproduced in various animal models. Previous work has shown that the lipid inflammatory mediator, platelet-activating factor (PAF), synthesized by activated neutrophils, can induce atrial and ventricular arrhythmias as well as repolarization abnormalities in isolated ventricular myocytes. We have previously shown that carbamylated PAF-induced repolarization abnormalities result from the protein kinase C (PKC) epsilon-dependent phosphorylation of the two-pore domain potassium channel TASK-1. We now demonstrate that canine peri-op AF is associated with the phosphorylation-dependent loss of TASK-1 current. Further studies identified threonine 383 in the C terminus of human and canine TASK-1 as the phosphorylation site required for PAF-dependent inhibition of the channel. Using a novel phosphorylation site-specific antibody targeting the phosphorylated channel, we have determined that peri-op AF is associated with the loss of TASK-1 current and increased phosphorylation of TASK-1 at this site.	[Harleton, Erin; Besana, Alessandra; Danilo, Peter, Jr.; Rosen, Michael R.; Robinson, Richard B.; Feinmark, Steven J.] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY 10032 USA; [Comas, George M.; Argenziano, Michael] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Rosen, Tove S.; Rosen, Michael R.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Rosen, Michael R.; Robinson, Richard B.; Feinmark, Steven J.] Columbia Univ, Med Ctr, Ctr Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Feinmark, SJ (corresponding author), Columbia Univ, Med Ctr, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	sjf1@columbia.edu			National Institutes of Health from NHLBI [R01 HL70105, HL67101]; National Center for Advancing Translational Sciences [TL1 TR000082]; PhRMA Foundation; Institut de Recherches Servier; Thoracic Surgery Foundation for Research and Education;  [TL1 RR024158]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070105, R01HL067101] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); PhRMA Foundation; Institut de Recherches Servier; Thoracic Surgery Foundation for Research and Education; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL70105 (to S. J. F.) and HL67101 (to M. R. R.) from NHLBI and Grant TL1 TR000082 from National Center for Advancing Translational Sciences (formerly NCRR) and Grant TL1 RR024158. This work was also supported by grants from the PhRMA Foundation, Institut de Recherches Servier, and a career development award from the Thoracic Surgery Foundation for Research and Education (to M. A.).	Baker KE, 2006, BRIT J PHARMACOL, V149, P269, DOI 10.1038/sj.bjp.0706846; Baker KE, 1999, J CARDIOVASC PHARM, V34, P394, DOI 10.1097/00005344-199909000-00012; Baker KE, 2004, BRIT J PHARMACOL, V142, P352, DOI 10.1038/sj.bjp.0705767; Baker WL, 2007, ANN PHARMACOTHER, V41, P587, DOI 10.1345/aph.1H594; Barbuti A, 2002, AM J PHYSIOL-HEART C, V282, pH2024, DOI 10.1152/ajpheart.00956.2001; Besana A, 2004, J BIOL CHEM, V279, P33154, DOI 10.1074/jbc.M403525200; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; CHAKRABARTY S, 1992, BRIT J PHARMACOL, V107, P705, DOI 10.1111/j.1476-5381.1992.tb14510.x; Decher N, 2011, CELL PHYSIOL BIOCHEM, V28, P77, DOI 10.1159/000331715; Dhein S, 1995, CARDIOVASC RES, V30, P881, DOI 10.1016/S0008-6363(95)00131-X; Donner BC, 2011, BASIC RES CARDIOL, V106, P75, DOI 10.1007/s00395-010-0128-x; Ehrlich JR, 2005, CARDIOVASC RES, V67, P520, DOI 10.1016/j.cardiores.2005.03.007; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; FLORES NA, 1990, BRIT J PHARMACOL, V101, P734, DOI 10.1111/j.1476-5381.1990.tb14149.x; FREEMAN LC, 1990, AM J VET RES, V51, P174; Gaspo R, 1999, CARDIOVASC RES, V42, P434, DOI 10.1016/S0008-6363(99)00036-X; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Hoffman BF, 1997, J CARDIOVASC ELECTR, V8, P679, DOI 10.1111/j.1540-8167.1997.tb01831.x; Hoffman BF, 1996, J CARDIOVASC ELECTR, V7, P120, DOI 10.1111/j.1540-8167.1996.tb00507.x; Hogue CW, 2005, CHEST, V128, p9S, DOI 10.1378/chest.128.2_suppl.9S; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii Y, 2005, CIRCULATION, V111, P2881, DOI 10.1161/CIRCULATIONAHA.104.475194; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Limberg SH, 2011, CELL PHYSIOL BIOCHEM, V28, P613, DOI 10.1159/000335757; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Montrucchio G, 2000, PHYSIOL REV, V80, P1669, DOI 10.1152/physrev.2000.80.4.1669; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Nattel S, 2009, J PHYSIOL-LONDON, V587, P1385, DOI 10.1113/jphysiol.2009.170621; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Putzke C, 2007, CARDIOVASC RES, V75, P59, DOI 10.1016/j.cardiores.2007.02.025; Qayumi AK, 1998, ANN THORAC SURG, V65, P1690, DOI 10.1016/S0003-4975(98)00275-6; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; Stangl V, 2002, CARDIOVASC RES, V53, P12, DOI 10.1016/S0008-6363(01)00420-5	36	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2829	2838		10.1074/jbc.M112.404095	http://dx.doi.org/10.1074/jbc.M112.404095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229553	Green Published, hybrid			2022-12-25	WOS:000314211500065
J	Shenkman, M; Groisman, B; Ron, E; Avezov, E; Hendershot, LM; Lederkremer, GZ				Shenkman, Marina; Groisman, Bella; Ron, Efrat; Avezov, Edward; Hendershot, Linda M.; Lederkremer, Gerardo Z.			A Shared Endoplasmic Reticulum-associated Degradation Pathway Involving the EDEM1 Protein for Glycosylated and Nonglycosylated Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE COMPLEX; MANNOSIDASE-LIKE PROTEIN; QUALITY-CONTROL; MISFOLDED PROTEINS; LIGHT-CHAINS; DISULFIDE REDUCTASE; HEAVY-CHAIN; IN-VIVO; RETENTION	Studies of misfolded protein targeting to endoplasmic reticulum-associated degradation (ERAD) have largely focused on glycoproteins, which include the bulk of the secretory proteins. Mechanisms of targeting of nonglycosylated proteins are less clear. Here, we studied three nonglycosylated proteins and analyzed their use of known glycoprotein quality control and ERAD components. Similar to an established glycosylated ERAD substrate, the uncleaved precursor of asialoglycoprotein receptor H2a, its nonglycosylated mutant, makes use of calnexin, EDEM1, and HRD1, but only glycosylated H2a is a substrate for the cytosolic SCFFbs2 E3 ubiquitin ligase with lectin activity. Two nonglycosylated BiP substrates, NS-1 kappa light chain and truncated Ig gamma heavy chain, interact with the ERAD complex lectins OS-9 and XTP3-B and require EDEM1 for degradation. EDEM1 associates through a region outside of its mannosidase-like domain with the nonglycosylated proteins. Similar to glycosylated substrates, proteasomal inhibition induced accumulation of the nonglycosylated proteins and ERAD machinery in the endoplasmic reticulum-derived quality control compartment. Our results suggest a shared ERAD pathway for glycosylated and nonglycosylated proteins composed of luminal lectin machinery components also capable of protein-protein interactions.	[Shenkman, Marina; Groisman, Bella; Ron, Efrat; Avezov, Edward; Lederkremer, Gerardo Z.] Tel Aviv Univ, George Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	Tel Aviv University; St Jude Children's Research Hospital	Lederkremer, GZ (corresponding author), Tel Aviv Univ, George Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gerardo@post.tau.ac.il	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Lederkremer, Gerardo/0000-0002-9857-7152; Avezov, Edward/0000-0002-2894-0585	Israel Science Foundation [1070/10]; German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation) [K 5-1]	Israel Science Foundation(Israel Science Foundation); German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation)	This work was supported in part by Grant 1070/10 from the Israel Science Foundation and German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation K 5-1).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Benyair R, 2011, WORLD J GASTROENTERO, V17, P5305, DOI 10.3748/wjg.v17.i48.5305; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Frenkel Z, 2004, MOL BIOL CELL, V15, P2133, DOI 10.1091/mbc.E03-12-0899; Groisman B, 2006, ISRAEL J CHEM, V46, P189, DOI 10.1560/2QPD-9WP9-NCYK-58X3; Groisman B, 2011, J BIOL CHEM, V286, P1292, DOI 10.1074/jbc.M110.154849; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Izawa T, 2012, MOL BIOL CELL, V23, P1283, DOI 10.1091/mbc.E11-08-0722; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Jakob CA, 2001, EMBO REP, V2, P423; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; MA J, 1990, MOL IMMUNOL, V27, P623, DOI 10.1016/0161-5890(90)90004-J; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Marin MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042998; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Shenkman M, 1997, P NATL ACAD SCI USA, V94, P11363, DOI 10.1073/pnas.94.21.11363; Shenkman M, 2000, J BIOL CHEM, V275, P2845, DOI 10.1074/jbc.275.4.2845; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Tamura T, 2011, J BIOL CHEM, V286, P24906, DOI 10.1074/jbc.M111.243998; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Yamaguchi Y, 2007, BIOCHEM BIOPH RES CO, V362, P712, DOI 10.1016/j.bbrc.2007.08.056; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, 2005, EMBO REP, V6, P239, DOI 10.1038/sj.embor.7400351	53	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2167	2178		10.1074/jbc.M112.438275	http://dx.doi.org/10.1074/jbc.M112.438275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233672	hybrid, Green Published			2022-12-25	WOS:000314211500007
J	Hoekzema, E; Carmona, S; Ramos-Quiroga, JA; Fernandez, VR; Picado, M; Bosch, R; Soliva, JC; Rovira, M; Vives, Y; Bulbena, A; Tobena, A; Casas, M; Vilarroya, O				Hoekzema, Elseline; Carmona, Susana; Antoni Ramos-Quiroga, J.; Richarte Fernandez, Vanesa; Picado, Marisol; Bosch, Rosa; Carlos Soliva, Juan; Rovira, Mariana; Vives, Yolanda; Bulbena, Antonio; Tobena, Adolf; Casas, Miguel; Vilarroya, Oscar			Laminar Thickness Alterations in the Fronto-Parietal Cortical Mantle of Patients with Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; AUTOMATED 3-D EXTRACTION; NEURAL MECHANISMS; VISUAL-ATTENTION; MATTER DEFICITS; CEREBRAL-CORTEX; FOLLOW-UP; CHILDREN; ADULTS; BRAIN	Although Attention-Deficit/Hyperactivity Disorder (ADHD) was initially regarded as a disorder exclusive to childhood, nowadays its prevalence in adulthood is well established. The development of novel techniques for quantifying the thickness of the cerebral mantle allows the further exploration of the neuroanatomical profiles underlying the child and adult form of the disorder. To examine the cortical mantle in children and adults with ADHD, we applied a vertex-wise analysis of cortical thickness to anatomical brain MRI scans acquired from children with (n = 43) and without ADHD (n = 41), as well as a group of adult neurotypical individuals (n = 31), adult patients with a history of stimulant treatment (n = 31) and medication-naive adults with ADHD (n = 24). We observed several clusters of reduced laminar cortical thickness in ADHD patients in comparison to neurotypical individuals. These differences were primarily located in the dorsal attention network, including the bilateral inferior and superior parietal cortex and a section of the frontal cortex (centered on the superior frontal and precentral gyrus bilaterally). Further laminar thickness deficits were observed in the bilateral orbitofrontal cortex and medial occipital cortex. The deficits in the cortical surface were especially pronounced in the child sample, while adult patients showed a more typical laminar thickness across the cerebral mantle. These findings show that the neuroanatomical profile of ADHD, especially the childhood form of the disorder, involves robust alterations in the cortical mantle, which are most prominent in brain regions subserving attentional processing. Citation: Hoekzema E, Carmona S, Ramos-Quiroga JA, Fernandez VR, Picado M, et al. (2012) Laminar Thickness Alterations in the Fronto-Parietal Cortical Mantle of Patients with Attention-Deficit/Hyperactivity Disorder. PLoS ONE 7(12): e48286. doi:10.1371/journal.pone.0048286	[Hoekzema, Elseline; Carmona, Susana; Picado, Marisol; Carlos Soliva, Juan; Tobena, Adolf; Vilarroya, Oscar] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Unitat Recerca Neurociencia Cognit, Bellaterra, Barcelona, Spain; [Hoekzema, Elseline; Carmona, Susana; Picado, Marisol; Carlos Soliva, Juan; Vilarroya, Oscar] Fundacio IMIM, Grp Recerca Neuroimatge, Barcelona, Spain; [Carmona, Susana] Harvard Univ, Harvard Social Cognit & Affect Neurosci Lab, Cambridge, MA 02138 USA; [Antoni Ramos-Quiroga, J.; Richarte Fernandez, Vanesa; Bosch, Rosa; Casas, Miguel] Hosp Univ Vall dHebron, CIBERSAM, Dept Psychiat, Barcelona, Spain; [Rovira, Mariana] CRC Corp Sanitaria, Barcelona, Spain; [Vives, Yolanda] Univ Autonoma Barcelona, IFAE, Inst Fis Altes Energies, Bellaterra, Barcelona, Spain; [Bulbena, Antonio] Hosp Mar, Inst Neuropsiquiat & Adicc, Barcelona, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Harvard University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Hoekzema, E (corresponding author), Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Unitat Recerca Neurociencia Cognit, Bellaterra, Barcelona, Spain.	hoekzema@gmail.com	tobena, adolf/G-1032-2010; Vilarroya, Oscar/AAH-3283-2021; vilarroya, oscar/K-7021-2013; Vives-Gilabert, Yolanda/ABB-7461-2021; Bulbena, Antonio/AAG-5411-2019	Vilarroya, Oscar/0000-0001-8285-5624; Bulbena, Antonio/0000-0003-2404-2478; Tobena, Adolf/0000-0001-6137-0660; Casas Brugue, Miquel/0000-0003-3496-8522; Hoekzema, Elseline/0000-0001-5814-8647; Carmona, Susanna/0000-0001-5853-6527; Ramos-Quiroga, Josep Antoni/0000-0003-1622-0350; Vives-Gilabert, Yolanda/0000-0002-3744-5893; Bosch, Rosa/0000-0002-7596-183X	Ministerio de Ciencia e Innovacion research grant from the Centro para el Desarrollo Tecnologico Industrial [SAF2009-10901]; Ministerio de Educacion y Ciencia (Spanish Government)	Ministerio de Ciencia e Innovacion research grant from the Centro para el Desarrollo Tecnologico Industrial(Ministry of Science and Innovation, Spain (MICINN)); Ministerio de Educacion y Ciencia (Spanish Government)(Spanish Government)	The authors want to thank TDAH Catalunya for their collaboration and for referring patients for their study. This work was supported by the Ministerio de Ciencia e Innovacion research grant (SAF2009-10901) from the Centro para el Desarrollo Tecnologico Industrial. EH received a PhD grant and SC a postdoctoral grant from the Ministerio de Educacion y Ciencia (Spanish Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Almeida Montes LG, 2012, J ATTEN DISORD; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Biederman J, 2011, J PSYCHIATR RES, V45, P150, DOI 10.1016/j.jpsychires.2010.06.009; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Carmona S, 2011, HUM BRAIN MAPP; Carmona S, 2009, BIOL PSYCHIAT, V66, P972, DOI 10.1016/j.biopsych.2009.05.013; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Duerden EG, 2012, BRAIN RES, V1445, P82, DOI 10.1016/j.brainres.2012.01.034; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hoekzema E, 2012, BRAIN STRUC IN PRESS; Hoekzema E, 2012, INDEPENDENT IN PRESS; Hoekzema E, 2011, HUM BRAIN MAPP, V32, P1741, DOI 10.1002/hbm.21143; Hoekzema E, 2010, HUM BRAIN MAPP, V31, P1942, DOI 10.1002/hbm.20988; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; Konrad K, 2005, NEUROIMAGE, V28, P429, DOI 10.1016/j.neuroimage.2005.06.065; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Narr KL, 2009, J AM ACAD CHILD PSY, V48, P1014, DOI 10.1097/CHI.0b013e3181b395c0; Overmeyer S, 2001, PSYCHOL MED, V31, P1425, DOI 10.1017/S0033291701004706; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Sasayama D, 2010, PSYCHIAT CLIN NEUROS, V64, P394, DOI 10.1111/j.1440-1819.2010.02102.x; Seidman LJ, 2006, BIOL PSYCHIAT, V60, P1071, DOI 10.1016/j.biopsych.2006.04.031; Seidman LJ, 2011, BIOL PSYCHIAT, V69, P857, DOI 10.1016/j.biopsych.2010.09.053; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2007, ARCH GEN PSYCHIAT, V64, P921, DOI 10.1001/archpsyc.64.8.921; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Shaw P, 2009, ARCH GEN PSYCHIAT, V66, P888, DOI 10.1001/archgenpsychiatry.2009.103; Shaw P, 2009, AM J PSYCHIAT, V166, P58, DOI 10.1176/appi.ajp.2008.08050781; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tremols V, 2008, PSYCHIAT RES-NEUROIM, V163, P270, DOI 10.1016/j.pscychresns.2007.04.017; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; Wolosin SM, 2009, HUM BRAIN MAPP, V30, P175, DOI 10.1002/hbm.20496	51	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e48286	10.1371/journal.pone.0048286	http://dx.doi.org/10.1371/journal.pone.0048286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239964	gold, Green Published			2022-12-25	WOS:000312290800003
J	Kim, JM; Stewart, R; Park, MS; Kang, HJ; Kim, SW; Shin, IS; Kim, HR; Shin, MG; Cho, KH; Yoon, JS				Kim, Jae-Min; Stewart, Robert; Park, Man-Seok; Kang, Hee-Ju; Kim, Sung-Wan; Shin, Il-Seon; Kim, Hye-Ran; Shin, Myung-Geun; Cho, Ki-Hyun; Yoon, Jin-Sang			Associations of BDNF Genotype and Promoter Methylation with Acute and Long-Term Stroke Outcomes in an East Asian Cohort	PLOS ONE			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; FORCED ARM USE; NEUROTROPHIC FACTOR; VAL66MET POLYMORPHISM; EPIGENETIC REGULATION; MET ALLELE; RAT-BRAIN; RECOVERY; GENE; DEPRESSION	Background: Brain derived neurotrophic factor (BDNF) has been shown to play an important role in poststroke recovery. BDNF secretion is influenced by genetic and epigenetic profiles. This study aimed to investigate whether BDNF val66met polymorphism and promoter methylation status were associated with outcomes at two weeks and one year after stroke. Methods and Findings: A total of 286 patients were evaluated at the time of admission and two weeks after stroke, and 222 (78%) were followed one year later in order to evaluate consequences of stroke at both acute and chronic stages. Stroke outcomes were dichotomised into good and poor by the modified Rankin Scale. Stroke severity (National Institutes of Health Stroke Scale), physical disability (Barthel Index), and cognitive function (Mini-Mental State Examination) were measured. Associations of BDNF genotype and methylation status on stroke outcomes and assessment scale scores were investigated using logistic regression, repeated measures ANOVA and partial correlation tests. BDNF val66met polymorphism was independently associated with poor outcome at 2 weeks and at 1 year, and with worsening physical disability and cognitive function over that period. Higher BDNF promoter methylation status was independently associated with worse outcomes at 1 year, and with the worsening of physical disability and cognitive function. No significant genotype-methylation interactions were found. Conclusions: A role for BDNF in poststroke recovery was supported, and clinical utility of BDNF genetic and epigenetic profile as prognostic biomarkers and a target for drug development was suggested.	[Kim, Jae-Min; Kang, Hee-Ju; Kim, Sung-Wan; Shin, Il-Seon; Yoon, Jin-Sang] Chonnam Natl Univ, Sch Med, Dept Psychiat, Kwangju, South Korea; [Stewart, Robert] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Park, Man-Seok; Cho, Ki-Hyun] Chonnam Natl Univ, Sch Med, Dept Neurol, Kwangju, South Korea; [Kim, Hye-Ran] Chonnam Natl Univ, Sch Med, Brain Korea Project 21, Kwangju, South Korea; [Kim, Hye-Ran] Chonnam Natl Univ, Sch Med, Ctr Biomed Human Resources, Kwangju, South Korea; [Shin, Myung-Geun] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea	Chonnam National University; University of London; King's College London; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Kim, JM (corresponding author), Chonnam Natl Univ, Sch Med, Dept Psychiat, Kwangju, South Korea.	jmkim@chonnam.ac.kr	KIM, Jae-Min/S-7637-2019; Stewart, Robert/B-1667-2010	Stewart, Robert/0000-0002-4435-6397	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0087344]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0087344). The funders had no role in study desing, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Berger C, 2004, EXP NEUROL, V185, P305, DOI 10.1016/j.expneurol.2003.10.008; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; Di Lazzaro V, 2007, NEUROSCI LETT, V422, P128, DOI 10.1016/j.neulet.2007.06.001; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kim JM, 2012, J AFFECT DISORDERS, V136, P833, DOI 10.1016/j.jad.2011.09.029; Kunugi H, 2004, BIOL PSYCHIAT, V56, P376, DOI 10.1016/j.biopsych.2004.06.017; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; MAHONEY F I, 1965, Md State Med J, V14, P61; Manso H, 2012, EUR J NEUROL, V19, P1151, DOI 10.1111/j.1468-1331.2011.03625.x; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Muller HD, 2008, STROKE, V39, P1012, DOI 10.1161/STROKEAHA.107.495069; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Rickhag M, 2007, BRAIN RES, V1151, P203, DOI 10.1016/j.brainres.2007.03.005; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vilkki J, 2008, NEUROSURGERY, V63, P198, DOI 10.1227/01.NEU.0000320382.21577.8E	33	54	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51280	10.1371/journal.pone.0051280	http://dx.doi.org/10.1371/journal.pone.0051280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240009	Green Published, gold			2022-12-25	WOS:000312290800045
J	Saxena, A; Bjorkbacka, H; Strom, A; Rattik, S; Berg, KE; Gomez, MF; Fredrikson, GN; Nilsson, J; Hultgardh-Nilsson, A				Saxena, Amit; Bjorkbacka, Harry; Strom, Asa; Rattik, Sara; Berg, Katarina E.; Gomez, Maria F.; Fredrikson, Gunilla Nordin; Nilsson, Jan; Hultgardh-Nilsson, Anna			Mobilization of Regulatory T Cells in Response to Carotid Injury Does Not Influence Subsequent Neointima Formation	PLOS ONE			English	Article							VASCULAR INJURY; IMMUNE-RESPONSES; ARTERIAL INJURY; MICE; ATHEROSCLEROSIS; INVOLVEMENT; LYMPHOCYTES; DEFICIENCY	Aim: T cells have been attributed an important role in modulating repair responses following vascular injury. The aim of this study was to investigate the role of different T cell subsets in this context. Methods and Results: A non-obstructive collar was introduced to inflict carotid artery injury in mice and subsequent activation of immune cells in draining lymph nodes and spleen were studied by flow cytometry. Carotid artery injury of wild type mice was associated with mobilization of both Th1 type CD4(+)IFN gamma(+) and regulatory CD4(+)CD25(+)FoxP3(+) T cells in draining lymph nodes. Studies using FoxP3-green fluorescent protein (GFP) transgenic C57/Bl6 mice demonstrated scattered presence of regulatory T cells in the adventitial tissue of injured arteries as well as a massive emigration of regulatory T cells from the spleen in response to carotid injury. However, deletion of antigen presentation to CD4+ T cells (H2(0) mice), as well as deletion of regulatory T cells (through treatment with blocking anti-CD25 antibodies), did not affect neointima formation. Also deletion of antigen presentation to CD8(+) T cells (Tap1(0) mice) was without effect on carotid collar-induced neointima formation. Conclusion: The results demonstrate that carotid artery injury is associated with mobilization of regulatory T cells. Depletion of regulatory T cells does not, however, influence the subsequent repair processes leading to the formation of a neointima. The results also demonstrate that lack of CD8(+) T cells does not influence neointima formation in presence of functional CD4(+) T cells and B cells.	[Saxena, Amit; Bjorkbacka, Harry; Rattik, Sara; Berg, Katarina E.; Gomez, Maria F.; Fredrikson, Gunilla Nordin; Nilsson, Jan] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Strom, Asa; Hultgardh-Nilsson, Anna] Lund Univ, Dept Expt Med, Lund, Sweden; [Fredrikson, Gunilla Nordin] Malmo Univ, Dept Hlth & Soc, Malmo, Sweden	Lund University; Lund University; Malmo University	Nilsson, J (corresponding author), Lund Univ, Dept Clin Sci Malmo, Lund, Sweden.	jan.nilsson@med.lu.se	Gomez, Maria F/D-3696-2014; Björkbacka, Harry/I-7157-2019	Gomez, Maria F/0000-0001-6210-3142; Björkbacka, Harry/0000-0003-3918-0857	Swedish Heart Lung Foundation; Swedish Research Council; Albert Pahlsson Foundation; Crafoord Foundation; Magnus Bergvall Foundation; Lars Hierta Foundation; Malmo University Hospital Foundation; Swedish Society of Medicine; Thelma Zoega Foundation; Swedish Strategic research Foundation; Vascular Wall Program, Lund University	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Albert Pahlsson Foundation; Crafoord Foundation; Magnus Bergvall Foundation; Lars Hierta Foundation; Malmo University Hospital Foundation; Swedish Society of Medicine; Thelma Zoega Foundation; Swedish Strategic research Foundation(Swedish Foundation for Strategic Research); Vascular Wall Program, Lund University	This work was supported by grants from the Swedish Heart Lung Foundation, The Swedish Research Council, The Albert Pahlsson Foundation, The Crafoord Foundation, The Magnus Bergvall Foundation, The Lars Hierta Foundation, The Malmo University Hospital Foundation, The Swedish Society of Medicine, The Thelma Zoega Foundation and the Swedish Strategic research Foundation. Amit Saxena was supported by the Vascular Wall Program, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Bienvenu B, 2005, J IMMUNOL, V175, P246, DOI 10.4049/jimmunol.175.1.246; Cercek B, 1997, ATHEROSCLEROSIS, V131, P59, DOI 10.1016/S0021-9150(96)06767-6; Dimayuga P, 2002, ARTERIOSCL THROM VAS, V22, P644, DOI 10.1161/01.ATV.0000012455.62765.BF; Dimayuga PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020214; Dimayuga PC, 2010, CURR OPIN LIPIDOL, V21, P416, DOI 10.1097/MOL.0b013e32833cacbe; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Kolbus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033932; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Oguchi S, 2000, ARTERIOSCL THROM VAS, V20, P1729, DOI 10.1161/01.ATV.20.7.1729; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203; Saxena A, 2011, CARDIOVASC RES, V91, P350, DOI 10.1093/cvr/cvr075; Stroem A, 2007, CIRC RES, V101, pE83, DOI 10.1161/CIRCRESAHA.107.160705; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Xu QB, 2004, AM J PATHOL, V165, P1, DOI 10.1016/S0002-9440(10)63270-1; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922	21	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51556	10.1371/journal.pone.0051556	http://dx.doi.org/10.1371/journal.pone.0051556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240042	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800078
J	Yuan, CZ; Li, X; Yan, S; Yang, QF; Liu, XY; Kong, BH				Yuan, Cunzhong; Li, Xiao; Yan, Shi; Yang, Qifeng; Liu, Xiaoyan; Kong, Beihua			The MTDH (-470G > A) Polymorphism Is Associated with Ovarian Cancer Susceptibility	PLOS ONE			English	Article							ASTROCYTE ELEVATED GENE-1; BREAST-CANCER; GERMLINE MUTATIONS; CELL CARCINOMA; AEG-1; OVEREXPRESSION; PROGRESSION; EXPRESSION; PATHOGENESIS; METASTASIS	MTDH(metadherin), an important oncogene that is widely overexpressed in various cancers, is a potential biomarker of tumor malignancy. Variants in MTDH have been associated with susceptibility to breast cancer. However, no studies assessing MTDH gene polymorphisms and their potential relationship to ovarian cancer susceptibility have been reported. Thus, we investigated the association of MTDH (-470G>A) polymorphism with ovarian cancer development in 145 ovarian cancer patients and 254 matched control subjects, using sequence analysis. We found that the MTDH (-470G>A) polymorphism was statistically correlated with ovarian cancer risk (under the additive genetic model, GG vs. GA vs AA, P = 0.042). Compared with genotypes containing the G allele (GG and GA), the AA genotype may decrease the risk of ovarian cancer (P = 0.0198, OR = 0.33, 95% CI [0.12 similar to 0.78]). Compared with the G allele, the A allele is protective against ovarian cancer risk (P = 0.01756, OR = 0.66, 95% CI [0.46 similar to 0.93]). Furthermore, a statistically significant association between the GG and GA+AA genotypes and the clinical stage was observed (P = 0.038). These data suggest that MTDH (-470G>A) could be a useful molecular marker for assessing ovarian cancer risk and for predicting ovarian cancer patient prognosis.	[Yuan, Cunzhong; Li, Xiao; Yan, Shi; Liu, Xiaoyan; Kong, Beihua] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China; [Yuan, Cunzhong; Li, Xiao; Yan, Shi; Liu, Xiaoyan; Kong, Beihua] Shandong Univ, Qilu Hosp, Gynecol Oncol Key Lib Shandong Prov, Jinan, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Yuan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China.	yuancunzhong@126.com; kongbeihua@yahoo.com.cn	yang, qiang/GYJ-0971-2022	Yuan, Cunzhong/0000-0002-8785-2139; Li, Xiao/0000-0001-9504-605X; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81001166, 30872738]; Natural Science Foundation of Shandong Province [ZR2010HQ050]; Foundation of Shandong Public Health Department [2009Q2012]; China Postdoctoral Science Foundation [201104636, 20100471551]; Independent Innovation Foundation of Shandong University [2012TS142]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation of Shandong Public Health Department; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Independent Innovation Foundation of Shandong University	This work was supported by the National Natural Science Foundation of China (81001166, 30872738), Natural Science Foundation of Shandong Province (ZR2010HQ050), Foundation of Shandong Public Health Department (2009Q2012), China Postdoctoral Science Foundation (201104636, 20100471551), Independent Innovation Foundation of Shandong University (2012TS142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Braem MGM, 2011, BBA-REV CANCER, V1816, P132, DOI 10.1016/j.bbcan.2011.05.002; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chen W, 2010, NEOPLASMA, V57, P522, DOI 10.4149/neo_2010_06_522; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Gnosa S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-109; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Li C, 2012, HISTOPATHOLOGY, V60, P953, DOI 10.1111/j.1365-2559.2012.04182.x; Li C, 2011, INT J GYNECOL CANCER, V21, P602, DOI 10.1097/IGC.0b013e3182145561; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liu XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017582; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Ma XD, 2011, GYNECOL ONCOL, V122, P554, DOI 10.1016/j.ygyno.2011.05.031; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Meng FL, 2011, INT J GYNECOL PATHOL, V30, P145, DOI 10.1097/PGP.0b013e3181ffd2f7; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Ramus SJ, 2012, HUM MUTAT; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Song LB, 2009, J PATHOL, V219, P317, DOI 10.1002/path.2595; Srivastava J, 2012, HEPATOLOGY; Thirkettle HJ, 2009, CLIN CANCER RES, V15, P3003, DOI 10.1158/1078-0432.CCR-08-2046; Xu JB, 2011, MED ONCOL, V28, P455, DOI 10.1007/s12032-010-9475-6; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Yuan C, 2008, PROTEOMICS, V8, P2230, DOI 10.1002/pmic.200700760; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-48; Zhao Y, 2012, ONCOL REP, V27, P1520, DOI 10.3892/or.2012.1692; Zhao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029363	36	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51561	10.1371/journal.pone.0051561	http://dx.doi.org/10.1371/journal.pone.0051561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240043	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800079
J	Fernando, P; Leimgruber, P; Prasad, T; Pastorini, J				Fernando, Prithiviraj; Leimgruber, Peter; Prasad, Tharaka; Pastorini, Jennifer			Problem-Elephant Translocation: Translocating the Problem and the Elephant?	PLOS ONE			English	Article							ASIAN ELEPHANTS; AFRICAN ELEPHANTS; PROTECTED AREA; MANAGEMENT; MOVEMENTS; BEHAVIOR; SELECTION; CONFLICT	Human-elephant conflict (HEC) threatens the survival of endangered Asian elephants (Elephas maximus). Translocating "problem-elephants" is an important HEC mitigation and elephant conservation strategy across elephant range, with hundreds translocated annually. In the first comprehensive assessment of elephant translocation, we monitored 16 translocations in Sri Lanka with GPS collars. All translocated elephants were released into national parks. Two were killed within the parks where they were released, while all the others left those parks. Translocated elephants showed variable responses: "homers" returned to the capture site, "wanderers" ranged widely, and "settlers" established home ranges in new areas soon after release. Translocation caused wider propagation and intensification of HEC, and increased elephant mortality. We conclude that translocation defeats both HEC mitigation and elephant conservation goals.	[Fernando, Prithiviraj; Pastorini, Jennifer] Ctr Conservat & Res, Rajagiriya, Sri Lanka; [Leimgruber, Peter] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Prasad, Tharaka] Dept Wildlife Conservat, Battaramulla, Sri Lanka; [Pastorini, Jennifer] Univ Zurich, Inst Anthropol, Zurich, Switzerland	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Zurich	Pastorini, J (corresponding author), Ctr Conservat & Res, Rajagiriya, Sri Lanka.	jenny@aim.uzh.ch	Pastorini, Jennifer/A-9959-2012; Leimgruber, Peter/O-1304-2015; Fernando, Prithiviraj/I-8238-2012	Pastorini, Jennifer/0000-0001-5883-0208; Leimgruber, Peter/0000-0002-3682-0153; Fernando, Prithiviraj/0000-0001-6968-4189	U.S. Fish and Wildlife Service; Asian Elephant Conservation Fund; Alexander Abraham Foundation; Sidney S. Byers Charitable Trust; Eco Health Alliance; Friends of the National Zoo (FONZ); Circus Knie; Smithsonian Women's Committee; Vontobel Stiftung; PAM-WCP Project of the DWC	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Asian Elephant Conservation Fund; Alexander Abraham Foundation; Sidney S. Byers Charitable Trust; Eco Health Alliance; Friends of the National Zoo (FONZ); Circus Knie; Smithsonian Women's Committee; Vontobel Stiftung; PAM-WCP Project of the DWC	This work was funded by the U.S. Fish and Wildlife Service, Asian Elephant Conservation Fund, Alexander Abraham Foundation, Sidney S. Byers Charitable Trust, Eco Health Alliance, Friends of the National Zoo (FONZ), Circus Knie, Smithsonian Women's Committee, Vontobel Stiftung, and the PAM-WCP Project of the DWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 1986, T NE SECT WILDL SOC, V43, P64; Arivazhagan Chelliya, 2008, Gajah, V29, P11; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Banks J., 1979, Loris, V15, P113; Baskaran N, 1996, RANGING BEHAV ASIAN, V15, P41; Benson JF, 2007, J WILDLIFE MANAGE, V71, P2393, DOI 10.2193/2006-142; BOSHOFF AF, 1988, S AFR J WILDL RES, V18, P38; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Butler H, 2005, WILDLIFE RES, V32, P165, DOI 10.1071/WR04020; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; Craven S, 1998, WILDLIFE SOC B, V26, P171; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; EBERHARDT L E, 1979, Southwestern Naturalist, V24, P705, DOI 10.2307/3670543; Ekanayaka Sampath K.K., 2011, Gajah, V34, P20; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; FERNANDO P, 1997, SRI LANKA NATURE, V1, P4; Fernando P., 2011, LORIS, V25, P32; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Fernando Prithiviraj, 2011, P151; Fernando Prithiviraj, 2011, Gajah, V35, P93; Fernando Prithiviraj, 2011, Gajah, V35, P15; FRITTS SH, 1984, J WILDLIFE MANAGE, V48, P709, DOI 10.2307/3801418; Garai Marion E., 2001, Pachyderm, V31, P52; Goodrich JM, 2005, ORYX, V39, P454, DOI 10.1017/S0030605305001146; Holevinski RA, 2006, WILDLIFE SOC B, V34, P845, DOI 10.2193/0091-7648(2006)34[845:CHOTNC]2.0.CO;2; IUCN, 1998, IUCN GUID REINTR; IUCN, 2019, IUCN RED LIST THREAT; Lahiri-Choudhury D. K., 1993, Oryx, V27, P53; LEHENAFF D, 1989, CAN J ZOOL, V67, P1102; Leimgruber P, 2003, ANIM CONSERV, V6, P347, DOI 10.1017/S1367943003003421; Lenain DM, 2001, J ARID ENVIRON, V48, P205, DOI 10.1006/jare.2000.0754; Lin L, 2008, ACTA THERIOL, V53, P365, DOI 10.1007/BF03195197; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Loredo-Prendeville I, 1994, P 16 VERT PEST C; Loveridge Andrew J., 2010, P161; Massei G, 2010, WILDLIFE RES, V37, P428, DOI 10.1071/WR08179; MILLER SD, 1982, J WILDLIFE MANAGE, V46, P869, DOI 10.2307/3808219; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Niskanen L., 2003, IUCN SSC AFESG GUIDE; O'Donnell MA, 2006, WILDLIFE SOC B, V34, P366, DOI 10.2193/0091-7648(2006)34[366:DSSOLF]2.0.CO;2; Oliver GW, 1998, MAR MAMMAL SCI, V14, P245, DOI 10.1111/j.1748-7692.1998.tb00714.x; PHILLIPS JB, 1995, ANIM BEHAV, V50, P855, DOI 10.1016/0003-3472(95)80146-4; Pinter-Wollman N, 2009, BEHAVIOUR, V146, P1171, DOI 10.1163/156853909X413105; Read MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000949; Rogers L.L., 1988, P76; ROGERS LL, 1986, WILDLIFE SOC B, V14, P76; Roy Mukti, 2010, Gajah, V33, P8; Ruth TK, 1998, J WILDLIFE MANAGE, V62, P1264, DOI 10.2307/3801990; Saaban Salman, 2011, Gajah, V35, P67; Sandell M., 1989, P164; Santiapillai C., 1990, ASIAN ELEPHANT ACTIO; Shier DM, 2012, CONSERV BIOL, V26, P116, DOI 10.1111/j.1523-1739.2011.01748.x; Short J, 2009, AUSTR ANIMAL WELFARE; Slotow R., 2004, Koedoe, V47, P91; Slotow R, 2008, ELEPHANT MANAGEMENT; Stuwe M, 1998, ORYX, V32, P68, DOI 10.1046/j.1365-3008.1998.00019.x; SUKUMAR R, 1991, BIOL CONSERV, V55, P93, DOI 10.1016/0006-3207(91)90007-V; Sukumar R., 2012, FIELD KEY ELEPHANT P; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Sullivan BK, 2004, BIOL CONSERV, V117, P235, DOI 10.1016/j.biocon.2003.07.002; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x	65	48	50	7	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50917	10.1371/journal.pone.0050917	http://dx.doi.org/10.1371/journal.pone.0050917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236404	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000312064100042
J	Topel, M; Antonelli, A; Yesson, C; Eriksen, B				Topel, Mats; Antonelli, Alexandre; Yesson, Chris; Eriksen, Bente			Past Climate Change and Plant Evolution in Western North America: A Case Study in Rosaceae	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; EVENING PRIMROSES OENOTHERA; PHYLOGENY; CLASSIFICATION; DNA; PHYLOGEOGRAPHY; CONSERVATISM; SEQUENCES; HISTORY; MODELS	Species in the ivesioid clade of Potentilla (Rosaceae) are endemic to western North America, an area that underwent widespread aridification during the global temperature decrease following the Mid-Miocene Climatic Optimum. Several morphological features interpreted as adaptations to drought are found in the clade, and many species occupy extremely dry habitats. Recent phylogenetic analyses have shown that the sister group of this clade is Potentilla section Rivales, a group with distinct moist habitat preferences. This has led to the hypothesis that the ivesioids (genera Ivesia, Horkelia and Horkeliella) diversified in response to the late Tertiary aridification of western North America. We used phyloclimatic modeling and a fossil-calibrated dated phylogeny of the family Rosaceae to investigate the evolution of the ivesioid clade. We have combined occurrence-and climate data from extant species, and used ancestral state reconstruction to model past climate preferences. These models have been projected into paleo-climatic scenarios in order to identify areas where the ivesioids may have occurred. Our analysis suggests a split between the ivesioids and Potentilla sect. Rivales around Late Oligocene/Early Miocene (similar to 23 million years ago, Ma), and that the ivesioids then diversified at a time when summer drought started to appear in the region. The clade is inferred to have originated on the western slopes of the Rocky Mountains from where a westward range expansion to the Sierra Nevada and the coast of California took place between similar to 12-2 Ma. Our results support the idea that climatic changes in southwestern North America have played an important role in the evolution of the local flora, by means of in situ adaptation followed by diversification.	[Topel, Mats; Antonelli, Alexandre; Eriksen, Bente] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Antonelli, Alexandre] Gothenburg Bot Garden, Gothenburg, Sweden; [Yesson, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England	University of Gothenburg; Zoological Society of London	Topel, M (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	mats.topel@bioenv.gu.se	Antonelli, Alexandre/ABE-6321-2020; Antonelli, Alexandre/A-5353-2011; Yesson, Chris/Q-1196-2017	Antonelli, Alexandre/0000-0003-1842-9297; Antonelli, Alexandre/0000-0003-1842-9297; Yesson, Chris/0000-0002-6731-4229; Topel, Mats/0000-0001-7989-696X	Helge Ax:son Johnsons stiftelse; Nilsson-Ehle donationerna [24966]; Swedish Research council [2004-1698]; Carl Tryggers Stiftelse; Wilhelm och Martina Lundgrens Vetenskapsfond [vet1-348/2007]; Adlerbertska forskningsstiftelsen [B 432 835/07]; Gothenburg Bioinformatics Network (GOTBIN)	Helge Ax:son Johnsons stiftelse; Nilsson-Ehle donationerna; Swedish Research council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse; Wilhelm och Martina Lundgrens Vetenskapsfond; Adlerbertska forskningsstiftelsen; Gothenburg Bioinformatics Network (GOTBIN)	This work was supported by Helge Ax:son Johnsons stiftelse (http://www.haxsonj.se/), Nilsson-Ehle donationerna (http://www.fysiografen.se/) (nr: 24966) (MT); The Swedish Research council (http://vr.se/), Carl Tryggers Stiftelse (http://www.carltryggersstiftelse.se/) and Helge Ax:son Johnsons Stiftelse (AA); Wilhelm och Martina Lundgrens Vetenskapsfond (http://www.wmlundgren.se/) (vet1-348/2007), Adlerbertska forskningsstiftelsen (B 432 835/07) and The Swedish Research council (2004-1698) (BE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Barbara Ertter for help with locating and identifying ivesioids in the field, gathering locality data from herbarium material, and for discussions during the initial stages of the project. We thank the UC Botanical garden at Berkeley and Gothenburg Botanical Garden for providing and caring for plant material used in this investigation. We also like to acknowledge Paul Valdes, University of Bristol, for his advice on use of the paleoclimate layers, Paula Topel for preparing all graphics, and two anonymous reviewers for their suggestions for improving the manuscript. Support from the Gothenburg Bioinformatics Network (GOTBIN) is also gratefully acknowledged.	Axelrod D. I., 1987, LATE OLIGOCENE CREED, V130, P1; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Dobes C, 2010, MOL PHYLOGENET EVOL, V56, P156, DOI 10.1016/j.ympev.2010.03.005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eriksson T, 1998, PLANT SYST EVOL, V211, P155, DOI 10.1007/BF00985357; Eriksson T, 2003, INT J PLANT SCI, V164, P197, DOI 10.1086/346163; ERTTER B, 1989, SYST BOT, V14, P231, DOI 10.2307/2418909; ERTTER B, 1993, SYST BOT, V18, P137, DOI 10.2307/2419793; Ertter B, 1993, JEPSON MANUAL HIGHER; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; Evans MEK, 2005, EVOLUTION, V59, P1914, DOI 10.1111/j.0014-3820.2005.tb01061.x; Faegri K., 1979, PRINCIPLES POLLINATI; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayashi K, 1998, PLANT SPEC BIOL, V13, P129; Heibl C., 2009, PHYLOCLIM INTEGRATIN; Hendry AP, 2010, EVOLUTION, V64, P1517, DOI 10.1111/j.1558-5646.2010.00947.x; Herman AB, 2002, REV PALAEOBOT PALYNO, V122, P1, DOI 10.1016/S0034-6667(02)00085-4; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hilbert DW, 2004, BIOL CONSERV, V116, P367, DOI 10.1016/S0006-3207(03)00230-1; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley SP, 1999, CRETACEOUS RES, V20, P97, DOI 10.1006/cres.1998.0140; Lanphere MA, 2000, GEOL S AM S, P71; Li JQ, 2002, SYST BOT, V27, P408; Mai Dieter Hans, 2001, Palaeontographica Abteilung B Palaeophytologie, V258, P1; MATHEWS WH, 1964, GEOL SOC AM BULL, V75, P465, DOI 10.1130/0016-7606(1964)75[465:PADOCV]2.0.CO;2; Matthews JV, 2003, QUATERNARY RES, V60, P9, DOI 10.1016/S0033-5894(03)00087-5; MATTHEWS JV, 1990, ARCTIC, V43, P364; McIntosh WC., 2004, GEOCHRONOLOGY CENTRA, V160, P205; Meyer H.W., 2003, FOSSILS FLORISSANT; Minnich RA, 2007, TERESTRIAL VEGETATIO; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Nylander J. A. A., 2004, MRAIC PL PROGRAM DIS; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson AT, 2004, DIVERS DISTRIB, V10, P237, DOI 10.1111/j.1366-9516.2004.00097.x; Pierrehumbert RT, 2002, NATURE, V419, P191, DOI 10.1038/nature01088; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; R Development Core Team, 2009, R FDN STAT COMP; Rambaut A, 2014, TRACER V1 6; Samylina VA., 1960, BOT ZH, V45, P335; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schorn, 1998, PALEOBIOS, V18, P21; STANDKE G, 1993, GEOL RUNDSCH, V82, P295; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 2005, TAXON, V54, P967, DOI 10.2307/25065481; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Topel M, 2011, PLOS CURRENTS TREE L, V16; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wehr W. C., 1994, WASHINGTON GEOL, V22, P27; Wolfe JA, 1990, US GEOLOGICAL SURVEY, V1923, P1; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yesson C, 2011, CLIMATE CHANGE ECOLO, P265; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	61	36	38	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50358	10.1371/journal.pone.0050358	http://dx.doi.org/10.1371/journal.pone.0050358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236369	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100015
J	Lindenmayer, DB; Zammit, C; Attwood, SJ; Burns, E; Shepherd, CL; Kay, G; Wood, J				Lindenmayer, David B.; Zammit, Charles; Attwood, Simon J.; Burns, Emma; Shepherd, Claire L.; Kay, Geoff; Wood, Jeff			A Novel and Cost-Effective Monitoring Approach for Outcomes in an Australian Biodiversity Conservation Incentive Program	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; RIVER RESTORATION; SPECIES RICHNESS; POLICY-MAKERS; MANAGEMENT; INFORMATION; VEGETATION; ABUNDANCE; WOODLAND; PAYMENTS	We report on the design and implementation of ecological monitoring for an Australian biodiversity conservation incentive scheme - the Environmental Stewardship Program. The Program uses competitive auctions to contract individual land managers for up to 15 years to conserve matters of National Environmental Significance (with an initial priority on nationally threatened ecological communities). The ecological monitoring was explicitly aligned with the Program's policy objective and desired outcomes and was applied to the Program's initial Project which targeted the critically endangered White Box-Yellow Box-Blakely's Red Gum Grassy Woodland and Derived Native Grassland ecological community in south eastern Australia. These woodlands have been reduced to <3% of their original extent and persist mostly as small remnants of variable condition on private farmland. We established monitoring sites on 153 farms located over 172,232 sq km. On each farm we established a monitoring site within the woodland patch funded for management and, wherever possible, a matched control site. The monitoring has entailed gathering data on vegetation condition, reptiles and birds. We also gathered data on the costs of experimental design, site establishment, field survey, and data analysis. The costs of monitoring are approximately 8.5% of the Program's investment in the first four years and hence are in broad accord with the general rule of thumb that 5-10% of a program's funding should be invested in monitoring. Once initial monitoring and site benchmarking are completed we propose to implement a novel rotating sampling approach that will maintain scientific integrity while achieving an annual cost-efficiency of up to 23%. We discuss useful lessons relevant to other monitoring programs where there is a need to provide managers with reliable early evidence of program effectiveness and to demonstrate opportunities for cost-efficiencies. Citation: Lindenmayer DB, Zammit C, Attwood SJ, Burns E, Shepherd CL, et al. (2012) A Novel and Cost-Effective Monitoring Approach for Outcomes in an Australian Biodiversity Conservation Incentive Program. PLoS ONE 7(12): e50872. doi:10.1371/journal.pone.0050872	[Lindenmayer, David B.; Burns, Emma; Shepherd, Claire L.; Kay, Geoff; Wood, Jeff] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Lindenmayer, David B.; Shepherd, Claire L.; Wood, Jeff] Australian Natl Univ, Australian Res Council Ctr Excellence Environm De, Canberra, ACT, Australia; [Lindenmayer, David B.; Shepherd, Claire L.] Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia; [Zammit, Charles; Attwood, Simon J.] Australian Govt Dept Sustainabil Environm Water P, Biodivers Conservat Branch, Canberra, ACT, Australia	Australian National University; Australian National University; Australian National University	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	david.lindenmayer@anu.edu.au	Lindenmayer, David B/P-7183-2017	Lindenmayer, David B/0000-0002-4766-4088				Alberts B, 2011, SCIENCE, V334, P1031, DOI 10.1126/science.1216650; [Anonymous], 2010, TEMPERATE WOODLAND C; Australian National Audit Office, 2007, AUDIT REPORT NO 21 2; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bernhardt ES, 2005, BIOSCIENCE, V55, P219, DOI 10.1641/0006-3568(2005)055[0219:ACSTFF]2.0.CO;2; Brooks SS, 2007, RESTOR ECOL, V15, P584, DOI 10.1111/j.1526-100X.2007.00253.x; Cardwell M., 2010, INT J LAND LAW AGR S, V4, P1; Carey PD, 2007, 25 YEARS OF LANDSCAP, P70; Cheng D, 2008, COMMUNICATING SCIENCE IN SOCIAL CONTEXTS: NEW MODELS, NEW PRACTICES, P1, DOI 10.1007/978-1-4020-8598-7; Commonwealth of Australia, 2009, ENVIRONMENTAL STEWAR; Commonwealth of Australia, 2011, ENVIRONMENTAL STEWAR; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Cunningham RB, 2007, ECOL APPL, V17, P609, DOI 10.1890/05-1892; Dripps K, 2008, LANDSCAPE ANALYIS AN; Driscoll D, 2000, IMPACT AND USE OF FI; Ecker S, 2010, PARTICIPATION IN THE; Eigenraam M, 2007, AGR ECON-BLACKWELL, V37, P261, DOI 10.1111/j.1574-0862.2007.00250.x; European Commission, 2005, AGRI ENVIRONMENT MEA; European Commission, 2006, RURAL DEVELOPMENT PO; Ferraro PJ, 2011, CONSERV BIOL, V25, P1134, DOI 10.1111/j.1523-1739.2011.01791.x; Field SA, 2002, AUSTRAL ECOL, V27, P624, DOI 10.1046/j.1442-9993.2002.01223.x; Field SA, 2007, AUSTRAL ECOL, V32, P485, DOI 10.1111/j.1442-9993.2007.01715.x; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Franklin JF, 1999, PAPER PRESENTED TO T; Fuentes-Montemayor E, 2011, BIOL CONSERV, V144, P2233, DOI 10.1016/j.biocon.2011.05.015; Gardner T., 2010, MONITORING FOREST BI; Gibbons JM, 2011, J APPL ECOL, V48, P1218, DOI 10.1111/j.1365-2664.2011.02022.x; Gibbons Philip, 2008, Ecological Management & Restoration, V9, P182, DOI 10.1111/j.1442-8903.2008.00416.x; Hajkowicz S, 2009, LAND USE POLICY, V26, P471, DOI 10.1016/j.landusepol.2008.06.004; Henderson B, 2008, AUSTRALAS J ENVIRON, V15, P113; Hodgson JA, 2010, ECOL LETT, V13, P1358, DOI 10.1111/j.1461-0248.2010.01528.x; Kerr JT, 2004, ECOL LETT, V7, P1163, DOI 10.1111/j.1461-0248.2004.00676.x; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2004, CONSERV BIOL, V18, P775, DOI 10.1111/j.1523-1739.2004.00550.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Kwok ABC, 2011, AUSTRAL ECOL, V36, P800, DOI 10.1111/j.1442-9993.2010.02219.x; Lawton JH, 2007, J APPL ECOL, V44, P465, DOI 10.1111/j.1365-2664.2007.01315.x; Lee Y, 2006, GENERALIZED LINEAR M; Lindenmayer D, 2012, BIODIVERSITY MONITORING IN AUSTRALIA, P1; Lindenmayer D, 2012, LAND USE INTENSIFICATION: EFFECTS ON AGRICULTURE, BIODIVERSITY AND ECOLOGICAL PROCESSES, P1; Lindenmayer D, 2012, BIOL CONSERV, V152, P62, DOI 10.1016/j.biocon.2012.02.026; Lindenmayer DB, 2009, EMU, V109, P100, DOI 10.1071/MU08029; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Lindenmayer DB, 2003, BIOL CONSERV, V110, P161, DOI 10.1016/S0006-3207(02)00171-4; Lindenmayer DB, 2011, WHAT MAKES A GOOD FA; Maron M, 2005, BIOL CONSERV, V124, P439, DOI 10.1016/j.biocon.2005.02.002; Martin TG, 2007, CONSERV BIOL, V21, P504, DOI 10.1111/j.1523-1739.2006.00624.x; McIntyre S, 2000, MANAGEMENT SUSTAINAB; McNie EC, 2007, ENVIRON SCI POLICY, V10, P17, DOI 10.1016/j.envsci.2006.10.004; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Muir MJ, 2010, REPORT TO CONSERVATI; Munro N, 2011, PLANTING FOR WILDLIF; Ninan KN, 2009, CONSERVING AND VALUI; OECD, 2010, PAYING FOR BIODIVERS; Pannell DJ, 2010, AUST J AGR RESOUR EC, V54, P437, DOI 10.1111/j.1467-8489.2010.00504.x; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Perkins AJ, 2011, J APPL ECOL, V48, P514, DOI 10.1111/j.1365-2664.2011.01958.x; Pyke G.H., 1983, METHODS CENSUSING BI, P55; Roth T, 2008, AGR ECOSYST ENVIRON, V125, P167, DOI 10.1016/j.agee.2007.12.012; Rudd MA, 2011, CONSERV BIOL, V25, P860, DOI 10.1111/j.1523-1739.2011.01712.x; Shanley P, 2009, BIOTROPICA, V41, P535, DOI 10.1111/j.1744-7429.2009.00561.x; Shine R, 1998, WILDLIFE RES, V25, P285, DOI 10.1071/WR97022; Spellerberg I. F., 2005, MONITORING ECOLOGICA, DOI DOI 10.1017/CBO9780511614699; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Welsh AH, 2000, BIOMETRICS, V56, P22, DOI 10.1111/j.0006-341X.2000.00022.x; Whitfield J, 2006, NATURE, V439, P908, DOI 10.1038/439908a; Whittingham MJ, 2007, J APPL ECOL, V44, P1, DOI 10.1111/j.1365-2664.2006.01263.x; World Bank, 1998, GUIDELINES FOR MONIT; Zammit C., 2010, TEMPERATE WOODLAND C	70	12	12	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50872	10.1371/journal.pone.0050872	http://dx.doi.org/10.1371/journal.pone.0050872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236399	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700020
J	Cucherousset, J; Bouletreau, S; Azemar, F; Compin, A; Guillaume, M; Santoul, F				Cucherousset, Julien; Bouletreau, Stephanie; Azemar, Frederic; Compin, Arthur; Guillaume, Mathieu; Santoul, Frederic			"Freshwater Killer Whales": Beaching Behavior of an Alien Fish to Hunt Land Birds	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSES; CATFISH SILURUS-GLANIS; INDIVIDUAL SPECIALIZATION; TROPHIC POSITION; TERRESTRIAL; ASSUMPTIONS; ECOLOGY; BIOLOGY; FRANCE; MODELS	The behavioral strategies developed by predators to capture and kill their prey are fascinating, notably for predators that forage for prey at, or beyond, the boundaries of their ecosystem. We report here the occurrence of a beaching behavior used by an alien and large-bodied freshwater predatory fish (Silurus glanis) to capture birds on land (i.e. pigeons, Columbia livia). Among a total of 45 beaching behaviors observed and filmed, 28% were successful in bird capture. Stable isotope analyses (delta C-13 and delta N-15) of predators and their putative prey revealed a highly variable dietary contribution of land birds among individuals. Since this extreme behavior has not been reported in the native range of the species, our results suggest that some individuals in introduced predator populations may adapt their behavior to forage on novel prey in new environments, leading to behavioral and trophic specialization to actively cross the water-land interface. Citation: Cucherousset J, Bouletreau S, Azemar F, Compin A, Guillaume M, et al. (2012) "Freshwater Killer Whales": Beaching Behavior of an Alien Fish to Hunt Land Birds. PLoS ONE 7(12): e50840. doi:10.1371/journal.pone.0050840	[Bouletreau, Stephanie; Azemar, Frederic; Compin, Arthur; Guillaume, Mathieu; Santoul, Frederic] Univ Toulouse, INP, UPS, EcoLab Lab Ecol Fonct & Environm, Toulouse, France; [Cucherousset, Julien] Univ Toulouse 3, CNRS, ENFA, Lab Evolut & Diversite Biol,UMR EDB 5174, F-31062 Toulouse, France; [Cucherousset, Julien] Univ Toulouse, UMR EDB 5174, Toulouse, France; [Bouletreau, Stephanie; Azemar, Frederic; Compin, Arthur; Guillaume, Mathieu; Santoul, Frederic] CNRS, EcoLab, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Santoul, F (corresponding author), Univ Toulouse, INP, UPS, EcoLab Lab Ecol Fonct & Environm, Toulouse, France.	frederic.santoul@univ-tlse3.fr	Azémar, Frédéric/A-9041-2010; COMPIN, Arthur/D-3826-2014; Bouletreau, Stephanie/T-2915-2019	Azémar, Frédéric/0000-0002-3098-8676; Santoul, Frederic/0000-0002-2932-2172; Bouletreau, Stephanie/0000-0002-0094-0196; Compin, Arthur/0000-0002-0756-8649; Cucherousset, Julien/0000-0003-0533-9479	"ERG Marie Curie" grant in the lab EDB, part of the "Laboratoire d"Excellence (LABEX) entitled TULIP [PERG08-GA-2010-276969, ANR - 10-LABX-41]	"ERG Marie Curie" grant in the lab EDB, part of the "Laboratoire d"Excellence (LABEX) entitled TULIP	JC was supported by an "ERG Marie Curie" grant (PERG08-GA-2010- 276969) in the lab EDB, part of the "Laboratoire d"Excellence (LABEX) entitled TULIP (ANR -10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Bartels P, 2012, ECOLOGY, V93, P1173, DOI 10.1890/11-1210.1; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Cucherousset J, 2012, FISHERIES MANAG ECOL, V19, P111, DOI 10.1111/j.1365-2400.2011.00824.x; Cucherousset J, 2011, OECOLOGIA, V167, P75, DOI 10.1007/s00442-011-1974-4; Cucherousset J, 2011, FISHERIES, V36, P215, DOI 10.1080/03632415.2011.574578; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Fry B., 2006, STABLE ISOTOPE ECOLO; GUINET C, 1995, CAN J ZOOL, V73, P27, DOI 10.1139/z95-004; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Poulet N, 2011, J FISH BIOL, V79, P1436, DOI 10.1111/j.1095-8649.2011.03084.x; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; R Development Core Team, 2012, R LANG ENV STAT COMP; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Schuster S, 2004, CURR BIOL, V14, P1565, DOI 10.1016/j.cub.2004.08.050; Stone R, 2007, SCIENCE, V316, P1684, DOI 10.1126/science.316.5832.1684; Syvaranta J, 2010, AQUAT BIOL, V8, P137, DOI 10.3354/ab00220; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762	28	40	41	4	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50840	10.1371/journal.pone.0050840	http://dx.doi.org/10.1371/journal.pone.0050840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227213	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200073
J	Domart, MC; Hobday, TMC; Peddie, CJ; Chung, GHC; Wang, A; Yeh, K; Jethwa, N; Zhang, QF; Wakelam, MJO; Woscholski, R; Byrne, RD; Collinson, LM; Poccia, DL; Larijani, B				Domart, Marie-Charlotte; Hobday, Tina M. C.; Peddie, Christopher J.; Chung, Gary H. C.; Wang, Alan; Yeh, Karen; Jethwa, Nirmal; Zhang, Qifeng; Wakelam, Michael J. O.; Woscholski, Rudiger; Byrne, Richard D.; Collinson, Lucy M.; Poccia, Dominic L.; Larijani, Banafshe			Acute Manipulation of Diacylglycerol Reveals Roles in Nuclear Envelope Assembly & Endoplasmic Reticulum Morphology	PLOS ONE			English	Article							PROTEIN-KINASE-C; LAMIN-B-RECEPTOR; MEMBRANE-FUSION; MAMMALIAN-CELLS; SEA-URCHIN; DYNAMICS; LIPIDS; ER; PHOSPHORYLATION; ORGANIZATION	The functions and morphology of cellular membranes are intimately related and depend not only on their protein content but also on the repertoire of lipids that comprise them. In the absence of in vivo data on lipid asymmetry in endomembranes, it has been argued that motors, scaffolding proteins or integral membrane proteins rather than non-lamellar bilayer lipids such as diacylglycerol (DAG), are responsible for shaping of organelles, local membrane curvature and fusion. The effects of direct alteration of levels of such lipids remain predominantly uninvestigated. Diacylglycerol (DAG) is a well documented second messenger. Here we demonstrate two additional conserved functions of DAG: a structural role in organelle morphology, and a role in localised extreme membrane curvature required for fusion for which proteins alone are insufficient. Acute and inducible DAG depletion results in failure of the nuclear envelope (NE) to reform at mitosis and reorganisation of the ER into multi-lamellar sheets as revealed by correlative light and electron microscopy and 3D reconstructions. Remarkably, depleted cells divide without a complete NE, and unless rescued by 1,2 or 1,3 DAG soon die. Attenuation of DAG levels by enzyme microinjection into echinoderm eggs and embryos also results in alterations of ER morphology and nuclear membrane fusion. Our findings demonstrate that DAG is an in vivo modulator of organelle morphology in mammalian and echinoderm cells, indicating a fundamental role conserved across the deuterostome superphylum.	[Domart, Marie-Charlotte; Hobday, Tina M. C.; Chung, Gary H. C.; Jethwa, Nirmal; Byrne, Richard D.; Larijani, Banafshe] Canc Res United Kingdom, Cell Biophys Lab, London Res Inst, London, England; [Peddie, Christopher J.; Collinson, Lucy M.] Canc Res United Kingdom, Elect Microscopy Unit, London Res Inst, London, England; [Wang, Alan; Yeh, Karen; Poccia, Dominic L.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Cambridge, England; [Woscholski, Rudiger] Univ London Imperial Coll Sci Technol & Med, Dept Chem, Fac Nat Sci, London SW7 2AY, England; [Woscholski, Rudiger] Univ London Imperial Coll Sci Technol & Med, Inst Biol Chem, London, England	Cancer Research UK; University of London; University College London; Cancer Research UK; University of London; University College London; Amherst College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London; Imperial College London	Larijani, B (corresponding author), Canc Res United Kingdom, Cell Biophys Lab, London Res Inst, London, England.	banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015	Larijani, Banafshe/0000-0003-4735-1169; Chung, Gary Hong Chun/0000-0001-6764-3041; Wakelam, Michael/0000-0003-4059-9276; Collinson, Lucy/0000-0003-0260-613X; Peddie, Christopher/0000-0002-8329-5419; Domart, Marie-Charlotte/0000-0002-5703-2922	Cancer Research United Kingdom core funding; Amherst College Faculty Research Award; Biotechnology and Biological Sciences Research Council (BBSRC) (MJOW); BBSRC [BBS/E/B/000C0415] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415] Funding Source: researchfish	Cancer Research United Kingdom core funding; Amherst College Faculty Research Award; Biotechnology and Biological Sciences Research Council (BBSRC) (MJOW); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The project was funded by Cancer Research United Kingdom core funding to London Research Institute (BL), an Amherst College Faculty Research Award of the H. Axel Schupf '57 Fund for Intellectual Life (DLP) and the Biotechnology and Biological Sciences Research Council (BBSRC) (MJOW). AW received support as a Schupf Fellow, Amherst College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Basanez G, 1996, BIOPHYS J, V70, P2299, DOI 10.1016/S0006-3495(96)79795-3; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Collas P, 1998, METHOD CELL BIOL, V53, P417; CULLIS PR, 1978, NATURE, V271, P672, DOI 10.1038/271672a0; DAS S, 1986, BIOCHEMISTRY-US, V25, P2882, DOI 10.1021/bi00358a022; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dumas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012208; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; GORDON SE, 1995, BIOPHYS J, V69, P409, DOI 10.1016/S0006-3495(95)79913-1; Gorjanacz M, 2009, J CELL SCI, V122, P1963, DOI 10.1242/jcs.044750; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; KIEHART DP, 1982, METHOD CELL BIOL, V25, P13, DOI 10.1016/S0091-679X(08)61418-1; Knorr RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032753; KONING AJ, 1993, CELL MOTIL CYTOSKEL, V25, P111, DOI 10.1002/cm.970250202; Larijani B, 2000, LIPIDS, V35, P1289, DOI 10.1007/s11745-000-0645-4; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; LONGO FJ, 1972, J MORPHOL, V138, P207, DOI 10.1002/jmor.1051380206; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Mattaj IW, 2004, NAT REV MOL CELL BIO, V5, P65, DOI 10.1038/nrm1263; Pettitt TR, 1999, J BIOL CHEM, V274, P36181, DOI 10.1074/jbc.274.51.36181; Poccia D, 2009, BIOCHEM J, V418, P233, DOI 10.1042/BJ20082105; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Sanchez-Pinera P, 1999, BIOCHEM J, V337, P387, DOI 10.1042/0264-6021:3370387; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Siniossoglou S, 2009, TRAFFIC, V10, P1181, DOI 10.1111/j.1600-0854.2009.00923.x; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Volkova EG, 2011, J ELECTRON MICROSC, V60, P57, DOI 10.1093/jmicro/dfq067; Watt S, 2002, SUBCELLULAR LOCALIZA, V81; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	41	46	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51150	10.1371/journal.pone.0051150	http://dx.doi.org/10.1371/journal.pone.0051150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227247	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200106
J	Liu, JX; Zhao, L; Li, GY; Xiong, SW; Nan, JF; Li, J; Yuan, K; von Deneen, KM; Liang, FR; Qin, W; Tian, J				Liu, Jixin; Zhao, Ling; Li, Guoying; Xiong, Shiwei; Nan, Jiaofen; Li, Jing; Yuan, Kai; von Deneen, Karen M.; Liang, Fanrong; Qin, Wei; Tian, Jie			Hierarchical Alteration of Brain Structural and Functional Networks in Female Migraine Sufferers	PLOS ONE			English	Article							HYPOTHALAMIC ACTIVATION; CORTICAL THICKNESS; MATTER CHANGES; CONNECTIVITY; ORGANIZATION; HEADACHE; VOXEL; PAIN; MODULARITY; FREQUENCY	Background: Little is known about the changes of brain structural and functional connectivity networks underlying the pathophysiology in migraine. We aimed to investigate how the cortical network reorganization is altered by frequent cortical overstimulation associated with migraine. Methodology/Principal Findings: Gray matter volumes and resting-state functional magnetic resonance imaging signal correlations were employed to construct structural and functional networks between brain regions in 43 female patients with migraine (PM) and 43 gender-matched healthy controls (HC) by using graph theory-based approaches. Compared with the HC group, the patients showed abnormal global topology in both structural and functional networks, characterized by higher mean clustering coefficients without significant change in the shortest absolute path length, which indicated that the PM lost optimal topological organization in their cortical networks. Brain hubs related to pain-processing revealed abnormal nodal centrality in both structural and functional networks, including the precentral gyrus, orbital part of the inferior frontal gyrus, parahippocampal gyrus, anterior cingulate gyrus, thalamus, temporal pole of the middle temporal gyrus and the inferior parietal gyrus. Negative correlations were found between migraine duration and regions with abnormal centrality. Furthermore, the dysfunctional connections in patients' cortical networks formed into a connected component and three dysregulated modules were identified involving pain-related information processing and motion-processing visual networks. Conclusions: Our results may reflect brain alteration dynamics resulting from migraine and suggest that long-term and high-frequency headache attacks may cause both structural and functional connectivity network reorganization. The disrupted information exchange between brain areas in migraine may be reshaped into a hierarchical modular structure progressively.	[Liu, Jixin; Li, Guoying; Xiong, Shiwei; Nan, Jiaofen; Li, Jing; Yuan, Kai; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China; [Zhao, Ling; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Chinese Academy of Sciences; Institute of Automation, CAS	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	Yuan, Kai/I-4150-2016; Tian, Jie/H-1190-2011; Life, PAM/M-9552-2013; tian, jie/M-6336-2013; Yuan, Kai/M-9403-2013; 秦, 伟/J-9770-2016	Yuan, Kai/0000-0002-3098-1124; Tian, Jie/0000-0003-0498-0432; 秦, 伟/0000-0003-4583-0406; Liang, Fanrong/0000-0003-2210-2027	National Key Basic Research and Development Program (973) [2012CB518501, 2011CB707702]; National Natural Science Foundation of China [30930112, 30970774, 81000640, 81000641, 81101036, 81101108, 31150110171, 30901900, 81271644, 31200837]; Fundamental Research Funds for the Central Universities	National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2012CB518501, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 81000640, 81000641, 81101036, 81101108, 31150110171, 30901900, 81271644, 31200837, the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerra NE, 2005, NEUROLOGY, V65, P751, DOI 10.1212/01.wnl.0000178745.11996.8c; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aderjan D, 2010, PAIN, V151, P97, DOI 10.1016/j.pain.2010.06.024; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chiapparini L, 2010, NEUROL SCI, V31, P19, DOI 10.1007/s10072-010-0266-9; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Detsky ME, 2006, JAMA-J AM MED ASSOC, V296, P1274, DOI 10.1001/jama.296.10.1274; Donaghy M, 2002, J NEUROL NEUROSUR PS, V73, P747, DOI 10.1136/jnnp.73.6.747; Eck J, 2011, PAIN, V152, P1104, DOI 10.1016/j.pain.2011.01.026; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; KAISER M, 2011, NEUROIMAGE; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Lipton RB, 2004, JAMA-J AM MED ASSOC, V291, P493, DOI 10.1001/jama.291.4.493; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027049; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Matharu MS, 2006, ANN NEUROL, V59, P535, DOI 10.1002/ana.20763; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Park CH, 2008, PHYSICA A, V387, P5958, DOI 10.1016/j.physa.2008.06.048; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sprenger T, 2005, PAIN, V113, P422, DOI 10.1016/j.pain.2004.09.021; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	59	71	80	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51250	10.1371/journal.pone.0051250	http://dx.doi.org/10.1371/journal.pone.0051250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227257	gold, Green Submitted, Green Published			2022-12-25	WOS:000312588200116
J	Masi, S; Chauffour, S; Bain, O; Todd, A; Guillot, J; Krief, S				Masi, Shelly; Chauffour, Sophie; Bain, Odile; Todd, Angelique; Guillot, Jacques; Krief, Sabrina			Seasonal Effects on Great Ape Health: A Case Study of Wild Chimpanzees and Western Gorillas	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; KIBALE NATIONAL-PARK; INTESTINAL PARASITES; MOUNTAIN GORILLAS; LOWLAND GORILLAS; PREGNANT-WOMEN; GASTROINTESTINAL PARASITES; BIOACTIVE PROPERTIES; POPULATION DECLINES; DIETARY-RESPONSE	Among factors affecting animal health, environmental influences may directly or indirectly impact host nutritional condition, fecundity, and their degree of parasitism. Our closest relatives, the great apes, are all endangered and particularly sensitive to infectious diseases. Both chimpanzees and western gorillas experience large seasonal variations in fruit availability but only western gorillas accordingly show large changes in their degree of frugivory. The aim of this study is to investigate and compare factors affecting health (through records of clinical signs, urine, and faecal samples) of habituated wild ape populations: a community (N = 46 individuals) of chimpanzees (Pan troglodytes) in Kanyawara, Kibale National Park (Uganda), and a western gorilla (G. gorilla) group (N = 13) in Bai Hokou in the Dzanga-Ndoki National Park (Central African Republic). Ape health monitoring was carried out in the wet and dry seasons (chimpanzees: July-December 2006; gorillas: April-July 2008 and December 2008-February 2009). Compared to chimpanzees, western gorillas were shown to have marginally greater parasite diversity, higher prevalence and intensity of both parasite and urine infections, and lower occurrence of diarrhea and wounds. Parasite infections (prevalence and load), but not abnormal urine parameters, were significantly higher during the dry season of the study period for western gorillas, who thus appeared more affected by the large temporal changes in the environment in comparison to chimpanzees. Infant gorillas were the most susceptible among all the age/sex classes (of both apes) having much more intense infections and urine blood concentrations, again during the dry season. Long term studies are needed to confirm the influence of seasonal factors on health and parasitism of these great apes. However, this study suggest climate change and forest fragmentation leading to potentially larger seasonal fluctuations of the environment may affect patterns of ape parasitism and further exacerbate health impacts on great ape populations that live in highly seasonal habitats.	[Masi, Shelly; Krief, Sabrina] Museum Natl Hist Nat, Dept Hommes, Soc UMR Ecoanthropol & Ethnobiol 7206, F-75231 Paris, France; [Chauffour, Sophie; Guillot, Jacques] Ecole Natl Vet Alfort, UMR Anses, Upec BIPAR, Maisons Alfort, France; [Bain, Odile] CNRS, UMR OSEB 7205, Paris, France; [Todd, Angelique] WWF, Dzanga Sangha Protected Areas, Bangui, Cent Afr Republ; [Krief, Sabrina] Projet Conservat Grands Singes, Paris, France	Museum National d'Histoire Naturelle (MNHN); Ecole Nationale Veterinaire d'Alfort (ENVA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; World Wildlife Fund	Masi, S (corresponding author), Museum Natl Hist Nat, Dept Hommes, Soc UMR Ecoanthropol & Ethnobiol 7206, F-75231 Paris, France.	masi@mnhn.fr	Todd, Angelique/AAR-3087-2021; Guillot, Jacques/J-9428-2016	Guillot, Jacques/0000-0003-3577-6979; Todd, Angelique/0000-0002-9207-4925	ATM 16 (Action Transversale du Museum national d'histoire naturelle); project "JC SAFAPE" of the ANR (Agence nationale de la recherche); Cleveland Metroparks Zoo; Cleveland Zoological Society	ATM 16 (Action Transversale du Museum national d'histoire naturelle); project "JC SAFAPE" of the ANR (Agence nationale de la recherche)(French National Research Agency (ANR)); Cleveland Metroparks Zoo; Cleveland Zoological Society	Funding: The authors thank the ATM 16 (Action Transversale du Museum national d'histoire naturelle), the project "JC SAFAPE" of the ANR (Agence nationale de la recherche), the Cleveland Metroparks Zoo, and the Cleveland Zoological Society, for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ashford RW, 2000, ANN TROP MED PARASIT, V94, P173, DOI 10.1080/00034980057518; Ashford RW, 1996, J ZOOL, V239, P507, DOI 10.1111/j.1469-7998.1996.tb05939.x; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Blake, 2005, LONG TERM SYSTEM MON; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Bowman D.D., 1995, GEORGIS PARASITOLOGY, Vsixth; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P1, DOI 10.1017/CBO9780511542343; Carter JL, 2006, NEPHROL DIAL TRANSPL, V21, P3031, DOI 10.1093/ndt/gfl373; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2007, AM J PHYS ANTHROPOL, V134, P240, DOI 10.1002/ajpa.20664; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Christensen CM, 1995, INT J PARASITOL, V25, P1491, DOI 10.1016/0020-7519(95)00085-2; COHEN S, 1992, PSYCHOL SCI, V3, P301, DOI 10.1111/j.1467-9280.1992.tb00677.x; Conklin-Brittain N. L., 2006, FEEDING ECOLOGY APES; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P971, DOI 10.1023/A:1020370119096; Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Crestian J., 1975, Recueil de Medecine Veterinaire de l'Ecole d'Alfort, V151, P13; DOLLFUS R. P., 1955, Archives de Museum d'Histoire Naturelle., V3, P27; DORAN DM, 2001, MOUNTAIN GORILLAS 3, P123, DOI DOI 10.1017/CBO9780511661631.006; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Dupain J, 2002, INT J PRIMATOL, V23, P1053, DOI 10.1023/A:1019697915897; DURETTEDESSET MC, 1992, SYST PARASITOL, V23, P159, DOI 10.1007/BF00010868; Freeland WJ, 1977, THESIS U MICHIGAN AR; Freeman AS, 2004, J WILDLIFE DIS, V40, P775, DOI 10.7589/0090-3558-40.4.775; Fujita S, 2011, PRIMATOL MONOGR, P353, DOI 10.1007/978-4-431-53921-6_37; Genton C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037106; Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290.x; Gillespie TR, 2005, J PARASITOL, V91, P569, DOI 10.1645/GE-434R; GOODALL J, 1983, Z TIERPSYCHOL, V61, P1; Goodall J., 1986, CHIMPANZEES GOMBE PA; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; Hartter J.N., 2007, THESIS U FLORIDA GAI; Hartter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032408; Hartter J, 2009, LANDSCAPE ECOL, V24, P643, DOI 10.1007/s10980-009-9339-7; Hastings Barkley E., 1992, American Association of Zoo Veterinarians Annual Proceedings, V1992, P301; HAUSFATER G, 1982, Primates, V23, P287, DOI 10.1007/BF02381167; Head JS, 2011, INT J PRIMATOL, V32, P755, DOI 10.1007/s10764-011-9499-6; HERCBERG S, 1986, HUM NUTR-CLIN NUTR, V40C, P371; Huffman MA, 1997, PRIMATES, V38, P111, DOI 10.1007/BF02382002; HUFFMAN MA, 1989, PRIMATES, V30, P51, DOI 10.1007/BF02381210; Huffman MA, 1996, INT J PRIMATOL, V17, P475, DOI 10.1007/BF02735188; Huffman Michael A., 1994, P129; International Union for Conservation of Nature, 2012, IUCN RED LIST THREAT; Janson C. H., 1999, PRIMATE COMMUNITIES; Kamiss Ami, 2006, RECENSEMENT POPULATI; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Koski KG, 2001, ANNU REV NUTR, V21, P297, DOI 10.1146/annurev.nutr.21.1.297; Krief S, 2006, AM J PRIMATOL, V68, P51, DOI 10.1002/ajp.20206; Krief S, 2005, J ETHNOPHARMACOL, V101, P1, DOI 10.1016/j.jep.2005.03.024; Krief S, 2005, J NAT PROD, V68, P897, DOI 10.1021/np049576i; Krief S, 2005, INT J PRIMATOL, V26, P467, DOI 10.1007/s10764-005-2934-9; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Krief S, 2008, J MED PRIMATOL, V37, P188, DOI 10.1111/j.1600-0684.2008.00285.x; Krief S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-116; Krief S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000630; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.3.CO;2-J; LANDSOUDSOUKATE J, 1995, ANN TROP MED PARASIT, V89, P73, DOI 10.1080/00034983.1995.11812931; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Leendertz SAJ, 2010, AM J PRIMATOL, V72, P689, DOI 10.1002/ajp.20825; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Levine N.D., 1968, NEMATODE PARASITES D; Lilly AA, 1999, AM J PRIMATOL, V48, P197, DOI 10.1002/(SICI)1098-2345(1999)48:3&lt;197::AID-AJP3&gt;3.0.CO;2-Y; Lilly AA, 2002, INT J PRIMATOL, V23, P555, DOI 10.1023/A:1014969617036; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Marquerdt WC, 1985, PARASITOLOGY, P349; Masi S, 2012, INFLUENCE FRUGIVORY; Masi S, 2008, SEASONAL INFLUENCE F; Masi S, 2012, PHYSIOL BEHAV, V105, P337, DOI 10.1016/j.physbeh.2011.08.012; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; Mehlman PT, 2002, INT J PRIMATOL, V23, P1257, DOI 10.1023/A:1021126920753; Milton K, 1996, J ZOOL, V239, P39, DOI 10.1111/j.1469-7998.1996.tb05435.x; Morel P. C., 1959, Revue Rev Elev, V12, P153; Muehlenbein MP, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-21; MULLOOLY JP, 1986, PUBLIC HEALTH REP, V101, P205; Murray DL, 1998, ECOLOGY, V79, P1209, DOI 10.1890/0012-9658(1998)079[1209:DPANSI]2.0.CO;2; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Pontzer H, 2006, INT J PRIMATOL, V27, P295, DOI 10.1007/s10764-005-9011-2; Profousova I, 2011, FOLIA MICROBIOL, V56, P339, DOI 10.1007/s12223-011-0053-x; Remis MJ, 2004, INT J PRIMATOL, V25, P825, DOI 10.1023/B:IJOP.0000029124.04610.c7; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; Rothman JM, 2009, CAM S BIO EVOL ANTHR, V57, P441; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Sleeman JM, 2000, J ZOO WILDLIFE MED, V31, P322, DOI 10.1638/1042-7260(2000)031[0322:GPOMGG]2.0.CO;2; Sleeman JM, 1998, J ZOO WILDLIFE MED, V29, P432; Soll SJ, 2010, P NATL ACAD SCI USA, V107, P19496, DOI 10.1073/pnas.1012344107; Stear MJ, 1995, PARASITE IMMUNOL, V17, P643, DOI 10.1111/j.1365-3024.1995.tb01010.x; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; STUART MD, 1993, J HELMINTHOL SOC W, V60, P111; TUTIN CEG, 1993, AM J PRIMATOL, V30, P195, DOI 10.1002/ajp.1350300305; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walsh PD, 2007, AM NAT, V169, P684, DOI 10.1086/513494; Waterman P.G., 1984, P177; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202; WRANGHAM R W, 1983, Primates, V24, P276, DOI 10.1007/BF02381090; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404	104	36	36	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49805	10.1371/journal.pone.0049805	http://dx.doi.org/10.1371/journal.pone.0049805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227152	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200014
J	Mi, DH; Jia, Q; Zheng, HH; Hoff, K; Zhao, XQ; Wang, CX; Liu, GF; Wang, YL; Liu, LP; Wang, XW; Wang, YJ				Mi, Donghua; Jia, Qian; Zheng, Huaguang; Hoff, Kolin; Zhao, Xingquan; Wang, Chunxue; Liu, Gaifen; Wang, Yilong; Liu, Liping; Wang, Xianwei; Wang, Yongjun		Invest Survey Abnormal Glucose	Metabolic Syndrome and Stroke Recurrence in Chinese Ischemic Stroke Patients - The ACROSS-China Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; CEREBRAL INFARCTION; ATTACK; IMPACT; MULTIFACTORIAL; PREVALENCE; PROGNOSIS; MORTALITY; SURVIVAL	Objective: Metabolic syndrome has emerged as a novel risk factor in cardiovascular disease due to its potential for predicting stroke in population-based studies. We investigated the relationship of metabolic syndrome with stroke recurrence. Methods: This was a retrospective analysis of Chinese patients enrolled in the prospective Abnormal gluCose Regulation in patients with acute strOke acroSS China (ACROSS-China) study after their first ischemic stroke. Metabolic syndrome was defined using the International Diabetes Federation (IDF) criteria. Vascular risk factors were assessed. Outcome was defined as recurrence of stroke within one year after the index ischemic stroke. Cox proportional hazards regression was performed to identify potential predictors of stroke recurrence. Results: The prevalence of metabolic syndrome among 2639 ischemic stroke patients was 51.35%. During the one-year follow-up, 195 strokes (7.4%) recurred. The multivariate hazard ratio (95% CI) of stroke recurrence was 1.94 (1.39-2.73) for metabolic syndrome. After adjustment for components, metabolic syndrome lost its association with stroke recurrence; in this model, high fasting plasma glucose (IDF definition) was a predictor for stroke recurrence. Conclusion: Metabolic syndrome may not be predictive for stroke recurrence beyond its component individual factors for Chinese ischemic stroke patients.	[Mi, Donghua; Jia, Qian; Zheng, Huaguang; Zhao, Xingquan; Wang, Chunxue; Liu, Gaifen; Wang, Yilong; Liu, Liping; Wang, Xianwei; Wang, Yongjun] Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China; [Hoff, Kolin] Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	Capital Medical University; University of Pennsylvania; Pennsylvania Medicine	Wang, YJ (corresponding author), Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China.	yongjunwang111@126.com	liu, li/HGC-0900-2022		Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National Science and Technology Major Project of China [2008ZX09312 -008]; State Key Development Program of (for) Basic Research of China [2009CB521905]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National Science and Technology Major Project of China; State Key Development Program of (for) Basic Research of China(National Basic Research Program of ChinaState Key Development Program for Basic Research of China)	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China. The grants were National Science and Technology Major Project of China (2008ZX09312 -008) and State Key Development Program of (for) Basic Research of China (2009CB521905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ALTER M, 1994, STROKE, V25, P1605, DOI 10.1161/01.STR.25.8.1605; Arenillas JF, 2008, NEUROLOGY, V71, P190, DOI 10.1212/01.wnl.0000317092.21210.e6; Boden-Albala B, 2008, STROKE, V39, P30, DOI 10.1161/STROKEAHA.107.496588; Bogousslavsky J, 1996, NEUROLOGY, V46, P1301, DOI 10.1212/WNL.46.5.1301; Boysen G, 2003, STROKE, V34, P1258, DOI 10.1161/01.STR.0000069017.78624.37; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Callahan A, 2011, ARCH NEUROL-CHICAGO, V68, P1245, DOI 10.1001/archneurol.2011.146; Elneihoum AM, 1998, STROKE, V29, P2114, DOI 10.1161/01.STR.29.10.2114; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; HIER DB, 1991, STROKE, V22, P155, DOI 10.1161/01.STR.22.2.155; Hillen T, 2003, STROKE, V34, P1457, DOI 10.1161/01.STR.0000072985.24967.7F; Iso H, 2007, STROKE, V38, P1744, DOI 10.1161/STROKEAHA.106.469072; Jia Q, 2012, STROKE, V43, P650, DOI 10.1161/STROKEAHA.111.633784; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Karapanayiotides T, 2004, NEUROLOGY, V62, P1558, DOI 10.1212/01.WNL.0000123252.55688.05; Katsnelson M, 2011, STROKE, V42, P3331, DOI 10.1161/STROKEAHA.111.632471; KIERS L, 1992, J NEUROL NEUROSUR PS, V55, P263, DOI 10.1136/jnnp.55.4.263; Koren-Morag N, 2005, STROKE, V36, P1366, DOI 10.1161/01.STR.0000169945.75911.33; Kurl S, 2006, STROKE, V37, P806, DOI 10.1161/01.STR.0000204354.06965.44; LAI SM, 1994, STROKE, V25, P958, DOI 10.1161/01.STR.25.5.958; Liou CW, 2008, EUR J NEUROL, V15, P802, DOI 10.1111/j.1468-1331.2008.02181.x; Liu Chuan, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P358, DOI 10.3760/cma.j.issn.0253-3758.2011.04.016; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Ovbiagele B, 2006, NEUROLOGY, V66, P1344, DOI 10.1212/01.wnl.0000210530.46058.5c; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; Sacco RL, 2006, CIRCULATION, V113, pE409, DOI 10.1161/circ.113.10.e409; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; SACCO RL, 1995, NEUROLOGY, V45, pS10; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; TAKANO K, 1992, STROKE, V23, P194, DOI 10.1161/01.STR.23.2.194; Towfighi A, 2009, STROKE, V40, P2704, DOI 10.1161/STROKEAHA.109.550228; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Weimar C, 2009, STROKE, V40, P350, DOI 10.1161/STROKEAHA.108.521419; Wu G, 2002, CHIN J PREV MED CHIN, V36, P298; Xu GL, 2007, CEREBROVASC DIS, V23, P117, DOI 10.1159/000097047	41	18	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51406	10.1371/journal.pone.0051406	http://dx.doi.org/10.1371/journal.pone.0051406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227264	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200123
J	Prilipko, O; Huynh, N; Schwartz, S; Tantrakul, V; Kushida, C; Paiva, T; Guilleminault, C				Prilipko, Olga; Huynh, Nelly; Schwartz, Sophie; Tantrakul, Visasiri; Kushida, Clete; Paiva, Teresa; Guilleminault, Christian			The Effects of CPAP Treatment on Task Positive and Default Mode Networks in Obstructive Sleep Apnea Patients: An fMRI Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; BODY-MASS INDEX; WORKING-MEMORY; COGNITIVE FUNCTION; BRAIN ACTIVATION; ATTENTIONAL NETWORKS; SUSTAINED ATTENTION; AIRWAY PRESSURE; DYSFUNCTION; DEPRIVATION	Introduction: Functional magnetic resonance imaging studies enable the investigation of neural correlates underlying behavioral performance. We investigate the effect of active and sham Continuous Positive Airway Pressure (CPAP) treatment on working memory function of patients with Obstructive Sleep Apnea Syndrome (OSAS) considering Task Positive and Default Mode networks (TPN and DMN). Methods: An experiment with 4 levels of visuospatial n-back task was used to investigate the pattern of cortical activation in 17 men with moderate or severe OSAS before and after 2 months of therapeutic (active) or sub-therapeutic (sham) CPAP treatment. Results: Patients with untreated OSAS had significantly less deactivation in the temporal regions of the DMN as compared to healthy controls, but activation within TPN regions was comparatively relatively preserved. After 2 months of treatment, active and sham CPAP groups exhibited opposite trends of cerebral activation and deactivation. After treatment, the active CPAP group demonstrated an increase of cerebral activation in the TPN at all task levels and of task-related cerebral deactivation in the anterior midline and medial temporal regions of the DMN at the 3-back level, associated with a significant improvement of behavioral performance, whereas the sham CPAP group exhibited less deactivation in the temporal regions of Default Mode Network and less Task Positive Network activation associated to longer response times at the 3-back. Conclusion: OSAS has a significant negative impact primarily on task-related DMN deactivation, particularly in the medial temporal regions, possibly due to nocturnal hypoxemia, as well as TPN activation, particularly in the right ventral frontoparietal network. After 2 months of active nasal CPAP treatment a positive response was noted in both TPN and DMN but without compete recovery of existing behavioral and neuronal deficits. Initiation of CPAP treatment early in the course of the disease may prevent or slow down the occurrence of irreversible impairment.	[Prilipko, Olga; Huynh, Nelly; Tantrakul, Visasiri; Kushida, Clete; Guilleminault, Christian] Stanford Univ, Sleep Clin, Redwood City, CA USA; [Prilipko, Olga; Huynh, Nelly; Tantrakul, Visasiri; Kushida, Clete; Guilleminault, Christian] Stanford Univ, Ctr Human Sleep Res, Redwood City, CA USA; [Schwartz, Sophie] Univ Geneva, Med Ctr, CH-1211 Geneva, Switzerland; [Paiva, Teresa] CENC, Dept Neurol, Lisbon, Portugal	Stanford University; Stanford University; University of Geneva	Guilleminault, C (corresponding author), Stanford Univ, Sleep Clin, Redwood City, CA USA.	cguil@stanford.edu		Paiva, Maria Teresa Aguiar dos Santos/0000-0002-7937-7841	Swiss National Foundation for Scientific Research; Swiss Foundation for Grants in Medicine and Biology (FSBMB)	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Swiss Foundation for Grants in Medicine and Biology (FSBMB)	This study was supported by research grants from Swiss National Foundation for Scientific Research and Swiss Foundation for Grants in Medicine and Biology (FSBMB), as well as Respironics, Resmed, and Covidien. The publication is supported by an unrestrictive educational grant from Kai sensor Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia MS, 2004, J INT NEUROPSYCH SOC, V10, P772, DOI 10.1017/S1355617704105134; Archbold KH, 2009, J CLIN SLEEP MED, V5, P21; Ayalon L, 2009, J SLEEP RES; Ayalon L, 2006, NEUROIMAGE, V31, P1817, DOI 10.1016/j.neuroimage.2006.02.042; Ayalon L, 2009, SLEEP, V32, P373, DOI 10.1093/sleep/32.3.373; Bartlett DJ, 2004, SLEEP MED, V5, P593, DOI 10.1016/j.sleep.2004.08.004; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Castronovo V, 2009, SLEEP, V32, P1161, DOI 10.1093/sleep/32.9.1161; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Choo WC, 2005, NEUROIMAGE, V25, P579, DOI 10.1016/j.neuroimage.2004.11.029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Drummond SPA, 2005, SLEEP, V28, P1059; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Farre R, 1999, LANCET, V353, P1154, DOI 10.1016/S0140-6736(99)01056-9; Felver-Gant JC, 2007, J CLIN SLEEP MED, V3, P589; Ferini-Strambi L, 2003, BRAIN RES BULL, V61, P87, DOI 10.1016/S0361-9230(03)00068-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gazdzinski S, 2010, OBESITY, V18, P743, DOI 10.1038/oby.2009.325; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Grady CL, 2009, CEREB CORTEX; Gujar N, 2009, J COGN NEUROSCI; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Kim DH, 2002, MAGNET RESON MED, V48, P715, DOI 10.1002/mrm.10267; Lau EYY, 2010, J INT NEUROPSYCH SOC, V16, P1077, DOI 10.1017/S1355617710000901; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; O'Donoghue FJ, 2012, SLEEP, V35, P41, DOI 10.5665/sleep.1582; Prilipko O, 2011, SLEEP, V34, P293, DOI 10.1093/sleep/34.3.293; Quan SF, 2011, SLEEP, V34, P303, DOI 10.1093/sleep/34.3.303; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saunamaki T, 2007, ACTA NEUROL SCAND, V115, P1, DOI 10.1111/j.1600-0404.2006.00744.x; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933	47	23	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e47433	10.1371/journal.pone.0047433	http://dx.doi.org/10.1371/journal.pone.0047433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227139	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200002
J	Sibley, CG; Bulbulia, J				Sibley, Chris G.; Bulbulia, Joseph			Faith after an Earthquake: A Longitudinal Study of Religion and Perceived Health before and after the 2011 Christchurch New Zealand Earthquake	PLOS ONE			English	Article							SIGNALING THEORY; EVOLUTION; BELIEF; SPIRITUALITY; ADJUSTMENT; RESPONSES; DISPLAYS; PSALMS; MODEL; GOODS	On 22 February 2011, Christchurch New Zealand (population 367,700) experienced a devastating earthquake, causing extensive damage and killing one hundred and eighty-five people. The earthquake and aftershocks occurred between the 2009 and 2011 waves of a longitudinal probability sample conducted in New Zealand, enabling us to examine how a natural disaster of this magnitude affected deeply held commitments and global ratings of personal health, depending on earthquake exposure. We first investigated whether the earthquake-affected were more likely to believe in God. Consistent with the Religious Comfort Hypothesis, religious faith increased among the earthquake-affected, despite an overall decline in religious faith elsewhere. This result offers the first population-level demonstration that secular people turn to religion at times of natural crisis. We then examined whether religious affiliation was associated with differences in subjective ratings of personal health. We found no evidence for superior buffering from having religious faith. Among those affected by the earthquake, however, a loss of faith was associated with significant subjective health declines. Those who lost faith elsewhere in the country did not experience similar health declines. Our findings suggest that religious conversion after a natural disaster is unlikely to improve subjective well-being, yet upholding faith might be an important step on the road to recovery. Citation: Sibley CG, Bulbulia J (2012) Faith after an Earthquake: A Longitudinal Study of Religion and Perceived Health before and after the 2011 Christchurch New Zealand Earthquake. PLoS ONE 7(12): e49648. doi:10.1371/journal.pone.0049648	[Bulbulia, Joseph] Univ New Zealand, Wellington, New Zealand; [Sibley, Chris G.] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Bulbulia, J (corresponding author), Univ New Zealand, Wellington, New Zealand.	Joseph.Bulbulia@vuw.ac.nz	Sibley, Chris G/D-2974-2009	Sibley, Chris G/0000-0002-4064-8800; Bulbulia, Joseph/0000-0002-5861-2056	University of Auckland FRDF [3624435/9853]; ECREA [3626075]; The Interacting Minds Project; Religion Cognition and Culture Unit at Aarhus University; Victoria University URF Grant [8-3046-108855]	University of Auckland FRDF; ECREA; The Interacting Minds Project; Religion Cognition and Culture Unit at Aarhus University; Victoria University URF Grant	Collection of the New Zealand Attitudes and Values Study 2009 (NZAVS-09) data analyzed in this paper was funded by University of Auckland FRDF (#3624435/9853) and ECREA (#3626075) grants awarded to Chris Sibley. The Interacting Minds Project and Religion Cognition and Culture Unit at Aarhus University, and Victoria University URF Grant (8-3046-108855) supported Joseph Bulbulia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorta CS, 2005, HUM NATURE-INT BIOS, V16, P323, DOI 10.1007/s12110-005-1014-3; [Anonymous], 2004, MODES RELIG COGNITIV; Atkinson QD, 2011, EVOL HUM BEHAV, V32, P41, DOI 10.1016/j.evolhumbehav.2010.07.008; Atran S, 2004, BEHAV BRAIN SCI, V27, P713, DOI 10.1017/S0140525X04000172; Atran S., 2002, GODS WE TRUST EVOLUT; Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Barrett HC, 2005, EVOL HUM BEHAV, V26, P313, DOI 10.1016/j.evolhumbehav.2004.08.015; Boyer P, 2006, BEHAV BRAIN SCI, V29, P595, DOI 10.1017/S0140525X06009332; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Bulbulia J., 2008, EVOLUTION RELIG STUD, P153; Bulbulia J, 2013, CONT TOP COGN NEUROS, P169; Bulbulia J, 2012, NUMEN-INT REV HIST R, V59, P564, DOI 10.1163/15685276-12341240; Bulbulia J, 2011, RELIGION, V41, P363, DOI 10.1080/0048721X.2011.604508; Bulbulia J, 2012, BIOL PHILOS, V27, P1, DOI 10.1007/s10539-011-9295-x; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Cambell David, 2003, RELIG SOCIAL CAPITAL, P87; Chen DL, 2010, J POLIT ECON, V118, P300, DOI 10.1086/652462; Cummins RA, 2003, SOC INDIC RES, V64, P159, DOI 10.1023/A:1024704320683; Dennett D. C., 2006, BREAKING SPELL RELIG; Festinger L, 1956, PROPHECY FAILS, DOI 10.1037/10030-000; Feuerbach Ludwig, 1957, ESSENCE CHRISTIANITY; Frazier W, 2009, THESIS MISSISSIPPI S; Freud Sigmund, 1927, FUTURE ILLUSION; Geertz AW, 2010, METH THEORY STUD REL, V22, P304, DOI 10.1163/157006810X531094; Geertz AW, 1999, HIST REFLECTIONS, V25, P445; Gervais W, 2011, RELIGION, P41; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Gray K, 2010, PERS SOC PSYCHOL REV, V14, P7, DOI 10.1177/1088868309350299; Haidt J, 2009, SOCIAL PSYCHOL BASES, P371, DOI [10.1093/acprof:oso/9780195320916.003.015, DOI 10.1093/ACPROF:OSO/9780195320916.003.015]; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Hick J, 1966, EVIL GOD LOVE; Houkamau CA, 2011, SOC INDIC RES, V103, P379, DOI 10.1007/s11205-010-9705-5; Hoverd W, 2008, NZ SOCIOLOGY, V23, P41; Hoverd W. J., 2010, NZ SOCIOLOGY, V25, P59; Hoverd WJ, 2012, J SCI STUD RELIG, V51, P286, DOI 10.1111/j.1468-5906.2012.01643.x; Inzlicht M, 2011, RELIG BRAIN BEHAV, V1, P192, DOI 10.1080/2153599X.2011.647849; Inzlicht M, 2010, PSYCHOL SCI, V21, P1184, DOI 10.1177/0956797610375451; Irons W., 2001, EVOLUTION CAPACITY C, P292; Johnson DDP, 2005, HUM NATURE-INT BIOS, V16, P410, DOI 10.1007/s12110-005-1017-0; Johnson Dominic., 2006, EVOLUTIONARY PSYCHOL, P4, DOI [10.1177/147470490600400119, DOI 10.1177/147470490600400119]; Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Kay AC, 2010, J PERS SOC PSYCHOL, V99, P725, DOI 10.1037/a0021140; Kay AC, 2010, PSYCHOL SCI, V21, P216, DOI 10.1177/0956797609357750; Koenig H. G, 2001, HDB RELIG HLTH; Lanman JA, 2012, J CONTEMP RELIG, V27, P49, DOI 10.1080/13537903.2012.642726; Leibniz GW., 1710, THEODICY ESSAYS GOOD; Lewis D., 1993, PHILOS PAP, V22, P149; Lienard P, 2006, AM ANTHROPOL, V108, P814, DOI 10.1525/aa.2006.108.4.814; Luhrmann Tanya M., 2012, GOD TALKS BACK UNDER; Malinowski Bronislaw, 1948, MAGIC SCI RELIG OTHE; Marx K, 1867, CAPTIAL CRITIQUE POL; McClenon James., 2002, WONDROUS HEALING SHA; MCINTOSH DN, 1993, J PERS SOC PSYCHOL, V65, P812, DOI 10.1037/0022-3514.65.4.812; McKay RT, 2009, BEHAV BRAIN SCI, V32, P493, DOI 10.1017/S0140525X09990975; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Morris P, 2002, SPIRIT STRANGE LAND; Norenzayan A, 2006, PERS SOC PSYCHOL B, V32, P174, DOI 10.1177/0146167205280251; Norenzayan A, CULTURAL EV IN PRESS; Norenzayan A, MAKING BIG IN PRESS; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Norris Pippa, 2004, SACRED SECULAR RELIG; Paldam M, 2012, RELIG TRANSITION LON; PALOUTZIAN RF, 1978, J PSYCHOL THEOL, V6, P266, DOI 10.1177/009164717800600403; Pargament K.I., 1997, PSYCHOL RELIG COPING; Putnam R.D., 2000, COLLAPSE REVIVAL AM; Richerson PJ, 2013, STRUNGMANN FORUM REP, P1; Richman K, 2012, STUD RELIG-SCI RELIG, V41, P148, DOI 10.1177/0008429812441314; Salsman JM, 2005, PERS SOC PSYCHOL B, V31, P522, DOI 10.1177/0146167204271563; Schjodt U, 2007, J COGN CULT, V7, P313, DOI 10.1163/156853707X208530; Schjoedt U, RELIG BRAIN IN PRESS; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schloss J, 2008, EVOLUTION RELIG STUD, P197; Seirmarco G, 2012, PSYCHOL RELIG SPIRIT, V4, P10, DOI 10.1037/a0023479; Shariff AF, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P119; Sibley C. G., 2012, J COGNITIVE SCI RELI, V1, P29, DOI DOI 10.1558/JCSR.V1I1.29; Sibley CG, 2011, SOC INDIC RES, V104, P103, DOI 10.1007/s11205-010-9729-x; Sosis R, 2007, CURR ANTHROPOL, V48, P903, DOI 10.1086/523015; Sosis Richard, 2003, Hum Nat, V14, P91, DOI 10.1007/s12110-003-1000-6; Sosis R, 2011, AM ANTHROPOL, V113, P40, DOI 10.1111/j.1548-1433.2010.01305.x; Sterelny Kim, 2007, Biology Theory, V2, P317, DOI 10.1162/biot.2007.2.3.317; Trevino KM, 2007, SOUTH MED J, V100, P946, DOI 10.1097/SMJ.0b013e3181454660; Turchin P., 2006, WAR PEACE WAR; Vazquez C, 2005, J ANXIETY DISORD, V19, P313, DOI 10.1016/j.janxdis.2004.03.002; Wilson DS, 2009, EVOL HUM BEHAV, V30, P190, DOI 10.1016/j.evolhumbehav.2008.12.002; Wilson DS, 2005, HUM NATURE-INT BIOS, V16, P382, DOI 10.1007/s12110-005-1016-1; Wilson DS, 2002, DRAWINS CATHEDRAL EV; Xygalatas Dimitris, 2008, EVOLUTION RELIG STUD, P189; Zuckerman P, 2009, SOCIOL COMPASS, V3, P949, DOI 10.1111/j.1751-9020.2009.00247.x; Zuckerman Phil., 2008, SOC GOD WHAT LEAST R	91	97	98	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49648	10.1371/journal.pone.0049648	http://dx.doi.org/10.1371/journal.pone.0049648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227147	Green Published, gold			2022-12-25	WOS:000312588200010
J	Okumura, F; Okumura, AJ; Uematsu, K; Hatakeyama, S; Zhang, DE; Kamura, T				Okumura, Fumihiko; Okumura, Akiko J.; Uematsu, Keiji; Hatakeyama, Shigetsugu; Zhang, Dong-Er; Kamura, Takumi			Activation of Double-stranded RNA-activated Protein Kinase (PKR) by Interferon-stimulated Gene 15 (ISG15) Modification Down-regulates Protein Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; ANTIVIRAL MOLECULE; CONJUGATION SYSTEM; VIRUS-INFECTION; MESSENGER-RNA; NS1 PROTEIN; P68 KINASE; IDENTIFICATION; ISGYLATION; LIGASE	The ubiquitin-like molecule ISG15 (UCRP) and protein modification by ISG15 (ISGylation) are strongly induced by interferon, genotoxic stress, and pathogen infection, suggesting that ISG15 plays an important role in innate immune responses. However, how ISGylation contributes to innate immune responses is not clear. The dsRNA-dependent protein kinase (PKR) inhibits translation by phosphorylating eIF2 alpha to exert its anti-viral effect. ISG15 and PKR are induced by interferon, suggesting that a relationship exists between ISGylation and translational regulation. Here, we report that PKR is ISGylated at lysines 69 and 159. ISG15-modified PKR is active in the absence of virus infection and phosphorylates eIF2 alpha to down-regulate protein translation. The present study describes a novel pathway for the activation of PKR and the regulation of protein translation.	[Okumura, Fumihiko; Okumura, Akiko J.; Uematsu, Keiji; Kamura, Takumi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Sapporo, Hokkaido 0608638, Japan; [Zhang, Dong-Er] Univ Calif San Diego, Dept Pathol, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Nagoya University; Hokkaido University; University of California System; University of California San Diego; University of California System; University of California San Diego	Okumura, F (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan.	okumura.fumihiko@a.mbox.nagoya-u.ac.jp; z47617a@nucc.cc.nagoya-u.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979	Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [24112006, 23659144] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid from Scientific Research on Innovative Areas and grants from the Ministry of Education, Science, Sports, and Culture of Japan.	Chen LM, 2011, INT J BIOCHEM CELL B, V43, P1427, DOI 10.1016/j.biocel.2011.06.006; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; FENG GS, 1992, P NATL ACAD SCI USA, V89, P5447, DOI 10.1073/pnas.89.12.5447; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Ishibashi O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001614; JARVIS AP, 1978, CELL, V14, P879, DOI 10.1016/0092-8674(78)90343-4; Jeon YJ, 2012, J CLIN INVEST, V122, P2622, DOI 10.1172/JCI61762; Jeon YJ, 2009, EMBO REP, V10, P374, DOI 10.1038/embor.2009.23; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Ketscher L, 2012, BIOCHEM BIOPH RES CO, V417, P135, DOI 10.1016/j.bbrc.2011.11.071; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; KORANT BD, 1984, J BIOL CHEM, V259, P4835; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova O, 2002, J BIOL CHEM, V277, P14703, DOI 10.1074/jbc.M111527200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Okumura F, 2011, BBA-MOL CELL RES, V1813, P1784, DOI 10.1016/j.bbamcr.2011.05.013; Okumura F, 2008, J BIOL CHEM, V283, P24484, DOI 10.1074/jbc.M803795200; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Oudshoorn D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029870; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	49	61	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2839	2847		10.1074/jbc.M112.401851	http://dx.doi.org/10.1074/jbc.M112.401851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229543	hybrid, Green Published			2022-12-25	WOS:000314211500066
J	Tran, DA; Shakeshaft, A; Ngo, AD; Rule, J; Wilson, DP; Zhang, L; Doran, C				Dam Anh Tran; Shakeshaft, Anthony; Ngo, Anh Duc; Rule, John; Wilson, David P.; Zhang, Lei; Doran, Christopher			Structural Barriers to Timely Initiation of Antiretroviral Treatment in Vietnam: Findings from Six Outpatient Clinics	PLOS ONE			English	Article							UP HIV TREATMENT; SCALE-UP; THERAPY; STIGMA; ZAMBIA; CARE; ART	In Vietnam, premature mortality due to AIDS-related conditions is commonly associated with late initiation to antiretroviral therapy (ART). This study explores reasons for late ART initiation among people living with HIV (PLHIV) from the perspectives of health care providers and PLHIV. The study was undertaken in six clinics from five provinces in Vietnam. Baseline CD4 counts were collected from patient records and grouped into three categories: very late initiators (<= 100 cells/mm(3) CD4), late initiators (100-200 cells/mm(3)) and timely initiators (200-350 cells/mm(3)). Thirty in-depth interviews with patients who started ART and 15 focus group discussions with HIV service providers were conducted and thematic analysis of the content performed. Of 934 patients, 62% started ART very late and 11% initiated timely treatment. The proportion of patients for whom a CD4 count was obtained within six months of their HIV diagnosis ranged from 22% to 72%. The proportion of patients referred to ART clinics by voluntary testing and counselling centres ranged from 1% to 35%. Structural barriers to timely ART initiation were poor linkage between HIV testing and HIV care and treatment services, lack of patient confidentiality and a shortage of HIV/AIDS specialists. If Vietnam's treatment practice is to align with WHO recommendations then the connection between voluntary counselling and testing service and ART clinics must be improved. Expansion and decentralization of HIV/AIDS services to allow implementation at the community level increased task sharing between doctors and nurses to overcome limited human resources, and improved patient confidentiality are likely to increase timely access to HIV treatment services for more patients.	[Dam Anh Tran; Shakeshaft, Anthony] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Dam Anh Tran; Wilson, David P.; Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Ngo, Anh Duc] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Rule, John] Univ New S Wales, Sch Publ Hlth, Sydney, NSW, Australia; [Doran, Christopher] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; University of South Australia; University of New South Wales Sydney; Hunter Medical Research Institute; University of Newcastle	Tran, DA (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia.	d.tran@unsw.edu.au; lzhang@kirby.unsw.edu.au	Wilson, David P/G-4614-2013; Shakeshaft, Anthony/U-4637-2017; Zhang, Lei/D-4039-2011	Shakeshaft, Anthony/0000-0002-5472-0930; Zhang, Lei/0000-0003-2343-084X; Tran, Anh Dam/0000-0001-8677-4637				[Anonymous], 2010, VIETN 2010 COUNTR PR; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Crisp N, 2008, LANCET, V371, P689, DOI 10.1016/S0140-6736(08)60309-8; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; George G, 2010, AIDS CARE, V22, P77, DOI 10.1080/09540120903544439; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kudale A, 2010, AIDS CARE, V22, P85, DOI 10.1080/09540121003758531; Maher L, 2007, INT J DRUG POLICY, V18, P296, DOI 10.1016/j.drugpo.2006.12.006; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; Nhan TD, 2010, CONTR NAT HIV AIDS C; Ha PN, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.4625; Pharris A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-705; Pharris A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016017; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Riyarto S, 2010, HEALTH POLICY PLANN, V25, P272, DOI 10.1093/heapol/czq004; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Turan J, 2011, AIDS BEHAV; Vietnam Administrative for HIV/AIDS Control, 2011, NAT HIV AIDS EP 1 3; Vietnam Ministry of Health, 2009, NAT GUID HIV AIDS DI; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; Walsh A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-272; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2006, ANT THER HIV INF AD	26	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51289	10.1371/journal.pone.0051289	http://dx.doi.org/10.1371/journal.pone.0051289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23240013	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000312290800049
J	Diaz-Ramos, A; Roig-Borrellas, A; Garcia-Melero, A; Llorens, A; Lopez-Alemany, R				Diaz-Ramos, Angels; Roig-Borrellas, Anna; Garcia-Melero, Ana; Llorens, Ana; Lopez-Alemany, Roser			Requirement of Plasminogen Binding to Its Cell-Surface Receptor alpha-Enolase for Efficient Regeneration of Normal and Dystrophic Skeletal Muscle	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; ACTIVATOR UPA; EXPRESSION; BETA; MYOGENESIS; MONOCYTES; IDENTIFICATION; INHIBITION; ISOFORMS; SYSTEM	Adult regenerative myogenesis is central for restoring normal tissue structure and function after muscle damage. In muscle repair after injury, as in severe myopathies, damaged and necrotic fibers are removed by infiltrating inflammatory cells and then replaced by muscle stem cells or satellite cells, which will fuse to form new myofibers. Extracellular proteolysis mediated by uPA-generated plasmin plays a critical role in controlling inflammation and satellite-cell-dependent myogenesis. alpha-enolase has been described as plasminogen receptor in several cell types, where it acts concentrating plasmin proteolytic activity on the cell surface. In this study, we investigated whether alpha-enolase plasminogen receptor plays a regulatory role during the muscular repair process. Inhibitors of alpha-enolase/plasminogen binding: MAb11G1 (a monoclonal antibody against alpha-enolase) and e-aminocaproic acid, EACA (a lysine analogue) inhibited the myogenic abilities of satellite cells-derived myoblasts. Furthermore, knockdown of alpha-enolase decreased myogenic fusion of myoblasts. Injured wild-type mice and dystrophic mdx mice were also treated with MAb11G1 and EACA. These treatments had negative impacts on muscle repair impairing satellite cell functions in vitro in agreement with blunted growth of new myofibers in vivo. Furthermore, both MAb11G1 and EACA treatments impaired adequate inflammatory cell infiltration and promoted extracellular matrix deposition in vivo, which resulted in persistent degeneration. These results demonstrate the novel requirement of alpha-enolase for restoring homeostasis of injured muscle tissue, by controlling the pericellular localization of plasmin activity.	[Diaz-Ramos, Angels; Roig-Borrellas, Anna; Garcia-Melero, Ana; Llorens, Ana; Lopez-Alemany, Roser] IDIBELL Inst Invest Biomed Bellvitge, Biol Clues Invas & Metastat Phenotype Res Grp, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Lopez-Alemany, R (corresponding author), IDIBELL Inst Invest Biomed Bellvitge, Biol Clues Invas & Metastat Phenotype Res Grp, Barcelona, Spain.	rlopez@idibell.cat	Lopez-Alemany, Roser/R-3565-2018	Lopez-Alemany, Roser/0000-0002-0913-0691	Ministerio de Ciencia e Innovacion, Spain [SAF2004-04717, SAF2007-63596]; Association Francaise des Myopathies, France [AFM 9869]; AFM	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Association Francaise des Myopathies, France; AFM(Association Francaise contre les Myopathies)	This study was supported by the Ministerio de Ciencia e Innovacion, Spain (SAF2004-04717, SAF2007-63596) and Association Francaise des Myopathies, France (AFM 9869). M.A.D. was supported by an AFM pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bryer SC, 2007, AM J PHYSIOL-REG I, V293, pR1152, DOI 10.1152/ajpregu.00132.2007; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Das R, 2009, CIRC RES, V105, P167, DOI 10.1161/CIRCRESAHA.109.200311; De Sousa LP, 2005, BIOCHEM BIOPH RES CO, V329, P237, DOI 10.1016/j.bbrc.2005.01.123; Fisher BA, 2011, ANN RHEUM DIS, V70, P1095, DOI 10.1136/ard.2010.138909; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Herren T, 2006, BIOCHEMISTRY-US, V45, P9463, DOI 10.1021/bi060756w; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Keller A, 2007, BBA-GEN SUBJECTS, V1770, P919, DOI 10.1016/j.bbagen.2007.01.015; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Lluis F, 2001, BLOOD, V97, P1703, DOI 10.1182/blood.V97.6.1703; Lopez-Alemany R, 2003, THROMB HAEMOSTASIS, V90, P724, DOI 10.1160/TH03-04-0291; Lopez-Alemany R, 2003, AM J HEMATOL, V72, P234, DOI 10.1002/ajh.10299; LOPEZALEMANY R, 1994, THROMB RES, V75, P371, DOI 10.1016/0049-3848(94)90252-6; Merkulova T, 2000, EUR J BIOCHEM, V267, P3735, DOI 10.1046/j.1432-1327.2000.01408.x; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Montes A, 2011, ARTHRITIS RHEUM-US, V63, P654, DOI 10.1002/art.30186; MunozCanoves P, 1997, THROMB HAEMOSTASIS, V77, P526; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; Sousa LP, 2005, BIOCHEM BIOPH RES CO, V337, P1065, DOI 10.1016/j.bbrc.2005.09.154; STEIN O, 1993, ARTERIOSCLER THROMB, V13, P1350, DOI 10.1161/01.ATV.13.9.1350; Suelves M, 2005, FRONT BIOSCI-LANDMRK, V10, P2978, DOI 10.2741/1754; Suelves M, 2002, BLOOD, V99, P2835, DOI 10.1182/blood.V99.8.2835; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; TAYLOR JM, 1995, J BIOL CHEM, V270, P2535, DOI 10.1074/jbc.270.6.2535; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Wold F., 1971, ENZYMES, P499; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Zhou WD, 2010, J PROTEOME RES, V9, P2929, DOI 10.1021/pr901109w	42	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50477	10.1371/journal.pone.0050477	http://dx.doi.org/10.1371/journal.pone.0050477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239981	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800019
J	Evans, RD; Murray, KL; Field, SN; Moore, JAY; Shedrawi, G; Huntley, BG; Fearns, P; Broomhall, M; McKinna, LIW; Marrable, D				Evans, Richard D.; Murray, Kathy L.; Field, Stuart N.; Moore, James A. Y.; Shedrawi, George; Huntley, Barton G.; Fearns, Peter; Broomhall, Mark; McKinna, Lachlan I. W.; Marrable, Daniel			Digitise This! A Quick and Easy Remote Sensing Method to Monitor the Daily Extent of Dredge Plumes	PLOS ONE			English	Article							ENVIRONMENTAL IMPACTS; SEDIMENTATION; TECHNOLOGIES; TEMPERATURE; SETTLEMENT	Technological advancements in remote sensing and GIS have improved natural resource managers' abilities to monitor large-scale disturbances. In a time where many processes are heading towards automation, this study has regressed to simple techniques to bridge a gap found in the advancement of technology. The near-daily monitoring of dredge plume extent is common practice using Moderate Resolution Imaging Spectroradiometer (MODIS) imagery and associated algorithms to predict the total suspended solids (TSS) concentration in the surface waters originating from floods and dredge plumes. Unfortunately, these methods cannot determine the difference between dredge plume and benthic features in shallow, clear water. This case study at Barrow Island, Western Australia, uses hand digitising to demonstrate the ability of human interpretation to determine this difference with a level of confidence and compares the method to contemporary TSS methods. Hand digitising was quick, cheap and required very little training of staff to complete. Results of ANOSIM R statistics show remote sensing derived TSS provided similar spatial results if they were thresholded to at least 3 mg L-1. However, remote sensing derived TSS consistently provided false-positive readings of shallow benthic features as Plume with a threshold up to TSS of 6 mg L-1, and began providing false-negatives (excluding actual plume) at a threshold as low as 4 mg L-1. Semi-automated processes that estimate plume concentration and distinguish between plumes and shallow benthic features without the arbitrary nature of human interpretation would be preferred as a plume monitoring method. However, at this stage, the hand digitising method is very useful and is more accurate at determining plume boundaries over shallow benthic features and is accessible to all levels of management with basic training.	[Evans, Richard D.; Murray, Kathy L.; Field, Stuart N.; Moore, James A. Y.; Shedrawi, George; Huntley, Barton G.] Dept Environm & Conservat, Kensington, WA, Australia; [Evans, Richard D.; Field, Stuart N.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Fearns, Peter; Broomhall, Mark; McKinna, Lachlan I. W.; Marrable, Daniel] Curtin Univ Technol, Remote Sensing & Satellite Res Grp, Dept Imaging & Appl Phys, Bentley, WA 6102, Australia	University of Western Australia; Curtin University	Evans, RD (corresponding author), Dept Environm & Conservat, Kensington, WA, Australia.	richard.evans@dec.wa.gov.au	Evans, Richard D./O-3559-2019; Evans, Richard D/K-5779-2013; Broomhall, Mark/C-1658-2013; Moore, James/K-3698-2013; McKinna, Lachlan/E-4312-2013; Fearns, Peter/A-5291-2008	Evans, Richard D./0000-0003-4364-4810; Broomhall, Mark/0000-0002-0255-4205; Moore, James/0000-0003-4641-8667; Fearns, Peter/0000-0002-2747-9037; Huntley, Barton/0000-0002-9519-4105; Shedrawi, George/0000-0002-4507-7293	Dredging Audit and Surveillance Program by the Gorgon Joint Venture as part of the environmental offsets	Dredging Audit and Surveillance Program by the Gorgon Joint Venture as part of the environmental offsets	This project was funded as part of the Dredging Audit and Surveillance Program by the Gorgon Joint Venture as part of the environmental offsets. The Gorgon project is a joint venture of the Australian subsidiaries of Chevron, Exxonmobil, Shell, Osaka Gas, Tokyo Gas and Chubu Electric Power. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez F, 2003, OCEAN COAST MANAGE, V46, P583, DOI 10.1016/S0964-5691(03)00036-X; BABCOCK R, 1991, CORAL REEFS, V9, P205, DOI 10.1007/BF00290423; Bainbridge ZT, 2012, MAR POLLUT BULL, V65, P236, DOI 10.1016/j.marpolbul.2012.01.043; Baith K., 2001, EOS T AM GEOPHYS UN, V82, P202, DOI [10.1029/01eo00109, DOI 10.1029/01E000109, DOI 10.1029/01EO00109]; BAK RPM, 1978, MAR POLLUT BULL, V9, P14, DOI 10.1016/0025-326X(78)90275-8; Chevron-Australia, 2009, G1NTPLNX0000373 CHEV, P255; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; DEC (Department of Environment and Conservation), 2007, MAN PLAN MONT BARR I; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Dickins D, 2011, COLD REG SCI TECHNOL, V65, P275, DOI 10.1016/j.coldregions.2010.10.015; Eastman J. R., 2009, IDRISI TAIGA; Erftemeijer PLA, 2006, MAR POLLUT BULL, V52, P1553, DOI 10.1016/j.marpolbul.2006.09.006; ESRI, 1999, ARCGIS 9.2 Build 1500, Patent No. [Patent No. 5 710 835, 5710835]; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Gutman G, 2012, INT J REMOTE SENS, V33, P4700, DOI 10.1080/01431161.2011.638341; Heath B, 2002, P 11 AUSTR RERM SENS, P476; IMCRA, 2006, GUID INT MAR COAST R; Islam A, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2834768; Johnston CA, 1998, GEOGRAPHIC INFORM SY; Kutser T, 2007, J COASTAL RES, P180; Lambrechts J, 2010, ESTUAR COAST SHELF S, V89, P154, DOI 10.1016/j.ecss.2010.06.009; Lyngby JE, 1996, MAR ECOL-P S Z N I, V17, P345, DOI 10.1111/j.1439-0485.1996.tb00513.x; Mas JF, 2004, ENVIRON MODELL SOFTW, V19, P461, DOI 10.1016/S1364-8152(03)00161-0; Miller RL, 2004, REMOTE SENS ENVIRON, V93, P259, DOI 10.1016/j.rse.2004.07.012; Modarres R, 2007, J STAT PLAN INFER, V137, P3643, DOI 10.1016/j.jspi.2007.03.040; Ni-Meister W., 2000, REMOTE SENSING REV, V18, P441; Partridge GJ, 2010, J FISH BIOL, V77, P227, DOI 10.1111/j.1095-8649.2010.02679.x; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Purdy R, 2010, J ENVIRON LAW, V22, P59, DOI 10.1093/jel/eqp027; Qian YG, 2012, INT J REMOTE SENS, V33, P5009, DOI 10.1080/01431161.2012.657365; Rodriguez-Guzman V., 2009, INT J SYSTEMS APPL E, V1, P36; Satapathy DR, 2008, INT J REMOTE SENS, V29, P355, DOI 10.1080/01431160701269002; Scott LP, 2007, J APPL REMOTE SENS, V1; Smith R, 1998, ANTIGONISH REV, P9; Vargas-Angel B, 2007, J INVERTEBR PATHOL, V95, P140, DOI 10.1016/j.jip.2007.01.003; Wells FE, 2000, RECORDS W AUSTR MUSE, P9; William BG, 2007, J APPL REMOTE SENS, V1; Wilson JS, 2005, J URBAN PLAN DEV, V131, P159, DOI 10.1061/(ASCE)0733-9488(2005)131:3(159)	39	26	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51668	10.1371/journal.pone.0051668	http://dx.doi.org/10.1371/journal.pone.0051668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240055	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800091
J	Rafiq, S; Russell, ML; Webby, R; Fonseca, K; Smieja, M; Singh, P; Loeb, M				Rafiq, Sajjad; Russell, Margaret L.; Webby, Richard; Fonseca, Kevin; Smieja, Marek; Singh, Pardeep; Loeb, Mark			Serological Response to Influenza Vaccination among Children Vaccinated for Multiple Influenza Seasons	PLOS ONE			English	Article								Background: To evaluate if, among children aged 3 to 15 years, influenza vaccination for multiple seasons affects the proportion sero-protected. Methodology/Principal Findings: Participants were 131 healthy children aged 3-15 years. Participants were vaccinated with trivalent inactivated seasonal influenza vaccine (TIV) over the 2005-06, 2006-07 and 2007-8 seasons. Number of seasons vaccinated were categorized as one (2007-08); two (2007-08 and 2006-07 or 2007-08 and 2005-06) or three (2005-06, 2006-07, and 2007-08). Pre- and post-vaccination sera were collected four weeks apart. Antibody titres were determined by hemagglutination inhibition (HAI) assay using antigens to A/Solomon Islands/03/06 (H1N1), A/Wisconsin/67/05 (H3N2) and B/Malaysia/2506/04. The proportions sero-protected were compared by number of seasons vaccinated using cut-points for seroprotection of 1:40 vs. 1:320. The proportions of children sero-protected against H1N1 and H3N2 was high (>85%) regardless of number of seasons vaccinated and regardless of cut-point for seroprotection. For B Malaysia there was no change in proportions sero-protected by number of seasons vaccinated; however the proportions protected were lower than for H1N1 and H3N2, and there was a lower proportion sero-protected when the higher, compared to lower, cut-point was used for sero-protection. Conclusion/Significance: The proportion of children sero-protected is not affected by number of seasons vaccinated.	[Russell, Margaret L.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Rafiq, Sajjad; Smieja, Marek; Singh, Pardeep; Loeb, Mark] McMaster Univ, Dept Pathol, Hamilton, ON, Canada; [Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Fonseca, Kevin] Prov Lab Publ Hlth, Calgary, AB, Canada; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Mol Med, Hamilton, ON, Canada; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Biostat, Hamilton, ON, Canada	University of Calgary; McMaster University; St Jude Children's Research Hospital; McMaster University; McMaster University; McMaster University	Russell, ML (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.	mlrussel@ucalgary.ca	Webby, Richard J/N-5657-2018	Rafiq, Sajjad/0000-0003-4873-4540; kumbara, arya/0000-0002-0395-1245	Canadian Institutes for Health Research (CIHR) [XIP 85564]; National Institute of Allergy and Infectious Diseases (NIH) [1 R34 AI072268-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R34AI072268] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Canadian Institutes for Health Research (CIHR): Grant XIP 85564 (http://www.cihr-irsc.gc.ca/) and National Institute of Allergy and Infectious Diseases (NIH): Grant 1 R34 AI072268-01 (http://www.niaid.nih.gov/Pages/default.aspx). Alberta Health and Wellness donated seasonal influenza vaccine for 2005-06 and for 2006-07 (Fluviral (R) GlaxoSmithKline Inc) but provided no funding for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Immunization Practices, 2006, MMWR Recomm Rep, V55, P1; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; BLACK SC, 2011, PEDIATR INFECT DIS J, V40, P30; Canada Health Canada, 2004, Canada Communicable Disease Report, V30, P1; Canada National Advisory Committee on Immunization, 2006, Canada Communicable Disease Report, V32, P1; CDC, 2008, MMWR EARLY RELEASE, V57, P1; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Gross PA, 1999, VACCINE, V17, P2284, DOI 10.1016/S0264-410X(98)00478-2; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453; National Advisory Committee on Immunization (NACI), 2007, Can Commun Dis Rep, V33, P1; Orr P., 2005, Canada Communicable Disease Report, V31, P1; World Health Organization, 2002, WHO MAN AN INFL DIAG; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b	15	0	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51498	10.1371/journal.pone.0051498	http://dx.doi.org/10.1371/journal.pone.0051498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240030	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800066
J	Sokolov, V; Ehrich, D; Yoccoz, NG; Sokolov, A; Lecomte, N				Sokolov, Vasiliy; Ehrich, Dorothee; Yoccoz, Nigel G.; Sokolov, Alexander; Lecomte, Nicolas			Bird Communities of the Arctic Shrub Tundra of Yamal: Habitat Specialists and Generalists	PLOS ONE			English	Article							POPULATION TRENDS; BIOTIC HOMOGENIZATION; ELLESMERE-ISLAND; ALEXANDRA FJORD; RESILIENCE; PENINSULA; FOREST; WILLOW	Background: The ratio of habitat generalists to specialists in birds has been suggested as a good indicator of ecosystem changes due to e. g. climate change and other anthropogenic perturbations. Most studies focusing on this functional component of biodiversity originate, however, from temperate regions. The Eurasian Arctic tundra is currently experiencing an unprecedented combination of climate change, change in grazing pressure by domestic reindeer and growing human activity. Methodology/Principal Findings: Here we monitored bird communities in a tundra landscape harbouring shrub and open habitats in order to analyse bird habitat relationships and quantify habitat specialization. We used ordination methods to analyse habitat associations and estimated the proportions of specialists in each of the main habitats. Correspondence Analysis identified three main bird communities, inhabiting upland, lowland and dense willow shrubs. We documented a stable structure of communities despite large multiannual variations of bird density (from 90 to 175 pairs/km(2)). Willow shrub thickets were a hotspot for bird density, but not for species richness. The thickets hosted many specialized species whose main distribution area was south of the tundra. Conclusion/Significance: If current arctic changes result in a shrubification of the landscape as many studies suggested, we would expect an increase in the overall bird abundance together with an increase of local specialists, since they are associated with willow thickets. The majority of these species have a southern origin and their increase in abundance would represent a strengthening of the boreal component in the southern tundra, perhaps at the expense of species typical of the subarctic zone, which appear to be generalists within this zone.	[Sokolov, Vasiliy] Russian Acad Sci, Ural Div, Inst Plant & Anim Ecol, Ekaterinburg, Russia; [Ehrich, Dorothee; Yoccoz, Nigel G.; Lecomte, Nicolas] Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway; [Sokolov, Alexander] Russian Acad Sci, Ural Div, Inst Plant & Anim Ecol, Ecol Res Stn, Labytnangi, Russia	Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; UiT The Arctic University of Tromso; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences	Sokolov, V (corresponding author), Russian Acad Sci, Ural Div, Inst Plant & Anim Ecol, Ekaterinburg, Russia.	vskolov@inbox.ru; nigel.yoccoz@uit.no	Ehrich, Dorothee/F-6492-2015; Sokolov, Aleksandr/P-3421-2017; Sokolov, Vasiliy/B-3657-2013; Yoccoz, Nigel/C-8561-2014	Ehrich, Dorothee/0000-0002-3028-9488; Sokolov, Aleksandr/0000-0002-1521-3856; Sokolov, Vasiliy/0000-0002-0115-3151; Yoccoz, Nigel/0000-0003-2192-1039; Lecomte, Nicolas/0000-0002-8473-5375	Russian Academy of Sciences [12-Pi-4-1043, 12-4-7-022-Arctic]; Russian Foundation for Basic Research support [11-04-01153-a]; Research Council of Norway through the Yggdrasil program [195738/V11]; University of Tromso; IPY project "Arctic Predators''; Natural Sciences and Engineering Research Council of Canada	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research support; Research Council of Norway through the Yggdrasil program(Research Council of Norway); University of Tromso; IPY project "Arctic Predators''; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Russian Academy of Sciences through the project no. 12-Pi-4-1043 and 12-4-7-022-Arctic (Ural Branch), the Russian Foundation for Basic Research support (grant no. 11-04-01153-a), the Research Council of Norway through the Yggdrasil program (project no. 195738/V11 to V.S.), University of Tromso, and the IPY project "Arctic Predators'' (http://www.arctic-predators.uit.no), as well as a postdoctoral fellowship from Natural Sciences and Engineering Research Council of Canada to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres BA, 2006, ARCTIC, V59, P311, DOI 10.14430/arctic316; [Anonymous], 2010, R LANG ENV STAT COMP; Baril Lisa M., 2009, Yellowstone Science, V17, P19; Barnagaud JY, 2011, GLOBAL ECOL BIOGEOGR, V20, P630, DOI 10.1111/j.1466-8238.2010.00629.x; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Chernov YI, 1997, ECOSY WORLD, V3, P361; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Chessel D, 1987, REV STAT APPL, V35, P55; Clavel J, 2010, FRONTIERS ECOLOGY EN; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Danilov NN, 1984, BIRDS YAMAL; Danilov NN, 1966, P I BIOL UD RAS, P1; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Den Herder M, 2004, J APPL ECOL, V41, P870, DOI 10.1111/j.0021-8901.2004.00952.x; den Herder M, 2008, BASIC APPL ECOL, V9, P324, DOI 10.1016/j.baae.2007.03.005; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P1493, DOI 10.1016/j.biocon.2010.03.031; Forbes BC, 2004, AMBIO, V33, P377, DOI 10.1639/0044-7447(2004)033[0377:GVIADT]2.0.CO;2; Forbes BC, 2009, P NATL ACAD SCI USA, V106, P22041, DOI 10.1073/pnas.0908286106; FREEDMAN B, 1982, CAN FIELD NAT, V96, P56; Golovatin MG, 2010, ENVIRON RES ADV, P1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Greenacre M, 2010, ECOLOGY, V91, P958, DOI 10.1890/09-0239.1; Gregory RD, 2010, ORNITHOL SCI, V9, P3, DOI 10.2326/osj.9.3; Hausner VH, 2003, ECOL APPL, V13, P999, DOI 10.1890/1051-0761(2003)13[999:SITFML]2.0.CO;2; Ims RA, 2007, ECOSYSTEMS, V10, P607, DOI 10.1007/s10021-007-9060-9; Ims RA, 2012, BIOL CONSERV, V149, P2, DOI 10.1016/j.biocon.2012.02.008; Jackson CR, 2011, J NAT CONSERV, V19, P87, DOI 10.1016/j.jnc.2010.06.006; JARVINEN O, 1979, Holarctic Ecology, V2, P75; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Killengreen ST, 2012, DIVERS DISTRIB, V18, P563, DOI 10.1111/j.1472-4642.2011.00861.x; Killengreen ST, 2011, J ANIM ECOL, V80, P1049, DOI 10.1111/j.1365-2656.2011.01840.x; KUCHERUK V V, 1975, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V80, P52; Liebezeit JR, 2009, ECOL APPL, V19, P1628, DOI 10.1890/08-1661.1; Magomedova MA., 2006, YAMAL PENINSULA VEGE; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Reif J, 2008, BIODIVERS CONSERV, V17, P3307, DOI 10.1007/s10531-008-9430-4; Ripple WJ, 2005, WEST N AM NATURALIST, V65, P269; RODRIGUES R, 1994, ECOL APPL, V4, P110, DOI 10.2307/1942120; Ryabitsev VK, 1993, DISTRIBUTION DYNAMIC; Sammler JE, 2008, CONDOR, V110, P325, DOI 10.1525/cond.2008.8438; Sdobnikov VM, 1937, P ALLUNION ARCTIC I, V94, P1; Shiyatov S., 1995, NATURE YAMAL, P32; Sokolov V.A., 2006, Izvestiya Chelyabinskogo Nauchnogo Tsentra, V3, P109; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TOMIALOJC L, 1990, AUK, V107, P447; Trefry SA, 2010, ARCTIC, V63, P308; Uspenskiy SM, 1960, LATITUDINAL ZONALITY, P55; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Walker DA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045004; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wiens J.A., 1992, ECOLOGY BIRD COMMUNI; Zhitkov BM, 1912, YB ZOOLOGICAL MUSEUM, V17, P311	63	31	33	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50335	10.1371/journal.pone.0050335	http://dx.doi.org/10.1371/journal.pone.0050335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239978	Green Published, gold			2022-12-25	WOS:000312290800016
J	Huang, ZX; Chen, ZS; Ke, CH; Zhao, J; You, WW; Zhang, J; Dong, WT; Chen, J				Huang, Zi-Xia; Chen, Zhi-Sen; Ke, Cai-Huan; Zhao, Jing; You, Wei-Wei; Zhang, Jie; Dong, Wei-Ting; Chen, Jun			Pyrosequencing of Haliotis diversicolor Transcriptomes: Insights into Early Developmental Molluscan Gene Expression	PLOS ONE			English	Article							LARVAL DEVELOPMENT; GASTROPOD HALIOTIS; RNA-SEQ; ABALONE; PROTEIN; IDENTIFICATION; METAMORPHOSIS; SPECIFICATION; TRANSITION; GENERATION	Background: The abalone Haliotis diversicolor is a good model for study of the settlement and metamorphosis, which are widespread marine ecological phenomena. However, information on the global gene backgrounds and gene expression profiles for the early development of abalones is lacking. Methodology/Principal Findings: In this study, eight non-normalized and multiplex barcode-labeled transcriptomes were sequenced using a 454 GS system to cover the early developmental stages of the abalone H. diversicolor. The assembly generated 35,415 unigenes, of which 7,566 were assigned GO terms. A global gene expression profile containing 636 scaffolds/contigs was constructed and was proven reliable using qPCR evaluation. It indicated that there may be existing dramatic phase transitions. Bioprocesses were proposed, including the 'lock system' in mature eggs, the collagen shells of the trochophore larvae and the development of chambered extracellular matrix (ECM) structures within the earliest postlarvae. Conclusion: This study globally details the first 454 sequencing data for larval stages of H. diversicolor. A basic analysis of the larval transcriptomes and cluster of the gene expression profile indicates that each stage possesses a batch of specific genes that are indispensable during embryonic development, especially during the two-cell, trochophore and early postlarval stages. These data will provide a fundamental resource for future physiological works on abalones, revealing the mechanisms of settlement and metamorphosis at the molecular level.	[Huang, Zi-Xia; Chen, Zhi-Sen; Ke, Cai-Huan; Chen, Jun] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Huang, Zi-Xia; Chen, Zhi-Sen; Ke, Cai-Huan; Zhao, Jing; You, Wei-Wei; Zhang, Jie; Dong, Wei-Ting; Chen, Jun] Xiamen Univ, Coll Ocean & Earth Sci, Dept Marine Biol, Xiamen, Peoples R China	Xiamen University; Xiamen University	Chen, J (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	chenjun@xmu.edu.cn	Ke, CH/G-4635-2010; Huang, Zixia/AAO-6936-2021	Huang, Zixia/0000-0002-1298-0486	National Natural Science Foundation of China [40976093]; National Basic Research Program of China (973) [2010CB126403]; Hi-Tech Research and Development (863) Program of China [2012AA10A412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China); Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (General Program, number 40976093), by the National Basic Research Program of China (973) (http://www.973.gov.cn/English/Index.aspx) (number 2010CB126403), and by the Hi-Tech Research and Development (863) Program of China (http://www.863.gov.cn/) (number 2012AA10A412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos J, 2001, DNA CELL BIOL, V20, P625, DOI 10.1089/104454901753340613; Becker S, 2001, GENE, V262, P15, DOI 10.1016/S0378-1119(00)00548-5; Chen J, 2012, INT J DEV BIOL, V56, P369, DOI 10.1387/ijdb.113487zc; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; CONSUL PC, 1973, TECHNOMETRICS, V15, P791, DOI 10.2307/1267389; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; Degnan Bernard M., 1993, Molecular Marine Biology and Biotechnology, V2, P1; DEGNAN BM, 1995, AM ZOOL, V35, P391; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Giusti AF, 2000, EVOL DEV, V2, P294, DOI 10.1046/j.1525-142x.2000.00071.x; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Hinman VF, 2003, EVOL DEV, V5, P508, DOI 10.1046/j.1525-142X.2003.03056.x; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Huan P, 2011, MAR BIOTECHNOL; Isachenko N, 2006, ONCOGENE, V25, P317, DOI 10.1038/sj.onc.1209022; Jackson D, 2005, MAR BIOL, V147, P681, DOI 10.1007/s00227-005-1603-z; Jackson D, 2002, INT J DEV BIOL, V46, P679; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jiang JZ, 2011, MAR GENOM, V4, P189, DOI 10.1016/j.margen.2011.05.001; Kamei N, 2000, DEV BIOL, V225, P267, DOI 10.1006/dbio.2000.9837; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; Larade K, 2004, BIOCHEM CELL BIOL, V82, P285, DOI 10.1139/o04-001; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005; Luetjens CM, 1998, ZYGOTE, V6, P239, DOI 10.1017/S0967199498000185; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Moran AL, 2003, BIOL BULL-US, V204, P270, DOI 10.2307/1543598; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MORSE DE, 1979, SCIENCE, V204, P407, DOI 10.1126/science.204.4391.407; Page LR, 2006, EVOL DEV, V8, P458, DOI 10.1111/j.1525-142X.2006.00119.x; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; RD R, 2001, J SHELLFISH RES, V20; Roberts RJ, 2001, J FISH DIS, V24, P1; Sawatpeera S, 2001, J SHELLFISH RES, V20, P593; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; vandenBiggelaar JAM, 1997, SEMIN CELL DEV BIOL, V8, P367, DOI 10.1006/scdb.1997.0161; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams EA, 2009, MOL ECOL, V18, P4434, DOI 10.1111/j.1365-294X.2009.04371.x; Williams EA, 2009, MOL ECOL, V18, P1006, DOI 10.1111/j.1365-294X.2008.04078.x; Wong YH, 2010, J NEUROSCI, V30, P4428, DOI 10.1523/JNEUROSCI.0473-10.2010; YANG Q, 1989, Science (Washington D C), V246, P806, DOI 10.1126/science.2814501; You WW, 2010, AQUAC RES, V41, P921, DOI 10.1111/j.1365-2109.2009.02376.x; Zhang JC, 1998, J BIOL CHEM, V273, P32273, DOI 10.1074/jbc.273.48.32273	58	31	34	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51279	10.1371/journal.pone.0051279	http://dx.doi.org/10.1371/journal.pone.0051279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236463	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100087
J	Isaias, IU; Volkmann, J; Marzegan, A; Marotta, G; Cavallari, P; Pezzoli, G				Isaias, Ioannis U.; Volkmann, Jens; Marzegan, Alberto; Marotta, Giorgio; Cavallari, Paolo; Pezzoli, Gianni			The Influence of Dopaminergic Striatal Innervation on Upper Limb Locomotor Synergies	PLOS ONE			English	Article							PARKINSONS-DISEASE; BASAL GANGLIA; SPINAL-CORD; WALKING; GAIT; ARM; COORDINATION; MOVEMENTS; PET	To determine the role of striatal dopaminergic innervation on upper limb synergies during walking, we measured arm kinematics in 13 subjects with Parkinson disease. Patients were recruited according to several inclusion criteria to represent the best possible in vivo model of dopaminergic denervation. Of relevance, we included only subjects with normal spatio-temporal parameters of the stride and gait speed to avoid an impairment of upper limbs locomotor synergies as a consequence of gait impairment per se. Dopaminergic innervation of the striatum was measured by FP-CIT and SPECT. All patients showed a reduction of gait-associated arms movement. No linear correlation was found between arm ROM reduction and contralateral dopaminergic putaminal innervation loss. Still, a partition analysis revealed a 80% chance of reduced arm ROM when putaminal dopamine content loss was >47%. A significant correlation was described between the asymmetry indices of the swinging of the two arms and dopaminergic striatal innervation. When arm ROM was reduced, we found a positive correlation between upper-lower limb phase shift modulation ( at different gait velocities) and striatal dopaminergic innervation. These findings are preliminary evidence that dopaminergic striatal tone plays a modulatory role in upper-limb locomotor synergies and upper-lower limb coupling while walking at different velocities.	[Isaias, Ioannis U.; Marzegan, Alberto; Cavallari, Paolo] Univ Milan, Sect Human Physiol Dept, LAMB P&L Mariani, Milan, Italy; [Isaias, Ioannis U.; Pezzoli, Gianni] ICP, CTO, Ctr Malattia Parkinson & Disturbi Movimento, Milan, Italy; [Isaias, Ioannis U.; Volkmann, Jens] Univ Klin Wurzburg, Neurol Klin & Poliklin, Wurzburg, Germany; [Marotta, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Med Nucl, Milan, Italy	University of Milan; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; IRCCS Ca Granda Ospedale Maggiore Policlinico	Isaias, IU (corresponding author), Univ Milan, Sect Human Physiol Dept, LAMB P&L Mariani, Milan, Italy.	iuisaias@yahoo.it	Cavallari, Paolo/C-5145-2012; Volkmann, Jens/AAK-7570-2020; Isaias, Ioannis Ugo/F-4492-2014; Marzegan, Alberto/AAA-8480-2020	Cavallari, Paolo/0000-0003-3160-9030; Isaias, Ioannis Ugo/0000-0002-3552-5144; Marzegan, Alberto/0000-0002-8389-7655; Pezzoli, Gianni/0000-0003-4665-6710; Volkmann, Jens/0000-0002-9570-593X; Marotta, Giorgio/0000-0002-5945-8628	Fondazione Grigioni per la malattia di Parkinson	Fondazione Grigioni per la malattia di Parkinson	The study was supported by the Fondazione Grigioni per la malattia di Parkinson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLESTEROS ML, 1965, ACTA PHYSIOL SCAND, V63, P296, DOI 10.1111/j.1748-1716.1965.tb04069.x; Baltadjeva R, 2006, J COMP NEUROL, V24, P1815; Benamer HTS, 2000, MOVEMENT DISORD, V15, P692, DOI 10.1002/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V; BUCHTAHL F, 1965, BRAIN, V88, P875, DOI 10.1093/brain/88.5.875; Calvini P, 2007, EUR J NUCL MED MOL I, V34, P1240, DOI 10.1007/s00259-006-0357-2; Carpinella I, 2007, IEEE T NEUR SYS REH, V15, P543, DOI 10.1109/TNSRE.2007.908933; Craik R., 1976, NEURAL CONTROL LOCOM, P51; Crenna P, 2008, BRAIN, V131, P3410, DOI 10.1093/brain/awn272; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; Donker SF, 2005, J MOTOR BEHAV, V37, P217, DOI 10.3200/JMBR.37.3.217-230; Doyon J, 1998, NEUROPSYCHOLOGIA, V36, P625, DOI 10.1016/S0028-3932(97)00168-1; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; GARCIARILL E, 1986, BRAIN RES REV, V11, P47, DOI 10.1016/0165-0173(86)90009-3; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; HELLSTRAND E, 1985, ACTA PHYSIOL SCAND, V125, P555, DOI 10.1111/j.1748-1716.1985.tb07756.x; Hirato M, 1995, ADV STER F, V11, P5; Hornykiewicz O, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.2_Suppl_2.S2; Isaias IU, 2010, MOVEMENT DISORD, V25, P679, DOI 10.1002/mds.22870; LINDVALL O, 1983, ANN NEUROL, V14, P255, DOI 10.1002/ana.410140302; Madriaga MA, 2004, J NEUROPHYSIOL, V92, P1566, DOI 10.1152/jn.01181.2003; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Morris ME, 1999, HUM MOVEMENT SCI, V18, P461, DOI 10.1016/S0167-9457(99)00020-2; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; Ouchi Y, 2001, BRAIN, V124, P784, DOI 10.1093/brain/124.4.784; Reiner A, 1998, BRAIN RES REV, V28, P235, DOI 10.1016/S0165-0173(98)00016-2; Stolze H, 2001, J NEUROL NEUROSUR PS, V70, P289, DOI 10.1136/jnnp.70.3.289; Takakusaki K, 2004, NEUROSCI RES, V50, P137, DOI 10.1016/j.neures.2004.06.015; Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Thompson RH, 2008, EUR J NEUROSCI, V27, P1452, DOI 10.1111/j.1460-9568.2008.06125.x; Wannier T, 2001, EXP BRAIN RES, V141, P375, DOI 10.1007/s002210100875; Winn Philip, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS194, DOI 10.1016/j.parkreldis.2008.04.030; Zehr EP, 2004, CAN J PHYSIOL PHARM, V82, P556, DOI 10.1139/Y04-056; Zifchock RA, 2008, GAIT POSTURE, V27, P622, DOI 10.1016/j.gaitpost.2007.08.006	33	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51464	10.1371/journal.pone.0051464	http://dx.doi.org/10.1371/journal.pone.0051464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236504	Green Published, gold			2022-12-25	WOS:000312064100121
J	Macher, HC; Martinez-Broca, MA; Rubio-Calvo, A; Leon-Garcia, C; Conde-Sanchez, M; Costa, A; Navarro, E; Guerrero, JM				Macher, Hada C.; Martinez-Broca, Maria A.; Rubio-Calvo, Amalia; Leon-Garcia, Cristina; Conde-Sanchez, Manuel; Costa, Alzenira; Navarro, Elena; Guerrero, Juan M.			Non-Invasive Prenatal Diagnosis of Multiple Endocrine Neoplasia Type 2A Using COLD-PCR Combined with HRM Genotyping Analysis from Maternal Serum	PLOS ONE			English	Article							CELL-FREE DNA; RESOLUTION MELTING ANALYSIS; CIRCULATING NUCLEIC-ACIDS; FETAL DNA; PREGNANT-WOMEN; BLOOD-PLASMA; DIGITAL PCR; CANCER; SENSITIVITY; MUTATIONS	The multiple endocrine neoplasia type 2A (MEN2A) is a monogenic disorder characterized by an autosomal dominant pattern of inheritance which is characterized by high risk of medullary thyroid carcinoma in all mutation carriers. Although this disorder is classified as a rare disease, the patients affected have a low life quality and a very expensive and continuous treatment. At present, MEN2A is diagnosed by gene sequencing after birth, thus trying to start an early treatment and by reduction of morbidity and mortality. We first evaluated the presence of MEN2A mutation (C634Y) in serum of 25 patients, previously diagnosed by sequencing in peripheral blood leucocytes, using HRM genotyping analysis. In a second step, we used a COLD-PCR approach followed by HRM genotyping analysis for non-invasive prenatal diagnosis of a pregnant woman carrying a fetus with a C634Y mutation. HRM analysis revealed differences in melting curve shapes that correlated with patients diagnosed for MEN2A by gene sequencing analysis with 100% accuracy. Moreover, the pregnant woman carrying the fetus with the C634Y mutation revealed a melting curve shape in agreement with the positive controls in the COLD-PCR study. The mutation was confirmed by sequencing of the COLD-PCR amplification product. In conclusion, we have established a HRM analysis in serum samples as a new primary diagnosis method suitable for the detection of C634Y mutations in MEN2A patients. Simultaneously, we have applied the increase of sensitivity of COLD-PCR assay approach combined with HRM analysis for the non-invasive prenatal diagnosis of C634Y fetal mutations using pregnant women serum.	[Macher, Hada C.; Rubio-Calvo, Amalia; Leon-Garcia, Cristina; Conde-Sanchez, Manuel; Costa, Alzenira; Guerrero, Juan M.] Univ Seville, SAS, CSIC, Dept Clin Biochem,Virgen del Rocio Univ Hosp,IBiS, Seville, Spain; [Martinez-Broca, Maria A.; Navarro, Elena] Univ Seville, SAS, CSIC, Dept Endocrinol,Virgen del Rocio Univ Hosp,IBiS, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Guerrero, JM (corresponding author), Univ Seville, SAS, CSIC, Dept Clin Biochem,Virgen del Rocio Univ Hosp,IBiS, Seville, Spain.	guerrero@us.es	IBIS, HIPERCOLESTERO/P-3953-2015; IBIS, NEUROINMUNO/O-9306-2015; Guerrero, Josep M./Y-2929-2019; Rubio, Amalia/L-1992-2017; Guerrero, Josep M./D-5519-2014	Rubio, Amalia/0000-0002-5905-0534; Guerrero, Josep M./0000-0001-5236-4592; Costa-Martins, Alzenira de Fatima/0000-0003-1788-743X; Guerrero, Juan Miguel/0000-0001-7553-0119; Macher, Hada/0000-0002-8622-1175	Instituto de Salud Carlos III [Red RETICEF RD06/00130001]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by a grant from the Instituto de Salud Carlos III (Red RETICEF RD06/00130001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom G, 2009, SURG CLIN N AM, V89, P1047, DOI 10.1016/j.suc.2009.06.016; Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Chiu RWK, 2011, SEMIN FETAL NEONAT M, V16, P88, DOI 10.1016/j.siny.2010.10.003; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Gagel R F, 1975, Trans Assoc Am Physicians, V88, P177; Moreira VG, 2009, CLIN CHEM, V55, P1958, DOI 10.1373/clinchem.2009.129072; Garcia-Moreira V, 2008, CLIN CHEM LAB MED, V44, P1410; Garcia-Olmo D, 2001, ANN NY ACAD SCI, V945, P265; Garcia-Olmo DC, 2004, HISTOL HISTOPATHOL, V19, P575, DOI 10.14670/HH-19.575; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Illanes S, 2007, EARLY HUM DEV, V83, P563, DOI 10.1016/j.earlhumdev.2006.11.001; Jahr S, 2001, CANCER RES, V61, P1659; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Macher HC, 2012, CLIN CHIM ACTA, V413, P490, DOI 10.1016/j.cca.2011.11.004; Margraf RL, 2006, CLIN CHEM, V52, P138, DOI 10.1373/clinchem.2005.052951; Marini F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-45; Milbury CA, 2011, EXPERT REV MOL DIAGN, V11, P159, DOI [10.1586/ERM.10.115, 10.1586/erm.10.115]; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Minon JM, 2008, TRANSFUSION, V48, P373, DOI 10.1111/j.1537-2995.2007.01533.x; Moline J, 2011, GENET MED, V13, P755, DOI 10.1097/GIM.0b013e318216cc6d; Norbury G, 2008, SEMIN FETAL NEONAT M, V13, P76, DOI 10.1016/j.siny.2007.12.008; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Pinzani P, 2010, METHODS, V50, P302, DOI 10.1016/j.ymeth.2010.02.004; Punales MK, 2003, J CLIN ENDOCR METAB, V88, P2644, DOI 10.1210/jc.2002-021422; Quayle FJ, 2007, SURGERY, V142, P800, DOI 10.1016/j.surg.2007.09.013; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; RAUE F, 1995, J INTERN MED, V238, P369, DOI 10.1111/j.1365-2796.1995.tb01212.x; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Schwarzenbach H, 2009, CLIN CANCER RES, V15, P1032, DOI 10.1158/1078-0432.CCR-08-1910; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Zhong XY, 2007, CLIN CHEM, V53, P1609, DOI 10.1373/clinchem.2006.084509	40	16	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51024	10.1371/journal.pone.0051024	http://dx.doi.org/10.1371/journal.pone.0051024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236420	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100052
J	Ishida, E; Hashimoto, K; Shimizu, H; Okada, S; Satoh, T; Kato, I; Yamada, M; Mori, M				Ishida, Emi; Hashimoto, Koshi; Shimizu, Hiroyuki; Okada, Shuichi; Satoh, Tetsurou; Kato, Ikuo; Yamada, Masanobu; Mori, Masatomo			Nesfatin-1 Induces the Phosphorylation Levels of cAMP Response Element-Binding Protein for Intracellular Signaling in a Neural Cell Line	PLOS ONE			English	Article							HYPOTHALAMUS; BRAIN	Nesfatin-1 is a novel anorexic peptide that reduces the food intake of rodents when administered either intraventricularly or intraperitoneally. However, the molecular mechanism of intracellular signaling via Nesfatin-1 is yet to be resolved. In the current study, we investigated the ability of different neuronal cell lines to respond to Nesfatin-1 and further elucidated the signal transduction pathway of Nesfatin-1. To achieve this, we transfected several cell lines with various combinations of reporter vectors containing different kinds of response elements and performed reporter assays with Nesfatin-1, its active midsegment encoding 30 amino acid residues (M30) and M30-derived mutants. Notably, we found that both Nesfatin-1 as well as M30, significantly increased cAMP response element (CRE) reporter activity in a mouse neuroblastoma cell line, NB41A3. An antagonist of Melanocortin 3/4 receptor, SHU9119, aborted the promoter activity, and a mutant M30, which exerts no anorexic effect in vivo did not induce the CRE reporter activity in NB41A3 cells. Western blotting analyses revealed that Nesfatin-1 and M30 significantly increased the phosphorylation levels of CRE-binding protein (CREB), without altering the intracellular cAMP levels. Further, our study showed that a mitogen-activated protein kinase (MAPK) kinase inhibitor and an L-type Calcium (Ca2+) channel blocker abolished the M30-induced CREB phosphorylation. Furthermore, the radioreceptor assay revealed that I-125-Nesfatin-1 binds in a saturable fashion to the membrane fractions of the mouse hypothalamus and NB41A3 cells, with Kd values of 0.79 nM and 0.17 nM, respectively. Collectively, our findings indicate the presence of a Nesfatin-1-specific receptor on the cell surface of NB41A3 cells and mouse hypothalamus. Our study highlights that Nesfatin-1, via its receptor, induces the phosphorylation of CREB, thus activating the intracellular signaling cascade in neurons. Citation: Ishida E, Hashimoto K, Shimizu H, Okada S, Satoh T, et al. (2012) Nesfatin-1 Induces the Phosphorylation Levels of cAMP Response Element-Binding Protein for Intracellular Signaling in a Neural Cell Line. PLoS ONE 7(12): e50918. doi:10.1371/journal.pone.0050918	[Ishida, Emi; Hashimoto, Koshi; Shimizu, Hiroyuki; Okada, Shuichi; Satoh, Tetsurou; Yamada, Masanobu; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma, Japan; [Shimizu, Hiroyuki] Takasaki Univ Hlth & Welf, Fac Hlth & Welf, Dept Hlth & Nutr, Gunma, Japan; [Kato, Ikuo] Hokuriku Univ, Fac Pharmaceut Sci, Dept Bioorgan Chem, Kanazawa, Ishikawa 92011, Japan	Gunma University; Hokuriku University	Hashimoto, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma, Japan.	khashimo@gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X	Japan Society for the Promotion of Science (JSPS) [20591045, 23591296]; JSPS [19209035, 22249038]; Grants-in-Aid for Scientific Research [22249038, 23591296] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) (20591045, 23591296) from the Japan Society for the Promotion of Science (JSPS) to K. Hashimoto and Grants-in-Aid for Scientific Research (A) (19209035, 22249038) from JSPS to M. Mori. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; BYLUND DB, 1993, AM J PHYSIOL, V265, pL421, DOI 10.1152/ajplung.1993.265.5.L421; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; Gonzalez R, 2011, J ENDOCRINOL, V208, pR9, DOI 10.1530/JOE-10-0492; Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V390, P958, DOI 10.1016/j.bbrc.2009.10.085; Nakata M, 2011, ENDOCR J, V58, P305, DOI 10.1507/endocrj.K11E-056; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Sheriff S, 1997, MOL PHARMACOL, V51, P597, DOI 10.1124/mol.51.4.597; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Shimizu H, 2009, ENDOCR J, V56, P537, DOI 10.1507/endocrj.K09E-117; Shimizu H, 2009, PEPTIDES, V30, P995, DOI 10.1016/j.peptides.2009.01.002; Shimizu-Albergine M, 2001, J NEUROSCI, V21, P1238; Stengel A, 2011, ENDOCRINOLOGY, V152, P4033, DOI 10.1210/en.2011-1500	13	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50918	10.1371/journal.pone.0050918	http://dx.doi.org/10.1371/journal.pone.0050918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236405	Green Submitted, Green Published, gold			2022-12-25	WOS:000312589700021
J	Almoguera, C; Prieto-Dapena, P; Personat, JM; Tejedor-Cano, J; Lindahl, M; Diaz-Espejo, A; Jordano, J				Almoguera, Concepcion; Prieto-Dapena, Pilar; Personat, Jose-Maria; Tejedor-Cano, Javier; Lindahl, Marika; Diaz-Espejo, Antonio; Jordano, Juan			Protection of the Photosynthetic Apparatus from Extreme Dehydration and Oxidative Stress in Seedlings of Transgenic Tobacco	PLOS ONE			English	Article							PHOTOSYSTEM-II; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; HEAT-STRESS; PROTEIN; PHOTOINHIBITION; OVEREXPRESSION; PLANTS	A genetic program that in sunflower seeds is activated by Heat Shock transcription Factor A9 (HaHSFA9) has been analyzed in transgenic tobacco seedlings. The ectopic overexpression of the HSFA9 program protected photosynthetic membranes, which resisted extreme dehydration and oxidative stress conditions. In contrast, heat acclimation of seedlings induced thermotolerance but not resistance to the harsh stress conditions employed. The HSFA9 program was found to include the expression of plastidial small Heat Shock Proteins that accumulate only at lower abundance in heat-stressed vegetative organs. Photosystem II (PSII) maximum quantum yield was higher for transgenic seedlings than for non-transgenic seedlings, after either stress treatment. Furthermore, protection of both PSII and Photosystem I (PSI) membrane protein complexes was observed in the transgenic seedlings, leading to their survival after the stress treatments. It was also shown that the plastidial D1 protein, a labile component of the PSII reaction center, and the PSI core protein PsaB were shielded from oxidative damage and degradation. We infer that natural expression of the HSFA9 program during embryogenesis may protect seed pro-plastids from developmental desiccation.	[Almoguera, Concepcion; Prieto-Dapena, Pilar; Personat, Jose-Maria; Tejedor-Cano, Javier; Diaz-Espejo, Antonio; Jordano, Juan] CSIC, Inst Recursos Nat & Agrobiol Sevilla, E-41080 Seville, Spain; [Lindahl, Marika] CSIC, Inst Biol Vegetal & Fotosintesis, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Consejo Superior de Investigaciones Cientificas (CSIC)	Jordano, J (corresponding author), CSIC, Inst Recursos Nat & Agrobiol Sevilla, E-41080 Seville, Spain.	juan.jordano@csic.es	Diaz-Espejo, Antonio/B-5361-2008; Lindahl, Marika/H-2259-2017; Diaz-Espejo, Antonio/S-3744-2019; Jordano, Juan/J-5829-2012; Almoguera, Concepción/J-7026-2014; Prieto-Dapena, Pilar/K-2090-2014	Diaz-Espejo, Antonio/0000-0002-4711-2494; Diaz-Espejo, Antonio/0000-0002-4711-2494; Jordano, Juan/0000-0002-2583-4453; Almoguera, Concepción/0000-0002-7961-6507; Prieto-Dapena, Pilar/0000-0002-2826-8688; Lindahl, Marika/0000-0003-1627-0809	European Regional Development Fund (FEDER); Spanish Ministry of Science and Innovation [BIO2008-00634, BIO2011-23440]; Andalusian Regional Government [BIO148]	European Regional Development Fund (FEDER)(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian Regional Government	This work was cofinanced by the European Regional Development Fund (FEDER) and the Spanish Ministry of Science and Innovation (Grants BIO2008-00634 and BIO2011-23440). Additional funds were obtained from the Andalusian Regional Government (Grant BIO148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P541, DOI 10.1007/s11120-008-9331-0; Almoguera C, 2002, J BIOL CHEM, V277, P43866, DOI 10.1074/jbc.M207330200; Armbruster U, 2010, PLANT CELL, V22, P3439, DOI 10.1105/tpc.110.077453; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Barua D, 2003, FUNCT PLANT BIOL, V30, P1071, DOI 10.1071/FP03106; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Deng X, 2003, PLANT SCI, V165, P851, DOI 10.1016/S0168-9452(03)00284-X; Dinakar C, 2012, PLANT SCI, V182, P29, DOI 10.1016/j.plantsci.2011.01.018; Garcia-Cerdan JG, 2011, PLANT J, V65, P368, DOI 10.1111/j.1365-313X.2010.04429.x; Georgieva K, 2009, J PLANT PHYSIOL, V166, P1520, DOI 10.1016/j.jplph.2009.03.010; Guo SJ, 2007, J PLANT PHYSIOL, V164, P126, DOI 10.1016/j.jplph.2006.01.004; Harndahl U, 1999, CELL STRESS CHAPERON, V4, P129; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Lepisto A, 2009, PLANT PHYSIOL, V149, P1261, DOI 10.1104/pp.108.133777; Lu Y, 2011, PLANT CELL, V23, P1861, DOI 10.1105/tpc.111.085456; Lundin B, 2008, PHOTOSYNTH RES, V98, P405, DOI 10.1007/s11120-008-9325-y; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MIYAO M, 1995, BIOCHEMISTRY-US, V34, P10019, DOI 10.1021/bi00031a025; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Neta-Sharir I, 2005, PLANT CELL, V17, P1829, DOI 10.1105/tpc.105.031914; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Osteryoung KW, 1992, RES PHOTOSYNTHESIS, VIV, P129; Prieto-Dapena P, 2008, PLANT J, V54, P1004, DOI 10.1111/j.1365-313X.2008.03465.x; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Sonoike K, 2011, PHYSIOL PLANTARUM, V142, P56, DOI 10.1111/j.1399-3054.2010.01437.x; Sugliani M, 2009, NEW PHYTOL, V184, P898, DOI 10.1111/j.1469-8137.2009.03023.x; Tejedor-Cano J, 2010, PLANT CELL ENVIRON, V33, P1408, DOI 10.1111/j.1365-3040.2010.02159.x	30	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51443	10.1371/journal.pone.0051443	http://dx.doi.org/10.1371/journal.pone.0051443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227265	gold, Green Published			2022-12-25	WOS:000312588200124
J	Cavallo, MG; Sentinelli, F; Barchetta, I; Costantino, C; Incani, M; Perra, L; Capoccia, D; Romeo, S; Cossu, E; Leonetti, F; Agati, L; Baroni, MG				Cavallo, Maria Gisella; Sentinelli, Federica; Barchetta, Ilaria; Costantino, Carmine; Incani, Michela; Perra, Laura; Capoccia, Danila; Romeo, Stefano; Cossu, Efisio; Leonetti, Frida; Agati, Luciano; Baroni, Marco G.			Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; EXPRESSION; LIPOLYSIS; MUSCLE; LIGAND	Background: Apelin is an adipokine that plays a role in the regulation of glucose homeostasis and in obesity. The relationship between apelin serum concentration and dysmetabolic conditions such as type 2 diabetes (T2D) is still controversial. Aims of our study are: 1) determine the circulating levels of apelin in a large cohort of Italian subjects with T2D, T1D and in non-diabetic controls; 2) identify putative metabolic determinants of modified apelin concentrations, in order to search possible mechanism of apelin control; 3) investigate changes in apelin levels in response to sharp modifications of glucose/insulin metabolism in T2D obese subjects before and 3 days after bariatric surgery. Methods: We recruited 369 subjects, 119 with T2D, 113 with T1D and 137 non-diabetic controls. All subjects underwent a complete clinical examination, including anthropometric and laboratory measurements. Serum apelin levels were determined by EIA (immunoenzyme assay). Results: Patients with T2D had significantly higher serum apelin levels compared to controls (1.23 +/- 1.1 ng/mL vs 0.91 +/- 0.7 ng/mL, P<0.001) and to T1D subjects (0.73 +/- 0.39 ng/mL, P<0.001). Controls and T1D subjects did not differ significantly in apelin levels. Apelin concentrations were directly associated with fasting blood glucose (FBG), body mass index (BMI), basal Disposition Index (DI-0), age, and diagnosis of T2D at bivariate correlation analysis. Multiple regression analysis confirmed that diagnosis of T2D, basal DI-0 and FBG were all determinants of serum apelin levels independently from age and BMI. Bariatric surgery performed in a subgroup of obese diabetic subjects (n = 12) resulted in a significant reduction of apelin concentrations compared to baseline levels (P = 0.01). Conclusions: Our study demonstrates that T2D, but not T1D, is associated with increased serum apelin levels compared to non-diabetic subjects. This association is dependent on impaired glucose homeostasis, and disappears after bariatric surgery, providing further evidence regarding the relationship between apelin and the regulation of glucose metabolism.	[Sentinelli, Federica; Incani, Michela; Perra, Laura; Romeo, Stefano; Cossu, Efisio; Baroni, Marco G.] Univ Cagliari, Dept Med Sci, Cagliari, Italy; [Cavallo, Maria Gisella; Barchetta, Ilaria; Costantino, Carmine] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rome, Italy; [Capoccia, Danila; Leonetti, Frida] Univ Roma La Sapienza, Dept Clin Sci, Rome, Italy; [Romeo, Stefano] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Agati, Luciano] Univ Roma La Sapienza, Dept Cardiovasc Sci, Rome, Italy	University of Cagliari; Sapienza University Rome; Sapienza University Rome; University of Gothenburg; Sapienza University Rome	Baroni, MG (corresponding author), Univ Cagliari, Dept Med Sci, Cagliari, Italy.	marcobaroni@medicina.unica.it	Agati, Luciano/AFQ-4559-2022; Romeo, Stefano/L-6861-2015; Leonetti, Frida/AAL-1295-2020; Sentinelli, Federica/AAF-1563-2020; Capoccia, Danila/AAT-2026-2020; Baroni, Marco Giorgio/AAH-3476-2020; Barchetta, Ilaria/I-3016-2019	Agati, Luciano/0000-0003-3186-1797; Romeo, Stefano/0000-0001-9168-4898; Baroni, Marco Giorgio/0000-0002-3224-6078; Barchetta, Ilaria/0000-0003-0530-8568; Sentinelli, Federica/0000-0002-5379-0590; INCANI, MICHELA/0000-0003-1623-5376; cavallo, maria gisella/0000-0001-6630-8049; LEONETTI, Frida/0000-0002-5606-8448	University of Cagliari; Ministry of Education, University and Research [2008J2FS4T]; Foundation Banco di Sardegna; Sapienza University of Rome	University of Cagliari; Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Foundation Banco di Sardegna(Fondazione Banco di Sardegna); Sapienza University of Rome	This work was funded by research grants from the University of Cagliari (ex-60% 2009-11 http://www.unica.it/), from the Ministry of Education, University and Research (PRIN 2008, n. 2008J2FS4T, http://prin.cineca.it/) and from the Foundation Banco di Sardegna (Research Projects 2011, http://www.fondazionebancodisardegna.it/), all awarded to MGB. MGC was funded by a research grant from Sapienza University of Rome (http://www.uniroma1.it/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Attane C, 2011, J MOL ENDOCRINOL, V46, P21, DOI 10.1677/JME-10-0105; Attane C, 2012, DIABETES, V61, P310, DOI 10.2337/db11-0100; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Cobelli C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1, DOI 10.1152/ajpendo.00421.2006; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Erdem G, 2008, EXP CLIN ENDOCR DIAB, V116, P289, DOI 10.1055/s-2007-1004564; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guo L, 2009, ENDOCR RES, V34, P142, DOI 10.3109/07435800903287079; Heinonen MV, 2009, NUTR METAB CARDIOVAS, V19, P626, DOI 10.1016/j.numecd.2008.12.008; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Ramon JM, 2012, J GASTROINTEST SURG, V16, P1116, DOI 10.1007/s11605-012-1855-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Meral C, 2010, J PEDIATR ENDOCR MET, V23, P497, DOI 10.1515/jpem.2010.081; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Telejko B, 2010, DIABETES RES CLIN PR, V87, P176, DOI 10.1016/j.diabres.2009.10.018; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zhang Yu, 2009, Diabetes Care, V32, pe150, DOI 10.2337/dc09-1146	28	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51236	10.1371/journal.pone.0051236	http://dx.doi.org/10.1371/journal.pone.0051236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227256	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200115
J	Dong, HS; Fahmy, TM; Metcalfe, SM; Morton, SL; Dong, X; Inverardi, L; Adams, DB; Gao, WD; Wang, HJ				Dong, Huansheng; Fahmy, Tarek M.; Metcalfe, Su M.; Morton, Steve L.; Dong, Xiao; Inverardi, Luca; Adams, David B.; Gao, Wenda; Wang, Hongjun			Immuno-Isolation of Pancreatic Islet Allografts Using Pegylated Nanotherapy Leads to Long-Term Normoglycemia in Full MHC Mismatch Recipient Mice	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; BETA-CELL NEOGENESIS; TRANSPLANTATION; TECHNOLOGIES; EXPRESSION; CAMOUFLAGE; SURVIVAL; DELIVERY; DEVICES; LIF	Two major hurdles need to be surmounted for cell therapy for diabetes: (i) allo-immune rejection of grafted pancreatic islets, or stem/precursor cell-derived insulin-secreting cells; and (ii) continuing auto-immunity against the diabetogenic endogenous target antigen. Nanotherapeutics offer a novel approach to overcome these problems and here we ask if creation of "stealth'' islets encapsulated within a thin cage of pegylated material of 100-200 nanometers thick provides a viable option for islet transplantation. The aims of this study were to test islet viability and functionality following encapsulation within the pegylated cage, and functional efficacy in vivo in terms of graft-derived control of normoglycemia in diabetic mice. We first demonstrated that pegylation of the islet surface, plus or minus nanoparticles, improved long-term islet viability in vitro compared to non-pegylated (naked) control islets. Moreover, pegylation of the islets with nanoparticles was compatible with glucose-stimulated insulin secretion and insulin biogenesis. We next looked for functionality of the created "stealth'' DBA/2 (H-2(d)) islets in vivo by comparing glycemic profiles across 4 groups of streptozotozin- induced diabetic C57BL/6 (H-2(b)) recipients of (i) naked islets; (ii) pegylated islets; (iii) pegylated islets with nanoparticles (empty); and (iv) pegylated islets with nanoparticles loaded with a cargo of leukemia inhibitory factor (LIF), a factor both promotes adaptive immune tolerance and regulates pancreatic beta cell mass. Without any other treatment, normoglycemia was lost after 17 d (+/27.5 d) in control group. In striking contrast, recipients in groups (ii), (iii), and (iv) showed long-term (>100 d) normoglycemia involving 30%; 43%, and 57% of the recipients in each respective group. In conclusion, construction of "stealth'' islets by pegylation-based nanotherapeutics not only supports islet structure and function, but also effectively isolates the islets from immune-mediated destruction. The added value of nanoparticles to deliver immune modulators plus growth factors such as LIF expands the potential of this novel therapeutic approach to cell therapy for diabetes. Citation: Dong H, Fahmy TM, Metcalfe SM, Morton SL, Dong X, et al. (2012) Immuno-Isolation of Pancreatic Islet Allografts Using Pegylated Nanotherapy Leads to Long-Term Normoglycemia in Full MHC Mismatch Recipient Mice. PLoS ONE 7(12): e50265. doi:10.1371/journal.pone.0050265	[Dong, Huansheng; Adams, David B.; Wang, Hongjun] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Fahmy, Tarek M.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Metcalfe, Su M.] Univ Cambridge, Dept Neurol, Brain Repair Ctr, Cambridge, England; [Morton, Steve L.] Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Dong, Xiao] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China; [Inverardi, Luca] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Gao, Wenda] Antagen Inst Biomed Res, Boston, MA USA	Medical University of South Carolina; Yale University; University of Cambridge; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Qingdao Agricultural University; University of Miami	Wang, HJ (corresponding author), Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA.	wangho@musc.edu	Wang, Hongjun/AAA-1319-2021		JDRF [41-2009-760, 5-2012-149]; National Institutes of Health/National Center for Research Resources Grant at South Carolina Clinical and Translational Research (SCTR) Institute [UL1RR029882]; Clinical and Translational Science Awards (CTSA)	JDRF(Juvenile Diabetes Research Foundation); National Institutes of Health/National Center for Research Resources Grant at South Carolina Clinical and Translational Research (SCTR) Institute; Clinical and Translational Science Awards (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported in part by JDRF grant 41-2009-760 (to WG, HW, TF, and SMM), the JDRF grant 5-2012-149 (to HW and DA), and the National Institutes of Health/National Center for Research Resources Grant Number UL1RR029882 at South Carolina Clinical and Translational Research (SCTR) Institute and the Clinical and Translational Science Awards (CTSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Basarkar A, 2009, PHARM RES-DORDR, V26, P72, DOI 10.1007/s11095-008-9710-4; Biancone L, 2002, CELL TRANSPLANT, V11, P309; De Breuck S, 2006, DIABETOLOGIA, V49, P108, DOI 10.1007/s00125-005-0079-1; Elcin YM, 2003, ADV EXP MED BIOL, V534, P255; Fort A, 2008, CELL TRANSPLANT, V17, P997, DOI 10.3727/096368908786991498; Gao W, 2009, CELL CYCLE, V8, P1444, DOI 10.4161/cc.8.9.8348; Giovagnoli S, 2005, J CONTROL RELEASE, V107, P65, DOI 10.1016/j.jconrel.2005.05.021; Giraldo Jaime A, 2010, J Diabetes Sci Technol, V4, P1238; Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Kobayashi T, 2003, TRANSPLANT P, V35, P484, DOI 10.1016/S0041-1345(02)03829-0; Lee DY, 2007, TISSUE ENG, V13, P2133, DOI 10.1089/ten.2006.0009; Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015; Mao GH, 2009, BIOMATERIALS, V30, P1706, DOI 10.1016/j.biomaterials.2008.12.030; Merani S, 2006, CLIN SCI, V110, P611, DOI 10.1042/CS20050342; Metcalfe SM, 2011, GENES IMMUN, V12, P157, DOI 10.1038/gene.2011.9; Metcalfe SM, 2005, TRANSPLANTATION, V79, P726, DOI 10.1097/01.TP.0000149324.42994.38; Mfopou JK, 2012, DIABETOLOGIA, V55, P1024, DOI 10.1007/s00125-011-2434-8; Murad KL, 1999, BLOOD, V94, P2135; Murad KT, 1999, BLOOD, V93, P2121, DOI 10.1182/blood.V93.6.2121.406a30_2121_2127; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a; SAWHNEY AS, 1994, BIOTECHNOL BIOENG, V44, P383, DOI 10.1002/bit.260440317; Scott MD, 1998, CURR PHARM DESIGN, V4, P423; Scott MD, 1997, P NATL ACAD SCI USA, V94, P7566, DOI 10.1073/pnas.94.14.7566; Teramura Y, 2008, BIOCONJUGATE CHEM, V19, P1389, DOI 10.1021/bc800064t; Wang HJ, 2005, DIABETES, V54, P1400, DOI 10.2337/diabetes.54.5.1400; Wilson JT, 2008, ADV DRUG DELIVER REV, V60, P124, DOI 10.1016/j.addr.2007.08.034	30	41	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50265	10.1371/journal.pone.0050265	http://dx.doi.org/10.1371/journal.pone.0050265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227162	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200023
J	Pilar, DR; Jaeger, A; Gomes, CFA; Stein, LM				Pilar, Denise Ranghetti; Jaeger, Antonio; Gomes, Carlos F. A.; Stein, Lilian Milnitsky			Passwords Usage and Human Memory Limitations: A Survey across Age and Educational Background	PLOS ONE			English	Article							FUZZY-TRACE THEORY; SECURITY; MEMORABILITY	The present article reports a survey conducted to identify the practices on passwords usage, focusing particularly on memory limitations and the use of passwords across individuals with different age and education backgrounds. A total of 263 participants were interviewed, with ages ranging from 18 to 93 years, and education level ranging from grade school to graduate degree. Contrary to our expectations, effects of cognitive decline due to aging were not observed on memory performance for passwords. The results suggested instead, that the number of password uses was the most influential factor on memory performance. That is, as the number of circumstances in which individuals utilized passwords increased, the incidence of forgotten and mixed-up passwords also increased. The theoretical significance of these findings and their implications for good practices on password usage are discussed.	[Pilar, Denise Ranghetti; Jaeger, Antonio; Stein, Lilian Milnitsky] Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol, Porto Alegre, RS, Brazil; [Gomes, Carlos F. A.] Cornell Univ, Dept Human Dev, Ithaca, NY USA	Pontificia Universidade Catolica Do Rio Grande Do Sul; Cornell University	Jaeger, A (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol, Porto Alegre, RS, Brazil.	lilian@pucrs.br	jaeger, antonio/F-7120-2013		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1999, COMMUN ACM, V42, P41, DOI 10.1145/322796.322806; Adams A., 1997, People and Computers XII. Proceedings of HCI '97, P1; Alley D, 2007, RES AGING, V29, P73, DOI 10.1177/0164027506294245; Armstrong L, 2002, BUS WEEK, P89; Barro RJ, 2010, 15902 NBER, DOI [10.1016/j.jdeveco.2012.10.001, DOI 10.1016/J.JDEVECO.2012.10.001]; Brainerd CJ, 2002, CURR DIR PSYCHOL SCI, V11, P164, DOI 10.1111/1467-8721.00192; Brown AS, 2004, APPL COGNITIVE PSYCH, V18, P641, DOI 10.1002/acp.1014; Brown Scott C, 2000, OXFORD HDB MEMORY, P93, DOI DOI 10.1016/J.ADOLESCENCE.2017.05.018; Carstens D., 2004, INFORM SCI J, V7, P67, DOI DOI 10.28945/503; Charoen D, 2008, SYST PRACT ACT RES, V21, P55, DOI 10.1007/s11213-007-9082-4; Colsher Patricia L., 1991, Annals of Epidemiology, V1, P215; CRAIK FIM, 1994, CURR DIR PSYCHOL SCI, V3, P155, DOI 10.1111/1467-8721.ep10770653; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Dempster F.N., 1995, INTERFERENCE INHIBIT; DOBBS AR, 1989, PSYCHOL AGING, V4, P500, DOI 10.1037/0882-7974.4.4.500; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Evans D A, 1993, Ann Epidemiol, V3, P71; GARDINER JM, 1991, MEM COGNITION, V19, P617, DOI 10.3758/BF03197157; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Harada Y, 1996, SCIENCE, V37, P21; Hoonakker P, 2009, PROCEEDINGS OF THE H; Horowitz AS, 2001, COMPUTERWORLD, V35, P38; Leibovici D, 1996, AGE AGEING, V25, P392, DOI 10.1093/ageing/25.5.392; MORRIS R, 1979, COMMUN ACM, V22, P594, DOI 10.1145/359168.359172; Nelson D, 2010, COMPUT HUM BEHAV, V26, P705, DOI 10.1016/j.chb.2010.01.007; Nyberg L, 1996, J GERONTOL B-PSYCHOL, V51, pP234, DOI 10.1093/geronb/51B.4.P234; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Papalia D. E., 2004, HUMAN DEV; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Porter S. N., 1982, Computers & Security, V1, P54, DOI 10.1016/0167-4048(82)90025-6; REYNA VF, 1995, LEARN INDIVID DIFFER, V7, P1, DOI 10.1016/1041-6080(95)90031-4; Yan J, 2004, IEEE SECUR PRIV, V2, P25, DOI 10.1109/MSP.2004.81; Zhang J, 2009, EUR J INFORM SYST, V18, P165, DOI 10.1057/ejis.2009.9; ZVIRAN M, 1993, COMPUT J, V36, P227, DOI 10.1093/comjnl/36.3.227; Zviran M., 1999, Journal of Management Information Systems, V15, P161	35	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51067	10.1371/journal.pone.0051067	http://dx.doi.org/10.1371/journal.pone.0051067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227232	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200092
J	Takao, D; Taniguchi, A; Takeda, T; Sonobe, S; Nonaka, S				Takao, Daisuke; Taniguchi, Atsushi; Takeda, Takaaki; Sonobe, Seiji; Nonaka, Shigenori			High-Speed Imaging of Amoeboid Movements Using Light-Sheet Microscopy	PLOS ONE			English	Article							PLANE ILLUMINATION MICROSCOPY; AMOEBA-PROTEUS; CELLS; SURFACE	Light-sheet microscopy has been developed as a powerful tool for live imaging in biological studies. The efficient illumination of specimens using light-sheet microscopy makes it highly amenable to high-speed imaging. We therefore applied this technology to the observation of amoeboid movements, which are too rapid to capture with conventional microscopy. To simplify the setup of the optical system, we utilized the illumination optics from a conventional confocal laser scanning microscope. Using this set-up we achieved high-speed imaging of amoeboid movements. Three-dimensional images were captured at the recording rate of 40 frames/s and clearly outlined the fine structures of fluorescent-labeled amoeboid cellular membranes. The quality of images obtained by our system was sufficient for subsequent quantitative analysis for dynamics of amoeboid movements. This study demonstrates the application of light-sheet microscopy for high-speed imaging of biological specimens. Citation: Takao D, Taniguchi A, Takeda T, Sonobe S, Nonaka S (2012) High-Speed Imaging of Amoeboid Movements Using Light-Sheet Microscopy. PLoS ONE 7(12): e50846. doi:10.1371/journal.pone.0050846	[Takao, Daisuke; Nonaka, Shigenori] Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 444, Japan; [Taniguchi, Atsushi; Sonobe, Seiji] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo, Japan; [Takeda, Takaaki] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Hyogo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Nonaka, S (corresponding author), Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 444, Japan.	snonaka@nibb.ac.jp	Nonaka, Shigenori/I-2132-2013; Takao, Daisuke/U-1849-2019	Nonaka, Shigenori/0000-0002-8093-0325; Takao, Daisuke/0000-0001-6136-6733; Taniguchi, Atsushi/0000-0001-5500-0671	Human Frontier Science Program (HFSP); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); CREST	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Human Frontier Science Program (HFSP, http://www.hfsp.org/), the Ministry of Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/), the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/index.html) and CREST (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulbitch A, 2000, PHYS REV E, V62, P3974, DOI 10.1103/PhysRevE.62.3974; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; GREBECKI A, 1986, J CELL SCI, V83, P23; GRIFFIN JL, 1960, EXP CELL RES, V21, P170, DOI 10.1016/0014-4827(60)90358-X; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2007, NAT METHODS, V4, P843, DOI 10.1038/NMETH1087; KOKUBO EIICHIRO, 2005, Journal of the Korean Astronomical Society, V38, P153; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; Nishihara E, 2007, PROTOPLASMA, V231, P25, DOI 10.1007/s00709-007-0247-x; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Soll DR, 2009, EUKARYOT CELL, V8, P1381, DOI 10.1128/EC.00121-09; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108	18	11	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50846	10.1371/journal.pone.0050846	http://dx.doi.org/10.1371/journal.pone.0050846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227214	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200075
J	Kim, J; Jia, XM; Buckett, PD; Liu, SH; Lee, CH; Wessling-Resnick, M				Kim, Jonghan; Jia, Xuming; Buckett, Peter D.; Liu, Sihao; Lee, Chih-Hao; Wessling-Resnick, Marianne			Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia	FASEB JOURNAL			English	Article						Belgrade rat; iron overload; divalent metal transporter 1	MICROCYTIC ANEMIA; BETA-THALASSEMIA; LIPID-METABOLISM; FERRITIN; DMT1; RAT; TRANSFERRIN; OVERLOAD; MICE; HYPERGLYCEMIA	Iron loading is associated with altered lipid metabolism, but underlying mechanisms remain unknown. We compared serum iron and triglycerides (TGs) in Belgrade rats, a genetic model of iron-loading anemia. Homozygous b/b rats had greater serum iron (68 vs. 28 mu M; P=0.0004) and TG levels (180 vs. 84 mg/dl; P=0.014) compared to +/b controls. To confirm the association between iron loading and high TGs, Fischer rats were fed chow containing 1% carbonyl iron. Compared to controls pair-fed normal chow, carbonyl iron-fed rats had elevated serum iron (42 vs. 21 mu M; P=0.007) and TGs (190 vs. 115 mg/dl; P=0.009). Despite normal hepatic production and secretion, TG clearance was lower in b/b than +/b rats due to reduced serum lipoprotein lipase (LPL) activity (3.1 vs. 5.0 mM/min; P=0.026). Likewise, LPL was lower in carbonyl iron-fed rats compared to controls (2.4 vs. 3.7 mM/min; P=0.017). Direct addition of iron to serum ex vivo or recombinant LPL in vitro decreased enzymatic activity in a dose-dependent manner. Lowering serum iron in Belgrade rats reduced TG levels (274 to 67 mg/dl, P=0.001). This study explains the relationship between iron status and lipid metabolism and provides mechanistic support for interventions that reduce serum iron levels in individuals at risk for hypertriglyceridemia.-Kim, J., Jia, X., Buckett, P. D., Liu, S., Lee, C.-H., Wessling-Resnick, M. Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia. FASEB J. 27, 1657-1663 (2013). www.fasebj.org	[Kim, Jonghan; Jia, Xuming; Buckett, Peter D.; Liu, Sihao; Lee, Chih-Hao; Wessling-Resnick, Marianne] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Wessling-Resnick, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wessling@hsph.harvard.edu	liu, sihao/A-8823-2015	liu, sihao/0000-0002-4188-3693	U.S. National Institutes of Health (NIH) [R01 ES014638, R01 DK064750, RC1 DK086774, R01 DK075046]; NIH Roadmap Fellowship [R90 DK071507]; Yerby Postdoctoral Fellowship at the Harvard School of Public Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075046, RC1DK086774, R01DK064750, P30DK034854, R90DK071507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014638] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerby Postdoctoral Fellowship at the Harvard School of Public Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the U.S. National Institutes of Health (NIH) to M.W.-R. (R01 ES014638, R01 DK064750, and RC1 DK086774) and to C.-H. L. (R01 DK075046). J.K. was supported by an NIH Roadmap Fellowship (R90 DK071507) and the Yerby Postdoctoral Fellowship at the Harvard School of Public Health. The authors thank Dr. David E. Cohen and Ms. Yingxia Li (Brigham and Women's Hospital and the Molecular and Cellular Biochemistry Core at the Harvard Digestive Diseases Center, Boston, MA, USA; P30 DK34854) for their help in separating lipid fractions by FPLC for analysis, and Dr. Jorge Plutsky (Joslin Diabetes Center, Boston, MA, USA) for helpful discussion and advice. The authors declare no conflicts of interest.	Al-Quobaili FA, 2004, SAUDI MED J, V25, P871; Beaumont C, 2006, BLOOD, V107, P4168, DOI 10.1182/blood-2005-10-4269; BELLQUINT J, 1981, BIOCHEM BIOPH RES CO, V99, P700, DOI 10.1016/0006-291X(81)91800-3; BOFILL C, 1994, METABOLISM, V43, P614, DOI 10.1016/0026-0495(94)90204-6; Brunet S, 1999, HEPATOLOGY, V29, P1809, DOI 10.1002/hep.510290612; Buckett PD, 2009, AM J PHYSIOL-GASTR L, V296, pG798, DOI 10.1152/ajpgi.90342.2008; Byrne S. L., 2013, ANN REV PHA IN PRESS, V53; Casanova-Esteban P, 2011, METABOLISM, V60, P830, DOI 10.1016/j.metabol.2010.07.035; Chaudhury C, 2006, J NUTR, V136, P2993, DOI 10.1093/jn/136.12.2993; Cherchi G M, 1983, Boll Soc Ital Biol Sper, V59, P1739; Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; CUTLER P, 1989, DIABETES, V38, P1207, DOI 10.2337/diabetes.38.10.1207; Davis MR, 2012, GENES NUTR, V7, P415, DOI 10.1007/s12263-011-0278-y; Fernandez-Real JM, 2002, DIABETES, V51, P1000, DOI 10.2337/diabetes.51.4.1000; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; GALAN P, 1984, COMP BIOCHEM PHYS B, V77, P647, DOI 10.1016/0305-0491(84)90292-X; Garrick M, 1997, BIOMETALS, V10, P65, DOI 10.1023/A:1018370804882; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hartman C, 2002, J PEDIATR-US, V141, P543, DOI 10.1067/mpd.2002.127498; Heilig E, 2005, AM J PHYSIOL-LUNG C, V288, pL887, DOI 10.1152/ajplung.00382.2004; Holm C, 2000, METH MOL B, V155, P97; Horonchik L, 2008, CHEM BIOL, V15, P647, DOI 10.1016/j.chembiol.2008.05.011; Iolascon A, 2006, BLOOD, V107, P349, DOI 10.1182/blood-2005-06-2477; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; JONES AL, 1984, J LIPID RES, V25, P1151; Kim J, 2011, AM J PHYSIOL-LUNG C, V300, pL659, DOI 10.1152/ajplung.00343.2010; LEWIS M, 1971, J LAB CLIN MED, V78, P546; Mateo-Gallego R, 2010, METABOLISM, V59, P154, DOI 10.1016/j.metabol.2009.06.021; Mims MP, 2005, BLOOD, V105, P1337, DOI 10.1182/blood-2004-07-2966; Nasr MR, 2008, J CLIN LIPIDOL, V2, P405, DOI 10.1016/j.jacl.2008.10.008; Papanastasiou DA, 1996, HAEMATOLOGIA, V27, P143; Ramey G, 2007, FEBS LETT, V581, P1053, DOI 10.1016/j.febslet.2007.02.002; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Silva M, 2008, NUTR RES, V28, P391, DOI 10.1016/j.nutres.2008.02.009; SLADICSIMIC D, 1969, ANN NY ACAD SCI, V165, P93, DOI 10.1111/j.1749-6632.1969.tb27779.x; Solanas-Barca M, 2009, J CLIN ENDOCR METAB, V94, P4391, DOI 10.1210/jc.2009-0814; Stangl GI, 1998, LIPIDS, V33, P889, DOI 10.1007/s11745-998-0285-8; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Tantawy AAG, 2009, HEMOGLOBIN, V33, P463, DOI 10.3109/03630260903343616; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Thompson K, 2006, J NUTR, V136, P3010, DOI 10.1093/jn/136.12.3010; Vari IS, 2007, DIABETES CARE, V30, P1795, DOI 10.2337/dc06-2312; Wlazlo N, 2012, CURR OPIN LIPIDOL, V23, P258, DOI 10.1097/MOL.0b013e328354752d; Yamagishi H, 2000, J NUTR BIOCHEM, V11, P455, DOI 10.1016/S0955-2863(00)00113-3	49	15	15	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1657	1663		10.1096/fj.12-224386	http://dx.doi.org/10.1096/fj.12-224386			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23241313	Green Published			2022-12-25	WOS:000316940800035
J	Pal, K; Mathur, M; Kumar, P; DeFea, K				Pal, Kasturi; Mathur, Maneesh; Kumar, Puneet; DeFea, Kathryn			Divergent beta-Arrestin-dependent Signaling Events Are Dependent upon Sequences within G-protein-coupled Receptor C Termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-2; SUBSTANCE-P; DESENSITIZATION; ENDOCYTOSIS; DOWNSTREAM; BETA-ARRESTIN-1; TRAFFICKING; MECHANISMS; MIGRATION; SCAFFOLD	beta-Arrestins are multifunctional adaptor proteins that, upon recruitment to an activated G-protein-coupled receptor, can promote desensitization of G-protein signaling and receptor internalization while simultaneously eliciting an independent signal. The result of beta-arrestin signaling depends upon the activating receptor. For example, activation of two G alpha(q)-coupled receptors, protease-activated receptor-2 (PAR(2)) and neurokinin-1 receptor (NK1R), results in drastically different signaling events. PAR(2) promotes beta-arrestin-dependent membrane-sequestered extracellular signal-regulated kinase (ERK1/2) activation, cofilin activation, and cell migration, whereas NK1R promotes nuclear ERK1/2 activation and proliferation. Using bioluminescence resonance energy transfer to monitor receptor/beta-arrestin interactions in real time, we observe that PAR(2) has a higher apparent affinity for both beta-arrestins than does NK1R, recruits them at a faster rate, and exhibits more rapid desensitization of the G-protein signal. Furthermore, recruitment of beta-arrestins to PAR(2) does not require prior G alpha(q) signaling events, whereas inhibition of G alpha(q) signaling intermediates inhibits recruitment of beta-arrestins to NK1R. Using chimeric receptors in which the C terminus of PAR(2) is fused to the N terminus of NK1R and vice versa and a critical Ser/Thr mutant of PAR(2), we demonstrate that interactions between beta-arrestins and specific phosphoresidues in the C termini of each receptor are crucial for determining the rate and magnitude of beta-arrestin recruitment as well as the ultimate signaling outcome.	[Pal, Kasturi; Mathur, Maneesh; DeFea, Kathryn] Univ Calif Riverside, Cell Mol Dev Biol Program, Riverside, CA 92521 USA; [Kumar, Puneet; DeFea, Kathryn] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	DeFea, K (corresponding author), Univ Calif Riverside, Div Biomed Sci, 900 Univ Ave, Riverside, CA 92521 USA.	kathryn.defea@ucr.edu	Pal, Kasturi/H-7059-2019	Pal, Kasturi/0000-0002-7328-5153; DeFea, Kathryn/0000-0001-6056-907X	National Institutes of Health Grant [R01GM066151]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066151] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM066151 (to K. A. D.).	Al-Ani B, 2004, MOL PHARMACOL, V65, P149, DOI 10.1124/mol.65.1.149; Bohm SK, 1997, BIOCHEM J, V322, P1; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 2001, AM J PHYSIOL-CELL PH, V280, pC1097, DOI 10.1152/ajpcell.2001.280.5.C1097; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; EXTON JH, 1994, ANNU REV PHYSIOL, V56, P349; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Kumar P, 2007, AM J PHYSIOL-CELL PH, V293, pC346, DOI 10.1152/ajpcell.00010.2007; Lovgren AK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001564; Luttrell LM, 2002, J CELL SCI, V115, P455; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Seatter MJ, 2004, CELL SIGNAL, V16, P21, DOI 10.1016/S0898-6568(03)00095-0; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Yu YJ, 2009, J NEUROSCI, V29, P222, DOI 10.1523/JNEUROSCI.4315-08.2009; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	31	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3265	3274		10.1074/jbc.M112.400234	http://dx.doi.org/10.1074/jbc.M112.400234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235155	hybrid, Green Published			2022-12-25	WOS:000314397900033
J	Savva, CG; da Costa, SPF; Bokori-Brown, M; Naylor, CE; Cole, AR; Moss, DS; Titball, RW; Basak, AK				Savva, Christos G.; da Costa, Sergio P. Fernandes; Bokori-Brown, Monika; Naylor, Claire E.; Cole, Ambrose R.; Moss, David S.; Titball, Richard W.; Basak, Ajit K.			Molecular Architecture and Functional Analysis of NetB, a Pore-forming Toxin from Clostridium perfringens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL GAMMA-HEMOLYSIN; NECROTIC ENTERITIS; ALPHA-HEMOLYSIN; CRYSTAL-STRUCTURE; MEMBRANE-FLUIDITY; BROILER-CHICKENS; PROTEIN; OLIGOMERIZATION; TRANSPORT; BINDING	NetB is a pore-forming toxin produced by Clostridium perfringens and has been reported to play a major role in the pathogenesis of avian necrotic enteritis, a disease that has emerged due to the removal of antibiotics in animal feedstuffs. Here we present the crystal structure of the pore form of NetB solved to 3.9 angstrom. The heptameric assembly shares structural homology to the staphylococcal alpha-hemolysin. However, the rim domain, a region that is thought to interact with the target cell membrane, shows sequence and structural divergence leading to the alteration of a phosphocholine binding pocket found in the staphylococcal toxins. Consistent with the structure we show that NetB does not bind phosphocholine efficiently but instead interacts directly with cholesterol leading to enhanced oligomerization and pore formation. Finally we have identified conserved and non-conserved amino acid positions within the rim loops that significantly affect binding and toxicity of NetB. These findings present new insights into the mode of action of these pore-forming toxins, enabling the design of more effective control measures against necrotic enteritis and providing potential new tools to the field of bionanotechnology.	[Savva, Christos G.; Naylor, Claire E.; Cole, Ambrose R.; Moss, David S.; Basak, Ajit K.] Univ London Birkbeck Coll, Dept Biol Sci, Sch Crystallog, Inst Struct & Mol Biol, London WC1E 7HX, England; [da Costa, Sergio P. Fernandes; Bokori-Brown, Monika; Titball, Richard W.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England	University of London; Birkbeck University London; University of Exeter	Titball, RW (corresponding author), Univ Exeter, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	r.w.titball@exeter.ac.uk; a.basak@mail.cryst.bbk.ac.uk	Bokori-Brown, Monika/Y-2302-2019		Wellcome Trust Award [WT089618MA]; European Union Marie Curie Network Grant [237942]	Wellcome Trust Award(Wellcome Trust); European Union Marie Curie Network Grant	This work was supported in part by Wellcome Trust Award WT089618MA (to D. M., Prof. H. Saibil, A. B., and R. T.). In addition, this work was supported by European Union Marie Curie Network Grant 237942 (to R. T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso A, 2000, BIOCHEMISTRY-US, V39, P14019, DOI 10.1021/bi001739o; [Anonymous], 2001, WHO GLOBAL STRATEGY; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BHAKDI S, 1981, P NATL ACAD SCI-BIOL, V78, P5475, DOI 10.1073/pnas.78.9.5475; Brennan J, 2001, POULTRY SCI, V80, P1451, DOI 10.1093/ps/80.10.1451; Brennan J, 2001, AVIAN DIS, V45, P210, DOI 10.2307/1593030; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/nnano.2009.12, 10.1038/NNANO.2009.12]; Comai M, 2002, MOL MICROBIOL, V44, P1251, DOI 10.1046/j.1365-2958.2002.02943.x; Dahiya JP, 2006, ANIM FEED SCI TECH, V129, P60, DOI 10.1016/j.anifeedsci.2005.12.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; EDWARDS DA, 1995, J CONTROL RELEASE, V34, P211, DOI 10.1016/0168-3659(94)00132-E; ELWINGER K, 1992, ACTA VET SCAND, V33, P369; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; Galdiero S, 2004, PROTEIN SCI, V13, P1503, DOI 10.1110/ps.03561104; Gholamiandekhordi AR, 2006, VET MICROBIOL, V113, P143, DOI 10.1016/j.vetmic.2005.10.023; Gu LQ, 2000, P NATL ACAD SCI USA, V97, P3959, DOI 10.1073/pnas.97.8.3959; KALDHUSDAL M, 1992, POULTRY SCI, V71, P1145, DOI 10.3382/ps.0711145; Kaldhusdal M, 2001, AVIAN DIS, V45, P149, DOI 10.2307/1593022; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007; Misakian M, 2003, J MEMBRANE BIOL, V195, P137, DOI 10.1007/s00232-003-0615-1; Monma N, 2004, J BIOCHEM, V136, P427, DOI 10.1093/jb/mvh140; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; Noskov SY, 2004, BIOPHYS J, V87, P2299, DOI 10.1529/biophysj.104.044008; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Potrich C, 2009, J MEMBRANE BIOL, V227, P13, DOI 10.1007/s00232-008-9140-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7; Sluis W. van der, 2000, World Poultry, V16, P42; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Steinthorsdottir V, 1998, FEMS MICROBIOL LETT, V158, P17, DOI 10.1016/S0378-1097(97)00470-9; Tanaka Y, 2011, PROTEIN SCI, V20, P448, DOI 10.1002/pro.579; TOMITA T, 1992, J BIOL CHEM, V267, P13391; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Van der Sluis W., 2000, WORLD POULTRY SCI J, V16, P56; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	45	67	72	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3512	3522		10.1074/jbc.M112.430223	http://dx.doi.org/10.1074/jbc.M112.430223			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239883	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000314397900056
J	Walavalkar, NM; Gordon, N; Williams, DC				Walavalkar, Ninad M.; Gordon, Nathaniel; Williams, David C., Jr.			Unique Features of the Anti-parallel, Heterodimeric Coiled-coil Interaction between Methyl-cytosine Binding Domain 2 (MBD2) Homologues and GATA Zinc Finger Domain Containing 2A (GATAD2A/p66 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR; DNA METHYLATION; HELIX FORMATION; FOLDING PROBLEM; PROTEINS MBD2; NURD COMPLEX; ULTRACENTRIFUGATION; ELECTROSTATICS; HETEROGENEITY; DIMERIZATION	The methyl-cytosine binding domain 2 (MBD2)-nucleosome remodeling and deacetylase (NuRD) complex recognizes methylated DNA and silences expression of associated genes through histone deacetylase and nucleosome remodeling functions. Our previous structural work demonstrated that a coiled-coil interaction between MBD2 and GATA zinc finger domain containing 2A (GATAD2A/p66 alpha) proteins recruits the chromodomain helicase DNA-binding protein (CHD4/Mi2 beta) to the NuRD complex and is necessary for MBD2-mediated DNA methylation-dependent gene silencing in vivo (Gnanapragasam, M. N., Scarsdale, J. N., Amaya, M. L., Webb, H. D., Desai, M. A., Walavalkar, N. M., Wang, S. Z., Zu Zhu, S., Ginder, G. D., and Williams, D. C., Jr. (2011) p66 alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex. Proc. Natl. Acad. Sci. U.S.A. 108, 7487-7492). The p66 alpha-MBD2 interaction differs from most coiled-coils studied to date by forming an anti-parallel heterodimeric complex between two peptides that are largely monomeric in isolation. To further characterize unique features of this complex that drive heterodimeric specificity and high affinity binding, we carried out biophysical analyses of MBD2 and the related homologues MBD3, MBD3-like protein 1 (MBD3L1), and MBD3-like protein 2 (MBD3L2) as well as specific mutations that modify charge-charge interactions and helical propensity of the coiled-coil domains. Analytical ultracentrifugation analyses show that the individual peptides remain monomeric in isolation even at 300 mu M in concentration for MBD2. Circular dichroism analyses demonstrate a direct correlation between helical content of the coiled-coil domains in isolation and binding affinity for p66 alpha. Furthermore, complementary electrostatic surface potentials and inherent helical content of each peptide are necessary to maintain high-affinity association. These factors lead to a binding affinity hierarchy of p66 alpha for the different MBD2 homologues (MBD2 approximate to MBD3 > MBD3L1 approximate to MBD3L2) and suggest a hierarchical regulatory model in tissue and life cycle stage-specific silencing by NuRD complexes.	[Walavalkar, Ninad M.] Virginia Commonwealth Univ, Integrat Life Sci Program, Richmond, VA 23298 USA; [Walavalkar, Ninad M.; Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23298 USA; [Walavalkar, Ninad M.; Williams, David C., Jr.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Gordon, Nathaniel] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Eastern Virginia Medical School	Williams, DC (corresponding author), Virginia Commonwealth Univ, Dept Pathol, POB 980035, Richmond, VA 23298 USA.	dwilliams8@mcvh-vcu.edu			National Institutes of Health Grant [R01-GM098264]; American Cancer Society ACS [IRG-73-001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098264] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society ACS(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM098264 (to D.C.W.). This work was also supported by American Cancer Society ACS IRG-73-001 (to D.C.W.).	Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Doyle M. L., 2001, CURR PROTOCOLS PROTE, P2041; Dragan AI, 2002, J MOL BIOL, V321, P891, DOI 10.1016/S0022-2836(02)00699-X; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Jiang CL, 2004, J BIOL CHEM, V279, P52456, DOI 10.1074/jbc.M409149200; Jiang CL, 2002, GENOMICS, V80, P621, DOI 10.1006/geno.2002.7001; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Kumita JR, 2000, P NATL ACAD SCI USA, V97, P3803, DOI 10.1073/pnas.97.8.3803; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Moran LB, 1999, P NATL ACAD SCI USA, V96, P10699, DOI 10.1073/pnas.96.19.10699; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Myers JK, 1999, J MOL BIOL, V289, P205, DOI 10.1006/jmbi.1999.2747; Schrodinger L., 2020, PYMOL; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sosnick TR, 1996, PROTEINS, V24, P427; Steinkruger JD, 2012, J AM CHEM SOC, V134, P2626, DOI 10.1021/ja208855x; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Yadav MK, 2006, BIOCHEMISTRY-US, V45, P4463, DOI 10.1021/bi060092q; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507	37	27	28	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3419	3427		10.1074/jbc.M112.431346	http://dx.doi.org/10.1074/jbc.M112.431346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239876	hybrid, Green Published			2022-12-25	WOS:000314397900046
J	Zheng, H; Li, Q; Chen, R; Zhang, J; Ran, Y; He, X; Li, S; Shu, HB				Zheng, Hao; Li, Qi; Chen, Rui; Zhang, Jing; Ran, Yong; He, Xiao; Li, Shu; Shu, Hong-Bing			The Dual-specificity Phosphatase DUSP14 Negatively Regulates Tumor Necrosis Factor- and Interleukin-1-induced Nuclear Factor-kappa B Activation by Dephosphorylating the Protein Kinase TAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; TNF-ALPHA; MAPKKK; TAB1; PHOSPHORYLATION; MOTIF	The transcription factor NF-kappa B is critically involved in the inflammatory response triggered by the proinflammatory cytokines TNF and IL-1. Various studies have demonstrated that activation of TAK1 (TGF-beta-activated kinase 1) is an essential step in TNF- and IL-1-induced NF-kappa B activation pathways. In this study, we identified a member of the dual-specificity phosphatase family, DUSP14, as a negative regulator of TNF- and IL-1-triggered NF-kappa B activation by expression screens. We found that DUSP14 interacted with TAK1 and that this interaction was enhanced by TNF or IL-1 stimulation. Overexpression of DUSP14 dephosphorylated TAK1 at Thr-187, a residue in the activation loop critically involved in TAK1 activation. Knockdown of DUSP14 increased basal as well as TNF- and IL-1-induced TAK1 phosphorylation at Thr-187. Overexpression of DUSP14, but not its phosphatase-deficient mutant, inhibited TNF- and IL-1-induced as well as TAK1-mediated NF-kappa B activation, whereas knockdown of DUSP14 had opposite effects. These findings suggest that DUSP14 negatively regulates TNF- or IL-1-induced NF-kappa B activation by dephosphorylating TAK1 at Thr-187. Our study reveals a new post-translational regulatory mechanism of NF-kappa B activation triggered by the proinflammatory cytokines.	[Zheng, Hao; Li, Qi; Chen, Rui; Zhang, Jing; Ran, Yong; He, Xiao; Li, Shu; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn			Chinese Ministry of Science and Technology [2012CB910201, 2010DFA31100]; National Science Foundation of China [91029302, 30921001]; Chinese 111 Project [B06018]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project)	This work was supported by Chinese Ministry of Science and Technology Grants 2012CB910201 and 2010DFA31100, National Science Foundation of China Grants 91029302 and 30921001, and Chinese 111 Project Grant B06018.	Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Lountos GT, 2009, ACTA CRYSTALLOGR D, V65, P1013, DOI 10.1107/S0907444909023762; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	23	42	44	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					819	825		10.1074/jbc.M112.412643	http://dx.doi.org/10.1074/jbc.M112.412643			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23229544	Green Published, hybrid			2022-12-25	WOS:000313570300007
J	Wan, Z; Perry, CGR; Macdonald, T; Chan, CB; Holloway, GP; Wright, DC				Wan, Zhongxiao; Perry, Christopher G. R.; Macdonald, Tara; Chan, Catherine B.; Holloway, Graham P.; Wright, David C.			IL-6 Is Not Necessary for the Regulation of Adipose Tissue Mitochondrial Content	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; INDUCED INSULIN-RESISTANCE; RECEPTOR-GAMMA; SKELETAL-MUSCLE; GENE-EXPRESSION; INTERLEUKIN-6; FAT; PGC-1-ALPHA; MICE; COACTIVATOR	Background: Adipose tissue mitochondria have been implicated as key mediators of systemic metabolism. We have shown that IL-6 activates AMPK, a mediator of mitochondrial biogenesis, in adipose tissue; however, IL-6(-/-) mice fed a high fat diet have been reported to develop insulin resistance. These findings suggest that IL-6 may control adipose tissue mitochondrial content in vivo, and that reductions in adipose tissue mitochondria may be causally linked to the development of insulin resistance in IL-6(-/-) mice fed a high fat diet. On the other hand, IL-6 has been implicated as a negative regulator of insulin action. Given these discrepancies the purpose of the present investigation was to further evaluate the relationship between IL-6, adipose tissue mitochondrial content and whole body insulin action. Methodology and Principal Findings: In cultured epididymal mouse adipose tissue IL-6 (75 ng/ml) induced the expression of the transcriptional co-activators PGC-1 alpha and PRC, reputed mediators of mitochondrial biogenesis. Similarly, IL-6 increased the expression of COXIV and CPT-1. These effects were absent in cultured subcutaneous adipose tissue and were associated with lower levels of GP130 and IL-6 receptor alpha protein content. Markers of mitochondrial content were intact in adipose tissue from chow fed IL-6(-/-) mice. When fed a high fat diet IL-6(-/-) mice were more glucose and insulin intolerant than controls fed the same diet; however this was not explained by decreases in adipose tissue mitochondrial content or respiration. Conclusions and Significance: Our findings demonstrate depot-specific differences in the ability of IL-6 to induce PGC-1 alpha and mitochondrial enzymes and demonstrate that IL-6 is not necessary for the maintenance of adipose tissue mitochondrial content in vivo. Moreover, reductions in adipose tissue mitochondria do not explain the greater insulin resistance in IL-6(-/-) mice fed a high fat diet. These results question the role of adipose tissue mitochondrial dysfunction in the etiology of insulin resistance.	[Perry, Christopher G. R.; Macdonald, Tara; Holloway, Graham P.; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Wan, Zhongxiao; Chan, Catherine B.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Guelph; University of Alberta	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca	Chan, Catherine/C-1162-2011	Chan, Catherine/0000-0003-3882-0592; Wright, David/0000-0003-3867-8901	Canadian Institutes of Health Research [MOP 115708-2011]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by an Operating Grant from the Canadian Institutes of Health Research (MOP 115708-2011) to DW and Natural Sciences and Engineering Research Council of Canada Discovery Grants to GH and CC. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adser H, 2011, ACTA PHYSIOL, V202, P165, DOI 10.1111/j.1748-1716.2011.02269.x; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bruce CR, 2004, AM J PHYSIOL-ENDOC M, V287, pE616, DOI 10.1152/ajpendo.00150.2004; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Deng T, 2011, J BIOL CHEM, V286, P30723, DOI 10.1074/jbc.M111.251926; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fried SK, 2000, METH MOL B, V155, P197; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Fritsche L, 2010, DIABETOLOGIA, V53, P1732, DOI 10.1007/s00125-010-1754-4; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Ijichi N, 2007, BIOCHEM BIOPH RES CO, V358, P813, DOI 10.1016/j.bbrc.2007.04.209; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji C, 2011, J BIOENERG BIOMEMBR; Karamitri A, 2009, J BIOL CHEM, V284, P20738, DOI 10.1074/jbc.M109.021766; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Kraunsoe R, 2010, J PHYSIOL-LONDON, V588, P2023, DOI 10.1113/jphysiol.2009.184754; Kubo M, 2009, BBA-GENE REGUL MECH, V1789, P71, DOI 10.1016/j.bbagrm.2008.08.012; Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013; Laye MJ, 2009, J PHYSIOL-LONDON, V587, P3729, DOI 10.1113/jphysiol.2009.172601; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mitra R, 2012, J MOL CELL CARDIOL, V52, P701, DOI 10.1016/j.yjmcc.2011.10.010; Nielsen NB, 2009, REGUL PEPTIDES, V155, P39, DOI 10.1016/j.regpep.2009.04.010; Pardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026989; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; Sutherland LN, 2008, AM J PHYSIOL-ENDOC M, V295, pE1076, DOI 10.1152/ajpendo.90408.2008; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Wada T, 2011, AM J PHYSIOL-ENDOC M, V300, pE1112, DOI 10.1152/ajpendo.00370.2010; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041719; Wan ZX, 2012, OBESITY, V20, P453, DOI 10.1038/oby.2011.252; Wan ZX, 2010, AM J PHYSIOL-CELL PH, V299, pC1162, DOI 10.1152/ajpcell.00188.2010; White UA, 2011, CURR PHARM DESIGN, V17, P340; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010	51	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51233	10.1371/journal.pone.0051233	http://dx.doi.org/10.1371/journal.pone.0051233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240005	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800041
J	Baraki, H; Zinne, N; Wedekind, D; Meier, M; Bleich, A; Glage, S; Hedrich, HJ; Kutschka, I; Haverich, A				Baraki, Hassina; Zinne, Norman; Wedekind, Dirk; Meier, Martin; Bleich, Andre; Glage, Silke; Hedrich, Hans-Juergen; Kutschka, Ingo; Haverich, Axel			Magnetic Resonance Imaging of Soft Tissue Infection with Iron Oxide Labeled Granulocytes in a Rat Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; COLONY-STIMULATING FACTOR; MR CONTRAST AGENTS; IN-VIVO; BONE-MARROW; STAPHYLOCOCCUS-AUREUS; PARTICLES; SUSCEPTIBILITY; MEDIASTINITIS; MACROPHAGES	Object: We sought to detect an acute soft tissue infection in rats by magnetic resonance imaging (MRI) using granulocytes, previously labeled with superparamagnetic particles of iron oxide (SPIO). Materials and Methods: Parasternal infection was induced by subcutaneous inoculation of Staphylococcus aureus suspension in rats. Granulocytes isolated from isogenic donor rats were labeled with SPIO. Infected rats were imaged by MRI before, 6 and 12 hours after intravenous injection of SPIO-labeled or unlabeled granulocytes. MR findings were correlated with histological analysis by Prussian blue staining and with re-isolated SPIO-labeled granulocytes from the infectious area by magnetic cell separation. Results: Susceptibility effects were present in infected sites on post-contrast T2*-weighted MR images in all animals of the experimental group. Regions of decreased signal intensity (SI) in MRI were detected at 6 hours after granulocyte administration and were more pronounced at 12 hours. SPIO-labeled granulocytes were identified by Prussian blue staining in the infected tissue and could be successfully re-isolated from the infected area by magnetic cell separation. Conclusion: The application of SPIO-labeled granulocytes in MRI offers new perspectives in diagnostic specificity and sensitifity to detect early infectious processes.	[Baraki, Hassina; Zinne, Norman; Kutschka, Ingo; Haverich, Axel] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-3000 Hannover, Germany; [Wedekind, Dirk; Meier, Martin; Bleich, Andre; Glage, Silke; Hedrich, Hans-Juergen] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School	Baraki, H (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-3000 Hannover, Germany.	baraki.hassina@mh-hannover.de	Haverich, Axel/AAC-7552-2022	Meier, Martin/0000-0001-8642-0409				Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Bakhru SH, 2012, INT J NANOMED, V7, P4613, DOI 10.2147/IJN.S28294; Bennewitz MF, 2012, MOL IMAGING BIOL; Bierry G, 2008, RADIOLOGY, V248, P114, DOI 10.1148/radiol.2481071260; Bierry G, 2012, SKELETAL RADIOL, V41, P1509, DOI 10.1007/s00256-012-1397-2; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Bruggink JLM, 2010, EUR J VASC ENDOVASC, V40, P348, DOI 10.1016/j.ejvs.2010.05.016; Bulte JWM, 2004, CURR PHARM BIOTECHNO, V5, P567; Cheng JL, 2010, CHIN J TRAUMATOL, V13, P173, DOI 10.3760/cma.j.issn.1008-1275.2010.03.008; Daldrup-Link HE, 2005, RADIOLOGY, V234, P197, DOI 10.1148/radiol.2341031236; Dodd SJ, 1999, BIOPHYS J, V76, P103, DOI 10.1016/S0006-3495(99)77182-1; ElOakley RM, 1996, ANN THORAC SURG, V61, P1030, DOI 10.1016/0003-4975(95)01035-1; FERRUCCI JT, 1990, AM J ROENTGENOL, V155, P943, DOI 10.2214/ajr.155.5.2120963; Gemmel F, 2012, EUR J NUCL MED MOL I, V39, P892, DOI 10.1007/s00259-012-2062-7; Cavalcanti JLG, 2011, EUR J RADIOL, V80, P60, DOI 10.1016/j.ejrad.2010.12.102; Gummert JF, 2002, THORAC CARDIOV SURG, V50, P87, DOI 10.1055/s-2002-26691; Guo RF, 2006, J IMMUNOL, V177, P1306, DOI 10.4049/jimmunol.177.2.1306; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hamm J, 2008, NMR BIOMED, V21, P120, DOI 10.1002/nbm.1168; Heiken Jay P, 2008, Cancer Imaging, V8 Spec No A, pS124, DOI 10.1102/1470-7330.2008.9018; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hoehn M, 2007, J PHYSIOL-LONDON, V584, P25, DOI 10.1113/jphysiol.2007.139451; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Ju SH, 2007, RADIOLOGY, V245, P206, DOI 10.1148/radiol.2443061290; Kaim AH, 2003, RADIOLOGY, V227, P169, DOI 10.1148/radiol.2272020490; Kaim AH, 2002, RADIOLOGY, V225, P808, DOI 10.1148/radiol.2253011485; Karzai W, 2005, ANESTHESIOLOGY, V103, P996, DOI 10.1097/00000542-200511000-00014; Kato N, 2002, INVEST RADIOL, V37, P292, DOI 10.1097/00004424-200205000-00007; Kiessling F, 2009, RADIOLOGY, V253, P462, DOI 10.1148/radiol.2532081815; Kircher MF, 2003, CANCER RES, V63, P6838; Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; LANDAY AL, 1989, CLIN IMMUNOL IMMUNOP, V52, P48, DOI 10.1016/0090-1229(89)90192-X; LANGE JMA, 1990, NEW ENGL J MED, V322, P1375, DOI 10.1056/NEJM199005103221907; Lee JS, 2006, RADIOLOGY, V241, P142, DOI 10.1148/radiol.2403051156; Lefevre S, 2011, RADIOLOGY, V258, P722, DOI 10.1148/radiol.10101272; Love Charito, 2004, J Nucl Med Technol, V32, P47; Lush CW, 2000, MICROCIRCULATION, V7, P83, DOI 10.1038/sj.mn.7300096; Lutz AM, 2004, RADIOLOGY, V233, P149, DOI 10.1148/radiol.2331031402; Misselwitz B, 2006, EUR J RADIOL, V58, P375, DOI 10.1016/j.ejrad.2005.12.044; Modo M, 2005, MOL IMAGING, V4, P143; MORIMOTO A, 1990, J PHYSIOL-LONDON, V427, P227, DOI 10.1113/jphysiol.1990.sp018169; Mulder WJM, 2006, NMR BIOMED, V19, P142, DOI 10.1002/nbm.1011; Namasivayam Saravanan, 2007, Cancer Imaging, V7, P2, DOI 10.1102/1470-7330.2007.0002; Ozcan AV, 2006, TEX HEART I J, V33, P107; Saleem BR, 2010, AM J SURG, V200, P47, DOI 10.1016/j.amjsurg.2009.05.018; Satta J, 1998, SCAND CARDIOVASC J, V32, P29; Specht K, 2005, NEUROIMAGE, V25, P287, DOI 10.1016/j.neuroimage.2004.11.022; TANAKA H, 1989, J PHARMACOL EXP THER, V251, P1199; Tang TY, 2009, ARTERIOSCL THROM VAS, V29, P1001, DOI 10.1161/ATVBAHA.108.165514; Tanimoto A, 2001, J MAGN RESON IMAGING, V14, P72, DOI 10.1002/jmri.1153; van desBank BL, 2012, NMR BIOMED, V26, P367, DOI [10.1002/nbm.2868, DOI 10.1002/NBM.2868]; Wang YXJ, 2008, BRIT J RADIOL, V81, P987, DOI 10.1259/bjr/55991430; WEISSKOFF RM, 1992, MAGNET RESON MED, V24, P375, DOI 10.1002/mrm.1910240219; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Yamaguchi H, 2001, Ann Thorac Cardiovasc Surg, V7, P94; Yamashiro T, 2008, RADIAT MED, V26, P343, DOI 10.1007/s11604-008-0238-7	59	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51770	10.1371/journal.pone.0051770	http://dx.doi.org/10.1371/journal.pone.0051770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236524	gold, Green Published, Green Submitted			2022-12-25	WOS:000312064100140
J	Karolemeas, K; Donnelly, CA; Conlan, AJK; Mitchell, AP; Clifton-Hadley, RS; Upton, P; Wood, JLN; McKinley, TJ				Karolemeas, Katerina; Donnelly, Christl A.; Conlan, Andrew J. K.; Mitchell, Andrew P.; Clifton-Hadley, Richard S.; Upton, Paul; Wood, James L. N.; McKinley, Trevelyan J.			The Effect of Badger Culling on Breakdown Prolongation and Recurrence of Bovine Tuberculosis in Cattle Herds in Great Britain	PLOS ONE			English	Article							HUSBANDRY PRACTICES; RISK-FACTORS; IMPACT; REMOVAL; MODEL	Bovine tuberculosis is endemic in cattle herds in Great Britain, with a substantial economic impact. A reservoir of Mycobacterium bovis within the Eurasian badger (Meles meles) population is thought to have hindered disease control. Cattle herd incidents, termed breakdowns, that are either 'prolonged' (lasting >= 240 days) or 'recurrent' (with another breakdown within a specified time period) may be important foci for onward spread of infection. They drain veterinary resources and can be demoralising for farmers. Randomised Badger Culling Trial (RBCT) data were re-analysed to examine the effects of two culling strategies on breakdown prolongation and recurrence, during and after culling, using a Bayesian hierarchical model. Separate effect estimates were obtained for the 'core' trial areas (where culling occurred) and the 'buffer' zones (up to 2 km outside of the core areas). For breakdowns that started during the culling period, 'reactive' (localised) culling was associated with marginally increased odds of prolongation, with an odds ratio (OR) of 1.7 (95% credible interval [CI] 1.1-2.4) within the core areas. This effect was not present after the culling ceased. There was no notable effect of 'proactive' culling on prolongation. In contrast, reactive culling had no effect on breakdown recurrence, though there was evidence of a reduced risk of recurrence in proactive core areas during the culling period (ORs and 95% CIs: 0.82 (0.64-1.0) and 0.69 (0.54-0.86) for 24- and 36-month recurrence respectively). Again these effects were not present after the culling ceased. There seemed to be no effect of culling on breakdown prolongation or recurrence in the buffer zones. These results suggest that the RBCT badger culling strategies are unlikely to reduce either the prolongation or recurrence of breakdowns in the long term, and that reactive strategies (such as employed during the RBCT) are, if anything, likely to impact detrimentally on breakdown persistence.	[Karolemeas, Katerina; Conlan, Andrew J. K.; Wood, James L. N.; McKinley, Trevelyan J.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England; [Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Mitchell, Andrew P.; Clifton-Hadley, Richard S.; Upton, Paul] Anim Hlth & Vet Labs Agcy, Surrey, England	University of Cambridge; Imperial College London	McKinley, TJ (corresponding author), Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England.	tjm44@cam.ac.uk	Conlan, Andrew/Q-3861-2019; Mitchell, Andrew P/L-6141-2014; Wood, James/A-1626-2008	Conlan, Andrew/0000-0002-2593-6353; Wood, James/0000-0002-0258-3188; Donnelly, Christl/0000-0002-0195-2463	Department for Environment, Food and Rural Affairs (Defra) [VT0105]; BBSRC [BB/I012192/1]; Alborada Trust; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Defra [SE3230, PU/T/WL/07/46]; Veterinary Laboratories Agency; Defra, United Kingdom [SE3230]; MRC; Hefce; Biotechnology and Biological Sciences Research Council [BB/I012192/1] Funding Source: researchfish; Medical Research Council [G0600719, G0600719B] Funding Source: researchfish; MRC [G0600719] Funding Source: UKRI	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alborada Trust; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Veterinary Laboratories Agency; Defra, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hefce(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KK, TJM and JLNW were supported by grant VT0105 from the Department for Environment, Food and Rural Affairs (Defra) and Hefce. TJM is also supported by BBSRC grant (BB/I012192/1). JLNW is also supported by the Alborada Trust and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security. AJKC was funded by Defra grant SE3230 Cambridge reference PU/T/WL/07/46), sponsored by the Veterinary Laboratories Agency. The work was also funded by Defra, United Kingdom, under contract SE3230. CAD thanks the MRC for Centre funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DA, 2010, P SOC VET EP PREV ME, P167; [Anonymous], 2012, VET REC, V171, P413, DOI 10.1136/vr.e7175; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Christiansen KH, 1992, CASE CONTROL STUDY H, P45; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Cox DR, 2005, P NATL ACAD SCI USA, V102, P17588, DOI 10.1073/pnas.0509003102; COX DR, 1955, J ROY STAT SOC B, V17, P129; Defra, 2005, GOV STRAT FRAM SUST; Defra, 2010, BOV TUB GOV APPR TAC; Defra, 2010, BOV TB BADG VACC DEP; Defra, 2005, BOV TB HIST BADG CON; Defra, 2012, BOV TB PIL AR CONF; Defra, 2005, REP IND SCI REV GROU; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Eves JA, 1999, IRISH VET J, V52, P199; Farm Crisis Network, 2009, STRESS LOSS REP IMP; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Godfray CJ, 2004, INDEPENDENT SCI REV; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; GRIFFIN JM, 1993, PREV VET MED, V17, P145, DOI 10.1016/0167-5877(93)90025-O; Jenkins HE, 2007, J APPL ECOL, V44, P897, DOI 10.1111/j.1365-2664.2007.01372.x; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Johnston WT, 2005, BIOL LETT-UK, V1, P53, DOI 10.1098/rsbl.2004.0249; Karolemeas K, 2011, PREV VET MED, V102, P22, DOI 10.1016/j.prevetmed.2011.06.004; Karolemeas K, 2010, PREV VET MED, V97, P183, DOI 10.1016/j.prevetmed.2010.09.007; King D., 2007, BOVINE TUBERCULOSIS; More SJ, 2007, VET REC, V161, P208, DOI 10.1136/vr.161.6.208; Olea-Popelka FJ, 2004, PREV VET MED, V63, P163, DOI 10.1016/j.prevetmed.2004.03.001; R Core Development Team, 2011, R LANG ENV STAT COMP; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Vial F, 2012, BIOL LETTERS, V8, P50, DOI 10.1098/rsbl.2011.0554; Vial F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018058; [Welsh Assembly Government wales.gov.uk/topics/environmentaluntryside/ahw/disease/bovinetuberculosis/?lang=en], 2012, BADG VACC N PEMBR WA; Wolfe DM, 2010, PREV VET MED, V94, P170, DOI 10.1016/j.prevetmed.2010.02.010; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128	43	6	6	0	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51342	10.1371/journal.pone.0051342	http://dx.doi.org/10.1371/journal.pone.0051342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236478	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100100
J	Malinowski, M; Pietraszek, K; Perreau, C; Boguslawski, M; Decot, V; Stoltz, JF; Vallar, L; Niewiarowska, J; Cierniewski, C; Maquart, FX; Wegrowski, Y; Brezillon, S				Malinowski, Mariusz; Pietraszek, Katarzyna; Perreau, Corinne; Boguslawski, Mateusz; Decot, Veronique; Stoltz, Jean-Francois; Vallar, Laurent; Niewiarowska, Jolanta; Cierniewski, Czeslaw; Maquart, Francois-Xavier; Wegrowski, Yanusz; Brezillon, Stephane			Effect of Lumican on the Migration of Human Mesenchymal Stem Cells and Endothelial Progenitor Cells: Involvement of Matrix Metalloproteinase-14	PLOS ONE			English	Article							HUMAN BONE-MARROW; ISCHEMIA-INDUCED NEOVASCULARIZATION; LEUCINE-RICH PROTEOGLYCAN; EXTRACELLULAR-MATRIX; TUMOR ANGIOGENESIS; GENE-EXPRESSION; STROMAL CELLS; IN-VITRO; CLEAVAGE; GROWTH	Background: Increasing number of evidence shows that soluble factors and extracellular matrix (ECM) components provide an optimal microenvironment controlling human bone marrow mesenchymal stem cell (MSC) functions. Successful in vivo administration of stem cells lies in their ability to migrate through ECM barriers and to differentiate along tissue-specific lineages, including endothelium. Lumican, a protein of the small leucine-rich proteoglycan (SLRP) family, was shown to impede cell migration and angiogenesis. The aim of the present study was to analyze the role of lumican in the control of MSC migration and transition to functional endothelial progenitor cell (EPC). Methodology/Principal Findings: Lumican inhibited tube-like structures formation on Matrigel (R) by MSC, but not EPC. Since matrix metalloproteinases (MMPs), in particular MMP-14, play an important role in remodelling of ECM and enhancing cell migration, their expression and activity were investigated in the cells grown on different ECM substrata. Lumican down-regulated the MMP-14 expression and activity in MSC, but not in EPC. Lumican inhibited MSC, but not EPC migration and invasion. The inhibition of MSC migration and invasion by lumican was reversed by MMP-14 overexpression. Conclusion/Significance: Altogether, our results suggest that lumican inhibits MSC tube-like structure formation and migration via mechanisms that involve a decrease of MMP-14 expression and activity. Citation: Malinowski M, Pietraszek K, Perreau C, Boguslawski M, Decot V, et al. (2012) Effect of Lumican on the Migration of Human Mesenchymal Stem Cells and Endothelial Progenitor Cells: Involvement of Matrix Metalloproteinase-14. PLoS ONE 7(12): e50709. doi:10.1371/journal.pone.0050709	[Malinowski, Mariusz; Pietraszek, Katarzyna; Perreau, Corinne; Boguslawski, Mateusz; Maquart, Francois-Xavier; Wegrowski, Yanusz; Brezillon, Stephane] Univ Reims, CNRS FRE 3481, Lab Biochim Med & Biol Mol, Reims, France; [Malinowski, Mariusz; Cierniewski, Czeslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Decot, Veronique; Stoltz, Jean-Francois] CHU Brabois, CNRS, Unite Therapie Cellulaire & Banque Tissus, Fac Med,UMR 7561, Vandoeuvre Les Nancy, France; [Vallar, Laurent] CRP Sante, Microarray Ctr, Luxembourg, Luxembourg; [Niewiarowska, Jolanta] Med Univ Lodz, Dept Mol & Med Biophys, Lodz, Poland; [Maquart, Francois-Xavier] CHU Reims, Reims, France	Universite de Reims Champagne-Ardenne; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CHU de Nancy; Universite de Lorraine; Luxembourg Institute of Health; Medical University Lodz; CHU de Reims	Brezillon, S (corresponding author), Univ Reims, CNRS FRE 3481, Lab Biochim Med & Biol Mol, Reims, France.	stephane.brezillon@univ-reims.fr	Karamanos, Nikos/A-3616-2008; Pietraszek-Gremplewicz, Katarzyna/AAM-2454-2020	Karamanos, Nikos/0000-0003-3618-0288; Niewiarowska, Jolanta/0000-0003-0561-7766; BREZILLON, stephane/0000-0001-7954-8340; Vallar, Laurent/0000-0002-4404-1010; Pietraszek-Gremplewicz, Katarzyna/0000-0002-4081-5314; Malinowski, Mariusz/0000-0002-1632-8647	INCa-CNRS-Polish Academy of Sciences program; Institut National du Cancer (INCa) (ACI Canceropoles); Region Champagne-Ardenne; Fonds Europeen de Developpement Regional (FEDER) (contrat de projet Etat-region (CPER)); Ligue Nationale contre le Cancer (comite de la Mame)	INCa-CNRS-Polish Academy of Sciences program; Institut National du Cancer (INCa) (ACI Canceropoles)(Region Grand-EstInstitut National du Cancer (INCA) France); Region Champagne-Ardenne(Region Grand-Est); Fonds Europeen de Developpement Regional (FEDER) (contrat de projet Etat-region (CPER)); Ligue Nationale contre le Cancer (comite de la Mame)	The authors thank the INCa-CNRS-Polish Academy of Sciences program, Institut National du Cancer (INCa) (ACI Canceropoles 2007-2009), the Region Champagne-Ardenne, the Fonds Europeen de Developpement Regional (FEDER) (contrat de projet Etat-region (CPER), CPER 2007-2013) and the Ligue Nationale contre le Cancer (comite de la Mame) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Albig Allan R., 2007, Angiogenesis, V10, P197, DOI 10.1007/s10456-007-9075-z; Berthelemy N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005514; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brezillon S, 2007, CLIN EXP DERMATOL, V32, P405, DOI 10.1111/j.1365-2230.2007.02437.x; Brezillon S, 2009, J PHYSIOL PHARMACOL, V60, P15; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Caiado F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003752; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; D'Onofrio MF, 2008, BIOCHEM BIOPH RES CO, V365, P266, DOI 10.1016/j.bbrc.2007.10.155; Davis GE, 2006, J INVEST DERM SYMP P, V11, P44, DOI 10.1038/sj.jidsymp.5650008; Dolhnikoff M, 1998, AM J RESP CELL MOL, V19, P582, DOI 10.1165/ajrcmb.19.4.2979; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; GROVER J, 1995, J BIOL CHEM, V270, P21942, DOI 10.1074/jbc.270.37.21942; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; Ho IAW, 2009, STEM CELLS, V27, P1366, DOI 10.1002/stem.50; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Jazayeri M, 2008, CELL BIOL INT, V32, P1183, DOI 10.1016/j.cellbi.2008.07.020; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Lecomte J, 2011, CELL MOL LIFE SCI, V68, P677, DOI 10.1007/s00018-010-0476-6; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Li YY, 2004, CANCER RES, V64, P7058, DOI 10.1158/0008-5472.CAN-04-1038; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu Y, 2007, BIOMATERIALS, V28, P1393, DOI 10.1016/j.biomaterials.2006.11.019; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Lozito TP, 2009, J CELL BIOCHEM, V107, P714, DOI 10.1002/jcb.22167; Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mimura T, 2011, CORNEA, V30, pS45, DOI 10.1097/ICO.0b013e31822816e0; Moby V, 2011, J BIOMED MATER RES A, V96A, P313, DOI 10.1002/jbm.a.32981; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Omoteyama K, 2007, BIOCHEM BIOPH RES CO, V353, P159, DOI 10.1016/j.bbrc.2006.11.145; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Radwanska A, 2008, LIFE SCI, V83, P651, DOI 10.1016/j.lfs.2008.09.008; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Semon JA, 2010, CELL TISSUE RES, V341, P147, DOI 10.1007/s00441-010-0994-4; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Thevenard J, 2010, INT J CANCER, V126, P1055, DOI 10.1002/ijc.24688; Troup S, 2003, CLIN CANCER RES, V9, P207; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Williams KE, 2011, CANCER MICROENVIRON, V4, P115, DOI 10.1007/s12307-010-0056-1; Zeltz C, 2010, EXP CELL RES, V316, P2922, DOI 10.1016/j.yexcr.2010.08.002	51	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50709	10.1371/journal.pone.0050709	http://dx.doi.org/10.1371/journal.pone.0050709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236386	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100028
J	Martin, KL; Hill, GA; Klein, RR; Arnett, DG; Burd, R; Limesand, KH				Martin, Katie L.; Hill, Grace A.; Klein, Rob R.; Arnett, Deborah G.; Burd, Randy; Limesand, Kirsten H.			Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model	PLOS ONE			English	Article							IN-VIVO; ACINAR-CELLS; APOPTOSIS; RADIOTHERAPY; SENSITIVITY; SUPPRESSION; P53; ENHANCEMENT; ROSCOVITINE; ANTAGONISTS	Background: Treatment of head and neck cancer with radiation often results in damage to surrounding normal tissues such as salivary glands. Permanent loss of function in the salivary glands often leads patients to discontinue treatment due to incapacitating side effects. It has previously been shown that IGF-1 suppresses radiation-induced apoptosis and enhances G2/M arrest leading to preservation of salivary gland function. In an effort to recapitulate the effects of IGF-1, as well as increase the likelihood of translating these findings to the clinic, the small molecule therapeutic Roscovitine, is being tested. Roscovitine is a cyclin-dependent kinase inhibitor that acts to transiently inhibit cell cycle progression and allow for DNA repair in damaged tissues. Methodology/Principal Findings: Treatment with Roscovitine prior to irradiation induced a significant increase in the percentage of cells in the G(2)/M phase, as demonstrated by flow cytometry. In contrast, mice treated with radiation exhibit no differences in the percentage of cells in G(2)/M when compared to unirradiated controls. Similar to previous studies utilizing IGF-1, pretreatment with Roscovitine leads to a significant up-regulation of p21 expression and a significant decrease in the number of PCNA positive cells. Radiation treatment leads to a significant increase in activated caspase-3 positive salivary acinar cells, which is suppressed by pretreatment with Roscovitine. Administration of Roscovitine prior to targeted head and neck irradiation preserves normal tissue function in mouse parotid salivary glands, both acutely and chronically, as measured by salivary output. Conclusions/Significance: These studies suggest that induction of transient G(2)/M cell cycle arrest by Roscovitine allows for suppression of apoptosis, thus preserving normal salivary function following targeted head and neck irradiation. This could have an important clinical impact by preventing the negative side effects of radiation therapy in surrounding normal tissues. Citation: Martin KL, Hill GA, Klein RR, Arnett DG, Burd R, et al. (2012) Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model. PLoS ONE 7(12): e51363. doi: 10.1371/journal.pone.0051363	[Martin, Katie L.; Limesand, Kirsten H.] Univ Arizona, Physiol Sci Grad Interdisciplinary Program, Tucson, AZ 85721 USA; [Klein, Rob R.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Hill, Grace A.; Arnett, Deborah G.; Burd, Randy; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona	Limesand, KH (corresponding author), Univ Arizona, Physiol Sci Grad Interdisciplinary Program, Tucson, AZ 85721 USA.	limesank@u.arizona.edu		Limesand, Kirsten/0000-0003-4295-4665; Burd, Randy/0000-0001-9195-2733	Cancer Center Support Grant [CCSG- CA 023074]; National Institutes of Health [R01 (DE18888)]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018888] Funding Source: NIH RePORTER	Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The Flow Cytometry Core Facility is supported in part from a Cancer Center Support Grant CCSG- CA 023074. This work was supported by the National Institutes of Health R01 (DE18888). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila JL, 2009, INT J RADIAT ONCOL, V73, P523, DOI 10.1016/j.ijrobp.2008.09.036; Braam PM, 2006, INT J RADIAT ONCOL, V66, P975, DOI 10.1016/j.ijrobp.2006.06.045; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen YNP, 1999, P NATL ACAD SCI USA, V96, P4325, DOI 10.1073/pnas.96.8.4325; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hall E, 2000, RADIOBIOLOGY RADIOLO; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Jerjes W, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-6; Li Y, 2007, INT J RADIAT ONCOL, V67, P660, DOI 10.1016/j.ijrobp.2006.09.021; Limesand KH, 2003, CELL DEATH DIFFER, V10, P345, DOI 10.1038/sj.cdd.4401153; Limesand KH, 2006, MOL CELL BIOL, V26, P8840, DOI 10.1128/MCB.01846-05; Limesand KH, 2010, INT J RADIAT ONCOL, V78, P579, DOI 10.1016/j.ijrobp.2010.03.035; Limesand KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004663; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maggiorella L, 2003, CANCER RES, V63, P2513; Meijer L, 1996, TRENDS CELL BIOL, V6, P393, DOI 10.1016/0962-8924(96)10034-9; Mendoza N, 2003, CANCER RES, V63, P1020; Mitchell GC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.28; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wallace M, 2001, ONCOGENE, V20, P3597, DOI 10.1038/sj.onc.1204496; Zhang F, 2008, J RADIAT RES, V49, P541, DOI 10.1269/jrr.08024	25	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51363	10.1371/journal.pone.0051363	http://dx.doi.org/10.1371/journal.pone.0051363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236487	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100106
J	Ciani, AC; Pellizzari, E				Ciani, Andrea Camperio; Pellizzari, Elena			Fecundity of Paternal and Maternal Non-Parental Female Relatives of Homosexual and Heterosexual Men	PLOS ONE			English	Article							KIN SELECTION HYPOTHESIS; MALE SEXUAL ORIENTATION; FRATERNAL BIRTH-ORDER; HIDDEN POPULATIONS; SAMOAN FAAFAFINE; MALE ANDROPHILIA; OLDER BROTHERS; BBC INTERNET; FAMILY-SIZE; COVARIANCE	A variety of social, developmental, biological and genetic factors influence sexual orientation in males. Thus, several hypotheses have attempted to explain the sustenance of genetic factors that influence male homosexuality, despite decreased fecundity within the homosexuals. Kin selection, the existence of maternal effects and two forms of balancing selection, sexually antagonistic selection and overdominance, have been proposed as compensatory mechanisms for reduced homosexual fecundity. Here, we suggest that the empirical support for kin selection and maternal effects cannot account for the low universal frequency and stability of the distribution of homosexuals. To identify the responsible compensatory mechanism, we analyzed fecundity in 2,100 European female relatives, i.e., aunts and grandmothers, of either homosexual or heterosexual probands who were matched in terms of age, culture and sampling strategy. Female relatives were chosen to avoid the sampling bias of the fraternal birth order effect, which occurs when indirectly sampling mothers though their homosexual sons. We observed that the maternal aunts and grandmothers of homosexual probands were significantly more fecund compared with the maternal aunts and maternal grandmothers of the heterosexual probands. No difference in fecundity was observed in the paternal female lines (grandmothers or aunts) from either of the two proband groups. Moreover, due to the selective increase in maternal female fecundity, the total female fecundity was significantly higher in homosexual than heterosexual probands, thus compensating for the reduced fecundity of homosexuals. Altogether, these data support an X-linked multi-locus sexually antagonistic hypothesis rather than an autosomal multi-locus overdominance hypothesis.	[Ciani, Andrea Camperio] Univ Padua, Dept Gen Psychol, Padua, Italy; [Pellizzari, Elena] GEA, Int Assoc Study & Conservat Ecosyst, Padua, Italy	University of Padua	Ciani, AC (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	andrea.camperio@unipd.it	Ciani, Andrea Camperio/A-8290-2013	Ciani, Andrea Camperio/0000-0002-4689-1799	University of Padova [CPDA 102089/10]	University of Padova	This research was partly funded by research grant CPDA 102089/10, from University of Padova (www.unipd.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Extra funding was provided personally by the authors' interest in science progress; no additional external fundings were received for this study.	BAILEY JM, 1993, BEHAV GENET, V23, P313, DOI 10.1007/BF01067431; BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; Bell A. P., 1978, HOMOSEXUALITIES A ST; Blanchard R, 2001, HORM BEHAV, V40, P105, DOI 10.1006/hbeh.2001.1681; Blanchard R, 2004, J THEOR BIOL, V230, P173, DOI 10.1016/j.jtbi.2004.04.021; Blanchard R, 2008, LATERALITY, V13, P51, DOI 10.1080/13576500701710432; Blanchard R, 2007, ARCH SEX BEHAV, V36, P163, DOI 10.1007/s10508-006-9159-7; Blanchard R, 2012, ARCH SEX BEHAV, V41, P551, DOI 10.1007/s10508-011-9888-0; Bobrow D, 2001, EVOL HUM BEHAV, V22, P361, DOI 10.1016/S1090-5138(01)00074-5; Bogaert AE, 1998, ARCH SEX BEHAV, V27, P467, DOI 10.1023/A:1018752513198; Bogaert AF, 2006, P NATL ACAD SCI USA, V103, P10771, DOI 10.1073/pnas.0511152103; Bogaert AF, 2011, FRONT NEUROENDOCRIN, V32, P247, DOI 10.1016/j.yfrne.2011.02.004; Camperio Ciani A, 2012, JOURNAL OF SEXUAL ME; Camperio Ciani A., 2011, EVOLUTION PERSONALIT, P425; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; Cantor JM, 2002, ARCH SEX BEHAV, V31, P63, DOI 10.1023/A:1014031201935; CHAHNAZARIAN A, 1988, SOC BIOL, V35, P214; Ciani AC, 2009, J SEX MED, V6, P449, DOI 10.1111/j.1743-6109.2008.00944.x; Ciani AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002282; Dawood K, 2000, ARCH SEX BEHAV, V29, P155, DOI 10.1023/A:1001955721992; EVANS SH, 1968, PSYCHOL BULL, V69, P225, DOI 10.1037/h0025666; Forrester D, 2011, J COGNITION CULTURE, V11, P3; GAMES PA, 1976, J EXP EDUC, V44, P51, DOI 10.1080/00220973.1976.11011551; Gavrilets S, 2007, P BIOL SCI, V273, P3031; Goodman L. A., 1961, ANN MATH STAT, V32; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herdt, 1997, SAME SEX DIFFERENT C; Hollimon S, 1997, WOMEN PREHISTORY N A, P173; Hoyle RL, 1998, ARTE EROTICO EN EL A; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Iemmola F, 2009, ARCH SEX BEHAV, V38, P393, DOI 10.1007/s10508-008-9381-6; ISTAT, 1995, ITALIAN WOMENS FECUN; JAMES WH, 1987, HUM BIOL, V59, P721; Jannini EA, 2010, J SEX MED, V7, P3245, DOI 10.1111/j.1743-6109.2010.02024.x; Jones J., 2005, VITAL HLTH STAT, V23; Jones MB, 1998, HUM BIOL, V70, P775; Kendler KS, 2000, AM J PSYCHIAT, V157, P1843, DOI 10.1176/appi.ajp.157.11.1843; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; LeVay S, 2010, GAY STRAIGHT AND THE; LeVay S., 2011, GAY STRAIGHT AND THE; [林振林 LIN Zhen-Lin], 2010, [心理科学进展, Advances in Psychological Science], V18, P262; LORD FM, 1967, PSYCHOL BULL, V68, P304, DOI 10.1037/h0025105; Miller EM, 2000, ARCH SEX BEHAV, V29, P1, DOI 10.1023/A:1001836320541; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nash G., 2001, INDECENT EXPOSURE SE, P43; Pattatucci AM, 1998, HUM BIOL, V70, P367; PEREZ MD, 1992, FAM PLANN PERSPECT, V24, P162, DOI 10.2307/2136019; Pillard RC, 1998, HUM BIOL, V70, P347; PILLARD RC, 1982, ARCH SEX BEHAV, V11, P511, DOI 10.1007/BF01542476; Rahman Q, 2005, ARCH SEX BEHAV, V34, P461, DOI 10.1007/s10508-005-4345-6; Rahman Q, 2008, ARCH SEX BEHAV, V37, P962, DOI 10.1007/s10508-007-9191-2; Reimers S, 2007, ARCH SEX BEHAV, V36, P147, DOI 10.1007/s10508-006-9143-2; Rieger G, 2012, ARCH SEX BEHAV, V41, P529, DOI 10.1007/s10508-012-9942-6; Schwartz G, 2010, ARCH SEX BEHAV, V39, P93, DOI 10.1007/s10508-009-9499-1; SLOANE DM, 1983, DEMOGRAPHY, V20, P353, DOI 10.2307/2061247; Spreen M., 1992, B METHODOLOGIE SOCIO, V36, P34, DOI [10.1177/075910639203600103, DOI 10.1177/075910639203600103]; SPROTT DA, 1970, PSYCHOL BULL, V73, P303, DOI 10.1037/h0028923; Trivers RL., 1972, SEXUAL SELECTION DES; VanderLaan DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036088; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P495, DOI 10.1007/s10508-009-9576-5; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; Vasey PL, 2007, EVOL HUM BEHAV, V28, P159, DOI 10.1016/j.evolhumbehav.2006.08.004; Vasey PL, 2012, ARCH SEX BEHAV, V41, P209, DOI 10.1007/s10508-011-9763-z; Vasey PL, 2010, EVOL HUM BEHAV, V31, P373, DOI 10.1016/j.evolhumbehav.2010.04.001; Vasey PL, 2009, HUM NATURE-INT BIOS, V20, P269, DOI 10.1007/s12110-009-9066-4; Vasey PL, 2010, ARCH SEX BEHAV, V39, P821, DOI 10.1007/s10508-008-9404-3; Wattenberg B, 1985, THE BIRTH DEARTH; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; WHITAM FL, 1993, ARCH SEX BEHAV, V22, P187, DOI 10.1007/BF01541765; Wilson E.O., 1975, P1; WOOD CH, 1977, J MARRIAGE FAM, V39, P129, DOI 10.2307/351069; Yates T., 1993, INTERPRETATIVE ARCHA, P31; Zietsch BP, 2008, EVOL HUM BEHAV, V29, P424, DOI 10.1016/j.evolhumbehav.2008.07.002	78	23	23	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51088	10.1371/journal.pone.0051088	http://dx.doi.org/10.1371/journal.pone.0051088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227237	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200097
J	Ito, Y; Ito, T; Karasawa, S; Enomoto, T; Nashimoto, A; Hase, Y; Sakamoto, S; Mimori, T; Matsumoto, Y; Yamaguchi, Y; Handa, H				Ito, Yuki; Ito, Takumi; Karasawa, Satoki; Enomoto, Teruya; Nashimoto, Akihiro; Hase, Yasuyoshi; Sakamoto, Satoshi; Mimori, Tsuneyo; Matsumoto, Yoshihisa; Yamaguchi, Yuki; Handa, Hiroshi			Identification of DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs) as a Novel Target of Bisphenol A	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; IONIZING-RADIATION; IN-VIVO; REPAIR; KU; EXPOSURE; BINDING; CANCER; RISK	Bisphenol A (BPA) forms the backbone of plastics and epoxy resins used to produce packaging for various foods and beverages. BPA is also an estrogenic disruptor, interacting with human estrogen receptors (ER) and other related nuclear receptors. Nevertheless, the effects of BPA on human health remain unclear. The present study identified DNA-dependent protein kinase catalytic subunit (DNA-PKcs) as a novel BPA-binding protein. DNA-PKcs, in association with the Ku heterodimer (Ku70/80), is a critical enzyme involved in the repair of DNA double-strand breaks. Low levels of DNA-PK activity are previously reported to be associated with an increased risk of certain types of cancer. Although the Kd for the interaction between BPA and a drug-binding mutant of DNA-PKcs was comparatively low (137 nM), high doses of BPA were required before cellular effects were observed (100-300 mu M). The results of an in vitro kinase assay showed that BPA inhibited DNA-PK kinase activity in a concentration-dependent manner. In M059K cells, BPA inhibited the phosphorylation of DNA-PKcs at Ser2056 and H2AX at Ser139 in response to ionizing radiation (IR)-irradiation. BPA also disrupted DNA-PKcs binding to Ku70/80 and increased the radiosensitivity of M059K cells, but not M059J cells (which are DNA-PKcs-deficient). Taken together, these results provide new evidence of the effects of BPA on DNA repair in mammalian cells, which are mediated via inhibition of DNA-PK activity. This study may warrant the consideration of the possible carcinogenic effects of high doses of BPA, which are mediated through its action on DNA-PK.	[Ito, Yuki; Karasawa, Satoki; Enomoto, Teruya; Nashimoto, Akihiro; Hase, Yasuyoshi; Sakamoto, Satoshi; Yamaguchi, Yuki; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa, Japan; [Ito, Takumi; Handa, Hiroshi] Tokyo Inst Technol, Solut Res Lab, Midori Ku, Yokohama, Kanagawa 227, Japan; [Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Sakyo Ku, Kyoto, Japan; [Matsumoto, Yoshihisa] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 152, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Kyoto University; Tokyo Institute of Technology	Handa, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa, Japan.	handa.h.aa@m.titech.ac.jp	Yamaguchi, Yuki/B-9390-2015; Sakamoto, Satoshi/ABA-8705-2020; Matsumoto, Yoshihisa/G-3430-2017	Yamaguchi, Yuki/0000-0002-0197-614X; Sakamoto, Satoshi/0000-0002-6165-1558; Matsumoto, Yoshihisa/0000-0002-0758-290X; Ito, Takumi/0000-0002-9997-2664	Ministry of Economy, Trade and Industry; Japan Science and Technology Agency; Japan's Ministry of Education, Culture, Sports, Science and Technology; New Energy and Industrial Technology Development Organization; Grants-in-Aid for Scientific Research [23710267] Funding Source: KAKEN	Ministry of Economy, Trade and Industry; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant for Research and Development Projects of High Sensitivity Environment Sensor from Ministry of Economy, Trade and Industry, by Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency, by the Global Centers of Excellence Program from Japan's Ministry of Education, Culture, Sports, Science and Technology and by a Grant for Research and Development Projects in Cooperation with Academic Institutions from the New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Auckley DH, 2001, CARCINOGENESIS, V22, P723, DOI 10.1093/carcin/22.5.723; Betancourt AM, 2010, J PROTEOMICS, V73, P1241, DOI 10.1016/j.jprot.2010.02.020; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FDA, 2010, UPD BISPH US FOOD CO; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; INOMATA Y, 1992, ANAL BIOCHEM, V206, P109, DOI 10.1016/S0003-2697(05)80018-1; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kienker LJ, 2000, NUCLEIC ACIDS RES, V28, P2752, DOI 10.1093/nar/28.14.2752; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kundakovic M, 2011, BRAIN BEHAV IMMUN, V25, P1084, DOI 10.1016/j.bbi.2011.02.005; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Matsumoto Y, 1997, BIOCHEM BIOPH RES CO, V234, P568, DOI 10.1006/bbrc.1997.6689; Milligan SR, 1998, ENVIRON HEALTH PERSP, V106, P23; MIMORI T, 1986, J BIOL CHEM, V261, P2274; Mori N, 2001, ONCOGENE, V20, P3609, DOI 10.1038/sj.onc.1204497; Nishio K, 2008, COLLOID SURFACE B, V64, P162, DOI 10.1016/j.colsurfb.2008.01.013; Prins Gail S, 2008, Fertil Steril, V89, pe41, DOI 10.1016/j.fertnstert.2007.12.023; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sakamoto S, 2009, CHEM REC, V9, P66, DOI 10.1002/tcr.20170; Someya M, 2006, CARCINOGENESIS, V27, P117, DOI 10.1093/carcin/bgi175; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Veuger SJ, 2003, CANCER RES, V63, P6008; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Yu YJ, 2001, CANCER RES, V61, P1820; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275; Zhu HT, 2009, J PEDIATR SURG, V44, P672, DOI 10.1016/j.jpedsurg.2008.10.067	41	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50481	10.1371/journal.pone.0050481	http://dx.doi.org/10.1371/journal.pone.0050481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227178	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200038
J	Kilpinen, O; Liu, DZ; Adamsen, APS				Kilpinen, Ole; Liu, Dezhao; Adamsen, Anders Peter S.			Real-Time Measurement of Volatile Chemicals Released by Bed Bugs during Mating Activities	PLOS ONE			English	Article							TRAUMATIC INSEMINATION; PTR-MS; CIMEX; PHEROMONE	In recent years, bed bug (Hemiptera: Cimicidae) problems have increased dramatically in many parts of the world, leading to a renewed interest in their chemical ecology. Most studies of bed bug semiochemicals have been based on the collection of volatiles over a period of time followed by chemical analysis. Here we present for the first time, a combination of proton transfer reaction mass spectrometry and video analysis for real-time measurement of semiochemicals emitted by isolated groups of bed bugs during specific behavioural activities. The most distinct peaks in the proton transfer reaction mass spectrometry recordings were always observed close to the termination of mating attempts, corresponding to the defensive emissions that bed bugs have been suspected to exploit for prevention of unwanted copulations. The main components of these emissions were (E)-2-hexenal and (E)-2-octenal recorded in ratios between 1:3 and 3:1. In the current study, the quantity varied over 1000 fold for both of the compounds with up to 40 mu g total release in a single emission. Males also emit defensive compounds due to homosexual copulation attempts by other males, and no significant differences were observed in the ratio or the amount of the two components released from males or females. In summary, this study has demonstrated that combining proton-transfer-reaction mass spectrometry with video analysis can provide detailed information about semiochemicals emitted during specific behavioural activities. Citation: Kilpinen O, Liu D, Adamsen APS (2012) Real-Time Measurement of Volatile Chemicals Released by Bed Bugs during Mating Activities. PLoS ONE 7(12): e50981. doi:10.1371/journal.pone.0050981	[Kilpinen, Ole] Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Slagelse, Denmark; [Liu, Dezhao; Adamsen, Anders Peter S.] Aarhus Univ, Fac Sci & Technol, Dept Engn, Tjele, Denmark	Aarhus University; Aarhus University	Kilpinen, O (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Slagelse, Denmark.	Ole.Kilpinen@agrsci.dk	Liu, Dezhao/L-7842-2019	Liu, Dezhao/0000-0003-0859-8775	Faculty of Agricultural Science, Aarhus University	Faculty of Agricultural Science, Aarhus University	The study was financed by a grant from the Faculty of Agricultural Science, Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos NG, 1998, J CHEM ECOL, V24, P1161, DOI 10.1023/A:1022442818196; Bisignano G, 2001, FEMS MICROBIOL LETT, V198, P9, DOI 10.1111/j.1574-6968.2001.tb10611.x; Blake RS, 2009, CHEM REV, V109, P861, DOI 10.1021/cr800364q; COLLINS RP, 1968, ANN ENTOMOL SOC AM, V61, P1338, DOI 10.1093/aesa/61.5.1338; Feilberg A, 2010, ENVIRON SCI TECHNOL, V44, P5894, DOI 10.1021/es100483s; Feldlaufer MF, 2010, J MED ENTOMOL, V47, P140, DOI 10.1603/ME09210; GILBY AR, 1965, PROC R SOC SER B-BIO, V162, P105, DOI 10.1098/rspb.1965.0027; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Harraca V, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-121; ISHIWATARI T, 1976, Applied Entomology and Zoology, V11, P38; ISHIWATARI T, 1974, Applied Entomology and Zoology, V9, P153; LEVINSON HZ, 1974, NATURWISSENSCHAFTEN, V61, P684, DOI 10.1007/BF00606522; LEVINSON HZ, 1971, EXPERIENTIA, V27, P102, DOI 10.1007/BF02137766; Liedtke HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018156; Lindinger W, 1998, INT J MASS SPECTROM, V173, P191, DOI 10.1016/S0168-1176(97)00281-4; Maleknia SD, 2007, INT J MASS SPECTROM, V262, P203, DOI 10.1016/j.ijms.2006.11.010; Panagiotakopulu E, 1999, ANTIQUITY, V73, P908, DOI 10.1017/S0003598X00065674; Pfiester M, 2009, J MED ENTOMOL, V46, P1015, DOI 10.1603/033.046.0506; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Reinhardt K, 2009, EVOLUTION, V63, P29, DOI 10.1111/j.1558-5646.2008.00502.x; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; *SAS I, 2000, SAS US GUID REL 8 01; Schaub A, 2010, PHYSIOL PLANTARUM, V138, P123, DOI 10.1111/j.1399-3054.2009.01322.x; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tasin M, 2012, SENSORS-BASEL, V12, P4091, DOI 10.3390/s120404091; Usinger RL, 1966, MONOGRAPH CIMICIDAE; Weeks ENI, 2011, PEST MANAG SCI, V67, P10, DOI 10.1002/ps.2024	29	11	11	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50981	10.1371/journal.pone.0050981	http://dx.doi.org/10.1371/journal.pone.0050981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227225	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200086
J	Kuo, KL; Hung, SC; Lin, YP; Tang, CF; Lee, TS; Lin, CP; Tarng, DC				Kuo, Ko-Lin; Hung, Szu-Chun; Lin, Yao-Ping; Tang, Ching-Fang; Lee, Tzong-Shyuan; Lin, Chih-Pei; Tarng, Der-Cherng			Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ACTIVATION; ADHESION MOLECULE EXPRESSION; OXYGEN SPECIES GENERATION; MEDIATED FENTON REACTIONS; CARDIAC SYNDROME-X; BODY IRON STORES; NF-KAPPA B; MYOCARDIAL-INFARCTION; PARENTERAL IRON; NADPH OXIDASE	Background: The association between intravenous (IV) iron administration and outcomes in hemodialysis (HD) patients is still debated. Therefore, this study was aimed to assess the relationship between the IV administration of ferric chloride hexahydrate (Atofen (R)) and cardiovascular (CV) outcome and the interaction between iron-induced oxidative stress and endothelial dysfunction in chronic HD patients. Methodology/Principal Findings: A cohort of 1239 chronic HD patients was recruited. In a follow-up of 12 months, Kaplan-Meier survival curves showed that higher doses of IV Atofen associated with higher risks for CV events and deaths in HD patients. In multivariate Cox models, compared to no iron supplementation, IV Atofen administration was an independent predictor for CV events and overall mortality. However, the nature of the observational cohort study possibly bears selection bias. We further found that IV Atofen enhanced the superoxide production of mononuclear cells (MNCs), the levels of circulating soluble adhesion molecules, and the adhesion of MNCs to human aortic endothelial cells (HAECs). In vitro experiments showed that Atofen increased the expression of intracellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in HAECs and aggravated the endothelial adhesiveness in a dose-dependent manner. These iron-induced changes were significantly attenuated by the co-treatment of HAECs with N-acetylcysteine and inhibitors of NADPH oxidase, nuclear factor kappa B, and activator protein-1. Conclusion: A cumulative dose of IV Atofen > 800 mg within 6 months was associated with an adverse CV outcome and a higher mortality among chronic HD patients. The detrimental effects of IV iron supplementation were partly due to the increased oxidative stress and induction of MNC adhesion to endothelial cells, a pivotal index of early atherogenesis. Citation: Kuo K-L, Hung S-C, Lin Y-P, Tang C-F, Lee T-S, et al. (2012) Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients. PLoS ONE 7(12): e50295. doi:10.1371/journal.pone.0050295	[Kuo, Ko-Lin; Lee, Tzong-Shyuan; Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Chih-Pei] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Lin, Chih-Pei] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Kuo, Ko-Lin; Hung, Szu-Chun] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Kuo, Ko-Lin; Hung, Szu-Chun] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Div Nephrol, Taipei, Taiwan; [Lin, Chih-Pei] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Div Gen Lab, Taipei, Taiwan; [Lin, Yao-Ping; Tang, Ching-Fang; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Lin, Yao-Ping; Tang, Ching-Fang; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Ctr Immunol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lin, CP (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	cplin@vghtpe.gov.tw; dctarng@vghtpe.gov.tw	Lee, Tzong-Shyuan/AAE-5803-2020	Lee, Tzong-Shyuan/0000-0002-9593-4062; Kuo, Ko-Lin/0000-0002-7477-0388	National Science Council [NSC 96-2628-B-010-001-MY3, NSC 99-2314-B-303-002-MY3]; Taipei Veterans General Hospital [V100C-143, V100E4-003]; Ministry of Education's Aim for the Top University Plan; Taipei Tzu Chi General Hospital [TCRD-TPE-97-15]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education's Aim for the Top University Plan(Ministry of Education, Taiwan); Taipei Tzu Chi General Hospital	This work was supported by grants from the National Science Council (NSC 96-2628-B-010-001-MY3 and NSC 99-2314-B-303-002-MY3), Taipei Veterans General Hospital (V100C-143 and V100E4-003), Ministry of Education's Aim for the Top University Plan, and Taipei Tzu Chi General Hospital (TCRD-TPE-97-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besarab A, 2000, J AM SOC NEPHROL, V11, P530, DOI 10.1681/ASN.V113530; Carlini RG, 2006, NEPHROL DIAL TRANSPL, V21, P3055, DOI 10.1093/ndt/gfl341; Chen JW, 2004, ARTERIOSCL THROM VAS, V24, P2075, DOI 10.1161/01.ATV.0000145016.69181.fa; Chen JW, 2003, ARTERIOSCL THROM VAS, V23, P1559, DOI 10.1161/01.ATV.0000089012.73180.63; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Drueke T, 2002, CIRCULATION, V106, P2212, DOI 10.1161/01.CIR.0000035250.66458.67; EVANS PJ, 1995, FREE RADICAL RES, V23, P465, DOI 10.3109/10715769509065267; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Feldman HI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133734; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2001, J CLIN INVEST, V108, P1423, DOI 10.1172/JCI200114453; HEINECKE JW, 1984, J CLIN INVEST, V74, P1890, DOI 10.1172/JCI111609; Henle ES, 1996, J BIOL CHEM, V271, P21177, DOI 10.1074/jbc.271.35.21177; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; Horl WH, 2007, J AM SOC NEPHROL, V18, P382, DOI 10.1681/ASN.2006080856; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Kartikasari AER, 2004, ARTERIOSCL THROM VAS, V24, P2257, DOI 10.1161/01.ATV.0000147406.00871.b3; Kiechl S, 1997, CIRCULATION, V96, P3300; Klipstein-Grobusch K, 1999, AM J CLIN NUTR, V69, P1231; Kuo KL, 2008, J AM SOC NEPHROL, V19, P1817, DOI 10.1681/ASN.2007101084; Kurtoglu E, 2003, BIOL TRACE ELEM RES, V96, P109, DOI 10.1385/BTER:96:1-3:109; Lee TS, 1999, CIRCULATION, V99, P1222, DOI 10.1161/01.CIR.99.9.1222; Leu HB, 2006, FREE RADICAL BIO MED, V40, P983, DOI 10.1016/j.freeradbiomed.2005.10.047; Li LX, 2009, ARTERIOSCL THROM VAS, V29, P732, DOI 10.1161/ATVBAHA.108.183210; Lim CS, 2004, KIDNEY INT, V65, P1802, DOI 10.1111/j.1523-1755.2004.00580.x; Lin CP, 2008, EUR J CLIN INVEST, V38, P106, DOI 10.1111/j.1365-2362.2007.01911.x; Lin CP, 2008, J BIOMED SCI, V15, P183, DOI 10.1007/s11373-007-9212-0; Lin CP, 2003, INT J CARDIOL, V89, P53, DOI 10.1016/S0167-5273(02)00428-X; Luo YZ, 1996, J BIOL CHEM, V271, P21167, DOI 10.1074/jbc.271.35.21167; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Rooyakkers TM, 2002, EUR J CLIN INVEST, V32, P9, DOI 10.1046/j.1365-2362.2002.0320s1009.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; Sengoelge G, 2003, J AM SOC NEPHROL, V14, P2639, DOI 10.1097/01.ASN.0000087087.61306.4A; SMITH C, 1992, BIOCHEM J, V286, P901, DOI 10.1042/bj2860901; Stadler N, 2004, ARTERIOSCL THROM VAS, V24, P949, DOI 10.1161/01.ATV.0000124892.90999.cb; SULLIVAN JL, 1981, LANCET, V1, P1293; SUNDERPLASSMANN G, 1995, NEPHROL DIAL TRANSPL, V10, P2070; Tuomainen TP, 1998, CIRCULATION, V97, P1461; Yin WH, 2007, INT J CARDIOL, V121, P276, DOI 10.1016/j.ijcard.2006.11.012; Zager RA, 2002, AM J KIDNEY DIS, V40, P90, DOI 10.1053/ajkd.2002.33917; Zager RA, 2004, KIDNEY INT, V66, P144, DOI 10.1111/j.1523-1755.2004.00716.x; Zhu Y, 1998, ARTERIOSCL THROM VAS, V18, P473, DOI 10.1161/01.ATV.18.3.473	45	58	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50295	10.1371/journal.pone.0050295	http://dx.doi.org/10.1371/journal.pone.0050295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227165	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200026
J	LaKind, JS; Goodman, M; Naiman, DQ				LaKind, Judy S.; Goodman, Michael; Naiman, Daniel Q.			Use of NHANES Data to Link Chemical Exposures to Chronic Diseases: A Cautionary Tale	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; URINARY BISPHENOL-A; PERSISTENT ORGANIC POLLUTANTS; NATIONAL-HEALTH; SERUM CONCENTRATIONS; METABOLIC SYNDROME; ADULT-POPULATION; ASSOCIATION; HYPERTENSION	Background: The National Health and Nutrition Examination Survey (NHANES) is one example of cross-sectional datasets that have been used to draw causal inferences regarding environmental chemical exposures and adverse health outcomes. Our objectives were to analyze four NHANES datasets using consistent a priori selected methods to address the following questions: Is there a consistent association between urinary bisphenol A (BPA) measures and diabetes, coronary heart disease (CHD), and/or heart attack across surveys? Is NHANES an appropriate dataset for investigating associations between chemicals with short physiologic half-lives such as BPA and chronic diseases with multi-factorial etiologies? Data on urinary BPA and health outcomes from 2003-2004, 2005-2006, 2007-2008, and 2009-2010 were available. Methodology and Findings: Regression models were adjusted for creatinine, age, gender, race/ethnicity, education, income, smoking, heavy drinking, BMI, waist circumference, calorie intake, family history of heart attack, hypertension, sedentary time, and total cholesterol. Urinary BPA was not significantly associated with adverse health outcomes for any of the NHANES surveys, with ORs (95% CIs) ranging from 0.996 (0.951-1.04) to 1.03 (0.978-1.09) for CHD, 0.987 (0.941-1.04) to 1.04 (0.996-1.09) for heart attack, and 0.957 (0.899-1.02) to 1.01 (0.980-1.05) for diabetes. Conclusions: Using scientifically and clinically supportable exclusion criteria and outcome definitions, we consistently found no associations between urinary BPA and heart disease or diabetes. These results do not support associations and causal inferences reported in previous studies that used different criteria and definitions. We are not drawing conclusions regarding whether BPA is a risk factor for these diseases. We are stating the opposite-that using cross-sectional datasets like NHANES to draw such conclusions about short-lived environmental chemicals and chronic complex diseases is inappropriate. We need to expend resources on appropriately designed epidemiologic studies and toxicological explorations to understand whether these types of chemicals play a causal role in chronic diseases.	[LaKind, Judy S.] LaKind Associates LLC, Catonsville, MD USA; [LaKind, Judy S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [LaKind, Judy S.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA USA; [Goodman, Michael] Emory Univ, Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Naiman, Daniel Q.] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Emory University; Johns Hopkins University	LaKind, JS (corresponding author), LaKind Associates LLC, Catonsville, MD USA.	lakindassoc@comcast.net		LaKind, Judy/0000-0002-0323-9178	Polycarbonate/BPA Global Group of the American Chemistry Council	Polycarbonate/BPA Global Group of the American Chemistry Council	This research was supported by the Polycarbonate/BPA Global Group of the American Chemistry Council (http://plastics.americanchemistry.com/Product-Groups-and-Stats/PolycarbonateBPA-Global-Group). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder was given the opportunity to proffer ONLY non-substantive editorial suggestions.	Adami HO, 2011, TOXICOL SCI, V122, P223, DOI 10.1093/toxsci/kfr113; American Heart Association, 2012, WHAT YOUR CHOL LEV M; [Anonymous], 2007, SCIENCEDAILY; Arif AA, 2007, INT ARCH OCC ENV HEA, V80, P711, DOI 10.1007/s00420-007-0183-2; Athyros VG, 2007, ANGIOLOGY, V58, P689, DOI 10.1177/0003319707306146; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Centers for Disease Control and Prevention, 2012, NAT REP HUM EXP ENV; Centers for Disease Control and Prevention National Center for Health Statistics, 2006, GEN INF NHANES 2003; Charreire H, 2011, BRIT J NUTR, V105, P902, DOI 10.1017/S000711451000440X; Claassen L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-248; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; DeNoon DJ, 2010, WEBMD HLTH NEWS 0112; Egeghy PP, 2011, INT J ENV RES PUB HE, V8, P1727, DOI 10.3390/ijerph8051727; Elobeid MA, 2010, INT J ENV RES PUB HE, V7, P2988, DOI 10.3390/ijerph7072988; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Everett CJ, 2008, ENVIRON RES, V108, P94, DOI 10.1016/j.envres.2008.05.006; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Goldberg M, 2011, ENVIRON RES, V111, P1007, DOI 10.1016/j.envres.2011.08.010; Ha MH, 2009, J HUM HYPERTENS, V23, P274, DOI 10.1038/jhh.2008.124; Harik-Khan RI, 2004, AM J EPIDEMIOL, V159, P351, DOI 10.1093/aje/kwh053; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Matthews VL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-71; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; National High Blood Pressure Education Program, 2004, NIH PUBL, P25; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Psaltopoulou Theodora, 2010, Rev Diabet Stud, V7, P26, DOI 10.1900/RDS.2010.7.26; Ranjit N, 2010, PEDIATRICS, V126, pE754, DOI 10.1542/peds.2010-1229; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P25; Shankar A, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/481641; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Stone NJ, 1996, CIRCULATION, V94, P2337, DOI 10.1161/01.CIR.94.9.2337; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wannamethee SG, 2002, J EPIDEMIOL COMMUN H, V56, P542, DOI 10.1136/jech.56.7.542; Wei M, 2009, JAMA-J AM MED ASSOC, V301, P720, DOI 10.1001/jama.2009.120; Weuve J, 2010, ENVIRON HEALTH PERSP, V118, P825, DOI 10.1289/ehp.0901543; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolff M, 2011, C EN NEWS       0718, V89; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687; You L, 2011, ENVIRON HEALTH PERSP, V119, P527, DOI 10.1289/ehp.1002572	49	67	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51086	10.1371/journal.pone.0051086	http://dx.doi.org/10.1371/journal.pone.0051086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227235	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200095
J	Petta, S; Macaluso, FS; Barcellona, MR; Camma, C; Cabibi, D; Di Marco, V; Craxi, A				Petta, Salvatore; Macaluso, Fabio Salvatore; Barcellona, Maria Rosa; Camma, Calogero; Cabibi, Daniela; Di Marco, Vito; Craxi, Antonio			Serum gamma-glutamyl Transferase Levels, Insulin Resistance and Liver Fibrosis in Patients with Chronic Liver Diseases	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; METABOLIC SYNDROME; MORTALITY RISK; WEIGHT-LOSS; GENOTYPE-1; STEATOSIS; INDEX; TRANSPEPTIDASE; VIRUS	Background and Aims: Serum levels of gamma-glutamyl-transpeptidase(c-GT) were associated with liver disease severity and metabolic alterations, which in turn are able to affect hepatic damage. In patients with nonalcoholic fatty liver disease (NAFLD), genotype 1 chronic hepatitis C (G1CHC) and chronic hepatitis B (CHB), we assessed the link between liver fibrosis and c-GT serum levels, and we evaluated if normal or high gamma-GT serum levels affect the association between insulin resistance (IR) and severity of liver fibrosis. Methods: 843 consecutive patients with chronic liver disease (CLD)(193 NAFLD, 481 G1CHC, 169 CHB) were evaluated by liver biopsy (Kleiner and Scheuer scores) and clinical and metabolic measurements. IR was diagnosed if HOMA>3. A serum gamma-GT concentration of > 36 IU/L in females and > 61 IU/L in males was considered the threshold value for identifying high levels of gamma-GT. Results: By multivariate logistic regression analysis, abnormal gamma-GT serum levels were independently linked to severe liver fibrosis in patients with NAFLD (OR2.711, CI1.120-6.564, p = 0.02), G1CHC (OR3.461, CI2.138-5.603, p < 0.001) and CHB (OR2.778, CI1.042-7.414, p = 0.04), together with IR and liver necroinflammation, and with a negative predictive value > 80%. Interestingly, among patients with high or normal gamma-GT values, even if IR prevalence was significantly higher in patients with severe fibrosis compared to those without, IR remained significantly associated with severe fibrosis in patients with abnormal gamma-GT values only (OR4.150, CI1.079-15.970, p = 0.03 for NAFLD; OR2.250, CI1.211-4.181, p = 0.01 for G1CHC; OR3.096, CI2.050-34.220, p = 0.01 for CHB). Conclusions: In patients with CLD, IR is independently linked to liver fibrosis only in patients with abnormal gamma-GT values, without differences according to liver disease etiology, and suggesting a role of gamma-GT as a marker of metabolic-induced liver damage. These data could be useful for the clinical and pharmacologic management of patients with CLD.	[Petta, Salvatore; Macaluso, Fabio Salvatore; Barcellona, Maria Rosa; Camma, Calogero; Di Marco, Vito; Craxi, Antonio] Univ Palermo, Sez Gastroenterol, DiBiMIS, Palermo, Italy; [Cabibi, Daniela] Univ Palermo, Cattedra Anat Patol, Palermo, Italy	University of Palermo; University of Palermo	Petta, S (corresponding author), Univ Palermo, Sez Gastroenterol, DiBiMIS, Palermo, Italy.	petsa@inwind.it	Di Marco, Vito/AAC-4612-2022; Macaluso, Fabio Salvatore/AFB-9138-2022; cabibi, daniela/D-7438-2013; Craxi, Antonio/K-9529-2016	Macaluso, Fabio Salvatore/0000-0001-5128-3846; cabibi, daniela/0000-0001-6571-6577; Craxi, Antonio/0000-0002-4480-9544; Petta, Salvatore/0000-0002-0822-9673; CAMMA', CALOGERO/0000-0002-9224-1914; DI MARCO, VITO/0000-0001-6397-4206				Belfort R, 2006, NEW ENGL J MED, V355, P22997; Calori G, 2011, HEPATOLOGY, V54, P145, DOI 10.1002/hep.24356; Camma C, 2006, HEPATOLOGY, V43, P64, DOI 10.1002/hep.20983; Camma C, 2009, J HEPATOL, V50, P648, DOI 10.1016/j.jhep.2009.01.003; Dixon JB, 2006, OBES SURG, V16, P1278, DOI 10.1381/096089206778663805; Everhart JE, 2009, GASTROENTEROLOGY, V137, P549, DOI 10.1053/j.gastro.2009.05.007; Gavin JR, 2000, DIABETES CARE, V23, pS4; Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135; Herzer K, 2007, LIVER INT, V27, P293, DOI 10.1111/j.1478-3231.2006.01422.x; Ikeda Y, 2001, ENDOCR J, V48, P81, DOI 10.1507/endocrj.48.81; Jo SK, 2009, CLIN CHIM ACTA, V403, P234, DOI 10.1016/j.cca.2009.03.035; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Leite NC, 2011, LIVER INT, V31, P700, DOI 10.1111/j.1478-3231.2011.02482.x; Loomba R, 2010, GASTROENTEROLOGY, V139, P836, DOI 10.1053/j.gastro.2010.06.009; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Middelberg RP, 2011, HUM MOL GENET, V21, P446; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; NEMESANSZKY E, 1985, CLIN CHEM, V31, P797; Park SH, 2009, AM J GASTROENTEROL, V104, P1135, DOI 10.1038/ajg.2009.6; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Petta S, 2008, AM J GASTROENTEROL, V103, P1136, DOI 10.1111/j.1572-0241.2008.01813.x; Petta S, 2012, J HEPATOL, V56, P1356, DOI 10.1016/j.jhep.2012.01.007; Petta S, 2011, LIVER INT, V31, P507, DOI 10.1111/j.1478-3231.2011.02453.x; Petta S, 2010, HEPATOLOGY, V52, P1543, DOI 10.1002/hep.23859; Poynard T, 2002, J VIRAL HEPATITIS, V9, P128, DOI 10.1046/j.1365-2893.2002.00341.x; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; *SAS I INC, 1992, SAS STAT SOFTW CHANG; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	35	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51165	10.1371/journal.pone.0051165	http://dx.doi.org/10.1371/journal.pone.0051165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227248	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200107
J	Serviene, E; Luksa, J; Orentaite, I; Lafontaine, DLJ; Urbonavicius, J				Serviene, Elena; Luksa, Juliana; Orentaite, Irma; Lafontaine, Denis L. J.; Urbonavicius, Jaunius			Screening the Budding Yeast Genome Reveals Unique Factors Affecting K2 Toxin Susceptibility	PLOS ONE			English	Article							K1 KILLER TOXIN; CELL-WALL; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; GENE; PREPROTOXIN; EXPRESSION; LETHALITY; TRANSPORT; PROTEINS	Background: Understanding how biotoxins kill cells is of prime importance in biomedicine and the food industry. The budding yeast (S. cerevisiae) killers serve as a convenient model to study the activity of biotoxins consistently supplying with significant insights into the basic mechanisms of virus-host cell interactions and toxin entry into eukaryotic target cells. K1 and K2 toxins are active at the cell wall, leading to the disruption of the plasma membrane and subsequent cell death by ion leakage. K28 toxin is active in the cell nucleus, blocking DNA synthesis and cell cycle progression, thereby triggering apoptosis. Genome-wide screens in the budding yeast S. cerevisiae identified several hundred effectors of K1 and K28 toxins. Surprisingly, no such screen had been performed for K2 toxin, the most frequent killer toxin among industrial budding yeasts. Principal Findings: We conducted several concurrent genome-wide screens in S. cerevisiae and identified 332 novel K2 toxin effectors. The effectors involved in K2 resistance and hypersensitivity largely map in distinct cellular pathways, including cell wall and plasma membrane structure/biogenesis and mitochondrial function for K2 resistance, and cell wall stress signaling and ion/pH homeostasis for K2 hypersensitivity. 70% of K2 effectors are different from those involved in K1 or K28 susceptibility. Significance: Our work demonstrates that despite the fact that K1 and K2 toxins share some aspects of their killing strategies, they largely rely on different sets of effectors. Since the vast majority of the host factors identified here is exclusively active towards K2, we conclude that cells have acquired a specific K2 toxin effectors set. Our work thus indicates that K1 and K2 have elaborated different biological pathways and provides a first step towards the detailed characterization of K2 mode of action.	[Serviene, Elena; Luksa, Juliana; Orentaite, Irma] Nat Res Ctr, Inst Bot, Genet Lab, Vilnius, Lithuania; [Serviene, Elena] Vilnius Gediminas Tech Univ, Dept Chem & Bioengn, Vilnius, Lithuania; [Orentaite, Irma] Vytautas Magnus Univ, Dept Biochem & Biotechnol, Kaunas, Lithuania; [Lafontaine, Denis L. J.] Univ Libre Bruxelles, Fonds Rech Sci, Gosselies, Belgium; [Lafontaine, Denis L. J.; Urbonavicius, Jaunius] Acad Wallonie Bruxelles, Ctr Microscopy & Mol Imaging, Gosselies, Belgium	Nature Research Center - Lithuania; Vilnius Gediminas Technical University; Vytautas Magnus University; Fonds de la Recherche Scientifique - FNRS; Universite Libre de Bruxelles	Serviene, E (corresponding author), Nat Res Ctr, Inst Bot, Genet Lab, Vilnius, Lithuania.	elena.serviene@botanika.lt; denis.lafontaine@ulb.ac.be	Lafontaine, Denis/I-7673-2013; Urbonavičius, Jaunius/AAB-4740-2022; Serviene, Elena/AFJ-8073-2022; Serviene, Elena/AAF-4940-2022	Lafontaine, Denis/0000-0001-7295-6288; 	Research Council of Lithuania (LMT) grant [MIP-061/2011]; FEDER (Fonds Europeen de Developpement Regional); Region Wallones (Programme Cibles); FRS-F.N.R.S; EMBO; FEBS Central and Eastern European collaborative	Research Council of Lithuania (LMT) grant(Research Council of Lithuania (LMTLT)); FEDER (Fonds Europeen de Developpement Regional)(European Commission); Region Wallones (Programme Cibles); FRS-F.N.R.S(Fonds de la Recherche Scientifique - FNRS); EMBO(European Molecular Biology Organization (EMBO)); FEBS Central and Eastern European collaborative	Research in the laboratory of ES was supported by the Research Council of Lithuania (LMT) grant MIP-061/2011. Research in the laboratory of DLJL was supported by FEDER (Fonds Europeen de Developpement Regional), Region Wallones (Programme Cibles) and the FRS-F.N.R.S. ES and IO were recipients of respective short-term fellowships (EMBO - to ES and FEBS Central and Eastern European collaborative - to LO) to visit the Lafontaine Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; BOSTIAN KA, 1984, CELL, V36, P741, DOI 10.1016/0092-8674(84)90354-4; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Breinig F, 2002, CELL, V108, P395, DOI 10.1016/S0092-8674(02)00634-7; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BUSSEY H, 1973, BIOCHIM BIOPHYS ACTA, V298, P868, DOI 10.1016/0005-2736(73)90391-X; BUSSEY H, 1990, EXPERIENTIA, V46, P193, DOI 10.1007/BF02027313; BUSSEY H, 1991, MOL MICROBIOL, V5, P2339, DOI 10.1111/j.1365-2958.1991.tb02079.x; Carroll SY, 2009, DEV CELL, V17, P552, DOI 10.1016/j.devcel.2009.08.006; Conti S, 2000, MOL MED, V6, P613, DOI 10.1007/BF03401799; DELAPENA P, 1980, BIOCHEM BIOPH RES CO, V96, P544, DOI 10.1016/0006-291X(80)91390-X; DELAPENA P, 1981, J BIOL CHEM, V256, P420; DIGNARD D, 1991, MOL GEN GENET, V227, P127, DOI 10.1007/BF00260717; Eisfeld K, 2000, MOL MICROBIOL, V37, P926, DOI 10.1046/j.1365-2958.2000.02063.x; Flegelova H, 2002, FEMS YEAST RES, V2, P73, DOI 10.1111/j.1567-1364.2002.tb00070.x; Gulbiniene G, 2004, FOOD TECHNOL BIOTECH, V42, P159; HAUSLER A, 1992, P NATL ACAD SCI USA, V89, P6846, DOI 10.1073/pnas.89.15.6846; HILL K, 1992, GENETICS, V130, P273; HUTCHINS K, 1983, J BACTERIOL, V154, P161, DOI 10.1128/JB.154.1.161-169.1983; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; Lebionka A., 2002, BIOLOGIJA, V4, P7; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Magliani W, 1997, CLIN MICROBIOL REV, V10, P369, DOI 10.1128/CMR.10.3.369; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; MARTINAC B, 1990, P NATL ACAD SCI USA, V87, P6228, DOI 10.1073/pnas.87.16.6228; MESKAUSKAS A, 1992, GENE, V111, P135, DOI 10.1016/0378-1119(92)90615-V; Novotna D, 2004, FEMS YEAST RES, V4, P803, DOI 10.1016/j.femsyr.2004.04.007; Page N, 2003, GENETICS, V163, P875; PFEIFFER P, 1984, ARCH MICROBIOL, V137, P357, DOI 10.1007/BF00410734; Polonelli L, 2000, MED MYCOL, V38, P281, DOI 10.1080/mmy.38.s1.281.292; Rodriguez-Cousino N, 2011, APPL ENVIRON MICROB, V77, P1822, DOI 10.1128/AEM.02501-10; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; SCHMITT MJ, 1995, VIROLOGY, V213, P341, DOI 10.1006/viro.1995.0007; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; VANVUUREN HJJ, 1992, AM J ENOL VITICULT, V43, P119; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005	41	14	15	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50779	10.1371/journal.pone.0050779	http://dx.doi.org/10.1371/journal.pone.0050779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227207	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200066
J	Chang, CM; Chu, CH; Tseng, ML; Huang, YW; Huang, HW; Chen, BH; Huang, DW; Tsai, DP				Chang, Chia Min; Chu, Cheng Hung; Tseng, Ming Lun; Huang, Yao-Wei; Huang, Hsin Wei; Chen, Bo Han; Huang, Ding-Wei; Tsai, Din Ping			Light Manipulation by Gold Nanobumps	PLASMONICS			English	Article						Surface plasmons; Nanostructures; Optics at surfaces; Scattering light; Focusing	SURFACE-PLASMON POLARITONS; GE2SB2TE5 THIN-FILMS; NEAR-FIELD; ENERGY-TRANSFER; SCATTERING; NANOPARTICLES; COMPONENTS; RESONANCE; OPTICS; CHAINS	Backward and forward scattering of surface plasmonic wave interactions from gold nanobumps on the surface of a 30-nm gold thin film demonstrate three-dimensional (3-D) focusing and diverging properties. Fan-shaped forward scattering of an individual nanobump is observed. A quarter-circle structure composed of nanobumps is exploited to manipulate scattering from each nanobump. Experimental results show that 3-D propagation vectors generated by the gold nanobumps with their heights of 16 nm can deflect the surface plasmonic waves to produce 3-D focusing at 3.6 mu m above the surface of the gold film. We clearly demonstrate that 3-D forward and backward focusing from gold nanobumps are with different amplitudes and directions of the vertical propagation vectors.	[Chang, Chia Min; Chu, Cheng Hung; Huang, Hsin Wei; Chen, Bo Han; Tsai, Din Ping] Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan; [Chang, Chia Min; Huang, Ding-Wei] Natl Taiwan Univ, Grad Inst Photon & Optoelect, Taipei 106, Taiwan; [Tseng, Ming Lun; Huang, Yao-Wei; Tsai, Din Ping] Natl Taiwan Univ, Grad Inst Appl Phys, Taipei 106, Taiwan; [Tsai, Din Ping] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Tsai, Din Ping] Natl Appl Res Labs, Instrument Technol Res Ctr, Hsinchu 300, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Applied Research Laboratories - Taiwan	Tsai, DP (corresponding author), Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan.	dptsai@phys.ntu.edu.tw	Chu, Cheng Hung/B-3258-2015; Han, Chen Bo/L-5535-2017; Tseng, Ming Lun/J-8127-2012; Chang, Chia Min/H-5646-2012; Huang, Yao-Wei/J-7444-2012; Tsai, Din Ping/F-1734-2011; Kok, Victor/C-1437-2013	Chu, Cheng Hung/0000-0002-8749-3930; Han, Chen Bo/0000-0003-3009-8822; Tseng, Ming Lun/0000-0003-0418-8162; Chang, Chia Min/0000-0003-3316-4530; Huang, Yao-Wei/0000-0001-8983-413X; Tsai, Din Ping/0000-0002-0883-9906; Kok, Victor/0000-0003-3440-8154	National Science Council, Taiwan [99-2911-I-002-127, 99-2120-M-002-012, 100-2923-M-002-007-MY3, 100-2120-M-002-008]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank the National Science Council, Taiwan, for the financial support of this project under grant numbers 99-2911-I-002-127, 99-2120-M-002-012, 100-2923-M-002-007-MY3, and 100-2120-M-002-008. They also thank the Molecular Imaging Center of the National Taiwan University for technical support.	Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; Chang CM, 2011, OPT EXPRESS, V19, P9492, DOI 10.1364/OE.19.009492; Chau YF, 2011, APPL PHYS A-MATER, V104, P801, DOI 10.1007/s00339-011-6416-y; Chau YF, 2011, PLASMONICS, V6, P581, DOI 10.1007/s11468-011-9238-z; Chen MW, 2008, PLASMONICS, V3, P157, DOI 10.1007/s11468-008-9069-8; Chen WT, 2011, OPT EXPRESS, V19, P12837, DOI 10.1364/OE.19.012837; Chen WT, 2010, OPT EXPRESS, V18, P19665, DOI 10.1364/OE.18.019665; Chiu KP, 2005, J KOREAN PHYS SOC, V47, pS119; Chu CH, 2011, OPT EXPRESS, V19, P12652, DOI 10.1364/OE.19.012652; Chu CH, 2010, OPT EXPRESS, V18, P18383, DOI 10.1364/OE.18.018383; Chung HY, 2010, PLASMONICS, V5, P363, DOI 10.1007/s11468-010-9151-x; Ditlbacher H, 2002, APPL PHYS LETT, V81, P1762, DOI 10.1063/1.1506018; Drezet A, 2005, APPL PHYS LETT, V86, P3; Drezet A, 2006, PLASMONICS, V1, P141, DOI 10.1007/s11468-006-9016-5; Evlyukhin AB, 2007, OPT EXPRESS, V15, P16667, DOI 10.1364/OE.15.016667; Fang ZY, 2010, PLASMONICS, V5, P207, DOI 10.1007/s11468-010-9135-x; Felidj N, 2006, PLASMONICS, V1, P35, DOI 10.1007/s11468-005-9004-1; Huang HJ, 2007, OPT EXPRESS, V15, P7132, DOI 10.1364/OE.15.007132; Kawazoe T, 2006, J NON-CRYST SOLIDS, V352, P2492, DOI 10.1016/j.jnoncrysol.2006.03.023; Kim H, 2008, OPT EXPRESS, V16, P3049, DOI 10.1364/OE.16.003049; Kiyan R, 2007, OPT EXPRESS, V15, P4205, DOI 10.1364/OE.15.004205; Lin WC, 2011, PLASMONICS, V6, P201, DOI 10.1007/s11468-010-9188-x; Nomura W, 2006, APPL PHYS B-LASERS O, V84, P257, DOI 10.1007/s00340-006-2165-6; Nomura W, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1920419; Peng TC, 2011, PLASMONICS, V6, P29, DOI 10.1007/s11468-010-9165-4; Radko IP, 2009, OPT EXPRESS, V17, P7228, DOI 10.1364/OE.17.007228; Radko IP, 2007, OPT EXPRESS, V15, P6576, DOI 10.1364/OE.15.006576; Samson ZL, 2010, PHYS STATUS SOLIDI-R, V4, P274, DOI 10.1002/pssr.201004252; Sanchez-Gil JA, 1999, PHYS REV B, V60, P8359, DOI 10.1103/PhysRevB.60.8359; Shchegrov AV, 1997, PHYS REV LETT, V78, P4269, DOI 10.1103/PhysRevLett.78.4269; Sterligov VA, 2005, OPT EXPRESS, V13, P4134, DOI 10.1364/OPEX.13.004134; Teperik TV, 2009, OPT EXPRESS, V17, P17483, DOI 10.1364/OE.17.017483; Wang Q, 2008, OPT EXPRESS, V16, P19271, DOI 10.1364/OE.16.019271; Yi MF, 2011, PLASMONICS, V6, P213, DOI 10.1007/s11468-010-9190-3; Yin LL, 2005, NANO LETT, V5, P1399, DOI 10.1021/nl050723m; Zayats AV, 2005, PHYS REP, V408, P131, DOI 10.1016/j.physrep.2004.11.001; Zhang DG, 2009, OPT EXPRESS, V17, P11315, DOI 10.1364/OE.17.011315	37	29	29	0	22	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1955			PLASMONICS	Plasmonics	SEP	2012	7	3					563	569		10.1007/s11468-012-9343-7	http://dx.doi.org/10.1007/s11468-012-9343-7			7	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	985YZ	23236389	Green Submitted			2022-12-25	WOS:000307307700024
J	Zhang, J; Bai, D; Ma, X; Guan, J; Zheng, X				Zhang, J.; Bai, D.; Ma, X.; Guan, J.; Zheng, X.			hCINAP is a novel regulator of ribosomal protein-HDM2-p53 pathway by controlling NEDDylation of ribosomal protein S14	ONCOGENE			English	Article						hCINAP; RPS14; NEDDylation; HDM2; p53	ADENYLATE KINASE; P53; HDM2; MDM2; IDENTIFICATION; DEGRADATION; ACTIVATION; FAP7	The tumor-suppressor p53 provides a critical brake on tumor development. HDM2 (human double-minute 2), a p53 E3 ubiquitin ligase, is the principal cellular antagonist of p53. Mounting evidence has suggested that ribosomal proteins (RPs) modulate HDM2-p53 as a novel pathway for regulating p53 signaling. However, the upstream regulators that mediate RP-HDM2-p53 circuits remain poorly understood. Here we identify human coilin-interacting nuclear ATPase protein (hCINAP) as an interacting partner of ribosomal protein S14 (RPS14). RPS14 stabilized and activated p53 by inhibiting HDM2-mediated p53 polyubiquitination and degradation. More importantly, RPS14 was specifically modified with NEDD8 and hCINAP inhibited RPS14 NEDDylation by recruiting NEDD8-specific protease 1. The decrease in RPS14 NEDDylation led to reduced stability and incorrect localization of RPS14, thereby attenuating the interaction between RPS14 and HDM2. Free HDM2 stimulated p53 polyubiquitination and degradation. In conclusion, we demonstrate that hCINAP acts as a novel regulator of RPS14-HDM2-p53 by regulating the interaction between RPS14 and HDM2 through the control of RPS14 NEDDylation. These findings suggest that hCINAP is an important regulator of RP-HDM2-p53 pathway and a potential anticancer drug target.	[Zhang, J.; Bai, D.; Guan, J.; Zheng, X.] State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Zhang, J.; Bai, D.; Ma, X.; Guan, J.; Zheng, X.] Peking Univ, Dept Biochem & Mol Biol, Sch Life Sci, Beijing 100871, Peoples R China	Peking University	Zheng, X (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	关, 俊宏/AAG-1046-2021	关, 俊宏/0000-0003-4900-0610	National Science Foundation of China [31170709, 30930020]; National High Technology and Development Program of China (973 Program) [2010CB911804]; International Center for Genetic Engineering and Biotechnology [CRP/CHN09-01]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); International Center for Genetic Engineering and Biotechnology	We sincerely thank Dr Jian Wang from the State Key Laboratory of Proteomics, Beijing Proteome Research Center for providing plasmids for HDM2 and its truncation constructs. We thank Dr Jun Gu at Peking University for providing the HCT116 cells and reporter plasmids. This work was supported by Grants from the National Science Foundation of China (31170709, 30930020), the National High Technology and Development Program of China (973 Program, 2010CB911804) and the International Center for Genetic Engineering and Biotechnology (project no. CRP/CHN09-01). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; de Marval PLM, 2011, ONCOTARGET, V2, P234; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; Dey A, 2010, SEMIN CANCER BIOL, V20, P3, DOI 10.1016/j.semcancer.2010.02.004; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Ha BH, 2008, BMB REP, V41, P435, DOI 10.5483/BMBRep.2008.41.6.435; Juhnke H, 2000, MOL MICROBIOL, V35, P936, DOI 10.1046/j.1365-2958.2000.01768.x; Lane D, 2010, COLD SPRING HARB PER, V2; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Malekkou A, 2010, FEBS LETT, V584, P4559, DOI 10.1016/j.febslet.2010.10.044; Meng G, 2008, BIOCHEMISTRY-MOSCOW+, V73, P38, DOI 10.1134/S0006297908010057; Moll UM, 2003, MOL CANCER RES, V1, P1001; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Pan WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021625; Santama N, 2005, J BIOL CHEM, V280, P36429, DOI 10.1074/jbc.M501982200; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Takahashi T, 2010, J TOXICOL SCI, V35, P945, DOI 10.2131/jts.35.945; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Zhai RT, 2006, FEBS LETT, V580, P3811, DOI 10.1016/j.febslet.2006.05.074; Zhang JF, 2010, CELL MOL LIFE SCI, V67, P1907, DOI 10.1007/s00018-010-0301-2; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhou X, 2012, ONCOGENE, V63, P1; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	39	43	45	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					246	254		10.1038/onc.2012.560	http://dx.doi.org/10.1038/onc.2012.560			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23246961				2022-12-25	WOS:000329440700012
J	Sayed, D; He, MZ; Yang, Z; Lin, L; Abdellatif, M				Sayed, Danish; He, Minzhen; Yang, Zhi; Lin, Lin; Abdellatif, Maha			Transcriptional Regulation Patterns Revealed by High Resolution Chromatin Immunoprecipitation during Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; MESSENGER-RNAS; HEART-DISEASE; MICRORNAS; PROMOTERS; GENOME; ACTIVATION; INITIATION; MYOCYTES	Cardiac hypertrophy is characterized by a generalized increase in gene expression that is commensurate with the increase in myocyte size and mass, on which is superimposed more robust changes in the expression of specialized genes. Both transcriptional and posttranscriptional mechanisms play fundamental roles in these processes; however, genome-wide characterization of the transcriptional changes has not been investigated. Our goal was to identify the extent and modes, RNA polymerase II (pol II) pausing versus recruitment, of transcriptional regulation underlying cardiac hypertrophy. We used anti-pol II and anti-histone H3K9-acetyl (H3K9ac) chromatin immunoprecipitation-deep sequencing to determine the extent of pol II recruitment and pausing, and the underlying epigenetic modifications, respectively, during cardiac growth. The data uniquely reveal two mutually exclusive modes of transcriptional regulation. One involves an incremental increase (30-50%) in the elongational activity of preassembled, promoter-paused, pol II, and encompasses similar to 25% of expressed genes that are essential/housekeeping genes (e. g. RNA synthesis and splicing). Another involves a more robust activation via de novo pol II recruitment, encompassing similar to 5% of specialized genes (e. g. contractile and extracellular matrix). Moreover, the latter subset has relatively shorter 3'-UTRs with fewer predicted targeting miRNA, whereas most miRNA targets fall in the former category, underscoring the significance of posttranscriptional regulation by miRNA. The results, for the first time, demonstrate that promoter-paused pol II plays a role in incrementally increasing housekeeping genes, proportionate to the increase in heart size. Additionally, the data distinguish between the roles of posttranscriptional versus transcriptional regulation of specific genes.	[Sayed, Danish; He, Minzhen; Yang, Zhi; Abdellatif, Maha] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Lin, Lin] Childrens Hosp, Boston, MA 02115 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Boston Children's Hospital	Abdellatif, M (corresponding author), Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA.	abdellma@umdnj.edu			National Institutes of Health [HL057970, HL104115]; American Heart Association [12SDG8820011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119726, R29HL057970, R01HL057970, R01HL104115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL057970 and HL104115 (to M. A.). This work was also supported by American Heart Association Scientist Development Grant 12SDG8820011 (to D. S.).	Abdellatif M, 1998, MOL CELL BIOL, V18, P6729, DOI 10.1128/MCB.18.11.6729; Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; CAREY RA, 1980, J MOL CELL CARDIOL, V12, P929, DOI 10.1016/0022-2828(80)90060-7; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; CUTILLETTA AF, 1978, J MOL CELL CARDIOL, V10, P677, DOI 10.1016/0022-2828(78)90403-0; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; FELDMAN AM, 1993, CIRC RES, V73, P184, DOI 10.1161/01.RES.73.1.184; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; KAMALA J, 1986, BIOCHEM INT, V13, P271; Kania G, 2009, TRENDS CARDIOVAS MED, V19, P247, DOI 10.1016/j.tcm.2010.02.005; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lis JT, 2000, GENE DEV, V14, P792; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Paradis P, 1996, J BIOL CHEM, V271, P10827, DOI 10.1074/jbc.271.18.10827; Rajan S, 2006, PHYSIOL GENOMICS, V27, P309, DOI 10.1152/physiolgenomics.00072.2006; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Sano M, 2004, CIRC RES, V95, P867, DOI 10.1161/01.RES.0000146675.88354.04; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; SCHNEIDER MD, 1992, BASIC RES CARDIOL, V87, P33; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; SIMPSON PC, 1989, J MOL CELL CARDIOL, V21, P79, DOI 10.1016/0022-2828(89)90774-8; Strom CC, 2005, FEBS J, V272, P2684, DOI 10.1111/j.1742-4658.2005.04684.x; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	39	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2546	2558		10.1074/jbc.M112.429449	http://dx.doi.org/10.1074/jbc.M112.429449			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229551	Green Published, hybrid			2022-12-25	WOS:000314211500040
J	Cousins, MM; Swan, D; Magaret, CA; Hoover, DR; Eshleman, SH				Cousins, Matthew M.; Swan, David; Magaret, Craig A.; Hoover, Donald R.; Eshleman, Susan H.			Analysis of HIV Using a High Resolution Melting (HRM) Diversity Assay: Automation of HRM Data Analysis Enhances the Utility of the Assay for Analysis of HIV Incidence	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION; INFECTION	Background: HIV diversity may be a useful biomarker for discriminating between recent and non-recent HIV infection. The high resolution melting (HRM) diversity assay was developed to quantify HIV diversity in viral populations without sequencing. In this assay, HIV diversity is expressed as a single numeric HRM score that represents the width of a melting peak. HRM scores are highly associated with diversity measures obtained with next generation sequencing. In this report, a software package, the HRM Diversity Assay Analysis Tool (DivMelt), was developed to automate calculation of HRM scores from melting curve data. Methods: DivMelt uses computational algorithms to calculate HRM scores by identifying the start (T1) and end (T2) melting temperatures for a DNA sample and subtracting them (T2-T1 = HRM score). DivMelt contains many user-supplied analysis parameters to allow analyses to be tailored to different contexts. DivMelt analysis options were optimized to discriminate between recent and non-recent HIV infection and to maximize HRM score reproducibility. HRM scores calculated using DivMelt were compared to HRM scores obtained using a manual method that is based on visual inspection of DNA melting curves. Results: HRM scores generated with DivMelt agreed with manually generated HRM scores obtained from the same DNA melting data. Optimal parameters for discriminating between recent and non-recent HIV infection were identified. DivMelt provided greater discrimination between recent and non-recent HIV infection than the manual method. Conclusion: DivMelt provides a rapid, accurate method of determining HRM scores from melting curve data, facilitating use of the HRM diversity assay for large-scale studies.	[Cousins, Matthew M.; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Swan, David; Magaret, Craig A.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA	Johns Hopkins University; Fred Hutchinson Cancer Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu		Cousins, Matthew/0000-0003-0067-9087	HIV Prevention Trials Network (HPTN); National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health; Office of AIDS Research of the National Institutes of Health and Department of Health and Human Services [U01AI068613, UM1AI068613]; NIAID [1R01-AI095068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068613, R01AI095068, U01AI068613] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research of the National Institutes of Health and Department of Health and Human Services; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health, and the Office of AIDS Research of the National Institutes of Health and Department of Health and Human Services [U01AI068613 and UM1AI068613 to SHE] and NIAID [1R01-AI095068 to SHE]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Cousins MM, 2012, J MOL DIAGN IN PRESS; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Erali M, 2007, MOL BEACONS SIGNALIN; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; James MM, 2012, PEDIAT INFECT DIS J; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Murphy G, 2008, EURO SURVEILL, V13; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; WITTWER CT, 2004, DIAGNOSTIC MOL MICRO, P71	18	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51359	10.1371/journal.pone.0051359	http://dx.doi.org/10.1371/journal.pone.0051359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240016	gold, Green Submitted, Green Published			2022-12-25	WOS:000312290800052
J	Garcia-Garcia, FJ; Mullol, J; Perez-Gonzalez, M; Pujols, L; Alobid, I; Roca-Ferrer, J; Picado, C				Josep Garcia-Garcia, Francesc; Mullol, Joaquim; Perez-Gonzalez, Maria; Pujols, Laura; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar			Signal Transduction Pathways (MAPKs, NF-kappa B, and C/EBP) Regulating COX-2 Expression in Nasal Fibroblasts from Asthma Patients with Aspirin Intolerance	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; BINDING-PROTEIN-BETA; SMOOTH-MUSCLE-CELLS; CYCLOOXYGENASE-2 EXPRESSION; TRANSCRIPTIONAL REGULATION; SENSITIVE ASTHMATICS; ENDOTHELIAL-CELLS; PROSTAGLANDIN E-2; EPITHELIAL-CELLS; UP-REGULATION	Background: Recent studies have revealed that cyclooxygenase-2 (COX-2) expression is down-regulated in aspirin-induced asthma (AIA). Various signal pathways (MAPKs, NF-kappa B and C/EBP) are involved in COX-2 regulation. Objective: To investigate the regulation of COX-2 expression through MAP-kinase pathway activation and nuclear factor translocation in aspirin-induced asthma (AIA). Methods: Fibroblasts were isolated from specimens of nasal mucosa (NM, N = 5) and nasal polyps (NP, N = 5). After IL-1 beta (1 ng/ml) incubation, COX-2 and phosphorylated forms of ERK, JNK and p38 MAPK were measured by Western blot. MAPK's role in IL-1 beta-induced COX-2 expression was assessed by treating cells with ERK (PD98059), JNK (SP600125) and p38 MAPK (SB203580) inhibitors (0.1-10 mM) prior to IL-1 beta exposure. NF-kappa B and C/EBP nuclear translocation was measured by Western blot and TransAM (R) after IL-1 beta (10 ng/ml) exposure. Results: No differences were observed in the MAPK phosphorylation time-course between NM and NP-AIA fibroblasts. The p38 MAPK inhibitor at 10 mM significantly reduced IL-1 beta-induced COX-2 expression in NM fibroblasts (85%). In NP-AIA fibroblasts the COX-2 inhibition (65%) at 1 and 10 mM was not statistically significant compared to non-treated cells. ERK and JNK inhibitors had no significant effect in either the NM or NP-AIA cultures. The effect of IL-1 beta on NF-kappa B and C/EBP subunits' nuclear translocation was similar between NM and NP-AIA fibroblasts. Conclusions: These results suggest that p38 MAPK is the only MAPK involved in IL-1 beta-induced COX-2 expression. NM and NP-AIA fibroblasts have similar MAPK phosphorylation dynamics and nuclear factor translocation (NF-kappa B and C/EBP). COX-2 downregulation observed in AIA patients appears not to be caused by differences in MAPK dynamics or transcription factor translocation.	[Josep Garcia-Garcia, Francesc; Mullol, Joaquim; Perez-Gonzalez, Maria; Pujols, Laura; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain; [Josep Garcia-Garcia, Francesc; Mullol, Joaquim; Perez-Gonzalez, Maria; Pujols, Laura; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Barcelona, Catalonia, Spain; [Mullol, Joaquim] Hosp Clin Barcelona, Unitat Rinol & Clin Olfacte, Serv Otorinolaringol, Barcelona, Catalonia, Spain; [Picado, Cesar] Univ Barcelona, Serv Pneumol & Al Lergia Resp, Hosp Clin, Barcelona, Catalonia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Picado, C (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain.	idib402@clinic.ub.es	Roca-Ferrer, Jordi/AFQ-4652-2022; /AAL-7347-2021; Pujols, Laura/G-8920-2015; /AFX-9519-2022; Gonzalez, Maria Perez/J-5846-2017	Roca-Ferrer, Jordi/0000-0002-9527-2273; Pujols, Laura/0000-0003-3708-5098; Gonzalez, Maria Perez/0000-0001-9013-6785; Perez Gonzalez, Maria/0000-0001-5525-5543	Spanish Ministry of Health [FIS PI030033, FIS PI080249]; Fundacio Catalana de Pneumologia (FUCAP); Fundacion Respira (Spanish Respiratory Society)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Fundacio Catalana de Pneumologia (FUCAP); Fundacion Respira (Spanish Respiratory Society)	This work was supported by grants from the Spanish Ministry of Health (FIS PI030033, FIS PI080249), Fundacio Catalana de Pneumologia (FUCAP), and Fundacion Respira (Spanish Respiratory Society). The funders had no role in the study design, data collection or analysis, or the decision to publish, or the preparation of the manuscript.	Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Birkenkamp KU, 2000, BRIT J PHARMACOL, V131, P99, DOI 10.1038/sj.bjp.0703534; Branski RC, 2010, LARYNGOSCOPE, V120, P1826, DOI 10.1002/lary.21017; Casadevall J, 2000, THORAX, V55, P921, DOI 10.1136/thorax.55.11.921; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Chen P, 2006, RESPIROLOGY, V11, P18, DOI 10.1111/j.1440-1843.2006.00779.x; Cho YH, 2003, MOL PHARMACOL, V63, P512, DOI 10.1124/mol.63.3.512; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI [10.4193/Rhino50E2, 10.4193/Rhino12.000]; Griffin BD, 2006, J BIOL CHEM, V281, P10316, DOI 10.1074/jbc.M509973200; Higashi N, 2010, J ALLERGY CLIN IMMUN, V125, P1084, DOI 10.1016/j.jaci.2009.12.977; Jedrzejczak-Czechowicz M, 2008, CLIN EXP ALLERGY, V38, P1108, DOI 10.1111/j.1365-2222.2008.02989.x; Joo M, 2004, J BIOL CHEM, V279, P6658, DOI 10.1074/jbc.M306267200; Kowalski ML, 2000, AM J RESP CRIT CARE, V161, P391, DOI 10.1164/ajrccm.161.2.9902034; Laporte JD, 2000, AM J PHYSIOL-LUNG C, V279, pL932, DOI 10.1152/ajplung.2000.279.5.L932; Liu WV, 2003, CANCER RES, V63, P3632; Nie M, 2003, MOL CELL BIOL, V23, P9233, DOI 10.1128/MCB.23.24.9233-9244.2003; Nieminen R, 2005, MEDIAT INFLAMM, P249, DOI 10.1155/MI.2005.249; Ogata S, 2007, J DENT RES, V86, P186, DOI 10.1177/154405910708600215; Picado C, 2003, ALLERGY, V58, P122, DOI 10.1034/j.1398-9995.2003.23792.x; Picado C, 2006, CURR ALLERGY ASTHM R, V6, P198, DOI 10.1007/s11882-006-0035-2; Pierzchalska M, 2003, J ALLERGY CLIN IMMUN, V111, P1041, DOI 10.1067/mai.2003.1491; Pujols L, 2004, J ALLERGY CLIN IMMUN, V114, P814, DOI 10.1016/j.jaci.2004.07.050; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roca-Ferrer J, 2006, THORAX, V61, P592, DOI 10.1136/thx.2004.039842; Roca-Ferrer J, 2011, J ALLERGY CLIN IMMUN, V128, P66, DOI 10.1016/j.jaci.2011.01.065; Saunders MA, 2001, J BIOL CHEM, V276, P18897, DOI 10.1074/jbc.M011147200; Schafer D, 1999, EUR RESPIR J, V13, P638, DOI 10.1183/09031936.99.13363899; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Stevenson DD, 2006, J ALLERGY CLIN IMMUN, V118, P773, DOI 10.1016/j.jaci.2006.07.024; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Ulivi V, 2008, J CELL BIOCHEM, V104, P1393, DOI 10.1002/jcb.21717; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; Wu KK, 2005, ARTERIOSCL THROM VAS, V25, P679, DOI 10.1161/01.ATV.0000157899.35660.61; Wu MH, 2005, J CLIN ENDOCR METAB, V90, P286, DOI 10.1210/jc.2004-1612; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35	38	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51281	10.1371/journal.pone.0051281	http://dx.doi.org/10.1371/journal.pone.0051281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240010	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800046
J	Shi, ZM; Yuan, BJ; Wittert, GA; Pan, XQ; Dai, Y; Adams, R; Taylor, AW				Shi, Zumin; Yuan, Baojun; Wittert, Gary A.; Pan, Xiaoqun; Dai, Yue; Adams, Robert; Taylor, Anne W.			Monosodium Glutamate Intake, Dietary Patterns and Asthma in Chinese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; INCIDENT ASTHMA; PREVALENCE; SYMPTOMS; OBESITY; OVERWEIGHT; SENSITIVITY; NUTRITION; ALCOHOL	Objectives: Emerging evidence shows that diet is related to asthma. The aim of this analysis was to investigate the association between monosodium glutamate (MSG) intake, overall dietary patterns and asthma. Methods: Data from 1486 Chinese men and women who participated in the Jiangsu Nutrition Study (JIN) were analyzed. In this study, MSG intake and dietary patterns were quantitatively assessed in 2002. Information on asthma history was collected during followed-up in 2007. Results: Of the sample, 1.4% reported ever having asthma. MSG intake was not positively associated with asthma. There was a significant positive association between 'traditional' (high loadings on rice, wheat flour, and vegetable) food pattern and asthma. No association between 'macho' (rich in meat and alcohol), 'sweet tooth' (high loadings on cake, milk, and yoghurt) 'vegetable rich' (high loadings on whole grain, fruit, and vegetable) food patterns and asthma was found. Smoking and overweight were not associated with asthma in the sample. Conclusion: While a 'Traditional' food pattern was positively associated with asthma among Chinese adults, there was no significant association between MSG intake and asthma.	[Shi, Zumin; Yuan, Baojun; Pan, Xiaoqun; Dai, Yue] Jiangsu Prov Ctr Dis Control & Prevent, Dept Nutr & Foodborne Dis Prevent, Nanjing, Jiangsu, Peoples R China; [Shi, Zumin; Wittert, Gary A.; Adams, Robert; Taylor, Anne W.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Jiangsu Provincial Center for Disease Control & Prevention; University of Adelaide	Shi, ZM (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Nutr & Foodborne Dis Prevent, Nanjing, Jiangsu, Peoples R China.	zumin.shi@adelaide.edu.au	Shi, Zumin/A-1093-2009; Adams, Robert/Z-3197-2019; Taylor, Anne w/F-5708-2010; wittert, gary/AAE-2398-2019	Shi, Zumin/0000-0002-3099-3299; Taylor, Anne w/0000-0002-4422-7974; Wittert, Gary/0000-0001-6818-6065	Jiangsu Provincial Natural Science Foundation [BK2008464]; Jiangsu Provincial Health Bureau, China; International Glutamate Technical Committee	Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Health Bureau, China; International Glutamate Technical Committee	The study was funded by Jiangsu Provincial Natural Science Foundation BK2008464 and Jiangsu Provincial Health Bureau, China. The data analysis was supported a research grant from International Glutamate Technical Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DH, 1981, NEW ENGL J MED, V305, P1154; ALLEN DH, 1987, J ALLERGY CLIN IMMUN, V80, P530, DOI 10.1016/0091-6749(87)90003-0; Arshi M, 2010, RESPIROLOGY, V15, P779, DOI 10.1111/j.1440-1843.2010.01767.x; Bakolis I, 2010, ALLERGY, V65, P606, DOI 10.1111/j.1398-9995.2009.02215.x; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Beyreuther K, 2007, EUR J CLIN NUTR, V61, P304, DOI 10.1038/sj.ejcn.1602526; Butler LM, 2006, AM J RESP CRIT CARE, V173, P264, DOI 10.1164/rccm.200506-901OC; Chan-Yeung M, 2002, EUR RESPIR J, V19, P853, DOI 10.1183/09031936.02.00250602; Chittleborough CR, 2010, RESPIROLOGY, V15, P107, DOI 10.1111/j.1440-1843.2009.01638.x; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Devereux G, 2010, P NUTR SOC, V69, P1, DOI 10.1017/S0029665109991753; He K, 2008, OBESITY, V16, P1875, DOI 10.1038/oby.2008.274; He K, 2011, AM J CLIN NUTR, V93, P1328, DOI 10.3945/ajcn.110.008870; Henkin S, 2008, ANN ALLERG ASTHMA IM, V100, P447, DOI 10.1016/S1081-1206(10)60469-3; Hernandez AF, 2011, CURR OPIN ALLERGY CL, V11, P90, DOI 10.1097/ACI.0b013e3283445939; Ho WC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-542; Hooper R, 2010, BRIT J NUTR, V103, P1354, DOI 10.1017/S0007114509993266; Insawang T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-50; KING G, 2001, POLITICAL ANAL, V0009; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Liu AH, 2006, J ALLERGY CLIN IMMUN, V117, P1063, DOI 10.1016/j.jaci.2006.03.027; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McKeever TM, 2010, AM J CLIN NUTR, V92, P408, DOI 10.3945/ajcn.2009.29021; MONERET-VAUTRIN D A, 1987, Allergie et Immunologie (Paris), V19, P29; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Santamaria F, 2011, OBESITY, V19, P1623, DOI 10.1038/oby.2011.1; SCHWARTZSTEIN RM, 1987, J ASTHMA, V24, P167, DOI 10.3109/02770908709070933; SEATON A, 1994, THORAX, V49, P171, DOI 10.1136/thx.49.2.171; Shaheen SO, 2009, THORAX, V64, P411, DOI 10.1136/thx.2008.104703; Shi Z, 2008, INT J OBESITY, V32, P975, DOI 10.1038/ijo.2008.21; Shi ZM, 2011, J HYPERTENS, V29, P846, DOI 10.1097/HJH.0b013e328344da8e; Shi ZM, 2011, BRIT J NUTR, V105, P1047, DOI 10.1017/S0007114510004630; Shi ZM, 2010, BRIT J NUTR, V104, P457, DOI 10.1017/S0007114510000760; Sisson JH, 2007, ALCOHOL, V41, P293, DOI 10.1016/j.alcohol.2007.06.003; Stevenson DD, 2000, J NUTR, V130, p1067S, DOI 10.1093/jn/130.4.1067S; Thu Hien VT, 2012, PUBLIC HEALTH NUTR, P1; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Varraso R, 2009, EUR RESPIR J, V33, P33, DOI 10.1183/09031936.00130807; Wilson D, 2008, RESP MED, V102, P1536, DOI 10.1016/j.rmed.2008.06.010; Woessner KM, 1999, J ALLERGY CLIN IMMUN, V104, P305, DOI 10.1016/S0091-6749(99)70371-4; Wood LG, 2009, PHARMACOL THERAPEUT, V123, P37, DOI 10.1016/j.pharmthera.2009.03.015; Woods RK, 1998, J ALLERGY CLIN IMMUN, V101, P762, DOI 10.1016/S0091-6749(98)70305-7; Yangzong YZ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-860; Yoneda J, 2011, FOOD CHEM TOXICOL, V49, P299, DOI 10.1016/j.fct.2010.10.032; Zhao WH, 2002, PUBLIC HEALTH NUTR, V5, P829, DOI 10.1079/PHN2002374; Zhou Y, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004357.pub4	47	15	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51567	10.1371/journal.pone.0051567	http://dx.doi.org/10.1371/journal.pone.0051567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240044	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800080
J	No, DY; Lee, SA; Choi, YY; Park, D; Jang, JY; Kim, DS; Lee, SH				No, Da Yoon; Lee, Seung-A; Choi, Yoon Young; Park, DoYeun; Jang, Ju Yun; Kim, Dong-Sik; Lee, Sang-Hoon			Functional 3D Human Primary Hepatocyte Spheroids Made by Co-Culturing Hepatocytes from Partial Hepatectomy Specimens and Human Adipose-Derived Stem Cells	PLOS ONE			English	Article							IN-VITRO; HEPATIC LINEAGE; DIFFERENTIATION; LIVER; TISSUE; SIZE; SCAFFOLDS; VIVO	We have generated human hepatocyte spheroids with uniform size and shape by co-culturing 1:1 mixtures of primary human hepatocytes (hHeps) from partial hepatectomy specimens and human adipose-derived stem cells (hADSCs) in concave microwells. The hADSCs in spheroids could compensate for the low viability and improve the functional maintenance of hHeps. Co-cultured spheroids aggregated and formed compact spheroidal shapes more rapidly, and with a significantly higher viability than mono-cultured spheroids. The liver-specific functions of co-cultured spheroids were greater, although they contained half the number of hepatocytes as mono-cultured spheroids. Albumin secretion by co-cultured spheroids was 10% higher on day 7, whereas urea secretion was similar, compared with mono-cultured spheroids. A quantitative cytochrome P450 assay showed that the enzymatic activity of co-cultured spheroids cultured for 9 days was 28% higher than that of mono-cultured spheroids. These effects may be due to the transdifferentiation potential and paracrine healing effects of hADSCs on hHeps. These co-cultured spheroids may be useful for creating artificial three-dimensional hepatic tissue constructs and for cell therapy with limited numbers of human hepatocytes. Citation: No DY, Lee S-A, Choi YY, Park D, Jang JY, et al. (2012) Functional 3D Human Primary Hepatocyte Spheroids Made by Co-Culturing Hepatocytes from Partial Hepatectomy Specimens and Human Adipose-Derived Stem Cells. PLoS ONE 7(12): e50723. doi:10.1371/journal.pone.0050723	[Kim, Dong-Sik] Korea Univ, Dept Surg, Seoul, South Korea; [No, Da Yoon; Lee, Seung-A; Choi, Yoon Young; Park, DoYeun; Lee, Sang-Hoon] Korea Univ, Dept Biomed Engn, Seoul, South Korea; [Jang, Ju Yun] Real Aesthet Plast Surg Clin, Seoul, South Korea	Korea University; Korea University	Kim, DS (corresponding author), Korea Univ, Dept Surg, Seoul, South Korea.	kimds1@korea.ac.kr; dbiomed@korea.ac.kr		Kim, Dong-Sik/0000-0002-0608-1580	Converging Research Center Program; Ministry of Education, Science and Technology [2012K001360]; National Research Laboratory (NRL) program; Korea Science and Engineering Foundation (KOSEF), Republic of Korea [2012026340]	Converging Research Center Program; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Laboratory (NRL) program(Korea Science and Engineering Foundation); Korea Science and Engineering Foundation (KOSEF), Republic of Korea(Korea Science and Engineering Foundation)	This research was supported by the Converging Research Center Program funded by the Ministry of Education, Science and Technology (No. 2012K001360) and the National Research Laboratory (NRL) program, the Korea Science and Engineering Foundation (KOSEF), Republic of Korea (No. 2012026340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarani U, 2003, LIVER TRANSPLANT, V9, P506, DOI 10.1053/jlts.2003.50087; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; Dvir-Ginzberg M, 2004, TISSUE ENG, V10, P1806, DOI 10.1089/ten.2004.10.1806; Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hong SH, 2005, BIOCHEM BIOPH RES CO, V330, P1153, DOI 10.1016/j.bbrc.2005.03.086; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V59, P1; Lee KH, 2011, LAB CHIP, V11, P1168, DOI [10.1039/c0lc00540a, 10.1039/c01c00540a]; LI AP, 1992, IN VITRO CELL DEV-AN, V28A, P673; Okura H, 2010, TISSUE ENG PART C-ME, V16, P761, DOI [10.1089/ten.tec.2009.0208, 10.1089/ten.TEC.2009.0208]; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Talens-Visconti R, 2007, TOXICOL IN VITRO, V21, P324, DOI 10.1016/j.tiv.2006.08.009; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; TONG JZ, 1994, BIOL CELL, V81, P77, DOI 10.1016/0248-4900(94)90058-2; van de Kerkhove MP, 2004, ANN SURG, V240, P216, DOI 10.1097/01.sla.0000132986.75257.19; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x; Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028; Zhang QH, 2007, DNA CELL BIOL, V26, P497, DOI 10.1089/dna.2006.0562; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	27	50	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50723	10.1371/journal.pone.0050723	http://dx.doi.org/10.1371/journal.pone.0050723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236387	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100029
J	Davies, JL; Cazier, JB; Dunlop, MG; Houlston, RS; Tomlinson, IP; Holmes, CC				Davies, Joanna L.; Cazier, Jean-Baptiste; Dunlop, Malcolm G.; Houlston, Richard S.; Tomlinson, Ian P.; Holmes, Chris C.			A Novel Test for Gene-Ancestry Interactions in Genome-Wide Association Data	PLOS ONE			English	Article							CANCER SUSCEPTIBILITY LOCUS; COLORECTAL-CANCER; IRON; SCAN; RISK; METAANALYSIS; DISEASE; VARIANT	Genome-wide association study (GWAS) data on a disease are increasingly available from multiple related populations. In this scenario, meta-analyses can improve power to detect homogeneous genetic associations, but if there exist ancestry-specific effects, via interactions on genetic background or with a causal effect that co-varies with genetic background, then these will typically be obscured. To address this issue, we have developed a robust statistical method for detecting susceptibility gene-ancestry interactions in multi-cohort GWAS based on closely-related populations. We use the leading principal components of the empirical genotype matrix to cluster individuals into "ancestry groups" and then look for evidence of heterogeneous genetic associations with disease or other trait across these clusters. Robustness is improved when there are multiple cohorts, as the signal from true gene-ancestry interactions can then be distinguished from gene-collection artefacts by comparing the observed interaction effect sizes in collection groups relative to ancestry groups. When applied to colorectal cancer, we identified a missense polymorphism in iron-absorption gene CYBRD1 that associated with disease in individuals of English, but not Scottish, ancestry. The association replicated in two additional, independently-collected data sets. Our method can be used to detect associations between genetic variants and disease that have been obscured by population genetic heterogeneity. It can be readily extended to the identification of genetic interactions on other covariates such as measured environmental exposures. We envisage our methodology being of particular interest to researchers with existing GWAS data, as ancestry groups can be easily defined and thus tested for interactions. Citation: Davies JL, Cazier J-B, Dunlop MG, Houlston RS, Tomlinson IP, et al. (2012) A Novel Test for Gene-Ancestry Interactions in Genome-Wide Association Data. PLoS ONE 7(12): e48687. doi:10.1371/journal.pone.0048687	[Davies, Joanna L.; Holmes, Chris C.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Cazier, Jean-Baptiste; Tomlinson, Ian P.; Holmes, Chris C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dunlop, Malcolm G.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Dunlop, Malcolm G.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Tomlinson, Ian P.] John Radcliffe Hosp, Oxford Comprehens Biomed Res Ctr, Oxford OX3 9DU, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; University of Edinburgh; University of London; Institute of Cancer Research - UK; University of Oxford	Holmes, CC (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	cholmes@stats.well.ox.ac.uk	Cazier, Jean-Baptiste/F-2369-2010; Dunlop, Malcolm G/F-1973-2011; Cazier, Jean-Baptiste/GLR-2949-2022	Cazier, Jean-Baptiste/0000-0001-7581-9051; Dunlop, Malcolm G/0000-0002-3033-5851; Cazier, Jean-Baptiste/0000-0001-7581-9051; Houlston, Richard/0000-0002-5268-0242; Holmes, Christopher/0000-0002-6667-4943	Wellcome Trust; Medical Research Council UK; Cancer Research UK (Programme Grant) [C348/A12076]; Cancer Research UK (Bobby Moore Fund); Medical Research Council [G0000657-53203]; MRC [MC_U127527198, MC_PC_U127527198] Funding Source: UKRI; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_U127527198, MC_PC_U127527198] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (Programme Grant)(Cancer Research UK); Cancer Research UK (Bobby Moore Fund); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for salaries of authors include Wellcome Trust (http://www.wellcome.ac.uk/) and Medical Research Council UK (http://www.mrc.ac.uk/index.htm). This work is partly funded by Cancer Research UK (Programme Grant C348/A12076 and the Bobby Moore Fund) and Medical Research Council (G0000657-53203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chua ACG, 2010, WORLD J GASTROENTERO, V16, P663, DOI 10.3748/wjg.v16.i6.663; Constantine CC, 2009, BRIT J HAEMATOL, V147, P140, DOI 10.1111/j.1365-2141.2009.07843.x; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; Lee DH, 2004, JNCI-J NATL CANCER I, V96, P403, DOI 10.1093/jnci/djh047; NELSON RL, 1994, JNCI-J NATL CANCER I, V86, P455, DOI 10.1093/jnci/86.6.455; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2009, NATURE GENETICS; Vlachodimitropoulou E, 2010, FREE RADICAL BIO MED, V48, P1366, DOI 10.1016/j.freeradbiomed.2010.02.021; Wurzelmann JI, 1996, CANCER EPIDEM BIOMAR, V5, P503; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e48687	10.1371/journal.pone.0048687	http://dx.doi.org/10.1371/journal.pone.0048687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236349	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700004
J	Fedina, TY; Kuo, TH; Dreisewerd, K; Dierick, HA; Yew, JY; Pletcher, SD				Fedina, Tatyana Y.; Kuo, Tsung-Han; Dreisewerd, Klaus; Dierick, Herman A.; Yew, Joanne Y.; Pletcher, Scott D.			Dietary Effects on Cuticular Hydrocarbons and Sexual Attractiveness in Drosophila	PLOS ONE			English	Article							LIFE-SPAN; S6 KINASE; FEMALE; MELANOGASTER; RESTRICTION; RECOGNITION; TEMPERATURE; MOJAVENSIS; COLEOPTERA; EVOLUTION	Dietary composition is known to have profound effects on many aspects of animal physiology, including lifespan, general health, and reproductive potential. We have previously shown that aging and insulin signaling significantly influence the composition and sexual attractiveness of Drosophila melanogaster female cuticular hydrocarbons (CHCs), some of which are known to be sex pheromones. Because diet is intimately linked to aging and to the activity of nutrient-sensing pathways, we asked how diet affects female CHCs and attractiveness. Here we report consistent and significant effects of diet composition on female CHC profiles across ages, with dietary yeast and sugar driving CHC changes in opposite directions. Surprisingly, however, we found no evidence that these changes affect female attractiveness. Multivariate comparisons among responses of CHC profiles to diet, aging, and insulin signaling suggest that diet may alter the levels of some CHCs in a way that results in profiles that are more attractive while simultaneously altering other CHCs in a way that makes them less attractive. For example, changes in short-chain CHCs induced by a high-yeast diet phenocopy changes caused by aging and by decreased insulin signaling, both of which result in less attractive females. On the other hand, changes in long-chain CHCs in response to the same diet result in levels that are comparable to those observed in attractive young females and females with increased insulin signaling. The effects of a high-sugar diet tend in the opposite direction, as levels of short-chain CHCs resemble those in attractive females with increased insulin signaling and changes in long-chain CHCs are similar to those caused by decreased insulin signaling. Together, these data suggest that diet-dependent changes in female CHCs may be sending conflicting messages to males.	[Fedina, Tatyana Y.; Pletcher, Scott D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kuo, Tsung-Han; Dierick, Herman A.; Pletcher, Scott D.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dreisewerd, Klaus; Yew, Joanne Y.] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Yew, Joanne Y.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yew, Joanne Y.] Temasek Life Sci Lab, Singapore, Singapore; [Pletcher, Scott D.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Baylor College of Medicine; University of Munster; National University of Singapore; University of Michigan System; University of Michigan	Pletcher, SD (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	spletch@umich.edu	Yew, Joanne/D-6562-2014; Dreisewerd, Klaus/K-3884-2015	Dreisewerd, Klaus/0000-0002-7619-808X	U.S. National Institutes of Health [R01AG030593, R01AG023166]; Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation; Alexander von Humboldt foundation; Singapore National Research Foundation [RF001-363]; National Institute of General Medical Sciences [GM074675, GM0676450]; National Science Foundation [IDS-075165]; National Institute on Aging [P30-AG-013283]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102279, R01GM074675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023166, P30AG013283, R01AG030593] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Singapore National Research Foundation(National Research Foundation, Singapore); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by U.S. National Institutes of Health (R01AG030593 and R01AG023166), the Glenn Foundation, the American Federation for Aging Research, the Ellison Medical Foundation (to S.D.P.), the Alexander von Humboldt foundation, Singapore National Research Foundation (RF001-363 to J.Y.Y.), the National Institute of General Medical Sciences (GM074675 and GM0676450) and the National Science Foundation (IDS-075165 to E. A. Kravitz). This work utilized the Drosophila Aging Core of the Nathan Shock Center of Excellence in the Biology of Aging funded by the National Institute on Aging (P30-AG-013283). Deposited in PMC for release after 12 months. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambuhl PM, 2011, INT J VITAM NUTR RES, V81, P162, DOI 10.1024/0300-9831/a000056; Andersson Malte, 1994; [Anonymous], 2003, ANIMAL SIGNALS; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Arienti M, 2010, INTEGR ZOOL, V5, P272, DOI 10.1111/j.1749-4877.2010.00213.x; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Catterson JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012062; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; COOK R, 1975, ANIM BEHAV, V23, P521, DOI 10.1016/0003-3472(75)90129-3; Etges WJ, 2006, J CHEM ECOL, V32, P2629, DOI 10.1007/s10886-006-9187-8; Etges WJ, 2009, EVOLUTION, V63, P1712, DOI 10.1111/j.1558-5646.2009.00661.x; Fanson BG, 2012, AGE, V34, P1361, DOI 10.1007/s11357-011-9308-3; Fedina TY, 2007, J INSECT PHYSIOL, V53, P93, DOI 10.1016/j.jinsphys.2006.10.011; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; GEER BW, 1977, INSECT BIOCHEM, V7, P371, DOI 10.1016/0020-1790(77)90040-3; Gosden TP, 2011, J EVOLUTION BIOL, V24, P685, DOI 10.1111/j.1420-9101.2010.02205.x; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Jolliffe I.T., 2002, SPRINGER SERIES STAT; Katewa SD, 2011, EXP GERONTOL, V46, P382, DOI 10.1016/j.exger.2010.11.036; Kent C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000962; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980; Lewis SM, 2012, J EVOLUTION BIOL, V25, P438, DOI 10.1111/j.1420-9101.2011.02408.x; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Richard DS, 2005, J INSECT PHYSIOL, V51, P455, DOI 10.1016/j.jinsphys.2004.12.013; Savarit F, 2002, J EXP BIOL, V205, P3241; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Spikes AE, 2010, J CHEM ECOL, V36, P943, DOI 10.1007/s10886-010-9837-8; Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Vigne P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000056; Yew JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016898; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037	49	71	73	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49799	10.1371/journal.pone.0049799	http://dx.doi.org/10.1371/journal.pone.0049799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227150	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200012
J	Fletcher, JM				Fletcher, Jason M.			Why Have Tobacco Control Policies Stalled? Using Genetic Moderation to Examine Policy Impacts	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; LUNG-CANCER; SUSCEPTIBILITY LOCUS; SUBUNIT GENES; DEPENDENCE; ASSOCIATION; SMOKING; ADDICTION; CHRNB3; TAXES	Background: Research has shown that tobacco control policies have helped produce the dramatic decline in use over the decades following the 1964 surgeon general's report. However, prevalence rates have stagnated during the past two decades in the US, even with large tobacco taxes and expansions of clean air laws. The observed differences in tobacco control policy effectiveness and why policies do not help all smokers are largely unexplained. Objective: The aim of this study was to determine the importance of genetics in explaining response to tobacco taxation policy by testing the potential of gene-policy interaction in determining adult tobacco use. Methods: A moderated regression analysis framework was used to test interactive effects between genotype and tobacco policy in predicting tobacco use. Cross sectional data of US adults from the National Health and Nutrition Examination Survey (NHANES) linked with genotype and geocodes were used to identify tobacco use phenotypes, state-level taxation rates, and variation in the nicotinic acetylcholine receptor (CHRNA6) genotype. Tobacco use phenotypes included current use, number of cigarettes smoked per day, and blood serum cotinine measurements. Results: Variation in the nicotinic acetylcholine receptor was found to moderate the influence of tobacco taxation on multiple measures of tobacco use. Individuals with the protective G/G polymorphism (51% of the sample) responded to taxation while others had no response. The estimated differences in response by genotype were C/C genotype: b = -0.016 se = 0.018; G/C genotype: b = 0.014 se = 0.017; G/G genotype: b = -0.071 se 0.029. Conclusions: This study provides novel evidence of "gene-policy'' interaction and suggests a genetic mechanism for the large differences in response to tobacco policies. The inability for these policies to reduce use for individuals with specific genotypes suggests alternative methods may be needed to further reduce use.	Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA	Yale University	Fletcher, JM (corresponding author), Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA.	jason.fletcher@yale.edu			Robert Wood Johnson Foundation Health & Society Scholars Program at Columbia University	Robert Wood Johnson Foundation Health & Society Scholars Program at Columbia University	This study was funded by a seed grant from the Robert Wood Johnson Foundation Health & Society Scholars Program at Columbia University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda J, 2006, AM ECON REV, V96, P1013, DOI 10.1257/aer.96.4.1013; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Aiken L.S., 1991, MULTIPLE REGRESSION; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Brant-Zawadzki PB, 2007, J VASC SURG, V45, p8A, DOI 10.1016/j.jvs.2007.02.033; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P524; Chaloupka FJ, 2000, HANDB ECON, V17, P1539; Conley DC, 2009, HDB MED SOCIOLOGY; DeCicca P, 2000, J RISK UNCERTAINTY, V21, P311, DOI 10.1023/A:1007819625751; Fletcher JM, 2009, 15130 NBER; Greenbaum L, 2009, MOL PSYCHIATR, V14, P912, DOI 10.1038/mp.2009.59; Gruber Jonathan, 2001, RISKY BEHAV YOUTHS E; Healthy People, 2005, LEDING HLTH INDICATO; Hoft NR, 2009, NEUROPSYCHOPHARMACOL, V34, P698, DOI 10.1038/npp.2008.122; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Inst. Med. (IOM), 2007, END TOB PROBL BLUEPR; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Meyer EL, 2008, J NEUROCHEM, V105, P1761, DOI 10.1111/j.1471-4159.2008.05266.x; Mineur YS, 2008, BIOCHEM PHARMACOL, V75, P323, DOI 10.1016/j.bcp.2007.06.010; NIDA, 2009, NIH PUBL; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Smith GD, 2007, J ROY SOC MED, V100, P432, DOI 10.1258/jrsm.100.9.432; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Zeiger JS, 2008, HUM MOL GENET, V17, P724, DOI 10.1093/hmg/ddm344	28	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50576	10.1371/journal.pone.0050576	http://dx.doi.org/10.1371/journal.pone.0050576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227187	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200047
J	Hui, DS; Chow, BK; Chu, L; Ng, SS; Lee, N; Gin, T; Chan, MTV				Hui, David S.; Chow, Benny K.; Chu, Leo; Ng, Susanna S.; Lee, Nelson; Gin, Tony; Chan, Matthew T. V.			Exhaled Air Dispersion during Coughing with and without Wearing a Surgical or N95 Mask	PLOS ONE			English	Article							HEALTH-CARE PERSONNEL; H1N1 2009 INFLUENZA; AEROSOL TRANSMISSION; OXYGEN DELIVERY; VIRUS; VENTILATION; INFECTION; OUTBREAK; HEMATOLOGY; MANAGEMENT	Objectives: We compared the expelled air dispersion distances during coughing from a human patient simulator (HPS) lying at 45 degrees with and without wearing a surgical mask or N95 mask in a negative pressure isolation room. Methods: Airflow was marked with intrapulmonary smoke. Coughing bouts were generated by short bursts of oxygen flow at 650, 320, and 220L/min to simulate normal, mild and poor coughing efforts, respectively. The coughing jet was revealed by laser light-sheet and images were captured by high definition video. Smoke concentration in the plume was estimated from the light scattered by smoke particles. Significant exposure was arbitrarily defined where there was >= 20% of normalized smoke concentration. Results: During normal cough, expelled air dispersion distances were 68, 30 and 15 cm along the median sagittal plane when the HPS wore no mask, a surgical mask and a N95 mask, respectively. In moderate lung injury, the corresponding air dispersion distances for mild coughing efforts were reduced to 55, 27 and 14 cm, respectively, p < 0.001. The distances were reduced to 30, 24 and 12 cm, respectively during poor coughing effort as in severe lung injury. Lateral dispersion distances during normal cough were 0, 28 and 15 cm when the HPS wore no mask, a surgical mask and a N95 mask, respectively. Conclusions: Normal cough produced a turbulent jet about 0.7 m towards the end of the bed from the recumbent subject. N95 mask was more effective than surgical mask in preventing expelled air leakage during coughing but there was still significant sideway leakage. Citation: Hui DS, Chow BK, Chu L, Ng SS, Lee N, et al. (2012) Exhaled Air Dispersion during Coughing with and without Wearing a Surgical or N95 Mask. PLoS ONE 7(12): e50845. doi:10.1371/journal.pone.0050845	[Hui, David S.; Ng, Susanna S.; Lee, Nelson] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Hui, David S.; Chow, Benny K.; Lee, Nelson] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Chow, Benny K.] Chinese Univ Hong Kong, Ctr Housing Innovat, Hong Kong, Hong Kong, Peoples R China; [Chu, Leo; Gin, Tony; Chan, Matthew T. V.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Hui, DS (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	dschui@cuhk.edu.hk	Chan, Matthew/J-2884-2013; Ng, Susanna SS/G-7431-2017; Lee, Nelson/B-6418-2008; Ng, Susanna/ABI-4965-2020; GIN, Tony/J-2521-2013; Hui, David Shu-Cheong/O-2754-2015	Chan, Matthew/0000-0002-3574-7855; Ng, Susanna SS/0000-0002-4554-7312; Lee, Nelson/0000-0002-0783-6607; GIN, Tony/0000-0001-7283-6761; Hui, David Shu-Cheong/0000-0003-4382-2445; CHOW, Benny/0000-0002-7391-233X	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Government of the Hong Kong Special Administrative Region [CU-09-01-05, PHE18]	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Government of the Hong Kong Special Administrative Region	This work was supported by the Research Fund for the Control of Infectious Diseases (# CU-09-01-05, PHE18), Food and Health Bureau, Government of the Hong Kong Special Administrative Region. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchbinder N, 2011, J HOSP INFECT, V79, P155, DOI 10.1016/j.jhin.2011.04.019; Chan MTV, 2012, AM J RESP C IN PRESS; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen LF, 2011, J INFECT DIS, V203, P838, DOI 10.1093/infdis/jiq124; Enstone JE, 2011, EMERG INFECT DIS, V17, P592, DOI 10.3201/eid1704.101679; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Godwin JA, 2004, ANESTH ANALG, V99, P1655, DOI 10.1213/01.ANE.0000134797.52793.AF; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Hui DS, 2007, CHEST, V132, P540, DOI 10.1378/chest.07-0636; Hui DS, 2006, CHEST, V130, P822, DOI 10.1378/chest.130.3.822; Hui DS, 2006, CHEST, V130, P730, DOI 10.1378/chest.130.3.730; Hui DS, 2011, RESPIROLOGY, V16, P1005, DOI 10.1111/j.1440-1843.2011.01995.x; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Hui DS, 2009, CHEST, V136, P998, DOI 10.1378/chest.09-0434; Hui DS, 2009, CHEST, V135, P648, DOI 10.1378/chest.08-1998; Hui DS, 2008, RESPIROLOGY S, pS10; Jefferson T, 2011, COCHRANE DB SYST REV, V7; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Johnson DF, 2009, CLIN INFECT DIS, V49, P275, DOI 10.1086/600041; Kwon SB, 2012, CHEMOSPHERE, V87, P1260, DOI 10.1016/j.chemosphere.2012.01.032; Lampotang S, 2006, ANESTH ANALG, V102, P168, DOI 10.1213/01.ANE.0000181833.23904.4E; Lavietes MH, 1998, EUR RESPIR J, V11, P156, DOI 10.1183/09031936.98.11010156; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MathSoft Inc, 2000, MATHC 8 0 WIND US GU; Moore C, 2011, J INFECT DIS, V203, P18, DOI 10.1093/infdis/jiq007; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Pantelic J, 2009, J R SOC INTERFACE, V6, pS715, DOI 10.1098/rsif.2009.0311.focus; Soo S.L., 1967, FLUID DYNAMICS MULTI; Suarez AA, 2002, AM J PHYS MED REHAB, V81, P506, DOI 10.1097/00002060-200207000-00007; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2007, LANCET INFECT DIS, V7, P758, DOI 10.1016/S1473-3099(07)70268-2; Tang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034818; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Tang JWT, 2009, NEW ENGL J MED, V361, pE62, DOI 10.1056/NEJMicm0904279; WHO, 2009, INF PREV CONTR HEALT; Wise ME, 2011, CLIN INFECT DIS, V52, pS198, DOI 10.1093/cid/ciq038; Wong BCK, 2010, CLIN INFECT DIS, V51, P1176, DOI 10.1086/656743; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zhu SW, 2006, BUILD ENVIRON, V41, P1691, DOI 10.1016/j.buildenv.2005.06.024	44	90	93	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50845	10.1371/journal.pone.0050845	http://dx.doi.org/10.1371/journal.pone.0050845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23239991	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200074
J	Westphal, C; Schubert, C; Prelle, K; Penkalla, A; Fliegner, D; Petrov, G; Regitz-Zagrosek, V				Westphal, Christina; Schubert, Carola; Prelle, Katja; Penkalla, Adam; Fliegner, Daniela; Petrov, George; Regitz-Zagrosek, Vera			Effects of Estrogen, an ER alpha Agonist and Raloxifene on Pressure Overload Induced Cardiac Hypertrophy	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; RECEPTOR-BETA; MYOCARDIAL-INFARCTION; POSTMENOPAUSAL WOMEN; HEART-FAILURE; MATRIX METALLOPROTEINASE-2; CARDIOMYOCYTE HYPERTROPHY; CARDIOVASCULAR EVENTS; RANDOMIZED-TRIAL; AORTIC-STENOSIS	The aim of this study was to investigate the effects of 17 beta-estradiol (E2), the selective ER alpha agonist 16 alpha-LE2, and the selective estrogen receptor modulator (SERM) raloxifene on remodeling processes during the development of myocardial hypertrophy (MH) in a mouse model of pressure overload. Myocardial hypertrophy in ovariectomized female C57BI/6J mice was induced by transverse aortic constriction (TAC). Two weeks after TAC, placebo treated mice developed left ventricular hypertrophy and mild systolic dysfunction. Estrogen treatment, but not 16 alpha-LE2 or raloxifene reduced TAC induced MH compared to placebo. E2, 16 alpha-LE2 and raloxifene supported maintenance of cardiac function in comparison with placebo. Nine weeks after induction of pressure overload, MH was present in all TAC groups, most pronounced in the raloxifene treated group. Ejection fraction (EF) was decreased in all animals. However, 16 alpha-LE2 treated animals showed a smaller reduction of EF than animals treated with placebo. E2 and 16 alpha-LE2, but not raloxifene diminished the development of fibrosis and reduced the TGF beta and CTGF gene expression. Treatment with E2 or 16 alpha-LE2 but not with raloxifene reduced survival rate after TAC significantly in comparison with placebo treatment. In conclusion, E2 and 16 alpha-LE2 slowed down the progression of MH and reduced systolic dysfunction after nine weeks of pressure overload. Raloxifene did not reduce MH but improved cardiac function two weeks after TAC. However, raloxifene was not able to maintain EF in the long term period.	[Westphal, Christina; Schubert, Carola; Fliegner, Daniela; Regitz-Zagrosek, Vera] Charite, Inst Gender Med, D-13353 Berlin, Germany; [Westphal, Christina; Schubert, Carola; Fliegner, Daniela; Regitz-Zagrosek, Vera] Ctr Cardiovasc Res, Berlin, Germany; [Prelle, Katja] Bayer Pharma, Wuppertal, Germany; [Penkalla, Adam; Petrov, George] German Heart Inst, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Bayer Healthcare Pharmaceuticals; German Heart Center Berlin	Westphal, C (corresponding author), Charite, Inst Gender Med, D-13353 Berlin, Germany.	christina.westphal@mdc-berlin.de	Petrov, George/H-4033-2013	Petrov, George/0000-0002-1045-6592; Regitz-Zagrosek, Vera/0000-0002-3566-3467; Schubert, Carola/0000-0002-9116-9105	Deutsche Forschungsgemeinschaft [DFG-GK-754II-III, FOR1054]; Commission of the European Community [EUGeneHeart-LSHM-CT-2005-018833]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Commission of the European Community(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft Grants DFG-GK-754II-III, FOR1054, and a grant from the Commission of the European Community (EUGeneHeart-LSHM-CT-2005-018833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Loza PA, 2007, HYPERTENSION, V50, P432, DOI 10.1161/HYPERTENSIONAHA.106.084798; Babiker FA, 2007, ACTA PHYSIOL, V189, P23, DOI 10.1111/j.1748-1716.2006.01633.x; Babiker FA, 2006, ARTERIOSCL THROM VAS, V26, P1524, DOI 10.1161/01.ATV.0000223344.11128.23; Backhaus K, 2008, MULTIVARIATE ANALYSE, V12, P323; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Bender R, 2007, Dtsch Med Wochenschr, V132 Suppl 1, pe24, DOI 10.1055/s-2007-959034; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Donaldson C, 2009, CIRC RES, V104, P265, DOI 10.1161/CIRCRESAHA.108.190397; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gardner JD, 2008, AM J PHYSIOL-HEART C, V294, pH198, DOI 10.1152/ajpheart.00281.2007; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Mahmoodzadeh S, 2010, CARDIOVASC RES, V85, P719, DOI 10.1093/cvr/cvp350; MENDELSON ME, 1994, CURR OPIN CARDIOL, V9, P619, DOI 10.1097/00001573-199409000-00018; Ogita H, 2004, HYPERTENSION, V43, P237, DOI 10.1161/01.HYP.0000109320.25921.b1; Patten RD, 2008, J CARD FAIL, V14, P245, DOI 10.1016/j.cardfail.2007.10.024; Pedram A, 2008, ENDOCRINOLOGY, V149, P3361, DOI 10.1210/en.2008-0133; Pelzer T, 2005, CARDIOVASC RES, V67, P604, DOI 10.1016/j.cardiores.2005.04.035; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Tamura T, 1999, HYPERTENSION, V33, P676, DOI 10.1161/01.HYP.33.2.676; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; van Eickels M, 2003, J AM COLL CARDIOL, V41, P2084, DOI 10.1016/S0735-1097(03)00423-6; Villar AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008476; WEBER KT, 1994, J MOL CELL CARDIOL, V26, P279, DOI 10.1006/jmcc.1994.1036; Wingrove CS, 1998, BBA-MOL BASIS DIS, V1406, P169, DOI 10.1016/S0925-4439(97)00097-5; Xu Y, 2003, CARDIOVASC RES, V57, P388, DOI 10.1016/S0008-6363(02)00705-8	38	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50802	10.1371/journal.pone.0050802	http://dx.doi.org/10.1371/journal.pone.0050802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227210	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200070
J	Fan, SJ; Zhang, Y; Hu, N; Sun, QH; Ding, XB; Li, GW; Zheng, B; Gu, M; Huang, FS; Sun, YQ; Zhou, ZQ; Lu, X; Huang, C; Ji, G				Fan, Shengjie; Zhang, Yu; Hu, Na; Sun, Qinhu; Ding, Xiaobo; Li, Guowen; Zheng, Bin; Gu, Ming; Huang, Feisi; Sun, Yin-Qiang; Zhou, Zhiqin; Lu, Xiong; Huang, Cheng; Ji, Guang			Extract of Kuding Tea Prevents High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice via Liver X Receptor (LXR) beta Antagonism	PLOS ONE			English	Article							NUCLEAR RECEPTORS; URSOLIC ACID; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; GREEN TEA; INTESTINAL-ABSORPTION; LIPID-METABOLISM; GENE-EXPRESSION; ILEX-KUDINGCHA; PPAR-GAMMA	Objective: To investigate the effects of ilex kudingcha C. J. Tseng (kuding tea), a traditional beverage in China, on the metabolic disorders in C57BL/6 mice induced by high-fat diets. Design: For the preventive experiment, the female C57BL/6 mice were fed with a standard diet (Chow), high-fat diet (HF), and high-fat diet mixed with 0.05% ethanol extract of kuding tea (EK) for 5 weeks. For the therapeutic experiment, the C57BL/6 mice were fed high-fat diet for 3 months, and then mice were split and EK was given with oral gavages for 2 weeks at 50 mg/day/kg. Body weight and daily food intake amounts were measured. At the end of treatment, the adipocyte images were assayed with a scanning electron microscope, and the fasting blood glucose, glucose tolerance test, serum lipid profile and lipids in the livers were analyzed. A reporter gene assay system was used to test the whether EK could act on nuclear receptor transcription factors, and the gene expression analysis was performed with a quantitative PCR assay. Results: In the preventive treatment, EK blocked the body weight gain, reduced the size of the adipocytes, lowered serum triglyceride, cholesterol, LDL-cholesterol, fasting blood glucose levels and glucose tolerance in high-fat diet-fed C57BL/6 mice. In the therapeutic treatment, EK reduced the size of the white adipocytes, serum TG and fasting blood glucose levels in obese mice. With the reporter assay, EK inhibited LXR beta transactivity and mRNA expression of LXRb target genes. Conclusion: We observed that EK has both preventive and therapeutic roles in metabolic disorders in mice induced with high-fat diets. The effects appear to be mediated through the antagonism of LXRb transactivity. Our data indicate that kuding tea is a useful dietary therapy and a potential source for the development of novel anti-obesity and lipid lowering drugs. Citation: Fan S, Zhang Y, Hu N, Sun Q, Ding X, et al. (2012) Extract of Kuding Tea Prevents High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice via Liver X Receptor (LXR) beta Antagonism. PLoS ONE 7(12): e51007. doi: 10.1371/journal.pone.0051007	[Fan, Shengjie; Zhang, Yu; Ding, Xiaobo; Zheng, Bin; Gu, Ming; Huang, Feisi; Huang, Cheng] Shanghai Univ Tradit Chinese Med, Sch Pharm, Drug Discovery Lab, Shanghai, Peoples R China; [Hu, Na; Sun, Yin-Qiang; Lu, Xiong] Shanghai Univ Tradit Chinese Med, Sci Expt Ctr, Shanghai, Peoples R China; [Sun, Qinhu] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Ding, Xiaobo; Zhou, Zhiqin; Ji, Guang] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Ding, Xiaobo; Zhou, Zhiqin] Minist Educ, Key Lab Hort Sci So Mountainous Reg, Chongqing, Peoples R China; [Li, Guowen] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Southwest University - China; Shanghai University of Traditional Chinese Medicine	Huang, C (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Pharm, Drug Discovery Lab, Shanghai, Peoples R China.	chuang.shutcm@gmail.com; jiliver@vip.sina.com			National Natural Science Foundation of China [30873260]; Talents Scheme from the Science and Technology Commission of Shanghai Municipality [09XD1403800]; Supporting Project for Elitists in the New Century from The Ministry of Education [NCET-07563]; Shanghai Leading Academic Discipline Project [J50305, E3008]; XinLin Scholar and Outstanding Team Training Plan of Shanghai University of Traditional Chinese Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents Scheme from the Science and Technology Commission of Shanghai Municipality; Supporting Project for Elitists in the New Century from The Ministry of Education; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); XinLin Scholar and Outstanding Team Training Plan of Shanghai University of Traditional Chinese Medicine	This work was supported by National Natural Science Foundation of China (no. 30873260), the Talents Scheme from the Science and Technology Commission of Shanghai Municipality (no. 09XD1403800), the Supporting Project for Elitists in the New Century from The Ministry of Education (no. NCET-07563), the Shanghai Leading Academic Discipline Project (no. J50305 and E3008), and the XinLin Scholar and Outstanding Team Training Plan of Shanghai University of Traditional Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Azevedo MF, 2010, PHYTOTHER RES, V24, pS220, DOI 10.1002/ptr.3118; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Chun TH, 2010, DIABETES, V59, P2484, DOI 10.2337/db10-0073; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Goldwasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012399; Gong HB, 2004, EXPERT OPIN THER TAR, V8, P49, DOI 10.1517/14728222.8.1.49; Gong ZW, 2009, ENDOCRINOLOGY, V150, P104, DOI 10.1210/en.2008-0322; Gupta R, 2012, NAT PROD RES, V26, P1125, DOI 10.1080/14786419.2011.560845; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Huang Z, 1997, CHIN J INFOR TRADIT, V4, P25; Jia Y, 2011, BIOORG MED CHEM LETT, V21, P5876, DOI 10.1016/j.bmcl.2011.07.095; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kanaya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026654; Kim JY, 2011, J ETHNOPHARMACOL, V133, P558, DOI 10.1016/j.jep.2010.10.037; Kim J, 2009, ARCH PHARM RES, V32, P983, DOI 10.1007/s12272-009-1702-3; Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS516; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liu Aihua, 2002, Zhong Yao Cai, V25, P148; Liu B, 2005, CHIN NUR RES, V19, P21; Loest HB, 2002, J NUTR, V132, P1282, DOI 10.1093/jn/132.6.1282; Lund EG, 2003, ARTERIOSCL THROM VAS, V23, P1169, DOI 10.1161/01.ATV.0000056743.42348.59; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Niesor EJ, 2001, CURR PHARM DESIGN, V7, P231, DOI 10.2174/1381612013398185; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Popovich N G, 1997, J Am Pharm Assoc (Wash), VNS37, P31; Popovich NG, 1997, J AM PHARM ASSOC, VNS37, P56; Rao VS, 2011, J MED FOOD, V14, P1375, DOI 10.1089/jmf.2010.0267; Raz I, 2005, DIABETES-METAB RES, V21, P3, DOI 10.1002/dmrr.493; Reddy KP, 2009, BIOORG MED CHEM LETT, V19, P4463, DOI 10.1016/j.bmcl.2009.05.034; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sheng XY, 2011, AM J PHYSIOL-ENDOC M, V300, pE886, DOI 10.1152/ajpendo.00332.2010; Song C, 2001, STEROIDS, V66, P473, DOI 10.1016/S0039-128X(00)00239-7; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wang Q, 1998, CHIN J ETHNOMED ETHN, V34, P12; Wang S, 1994, CHIN J INTEGR MED, V11, P670; Wang S, 2006, J NUTR BIOCHEM, V17, P492, DOI 10.1016/j.jnutbio.2006.03.004; Wong IYF, 2001, J AGR FOOD CHEM, V49, P3113, DOI 10.1021/jf0100604; [吴弢 Wu Tao], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1460; Zheng J, 2009, PLANTA MED, V75, P1410, DOI 10.1055/s-0029-1185722; Zheng J, 2009, CLIN HEMORHEOL MICRO, V42, P29, DOI 10.3233/CH-2009-1183; Zhu F, 2009, J AGR FOOD CHEM, V57, P6082, DOI 10.1021/jf901020h	51	57	59	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51007	10.1371/journal.pone.0051007	http://dx.doi.org/10.1371/journal.pone.0051007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226556	Green Published, gold, Green Submitted			2022-12-25	WOS:000312108500039
J	Ethayathulla, AS; Nguyen, HT; Viadiu, H				Ethayathulla, Abdul S.; Nguyen, H. Thien; Viadiu, Hector			Crystal Structures of the DNA-binding Domain Tetramer of the p53 Tumor Suppressor Family Member p73 Bound to Different Full-site Response Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; P63; ACETYLATION; APOPTOSIS; PROLIFERATION; VISUALIZATION; RECOGNITION; SYSTEM; MUTANT; MICE	How cells choose between developmental pathways remains a fundamental biological question. In the case of the p53 protein family, its three transcription factors (p73, p63, and p53) each trigger a gene expression pattern that leads to specific cellular pathways. At the same time, these transcription factors recognize the same response element (RE) consensus sequences, and their transactivation of target genes overlaps. We aimed to understand target gene selectivity at the molecular level by determining the crystal structures of the p73 DNA-binding domain (DBD) in complex with full-site REs that vary in sequence. We report two structures of the p73 DBD bound as a tetramer to 20-bp full-site REs based on two distinct quartersites: GAACA and GAACC. Our study confirms that the DNA-binding residues are conserved within the p53 family, whereas the dimerization and tetramerization interfaces diverge. Moreover, a conserved lysine residue in loop L1 of the DBD senses the presence of guanines in positions 2 and 3 of the quarter-site RE, whereas a conserved arginine in loop 3 adapts to changes in position 5. Sequence variations in the RE elicit a p73 conformational response that might explain target gene specificity.	[Ethayathulla, Abdul S.; Nguyen, H. Thien; Viadiu, Hector] Univ Calif San Diego, Dept Chem & Biochem, Lab Struct Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Viadiu, H (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Lab Struct Biochem, 9500 Gilman Dr,MC 0378, La Jolla, CA 92093 USA.	viadiu@ucsd.edu	Viadiu, Hector/E-7785-2013		United States Department of Energy; National Institutes of Health [P41RR001209]; Basic Energy Sciences, Office of Science, United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Preliminary crystals were diffracted at beamline BL7-1 of the Stanford Synchrotron Radiation Lightsource (supported by the United States Department of Energy and National Institutes of Health Grant P41RR001209), and diffraction data were collected at beamline 8.2.2 of the Advanced Light Source at the Lawrence Berkeley National Laboratory (supported by Grant DE-AC02-05CH11231 from the Director, Basic Energy Sciences, Office of Science, United States Department of Energy).	Arbely E, 2011, P NATL ACAD SCI USA, V108, P8251, DOI 10.1073/pnas.1105028108; Arrowsmith CH, 1999, CELL DEATH DIFFER, V6, P1169, DOI 10.1038/sj.cdd.4400619; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen C, 2012, J BIOL CHEM, V287, P7477, DOI 10.1074/jbc.M111.315820; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Emamzadah S, 2011, MOL CANCER RES, V9, P1493, DOI 10.1158/1541-7786.MCR-11-0351; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ethayathulla AS, 2012, P NATL ACAD SCI USA, V109, P6066, DOI 10.1073/pnas.1115463109; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Kommagani R, 2010, CELL DEATH DIFFER, V17, P398, DOI 10.1038/cdd.2009.135; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levrero M, 2000, J CELL SCI, V113, P1661; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Malecka KA, 2009, ONCOGENE, V28, P325, DOI 10.1038/onc.2008.400; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petty TJ, 2011, EMBO J, V30, P2167, DOI 10.1038/emboj.2011.127; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; Zupnick A, 2006, J BIOL CHEM, V281, P20464, DOI 10.1074/jbc.M603387200	44	14	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4744	4754		10.1074/jbc.M112.408039	http://dx.doi.org/10.1074/jbc.M112.408039			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23243311	Green Published, hybrid			2022-12-25	WOS:000315340400023
J	Kaur, G; Lieu, KG; Jans, DA				Kaur, Gurpreet; Lieu, Kim G.; Jans, David A.			70-kDa Heat Shock Cognate Protein hsc70 Mediates Calmodulin-dependent Nuclear Import of the Sex-determining Factor SRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC CHAPERONES; BINDING DOMAIN; HMG-BOX; TRANSPORT; TRANSLOCATION; LOCALIZATION; REVERSAL; REQUIRES; PATHWAY; SIGNAL	We recently showed that the developmentally important family of SOX(SRY (sex determining region on the Y chromosome)related high mobility group (HMG) box) proteins require the calcium-binding protein calmodulin (CaM) for optimal nuclear accumulation, with clinical mutations in SRY that specifically impair nuclear accumulation via this pathway resulting in XY sex reversal. However, the mechanism by which CaM facilitates nuclear accumulation is unknown. Here, we show, for the first time, that the 70-kDa heat shock cognate protein hsc70 plays a key role in CaM-dependent nuclear import of SRY. Using a reconstituted nuclear import assay, we show that antibodies to hsc70 significantly reduce nuclear accumulation of wild type SRY and mutant derivatives thereof that retain CaM-dependent nuclear import, with an increased rate of nuclear accumulation upon addition of both CaM and hsc70, in contrast to an SRY mutant derivative with impaired CaM binding. siRNA knockdown of hsc70 in intact cells showed similar results, indicating clear dependence upon hsc70 for CaM-dependent nuclear import. Analysis using the technique of fluorescence recovery after photobleaching indicated that hsc70 is required for the maximal rate of SRY nuclear import in living cells but has no impact upon SRY nuclear retention/nuclear dynamics. Finally, we demonstrate direct binding of hsc70 to the SRY.CaM complex, with immunoprecipitation experiments from cell extracts showing association of hsc70 with wild type SRY, but not with a mutant derivative with impaired CaM binding, dependent on Ca2+. Our novel findings strongly implicate hsc70 in CaM-dependent nuclear import of SRY.	[Kaur, Gurpreet; Lieu, Kim G.; Jans, David A.] Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University	Jans, DA (corresponding author), Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Bldg 77, Clayton, Vic 3800, Australia.	david.jans@monash.edu		Jans, David/0000-0001-5115-4745	Australian Research Council [COE348239]; National Health and Medical Research Council (Australia) [APP1002486]	Australian Research Council(Australian Research Council); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant COE348239 and National Health and Medical Research Council (Australia) Grant APP1002486.	Akakura S, 2001, J BIOL CHEM, V276, P14649, DOI 10.1074/jbc.M100200200; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; Florin L, 2004, J VIROL, V78, P5546, DOI 10.1128/JVI.78.11.5546-5553.2004; Forwood JK, 2002, BIOCHEMISTRY-US, V41, P9333, DOI 10.1021/bi025548s; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; Kaur G, 2011, FASEB J, V25, P665, DOI 10.1096/fj.10-173351; Kaur G, 2010, BIOCHEM J, V430, P39, DOI 10.1042/BJ20091758; Kose S, 2005, J CELL BIOL, V171, P19, DOI 10.1083/jcb.200506074; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lam MHC, 2001, TRAFFIC, V2, P812, DOI 10.1034/j.1600-0854.2001.21110.x; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; Moriya M, 2004, MOL REPROD DEV, V69, P316, DOI 10.1002/mrd.20134; Roth DM, 2009, J CELL BIOCHEM, V107, P1160, DOI 10.1002/jcb.22218; Roth DM, 2011, J BIOL CHEM, V286, P14335, DOI 10.1074/jbc.M110.210302; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; STEVENSON MA, 1990, MOL CELL BIOL, V10, P1234, DOI 10.1128/MCB.10.3.1234; YANG J, 1994, MOL CELL BIOL, V14, P5088, DOI 10.1128/MCB.14.8.5088; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhou Y, 2010, J AM SOC NEPHROL, V21, P598, DOI 10.1681/ASN.2009050552	28	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4148	4157		10.1074/jbc.M112.436741	http://dx.doi.org/10.1074/jbc.M112.436741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23235156	hybrid, Green Published			2022-12-25	WOS:000314845000043
J	Garcia, BL; Summers, BJ; Ramyar, KX; Tzekou, A; Lin, Z; Ricklin, D; Lambris, JD; Laity, JH; Geisbrecht, BV				Garcia, Brandon L.; Summers, Brady J.; Ramyar, Kasra X.; Tzekou, Apostolia; Lin, Zhuoer; Ricklin, Daniel; Lambris, John D.; Laity, John H.; Geisbrecht, Brian V.			A Structurally Dynamic N-terminal Helix Is a Key Functional Determinant in Staphylococcal Complement Inhibitor (SCIN) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE EVASION; BACKBONE DYNAMICS; CHEMICAL-SHIFTS; COMPONENT C3; ASSIGNMENT; BINDING; SYSTEM; INSIGHTS; FAMILY; C-13	Complement is a network of interacting circulatory and cell surface proteins that recognizes, marks, and facilitates clearance of microbial invaders. To evade complement attack, the pathogenic organism Staphylococcus aureus expresses a number of secreted proteins that interfere with activation and regulation of the complement cascade. Staphylococcal complement inhibitors (SCINs) are one important class of these immunomodulators and consist of three active members (SCIN-A/-B/-C).SCINs inhibit a critical enzymatic complex, the alternative pathway C3 convertase, by targeting a functional "hot spot" on the central opsonin of complement, C3b. Although N-terminal truncation mutants of SCINs retain complement inhibitory properties, they are significantly weaker binders of C3b. To provide a structural basis for this observation, we undertook a series of crystallographic and NMR dynamics studies on full-length SCINs. This work reveals that N-terminal SCIN domains are characterized by a conformationally dynamic helical motif. C3b binding and functional experiments further demonstrate that this sequence-divergent N-terminal region of SCINs is both functionally important and context-dependent. Finally, surface plasmon resonance data provide evidence for the formation of inhibitor.enzyme.substrate complexes ((SCIN center dot C3bBb)center dot C3). Similar to the (SCIN center dot C3bBb)(2) pseudodimeric complexes, ((SCIN center dot C3bBb)center dot C3) interferes with the interaction of complement receptors and C3b. This activity provides an additional mechanism by which SCIN couples convertase inhibition to direct blocking of phagocytosis. Together, these data suggest that tethering multi-host protein complexes by small modular bacterial inhibitors may be a global strategy of immune evasion used by S. aureus. The work presented here provides detailed structure-activity relationships and improves our understanding of how S. aureus circumvents human innate immunity.	[Garcia, Brandon L.; Summers, Brady J.; Ramyar, Kasra X.; Laity, John H.; Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; [Tzekou, Apostolia; Lin, Zhuoer; Ricklin, Daniel; Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Missouri System; University of Missouri Kansas City; University of Pennsylvania	Geisbrecht, BV (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, 5100 Rockhill Rd, Kansas City, MO 64110 USA.	GeisbrechtB@umkc.edu	Ricklin, Daniel/F-5104-2011; Lambris, John/Q-5633-2018	Ricklin, Daniel/0000-0001-6140-0233; Lambris, John/0000-0002-9370-5776	United Staets Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Institutes of Health [AI071028, AI030040, AI068730, AI072106]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030040, R01AI071028, R01AI030040, R01AI072106, P01AI068730] Funding Source: NIH RePORTER	United Staets Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge generous technical assistance of Drs. Rod Salazar and Andy Howard during x-ray diffraction data collection and Dr. Samuel Bouyain for use of the EnSpire plate reader. Use of the Advanced Photon Source was supported by the United Staets Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory.; This work was supported, in whole or in part, by National Institutes of Health Grants AI071028, AI030040, AI068730, and AI072106 (to B. V. G. and J. D. L.). This work was also supported by an American Heart Association predoctoral fellowship (to B. L. G.).	Bowman P, 2006, BBA-PROTEINS PROTEOM, V1764, P182, DOI 10.1016/j.bbapap.2005.12.016; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; FRIEDRICHS MS, 1994, J BIOMOL NMR, V4, P703, DOI 10.1007/BF00404279; Garcia BL, 2012, J BIOL CHEM, V287, P628, DOI 10.1074/jbc.M111.298984; Garcia BL, 2012, ADV EXP MED BIOL, V946, P113, DOI 10.1007/978-1-4614-0106-3_7; Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029; Garcia BL, 2009, ACTA CRYSTALLOGR F, V65, P482, DOI 10.1107/S174430910901207X; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Jongerius I, 2010, J IMMUNOL, V184, P420, DOI 10.4049/jimmunol.0902865; KAM CM, 1987, J BIOL CHEM, V262, P3444; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Ko YP, 2011, J BIOL CHEM, V286, P9865, DOI 10.1074/jbc.M110.199687; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; Leopold M. F., 1994, Molecular Biotechnology, V2, P61, DOI 10.1007/BF02789290; LOHR F, 1995, J BIOMOL NMR, V5, P25, DOI 10.1007/BF00227467; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER AG, 1992, J BIOMOL NMR, V2, P103, DOI 10.1007/BF02192804; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Ringe D, 1986, Methods Enzymol, V131, P389; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Sandhu KS, 2007, PROTEINS, V68, P109, DOI 10.1002/prot.21328; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	58	15	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2870	2881		10.1074/jbc.M112.426858	http://dx.doi.org/10.1074/jbc.M112.426858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233676	hybrid, Green Published			2022-12-25	WOS:000314211500069
J	Guo, W; Wong, S; Li, M; Liang, WT; Liesa, M; Serra, C; Jasuja, R; Bartke, A; Kirkland, JL; Shirihai, O; Bhasin, S				Guo, Wen; Wong, Siu; Li, Michelle; Liang, Wentao; Liesa, Marc; Serra, Carlo; Jasuja, Ravi; Bartke, Andrzej; Kirkland, James L.; Shirihai, Orian; Bhasin, Shalender			Testosterone Plus Low-Intensity Physical Training in Late Life Improves Functional Performance, Skeletal Muscle Mitochondrial Biogenesis, and Mitochondrial Quality Control in Male Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; OLDER MEN; SIGNAL-TRANSDUCTION; BODY-COMPOSITION; EXPRESSION; AUTOPHAGY; EXERCISE; PATHWAYS; MOBILITY; SENSITIVITY	Testosterone supplementation increases muscle mass in older men but has not been shown to consistently improve physical function and activity. It has been hypothesized that physical exercise is required to induce the adaptations necessary for translation of testosterone-induced muscle mass gain into functional improvements. However, the effects of testosterone plus low intensity physical exercise training (T/PT) on functional performance and bioenergetics are unknown. In this pilot study, we tested the hypothesis that combined administration of T/PT would improve functional performance and bioenergetics in male mice late in life more than low-intensity physical training alone. 28-month old male mice were randomized to receive T/PT or vehicle plus physical training (V/PT) for 2 months. Compare to V/PT control, administration of T/PT was associated with improvements in muscle mass, grip strength, spontaneous physical movements, and respiratory activity. These changes were correlated with increased mitochondrial DNA copy number and expression of markers for mitochondrial biogenesis. Mice receiving T/PT also displayed increased expression of key elements for mitochondrial quality control, including markers for mitochondrial fission-and-fusion and mitophagy. Concurrently, mice receiving T/PT also displayed increased expression of markers for reduced tissue oxidative damage and improved muscle quality. Conclusion: Testosterone administered with low-intensity physical training improves grip strength, spontaneous movements, and respiratory activity. These functional improvements were associated with increased muscle mitochondrial biogenesis and improved mitochondrial quality control. Citation: Guo W, Wong S, Li M, Liang W, Liesa M, et al. (2012) Testosterone Plus Low-Intensity Physical Training in Late Life Improves Functional Performance, Skeletal Muscle Mitochondrial Biogenesis, and Mitochondrial Quality Control in Male Mice. PLoS ONE 7(12): e51180. doi:10.1371/journal.pone.0051180	[Guo, Wen; Wong, Siu; Li, Michelle; Liang, Wentao; Liesa, Marc; Jasuja, Ravi; Shirihai, Orian; Bhasin, Shalender] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Bartke, Andrzej] So Illinois Sch Med, Dept Internal Med, Springfield, IL USA; [Kirkland, James L.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA	Boston University; Southern Illinois University System; Southern Illinois University; Mayo Clinic	Guo, W (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	wguo@bu.edu	Kirkland, James/F-9159-2016; Bartke, Andzej/D-6640-2017; Liesa, Marc/K-8590-2019	Bartke, Andzej/0000-0002-2569-557X; Liesa, Marc/0000-0002-5909-8570; Liang, Wentao/0000-0002-0609-6280; Shirihai, Orian/0000-0002-9502-2661; Guo, Wen/0000-0002-4474-2837	National Institutes of Health (NIH) [1R21AG037859, RO1AG037193, AG13925, DK074778, PO1AG031736]; Boston Claude D. Pepper Older Americans Independence Center [5P30AG031679]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031736, R01AG037193, P30AG031679, R01AG013925, R21AG037859] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Claude D. Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants 1R21AG037859 (WG), RO1AG037193 (SB), AG13925 (JLK), DK074778 (OS) and PO1AG031736 (AB) and by the Boston Claude D. Pepper Older Americans Independence Center (5P30AG031679). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Apostolova N, 2011, CURR PHARM DESIGN, V17, P4047, DOI 10.2174/138161211798764924; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bori Z, 2012, EXP GERONTOL, V47, P417, DOI 10.1016/j.exger.2012.03.004; Caminiti G, 2009, J AM COLL CARDIOL, V54, P919, DOI 10.1016/j.jacc.2009.04.078; Carter CS, 2012, J GERONTOL A-BIOL, V67, P17, DOI 10.1093/gerona/glr042; Carter CS, 2002, J GERONTOL A-BIOL, V57, pB193, DOI 10.1093/gerona/57.5.B193; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Cuevas-Ramos D, 2012, CURR OPIN PEDIATR, V24, P523, DOI 10.1097/MOP.0b013e3283557d22; Dhatariya KK, 2008, MAYO CLIN PROC, V83, P1218, DOI 10.4065/83.11.1218; Egan B, 2011, PROTEOMICS, V11, P1413, DOI 10.1002/pmic.201000597; Fernando SM, 2010, ENDOCRINOLOGY, V151, P3125, DOI 10.1210/en.2010-0018; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Gorar S, 2010, GYNECOL ENDOCRINOL, V26, P819, DOI 10.3109/09513590.2010.487587; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hirota Y., 2012, INT J CELL BIOL, V2012; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Ibebunjo C, 2011, AM J PHYSIOL-ENDOC M, V300, pE327, DOI 10.1152/ajpendo.00402.2010; Ichimura Y, 2010, SEMIN IMMUNOPATHOL, V32, P431, DOI 10.1007/s00281-010-0220-1; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Jamart C, 2012, J APPL PHYSIOL, V112, P1529, DOI 10.1152/japplphysiol.00952.2011; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Koltai E, 2012, AM J PHYSIOL-REG I, V303, pR127, DOI 10.1152/ajpregu.00337.2011; Komatsu M, 2012, PHARM RES; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Krasnoff JB, 2010, J CLIN ENDOCR METAB, V95, P2790, DOI 10.1210/jc.2009-2680; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Lanza IR, 2010, ACTA PHYSIOL, V199, P529, DOI 10.1111/j.1748-1716.2010.02124.x; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Liu Y, 2012, AGE DORDR; Liu YL, 2012, TOXICOL APPL PHARM, V264, P212, DOI 10.1016/j.taap.2012.08.003; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; MCNABNEY LA, 1992, AM J PHYSIOL, V263, pC429, DOI 10.1152/ajpcell.1992.263.2.C429; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Musa M, 2011, J ENDOCRINOL, V210, P93, DOI 10.1530/JOE-11-0071; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Pansarasa O, 2002, EUR J APPL PHYSIOL, V87, P550, DOI 10.1007/s00421-002-0668-3; Parise G, 2010, INTERD T GERONT GERI, V37, P142, DOI 10.1159/000319999; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Rodriguez-Cuenca S, 2007, AM J PHYSIOL-ENDOC M, V292, pE340, DOI 10.1152/ajpendo.00175.2006; Rosser EM, 2004, ORG BIOMOL CHEM, V2, P142, DOI 10.1039/b311242j; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Salehzadeh F, 2011, J ENDOCRINOL, V210, P219, DOI 10.1530/JOE-10-0497; Schaap LA, 2005, CLIN ENDOCRINOL, V63, P152, DOI 10.1111/j.1365-2265.2005.02315.x; Schafer A, 2009, BIOL CHEM, V390, P707, DOI 10.1515/BC.2009.086; Seidman SN, 2007, PSYCHOPHARMACOL BULL, V40, P205; Sestili P, 2009, MOL NUTR FOOD RES, V53, P1187, DOI 10.1002/mnfr.200800504; Shaid S, 2012, CELL DEATH DIFFER; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Travison TG, 2011, J GERONTOL A-BIOL, V66, P1090, DOI 10.1093/gerona/glr100; Tu P, 2009, DIABETES, V58, P1739, DOI 10.2337/db09-0349; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Widegren U, 2001, ACTA PHYSIOL SCAND, V172, P227, DOI 10.1046/j.1365-201x.2001.00855.x; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Wong YT, 2009, FREE RADICAL BIO MED, V46, P799, DOI 10.1016/j.freeradbiomed.2008.12.016; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Xu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010572; Zahavi A, 2011, J THEOR BIOL, V280, P146, DOI 10.1016/j.jtbi.2011.04.013	67	37	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51180	10.1371/journal.pone.0051180	http://dx.doi.org/10.1371/journal.pone.0051180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240002	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800038
J	Kaufmann, KW; Meiler, J				Kaufmann, Kristian W.; Meiler, Jens			Using ROSETTALIGAND for Small Molecule Docking into Comparative Models	PLOS ONE			English	Article							PROTEIN-LIGAND DOCKING; ALL-ATOM REFINEMENT; STRUCTURE PREDICTION; HOMOLOGY MODELS; DATA-BANK; CASP8; ACCURACY; DESIGN; FLEXIBILITY; SEQUENCE	Computational small molecule docking into comparative models of proteins is widely used to query protein function and in the development of small molecule therapeutics. We benchmark ROSETTALIGAND docking into comparative models for nine proteins built during CASP8 that contain ligands. We supplement the study with 21 additional protein/ligand complexes to cover a wider space of chemotypes. During a full docking run in 21 of the 30 cases, ROSETTALIGAND successfully found a native-like binding mode among the top ten scoring binding modes. From the benchmark cases we find that careful template selection based on ligand occupancy provides the best chance of success while overall sequence identity between template and target do not appear to improve results. We also find that binding energy normalized by atom number is often less than -0.4 in native-like binding modes. Citation: Kaufmann KW, Meiler J (2012) Using ROSETTALIGAND for Small Molecule Docking into Comparative Models. PLoS ONE 7(12): e50769. doi:10.1371/journal.pone.0050769	[Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN USA; [Meiler, Jens] Vanderbilt Univ, Inst Biol Chem, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.	jens.meiler@vanderbilt.edu		Meiler, Jens/0000-0001-8945-193X	National Institutes of Health (NIH), National Institute on Drug Abuse, National Research Service Awards [5F31DA024528-02]; National Institutes of Health [1R01MH090192, 1R01GM080403]; NIH [R01 GM080403, R01 MH090192, R01 GM099842]; NSF [0742762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, R01GM099842, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024528] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Drug Abuse, National Research Service Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	KK was supported by National Institutes of Health (NIH), National Institute on Drug Abuse, National Research Service Awards 5F31DA024528-02. JM was supported by National Institutes of Health grants 1R01MH090192 and 1R01GM080403. Work in the Meiler laboratory is supported through NIH (R01 GM080403, R01 MH090192, R01 GM099842) and NSF (Career 0742762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brylinski M, 2009, J COMPUT CHEM; Brylinski M, 2008, J COMPUT CHEM, V29, P1574, DOI 10.1002/jcc.20917; Brylinski M, 2010, J COMPUT CHEM, V31, P1093, DOI 10.1002/jcc.21395; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Davis IW, 2009, PROTEIN SCI, V18, P1998, DOI 10.1002/pro.192; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Durrant JD, 2011, J CHEM INF MODEL, V51, P2897, DOI 10.1021/ci2003889; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; Ferrara P, 2007, J MOL MODEL, V13, P897, DOI 10.1007/s00894-007-0207-6; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guvench O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000435; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Jain AN, 2009, J COMPUT AID MOL DES, V23, P355, DOI 10.1007/s10822-009-9266-3; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Kaufmann K, 2008, LECT NOTES INFORM, V136, P148; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; London N, 2007, PROTEINS, V69, P809, DOI 10.1002/prot.21736; MacCallum JL, 2009, PROTEINS, V77, P66, DOI 10.1002/prot.22538; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Misura KMS, 2006, P NATL ACAD SCI USA, V103, P5361, DOI 10.1073/pnas.0509355103; Nannemann DP, 2010, PROTEIN ENG DES SEL, V23, P607, DOI 10.1093/protein/gzq033; Nayeem A, 2006, PROTEIN SCI, V15, P808, DOI 10.1110/ps.051892906; R Development Core Team, 2005, R LANG ENV STAT COMP; Raman S, 2009, PROTEINS; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Rester U, 2006, QSAR COMB SCI, V25, P605, DOI 10.1002/qsar.200510183; Saxena A, 2009, METHOD ENZYMOL, V467, P307, DOI 10.1016/S0076-6879(09)67012-9; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Taylor RD, 2002, J COMPUT AID MOL DES, V16, P151, DOI 10.1023/A:1020155510718; Tress ML, 2009, PROTEINS, V77, P10, DOI 10.1002/prot.22497; Verdonk ML, 2008, J CHEM INF MODEL, V48, P2214, DOI 10.1021/ci8002254; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	47	32	33	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50769	10.1371/journal.pone.0050769	http://dx.doi.org/10.1371/journal.pone.0050769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239984	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800022
J	Sa-Pinto, A; Branco, MS; Alexandrino, PB; Fontaine, MC; Baird, SJE				Sa-Pinto, Alexandra; Branco, Madalena S.; Alexandrino, Paulo B.; Fontaine, Michael C.; Baird, Stuart J. E.			Barriers to Gene Flow in the Marine Environment: Insights from Two Common Intertidal Limpet Species of the Atlantic and Mediterranean	PLOS ONE			English	Article							CERASTODERMA-GLAUCUM BIVALVIA; POPULATION-STRUCTURE; ALLOZYME VARIATION; PATELLA-RUSTICA; SEA; PATTERNS; PHYLOGEOGRAPHY; EASTERN; DIFFERENTIATION; CONNECTIVITY	Knowledge of the scale of dispersal and the mechanisms governing gene flow in marine environments remains fragmentary despite being essential for understanding evolution of marine biota and to design management plans. We use the limpets Patella ulyssiponensis and Patella rustica as models for identifying factors affecting gene flow in marine organisms across the North-East Atlantic and the Mediterranean Sea. A set of allozyme loci and a fragment of the mitochondrial gene cytochrome C oxidase subunit I were screened for genetic variation through starch gel electrophoresis and DNA sequencing, respectively. An approach combining clustering algorithms with clinal analyses was used to test for the existence of barriers to gene flow and estimate their geographic location and abruptness. Sharp breaks in the genetic composition of individuals were observed in the transitions between the Atlantic and the Mediterranean and across southern Italian shores. An additional break within the Atlantic cluster separates samples from the Alboran Sea and Atlantic African shores from those of the Iberian Atlantic shores. The geographic congruence of the genetic breaks detected in these two limpet species strongly supports the existence of transpecific barriers to gene flow in the Mediterranean Sea and Northeastern Atlantic. This leads to testable hypotheses regarding factors restricting gene flow across the study area. Citation: Sa-Pinto A, Branco MS, Alexandrino PB, Fontaine MC, Baird SJE (2012) Barriers to Gene Flow in the Marine Environment: Insights from Two Common Intertidal Limpet Species of the Atlantic and Mediterranean. PLoS ONE 7(12): e50330. doi:10.1371/journal.pone.0050330	[Sa-Pinto, Alexandra; Branco, Madalena S.; Alexandrino, Paulo B.; Baird, Stuart J. E.] Ctr Invest Biodiversidade & Recursos Genet CIBIO, Vairao, Portugal; [Alexandrino, Paulo B.] Univ Porto, Fac Ciencias, Dept Zool Antropol, P-4100 Oporto, Portugal; [Fontaine, Michael C.] Univ Paris 11, Orsay, France; [Fontaine, Michael C.] CNRS, F-91405 Orsay, France; [Fontaine, Michael C.] Univ Paris 07, Ecoanthropol & Ethnobiol UMR 5145, CNRS, MNHN,Musee Homme, Paris, France; [Baird, Stuart J. E.] CBGP, Montpelier Lez, France	Universidade do Porto; Universidade do Porto; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD)	Sa-Pinto, A (corresponding author), Ctr Invest Biodiversidade & Recursos Genet CIBIO, Campus Agrario Vairao, Vairao, Portugal.	xanasapinto@gmail.com; palexan@mail.icav.up.pt	Alexandrino, Paulo/A-3582-2010; Baird, Stuart J. E./B-3872-2011; Sa-Pinto, Alexandra Isabel/L-7809-2013; Branco, Madalena/L-8304-2013; Fontaine, Michael/G-5350-2011	Alexandrino, Paulo/0000-0002-8968-2452; Sa-Pinto, Alexandra Isabel/0000-0002-6049-110X; Branco, Madalena/0000-0003-4439-1923; Fontaine, Michael/0000-0003-1156-4154	FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; national funds through FCT Fundacao para a Ciencia e a Tecnologia [POCTI/BSE/42300/2001, FCOMP-01-0124-FEDER-PTDC/MAR/118205/2010]; FCT [SFRH/BPD/48750/2008, SFRH/BPD/40073/2007]; FRS-FNRS ("mandat Aspirant''); ANR 'NUTGENEVOL' [07-BLAN-0064]; FCT's Ciencia programme	FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; national funds through FCT Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FRS-FNRS ("mandat Aspirant'')(Fonds de la Recherche Scientifique - FNRS); ANR 'NUTGENEVOL'(French National Research Agency (ANR)); FCT's Ciencia programme	This work was financed by FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE and national funds through FCT Fundacao para a Ciencia e a Tecnologia - within the scope of the projects POCTI/BSE/42300/2001 and FCOMP-01-0124-FEDER-PTDC/MAR/118205/2010. A. Sa-Pinto and M. Branco are supported by FCT grants SFRH/BPD/48750/2008 and SFRH/BPD/40073/2007, respectively. M.C. Fontaine was supported by a Belgian research fellowship from the FRS-FNRS ("mandat Aspirant'') and now by an ANR 'NUTGENEVOL' (07-BLAN-0064) Post-doctoral fellowship. S.J.E. Baird is financed by the FCT's Ciencia 2007 programme. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams DC, 2004, ECOLOGY, V85, P2664, DOI 10.1890/04-0648; Arnaud-Haond S, 2007, J BIOGEOGR, V34, P963, DOI 10.1111/j.1365-2699.2006.01671.x; Bahri-Sfar L, 2000, P ROY SOC B-BIOL SCI, V267, P929, DOI 10.1098/rspb.2000.1092; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Bargelloni L, 2005, MOL PHYLOGENET EVOL, V36, P523, DOI 10.1016/j.ympev.2005.04.017; Bargelloni L, 2003, J EVOLUTION BIOL, V16, P1149, DOI 10.1046/j.1420-9101.2003.00620.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P13; Barton NH, 1995, ANAL APPL ANAL HYBRI; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Borsa P, 1997, MAR BIOL, V129, P233, DOI 10.1007/s002270050164; Calderon I, 2008, MAR BIOL, V154, P137, DOI 10.1007/s00227-008-0908-0; Christiaens J, 1973, B MUS NATN HIST NAT, V3, P1305; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2006, FISH B-NOAA, V104, P550; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; DODD J. M., 1957, PUBBL STAZ ZOOL NAPOLI, V29, P172; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fischer-Piette E., 1959, Journal de Conchyliologie, V99, P135; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Gaines Steven D., 2009, P227; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Goldson AJ, 2001, MAR BIOL, V138, P1037, DOI 10.1007/s002270000511; Guedj B, 2011, MOL ECOL RESOUR, V11, P1119, DOI 10.1111/j.1755-0998.2011.03045.x; Guerra-Garcia JM, 2004, BIOL CONSERV, V116, P319, DOI 10.1016/S0006-3207(03)00201-5; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KNOWLTON N, 1986, B MAR SCI, V39, P213; Koufopanou V, 1999, MOL PHYLOGENET EVOL, V11, P138, DOI 10.1006/mpev.1998.0557; Kruuk LEB, 1999, GENETICS, V153, P1959; Lemaire C, 2005, J EVOLUTION BIOL, V18, P70, DOI 10.1111/j.1420-9101.2004.00828.x; Longhurst AR, 1998, ECOLOGICAL GEOGRAPHY; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; Manel S, 2007, MOL ECOL, V16, P2031, DOI 10.1111/j.1365-294X.2007.03293.x; MANTEL N, 1967, CANCER RES, V27, P209; Mariani S, 2002, MAR BIOL, V140, P687, DOI 10.1007/s00227-001-0753-x; Mattiangeli V, 2003, MAR ECOL-P S Z N I, V24, P247, DOI 10.1046/j.0173-9565.2003.00795.x; Nikula R, 2003, MAR BIOL, V143, P339, DOI 10.1007/s00227-003-1088-6; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Perez-Losada M, 2002, HEREDITY, V89, P417, DOI 10.1038/sj.hdy.6800160; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Pritchard JK, 2000, GENETICS, V155, P945; Ramon MM, 1997, HEREDITY, V78, P520, DOI 10.1038/hdy.1997.81; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ribeiro PA, 2010, J BIOGEOGR, V37, P1782, DOI 10.1111/j.1365-2699.2010.02330.x; Ribeiro PMA., 2008, THESIS U SOUTHAMPTON; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Rios C, 2002, J EXP MAR BIOL ECOL, V267, P223, DOI 10.1016/S0022-0981(01)00371-9; Rohling EJ, 2009, PHYS GEOGRAPHY MEDIT; Rolland JL, 2007, MAR BIOL, V151, P327, DOI 10.1007/s00227-006-0484-0; Sa-Pinto A, 2005, J EXP MAR BIOL ECOL, V325, P95, DOI 10.1016/j.jembe.2005.04.025; Sa-Pinto A, 2008, MOL ECOL, V17, P519, DOI 10.1111/j.1365-294X.2007.03563.x; Sa-Pinto A, 2007, SCI MAR, V71, P801, DOI 10.3989/scimar.2007.71n4801; Sa-Pinto A, 2010, BIOL J LINN SOC, V100, P154, DOI 10.1111/j.1095-8312.2010.01405.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmidt PS, 2001, EVOLUTION, V55, P1336; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Smith FGW, 1935, PHILOS T ROY SOC B, V225, P95, DOI 10.1098/rstb.1935.0008; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Stefanni S, 2003, MOL PHYLOGENET EVOL, V28, P601, DOI 10.1016/S1055-7903(03)00054-X; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; SZYMURA JM, 1986, EVOLUTION, V40, P1141, DOI 10.1111/j.1558-5646.1986.tb05740.x; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Veliz D, 2004, J EVOLUTION BIOL, V17, P953, DOI 10.1111/j.1420-9101.2004.00753.x; Weber LI, 2005, MAR BIOL, V147, P153, DOI 10.1007/s00227-004-1540-2; Wolfram Research Inc., 2008, MATH VERS 7 0; WOMBLE WH, 1951, SCIENCE, V114, P315, DOI 10.1126/science.114.2961.315; Wright S, 1943, GENETICS, V28, P114; Xavier R, 2009, MOL ECOL, V18, P3283, DOI 10.1111/j.1365-294X.2009.04260.x; Zhan AB, 2009, MAR BIOTECHNOL, V11, P223, DOI 10.1007/s10126-008-9138-1	89	39	40	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50330	10.1371/journal.pone.0050330	http://dx.doi.org/10.1371/journal.pone.0050330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239977	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800015
J	Sebina, I; Cliff, JM; Smith, SG; Nogaro, S; Webb, EL; Riley, EM; Dockrell, HM; Elliott, AM; Hafalla, JCR; Cose, S				Sebina, Ismail; Cliff, Jacqueline M.; Smith, Steven G.; Nogaro, Sarah; Webb, Emily L.; Riley, Eleanor M.; Dockrell, Hazel M.; Elliott, Alison M.; Hafalla, Julius C. R.; Cose, Stephen			Long-Lived Memory B-Cell Responses following BCG Vaccination	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; INFECTION; LYMPHOCYTES; ASSAY; PERSISTENCE; BIOMARKERS; PROTECTION; PROFILES; ANTIGENS	The role of T-cells in immunity against Mycobacterium tuberculosis (M. tuberculosis) infection has been extensively studied, however, that of B-cells still remains comparatively unexplored. In this study, we determined the presence and frequencies of mycobacteria-specific memory B-cells (MBCs) in peripheral blood from clinically healthy, Bacillus Calmette Guerin (BCG) vaccinated (n = 79) and unvaccinated (n = 14) donors. Purified protein derivative (PPD)-specific MBCs were present in most donors (both vaccinated and unvaccinated) but their frequencies were significantly higher in vaccinated than in unvaccinated donors. MBCs specific for other mycobacterial antigens [antigen-85A (Ag85A), antigen-85B (Ag85B), 6 kDalton early secretory antigenic target (ESAT-6) and the 10 kDalton-culture filtrate protein (CFP-10)] were less prevalent than those recognising PPD. Furthermore, PPD-specific MBCs were detected in BCG vaccinated donors without ESAT-6 and CFP-10 specific responses. Together, these results indicate that BCG vaccination induces long-lived MBC responses. Similar patterns of response were seen when we examined mycobacteria-specific antibody and T-cell responses in these donors. Our data show for the first time that BCG vaccination elicits long-lived mycobacteria-specific MBC responses in healthy individuals, suggesting a more substantial role of B-cells in the response to BCG and other mycobacterial infections than previously thought.	[Sebina, Ismail; Cliff, Jacqueline M.; Smith, Steven G.; Nogaro, Sarah; Riley, Eleanor M.; Dockrell, Hazel M.; Hafalla, Julius C. R.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Webb, Emily L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Elliott, Alison M.; Cose, Stephen] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Sebina, Ismail; Elliott, Alison M.; Cose, Stephen] MRC, Coinfect Studies Programme, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute	Sebina, I (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.	ismail.sebina@mrcuganda.org; Stephen.Cose@mrcuganda.org	Cose, Stephen/H-4851-2019; Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020	Cose, Stephen/0000-0002-5156-037X; Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Webb, Emily/0000-0002-4019-7456; Elliott, Alison/0000-0003-2818-9549; Sebina, Ismail/0000-0003-3232-3472; Dockrell, Hazel/0000-0003-1869-9107; Smith, Steven/0000-0001-5623-7806; Cliff, Jackie/0000-0002-5653-1818	Wellcome Trust [092779]; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant number: 092779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2009, CLIN EXP IMMUNOL, V157, P235, DOI 10.1111/j.1365-2249.2009.03967.x; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Ashenafi S, 2013, THORAX, V68, P269, DOI 10.1136/thoraxjnl-2012-201817; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blanchard-Rohner G, 2009, BLOOD, V114, P4998, DOI 10.1182/blood-2009-03-211052; Bosio CM, 2000, J IMMUNOL, V164, P6417, DOI 10.4049/jimmunol.164.12.6417; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cooper AM, 2009, EUR J IMMUNOL, V39, P649, DOI 10.1002/eji.200839090; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Elliott AM, 1999, INT J TUBERC LUNG D, V3, P239; Feng L, 2011, EUR J IMMUNOL, V41, P3261, DOI 10.1002/eji.201141625; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1722, DOI 10.1128/IAI.69.3.1722-1728.2001; Hernandez J, 2010, IMMUNOL INVEST, V39, P197, DOI 10.3109/08820130903586346; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kelly DF, 2005, JAMA-J AM MED ASSOC, V294, P3019, DOI 10.1001/jama.294.23.3019; Lalor MK, 2010, VACCINE, V28, P1635, DOI 10.1016/j.vaccine.2009.11.004; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Sutherland JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025230; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tjanlund A, 2006, INT IMMUNOL, V18, P807, DOI 10.1093/intimm/dxl017; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0; Weir RE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-9; Weiss GE, 2012, J IMMUNOL METHODS, V375, P68, DOI 10.1016/j.jim.2011.09.006; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Yoon SO, 2009, J LEUKOCYTE BIOL, V86, P1311, DOI 10.1189/jlb.0409268	36	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51381	10.1371/journal.pone.0051381	http://dx.doi.org/10.1371/journal.pone.0051381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240017	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000312290800053
J	Wappenschmidt, B; Becker, AA; Hauke, J; Weber, U; Engert, S; Kohler, J; Kast, K; Arnold, N; Rhiem, K; Hahnen, E; Meindl, A; Schmutzler, RK				Wappenschmidt, Barbara; Becker, Alexandra A.; Hauke, Jan; Weber, Ute; Engert, Stefanie; Koehler, Juliane; Kast, Karin; Arnold, Norbert; Rhiem, Kerstin; Hahnen, Eric; Meindl, Alfons; Schmutzler, Rita K.			Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction	PLOS ONE			English	Article							SEQUENCE VARIANTS; UNCLASSIFIED VARIANTS; SUSCEPTIBILITY GENE; MISSENSE MUTATIONS; GERMLINE MUTATIONS; HIGH PROPORTION; RNA; RISK; WOMEN; SUBSTITUTIONS	Screening for pathogenic mutations in breast and ovarian cancer genes such as BRCA1/2, CHEK2 and RAD51C is common practice for individuals from high-risk families. However, test results may be ambiguous due to the presence of unclassified variants (UCV) in the concurrent absence of clearly cancer-predisposing mutations. Especially the presence of intronic or exonic variants within these genes that possibly affect proper pre-mRNA processing poses a challenge as their functional implications are not immediately apparent. Therefore, it appears necessary to characterize potential splicing UCV and to develop appropriate classification tools. We investigated 30 distinct BRCA1 variants, both intronic and exonic, regarding their spliceogenic potential by commonly used in silico prediction algorithms (HSF, MaxEntScan) along with in vitro transcript analyses. A total of 25 variants were identified spliceogenic, either causing/enhancing exon skipping or activation of cryptic splice sites, or both. Except from a single intronic variant causing minor effects on BRCA1 pre-mRNA processing in our analyses, 23 out of 24 intronic variants were correctly predicted by MaxEntScan, while HSF was less accurate in this cohort. Among the 6 exonic variants analyzed, 4 severely impair correct pre-mRNA processing, while the remaining two have partial effects. In contrast to the intronic alterations investigated, only half of the spliceogenic exonic variants were correctly predicted by HSF and/or MaxEntScan. These data support the idea that exonic splicing mutations are commonly disease-causing and concurrently prone to escape in silico prediction, hence necessitating experimental in vitro splicing analysis. Citation: Wappenschmidt B, Becker AA, Hauke J, Weber U, Engert S, et al. (2012) Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction. PLoS ONE 7(12): e50800. doi: 10.1371/journal.pone.0050800	[Wappenschmidt, Barbara; Becker, Alexandra A.; Hauke, Jan; Weber, Ute; Koehler, Juliane; Rhiem, Kerstin; Hahnen, Eric; Schmutzler, Rita K.] Univ Hosp Cologne, Dept Obstet & Gynaecol, Div Mol Gynaecooncol, Cologne, Germany; [Wappenschmidt, Barbara; Becker, Alexandra A.; Hauke, Jan; Weber, Ute; Koehler, Juliane; Rhiem, Kerstin; Hahnen, Eric; Schmutzler, Rita K.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Hauke, Jan] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Engert, Stefanie; Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynaecol, D-8000 Munich, Germany; [Kast, Karin] Tech Univ Dresden, Dept Gynecol & Obstet, D-01062 Dresden, Germany; [Arnold, Norbert] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Obstet & Gynaecol, Div Oncol, Kiel, Germany	University of Cologne; University of Cologne; University of Cologne; Technical University of Munich; Technische Universitat Dresden; University of Kiel; Schleswig Holstein University Hospital	Schmutzler, RK (corresponding author), Univ Hosp Cologne, Dept Obstet & Gynaecol, Div Mol Gynaecooncol, Cologne, Germany.	Rita.Schmutzler@uk-koeln.de	Arnold, Norbert/E-3012-2010	Arnold, Norbert/0000-0003-4523-8808; Hauke, Jan/0000-0001-8236-4075	Deutsche Krebshilfe [107364]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This study was kindly supported by the Deutsche Krebshilfe to R.S. and B.W. (grant no 107364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem C, 2003, CANCER, V97, P1, DOI 10.1002/cncr.11048; Anczukow O, 2008, GENE CHROMOSOME CANC, V47, P418, DOI 10.1002/gcc.20546; Bergthorsson JT, 2001, J MED GENET, V38, P361, DOI 10.1136/jmg.38.6.361; Bonnet C, 2008, J MED GENET, V45, P438, DOI 10.1136/jmg.2007.056895; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Claes K, 2002, ONCOGENE, V21, P4171, DOI 10.1038/sj.onc.1205520; Coupier I, 2004, ONCOGENE, V23, P914, DOI 10.1038/sj.onc.1207191; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Dong J, 1998, HUM GENET, V103, P154; Dosil V, 2010, CLIN CHEM, V56, P53, DOI 10.1373/clinchem.2009.132274; Evans DGR, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.9.e107; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; Gaildrat P, 2010, J MED GENET, V47, P398, DOI 10.1136/jmg.2009.074047; Gross E, 2000, HUM MUTAT, V16, P345, DOI 10.1002/1098-1004(200010)16:4<345::AID-HUMU7>3.0.CO;2-#; Hofmann W, 2002, INT J CANCER, V97, P472, DOI 10.1002/ijc.1626; Houdayer C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/humu.20765; Kiechle M, 2000, Hum Mutat, V16, P529, DOI 10.1002/1098-1004(200012)16:6<529::AID-HUMU14>3.0.CO;2-K; KRAWCZAK M, 1992, HUM GENET, V90, P41; Kroiss R, 2005, HUM MUTAT, V26, P583, DOI 10.1002/humu.20261; Lastella P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-243; Lu ML, 1996, CANCER RES, V56, P4578; McKean-Cowdin R, 2005, HUM GENET, V116, P497, DOI 10.1007/s00439-004-1240-5; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Pettigrew CA, 2008, BREAST CANCER RES TR, V110, P227, DOI 10.1007/s10549-007-9714-5; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Raponi M, 2011, HUM MUTAT, V32, P436, DOI 10.1002/humu.21458; Scholl T, 1999, AM J MED GENET, V85, P113, DOI 10.1002/(SICI)1096-8628(19990716)85:2<113::AID-AJMG3>3.3.CO;2-M; Schwartz GF, 2008, CANCER, V113, P2627, DOI 10.1002/cncr.23903; Scott CL, 2003, HUM GENET, V112, P542, DOI 10.1007/s00439-003-0908-6; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Spearman AD, 2008, J CLIN ONCOL, V26, P5393, DOI 10.1200/JCO.2008.17.8228; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; TAKAHASHI H, 1995, CANCER RES, V55, P2998; Tesoriero A A, 2005, Hum Mutat, V26, P495, DOI 10.1002/humu.9379; Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100; Thomassen M, 2012, BREAST CANCER RES TR, V132, P1009, DOI 10.1007/s10549-011-1674-0; Vreeswijk MPG, 2009, HUM MUTAT, V30, P107, DOI 10.1002/humu.20811; Walker LC, 2010, HUM MUTAT, V31, pE1484, DOI 10.1002/humu.21267; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Whiley PJ, 2011, HUM MUTAT, V32, P678, DOI 10.1002/humu.21495; Whiley PJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-80; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103	49	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50800	10.1371/journal.pone.0050800	http://dx.doi.org/10.1371/journal.pone.0050800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239986	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800023
J	Canete, R; Diaz, MM; Garcia, RA; Martinez, PML; Ponce, FM				Canete, Roberto; Morales Diaz, Mariuska; Avalos Garcia, Roxana; Laud Martinez, Pedro Miguel; Manuel Ponce, Felix			Intestinal Parasites in Children from a Day Care Centre in Matanzas City, Cuba	PLOS ONE			English	Article							JUAN-Y-MARTINEZ; PINAR-DEL-RIO; RISK-FACTORS; MINAS-GERAIS; HAVANA CITY; PREVALENCE; BLASTOCYSTIS; BRAZIL; INFECTIONS; GIARDIASIS	Background: Intestinal parasitic infections are widely distributed throughout the world and children are the most affected population. Day care centres are environments where children have proven to be more susceptible to acquiring IP. Methods and Principal Findings: A cross-sectional study was carried to determine the prevalence of intestinal parasites in stool samples among children who attend to a day care centre in an urban area of Matanzas city, Cuba, from March to June 2012. 104 children under five years old were included on the study after informed consent form was signed by parents or legal guardians. Three fresh faecal samples were collected from each child in different days and were examined by direct wet mount, formalin-ether, and Kato-Katz techniques. Data relating to demography, socioeconomic status, source of drinking water, and personal hygiene habits were also collected using a standardized questionnaire. In total, 71.1% of children harbored at least one type of intestinal parasite and 47 (45.2%) were infected by more than one species. Giardia duodenalis and Blastocystis sp. were the most common parasites found, with prevalence rates of 54.8% and 38.5% respectively. Conclusions: Despite public health campaigns, improvement in the level of education, and the availability of and access to medical services in Cuba infections by intestinal protozoan is high in this centre. Almost nothing is published regarding intestinal parasites in Matanzas province during the last 40 years so this work could also be the initial point to carry out other studies to clarify the IP status in this region.	[Canete, Roberto] Ctr Hyg Epidemiol & Microbiol, Matanzas City, Cuba; [Morales Diaz, Mariuska; Avalos Garcia, Roxana; Laud Martinez, Pedro Miguel; Manuel Ponce, Felix] Faustino Perez Hernandez Hosp, Matanzas, Cuba; [Canete, Roberto] Cuban Inst Gastroenterol, Havana, Cuba		Canete, R (corresponding author), Ctr Hyg Epidemiol & Microbiol, Matanzas City, Cuba.	parasitologia.mtz@infomed.sld.cu						Artieda J., 2012, EURO SURVEILL, V17; Pereira Maria das Graças Cabral, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P139; Cartwright CP, 1999, J CLIN MICROBIOL, V37, P2408, DOI 10.1128/JCM.37.8.2408-2411.1999; Chirdan O O, 2010, Niger J Med, V19, P219; Dominguez Leon SI, 2011, REV MED ELECT, V33; Escobedo AA, 2007, TROP DOCT, V37, P236, DOI 10.1258/004947507782332991; Escobedo AA, 2008, W INDIAN MED J, V57, P377; Escobedo AA, 2011, ACTA TROP, V119, P99, DOI 10.1016/j.actatropica.2011.04.014; GRAHAM CLARENCE F., 1941, AMER JOUR TROP MED, V21, P159; Gurgel RQ, 2005, REV SOC BRAS MED TRO, V38, P267, DOI 10.1590/S0037-86822005000300014; Mehraj V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003680; Menezes AL, 2008, REV INST MED TROP SP, V50, P57, DOI 10.1590/S0036-46652008000100013; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Nunez FA, 1999, ACTA TROP, V73, P237, DOI 10.1016/S0001-706X(99)00032-7; Núñez Fidel Ángel, 2003, Cad. Saúde Pública, V19, P677, DOI 10.1590/S0102-311X2003000200036; Goncalves ALR, 2011, REV SOC BRAS MED TRO, V44, P191, DOI 10.1590/S0037-86822011005000022; Rivero LR, 2008, TRENDS PARASITOL, V24, P440, DOI 10.1016/j.pt.2008.06.008; Sagebiel D, 2009, PARASITOL RES, V105, P681, DOI 10.1007/s00436-009-1438-5; Staat MA, 2011, PEDIATRICS, V128, pE613, DOI 10.1542/peds.2010-3032; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2009, TRENDS PARASITOL, V25, P23, DOI 10.1016/j.pt.2008.09.010; Stensvold CR, 2010, J CLIN GASTROENTEROL, V44, P85, DOI 10.1097/MCG.0b013e3181bb86ba; Wordemann M, 2006, TROP MED INT HEALTH, V11, P1813, DOI 10.1111/j.1365-3156.2006.01745.x	23	32	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51394	10.1371/journal.pone.0051394	http://dx.doi.org/10.1371/journal.pone.0051394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236493	Green Submitted, gold, Green Published			2022-12-25	WOS:000312064100112
J	Tang, M; Ivakine, E; Mahadevan, V; Salter, MW; McInnes, RR				Tang, Man; Ivakine, Evgueni; Mahadevan, Vivek; Salter, Michael W.; McInnes, Roderick R.			Neto2 Interacts with the Scaffolding Protein GRIP and Regulates Synaptic Abundance of Kainate Receptors	PLOS ONE			English	Article							MOSSY-FIBER SYNAPSES; RAT-BRAIN; GLUTAMATE RECEPTORS; GLUR6-DEFICIENT MICE; AUXILIARY SUBUNIT; NERVOUS-SYSTEM; AMPA; EXPRESSION; MODULATION; ACTIVATION	Kainate receptors (KARs) are a class of ionotropic glutamate receptors that are expressed throughout the central nervous system. The function and subcellular localization of KARs are tightly regulated by accessory proteins. We have previously identified the single-pass transmembrane proteins, Neto1 and Neto2, to be associated with native KARs. In the hippocampus, Neto1, but not Neto2, controls the abundance and modulates the kinetics of postsynaptic KARs. Here we evaluated whether Neto2 regulates synaptic KAR levels in the cerebellum where Neto1 expression is limited to the deep cerebellar nuclei. In the cerebellum, where Neto2 is present abundantly, we found a,similar to 40% decrease in GluK2-KARs at the postsynaptic density (PSD) of Neto2-null mice. No change, however, was observed in total level of GluK2-KARs, thereby suggesting a critical role of Neto2 on the synaptic localization of cerebellar KARs. The presence of a putative class II PDZ binding motif on Neto2 led us to also investigate whether it interacts with PDZ domain-containing proteins previously implicated in regulating synaptic abundance of KARs. We identified a PDZ-dependent interaction between Neto2 and the scaffolding protein GRIP. Furthermore, coexpression of Neto2 significantly increased the amount of GRIP associated with GluK2, suggesting that Neto2 may promote and/or stabilize GluK2: GRIP interactions. Our results demonstrate that Neto2, like Neto1, is an important auxiliary protein for modulating the synaptic levels of KARs. Moreover, we propose that the interactions of Neto1/2 with various scaffolding proteins is a critical mechanism by which KARs are stabilized at diverse synapses. Citation: Tang M, Ivakine E, Mahadevan V, Salter MW, McInnes RR (2012) Neto2 Interacts with the Scaffolding Protein GRIP and Regulates Synaptic Abundance of Kainate Receptors. PLoS ONE 7(12): e51433. doi:10.1371/journal.pone.0051433	[Salter, Michael W.] Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Tang, Man; Ivakine, Evgueni; Mahadevan, Vivek; McInnes, Roderick R.] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Tang, Man; McInnes, Roderick R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [McInnes, Roderick R.] McGill Univ, Jewish Gen Hosp, Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University	Salter, MW (corresponding author), Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mike.salter@utoronto.ca; rod.mcinnes@mcgill.ca	Mahadevan, Vivek/O-4114-2018; Mahadevan, Vivek/M-9153-2014	Mahadevan, Vivek/0000-0002-0805-827X; Mahadevan, Vivek/0000-0002-0805-827X; Ivakine, Evgueni/0000-0003-2132-4699	Canadian Institutes of Health Research (CIHR) [MOP-7315, IOP-54037]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the Canadian Institutes of Health Research (CIHR) to RRM (MOP-7315 and IOP-54037). RRM and MWS hold Canada Research Chairs. MWS is the Anne and Max Tanenbaum Chair in Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHN S, 1994, J NEUROSCI, V14, P5525; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; Fernandes HB, 2009, NEURON, V63, P818, DOI 10.1016/j.neuron.2009.08.010; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim YJ, 2012, GENES DEV; Michishita M, 2004, DEV BRAIN RES, V153, P135, DOI 10.1016/j.devbrainres.2004.06.012; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Ripellino JA, 1998, NEUROSCIENCE, V82, P485; Rodriguez-Moreno A, 2007, TRENDS NEUROSCI, V30, P630, DOI 10.1016/j.tins.2007.10.001; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WISDEN W, 1993, J NEUROSCI, V13, P3582; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	33	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51433	10.1371/journal.pone.0051433	http://dx.doi.org/10.1371/journal.pone.0051433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236500	gold, Green Submitted, Green Published			2022-12-25	WOS:000312589700040
J	Hart, V; Kusta, T; Nemec, P; Blahova, V; Jezek, M; Novakova, P; Begall, S; Cerveny, J; Hanzal, V; Malkemper, EP; Stipek, K; Vole, C; Burda, H				Hart, Vlastimil; Kusta, Tomas; Nemec, Pavel; Blahova, Veronika; Jezek, Milos; Novakova, Petra; Begall, Sabine; Cerveny, Jaroslav; Hanzal, Vladimir; Malkemper, Erich Pascal; Stipek, Kamil; Vole, Christiane; Burda, Hynek			Magnetic Alignment in Carps: Evidence from the Czech Christmas Fish Market	PLOS ONE			English	Article							SOCKEYE-SALMON; COMPASS ORIENTATION; ONCORHYNCHUS-NERKA; ANGUILLA-JAPONICA; CYPRINUS-CARPIO; EUROPEAN EEL; COMMON CARP; FIELD; SENSE; RIVER	While magnetoreception in birds has been studied intensively, the literature on magnetoreception in bony fish, and particularly in non-migratory fish, is quite scarce. We examined alignment of common carps (Cyprinus carpio) at traditional Christmas sale in the Czech Republic. The sample comprised measurements of the directional bearings in 14,537 individual fish, distributed among 80 large circular plastic tubs, at 25 localities in the Czech Republic, during 817 sampling sessions, on seven subsequent days in December 2011. We found that carps displayed a statistically highly significant spontaneous preference to align their bodies along the North-South axis. In the absence of any other common orientation cues which could explain this directional preference, we attribute the alignment of the fish to the geomagnetic field lines. It is apparent that the display of magnetic alignment is a simple experimental paradigm of great heuristic potential.	[Hart, Vlastimil; Kusta, Tomas; Jezek, Milos; Novakova, Petra; Cerveny, Jaroslav; Hanzal, Vladimir; Stipek, Kamil; Burda, Hynek] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Protect & Wildlife Management, Prague, Czech Republic; [Nemec, Pavel; Blahova, Veronika] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Begall, Sabine; Malkemper, Erich Pascal; Vole, Christiane; Burda, Hynek] Univ Duisburg Essen, Fac Biol, Dept Gen Zool, Essen, Germany	Czech University of Life Sciences Prague; Charles University Prague; University of Duisburg Essen	Burda, H (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Protect & Wildlife Management, Prague, Czech Republic.	hynek.burda@uni-due.de	Hart, Vlastimil/P-4604-2016; Červený, Jaroslav/A-2809-2015; Malkemper, Erich Pascal/J-9891-2015; Nemec, Pavel/K-1163-2012; Hanzal, Vladimir/AAD-9567-2019; Ježek, Miloš/AAB-8880-2021; Červený, Jaroslav/AGZ-6188-2022; Malkemper, Erich Pascal/AAV-2989-2021	Malkemper, Erich Pascal/0000-0003-1099-0119; Nemec, Pavel/0000-0003-0277-0239; Ježek, Miloš/0000-0002-4127-9947; Červený, Jaroslav/0000-0002-2723-0936; Malkemper, Erich Pascal/0000-0003-1099-0119; Hart, Vlastimil/0000-0003-4901-3817	Grant Agency of the Czech Republic [506/11/2121]; Grant Agency of the Charles University [116510]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Charles University	The study was supported by the Grant Agency of the Czech Republic (Grant 506/11/2121 to HB) and Grant Agency of the Charles University [Grant 116510 to PN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batschelet E, 1981, CIRCULAR STAT BIOL; BECKER G, 1974, NATURWISSENSCHAFTEN, V61, P220, DOI 10.1007/BF00599929; BECKER G, 1963, NATURWISSENSCHAFTEN, V50, P455, DOI 10.1007/BF00601615; BECKER GUNTHER, 1964, Z VERGLEICHENDE PHYSIOL, V49, P301, DOI 10.1007/BF00302681; Begall S, 2011, J COMP PHYSIOL A, V197, P1127, DOI 10.1007/s00359-011-0674-1; Begall S, 2012, MAMMAL BIOL; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; Burda H, 2009, P NATL ACAD SCI USA, V106, P5708, DOI 10.1073/pnas.0811194106; Cerveny J, 2011, BIOL LETTERS, V7, P355, DOI 10.1098/rsbl.2010.1145; CHEW GL, 1989, CAN J ZOOL, V67, P641, DOI 10.1139/z89-092; Daniel AJ, 2011, N AM J FISH MANAGE, V31, P352, DOI 10.1080/02755947.2011.576205; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Formicki K, 2004, J APPL ICHTHYOL, V20, P402, DOI 10.1111/j.1439-0426.2004.00568.x; Formicki K, 2004, J APPL ICHTHYOL, V20, P290, DOI 10.1111/j.1439-0426.2004.00556.x; HANSON M, 1987, J MAGN MAGN MATER, V66, P1, DOI 10.1016/0304-8853(87)90120-X; HANSON M, 1987, COMP BIOCHEM PHYS A, V86, P169, DOI 10.1016/0300-9629(87)90296-9; Haugh CV, 1998, J NAVIGATION, V51, P35, DOI 10.1017/S0373463397007595; Hellinger J, 2012, J COMP PHYSIOL A, V198, P593, DOI 10.1007/s00359-012-0732-3; Hellinger J, 2009, J COMP PHYSIOL A, V195, P873, DOI 10.1007/s00359-009-0466-z; Jones MJ, 2009, ECOL FRESHW FISH, V18, P72, DOI 10.1111/j.1600-0633.2008.00324.x; Nishi T, 2006, NIPPON SUISAN GAKK, V72, P27, DOI 10.2331/suisan.72.27; Nishi T, 2005, J FISH BIOL, V67, P1213, DOI 10.1111/j.1095-8649.2005.00817.x; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; Oca J, 2004, AQUACULT ENG, V31, P221, DOI 10.1016/j.aquaeng.2004.04.002; Phillips JB, 2002, J EXP BIOL, V205, P3903; QUINN TP, 1982, J COMP PHYSIOL, V147, P547, DOI 10.1007/BF00612020; QUINN TP, 1981, J EXP ZOOL, V217, P137, DOI 10.1002/jez.1402170114; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; ROMMEL SA, 1973, J FISH RES BOARD CAN, V30, P657, DOI 10.1139/f73-114; Schlegel PA, 2007, J ETHOL, V25, P177, DOI 10.1007/s10164-006-0016-x; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; Stuart IG, 2006, FISHERIES MANAG ECOL, V13, P213, DOI 10.1111/j.1365-2400.2006.00495.x; Takebe A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00727; TESCH F W, 1973, Netherlands Journal of Sea Research, V7, P46, DOI 10.1016/0077-7579(73)90031-8; TESCH FW, 1974, HELGOLAND WISS MEER, V26, P382, DOI 10.1007/BF01627623; Thake MA, 1981, IBIS, V123, P47; Vacha M, 2010, BEHAVIOUR, V147, P425, DOI 10.1163/000579509X12580965484148; van Ginneken V, 2005, ENVIRON BIOL FISH, V72, P313, DOI 10.1007/s10641-004-2585-2; WALKER MM, 1988, J EXP BIOL, V140, P51; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WALKER MM, 1986, NATURWISSENSCHAFTEN, V73, P12, DOI 10.1007/BF01168800; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko Roswitha, 2009, Communicative & Integrative Biology, V2, P100; Yano A, 1996, NIPPON SUISAN GAKK, V62, P911; Yano A, 1997, MAR BIOL, V129, P523, DOI 10.1007/s002270050193	47	28	29	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51100	10.1371/journal.pone.0051100	http://dx.doi.org/10.1371/journal.pone.0051100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227241	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200100
J	James, RG; Davidson, KC; Bosch, KA; Biechele, TL; Robin, NC; Taylor, RJ; Major, MB; Camp, ND; Fowler, K; Martins, TJ; Moon, RT				James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Major, Michael B.; Camp, Nathan D.; Fowler, Kerry; Martins, Timothy J.; Moon, Randall T.			WIKI4, a Novel Inhibitor of Tankyrase and Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CATENIN; SULFATE PROTEOGLYCAN; MOUSE DEVELOPMENT; PATHWAY; ACTIVATION; DIFFERENTIATION; REGENERATION; REQUIREMENT; GROWTH	The Wnt/beta-catenin signaling pathway controls important cellular events during development and often contributes to disease when dysregulated. Using high throughput screening we have identified a new small molecule inhibitor of Wnt/beta-catenin signaling, WIKI4. WIKI4 inhibits expression of beta-catenin target genes and cellular responses to Wnt/beta-catenin signaling in cancer cell lines as well as in human embryonic stem cells. Furthermore, we demonstrate that WIKI4 mediates its effects on Wnt/beta-catenin signaling by inhibiting the enzymatic activity of TNKS2, a regulator of AXIN ubiquitylation and degradation. While TNKS has previously been shown to be the target of small molecule inhibitors of Wnt/beta-catenin signaling, WIKI4 is structurally distinct from previously identified TNKS inhibitors.	[James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Camp, Nathan D.; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Camp, Nathan D.; Martins, Timothy J.; Moon, Randall T.] Inst Stem Cell & Regenerat Med, Seattle, WA USA; [Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Camp, Nathan D.; Moon, Randall T.] Howard Hughes Med Inst, Seattle, WA USA; [Martins, Timothy J.] Quellos High Throughput Screening Core, Seattle, WA USA; [James, Richard G.; Davidson, Kathryn C.; Bosch, Katherine A.; Biechele, Travis L.; Robin, Nicholas C.; Taylor, Russell J.; Camp, Nathan D.; Martins, Timothy J.; Moon, Randall T.] Univ Washington, Sch Med, Seattle, WA USA; [Major, Michael B.] Univ North Carolina Chapel Hill, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Fowler, Kerry] KWF Consulting, Seattle, WA USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Moon, RT (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	rtmoon@uw.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Major, Michael/0000-0002-6753-8513; james, richard/0000-0002-2302-7367	National Institutes of Health (NIH) [PO1 GM081619, U01 HL100395]; NIH/National Heart, Lung, and Blood Institute K99/R00 grant [1K99HL103768-01]; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Training Grant [T32AR056969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103768, U01HL100395, K99HL103768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute K99/R00 grant; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grants PO1 GM081619 and U01 HL100395. RGJ was funded by the NIH/National Heart, Lung, and Blood Institute K99/R00 grant 1K99HL103768-01. TLB was funded in part through NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Training Grant T32AR056969. RTM is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COOPER S, 1992, BIOCHEM J, V286, P959, DOI 10.1042/bj2860959; Cooper S, 2002, J ANAT, V200, P259, DOI 10.1046/j.1469-7580.2002.00034.x; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Ge XL, 2012, MOL MED REP, V5, P1433, DOI 10.3892/mmr.2012.835; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Koesters R, 2003, J PATHOL, V199, P68, DOI 10.1002/path.1248; Li FQ, 2005, CURR NEUROVASC RES, V2, P331, DOI 10.2174/156720205774322557; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2008, SCI SIGNAL, V1, pra12; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Miyoshi Y, 1998, CANCER RES, V58, P2524; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; PERA MF, 1988, DIFFERENTIATION, V39, P139, DOI 10.1111/j.1432-0436.1988.tb00089.x; Roh H, 2001, CANCER RES, V61, P6563; Shimizu N, 2012, DEV BIOL; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tanaka SS, 2011, DEV GROWTH DIFFER, V53, P843, DOI 10.1111/j.1440-169X.2011.01292.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	49	71	74	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50457	10.1371/journal.pone.0050457	http://dx.doi.org/10.1371/journal.pone.0050457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227175	Green Published, Green Submitted, gold			2022-12-25	WOS:000323179700004
J	Kapfhamer, D; King, I; Zou, ME; Lim, JP; Heberlein, U; Wolf, FW				Kapfhamer, David; King, Ian; Zou, Mimi E.; Lim, Jana P.; Heberlein, Ulrike; Wolf, Fred W.			JNK Pathway Activation Is Controlled by Tao/TAOK3 to Modulate Ethanol Sensitivity	PLOS ONE			English	Article							N-TERMINAL-KINASE; DUAL-SPECIFICITY PHOSPHATASES; JUN NH2-TERMINAL KINASE; INDUCED CELL-DEATH; OXIDATIVE STRESS; PROTEIN-KINASE; INFLAMMATORY MEDIATORS; STE20-LIKE KINASE; INDUCED APOPTOSIS; ALCOHOL	Neuronal signal transduction by the JNK MAP kinase pathway is altered by a broad array of stimuli including exposure to the widely abused drug ethanol, but the behavioral relevance and the regulation of JNK signaling is unclear. Here we demonstrate that JNK signaling functions downstream of the Sterile20 kinase family gene tao/Taok3 to regulate the behavioral effects of acute ethanol exposure in both the fruit fly Drosophila and mice. In flies tao is required in neurons to promote sensitivity to the locomotor stimulant effects of acute ethanol exposure and to establish specific brain structures. Reduced expression of key JNK pathway genes substantially rescued the structural and behavioral phenotypes of tao mutants. Decreasing and increasing JNK pathway activity resulted in increased and decreased sensitivity to the locomotor stimulant properties of acute ethanol exposure, respectively. Further, JNK expression in a limited pattern of neurons that included brain regions implicated in ethanol responses was sufficient to restore normal behavior. Mice heterozygous for a disrupted allele of the homologous Taok3 gene (Taok3Gt) were resistant to the acute sedative effects of ethanol. JNK activity was constitutively increased in brains of Taok3Gt/+ mice, and acute induction of phospho-JNK in brain tissue by ethanol was occluded in Taok3Gt/+ mice. Finally, acute administration of a JNK inhibitor conferred resistance to the sedative effects of ethanol in wild-type but not Taok3Gt/+ mice. Taken together, these data support a role of a TAO/TAOK3-JNK neuronal signaling pathway in regulating sensitivity to acute ethanol exposure in flies and in mice.	[Kapfhamer, David; Zou, Mimi E.; Lim, Jana P.; Heberlein, Ulrike; Wolf, Fred W.] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA; [Kapfhamer, David; Zou, Mimi E.; Lim, Jana P.; Heberlein, Ulrike; Wolf, Fred W.] Univ Calif San Francisco, Res Ctr, Emeryville, CA USA; [King, Ian; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kapfhamer, D (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA.	dkapfhamer@gallo.ucsf.edu; fwolf@ucmerced.edu		King, Ian/0000-0003-3405-9767	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism Grant [P50 AA017072]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035, P50AA017072] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism Grant P50 AA017072 (FWW, UH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroor AR, 2010, ALCOHOL CLIN EXP RES, V34, P1543, DOI 10.1111/j.1530-0277.2010.01239.x; Aroor AR, 2004, LIFE SCI, V74, P2339, DOI 10.1016/j.lfs.2003.11.001; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Boyce-Rustay JM, 2006, ALCOHOL CLIN EXP RES, V30, P1957, DOI 10.1111/j.1530-0277.2006.00241.x; Chen Z, 2001, J BIOL CHEM, V276, P16070, DOI 10.1074/jbc.M100681200; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Cui SZ, 2011, ACTA PHARMACOL SIN, V32, P175, DOI 10.1038/aps.2010.199; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; Davies DL, 2013, ALCOHOL CLIN EXP RES, V37, P8, DOI 10.1111/j.1530-0277.2012.01846.x; de la Monte SM, 2000, ALCOHOL CLIN EXP RES, V24, P716, DOI 10.1097/00000374-200005000-00017; Downing C, 2003, GENES BRAIN BEHAV, V2, P140, DOI 10.1034/j.1601-183X.2003.00022.x; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; Faccidomo S, 2009, PSYCHOPHARMACOLOGY, V204, P135, DOI 10.1007/s00213-008-1444-9; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Fee JR, 2004, ALCOHOL CLIN EXP RES, V28, P1459, DOI 10.1097/01.ALC.0000141809.53115.71; French RL, 2009, P NATL ACAD SCI USA, V106, P20924, DOI 10.1073/pnas.0910813106; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Gibson GE, 2002, NEUROCHEM INT, V40, P493, DOI 10.1016/S0197-0186(01)00120-6; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; Goodrich LV, 2008, NEURON, V60, P9, DOI 10.1016/j.neuron.2008.09.003; Han JY, 2008, J NEUROSCI RES, V86, P3221, DOI 10.1002/jnr.21759; Han JY, 2006, NEUROSCI LETT, V398, P113, DOI 10.1016/j.neulet.2005.12.065; Hogan B, 1994, MANIPULATING MOUSE E; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Insolera R, 2011, DEV NEUROBIOL, V71, P483, DOI 10.1002/dneu.20867; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Jung ME, 2011, NEUROBIOL AGING, V32, P2266, DOI 10.1016/j.neurobiolaging.2010.01.005; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Kapfhamer D., 2012, GENES BRAIN BEHAV; King Ian, 2011, Commun Integr Biol, V4, P554, DOI 10.4161/cib.4.5.16051; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kong EC, 2010, ALCOHOL CLIN EXP RES, V34, P302, DOI 10.1111/j.1530-0277.2009.01093.x; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Ku BM, 2007, NEUROSCI LETT, V419, P64, DOI 10.1016/j.neulet.2007.03.049; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McAlhany RE, 2000, DEV BRAIN RES, V119, P209, DOI 10.1016/S0165-3806(99)00171-6; Milton VJ, 2012, DEV NEUROBIOL, V72, P100, DOI 10.1002/dneu.20957; Milton VJ, 2011, P NATL ACAD SCI USA, V108, P17521, DOI 10.1073/pnas.1014511108; Mitchell JM, 2012, PSYCHOPHARM BERL; Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200; Mitsuyama K, 2006, CLIN EXP IMMUNOL, V143, P24, DOI 10.1111/j.1365-2249.2005.02959.x; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; Morean ME, 2010, ALCOHOL CLIN EXP RES, V34, P385, DOI 10.1111/j.1530-0277.2009.01103.x; Naassila M, 2004, NEUROPHARMACOLOGY, V46, P243, DOI 10.1016/j.neuropharm.2003.09.002; Naassila M, 2002, J NEUROSCI, V22, P10487; Nagata H, 2009, HEPATOLOGY, V49, P1944, DOI 10.1002/hep.22860; Newton PM, 2007, BEHAV NEUROSCI, V121, P439, DOI 10.1037/0735-7044.121.2.439; Ng J, 2012, DEVELOPMENT, V139, P165, DOI 10.1242/dev.068668; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Palmer AA, 2004, PSYCHOPHARMACOLOGY, V176, P386, DOI 10.1007/s00213-004-1896-5; Pascual M, 2003, J NEUROCHEM, V87, P1535, DOI 10.1046/j.1471-4159.2003.02130.x; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Peng JS, 2009, J NEUROSCI, V29, P8408, DOI 10.1523/JNEUROSCI.0714-09.2009; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Radwanska K, 2008, NEUROPSYCHOPHARMACOL, V33, P1835, DOI 10.1038/sj.npp.1301567; Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016; Ren J, 2009, TOXICOL LETT, V187, P149, DOI 10.1016/j.toxlet.2009.02.019; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Sahara N, 2008, EUR J NEUROSCI, V27, P2897, DOI 10.1111/j.1460-9568.2008.06258.x; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Takahama K, 2012, BIOCHEM BIOPH RES CO, V417, P807, DOI 10.1016/j.bbrc.2011.12.040; Takamura M, 2007, LIFE SCI, V80, P1335, DOI 10.1016/j.lfs.2006.12.034; Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Valles SL, 2004, BRAIN PATHOL, V14, P365; Villegas SN, 2006, BRAIN RES BULL, V71, P116, DOI 10.1016/j.brainresbull.2006.08.014; Wagle M, 2011, J NEUROSCI, V31, P214, DOI 10.1523/JNEUROSCI.3339-10.2011; Wang JW, 2007, J NEUROSCI, V27, P574, DOI 10.1523/JNEUROSCI.5094-06.2007; Weber U, 2000, DEVELOPMENT, V127, P3619; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Wolf FW, 2002, J NEUROSCI, V22, P11035; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Young CL, 2008, NEUROBIOL DIS, V31, P355, DOI 10.1016/j.nbd.2008.05.009; Yustein JT, 2003, ONCOGENE, V22, P6129, DOI 10.1038/sj.onc.1206605; Zihni C, 2006, J BIOL CHEM, V281, P7317, DOI 10.1074/jbc.M513769200	97	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50594	10.1371/journal.pone.0050594	http://dx.doi.org/10.1371/journal.pone.0050594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227189	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200049
J	van Rijn, H; Dalenberg, JR; Borst, JP; Sprenger, SA				van Rijn, Hedderik; Dalenberg, Jelle R.; Borst, Jelmer P.; Sprenger, Simone A.			Pupil Dilation Co-Varies with Memory Strength of Individual Traces in a Delayed Response Paired-Associate Task	PLOS ONE			English	Article							PICTURE-WORD INTERFERENCE; PUPILLOMETRIC ANALYSIS; RETRIEVAL EFFORT; LOAD; STIMULATION; ALLOCATION; DECISIONS; SELECTION; DYNAMICS; INSIGHTS	Studies on cognitive effort have shown that pupil dilation is a reliable indicator of memory load. However, it is conceivable that there are other sources of effort involved in memory that also affect pupil dilation. One of these is the ease with which an item can be retrieved from memory. Here, we present the results of an experiment in which we studied the way in which pupil dilation acts as an online marker for memory processing during the retrieval of paired associates while reducing confounds associated with motor responses. Paired associates were categorized into sets containing either 4 or 7 items. After learning the paired associates once, pupil dilation was measured during the presentation of the retrieval cue during four repetitions of each set. Memory strength was operationalized as the number of repetitions (frequency) and set-size, since having more items per set results in a lower average recency. Dilation decreased with increased memory strength, supporting the hypothesis that the amplitude of the evoked pupillary response correlates positively with retrieval effort. Thus, while many studies have shown that "memory load'' influences pupil dilation, our results indicate that the task-evoked pupillary response is also sensitive to the experimentally manipulated memory strength of individual items. As these effects were observed well before the response had been given, this study also suggests that pupil dilation can be used to assess an item's memory strength without requiring an overt response.	[van Rijn, Hedderik] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Dalenberg, Jelle R.; Borst, Jelmer P.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [Sprenger, Simone A.] Univ Groningen, Dept English Language & Linguist, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van Rijn, H (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	hedderik@van-rijn.org	Borst, Jelmer/C-4666-2008; van Rijn, Hedderik/L-3685-2014	Borst, Jelmer/0000-0002-4493-8223; van Rijn, Hedderik/0000-0002-0461-9850; Dalenberg, Jelle R./0000-0001-8580-5358	University of Groningen	University of Groningen	This study was funded by the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, CANADIAN PSYCHOL; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Barbur JL, 2004, THE VISUAL NEUROSCIE, P641; Barbur L, 2007, OPHTHAL PHYSL OPT, V12, P137; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Chapman CR, 1999, PSYCHOPHYSIOLOGY, V36, P44, DOI 10.1017/S0048577299970373; Chua FK, 2005, PERCEPT PSYCHOPHYS, V67, P770, DOI 10.3758/BF03193532; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Finnigan S, 2002, NEUROPSYCHOLOGIA, V40, P2288, DOI 10.1016/S0028-3932(02)00113-6; Freeman E, 2010, J MEM LANG, V62, P1, DOI 10.1016/j.jml.2009.09.004; Gagl B, 2011, BEHAV RES METHODS, V43, P1171, DOI 10.3758/s13428-011-0109-5; Gamlin PDR, 1998, VISION RES, V38, P3353, DOI 10.1016/S0042-6989(98)00096-0; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Hyona J, 2007, Q J EXPT PSYCHOL A, V1995; Jainta S, 2010, INT J PSYCHOPHYSIOL, V77, P1, DOI 10.1016/j.ijpsycho.2010.03.008; Jainta Stephanie, 2011, Front Hum Neurosci, V5, P97, DOI 10.3389/fnhum.2011.00097; Kafkas A, 2012, NEUROPSYCHO IN PRESS; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Karatekin C, 2004, INT J PSYCHOPHYSIOL, V52, P7, DOI 10.1016/j.ijpsycho.2003.12.002; Kietzmann TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022614; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Kononowicz TW, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00048; Kuchinke L, 2007, INT J PSYCHOPHYSIOL, V65, P132, DOI 10.1016/j.ijpsycho.2007.04.004; MAGLIERO A, 1983, MEM COGNITION, V11, P609, DOI 10.3758/BF03198285; Michelet T, 2010, J NEUROPHYSIOL, V104, P119, DOI 10.1152/jn.00819.2009; Moresi S, 2008, INT J PSYCHOPHYSIOL, V67, P124, DOI 10.1016/j.ijpsycho.2007.10.011; Newman AJ, 2012, J COGNITIVE NEUROSCI, V24, P1205, DOI 10.1162/jocn_a_00143; Pinheiro J, 2001, MIXED EFFECTS MODELS; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; Raaijmakers J. G. W., 2008, LEARNING MEMORY COMP, V2, P445; RICHER F, 1983, J EXP PSYCHOL HUMAN, V9, P360, DOI 10.1037/0096-1523.9.3.360; Robb WGK, 2002, PSYCHON B REV, V9, P583, DOI 10.3758/BF03196316; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; SR Research Ltd, 2009, EYELINK 1000 US MAN; Van der Meer E, 2010, PSYCHOPHYSIOLOGY, V47, P158, DOI 10.1111/j.1469-8986.2009.00884.x; Van Gerven PWM, 2004, PSYCHOPHYSIOLOGY, V41, P167, DOI 10.1111/j.1469-8986.2003.00148.x; van Maanen L, 2012, COGNITIVE SCI, V36, P62, DOI 10.1111/j.1551-6709.2011.01213.x; van Maanen L, 2010, TOP COGN SCI, V2, P168, DOI 10.1111/j.1756-8765.2009.01069.x; van Maanen L, 2009, PSYCHON B REV, V16, P987, DOI 10.3758/PBR.16.6.987; VANDERMOLEN MW, 1989, PSYCHOPHYSIOLOGY, V26, P70; Vo MLH, 2008, PSYCHOPHYSIOLOGY, V45, P130, DOI 10.1111/j.1469-8986.2007.00606.x; Wagenmakers EJ, 2004, COGNITIVE PSYCHOL, V48, P332, DOI 10.1016/j.cogpsych.2003.08.001; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wolffsohn JS, 2001, OPHTHAL PHYSL OPT, V21, P108, DOI 10.1016/S0275-5408(00)00050-8; Zylberberg A, 2012, FRONTIERS COGNITION, V3	55	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51134	10.1371/journal.pone.0051134	http://dx.doi.org/10.1371/journal.pone.0051134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227244	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200103
J	Vermeire, J; Naessens, E; Vanderstraeten, H; Landi, A; Iannucci, V; Van Nuffel, A; Taghon, T; Pizzato, M; Verhasselt, B				Vermeire, Jolien; Naessens, Evelien; Vanderstraeten, Hanne; Landi, Alessia; Iannucci, Veronica; Van Nuffel, Anouk; Taghon, Tom; Pizzato, Massimo; Verhasselt, Bruno			Quantification of Reverse Transcriptase Activity by Real-Time PCR as a Fast and Accurate Method for Titration of HIV, Lenti- and Retroviral Vectors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PORCINE ENDOGENOUS RETROVIRUSES; POLYMERASE-CHAIN-REACTION; REPLICATION-COMPETENT; MONITOR RETROVIRUS; CELL-CULTURE; ASSAY; INFECTIVITY; TYPE-1; STEP	Quantification of retroviruses in cell culture supernatants and other biological preparations is required in a diverse spectrum of laboratories and applications. Methods based on antigen detection, such as p24 for HIV, or on genome detection are virus specific and sometimes suffer from a limited dynamic range of detection. In contrast, measurement of reverse transcriptase (RT) activity is a generic method which can be adapted for higher sensitivity using real-time PCR quantification (qPCR-based product-enhanced RT (PERT) assay). We present an evaluation of a modified SYBR Green I-based PERT assay (SG-PERT), using commercially available reagents such as MS2 RNA and ready-to-use qPCR mixes. This assay has a dynamic range of 7 logs, a sensitivity of 10 nU HIV-1 RT and outperforms p24 ELISA for HIV titer determination by lower inter-run variation, lower cost and higher linear range. The SG-PERT values correlate with transducing and infectious units in HIV-based viral vector and replication-competent HIV-1 preparations respectively. This assay can furthermore quantify Moloney Murine Leukemia Virus-derived vectors and can be performed on different instruments, such as Roche Lightcycler (R) 480 and Applied Biosystems ABI 7300. We consider this test to be an accurate, fast and relatively cheap method for retroviral quantification that is easily implemented for use in routine and research laboratories.	[Vermeire, Jolien; Naessens, Evelien; Vanderstraeten, Hanne; Landi, Alessia; Iannucci, Veronica; Van Nuffel, Anouk; Taghon, Tom; Verhasselt, Bruno] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Pizzato, Massimo] Univ Trento, Ctr Integrat Biol CIBIO, Trento, Italy	Ghent University; University of Trento	Verhasselt, B (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium.	bruno.verhasselt@ugent.be	Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Verhasselt, Bruno/0000-0002-4645-1144; Taghon, Tom/0000-0002-5781-0288	SBO CellCoVir grant from the agency for Innovation by Science and Technology (IWT) Flanders, Belgium; HIV-STOP Interuniversity Attraction Poles program of Belgian Science Policy; European Union [Health-2007-2.3.2-1]; Ghent University [BOF11/GOA/013]; Research Foundation - Flanders (FWO)	SBO CellCoVir grant from the agency for Innovation by Science and Technology (IWT) Flanders, Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); HIV-STOP Interuniversity Attraction Poles program of Belgian Science Policy; European Union(European Commission); Ghent University(Ghent University); Research Foundation - Flanders (FWO)(FWO)	This work was supported by SBO CellCoVir grant from the agency for Innovation by Science and Technology (IWT) Flanders, Belgium; HIV-STOP Interuniversity Attraction Poles program of Belgian Science Policy, European Union FP7 Health-2007-2.3.2-1 Collaborative Project iNEF, Ghent University grant BOF11/GOA/013 and grants from the Research Foundation - Flanders (FWO) to BV. JV and AL are PhD fellows, TT is a postdoctoral researcher and BV is a Senior Clinical Investigator of the FWO. VI is a PhD fellow supported by the BOF program of the Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BA, 1998, BIOTECHNIQUES, V25, P98, DOI 10.2144/98251st06; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Boni J, 1996, CLIN DIAGN VIROL, V5, P43, DOI 10.1016/0928-0197(95)00159-X; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Brorson K, 2002, BIOLOGICALS, V30, P15, DOI 10.1006/biol.2001.0290; Brorson K, 2001, BIOTECHNOL PROGR, V17, P188, DOI 10.1021/bp000153q; Chang A, 1997, J VIROL METHODS, V65, P45, DOI 10.1016/S0166-0934(96)02168-4; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Clemenceau B, 2001, DIABETOLOGIA, V44, P2044, DOI 10.1007/s001250100010; Cortes MJ, 2002, J BIOL CHEM, V277, P1770, DOI 10.1074/jbc.M109807200; D'Costa J, 2009, CURR OPIN MOL THER, V11, P554; Delenda C, 2005, GENE THER, V12, pS36, DOI 10.1038/sj.gt.3302614; Dropulic B, 2011, HUM GENE THER, V22, P649, DOI 10.1089/hum.2011.058; EBERLE J, 1992, J VIROL METHODS, V40, P347, DOI 10.1016/0166-0934(92)90092-R; Fan XY, 2006, J CLIN VIROL, V37, P305, DOI 10.1016/j.jcv.2006.08.007; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Heneine W, 2001, J INFECT DIS, V183, P648, DOI 10.1086/318540; Hussain AI, 2003, J VIROL, V77, P1105, DOI 10.1128/JVI.77.2.1105-1111.2003; Ikeda Y, 2002, GENE THER, V9, P932, DOI 10.1038/sj.gt.3301708; Imbeault M, 2009, VIROLOGY, V393, P160, DOI 10.1016/j.virol.2009.07.009; Johnson JA, 2001, J VIROL, V75, P3605, DOI 10.1128/JVI.75.8.3605-3612.2001; Khan AS, 1998, J CLIN VIROL, V11, P7, DOI 10.1016/S0928-0197(98)00042-7; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Lerma JGG, 1998, J INFECT DIS, V177, P1221, DOI 10.1086/515272; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Lovatt A, 1999, J VIROL METHODS, V82, P185, DOI 10.1016/S0166-0934(99)00111-1; Ma YK, 2009, J VIROL METHODS, V157, P133, DOI 10.1016/j.jviromet.2009.01.002; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Maudru T, 1998, J CLIN VIROL, V11, P19, DOI 10.1016/S0928-0197(98)00044-0; Maudru T, 1998, BIOTECHNIQUES, V25, P972, DOI 10.2144/98256bm08; Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; PYRA H, 1994, P NATL ACAD SCI USA, V91, P1544, DOI 10.1073/pnas.91.4.1544; ROYBURMAN P, 1976, J VIROL, V19, P1107, DOI 10.1128/JVI.19.3.1107-1110.1976; Sanchez-Antequera Y, 2011, BLOOD, V117, pE171, DOI 10.1182/blood-2010-08-302646; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Sears JF, 1999, J CLIN MICROBIOL, V37, P1704, DOI 10.1128/JCM.37.6.1704-1708.1999; Sears JF, 2003, J VIROL METHODS, V108, P139, DOI 10.1016/S0166-0934(02)00287-2; Shahabuddin M, 2001, J CLIN MICROBIOL, V39, P675, DOI 10.1128/JCM.39.2.675-684.2001; SILVER J, 1993, NUCLEIC ACIDS RES, V21, P3593, DOI 10.1093/nar/21.15.3593; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; Stove V, 2003, BLOOD, V102, P2925, DOI 10.1182/blood-2003-03-0833; Stove V, 2006, ELECTRON J BIOTECHN, V9, P572, DOI 10.2225/vol9-issue5-fulltext-13; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Tschochner M, 2007, J VIROL METHODS, V141, P87, DOI 10.1016/j.jviromet.2006.11.040; Verhasselt B, 1999, BLOOD, V94, P2809, DOI 10.1182/blood.V94.8.2809.420k11_2809_2818; Yamamoto S, 1996, J VIROL METHODS, V61, P135, DOI 10.1016/0166-0934(96)02078-2; Zhang Bing, 2004, Genet Vaccines Ther, V2, P6, DOI 10.1186/1479-0556-2-6	54	102	104	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50859	10.1371/journal.pone.0050859	http://dx.doi.org/10.1371/journal.pone.0050859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227216	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200077
J	Wang, D; Zhai, B; Hu, FL; Liu, C; Zhao, JP; Xu, J				Wang, Dong; Zhai, Bo; Hu, Fengli; Liu, Chang; Zhao, Jinpeng; Xu, Jun			High YKL-40 Serum Concentration Is Correlated with Prognosis of Chinese Patients with Breast Cancer	PLOS ONE			English	Article							EXPRESSION; PROTEIN; GLYCOPROTEIN; MARKER; GRADE	This study aimed to investigate the association between serum YKL-40 and prognosis of breast cancer in a Chinese population. Expression of YKL-40 of 120 Chinese patients with breast cancer and 30 controls (benign breast lesions) was measured in tumor tissue by immunohistochemistry and in serum by ELISA. Differences in YKL-40 positivity grouped by specific patients' characteristics were compared using Pearson Chi-square test for rates of intratumoral staining, one-way ANOVA with a Bonferroni post-hoc comparison, or two-sample t-test for mean YKL-40 serum concentrations. Factors associated with overall survival were identified by univariate and multivariate cox-regression analyses. YKL-40 was elevated in approximately 75% of Chinese patients with breast cancer. A significantly higher percentage of patients with YKL-40 positive tumors had larger tumor size, higher TNM stage, and/or lymph node metastasis. Significantly higher mean YKL-40 serum concentrations were observed in patient subgroups with invasive lobular carcinoma (P < 0.0167), higher TNM stage (P < 0.001), and positive lymph node metastasis (P < 0.001). The estimated mean survival time of patients with YKL-40 positive tumors was significantly shorter than for patients with YKL-40 negative tumors (55.13 months vs 65.78 months, P=0.017). Multivariable Cox-regression analysis identified a significant association of overall survival time with YKL-40 serum concentration. Patients with YKL-40 positive tumors had significantly shorter disease free survival times than those with YKL-40 negative tumors. We propose that the potential utility of YKL-40 intratumoral staining or serum concentration as a biomarker for breast cancer is greatest within 5 years of diagnosis.	[Wang, Dong; Zhai, Bo; Liu, Chang; Zhao, Jinpeng; Xu, Jun] Harbin Med Univ, Dept Gen Surg, Hosp 4, Harbin, Peoples R China; [Hu, Fengli] Harbin Med Univ, Dept Gastroenterol, Hosp 4, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, D (corresponding author), Harbin Med Univ, Dept Gen Surg, Hosp 4, Harbin, Peoples R China.	doctorwd1975@163.com			Heilongjiang Province Education Bureau [12511251, 11551208]; Heilongjiang Province Health Bureau [2010-148, 2010-147]	Heilongjiang Province Education Bureau; Heilongjiang Province Health Bureau	This work is supported in part by funding from Heilongjiang Province Education Bureau (12511251 and 11551208), and Heilongjiang Province Health Bureau (2010-148 and 2010-147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BREAST CANC FACTS FI; Bi J, 2009, HUM PATHOL, V40, P1790, DOI 10.1016/j.humpath.2009.07.005; Bojesen SE, 2011, CLIN CHIM ACTA, V412, P709, DOI 10.1016/j.cca.2011.01.022; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; JOHANSEN JS, 1995, EUR J CANCER, V31A, P1437, DOI 10.1016/0959-8049(95)00196-P; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Junker N, 2005, LUNG CANCER, V48, P223, DOI 10.1016/j.lungcan.2004.11.011; Kim Steve H, 2007, World J Surg Oncol, V5, P17, DOI 10.1186/1477-7819-5-17; Peng C, 2010, J INT MED RES, V38, P1448, DOI 10.1177/147323001003800427; Qin WY, 2007, INT J CANCER, V121, P1536, DOI 10.1002/ijc.22881; Roslind A, 2008, BREAST CANCER RES TR, V112, P275, DOI 10.1007/s10549-007-9870-7; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shao R, 2011, BRIT J CANCER, V105, P1203, DOI 10.1038/bjc.2011.347; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Stawerski P, 2011, PATHOL RES PRACT, V207, P573, DOI 10.1016/j.prp.2011.06.008; Thom I, 2010, CANCER-AM CANCER SOC, V116, P4114, DOI 10.1002/cncr.25196; Xiao XQ, 2011, HEPATOB PANCREAT DIS, V10, P605, DOI 10.1016/S1499-3872(11)60103-3; Yamac D, 2008, ADV THER, V25, P801, DOI 10.1007/s12325-008-0082-2	23	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51127	10.1371/journal.pone.0051127	http://dx.doi.org/10.1371/journal.pone.0051127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227243	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200102
J	Wang, H; Chalovich, JM; Marriott, G				Wang, Hui; Chalovich, Joseph M.; Marriott, Gerard			Structural Dynamics of Troponin I during Ca2+-Activation of Cardiac Thin Filaments: A Multi-Site Forster Resonance Energy Transfer Study	PLOS ONE			English	Article							SKELETAL-MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; TROPOMYOSIN POSITIONS; MYOSIN SUBFRAGMENT-1; COOPERATIVE BINDING; CRYSTAL-STRUCTURE; REGULATED ACTIN; C-TERMINUS; CONTRACTION; COMPLEX	A multi-site, steady-state Forster resonance energy transfer (FRET) approach was used to quantify Ca2+-induced changes in proximity between donor loci on human cardiac troponin I (cTnI), and acceptor loci on human cardiac tropomyosin (cTm) and F-actin within functional thin filaments. A fluorescent donor probe was introduced to unique and key cysteine residues on the C- and N-termini of cTnI. A FRET acceptor probe was introduced to one of three sites located on the inner or outer domain of F-actin, namely Cys-374 and the phalloidin-binding site on F-actin, and Cys-190 of cTm. Unlike earlier FRET analyses of protein dynamics within the thin filament, this study considered the effects of non-random distribution of dipoles for the donor and acceptor probes. The major conclusion drawn from this study is that Ca2+ and myosin S1-binding to the thin filament results in movement of the C-terminal domain of cTnI from the outer domain of F-actin towards the inner domain, which is associated with the myosin-binding. A hinge-linkage model is used to best-describe the finding of a Ca2+-induced movement of the C-terminus of cTnI with a stationary N-terminus. This dynamic model of the activation of the thin filament is discussed in the context of other structural and biochemical studies on normal and mutant cTnI found in hypertrophic cardiomyopathies. Citation: Wang H, Chalovich JM, Marriott G (2012) Structural Dynamics of Troponin I during Ca2+-Activation of Cardiac Thin Filaments: A Multi-Site Forster Resonance Energy Transfer Study. PLoS ONE 7(12): e50420. doi:10.1371/journal.pone.0050420	[Wang, Hui] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Chalovich, Joseph M.] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC USA; [Marriott, Gerard] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; East Carolina University; University of California System; University of California Berkeley	Marriott, G (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	marriott1@berkeley.edu	Wang, Hui/A-2312-2012	Chalovich, Joseph/0000-0002-1243-4055; Marriott, Gerard/0000-0003-3197-4839	National Institutes of Health [HLO69970, AR40540]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (HLO69970 awarded to GM and AR40540 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchiocchi C, 2002, BIOPHYS J, V82, P1524, DOI 10.1016/S0006-3495(02)75505-7; CHALOVICH JM, 1992, PHARMACOL THERAPEUT, V55, P95, DOI 10.1016/0163-7258(92)90013-P; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; DALE RE, 1974, BIOPOLYMERS, V13, P1573, DOI 10.1002/bip.1974.360130807; Dale RE, 1975, BIOCH FLUORESCENCE C, P115; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; GREASER ML, 1971, J BIOL CHEM, V246, P4226; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; HEIDECKER M, 1995, BIOCHEMISTRY-US, V34, P11017, DOI 10.1021/bi00035a007; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; MARRIOTT G, 1988, BIOCHEMISTRY-US, V27, P6214, DOI 10.1021/bi00417a004; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Miki M, 1998, J BIOCHEM-TOKYO, V123, P1104; Miki M, 2004, J BIOCHEM, V136, P39, DOI 10.1093/jb/mvh090; Miki M, 1998, J BIOCHEM-TOKYO, V123, P324; Miki M, 1990, EUR J BIOCH, V187, P155; Miki Masao, 2002, Results Probl Cell Differ, V36, P191; Munoz-Losa A, 2009, BIOPHYS J, V96, P4779, DOI 10.1016/j.bpj.2009.03.052; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; She MD, 1998, J MOL BIOL, V281, P445, DOI 10.1006/jmbi.1998.1933; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TAO T, 1989, BIOCHEMISTRY-US, V28, P5902, DOI 10.1021/bi00440a029; TAO T, 1983, BIOCHEMISTRY-US, V22, P3059, DOI 10.1021/bi00282a006; TAO T, 1990, SCIENCE, V247, P1339, DOI 10.1126/science.2138356; VanBeek DB, 2007, BIOPHYS J, V92, P4168, DOI 10.1529/biophysj.106.092650; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2; Wang H, 2008, BIOPHYS J, V94, P4358, DOI 10.1529/biophysj.107.121129; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Xing J, 2009, J BIOL CHEM, V284, P16432, DOI 10.1074/jbc.M808075200; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3; Yan YL, 2003, METHOD ENZYMOL, V360, P561; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	59	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50420	10.1371/journal.pone.0050420	http://dx.doi.org/10.1371/journal.pone.0050420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227172	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200033
J	Lee, H; Kim, DK; Oh, KH; Joo, KW; Kim, YS; Chae, DW; Kim, S; Chin, HJ				Lee, Hajeong; Kim, Dong Ki; Oh, Kook-Hwan; Joo, Kwon Wook; Kim, Yon Su; Chae, Dong-Wan; Kim, Suhnggwon; Chin, Ho Jun			Mortality of IgA Nephropathy Patients: A Single Center Experience over 30 Years	PLOS ONE			English	Article							PROGNOSIS; THERAPY	Research on the prognosis of IgA nephropathy (IgAN) has focused on renal survival, with little information being available on patient survival. Hence, this investigation aimed to explore long-term patient outcome in IgAN patients. Clinical and pathological characteristics at the time of renal biopsy were reviewed in 1,364 IgAN patients from 1979 to 2008. The outcomes were patient death and end stage renal disease (ESRD) progression. Overall, 71 deaths (5.3%) and 277 cases of ESRD (20.6%) occurred during 13,916 person-years. Ten-, 20-, and 30-year patient survival rates were 96.3%, 91.8%, and 82.7%, respectively. More than 50% patient deaths occurred without ESRD progression. Overall mortality was elevated by 43% from an age/sex-matched general population (GP) (standardized mortality ratio [SMR], 1.43; 95% confidence interval [CI], 1.04-1.92). Men had comparable mortality to GP (SMR, 1.22; 95% CI, 0.82-1.75), but, in women, the mortality rate was double (SMR, 2.17; 95% CI, 1.21-3.57). Patients with renal risk factors such as initial renal dysfunction (estimated glomerular filgration rate <60 ml/min per 1.73m(2); SMR, 1.70; 95% CI, 1.13-2.46), systolic blood pressure >= 140 mmHg (SMR, 1.88; 95% CI, 1.19-2.82) or proteinuria >= 1 g/day (SMR, 1.66; 95% CI, 1.16-2.29) had an elevated mortality rate. Patients with preserved renal function, normotension, and proteinuria <1 g/day, however, had a similar mortality rate to GP. When risk stratification was performed by counting the number of major risk factors present at diagnosis, low-risk IgAN patients had a mortality rate equal to that of GP, whereas high-risk patients had a mortality rate higher than that of GP. This investigation demonstrated that overall mortality in IgAN patients was higher than that of GP. Women and patients with renal risk factors had a higher mortality than that of GP, Therefore, strategies optimized to alleviate major renal risk factors are warranted to reduce patient mortality.	[Lee, Hajeong; Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Immunol, Seoul, South Korea; [Lee, Hajeong; Kim, Dong Ki; Oh, Kook-Hwan; Joo, Kwon Wook; Kim, Yon Su; Kim, Suhnggwon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Joo, Kwon Wook; Kim, Yon Su; Chae, Dong-Wan; Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ Hosp, Kidney Res Inst, Seoul 110744, South Korea; [Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Immunol, Seoul, South Korea.	mednep@snubh.org	Kim, Suhnggwon/J-5407-2012; Chin, Ho Jun/J-5678-2012; Kim, Dong Ki/J-5389-2012; Joo, Kwon Wook/J-5675-2012	Kim, Dong Ki/0000-0002-5195-7852; 				ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; BEUKHOF JR, 1986, KIDNEY INT, V29, P549, DOI 10.1038/ki.1986.33; Bjorneklett R, 2012, NEPHROL DIAL TRANSPL, V27, P1485, DOI 10.1093/ndt/gfr446; Chang JH, 2009, NEPHROL DIAL TRANSPL, V24, P2406, DOI 10.1093/ndt/gfp091; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Frimat L, 1997, NEPHROL DIAL TRANSPL, V12, P2569; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Kang SH, 2012, NEPHROL DIAL TRANSPL, V27, P252, DOI 10.1093/ndt/gfr295; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Kim SY, 2003, NEPHROLOGY, V8, pS2, DOI 10.1046/j.1440-1797.8.s.5.x; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Myllymaki JM, 2007, KIDNEY INT, V71, P343, DOI 10.1038/sj.ki.5002046; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Walsh M, 2010, CLIN J AM SOC NEPHRO, V5, P425, DOI 10.2215/CJN.06530909; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904	22	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51225	10.1371/journal.pone.0051225	http://dx.doi.org/10.1371/journal.pone.0051225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226568	gold, Green Published, Green Submitted			2022-12-25	WOS:000312108500051
J	Zhao, DH; Xie, D; Zhou, HJ; Jiang, H; An, SQ				Zhao, Dehua; Xie, Dong; Zhou, Hengjie; Jiang, Hao; An, Shuqing			Estimation of Leaf Area Index and Plant Area Index of a Submerged Macrophyte Canopy Using Digital Photography	PLOS ONE			English	Article							SEAGRASS; ANGLE; LAI; PHOSPHORUS; PARTICLES; LAI-2000; SYSTEM; CROPS; WATER	Non-destructive estimation using digital cameras is a common approach for estimating leaf area index (LAI) of terrestrial vegetation. However, no attempt has been made so far to develop non-destructive approaches to LAI estimation for aquatic vegetation. Using the submerged plant species Potamogeton malainus, the objective of this study was to determine whether the gap fraction derived from vertical photographs could be used to estimate LAI of aquatic vegetation. Our results suggested that upward-oriented photographs taken from beneath the water surface were more suitable for distinguishing vegetation from other objects than were downward-oriented photographs taken from above the water surface. Exposure settings had a substantial influence on the identification of vegetation in upward-oriented photographs. Automatic exposure performed nearly as well as the optimal trial exposure, making it a good choice for operational convenience. Similar to terrestrial vegetation, our results suggested that photographs taken for the purpose of distinguishing gap fraction in aquatic vegetation should be taken under diffuse light conditions. Significant logarithmic relationships were observed between the vertical gap fraction derived from upward-oriented photographs and plant area index (PAI) and LAI derived from destructive harvesting. The model we developed to depict the relationship between PAI and gap fraction was similar to the modified theoretical Poisson model, with coefficients of 1.82 and 1.90 for our model and the theoretical model, respectively. This suggests that vertical upward-oriented photographs taken from below the water surface are a feasible alternative to destructive harvesting for estimating PAI and LAI for the submerged aquatic plant Potamogeton malainus. Citation: Zhao D, Xie D, Zhou H, Jiang H, An S (2012) Estimation of Leaf Area Index and Plant Area Index of a Submerged Macrophyte Canopy Using Digital Photography. PLoS ONE 7(12): e51034. doi: 10.1371/journal.pone.0051034	[Zhao, Dehua; Xie, Dong; Zhou, Hengjie; Jiang, Hao; An, Shuqing] Nanjing Univ, Dept Biol Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Zhao, DH (corresponding author), Nanjing Univ, Dept Biol Sci & Technol, Nanjing, Jiangsu, Peoples R China.	dhzhao@nju.edu.cn			National Natural Science Foundation of China [31000226]; State Key Development Program for Basic Research of China [2008CB418004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This research was supported by the National Natural Science Foundation of China (31000226), and the State Key Development Program for Basic Research of China (2008CB418004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JM, 2008, ENVIRON SCI TECHNOL, V42, P4052, DOI 10.1021/es702439u; Babin M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000882; Baret F, 2010, AGR FOREST METEOROL, V150, P1393, DOI 10.1016/j.agrformet.2010.04.011; BLINDOW I, 1993, FRESHWATER BIOL, V30, P159, DOI 10.1111/j.1365-2427.1993.tb00796.x; Bowers DG, 2006, ESTUAR COAST SHELF S, V67, P219, DOI 10.1016/j.ecss.2005.11.010; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Brisson J, 2009, SCI TOTAL ENVIRON, V407, P3923, DOI 10.1016/j.scitotenv.2008.05.047; Camargo JA, 2011, ECOL INDIC, V11, P911, DOI 10.1016/j.ecolind.2010.10.001; CHEN JM, 1992, PLANT CELL ENVIRON, V15, P421, DOI 10.1111/j.1365-3040.1992.tb00992.x; Chen JM, 1997, J GEOPHYS RES-ATMOS, V102, P29429, DOI 10.1029/97JD01107; Cheng XY, 2006, CHINESE SCI BULL, V51, P1603, DOI 10.1007/s11434-006-2005-4; Demarez V, 2008, AGR FOREST METEOROL, V148, P644, DOI 10.1016/j.agrformet.2007.11.015; Dierberg FE, 2002, WATER RES, V36, P1409, DOI 10.1016/S0043-1354(01)00354-2; Dierssen HM, 2003, LIMNOL OCEANOGR, V48, P444, DOI 10.4319/lo.2003.48.1_part_2.0444; Doxaran D, 2009, LIMNOL OCEANOGR, V54, P1257, DOI 10.4319/lo.2009.54.4.1257; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; Garriques S, 2008, AGR FOREST METEOROL, V148, P1193, DOI 10.1016/j.agrformet.2008.02.014; Graham EA, 2009, ENVIRON EXP BOT, V65, P238, DOI 10.1016/j.envexpbot.2008.09.013; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Knight RL, 2003, ECOL ENG, V20, P45, DOI 10.1016/S0925-8574(03)00003-X; KUUSK A, 1995, REMOTE SENS ENVIRON, V51, P342, DOI 10.1016/0034-4257(94)00059-V; La Peyre MK, 2012, ESTUAR COAST SHELF S, V98, P108, DOI 10.1016/j.ecss.2011.12.010; LANG ARG, 1986, AUST J BOT, V34, P349, DOI 10.1071/BT9860349; Liu JG, 2010, AGR FOREST METEOROL, V150, P1485, DOI 10.1016/j.agrformet.2010.08.002; [刘伟龙 Liu Weilong], 2007, [生态学报, Acta Ecologica Sinica], V27, P159; Liu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032155; Livingston RJ, 1998, AQUAT BOT, V60, P135, DOI 10.1016/S0304-3770(97)00079-X; Luisa EM, 2008, AGR FOREST METEOROL, V148, P1553, DOI 10.1016/j.agrformet.2008.05.005; Macfarlane C, 2007, AGR FOREST METEOROL, V143, P176, DOI 10.1016/j.agrformet.2006.10.013; Morisette JT, 2006, IEEE T GEOSCI REMOTE, V44, P1804, DOI 10.1109/TGRS.2006.872529; Nackaerts K, 2000, AGR FOREST METEOROL, V101, P247, DOI 10.1016/S0168-1923(00)00090-3; Nfon E, 2011, SCI TOTAL ENVIRON, V409, P5416, DOI 10.1016/j.scitotenv.2011.08.070; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Rosqvist K, 2010, AQUAT BOT, V93, P39, DOI 10.1016/j.aquabot.2010.03.002; Sakamoto T, 2012, AGR FOREST METEOROL, V154, P113, DOI 10.1016/j.agrformet.2011.10.014; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; WANG YP, 1988, AGR FOREST METEOROL, V43, P319, DOI 10.1016/0168-1923(88)90057-3; Weiss M, 2004, AGR FOREST METEOROL, V121, P37, DOI 10.1016/j.agrformet.2003.08.001; Yang CY, 2010, INT J REMOTE SENS, V31, P4595, DOI 10.1080/01431161.2010.485138; Yang DT, 2009, SENSORS-BASEL, V9, P830, DOI 10.3390/s90200830; Zhang YQ, 2005, AGR FOREST METEOROL, V133, P166, DOI 10.1016/j.agrformet.2005.09.009	42	5	5	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51034	10.1371/journal.pone.0051034	http://dx.doi.org/10.1371/journal.pone.0051034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226557	gold, Green Published, Green Submitted			2022-12-25	WOS:000312108500040
J	Li, XW; Liu, XY; Cui, L; Brunson, C; Zhao, W; Bhat, NR; Zhang, N; Wen, XJ				Li, Xiaowei; Liu, Xiaoyan; Cui, Lin; Brunson, Christopher; Zhao, Wen; Bhat, Narayan R.; Zhang, Ning; Wen, Xuejun			Engineering an in situ crosslinkable hydrogel for enhanced remyelination	FASEB JOURNAL			English	Article						biomaterials; oligodendrocyte progenitor cells; transplantation; spinal cord regeneration	SPINAL-CORD-INJURY; OLIGODENDROCYTE PRECURSOR CELLS; MULTIPLE-SCLEROSIS; STEM-CELLS; MYELIN REGENERATION; NEURAL PRECURSORS; PROGENITOR CELLS; VIRAL MODEL; DIFFERENTIATION; DEMYELINATION	Remyelination has to occur to fully regenerate injured spinal cords or brain tissues. A growing body of evidence has suggested that exogenous cell transplantation is one promising strategy to promote remyelination. However, direct injection of neural stem cells or oligodendrocyte progenitor cells (OPCs) to the lesion site may not be an optimal therapeutic strategy due to poor viability and functionality of transplanted cells resulted from the local hostile tissue environment. The overall objective of this study was to engineer an injectable biocompatible hydrogel system as a supportive niche to provide a regeneration permissive microenvironment for transplanted OPCs to survive, functionally differentiate, and remyelinate central nervous system (CNS) lesions. A highly biocompatible hydrogel, based on thiol-functionalized hyaluronic acid and thiol-functionalized gelatin, which can be crosslinked by poly-(ethylene glycol) diacrylate (PEGDA), was used. These hydrogels were optimized first regarding cell adhesive properties and mechanical properties to best support the growth properties of OPCs in culture. Transplanted OPCs with the hydrogels optimized in vitro exhibited enhanced survival and oligodendrogenic differentiation and were able to remyelinate demyelinated axons inside ethidium bromide (EB) demyelination lesion in adult spinal cord. This study provides a new possible therapeutic approach to treat CNS injuries in which cell therapies may be essential.-Li, X., Liu, X., Cui, L., Brunson, C., Zhao, W., Bhat, N. R., Zhang, N., Wen, X. Engineering an in situ crosslinkable hydrogel for enhanced remyelination. FASEB J. 27, 1127-1136 (2013). www.fasebj.org	[Li, Xiaowei; Liu, Xiaoyan; Cui, Lin; Zhao, Wen; Zhang, Ning; Wen, Xuejun] Clemson Univ, Dept Bioengn, Clemson MUSC Bioengn Program, Charleston, SC 29425 USA; [Brunson, Christopher] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Zhao, Wen] Beijing Aerosp Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China; [Bhat, Narayan R.; Wen, Xuejun] Med Univ S Carolina, Inst Neurosci, Charleston, SC 29425 USA; [Zhang, Ning] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Wen, Xuejun] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Wen, Xuejun] Med Univ S Carolina, Dept Orthoped Surg, Charleston, SC 29425 USA; [Wen, Xuejun] Tongji Univ, Inst Adv Mat & Nano Biomed iNANO, Shanghai 200092, Peoples R China	Clemson University; Medical University of South Carolina; Stanford University; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Tongji University	Zhang, N (corresponding author), Clemson Univ, Dept Bioengn, Clemson MUSC Bioengn Program, 68 President St,BEB 313, Charleston, SC 29425 USA.	nzhang@clemson.edu; xjwen@clemson.edu	Li, Xiaowei/E-4973-2014	Li, Xiaowei/0000-0001-6237-599X	U.S. National Institutes of Health [R01-NS050243]; National Science Foundation [0748129]; American Heart Association [10PRE4280017]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050243] Funding Source: NIH RePORTER; Directorate For Engineering [1346387] Funding Source: National Science Foundation	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by U.S. National Institutes of Health grant R01-NS050243, National Science Foundation grant 0748129, and American Heart Association grant 10PRE4280017.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Boudou T, 2006, BIORHEOLOGY, V43, P721; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Carbajal KS, 2011, GLIA, V59, P1813, DOI 10.1002/glia.21225; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171; Deverman BE, 2012, J NEUROSCI, V32, P2100, DOI 10.1523/JNEUROSCI.3803-11.2012; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Einstein O, 2009, J NEUROSCI, V29, P15694, DOI 10.1523/JNEUROSCI.3364-09.2009; Ghosh K, 2005, BIOMACROMOLECULES, V6, P2857, DOI 10.1021/bm050361c; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049; Hur EM, 2011, P NATL ACAD SCI USA, V108, P5057, DOI 10.1073/pnas.1011258108; Jadasz JJ, 2012, CELL TISSUE RES, V349, P331, DOI 10.1007/s00441-012-1331-x; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055; Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948; Sasaki M, 2011, EXP NEUROL, V229, P88, DOI 10.1016/j.expneurol.2011.01.010; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Yang JX, 2009, J NEUROL SCI, V276, P1, DOI 10.1016/j.jns.2008.08.020; Zawadzka M, 2007, CURR OPIN NEUROL, V20, P294, DOI 10.1097/WCO.0b013e32813aee7f; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958	36	36	38	5	87	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1127	1136		10.1096/fj.12-211151	http://dx.doi.org/10.1096/fj.12-211151			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23239823	Green Published			2022-12-25	WOS:000315585200026
J	Tan, B; Young, DA; Lu, ZH; Wang, T; Meier, TI; Shepard, RL; Roth, K; Zhai, Y; Huss, K; Kuo, MS; Gillig, J; Parthasarathy, S; Burkholder, TP; Smith, MC; Geeganage, S; Zhao, GS				Tan, Bo; Young, Debra A.; Lu, Zhao-Hai; Wang, Tao; Meier, Timothy I.; Shepard, Robert L.; Roth, Kenneth; Zhai, Yan; Huss, Karen; Kuo, Ming-Shang; Gillig, James; Parthasarathy, Saravanan; Burkholder, Timothy P.; Smith, Michele C.; Geeganage, Sandaruwan; Zhao, Genshi			Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD(+) Biosynthesis, in Human Cancer Cells METABOLIC BASIS AND POTENTIAL CLINICAL IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-CANCER; FK866; DEPLETION; PATHWAY; TARGET; DEATH; FLUX; OVEREXPRESSION; CONTRIBUTES; SURVIVAL	Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the first rate-limiting step in converting nicotinamide to NAD(+), essential for cellular metabolism, energy production, and DNA repair. NAMPT has been extensively studied because of its critical role in these cellular processes and the prospect of developing therapeutics against the target, yet how it regulates cellular metabolism is not fully understood. In this study we utilized liquid chromatography-mass spectrometry to examine the effects of FK866, a small molecule inhibitor of NAMPT currently in clinical trials, on glycolysis, the pentose phosphate pathway, the tricarboxylic acid (TCA) cycle, and serine biosynthesis in cancer cells and tumor xenografts. We show for the first time that NAMPT inhibition leads to the attenuation of glycolysis at the glyceraldehyde 3-phosphate dehydrogenase step due to the reduced availability of NAD(+) for the enzyme. The attenuation of glycolysis results in the accumulation of glycolytic intermediates before and at the glyceraldehyde 3-phosphate dehydrogenase step, promoting carbon overflow into the pentose phosphate pathway as evidenced by the increased intermediate levels. The attenuation of glycolysis also causes decreased glycolytic intermediates after the glyceraldehyde 3-phosphate dehydrogenase step, thereby reducing carbon flow into serine biosynthesis and the TCA cycle. Labeling studies establish that the carbon overflow into the pentose phosphate pathway is mainly through its non-oxidative branch. Together, these studies establish the blockade of glycolysis at the glyceraldehyde 3-phosphate dehydrogenase step as the central metabolic basis of NAMPT inhibition responsible for ATP depletion, metabolic perturbation, and subsequent tumor growth inhibition. These studies also suggest that altered metabolite levels in tumors can be used as robust pharmacodynamic markers for evaluating NAMPT inhibitors in the clinic.	[Young, Debra A.; Lu, Zhao-Hai; Wang, Tao; Meier, Timothy I.; Shepard, Robert L.; Smith, Michele C.; Geeganage, Sandaruwan; Zhao, Genshi] Eli Lilly & Co, Lilly Res Labs, Canc Res, Indianapolis, IN 46285 USA; [Gillig, James; Parthasarathy, Saravanan; Burkholder, Timothy P.] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res, Indianapolis, IN 46285 USA; [Tan, Bo; Roth, Kenneth; Zhai, Yan; Huss, Karen; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Translat Sci & Technol, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Geeganage, S (corresponding author), Eli Lilly & Co, Lilly Res Labs, Canc Res, DC0434, Indianapolis, IN 46285 USA.	Geeganage_Sandaruwan@Lilly.com; Zhao_Genshi@Lilly.com			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This work was supported by Eli Lilly and Company.	Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Drevs J, 2003, ANTICANCER RES, V23, P4853; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Galli U, 2008, CHEMMEDCHEM, V3, P771, DOI 10.1002/cmdc.200700311; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Kelly AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025357; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kirkland JB, 2009, CURR PHARM DESIGN, V15, P3, DOI 10.2174/138161209787185823; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; OLSON JA, 1952, J BIOL CHEM, V197, P67; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Putt KS, 2004, ANAL BIOCHEM, V326, P78, DOI 10.1016/j.ab.2003.11.015; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Rosso L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000150; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Spanaki C, 2012, NEUROTOX RES, V21, P117, DOI 10.1007/s12640-011-9285-4; Spanaki C, 2010, J BIOL CHEM, V285, P16748, DOI 10.1074/jbc.M109.092999; Tong L., 2008, U.S. Patent, Patent No. 0020413; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	50	126	134	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3500	3511		10.1074/jbc.M112.394510	http://dx.doi.org/10.1074/jbc.M112.394510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239881	Green Published, hybrid			2022-12-25	WOS:000314397900055
J	Basset, A; Zhang, F; Benes, C; Sayeed, S; Herd, M; Thompson, C; Golenbock, DT; Camilli, A; Malley, R				Basset, Alan; Zhang, Fan; Benes, Cyril; Sayeed, Sabina; Herd, Muriel; Thompson, Claudette; Golenbock, Douglas T.; Camilli, Andrew; Malley, Richard			Toll-like Receptor (TLR) 2 Mediates Inflammatory Responses to Oligomerized RrgA Pneumococcal Pilus Type 1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; ELICIT PROTECTION; FUSION PROTEIN; CUTTING EDGE; MICE; PNEUMOLYSIN; RECOGNITION; VACCINE; COMPONENTS; VIRULENCE	The pneumococcal type 1 pilus is an inflammatory and adherence-promoting structure associated with increased virulence in mouse models. We show that RrgA, an ancillary pilus subunit devoid of a lipidation motif, particularly when presented as part of an oligomer, is a TLR2 agonist. The surface-exposed domain III, and in particular a 49-amino acid sequence (P3), of the protein is responsible for the TLR2 activity of RrgA. A pneumococcal mutant carrying RrgA with a deletion of the P3 region was significantly reduced in its ability to activate TLR2 and induce TNF-alpha responses after mouse intraperitoneal infection, whereas no such difference could be noted when TLR2(-/-) mice were challenged, further implicating this region in recognition by TLR2. Thus, we conclude that the type 1 pneumococcal pilus can activate cells via TLR2, and the ancillary pilus subunit RrgA is a key component of this activation.	[Basset, Alan; Zhang, Fan; Sayeed, Sabina; Herd, Muriel; Malley, Richard] Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Benes, Cyril] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Thompson, Claudette] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 01225 USA; [Golenbock, Douglas T.] Univ Massachusetts, Med Ctr, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Tufts University; Tufts University	Malley, R (corresponding author), Childrens Hosp, Dept Med, Div Infect Dis, Enders 861-4,300 Longwood Ave, Boston, MA 02115 USA.	richard.malley@childrens.harvard.edu		Sayeed, Sabina/0000-0002-3753-0393	National Institutes of Health [R01 AI066013]; Children's Hospital, Boston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital, Boston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI066013 (to R. M.).; Supported by the Translational Research Program at Children's Hospital, Boston. To whom correspondence should be addressed: Division of Infectious Diseases, Boston Children's Hospital, Enders 861.4, 300 Longwood Ave., Boston, MA 02115. Tel.: 617-919-2902; Fax: 617-730-0255; E-mail: richard.malley@childrens.harvard.edu.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Basset A, 2012, J BACTERIOL, V194, P1088, DOI 10.1128/JB.06078-11; Basset A, 2011, INFECT IMMUN, V79, P2974, DOI 10.1128/IAI.05117-11; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Briles DE, 2000, VACCINE, V18, P1707, DOI 10.1016/S0264-410X(99)00511-3; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Ehl S, 2004, EUR J IMMUNOL, V34, P1146, DOI 10.1002/eji.200324449; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Gilbert RJC, 1998, J MOL BIOL, V284, P1223, DOI 10.1006/jmbi.1998.2258; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hanage WP, 2008, FUTURE MICROBIOL, V3, P23, DOI 10.2217/17460913.3.1.23; Harfouche C, 2012, INFECT IMMUN, V80, P451, DOI 10.1128/IAI.05780-11; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lipsitch M, 2001, AM J EPIDEMIOL, V154, P85, DOI 10.1093/aje/154.1.85; Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Moffitt KL, 2011, CURR OPIN IMMUNOL, V23, P407, DOI 10.1016/j.coi.2011.04.002; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Regev-Yochay G, 2010, VACCINE, V28, P4842, DOI 10.1016/j.vaccine.2010.04.042; Regev-Yochay G, 2009, CLIN INFECT DIS, V48, P760, DOI 10.1086/597040; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Yoshimura A, 1999, J IMMUNOL, V163, P1	51	35	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2665	2675		10.1074/jbc.M112.398875	http://dx.doi.org/10.1074/jbc.M112.398875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233677	hybrid, Green Published			2022-12-25	WOS:000314211500051
J	Huillet, E; Tempelaars, MH; Andre-Leroux, G; Wanapaisan, P; Bridoux, L; Makhzami, S; Panbangred, W; Martin-Verstraete, I; Abee, T; Lereclus, D				Huillet, Eugenie; Tempelaars, Marcel H.; Andre-Leroux, Gwenaelle; Wanapaisan, Pagakrong; Bridoux, Ludovic; Makhzami, Samira; Panbangred, Watanalai; Martin-Verstraete, Isabelle; Abee, Tjakko; Lereclus, Didier			PlcRa, a New Quorum-Sensing Regulator from Bacillus cereus, Plays a Role in Oxidative Stress Responses and Cysteine Metabolism in Stationary Phase	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CELL-CELL COMMUNICATION; III PANTOTHENATE KINASE; GENE-EXPRESSION; VIRULENCE REGULON; GLOBAL REGULATOR; BINDING PROTEIN; TOXIN GENE; SUBTILIS; ANTHRACIS	We characterized a new quorum-sensing regulator, PlcRa, which is present in various members of the B. cereus group and identified a signaling heptapeptide for PlcRa activity: PapRa(7). We demonstrated that PlcRa is a 3D structural paralog of PlcR using sequence analysis and homology modeling. A comparison of the transcriptomes at the onset of stationary phase of a Delta plcRa mutant and the wild-type B. cereus ATCC 14579 strain showed that 68 genes were upregulated and 49 genes were downregulated in the DplcRa mutant strain (>3-fold change). Genes involved in the cysteine metabolism (putative CymR regulon) were downregulated in the Delta plcRa mutant strain. We focused on the gene with the largest difference in expression level between the two conditions, which encoded -AbrB2-a new regulator of the AbrB family. We demonstrated that purified PlcRa bound specifically to the abrB2 promoter in the presence of synthetic PapRa(7), in an electrophoretic mobility shift assay. We further showed that the AbrB2 regulator controlled the expression of the yrrT operon involved in methionine to cysteine conversion. We found that the DplcRa mutant strain was more sensitive to hydrogen peroxide-and disulfide-induced stresses than the wild type. When cystine was added to the culture of the DplcRa mutant, challenged with hydrogen peroxide, growth inhibition was abolished. In conclusion, we identified a new RNPP transcriptional regulator in B. cereus that activated the oxidative stress response and cysteine metabolism in transition state cells.	[Huillet, Eugenie; Wanapaisan, Pagakrong; Bridoux, Ludovic; Lereclus, Didier] INRA, Micalis Genet Microbienne & Environm UMR1319, Guyancourt, France; [Tempelaars, Marcel H.; Abee, Tjakko] Wageningen Univ, Food Microbiol Lab, Wageningen, Netherlands; [Andre-Leroux, Gwenaelle] Inst Pasteur, CNRS, UMR 3528, Paris, France; [Wanapaisan, Pagakrong; Panbangred, Watanalai] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Makhzami, Samira] INRA, UMR GABI, ICE, Jouy En Josas, France; [Martin-Verstraete, Isabelle] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Martin-Verstraete, Isabelle] Univ Paris Diderot, Paris, France	INRAE; Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Huillet, E (corresponding author), INRA, Micalis Genet Microbienne & Environm UMR1319, Guyancourt, France.	Eugenie.Huillet@jouy.inra.fr; Didier.Lereclus@jouy.inra.fr	Martin-Verstraete, Isabelle/R-7109-2019; Lereclus, Didier/AAD-8293-2019; Tempelaars, Marcel/C-5077-2008	Martin-Verstraete, Isabelle/0000-0002-8376-7690; Wanapaisan, Pagakrong/0000-0002-7682-5936; Lereclus, Didier/0000-0001-9047-9104; Tempelaars, Marcel/0000-0003-0635-5606	French National Research Agency [ANR-09-Blan-0253]; INRA (MICA department)	French National Research Agency(French National Research Agency (ANR)); INRA (MICA department)	This work was supported by the French National Research Agency (Cell.com project; NoANR-09-Blan-0253) and by INRA (MICA department). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Auger S, 2002, J BACTERIOL, V184, P5179, DOI 10.1128/JB.184.18.5179-5186.2002; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceragioli M, 2010, APPL ENVIRON MICROB, V76, P3352, DOI 10.1128/AEM.03003-09; Choi SY, 2006, J BACTERIOL, V188, P5741, DOI 10.1128/JB.00443-06; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Declerck N, 2007, P NATL ACAD SCI USA, V104, P18490, DOI 10.1073/pnas.0704501104; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; Graumann PL, 2009, CHROMOSOME RES, V17, P265, DOI 10.1007/s10577-008-9014-x; Hadjifrangiskou M, 2007, J BACTERIOL, V189, P1874, DOI 10.1128/JB.01333-06; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; Hullo MF, 2010, FEMS MICROBIOL LETT, V309, P201, DOI 10.1111/j.1574-6968.2010.02043.x; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; LERECLUS D, 1992, BIO-TECHNOL, V10, P418, DOI 10.1038/nbt0492-418; Mols M, 2011, ENVIRON MICROBIOL, V13, P1387, DOI 10.1111/j.1462-2920.2011.02433.x; Moran Charles P. Jr., 1993, P653; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Nicely NI, 2007, BIOCHEMISTRY-US, V46, P3234, DOI 10.1021/bi062299p; Paige C, 2008, J BACTERIOL, V190, P6271, DOI 10.1128/JB.00860-08; Parashar V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000589; Perchat S, 2011, MOL MICROBIOL, V82, P619, DOI 10.1111/j.1365-2958.2011.07839.x; Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pohl S, 2011, PROTEOMICS, V11, P3036, DOI 10.1002/pmic.201100085; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Ross CL, 2006, J BACTERIOL, V188, P7823, DOI 10.1128/JB.00525-06; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvetti S, 2011, APPL ENVIRON MICROB, V77, P5149, DOI 10.1128/AEM.00245-11; Sanchis V, 1996, J BIOTECHNOL, V48, P81, DOI 10.1016/0168-1656(96)01404-6; Shi K, 2005, P NATL ACAD SCI USA, V102, P18596, DOI 10.1073/pnas.0506163102; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Smeesters PR, 2011, RES MICROBIOL, V162, P446, DOI 10.1016/j.resmic.2011.02.009; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Soutourina O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000894; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; Tanous C, 2008, J BIOL CHEM, V283, P35551, DOI 10.1074/jbc.M805951200; Tu WY, 2012, J BACTERIOL, V194, P925, DOI 10.1128/JB.06005-11; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; Wang L, 2012, APPL MICROBIOL BIOTE; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	55	19	20	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51047	10.1371/journal.pone.0051047	http://dx.doi.org/10.1371/journal.pone.0051047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239999	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800035
J	Nfon, C; Berhane, Y; Pasick, J; Embury-Hyatt, C; Kobinger, G; Kobasa, D; Babiuk, S				Nfon, Charles; Berhane, Yohannes; Pasick, John; Embury-Hyatt, Carissa; Kobinger, Gary; Kobasa, Darwyn; Babiuk, Shawn			Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1	PLOS ONE			English	Article							A VIRUS; HONG-KONG; HETEROSUBTYPIC IMMUNITY; MONOCLONAL-ANTIBODY; POULTRY; MICE; CHALLENGE; VACCINE; HEMAGGLUTININ; TRANSMISSION	There is a critical need to have vaccines that can protect against emerging pandemic influenza viruses. Commonly used influenza vaccines are killed whole virus that protect against homologous and not heterologous virus. Using chickens we have explored the possibility of using live low pathogenic avian influenza (LPAI) A/goose/AB/223/2005 H1N1 or A/WBS/MB/325/2006 H1N2 to induce immunity against heterologous highly pathogenic avian influenza (HPAI) A/chicken/Vietnam/14/2005 H5N1. H1N1 and H1N2 replicated in chickens but did not cause clinical disease. Following infection, chickens developed nucleoprotein and H1 specific antibodies, and reduced H5N1 plaque size in vitro in the absence of H5 neutralizing antibodies at 21 days post infection (DPI). In addition, heterologous cell mediated immunity (CMI) was demonstrated by antigen-specific proliferation and IFN-gamma secretion in PBMCs re-stimulated with H5N1 antigen. Following H5N1 challenge of both pre-infected and naive controls chickens housed together, all naive chickens developed acute disease and died while H1N1 or H1N2 pre-infected chickens had reduced clinical disease and 70-80% survived. H1N1 or H1N2 pre-infected chickens were also challenged with H5N1 and naive chickens placed in the same room one day later. All pre-infected birds were protected from H5N1 challenge but shed infectious virus to naive contact chickens. However, disease onset, severity and mortality was reduced and delayed in the naive contacts compared to directly inoculated naive controls. These results indicate that prior infection with LPAI virus can generate heterologous protection against HPAI H5N1 in the absence of specific H5 antibody. Citation: Nfon C, Berhane Y, Pasick J, Embury-Hyatt C, Kobinger G, et al. (2012) Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1. PLoS ONE 7(12): e51933. doi: 10.1371/journal.pone.0051933	[Nfon, Charles; Berhane, Yohannes; Pasick, John; Embury-Hyatt, Carissa; Babiuk, Shawn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Kobinger, Gary; Kobasa, Darwyn] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Berhane, Yohannes] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Kobinger, Gary; Kobasa, Darwyn] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Babiuk, Shawn] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada	Canadian Food Inspection Agency; Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Manitoba	Babiuk, S (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	shawn.babiuk@inspection.gc.ca			Canadian Institutes of Health Research influenza team grant FRN [90191]	Canadian Institutes of Health Research influenza team grant FRN(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research influenza team grant FRN# 90191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNINK JR, 1987, J VIROL, V61, P1098, DOI 10.1128/JVI.61.4.1098-1102.1987; Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; Bodewes R, 2011, J VIROL, V85, P2695, DOI 10.1128/JVI.02371-10; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Butler D, 2010, NATURE, V464, P1112, DOI 10.1038/4641112a; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; Dalgaard TS, 2010, VACCINE, V28, P4506, DOI 10.1016/j.vaccine.2010.04.044; Drew TW, 2008, OIE MANUAL DIAGNOSTI, P465; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fouchier RAM, 2012, SCIENCE, V335, P662, DOI 10.1126/science.1218376; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kawaoka Y, 2012, NATURE, V482, P155, DOI 10.1038/nature10884; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Masic A, 2009, J VIROL, V83, P10198, DOI 10.1128/JVI.00926-09; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; Pederson J, 2008, METHODS MOL BIOL AVI; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Shi JZ, 2012, ANTIVIR RES, V93, P346, DOI 10.1016/j.antiviral.2012.01.001; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suarez DL, 2000, AVIAN DIS, V44, P356, DOI 10.2307/1592550; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Van Reeth K, 2009, VACCINE, V27, P6330, DOI 10.1016/j.vaccine.2009.03.021; Webster R, 2002, WHO MANUAL ANIMAL IN; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhou EM, 1998, AVIAN DIS, V42, P517, DOI 10.2307/1592678	40	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51933	10.1371/journal.pone.0051933	http://dx.doi.org/10.1371/journal.pone.0051933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240067	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800103
J	Osamor, VC; Adebiyi, EF; Oyelade, JO; Doumbia, S				Osamor, Victor Chukwudi; Adebiyi, Ezekiel Femi; Oyelade, Jelilli Olarenwaju; Doumbia, Seydou			Reducing the Time Requirement of k-Means Algorithm	PLOS ONE			English	Article							EXPRESSION DATA	Traditional k-means and most k-means variants are still computationally expensive for large datasets, such as microarray data, which have large datasets with large dimension size d. In k-means clustering, we are given a set of n data points in d-dimensional space R-d and an integer k. The problem is to determine a set of k points in R-d, called centers, so as to minimize the mean squared distance from each data point to its nearest center. In this work, we develop a novel k-means algorithm, which is simple but more efficient than the traditional k-means and the recent enhanced k-means. Our new algorithm is based on the recently established relationship between principal component analysis and the k-means clustering. We provided the correctness proof for this algorithm. Results obtained from testing the algorithm on three biological data and six non-biological data (three of these data are real, while the other three are simulated) also indicate that our algorithm is empirically faster than other known k-means algorithms. We assessed the quality of our algorithm clusters against the clusters of a known structure using the Hubert-Arabie Adjusted Rand index (ARI(HA)). We found that when k is close to d, the quality is good (ARI(HA)> 0.8) and when k is not close to d, the quality of our new k-means algorithm is excellent (ARI(HA)> 0.9). In this paper, emphases are on the reduction of the time requirement of the k-means algorithm and its application to microarray data due to the desire to create a tool for clustering and malaria research. However, the new clustering algorithm can be used for other clustering needs as long as an appropriate measure of distance between the centroids and the members is used. This has been demonstrated in this work on six non-biological data. Citation: Osamor VC, Adebiyi EF, Oyelade JO, Doumbia S (2012) Reducing the Time Requirement of k-Means Algorithm. PLoS ONE 7(12): e49946. doi:10.1371/journal.pone.0049946	[Osamor, Victor Chukwudi; Adebiyi, Ezekiel Femi; Oyelade, Jelilli Olarenwaju] Covenant Univ, Coll Sci & Technol, Dept Comp & Informat Sci, Ota, Ogun State, Nigeria; [Doumbia, Seydou] Univ Bamako, MRTC, Bamako, Mali	Covenant University; University of Bamako	Adebiyi, EF (corresponding author), Covenant Univ, Coll Sci & Technol, Dept Comp & Informat Sci, Ota, Ogun State, Nigeria.	e.adebiyi@daad-alumni.de	Osamor, Victor/P-1264-2019; Oyelade, Jelili/O-2157-2019; Oyelade, Jelili O./M-8123-2013	Oyelade, Jelili/0000-0002-5476-4992; Osamor, Victor/0000-0003-1868-0967	Covenant University Staff Development grant	Covenant University Staff Development grant	This work was funded by the Covenant University Staff Development grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2002, DNA MICROARRAYS GENE; Bezdek JC, 1981, PATTERN RECOGNITION, DOI 10.1007/978-1-4757-0450-1; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Dash B., 2010, J INT J ENG SCI TECH, V2, P59, DOI [10.4314/ijest.v2i2.59139, DOI 10.4314/IJEST.V2I2.59139]; Deelers S, 2007, PROC WRLD ACAD SCI E, V26, P323; Dembele D, 2003, BIOINFORMATICS, V19, P973, DOI 10.1093/bioinformatics/btg119; Ding C, 2004, SIAM PROC S, P497; Ding C., 2004, ACM INT C P SERIES, V69, P29; Fahim A., 2006, J ZHEJIANG U SCI A, V7, P1626, DOI 10.1631/jzus.2006.A1626; FAN K, 1949, P NATL ACAD SCI USA, V35, P652, DOI 10.1073/pnas.35.11.652; Feng Yu, 2006, P 20 ANN C NEUR INF; Hamerly G., 2003, P 17 ANN C NEUR INF; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Kanungo T, 2004, COMP GEOM-THEOR APPL, V28, P89, DOI 10.1016/j.comgeo.2004.03.003; Kumar A, 2004, ANN IEEE SYMP FOUND, P454, DOI 10.1109/FOCS.2004.7; Kumar R., 2011, INT J INNOVATION MAN, V2, P49; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lloyd S., 1957, IEEE T INFORM THEORY; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Nazeer KAA, 2009, LECT NOTES ENG COMP, P308; Osamor V, 2009, INT J ENG TECHNOL, V2, P215; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SELIM SZ, 1984, IEEE T PATTERN ANAL, V6, P81, DOI 10.1109/TPAMI.1984.4767478; Steinley D, 2004, PSYCHOL METHODS, V9, P386, DOI 10.1037/1082-989X.9.3.386; Tajunisha N., 2011, INT J DATABASE MGT S, V3, P196; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Yedla M., 2010, INT J COMPUT SCI INF, V1, P121; Yona Golan, 2009, V541, P479, DOI 10.1007/978-1-59745-243-4_21; Zha HY, 2002, ADV NEUR IN, V14, P1057	30	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49946	10.1371/journal.pone.0049946	http://dx.doi.org/10.1371/journal.pone.0049946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239974	Green Published, gold			2022-12-25	WOS:000312290800012
J	Pinheiro, MB; Antonelli, LR; Sathler-Avelar, R; Vitelli-Avelar, DM; Spindola-de-Miranda, S; Guimaraes, TMPD; Teixeira-Carvalho, A; Martins, OA; Toledo, VPCP				Pinheiro, Melina B.; Antonelli, Lis R.; Sathler-Avelar, Renato; Vitelli-Avelar, Danielle M.; Spindola-de-Miranda, Silvana; Guimaraes, Tania M. P. D.; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo A.; Toledo, Vicente P. C. P.			CD4-CD8-alpha beta and gamma delta T Cells Display Inflammatory and Regulatory Potentials during Human Tuberculosis	PLOS ONE			English	Article							DOUBLE-NEGATIVE CD4(-)CD8(-); ACTIVE PULMONARY TUBERCULOSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; RHEUMATOID-ARTHRITIS; TH1 RESPONSES; LYMPHOCYTES-T; INFECTION	T-cells play an important role controlling immunity against pathogens and therefore influence the outcome of human diseases. Although most T-lymphocytes co-express either CD4 or CD8, a smaller T-cell subset found the in the human peripheral blood that expresses the alpha beta or gamma delta T-cell-receptor (TCR) lacks the CD4 and CD8 co-receptors. These double negative (DN) T-cells have been shown to display important immunological functions in human diseases. To better understand the role of DN T-cells in human Mycobacterium tuberculosis, we have characterized their frequency, activation and cytokine profile in a well-defined group of tuberculosis patients, categorized as severe and non-severe based on their clinical status. Our data showed that whereas high frequency of alpha beta DN T-cells observed in M. tuberculosis-infected patients are associated with disease severity, decreased proportion of gamma delta DN T-cells are found in patients with severe tuberculosis. Together with activation of CD4(+) and CD8(+) T-cells, higher frequencies of both alpha beta and gamma delta DN T-cells from tuberculosis patients also express the chronic activation marker HLA-DR. However, the expression of CD69, an early activation marker, is selectively observed in DN T-cells. Interestingly, while alpha beta and gamma delta DN T-cells from patients with non-severe tuberculosis display a pro-inflammatory cytokine profile, characterized by enhanced IFN-gamma, the gamma delta DN T-cells from patients with severe disease express a modulatory profile exemplified by enhanced interleukin-10 production. Overall, our findings suggest that alpha beta and gamma delta DN T-cell present disparate immunoregulatory potentials and seems to contribute to the development/maintenance of distinct clinical aspects of TB, as part of the complex immunological network triggered by the TB infection.	[Antonelli, Lis R.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunopatol, Belo Horizonte, MG, Brazil; [Pinheiro, Melina B.; Guimaraes, Tania M. P. D.; Toledo, Vicente P. C. P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Sathler-Avelar, Renato; Vitelli-Avelar, Danielle M.; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo A.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil; [Spindola-de-Miranda, Silvana] Univ Fed Minas Gerais, Dept Clin Med, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Antonelli, LR (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunopatol, Belo Horizonte, MG, Brazil.	lisantonelli@cpqrr.fiocruz.br; toledovp.bh@terra.com.br	Martins-Filho, Olindo Assis/ABE-6278-2021; guimarães, Tania Mara Pinto Dabés/ABD-1337-2021; Antonelli, Lis/R-4910-2019; de Miranda, S Spindola/A-7335-2013; Antonelli, Lis/G-2907-2012; Antonelli, Guido/K-7915-2016	Martins-Filho, Olindo Assis/0000-0002-5494-4889; Antonelli, Lis/0000-0002-4969-8812; 	Foundation for Research Support of Minas Gerais (FAPEMIG); National Counsel of Technological and Scientific Development (CNPq)	Foundation for Research Support of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank Foundation for Research Support of Minas Gerais (FAPEMIG) and National Counsel of Technological and Scientific Development (CNPq) for the financial support and the Program for Technological Development in Tools for Health - PDTIS - FIOCRUZ for use of its facilities. LRA, ATC and OAMF are CNPq fellows (PQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1995, J INFECT DIS, V171, P400, DOI 10.1093/infdis/171.2.400; Al-Moamary MS, 1999, CHEST, V116, P726, DOI 10.1378/chest.116.3.726; Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Villani FNA, 2010, INFECT IMMUN, V78, P4421, DOI 10.1128/IAI.00179-10; Antonelli LRV, 2006, INFECT IMMUN, V74, P6317, DOI 10.1128/IAI.00890-06; BARNES PF, 1992, J INFECT DIS, V165, P506, DOI 10.1093/infdis/165.3.506; Botha T, 2003, J IMMUNOL, V171, P3110, DOI 10.4049/jimmunol.171.6.3110; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Byrd TF, 1997, J CLIN INVEST, V99, P2518, DOI 10.1172/JCI119436; Casetti R, 2008, CELL MOL IMMUNOL, V5, P161, DOI 10.1038/cmi.2008.20; Del Prete G.F., 1993, J IMMUNOL, V150, P1; DELLABONA P, 1993, J EXP MED, V177, P1763, DOI 10.1084/jem.177.6.1763; Derrick SC, 2007, IMMUNOLOGY, V120, P192, DOI 10.1111/j.1365-2567.2006.02491.x; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Gioia C, 2003, INT J IMMUNOPATH PH, V16, P247, DOI 10.1177/039463200301600310; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; JANIS EM, 1989, SCIENCE, V244, P713, DOI 10.1126/science.2524098; Jankovic D, 2007, NAT IMMUNOL, V8, P1281, DOI 10.1038/ni1207-1281; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Liu MF, 1999, CLIN RHEUMATOL, V18, P227, DOI 10.1007/s100670050089; Liu MF, 1998, SCAND J RHEUMATOL, V27, P130; Montoya CJ, 2008, CLIN IMMUNOL, V127, P1, DOI 10.1016/j.clim.2007.12.006; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Priya VHS, 2010, CYTOKINE, V52, P190, DOI 10.1016/j.cyto.2010.07.001; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Sieling PA, 2000, J IMMUNOL, V165, P5338, DOI 10.4049/jimmunol.165.9.5338; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Streitz M, 2011, J INFECT DIS, V203, P378, DOI 10.1093/infdis/jiq065; Thomson CW, 2006, IMMUNOL RES, V35, P163, DOI 10.1385/IR:35:1:163; THOMSSEN H, 1995, IMMUNOLOGY, V85, P33; UETA C, 1994, INFECT IMMUN, V62, P5434, DOI 10.1128/IAI.62.12.5434-5441.1994; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960	42	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50923	10.1371/journal.pone.0050923	http://dx.doi.org/10.1371/journal.pone.0050923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239994	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800030
J	Steenhard, BM; Vanacore, R; Friedman, D; Zelenchuk, A; Stroganova, L; Isom, K; St John, PL; Hudson, BG; Abrahamson, DR				Steenhard, Brooke M.; Vanacore, Roberto; Friedman, David; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Hudson, Billy G.; Abrahamson, Dale R.			Upregulated Expression of Integrin alpha 1 in Mesangial Cells and Integrin alpha 3 and Vimentin in Podocytes of Col4a3-Null (Alport) Mice	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEINS; EXTRACELLULAR-MATRIX RECEPTORS; BASEMENT-MEMBRANES; IV COLLAGEN; MOUSE MODEL; KIDNEY; LACKING; LAMININ; NESTIN; DESMIN	Alport disease in humans, which usually results in proteinuria and kidney failure, is caused by mutations to the COL4A3, COL4A4, or COL4A5 genes, and absence of collagen alpha 3 alpha 4 alpha 5(IV) networks found in mature kidney glomerular basement membrane (GBM). The Alport mouse harbors a deletion of the Col4a3 gene, which also results in the lack of GBM collagen alpha 3 alpha 4 alpha 5(IV). This animal model shares many features with human Alport patients, including the retention of collagen alpha 1 alpha 2 alpha 1(IV) in GBMs, effacement of podocyte foot processes, gradual loss of glomerular barrier properties, and progression to renal failure. To learn more about the pathogenesis of Alport disease, we undertook a discovery proteomics approach to identify proteins that were differentially expressed in glomeruli purified from Alport and wild-type mouse kidneys. Pairs of cy3- and cy5-labeled extracts from 5-week old Alport and wild-type glomeruli, respectively, underwent 2-dimensional difference gel electrophoresis. Differentially expressed proteins were digested with trypsin and prepared for mass spectrometry, peptide ion mapping/fingerprinting, and protein identification through database searching. The intermediate filament protein, vimentin, was upregulated similar to 2.5 fold in Alport glomeruli compared to wild-type. Upregulation was confirmed by quantitative real time RT-PCR of isolated Alport glomeruli (5.4 fold over wild-type), and quantitative confocal immunofluorescence microscopy localized over-expressed vimentin specifically to Alport podocytes. We next hypothesized that increases in vimentin abundance might affect the basement membrane protein receptors, integrins, and screened Alport and wild-type glomeruli for expression of integrins likely to be the main receptors for GBM type IV collagen and laminin. Quantitative immunofluorescence showed an increase in integrin alpha 1 expression in Alport mesangial cells and an increase in integrin alpha 3 in Alport podocytes. We conclude that overexpression of mesangial integrin alpha 1 and podocyte vimentin and integrin alpha 3 may be important features of glomerular Alport disease, possibly affecting cell-signaling, cell shape and cellular adhesion to the GBM.	[Steenhard, Brooke M.; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Abrahamson, Dale R.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Steenhard, Brooke M.; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Abrahamson, Dale R.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Friedman, David] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Vanderbilt University; Vanderbilt University	Abrahamson, DR (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.	dabrahamson@kumc.edu	Vanacore, Roberto/AAD-6399-2020; Singh, Shree Ram/B-7614-2008	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100; Singh, Shree Ram/0000-0001-6545-583X	National Institutes of Health [P01DK065123, P20GM104936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK065123, R01DK018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health grants P01DK065123 and P20GM104936. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2465, DOI 10.1681/ASN.2007030328; Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Abrahamson DR, 2003, KIDNEY INT, V63, P826, DOI 10.1046/j.1523-1755.2003.00800.x; ABRAHAMSON DR, 1989, J CELL BIOL, V109, P3477, DOI 10.1083/jcb.109.6.3477; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Cosgrove D, 2007, KIDNEY INT, V71, P615, DOI 10.1038/sj.ki.5002115; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Cosgrove D, 2000, AM J PATHOL, V157, P1649, DOI 10.1016/S0002-9440(10)64802-X; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Franco AT, 2009, MOL CELL PROTEOMICS, V8, P1947, DOI 10.1074/mcp.M900139-MCP200; Haraldsson B, 2012, CURR OPIN NEPHROL HY, V21, P258, DOI 10.1097/MNH.0b013e3283522e7a; Heidet L, 2003, AM J PATHOL, V163, P1633, DOI 10.1016/S0002-9440(10)63520-1; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; HOLTHOFER H, 1984, LAB INVEST, V50, P552; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kalluri R, 1997, J CLIN INVEST, V99, P2470, DOI 10.1172/JCI119431; Kashtan CE, 2001, J AM SOC NEPHROL, V12, P252, DOI 10.1681/ASN.V122252; Kashtan CE, 2011, NEPHRON CLIN PRACT, V118, pC9, DOI 10.1159/000320876; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kreis S, 2005, EXP CELL RES, V305, P110, DOI 10.1016/j.yexcr.2004.12.023; Kuhara T, 1997, J AM SOC NEPHROL, V8, P1679; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Mathew S, 2012, PEDIATR NEPHROL, V27, P891, DOI 10.1007/s00467-011-1890-1; Meehan DT, 2009, KIDNEY INT, V76, P968, DOI 10.1038/ki.2009.324; Miner JH, 2011, ORGANOGENESIS, V7, P75, DOI 10.4161/org.7.2.15275; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Ostalska-Nowicka D, 2004, HISTOCHEM CELL BIOL, V121, P109, DOI 10.1007/s00418-004-0619-7; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Perry J, 2007, PEDIATR DEVEL PATHOL, V10, P369, DOI 10.2350/06-11-0193.1; Pozzi A, 2011, CURR OPIN CELL BIOL, V23, P547, DOI 10.1016/j.ceb.2011.04.003; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; SHIKATA K, 1995, AM J KIDNEY DIS, V25, P680, DOI 10.1016/0272-6386(95)90542-1; STAMENKOVIC I, 1986, AM J PATHOL, V125, P465; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Wang RX, 2000, KIDNEY INT, V57, P1847, DOI 10.1046/j.1523-1755.2000.00034.x; Wyss HM, 2011, AM J PHYSIOL-CELL PH, V300, pC397, DOI 10.1152/ajpcell.00438.2010; Yaoita E, 1999, HISTOCHEM CELL BIOL, V111, P107, DOI 10.1007/s004180050340; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9; Zou J, 2007, CHINESE MED J-PEKING, V120, P1203, DOI 10.1097/00029330-200707010-00018	62	13	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50745	10.1371/journal.pone.0050745	http://dx.doi.org/10.1371/journal.pone.0050745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236390	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100032
J	Wigelsworth, DJ; Ruthel, G; Schnell, L; Herrlich, P; Blonder, J; Veenstra, TD; Carman, RJ; Wilkins, TD; Guy, TVN; Pauillac, S; Gibert, M; Sauvonnet, N; Stiles, BG; Popoff, MR; Barth, H				Wigelsworth, Darran J.; Ruthel, Gordon; Schnell, Leonie; Herrlich, Peter; Blonder, Josip; Veenstra, Timothy D.; Carman, Robert J.; Wilkins, Tracy D.; Guy Tran Van Nhieu; Pauillac, Serge; Gibert, Maryse; Sauvonnet, Nathalie; Stiles, Bradley G.; Popoff, Michel R.; Barth, Holger			CD44 Promotes Intoxication by the Clostridial Iota-Family Toxins	PLOS ONE			English	Article							BOTULINUM C2 TOXIN; BINDING DOMAIN; LIPID RAFTS; RECEPTOR; ACTIN; PROTEINS; ASSOCIATION; COMPONENT; INTERNALIZATION; POLYMERIZATION	Various pathogenic clostridia produce binary protein toxins associated with enteric diseases of humans and animals. Separate binding/translocation (B) components bind to a protein receptor on the cell surface, assemble with enzymatic (A) component(s), and mediate endocytosis of the toxin complex. Ultimately there is translocation of A component(s) from acidified endosomes into the cytosol, leading to destruction of the actin cytoskeleton. Our results revealed that CD44, a multifunctional surface protein of mammalian cells, facilitates intoxication by the iota family of clostridial binary toxins. Specific antibody against CD44 inhibited cytotoxicity of the prototypical Clostridium perfringens iota toxin. Versus CD44(+) melanoma cells, those lacking CD44 bound less toxin and were dose-dependently resistant to C. perfringens iota, as well as Clostridium difficile and Clostridium spiroforme iota-like, toxins. Purified CD44 specifically interacted in vitro with iota and iota-like, but not related Clostridium botulinum C2, toxins. Furthermore, CD44 knockout mice were resistant to iota toxin lethality. Collective data reveal an important role for CD44 during intoxication by a family of clostridial binary toxins.	[Stiles, Bradley G.] Wilson Coll, Dept Biol, Chambersburg, PA 17201 USA; [Ruthel, Gordon] Univ Penn, Core Imaging Facil, Sch Vet Med, Philadelphia, PA 19104 USA; [Schnell, Leonie; Barth, Holger] Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, Ulm, Germany; [Wigelsworth, Darran J.] USA, Med Res Inst Infect Dis, Integrated Toxicol Div, Frederick, MD USA; [Herrlich, Peter] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Blonder, Josip; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Frederick, MD 21701 USA; [Carman, Robert J.; Wilkins, Tracy D.] TechLab Inc, Blacksburg, VA USA; [Guy Tran Van Nhieu] Coll France, Dept Intracellular Commun & Infect Microorgan, F-75231 Paris, France; [Pauillac, Serge; Gibert, Maryse; Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Sauvonnet, Nathalie] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France	University of Pennsylvania; Ulm University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); TechLab; UDICE-French Research Universities; PSL Research University Paris; College de France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Stiles, BG (corresponding author), Wilson Coll, Dept Biol, Chambersburg, PA 17201 USA.	bstiles@wilson.edu; mpopoff@pasteur.fr; holger.barth@uni-ulm.de	Barth, Holger/E-7920-2013; Popoff, Michel/O-7719-2016; Van Nhieu, Guy Tran/Y-6359-2018; Ruthel, Gordon/GYU-9133-2022	Popoff, Michel/0000-0001-9305-8989; Van Nhieu, Guy Tran/0000-0002-3901-2186; Ruthel, Gordon/0000-0001-9193-5589; sauvonnet, nathalie/0000-0003-0306-3376	Institut Pasteur; Faculty Fund for Research at Wilson College; Faculty of Medicine at the University of Ulm plus Deutsche Forschungsgemeinschaft (DFG) [BA 2087/2-1]	Institut Pasteur(European Commission); Faculty Fund for Research at Wilson College; Faculty of Medicine at the University of Ulm plus Deutsche Forschungsgemeinschaft (DFG)	Funding was provided in part by the Institut Pasteur (MRP), Faculty Fund for Research at Wilson College (BGS), as well as the Faculty of Medicine at the University of Ulm plus Deutsche Forschungsgemeinschaft (DFG grant BA 2087/2-1) to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1992, MOL MICROBIOL, V6, P2905, DOI 10.1111/j.1365-2958.1992.tb01749.x; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2012, TOXICON, V60, P572, DOI 10.1016/j.toxicon.2012.04.338; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; Blonder J, 2005, J PROTEOME RES, V4, P523, DOI 10.1021/pr049790s; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Freistadt MS, 1997, MOL IMMUNOL, V34, P1247, DOI 10.1016/S0161-5890(98)00003-0; FRITZ G, 1995, INFECT IMMUN, V63, P2334, DOI 10.1128/IAI.63.6.2334-2340.1995; Gibert M, 2011, CELL MICROBIOL, V13, P154, DOI 10.1111/j.1462-5822.2010.01527.x; Hale ML, 2004, INFECT IMMUN, V72, P2186, DOI 10.1128/IAI.72.4.2186-2193.2004; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hilger H, 2009, INFECT IMMUN, V77, P5593, DOI 10.1128/IAI.00710-09; Holdeman L.V., 1975, ANAEROBE LAB MANUAL; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lee JL, 2008, MOL CELL BIOL, V28, P5710, DOI 10.1128/MCB.00186-08; Lefebvre DC, 2010, MOL IMMUNOL, V47, P1882, DOI 10.1016/j.molimm.2010.03.018; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Liu D, 1996, J EXP MED, V183, P1987, DOI 10.1084/jem.183.5.1987; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; Martchenko M, 2010, P NATL ACAD SCI USA, V107, P15583, DOI 10.1073/pnas.1010145107; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; Nagahama M, 2004, INFECT IMMUN, V72, P3267, DOI 10.1128/IAI.72.6.3267-3275.2004; Nagahama M, 2002, INFECT IMMUN, V70, P1909, DOI 10.1128/IAI.70.4.1909-1914.2002; Nagahama M, 2009, INFECT IMMUN, V77, P5139, DOI 10.1128/IAI.00638-09; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Perelle S, 1997, FEMS MICROBIOL LETT, V146, P117, DOI [10.1016/S0378-1097(96)00463-6, 10.1111/j.1574-6968.1997.tb10180.x]; Pilpa RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002354; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Protin U, 1999, J IMMUNOL, V163, P4917; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Richard JF, 2002, MOL MICROBIOL, V43, P907, DOI 10.1046/j.1365-2958.2002.02806.x; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; SHEPLEY MP, 1994, J VIROL, V68, P1301, DOI 10.1128/JVI.68.3.1301-1308.1994; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; STILES BG, 1986, INFECT IMMUN, V54, P683, DOI 10.1128/IAI.54.3.683-688.1986; Stiles BG, 2002, BIOCHEM J, V367, P801, DOI 10.1042/BJ20020566; Stiles BG, 2000, INFECT IMMUN, V68, P3475, DOI 10.1128/IAI.68.6.3475-3484.2000; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509	60	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51356	10.1371/journal.pone.0051356	http://dx.doi.org/10.1371/journal.pone.0051356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236484	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100104
J	Xiang, BG; Zhang, GY; Ren, HM; Sunkara, M; Morris, AJ; Gartner, TK; Smyth, SS; Li, ZY				Xiang, Binggang; Zhang, Guoying; Ren, Hongmei; Sunkara, Manjula; Morris, Andrew J.; Gartner, T. Kent; Smyth, Susan S.; Li, Zhenyu			The P2Y(12) Antagonists, 2MeSAMP and Cangrelor, Inhibit Platelet Activation through P2Y(12)/G(i)-Dependent Mechanism	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ANTIPLATELET THERAPY; ANTITHROMBOTIC DRUGS; IN-VITRO; RECEPTOR; ADP; AGGREGATION; RAP1B; PHOSPHORYLATION; IDENTIFICATION	Background: ADP is an important physiological agonist that induces integrin activation and platelet aggregation through its receptors P2Y(1) (G alpha(q)-coupled) and P2Y(12) (G alpha(i)-coupled). P2Y(12) plays a critical role in platelet activation and thrombosis. Adenosine-based P2Y(12) antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt hydrate (2MeSAMP) and Cangrelor (AR-C69931MX) have been widely used to demonstrate the role of P2Y(12) in platelet function. Cangrelor is being evaluated in clinical trials of thrombotic diseases. However, a recent study reported that both 2MeSAMP and Cangrelor raise intra-platelet cAMP levels and inhibit platelet aggregation through a P2Y(12)-independent mechanism. Methodology/Principal Findings: The present work, using P2Y(12) deficient mice, sought to clarify previous conflicting reports and to elucidate the mechanisms by which 2MeSAMP and Cangrelor inhibit platelet activation and thrombosis. 2MeSAMP and Cangrelor inhibited aggregation and ATP release of wild-type but not P2Y(12) deficient platelets. 2MeSAMP and Cangrelor neither raised intracellular cAMP concentrations nor induced phosphorylation of vasodilator-stimulated phosphoprotein (VASP) in washed human or mouse platelets. Furthermore, unlike the activators (PGI(2) and forskolin) of the cAMP pathway, 2MeSAMP and Cangrelor failed to inhibit Ca2+ mobilization, Akt phosphorylation, and Rap1b activation in P2Y(12) deficient platelets. Importantly, while injection of Cangrelor inhibited thrombus formation in a FeCl3-induced thrombosis model in wild-type mice, it failed to affect thrombus formation in P2Y(12) deficient mice. Conclusions: These data together demonstrate that 2MeSAMP and Cangrelor inhibit platelet function through the P2Y(12)-dependent mechanism both in vitro and in vivo. Citation: Xiang B, Zhang G, Ren H, Sunkara M, Morris AJ, et al. (2012) The P2Y(12) Antagonists, 2MeSAMP and Cangrelor, Inhibit Platelet Activation through P2Y(12)/G(i)-Dependent Mechanism. PLoS ONE 7(12): e51037. doi:10.1371/journal.pone.0051037	[Xiang, Binggang; Zhang, Guoying; Ren, Hongmei; Sunkara, Manjula; Morris, Andrew J.; Smyth, Susan S.; Li, Zhenyu] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY USA; [Gartner, T. Kent] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [Smyth, Susan S.] Lexington VA Med Ctr, Lexington, KY USA	University of Kentucky; University of Memphis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Li, ZY (corresponding author), Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY USA.	zhenyuli08@uky.edu	sunkara, Manjula/H-7944-2016; Xiang, Binggang/N-6494-2013	sunkara, Manjula/0000-0001-6151-1929; 	American Heart Association Midwest [0855698G]; Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease Grant from the National Institutes of Health/National Center for Research Resources [P20RR021954]; American Heart Association Postdoctoral Fellowship Award; Lexington VA Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078663] Funding Source: NIH RePORTER	American Heart Association Midwest(American Heart Association); Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease Grant from the National Institutes of Health/National Center for Research Resources; American Heart Association Postdoctoral Fellowship Award(American Heart Association); Lexington VA Medical Center(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by American Heart Association Midwest affiliate Grant-in-Aid 0855698G (to ZL), and in part by the Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease Grant P20RR021954 from the National Institutes of Health/National Center for Research Resources. B. Xiang is a recipient of the American Heart Association Postdoctoral Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by resources provided by the Lexington VA Medical Center. We are grateful to Dr. Richard Charnigo for his assistance with statistical analysis and Susan Quick for editorial assistance. Cangrelor was provided free of charge from The Medicine's Company.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Angiolillo DJ, 2012, JAMA-J AM MED ASSOC, V307, P265, DOI 10.1001/jama.2011.2002; AU JLS, 1989, CLIN CHEM, V35, P48; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bodnar RJ, 2002, J BIOL CHEM, V277, P47080, DOI 10.1074/jbc.M208329200; BUTT E, 1994, J BIOL CHEM, V269, P14509; CATTANEO M, 1992, BLOOD, V80, P2787; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Damman P, 2012, J THROMB THROMBOLYS, V33, P143, DOI 10.1007/s11239-011-0667-5; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Faxon DP, 2010, NAT REV CARDIOL, V7, P124, DOI 10.1038/nrcardio.2009.247; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Jantzen HM, 2001, J CLIN INVEST, V108, P477; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Johnston-Cox HA, 2011, J CELL PHYSIOL, V226, P46, DOI 10.1002/jcp.22379; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Kunapuli SP, 2003, CURR PHARM DESIGN, V9, P2303, DOI 10.2174/1381612033453947; Larson MK, 2003, BLOOD, V101, P1409, DOI 10.1182/blood-2002-05-1533; Liu J, 2008, J THROMB HAEMOST, V6, P1915, DOI 10.1111/j.1538-7836.2008.03135.x; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; Lova P, 2004, J BIOL CHEM, V279, P25299, DOI 10.1074/jbc.M313199200; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Maloney SF, 2010, INTEGR BIOL-UK, V2, P183, DOI 10.1039/b919728a; Ohlmann P, 1995, BIOCHEM J, V312, P775, DOI 10.1042/bj3120775; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Shankar H, 2006, BLOOD, V108, P3027, DOI 10.1182/blood-2006-03-010330; Smyth SS, 2009, ARTERIOSCL THROM VAS, V29, P449, DOI 10.1161/ATVBAHA.108.176388; Srinivasan S, 2009, J BIOL CHEM, V284, P16108, DOI 10.1074/jbc.M809780200; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Storey RF, 2001, PLATELETS, V12, P443, DOI 10.1080/09537100120085450; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Woulfe DS, 2010, EXPERT REV HEMATOL, V3, P81, DOI 10.1586/EHM.09.75; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x; Zhang GY, 2011, J BIOL CHEM, V286, P39466, DOI 10.1074/jbc.M111.239608; Zhang GY, 2011, BLOOD, V118, P3670, DOI 10.1182/blood-2011-03-341107	41	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51037	10.1371/journal.pone.0051037	http://dx.doi.org/10.1371/journal.pone.0051037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236426	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700028
J	Chan, CC; Cheng, LY; Lu, J; Huang, YH; Chiou, SH; Tsai, PH; Huo, TI; Lin, HC; Lee, FY				Chan, Che-Chang; Cheng, Ling-Yi; Lu, Jean; Huang, Yi-Hsiang; Chiou, Shih-Hwa; Tsai, Ping-Hsing; Huo, Teh-Ia; Lin, Han-Chieh; Lee, Fa-Yauh			The Role of Interferon-gamma Inducible Protein-10 in a Mouse Model of Acute Liver Injury Post Induced Pluripotent Stem Cells Transplantation	PLOS ONE			English	Article							HEPATOCYTE TRANSPLANTATION; CHRONIC HEPATITIS; CXC CHEMOKINES; DISEASE; MICE; REGENERATION; EXPRESSION; FIBROSIS; THERAPY; INHIBITION	Background: Liver injuries are important medical problems that require effective therapy. Stem cell or hepatocyte transplantation has the potential to restore function of the damaged liver and ameliorate injury. However, the regulatory factors crucial for the repair and regeneration after cell transplantation have not been fully characterized. Our study investigated the effects and the expression of the regulatory factors in mouse models of acute liver injury either transplanted with the induced pluripotent stem cells (iPS) or the hepatocytes that differentiated from iPS cells (iHL). Methods/Principal Findings: Mice received CCl4 injection and were randomized to receive vehicle, iPS, or iHL transfusions vial tail veins and were observed for 24, 48 or 72 hours. The group of mice with iPS transplantation performed better than the group of mice receiving iHL in reducing the serum alanine aminotransferase, aspartate aminotransferase, and liver necrosis areas at 24 hours after CCl4 injury. Moreover, iPS significantly increased the numbers of proliferating hepatocytes at 48 hours. Cytokine array identified that chemokine IP-10 could be the potential regulatory factor that ameliorates liver injury. Further studies revealed that iPS secreted IP-10 in vitro and transfusion of iPS increased IP-10 protein and mRNA expressions in the injured livers in vivo. The primary hepatocytes and non-parenchyma cells were isolated from normal and injured livers. Hepatocytes from injured livers that received iPS treatment expressed more IP-10 mRNA than their nonhepatocyte counter-parts. In addition, animal studies revealed that administration of recombinant IP-10 (rIP-10) effectively reduced liver injuries while IP-10-neutralizing antibody attenuated the protective effects of iPS and decreased hepatocyte proliferation. Both iPS and rIP-10 significantly reduced the 72-hour mortality rate in mice that received multiple CCl4-injuries. Conclusions/Significance: These findings suggested that IP-10 may have an important regulatory role in facilitating the repair and regeneration of injured liver after iPS transplantation.	[Chan, Che-Chang; Cheng, Ling-Yi; Huang, Yi-Hsiang; Chiou, Shih-Hwa] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chiou, Shih-Hwa; Tsai, Ping-Hsing; Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lu, Jean] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chan, Che-Chang; Cheng, Ling-Yi; Huang, Yi-Hsiang; Huo, Teh-Ia; Lin, Han-Chieh; Lee, Fa-Yauh] Taipei Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Chiou, Shih-Hwa; Tsai, Ping-Hsing] Taipei Vet Gen Hosp, Dept Med Res & Educ, Stem Cell Lab, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Huang, YH (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.	yhhuang@vghtpe.gov.tw; shchiou@vghtpe.gov.tw		Huang, Yi-Hsiang/0000-0001-5241-5425	National Science Council [NSC97-2314-B-075-027-MY2, NSC97-3111-B-075-001-MY3, NSC98-2314- B-075-008-MY3]; Taipei Veterans General Hospital [V97B1-014, V98C1-016]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan(Ministry of Education, Taiwan)	This study was supported by research grants from the National Science Council (NSC97-2314-B-075-027-MY2, NSC97-3111-B-075-001-MY3, NSC98-2314- B-075-008-MY3), Taipei Veterans General Hospital (V97B1-014, V98C1-016), and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Bone-Larson CL, 2001, J IMMUNOL, V167, P7077, DOI 10.4049/jimmunol.167.12.7077; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Flohr TR, 2009, CURR OPIN ORGAN TRAN, V14, P64, DOI 10.1097/MOT.0b013e328320fd7b; Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009; Heydtmann M, 2009, HEPATOLOGY, V49, P676, DOI 10.1002/hep.22763; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Kakinuma S, 2009, J GASTROENTEROL, V44, P167, DOI 10.1007/s00535-008-2297-z; Kao CL, 2010, STEM CELLS DEV, V19, P247, DOI 10.1089/scd.2009.0186; Kawashita Y, 2005, SURG TODAY, V35, P705, DOI 10.1007/s00595-005-3024-5; Koniaris LG, 2001, J IMMUNOL, V167, P399, DOI 10.4049/jimmunol.167.1.399; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Nakaya I, 2007, NEPHRON EXP NEPHROL, V107, pE12, DOI 10.1159/000106505; Nanji AA, 1999, HEPATOLOGY, V30, P934, DOI 10.1002/hep.510300402; Narumi S, 1997, J IMMUNOL, V158, P5536; Navarro-Alvarez N, 2009, CURR STEM CELL RES T, V4, P141, DOI 10.2174/157488809788167418; Njoku DB, 2009, J AUTOIMMUN, V32, P52, DOI 10.1016/j.jaut.2008.11.003; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Puppi Juliana, 2009, V481, P1, DOI 10.1007/978-1-59745-201-4_1; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Singh UP, 2008, J INTERF CYTOK RES, V28, P31, DOI 10.1089/jir.2007.0059; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi E, 2006, GASTROENTEROLOGY, V130, P521, DOI 10.1053/j.gastro.2005.10.050; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yamanouchi K, 2009, HEPATOLOGY, V49, P258, DOI 10.1002/hep.22573; Yoneyama H, 2007, MED MOL MORPHOL, V40, P191, DOI 10.1007/s00795-007-0371-x; Yoshimi A, 2009, BIOL BLOOD MARROW TR, V15, P389, DOI 10.1016/j.bbmt.2008.11.021; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zhai YA, 2008, HEPATOLOGY, V47, P207, DOI 10.1002/hep.21986	35	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50577	10.1371/journal.pone.0050577	http://dx.doi.org/10.1371/journal.pone.0050577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227188	gold, Green Submitted, Green Published			2022-12-25	WOS:000312588200048
J	Chen, HD; Hayek, S; Guzman, JR; Gillitt, ND; Ibrahim, SA; Jobin, C; Sang, SM				Chen, Huadong; Hayek, Saeed; Guzman, Javier Rivera; Gillitt, Nicholas D.; Ibrahim, Salam A.; Jobin, Christian; Sang, Shengmin			The Microbiota Is Essential for the Generation of Black Tea Theaflavins-Derived Metabolites	PLOS ONE			English	Article							CANCER CALU-6 CELLS; GALLIC ACID; COLON CARCINOGENESIS; MASS-SPECTROMETRY; BACILLUS-SUBTILIS; GUT MICROBIOME; POLYPHENOLS; APOPTOSIS; HUMANS; GROWTH	Background: Theaflavins including theaflavin (TF), theaflavin-3-gallate (TF3G), theaflavin-3'-gallate (TF3'G), and theaflavin-3,3'-digallate (TFDG), are the most important bioactive polyphenols in black tea. Because of their poor systemic bioavailability, it is still unclear how these compounds can exert their biological functions. The objective of this study is to identify the microbial metabolites of theaflavins in mice and in humans. Methods and Findings: In the present study, we gavaged specific pathogen free (SPF) mice and germ free (GF) mice with 200 mg/kg TFDG and identified TF, TF3G, TF3'G, and gallic acid as the major fecal metabolites of TFDG in SPF mice. These metabolites were absent in TFDG- gavaged GF mice. The microbial bioconversion of TFDG, TF3G, and TF3'G was also investigated in vitro using fecal slurries collected from three healthy human subjects. Our results indicate that TFDG is metabolized to TF, TF3G, TF3'G, gallic acid, and pyrogallol by human microbiota. Moreover, both TF3G and TF3'G are metabolized to TF, gallic acid, and pyrogallol by human microbiota. Importantly, we observed interindividual differences on the metabolism rate of gallic acid to pyrogallol among the three human subjects. In addition, we demonstrated that Lactobacillus plantarum 299v and Bacillus subtilis have the capacity to metabolize TFDG. Conclusions: The microbiota is important for the metabolism of theaflavins in both mice and humans. The in vivo functional impact of microbiota-generated theaflavins-derived metabolites is worthwhile of further study. Citation: Chen H, Hayek S, Rivera Guzman J, Gillitt ND, Ibrahim SA, et al. (2012) The Microbiota Is Essential for the Generation of Black Tea Theaflavins-Derived Metabolites. PLoS ONE 7(12): e51001. doi:10.1371/journal.pone.0051001	[Guzman, Javier Rivera; Jobin, Christian] Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27515 USA; [Guzman, Javier Rivera; Jobin, Christian] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Chen, Huadong; Hayek, Saeed; Sang, Shengmin] N Carolina Agr & Tech State Univ, Ctr Excellence Postharvest Technol, Kannapolis, NC USA; [Hayek, Saeed; Ibrahim, Salam A.] N Carolina Agr & Tech State Univ, Dept Family & Consumer Sci, Greensboro, NC USA; [Gillitt, Nicholas D.] Dole Nutr Res Lab, Kannapolis, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina A&T State University; University of North Carolina; North Carolina A&T State University	Jobin, C (corresponding author), Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27515 USA.	job@med.un.ed; ssang@nact.edu	Ibrahim, Salam/AAC-7678-2019; Chen, Huadong/H-2272-2013	Rivera Guzman, Javier/0000-0001-9004-6739	United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2009-65503-21116, 2012-67017-30175]; USDA-NIFA Transdisciplinary Graduate Training from the National Institute of Food and Agriculture Bioactive Food Components for Optimal Health and Improving Food Quality and Value programs [2010-65200-20354]; National Institutes of Health (NIH) [R01 DK73338, R01 DK47700]; NIH Training, Workforce Development, and Diversity division of the National Institute of General Medical Sciences [K12GM000678, P30 DK034987]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, P30DK034987, R01DK073338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER	United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA)); USDA-NIFA Transdisciplinary Graduate Training from the National Institute of Food and Agriculture Bioactive Food Components for Optimal Health and Improving Food Quality and Value programs; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training, Workforce Development, and Diversity division of the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by funding from United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) grants 2009-65503-21116 (SS) and 2012-67017-30175 (SS), the USDA-NIFA Transdisciplinary Graduate Training grant no. 2010-65200-20354 from the National Institute of Food and Agriculture Bioactive Food Components for Optimal Health and Improving Food Quality and Value programs (SH), National Institutes of Health (NIH) R01 DK73338 (CJ), R01 DK47700 (CJ), the NIH Training, Workforce Development, and Diversity division of the National Institute of General Medical Sciences K12GM000678 (JRG and by P30 DK034987 to CGIBD. The funders had no role in study desigh, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Chen HD, 2011, J CHROMATOGR A, V1218, P7297, DOI 10.1016/j.chroma.2011.08.056; Choi KC, 2009, MOL CANCER RES, V7, P2011, DOI 10.1158/1541-7786.MCR-09-0239; Daykin CA, 2005, J AGR FOOD CHEM, V53, P1428, DOI 10.1021/jf048439o; Droge MJ, 2001, EUR J BIOCHEM, V268, P3332, DOI 10.1046/j.1432-1327.2001.02238.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fotakopoulou I, 2007, J ORG CHEM, V72, P782, DOI 10.1021/jo061871f; Giftson JS, 2010, INVEST NEW DRUG, V28, P251, DOI 10.1007/s10637-009-9241-9; Gordon JI, 2011, P NATL ACAD SCI USA, V108, P4513, DOI 10.1073/pnas.1101958108; Gross G, 2010, J AGR FOOD CHEM, V58, P10236, DOI 10.1021/jf101475m; GUSTAFSSON BE, 1982, SCAND J GASTROENTERO, V17, P117; Han YH, 2008, INT J ONCOL, V33, P1099, DOI 10.3892/ijo_00000099; Han YH, 2008, TOXICOL IN VITRO, V22, P1605, DOI 10.1016/j.tiv.2008.06.014; Han YH, 2008, LUNG CANCER, V59, P301, DOI 10.1016/j.lungcan.2007.08.034; Han YH, 2009, J BIOCHEM MOL TOXIC, V23, P36, DOI 10.1002/jbt.20263; Han YH, 2009, CHEM-BIOL INTERACT, V177, P107, DOI 10.1016/j.cbi.2008.10.014; Henning SM, 2006, J NUTR, V136, P1839, DOI 10.1093/jn/136.7.1839; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hodgson JM, 2000, J AGR FOOD CHEM, V48, P2276, DOI 10.1021/jf000089s; Hong HA, 2009, RES MICROBIOL, V160, P134, DOI 10.1016/j.resmic.2008.11.002; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; Kaur M, 2009, PHARM RES-DORDR, V26, P2133, DOI 10.1007/s11095-009-9926-y; Kawada M, 2001, ANTI-CANCER DRUG, V12, P847, DOI 10.1097/00001813-200111000-00009; Kohri T, 2003, J AGR FOOD CHEM, V51, P5561, DOI 10.1021/jf034450x; Kumar G, 2010, MINI-REV MED CHEM, V10, P492, DOI 10.2174/138955710791384063; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lo C, 2010, INT J ONCOL, V37, P377, DOI 10.3892/ijo_00000686; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Meselhy MR, 1997, CHEM PHARM BULL, V45, P888; MOLIN G, 1993, J APPL BACTERIOL, V74, P314, DOI 10.1111/j.1365-2672.1993.tb03031.x; Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7; Niculescu MD, 2007, J NUTR BIOCHEM, V18, P380, DOI 10.1016/j.jnutbio.2006.06.002; Raina K, 2008, MOL CANCER THER, V7, P1258, DOI 10.1158/1535-7163.MCT-07-2220; Ribitsch D, 2011, BIOTECHNOL PROG; Roowi S, 2010, J AGR FOOD CHEM, V58, P1296, DOI 10.1021/jf9032975; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Sang SM, 2004, BIOORGAN MED CHEM, V12, P459, DOI 10.1016/j.bmc.2003.10.024; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Senapathy JG, 2011, FOOD CHEM TOXICOL, V49, P887, DOI 10.1016/j.fct.2010.12.012; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tabasco R, 2011, FOOD MICROBIOL, V28, P1345, DOI 10.1016/j.fm.2011.06.005; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Yang CJ, 2009, LUNG CANCER, V66, P162, DOI 10.1016/j.lungcan.2009.01.016; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	50	52	53	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51001	10.1371/journal.pone.0051001	http://dx.doi.org/10.1371/journal.pone.0051001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227227	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200088
J	Drew, DR; Hodder, AN; Wilson, DW; Foley, M; Mueller, I; Siba, PM; Dent, AE; Cowman, AF; Beeson, JG				Drew, Damien R.; Hodder, Anthony N.; Wilson, Danny W.; Foley, Michael; Mueller, Ivo; Siba, Peter M.; Dent, Arlene E.; Cowman, Alan F.; Beeson, James G.			Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria	PLOS ONE			English	Article							GROWTH-INHIBITORY ANTIBODIES; VARIANT SURFACE-ANTIGENS; BLOOD-STAGE MALARIA; ERYTHROCYTE INVASION; CANDIDATE ANTIGEN; PREGNANT-WOMEN; IN-VITRO; BINDING; GENES; PROTECTION	Apical Membrane Antigen 1 (AMA1) is a leading malaria vaccine candidate and a target of naturally-acquired human immunity. Plasmodium falciparum AMA1 is polymorphic and in vaccine trials it induces strain-specific protection. This antigenic diversity is a major roadblock to development of AMA1 as a malaria vaccine and understanding how to overcome it is essential. To assess how AMA1 antigenic diversity limits cross-strain growth inhibition, we assembled a panel of 18 different P. falciparum isolates which are broadly representative of global AMA1 sequence diversity. Antibodies raised against four well studied AMA1 alleles (W2Mef, 3D7, HB3 and FVO) were tested for growth inhibition of the 18 different P. falciparum isolates in growth inhibition assays (GIA). All antibodies demonstrated substantial cross-inhibitory activity against different isolates and a mixture of the four different AMA1 antibodies inhibited all 18 isolates tested, suggesting significant antigenic overlap between AMA1 alleles and limited antigenic diversity of AMA1. Cross-strain inhibition by antibodies was only moderately and inconsistently correlated with the level of sequence diversity between AMA1 alleles, suggesting that sequence differences are not a strong predictor of antigenic differences or the cross-inhibitory activity of anti-allele antibodies. The importance of the highly polymorphic C1-L region for inhibitory antibodies and potential vaccine escape was assessed by generating novel transgenic P. falciparum lines for testing in GIA. While the polymorphic C1-L epitope was identified as a significant target of some growth-inhibitory antibodies, these antibodies only constituted a minor proportion of the total inhibitory antibody repertoire, suggesting that the antigenic diversity of inhibitory epitopes is limited. Our findings support the concept that a multi-allele AMA1 vaccine would give broad coverage against the diversity of AMA1 alleles and establish new tools to define polymorphisms important for vaccine escape. Citation: Drew DR, Hodder AN, Wilson DW, Foley M, Mueller I, et al. (2012) Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria. PLoS ONE 7(12): e51023. doi:10.1371/journal.pone.0051023	[Drew, Damien R.; Mueller, Ivo; Beeson, James G.] Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Drew, Damien R.; Hodder, Anthony N.; Wilson, Danny W.; Cowman, Alan F.; Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Foley, Michael] La Trobe Univ, Bundoora, Vic, Australia; [Mueller, Ivo; Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Dent, Arlene E.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Beeson, James G.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Burnet Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; La Trobe University; PNG Institute Of Medical Research; Case Western Reserve University; Monash University	Beeson, JG (corresponding author), Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia.	beeson@burnet.edu.au	Cowman, Alan F/C-7642-2013; Wilson, Danny W/E-6186-2019; Mueller, Ivo/C-7251-2013	Cowman, Alan F/0000-0001-5145-9004; Wilson, Danny W/0000-0002-5073-1405; Mueller, Ivo/0000-0001-6554-6889; Foley, Michael/0000-0003-1349-4698	PATH Malaria Vaccine Initiative; US Agency for International Development; National Health and Medical Research Council of Australia; Infrastructure for Research Institutes Support Scheme Grant; Australian Research Council; Victorian State Government Operational Infrastructure Support grant	PATH Malaria Vaccine Initiative; US Agency for International Development(United States Agency for International Development (USAID)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Infrastructure for Research Institutes Support Scheme Grant; Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure Support grant	Funding was provided by the PATH Malaria Vaccine Initiative; US Agency for International Development; National Health and Medical Research Council of Australia (program grant to JGB and AFC; Infrastructure for Research Institutes Support Scheme Grant); Australian Research Council (Future Fellowship to JGB); and a Victorian State Government Operational Infrastructure Support grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Anders RF, 2010, HUM VACCINES, V6, P39, DOI 10.4161/hv.6.1.10712; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; BHASIN VK, 1984, AM J TROP MED HYG, V33, P534, DOI 10.4269/ajtmh.1984.33.534; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2010, INFECT IMMUN, V78, P661, DOI 10.1128/IAI.00866-09; Elliott SR, 2007, AM J TROP MED HYG, V76, P860, DOI 10.4269/ajtmh.2007.76.860; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Fowler EV, 2002, MOL BIOCHEM PARASIT, V120, P117, DOI 10.1016/S0166-6851(01)00443-1; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Healer J, 2005, INFECT IMMUN, V73, P2444, DOI 10.1128/IAI.73.4.2444-2451.2005; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-182; Kusi KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015391; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Pearce JA, 2004, INFECT IMMUN, V72, P2321, DOI 10.1128/IAI.72.4.2321-2328.2004; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, GENETICS, V165, P555; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V42, P285, DOI 10.1016/0166-6851(90)90172-I; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	49	58	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51023	10.1371/journal.pone.0051023	http://dx.doi.org/10.1371/journal.pone.0051023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227229	Green Published, gold			2022-12-25	WOS:000312588200090
J	Tekle, YI; Nielsen, KM; Liu, JZ; Pettigrew, MM; Meyers, LA; Galvani, AP; Townsend, JP				Tekle, Yonas I.; Nielsen, Kaare M.; Liu, Jingzhou; Pettigrew, Melinda M.; Meyers, Lauren A.; Galvani, Alison P.; Townsend, Jeffrey P.			Controlling Antimicrobial Resistance through Targeted, Vaccine-Induced Replacement of Strains	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINES; ACUTE OTITIS-MEDIA; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; SEROTYPE REPLACEMENT; MOLECULAR ANALYSIS; INVASIVE DISEASE; UNITED-STATES; COMMUNITY	Vaccination has proven effective in controlling many infectious diseases. However, differential effectiveness with regard to pathogen genotype is a frequent reason for failures in vaccine development. Often, insufficient immune response is induced to prevent infection by the diversity of existing serotypes present in pathogenic populations of bacteria. These vaccines that target a too narrow spectrum of serotypes do not offer sufficient prevention of infections, and can also lead to undesirable strain replacements. Here, we examine a novel idea to specifically exploit the narrow spectrum coverage of some vaccines to combat specific, emerging multi- and pan-resistant strains of pathogens. Application of a narrow-spectrum vaccine could serve to prevent infections by some strains that are hard to treat, rather than offer the vaccinated individual protection against infections by the pathogenic species as such. We suggest that vaccines targeted to resistant serotypes have the potential to become important public health tools, and would represent a new approach toward reducing the burden of particular multi-resistant strains occurring in hospitals. Vaccines targeting drug-resistant serotypes would also be the first clinical intervention with the potential to drive the evolution of pathogenic populations toward drug-sensitivity. We illustrate the feasibility of this approach by modeling a hypothetical vaccine that targets a subset of methicillin-resistant Staphylococcus aureus (MRSA) genotypes, in combination with drug treatment targeted at drug-sensitive genotypes. We find that a combined intervention strategy can limit nosocomial outbreaks, even when vaccine efficacy is imperfect. The broader utility of vaccine-based resistance control strategies should be further explored taking into account population structure, and the resistance and transmission patterns of the pathogen considered.	[Tekle, Yonas I.; Liu, Jingzhou; Pettigrew, Melinda M.; Galvani, Alison P.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Tekle, Yonas I.; Galvani, Alison P.; Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, Sch Med, New Haven, CT USA; [Nielsen, Kaare M.] Univ Tromso, Dept Pharm, Tromso, Norway; [Nielsen, Kaare M.] Genok Ctr Biosafety, Tromso, Norway; [Townsend, Jeffrey P.] Yale Univ, Grad Program Microbiol, New Haven, CT USA; [Meyers, Lauren A.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Meyers, Lauren A.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Tekle, Yonas I.] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA	Yale University; Yale University; UiT The Arctic University of Tromso; Yale University; University of Texas System; University of Texas Austin; The Santa Fe Institute; Spelman College	Tekle, YI (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.	ytekle@spelman.edu	Liu, J/C-5620-2013; Townsend, Jeffrey/H-2747-2019; Nielsen, Kaare Magne/G-8107-2018	Townsend, Jeffrey/0000-0002-9890-3907; Nielsen, Kaare Magne/0000-0002-7217-2114; Meyers, Lauren/0000-0002-5828-8874; Pettigrew, Melinda/0000-0001-8145-7536	NIH MIDAS [U01 GM087719-01]; ASPIRE; NSF [HRD-0714553]; Faculty of Health Science, University of Tromso; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASPIRE; NSF(National Science Foundation (NSF)); Faculty of Health Science, University of Tromso; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support of NIH MIDAS grant U01 GM087719-01. YIT acknowledge financial support from ASPIRE, NSF grant HRD-0714553. KMN acknowledge financial support from The Faculty of Health Science, University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnoli F, 2012, FRONTIERS CELLULAR I; Bagnoli F, 2011, OMICS, V15, P545, DOI 10.1089/omi.2010.0127; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Boyce JM, 1998, JAMA-J AM MED ASSOC, V279, P623, DOI 10.1001/jama.279.8.623; Catalano G, 2003, SOUTH MED J, V96, P141, DOI 10.1097/01.SMJ.0000050683.36014.2E; Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; COLLEY EW, 1965, LANCET, V1, P595; D'Agata EMC, 2010, MATH MODEL NAT PHENO, V5, P76, DOI 10.1051/mmnp/20105306; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; Dall'Antonia M, 2005, J HOSP INFECT, V61, P62, DOI 10.1016/j.jhin.2005.01.008; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Feikin DR, 2002, CLIN INFECT DIS, V35, P547, DOI 10.1086/341896; Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; Iannelli M, 2005, MATH BIOSCI, V195, P23, DOI 10.1016/j.mbs.2005.01.004; Kajita E, 2007, NAT REV MICROBIOL, V5, P700, DOI 10.1038/nrmicro1660; Khatib R, 2003, J CLIN MICROBIOL, V41, P1717, DOI 10.1128/JCM.41.4.1717-1719.2003; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2001, AM J EPIDEMIOL, V154, P85, DOI 10.1093/aje/154.1.85; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCarthy NL, 2010, AM J INFECT CONTROL, V38, P600, DOI 10.1016/j.ajic.2010.01.006; McEllistrem MC, 2003, J INFECT DIS, V188, P1679, DOI 10.1086/379665; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Perez-Trallero E, 2002, LANCET, V360, P953, DOI 10.1016/S0140-6736(02)11061-0; Ribeiro GS, 2003, J INFECT DIS, V187, P109, DOI 10.1086/345863; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; SARAVOLATZ LD, 1982, ANN INTERN MED, V96, P11, DOI 10.7326/0003-4819-96-1-11; Schaffer AC, 2009, INFECT DIS CLIN N AM, V23, P153, DOI 10.1016/j.idc.2008.10.005; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Shinefield HR, 2000, PEDIATR INFECT DIS J, V19, P394, DOI 10.1097/00006454-200004000-00036; Spellberg B, 2011, SEMIN IMMUNOPATHOL; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Urwin G, 1996, CLIN INFECT DIS, V22, P1069, DOI 10.1093/clinids/22.6.1069; Varrone John J, 2011, Bonekey Osteovision, V8, P187; Webb GF, 2009, J BIOL DYNAM, V48, P271; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x	47	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50688	10.1371/journal.pone.0050688	http://dx.doi.org/10.1371/journal.pone.0050688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227198	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200057
J	Zanlungo, F; Ikeda, T; Kanda, T				Zanlungo, Francesco; Ikeda, Tetsushi; Kanda, Takayuki			A Microscopic "Social Norm'' Model to Obtain Realistic Macroscopic Velocity and Density Pedestrian Distributions	PLOS ONE			English	Article							FORCE MODEL	We propose a way to introduce in microscopic pedestrian models a "social norm'' in collision avoiding and overtaking, i.e. the tendency, shared by pedestrians belonging to the same culture, to avoid collisions and perform overtaking in a preferred direction. The "social norm'' is implemented, regardless of the specific collision avoiding model, as a rotation in the perceived velocity vector of the opponent at the moment of computation of the collision avoiding strategy, and justified as an expectation that the opponent will follow the same "social norm'' (for example a tendency to avoid on the left and overtake on the right, as proposed in this work for Japanese pedestrians). By comparing with real world data, we show that the introduction of this norm allows for a better reproduction of macroscopic pedestrian density and velocity patterns.	[Zanlungo, Francesco; Ikeda, Tetsushi; Kanda, Takayuki] ATR, Intelligent Robot & Commun Labs, Kyoto, Japan; [Zanlungo, Francesco; Ikeda, Tetsushi; Kanda, Takayuki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Japan Science & Technology Agency (JST)	Zanlungo, F (corresponding author), ATR, Intelligent Robot & Commun Labs, Kyoto, Japan.	zanlungo@atr.jp	Kanda, Takayuki/I-5843-2016	Kanda, Takayuki/0000-0002-9546-5825	Japan Science and Technology Agency, CREST	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This research has been funded by the Japan Science and Technology Agency, CREST (http://www.jst.go.jp/kisoken/crest/en/index.html). The research area is "Creation of Human-Harmonized Information Technology for Convivial Society'' (http://www.jst.go.jp/kisoken/crest/en/research_area/ongoing/areah21-1.html) and the project is "Enabling a mobile social robot to adapt to a public space in a city'' (project leader TK) (http://www.jst.go.jp/kisoken/crest/en/areah21/1-11.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVENI AF, 1977, SOCIOMETRY, V40, P96, DOI 10.2307/3033551; COLEMAN JS, 1961, SOCIOMETRY, V24, P36, DOI 10.2307/2785927; Glas DF, 2009, ADV ROBOTICS, V23, P405, DOI 10.1163/156855309X408754; Guy SJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016110; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2001, ENVIRON PLANN B, V28, P361, DOI 10.1068/b2697; Helbing D, 2002, PEDESTRIAN EVACUATIO, V21; Helbing D, 2010, ENCY COMPLEXITY SYST, P6476, DOI DOI 10.1007/978-0-387-30440-3_382; Hoogendoorn S, 2005, TRAFFIC AND GRANULAR FLOW '03, P373, DOI 10.1007/3-540-28091-X_36; James John, 1953, AM SOCIOLOGICAL REV; Johansson Anders, 2007, PEDESTRIAN EVACUATIO, P267, DOI DOI 10.1007/978-3-540-47064-9; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; Kretz T, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10001; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Ondrej J, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778860; Reynolds CW., 1999, GAM DEV C, P763; Rudloff C, 2012, PED EV DYN IN PRESS, V2012; Shukla PK, 2010, LECT NOTES COMPUT SC, V6024, P21, DOI 10.1007/978-3-642-12239-2_3; Zanlungo F, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68005; Zanlungo F, 2012, PEDESTRIAN IN PRESS	22	25	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50720	10.1371/journal.pone.0050720	http://dx.doi.org/10.1371/journal.pone.0050720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227202	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200061
J	Chong, HH; Yao, X; Qiu, ZL; Sun, JP; Zhang, M; Waltersperger, S; Wang, MT; Liu, SL; Cui, S; He, YX				Chong, Huihui; Yao, Xue; Qiu, Zonglin; Sun, Jianping; Zhang, Meng; Waltersperger, Sandro; Wang, Meitian; Liu, Shan-Lu; Cui, Sheng; He, Yuxian			Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1	FASEB JOURNAL			English	Article						M-T hook; crystal structure	IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL MEMBRANE-FUSION; CELL-CELL FUSION; ENVELOPE GLYCOPROTEIN; SYNTHETIC PEPTIDE; ATOMIC-STRUCTURE; CORE STRUCTURE; GP41; ENTRY; DESIGN	Peptides derived from the C-terminal heptad repeat (C peptides) of HIV-1 gp41 are potent inhibitors against virus entry. However, development of a short C peptide possessing high anti-HIV potency is considered a daunting challenge. We recently discovered that the residues Met626 and Thr627 preceding the pocket-binding domain of the C peptide adopt a unique M-T hook structure that is crucial for the design of HIV-1 fusion inhibitors. In this study, we first presented a proof-of-concept prototype that the M-T hook residues can dramatically improve the antiviral activity and thermostability of a short C peptide. We then generated a 24-mer peptide termed MT-SC22EK by incorporating the M-T hook structure to the N terminus of the poorly active short C peptide SC22EK. Amazingly, MT-SC22EK inhibited HIV-1-mediated cell fusion and infection at a level comparable to C34, T1249, SC29EK, and sifuvirtide, and it was highly active against diverse HIV-1 subtypes and variants, including those T20 (enfuvirtide) and SC29EK-resistant viruses. The high-resolution crystal structure of MT-SC22EK reveals the N-terminal M-T hook conformation folded by incorporated Met626 and Thr627 and identifies the C-terminal boundary critical for the anti-HIV activity. Collectively, our studies provide new insights into the mechanisms of HIV-1 fusion and its inhibition.-Chong, H., Yao, X., Qiu, Z., Sun, J., Zhang, M., Waltersperger, S., Wang, M., Liu, S.-L., Cui, S., and He, Y. Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1. FASEB J. 27, 1203-1213 (2013). www.fasebj.org	[Chong, Huihui; Yao, Xue; Qiu, Zonglin; Sun, Jianping; Zhang, Meng; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Chong, Huihui; Yao, Xue; Qiu, Zonglin; Sun, Jianping; Zhang, Meng; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China; [Waltersperger, Sandro; Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland; [Liu, Shan-Lu] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Missouri System; University of Missouri Columbia	Cui, S (corresponding author), Chinese Acad Med Sci, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	cui.sheng@ipb.pumc.edu.cn; yhe@ipb.pumc.edu.cn	Cui, Sheng/AAQ-1721-2020; Liu, Shan-Lu/L-5923-2016; Wang, Meitian/D-3208-2013; Sheng, CUI/M-6405-2013	Liu, Shan-Lu/0000-0003-1620-3817; Sheng, CUI/0000-0001-6329-3582; Wang, Meitian/0000-0002-5340-3036	National Outstanding Youth Award of National Science Foundation of China (NSFC) [81025009]; National 973 Program of China [2010CB530100]; Natural Science Foundation of China [81271830]; Beijing Natural Science Foundation [7122116]	National Outstanding Youth Award of National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Outstanding Youth Award of National Science Foundation of China (NSFC; 81025009), National 973 Program of China (2010CB530100), Natural Science Foundation of China (81271830), and Beijing Natural Science Foundation (7122116). The coordinates and structure factors for SC22EK/T21 and MT-SC22EK/T21 complexes were deposited to the Protein Data Bank (PDB ID: 3VU5, 3VU6; http://www.pdb.org). Author contributions: Y. H. and S. C. conceived and designed the experiments; H. C., X. Y., Z. Q., M. Z., S. W., and M. W. performed the experiments; H. C., S. L., Y. H., and S. C. analyzed the data; Y. H. and S. C. wrote the paper. The authors declare no conflicts of interest.	Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chong HH, 2012, J BIOL CHEM, V287, P34558, DOI 10.1074/jbc.M112.390393; Chong HH, 2012, J BIOL CHEM, V287, P20281, DOI 10.1074/jbc.M112.354126; Chong HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032599; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jin BS, 2000, AIDS RES HUM RETROV, V16, P1797, DOI 10.1089/08892220050195757; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Nishikawa H, 2008, BIOORGAN MED CHEM, V16, P9184, DOI 10.1016/j.bmc.2008.09.018; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Shimura K, 2010, J BIOL CHEM, V285, P39471, DOI 10.1074/jbc.M110.145789; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2010, FASEB J, V24, P4196, DOI 10.1096/fj.09-151704; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xie D, 2010, ANTIMICROB AGENTS CH, V54, P191, DOI 10.1128/AAC.00976-09; Yao X, 2012, J BIOL CHEM, V287, P6788, DOI 10.1074/jbc.M111.317883	44	50	53	1	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1203	1213		10.1096/fj.12-222547	http://dx.doi.org/10.1096/fj.12-222547			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23233535				2022-12-25	WOS:000315585200032
J	Eckers, E; Petrungaro, C; Gross, D; Riemer, J; Hell, K; Deponte, M				Eckers, Elisabeth; Petrungaro, Carmelina; Gross, Dominik; Riemer, Jan; Hell, Kai; Deponte, Marcel			Divergent Molecular Evolution of the Mitochondrial Sulfhydryl: Cytochrome c Oxidoreductase Erv in Opisthokonts and Parasitic Protists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; R THIOREDOXIN REDUCTASE; INTERMEMBRANE SPACE; PROTEIN IMPORT; LIVER-REGENERATION; ELECTRON-TRANSFER; BIOCHEMICAL-CHARACTERIZATION; PLASMODIUM-FALCIPARUM; SWISS-MODEL; OXIDASE	Mia40 and the sulfhydryl: cytochrome c oxidoreductase Erv1/ALR are essential for oxidative protein import into the mitochondrial intermembrane space in yeast and mammals. Although mitochondrial protein import is functionally conserved in the course of evolution, many organisms seem to lack Mia40. Moreover, except for in organello import studies and in silico analyses, nothing is known about the function and properties of protist Erv homologues. Here we compared Erv homologues from yeast, the kinetoplastid parasite Leishmania tarentolae, and the non-related malaria parasite Plasmodium falciparum. Both parasite proteins have altered cysteine motifs, formed intermolecular disulfide bonds in vitro and in vivo, and could not replace Erv1 from yeast despite successful mitochondrial protein import in vivo. To analyze its enzymatic activity, we established the expression and purification of recombinant full-length L. tarentolae Erv and compared the mechanism with related and non-related flavoproteins. Enzyme assays indeed confirmed an electron transferase activity with equine and yeast cytochrome c, suggesting a conservation of the enzymatic activity in different eukaryotic lineages. However, although Erv and non-related flavoproteins are intriguing examples of convergent molecular evolution resulting in similar enzyme properties, the mechanisms of Erv homologues from parasitic protists and opisthokonts differ significantly. In summary, the Erv-mediated reduction of cytochrome c might be highly conserved throughout evolution despite the apparent absence of Mia40 in many eukaryotes. Nevertheless, the knowledge on mitochondrial protein import in yeast and mammals cannot be generally transferred to all other eukaryotes, and the corresponding pathways, components, and mechanisms remain to be analyzed.	[Eckers, Elisabeth; Deponte, Marcel] Heidelberg Univ, Dept Parasitol, D-69120 Heidelberg, Germany; [Petrungaro, Carmelina; Riemer, Jan] Univ Kaiserslautern, Div Cellular Biochem, D-67663 Kaiserslautern, Germany; [Gross, Dominik; Hell, Kai] Univ Munich, Adolf Butenandt Inst, Lehrstuhl Physiol Chem, D-81377 Munich, Germany	Ruprecht Karls University Heidelberg; University of Kaiserslautern; University of Munich	Deponte, M (corresponding author), Heidelberg Univ, Dept Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	marcel.deponte@gmx.de	Riemer, Jan/AAC-1072-2021; Groß, Dominik/C-6050-2015	Groß, Dominik/0000-0001-9979-8531; Riemer, Jan/0000-0002-7574-8457; Deponte, Marcel/0000-0003-2141-917X	Deutsche Forschungsgemeinschaft [DE 1431/2, SFB 594,B13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants DE 1431/2 (to M. D.) and SFB 594,B13 (to K. H.).	Aliverti A, 1999, METH MOL B, V131, P9; Allen JWA, 2008, FEBS LETT, V582, P2817, DOI 10.1016/j.febslet.2008.07.015; Ang SK, 2009, J BIOL CHEM, V284, P28754, DOI 10.1074/jbc.M109.021113; Banci L, 2012, J AM CHEM SOC, V134, P1442, DOI 10.1021/ja209881f; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Bauer H, 2003, J BIOL CHEM, V278, P33020, DOI 10.1074/jbc.M303762200; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrie C, 2010, J BIOL CHEM, V285, P36138, DOI 10.1074/jbc.M110.121202; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Deponte M, 2005, J BIOL CHEM, V280, P20628, DOI 10.1074/jbc.M412519200; Deponte M, 2005, MOL BIOCHEM PARASIT, V140, P87, DOI 10.1016/j.molbiopara.2004.12.008; Deponte M, 2009, J BIOCHEM, V146, P599, DOI 10.1093/jb/mvp133; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Farver O, 2009, J BIOL CHEM, V284, P2098, DOI 10.1074/jbc.M806316200; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gross DP, 2011, MOL BIOL CELL, V22, P3758, DOI 10.1091/mbc.E11-04-0296; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harner M, 2011, EMBO J, V30, P3232, DOI 10.1038/emboj.2011.235; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Hiller N, 2006, PROTEIN SCI, V15, P281, DOI 10.1110/ps.051891106; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Kallergi E, 2012, ACS CHEM BIOL, V7, P707, DOI 10.1021/cb200485b; Kloppel C, 2011, MOL BIOL CELL, V22, P3749, DOI 10.1091/mbc.E11-04-0293; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; McMillan PJ, 2006, J BIOL CHEM, V281, P32967, DOI 10.1074/jbc.M601141200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Simpson L, 1996, Methods Enzymol, V264, P99, DOI 10.1016/S0076-6879(96)64012-9; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Wu CK, 2003, PROTEIN SCI, V12, P1109, DOI 10.1110/ps.0238103	51	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2676	2688		10.1074/jbc.M112.420745	http://dx.doi.org/10.1074/jbc.M112.420745			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233680	hybrid, Green Published			2022-12-25	WOS:000314211500052
J	Wang, LH; Liu, W; Jiang, W; Lin, J; Jiang, YD; Li, B; Pang, D				Wang, Lihong; Liu, Wei; Jiang, Wei; Lin, Jing; Jiang, Yongdong; Li, Bo; Pang, Da			A miRNA Binding Site Single-Nucleotide Polymorphism in the 3 '-UTR Region of the IL23R Gene Is Associated with Breast Cancer	PLOS ONE			English	Article							INTERLEUKIN-23 RECEPTOR; CHINESE POPULATION; IL-23; RISK; DIFFERENTIATION; SUSCEPTIBILITY; INFLAMMATION; CELLS; AXIS	Background: Research into the etiology of breast cancer has recently focused on the role of the immunity and inflammation. Interleukin-23 and its receptor (IL23R) guide T cells towards the Th17 phenotype. IL23R single nucleotide polymorphisms (SNPs) have been shown to be associated with digestive system cancers. To evaluate the influences of IL23R gene polymorphisms on the risk of sporadic breast cancer, a case-control study was conducted in Chinese Han women. Methodology and Principal Findings: We genotyped two tag SNPs (rs10889677 in the 3'-UTR region and nonsynonymous variants rs1884444 in exon 2) in IL23R gene of 491 breast cancer patients and 502 matched healthy controls. The genotypes were determined using the SNaPshot technique. The differences in the genotypic distribution between breast cancer patients and healthy controls were analyzed with the Chi-square test for trends. For rs10889677 in IL23R, the frequencies of the AA genotype and the A allele were statistical significant higher in breast cancer patients than in controls (P = 0.0084 and P = 0.0171, respectively), whereas the C allele was associated with an earlier age of breast cancer onset (50.6 years for AA, 48.7 years for AC and 46.0 years for CC (P = 0.0114)) in case-only study. The clinical features analysis demonstrated significant associations between rs1884444 in IL23R and human epidermal growth factor receptor 2 (Her-2) and tumor size status. Conclusions and Significance: Our results suggest that a miRNA binding site SNP in the 39-UTR region of the IL23R gene may be associated with the risk of breast cancer and contribute to the early development of breast cancer in Chinese women.	[Wang, Lihong; Lin, Jing; Pang, Da] Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China; [Liu, Wei] Harbin Med Univ, Affiliated Hosp 1, Dept Pathol, Harbin, Peoples R China; [Jiang, Wei] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Jiang, Yongdong; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China; [Li, Bo] Harbin Med Univ, Dept Immunol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Pang, D (corresponding author), Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China.	2824607@qq.com; pangdasir@163.com			Key Science and Technology Program of Heilongjiang Province, China [GC08C501]; National Natural Science Foundation of China [30900837]	Key Science and Technology Program of Heilongjiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Science and Technology Program of Heilongjiang Province, China (Grant number GC08C501) and National Natural Science Foundation of China (Grant Number 30900837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan C, 2011, EXPERT OPIN THER TAR, V15, P21, DOI 10.1517/14656566.2011.537260; Chalmin F, 2012, IMMUNITY; Chen J, 2010, INT J OBESITY, V34, P1227, DOI 10.1038/ijo.2010.29; Chen JJ, 2010, MOL CARCINOGEN, V49, P862, DOI 10.1002/mc.20661; Chien MH, 2012, HEAD NECK-J SCI SPEC, V34, P551, DOI 10.1002/hed.21779; Chu HJ, 2012, INT J CANCER, V130, P1093, DOI 10.1002/ijc.26130; Cole SW, 2009, J CLIN ONCOL, V27, P3418, DOI 10.1200/JCO.2009.21.9782; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Huber AK, 2008, J CLIN ENDOCR METAB, V93, P1077, DOI 10.1210/jc.2007-2190; Kan SH, 2008, GENES IMMUN, V9, P631, DOI 10.1038/gene.2008.64; Langowski JL, 2007, TRENDS IMMUNOL, V28, P207, DOI 10.1016/j.it.2007.03.006; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shime H, 2008, J IMMUNOL, V180, P7175, DOI 10.4049/jimmunol.180.11.7175; Tan ZY, 2009, INT J BIOCHEM CELL B, V41, P733, DOI 10.1016/j.biocel.2008.04.027; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034400; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	21	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49823	10.1371/journal.pone.0049823	http://dx.doi.org/10.1371/journal.pone.0049823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239971	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800009
J	Yamamoto, S; Ouchi, Y; Nakatsuka, D; Tahara, T; Mizuno, K; Tajima, S; Onoe, H; Yoshikawa, E; Tsukada, H; Iwase, M; Yamaguti, K; Kuratsune, H; Watanabe, Y				Yamamoto, Shigeyuki; Ouchi, Yasuomi; Nakatsuka, Daisaku; Tahara, Tsuyoshi; Mizuno, Kei; Tajima, Seiki; Onoe, Hirotaka; Yoshikawa, Etsuji; Tsukada, Hideo; Iwase, Masao; Yamaguti, Kouzi; Kuratsune, Hirohiko; Watanabe, Yasuyoshi			Reduction of [C-11](+)3-MPB Binding in Brain of Chronic Fatigue Syndrome with Serum Autoantibody against Muscarinic Cholinergic Receptor	PLOS ONE			English	Article							ACETYLCHOLINESTERASE ACTIVITY; NEUROTRANSMITTER RECEPTORS; PET LIGANDS; BARRIER; IMPAIRMENT; IMMUNOGLOBULIN; SCHIZOPHRENIA; TRANSPORTERS; PERMEABILITY; HYPOTHESIS	Background: Numerous associations between brain-reactive antibodies and neurological or psychiatric symptoms have been proposed. Serum autoantibody against the muscarinic cholinergic receptor (mAChR) was increased in some patients with chronic fatigue syndrome (CFS) or psychiatric disease. We examined whether serum autoantibody against mAChR affected the central cholinergic system by measuring brain mAChR binding and acetylcholinesterase activity using positron emission tomography (PET) in CFS patients with positive [CFS(+)] and negative [CFS(-)] autoantibodies. Methodology: Five CFS(+) and six CFS(-) patients, as well as 11 normal control subjects underwent a series of PET measurements with N-[C-11]methyl-3-piperidyl benzilate [C-11](+)3-MPB for the mAChR binding and N-[C-11]methyl-4-piperidyl acetate [C-11]MP4A for acetylcholinesterase activity. Cognitive function of all subjects was assessed by neuropsychological tests. Although the brain [C-11](+)3-MPB binding in CFS(-) patients did not differ from normal controls, CFS(+) patients showed significantly lower [C-11](+) 3-MPB binding than CFS(-) patients and normal controls. In contrast, the [C-11] MP4A index showed no significant differences among these three groups. Neuropsychological measures were similar among groups. Conclusion: The present results demonstrate that serum autoantibody against the mAChR can affect the brain mAChR without altering acetylcholinesterase activity and cognitive functions in CFS patients. Citation: Yamamoto S, Ouchi Y, Nakatsuka D, Tahara T, Mizuno K, et al. (2012) Reduction of [C-11](+)3-MPB Binding in Brain of Chronic Fatigue Syndrome with Serum Autoantibody against Muscarinic Cholinergic Receptor. PLoS ONE 7(12): e51515. doi:10.1371/journal.pone.0051515	[Yamamoto, Shigeyuki; Nakatsuka, Daisaku; Tajima, Seiki; Yamaguti, Kouzi; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno Ku, Osaka 558, Japan; [Yamamoto, Shigeyuki; Yoshikawa, Etsuji; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Ouchi, Yasuomi] Hamamatsu Univ Sch Med, Mol Imaging Frontier Res Ctr, Hamamatsu, Shizuoka, Japan; [Tahara, Tsuyoshi; Mizuno, Kei; Onoe, Hirotaka; Watanabe, Yasuyoshi] RIKEN Ctr Mol Imaging Sci CMIS, Kobe, Hyogo, Japan; [Iwase, Masao] Osaka Univ, Grad Sch Med, Dept Clin Neurosci, Suita, Osaka, Japan; [Kuratsune, Hirohiko] Kansai Univ Welf Sci, Fac Hlth Sci Welf, Dept Hlth Sci, Kashiwara, Japan	Osaka Metropolitan University; Hamamatsu Photonics; Hamamatsu University School of Medicine; RIKEN; Osaka University	Watanabe, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno Ku, Osaka 558, Japan.	yywata@riken.jp			Special Coordination Funds for Promoting Science and Technology; 21st Century COE Program "Base to Overcome Fatigue'' from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor, and Welfare	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century COE Program "Base to Overcome Fatigue'' from the Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Special Coordination Funds for Promoting Science and Technology, the 21st Century COE Program "Base to Overcome Fatigue'' from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and grants from Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221; AHLSKOG JE, 1991, ANN NEUROL, V30, P185, DOI 10.1002/ana.410300210; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; AXELSSON R, 1982, BRIT J PSYCHIAT, V141, P273, DOI 10.1192/bjp.141.3.273; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Borda T, 2002, J IMMUNOL, V168, P3667, DOI 10.4049/jimmunol.168.7.3667; Buck A, 2000, J CEREBR BLOOD F MET, V20, P253, DOI 10.1097/00004647-200002000-00005; Bymaster FP, 2002, CNS NEUROL DISORD-DR, V1, P163, DOI 10.2174/1568007024606249; COLLERTON D, 1986, NEUROSCIENCE, V19, P1, DOI 10.1016/0306-4522(86)90002-3; Crook JM, 2000, BIOL PSYCHIAT, V48, P381, DOI 10.1016/S0006-3223(00)00918-5; Dean B, 2002, MOL PSYCHIATR, V7, P1083, DOI 10.1038/sj.mp.4001199; Diamond B, 2006, ADV IMMUNOL, V89, P289, DOI 10.1016/S0065-2776(05)89007-8; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Eggers C, 2007, EUR J NEUROL, V14, P690, DOI 10.1111/j.1468-1331.2007.01737.x; ENNA SJ, 1976, NEW ENGL J MED, V294, P1305, DOI 10.1056/NEJM197606102942402; FLYNN DD, 1995, J NEUROCHEM, V64, P1888; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Ganzinelli S, 2006, NEUROPHARMACOLOGY, V50, P362, DOI 10.1016/j.neuropharm.2005.09.013; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hatcher S, 2003, PSYCHOL MED, V33, P1185, DOI 10.1017/S0033291703008274; Hohmann C, 1998, PSYCHOPHARMACOLOGY A, P69; Horikoshi T., 2004, International Journal of Cosmetic Science, V26, P9, DOI 10.1111/j.0142-5463.2004.00200.x; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Irie T, 1996, J NUCL MED, V37, P649; Kobayashi Y, 2002, J NEUROPHYSIOL, V88, P715, DOI 10.1152/jn.2002.88.2.715; Kuang F, 2004, INT J NEUROSCI, V114, P575, DOI 10.1080/00207450490422731; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LANGE KW, 1992, J NEUROL, V239, P103, DOI 10.1007/BF00862983; LEVY JA, 1994, CLIN INFECT DIS, V18, pS117, DOI 10.1093/clinids/18.Supplement_1.S117; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lyall M, 2003, J PSYCHOSOM RES, V55, P79, DOI 10.1016/S0022-3999(02)00515-9; Matsumura M, 1997, NEUROSCI RES, V28, P155, DOI 10.1016/S0168-0102(97)00039-4; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Morshed SA, 2001, BIOL PSYCHIAT, V50, P566, DOI 10.1016/S0006-3223(01)01096-4; Namba H, 1998, LANCET, V351, P881, DOI 10.1016/S0140-6736(05)70293-2; Namba H, 1999, EUR J NUCL MED, V26, P135, DOI 10.1007/s002590050369; Nishiyama S, 2001, SYNAPSE, V40, P159, DOI 10.1002/syn.1038; NOY S, 1994, NEUROPSYCHOBIOLOGY, V30, P157, DOI 10.1159/000119155; Ota T, 2004, ANN NUCL MED, V18, P187, DOI 10.1007/BF02984999; Paul R, 2003, BRAIN, V126, P1873, DOI 10.1093/brain/awg171; Perlmutter SJ, 1999, LANCET, V354, P1153, DOI 10.1016/S0140-6736(98)12297-3; PERRY EK, 1986, BRIT MED BULL, V42, P63, DOI 10.1093/oxfordjournals.bmb.a072100; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Reina S, 2004, J NEUROIMMUNOL, V150, P107, DOI 10.1016/j.jneuroim.2004.01.019; REINIKAINEN KJ, 1987, LIFE SCI, V41, P453, DOI 10.1016/0024-3205(87)90221-9; Reitan R, 1956, TRAIL MAKING TEST MA; RINNE JO, 1985, BRAIN RES, V336, P19, DOI 10.1016/0006-8993(85)90411-1; Schwarz MJ, 1998, NEUROSCI LETT, V253, P201, DOI 10.1016/S0304-3940(98)00655-7; Sellin AK, 2008, CNS SPECTRUMS, V13, P985, DOI 10.1017/S1092852900014048; Spreen O, 1998, COMPENDIUM NEUROPSYC; STERIADE M, 1992, NEUROLOGY, V42, P9; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Takahashi K, 1998, THESIS TOHOKU U, V3041, P1; Tanaka M, 2010, MED HYPOTHESES, V75, P244, DOI 10.1016/j.mehy.2010.02.032; Tanaka S, 2003, J NEUROIMMUNOL, V141, P155, DOI 10.1016/S0165-5728(03)00252-2; Tanaka S, 2003, INT J MOL MED, V12, P225; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Tsuchiya H, 2000, NEUROPSYCHOLOGIA, V38, P645, DOI 10.1016/S0028-3932(99)00108-6; Tsukada H, 2001, SYNAPSE, V39, P182, DOI 10.1002/1098-2396(200102)39:2<182::AID-SYN10>3.0.CO;2-Q; WASTEK GJ, 1978, MOL PHARMACOL, V14, P768; Wechsler D, 1987, WMS R WECHSLER MEMOR; Yamamoto S, 2004, NEUROREPORT, V15, P2571, DOI 10.1097/00001756-200412030-00002; Yamamoto S, 2011, NEUROIMAGE, V58, P1, DOI 10.1016/j.neuroimage.2011.06.031; Yamamoto S, 2011, NEUROPSYCHOPHARMACOL, V36, P1455, DOI 10.1038/npp.2011.31; Yamamoto S, 2011, SYNAPSE, V65, P548, DOI 10.1002/syn.20881; Zavitsanou K, 2004, NEUROPSYCHOPHARMACOL, V29, P1585, DOI 10.1038/sj.npp.1300509	67	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51515	10.1371/journal.pone.0051515	http://dx.doi.org/10.1371/journal.pone.0051515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240035	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800071
J	Zou, H; Zhang, J; Li, WX; Wu, SG; Wang, GT				Zou, Hong; Zhang, Jin; Li, Wenxiang; Wu, Shangong; Wang, Guitang			Mitochondrial Genome of the Freshwater Jellyfish Craspedacusta sowerbyi and Phylogenetics of Medusozoa	PLOS ONE			English	Article							CLASS-LEVEL RELATIONSHIPS; PHYLUM-CNIDARIA; EVOLUTION; HYDROZOA; SEQUENCE; LANKESTER; INSIGHTS; MEDUSAE; MODELS; TAXA	The 17,922 base pairs (bp) nucleotide sequence of the linear mitochondrial DNA (mtDNA) molecule of the freshwater jellyfish Craspedacusta sowerbyi (Hydrozoa, Trachylina, Limnomedusae) has been determined. This sequence exhibits surprisingly low A+T content (57.1%), containing genes for 13 energy pathway proteins, a small and a large subunit rRNAs, and methionine and tryptophan tRNAs. Mitochondrial ancestral medusozoan gene order (AMGO) was found in the C. sowerbyi, as those found in Cubaia aphrodite (Hydrozoa, Trachylina, Limnomedusae), discomedusan Scyphozoa and Staurozoa. The genes of C. sowerbyi mtDNA are arranged in two clusters with opposite transcriptional polarities, whereby transcription proceeds toward the ends of the DNA molecule. Identical inverted terminal repeats (ITRs) flank the ends of the mitochondrial DNA molecule, a characteristic typical of medusozoans. In addition, two open reading frames (ORFs) of 354 and 1611 bp in length were found downstream of the large subunit rRNA gene, similar to the two ORFs of ORF314 and polB discovered in the linear mtDNA of C. aphrodite, discomedusan Scyphozoa and Staurozoa. Phylogenetic analyses of C. sowerbyi and other cnidarians were carried out based on both nucleotide and inferred amino acid sequences of the 13 mitochondrial energy pathway genes. Our working hypothesis supports the monophyletic Medusozoa being a sister group to Octocorallia (Cnidaria, Anthozoa). Within Medusozoa, the phylogenetic analysis suggests that Staurozoa may be the earliest diverging class and the sister group of all other medusozoans. Cubozoa and coronate Scyphozoa form a clade that is the sister group of Hydrozoa plus discomedusan Scyphozoa. Hydrozoa is the sister group of discomedusan Scyphozoa. Semaeostomeae is a paraphyletic clade with Rhizostomeae, while Limnomedusae (Trachylina) is the sister group of hydroidolinans and may be the earliest diverging lineage among Hydrozoa.	[Zou, Hong; Zhang, Jin; Li, Wenxiang; Wu, Shangong; Wang, Guitang] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei Province, Peoples R China; [Zou, Hong; Zhang, Jin; Li, Wenxiang; Wu, Shangong; Wang, Guitang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China; [Zou, Hong; Zhang, Jin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, GT (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei Province, Peoples R China.	gtwang@ihb.ac.cn			National Technology System for Conventional Freshwater Fish Industries [CARS-46-08]; National Program on Key Basic Research Project [2009CB118705]	National Technology System for Conventional Freshwater Fish Industries; National Program on Key Basic Research Project(National Basic Research Program of China)	This research was supported by the National Technology System for Conventional Freshwater Fish Industries (CARS-46-08) and the National Program on Key Basic Research Project (Grant no. 2009CB118705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER TS, 1976, AM MIDL NAT, V95, P323, DOI 10.2307/2424397; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; Boothroyd IKG, 2002, HYDROBIOLOGIA, V468, P23, DOI 10.1023/A:1015206320300; Bouillon J., 2000, THALASSIA SALENTINA, V24, P3, DOI DOI 10.1285/I15910725V24P3; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Collins AG, 2000, SCI MAR, V64, P5, DOI 10.3989/scimar.2000.64s15; Collins AG, 2008, J MAR BIOL ASSOC UK, V88, P1673, DOI 10.1017/S0025315408001732; Fritz GB, 2009, J LIMNOL, V68, P46, DOI 10.4081/jlimnol.2009.46; Hall B.G., 2004, PHYLOGENETIC TREES M; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Jankowski T, 2001, HYDROBIOLOGIA, V462, P91, DOI 10.1023/A:1013126015171; Jankowski T, 2008, HYDROBIOLOGIA, V595, P35, DOI 10.1007/s10750-007-9001-9; Kayal E, 2008, GENE, V410, P177, DOI 10.1016/j.gene.2007.12.002; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kim JH, 1999, MOL BIOL EVOL, V16, P423, DOI 10.1093/oxfordjournals.molbev.a026124; KRAMP PL, 1950, P ZOOL SOC LOND, V120, P165, DOI 10.1111/j.1096-3642.1950.tb01469.x; Kramp PL, 1961, J MAR BIOL ASSOC UK, V40, P213; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; LEONARD JL, 1980, NATURE, V284, P377, DOI 10.1038/284377a0; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; PENNAK ROBERT W., 1956, TRANS AMER MICROSC SOC, V75, P324, DOI 10.2307/3223963; PETERSEN KW, 1990, ZOOL J LINN SOC-LOND, V100, P101, DOI 10.1111/j.1096-3642.1990.tb01862.x; PETERSEN KW, 1979, BIOL SYSTEMATICS COL, P105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salvini-Plawen, 1978, Z ZOOL SYST EVOL, V16, P40; Sambrook J., 2002, MOL CLONING LAB MANU; SATTERLIE RA, 1980, NATURE, V284, P377, DOI 10.1038/284377b0; SCHUCHERT P, 1993, Z ZOOL SYST EVOL, V31, P161; Shao ZY, 2006, GENE, V381, P92, DOI 10.1016/j.gene.2006.06.021; Silva WM, 2007, BIOTA NEOTROP, V7, P227; Smith DR, 2012, GENOME BIOL EVOL, V4, P52, DOI 10.1093/gbe/evr127; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; van Oppen MJH, 2002, J MOL EVOL, V55, P1, DOI 10.1007/s00239-001-0075-0; Voigt O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-350; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Zhang LQ, 2009, J PLANKTON RES, V31, P563, DOI 10.1093/plankt/fbp005	52	42	43	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51465	10.1371/journal.pone.0051465	http://dx.doi.org/10.1371/journal.pone.0051465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240028	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800064
J	Bessadottir, M; Egilsson, M; Einarsdottir, E; Magnusdottir, IH; Ogmundsdottir, MH; Omarsdottir, S; Ogmundsdottir, HM				Bessadottir, Margret; Egilsson, Mar; Einarsdottir, Eydis; Magnusdottir, Iris H.; Ogmundsdottir, Margret H.; Omarsdottir, Sesselja; Ogmundsdottir, Helga M.			Proton-Shuttling Lichen Compound Usnic Acid Affects Mitochondrial and Lysosomal Function in Cancer Cells	PLOS ONE			English	Article							WILD-TYPE P53; TARGETING AUTOPHAGY; PANCREATIC-CANCER; MTOR INHIBITORS; SUPPRESSION; RECEPTOR; PROTEIN; STRESS; AGENTS; DEATH	The lichen compound usnic acid (UA) is a lipophilic weak acid that acts as a proton shuttle and causes loss of mitochondrial inner membrane potential. In the current study we show that UA treatment induced the formation of autophagosomes in human cancer cells, but had minimal effects on normal human fibroblasts. However, autophagic flux was incomplete, degradation of autophagosomal content did not occur and acidification was defective. UA-treated cells showed reduced ATP levels and activation of AMP kinase as well as signs of cellular stress. UA is thus likely to trigger autophagosome formation both by energy depletion and stress conditions. Our findings indicate that the H+-shuttling effect of UA operates not only in mitochondria as previously shown, but also in lysosomes, and have implications for therapeutic manipulation of autophagy and pH-determined drug distribution.	[Bessadottir, Margret; Egilsson, Mar; Ogmundsdottir, Margret H.; Ogmundsdottir, Helga M.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Bessadottir, Margret; Einarsdottir, Eydis; Magnusdottir, Iris H.; Omarsdottir, Sesselja] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland	University of Iceland; University of Iceland	Ogmundsdottir, HM (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.	helgaogm@hi.is	Ögmundsdóttir, Helga M/L-6970-2015	Multhoff, Gabriele/0000-0002-2616-3137; Bessadottir, Margret/0000-0002-9750-8892	Eimskip Doctoral Fund; University of Iceland Research Fund	Eimskip Doctoral Fund; University of Iceland Research Fund	This work was supported by the Eimskip Doctoral Fund and the University of Iceland Research Fund (www.hi.is). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Khatwa A. N., 1996, Natural Toxins, V4, P96, DOI 10.1002/19960402NT7; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bezivin C, 2004, PLANTA MED, V70, P874, DOI 10.1055/s-2004-827240; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Cardarelli M, 1997, CELL MOL LIFE SCI, V53, P667, DOI 10.1007/s000180050086; CASEY G, 1991, ONCOGENE, V6, P1791; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Einarsdottir E, 2010, PLANTA MED, V76, P969, DOI 10.1055/s-0029-1240851; Eisold S, 2004, WORLD J GASTROENTERO, V10, P3583, DOI 10.3748/wjg.v10.i24.3583; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Garrido-Laguna I, 2010, BRIT J CANCER, V103, P649, DOI 10.1038/sj.bjc.6605819; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gong YP, 2000, LEUKEMIA RES, V24, P769, DOI 10.1016/S0145-2126(00)00048-5; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Han D, 2004, BIOCHEM PHARMACOL, V67, P439, DOI 10.1016/j.bcp.2003.09.032; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Joseph A, 2009, MITOCHONDRION, V9, P149, DOI 10.1016/j.mito.2009.02.002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaushik S, 2010, DIABETES OBES METAB, V12, P4, DOI 10.1111/j.1463-1326.2010.01263.x; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Koparal AT, 2006, NAT PROD RES, V20, P1300, DOI 10.1080/14786410601101910; KUPCHAN SM, 1975, EXPERIENTIA, V31, P625; LOZY F, 2012, SEMIN CELL DEV BIOL; Mancias JD, 2011, ONCOTARGET, V2, P1302; Mayer M, 2005, ANTI-CANCER DRUG, V16, P805, DOI 10.1097/01.cad.0000175588.09070.77; Nash TH., 1996, LICHEN BIOL; Ndolo Rosemary A, 2010, Mol Cell Pharmacol, V2, P131; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; TAKAI M, 1979, J MED CHEM, V22, P1380, DOI 10.1021/jm00197a019; Ulivieri C, 2010, TISSUE CELL, V42, P339, DOI 10.1016/j.tice.2010.10.004; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	37	21	22	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51296	10.1371/journal.pone.0051296	http://dx.doi.org/10.1371/journal.pone.0051296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227259	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200118
J	Brucker, RM; Bordenstein, SR				Brucker, Robert M.; Bordenstein, Seth R.			In Vitro Cultivation of the Hymenoptera Genetic Model, Nasonia	PLOS ONE			English	Article								The wasp genus Nasonia is a genetic model with unique advantages for the study of interspecific differences, including haplodiploidy and interfertile species. However, as a parasitoid, Nasonia is confined within a fly host, thus restricting direct observations and manipulation of development over time. Here, we present the first in vitro cultivation method for this system that decouples Nasonia from its host, allowing continuous observations from embryo to adulthood. Using transwell plates and a simple Nasonia rearing medium, we demonstrate a technique that will significantly expand the utility of the Nasonia model.	[Brucker, Robert M.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Brucker, RM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	bruckerm@gmail.com; s.bordenstein@vanderbilt.edu	Brucker, Robert/F-3052-2013	Brucker, Robert/0000-0002-0854-848X	NSF [DEB 1046149]; Division Of Environmental Biology [1046149] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support of this work was provided by NSF award DEB 1046149 to SRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grenier S., 2012, KARAELMAS SCI ENG J, V2, P1; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Muers Mary, 2010, Nat Rev Genet, V11, P170; Werren J.H, 2009, COLD SPRING HARB PRO; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028	5	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51269	10.1371/journal.pone.0051269	http://dx.doi.org/10.1371/journal.pone.0051269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227258	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200117
J	MacIntosh, AJJ; Jacobs, A; Garcia, C; Shimizu, K; Mouri, K; Huffman, MA; Hernandez, AD				MacIntosh, Andrew J. J.; Jacobs, Armand; Garcia, Cecile; Shimizu, Keiko; Mouri, Keiko; Huffman, Michael A.; Hernandez, Alexander D.			Monkeys in the Middle: Parasite Transmission through the Social Network of a Wild Primate	PLOS ONE			English	Article							FECAL EGG COUNTS; GROOMING SITE PREFERENCES; JAPANESE MACAQUES; CONTACT NETWORKS; PATHOGEN TRANSMISSION; SPECIES RICHNESS; INFECTION; BEHAVIOR; ORGANIZATION; POPULATION	In wildlife populations, group-living is thought to increase the probability of parasite transmission because contact rates increase at high host densities. Physical contact, such as social grooming, is an important component of group structure, but it can also increase the risk of exposure to infection for individuals because it provides a mechanism for transmission of potentially pathogenic organisms. Living in groups can also create variation in susceptibility to infection among individuals because circulating levels of immunosuppressive hormones like glucocorticoids often depend on an individual's position within the group's social structure. Yet, little is known about the relative roles of socially mediated exposure versus susceptibility in parasite transmission among free-living animal groups. To address this issue, we investigate the relationship between host dominance hierarchy and nematode parasite transmission among females in a wild group of Japanese macaques (Macaca fuscata yakui). We use social network analysis to describe each individual female's position within the grooming network in relation to dominance rank and relative levels of infection. Our results suggest that the number of directly-transmitted parasite species infecting each female, and the relative amount of transmission stages that one of these species sheds in faeces, both increase with dominance rank. Female centrality within the network, which shows positive associations with dominance hierarchy, is also positively associated with infection by certain parasite species, suggesting that the measured rank-bias in transmission may reflect variation in exposure rather than susceptibility. This is supported by the lack of a clear relationship between rank and faecal cortisol, as an indicator of stress, in a subset of these females. Thus, socially mediated exposure appears to be important for direct transmission of nematode parasites, lending support to the idea that a classical fitness trade-off inherent to living in groups can exist.	[MacIntosh, Andrew J. J.; Huffman, Michael A.] Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 484, Japan; [Jacobs, Armand] Univ Strasbourg, Dept Ecol Physiol & Ethol, Inst Pluridisciplinaire Hubert Curien, CNRS,UMR7178, Strasbourg, Alsace, France; [Garcia, Cecile] CNRS, Lab Dynam Evolut Humaine, UPR 2147, Paris, Ile De France, France; [Shimizu, Keiko; Mouri, Keiko] Okayama Univ Sci, Dept Zool, Fac Sci, Okayama, Japan; [Hernandez, Alexander D.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	Kyoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Okayama University of Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	MacIntosh, AJJ (corresponding author), Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 484, Japan.	macintosh@pri.kyoto-u.ac.jp	MacIntosh, Andrew/B-2242-2013; Hernandez, Alexander/E-8705-2010; Hernandez, Alexander D/AGK-6452-2022	MacIntosh, Andrew/0000-0002-9136-7099; Hernandez, Alexander/0000-0001-8708-3774; Hernandez, Alexander D/0000-0001-8708-3774; Huffman, Michael A/0000-0002-6166-7795	Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT); French Ministry of Higher Education and Research; Japan Society for the Promotion of Science (JSPS)	Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); French Ministry of Higher Education and Research; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A.J.J. MacIntosh was financially supported by the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/:Monbukagakusho scholarship), A. Jacobs and C. Garcia by a grant from the French Ministry of Higher Education and Research, and C. Garcia and A. D. Hernandez by a Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/) postdoctoral fellowship, inclusive of Grants-in-Aid from JSPS to M. A. Huffman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Acha P.N., 2003, ZOONOSES COMMUNICABL; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; ANDERSON R M, 1991; Arizono N, 2012, KOREAN J PARASITOL, V50, P253, DOI 10.3347/kjp.2012.50.3.253; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; BARGER IA, 1989, VET PARASITOL, V32, P21, DOI 10.1016/0304-4017(89)90153-2; Bartolomucci A, 2007, FRONT NEUROENDOCRIN, V28, P28, DOI 10.1016/j.yfrne.2007.02.001; BARTON R, 1985, INT J PRIMATOL, V6, P519, DOI 10.1007/BF02735574; Bates D., 2010, LME4 LINEAR MIXED EF; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Borgatti SP, 2002, UCINET 6 WINDOWS SOF; Chapman CA, 2011, AM J PRIMATOL ONLINE; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Combes Claude., 2001, PARASITISM ECOLOGY E; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Croll NA., 1977, BIOL NEMATODES, P152; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Fooden J, 2003, PRIMATES, V44, P109, DOI 10.1007/s10329-002-0011-y; FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816; FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609; Godfrey SS, 2010, INT J PARASITOL, V40, P1575, DOI 10.1016/j.ijpara.2010.06.002; Godfrey SS, 2009, BEHAV ECOL SOCIOBIOL, V63, P1045, DOI 10.1007/s00265-009-0730-9; Gotoh S, 2000, PRIMATES, V41, P291, DOI 10.1007/BF02557598; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; GRANZER M, 1991, INT J PARASITOL, V21, P429, DOI 10.1016/0020-7519(91)90100-L; Griffin RH, 2012, EVOL ECOL, V26, P779, DOI 10.1007/s10682-011-9526-2; GUST DA, 1993, HORM BEHAV, V27, P318, DOI 10.1006/hbeh.1993.1024; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; HAUSFATER G, 1976, NATURE, V262, P688, DOI 10.1038/262688a0; Hernandez AD, 1995, J PARASITOL, V81, P865, DOI 10.2307/3284031; Hernandez AD, 2009, CAM S BIO EVOL ANTHR, V57, P387; Hoffman CL, 2010, AM J PRIMATOL, V72, P559, DOI 10.1002/ajp.20793; Hudson P. J., 1995, P144, DOI 10.1017/CBO9780511629396.006; ITOH K, 1988, JPN J VET RES, V36, P235; JUDGE PG, 1994, FOLIA PRIMATOL, V63, P63, DOI 10.1159/000156792; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Macinnis A.J., 1976, P3; MacIntosh AJJ, 2011, J R SOC INTERFACE, V8, P1497, DOI 10.1098/rsif.2011.0049; MacIntosh AJJ, 2010, PRIMATES, V51, P353, DOI 10.1007/s10329-010-0211-9; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; MOLLER AP, 1993, ADV STUD BEHAV, V22, P65, DOI 10.1016/S0065-3454(08)60405-2; Moore J, 2001, PARASITES BEHAV ANIM; Mooring MS, 2004, BIOL J LINN SOC, V81, P17, DOI 10.1111/j.1095-8312.2004.00273.x; Muehlenbein MP, 2006, AM J PHYS ANTHROPOL, V130, P546, DOI 10.1002/ajpa.20391; MullerGraf CDM, 1996, PARASITOLOGY, V112, P489, DOI 10.1017/S0031182000076952; Naug D, 2002, J THEOR BIOL, V215, P427, DOI 10.1006/jtbi.2001.2524; Nunn CL, 2004, AM NAT, V164, pS90, DOI 10.1086/424608; Nunn CL, 2011, PLOS ONE, V6; Nunn CL, 2006, INFECT DIS PRIMATES; Otterstatter MC, 2007, OECOLOGIA, V154, P411, DOI 10.1007/s00442-007-0834-8; Perkins SE, 2009, J ANIM ECOL, V78, P1015, DOI 10.1111/j.1365-2656.2009.01557.x; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; R Core Team, 2012, R LANG ENV STAT COMP; ROBERTS JL, 1981, VET PARASITOL, V8, P165, DOI 10.1016/0304-4017(81)90044-3; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Saunders LM, 2001, J HELMINTHOL, V75, P367, DOI 10.1017/S0022149X01000579; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schmidt-Hempel P, 1998, PARASITES SOCIAL INS; Seivwright LJ, 2004, J HELMINTHOL, V78, P69, DOI 10.1079/JOH2003220; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; SHIDELER SE, 1993, BIOL REPROD, V48, P1290, DOI 10.1095/biolreprod48.6.1290; SPARKS JOHN, 1967, P148; STEAR MJ, 1995, INT J PARASITOL, V25, P375, DOI 10.1016/0020-7519(94)00136-C; Takahata Y, 1998, PRIMATES, V39, P339, DOI 10.1007/BF02573082; Talvik H, 1997, PARASITOL RES, V83, P563, DOI 10.1007/s004360050298; TANAKA I, 1993, ANTHROPOL SCI, V101, P187, DOI 10.1537/ase.101.187; Tanaka T., 1967, Primates, V8, P91, DOI 10.1007/BF01772154; VANSCHAIK CP, 1991, PRIMATES, V32, P345, DOI 10.1007/BF02382675; Vitone ND, 2004, EVOL ECOL RES, V6, P183; Wasserman S., 1994, SOCIAL NETWORK ANAL; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; Yamagiwa J, 1998, PRIMATES, V39, P257, DOI 10.1007/BF02573076; YOUNG KH, 1979, J CLIN MICROBIOL, V10, P852, DOI 10.1128/JCM.10.6.852-853.1979; Zamma K, 2002, PRIMATES, V43, P41, DOI 10.1007/BF02629575; Zuur Alain F., 2009, P1	86	115	121	1	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51144	10.1371/journal.pone.0051144	http://dx.doi.org/10.1371/journal.pone.0051144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227246	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200105
J	Snowdon, C; van der Merwe, G				Snowdon, Chris; van der Merwe, George			Regulation of Hxt3 and Hxt7 Turnover Converges on the Vid30 Complex and Requires Inactivation of the Ras/cAMP/PKA Pathway in Saccharomyces cerevisiae	PLOS ONE			English	Article							ADENYLATE-CYCLASE PATHWAY; HEXOSE TRANSPORTER HXT7P; TOR-SIGNALING PATHWAY; PROTEIN-KINASE; GENE-EXPRESSION; INDUCED DEGRADATION; STRESS-RESPONSE; GID COMPLEX; YEAST; ENDOCYTOSIS	Eukaryotic cells adjust their intracellular protein complement as a mechanism to adapt to changing environmental signals. In Saccharomyces cerevisiae the hexose transporters Hxt3 and Hxt7 are expressed and function on the plasma membrane in high and low glucose abundance, respectively. By contrast, Hxt3 is endocytosed and degraded in the vacuole when cells are starved of glucose and Hxt7 in response to rapamycin treatment or when nitrogen is limiting. Yeast uses several signaling pathways, including the TORC1 and Ras/cAMP/Protein Kinase A (PKA) pathways, to adapt to nutrient changes in the environment. The multi-protein Vid30 complex (Vid30c), an E3 ubiquitin ligase required for the degradation of FBPase, assists in this adaptation process in a mechanism that is poorly understood. Here we show the endocytosis and the subsequent degradation of both Hxt3 and Hxt7, in response to different nutrient signals, is dependent on components of the Vid30c. Additionally, we define the signaling events required for the turnover of Hxt3 and Hxt7 by showing that Hxt3 turnover requires Ras2 and PKA inactivation, whereas Hxt7 turnover requires TORC1 and Ras2 inactivation. Further investigation led us to identify Rim15, a kinase that is inhibited by both the TORC1 and Ras/cAMP/PKA pathways, as a key downstream effector in signaling both turnover events. Finally, we show that the turnover of both Hxt3 and Hxt7 is dependent on the essential E3 ubiquitin ligase, Rsp5, indicating that the role of the Vid30c might be indirect of Hxt ubiquitylation.	[Snowdon, Chris; van der Merwe, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	van der Merwe, G (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	gvanderm@uoguelph.ca			NSERC [262276-08]; OMAFRA [SR9231]; Genome Canada/Genome British Columbia [151WIN]; Ontario Graduate Scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); OMAFRA; Genome Canada/Genome British Columbia(Genome Canada); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by: NSERC (Discovery Grant #262276-08), OMAFRA (SR9231), and Genome Canada/Genome British Columbia (151WIN) grants awarded to GvdM, and an Ontario Graduate Scholarship to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Cameroni E, 2004, CELL CYCLE, V3, P462; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CRECHET JB, 1990, J BIOL CHEM, V265, P1563; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Griffioen G, 2002, CURR GENET, V41, P199, DOI 10.1007/s00294-002-0308-9; HANEY SA, 1994, J BIOL CHEM, V269, P16541; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; HIXSON CS, 1980, J BIOL CHEM, V255, P2137; Hoffman M, 1996, GENETICS, V143, P1555; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Petkova MI, 2010, J BIOL CHEM, V285, P19521, DOI 10.1074/jbc.M109.085282; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Krampe S, 1998, FEBS LETT, V441, P343, DOI 10.1016/S0014-5793(98)01583-X; Krampe S, 2002, FEBS LETT, V513, P193, DOI 10.1016/S0014-5793(02)02297-4; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; MBONYI K, 1988, BIOCHIM BIOPHYS ACTA, V971, P223, DOI 10.1016/S0005-2728(88)80110-5; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Perez-Valle J, 2010, EUKARYOT CELL, V9, P1881, DOI 10.1128/EC.00184-10; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Powers T, 2003, CURR TOP MICROBIOL, V279, P39; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Snowdon C, 2008, FEMS YEAST RES, V8, P204, DOI 10.1111/j.1567-1364.2007.00327.x; Snowdon C, 2009, FEMS YEAST RES, V9, P372, DOI 10.1111/j.1567-1364.2009.00497.x; Springael JY, 1999, BIOCHEM BIOPH RES CO, V257, P561, DOI 10.1006/bbrc.1999.0505; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; van der Merwe GK, 2001, J BIOL CHEM, V276, P28659, DOI 10.1074/jbc.M102280200; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Vidan S, 1997, MOL CELL BIOL, V17, P2688, DOI 10.1128/MCB.17.5.2688; WILSON RB, 1988, MOL CELL BIOL, V8, P505, DOI 10.1128/MCB.8.1.505; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	66	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50458	10.1371/journal.pone.0050458	http://dx.doi.org/10.1371/journal.pone.0050458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227176	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200036
J	Yokoyama, K; Nakashima, A; Urashima, M; Suga, H; Mimura, T; Kimura, Y; Kanazawa, Y; Yokota, T; Sakamoto, M; Ishizawa, S; Nishimura, R; Kurata, H; Tanno, Y; Tojo, K; Kageyama, S; Ohkido, I; Utsunomiya, K; Hosoya, T				Yokoyama, Keitaro; Nakashima, Akio; Urashima, Mitsuyoshi; Suga, Hiroaki; Mimura, Takeshi; Kimura, Yasuo; Kanazawa, Yasushi; Yokota, Tamotsu; Sakamoto, Masaya; Ishizawa, Sho; Nishimura, Rimei; Kurata, Hideaki; Tanno, Yudo; Tojo, Katsuyoshi; Kageyama, Shigeru; Ohkido, Ichiro; Utsunomiya, Kazunori; Hosoya, Tatsuo			Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene Fok/Polymorphisms for Renal Function in Patients with Type 2 Diabetes	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; 25-HYDROXYVITAMIN D; D INSUFFICIENCY; POLYMORPHISM; PREVALENCE; WOMEN	Background: We aimed to examine associations among serum 25-hydroxyvitamin D (25OHD) levels, 1,25-dihyroxyvitamin D (1,25OHD) levels, vitamin D receptor (VDR) polymorphisms, and renal function based on estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes. Methods: In a cross-sectional study of 410 patients, chronic kidney disease (CKD) stage assessed by eGFR was compared with 25OHD, 1,25OHD, and VDR FokI (rs10735810) polymorphisms by an ordered logistic regression model adjusted for the following confounders: disease duration, calendar month, use of angiotensin converting enzyme inhibitors/angiotensin receptor blockers or statins, and serum calcium, phosphate, and intact parathyroid hormone levels. Results: 1,25OHD levels, rather than 25OHD levels, showed seasonal oscillations; peak levels were seen from May to October and the lowest levels were seen from December to February. These findings were evident in patients with CKD stage 3 similar to 5 but not stage 1 similar to 2. eGFR was in direct proportion to both 25OHD and 1,25OHD levels (P<0.0001), but it had stronger linearity with 1,25OHD (r = 0.73) than 25OHD (r = 0.22) levels. Using multivariate analysis, 1,25OHD levels (P<0.001), but not 25OHD levels, were negatively associated with CKD stage. Although FokI polymorphisms by themselves showed no significant associations with CKD stage, a significant interaction between 1,25OHD and FokITT was observed (P = 0.008). The positive association between 1,25OHD and eGFR was steeper in Fok/CT and CC polymorphisms (r = 0.74) than Fok/TT polymorphisms (r = 0.65). Conclusions: These results suggest that higher 1,25OHD levels may be associated with better CKD stages in patients with type 2 diabetes and that this association was modified by FokI polymorphisms.	[Nakashima, Akio; Urashima, Mitsuyoshi; Suga, Hiroaki; Mimura, Takeshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan; [Yokoyama, Keitaro; Nakashima, Akio; Tanno, Yudo; Ohkido, Ichiro; Hosoya, Tatsuo] Jikei Univ, Div Kidney, Dept Internal Med, Sch Med, Tokyo, Japan; [Kimura, Yasuo] Shin Kashiwa Clin, Chiba, Japan; [Kanazawa, Yasushi; Yokota, Tamotsu; Sakamoto, Masaya; Ishizawa, Sho; Nishimura, Rimei; Kurata, Hideaki; Tojo, Katsuyoshi; Utsunomiya, Kazunori] Jikei Univ, Div Diabet Metab & Endocrinol, Dept Internal Med, Sch Med, Tokyo, Japan; [Kageyama, Shigeru] Jikei Univ, Sch Med, Div Clin Pharmacol & Therapeut, Tokyo, Japan	Jikei University; Jikei University; Jikei University; Jikei University	Urashima, M (corresponding author), Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan.	urashima@jikei.ac.jp		Nakashima, Akio/0000-0002-3730-0301	MEXT; Jikei University School of Medicine; Grants-in-Aid for Scientific Research [23591553] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jikei University School of Medicine(Jikei University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities and by the Jikei University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Colin EM, 2000, CLIN ENDOCRINOL, V52, P211, DOI 10.1046/j.1365-2265.2000.00909.x; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Dimitriadou M, 2011, PEDIATR HEMAT ONCOL, V28, P509, DOI 10.3109/08880018.2011.579231; Gross C, 1996, J BONE MINER RES, V11, P1850; Hama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029634; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kabadi SM, 2012, DIABETES CARE, V35, P2048, DOI 10.2337/dc12-0235; Martin RJL, 2010, NEPHROL DIAL TRANSPL, V25, P497, DOI 10.1093/ndt/gfp515; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Suzuki M, 2012, MOVEMENT DISORD, V27, P264, DOI 10.1002/mds.24016; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Tripathi G, 2010, RENAL FAILURE, V32, P969, DOI 10.3109/0886022X.2010.501934; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vaidya A, 2011, CLIN ENDOCRINOL, V74, P783, DOI 10.1111/j.1365-2265.2011.03991.x; van der Mei IAF, 2007, ENVIRON HEALTH PERSP, V115, P1132, DOI 10.1289/ehp.9937; Vedralova M, 2012, KIDNEY BLOOD PRESS R, V36, P1, DOI 10.1159/000339021; Vejakama P, 2012, DIABETOLOGIA, V55, P566, DOI 10.1007/s00125-011-2398-8; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamaji T, 2012, AM J EPIDEMIOL, V175, P236, DOI 10.1093/aje/kwr295	25	16	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51171	10.1371/journal.pone.0051171	http://dx.doi.org/10.1371/journal.pone.0051171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226566	Green Published, gold, Green Submitted			2022-12-25	WOS:000312108500048
J	Deepa, SS; Pulliam, D; Hill, S; Shi, Y; Walsh, ME; Salmon, A; Sloane, L; Zhang, N; Zeviani, M; Viscomi, C; Musi, N; Van Remmen, H				Deepa, Sathyaseelan S.; Pulliam, Daniel; Hill, Shauna; Shi, Yun; Walsh, Michael E.; Salmon, Adam; Sloane, Lauren; Zhang, Ning; Zeviani, Massimo; Viscomi, Carlo; Musi, Nicolas; Van Remmen, Holly			Improved insulin sensitivity associated with reduced mitochondrial complex IV assembly and activity	FASEB JOURNAL			English	Article						fatty acid oxidation; PGC-1 alpha; longevity; Surf1	CYTOCHROME-C-OXIDASE; ACTIVATED RECEPTOR-ALPHA; FATTY-ACID OXIDATION; ADIPOSE-TISSUE; LIFE-SPAN; GLUCOSE-METABOLISM; SKELETAL-MUSCLE; GROWTH-HORMONE; KNOCKOUT MICE; UP-REGULATION	Mice lacking Surf1, a complex IV assembly protein, have similar to 50-70% reduction in cytochrome c oxidase activity in all tissues yet a paradoxical increase in lifespan. Here we report that Surf1(-/-) mice have lower body (15%) and fat (20%) mass, in association with reduced lipid storage, smaller adipocytes, and elevated indicators of fatty acid oxidation in white adipose tissue (WAT) compared with control mice. The respiratory quotient in the Surf1(-/-) mice was significantly lower than in the control animals (0.83-0.93 vs. 0.90-0.98), consistent with enhanced fat utilization in Surf1(-/-) mice. Elevated fat utilization was associated with increased insulin sensitivity measured as insulin-stimulated glucose uptake, as well as an increase in insulin receptor levels (similar to 2-fold) and glucose transporter type 4 (GLUT4; similar to 1.3-fold) levels in WAT in the Surf1(-/-) mice. The expression of peroxisome proliferator-activated receptor gamma-coactivator 1-alpha (PGC-1 alpha) mRNA and protein was up-regulated by 2.5- and 1.9-fold, respectively, in WAT from Surf1(-/-) mice, and the expression of PGC-1 alpha target genes and markers of mitochondrial biogenesis was elevated. Together, these findings point to a novel and unexpected link between reduced mitochondrial complex IV activity, enhanced insulin sensitivity, and increased mitochondrial biogenesis that may contribute to the increased longevity in the Surf1(-/-) mice.-Deepa, S. S., Pulliam, D., Hill, S., Shi, Y., Walsh, M. E., Salmon, A., Sloane, L., Zhang, N., Zeviani, M., Viscomi, C., Musi, N., Van Remmen, H. Improved insulin sensitivity associated with reduced mitochondrial complex IV assembly and activity. FASEB J. 27, 1371-1380 (2013). www.fasebj.org	[Deepa, Sathyaseelan S.; Pulliam, Daniel; Hill, Shauna; Shi, Yun; Walsh, Michael E.; Salmon, Adam; Sloane, Lauren; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA; [Deepa, Sathyaseelan S.; Pulliam, Daniel; Hill, Shauna; Walsh, Michael E.; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78245 USA; [Zhang, Ning; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, San Antonio, TX 78245 USA; [Salmon, Adam; Musi, Nicolas; Van Remmen, Holly] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Zeviani, Massimo; Viscomi, Carlo] Ist Ricovero & Cura Carattere Sci, Fdn Ist Neurol Carlo Besta, Unit Mol Neurogenet, Milan, Italy	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta	Van Remmen, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, 15355 Lambda Dr,Mail Code 5566, San Antonio, TX 78245 USA.	vanremmen@uthscsa.edu	Zeviani, Massimo/K-2891-2014; Zeviani, Massimo/AAU-2632-2021; viscomi, Carlo/R-1940-2016	Zeviani, Massimo/0000-0002-9067-5508; Viscomi, Carlo/0000-0001-6050-0566; Deepa, Sathyaseelan/0000-0002-3669-4820	Ellison Medical Foundation; Telethon grant [GPP10005]; Italian Ministry of Health [GR2010-2306756]	Ellison Medical Foundation(Lawrence Ellison Foundation); Telethon grant(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	The authors thank Yuhong Liu, Li Yan, Marian Sabia, Amanda Jernigan, and Barbara Hunter for technical support. This work was supported by an Ellison Medical Foundation Senior Scholar award to H. V. R. Telethon grant GPP10005 to M.Z. and Italian Ministry of Health grant GR2010-2306756 to C.V. are also acknowledged. The authors report no conflicts of interest.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; CAHILL GF, 1960, J BIOL CHEM, V235, P1246; CAPALDI RA, 1990, ARCH BIOCHEM BIOPHYS, V280, P252, DOI 10.1016/0003-9861(90)90327-U; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Dominici FP, 2000, J ENDOCRINOL, V166, P579, DOI 10.1677/joe.0.1660579; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; FOUCHEREAUPERON M, 1980, BIOCHIM BIOPHYS ACTA, V631, P451, DOI 10.1016/0304-4165(80)90021-5; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gnudi L, 1996, P NUTR SOC, V55, P191, DOI 10.1079/PNS19960020; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Hughes BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026116; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221; Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; RODBELL M, 1964, J BIOL CHEM, V239, P375; RONNETT GV, 1982, J BIOL CHEM, V257, P4285; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wang ZH, 2006, J GERONTOL A-BIOL, V61, P323, DOI 10.1093/gerona/61.4.323; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; WONG A, 1995, GENETICS, V139, P1247; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	47	25	25	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1371	1380		10.1096/fj.12-221879	http://dx.doi.org/10.1096/fj.12-221879			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23241310				2022-12-25	WOS:000316940800010
J	Chi, PI; Huang, WR; Lai, IH; Cheng, CY; Liu, HJ				Chi, Pei I.; Huang, Wei R.; Lai, I. H.; Cheng, Ching Y.; Liu, Hung J.			The p17 Nonstructural Protein of Avian Reovirus Triggers Autophagy Enhancing Virus Replication via Activation of Phosphatase and Tensin Deleted on Chromosome 10 (PTEN) and AMP-activated Protein Kinase (AMPK), as well as dsRNA-dependent Protein Kinase (PKR)/eIF2 alpha Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS GENOME SEGMENTS; DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; CONJUGATION SYSTEM; CELL-DEATH; SIGMA-C; MAMMALIAN AUTOPHAGY; APOPTOSIS INDUCTION; CULTURED-CELLS; VERO CELLS	Autophagy has been shown to facilitate replication or production of avian reovirus (ARV); nevertheless, how ARV induces autophagy remains largely unknown. Here, we demonstrate that the nonstructural protein p17 of ARV functions as an activator of autophagy. ARV-infected or p17-transfected cells present a fast and strong induction of autophagy, resulting in an increased level of autophagic proteins Beclin 1 and LC3-II. Although autophagy was suppressed by 3-methyladenine or shRNAs targeting autophagic proteins (Beclin 1, ATG7, and LC3) as well as by overexpression of Bcl-2, viral transcription, sigma C protein synthesis, and virus yield were all significantly reduced, suggesting a key role of autophagosomes in supporting ARV replication. Furthermore, we revealed for the first time that p17 positively regulates phosphatase and tensin deleted on chromosome 10 (PTEN), AMP-activated protein kinase (AMPK), and dsRNA dependent protein kinase RNA (PKR)/eIF2 alpha signaling pathways, accompanied by down-regulation of Akt and mammalian target of rapamycin complex 1, thereby triggering autophagy. By using p53, PTEN, PKR, AMPK, and p17 short hairpin RNA (shRNA), activation of signaling pathways and LC3-II levels was significantly suppressed, suggesting that p17 triggers autophagy through activation of p53/PTEN, AMPK, and PKR signaling pathways. Furthermore, colocalization of LC3 with viral proteins (p17 and sigma C), p62 with LAMP2 and LC3 with Rab7 was observed under a fluorescence microscope. The expression level of p62 was increased at 18 h postinfection and then slightly decreased 24 h postinfection compared with mock infection and thapsigargin treatment. Furthermore, disruption of autophagosome-lysosome fusion by shRNAs targeting LAMP2 or Rab7a resulted in inhibition of viral protein synthesis and virus yield, suggesting that formation of autolysosome benefits virus replication. Taken together, our results suggest that ARV induces formation of autolysosome but does not induce complete autophagic flux.	[Chi, Pei I.; Huang, Wei R.; Lai, I. H.; Cheng, Ching Y.; Liu, Hung J.] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan; [Liu, Hung J.] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan	National Chung Hsing University; National Chung Hsing University	Liu, HJ (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw		Liu, Hung-Jen/0000-0002-1460-1494; Huang, Wei-Ru/0000-0002-2508-8374	National Science Council, Taiwan [NSC 99-2321-B-005-015-MY3]; Ministry of Education, Taiwan under the Aiming for Top University plan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan under the Aiming for Top University plan	This work was supported by National Science Council, Taiwan, Grant NSC 99-2321-B-005-015-MY3 (to H.- J. L.) and by the Ministry of Education, Taiwan under the Aiming for Top University plan.	Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Chulu JLC, 2007, BIOCHEM BIOPH RES CO, V356, P529, DOI 10.1016/j.bbrc.2007.02.164; Chulu JLC, 2010, J VIROL, V84, P7683, DOI 10.1128/JVI.02604-09; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Geiser V, 2008, MICROB PATHOGENESIS, V44, P459, DOI 10.1016/j.micpath.2007.10.014; Gonzalez-Lopez C, 2003, J GEN VIROL, V84, P1629, DOI 10.1099/vir.0.19004-0; Grande A, 2000, VIROLOGY, V274, P367, DOI 10.1006/viro.2000.0473; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hsu CJ, 2006, AVIAN PATHOL, V35, P320, DOI 10.1080/03079450600823386; Hsu HW, 2005, AVIAN DIS, V49, P36, DOI 10.1637/7264-081904R1; Huang PH, 2005, VIROLOGY, V332, P584, DOI 10.1016/j.virol.2004.12.005; Huang WR, 2011, J BIOL CHEM, V286, P30780, DOI 10.1074/jbc.M111.257154; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Ji WT, 2008, VET MICROBIOL, V129, P252, DOI 10.1016/j.vetmic.2007.11.025; Ji WT, 2009, J GEN VIROL, V90, P3002, DOI 10.1099/vir.0.013953-0; Ji WT, 2009, BIOCHEM BIOPH RES CO, V384, P301, DOI 10.1016/j.bbrc.2009.04.116; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kleijn M, 1996, VIROLOGY, V217, P486, DOI 10.1006/viro.1996.0143; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Lee DY, 2008, BLOOD, V111, P2280, DOI 10.1182/blood-2007-07-100032; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Lin PY, 2010, VIROLOGY, V400, P104, DOI 10.1016/j.virol.2010.01.024; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Liu HJ, 2003, VIROLOGY, V314, P336, DOI 10.1016/S0042-6822(03)00415-X; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Meng SS, 2012, ARCH VIROL, V157, P661, DOI 10.1007/s00705-012-1226-x; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Mizushima N, 2003, INT J BIOCHEM CELL B, V35, P553, DOI 10.1016/S1357-2725(02)00343-6; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Zhou XB, 2009, VIROLOGY, V385, P192, DOI 10.1016/j.virol.2008.12.003	71	66	72	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3571	3584		10.1074/jbc.M112.390245	http://dx.doi.org/10.1074/jbc.M112.390245			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23233667	Green Published, hybrid			2022-12-25	WOS:000314397900062
J	Ng, S; Giraud, E; Duncan, O; Law, SR; Wang, Y; Xu, L; Narsai, R; Carrie, C; Walker, H; Day, DA; Blanco, NE; Strand, A; Whelan, J; Ivanova, A				Ng, Sophia; Giraud, Estelle; Duncan, Owen; Law, Simon R.; Wang, Yan; Xu, Lin; Narsai, Reena; Carrie, Chris; Walker, Hayden; Day, David A.; Blanco, Nicolas E.; Strand, Asa; Whelan, James; Ivanova, Aneta			Cyclin-dependent Kinase E1 (CDKE1) Provides a Cellular Switch in Plants between Growth and Stress Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR GENE-EXPRESSION; ALTERNATIVE OXIDASE; ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL PROTEINS; TOBACCO CELLS; ATP SYNTHASE; FLORAL DIP; SIGNALS; TRANSFORMATION	Plants must deal effectively with unfavorable growth conditions that necessitate a coordinated response to integrate cellular signals with mitochondrial retrograde signals. A genetic screen was carried out to identify regulators of alternative oxidase (rao mutants), using AOX1a expression as a model system to study retrograde signaling in plants. Two independent rao1 mutant alleles identified CDKE1 as a central nuclear component integrating mitochondrial retrograde signals with energy signals under stress. CDKE1 is also necessary for responses to general cellular stresses, such as H2O2 and cold that act, at least in part, via anterograde pathways, and integrates signals from central energy/stress sensing kinase signal transduction pathways within the nucleus. Together, these results place CDKE1 as a central kinase integrating diverse cellular signals and shed light on a mechanism by which plants can effectively switch between growth and stress responses.	[Ng, Sophia; Giraud, Estelle; Duncan, Owen; Law, Simon R.; Wang, Yan; Xu, Lin; Narsai, Reena; Carrie, Chris; Walker, Hayden; Whelan, James; Ivanova, Aneta] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Day, David A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Blanco, Nicolas E.; Strand, Asa] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden	University of Western Australia; Flinders University South Australia; Umea University	Ivanova, A (corresponding author), Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	aneta.ivanova@uwa.edu.au	Day, David/F-6325-2011; Whelan, James/F-6402-2011; Carrie, Chris/A-2638-2010; Ng, Sophia/J-8014-2014	Day, David/0000-0001-7967-2173; Whelan, James/0000-0001-5754-025X; Carrie, Chris/0000-0002-4240-4674; Duncan, Owen/0000-0001-6999-1509; Xu, Lin/0000-0001-7476-2655; WANG, YAN/0000-0003-1600-2863; Law, Simon/0000-0003-0389-6650; Blanco, Nicolas/0000-0002-5010-1307; Ng, Sophia/0000-0002-1677-863X				Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Bitrian M, 2011, PLANT J, V65, P829, DOI 10.1111/j.1365-313X.2010.04462.x; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRADBEER JW, 1979, NATURE, V279, P816, DOI 10.1038/279816a0; Busso C, 2010, FEBS J, V277, P4530, DOI 10.1111/j.1742-4658.2010.07862.x; CAMOUGRAND N, 1995, J MOL BIOL, V247, P588, DOI 10.1006/jmbi.1995.0165; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Citovsky V, 2008, METHODS, V45, P196, DOI 10.1016/j.ymeth.2008.06.007; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gerin S, 2010, BBA-BIOENERGETICS, V1797, P994, DOI 10.1016/j.bbabio.2010.02.034; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Giraud E, 2008, PLANT PHYSIOL, V147, P595, DOI 10.1104/pp.107.115121; Giraud E, 2010, PLANT CELL, V22, P3921, DOI 10.1105/tpc.110.074518; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; Ho LHM, 2008, PLANT PHYSIOL, V147, P1858, DOI 10.1104/pp.108.121384; Jazwinski SM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00139; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kindgren P, 2012, MOL PLANT, V5, P901, DOI 10.1093/mp/ssr112; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Le Hir H, 2008, CELL, V133, P213, DOI 10.1016/j.cell.2008.04.002; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Lin MZ, 2011, NUCLEIC ACIDS RES, V39, pD1134, DOI 10.1093/nar/gkq938; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Mathur S, 2011, PLANT PHYSIOL, V157, P1609, DOI 10.1104/pp.111.188300; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moellering ER, 2010, PLANT PHYSIOL, V152, P1951, DOI 10.1104/pp.110.153262; Parsons HL, 1999, PLANT PHYSIOL, V121, P1309, DOI 10.1104/pp.121.4.1309; PELISSIER P, 1995, CURR GENET, V27, P409, DOI 10.1007/BF00311209; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Ramel F, 2012, P NATL ACAD SCI USA, V109, P5535, DOI 10.1073/pnas.1115982109; RHOADS DM, 1992, PLANT CELL, V4, P1131, DOI 10.1105/tpc.4.9.1131; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Sieger SM, 2005, J EXP BOT, V56, P1499, DOI 10.1093/jxb/eri146; Sun XW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1486; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Wang WM, 2004, DEVELOPMENT, V131, P3147, DOI 10.1242/dev.01187; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zhang R, 2009, PHOTOSYNTH RES, V100, P29, DOI 10.1007/s11120-009-9420-8; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	58	96	97	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3449	3459		10.1074/jbc.M112.416727	http://dx.doi.org/10.1074/jbc.M112.416727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23229550	Green Published, hybrid			2022-12-25	WOS:000314397900049
J	Egger, J; Kapur, T; Nimsky, C; Kikinis, R				Egger, Jan; Kapur, Tina; Nimsky, Christopher; Kikinis, Ron			Pituitary Adenoma Volumetry with 3D Slicer	PLOS ONE			English	Article							TUMOR VOLUME; GROWTH; PEGVISOMANT	In this study, we present pituitary adenoma volumetry using the free and open source medical image computing platform for biomedical research: (3D) Slicer. Volumetric changes in cerebral pathologies like pituitary adenomas are a critical factor in treatment decisions by physicians and in general the volume is acquired manually. Therefore, manual slice-by-slice segmentations in magnetic resonance imaging (MRI) data, which have been obtained at regular intervals, are performed. In contrast to this manual time consuming slice-by-slice segmentation process Slicer is an alternative which can be significantly faster and less user intensive. In this contribution, we compare pure manual segmentations of ten pituitary adenomas with semi-automatic segmentations under Slicer. Thus, physicians drew the boundaries completely manually on a slice-by-slice basis and performed a Slicer-enhanced segmentation using the competitive region-growing based module of Slicer named GrowCut. Results showed that the time and user effort required for GrowCut-based segmentations were on average about thirty percent less than the pure manual segmentations. Furthermore, we calculated the Dice Similarity Coefficient (DSC) between the manual and the Slicer-based segmentations to proof that the two are comparable yielding an average DSC of 81.97 +/- 3.39%.	[Egger, Jan; Kapur, Tina; Kikinis, Ron] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA; [Egger, Jan; Nimsky, Christopher] Univ Hosp Marburg, Dept Neurosurg, Marburg, Germany; [Egger, Jan] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University Hospital of Giessen & Marburg; Philipps University Marburg	Egger, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA.	egger@bwh.harvard.edu	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410	National Institutes of Health (NIH) [P41EB015898]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218, P41RR019703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149, P41EB015898] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health (NIH) grant P41EB015898. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biller BMK, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-10; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Buchfelder M, 2009, BEST PRACT RES CL EN, V23, P677, DOI 10.1016/j.beem.2009.05.002; Buhk JH, 2010, J CLIN ENDOCR METAB, V95, P552, DOI 10.1210/jc.2009-1239; Cootes T. F., 1992, BMVC92. Proceedings of the British Machine Vision Conference, P266; Cootes T. F., 2004, TECHNICAL REPORT; Descoteaux Maxime, 2006, Comput Aided Surg, V11, P247, DOI 10.3109/10929080601017212; Egger J., 2010, P BIOSIGNAL, P1; Egger J, 2007, COMP MED SY, P177, DOI 10.1109/CBMS.2007.5; Egger J, 2012, J MED SYST, V36, P2097, DOI 10.1007/s10916-011-9673-6; Egger J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00420; Felkel P, 2001, COMPUT GRAPH FORUM, V20, pC26, DOI 10.1111/1467-8659.00495; Gondim JA, 2006, ARQ NEURO-PSIQUIAT, V64, P971, DOI 10.1590/S0004-282X2006000600016; Greiner K., 2008, P BILDV MED BVM BERL, P51; Honegger J, 2008, EUR J ENDOCRINOL, V158, P287, DOI 10.1530/EJE-07-0502; Jimenez C, 2008, EUR J ENDOCRINOL, V159, P517, DOI 10.1530/EJE-08-0205; JONES AP, 1990, ACTA NEUROCHIR, V107, P61, DOI 10.1007/BF01402614; Korsisaari N, 2008, CLIN CANCER RES, V14, P249, DOI 10.1158/1078-0432.CCR-07-1552; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; National Cancer Institute-Pituitary Tumors Treatment, PITUITARY TUMORS TRE; Neubauer A, 2005, IEEE T VIS COMPUT GR, V11, P497, DOI 10.1109/TVCG.2005.70; Neuberger A, 2005, ZI SCH BUS FIN MA, P1; Nobels FRE, 2000, EUR J ENDOCRINOL, V143, P615, DOI 10.1530/eje.0.1430615; Pamir MN, 2007, NEUROSURGERY, V61, P270, DOI 10.1227/01.NEU.0000255519.96837.C7; Sampa MP, 2006, IEEE IMAGE PROC, P81, DOI 10.1109/ICIP.2006.312367; Weber MA, 2007, RADIOLOGE, V47, P492, DOI 10.1007/s00117-007-1495-7; Wolfsberger S, 2006, NEUROSURGERY, V59, P1001, DOI 10.1227/01.NEU.0000245594.61828.41; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; Zukic D, 2011, PROC SPIE, V7963, DOI 10.1117/12.877660	30	48	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51788	10.1371/journal.pone.0051788	http://dx.doi.org/10.1371/journal.pone.0051788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240062	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800098
J	Khosh, N; Brown, CE; Aboody, KS; Barish, ME				Khosh, Nousha; Brown, Christine E.; Aboody, Karen S.; Barish, Michael E.			Contact and Encirclement of Glioma Cells In Vitro Is an Intrinsic Behavior of a Clonal Human Neural Stem Cell Line	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; GENE-THERAPY; BONE-MARROW; MYOSIN-II; BRAIN REPAIR; MIGRATION; TROPISM; PROGENITORS; TUMORS; GROWTH	Pathotropic neural stem and/or progenitor cells (NSCs) can potentially deliver therapeutic agents to otherwise inaccessible cancers. In glioma, NSCs are found in close contact with tumor cells, raising the possibility that specificity of NSC contact with glioma targets originates in the tumor cells themselves. Alternatively, target preferences may originate, at least in part, in the tumor microenvironment. To better understand mechanisms underlying NSC interactions with glioma cells, we examined NSC-target cell contacts in a highly simplified 3-dimensional peptide hydrogel (Puramatrix) in which cell behaviors can be studied in the relative absence of external cues. HB1.F3 is an immortalized clonal human NSC line extensively characterized in preclinical investigations. To study contact formation between HB1.F3 NSCs and glioma cells, we first examined co-cultures of eGFP-expressing HB1.F3 (HB1.F3.eGFP) NSCs and dsRed-expressing U251 glioma (U251.dsRed) cells. Using confocal microscopy, HB1.F3.eGFP cells were observed contacting or encircling U251.dsRed glioma cells, but never the reverse. Next, examining specificity of these contacts, no significant quantitative differences in either percentages of HB1.F3 NSCs contacting targets, or in the extent of target cell encirclement, were observed when HB1.F3.eGFP cells were presented with various potential target cells (human glioma and breast cancer cell lines, patient-derived brain tumor lines, non-tumor fibroblasts, primary mouse and human astroglial cells, and primary adult and newborn human dermal fibroblasts) except that interactions between HB1.F3 cells did not progress beyond establishing contacts. Finally cytoskeletal mechanisms employed by HB1.F3.eGFP cells varied with the substrate. When migrating in Puramatrix, HB1.F3 NSCs exhibited intermittent process extension followed by soma translocation, while during encirclement their movements were more amoeboid. We conclude that formation of contacts and subsequent encirclement of target cells by HB1.F3 NSCs is an intrinsic property of these NSCs, and that preferential contact formation with tumor cells in vivo must therefore be highly dependent on microenvironmental cues. Citation: Khosh N, Brown CE, Aboody KS, Barish ME (2012) Contact and Encirclement of Glioma Cells In Vitro Is an Intrinsic Behavior of a Clonal Human Neural Stem Cell Line. PLoS ONE 7(12): e51859. doi: 10.1371/journal.pone.0051859	[Khosh, Nousha; Aboody, Karen S.; Barish, Michael E.] Beckman Res Inst City Hope, Dept Neurosci, Duarte, CA 91010 USA; [Brown, Christine E.] Beckman Res Inst City Hope, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA; [Aboody, Karen S.] Beckman Res Inst City Hope, Div Neurosurg, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Barish, ME (corresponding author), Beckman Res Inst City Hope, Dept Neurosci, Duarte, CA 91010 USA.	mbarish@coh.org		Brown, Christine/0000-0003-4915-8207	California Institute for Regenerative Medicine (CIRM) Disease Team [DR1-01421]; Rosalinde and Arthur Gilbert Foundation; Beckman Research Institute	California Institute for Regenerative Medicine (CIRM) Disease Team; Rosalinde and Arthur Gilbert Foundation; Beckman Research Institute	Supported by California Institute for Regenerative Medicine (CIRM) Disease Team grant DR1-01421, the Rosalinde and Arthur Gilbert Foundation, and the Beckman Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007; Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Achanta P, 2010, ANTI-CANCER AGENT ME, V10, P121, DOI 10.2174/187152010790909290; Ahmed AU, 2011, MOL PHARMACEUT, V8, P1559, DOI 10.1021/mp200161f; Ahmed AU, 2010, CURR OPIN MOL THER, V12, P546; An JH, 2009, J PROTEOME RES, V8, P2873, DOI 10.1021/pr900020q; Arocena M, 2010, J NEUROSCI RES, V88, P3267, DOI 10.1002/jnr.22502; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bexell D, 2010, MOL THER, V18, P1067, DOI 10.1038/mt.2010.58; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Colombo E, 2006, STEM CELLS, V24, P825, DOI 10.1634/stemcells.2005-0313; Ehtesham M, 2002, CANCER RES, V62, P5657; Ehtesham Moneeb, 2005, Neurosurg Focus, V19, pE5; Elvira G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044466; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jurvansuu J, 2008, CANCER RES, V68, P4614, DOI 10.1158/0008-5472.CAN-07-5291; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kendall SE, 2008, STEM CELLS, V26, P1575, DOI 10.1634/stemcells.2007-0887; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim DS, 2009, STEM CELLS DEV, V18, P511, DOI 10.1089/scd.2008.0050; Kim SU, 2007, BRAIN DEV-JPN, V29, P193, DOI 10.1016/j.braindev.2006.07.012; Kim SU, 2011, STEM CELL REV REP, V7, P130, DOI 10.1007/s12015-010-9154-1; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kosztowski T, 2009, EXPERT REV ANTICANC, V9, P597, DOI 10.1586/ERA.09.22; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lee DH, 2009, CLIN CANCER RES, V15, P4925, DOI 10.1158/1078-0432.CCR-08-3076; Lin D, 2007, NEUROIMAGE, V37, pS18, DOI 10.1016/j.neuroimage.2007.03.076; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Momin EN, 2010, CURR STEM CELL RES T, V5, P326; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; RASHEED BKA, 1994, CANCER RES, V54, P1324; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; Staflin K, 2007, J NEUROSCI RES, V85, P2147, DOI 10.1002/jnr.21344; Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tormin A, 2009, CYTOTHERAPY, V11, P114, DOI 10.1080/14653240802716590; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Yuan XP, 2006, CANCER RES, V66, P2630, DOI 10.1158/0008-5472.CAN-05-1682; Zerlin M, 1997, J COMP NEUROL, V387, P537, DOI 10.1002/(SICI)1096-9861(19971103)387:4<537::AID-CNE5>3.0.CO;2-3; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhao DH, 2008, MOL CANCER RES, V6, P1819, DOI 10.1158/1541-7786.MCR-08-0146; Zhong J, 2010, J ONCOL, V2010, DOI 10.1155/2010/430142	62	3	4	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51859	10.1371/journal.pone.0051859	http://dx.doi.org/10.1371/journal.pone.0051859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240066	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800102
J	Awaya, T; Kato, T; Mizuno, Y; Chang, H; Niwa, A; Umeda, K; Nakahata, T; Heike, T				Awaya, Tomonari; Kato, Takeo; Mizuno, Yuta; Chang, Hsi; Niwa, Akira; Umeda, Katsutsugu; Nakahata, Tatsutoshi; Heike, Toshio			Selective Development of Myogenic Mesenchymal Cells from Human Embryonic and Induced Pluripotent Stem Cells	PLOS ONE			English	Article							SATELLITE CELL; MUSCLE DEVELOPMENT; DIFFERENTIATION; GENERATION; MOUSE; DERIVATION; ESTABLISHMENT; REGENERATION; FIBROBLASTS; MAINTENANCE	Human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells are promising sources for the cell therapy of muscle diseases and can serve as powerful experimental tools for skeletal muscle research, provided an effective method to induce skeletal muscle cells is established. However, the current methods for myogenic differentiation from human ES cells are still inefficient for clinical use, while myogenic differentiation from human iPS cells remains to be accomplished. Here, we aimed to establish a practical differentiation method to induce skeletal myogenesis from both human ES and iPS cells. To accomplish this goal, we developed a novel stepwise culture method for the selective expansion of mesenchymal cells from cell aggregations called embryoid bodies. These mesenchymal cells, which were obtained by dissociation and re-cultivation of embryoid bodies, uniformly expressed CD56 and the mesenchymal markers CD73, CD105, CD166, and CD29, and finally differentiated into mature myotubes in vitro. Furthermore, these myogenic mesenchymal cells exhibited stable long-term engraftment in injured muscles of immunodeficient mice in vivo and were reactivated upon subsequent muscle damage, increasing in number to reconstruct damaged muscles. Our simple differentiation system facilitates further utilization of ES and iPS cells in both developmental and pathological muscle research and in serving as a practical donor source for cell therapy of muscle diseases.	[Awaya, Tomonari; Kato, Takeo; Mizuno, Yuta; Chang, Hsi; Niwa, Akira; Umeda, Katsutsugu; Heike, Toshio] Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto, Japan; [Niwa, Akira; Nakahata, Tatsutoshi] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan	Kyoto University; Kyoto University	Awaya, T (corresponding author), Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto, Japan.	awaya@kuhp.kyoto-u.ac.jp	Awaya, Tomonari/O-2757-2015	Awaya, Tomonari/0000-0002-9004-3172	Japan Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [22249042, 23791170] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bismuth K, 2010, EXP CELL RES, V316, P3081, DOI 10.1016/j.yexcr.2010.08.018; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; Chang H, 2009, FASEB J, V23, P1907, DOI 10.1096/fj.08-123661; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Guan K, 1999, CYTOTECHNOLOGY, V30, P211, DOI 10.1023/A:1008041420166; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Meregalli M, 2010, BIODRUGS, V24, P237, DOI 10.2165/11534300-000000000-00000; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Ozasa S, 2007, BIOCHEM BIOPH RES CO, V357, P957, DOI 10.1016/j.bbrc.2007.04.032; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Ryan T, 2012, STEM CELL REV REP, V8, P482, DOI 10.1007/s12015-011-9284-0; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Scharner J, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-28; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	39	57	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51638	10.1371/journal.pone.0051638	http://dx.doi.org/10.1371/journal.pone.0051638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236522	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100138
J	Ene, CI; Edwards, L; Riddick, G; Baysan, M; Woolard, K; Kotliarova, S; Lai, C; Belova, G; Cam, M; Walling, J; Zhou, M; Stevenson, H; Kim, HS; Killian, K; Veenstra, T; Bailey, R; Song, H; Zhang, W; Fine, HA				Ene, Chibawanye I.; Edwards, Lincoln; Riddick, Gregory; Baysan, Mehmet; Woolard, Kevin; Kotliarova, Svetlana; Lai, Chen; Belova, Galina; Cam, Maggie; Walling, Jennifer; Zhou, Ming; Stevenson, Holly; Kim, Hong Sug; Killian, Keith; Veenstra, Timothy; Bailey, Rolanda; Song, Hua; Zhang, Wei; Fine, Howard A.			Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization	PLOS ONE			English	Article							INITIATING CELLS; GENOME BROWSER; HUMAN GLIOBLASTOMA; H3K27 DEMETHYLASE; DNA METHYLATION; STEM-CELLS; DIFFERENTIATION; PATHWAY; REPRESSION; UCSC	Histone methylation regulates normal stem cell fate decisions through a coordinated interplay between histone methyltransferases and demethylases at lineage specific genes. Malignant transformation is associated with aberrant accumulation of repressive histone modifications, such as polycomb mediated histone 3 lysine 27 (H3K27me3) resulting in a histone methylation mediated block to differentiation. The relevance, however, of histone demethylases in cancer remains less clear. We report that JMJD3, a H3K27me3 demethylase, is induced during differentiation of glioblastoma stem cells (GSCs), where it promotes a differentiation-like phenotype via chromatin dependent (INK4A/ARF locus activation) and chromatin independent (nuclear p53 protein stabilization) mechanisms. Our findings indicate that deregulation of JMJD3 may contribute to gliomagenesis via inhibition of the p53 pathway resulting in a block to terminal differentiation.	[Fine, Howard A.] NYU, Ctr Canc, Langone Med Ctr, New York, NY 10003 USA; [Ene, Chibawanye I.; Edwards, Lincoln; Riddick, Gregory; Baysan, Mehmet; Woolard, Kevin; Kotliarova, Svetlana; Lai, Chen; Belova, Galina; Cam, Maggie; Walling, Jennifer; Kim, Hong Sug; Bailey, Rolanda; Song, Hua; Zhang, Wei] NINDS, Neurooncol Branch, Ctr Canc Res, NCI,NIH, Bethesda, MD 20892 USA; [Ene, Chibawanye I.] NIH, NIH Oxford Cambridge Res Scholars Program, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy] NCI, Lab Prote & Analyt Technol, Frederick Natl Lab Canc Res, NIH, Frederick, MD 21701 USA; [Stevenson, Holly; Killian, Keith] NCI, Mol Profiling Core, Genet Branch, NIH, Bethesda, MD 20892 USA	New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fine, HA (corresponding author), NYU, Ctr Canc, Langone Med Ctr, New York, NY 10003 USA.	Howard.Fine@nyumc.org	kim, Hong Sug/G-2731-2014; baysan, mehmet/O-1710-2018; Ene, Cosmin-Victor/W-3630-2017	baysan, mehmet/0000-0001-7359-2965; Ene, Chibawanye/0000-0002-2653-281X; Ene, Cosmin-Victor/0000-0002-1357-9504	Howard Hughes Medical Institute National Cancer Institute, National Institute of Health; NATIONAL CANCER INSTITUTE [ZICBC011041] Funding Source: NIH RePORTER	Howard Hughes Medical Institute National Cancer Institute, National Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Howard Hughes Medical Institute National Cancer Institute, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho W, 2009, J NEUROCHEM, V110, P343, DOI 10.1111/j.1471-4159.2009.06146.x; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kachirskaia I, 2008, J BIOL CHEM, V283, P34660, DOI 10.1074/jbc.M806020200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lu C, 2012, NATURE; Lu J, 2010, J NEUROSURG, V113, P225, DOI 10.3171/2009.11.JNS091272; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stadler M. B., 2011, NATURE; Testa G, 2011, BIOESSAYS, V33, P519, DOI 10.1002/bies.201100021; Turcan S, 2012, NATURE; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	45	78	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51407	10.1371/journal.pone.0051407	http://dx.doi.org/10.1371/journal.pone.0051407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236496	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100115
J	Glukhov, AS; Krutilina, AI; Shlyapnikov, MG; Severinov, K; Lavysh, D; Kochetkov, VV; McGrath, JW; de Leeuwe, C; Shaburova, OV; Krylov, VN; Akulenko, NV; Kulakov, LA				Glukhov, Anatoly S.; Krutilina, Antonina I.; Shlyapnikov, Michael G.; Severinov, Konstantin; Lavysh, Daria; Kochetkov, Vladimir V.; McGrath, John W.; de Leeuwe, Colin; Shaburova, Olga V.; Krylov, Victor N.; Akulenko, Natalia V.; Kulakov, Leonid A.			Genomic Analysis of Pseudomonas putida Phage tf with Localized Single-Strand DNA Interruptions	PLOS ONE			English	Article							TEMPERATE BACTERIOPHAGE; SEQUENCE; AERUGINOSA; RESEMBLES; ALIGNMENT; PROTEINS; HOMOLOGY; MUTANTS; KT2440	The complete sequence of the 46,267 bp genome of the lytic bacteriophage tf specific to Pseudomonas putida PpG1 has been determined. The phage genome has two sets of convergently transcribed genes and 186 bp long direct terminal repeats. The overall genomic architecture of the tf phage is similar to that of the previously described Pseudomonas aeruginosa phages PaP3, LUZ24 and phiMR299-2, and 39 out of the 72 products of predicted tf open reading frames have orthologs in these phages. Accordingly, tf was classified as belonging to the LUZ24-like bacteriophage group. However, taking into account very low homology levels between tf DNA and that of the other phages, tf should be considered as an evolutionary divergent member of the group. Two distinguishing features not reported for other members of the group were found in the tf genome. Firstly, a unique end structure - a blunt right end and a 4-nucleotide 3'-protruding left end - was observed. Secondly, 14 single-chain interruptions (nicks) were found in the top strand of the tf DNA. All nicks were mapped within a consensus sequence 5'-TACT/RTGMC-3'. Two nicks were analyzed in detail and were shown to be present in more than 90% of the phage population. Although localized nicks were previously found only in the DNA of T5-like and phiKMV-like phages, it seems increasingly likely that this enigmatic structural feature is common to various other bacteriophages.	[McGrath, John W.; de Leeuwe, Colin; Akulenko, Natalia V.; Kulakov, Leonid A.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Glukhov, Anatoly S.; Krutilina, Antonina I.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia; [Shlyapnikov, Michael G.; Kochetkov, Vladimir V.] Russian Acad Sci, Skryabin Inst Biochem & Physiol Microorganisms, Pushchino 142292, Russia; [Severinov, Konstantin; Lavysh, Daria; Akulenko, Natalia V.] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Severinov, Konstantin; Lavysh, Daria; Akulenko, Natalia V.] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Severinov, Konstantin; Akulenko, Natalia V.] Rutgers State Univ, Waksman Inst, Piscataway, NJ USA; [Shaburova, Olga V.; Krylov, Victor N.] RAMS, II Mechnikov Res Inst Vaccines & Sera, Lab Genet Bacteriophages, Dept Microbiol, Moscow, Russia	Queens University Belfast; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Rutgers State University New Brunswick; Russian Academy of Medical Sciences; Research Institute of Vaccines and Sera Mechnikov, RAMS	Kulakov, LA (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	l.kulakov@qub.ac.uk	Shaburova, Olga/AAK-2332-2021; Severinov, Konstantin/C-8545-2016	, Olga/0000-0003-0368-3794	School of Biological Sciences; QUESTOR Centre; Russian Academy of Science [02.740.11.077]; Charles and Johanna Busch Biomedical Foundation	School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); QUESTOR Centre; Russian Academy of Science(Russian Academy of Sciences); Charles and Johanna Busch Biomedical Foundation	Work of LAK group was supported by the School of Biological Sciences and the QUESTOR Centre. Work in KS laboratory was supported by a Russian Academy of Science program grant in Molecular and Cellular Biology and Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia 2009-2012", state contract 02.740.11.077. NVA was partially supported by a fellowship from Charles and Johanna Busch Biomedical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON J, 1966, J MOL BIOL, V18, P262, DOI 10.1016/S0022-2836(66)80245-0; ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAUER CE, 1985, J MOL BIOL, V181, P187, DOI 10.1016/0022-2836(85)90084-1; BECKMAN LD, 1971, J MOL BIOL, V62, P551, DOI 10.1016/0022-2836(71)90155-0; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Cornelissen A, 2012, J VIROL, V86, P1844, DOI 10.1128/JVI.06330-11; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; Jonston JV, 1977, J VIROL, V22, P510; Kim S, 2012, J VIROL, V86, P3400, DOI 10.1128/JVI.07191-11; Kimura K, 2003, APPL ENVIRON MICROB, V69, P2491, DOI 10.1128/AEM.69.5.2491-2497.2003; Kovalyova IV, 2003, VIROLOGY, V311, P305, DOI 10.1016/S0042-6822(03)00124-7; KULAKOV LA, 1981, GENETIKA+, V17, P1737; KULAKOV LA, 1985, MOL GEN GENET, V200, P123, DOI 10.1007/BF00383324; Kulakov LA, 1988, MOL GENET MIKROBIOL, V6, P12; Kulakov LA, 2009, VIROLOGY, V391, P1, DOI 10.1016/j.virol.2009.06.024; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; LEE LF, 1966, J BACTERIOL, V92, P1821, DOI 10.1128/JB.92.6.1821-1827.1966; Miller J.H., 1972, EXPT MOL GENETICS; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nilsson M, 2011, ENVIRON MICROBIOL, V13, P1357, DOI 10.1111/j.1462-2920.2011.02447.x; Rhoades M, 1984, J VIROL, V51, P533; Robison K, 1998, J MOL BIOL, V284, P241, DOI 10.1006/jmbi.1998.2160; ROGERS SG, 1979, J VIROL, V29, P716, DOI 10.1128/JVI.29.2.716-725.1979; Sambrook J., 2002, MOL CLONING LAB MANU; Savalia D, 2008, J MOL BIOL, V377, P774, DOI 10.1016/j.jmb.2007.12.077; SHAW AR, 1979, J VIROL, V29, P220, DOI 10.1128/JVI.29.1.220-231.1979; Tan YL, 2007, CELL MICROBIOL, V9, P479, DOI 10.1111/j.1462-5822.2006.00804.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tremblay DM, 1999, VIROLOGY, V255, P63, DOI 10.1006/viro.1998.9525; Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049	38	15	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51163	10.1371/journal.pone.0051163	http://dx.doi.org/10.1371/journal.pone.0051163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236447	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100075
J	Grabowski, TB; Boswell, KM; McAdam, BJ; Wells, RJD; Marteinsdottir, G				Grabowski, Timothy B.; Boswell, Kevin M.; McAdam, Bruce J.; Wells, R. J. David; Marteinsdottir, Gudrun			Characterization of Atlantic Cod Spawning Habitat and Behavior in Icelandic Coastal Waters	PLOS ONE			English	Article							NORTHEAST ARCTIC COD; GADUS-MORHUA L.; REPRODUCTIVE SUCCESS; MIGRATORY BEHAVIOR; RELATIVE DENSITY; TARGET-STRENGTH; SITE FIDELITY; MATE CHOICE; FISHES; SIZE	The physical habitat used during spawning may potentially be an important factor affecting reproductive output of broadcast spawning marine fishes, particularly for species with complex, substrate-oriented mating systems and behaviors, such as Atlantic cod Gadus morhua. We characterized the habitat use and behavior of spawning Atlantic cod at two locations off the coast of southwestern Iceland during a 2-d research cruise (15-16 April 2009). We simultaneously operated two different active hydroacoustic gear types, a split beam echosounder and a dual frequency imaging sonar (DIDSON), as well as a remotely operated underwater vehicle (ROV). A total of five fish species were identified through ROV surveys: including cusk Brosme brosme, Atlantic cod, haddock Melanogrammus aeglefinus, lemon sole Microstomus kitt, and Atlantic redfish Sebastes spp. Of the three habitats identified in the acoustic surveys, the transitional habitat between boulder/lava field and sand habitats was characterized by greater fish density and acoustic target strength compared to that of sand or boulder/lava field habitats independently. Atlantic cod were observed behaving in a manner consistent with published descriptions of spawning. Individuals were observed ascending 1-5 m into the water column from the bottom at an average vertical swimming speed of 0.20-0.25 m s(-1) and maintained an average spacing of 1.0-1.4 m between individuals. Our results suggest that cod do not choose spawning locations indiscriminately despite the fact that it is a broadcast spawning fish with planktonic eggs that are released well above the seafloor.	[Grabowski, Timothy B.; McAdam, Bruce J.; Marteinsdottir, Gudrun] Univ Iceland, Inst Biol, Reykjavik, Iceland; [Grabowski, Timothy B.] Texas Tech Univ, US Geol Survey, Texas Cooperat Fish & Wildlife Res Unit, Lubbock, TX 79409 USA; [Boswell, Kevin M.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Boswell, Kevin M.] Florida Int Univ, Marine Sci Program, Dept Biol Sci, N Miami, FL USA; [McAdam, Bruce J.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Wells, R. J. David] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	University of Iceland; Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; Louisiana State University System; Louisiana State University; State University System of Florida; Florida International University; University of Stirling; Texas A&M University System	Grabowski, TB (corresponding author), Univ Iceland, Inst Biol, Reykjavik, Iceland.	t.grabowski@ttu.edu	Boswell, Kevin M./B-6380-2016	Boswell, Kevin M./0000-0002-2037-1541; Marteinsdottir, Gudrun/0000-0001-6939-2434; Grabowski, Timothy/0000-0001-9763-8948	Icelandic Ministry of Fisheries and Agriculture (Sjavarutvegs-og Landbunaoarraoherra)	Icelandic Ministry of Fisheries and Agriculture (Sjavarutvegs-og Landbunaoarraoherra)	Funding for this project was provided by the Icelandic Ministry of Fisheries and Agriculture (Sjavarutvegs-og Landbunaoarraoherra). Funding was used to support the salary of two authors while they were employed at the University of Iceland (TBG, BJM), the travel costs of two authors (KMB, RJDW), and the costs associated with chartering the research vessel and transportation and insurance of equipment used in this study. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD GP, 1992, ICES J MAR SCI, V49, P357, DOI 10.1093/icesjms/49.3.357; BALON EK, 1975, J FISH RES BOARD CAN, V32, P821, DOI 10.1139/f75-110; Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Bigelow H. B., 1953, FISHERY B FISH WILDL; Boswell KM, 2010, MAR COAST FISH, V2, P83, DOI 10.1577/C09-022.1; BRANDER K, 2005, 274 ICES COOP RES; Brandt Stephen B., 1996, P385; BRAWN VIVIEN M., 1961, BEHAVIOUR, V18, P177, DOI 10.1163/156853961X00114; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Checkley David M. Jr., 1999, Fisheries Oceanography, V8, P22; Choat JH, 2012, FISH FISH SER, V35, P85, DOI 10.1007/978-94-007-1980-4_4; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Ermolchev VA, 2009, ICES J MAR SCI, V66, P1225, DOI 10.1093/icesjms/fsp024; Florin AB, 2010, FISH RES, V102, P207, DOI 10.1016/j.fishres.2009.12.002; Fudge SB, 2009, ICES J MAR SCI, V66, P1259, DOI 10.1093/icesjms/fsp097; Godo OR, 2000, FISH RES, V48, P127, DOI 10.1016/S0165-7836(00)00177-6; Grabowski TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017528; Hunter E, 2003, P ROY SOC B-BIOL SCI, V270, P2097, DOI 10.1098/rspb.2003.2473; Hutchings JA, 1999, CAN J FISH AQUAT SCI, V56, P97, DOI 10.1139/cjfas-56-1-97; HUTCHINGS JA, 1993, CAN J FISH AQUAT SCI, V50, P2468, DOI 10.1139/f93-271; JONES FRH, 1985, J COMP PHYSIOL B, V155, P319; Jonsdottir IG, 2010, MARINE RES ICELAND, V155; Jonsdottir IG, 2006, ICES J MAR SCI, V63, P1501, DOI 10.1016/j.icesjms.2006.05.006; Jonsson G., 2006, ISLENSKIR FISKAR; Knickle DC, 2012, FISH RES, V129, P8, DOI 10.1016/j.fishres.2012.05.013; Kristjansson L, 1983, ISLENSKIR SJAVARHAET, V3; Lawson GL, 2000, CAN J FISH AQUAT SCI, V57, P1011, DOI 10.1139/cjfas-57-5-1011; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Marteinsdottir G, 2000, ICES J MAR SCI, V57, P824, DOI 10.1006/jmsc.2000.0568; Marteinsdottir G, 1995, ICES C G, P15; Meager JJ, 2010, CAN J FISH AQUAT SCI, V67, P1221, DOI 10.1139/F10-066; Meager JJ, 2009, MAR ECOL PROG SER, V389, P233, DOI 10.3354/meps08156; Nemerson D, 2000, FISH B-NOAA, V98, P118; Nordeide JT, 2000, FISH FISH, V1, P90, DOI 10.1046/j.1467-2979.2000.00005.x; Nordeide JT, 1998, SARSIA, V83, P373, DOI 10.1080/00364827.1998.10413696; Ona E, 1996, ICES J MAR SCI, V53, P677, DOI 10.1006/jmsc.1996.0087; PETERSEN CW, 1992, ECOLOGY, V73, P391, DOI 10.2307/1940747; Petursdottir G, 2006, FISH RES, V80, P182, DOI 10.1016/j.fishres.2006.05.002; Rakitin A, 2001, MAR BIOL, V138, P1077, DOI 10.1007/s002270100551; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Robichaud D, 2001, CAN J FISH AQUAT SCI, V58, P2325, DOI 10.1139/cjfas-58-12-2325; Rose GA, 1996, ICES J MAR SCI, V53, P259, DOI 10.1006/jmsc.1996.0032; ROSE GA, 1993, NATURE, V366, P458, DOI 10.1038/366458a0; Rowe S, 2003, TRENDS ECOL EVOL, V18, P567, DOI 10.1016/j.tree.2003.09.004; Rowe S, 2008, MAR ECOL PROG SER, V354, P257, DOI 10.3354/meps07175; Schabenberger O.., 2005, INTRO GLIMMIX PROCED; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Skjaeraasen JE, 2011, ICES J MAR SCI, V68, P1472, DOI 10.1093/icesjms/fsr055; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085; Svedang H, 2007, MAR ECOL PROG SER, V345, P1, DOI 10.3354/meps07140; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; WARNER RR, 1990, AM NAT, V135, P205, DOI 10.1086/285039; Wells RJD, 2007, AM FISH S S, V60, P39; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008	57	13	13	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51321	10.1371/journal.pone.0051321	http://dx.doi.org/10.1371/journal.pone.0051321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236471	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100095
J	Merbah, M; Arakelyan, A; Edmonds, T; Ochsenbauer, C; Kappes, JC; Shattock, RJ; Grivel, JC; Margolis, LB				Merbah, Melanie; Arakelyan, Anush; Edmonds, Tara; Ochsenbauer, Christina; Kappes, John C.; Shattock, Robin J.; Grivel, Jean-Charles; Margolis, Leonid B.			HIV-1 Expressing the Envelopes of Transmitted/Founder or Control/Reference Viruses Have Similar Infection Patterns of CD4 T-Cells in Human Cervical Tissue Ex Vivo	PLOS ONE			English	Article							HUMAN LYMPHOID-TISSUE; SIMIAN IMMUNODEFICIENCY VIRUS; SEXUAL TRANSMISSION; CXCR4-TROPIC HIV-1; TYPE-1 INFECTION; MOLECULAR CLONES; PATHOGENESIS; CCR5; DISSEMINATION; DETERMINANTS	Recently, it was found that 80% of sexual HIV-1 transmissions are established by a single virion/viral genome. To investigate whether the transmitted/founder (T/F) viruses have specific biological properties favoring sexual transmission, we inoculated human cervical tissue explants with isogenic HIV-1 viruses encoding Env sequences from T/F and control reference (C/R) HIV-1 variants as well as with full length T/F HIV-1 and compared their replication efficiencies, T cell depletion, and the activation status of infected cells. We found that all the HIV-1 variants were capable of transmitting infection to cervical tissue ex vivo and in this system preferentially replicate in activated CD4 T cells and deplete these cells. There was no difference in the biological properties of T/F and C/R HIV-1 variants as evaluated in ex vivo cervical tissue. Citation: Merbah M, Arakelyan A, Edmonds T, Ochsenbauer C, Kappes JC, et al. (2012) HIV-1 Expressing the Envelopes of Transmitted/Founder or Control/Reference Viruses Have Similar Infection Patterns of CD4 T-Cells in Human Cervical Tissue Ex Vivo. PLoS ONE 7(12): e50839. doi:10.1371/journal.pone.0050839	[Merbah, Melanie; Arakelyan, Anush; Grivel, Jean-Charles; Margolis, Leonid B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Intercellular Interact, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Edmonds, Tara; Ochsenbauer, Christina; Kappes, John C.] Univ Alabama Birmingham, Birmingham, AL USA; [Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, London, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Alabama System; University of Alabama Birmingham; Imperial College London	Grivel, JC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Intercellular Interact, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	grigri@helix.nih.gov		Grivel, Jean-Charles/0000-0003-0365-3181; Merbah, Melanie/0000-0002-5641-8612	Intramural NICHD Program; Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, U19AI067854] Funding Source: NIH RePORTER	Intramural NICHD Program; Center for HIV/AIDS Vaccine Immunology (CHAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of MM, AA, J-CG and LBM was supported by the Intramural NICHD Program. RS, CO, TGE and JCK were supported by the Center for HIV/AIDS Vaccine Immunology (CHAVI) # U19 AI067854-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Blanchet F, 2011, CURR OPIN HIV AIDS, V6, P391, DOI 10.1097/COH.0b013e328349b0a0; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; Chung NPY, 2010, J BIOL CHEM, V285, P2100, DOI 10.1074/jbc.M109.030619; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Karlsson I, 2005, J VIROL, V79, P11151, DOI 10.1128/JVI.79.17.11151-11160.2005; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Saba E, 2010, MUCOSAL IMMUNOL, V3, P280, DOI 10.1038/mi.2010.2; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032539; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Turville SG, 2006, CURR OPIN HIV AIDS, V1, P3, DOI 10.1097/01.COH.0000194109.14601.20; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960	30	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50839	10.1371/journal.pone.0050839	http://dx.doi.org/10.1371/journal.pone.0050839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236398	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700019
J	Stieglitz, J; Blackwell, AD; Gutierrez, RQ; Linares, EC; Gurven, M; Kaplan, H				Stieglitz, Jonathan; Blackwell, Aaron D.; Quispe Gutierrez, Raul; Cortez Linares, Edhitt; Gurven, Michael; Kaplan, Hillard			Modernization, Sexual Risk-Taking, and Gynecological Morbidity among Bolivian Forager-Horticulturalists	PLOS ONE			English	Article							REPRODUCTIVE-TRACT INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; RURAL WOMEN; TRANSMITTED-DISEASES; BACTERIAL VAGINOSIS; 1ST INTERCOURSE; HIV; PREVALENCE; BEHAVIOR; COMMUNITY	Sexual risk-taking and reproductive morbidity are common among rapidly modernizing populations with little material wealth, limited schooling, minimal access to modern contraception and healthcare, and gendered inequalities in resource access that limit female autonomy in cohabiting relationships. Few studies have examined how modernization influences sexual risk-taking and reproductive health early in demographic transition. Tsimane are a natural fertility population of Bolivian forager-farmers; they are not urbanized, reside in small-scale villages, and lack public health infrastructure. We test whether modernization is associated with greater sexual risk-taking, report prevalence of gynecological morbidity (GM), and test whether modernization, sexual risk-taking and parity are associated with greater risk of GM. Data were collected from 2002-2010 using interviews, clinical exams, and laboratory analysis of cervical cells. We find opposing effects of modernization on both sexual risk-taking and risk of GM. Residential proximity to town and Spanish fluency are associated with greater likelihood of men's infidelity, and with number of lifetime sexual partners for men and women. However, for women, literacy is associated with delayed sexual debut after controlling for town proximity. Fifty-five percent of women present at least one clinical indicator of GM (n = 377); 48% present inflammation of cervical cells, and in 11% the inflammation results from sexually transmitted infection (trichomoniasis). Despite having easier access to modern healthcare, women residing near town experience greater likelihood of cervical inflammation and trichomoniasis relative to women in remote villages; women who are fluent in Spanish are also more likely to present trichomoniasis relative to women with moderate or no fluency. However, literate women experience lower likelihood of trichomoniasis. Parity has no effect on risk of GM. Our results suggest a net increase in risk of reproductive morbidity among rapidly modernizing, resource-stressed populations. Citation: Stieglitz J, Blackwell AD, Quispe Gutierrez R, Cortez Linares E, Gurven M, et al. (2012) Modernization, Sexual Risk-Taking, and Gynecological Morbidity among Bolivian Forager-Horticulturalists. PLoS ONE 7(12): e50384. doi:10.1371/journal.pone.0050384	[Stieglitz, Jonathan; Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Blackwell, Aaron D.; Gurven, Michael] Univ Calif Santa Barbara, Integrat Anthropol Sci Unit, Santa Barbara, CA 93106 USA; [Quispe Gutierrez, Raul; Cortez Linares, Edhitt] Proyecto Salud & Antropol Tsimane, San Borja, Beni, Bolivia	University of New Mexico; University of California System; University of California Santa Barbara	Stieglitz, J (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	jonathan.stieglitz@gmail.com	Blackwell, Aaron/B-5258-2008	Blackwell, Aaron/0000-0002-5871-9865; Kaplan, Hillard/0000-0002-7398-7358; Gurven, Michael/0000-0002-5661-527X	National Science Foundation [BCS-0422690]; National Institutes of Health/National Institute on Aging [R01AG024119, R56AG024119]; NATIONAL INSTITUTE ON AGING [R56AG024119, R01AG024119] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by the National Science Foundation (http://www.nsf.gov), BCS-0422690, and the National Institutes of Health/National Institute on Aging (http://www.nia.nih.gov), R01AG024119 and R56AG024119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afable-Munsuz A, 2006, PERSPECT SEX REPRO H, V38, P208, DOI 10.1111/j.1931-2393.2006.tb00281.x; Arrossi S, 2003, SALUD PUBLICA MEXICO, V45, pS306; Bhatia J, 2000, STUD FAMILY PLANN, V31, P267, DOI 10.1111/j.1728-4465.2000.00267.x; Bhatia JC, 1997, STUD FAMILY PLANN, V28, P95, DOI 10.2307/2138112; Blackwell AD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001218; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Garcia PJ, 2004, B WORLD HEALTH ORGAN, V82, P483; GLENN ND, 1977, ANN AM ACAD POLIT SS, V429, P36, DOI 10.1177/000271627742900105; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gueye M, 2001, INT FAM PLAN PERSPEC, V27, P56, DOI 10.2307/2673815; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Gurven M, 2009, HUM NATURE-INT BIOS, V20, P151, DOI 10.1007/s12110-009-9062-8; Kaestle CE, 2005, AM J EPIDEMIOL, V161, P774, DOI 10.1093/aje/kwi095; Kahn JA, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e5; Kirby D, 2002, J SEX RES, V39, P27, DOI 10.1080/00224490209552116; Koenig MA, 2004, INT FAM PLAN PERSPEC, V30, P156, DOI 10.1363/3015604; LANDMAN K, 2008, PLOS ONE, V3, P1; Levine WC, 1998, AIDS, V12, P1899, DOI 10.1097/00002030-199814000-00022; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Miller HG, 1999, FAM PLANN PERSPECT, V31, P4, DOI 10.2307/2991550; MOSHA F, 1993, GENITOURIN MED, V69, P415; NICHOLS D, 1986, STUD FAMILY PLANN, V17, P100, DOI 10.2307/1967070; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Norris AE, 1999, SEX TRANSM DIS, V26, P17, DOI 10.1097/00007435-199901000-00004; Nunn CL, 2003, ANIM BEHAV, V66, P37, DOI 10.1006/anbe.2003.2130; O'Donnell L, 2001, FAM PLANN PERSPECT, V33, P268, DOI 10.2307/3030194; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pan American Health Organization, 2009, CHALL POS HIV EP LAT; Passey M, 1998, SEX TRANSM INFECT, V74, P120, DOI 10.1136/sti.74.2.120; Patel V, 2006, SEX TRANSM INFECT, V82, P243, DOI 10.1136/sti.2005.016451; Schiff M, 2000, INT J EPIDEMIOL, V29, P983, DOI 10.1093/ije/29.6.983; SCHULZ KF, 1987, GENITOURIN MED, V63, P320; Shaw M, 2001, SEX TRANSM INFECT, V77, P358, DOI 10.1136/sti.77.5.358; Silverman JG, 2008, JAMA-J AM MED ASSOC, V300, P703, DOI 10.1001/jama.300.6.703; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Stephenson R, 2006, INT FAM PLAN PERSPEC, V32, P201, DOI 10.1363/3220106; Stieglitz J, 2012, EVOL HUM BEHAV, V33, P438, DOI 10.1016/j.evolhumbehav.2011.12.006; Stieglitz J, 2011, AM J HUM BIOL, V23, P445, DOI 10.1002/ajhb.21149; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; Tonon SA, 2004, INT J INFECT DIS, V8, P13, DOI 10.1016/j.ijid.2003.03.001; Trent M, 2011, SEX TRANSM DIS, V38, P879, DOI 10.1097/OLQ.0b013e31821f918c; United Nations Population Fund, 2011, STAT WORLD POP 2011; United Nations Statistics Division, 2005, DES HOUS SURV SAMPL; United States Agency for International Development, 2011, LAT AM CAR SEL EC SO; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Walraven G, 2001, LANCET, V357, P1161, DOI 10.1016/S0140-6736(00)04333-6; Wardlow H, 2007, AM J PUBLIC HEALTH, V97, P1006, DOI 10.2105/AJPH.2006.088559; WEIS DL, 1985, J MARRIAGE FAM, V47, P173, DOI 10.2307/352079; Yang XS, 2008, SOC PROBL, V55, P322, DOI 10.1525/sp.2008.55.3.322; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; Zabin LS, 2009, STUD FAMILY PLANN, V40, P1, DOI 10.1111/j.1728-4465.2009.00182.x; ZABIN LS, 1986, DEMOGRAPHY, V23, P595, DOI 10.2307/2061353; Zurayk H, 1993, Health Transit Rev, V3, P17	58	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50384	10.1371/journal.pone.0050384	http://dx.doi.org/10.1371/journal.pone.0050384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057UO	23236371	gold, Green Published			2022-12-25	WOS:000312589700013
J	Xu, J; Wang, S; Zhao, WJ; Xi, YB; Yan, YB; Yao, K				Xu, Jia; Wang, Sha; Zhao, Wei-Jie; Xi, Yi-Bo; Yan, Yong-Bin; Yao, Ke			The Congenital Cataract-Linked A2V Mutation Impairs Tetramer Formation and Promotes Aggregation of beta B2-Crystallin	PLOS ONE			English	Article							LENS BETA-CRYSTALLIN; SITE-DIRECTED MUTAGENESIS; CHINESE FAMILY; EYE LENS; ASSOCIATION PROPERTIES; MASS-SPECTROMETRY; BETA-B1-CRYSTALLIN; BETA-A3-CRYSTALLIN; EXTENSION; FLUORESCENCE	beta/gamma-Crystallins, the major structural proteins in human lens, are highly conserved in their tertiary structures but distinct in the quaternary structures. The N- and C-terminal extensions have been proposed to play a crucial role in mediating the size of beta-crystallin assembly. In this research, we investigated the molecular mechanism underlying the congenital hereditary cataract caused by the recently characterized A2V mutation in beta B2-crystallin. Spectroscopic experiments indicated that the mutation did not affect the secondary and tertiary structures of beta B2-crystallin. The mutation did not affect the formation of beta B2/beta A3-crystallin heteromer as well as the stability and folding of the heteromer, suggesting that the mutation might not interfere with the protein interacting network in the lens. However, the tetramerization of beta B2-crystallin at high protein concentrations was retarded by the A2V mutation. The mutation slightly decreased the thermal stability and promoted the thermal aggregation of beta B2-crystallin. Although it did not influence the stability of beta B2-crystallin against denaturation induced by chemical denaturants and UV irradiation, the A2V mutant was more prone to be trapped in the off-pathway aggregation process during kinetic refolding. Our results suggested that the A2V mutation might lead to injury of lens optical properties by decreasing beta B2-crystallin stability against heat treatment and by impairing beta B2-crystallin assembly into high-order homo-oligomers. Citation: Xu J, Wang S, Zhao W-J, Xi Y-B, Yan Y-B, et al. (2012) The Congenital Cataract-Linked A2V Mutation Impairs Tetramer Formation and Promotes Aggregation of beta B2-Crystallin. PLoS ONE 7(12): e51200. doi:10.1371/journal.pone.0051200	[Wang, Sha; Zhao, Wei-Jie; Xi, Yi-Bo; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Xu, Jia; Yao, Ke] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [Xi, Yi-Bo] Lanzhou Univ, Inst Biophys, Lanzhou 730000, Peoples R China	Tsinghua University; Zhejiang University; Lanzhou University	Yan, YB (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ybyan@tsinghua.edu.cn; xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021; Yan, Yong-Bin/A-4282-2008	Yan, Yong-Bin/0000-0002-8565-3558; Yao, Ke/0000-0002-6764-7365	National Key Basic Research and Development Program of China [2010CB912402]; National Natural Science Foundation of China [81130018, 30970559]; National Twelfth Five-Year Plan Foundation of China [2012BAI08B01]; Zhejiang Key Innovation Team Project [2009R50039]; Zhejiang Key Laboratory Fund [2011E10006]	National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Twelfth Five-Year Plan Foundation of China; Zhejiang Key Innovation Team Project; Zhejiang Key Laboratory Fund	This study was supported by the National Key Basic Research and Development Program of China (No. 2010CB912402), National Natural Science Foundation of China (Nos. 81130018 and 30970559), National Twelfth Five-Year Plan Foundation of China (No. 2012BAI08B01), Zhejiang Key Innovation Team Project (No. 2009R50039) and Zhejiang Key Laboratory Fund (No. 2011E10006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1996, Methods Mol Biol, V57, P177; Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Banh A, 2006, PROG RETIN EYE RES, V25, P189, DOI 10.1016/j.preteyeres.2005.10.001; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan MP, 2008, BIOCHEMISTRY-US, V47, P11062, DOI 10.1021/bi8012438; COOPER PG, 1993, EUR J BIOCHEM, V213, P321, DOI 10.1111/j.1432-1033.1993.tb17765.x; Dolinska MB, 2009, BIOCHEMISTRY; Fu L, 2002, J STRUCT BIOL, V139, P191, DOI 10.1016/S1047-8477(02)00545-2; Gu F, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20724; He GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033700; Hejtmancik JF, 2004, EXP EYE RES, V79, P377, DOI 10.1016/j.exer.2004.06.011; Hejtmancik JF, 1997, PROTEIN ENG, V10, P1347, DOI 10.1093/protein/10.11.1347; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Koteiche HA, 2007, FEBS LETT, V581, P1933, DOI 10.1016/j.febslet.2007.04.004; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Li XQ, 2012, HUM MUTAT, V33, P391, DOI 10.1002/humu.21648; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; NALINI V, 1994, J MOL BIOL, V236, P1250, DOI 10.1016/0022-2836(94)90025-6; Pang M, 2010, BBA-PROTEINS PROTEOM, V1804, P948, DOI 10.1016/j.bbapap.2010.01.001; Sergeev YV, 2004, BIOCHEMISTRY-US, V43, P415, DOI 10.1021/bi034617f; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; SLINGSBY C, 1990, BIOCHEMISTRY-US, V29, P6592, DOI 10.1021/bi00480a007; Slingsby C, 1999, EYE, V13, P395, DOI 10.1038/eye.1999.113; Srivastava K, 2009, BIOCHEMISTRY-US, V48, P7179, DOI 10.1021/bi900313c; Takata T, 2009, MOL VIS, V15, P241; TUROVEROV KK, 1976, FEBS LETT, V62, P4, DOI 10.1016/0014-5793(76)80003-8; Van Montfort RLM, 2003, PROTEIN SCI, V12, P2606, DOI 10.1110/ps.03265903; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; Wang S, 2011, BIOCHEMISTRY-US, V50, P10451, DOI 10.1021/bi201375p; Wieligmann K, 1999, J MOL BIOL, V286, P989, DOI 10.1006/jmbi.1999.2554; Yao K, 2011, MOL VIS, V17, P144; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020564; Zhang ZL, 2001, EXP EYE RES, V73, P203, DOI 10.1006/exer.2001.1023; ZIGLER JS, 1980, EXP EYE RES, V31, P41, DOI 10.1016/0014-4835(80)90089-5	40	16	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51200	10.1371/journal.pone.0051200	http://dx.doi.org/10.1371/journal.pone.0051200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236454	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700031
J	Aravena, P; Delevoye-Turrell, Y; Deprez, V; Cheylus, A; Paulignan, Y; Frak, V; Nazir, T				Aravena, Pia; Delevoye-Turrell, Yvonne; Deprez, Viviane; Cheylus, Anne; Paulignan, Yves; Frak, Victor; Nazir, Tatjana			Grip Force Reveals the Context Sensitivity of Language-Induced Motor Activity during "Action Words'' Processing: Evidence from Sentential Negation	PLOS ONE			English	Article							TEXT INFORMATION; MENTAL-IMAGERY; HUMAN BRAIN; REPRESENTATION; COMPREHENSION; SYSTEM; CORTEX; VERBS; MODULATION; ACTIVATION	Background: Studies demonstrating the involvement of motor brain structures in language processing typically focus on time windows beyond the latencies of lexical-semantic access. Consequently, such studies remain inconclusive regarding whether motor brain structures are recruited directly in language processing or through post-linguistic conceptual imagery. In the present study, we introduce a grip-force sensor that allows online measurements of language-induced motor activity during sentence listening. We use this tool to investigate whether language-induced motor activity remains constant or is modulated in negative, as opposed to affirmative, linguistic contexts. Methodology/Principal Findings: Participants listened to spoken action target words in either affirmative or negative sentences while holding a sensor in a precision grip. The participants were asked to count the sentences containing the name of a country to ensure attention. The grip force signal was recorded continuously. The action words elicited an automatic and significant enhancement of the grip force starting at approximately 300 ms after target word onset in affirmative sentences; however, no comparable grip force modulation was observed when these action words occurred in negative contexts. Conclusions/Significance: Our findings demonstrate that this simple experimental paradigm can be used to study the online crosstalk between language and the motor systems in an ecological and economical manner. Our data further confirm that the motor brain structures that can be called upon during action word processing are not mandatorily involved; the crosstalk is asymmetrically governed by the linguistic context and not vice versa. Citation: Aravena P, Delevoye-Turrell Y, Deprez V, Cheylus A, Paulignan Y, et al. (2012) Grip Force Reveals the Context Sensitivity of Language-Induced Motor Activity during "Action Words'' Processing: Evidence from Sentential Negation. PLoS ONE 7(12): e50287. doi:10.1371/journal.pone.0050287	[Aravena, Pia; Deprez, Viviane; Cheylus, Anne; Paulignan, Yves; Nazir, Tatjana] Univ Lyon 1, CNRS UCBL, Inst Sci Cognit L2C2, F-69365 Lyon, France; [Delevoye-Turrell, Yvonne] Univ Lille Nord France, UDL3, Lab URECA, Lille, France; [Frak, Victor] Univ Montreal, Inst Readaptat Gingras Lindsay Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lille - ISITE; Universite de Lille; Universite de Montreal	Aravena, P (corresponding author), Univ Lyon 1, CNRS UCBL, Inst Sci Cognit L2C2, F-69365 Lyon, France.	pia.aravena@isc.cnrs.fr	Cheylus, Anne/GSD-3809-2022	Cheylus, Anne/0000-0002-4243-3686; Deprez, Viviane/0000-0002-2121-5559; Nazir, Tatjana/0000-0002-6313-9259; Paulignan, Yves/0000-0001-9474-3080; Frak, Victor/0000-0002-3311-777X	CNRS (Centre National de la Recherche Scientifique), a PhD fellowship from Becas Chile, Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile)	CNRS (Centre National de la Recherche Scientifique), a PhD fellowship from Becas Chile, Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile)	CNRS (Centre National de la Recherche Scientifique), a PhD fellowship from Becas Chile, Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Fargier R, 2011, CORTEX; Fauconnier G., 1994, MENTAL SPACES ASPECT; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Frak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009728; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gaskell MG, 1997, LANG COGNITIVE PROC, V12, P613, DOI 10.1080/016909697386646; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Goldfield BA, 2000, J CHILD LANG, V27, P501, DOI 10.1017/S0305000900004244; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hebb Donald O., 1949, ORG BEHAV; Hoenig K, 2008, J COGNITIVE NEUROSCI, V20, P1799, DOI 10.1162/jocn.2008.20123; Ibanez A., 2012, CORTEX; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jirak D, 2010, CONSCIOUS COGN, V19, P711, DOI 10.1016/j.concog.2010.06.020; Kaup B, 2001, MEM COGNITION, V29, P960, DOI 10.3758/BF03195758; Kaup B, 2007, Q J EXP PSYCHOL, V60, P976, DOI 10.1080/17470210600823512; Lakoff George., 1999, PHILOS FLESH EMBODIE; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016855; Ludtke J, 2008, J COGNITIVE NEUROSCI, V20, P1355, DOI 10.1162/jocn.2008.20093; MACDONALD MC, 1989, J EXP PSYCHOL LEARN, V15, P633, DOI 10.1037/0278-7393.15.4.633; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Meteyard L, 2010, CORTEX; New B, 2001, ANN PSYCHOL, V101, P447; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Papeo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004508; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pulvermuller F, 2006, CEREB CORTEX, V16, P1193, DOI 10.1093/cercor/bhj060; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2012, J NEUROLINGUISTICS; Pylyshyn ZW, 2002, BEHAV BRAIN SCI, V25, P157, DOI 10.1017/S0140525X02000043; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tettamanti M, 2008, NEUROIMAGE, V43, P358, DOI 10.1016/j.neuroimage.2008.08.004; Tomasino B, 2010, NEUROSCIENCE, V169, P246, DOI 10.1016/j.neuroscience.2010.04.039; van Dam WO, 2011, HUM BRAIN MAPP; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Willems RM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00116; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	49	58	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50287	10.1371/journal.pone.0050287	http://dx.doi.org/10.1371/journal.pone.0050287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227164	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000312588200025
J	Karjalainen, MK; Huusko, JM; Ulvila, J; Sotkasiira, J; Luukkonen, A; Teramo, K; Plunkett, J; Anttila, V; Palotie, A; Haataja, R; Muglia, LJ; Hallman, M				Karjalainen, Minna K.; Huusko, Johanna M.; Ulvila, Johanna; Sotkasiira, Jenni; Luukkonen, Aino; Teramo, Kari; Plunkett, Jevon; Anttila, Verneri; Palotie, Aarno; Haataja, Ritva; Muglia, Louis J.; Hallman, Mikko			A Potential Novel Spontaneous Preterm Birth Gene, AR, Identified by Linkage and Association Analysis of X Chromosomal Markers	PLOS ONE			English	Article							ANDROGEN RECEPTOR GENE; FACTOR-I RECEPTOR; SINGLE-NUCLEOTIDE POLYMORPHISM; TUMOR-NECROSIS-FACTOR; PROSTATE-CANCER; FAMILIAL PATTERNS; GESTATIONAL-AGE; GENOME; DISEQUILIBRIUM; DELIVERY	Preterm birth is the major cause of neonatal mortality and morbidity. In many cases, it has severe life-long consequences for the health and neurological development of the newborn child. More than 50% of all preterm births are spontaneous, and currently there is no effective prevention. Several studies suggest that genetic factors play a role in spontaneous preterm birth (SPTB). However, its genetic background is insufficiently characterized. The aim of the present study was to perform a linkage analysis of X chromosomal markers in SPTB in large northern Finnish families with recurrent SPTBs. We found a significant linkage signal (HLOD = 3.72) on chromosome locus Xq13.1 when the studied phenotype was being born preterm. There were no significant linkage signals when the studied phenotype was giving preterm deliveries. Two functional candidate genes, those encoding the androgen receptor (AR) and the interleukin-2 receptor gamma subunit (IL2RG), located near this locus were analyzed as candidates for SPTB in subsequent case-control association analyses. Nine single-nucleotide polymorphisms (SNPs) within these genes and an AR exon-1 CAG repeat, which was previously demonstrated to be functionally significant, were analyzed in mothers with preterm delivery (n = 272) and their offspring (n = 269), and in mothers with exclusively term deliveries (n = 201) and their offspring (n = 199), all originating from northern Finland. A replication study population consisting of individuals born preterm (n = 111) and term (n = 197) from southern Finland was also analyzed. Long AR CAG repeats (>= 26) were overrepresented and short repeats (<= 19) underrepresented in individuals born preterm compared to those born at term. Thus, our linkage and association results emphasize the role of the fetal genome in genetic predisposition to SPTB and implicate AR as a potential novel fetal susceptibility gene for SPTB.	[Karjalainen, Minna K.; Huusko, Johanna M.; Ulvila, Johanna; Sotkasiira, Jenni; Luukkonen, Aino; Haataja, Ritva; Hallman, Mikko] Univ Oulu, Dept Pediat, Inst Clin Med, SF-90100 Oulu, Finland; [Teramo, Kari] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Plunkett, Jevon] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Anttila, Verneri; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Anttila, Verneri; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Cambridge, MA USA; [Haataja, Ritva] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Muglia, Louis J.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Ctr Prevent Preterm Birth, Cincinnati, OH USA	University of Oulu; University of Helsinki; Helsinki University Central Hospital; Stanford University; University of Helsinki; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oulu; Cincinnati Children's Hospital Medical Center	Karjalainen, MK (corresponding author), Univ Oulu, Dept Pediat, Inst Clin Med, SF-90100 Oulu, Finland.	minna.k.karjalainen@oulu.fi	Hallman, Niilo/AHD-9810-2022; Huusko, Johanna M/H-9448-2019	Palotie, Aarno/0000-0002-2527-5874; Karjalainen, Minna K/0000-0003-3184-3775; Saastamoinen, Ritva/0000-0002-8899-0381; Anttila, Verneri/0000-0002-0073-4675	Academy of Finland [105734, 126662, 125911]; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Alma and K.A. Snellman Foundation; Foundation of Pediatric Research in Finland; University of Oulu Faculty of Medicine; Ministry of Social Affairs and Health; Wellcome Trust [WTO89062]; Academy of Finland Center of Excellence for Complex Disease Genetics [200923]; March of Dimes; Children's Discovery Institute at Washington University School of Medicine and St. Louis Children's Hospital; National Center for Research Resources [U54 RR020278]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Alma and K.A. Snellman Foundation; Foundation of Pediatric Research in Finland; University of Oulu Faculty of Medicine; Ministry of Social Affairs and Health; Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland Center of Excellence for Complex Disease Genetics(Academy of Finland); March of Dimes(March of Dimes); Children's Discovery Institute at Washington University School of Medicine and St. Louis Children's Hospital; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Academy of Finland (grant number 105734 to RH, 126662 and 125911 to MH), the Sigrid Juselius Foundation (MH), the Emil Aaltonen Foundation (MKK), the Alma and K.A. Snellman Foundation (MKK), the Foundation of Pediatric Research in Finland (RH), and University of Oulu Faculty of Medicine (RH). Oulu University Hospital was supported by the Ministry of Social Affairs and Health (MH), the Wellcome Trust (grant number WTO89062 to AP), the Academy of Finland Center of Excellence for Complex Disease Genetics 200923 (AP) and by a grant from the March of Dimes, the Children's Discovery Institute at Washington University School of Medicine and St. Louis Children's Hospital awarded to LJM. The Broad Institute Center for Genotyping and Analysis was supported by grant U54 RR020278 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman CM, 2012, J ANDROL, V33, P210, DOI 10.2164/jandrol.111.013391; Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; Annells MF, 2004, AM J OBSTET GYNECOL, V191, P2056, DOI 10.1016/j.ajog.2004.04.021; Aruna M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017718; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basso O, 1999, J EPIDEMIOL COMMUN H, V53, P20, DOI 10.1136/jech.53.1.20; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; Chen Dafang, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P377; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Di Renzo GC, 2011, EUR J OBSTET GYN R B, V159, P342, DOI 10.1016/j.ejogrb.2011.09.024; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Engel SAM, 2005, EPIDEMIOLOGY, V16, P469, DOI 10.1097/01.ede.0000164539.09250.31; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goode EL, 2005, GENET EPIDEMIOL, V29, pS72, DOI 10.1002/gepi.20112; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Haataja R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001293; Haram K, 2003, ACTA OBSTET GYN SCAN, V82, P687, DOI 10.1034/j.1600-0412.2003.00218.x; Hartel C, 2004, MOL HUM REPROD, V10, P911, DOI 10.1093/molehr/gah120; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Hiekkalinna T, 2005, TWIN RES HUM GENET, V8, P16, DOI 10.1375/twin.8.1.16; Hiekkalinna T, 2011, HUM HERED, V71, P256, DOI 10.1159/000329467; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hsu TY, 2009, TAIWAN J OBSTET GYNE, V48, P262, DOI 10.1016/S1028-4559(09)60301-6; Iacovidou N, 2010, ANN NY ACAD SCI, V1205, P130, DOI 10.1111/j.1749-6632.2010.05657.x; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Karjalainen MK, 2011, THESIS U OULU; Karvela M, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2008.04.071; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Kistka ZAF, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.12.014; Kumar R, 2011, LIFE SCI, V88, P565, DOI 10.1016/j.lfs.2011.01.021; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Meazza R, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/861920; Michels G, 2008, FRONT NEUROENDOCRIN, V29, P182, DOI 10.1016/j.yfrne.2007.08.004; Miles HL, 2010, ARCH DIS CHILD-FETAL, V95, pF435, DOI 10.1136/adc.2009.173575; Myking S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-174; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Pandini G, 2009, ANN NY ACAD SCI, V1155, P263, DOI 10.1111/j.1749-6632.2009.04361.x; Payseur BA, 2008, AM J HUM GENET, V82, P1039, DOI 10.1016/j.ajhg.2008.02.018; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Plunkett J, 2009, HUM HERED, V68, P209, DOI 10.1159/000224641; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romero R, 2010, AM J OBSTET GYNECOL, V202; Sajjad Y, 2007, ASIAN J ANDROL, V9, P751, DOI 10.1111/j.1745-7262.2007.00320.x; Schayek H, 2010, MOL CELL ENDOCRINOL, V323, P239, DOI 10.1016/j.mce.2010.04.017; Schayek H, 2010, EXP CELL RES, V316, P1479, DOI 10.1016/j.yexcr.2010.03.007; Simard M, 2010, MOL CELL ENDOCRINOL, V319, P79, DOI 10.1016/j.mce.2009.12.007; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Strauch K, 2003, HUM HERED, V55, P202, DOI 10.1159/000073204; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; THL (The Finnish National Institute for Health and Welfare), 2010, 262010 THL, V26; Ulgen A, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S13; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Varilo T, 1999, THESIS U HELSINKI; Vladic-Stjernholm Y, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-116; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Wilson CM, 1996, MOL CELL ENDOCRINOL, V120, P51, DOI 10.1016/0303-7207(96)03819-1; Winkvist A, 1998, INT J EPIDEMIOL, V27, P248, DOI 10.1093/ije/27.2.248; York TP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012391	70	30	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51378	10.1371/journal.pone.0051378	http://dx.doi.org/10.1371/journal.pone.0051378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227263	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200122
J	Meade, KA; White, KJ; Pickford, CE; Holley, RJ; Marson, A; Tillotson, D; van Kuppevelt, TH; Whittle, JD; Day, AJ; Merry, CLR				Meade, Kate A.; White, Kathryn J.; Pickford, Claire E.; Holley, Rebecca J.; Marson, Andrew; Tillotson, Donna; van Kuppevelt, Toin H.; Whittle, Jason D.; Day, Anthony J.; Merry, Catherine L. R.			Immobilization of Heparan Sulfate on Electrospun Meshes to Support Embryonic Stem Cell Culture and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; PROTEIN INTERACTIONS; BINDING SURFACES; SELF-RENEWAL; BONE-MARROW; IN-VIVO; SCAFFOLDS; SPECIFICATION; HYALURONAN; ANTIBODIES	As our understanding of what guides the behavior of multi- and pluripotent stem cells deepens, so too does our ability to utilize certain cues to manipulate their behavior and maximize their therapeutic potential. Engineered, biologically functionalized materials have the capacity to influence stem cell behavior through a powerful combination of biological, mechanical, and topographical cues. Here, we present the development of a novel electrospun scaffold, functionalized with glycosaminoglycans (GAGs) ionically immobilized onto the fiber surface. Bound GAGs retained the ability to interact with GAG-binding molecules and, crucially, presented GAG sulfation motifs fundamental to mediating stem cell behavior. Bound GAG proved to be biologically active, rescuing the neural differentiation capacity of heparan sulfate-deficient mouse embryonic stem cells and functioning in concert with FGF4 to facilitate the formation of extensive neural processes across the scaffold surface. The combination of GAGs with electrospun scaffolds creates a biomaterial with potent applicability for the propagation and effective differentiation of pluripotent stem cells.	[Meade, Kate A.; White, Kathryn J.; Pickford, Claire E.; Marson, Andrew; Tillotson, Donna; Merry, Catherine L. R.] Univ Manchester, Sch Mat, Stem Cell Glycobiol Grp, Manchester M1 7HS, Lancs, England; [White, Kathryn J.] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Holley, Rebecca J.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Whittle, Jason D.] Univ S Australia, Mawson Inst, Adelaide, SA 5001, Australia	University of Manchester; University of Leeds; University of Manchester; Radboud University Nijmegen; University of South Australia	Day, AJ (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Anthony.day@manchester.ac.uk; catherine.merry@manchester.ac.uk	Day, Anthony/O-1658-2015; van Kuppevelt, A.H.M.S.M./L-4463-2015; Whittle, Jason D/E-5842-2011; Pickford, Claire/C-9815-2013	Day, Anthony/0000-0002-1415-3134; Whittle, Jason D/0000-0002-8250-1639; merry, catherine/0000-0002-3490-2809	Engineering and Physical Sciences Research Council; Medical Research Council; The Human Frontier Science Program; EPSRC [EP/H046070/1] Funding Source: UKRI; MRC [G0701165] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H046070/1] Funding Source: researchfish; Medical Research Council [G0701165] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Human Frontier Science Program(Human Frontier Science Program); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Engineering and Physical Sciences Research Council (to K. M., A. J. D., A. M., and C. L. R. M.), the Medical Research Council (to C. L. R. M.), and The Human Frontier Science Program (to R. J. H., C. P., and C. L. R. M.).	Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1002/adfm.200400562; Bateman KL, 2000, ADV EXP MED BIOL, V480, P65; Baxter MA, 2009, STEM CELL RES, V3, P28, DOI 10.1016/j.scr.2009.03.002; Briggs D., 1992, HIGH RESOLUTION XPS; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; Helledie T, 2012, STEM CELLS DEV, V21, P1897, DOI 10.1089/scd.2011.0367; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Holley RJ, 2011, J BIOL CHEM, V286, P6241, DOI 10.1074/jbc.M110.178483; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221; Kurpinski KT, 2010, BIOMATERIALS, V31, P3536, DOI 10.1016/j.biomaterials.2010.01.062; Lam HJ, 2010, TISSUE ENG PT A, V16, P2641, DOI [10.1089/ten.tea.2009.0414, 10.1089/ten.TEA.2009.0414]; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Nur-E-Kamal A, 2008, MOL CELL BIOCHEM, V309, P157, DOI 10.1007/s11010-007-9654-8; Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170; Park K, 2009, MACROMOL BIOSCI, V9, P221, DOI 10.1002/mabi.200800187; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Pickford CE, 2011, STEM CELLS, V29, P629, DOI 10.1002/stem.610; Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018; Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586; Robinson DE, 2012, BIOMATERIALS, V33, P1007, DOI 10.1016/j.biomaterials.2011.10.042; Shard AG, 2004, J PHYS CHEM B, V108, P12472, DOI 10.1021/jp048250f; Smith RAA, 2011, BIOCHEM SOC T, V39, P383, DOI 10.1042/BST0390383; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Spadaccio C, 2010, REGEN MED, V5, P645, DOI 10.2217/RME.10.25; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wijnhoven TJ, 2008, GLYCOCONJUGATE J, V25, P177, DOI 10.1007/s10719-007-9070-z; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Yang ZL, 2012, BIOMATERIALS, V33, P6615, DOI 10.1016/j.biomaterials.2012.06.055; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	50	35	36	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5530	5538		10.1074/jbc.M112.423012	http://dx.doi.org/10.1074/jbc.M112.423012			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23235146	hybrid, Green Published			2022-12-25	WOS:000315342500027
J	Miller, VJ; Sharma, P; Kudlyk, TA; Frost, L; Rofe, AP; Watson, IJ; Duden, R; Lowe, M; Lupashin, VV; Ungar, D				Miller, Victoria J.; Sharma, Prateek; Kudlyk, Tetyana A.; Frost, Laura; Rofe, Adam P.; Watson, Irene J.; Duden, Rainer; Lowe, Martin; Lupashin, Vladimir V.; Ungar, Daniel			Molecular Insights into Vesicle Tethering at the Golgi by the Conserved Oligomeric Golgi (COG) Complex and the Golgin TATA Element Modulatory Factor (TMF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE TRANSPORT; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; BINDING-SITES; SNARE COMPLEX; RAB GTPASES; PROTEIN; P115; GLYCOSYLATION; TRAFFICKING	Protein sorting between eukaryotic compartments requires vesicular transport, wherein tethering provides the first contact between vesicle and target membranes. Here we map and start to functionally analyze the interaction network of the conserved oligomeric Golgi (COG) complex that mediates retrograde tethering at the Golgi. The interactions of COG subunits with members of transport factor families assign the individual subunits as specific interaction hubs. Functional analysis of selected interactions suggests a mechanistic tethering model. We find that the COG complex interacts with two different Rabs in addition to each end of the golgin "TATA element modulatory factor" (TMF). This allows COG to potentially bridge the distance between the distal end of the golgin and the target membrane thereby promoting tighter docking. Concurrently we show that the central portion of TMF can bind to Golgi membranes that are liberated of their COPI cover. This latter interaction could serve to bring vesicle and target membranes into close apposition prior to fusion. A target selection mechanism, in which a hetero-oligomeric tethering factor organizes Rabs and coiled transport factors to enable protein sorting specificity, could be applicable to vesicle targeting throughout eukaryotic cells.	[Miller, Victoria J.; Sharma, Prateek; Rofe, Adam P.; Watson, Irene J.; Ungar, Daniel] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Kudlyk, Tetyana A.; Lupashin, Vladimir V.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Frost, Laura; Lowe, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Duden, Rainer] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biol, D-23562 Lubeck, Germany	University of York - UK; University of Arkansas System; University of Arkansas Medical Sciences; University of Manchester; University of Lubeck	Ungar, D (corresponding author), Univ York, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England.	dani.ungar@york.ac.uk	Lupashin, Vladimir/AAB-4312-2020; Ungar, Daniel/A-5302-2012; Duden, Rainer/C-8917-2011; Duden, Rainer/GXH-3206-2022; Lupashin, Vladimir/E-3013-2013	Lupashin, Vladimir/0000-0002-2350-1962; Ungar, Daniel/0000-0002-9852-6160; Lupashin, Vladimir/0000-0002-2350-1962	National Institutes of Health [1R01GM083144]; BBSRC [BB/F006993/1/, 201098]; MRC Senior Fellowship [G117/494]; DFG grant (Excellence Cluster "Inflammation at Interfaces"); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083144] Funding Source: NIH RePORTER; BBSRC [BB/F006993/1] Funding Source: UKRI; MRC [G117/494] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1098652, BB/F006993/1] Funding Source: researchfish; Medical Research Council [G117/494] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Senior Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFG grant (Excellence Cluster "Inflammation at Interfaces")(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by a National Institutes of Health Grant 1R01GM083144, (to V.L.), BBSRC Grant BB/F006993/1/ and a Marie Curie Grant 201098 (to D.U.), a MRC Senior Fellowship to ML (G117/494), and a DFG grant (Excellence Cluster "Inflammation at Interfaces") (to R.D.).	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Belloni G, 2012, J CELL SCI, V125, P5441, DOI 10.1242/jcs.108878; Chen TY, 2003, BIOCHEM BIOPH RES CO, V303, P1114, DOI 10.1016/S0006-291X(03)00482-0; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Hughson FM, 2010, CURR OPIN CELL BIOL, V22, P454, DOI 10.1016/j.ceb.2010.03.011; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; James P, 1996, GENETICS, V144, P1425; Kelly EE, 2012, BIOL CELL, V104, P84, DOI 10.1111/boc.201100080; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Laufman O, 2011, J CELL BIOL, V194, P459, DOI 10.1083/jcb.201102045; Laufman O, 2009, EMBO J, V28, P2006, DOI 10.1038/emboj.2009.168; Lees JA, 2010, NAT STRUCT MOL BIOL, V17, P1292, DOI 10.1038/nsmb.1917; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; LI GP, 1993, J BIOL CHEM, V268, P24475; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Miller VJ, 2012, TRAFFIC, V13, P891, DOI 10.1111/j.1600-0854.2012.01338.x; Munro S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005256; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Oka T, 2005, J BIOL CHEM, V280, P32736, DOI 10.1074/jbc.M505558200; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; Opdam FJM, 2000, J CELL SCI, V113, P2725; Peanne R, 2011, GLYCOBIOLOGY, V21, P864, DOI 10.1093/glycob/cwq176; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Pokrovskaya ID, 2011, GLYCOBIOLOGY, V21, P1554, DOI 10.1093/glycob/cwr028; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Richardson BC, 2009, P NATL ACAD SCI USA, V106, P13329, DOI 10.1073/pnas.0901966106; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; SARASTE J, 1995, J CELL SCI, V108, P1541; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145; SHIBUYA N, 1988, J BIOL CHEM, V263, P728; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Sohda M, 2010, TRAFFIC, V11, P1552, DOI 10.1111/j.1600-0854.2010.01123.x; Suvorova ES, 2002, J CELL BIOL, V157, P631, DOI 10.1083/jcb.200111081; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Ungar D, 2005, J BIOL CHEM, V280, P32729, DOI 10.1074/jbc.M504590200; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; Vasile E, 2006, EXP CELL RES, V312, P3132, DOI 10.1016/j.yexcr.2006.06.005; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Willett R., 2012, NAT COMMUN IN PRESS; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	67	53	55	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4229	4240		10.1074/jbc.M112.426767	http://dx.doi.org/10.1074/jbc.M112.426767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23239882	Green Published, hybrid			2022-12-25	WOS:000314845000052
J	de St Pierre, M; Gandini, F; Perego, UA; Bodner, M; Gomez-Carballa, A; Corach, D; Angerhofer, N; Woodward, SR; Semino, O; Salas, A; Parson, W; Moraga, M; Achilli, A; Torroni, A; Olivieri, A				de St Pierre, Michelle; Gandini, Francesca; Perego, Ugo A.; Bodner, Martin; Gomez-Carballa, Alberto; Corach, Daniel; Angerhofer, Norman; Woodward, Scott R.; Semino, Ornella; Salas, Antonio; Parson, Walther; Moraga, Mauricio; Achilli, Alessandro; Torroni, Antonio; Olivieri, Anna			Arrival of Paleo-Indians to the Southern Cone of South America: New Clues from Mitogenomes	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; DEL-FUEGO-PATAGONIA; Y-CHROMOSOME; AMERINDIAN POPULATIONS; EXTINCT ABORIGINES; MTDNA HAPLOGROUPS; GENETIC-STRUCTURE; NEW-WORLD; LINEAGES; HISTORY	With analyses of entire mitogenomes, studies of Native American mitochondrial DNA (mtDNA) variation have entered the final phase of phylogenetic refinement: the dissection of the founding haplogroups into clades that arose in America during and after human arrival and spread. Ages and geographic distributions of these clades could provide novel clues on the colonization processes of the different regions of the double continent. As for the Southern Cone of South America, this approach has recently allowed the identification of two local clades (D1g and D1j) whose age estimates agree with the dating of the earliest archaeological sites in South America, indicating that Paleo-Indians might have reached that region from Beringia in less than 2000 years. In this study, we sequenced 46 mitogenomes belonging to two additional clades, termed B2i2 (former B2l) and C1b13, which were recently identified on the basis of mtDNA control-region data and whose geographical distributions appear to be restricted to Chile and Argentina. We confirm that their mutational motifs most likely arose in the Southern Cone region. However, the age estimate for B2i2 and C1b13 (11-13,000 years) appears to be younger than those of other local clades. The difference could reflect the different evolutionary origins of the distinct South American-specific sub-haplogroups, with some being already present, at different times and locations, at the very front of the expansion wave in South America, and others originating later in situ, when the tribalization process had already begun. A delayed origin of a few thousand years in one of the locally derived populations, possibly in the central part of Chile, would have limited the geographical and ethnic diffusion of B2i2 and explain the present-day occurrence that appears to be mainly confined to the Tehuelche and Araucanian-speaking groups.	[Gandini, Francesca; Perego, Ugo A.; Semino, Ornella; Torroni, Antonio; Olivieri, Anna] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [de St Pierre, Michelle] Univ Chile, Fac Ciencias, Dept Ecol, Inst Ecol & Biodiversidad, Santiago, Chile; [de St Pierre, Michelle; Moraga, Mauricio] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago 7, Chile; [Perego, Ugo A.; Angerhofer, Norman; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Bodner, Martin; Parson, Walther] Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria; [Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Fac Med, Santiago De Compostela, Galicia, Spain; [Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Inst Ciencias Forenses, Fac Med, Santiago De Compostela, Galicia, Spain; [Corach, Daniel] Univ Buenos Aires, Fac Farm & Bioquim, Serv Huellas Digitales Genet, RA-1113 Buenos Aires, DF, Argentina; [Angerhofer, Norman; Woodward, Scott R.] AncestryDNA, Provo, UT USA; [Parson, Walther] Penn State Univ, Eberly Coll Sci, University Pk, PA 16802 USA; [Moraga, Mauricio] Univ Chile, Fac Ciencias Sociales, Dept Antropol, Santiago, Chile; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy	University of Pavia; Universidad de Chile; Universidad de Chile; Medical University of Innsbruck; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Buenos Aires; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidad de Chile; University of Perugia	Torroni, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol, Via Palestro 3, I-27100 Pavia, Italy.	antonio.torroni@unipv.it; anna.olivieri@unipv.it	Achilli, Alessandro/I-9236-2012; Perego, Ugo/AAG-9327-2019; Salas, Antonio/E-3977-2012; Torroni, Antonio/E-1557-2011; de Saint Pierre, Michelle/K-3894-2015; OLIVIERI, ANNA/I-9235-2012; Parson, Walther/AAD-6845-2020; Salas, Antonio/U-2029-2019; Gómez-Carballa, Alberto/I-4610-2014; Gandini, Francesca/H-8936-2015	Achilli, Alessandro/0000-0001-6871-3451; Salas, Antonio/0000-0002-2336-702X; Torroni, Antonio/0000-0002-4163-4478; de Saint Pierre, Michelle/0000-0001-6516-5314; OLIVIERI, ANNA/0000-0002-3941-8098; Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Gandini, Francesca/0000-0001-8930-8295; Bodner, Martin/0000-0002-3870-9862; SEMINO, Ornella/0000-0002-9675-9403; Parson, Walther/0000-0002-5692-2392; Corach, Daniel/0000-0002-0662-7424	Fondazione Alma Mater Ticinensis; Sorenson Molecular Genealogy Foundation; Ministerio de Ciencia e Innovacion [SAF2011-26983]; Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; FIRB-Futuro in Ricerca (Italian Ministry of the University); CONICYT; MECESUP UCH; Austrian Science Fund (FWF) [P22880-B12]	Fondazione Alma Mater Ticinensis; Sorenson Molecular Genealogy Foundation; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; FIRB-Futuro in Ricerca (Italian Ministry of the University); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); MECESUP UCH; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research received support from the Fondazione Alma Mater Ticinensis (to AT and OS), the Sorenson Molecular Genealogy Foundation (to UAP and SRW), the Ministerio de Ciencia e Innovacion grant SAF2011-26983 (to AS), the Italian Ministry of the University: Progetti Ricerca Interesse Nazionale 2009 (to AA, OS and AT) and FIRB-Futuro in Ricerca (Italian Ministry of the University) (to AA and AO). MSP was supported by a doctoral fellowship from CONICYT and an intern scholarship from the MECESUP UCH 0803 project. WP was supported by the Austrian Science Fund (FWF): P22880-B12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Bobillo MC, 2010, INT J LEGAL MED, V124, P263, DOI 10.1007/s00414-009-0366-3; Curry A, 2012, NATURE, V485, P30, DOI 10.1038/485030a; Pierre MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043486; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; EMPOP, 2012, EUR DNA PROF GROUP M; Erlandson JM, 2008, J ISL COAST ARCHAEOL, V3, P277; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Fix AG, 2005, AM J PHYS ANTHROPOL, V128, P430, DOI 10.1002/ajpa.20230; Forster P, 1996, AM J HUM GENET, V59, P935; Garcia-Bour J, 2004, AM J PHYS ANTHROPOL, V123, P361, DOI 10.1002/ajpa.10337; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert T., 2008, LOGIC CIRCUITS CARBO, V320, P786; GINTHER C, 1993, EXS, V67, P211; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gomez-Carballa A, 2012, AM J PHYS ANTHROPOL, V147, P78, DOI 10.1002/ajpa.21629; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Hrdlika A., 1925, OLD AM; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kashani BH, 2012, AM J PHYS ANTHROPOL, V147, P35, DOI 10.1002/ajpa.21614; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Keyeux G, 2002, HUM BIOL, V74, P211, DOI 10.1353/hub.2002.0022; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Lalueza C, 1997, HUM MOL GENET, V6, P41, DOI 10.1093/hmg/6.1.41; Lalueza-Fox C, 2001, ANN HUM GENET, V65, P137, DOI 10.1017/S0003480001008533; Luiselli D, 2000, AM J PHYS ANTHROPOL, V113, P5, DOI 10.1002/1096-8644(200009)113:1<5::AID-AJPA2>3.0.CO;2-U; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Malhi RS, 2003, AM J PHYS ANTHROPOL, V120, P108, DOI 10.1002/ajpa.10138; Moraga M, 2010, MAGALLANIA, V38, P103, DOI 10.4067/S0718-22442010000200006; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; Perego UA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038337; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pucciarelli HM, 2006, HOMO, V57, P133, DOI 10.1016/j.jchb.2005.12.003; Raff J, 2010, HUM BIOL, V82, P677, DOI 10.3378/027.082.0510; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rothhammer F, 2001, HIGH ALT MED BIOL, V2, P227, DOI 10.1089/152702901750265323; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SMGF, 2012, SOR MOL GEN FDN MIT; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1992, HUM BIOL, V64, P403; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	81	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51311	10.1371/journal.pone.0051311	http://dx.doi.org/10.1371/journal.pone.0051311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23240014	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000312290800050
J	Dwivedi, V; Manickam, C; Binjawadagi, B; Joyappa, D; Renukaradhya, GJ				Dwivedi, Varun; Manickam, Cordelia; Binjawadagi, Basavaraj; Joyappa, Dechamma; Renukaradhya, Gourapura J.			Biodegradable Nanoparticle-Entrapped Vaccine Induces Cross-Protective Immune Response against a Virulent Heterologous Respiratory Viral Infection in Pigs	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; SYNDROME VIRUS-VACCINE; INTRANASAL DELIVERY; PORCINE; MICROSPHERES; ANTIGEN; SYSTEM; MICE; IMMUNIZATION; ANTIBODY	Biodegradable nanoparticle-based vaccine development research is unexplored in large animals and humans. In this study, we illustrated the efficacy of nanoparticle-entrapped UV-killed virus vaccine against an economically important respiratory viral disease of pigs called porcine reproductive and respiratory syndrome virus (PRRSV). We entrapped PLGA [poly (lactide-co-glycolides)] nanoparticles with killed PRRSV antigens (Nano-KAg) and detected its phagocytosis by pig alveolar macrophages. Single doses of Nano-KAg vaccine administered intranasally to pigs upregulated innate and PRRSV specific adaptive responses. In a virulent heterologous PRRSV challenge study, Nano-KAg vaccine significantly reduced the lung pathology and viremia, and the viral load in the lungs. Immunologically, enhanced innate and adaptive immune cell population and associated cytokines with decreased secretion of immunosuppressive mediators were observed at both mucosal sites and blood. In summary, we demonstrated the benefits of intranasal delivery of nanoparticle-based viral vaccine in eliciting cross-protective immune response in pigs, a potential large animal model.	[Dwivedi, Varun; Manickam, Cordelia; Binjawadagi, Basavaraj; Renukaradhya, Gourapura J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Dwivedi, Varun; Manickam, Cordelia; Binjawadagi, Basavaraj; Renukaradhya, Gourapura J.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Joyappa, Dechamma] Indian Vet Res Inst, Foot & Mouth Dis Lab, Hebbal, Bengaluru, India	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Renukaradhya, GJ (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	gourapura.1@osu.edu		Gourapura, Renukaradhya/0000-0003-2861-180X	National Pork Board (NPB) [09-213]; United States Department of Agriculture-National Institute of Food and Agriculture PRRSCAP2 [2008-55620-19132]	National Pork Board (NPB); United States Department of Agriculture-National Institute of Food and Agriculture PRRSCAP2	This work was supported by National Pork Board (NPB# 09-213) and United States Department of Agriculture-National Institute of Food and Agriculture PRRSCAP2 (2008-55620-19132) awards to GJR. Salaries and research support were provided by state and federal funds appropriated to Ohio Agricultural Research and Development Center and Public Health Preparedness for Infectious Diseases, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUADO MT, 1992, IMMUNOBIOLOGY, V184, P113, DOI 10.1016/S0171-2985(11)80470-5; AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7; Albina E, 1998, J INTERF CYTOK RES, V18, P485, DOI 10.1089/jir.1998.18.485; Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429; Baras B, 1999, INFECT IMMUN, V67, P2643, DOI 10.1128/IAI.67.5.2643-2648.1999; Bassaganya-Riera J, 2004, VIRAL IMMUNOL, V17, P25, DOI 10.1089/088282404322875430; Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Cavanagh D, 1997, ARCH VIROL, V142, P629; Christopher-Hennings J, 2001, J VET DIAGN INVEST, V13, P133, DOI 10.1177/104063870101300207; DONE SH, 1995, VET REC, V136, P32, DOI 10.1136/vr.136.2.32; Dwivedi V, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-45; Dwivedi V, 2011, VACCINE, V29, P4058, DOI 10.1016/j.vaccine.2011.03.006; Dwivedi V, 2011, VACCINE, V29, P4067, DOI 10.1016/j.vaccine.2011.03.005; Ganter M, 1997, RES VET SCI, V63, P215, DOI 10.1016/S0034-5288(97)90023-0; Greenway TE, 1998, VACCINE, V16, P1314, DOI 10.1016/S0264-410X(98)00008-5; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gupta RK, 1998, DEV BIOLOGICALS, V92, P63; HALBUR PG, 1995, VET PATHOL, V32, P200, DOI 10.1177/030098589503200218; Hein WR, 2003, NAT REV IMMUNOL, V3, P79, DOI 10.1038/nri977; HOLMGREN J, 1992, IMMUNOBIOLOGY, V184, P157, DOI 10.1016/S0171-2985(11)80473-0; Holtkamp D., 2011, PRRS COSTS IND 664 M; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Jung K, 2007, J VIROL, V81, P13681, DOI 10.1128/JVI.01702-07; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim WI, 2007, VET MICROBIOL, V123, P1, DOI 10.1016/j.vetmic.2007.03.007; LeRoith T, 2011, VET IMMUNOL IMMUNOP, V140, P312, DOI 10.1016/j.vetimm.2010.12.011; Li B, 2009, EMERG INFECT DIS, V15, P2032, DOI 10.3201/eid1512.090390; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Mengeling WL, 2003, VET MICROBIOL, V93, P13, DOI 10.1016/S0378-1135(02)00427-3; Mestecky J, 1997, Behring Inst Mitt, P33; Miyake A, 2004, J MED VIROL, V73, P368, DOI 10.1002/jmv.20100; Nagao G, 2011, COLLOID SURFACE B, V84, P317, DOI 10.1016/j.colsurfb.2011.01.018; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; OGRA PL, 1969, J IMMUNOL, V102, P1423; Olin MR, 2005, VIRAL IMMUNOL, V18, P490, DOI 10.1089/vim.2005.18.490; PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1; Piotrowicz A, 2005, APPL CHEM CHEM ENG, P108; Rajapaksa TE, 2010, J BIOL CHEM, V285, P23739, DOI 10.1074/jbc.M110.126359; Renukaradhya Gourapura J., 2012, Animal Health Research Reviews, V13, P21, DOI 10.1017/S1466252312000023; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Schaumann F, 2004, AM J RESP CRIT CARE, V170, P898, DOI 10.1164/rccm.200403-423OC; Shephard MJ, 2003, RES VET SCI, V74, P187, DOI 10.1016/S0034-5288(02)00180-7; Shibata Y, 1997, INFECT IMMUN, V65, P1734, DOI 10.1128/IAI.65.5.1734-1741.1997; Singh M, 2001, J CONTROL RELEASE, V70, P267, DOI 10.1016/S0168-3659(00)00330-8; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Welsh RM, 1997, IMMUNOL REV, V159, P79, DOI 10.1111/j.1600-065X.1997.tb01008.x; Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798	50	27	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51794	10.1371/journal.pone.0051794	http://dx.doi.org/10.1371/journal.pone.0051794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240064	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800100
J	Brinkman, DL; Aziz, A; Loukas, A; Potriquet, J; Seymour, J; Mulvenna, J				Brinkman, Diane L.; Aziz, Ammar; Loukas, Alex; Potriquet, Jeremy; Seymour, Jamie; Mulvenna, Jason			Venom Proteome of the Box Jellyfish Chironex fleckeri	PLOS ONE			English	Article							SEA WASP; PARTIAL-PURIFICATION; STATISTICAL-MODEL; HYDRA-VULGARIS; PROTEINS; GENE; IDENTIFICATION; ENVENOMATION; NEMATOCYSTS; DIVERSITY	The nematocyst is a complex intracellular structure unique to Cnidaria. When triggered to discharge, the nematocyst explosively releases a long spiny, tubule that delivers an often highly venomous mixture of components. The box jellyfish, Chironex fleckeri, produces exceptionally potent and rapid-acting venom and its stings to humans cause severe localized and systemic effects that are potentially life-threatening. In an effort to identify toxins that could be responsible for the serious health effects caused by C. fleckeri and related species, we used a proteomic approach to profile the protein components of C. fleckeri venom. Collectively, 61 proteins were identified, including toxins and proteins important for nematocyte development and nematocyst formation (nematogenesis). The most abundant toxins identified were isoforms of a taxonomically restricted family of potent cnidarian proteins. These toxins are associated with cytolytic, nociceptive, inflammatory, dermonecrotic and lethal properties and expansion of this important protein family goes some way to explaining the destructive and potentially fatal effects of C. fleckeri venom. Venom proteins and their post-translational modifications (PTMs) were further characterized using toxin-specific antibodies and phosphoprotein/glycoprotein-specific stains. Results indicated that glycosylation is a common PTM of the toxin family while a lack of cross-reactivity by toxin-specific antibodies infers there is significant divergence in structure and possibly function among family members. This study provides insight into the depth and diversity of protein toxins produced by harmful box jellyfish and represents the first description of a cubozoan jellyfish venom proteome.	[Mulvenna, Jason] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Brinkman, Diane L.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Aziz, Ammar; Loukas, Alex; Potriquet, Jeremy; Seymour, Jamie] James Cook Univ, Queensland Trop Hlth Alliance, Douglas, Qld, Australia; [Seymour, Jamie] Queensland Emergency Med Res Fdn, Milton, Qld, Australia	QIMR Berghofer Medical Research Institute; Australian Institute of Marine Science; James Cook University	Mulvenna, J (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	jason.mulvenna@qimr.edu.au	Brinkman, Diane L/A-1084-2010; Mulvenna, Jason/H-7110-2014; Seymour, Jamie E/C-9748-2013; Loukas, Alex/B-7355-2014	Brinkman, Diane L/0000-0002-6954-7667; Mulvenna, Jason/0000-0003-3521-8061; Seymour, Jamie E/0000-0002-4805-3289; Loukas, Alex/0000-0002-0896-8441	National Health and Medical Research Council, Australia (NHMRC); NHMRC	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported using infrastructure provided by the Australian Government through the Linkage Infrastructure, Equipment and Facilities scheme from the Australian Research Council. JM is supported by a Career Development Fellowship from the National Health and Medical Research Council, Australia (NHMRC). AL is supported by a senior research fellowship from NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Avila Soria G., 2009, THESIS J COOK U; Baek JH, 2009, ARCH INSECT BIOCHEM, V71, P205, DOI 10.1002/arch.20316; Balasubramanian PG, 2012, J BIOL CHEM, V287, P9672, DOI 10.1074/jbc.M111.328203; BEADNELL CE, 1992, MED J AUSTRALIA, V156, P655, DOI 10.5694/j.1326-5377.1992.tb121467.x; Birrell GW, 2007, MOL CELL PROTEOMICS, V6, P973, DOI 10.1074/mcp.M600419-MCP200; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; Brinkman D, 2008, TOXICON, V51, P853, DOI 10.1016/j.toxicon.2007.12.017; Brinkman D, 2007, TOXICON, V50, P850, DOI 10.1016/j.toxicon.2007.06.016; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; Casewell NR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-564; Datu BJD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000130; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084; Fedders H, 2004, DEV GENES EVOL, V214, P72, DOI 10.1007/s00427-003-0378-9; Fenner PJ, 1996, MED J AUSTRALIA, V165, P658, DOI 10.5694/j.1326-5377.1996.tb138679.x; Halai R, 2009, NAT PROD REP, V26, P526, DOI 10.1039/b819311h; Hidaka Michio, 1993, Advances in Comparative and Environmental Physiology, V15, P45; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang JS, 2007, P NATL ACAD SCI USA, V104, P14735, DOI 10.1073/pnas.0703331104; Hwang JS, 2010, P NATL ACAD SCI USA, V107, P18539, DOI 10.1073/pnas.1003256107; Kass-Simon G, 2002, CAN J ZOOL, V80, P1772, DOI 10.1139/Z02-135; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KLUG M, 1991, TOXICON, V29, P129, DOI 10.1016/0041-0101(91)90046-T; Koch AW, 1998, J CELL SCI, V111, P1545; KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassen S, 2011, TOXICON, V57, P721, DOI 10.1016/j.toxicon.2011.02.004; Lewis C, 2009, ZOOTAXA, P59, DOI 10.11646/zootaxa.2030.1.5; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; LUMLEY J, 1988, MED J AUSTRALIA, V148, P527, DOI 10.5694/j.1326-5377.1988.tb99466.x; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Milde S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r8; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P97, DOI 10.1271/bbb.66.97; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P589, DOI 10.1006/bbrc.2000.3352; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P582, DOI 10.1006/bbrc.2000.3353; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Pereira P, 2010, CLIN TOXICOL, V48, P390, DOI 10.3109/15563651003662675; Ruyssers NE, 2009, INFLAMM BOWEL DIS, V15, P491, DOI 10.1002/ibd.20787; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; SLAUTTERBACK DB, 1959, J BIOPHYS BIOCHEM CY, V5, P441, DOI 10.1083/jcb.5.3.441; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P1942, DOI 10.1074/mcp.M600030-MCP200; Steele RE, 2011, TRENDS GENET, V27, P7, DOI 10.1016/j.tig.2010.10.002; Szczepanek S, 2002, J CELL SCI, V115, P745; WEBER J, 1995, ROUX ARCH DEV BIOL, V205, P171, DOI 10.1007/BF00357763; WEBER J, 1994, COMP BIOCHEM PHYS B, V107, P21, DOI 10.1016/0305-0491(94)90220-8	50	45	45	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e47866	10.1371/journal.pone.0047866	http://dx.doi.org/10.1371/journal.pone.0047866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236347	gold, Green Published, Green Accepted			2022-12-25	WOS:000312064100002
J	Tan, L; Lemey, P; Houspie, L; Viveen, MC; Jansen, NJG; van Loon, AM; Wiertz, E; van Bleek, GM; Martin, DP; Coenjaerts, FE				Tan, Lydia; Lemey, Philippe; Houspie, Lieselot; Viveen, Marco C.; Jansen, Nicolaas J. G.; van Loon, Anton M.; Wiertz, Emmanuel; van Bleek, Grada M.; Martin, Darren P.; Coenjaerts, Frank E.			Genetic Variability among Complete Human Respiratory Syncytial Virus Subgroup A Genomes: Bridging Molecular Evolutionary Dynamics and Epidemiology	PLOS ONE			English	Article							CIRCULATION PATTERNS; FUSION PROTEIN; G-GLYCOPROTEIN; GROUP-A; B STRAINS; RS VIRUS; INFECTION; CHILDREN; RECOMBINATION; DISEASE	Human respiratory syncytial virus (RSV) is an important cause of severe lower respiratory tract infections in infants and the elderly. In the vast majority of cases, however, RSV infections run mild and symptoms resemble those of a common cold. The immunological, clinical, and epidemiological profile of severe RSV infections suggests a disease caused by a virus with typical seasonal transmission behavior, lacking clear-cut virulence factors, but instead causing disease by modifying the host's immune response in a way that stimulates pathogenesis. Yet, the interplay between RSV-evoked immune responses and epidemic behavior, and how this affects the genomic evolutionary dynamics of the virus, remains poorly understood. Here, we present a comprehensive collection of 33 novel RSV subgroup A genomes from strains sampled over the last decade, and provide the first measurement of RSV-A genomic diversity through time in a phylodynamic framework. In addition, we map amino acid substitutions per protein to determine mutational hotspots in specific domains. Using Bayesian genealogical inference, we estimated the genomic evolutionary rate to be 6.47x10(-4) (credible interval: 5.56x10(-4), 7.38x10(-4)) substitutions/site/year, considerably slower than previous estimates based on G gene sequences only. The G gene is however marked by elevated substitution rates compared to other RSV genes, which can be attributed to relaxed selective constraints. In line with this, site-specific selection analyses identify the G gene as the major target of diversifying selection. Importantly, statistical analysis demonstrates that the immune driven positive selection does not leave a measurable imprint on the genome phylogeny, implying that RSV lineage replacement mainly follows nonselective epidemiological processes. The roughly 50 years of RSV-A genomic evolution are characterized by a constant population size through time and general co-circulation of lineages over many epidemic seasons - a conclusion that might be taken into account when developing future therapeutic and preventive strategies.	[Tan, Lydia; Viveen, Marco C.; van Loon, Anton M.; Wiertz, Emmanuel; Coenjaerts, Frank E.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Lemey, Philippe; Houspie, Lieselot] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium; [Jansen, Nicolaas J. G.; van Bleek, Grada M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands; [Martin, Darren P.] Univ Cape Town, Fac Hlth Sci, Computat Biol Dept, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	Utrecht University; Utrecht University Medical Center; KU Leuven; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Cape Town	Coenjaerts, FE (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	f.e.j.coenjaerts@umcutrecht.nl	Martin, Darren/ABE-3614-2021; Martin, Darren P/C-4599-2008; Lemey, Philippe/C-3755-2018	Lemey, Philippe/0000-0003-2826-5353	European Union under project GRACE; EC [LSHM-CT-2005-518226]; European Union [278433-PREDEMICS]; ERC [260864]	European Union under project GRACE; EC(European CommissionEuropean Commission Joint Research Centre); European Union(European Commission); ERC(European Research Council (ERC)European Commission)	The research leading to these results has received funding from the European Union Sixth Framework Programme under the project GRACE, EC Grant Agreement number LSHM-CT-2005-518226 (to FC and MV), as well as the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no. 278433-PREDEMICS (to PL) and ERC Grant agreement no. 260864 (to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors has any relevant financial or nonfinancial relationship to disclose.	ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; ANDERSON LJ, 1991, J INFECT DIS, V163, P687, DOI 10.1093/infdis/163.4.687; Baele G., 2012, MOL BIOL EVOL; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Drummond AJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-68; ENGLUND JA, 1991, J CLIN MICROBIOL, V29, P115, DOI 10.1128/JCM.29.1.115-119.1991; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; FRIEDEWALD WT, 1968, J AMER MED ASSOC, V204, P690, DOI 10.1001/jama.1968.03140210044011; Gaunt ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017427; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; HENDRY RM, 1989, J INFECT DIS, V160, P185, DOI 10.1093/infdis/160.2.185; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIM HW, 1971, PEDIATRICS, V48, P745; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Klouwenberg PK, 2009, CRIT REV IMMUNOL, V29, P531, DOI 10.1615/CritRevImmunol.v29.i6.40; Kruijsen D, 2011, VACCINE, V29, P2730, DOI 10.1016/j.vaccine.2011.01.087; Kruijsen D, 2010, J IMMUNOL, V185, P6489, DOI 10.4049/jimmunol.1002645; Kumaria R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-372; Langedijk JPM, 1998, VIROLOGY, V243, P293, DOI 10.1006/viro.1998.9066; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Lemey P, 2012, BIOINFORMATICS; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin D, 2006, J GEN VIROL, V87, P1649, DOI 10.1099/vir.0.81715-0; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; MUFSON MA, 1988, J INFECT DIS, V157, P143, DOI 10.1093/infdis/157.1.143; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; MURPHY BR, 1994, VIRUS RES, V32, P13, DOI 10.1016/0168-1702(94)90059-0; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Rixon HWM, 2002, J GEN VIROL, V83, P61, DOI 10.1099/0022-1317-83-1-61; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Simard C, 1995, ANTIVIR RES, V28, P303, DOI 10.1016/0166-3542(95)00053-4; Spann KM, 2003, J VIROL, V77, P11201, DOI 10.1128/JVI.77.20.11201-11211.2003; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Tang YW, 1997, J CLIN INVEST, V99, P2183, DOI 10.1172/JCI119391; Wertheim JO, 2009, J VIROL, V83, P4690, DOI 10.1128/JVI.02358-08; White LJ, 2007, MATH BIOSCI, V209, P222, DOI 10.1016/j.mbs.2006.08.018; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; WRIGHT PF, 1971, J INFECT DIS, V124, P505, DOI 10.1093/infdis/124.5.505; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Zimmer G, 2001, J VIROL, V75, P4744, DOI 10.1128/JVI.75.10.4744-4751.2001; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	72	60	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51439	10.1371/journal.pone.0051439	http://dx.doi.org/10.1371/journal.pone.0051439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236501	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100119
J	Michel, T; Poli, A; Domingues, O; Mauffray, M; Theresine, M; Brons, NHC; Hentges, F; Zimmer, J				Michel, Tatiana; Poli, Aurelie; Domingues, Olivia; Mauffray, Marion; Theresine, Maud; Brons, Nicolaas H. C.; Hentges, Francois; Zimmer, Jacques			Mouse Lung and Spleen Natural Killer Cells Have Phenotypic and Functional Differences, in Part Influenced by Macrophages	PLOS ONE			English	Article							NK-CELLS; VIRUS INFECTION; INTERLEUKIN-15; MATURATION; TRAFFICKING; EXPRESSION; RECEPTOR; SUBSETS; RAT	NK cells are lymphocytes of the innate immune system which are a first line of defense against infections and tumor cells, in bone marrow and peripheral organs like lung and spleen. The lung is an organ in contact with respiratory pathogens and the site of inflammatory disorders triggered by the respiratory environment. In contrast, spleen is a lymphatic organ connected to the blood system which regulates the systemic immune response. Here we compare NK cell maturation and expansion as well as expression of NK cell receptors in spleen and lung compartments. We show that spleen and lung NK cells differ in phenotypic and functional characteristics due to a difference of maturity and cellular microenvironment. Indeed we observe that spleen and lung macrophages have the capacity to influence the cytotoxicity of NK cells by cell-to-cell contact. This suggests that the differences of NK cell subsets are in part due to a modulation by the organ environment.	[Michel, Tatiana; Poli, Aurelie; Domingues, Olivia; Mauffray, Marion; Theresine, Maud; Hentges, Francois; Zimmer, Jacques] Ctr Rech Publ Sante CRP Sante, Lab Immunogenet & Allergol, Luxembourg, Luxembourg; [Brons, Nicolaas H. C.] Ctr Rech Publ Sante CRP Sante, Core Facil Flow Cytometry, Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Institute of Health	Michel, T (corresponding author), Ctr Rech Publ Sante CRP Sante, Lab Immunogenet & Allergol, Luxembourg, Luxembourg.	tatiana.michel@crp-sante.lu		Michel, Tatiana/0000-0002-0146-9236; Zimmer, Jacques/0000-0002-7118-6944; Poli, Aurelie/0000-0002-7986-0761	Ministry of Higher Education and Research of Luxembourg; FNR (Fond National de la Recherche), Luxembourg	Ministry of Higher Education and Research of Luxembourg; FNR (Fond National de la Recherche), Luxembourg(Luxembourg National Research Fund)	This work was supported by the Ministry of Higher Education and Research of Luxembourg and by a grant from the FNR (Fond National de la Recherche), Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2006, CLIN EXP IMMUNOL, V143, P180, DOI 10.1111/j.1365-2249.2005.02976.x; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; BORDIGNON C, 1982, CLIN EXP IMMUNOL, V47, P437; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Doherty TM, 1996, J IMMUNOL, V156, P735; Grant LR, 2008, GENES IMMUN, V9, P316, DOI 10.1038/gene.2008.20; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Grundy MA, 2006, EXP CELL RES, V312, P3920, DOI 10.1016/j.yexcr.2006.08.019; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hazeldine J, 2012, AGING CELL; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; Hocke AC, 2007, CYTOKINE, V38, P61, DOI 10.1016/j.cyto.2007.05.009; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Poli A, 2010, IMMUNOLOGY; Prlic M, 2005, J IMMUNOL, V175, P2152, DOI 10.4049/jimmunol.175.4.2152; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; REYNOLDS CW, 1981, J NATL CANCER I, V66, P837; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; STEINSTREILEIN J, 1983, J IMMUNOL, V131, P2699; Takeda K, 2000, J IMMUNOL, V164, P1741, DOI 10.4049/jimmunol.164.4.1741; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wang J, 2012, IMMUNOLOGY; WEISSMAN DN, 1986, J ALLERGY CLIN IMMUN, V78, P571, DOI 10.1016/0091-6749(86)90073-4; ZOLLER M, 1982, IMMUNOBIOLOGY, V163, P497	31	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51230	10.1371/journal.pone.0051230	http://dx.doi.org/10.1371/journal.pone.0051230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227255	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200114
J	Sarkar, S; Brautigan, DL; Parsons, SJ; Larner, JM				Sarkar, S.; Brautigan, D. L.; Parsons, S. J.; Larner, J. M.			Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells	ONCOGENE			English	Article						prostate cancer; androgen receptor; 2-methoxyestradiol; CHIP; mitotic arrest	ENDOGENOUS MAMMALIAN METABOLITE; ACTIVATED PROTEIN-KINASE; INHIBITS ANGIOGENESIS; ESTROGEN METABOLITE; CDC6 TRANSCRIPTION; ENDOTHELIAL-CELLS; CYCLE PROGRESSION; 2-METHOXYESTRADIOL; EXPRESSION; APOPTOSIS	The androgen receptor (AR) has a vital role in the onset and progression of prostate cancer by promoting G1-S progression, possibly by functioning as a licensing factor for DNA replication. We here report that low dose 2-methoxyestradiol (2-ME), an endogenous estrogen metabolite, induces mitotic arrest in prostate cancer cells involving activation of the E3 ligase CHIP (C-terminus of Hsp70-interacting protein) and degradation of the AR. Depletion of the AR by small interfering RNA (siRNA) eliminates 2-ME-induced arrest and introducing AR into PC3-M cells confers 2-ME-induced mitotic arrest. Knockdown of CHIP or MDM2 (mouse homolog of double minute 2 protein) individually or in combination reduced AR degradation and abrogated M phase arrest induced by 2-ME. Our data link AR degradation via ubiquitination to mitotic arrest. Targeting the AR by activating E3 ligases such as CHIP represents a novel strategy for the treatment of prostate cancer.	[Sarkar, S.; Larner, J. M.] Univ Virginia, Sch Med, Hlth Sci Ctr, Dept Radiat Oncol, Charlottesville, VA 22908 USA; [Brautigan, D. L.] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Brautigan, D. L.; Parsons, S. J.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Larner, JM (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Radiat Oncol, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	jml2p@virginia.edu			National Institutes of Health [5R01CA142823-02]; Charles R. Burnett Jr and W. Griffin Burnett Fund; NATIONAL CANCER INSTITUTE [R01CA142823, R01CA120413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles R. Burnett Jr and W. Griffin Burnett Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health grant 5R01CA142823-02 (to J. M. L.) as well as the Charles R. Burnett Jr and W. Griffin Burnett Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; Casarez EV, 2007, CANCER RES, V67, P8316, DOI 10.1158/0008-5472.CAN-07-1755; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; CUSHMAN M, 1995, J MED CHEM, V38, P2041, DOI 10.1021/jm00012a003; D'Antonio JM, 2009, ENDOCR-RELAT CANCER, V16, P325, DOI 10.1677/ERC-08-0205; Day JM, 2003, J STEROID BIOCHEM, V84, P317, DOI 10.1016/S0960-0760(03)00045-1; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Gao XH, 2005, ENDOCRINOLOGY, V146, P1707, DOI 10.1210/en.2004-1198; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Hamel E, 1996, BIOCHEMISTRY-US, V35, P1304, DOI 10.1021/bi951559s; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jin F, 2009, NUCLEIC ACIDS RES, V37, P4826, DOI 10.1093/nar/gkp510; Kumar AP, 2001, MOL CARCINOGEN, V31, P111, DOI 10.1002/mc.1046; Lara PN, 1999, CANCER INVEST, V17, P137; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Mallik I, 2008, BBA-MOL CELL RES, V1783, P1737, DOI 10.1016/j.bbamcr.2008.05.006; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; PERTSCHUK LP, 1994, ANN SURG ONCOL, V1, P495, DOI 10.1007/BF02303615; Prins GS, 1998, J UROLOGY, V159, P641, DOI 10.1016/S0022-5347(01)63692-9; Qadan LR, 2001, BIOCHEM BIOPH RES CO, V285, P1259, DOI 10.1006/bbrc.2001.5320; Schiewer MJ, 2012, MOL CELL ENDOCRINOL, V352, P34, DOI 10.1016/j.mce.2011.06.033; Sharifi Nima, 2006, Am J Ther, V13, P166, DOI 10.1097/00045391-200603000-00013; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Szostak MJ, 2000, ONCOL REP, V7, P699; Tsukamoto A, 1998, BIOCHEM BIOPH RES CO, V248, P9, DOI 10.1006/bbrc.1998.8902; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yue TL, 1997, MOL PHARMACOL, V51, P951, DOI 10.1124/mol.51.6.951	36	70	72	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					26	33		10.1038/onc.2012.561	http://dx.doi.org/10.1038/onc.2012.561			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23246967	Green Accepted			2022-12-25	WOS:000329212000004
J	Singh, Y; Kaul, V; Mehra, A; Chatterjee, S; Tousif, S; Dwivedi, VP; Suar, M; Van Kaer, L; Bishai, WR; Das, G				Singh, Yogesh; Kaul, Vandana; Mehra, Alka; Chatterjee, Samit; Tousif, Sultan; Dwivedi, Ved Prakash; Suar, Mrutyunjay; Van Kaer, Luc; Bishai, William R.; Das, Gobardhan			Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISMS; CYTOKINES; INDUCTION; DEFENSE	Mycobacterium tuberculosis resides and replicates within host phagocytes by modulating host microbicidal responses. In addition, it suppresses the production of host protective cytokines to prevent activation of and antigen presentation by M. tuberculosis-infected cells, causing dysregulation of host protective adaptive immune responses. Many cytokines are regulated by microRNAs (miRNAs), a newly discovered class of small noncoding RNAs, which have been implicated in modulating host immune responses in many bacterial and viral diseases. Here, we show that miRNA-99b (miR-99b), an orphan miRNA, plays a key role in the pathogenesis of M. tuberculosis infection. We found that miR-99b expression was highly up-regulated in M. tuberculosis strain H37Rv-infected dendritic cells (DCs) and macrophages. Blockade of miR-99b expression by antagomirs resulted in significantly reduced bacterial growth in DCs. Interestingly, knockdown of miR-99b in DCs significantly up-regulated proinflammatory cytokines such as IL-6, IL-12, and IL-1 beta. Furthermore, mRNA and membrane-bound protein data indicated that inhibition of miR-99b augments TNF-alpha and TNFRSF-4 production. Thus, miR-99b targets TNF-alpha and TNFRSF-4 receptor genes. Treatment of anti-miR-99b-transfected DCs with anti-TNF-alpha antibody resulted in increased bacterial burden. Thus, our findings unveil a novel host evasion mechanism adopted by M. tuberculosis via miR-99b, which may open up new avenues for designing miRNA-based vaccines and therapies.	[Singh, Yogesh; Kaul, Vandana; Mehra, Alka; Chatterjee, Samit; Tousif, Sultan; Dwivedi, Ved Prakash] Int Ctr Genet Engn & Biotechnol ICGEB, Immunol Grp, New Delhi 110067, India; [Mehra, Alka] NYU, Sch Med, Div Infect Dis, New York, NY 10016 USA; [Chatterjee, Samit] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21218 USA; [Suar, Mrutyunjay] Ind Technol Univ, Sch Biotechnol, Infect Biol Lab, Kalinga Inst, Bhubaneswar 751024, Orissa, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Bishai, William R.] Kwazulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; New York University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indian Institute of Technology System (IIT System); Indian Institute of Technology Bhubaneswar; Vanderbilt University	Singh, Y (corresponding author), Univ London, MicroRNA & Lymphocyte Dev Lab, Infect & Immun Res Grp, Dept Comparat Biomed Sci,Royal Vet Coll, Camden Campus, London NW1 0TU, England.	ysingh@rvc.ac.uk; dasgo@icgeb.res.in	Van Kaer, Luc/H-1033-2015; kaul, vandana/C-9788-2018; Mehra, Alka/GLU-8765-2022; Chatterjee, Samit/ABZ-2522-2022; Singh, Yogesh/T-8230-2017	Van Kaer, Luc/0000-0001-5275-2309; kaul, vandana/0000-0002-1841-5584; Chatterjee, Samit/0000-0001-8176-3410; Singh, Yogesh/0000-0001-6919-6273; Suar, Mrutyunjay/0000-0003-4815-5477; Dwivedi, Ved Prakash/0000-0003-4321-2567; Mehra, Alka/0000-0003-4206-7863; Tousif, Sultan/0000-0001-6174-6541	Wellcome Trust/Department of Biotechnology (DBT) alliance	Wellcome Trust/Department of Biotechnology (DBT) alliance(Department of Biotechnology (DBT) India)	This research was supported by a grant from the Wellcome Trust/Department of Biotechnology (DBT) alliance.	Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Behar SM, 2011, MICROBES INFECT, V13, P749, DOI 10.1016/j.micinf.2011.03.002; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Larner-Svensson HM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-68; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P841, DOI 10.1111/j.1348-0421.2003.tb03450.x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998	25	119	131	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5056	5061		10.1074/jbc.C112.439778	http://dx.doi.org/10.1074/jbc.C112.439778			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23233675	Green Published, hybrid			2022-12-25	WOS:000315340400053
J	Kawai, M; Kinoshita, S; Kimoto, A; Hasegawa, Y; Miyagawa, K; Yamazaki, M; Ohata, Y; Ozono, K; Michigami, T				Kawai, Masanobu; Kinoshita, Saori; Kimoto, Akihito; Hasegawa, Yasuhiro; Miyagawa, Kazuaki; Yamazaki, Miwa; Ohata, Yasuhisa; Ozono, Keiichi; Michigami, Toshimi			FGF23 Suppresses Chondrocyte Proliferation in the Presence of Soluble alpha-Klotho both in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CIRCULATING LEVELS; FACTOR RECEPTOR-3; BONE-DEVELOPMENT; INDIAN HEDGEHOG; PHOSPHATE; MICE; DIFFERENTIATION; FGF-23; FGFR3	Fibroblast growth factor-23 (FGF23) is well established to play crucial roles in the regulation of phosphate homeostasis. X-linked hypophosphatemic rickets (XLH) is characterized by impaired mineralization and growth retardation associated with elevated circulating FGF23 levels. Administration of phosphate and calcitriol is effective in improving growth retardation, but is not sufficient to fully reverse impaired growth, suggesting the existence of a disease-specific mechanism in the development of growth retardation in addition to dysregulated phosphate metabolism. However, the precise mechanisms of growth retardation in XLH remain elusive. Here, we postulated that FGF23 suppressed chondrocyte proliferation in the presence of soluble alpha-Klotho (sKL). In vitro and ex vivo studies revealed that FGF23 formed a protein complex with sKL through KL1 internal repeat and suppressed the linear growth of metatarsals in the presence of sKL, which was antagonized by co-incubation with neutralizing antibodies against FGF23 or by knocking-down FGFR3 expression. Additionally, FGF23 binding to FGFR3 was enhanced in the presence of sKL. Histologically, the length of the proliferating zone was diminished and was associated with decreased chondrocyte proliferation. FGF23/sKL suppressed Indian hedgehog (Ihh) expression and administration of Ihh protein partially rescued the suppressive effect of FGF23/sKL on metatarsal growth. Intraperitoneal administration of sKL in Hyp mice, a murine model for XLH, caused a decrease in the length of the proliferating zone associated with decreased chondrocyte proliferation without altering circulating phosphate levels. These findings suggest that suppression of chondrocyte proliferation by FGF23 could have a causative role in the development of growth retardation in XLH.	[Kawai, Masanobu; Kinoshita, Saori; Miyagawa, Kazuaki; Yamazaki, Miwa; Ohata, Yasuhisa; Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi, Osaka 5941101, Japan; [Kimoto, Akihito] Osaka Med Ctr, Dept Pathol, Izumi, Osaka 5941101, Japan; [Kawai, Masanobu] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Hasegawa, Yasuhiro; Ohata, Yasuhisa; Ozono, Keiichi] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Kawai, M (corresponding author), Osaka Med Ctr, Dept Bone & Mineral Res, 840 Murodo Cho Izumi, Izumi, Osaka 5941101, Japan.	kawaim@mch.pref.osaka.jp	Michigami, Toshimi/AAU-2326-2021; Ohata, Yasuhisa/AAJ-4615-2020	Ohata, Yasuhisa/0000-0001-6084-6620; Kawai, Masanobu/0000-0003-4466-1559	Japan Foundation for Pediatric Research; Grants-in-Aid for Scientific Research [23791216, 23591227] Funding Source: KAKEN	Japan Foundation for Pediatric Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Japan Foundation for Pediatric Research (to M. K.).	Aono Y, 2009, J BONE MINER RES, V24, P1879, DOI [10.1359/JBMR.090509, 10.1359/jbmr.090509]; Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; Carpenter TO, 2010, J CLIN ENDOCR METAB, V95, pE352, DOI 10.1210/jc.2010-0589; Chen L, 1999, J CLIN INVEST, V104, P1517, DOI 10.1172/JCI6690; Chen L, 2001, HUM MOL GENET, V10, P457, DOI 10.1093/hmg/10.5.457; CHESNEY RW, 1983, PEDIATRICS, V71, P559; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; FRIEDMAN NE, 1993, J CLIN ENDOCR METAB, V76, P839, DOI 10.1210/jc.76.4.839; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; jbc.org, SCI; Kawai M, 2011, J BIOL CHEM, V286, P14670, DOI 10.1074/jbc.M110.193334; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Koshimizu T, 2012, J BIOL CHEM, V287, P15760, DOI 10.1074/jbc.M111.308072; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ohata Y, 2011, J CLIN ENDOCR METAB, V96, pE943, DOI 10.1210/jc.2010-2357; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Segev O, 2000, HUM MOL GENET, V9, P249, DOI 10.1093/hmg/9.2.249; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang H, 2008, J BONE MINER RES, V23, P939, DOI 10.1359/JBMR.080220; Wang YC, 1999, P NATL ACAD SCI USA, V96, P4455, DOI 10.1073/pnas.96.8.4455; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110	38	38	39	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2414	2427		10.1074/jbc.M112.410043	http://dx.doi.org/10.1074/jbc.M112.410043			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23235154	hybrid, Green Published			2022-12-25	WOS:000314211500029
J	Chen, SY; Lewis, B; Moran, A; Xie, T				Chen, Shuyi; Lewis, Brandy; Moran, Andrea; Xie, Ting			Cadherin-Mediated Cell Adhesion Is Critical for the Closing of the Mouse Optic Fissure	PLOS ONE			English	Article							EYE DEVELOPMENT; ALPHA-CATENIN; ADHERENS JUNCTIONS; VERTEBRATE RETINA; CRE RECOMBINASE; CHARGE-SYNDROME; BETA-CATENIN; GENE; MORPHOGENESIS; MUTATION	Coloboma is a congenital disease that contributes significantly to childhood blindness. It results from the failure in closing the optic fissure, a transient opening on the ventral side of the developing eye. Although human and mouse genetic studies have identified a number of genes associated with coloboma, the detailed cellular mechanisms underlying the optic fissure closure and coloboma formation remain largely undefined. N-cadherin-mediated cell adhesion has been shown to be important for the optic fissure closure in zebrafish, but it remains to be determined experimentally how cell-cell adhesions are involved in the mammalian optic fissure closing process. alpha-catenin is required for cell adhesion mediated by all of the classic cadherin molecules, including N-cadherin. In this study, we used the Cre-mediated conditional knockout technique to specifically delete alpha-catenin from the developing mouse eye to show that it is required for the successful closing of the optic fissure. In alpha-catenin conditional mutant optic cups, the major cell fates, including the optic fissure margin, neural retina and retinal pigmented epithelium, are specified normally, and the retinal progenitor cells proliferate normally. However, adherens junctions components, including N-cadherin, beta-catenin and filamentous actin, fail to accumulate on the apical side of alpha-catenin mutant retinal progenitor cells, where adherens junctions are normally abundant, and the organization of the neural retina and the optic fissure margin is disrupted. Finally, the alpha-catenin mutant retina gradually degenerates in the adult mouse eye. Therefore, our results show that alpha-catenin-mediated cell adhesion and cell organization are important for the fissure closure in mice, and further suggest that genes that regulate cell adhesion may underlie certain coloboma cases in humans.	[Chen, Shuyi; Lewis, Brandy; Moran, Andrea; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Xie, Ting] Univ Kansas, Med Ctr, Dept Cell Biol & Anat, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Chen, SY (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	sch@stowers.org; tgx@stowers.org			Stowers Institute for Medical Research	Stowers Institute for Medical Research	This work is supported by The Stowers Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HERO I, 1990, INVEST OPHTH VIS SCI, V31, P197; Kaufman MH, 1992, ATLAS MOUSE DEV, Vxvi; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Mui SH, 2005, GENE DEV, V19, P1249, DOI 10.1101/gad.1276605; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Oliver G, 1995, DEVELOPMENT, V121, P4045; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Martinez-Morales JR, 2009, CURR OPIN GENET DEV, V19, P511, DOI 10.1016/j.gde.2009.08.003; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schimmenti LA, 2003, AM J MED GENET A, V116A, P215, DOI 10.1002/ajmg.a.10884; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Torres MA, 1996, DEVELOPMENT, V122, P3381; Uemonsa T, 2002, DEV BIOL, V248, P319, DOI 10.1006/dbio.2002.0737; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	41	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51705	10.1371/journal.pone.0051705	http://dx.doi.org/10.1371/journal.pone.0051705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240058	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800094
J	Fahnoe, KC; Flanagan, ME; Gibson, G; Shanmugasundaram, V; Che, Y; Tomaras, AP				Fahnoe, Kelly C.; Flanagan, Mark E.; Gibson, Glenn; Shanmugasundaram, Veerabahu; Che, Ye; Tomaras, Andrew P.			Non-Traditional Antibacterial Screening Approaches for the Identification of Novel Inhibitors of the Glyoxylate Shunt in Gram-Negative Pathogens	PLOS ONE			English	Article							CYSTIC-FIBROSIS ISOLATE; PSEUDOMONAS-AERUGINOSA; ISOCITRATE LYASE; MALATE SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; BAD BUGS; RESISTANCE; PERSISTENCE; CHALLENGES; INFECTION	Antibacterial compounds that affect bacterial viability have traditionally been identified, confirmed, and characterized in standard laboratory media. The historical success of identifying new antibiotics via this route has justifiably established a traditional means of screening for new antimicrobials. The emergence of multi-drug-resistant (MDR) bacterial pathogens has expedited the need for new antibiotics, though many in the industry have questioned the source(s) of these new compounds. As many pharmaceutical companies' chemical libraries have been exhaustively screened via the traditional route, we have concluded that all compounds with any antibacterial potential have been identified. While new compound libraries and platforms are being pursued, it also seems prudent to screen the libraries we currently have in hand using alternative screening approaches. One strategy involves screening under conditions that better reflect the environment pathogens experience during an infection, and identifying in vivo essential targets and pathways that are dispensable for growth in standard laboratory media in vitro. Here we describe a novel screening strategy for identifying compounds that inhibit the glyoxylate shunt in Pseudomonas aeruginosa, a pathway that is required for bacterial survival in the pulmonary environment. We demonstrate that these compounds, which were not previously identified using traditional screening approaches, have broad-spectrum antibacterial activity when they are tested under in vivo-relevant conditions. We also show that these compounds have potent activity on both enzymes that comprise the glyoxylate shunt, a feature that was supported by computational homology modeling. By dual-targeting both enzymes in this pathway, we would expect to see a reduced propensity for resistance development to these compounds. Taken together, these data suggest that understanding the in vivo environment that bacterial pathogens must tolerate, and adjusting the antibacterial screening paradigm to reflect those conditions, could identify novel antibiotics for the treatment of serious MDR pathogens.	[Fahnoe, Kelly C.; Flanagan, Mark E.; Gibson, Glenn; Shanmugasundaram, Veerabahu; Che, Ye; Tomaras, Andrew P.] Pfizer Worldwide Res & Dev, Antibacterials Res Unit, Groton, CT 06340 USA	Pfizer	Tomaras, AP (corresponding author), Pfizer Worldwide Res & Dev, Antibacterials Res Unit, Groton, CT 06340 USA.	andrew.tomaras@pfizer.com		Che, Ye/0000-0002-1278-4442; SHANMUGASUNDARAM, VEERABAHU/0000-0003-0566-6779	Pfizer	Pfizer(Pfizer)	The work was solely funded by Pfizer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstrom DM, 2006, PROTEIN SCI, V15, P2002, DOI 10.1110/ps.062300206; ARMSTRONG GD, 1995, J INFECT DIS, V171, P1042, DOI 10.1093/infdis/171.4.1042; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; CHELL RM, 1978, BIOCHEM J, V173, P165, DOI 10.1042/bj1730165; Clinical and Laboratory Standards Institute (CLSI), 2009, CLSI PUBL, VM07-A8; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Hagins JM, 2011, CAN J MICROBIOL, V57, P186, DOI 10.1139/W10-118; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Hu JF, 2006, J NAT PROD, V69, P118, DOI 10.1021/np049600s; KHAN AS, 1993, PROTEIN EXPRES PURIF, V4, P519, DOI 10.1006/prep.1993.1068; Levy SB, 1997, CIBA F SYMP, V207, P1; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Ogawa W, 2005, BIOL PHARM BULL, V28, P1505, DOI 10.1248/bpb.28.1505; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rogers SA, 2010, ORG BIOMOL CHEM, V8, P3857, DOI 10.1039/c0ob00063a; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHLOSS JV, 1982, BIOCHEMISTRY-US, V21, P4420, DOI 10.1021/bi00261a035; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shingnapurkar D, 2012, BIOORG MED CHEM LETT, V22, P3172, DOI 10.1016/j.bmcl.2012.03.047; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; Smith KM, 2003, CHEM BIOL, V10, P81, DOI 10.1016/s1074-5521(03)00002-4; Svensson A, 2001, CHEMBIOCHEM, V2, P915, DOI 10.1002/1439-7633(20011203)2:12<915::AID-CBIC915>3.3.CO;2-D; Umland TG, 2012, MBIO, P3; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	36	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51732	10.1371/journal.pone.0051732	http://dx.doi.org/10.1371/journal.pone.0051732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240059	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800095
J	Kahramanogullari, O; Fantaccini, G; Lecca, P; Morpurgo, D; Priami, C				Kahramanogullari, Ozan; Fantaccini, Gianluca; Lecca, Paola; Morpurgo, Daniele; Priami, Corrado			Algorithmic Modeling Quantifies the Complementary Contribution of Metabolic Inhibitions to Gemcitabine Efficacy	PLOS ONE			English	Article							JAPANESE CANCER-PATIENTS; PANCREATIC-CANCER; RIBONUCLEOTIDE REDUCTASE; DEOXYCYTIDINE KINASE; SYSTEMS PHARMACOLOGY; PATIENTS IMPACT; IN-VITRO; RESISTANCE; PHARMACOKINETICS; MECHANISMS	Gemcitabine (2,2-difluorodeoxycytidine, dFdC) is a prodrug widely used for treating various carcinomas. Gemcitabine exerts its clinical effect by depleting the deoxyribonucleotide pools, and incorporating its triphosphate metabolite (dFdC-TP) into DNA, thereby inhibiting DNA synthesis. This process blocks the cell cycle in the early S phase, eventually resulting in apoptosis. The incorporation of gemcitabine into DNA takes place in competition with the natural nucleoside dCTP. The mechanisms of indirect competition between these cascades for common resources are given with the race for DNA incorporation; in clinical studies dedicated to singling out mechanisms of resistance, ribonucleotide reductase (RR) and deoxycytidine kinase (dCK) and human equilibrative nucleoside transporter1 (hENT1) have been associated to efficacy of gemcitabine with respect to their roles in the synthesis cascades of dFdC-TP and dCTP. However, the direct competition, which manifests itself in terms of inhibitions between these cascades, remains to be quantified. We propose an algorithmic model of gemcitabine mechanism of action, verified with respect to independent experimental data. We performed in silico experiments in different virtual conditions, otherwise difficult in vivo, to evaluate the contribution of the inhibitory mechanisms to gemcitabine efficacy. In agreement with the experimental data, our model indicates that the inhibitions due to the association of dCTP with dCK and the association of gemcitabine diphosphate metabolite (dFdC-DP) with RR play a key role in adjusting the efficacy. While the former tunes the catalysis of the rate-limiting first phosphorylation of dFdC, the latter is responsible for depletion of dCTP pools, thereby contributing to gemcitabine efficacy with a dependency on nucleoside transport efficiency. Our simulations predict the existence of a continuum of non-efficacy to high-efficacy regimes, where the levels of dFdC-TP and dCTP are coupled in a complementary manner, which can explain the resistance to this drug in some patients. Citation: Kahramanogullari O, Fantaccini G, Lecca P, Morpurgo D, Priami C (2012) Algorithmic Modeling Quantifies the Complementary Contribution of Metabolic Inhibitions to Gemcitabine Efficacy. PLoS ONE 7(12): e50176. doi:10.1371/journal.pone.0050176	[Kahramanogullari, Ozan; Fantaccini, Gianluca; Lecca, Paola; Morpurgo, Daniele; Priami, Corrado] Microsoft Res Univ Trento Ctr Computat & Syst Bio, Rovereto, Trento, Italy; [Priami, Corrado] Univ Trento, Dept Math, Povo, Trento, Italy	University of Trento	Kahramanogullari, O (corresponding author), Microsoft Res Univ Trento Ctr Computat & Syst Bio, Rovereto, Trento, Italy.	ozan@cosbi.eu	Lecca, Paola/AAJ-2457-2021	Lecca, Paola/0000-0002-7224-136X				Albano G, 2006, J THEOR BIOL, V242, P329, DOI 10.1016/j.jtbi.2006.03.001; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Artin E, 2009, BIOCHEMISTRY-US, V48, P11622, DOI 10.1021/bi901590q; Battaglia MA, 2011, IET SYST BIOL, V5, P34, DOI 10.1049/iet-syb.2009.0073; Bergman AM, 2000, EUR J CANCER, V36, P1974, DOI 10.1016/S0959-8049(00)00246-X; Beumer JH, 2008, CLIN CANCER RES, V14, P3529, DOI 10.1158/1078-0432.CCR-07-4885; Cardelli L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00656; Cucurull-Sanchez L, 2012, DRUG DISCOV TODAY, V17, P665, DOI 10.1016/j.drudis.2012.01.015; Dalchau N, 2011, PLOS COMPUTATIONAL B, V7, P1; Danesi R, 2003, PHARMACOL REV, V55, P57, DOI 10.1124/pr.55.1.4; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Dematte L, 2008, LECT NOTES COMPUT SC, V5016, P313; Dematte L, 2010, SYST BIO, V1, P777, DOI 10.1007/978-1-4419-5797-9_31; Dumontet C, 1999, BRIT J HAEMATOL, V106, P78, DOI 10.1046/j.1365-2141.1999.01509.x; Duxbury MS, 2004, ONCOGENE, V23; Eriksson S, 2002, CELLULAR MOL LIFE SC, V59; Fryer RA, 2011, ANTICANCER RES, V31, P3747; Fujita H, 2010, NEOPLASIA, V12, P807, DOI 10.1593/neo.10458; Funel N, 2008, LAB INVEST, V88, P773, DOI 10.1038/labinvest.2008.40; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Garcia-Manteiga J, 2003, CLIN CANCER RES, V9, P5000; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Giovannetti E, 2004, CLIN CANCER RES, V10, P2936, DOI 10.1158/1078-0432.CCR-03-0520; Goan YG, 1999, CANCER RES, V59, P4204; Guerriero ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-40; HEINEMANN V, 1992, CANCER RES, V52, P533; Kahramanogullari O, 2011, ENVIRON MODELL SOFTW, V26, P685, DOI 10.1016/j.envsoft.2010.12.007; Kim MY, 1989, BIOCHEMISTRY-US, V28; Kroep JR, 2002, MOL CANCER THER, V1, P371; Lecca P., 2011, 2011 UkSim 13th International Conference on Computer Modelling and Simulation (UKSim 2011), P75, DOI 10.1109/UKSIM.2011.24; Lo CF, 2009, P WORLD C ENG WCE 20; Macheras P., 2006, MODELING BIOPHARMACE; Mackey JR, 1998, CANCER RES, V58, P4349; Maring JG, 2010, EUR J CLIN PHARMACOL, V66, P611, DOI 10.1007/s00228-010-0799-0; Metharom E, 2010, ANTICANCER RES, V30, P3669; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Priami C, 2009, P 7 INT C COMP METH, DOI [10.1007/978-3-642-03845-7_3, DOI 10.1007/978-3-642-03845-7_3]; Priami C, 2009, COMMUN ACM, V52, P80, DOI 10.1145/1506409.1506427; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Ren QF, 1998, CLIN CANCER RES, V4, P2811; Romanel A, 2011, PLOS ONE, V7, P1; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Sebastiani V, 2006, CLIN CANCER RES, V12, P2492, DOI 10.1158/1078-0432.CCR-05-2655; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Skrypek N, 2013, ONCOGENE, V32, P1714, DOI 10.1038/onc.2012.179; Sugiyama E, 2007, J CLIN ONCOL, V25, P32, DOI 10.1200/JCO.2006.06.7405; Sugiyama E, 2010, CLIN PHARMACOKINET, V49, P549, DOI 10.2165/11532970-000000000-00000; Tham LS, 2008, CLIN CANCER RES, V14, P4213, DOI 10.1158/1078-0432.CCR-07-4754; van der Graaf PH, 2011, PHARM RES-DORDR, V28, P1460, DOI 10.1007/s11095-011-0467-9; Veltkamp SA, 2008, MOL CANCER THER, V7, P2415, DOI 10.1158/1535-7163.MCT-08-0137; Veltkamp SA, 2008, ONCOLOGIST, V13, P261, DOI 10.1634/theoncologist.2007-0215; Voutsadakis IA, 2011, WORLD J GASTRO ONCOL, V3, P153, DOI 10.4251/wjgo.v3.i11.153; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Wang SS, 2010, CHEM RES TOXICOL, V23, P1653, DOI 10.1021/tx1003547; Xie KC, 1996, CANCER RES, V56, P3030; XU YZ, 1992, BIOCHEM PHARMACOL, V44, P1819	63	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50176	10.1371/journal.pone.0050176	http://dx.doi.org/10.1371/journal.pone.0050176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239976	gold, Green Submitted, Green Published			2022-12-25	WOS:000312290800014
J	McEvoy, AL; Hoi, H; Bates, M; Platonova, E; Cranfill, PJ; Baird, MA; Davidson, MW; Ewers, H; Liphardt, J; Campbell, RE				McEvoy, Ann L.; Hoi, Hiofan; Bates, Mark; Platonova, Evgenia; Cranfill, Paula J.; Baird, Michelle A.; Davidson, Michael W.; Ewers, Helge; Liphardt, Jan; Campbell, Robert E.			mMaple: A Photoconvertible Fluorescent Protein for Use in Multiple Imaging Modalities	PLOS ONE			English	Article							QUANTUM YIELD; RESOLUTION; MICROSCOPY; CELLS; CHEMOTAXIS; EVOLUTION; NANOSCOPY; BRIGHT; GUIDE; LIMIT	Recent advances in fluorescence microscopy have extended the spatial resolution to the nanometer scale. Here, we report an engineered photoconvertible fluorescent protein (pcFP) variant, designated as mMaple, that is suited for use in multiple conventional and super-resolution imaging modalities, specifically, widefield and confocal microscopy, structured illumination microscopy (SIM), and single-molecule localization microscopy. We demonstrate the versatility of mMaple by obtaining super-resolution images of protein organization in Escherichia coli and conventional fluorescence images of mammalian cells. Beneficial features of mMaple include high photostability of the green state when expressed in mammalian cells and high steady state intracellular protein concentration of functional protein when expressed in E. coli. mMaple thus enables both fast live-cell ensemble imaging and high precision single molecule localization for a single pcFP-containing construct.	[McEvoy, Ann L.; Liphardt, Jan] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Hoi, Hiofan; Campbell, Robert E.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Bates, Mark] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Platonova, Evgenia; Ewers, Helge] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Cranfill, Paula J.; Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cranfill, Paula J.; Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Liphardt, Jan] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Liphardt, Jan] Univ Calif Berkeley, Bay Area Phys Sci Oncol Ctr, Berkeley, CA 94720 USA; [Liphardt, Jan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Cranfill, Paula J.; Baird, Michelle A.; Davidson, Michael W.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of Alberta; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	McEvoy, AL (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	almcevoy@berkeley.edu; robert.e.campbell@ualberta.ca	Ewers, Helge/ABF-3629-2021	Ewers, Helge/0000-0003-3948-4332; Campbell, Robert E./0000-0003-0604-092X; Liphardt, Jan/0000-0003-2835-5025; , ENIGMA/0000-0002-0894-2831	National Science Foundation (NSF); Natural Sciences and Engineering Research Council (NSERC); Canada Research Chair in Bioanalytical Chemistry; European Molecular Biology Organization; National Institutes of Health [GM77856, GM084716]; National Cancer Institute (NCI) Physical Sciences Oncology program [U54CA143836]; Department of Energy (DOE) Office of Basic Energy Sciences (FWP SISGRKN); Office of Science, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Centre of Competence in Research (NCCR) Neural Plasticity and Repair; Holcim Foundation; National Competence Center in Biomedical Imaging (NCCBI); NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084716, R01GM077856] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Bioanalytical Chemistry; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI) Physical Sciences Oncology program; Department of Energy (DOE) Office of Basic Energy Sciences (FWP SISGRKN)(United States Department of Energy (DOE)); Office of Science, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Centre of Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Holcim Foundation; National Competence Center in Biomedical Imaging (NCCBI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ALM was funded by the National Science Foundation (NSF) graduate fellowship. REC is funded by Natural Sciences and Engineering Research Council (NSERC) and holds a Canada Research Chair in Bioanalytical Chemistry. MB is funded by the European Molecular Biology Organization. This work was partially funded by the National Institutes of Health (GM77856 and GM084716 to JTL), the National Cancer Institute (NCI) Physical Sciences Oncology program (U54CA143836 to JTL), the Department of Energy (DOE) Office of Basic Energy Sciences (FWP SISGRKN), and the Director, Office of Science, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. HE was supported by the National Centre of Competence in Research (NCCR) Neural Plasticity and Repair and the Holcim Foundation, EP was supported by the National Competence Center in Biomedical Imaging (NCCBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bates M., 2011, IMAGING LAB MANUAL, P547; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BRANNON JH, 1978, J PHYS CHEM-US, V82, P705, DOI 10.1021/j100495a018; Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Fischer M, 1996, CHEM PHYS LETT, V260, P115, DOI 10.1016/0009-2614(96)00838-X; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Hein B, 2010, BIOPHYS J, V98, P158, DOI 10.1016/j.bpj.2009.09.053; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Henderson JN, 2005, P NATL ACAD SCI USA, V102, P12712, DOI 10.1073/pnas.0502250102; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoi HF, 2010, J MOL BIOL, V401, P776, DOI 10.1016/j.jmb.2010.06.056; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Iafolla MAJ, 2008, PROTEINS, V72, P1233, DOI 10.1002/prot.22024; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Lee HLD, 2010, J AM CHEM SOC, V132, P15099, DOI 10.1021/ja1044192; Lefman J, 2011, MICROSC MICROANAL, V17, P191, DOI 10.1017/S1431927611000158; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rankin BR, 2011, BIOPHYS J, V100, pL63, DOI 10.1016/j.bpj.2011.05.020; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SANDERS DA, 1989, J BACTERIOL, V171, P6271, DOI 10.1128/jb.171.11.6271-6278.1989; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922; Zhao HM, 2006, NAT PROTOC, V1, P1865, DOI 10.1038/nprot.2006.309	54	89	91	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51314	10.1371/journal.pone.0051314	http://dx.doi.org/10.1371/journal.pone.0051314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240015	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800051
J	Berger, WT; Ralph, BP; Kaczocha, M; Sun, J; Balius, TE; Rizzo, RC; Haj-Dahmane, S; Ojima, I; Deutsch, DG				Berger, William T.; Ralph, Brian P.; Kaczocha, Martin; Sun, Jing; Balius, Trent E.; Rizzo, Robert C.; Haj-Dahmane, Samir; Ojima, Iwao; Deutsch, Dale G.			Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters - A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ALPHA-TRUXILLIC ACID; DERIVATIVES; PAIN	Fatty acid binding proteins (FABPs), in particular FABP5 and FABP7, have recently been identified by us as intracellular transporters for the endocannabinoid anandamide (AEA). Furthermore, animal studies by others have shown that elevated levels of endocannabinoids resulted in beneficial pharmacological effects on stress, pain and inflammation and also ameliorate the effects of drug withdrawal. Based on these observations, we hypothesized that FABP5 and FABP7 would provide excellent pharmacological targets. Thus, we performed a virtual screening of over one million compounds using DOCK and employed a novel footprint similarity scoring function to identify lead compounds with binding profiles similar to oleic acid, a natural FABP substrate. Forty-eight compounds were purchased based on their footprint similarity scores (FPS) and assayed for biological activity against purified human FABP5 employing a fluorescent displacement-binding assay. Four compounds were found to exhibit approximately 50% inhibition or greater at 10 mu M, as good as or better inhibitors of FABP5 than BMS309403, a commercially available inhibitor. The most potent inhibitor, gamma-truxillic acid 1-naphthyl ester (ChemDiv 8009-2334), was determined to have K-i value of 1.19+/-0.01 mu M. Accordingly a novel alpha-truxillic acid 1-naphthyl mono-ester (SB-FI-26) was synthesized and assayed for its inhibitory activity against FABP5, wherein SB-FI-26 exhibited strong binding (K-i 0.93+/-0.08 mu M). Additionally, we found SB-FI-26 to act as a potent anti-nociceptive agent with mild anti-inflammatory activity in mice, which strongly supports our hypothesis that the inhibition of FABPs and subsequent elevation of anandamide is a promising new approach to drug discovery. Truxillic acids and their derivatives were also shown by others to have anti-inflammatory and anti-nociceptive effects in mice and to be the active component of Chinese a herbal medicine (Incarvillea sinensis) used to treat rheumatism and pain in humans. Our results provide a likely mechanism by which these compounds exert their effects.	[Berger, William T.; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Haj-Dahmane, Samir] SUNY Buffalo, Res Inst Addict, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ojima, I (corresponding author), SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	Iwao.Ojima@stonybrook.edu; Dale.Deutsch@stonybrook.edu	Berger, William/E-7452-2013	Ojima, Iwao/0000-0002-3628-1161; Kaczocha, Martin/0000-0002-2527-1398; Balius, Trent/0000-0002-6811-4667	United States National Institutes of Health [DA02695301, DA01641904, DA032232]; SUNY-REACH; SBU/BNL; SBU TRO FUSION; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032232] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUNY-REACH; SBU/BNL; SBU TRO FUSION; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by United States National Institutes of Health grants DA02695301 (D. G. D.), DA01641904 (D. G. D.), and DA032232 (M. K.). SUNY-REACH (D. G. D. and S. H-D.) SBU/BNL Seed Grant (D. G. D. and I. W.) and SBU TRO FUSION Award (D. G. D. and I.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2009, EXPERT OPIN DRUG DIS, V4, P763, DOI 10.1517/17460440903018857; [Anonymous], 2011, DOCK6 5; Arendaruk AP SA, 1967, KHIM FARM ZH, P18; Balius TE, 2011, J COMPUT CHEM, V32, P2273, DOI 10.1002/jcc.21814; Barf T, 2009, BIOORG MED CHEM LETT, V19, P1745, DOI 10.1016/j.bmcl.2009.01.084; Chi YM, 2006, BIOL PHARM BULL, V29, P580, DOI 10.1248/bpb.29.580; Chi YM, 2005, BIOL PHARM BULL, V28, P1776, DOI 10.1248/bpb.28.1776; Churi SB, 2008, J PAIN, V9, P639, DOI 10.1016/j.jpain.2008.02.002; Cravatt BF, 2004, J NEUROBIOL, V61, P149, DOI 10.1002/neu.20080; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P181, DOI 10.1016/j.tips.2012.01.001; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Haj-Dahmane S, 2005, J NEUROSCI, V25, P896, DOI 10.1523/JNEUROSCI.3258-04.2005; Haj-Dahmane S, 2009, J PHARMACOL EXP THER, V331, P186, DOI 10.1124/jpet.109.153858; Holden PM, 2012, BIOORG MED CHEM LETT, V22, P3011, DOI 10.1016/j.bmcl.2012.02.017; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lichtman A H, 1990, NIDA Res Monogr, V105, P422; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Nakamura M, 1999, J NAT PROD, V62, P1293, DOI 10.1021/np990041c; Steri R, 2010, BIOORG MED CHEM LETT, V20, P2920, DOI 10.1016/j.bmcl.2010.03.026; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Veerkamp JH, 2001, J MOL NEUROSCI, V16, P133, DOI 10.1385/JMN:16:2-3:133; Yang H, 2011, MACROMOLECULES, V44, P159, DOI 10.1021/ma1016264	31	100	103	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50968	10.1371/journal.pone.0050968	http://dx.doi.org/10.1371/journal.pone.0050968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236415	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100048
J	Doidge, R; Mittal, S; Aslam, A; Winkler, GS				Doidge, Rachel; Mittal, Saloni; Aslam, Akhmed; Winkler, G. Sebastiaan			The Anti-Proliferative Activity of BTG/TOB Proteins Is Mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) Deadenylase Subunits of the Ccr4-Not Complex	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLATION; POLY(A)-BINDING PROTEIN; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; GROWTH-INHIBITION; STRUCTURAL BASIS; TOB; BTG2; PHOSPHORYLATION; OVEREXPRESSION	The human BTG/TOB protein family comprises six members (BTG1, BTG2/PC3/Tis21, BTG3/Ana, BTG4/PC3B, TOB1/Tob, and TOB2) that are characterised by a conserved BTG domain. This domain mediates interactions with the highly similar Caf1a (CNOT7) and Caf1b (CNOT8) catalytic subunits of the Ccr4-Not deadenylase complex. BTG/TOB proteins have anti-proliferative activity: knockdown of BTG/TOB can result in increased cell proliferation, whereas over-expression of BTG/TOB leads to inhibition of cell cycle progression. It was unclear whether the interaction between BTG/TOB proteins and the Caf1a/Caf1b deadenylases is necessary for the anti-proliferative activity of BTG/TOB. To address this question, we further characterised surface-exposed amino acid residues of BTG2 and TOB1 that mediate the interaction with the Caf1a and Caf1b deadenylase enzymes. We then analysed the role of BTG2 and TOB1 in the regulation of cell proliferation, translation and mRNA abundance using a mutant that is no longer able to interact with the Caf1a/Caf1b deadenylases. We conclude that the anti-proliferative activity of BTG/TOB proteins is mediated through interactions with the Caf1a and Caf1b deadenylase enzymes. Furthermore, we show that the activity of BTG/TOB proteins in the regulation of mRNA abundance and translation is dependent on Caf1a/Caf1b, and does not appear to require other Ccr4-Not components, including the Ccr4a (CNOT6)/Ccr4b (CNOT6L) deadenylases, or the non-catalytic subunits CNOT1 or CNOT3.	[Doidge, Rachel; Mittal, Saloni; Aslam, Akhmed; Winkler, G. Sebastiaan] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Winkler, GS (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	sebastiaan.winkler@nottingham.ac.uk	Aslam, Akhmed/C-4493-2019	Aslam, Akhmed/0000-0002-0416-936X; Winkler, Sebastiaan/0000-0002-0476-162X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/002338X/1]; Association for International Cancer Research (AICR) [07-0494]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/E02338X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E02338X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Association for International Cancer Research (AICR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants to GSW from the Biotechnology and Biological Sciences Research Council (BBSRC grant BB/002338X/1; www.bbsrc.ac.uk) and the Association for International Cancer Research (AICR grant 07-0494; www.aicr.org). RD was supported by a studentship from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Bartlam M, 2010, PROTEIN CELL, V1, P443, DOI 10.1007/s13238-010-0060-8; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Doidge R, 2012, BIOCHEM SOC T, V40, P896, DOI 10.1042/BST20120074; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Ezzeddine N, 2012, MOL CELL BIOL, V32, P1089, DOI 10.1128/MCB.06370-11; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gehring NH, 2008, METHOD ENZYMOL, V448, P467, DOI 10.1016/S0076-6879(08)02623-2; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Hata K, 2007, EXP CELL RES, V313, P2356, DOI 10.1016/j.yexcr.2007.03.021; Hong JW, 2005, J BIOL CHEM, V280, P21256, DOI 10.1074/jbc.M500318200; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hosoda N, 2011, EMBO J, V30, P1311, DOI 10.1038/emboj.2011.37; Ito Y, 2005, CANCER LETT, V220, P237, DOI 10.1016/j.canlet.2004.08.017; Iwanaga K, 2003, CANCER LETT, V202, P71, DOI 10.1016/j.canlet.2003.08.019; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Lim IK, 1998, MOL CARCINOGEN, V23, P25, DOI 10.1002/(SICI)1098-2744(199809)23:1<25::AID-MC4>3.0.CO;2-G; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; O'Malley S, 2009, INT J CANCER, V125, P1805, DOI 10.1002/ijc.24490; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Ruan L, 2010, J BIOL CHEM, V285, P27624, DOI 10.1074/jbc.M110.138867; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Wiederhold K, 2010, BIOCHEM SOC T, V38, P1531, DOI 10.1042/BST0381531; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yang X, 2008, NUCLEIC ACIDS RES, V36, P6872, DOI 10.1093/nar/gkn825; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003	46	51	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51331	10.1371/journal.pone.0051331	http://dx.doi.org/10.1371/journal.pone.0051331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236473	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100096
J	Goh, SL; Wang, Q; Byrnes, LJ; Sondermann, H				Goh, Shih Lin; Wang, Qi; Byrnes, Laura J.; Sondermann, Holger			Versatile Membrane Deformation Potential of Activated Pacsin	PLOS ONE			English	Article							F-BAR DOMAIN; SYNDAPIN-I; MEDIATED ENDOCYTOSIS; AMPHIPATHIC HELICES; DYNAMIN ISOFORMS; STRUCTURAL BASIS; RICH DOMAIN; SH3 DOMAIN; N-WASP; CURVATURE	Endocytosis is a fundamental process in signaling and membrane trafficking. The formation of vesicles at the plasma membrane is mediated by the G protein dynamin that catalyzes the final fission step, the actin cytoskeleton, and proteins that sense or induce membrane curvature. One such protein, the F-BAR domain-containing protein pacsin, contributes to this process and has been shown to induce a spectrum of membrane morphologies, including tubules and tube constrictions in vitro. Full-length pacsin isoform 1 (pacsin-1) has reduced activity compared to its isolated F-BAR domain, implicating an inhibitory role for its C-terminal Src homology 3 (SH3) domain. Here we show that the autoinhibitory, intramolecular interactions in pacsin-1 can be released upon binding to the entire proline-rich domain (PRD) of dynamin-1, resulting in potent membrane deformation activity that is distinct from the isolated F-BAR domain. Most strikingly, we observe the generation of small, homogenous vesicles with the activated protein complex under certain experimental conditions. In addition, liposomes prepared with different methods yield distinct membrane deformation morphologies of BAR domain proteins and apparent activation barriers to pacsin-1's activity. Theoretical free energy calculations suggest bimodality of the protein-membrane system as a possible source for the different outcomes, which could account for the coexistence of energetically equivalent membrane structures induced by BAR domain-containing proteins in vitro. Taken together, our results suggest a versatile role for pacsin-1 in sculpting cellular membranes that is likely dependent both on protein structure and membrane properties.	[Goh, Shih Lin; Wang, Qi; Byrnes, Laura J.; Sondermann, Holger] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Sondermann, H (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	hs293@cornell.edu			PEW scholarship in the Biomedical Sciences	PEW scholarship in the Biomedical Sciences	The work was supported by a PEW scholarship in the Biomedical Sciences (to H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Barylko B, 2010, BIOCHEMISTRY-US, V49, P10592, DOI 10.1021/bi101343p; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Buboltz JT, 1999, BBA-BIOMEMBRANES, V1417, P232, DOI 10.1016/S0005-2736(99)00006-1; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Campelo F, 2010, FEBS LETT, V584, P1830, DOI 10.1016/j.febslet.2009.10.023; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Edeling MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008150; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HIGASHI K, 1987, J BIOCHEM-TOKYO, V101, P433, DOI 10.1093/oxfordjournals.jbchem.a121928; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kiessling V, 2009, BBA-BIOMEMBRANES, V1788, P64, DOI 10.1016/j.bbamem.2008.09.003; Koch D, 2011, EMBO J, V30, P4955, DOI 10.1038/emboj.2011.339; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; Manneville JB, 2012, METHOD CELL BIOL, V108, P47, DOI 10.1016/B978-0-12-386487-1.00003-1; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Modregger J, 2000, J CELL SCI, V113, P4511; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1; Plomann M, 2010, J MOL BIOL, V400, P129, DOI 10.1016/j.jmb.2010.05.008; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Quana A, 2012, P NATL ACAD SCI USA, V109, P3760, DOI 10.1073/pnas.1108294109; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shimada A, 2010, FEBS LETT, V584, P1111, DOI 10.1016/j.febslet.2010.02.058; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhao J, 2007, BBA-BIOMEMBRANES, V1768, P2764, DOI 10.1016/j.bbamem.2007.07.008; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	75	19	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51628	10.1371/journal.pone.0051628	http://dx.doi.org/10.1371/journal.pone.0051628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236520	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100136
J	Hu, RM; Liao, ST; Huang, CC; Huang, YW; Yang, TC				Hu, Rouh-Mei; Liao, Sih-Ting; Huang, Chiang-Ching; Huang, Yi-Wei; Yang, Tsuey-Ching			An Inducible Fusaric Acid Tripartite Efflux Pump Contributes to the Fusaric Acid Resistance in Stenotrophomonas maltophilia	PLOS ONE			English	Article							L2 BETA-LACTAMASES; ESCHERICHIA-COLI; GENOME SEQUENCE; SYSTEM; GENE; EXPRESSION; MECHANISM; ENDOPHYTE; RESPONSES; CLONING	Background: Fusaric acid (5-butylpicolinic acid), a mycotoxin, is noxious to some microorganisms. Stenotrophomonas maltophilia displays an intrinsic resistance to fusaric acid. This study aims to elucidate the mechanism responsible for the intrinsic fusaric acid resistance in S. maltophilia. Methodology: A putative fusaric acid resistance-involved regulon fuaR-fuaABC was identified by the survey of the whole genome sequence of S. maltophilia K279a. The fuaABC operon was verified by reverse transcriptase-PCR. The contribution of the fuaABC operon to the antimicrobial resistance was evaluated by comparing the antimicrobials susceptibility between the wild-type strain and fuaABC knock-out mutant. The regulatory role of fuaR in the expression of the fuaABC operon was assessed by promoter transcription fusion assay. Results: The fuaABC operon was inducibly expressed by fusaric acid and the inducibility was fuaR dependent. FuaR functioned as a repressor of the fuaABC operon in absence of a fusaric acid inducer and as an activator in its presence. Overexpression of the fuaABC operon contributed to the fusaric acid resistance. Significance: A novel tripartite fusaric acid efflux pump, FuaABC, was identified in this study. Distinct from the formally classification, the FuaABC may constitute a new type of subfamily of the tripartite efflux pump.	[Liao, Sih-Ting; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Hu, Rouh-Mei] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Huang, Chiang-Ching] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Huang, Yi-Wei] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan	National Yang Ming Chiao Tung University; Asia University Taiwan; China Medical University Taiwan; National Chung Hsing University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	tcyang@ym.edu.tw	Huang, Yi-Wei/K-9717-2019		National Science Council, Taiwan [NSC 101-2320-B-010-053-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant NSC 101-2320-B-010-053-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; Bolhuis H, 1997, FEMS MICROBIOL REV, V21, P55, DOI 10.1016/S0168-6445(97)00051-X; Bouizgarne B, 2006, NEW PHYTOL, V169, P209, DOI 10.1111/j.1469-8137.2005.01561.x; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; CLSI, 2018, PERFORMANCE STANDARD; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Dunne C, 1997, MICROBIOL-UK, V143, P3921, DOI 10.1099/00221287-143-12-3921; Fetherston JD, 1996, MOL MICROBIOL, V22, P315, DOI 10.1046/j.1365-2958.1996.00118.x; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hu RM, 2008, ANTIMICROB AGENTS CH, V52, P1198, DOI 10.1128/AAC.00682-07; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jakobi M, 1996, J ANTIBIOT, V49, P1101, DOI 10.7164/antibiotics.49.1101; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kuzniak E, 2001, PLANT SCI, V160, P723, DOI 10.1016/S0168-9452(00)00457-X; Lin CW, 2008, LETT APPL MICROBIOL, V47, P393, DOI 10.1111/j.1472-765X.2008.02443.x; Lin CW, 2009, RES MICROBIOL, V160, P152, DOI 10.1016/j.resmic.2008.11.001; Lira F, 2012, J BACTERIOL, V194, P3563, DOI 10.1128/JB.00602-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; Pan JH, 2011, ARCH PHARM RES, V34, P1177, DOI 10.1007/s12272-011-0716-9; Pietras Z, 2008, CURR DRUG TARGETS, V9, P719, DOI 10.2174/138945008785747743; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rosner JL, 1997, CURR TOP CELL REGUL, V35, P163, DOI 10.1016/S0070-2137(97)80007-6; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Sanchez MB, 2009, FUTURE MICROBIOL, V4, P655, DOI 10.2217/FMB.09.45; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; UTSUMI R, 1991, AGR BIOL CHEM TOKYO, V55, P1913, DOI 10.1080/00021369.1991.10870864; WALLACE RG, 1980, GENE, V12, P179, DOI 10.1016/0378-1119(80)90100-6; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204; Zhu B, 2012, J BACTERIOL, V194, P1280, DOI 10.1128/JB.06702-11	35	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51053	10.1371/journal.pone.0051053	http://dx.doi.org/10.1371/journal.pone.0051053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236431	gold, Green Submitted, Green Published			2022-12-25	WOS:000312064100060
J	Niemantsverdriet, M; Nagle, P; Chiu, RK; Langendijk, JA; Kampinga, HH; Coppes, RP				Niemantsverdriet, Maarten; Nagle, Peter; Chiu, Roland K.; Langendijk, Johannes A.; Kampinga, Harm H.; Coppes, Robert P.			Delta Np73 Enhances Promoter Activity of TGF-beta Induced Genes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SERIAL ANALYSIS; MICE DEFICIENT; P53; EXPRESSION; P73; IDENTIFICATION; INHIBITOR; RADIATION; BINDING	The p53 homolog p73 is frequently overexpressed in cancers. Especially the transactivation domain truncated isoform Delta Np73 has oncogenic properties and its upregulation is associated with poor patient survival. It has been shown that Delta Np73 has an inhibitory effect on the transactivation capacity of p53 and other p73 isoforms. Here, we confirm this finding but surprisingly find that Delta Np73 may also stimulate the expression of TGF-beta signaling targets. Promoter-reporter analysis indicated that the presence of Smad Binding Elements (SBE) in the promoter is sufficient for stimulation of gene expression by Delta Np73. TGF-beta signaling was less efficient in Delta Np73 downregulated cells, whereas tetracycline induced Delta Np73 increased expression of endogenous TGF-beta regulated genes PAI-1 and Col1a1. Pull-down assays with SBE DNA suggest that Delta Np73 enhances smad3/4 binding to SBEs, thereby stimulating TGF-beta signaling. Chromatin immunoprecipitation assays confirmed a direct interaction between Delta Np73 and SBE. Given the role of TGF-beta signaling in carcinogenesis, tumor invasion and metastasis via targets like PAI-1 and Col1a1, our data suggest a model on how this effect of Delta Np73 could be a contributing factor in cancer progression.	[Niemantsverdriet, Maarten; Nagle, Peter; Chiu, Roland K.; Kampinga, Harm H.; Coppes, Robert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands; [Niemantsverdriet, Maarten; Nagle, Peter; Chiu, Roland K.; Langendijk, Johannes A.; Coppes, Robert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands	University of Groningen; University of Groningen	Coppes, RP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands.	r.p.coppes@umcg.nl	Nagle, Peter/AGI-9589-2022; Nagle, Peter/ABA-2482-2020; Coppes, Robert P/B-4089-2008	Nagle, Peter/0000-0001-6150-2571; Coppes, Robert P/0000-0001-5503-1064; Langendijk, Johannes A./0000-0003-1083-372X; Kampinga, Harm/0000-0002-8966-8466				Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Craig AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-195; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; deWinter JP, 1997, ONCOGENE, V14, P1891, DOI 10.1038/sj.onc.1201017; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Falanga V, 2002, J CELL PHYSIOL, V191, P42, DOI 10.1002/jcp.10065; Fujitani M, 2010, CURR BIOL, V20, P2058, DOI 10.1016/j.cub.2010.10.029; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Hageman J, 2005, CLIN CANCER RES, V11, P5956, DOI 10.1158/1078-0432.CCR-05-0427; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Killick R, 2011, MOL NEUROBIOL, V43, P139, DOI 10.1007/s12035-011-8172-6; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Liu SS, 2006, CLIN CANCER RES, V12, P3922, DOI 10.1158/1078-0432.CCR-05-2573; Markl B, 2010, J SURG ONCOL, V102, P235, DOI 10.1002/jso.21611; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Niemantsverdriet M, 2005, EXP CELL RES, V310, P237, DOI 10.1016/j.yexcr.2005.07.016; Niemantsverdriet M, 2010, RADIOTHER ONCOL, V97, P33, DOI 10.1016/j.radonc.2010.04.002; Oswald C, 2008, CELL CYCLE, V7, P1726, DOI 10.4161/cc.7.12.6148; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Piccolo S, 2008, CELL, V133, P767, DOI 10.1016/j.cell.2008.05.013; Rundle CH, 2008, CALCIFIED TISSUE INT, V83, P276, DOI 10.1007/s00223-008-9169-7; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Uramoto H, 2004, CLIN CANCER RES, V10, P6905, DOI 10.1158/1078-0432.CCR-04-0290; Vella V, 2009, INT J CANCER, V124, P2539, DOI 10.1002/ijc.24221; Vilgelm AE, 2010, ONCOGENE, V29, P5861, DOI 10.1038/onc.2010.319; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Whitman M, 2003, CELL, V113, P275, DOI 10.1016/S0092-8674(03)00317-9; Wierenga ATJ, 2002, LEUKEMIA RES, V26, P1105, DOI 10.1016/S0145-2126(02)00054-1; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yasui W, 2004, CANCER SCI, V95, P385, DOI 10.1111/j.1349-7006.2004.tb03220.x; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179	53	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50815	10.1371/journal.pone.0050815	http://dx.doi.org/10.1371/journal.pone.0050815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236396	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100036
J	Yu, PL; Wang, Q; Zhang, LH; Lee, HC; Zhang, LR; Yue, JB				Yu, Peilin; Wang, Qian; Zhang, Li-He; Lee, Hon-Cheung; Zhang, Liangren; Yue, Jianbo			A Cell Permeable NPE Caged ADP-Ribose for Studying TRPM2	PLOS ONE			English	Article							OXIDATIVE STRESS; ION-CHANNEL; INTRACELLULAR CALCIUM; INSULIN-SECRETION; BIPOLAR DISORDER; CATION CHANNELS; BETA-CELLS; ACTIVATION; ZINC; CA2+	Transient potential receptor melastatin-2 (TRPM2) is a non-selective Ca2+-permeable cation channel of the TRPM channel subfamily and is mainly activated by intracellular adenosine diphosphate ribose (ADPR). Here we synthesized a 1-(2-nitrophenyl) ethyl caged ADPR (NPE-ADPR) and found that uncaging of NPE-ADPR efficiently stimulated Ca2+, Mg2+, and Zn2+ influx in a concentration-dependent manner in intact human Jurkat T-lymphocytes. The cation influx was inhibited by inhibitors or knockdown of TRPM2. Likewise, uncaging of NPE-ADPR markedly induced cation entry in HEK 293 cells that overexpress TRPM2. As expected, high temperature increased the ability of the photolyzed NPE-ADPR to induce cation entry, whereas acidic pH inhibited. Moreover, the absence of extracellular Ca2+ significantly inhibited Mg2+ and Zn2+ influx after uncaging NPE-ADPR. On the other hand, the absence of extracellular Na+ or Mg2+ had no effect on photolyzed NPE-ADPR induced Ca2+ entry. Taken together, our results indicated that NPE-ADPR is a cell permeable ADPR analogue that is useful for studying TRPM2-mediated cation entry in intact cells.	[Yu, Peilin; Wang, Qian; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Yu, Peilin; Zhang, Li-He; Lee, Hon-Cheung; Zhang, Liangren] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Yu, Peilin] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China	University of Hong Kong; Peking University; Zhejiang University	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	Yue, Jianbo/AAC-4588-2019; WANG, Qian/R-3192-2017; Zhang, Liang/GWM-6088-2022; Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/K-8002-2015	Yue, Jianbo/0000-0001-6384-5447	Research Grant Council (RGC) [HKU 784710M, HKU 782709M, HKU 785911M]; National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong [N_HKU 737/09]; NSFC [20910094]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong; NSFC(National Natural Science Foundation of China (NSFC)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) grants (HKU 784710M, HKU 782709M, HKU 785911M) and a National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong (N_HKU 737/09) and NSFC (20910094), and a Special Fellow Award from the Leukemia and Lymphoma Society of America (J.Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Gustafsson AJ, 2011, MOL CELL ENDOCRINOL, V333, P8, DOI 10.1016/j.mce.2010.11.004; Heiner I, 2006, BIOCHEM J, V398, P225, DOI 10.1042/BJ20060183; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Islam MS, 2011, ADV EXP MED BIOL, V704, P811, DOI 10.1007/978-94-007-0265-3_42; Jiang LH, 2010, EXPERT OPIN THER TAR, V14, P973, DOI 10.1517/14728222.2010.510135; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Naziroglu M, J MEMBR BIOL, V241, P51; Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Sauve AA, 2004, CURR MED CHEM, V11, P807, DOI 10.2174/0929867043455675; Scharenberg AM, 2009, ISLETS, V1, P165, DOI 10.4161/isl.1.2.9434; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; Sumoza-Toledo A., 2010, J PHYSL, V589, P1515; Sumoza-Toledo A, 2011, FASEB J, V25, P3529, DOI 10.1096/fj.10-178483; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Takahashi N, CELL CALCIUM, V50, P279; Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; Wei WJ, 2012, J BIOL CHEM, V287, P35599, DOI 10.1074/jbc.M112.392530; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Xie Yu-Feng, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P95; Xu C, 2006, AM J MED GENET B, V141B, P36, DOI 10.1002/ajmg.b.30239; Xu C, 2009, BIPOLAR DISORD, V11, P1, DOI 10.1111/j.1399-5618.2008.00655.x; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Yang W, 2011, J BIOL CHEM, V286, P23789, DOI 10.1074/jbc.M111.247478; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; Yu PL, 2012, J BIOL CHEM, V287, P24774, DOI 10.1074/jbc.M111.329854; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767	55	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51028	10.1371/journal.pone.0051028	http://dx.doi.org/10.1371/journal.pone.0051028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236422	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100053
J	Vlachakis, D; Pavlopoulou, A; Tsiliki, G; Komiotis, D; Stathopoulos, C; Balatsos, NAA; Kossida, S				Vlachakis, Dimitrios; Pavlopoulou, Athanasia; Tsiliki, Georgia; Komiotis, Dimitri; Stathopoulos, Constantinos; Balatsos, Nikolaos A. A.; Kossida, Sophia			An Integrated In Silico Approach to Design Specific Inhibitors Targeting Human Poly(A)-Specific Ribonuclease	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLATION; STRUCTURAL BASIS; BINDING PROTEIN; POLY(A) BINDING; CAP-BINDING; DOMAIN; DECAY; PARN; IDENTIFICATION; ALGORITHMS	Poly(A)-specific ribonuclease (PARN) is an exoribonuclease/deadenylase that degrades 3'-end poly(A) tails in almost all eukaryotic organisms. Much of the biochemical and structural information on PARN comes from the human enzyme. However, the existence of PARN all along the eukaryotic evolutionary ladder requires further and thorough investigation. Although the complete structure of the full-length human PARN, as well as several aspects of the catalytic mechanism still remain elusive, many previous studies indicate that PARN can be used as potent and promising anti-cancer target. In the present study, we attempt to complement the existing structural information on PARN with in-depth bioinformatics analyses, in order to get a hologram of the molecular evolution of PARNs active site. In an effort to draw an outline, which allows specific drug design targeting PARN, an unequivocally specific platform was designed for the development of selective modulators focusing on the unique structural and catalytic features of the enzyme. Extensive phylogenetic analysis based on all the publicly available genomes indicated a broad distribution for PARN across eukaryotic species and revealed structurally important amino acids which could be assigned as potentially strong contributors to the regulation of the catalytic mechanism of PARN. Based on the above, we propose a comprehensive in silico model for the PARN's catalytic mechanism and moreover, we developed a 3D pharmacophore model, which was subsequently used for the introduction of DNP-poly(A) amphipathic substrate analog as a potential inhibitor of PARN. Indeed, biochemical analysis revealed that DNP-poly(A) inhibits PARN competitively. Our approach provides an efficient integrated platform for the rational design of pharmacophore models as well as novel modulators of PARN with therapeutic potential. Citation: Vlachakis D, Pavlopoulou A, Tsiliki G, Komiotis D, Stathopoulos C, et al. (2012) An Integrated In Silico Approach to Design Specific Inhibitors Targeting Human Poly(A)-Specific Ribonuclease. PLoS ONE 7(12): e51113. doi:10.1371/journal.pone.0051113	[Komiotis, Dimitri; Balatsos, Nikolaos A. A.] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Vlachakis, Dimitrios; Pavlopoulou, Athanasia; Tsiliki, Georgia; Kossida, Sophia] Acad Athens, Biomed Res Fdn, Bioinformat & Med Informat Lab, Athens, Greece; [Stathopoulos, Constantinos] Univ Patras, Sch Med, Dept Biochem, Rion, Greece	University of Thessaly; Academy of Athens; University of Patras	Balatsos, NAA (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.	balatsos@bio.uth.gr; skossida@bioacademy.gr	Pavlopoulou, Athanasia/AAH-1204-2020; Kossida, Sofia/ABG-3526-2020; Vlachakis, Dimitrios/O-4323-2018; Pavlopoulou, Athanasia/ABB-3275-2021	Vlachakis, Dimitrios/0000-0003-1823-6102; Stathopoulos, Constantinos/0000-0002-5699-4118; Pavlopoulou, Athanasia/0000-0002-0815-3808; Tsiliki, Georgia/0000-0001-7209-3670; Balatsos, Nikolaos/0000-0002-1146-1174				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], MOL OP ENV MOE 2011; Ashun MA, 1996, ANTIMICROB AGENTS CH, V40, P2311, DOI 10.1128/AAC.40.10.2311; ASTROM J, 1991, EMBO J, V10, P3067, DOI 10.1002/j.1460-2075.1991.tb07858.x; ASTROM J, 1992, J BIOL CHEM, V267, P18154; Balatsos NAA, 2006, J BIOL CHEM, V281, P4517, DOI 10.1074/jbc.M508590200; Balatsos N, 2012, BIOCHIMIE, V94, P214, DOI 10.1016/j.biochi.2011.10.011; Balatsos NAA, 2009, BIOCHEMISTRY-US, V48, P6044, DOI 10.1021/bi900236k; Balatsos NAA, 2009, J ENZYM INHIB MED CH, V24, P516, DOI [10.1080/14756360802218763, 10.1080/14756360802218763 ]; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Cheng YA, 2006, PROTEIN PEPTIDE LETT, V13, P125, DOI 10.2174/092986606775101580; Chiba Y, 2004, GENE, V328, P95, DOI 10.1016/j.gene.2003.11.028; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Henriksson N, 2010, J BIOL CHEM, V285, P163, DOI 10.1074/jbc.M109.043893; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jones G, 1995, J COMPUT AID MOL DES, V9, P532, DOI 10.1007/BF00124324; Kazius J, 2005, J MED CHEM, V48, P312, DOI 10.1021/jm040835a; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim JH, 2008, METHOD ENZYMOL, V448, P119, DOI 10.1016/S0076-6879(08)02607-4; Korner CG, 1997, J BIOL CHEM, V272, P10448; Labute P, 2001, J MED CHEM, V44, P1483, DOI 10.1021/jm0002634; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lin S.K., 2000, MOLECULES, V5, P987, DOI [10.3390/50700987, DOI 10.3390/50700987]; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Manful T, 2011, RNA, V17, P2039, DOI 10.1261/rna.2837311; Maragozidis P, ACTA HAEMATOL, V128, P39; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Marshall G.R., 1979, COMPUTER ASSISTED DR, P205; Martin YC, 1995, DISTANCE COMP DISCO, P318; Martinez J, 2001, J BIOL CHEM, V276, P27923, DOI 10.1074/jbc.M102270200; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Nilsson P, 2007, J BIOL CHEM, V282, P32902, DOI 10.1074/jbc.M702375200; Olsen DS, 1998, GENETICS, V149, P1495; Opyrchal M, 2005, INSECT BIOCHEM MOLEC, V35, P1321, DOI 10.1016/j.ibmb.2005.08.004; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pettifer S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S19; R Development Core Team, 2012, R LANG ENV STAT COMP; Ren YG, 2002, J BIOL CHEM, V277, P5982, DOI 10.1074/jbc.M111515200; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seal R, 2005, NUCLEIC ACIDS RES, V33, P376, DOI 10.1093/nar/gki169; Sellis D, 2009, BIOINFORM BIOL INSIG, V3, P99; Smith G. M., 1990, TETRAHEDRON COMPUT M, V3, P615; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Thore S, 2003, EMBO REP, V4, P1150, DOI 10.1038/sj.embor.7400020; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu MS, 2009, STRUCTURE, V17, P276, DOI 10.1016/j.str.2008.11.012; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869	70	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51113	10.1371/journal.pone.0051113	http://dx.doi.org/10.1371/journal.pone.0051113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236441	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700030
J	Hansson, C; Shirazi, RH; Naslund, J; Vogel, H; Neuber, C; Holm, G; Anckarsater, H; Dickson, SL; Eriksson, E; Skibicka, KP				Hansson, Caroline; Shirazi, Rozita H.; Naslund, Jakob; Vogel, Heike; Neuber, Corinna; Holm, Goran; Anckarsater, Henrik; Dickson, Suzanne L.; Eriksson, Elias; Skibicka, Karolina P.			Ghrelin Influences Novelty Seeking Behavior in Rodents and Men	PLOS ONE			English	Article							EXON III POLYMORPHISM; NUCLEUS-ACCUMBENS; INDIVIDUAL-DIFFERENCES; ABDOMINAL OBESITY; RECEPTOR GENE; PREFRONTAL CORTEX; FOOD-REWARD; ALCOHOL-USE; DOPAMINE; RATS	Recent discoveries indicate an important role for ghrelin in drug and alcohol reward and an ability of ghrelin to regulate mesolimbic dopamine activity. The role of dopamine in novelty seeking, and the association between this trait and drug and alcohol abuse, led us to hypothesize that ghrelin may influence novelty seeking behavior. To test this possibility we applied several complementary rodent models of novelty seeking behavior, i.e. inescapable novelty-induced locomotor activity (NILA), novelty-induced place preference and novel object exploration, in rats subjected to acute ghrelin receptor (growth hormone secretagogue receptor; GHSR) stimulation or blockade. Furthermore we assessed the possible association between polymorphisms in the genes encoding ghrelin and GHSR and novelty seeking behavior in humans. The rodent studies indicate an important role for ghrelin in a wide range of novelty seeking behaviors. Ghrelin-injected rats exhibited a higher preference for a novel environment and increased novel object exploration. Conversely, those with GHSR blockade drastically reduced their preference for a novel environment and displayed decreased NILA. Importantly, the mesolimbic ventral tegmental area selective GHSR blockade was sufficient to reduce the NILA response indicating that the mesolimbic GHSRs might play an important role in the observed novelty responses. Moreover, in untreated animals, a striking positive correlation between NILA and sucrose reward behavior was detected. Two GHSR single nucleotide polymorphisms (SNPs), rs2948694 and rs495225, were significantly associated with the personality trait novelty seeking, as assessed using the Temperament and Character Inventory (TCI), in human subjects. This study provides the first evidence for a role of ghrelin in novelty seeking behavior in animals and humans, and also points to an association between food reward and novelty seeking in rodents. Citation: Hansson C, Shirazi RH, Naslund J, Vogel H, Neuber C, et al. (2012) Ghrelin Influences Novelty Seeking Behavior in Rodents and Men. PLoS ONE 7(12): e50409. doi:10.1371/journal.pone.0050409	[Hansson, Caroline; Shirazi, Rozita H.; Vogel, Heike; Dickson, Suzanne L.; Skibicka, Karolina P.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Endocrinol, Gothenburg, Sweden; [Hansson, Caroline; Neuber, Corinna] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Clin & Mol Med, Gothenburg, Sweden; [Naslund, Jakob; Eriksson, Elias] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden; [Holm, Goran] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Metab & Cardiovasc Dis, Gothenburg, Sweden; [Anckarsater, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg	Skibicka, KP (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Endocrinol, Gothenburg, Sweden.	karolina.skibicka@neuro.gu.se	Dickson, Suzanne L/U-4628-2019; Näslund, Jakob/I-7491-2019	Dickson, Suzanne/0000-0002-3822-5294; Naslund, Jakob/0000-0003-2782-5160	Swedish Research Council for Medicine [2011-3054, 2009-S266, 12208, 2009-2618, 2009-4746]; European Commission 7th Framework [FP7-HEALTH-2009-241592, FP7-KBBE-2009-3-245009, FP7-KBBE-2010-4-66408]; Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg [ALFGBG-138741]; NovoNordisk Foundation; Bertil Hallsten's Foundation; Brain Foundation; Soderberg's Foundation; Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research [A305-188]; Novo Nordisk Fonden [NNF12OC1016479] Funding Source: researchfish	Swedish Research Council for Medicine; European Commission 7th Framework; Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg; NovoNordisk Foundation(Novo Nordisk Foundation); Bertil Hallsten's Foundation; Brain Foundation; Soderberg's Foundation; Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research(Swedish Foundation for Strategic Research); Novo Nordisk Fonden(Novo Nordisk Foundation)	Swedish Research Council for Medicine (2011-3054 to K.P.S., 2009-S266 to S.L.D., 12208, 2009-2618), 2009-4746 to E.E.), European Commission 7th Framework [FP7-HEALTH-2009-241592 (EurOCHIP), FP7-KBBE-2009-3-245009 (NeuroFAST), and FP7-KBBE-2010-4-66408 (Full4Health)], Forskning och Utvecklingsarbete/Avtal om Lakarutbildning och Forskning Goteborg (ALFGBG-138741), NovoNordisk Foundation, Bertil Hallsten's Foundation, the Brain Foundation, Soderberg's Foundation, and the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research (A305-188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680; Ballaz SJ, 2007, NEUROSCIENCE, V149, P192, DOI 10.1016/j.neuroscience.2007.07.043; Belin D, 2011, NEUROPSYCHOPHARMACOL, V36, P569, DOI 10.1038/npp.2010.188; Berlyne DE, 1950, B J PSYCHOL-GEN SECT, V41, P68, DOI 10.1111/j.2044-8295.1950.tb00262.x; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; Cain ME, 2008, NEUROPSYCHOPHARMACOL, V33, P1149, DOI 10.1038/sj.npp.1301478; Cain ME, 2005, EXP CLIN PSYCHOPHARM, V13, P367, DOI 10.1037/1064-1297.13.4.367; Chefer VI, 2003, J NEUROSCI, V23, P3076; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Costoli T, 2005, NEUROSCI BIOBEHAV R, V29, P113, DOI 10.1016/j.neubiorev.2004.09.016; Dellu F, 1996, NEUROPSYCHOBIOLOGY, V34, P136, DOI 10.1159/000119305; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; ERICSON E, 1991, J PHARMACOL METHOD, V25, P111, DOI 10.1016/0160-5402(91)90002-M; Finger BC, 2012, PSYCHOPHARMACOLOGY, V220, P173, DOI 10.1007/s00213-011-2468-0; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Gueorguiev M, 2009, OBESITY, V17, P745, DOI 10.1038/oby.2008.589; HOOKS MS, 1992, BRAIN RES, V587, P306; HOOKS MS, 1994, J NEUROSCI, V14, P6144; HOOKS MS, 1991, SYNAPSE, V9, P121, DOI 10.1002/syn.890090206; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Kabbaj M, 2000, J NEUROSCI, V20, P6983, DOI 10.1523/JNEUROSCI.20-18-06983.2000; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Landgren S, 2008, ALCOHOL CLIN EXP RES, V32, P2054, DOI 10.1111/j.1530-0277.2008.00793.x; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; MISSLIN R, 1982, PSYCHONEUROENDOCRINO, V7, P217, DOI 10.1016/0306-4530(82)90015-4; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; Piazza P.V., 1990, Behav Pharmacol, V1, P339; PIAZZA PV, 1991, BRAIN RES, V567, P169, DOI 10.1016/0006-8993(91)91452-7; PIERCE RC, 1990, PHARMACOL BIOCHEM BE, V36, P321, DOI 10.1016/0091-3057(90)90411-A; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; Rebec GV, 1997, BRAIN RES, V776, P61, DOI 10.1016/S0006-8993(97)01004-4; Rebec GV, 1997, NEUROSCIENCE, V76, P707, DOI 10.1016/S0306-4522(96)00382-X; RODGERS RJ, 1979, PSYCHOPHARMACOLOGY, V65, P103, DOI 10.1007/BF00491988; Rosmond R, 1998, INT J OBESITY, V22, P1184, DOI 10.1038/sj.ijo.0800745; Rosmond R, 1998, OBES RES, V6, P338, DOI 10.1002/j.1550-8528.1998.tb00361.x; Rosmond R, 1998, METABOLISM, V47, P1187, DOI 10.1016/S0026-0495(98)90321-3; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2012, ENDOCRINOLOGY, V153, P1194, DOI 10.1210/en.2011-1606; Skibicka KP, 2011, PEPTIDES, V32, P2265, DOI 10.1016/j.peptides.2011.05.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Staner L, 1998, AM J MED GENET, V81, P192, DOI 10.1002/(SICI)1096-8628(19980328)81:2<192::AID-AJMG12>3.3.CO;2-I; Vanyukov MM, 1998, BEHAV GENET, V28, P75, DOI 10.1023/A:1021463722326; von Horsten S, 1998, BRAIN RES, V806, P282, DOI 10.1016/S0006-8993(98)00772-0; Wang HJ, 2004, J CLIN ENDOCR METAB, V89, P157, DOI 10.1210/jc.2003-031395; Wellman PJ, 2008, REGUL PEPTIDES, V146, P33, DOI 10.1016/j.regpep.2007.07.007; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013; Yannielli PC, 2007, J NEUROSCI, V27, P2890, DOI 10.1523/JNEUROSCI.3913-06.2007; ZUCKERMAN M, 1990, J PERS, V58, P313, DOI 10.1111/j.1467-6494.1990.tb00918.x	57	30	30	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50409	10.1371/journal.pone.0050409	http://dx.doi.org/10.1371/journal.pone.0050409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227170	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200031
J	Schmidt-Roach, S; Miller, KJ; Woolsey, E; Gerlach, G; Baird, AH				Schmidt-Roach, Sebastian; Miller, Karen J.; Woolsey, Erika; Gerlach, Gabriele; Baird, Andrew H.			Broadcast Spawning by Pocillopora Species on the Great Barrier Reef	PLOS ONE			English	Article							ASEXUAL REPRODUCTION; GENOTYPIC DIVERSITY; LUNAR PERIODICITY; GENETIC-STRUCTURE; EASTERN PACIFIC; CORALS; POPULATIONS; DAMICORNIS; PATTERNS; SCLERACTINIA	The coral genus Pocillopora is one of the few to include some species that broadcast spawn gametes and some species that brood larvae, although reports of reproductive mode and timing vary within and among species across their range. Notably, the ubiquitous Pocillopora damicornis has been described as both a brooder and spawner, although evidence of broadcast spawning is rare. Here, we report observations of broadcast-spawning in four species of Pocillopora on the Great Barrier Reef (GBR), including P. damicornis. All species spawned predictably during the early morning, two days following the full moon, and spawning was observed in multiple months over the summer period (November to February). Eggs and sperm were free-spawned concurrently. Eggs were negatively buoyant and contained Symbiodinium. This newfound knowledge on the mode, timing and regularity of broadcast spawning in Pocillopora spp. on the GBR brings us one step closer to elucidating the complex reproductive ecology of these species.	[Schmidt-Roach, Sebastian; Miller, Karen J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Schmidt-Roach, Sebastian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Woolsey, Erika; Baird, Andrew H.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Gerlach, Gabriele] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany	University of Tasmania; Australian Institute of Marine Science; James Cook University; Carl von Ossietzky Universitat Oldenburg	Schmidt-Roach, S (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	s.schmidt-roach@aims.gov.au	Baird, Andrew Hamilton/C-8449-2009; Miller, Karen/A-7902-2011; Schmidt-Roach, Sebastian/N-7129-2013; Miller, Karen/V-4098-2019; Gerlach, Gabriele/K-5919-2012	Baird, Andrew Hamilton/0000-0001-8504-4077; Schmidt-Roach, Sebastian/0000-0002-7783-0198; Woolsey, Erika/0000-0002-5339-3499	Commonwealth Environment Research Facilities (CERF) program; Australian Government initiative supporting world class, public good research; Winifred Violet Scott Estate Trust; Endeavour International Postgraduate Research Scholarship (EIPRS); CERF Marine Biodiversity Hub scholarship	Commonwealth Environment Research Facilities (CERF) program; Australian Government initiative supporting world class, public good research(Australian Government); Winifred Violet Scott Estate Trust; Endeavour International Postgraduate Research Scholarship (EIPRS)(Australian Government); CERF Marine Biodiversity Hub scholarship	This work has been funded through the Commonwealth Environment Research Facilities (CERF) program, an Australian Government initiative supporting world class, public good research. The CERF Marine Biodiversity Hub is a collaborative partnership between the University of Tasmania, CSIRO Wealth from Oceans Flagship, Geoscience Australia, Australian Institute of Marine Science and Museum Victoria. Additionally this study was kindly supported by a research award from the Winifred Violet Scott Estate Trust. S. S-R is also supported by an Endeavour International Postgraduate Research Scholarship (EIPRS) and CERF Marine Biodiversity Hub scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Ayre DJ, 2000, EVOLUTION, V54, P1590; Babcock RC, 2003, ZOOL STUD, V42, P211; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2000, CORAL REEFS, V19, P179, DOI 10.1007/PL00006955; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; Bouwmeester J., 2011, GALAXEA J CORAL REEF, V13, P23; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Combosch DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021200; Cumbo VR, 2012, MAR BIOL, V159, P2853, DOI 10.1007/s00227-012-2046-y; Douek J, 2011, GENETICA, V139, P1531, DOI 10.1007/s10709-012-9653-x; Fadlallah YH, 1985, 5TH P INT COR REEF C, V4, P313, DOI 10.1007/BF00347520; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiene-Severns P, 1998, 42 U HAW; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; GLYNN PW, 1991, MAR BIOL, V109, P355, DOI 10.1007/BF01313501; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harriott V.J., 1983, Coral Reefs, V2, P9, DOI 10.1007/BF00304727; Harrison P.L., 1990, CORAL REEFS, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hirose M, 2000, BIOL BULL, V199, P68, DOI 10.2307/1542708; Kinzie Robert A. Iii, 1993, Galaxea, V11, P93; Kuanui P, 2008, MAR FRESHWATER RES, V11, P375; Marshall S. M., 1933, Scientific Reports Great Barrier Reef Expedition, V3, P219; Miller K, 1997, BIOL BULL, V192, P98, DOI 10.2307/1542579; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Muir P, 1984, THESIS J COOK U, P60; Paz-Garcia DA, 2012, PAC SCI, V66, P43, DOI 10.2984/66.1.3; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; RICHMOND RH, 1984, B MAR SCI, V34, P280; Riddle D, 2009, 1 REPORT POCILLOPORA; Riddle D., 2008, ADV AQUARISTS ONLINE, V7, P10; Rodriguez-Troncoso AP, 2011, MAR BIOL, V158, P2673, DOI 10.1007/s00227-011-1765-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai K, 1997, MAR ECOL PROG SER, V151, P67, DOI 10.3354/meps151067; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schmidt-Roach S, 2008, J EXP MAR BIOL ECOL, V367, P37, DOI 10.1016/j.jembe.2008.08.012; Sere MG, 2010, J EXP MAR BIOL ECOL, V395, P63, DOI 10.1016/j.jembe.2010.08.014; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; Sherman CDH, 2006, CORAL REEFS, V25, P7, DOI 10.1007/s00338-005-0053-x; SHLESINGER Y, 1985, SCIENCE, V228, P1333, DOI 10.1126/science.228.4705.1333; SIER CJS, 1994, MAR BIOL, V118, P713, DOI 10.1007/BF00347520; STIMSON JS, 1978, MAR BIOL, V48, P173, DOI 10.1007/BF00395017; STODDART JA, 1984, CORAL REEFS, V3, P149, DOI 10.1007/BF00301959; STODDART JA, 1984, MAR BIOL, V81, P19, DOI 10.1007/BF00397621; STODDART JA, 1983, MAR BIOL, V76, P279, DOI 10.1007/BF00393029; STODDART JA, 1985, MAR ECOL PROG SER, V23, P153, DOI 10.3354/meps023153; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Veron J.E.N., 2000, CORALS WORLD, V2, P429; Villanueva RD, 2008, MAR ECOL PROG SER, V370, P111, DOI 10.3354/meps07659; WARD S, 1992, MAR BIOL, V112, P641, DOI 10.1007/BF00346182; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Yeoh SR, 2010, MAR BIOL, V157, P351, DOI 10.1007/s00227-009-1322-y	59	53	53	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50847	10.1371/journal.pone.0050847	http://dx.doi.org/10.1371/journal.pone.0050847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227215	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000312588200076
J	Jin, W; Su, XX; Xu, M; Liu, Y; Shi, JY; Lu, L; Niu, WQ				Jin, Wei; Su, Xiuxiu; Xu, Min; Liu, Yan; Shi, Jingyi; Lu, Lin; Niu, Wenquan			Interactive Association of Five Candidate Polymorphisms in Apelin/APJ Pathway with Coronary Artery Disease among Chinese Hypertensive Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ORPHAN RECEPTOR; AGTRL1 GENE; HAN CHINESE; APJ; SYSTEM; SUSCEPTIBILITY; VALIDATION; LIGAND	Background: Via sequencing the genes of apelin/angiotensin receptor-like 1 (apelin/APJ) pathway, we have recently identified and validated four common polymorphisms (rs3761581, rs56204867, rs7119375, and rs10501367) implicated in the development of hypertension. Extending these findings, we, in Chinese hypertensive patients, sought to investigate the association of these four polymorphisms and one additional promising candidate (rs9943582) from this pathway with the risk of developing coronary artery disease (CAD). Methodology/Principal Findings: Genotypes were obtained from 994 sporadic CAD patients and 708 age-and sex-matched controls. All participants were hypertensives and angiographically-confirmed. Data were analyzed by Haplo.Stats and multifactor dimensionality reduction (MDR) softwares. Genotype distributions of five examined polymorphisms satisfied Hardy-Weinberg equilibrium in controls of both genders. Single-locus analyses exhibited no significant differences in the genotype/allele frequencies of examined polymorphisms between CAD patients and controls (P > 0.05), even after controlling traditional cardiovascular confounders. In haplotype analyses, low-penetrance haplotype G-A (in order of rs56204867 and rs3761581 from apelin gene) was significantly overrepresented in controls (1.73%) relative to in CAD patients (0.4%) in males (P = 0.047). Further interaction analyses suggested an overall best MDR model including rs3761581 in males (P = 0.0408) and including rs7119375 and rs9943582 in females (P < 0.0001), which were further substantiated in the classical logistical regression model. Conclusions: Our findings demonstrated a contributive role of low-penetrance haplotype in apelin gene on CAD in males, and more importantly, interactive effects of genetic defects in apelin/APJ pathway might confer a potential risk in Chinese hypertensive patients. Citation: Jin W, Su X, Xu M, Liu Y, Shi J, et al. (2012) Interactive Association of Five Candidate Polymorphisms in Apelin/APJ Pathway with Coronary Artery Disease among Chinese Hypertensive Patients. PLoS ONE 7(12): e51123. doi:10.1371/journal.pone.0051123	[Jin, Wei; Shi, Jingyi; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Jin, Wei; Su, Xiuxiu; Xu, Min; Liu, Yan; Lu, Lin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Res Inst Hypertens, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Niu, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	niuwenquan@yahoo.cn		Jin, Wei/0000-0002-2905-2109	Shanghai Rising Star Program [11QA1405500]; National Natural Science Foundation of China [81070177, 30900808]	Shanghai Rising Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Rising Star Program (11QA1405500), and the National Natural Science Foundation of China (81070177, 30900808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton M, 2009, HYPERTENSION, V54, P11, DOI 10.1161/HYPERTENSIONAHA.108.120022; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Falcone C, 2012, MOL MED REP, V5, P321, DOI 10.3892/mmr.2011.685; Foldes G, 2003, BIOCHEM BIOPH RES CO, V308, P480, DOI 10.1016/S0006-291X(03)01424-4; Gao LAR, 2010, CELL TRANSPLANT, V19, P949, DOI 10.3727/096368910X504450; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hinohara K, 2009, J HUM GENET, V54, P554, DOI 10.1038/jhg.2009.78; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Kalea AZ, 2010, CURR OPIN INVEST DR, V11, P273; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Khanna M, 1999, ONCOGENE, V18, P27, DOI 10.1038/sj.onc.1202291; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Li WW, 2009, J HYPERTENS, V27, P1194, DOI 10.1097/HJH.0b013e32832a3eb1; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Niu WQ, 2010, J HYPERTENS, V28, P1854, DOI 10.1097/HJH.0b013e32833b1fad; Niu WQ, 2009, J HYPERTENS, V27, P1384, DOI 10.1097/HJH.0b013e32832b7e0d; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Padmanabhan S, 2008, J HYPERTENS, V26, P1275, DOI 10.1097/HJH.0b013e3282ff634f; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Pitkin SL, 2010, BRIT J PHARMACOL, V160, P1785, DOI 10.1111/j.1476-5381.2010.00821.x; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; WILSON PWF, 1994, AM J HYPERTENS, V7, pS7, DOI 10.1093/ajh/7.7.7S; Zintzaras E, 2008, ARCH INTERN MED, V168, P1077, DOI 10.1001/archinte.168.10.1077	29	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e51123	10.1371/journal.pone.0051123	http://dx.doi.org/10.1371/journal.pone.0051123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226564	Green Submitted, gold, Green Published			2022-12-25	WOS:000312104700031
J	Cotella, D; Hernandez-Enriquez, B; Duan, ZB; Wu, XL; Gazula, VR; Brown, MR; Kaczmarek, LK; Sesti, F				Cotella, Diego; Hernandez-Enriquez, Berenice; Duan, Zhibing; Wu, Xilong; Gazula, Valeswara-Rao; Brown, Maile R.; Kaczmarek, Leonard K.; Sesti, Federico			An evolutionarily conserved mode of modulation of Shaw-like K+ channels	FASEB JOURNAL			English	Article						acid phosphatase; neuronal adaptation; C. elegans	PROSTATIC ACID-PHOSPHATASE; POTASSIUM CHANNEL; MICE LACKING; ETHANOL TOLERANCE; AUDITORY NEURONS; KV3.1; RESPONSES; PHOSPHORYLATION; IDENTIFICATION; STIMULATION	Voltage-gated K+ channels of the Shaw family (also known as the KCNC or Kv3 family) play pivotal roles in mammalian brains, and genetic or pharmacological disruption of their activities in mice results in a spectrum of behavioral defects. We have used the model system of Caenorhabditis elegans to elucidate conserved molecular mechanisms that regulate these channels. We have now found that the C. elegans Shaw channel KHT-1, and its mammalian homologue, murine Kv3.1b, are both modulated by acid phosphatases. Thus, the C. elegans phosphatase ACP-2 is stably associated with KHT-1, while its mammalian homolog, prostatic acid phosphatase (PAP; also known as ACPP-201) stably associates with murine Kv3.1b K+ channels in vitro and in vivo. In biochemical experiments both phosphatases were able to reverse phosphorylation of their associated channel. The effect of phosphorylation on both channels is to produce a decrease in current amplitude and electrophysiological analyses demonstrated that dephosphorylation reversed the effects of phosphorylation on the magnitude of the macroscopic currents. ACP-2 and KHT-1 were colocalized in the nervous system of C. elegans and, in the mouse nervous system, PAP and Kv3.1b were colocalized in subsets of neurons, including in the brain stem and the ventricular zone. Taken together, this body of evidence suggests that acid phosphatases are general regulatory partners of Shaw-like K+ channels.-Cotella, D., Hernandez-Enriquez, B., Duan, Z., Wu, X., Gazula, V.-R., Brown, M. R., Kaczmarek, L. K., and Sesti, F. An evolutionarily conserved mode of modulation of Shaw-like K+ channels. FASEB J. 27, 1381-1393 (2013). www.fasebj.org	[Cotella, Diego; Hernandez-Enriquez, Berenice; Duan, Zhibing; Wu, Xilong; Sesti, Federico] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Gazula, Valeswara-Rao; Brown, Maile R.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Yale University	Sesti, F (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	sestife@umdnj.edu	cotella, diego/J-8422-2019	cotella, diego/0000-0003-2714-4744	U.S. National Institutes of Health [DC 01919]; National Science Foundation [0842708, 1026958]; American Heart Association [09GRNT2250529]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank the C. elegans Gene Knockout Consortium (University of British Columbia, Vancouver, BC, Canada) for the F14E5.4-KO (RB1704) strain, Dr. Shuang Liu for critical reading of the manuscript, and Dr. Costantino Vetriani for help with phylogenic calculations. The Kv3.1b cDNA was a gift from Dr. Geoffrey Abbott (University of California-Irvine, Irvine, CA, USA). This work was supported by a U.S. National Institutes of Health grant (DC 01919) to L. K. and two National Science Foundation grants (0842708 and 1026958) and an American Heart Association grant (09GRNT2250529) to F.S.	Aumuller G, 1999, UROLOGY, V53, P1041, DOI 10.1016/S0090-4295(98)00631-1; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Cai SQ, 2009, EMBO J, V28, P1601, DOI 10.1038/emboj.2009.112; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cowmeadow RB, 2006, ALCOHOL CLIN EXP RES, V30, P745, DOI 10.1111/j.1530-0277.2006.00087.x; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; CRITZ SD, 1993, J NEUROCHEM, V60, P1175, DOI 10.1111/j.1471-4159.1993.tb03273.x; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Deschaux O, 1997, NEUROSCI LETT, V227, P57, DOI 10.1016/S0304-3940(97)00301-7; Engel JE, 1998, J NEUROSCI, V18, P2254; Espinosa F, 2001, J NEUROSCI, V21, P6657, DOI 10.1523/JNEUROSCI.21-17-06657.2001; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Graddis TJ, 2011, INT J CLIN EXP PATHO, V4, P295; Hassan MI, 2010, EXPERT REV ANTICANC, V10, P1055, DOI 10.1586/ERA.10.46; Ho CS, 1997, P NATL ACAD SCI USA, V94, P1533, DOI 10.1073/pnas.94.4.1533; ITO K, 1987, BRAIN RES, V409, P97, DOI 10.1016/0006-8993(87)90745-1; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Keller C. C., 2005, INT WORM M, V539A; LEDEBUR IX, 1966, ELECTROEN CLIN NEURO, V20, P370, DOI 10.1016/0013-4694(66)90005-8; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; Mason P, 2005, J COMP NEUROL, V493, P2, DOI 10.1002/cne.20751; Matsukawa H, 2003, J NEUROSCI, V23, P7677; Pietrzykowski AZ, 2004, J NEUROSCI, V24, P8322, DOI 10.1523/JNEUROSCI.1536-04.2004; Pravetoni M, 2008, GENES BRAIN BEHAV, V7, P523, DOI 10.1111/j.1601-183X.2008.00388.x; Quessy S, 2004, EXP BRAIN RES, V156, P342, DOI 10.1007/s00221-003-1787-8; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; RISLEY JM, 1987, ARCH BIOCHEM BIOPHYS, V258, P404, DOI 10.1016/0003-9861(87)90361-4; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Song P, 2006, J BIOL CHEM, V281, P15582, DOI 10.1074/jbc.M512866200; Taylor-Blake B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008674; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; von Hehn CAA, 2004, J NEUROSCI, V24, P1936, DOI 10.1523/JNEUROSCI.4554-03.2004; Wang Y, 2007, BIOPHYS J, V93, P3083, DOI 10.1529/biophysj.107.110320; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	42	7	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1381	1393		10.1096/fj.12-222778	http://dx.doi.org/10.1096/fj.12-222778			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23233530	Green Published			2022-12-25	WOS:000316940800011
J	Aston-Mourney, K; Zraika, S; Udayasankar, J; Subramanian, SL; Green, PS; Kahn, SE; Hull, RL				Aston-Mourney, Kathryn; Zraika, Sakeneh; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Green, Pattie S.; Kahn, Steven E.; Hull, Rebecca L.			Matrix Metalloproteinase-9 Reduces Islet Amyloid Formation by Degrading Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL APOPTOSIS; DIABETES-MELLITUS; TRANSGENIC MOUSE; PANCREATIC-ISLETS; FIBRIL FORMATION; HUMAN AMYLIN; PEPTIDE; MICE; INSULIN; HYPERGLYCEMIA	Deposition of islet amyloid polypeptide ( IAPP) as amyloid is a pathological hallmark of the islet in type 2 diabetes, which is toxic to beta-cells. We previously showed that the enzyme neprilysin reduces islet amyloid deposition and thereby reduces beta-cell apoptosis, by inhibiting fibril formation. Two other enzymes, matrix metalloproteinase ( MMP)-2 and MMP-9, are extracellular gelatinases capable of degrading another amyloidogenic peptide, A beta, the constituent of amyloid deposits in Alzheimer disease. We therefore investigated whether MMP-2 and MMP-9 play a role in reducing islet amyloid deposition. MMP-2 and MMP-9 mRNA were present in mouse islets but only MMP-9 activity was detectable. In an islet culture model where human IAPP ( hIAPP) transgenic mouse islets develop amyloid but nontransgenic islets do not, a broad spectrum MMP inhibitor ( GM6001) and an MMP-2/9 inhibitor increased amyloid formation and the resultant beta-cell apoptosis. In contrast, a specific MMP-2 inhibitor had no effect on either amyloid deposition or beta-cell apoptosis. Mass spectrometry demonstrated that MMP-9 degraded amyloidogenic hIAPP but not nonamyloidogenic mouse IAPP. Thus, MMP-9 constitutes an endogenous islet protease that limits islet amyloid deposition and its toxic effects via degradation of hIAPP. Because islet MMP-9 mRNA levels are decreased in type 2 diabetic subjects, islet MMP-9 activity may also be decreased in human type 2 diabetes, thereby contributing to increased islet amyloid deposition and beta-cell loss. Approaches to increase islet MMP-9 activity could reduce or prevent amyloid deposition and its toxic effects in type 2 diabetes.	[Aston-Mourney, Kathryn; Zraika, Sakeneh; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Green, Pattie S.; Kahn, Steven E.; Hull, Rebecca L.] Vet Affairs Puget Sound Hlth Care Syst, Washington, WA 98108 USA; [Aston-Mourney, Kathryn; Zraika, Sakeneh; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Green, Pattie S.; Kahn, Steven E.; Hull, Rebecca L.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Aston-Mourney, Kathryn] Deakin Univ, Sch Med, Metab Res Unit, Waurn Ponds, Vic 3216, Australia	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Deakin University	Hull, RL (corresponding author), VA Puget Sound Hlth Care Syst, 1660 S Columbian Way 151, Seattle, WA 98108 USA.	rhull@u.washington.edu	Hull-Meichle, Rebecca L./CAG-5879-2022; Aston-Mourney, Kathryn/AGY-5164-2022	Aston-Mourney, Kathryn/0000-0003-1412-6715; Kahn, Steven/0000-0001-7307-9002; Hull, Rebecca/0000-0001-9690-4087	Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA); National Institutes of Health [DK-075998, DK-074404, DK-080945, DK-017047, DK-007247]; American Diabetes Association Mentor-Based fellowship; University of Washington McAbee fellowship; Deakin University Alfred Deakin Postdoctoral research fellowship; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK080945, T32DK007247, K01DK074404, R01DK075998, P30DK017047, R00DK080945] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Mentor-Based fellowship(American Diabetes Association); University of Washington McAbee fellowship; Deakin University Alfred Deakin Postdoctoral research fellowship; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA) and National Institutes of Health Grants DK-075998 (to S. E. K.), DK-074404 (to R. L. H.), DK-080945 (to S. Z.), DK-017047 (to the Cellular and Molecular Imaging Core of the University of Washington Diabetes Research Center), and DK-007247.; Supported by an American Diabetes Association Mentor-Based fellowship, the University of Washington McAbee fellowship, and a Deakin University Alfred Deakin Postdoctoral research fellowship.; Supported by a Juvenile Diabetes Research Foundation postdoctoral fellowship.	Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bai JZ, 1999, BIOCHEM J, V343, P53, DOI 10.1042/0264-6021:3430053; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; DALESSIO DA, 1994, DIABETES, V43, P1457, DOI 10.2337/diabetes.43.12.1457; Guan H, 2012, DIABETOLOGIA, V55, P2989, DOI 10.1007/s00125-012-2678-y; HOPPENER JWM, 1993, DIABETOLOGIA, V36, P1258, DOI 10.1007/BF00400803; Hull RL, 2005, DIABETES, V54, P2235, DOI 10.2337/diabetes.54.7.2235; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Levy M, 2006, FEBS J, V273, P5724, DOI 10.1111/j.1742-4658.2006.05562.x; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Mazzaglia A, 2010, J PHYS CHEM B, V114, P705, DOI 10.1021/jp908436s; Miettinen PJ, 2000, DEVELOPMENT, V127, P2617; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Subramanian SL, 2012, DIABETOLOGIA, V55, P166, DOI 10.1007/s00125-011-2338-7; Tomita T, 1997, MODERN PATHOL, V10, P47; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Zhou YP, 2005, DIABETES, V54, P2612, DOI 10.2337/diabetes.54.9.2612; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x; Zraika S, 2007, BIOCHEM BIOPH RES CO, V354, P234, DOI 10.1016/j.bbrc.2006.12.187; Zraika S, 2010, J BIOL CHEM, V285, P18177, DOI 10.1074/jbc.M109.082032	36	29	33	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3553	3559		10.1074/jbc.M112.438457	http://dx.doi.org/10.1074/jbc.M112.438457			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23229548	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000314397900060
J	Cho, JH; Dimri, M; Dimri, GP				Cho, Joon-Ho; Dimri, Manjari; Dimri, Goberdhan P.			A Positive Feedback Loop Regulates the Expression of Polycomb Group Protein BMI1 via WNT Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MAMMARY EPITHELIAL-CELLS; STEM-CELLS; SELF-RENEWAL; BETA-CATENIN/TCF; COLON-CANCER; H-RAS; C-MYC; PROLIFERATION; SENESCENCE	Polycomb group protein BMI1 plays an important role in cellular homeostasis by maintaining a balance between proliferation and senescence. It is often overexpressed in cancer cells and is required for self-renewal of stem cells. At present, very little is known about the signaling pathways that regulate the expression of BMI1. Here, we report that BMI1 autoactivates its own promoter via an E-box present in its promoter. We show that BMI1 acts as an activator of the WNT pathway by repressing Dickkopf (DKK) family of WNT inhibitors. BMI1 mediated repression of DKK proteins; in particular, DKK1 led to up-regulation of WNT target c-Myc, which in turn further led to transcriptional autoactivation of BMI1. Thus, a positive feedback loop connected by the WNT signaling pathway regulates BMI1 expression. This positive feedback loop regulating BMI1 expression may be relevant to the role of BMI1 in promoting cancer and maintaining stem cell phenotype.	[Cho, Joon-Ho; Dimri, Manjari; Dimri, Goberdhan P.] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Dimri, GP (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	gdimri@gwu.edu	Dimri, Goberdhan/AAO-4210-2021		National Institutes of Health Grant from the NCI [RO1 CA094150]; United States Army Medical Research and Materiel Command Award [W81XWH-09-1-0685]; NATIONAL CANCER INSTITUTE [R01CA094150] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NCI; United States Army Medical Research and Materiel Command Award(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA094150 from the NCI (to G. P. D.). This work was also supported by United States Army Medical Research and Materiel Command Award W81XWH-09-1-0685 (to G. P. D.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Dimri GP, 2002, CANCER RES, V62, P4736; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Glinsky GV, 2005, CELL CYCLE, V4, P1171, DOI 10.4161/cc.4.9.2001; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Wilkins JA, 2008, CANCER RES, V68, P4963, DOI 10.1158/0008-5472.CAN-07-5558; Yadav AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-158; Yu TX, 2012, J BIOL CHEM, V287, P3760, DOI 10.1074/jbc.M111.316349	42	62	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3406	3418		10.1074/jbc.M112.422931	http://dx.doi.org/10.1074/jbc.M112.422931			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23239878	Green Published, hybrid			2022-12-25	WOS:000314397900045
J	Harpsoe, K; Hald, H; Timmermann, DB; Jensen, ML; Dyhring, T; Nielsen, EO; Peters, D; Balle, T; Gajhede, M; Kastrup, JS; Ahring, PK				Harpsoe, Kasper; Hald, Helle; Timmermann, Daniel B.; Jensen, Marianne L.; Dyhring, Tino; Nielsen, Elsebet O.; Peters, Dan; Balle, Thomas; Gajhede, Michael; Kastrup, Jette S.; Ahring, Philip K.			Molecular Determinants of Subtype-selective Efficacies of Cytisine and the Novel Compound NS3861 at Heteromeric Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOKING-CESSATION DRUGS; LIGAND-BINDING DOMAIN; 4 BETA 2; ALLOSTERIC MODULATOR; HYDROGEN-BOND; ALPHA-4-BETA-2; SENSITIVITY; ALPHA; RAT; AGONISTS	Deciphering which specific agonist-receptor interactions affect efficacy levels is of high importance, because this will ultimately aid in designing selective drugs. The novel compound NS3861 and cytisine are agonists of nicotinic acetylcholine receptors (nAChRs) and both bind with high affinity to heteromeric alpha 3 beta 4 and alpha 4 beta 2 nAChRs. However, initial data revealed that the activation patterns of the two compounds show very distinct maximal efficacy readouts at various heteromeric nAChRs. To investigate the molecular determinants behind these observations, we performed in-depth patch clamp electrophysiological measurements of efficacy levels at heteromeric combinations of alpha 3- and alpha 4-, with beta 2- and beta 4-subunits, and various chimeric constructs thereof. Compared with cytisine, which selectively activates receptors containing beta 4- but not beta 2-subunits, NS3861 displays the opposite beta-subunit preference and a complete lack of activation at alpha 4-containing receptors. The maximal efficacy of NS3861 appeared solely dependent on the nature of the ligand-binding domain, whereas efficacy of cytisine was additionally affected by the nature of the beta-subunit transmembrane domain. Molecular docking to nAChR subtype homology models suggests agonist specific interactions to two different residues on the complementary subunits as responsible for the beta-subunit preference of both compounds. Furthermore, a principal subunit serine to threonine substitution may explain the lack of NS3861 activation at alpha 4-containing receptors. In conclusion, our results are consistent with a hypothesis where agonist interactions with the principal subunit (alpha) primarily determine binding affinity, whereas interactions with key amino acids at the complementary subunit (beta) affect agonist efficacy.	[Harpsoe, Kasper; Hald, Helle; Gajhede, Michael; Kastrup, Jette S.] Univ Copenhagen, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark; [Hald, Helle; Timmermann, Daniel B.; Jensen, Marianne L.; Dyhring, Tino; Nielsen, Elsebet O.; Peters, Dan; Ahring, Philip K.] Aniona ApS, DK-2750 Ballerup, Denmark; [Balle, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Copenhagen; University of Sydney	Ahring, PK (corresponding author), Aniona ApS, 93 Pederstrupvej, DK-2750 Ballerup, Denmark.	pka@aniona.com	Harpsøe, Kasper/V-6870-2018; Hald, Helle/J-3561-2013	Harpsøe, Kasper/0000-0002-9326-9644; Dyhring, Tino/0000-0002-9607-0577; Balle, Thomas/0000-0002-0233-8350; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287	Drug Research Academy, Faculty of Pharmaceutical Sciences, University of Copenhagen; Danish Ministry of Science, Innovation and Higher Education; Carlsberg Foundation; Lundbeck Foundation	Drug Research Academy, Faculty of Pharmaceutical Sciences, University of Copenhagen; Danish Ministry of Science, Innovation and Higher Education; Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Drug Research Academy, Faculty of Pharmaceutical Sciences, University of Copenhagen (to K. H.), the Danish Ministry of Science, Innovation and Higher Education (to H. H.), the Carlsberg Foundation (to T. B. and K. H.), and the Lundbeck Foundation (to T. B.).	[Anonymous], 2011, SCHROD SUIT 2011 PRO; [Anonymous], 2011, MACROMODEL VERS 9 9; [Anonymous], 2011, PYMOL MOL GRAPH SYST; [Anonymous], 2011, MAESTR VERS 9 2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Blum AP, 2010, P NATL ACAD SCI USA, V107, P13206, DOI 10.1073/pnas.1007140107; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buisson B, 1996, J NEUROSCI, V16, P7880; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chavez-Noriega LE, 2000, NEUROPHARMACOLOGY, V39, P2543, DOI 10.1016/S0028-3908(00)00134-9; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Harvey SC, 1996, J NEUROCHEM, V67, P1953; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; HOUGHTLING RA, 1995, MOL PHARMACOL, V48, P280; Houlihan LM, 2001, J NEUROCHEM, V78, P1029, DOI 10.1046/j.1471-4159.2001.00481.x; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuryatov A, 2000, EUR J PHARMACOL, V393, P11, DOI 10.1016/S0014-2999(00)00027-3; Lewis TM, 1997, J PHYSIOL-LONDON, V505, P299, DOI 10.1111/j.1469-7793.1997.299bb.x; LUETJE CW, 1991, J NEUROSCI, V11, P837; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mirza NR, 2008, J PHARMACOL EXP THER, V327, P954, DOI 10.1124/jpet.108.138859; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parker MJ, 1998, MOL PHARMACOL, V54, P1132, DOI 10.1124/mol.54.6.1132; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Pohlsgaard J, 2011, NEUROPHARMACOLOGY, V60, P135, DOI 10.1016/j.neuropharm.2010.08.004; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; Quik M, 1996, J NEUROCHEM, V67, P145; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Rucktooa P, 2012, J BIOL CHEM, V287, P23283, DOI 10.1074/jbc.M112.360347; Schrodinger LLC, 2011, SCHROD SUIT 2011 IND; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; SINE SM, 1984, BIOPHYS J, V46, P277, DOI 10.1016/S0006-3495(84)84022-9; SLILATY SN, 1990, ANAL BIOCHEM, V185, P194, DOI 10.1016/0003-2697(90)90279-I; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436	46	23	24	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2559	2570		10.1074/jbc.M112.436337	http://dx.doi.org/10.1074/jbc.M112.436337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229547	hybrid, Green Published			2022-12-25	WOS:000314211500041
J	Lipinska, N; Zietkiewicz, S; Sobczak, A; Jurczyk, A; Potocki, W; Morawiec, E; Wawrzycka, A; Gumowski, K; Slusarz, M; Rodziewicz-Motowidlo, S; Chrusciel, E; Liberek, K				Lipinska, Natalia; Zietkiewicz, Szymon; Sobczak, Alicja; Jurczyk, Agnieszka; Potocki, Wojciech; Morawiec, Ewa; Wawrzycka, Aleksandra; Gumowski, Krzysztof; Slusarz, Magdalena; Rodziewicz-Motowidlo, Sylwia; Chrusciel, Elzbieta; Liberek, Krzysztof			Disruption of Ionic Interactions between the Nucleotide Binding Domain 1 (NBD1) and Middle (M) Domain in Hsp100 Disaggregase Unleashes Toxic Hyperactivity and Partial Independence from Hsp70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISAGGREGATION; CLPB CHAPERONE; DNAK CHAPERONE; SACCHAROMYCES-CEREVISIAE; GUANIDINE-HYDROCHLORIDE; ESCHERICHIA-COLI; CENTRAL PORE; COILED-COIL; YEAST; PRION	Hsp100 chaperones cooperate with the Hsp70 chaperone system to disaggregate and reactivate heat-denatured aggregated proteins to promote cell survival after heat stress. The homology models of Hsp100 disaggregases suggest the presence of a conserved network of ionic interactions between the first nucleotide binding domain (NBD1) and the coiled-coil middle subdomain, the signature domain of disaggregating chaperones. Mutations intended to disrupt the putative ionic interactions in yeast Hsp104 and bacterial ClpB disaggregases resulted in remarkable changes of their biochemical properties. These included an increase in ATPase activity, a significant increase in the rate of in vitro substrate renaturation, and partial independence from the Hsp70 chaperone in disaggregation. Paradoxically, the increased activities resulted in serious growth impediments in yeast and bacterial cells instead of improvement of their thermotolerance. Our results suggest that this toxic activity is due to the ability of the mutated disaggregases to unfold independently from Hsp70, native folded proteins. Complementary changes that restore particular salt bridges within the suggested network suppressed the toxic effects. We propose a novel structural aspect of Hsp100 chaperones crucial for specificity and efficiency of the disaggregation reaction.	[Lipinska, Natalia; Zietkiewicz, Szymon; Sobczak, Alicja; Jurczyk, Agnieszka; Potocki, Wojciech; Morawiec, Ewa; Wawrzycka, Aleksandra; Gumowski, Krzysztof; Chrusciel, Elzbieta; Liberek, Krzysztof] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, PL-80822 Gdansk, Poland; [Slusarz, Magdalena; Rodziewicz-Motowidlo, Sylwia] Univ Gdansk, Fac Chem, PL-80852 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Zietkiewicz, S (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, Kladki 24, PL-80822 Gdansk, Poland.	szymon@biotech.ug.gda.pl; liberek@biotech.ug.gda.pl	Liberek, Krzysztof/F-5812-2011; Ziętkiewicz, Szymon/L-5259-2014; Potocki, Wojciech/AAG-8486-2019	Potocki, Wojciech/0000-0001-6476-4833; Slusarz, Magdalena J./0000-0002-9411-4679; Zietkiewicz, Szymon/0000-0002-3435-4603; Rodziewicz-Motowidlo, Sylwia/0000-0002-4471-5951; Liberek, Krzysztof/0000-0002-7532-9279; Chrusciel, Elzbieta/0000-0001-9621-2013; Klosowska, Agnieszka/0000-0001-5295-9473	Foundation for Polish Science [2009-3/5]; Ministry of Science and Higher Education [N N301 507338]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Foundation for Polish Science under the TEAM 2009-3/5 Programme (to N. L., S. Z., A. J., W. P., E. M., and A. W.).; Supported by Ministry of Science and Higher Education Grant N N301 507338.	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Case D, 2006, AMBER 9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Konieczny I, 1997, J BIOL CHEM, V272, P33312, DOI 10.1074/jbc.272.52.33312; Konieczny I, 2002, J BIOL CHEM, V277, P18483, DOI 10.1074/jbc.M107580200; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Norden C, 2004, MOL MICROBIOL, V53, P469, DOI 10.1111/j.1365-2958.2004.04148.x; Nowicki L, 2012, CELL STRESS CHAPERON, V17, P361, DOI 10.1007/s12192-011-0312-4; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; SHIFRINE M, 1954, J BACTERIOL, V68, P28, DOI 10.1128/JB.68.1.28-35.1954; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; WOO KM, 1992, J BIOL CHEM, V267, P20429; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; Zietkiewicz S, 2010, BIOPOLYMERS, V93, P47, DOI 10.1002/bip.21294; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x	51	47	47	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2857	2869		10.1074/jbc.M112.387589	http://dx.doi.org/10.1074/jbc.M112.387589			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233670	Green Published, hybrid			2022-12-25	WOS:000314211500068
J	Hosseinpour, B; HajiHoseini, V; Kashfi, R; Ebrahimie, E; Hemmatzadeh, F				Hosseinpour, Batool; HajiHoseini, Vahid; Kashfi, Rafieh; Ebrahimie, Esmaeil; Hemmatzadeh, Farhid			Protein Interaction Network of Arabidopsis thaliana Female Gametophyte Development Identifies Novel Proteins and Relations	PLOS ONE			English	Article							POLYCOMB GROUP GENE; ENDOSPERM DEVELOPMENT; JASMONIC ACID; CENTRAL CELL; EXPRESSION; AUXIN; DEFENSE; FAMILY; SPECIFICATION; MUTATIONS	Although the female gametophyte in angiosperms consists of just seven cells, it has a complex biological network. In this study, female gametophyte microarray data from Arabidopsis thaliana were integrated into the Arabidopsis interactome database to generate a putative interaction map of the female gametophyte development including proteome map based on biological processes and molecular functions of proteins. Biological and functional groups as well as topological characteristics of the network were investigated by analyzing phytohormones, plant defense, cell death, transporters, regulatory factors, and hydrolases. This approach led to the prediction of critical members and bottlenecks of the network. Seventy-four and 24 upregulated genes as well as 171 and 3 downregulated genes were identified in subtracted networks based on biological processes and molecular function respectively, including novel genes such as the pathogenesis-related protein 4, ER type Ca2+ ATPase 3, dihydroflavonol reductase, and ATP disulfate isomerase. Biologically important relationships between genes, critical nodes, and new essential proteins such as AT1G26830, AT5G20850, CYP74A, AT1G42396, PR4 and MEA were found in the interactome's network. The positions of novel genes, both upregulated and downregulated, and their relationships with biological pathways, in particular phytohormones, were highlighted in this study. Citation: Hosseinpour B, HajiHoseini V, Kashfi R, Ebrahimie E, Hemmatzadeh F (2012) Protein Interaction Network of Arabidopsis thaliana Female Gametophyte Development Identifies Novel Proteins and Relations. PLoS ONE 7(12): e49931. doi:10.1371/journal.pone.0049931	[Kashfi, Rafieh; Ebrahimie, Esmaeil] Shiraz Univ, Coll Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran; [Hosseinpour, Batool] Iranian Res Org Sci & Technol, Inst Agr, Tehran, Iran; [HajiHoseini, Vahid] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Hemmatzadeh, Farhid] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia	Shiraz University; University of Tehran; University of Adelaide; University of Adelaide	Ebrahimie, E (corresponding author), Shiraz Univ, Coll Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran.	esmaeil.ebrahimie@adelaide.edu.au; farhid.hemmatzadeh@adelaide.edu.au	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Hemmatzadeh, Farhid/0000-0002-4572-8869				Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chevalier E, 2011, NEW PHYTOL, V192, P13, DOI 10.1111/j.1469-8137.2011.03836.x; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Collinge MA, 2004, PLANT CELL, V16, P1035, DOI 10.1105/tpc.019059; FALK A, 1995, PLANT PHYSIOL, V108, P1369, DOI 10.1104/pp.108.4.1369; Feuerstein A, 2010, PLANT BIOLOGY, V12, P105, DOI 10.1111/j.1438-8677.2010.00389.x; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ge XC, 2010, CURR BIOL, V20, pR988, DOI 10.1016/j.cub.2010.09.040; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; He F, 2010, PLANT PHYSIOL, V153, P1492, DOI 10.1104/pp.110.153650; Houston NL, 2005, PLANT PHYSIOL, V137, P762, DOI 10.1104/pp.104.056507; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Idowu OC, 2004, BACILLUS SUBTILIS PR, V2004, P623; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Kagi C, 2010, P NATL ACAD SCI USA, V107, P22350, DOI 10.1073/pnas.1012795108; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; KIYOSUE T, 1994, PLANT J, V6, P259, DOI 10.1046/j.1365-313X.1994.6020259.x; Li L, 2001, PLANT PHYSIOL, V127, P1414, DOI 10.1104/pp.010705; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Martin MN, 2007, PLANT PHYSIOL, V144, P1715, DOI 10.1104/pp.106.094409; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Mitchell AG, 1997, J BIOL CHEM, V272, P28281, DOI 10.1074/jbc.272.45.28281; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Norman-Setterblad C, 2000, MOL PLANT MICROBE IN, V13, P430, DOI 10.1094/MPMI.2000.13.4.430; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2; Steffen JG, 2007, PLANT J, V51, P281, DOI 10.1111/j.1365-313X.2007.03137.x; Wang D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-110; Wen HC, 2003, CELL SIGNAL, V15, P37, DOI 10.1016/S0898-6568(02)00047-5; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yadegari R, 2000, PLANT CELL, V12, P2367, DOI 10.1105/tpc.12.12.2367; Yang WC, 2010, ANNU REV PLANT BIOL, V61, P89, DOI 10.1146/annurev-arplant-042809-112203; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HJ, 2005, PLANT PHYSIOL, V139, P1853, DOI 10.1104/pp.105.067314; Yu QB, 2008, CELL RES, V18, P1007, DOI 10.1038/cr.2008.286; ZHANG XS, 1993, PLANT CELL, V5, P403, DOI 10.1105/tpc.5.4.403	59	20	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49931	10.1371/journal.pone.0049931	http://dx.doi.org/10.1371/journal.pone.0049931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239973	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800011
J	Warchol, ME; Schwendener, RA; Hirose, K				Warchol, Mark E.; Schwendener, Reto A.; Hirose, Keiko			Depletion of Resident Macrophages Does Not Alter Sensory Regeneration in the Avian Cochlea	PLOS ONE			English	Article							LIPOSOME-MEDIATED DEPLETION; HAIR-CELLS; SUPPORTING CELLS; ORGAN-CULTURES; HYALINE CELLS; MECHANISM; DAMAGE; ATP	Macrophages are the primary effector cells of the innate immune system and are also activated in response to tissue injury. The avian cochlea contains a population of resident macrophages, but the precise function of those cells is not known. The present study characterized the behavior of cochlear macrophages after aminoglycoside ototoxicity and also examined the possible role of macrophages in sensory regeneration. We found that the undamaged chick cochlea contains a large resting population of macrophages that reside in the hyaline cell region, immediately outside the abneural (inferior) border of the sensory epithelium. Following ototoxic injury, macrophages appear to migrate out of the hyaline cell region and towards the basilar membrane, congregating immediately below the lesioned sensory epithelium. In order to determine whether recruited macrophages contribute to the regeneration of sensory receptors, we quantified supporting cell proliferation and hair cell recovery after the elimination of most resident macrophages via application of liposomally-encapsulated clodronate. Examination of macrophage-depleted specimens at two days following ototoxic injury revealed no deficits in hair cell clearance, when compared to normal controls. In addition, we found that elimination of macrophages did not affect either regenerative proliferation of supporting cells or the production of replacement hair cells. However, we did find that macrophage-depleted cochleae contained reduced numbers of proliferative mesothelial cells below the basilar membrane. Our data suggest that macrophages are not required for normal debris clearance and regeneration, but that they may play a role in the maintenance of the basilar membrane.	[Warchol, Mark E.; Hirose, Keiko] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Warchol, Mark E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Schwendener, Reto A.] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland	Washington University (WUSTL); Washington University (WUSTL); University of Zurich	Warchol, ME (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA.	warcholm@ent.wustl.edu	Schwendener, Reto A/F-6373-2011	Schwendener, Reto/0000-0002-8114-6321	 [R01DC006283];  [R01DC011315];  [P30DC004665]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006283, R01DC011315, P30DC004665] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by grants R01DC006283 (to MEW) and R01DC011315 (to KH). Additional support for imaging was provided by grant P30DC004665. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrashkin KA, 2006, HEARING RES, V218, P20, DOI 10.1016/j.heares.2006.04.001; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Bhave SA, 1998, J COMP NEUROL, V398, P241, DOI 10.1002/(SICI)1096-9861(19980824)398:2<241::AID-CNE6>3.0.CO;2-0; Bird JE, 2010, J NEUROSCI, V30, P12545, DOI 10.1523/JNEUROSCI.3042-10.2010; COTANCHE DA, 1987, HEARING RES, V30, P181, DOI 10.1016/0378-5955(87)90135-3; COTANCHE DA, 1992, J COMP NEUROL, V324, P353, DOI 10.1002/cne.903240306; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; GIROD DA, 1989, HEARING RES, V42, P175, DOI 10.1016/0378-5955(89)90143-3; Hirose K, 2005, J COMP NEUROL, V489, P180, DOI 10.1002/cne.20619; Hirose K, 2004, J COMP NEUROL, V470, P164, DOI 10.1002/cne.11046; Jones JE, 1996, J NEUROSCI, V16, P649; Lahne M, 2008, J NEUROSCI, V28, P4918, DOI 10.1523/JNEUROSCI.4914-07.2008; Lippe WR, 2002, J COMP PHYSIOL A, V188, P381, DOI 10.1007/s00359-002-0312-z; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Matsui JI, 2002, J NEUROSCI, V22, P1218, DOI 10.1523/JNEUROSCI.22-04-01218.2002; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; O'Halloran EK, 2004, J COMP NEUROL, V475, P340, DOI 10.1002/cne.20162; ROBERSON DW, 1994, AM J OTOL, V15, P28; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Sato E, 2010, JARO-J ASSOC RES OTO, V11, P223, DOI 10.1007/s10162-009-0198-3; Shang JL, 2010, JARO-J ASSOC RES OTO, V11, P203, DOI 10.1007/s10162-009-0206-7; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Slepecky N. B., 1996, COCHLEA, V8, P44; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Stone JS, 1996, J NEUROSCI, V16, P6157; Taylor RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030577; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Warchol ME, 1996, J NEUROSCI, V16, P5466; Warchol ME, 1997, J NEUROBIOL, V33, P724, DOI 10.1002/(SICI)1097-4695(19971120)33:6<724::AID-NEU2>3.0.CO;2-B; Warchol ME, 1999, J NEUROCYTOL, V28, P889, DOI 10.1023/A:1007026306730; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zidanic M, 2002, J COMP NEUROL, V445, P159, DOI 10.1002/cne.10160	36	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51574	10.1371/journal.pone.0051574	http://dx.doi.org/10.1371/journal.pone.0051574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240046	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800082
J	Burgel, PR; Paillasseur, JL; Peene, B; Dusser, D; Roche, N; Coolen, J; Troosters, T; Decramer, M; Janssens, W				Burgel, Pierre-Regis; Paillasseur, Jean-Louis; Peene, Bernard; Dusser, Daniel; Roche, Nicolas; Coolen, Johan; Troosters, Thierry; Decramer, Marc; Janssens, Wim			Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality	PLOS ONE			English	Article								Rationale: In COPD patients, mortality risk is influenced by age, severity of respiratory disease, and comorbidities. With an unbiased statistical approach we sought to identify clusters of COPD patients and to examine their mortality risk. Methods: Stable COPD subjects (n = 527) were classified using hierarchical cluster analysis of clinical, functional and imaging data. The relevance of this classification was validated using prospective follow-up of mortality. Results: The most relevant patient classification was that based on three clusters (phenotypes). Phenotype 1 included subjects at very low risk of mortality, who had mild respiratory disease and low rates of comorbidities. Phenotype 2 and 3 were at high risk of mortality. Phenotype 2 included younger subjects with severe airflow limitation, emphysema and hyperinflation, low body mass index, and low rates of cardiovascular comorbidities. Phenotype 3 included older subjects with less severe respiratory disease, but higher rates of obesity and cardiovascular comorbidities. Mortality was associated with the severity of airflow limitation in Phenotype 2 but not in Phenotype 3 subjects, and subjects in Phenotype 2 died at younger age. Conclusions: We identified three COPD phenotypes, including two phenotypes with high risk of mortality. Subjects within these phenotypes may require different therapeutic interventions to improve their outcome.	[Burgel, Pierre-Regis; Dusser, Daniel] Hop Cochin, AP HP, Serv Pneumol, F-75674 Paris, France; [Burgel, Pierre-Regis; Dusser, Daniel; Roche, Nicolas] Univ Paris 05, Paris, France; [Paillasseur, Jean-Louis] Clindatafirst, Clamart, France; [Peene, Bernard; Troosters, Thierry; Decramer, Marc; Janssens, Wim] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Div Resp, Louvain, Belgium; [Roche, Nicolas] Hop Hotel Dieu, AP HP, Serv Pneumol, F-75181 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Burgel, PR (corresponding author), Hop Cochin, AP HP, Serv Pneumol, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	pierre-regis.burgel@cch.aphp.fr	Roche, Nicolas/AAE-9206-2021; Roche, Nicolas/AAP-4445-2021	Burgel, Pierre Regis/0000-0003-0903-9828; roche, nicolas/0000-0002-3162-5033; Janssens, Wim/0000-0003-1830-2982	Association Cardif (Paris, France); Fonds de Recherche en Sante Respiratoire (Paris, France)	Association Cardif (Paris, France); Fonds de Recherche en Sante Respiratoire (Paris, France)	This study was funded by grants from Association Cardif (Paris, France) and Fonds de Recherche en Sante Respiratoire (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2011, EUR RESPIR J, V38, P749, DOI 10.1183/09031936.00062211; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Dolan S, 2005, CURR OPIN PULM MED, V11, P149, DOI 10.1097/01.mcp.0000153548.36054.8f; Fingleton J, 2011, THORAX, V66, P363, DOI 10.1136/thx.2010.155564; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Foreman MG, 2011, AM J RESP CRIT CARE, V184, P414, DOI 10.1164/rccm.201011-1928OC; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x; Weatherall M, 2010, EUR RESPIR J, V36, P472, DOI 10.1183/09031936.00035210; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408	20	93	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51048	10.1371/journal.pone.0051048	http://dx.doi.org/10.1371/journal.pone.0051048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236428	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100058
J	Daltrozzo, J; Claude, L; Tillmann, B; Bastuji, H; Perrin, F				Daltrozzo, Jerome; Claude, Lea; Tillmann, Barbara; Bastuji, Helene; Perrin, Fabien			Working Memory Is Partially Preserved during Sleep	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; WORD RECOGNITION; SPEECH; COMPONENT; COMPREHENSION; MECHANISMS; REPETITION; COGNITION; CHILDREN; NOISE	Although several cognitive processes, including speech processing, have been studied during sleep, working memory (WM) has never been explored up to now. Our study assessed the capacity of WM by testing speech perception when the level of background noise and the sentential semantic length (SSL) (amount of semantic information required to perceive the incongruence of a sentence) were modulated. Speech perception was explored with the N400 component of the event-related potentials recorded to sentence final words (50% semantically congruent with the sentence, 50% semantically incongruent). During sleep stage 2 and paradoxical sleep: (1) without noise, a larger N400 was observed for (short and long SSL) sentences ending with a semantically incongruent word compared to a congruent word (i.e. an N400 effect); (2) with moderate noise, the N400 effect (observed at wake with short and long SSL sentences) was attenuated for long SSL sentences. Our results suggest that WM for linguistic information is partially preserved during sleep with a smaller capacity compared to wake.	[Daltrozzo, Jerome; Claude, Lea; Tillmann, Barbara; Perrin, Fabien] Lyon Neurosci Res Ctr, CNRS, UMR5292, Auditory Cognit & Psychoacoust Team, Lyon, France; [Daltrozzo, Jerome; Claude, Lea; Tillmann, Barbara; Perrin, Fabien] Lyon Neurosci Res Ctr, INSERM, U1028, Auditory Cognit & Psychoacoust Team, Lyon, France; [Claude, Lea; Bastuji, Helene] Lyon Neurosci Res Ctr, CNRS, UMR5292, Cent Integrat Pain Human Team, Lyon, France; [Claude, Lea; Bastuji, Helene] Lyon Neurosci Res Ctr, Cent Integrat Pain Human Team, INSERM, U1028, Lyon, France; [Daltrozzo, Jerome; Claude, Lea; Tillmann, Barbara; Bastuji, Helene; Perrin, Fabien] Lyon Univ, Lyon, France; [Claude, Lea; Bastuji, Helene] Hosp Civils Lyon, Neurol Hosp, Sleep Unit, Bron, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Daltrozzo, J (corresponding author), Lyon Neurosci Res Ctr, CNRS, UMR5292, Auditory Cognit & Psychoacoust Team, Lyon, France.	jerome.daltrozzo@gmail.com		BASTUJI, Helene/0000-0002-6690-2707; , Fabien/0000-0002-1444-3414	French National Agency for Research [ANR-07-JCJC-0095 - CSD 8]; French National Agency for Research (ANR PICS)	French National Agency for Research(French National Research Agency (ANR)); French National Agency for Research (ANR PICS)(French National Research Agency (ANR))	The work was supported by the French National Agency for Research (grant ANR-07-JCJC-0095 - CSD 8 and ANR PICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute, 2004, S362004 ANSI; Baddeley A, 1998, CR ACAD SCI III-VIE, V321, P167, DOI 10.1016/S0764-4469(97)89817-4; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bastuji H, 2002, INT J PSYCHOPHYSIOL, V46, P243, DOI 10.1016/S0167-8760(02)00116-2; Bayles KA, 2003, J COMMUN DISORD, V36, P209, DOI 10.1016/S0021-9924(03)00020-0; BESSON M, 1993, J EXP PSYCHOL LEARN, V19, P1115, DOI 10.1037/0278-7393.19.5.1115; BRADY S, 1983, J EXP CHILD PSYCHOL, V35, P345, DOI 10.1016/0022-0965(83)90087-5; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Brualla J, 1998, EVOKED POTENTIAL, V108, P283, DOI 10.1016/S0168-5597(97)00102-0; Campbell K, 2010, NOISE HEALTH, V12, P137, DOI 10.4103/1463-1741.63216; CARSKADON MA, 2000, PRINCIPLES PRACTICE, P15; Choi S, 2008, J SPEECH LANG HEAR R, V51, P1042, DOI 10.1044/1092-4388(2008/076); Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; CONNOLLY JF, 1992, BRAIN LANG, V43, P1, DOI 10.1016/0093-934X(92)90018-A; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Daltrozzo J, 2012, BRAIN SCI, V2, P267, DOI 10.3390/brainsci2030267; DANEMAN M, 1991, J PSYCHOLINGUIST RES, V20, P445, DOI 10.1007/BF01067637; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; Grosjean F, 1996, LANG COGNITIVE PROC, V11, P597, DOI 10.1080/016909696386999; Haarmann HJ, 1997, BRAIN LANG, V59, P76, DOI 10.1006/brln.1997.1814; Ibanez A, 2006, BRAIN LANG, V98, P264, DOI 10.1016/j.bandl.2006.05.005; Iber C, 2007, AASM MANUAL SCORING; Kotchoubey B, 2006, NEUROSCI BIOBEHAV R, V30, P42, DOI 10.1016/j.neubiorev.2005.04.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LAVIE P, 1984, INT J NEUROSCI, V23, P111, DOI 10.3109/00207458408985352; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Maquet P, 2000, J SLEEP RES, V9, P207; Maquet P, 1997, J NEUROSCI, V17, P2807; Mattys SL, 2009, COGNITIVE PSYCHOL, V59, P203, DOI 10.1016/j.cogpsych.2009.04.001; Montgomery JW, 2003, J COMMUN DISORD, V36, P221, DOI 10.1016/S0021-9924(03)00021-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Olichney JM, 2000, BRAIN, V123, P1948, DOI 10.1093/brain/123.9.1948; Perrin F, 2002, NEUROREPORT, V13, P1345, DOI 10.1097/00001756-200207190-00026; Pisoni DB, 2003, EAR HEARING, V24, p106S, DOI 10.1097/01.AUD.0000051692.05140.8E; Qin MK, 2003, J ACOUST SOC AM, V114, P446, DOI 10.1121/1.1579009; Ronnberg J, 2007, AG SPEECH COMM 2 INT; Ronnberg J, 2010, NOISE HEALTH, V12, P263, DOI 10.4103/1463-1741.70505; Ronnberg J, 2008, INT J AUDIOL, V47, pS99, DOI 10.1080/14992020802301167; SALAME P, 1987, ERGONOMICS, V30, P1185, DOI 10.1080/00140138708966007; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Stickgold R, 1999, J COGNITIVE NEUROSCI, V11, P182, DOI 10.1162/089892999563319; Surprenant AM, 1999, INT J PSYCHOL, V34, P328, DOI 10.1080/002075999399648; Zhou S, 2004, BRAIN TOPOGR, V17, P27, DOI 10.1023/B:BRAT.0000047334.48256.9f	49	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50997	10.1371/journal.pone.0050997	http://dx.doi.org/10.1371/journal.pone.0050997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236418	gold, Green Submitted, Green Published			2022-12-25	WOS:000312064100050
J	Fujino, K; Horie, M; Honda, T; Nakamura, S; Matsumoto, Y; Francischetti, IMB; Tomonaga, K				Fujino, Kan; Horie, Masayuki; Honda, Tomoyuki; Nakamura, Shoko; Matsumoto, Yusuke; Francischetti, Ivo M. B.; Tomonaga, Keizo			Evolutionarily Conserved Interaction between the Phosphoproteins and X Proteins of Bornaviruses from Different Vertebrate Species	PLOS ONE			English	Article							BORNA-DISEASE VIRUS; PROVENTRICULAR DILATATION DISEASE; NUCLEAR-LOCALIZATION; AVIAN BORNAVIRUS; RNA; IMPORT; CANADA; DOMAIN; SIGNAL; GEESE	Bornavirus, a non-segmented, negative-strand RNA viruses, is currently classified into several genetically distinct genotypes, such as Borna disease virus (BDV) and avian bornaviruses (ABVs). Recent studies revealed that bornavirus genotypes show unique sequence variability in the putative 5' untranslated region (5' UTR) of X/P mRNA, a bicistronic mRNA for the X protein and phosphoprotein (P). In this study, to understand the evolutionary relationship among the bornavirus genotypes, we investigated the functional interaction between the X and P proteins of four bornavirus genotypes, BDV, ABV genotype 4 and 5 and reptile bornavirus (RBV), the putative 5' UTRs of which exhibit variation in the length. Immunofluorescence and immunoprecipitation analyses using mammalian and avian cell lines revealed that the X proteins of bornaviruses conserve the ability to facilitate the export of P from the nucleus to the cytoplasm via interaction with P. Furthermore, we showed that inter-genotypic interactions may occur between X and P among the genotypes, except for X of RBV. In addition, a BDV minireplicon assay demonstrated that the X and P proteins of ABVs, but not RBV, can affect the polymerase activity of BDV. This study demonstrates that bornaviruses may have conserved the fundamental function of a regulatory protein during their evolution, whereas RBV has evolved distinctly from the other bornavirus genotypes.	[Fujino, Kan; Horie, Masayuki; Honda, Tomoyuki; Nakamura, Shoko; Matsumoto, Yusuke; Tomonaga, Keizo] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 606, Japan; [Francischetti, Ivo M. B.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tomonaga, K (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 606, Japan.	tomonaga@virus.kyoto-u.ac.jp	Fujino, Kan/AAS-2464-2021	Horie, Masayuki/0000-0003-4682-7698; Matsumoto, Yusuke/0000-0003-3500-2279	Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Funding Program for Next Generation World-Leading Researchers (NEXT program) from Japan Society for the Promotion of Science (JSPS) (KT), Research Grants from Takeda Science Foundation (KT) and the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (IMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delnatte P, 2011, VET REC, V169, P108, DOI 10.1136/vr.d4620; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; GonzalezDunia D, 1997, BRAIN RES BULL, V44, P647, DOI 10.1016/S0361-9230(97)00276-1; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Horie M, 2012, MICROBIOL IMMUNOL, V56, P346, DOI 10.1111/j.1348-0421.2012.00436.x; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Jordan I, 2001, REV MED VIROL, V11, P37, DOI 10.1002/rmv.300; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kobayashi T, 2003, J VIROL, V77, P8099, DOI 10.1128/JVI.77.14.8099-8107.2003; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Malik TH, 2000, J VIROL, V74, P3413, DOI 10.1128/JVI.74.7.3413-3417.2000; Nakamura Y, 2000, J VIROL, V74, P4601, DOI 10.1128/JVI.74.10.4601-4611.2000; Payne S, 2011, J VIROL, V85, P12053, DOI 10.1128/JVI.05700-11; Pleschka S, 2001, J GEN VIROL, V82, P2681, DOI 10.1099/0022-1317-82-11-2681; Poenisch M, 2008, J GEN VIROL, V89, P1442, DOI 10.1099/vir.0.2008/000638-0; Poenisch M, 2009, J VIROL, V83, P4297, DOI 10.1128/JVI.02321-08; ROTT R, 1995, CURR TOP MICROBIOL, V190, P17; Rubbenstroth D, 2012, VET MICROBIOL; SCHNEIDER PA, 1994, J VIROL, V68, P63, DOI 10.1128/JVI.68.1.63-68.1994; Schneider U, 2003, J VIROL, V77, P11781, DOI 10.1128/JVI.77.21.11781-11789.2003; Schwemmle M, 1998, J BIOL CHEM, V273, P9007, DOI 10.1074/jbc.273.15.9007; Schwemmle M, 1999, J GEN VIROL, V80, P97, DOI 10.1099/0022-1317-80-1-97; Shoya Y, 1998, J VIROL, V72, P9755, DOI 10.1128/JVI.72.12.9755-9762.1998; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Watanabe Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000654; Weissenbock H, 2009, J VIROL, V83, P11367, DOI 10.1128/JVI.01343-09; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353; Wolff T, 2002, J BIOL CHEM, V277, P12151, DOI 10.1074/jbc.M109103200; Yanai H, 2006, J VIROL, V80, P1121, DOI 10.1128/JVI.80.3.1121-1129.2006; Yanai H, 2006, MICROBES INFECT, V8, P1522, DOI 10.1016/j.micinf.2006.01.010	30	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51161	10.1371/journal.pone.0051161	http://dx.doi.org/10.1371/journal.pone.0051161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236446	Green Submitted, gold, Green Published			2022-12-25	WOS:000312064100074
J	Li, W; Gao, KS; Beardall, J				Li, Wei; Gao, Kunshan; Beardall, John			Interactive Effects of Ocean Acidification and Nitrogen-Limitation on the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							CARBON CONCENTRATING MECHANISMS; ULTRAVIOLET-RADIATION; CO2 CONCENTRATION; MARINE; PHOTOSYNTHESIS; PHYTOPLANKTON; SEAWATER; GROWTH; IRON; SENSITIVITY	Climate change is expected to bring about alterations in the marine physical and chemical environment that will induce changes in the concentration of dissolved CO2 and in nutrient availability. These in turn are expected to affect the physiological performance of phytoplankton. In order to learn how phytoplankton respond to the predicted scenario of increased CO2 and decreased nitrogen in the surface mixed layer, we investigated the diatom Phaeodactylum tricornutum as a model organism. The cells were cultured in both low CO2 (390 mu atm) and high CO2 (1000 mu atm) conditions at limiting (10 mu mol L-1) or enriched (110 mu mol L-1) nitrate concentrations. Our study shows that nitrogen limitation resulted in significant decreases in cell size, pigmentation, growth rate and effective quantum yield of Phaeodactylum tricornutum, but these parameters were not affected by enhanced dissolved CO2 and lowered pH. However, increased CO2 concentration induced higher rETR(max) and higher dark respiration rates and decreased the CO2 or dissolved inorganic carbon (DIC) affinity for electron transfer (shown by higher values for K-1/2 DIC or K-1/2 CO2). Furthermore, the elemental stoichiometry (carbon to nitrogen ratio) was raised under high CO2 conditions in both nitrogen limited and nitrogen replete conditions, with the ratio in the high CO2 and low nitrate grown cells being higher by 45% compared to that in the low CO2 and nitrate replete grown ones. Our results suggest that while nitrogen limitation had a greater effect than ocean acidification, the combined effects of both factors could act synergistically to affect marine diatoms and related biogeochemical cycles in future oceans.	[Li, Wei; Gao, Kunshan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Beardall, John] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Xiamen University; Monash University	Gao, KS (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	ksgao@xmu.edu.cn	Beardall, John/L-5262-2019; gao, kunshan/G-3374-2010	Beardall, John/0000-0001-7684-446X; Gao, Kunshan/0000-0001-7365-6332	National Basic Research Program of China [2009CB421207, 2011CB200902]; National Natural Science Foundation [40930846, 41120164007]; Program for Changjiang Scholars and Innovative Research Team [IRT0941]; China-Japan collaboration project from MOST [S2012GR0290]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China-Japan collaboration project from MOST	This study was supported by National Basic Research Program of China (No. 2009CB421207 and 2011CB200902), National Natural Science Foundation (No. 40930846, No. 41120164007), Program for Changjiang Scholars and Innovative Research Team (IRT0941) and China-Japan collaboration project from MOST (S2012GR0290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Beardall J, 2001, AQUAT SCI, V63, P44, DOI 10.1007/PL00001344; BEARDALL J, 1982, J EXP BOT, V33, P729, DOI 10.1093/jxb/33.4.729; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Beman JM, 2011, P NATL ACAD SCI USA, V108, P208, DOI 10.1073/pnas.1011053108; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CARACO N, 1990, BIOGEOCHEMISTRY, V9, P277; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Doney SC, 2006, SCI AM, V294, P58, DOI 10.1038/scientificamerican0306-58; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DOUCETTE GJ, 1990, MAR ECOL PROG SER, V62, P293, DOI 10.3354/meps062293; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Gao Kun-shan, 2011, Xiamen Daxue Xuebao (Ziran Kexue Ban), V50, P411; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Gordillo FJL, 2003, PLANTA, V218, P315, DOI 10.1007/s00425-003-1087-3; HIPKIN CR, 1983, MAR BIOL, V77, P101, DOI 10.1007/BF00396306; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Kaffes A, 2010, J EXP MAR BIOL ECOL, V393, P1, DOI 10.1016/j.jembe.2010.06.004; LARSSON CM, 1985, J EXP BOT, V36, P1387, DOI 10.1093/jxb/36.9.1387; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Litchman E, 2002, LIMNOL OCEANOGR, V47, P86, DOI 10.4319/lo.2002.47.1.0086; Millero FJ, 2009, OCEANOGRAPHY, V22, P72, DOI 10.5670/oceanog.2009.98; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Portner H. O., 2010, GUIDE BEST PRACTICES, P167; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riegman R, 2000, J PHYCOL, V36, P87, DOI 10.1046/j.1529-8817.2000.99023.x; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Sobrino C, 2008, LIMNOL OCEANOGR, V53, P494, DOI 10.4319/lo.2008.53.2.0494; Strickland J.D.H., 1972, B FISH RES BOARD CAN, V157, P49, DOI DOI 10.1002/IROH.19700550118; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Watson R, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, pIX; Wichard T, 2007, CHEMBIOCHEM, V8, P1146, DOI 10.1002/cbic.200700053; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Young EB, 2005, CAN J BOT, V83, P917, DOI 10.1139/B05-081	52	67	71	2	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51590	10.1371/journal.pone.0051590	http://dx.doi.org/10.1371/journal.pone.0051590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236517	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100133
J	Maslanik, T; Tannura, K; Mahaffey, L; Loughridge, AB; Benninson, L; Ursell, L; Greenwood, BN; Knight, R; Fleshner, M				Maslanik, Thomas; Tannura, Kate; Mahaffey, Lucas; Loughridge, Alice Brianne; Benninson, Lida; Ursell, Luke; Greenwood, Benjamin N.; Knight, Rob; Fleshner, Monika			Commensal Bacteria and MAMPs Are Necessary for Stress-Induced Increases in IL-1 beta and IL-18 but Not IL-6, IL-10 or MCP-1	PLOS ONE			English	Article							NLRP3 INFLAMMASOME ACTIVATION; EXTRACELLULAR HSP72; INTESTINAL SENSITIZATION; ENDOTOXIN INHIBITOR; IMMUNE-RESPONSES; INNATE IMMUNITY; T-CELL; EXPOSURE; COLONIZATION; BRAIN	Regular interactions between commensal bacteria and the enteric mucosal immune environment are necessary for normal immunity. Alterations of the commensal bacterial communities or mucosal barrier can disrupt immune function. Chronic stress interferes with bacterial community structure (specifically, alpha-diversity) and the integrity of the intestinal barrier. These interferences can contribute to chronic stress-induced increases in systemic IL-6 and TNF-alpha. Chronic stress, however, produces many physiological changes that could indirectly influence immune activity. In addition to IL-6 and TNF-alpha, exposure to acute stressors upregulates a plethora of inflammatory proteins, each having unique synthesis and release mechanisms. We therefore tested the hypothesis that acute stress-induced inflammatory protein responses are dependent on the commensal bacteria, and more specifically, lipopolysaccharide (LPS) shed from Gram-negative intestinal commensal bacteria. We present evidence that both reducing commensal bacteria using antibiotics and neutralizing LPS using endotoxin inhibitor (EI) attenuates increases in some (inflammasome dependent, IL-1 and IL-18), but not all (inflammasome independent, IL-6, IL-10, and MCP-1) inflammatory proteins in the blood of male F344 rats exposed to an acute tail shock stressor. Acute stress did not impact alpha- or beta-diversity measured using 16S rRNA diversity analyses, but selectively reduced the relative abundance of Prevotella. These findings indicate that commensal bacteria contribute to acute stress-induced inflammatory protein responses, and support the presence of LPS-mediated signaling in stress-evoked cytokine and chemokine production. The selectivity of the commensal bacteria in stress-evoked IL-1 beta and IL-18 responses may implicate the inflammasome in this response.	[Maslanik, Thomas; Tannura, Kate; Mahaffey, Lucas; Loughridge, Alice Brianne; Benninson, Lida; Greenwood, Benjamin N.; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Maslanik, Thomas; Tannura, Kate; Mahaffey, Lucas; Loughridge, Alice Brianne; Benninson, Lida; Greenwood, Benjamin N.; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Ursell, Luke; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Ursell, Luke; Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Fleshner, M (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	fleshner@colorado.edu	Knight, Rob/D-1299-2010	Knight, Rob/0000-0002-0975-9019; Fleshner, Monika/0000-0002-0470-0827	National Science Foundation [IOS 1022451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The studies published in this manuscript were funded by the National Science Foundation, grant number IOS 1022451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RG, 2012, BRAIN BEHAV IMMUN, V26, P371, DOI 10.1016/j.bbi.2011.11.002; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bailey MT, 2009, PHYSIOL BEHAV, V98, P351, DOI 10.1016/j.physbeh.2009.06.013; Bailey MT, 2006, J NEUROIMMUNOL, V171, P29, DOI 10.1016/j.jneuroim.2005.09.008; Bailey MT, 2004, J PEDIATR GASTR NUTR, V38, P414, DOI 10.1097/00005176-200404000-00009; Bailey MT, 1999, DEV PSYCHOBIOL, V35, P146, DOI 10.1002/(SICI)1098-2302(199909)35:2<146::AID-DEV7>3.0.CO;2-G; Barker LA, 2005, BRIT J PHARMACOL, V145, P872, DOI 10.1038/sj.bjp.0706257; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Brown AP, 2000, CONTEMP TOP LAB ANIM, V39, P17; Campisi J, 2003, J APPL PHYSIOL, V94, P43, DOI 10.1152/japplphysiol.00681.2002; Campisi J, 2003, CELL STRESS CHAPERON, V8, P272, DOI 10.1379/1466-1268(2003)008<0272:SEHIAF>2.0.CO;2; Campisi J, 2003, AM J PHYSIOL-REG I, V284, pR520, DOI 10.1152/ajpregu.00513.2002; Campisi J, 2002, PHYSIOL BEHAV, V77, P291, DOI 10.1016/S0031-9384(02)00861-2; Campisi J, 2012, STRESS; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caso JR, 2009, AM J PHYSIOL-REG I, V296, pR979, DOI 10.1152/ajpregu.90825.2008; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhabhar FS, 2000, ANN NY ACAD SCI, V917, P876, DOI 10.1111/j.1749-6632.2000.tb05454.x; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Febbraio MA, 2002, J PHYSIOL-LONDON, V544, P957, DOI 10.1113/jphysiol.2002.025148; Fleshner M, 2004, PSYCHONEUROENDOCRINO, V29, P1142, DOI 10.1016/j.psyneuen.2004.01.007; Fleshner M, 1996, AM J PHYSIOL-REG I, V271, pR1344, DOI 10.1152/ajpregu.1996.271.5.R1344; FLESHNER M, 1995, BRAIN BEHAV IMMUN, V9, P101, DOI 10.1006/brbi.1995.1011; Fleshner M, 2005, INT J HYPERTHER, V21, P457, DOI 10.1080/02656730500088211; FLESHNER M, 2007, HEAT SHOCK PROTEINS, P235; Fleshner M, 2010, HEAT SHOCK PROTEINS, V5, P193, DOI 10.1007/978-90-481-3381-9_12; Frink M, 2007, AM J PHYSIOL-REG I, V292, pR1110, DOI 10.1152/ajpregu.00650.2006; Gazda LS, 2003, STRESS, V6, P259, DOI 10.1080/10253890310001594441; Girotti M, 2011, PSYCHONEUROENDOCRINO, V36, P1164, DOI 10.1016/j.psyneuen.2011.02.008; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; Grisanti LA, 2011, J PHARMACOL EXP THER, V338, P648, DOI 10.1124/jpet.110.178012; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Gueguinou N, 2011, PSYCHONEUROENDOCRINO; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; HOCHACHKA PW, 1995, COMP BIOCHEM PHYS B, V112, P361, DOI 10.1016/0305-0491(96)85239-4; Hoggatt AF, 2010, J AM ASSOC LAB ANIM, V49, P329; Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090; Johnson JD, 2008, BRAIN BEHAV IMMUN, V22, P1078, DOI 10.1016/j.bbi.2008.03.007; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Katafuchi T, 2003, MOL BRAIN RES, V118, P24, DOI 10.1016/S0169-328X(03)00331-0; Keita AV, 2010, NEUROGASTROENT MOTIL, V22, P718, DOI 10.1111/j.1365-2982.2010.01498.x; Knowles SR, 2008, BIOL PSYCHOL, V77, P132, DOI 10.1016/j.biopsycho.2007.09.010; Kranich J, 2011, SEMIN IMMUNOL, V23, P139, DOI 10.1016/j.smim.2011.01.011; Kuhn R, 2005, WORLD J SURG, V29, P766, DOI 10.1007/s00268-005-7409-9; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Kuwahira I, 1999, J APPL PHYSIOL, V86, P181, DOI 10.1152/jappl.1999.86.1.181; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Liu T, 2006, IMMUNOL CELL BIOL, V84, P430, DOI 10.1111/j.1440-1711.2006.01452.x; Lundgren O, 2000, GUT, V47, P33; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Mah KW, 2006, INT ARCH ALLERGY IMM, V140, P157, DOI 10.1159/000092555; MAIER SF, 1994, AM PSYCHOL, V49, P1004, DOI 10.1037/0003-066X.49.12.1004; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; Maslanik T, 2012, BRAIN BEHAV IN PRESS; Maslanik T, 2012, BRAIN BEHAV IMMUN, V26, P142, DOI 10.1016/j.bbi.2011.08.006; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Moraska A, 2002, J APPL PHYSIOL, V93, P207, DOI 10.1152/japplphysiol.01151.2001; MYCHAJLONKA M, 1980, ANTIMICROB AGENTS CH, V17, P572, DOI 10.1128/AAC.17.4.572; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Nickerson M, 2006, J APPL PHYSIOL, V101, P566, DOI 10.1152/japplphysiol.00259.2006; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Ricart-Jane D, 2002, METABOLISM, V51, P925, DOI 10.1053/meta.2002.33353; Sambol JT, 2001, SURG RES, P599; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Walsh RC, 2001, CELL STRESS CHAPERON, V6, P386, DOI 10.1379/1466-1268(2001)006<0386:EISHIH>2.0.CO;2; Yang PC, 2006, AM J PATHOL, V168, P104, DOI 10.2353/ajpath.2006.050575; Yatsunenko T, 2012, NATURE; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006	88	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50636	10.1371/journal.pone.0050636	http://dx.doi.org/10.1371/journal.pone.0050636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236381	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100023
J	Peers, MJL; Thornton, DH; Murray, DL				Peers, Michael J. L.; Thornton, Daniel H.; Murray, Dennis L.			Reconsidering the Specialist-Generalist Paradigm in Niche Breadth Dynamics: Resource Gradient Selection by Canada Lynx and Bobcat	PLOS ONE			English	Article							SPECIES DISTRIBUTION; PHENOTYPIC PLASTICITY; PERFORMANCE; EVOLUTION; COYOTES; JACK; DISTRIBUTIONS; SPECIFICITY; POPULATION; ABUNDANCE	The long-standing view in ecology is that disparity in overall resource selection is the basis for identifying niche breadth patterns, with species having narrow selection being classified "specialists" and those with broader selection being "generalists". The standard model of niche breadth characterizes generalists and specialists as having comparable levels of overall total resource exploitation, with specialists exploiting resources at a higher level of performance over a narrower range of conditions. This view has gone largely unchallenged. An alternate model predicts total resource use being lower for the specialized species with both peaking at a comparable level of performance over a particular resource gradient. To reconcile the niche breadth paradigm we contrasted both models by developing range-wide species distribution models for Canada lynx, Lynx canadensis, and bobcat, Lynx rufus. Using a suite of environmental factors to define each species' niche, we determined that Canada lynx demonstrated higher total performance over a restricted set of variables, specifically those related to snow and altitude, while bobcat had higher total performance across most variables. Unlike predictions generated by the standard model, bobcat level of exploitation was not compromised by the trade-off with peak performance, and Canada lynx were not restricted to exploiting a narrower range of conditions. Instead, the emergent pattern was that specialist species have a higher total resource utilization and peak performance value within a smaller number of resources or environmental axes than generalists. Our results also indicate that relative differences in niche breadth are strongly dependent on the variable under consideration, implying that the appropriate model describing niche breadth dynamics between specialists and generalists may be more complex than either the traditional heuristic or our modified version. Our results demonstrate a need to re-evaluate traditional, but largely untested, assumptions regarding resource utilization in species with broad and narrow niches.	[Peers, Michael J. L.; Thornton, Daniel H.; Murray, Dennis L.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Thornton, Daniel H.] Panthera, New York, NY USA	Trent University	Peers, MJL (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	michaelpeers@trentu.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	NSERC Discovery Grant www.nserc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2009, J EVOLUTION BIOL, V22, P907, DOI 10.1111/j.1420-9101.2009.01694.x; Anderson EM, 2003, WILD MAMMALS N AM BI, P758; Bailey TN, 1979, P BOBC RES C NAT WIL, V6, P62; Barkae ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033506; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Dennis RLH, 2011, BIOL J LINN SOC, V104, P725, DOI 10.1111/j.1095-8312.2011.01789.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; DIBELLO FJ, 1990, CAN FIELD NAT, V104, P403; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Garcia-Robledo C, 2012, J EVOLUTION BIOL, V25, P38, DOI 10.1111/j.1420-9101.2011.02401.x; GILCHRIST GW, 1995, AM NAT, V146, P252, DOI 10.1086/285797; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof AR, 2012, DIVERS DISTRIB, V18, P554, DOI 10.1111/j.1472-4642.2011.00876.x; HUEY RB, 1984, EVOLUTION, V38, P441, DOI 10.1111/j.1558-5646.1984.tb00302.x; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; KOEHLER GM, 1990, CAN J ZOOL, V68, P845, DOI 10.1139/z90-122; Kou XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023115; Krasnov BR, 2006, PARASITOLOGY, V133, P81, DOI 10.1017/S0031182006000059; Levins R., 1968, EVOLUTION CHANGING E; LITVAITIS JA, 1986, J MAMMAL, V67, P389, DOI 10.2307/1380893; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Lutolf M, 2006, J APPL ECOL, V43, P802, DOI 10.1111/j.1365-2664.2006.01191.x; MacArthur R.H., 1972, pvii; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; McCord C.M., 1982, P728; McKelvey Kevin S., 2000, P207; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; McNaughton SJ, 1979, GEN ECOLOGY; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; MURRAY DL, 1991, OECOLOGIA, V88, P463, DOI 10.1007/BF00317707; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; Oliver TH, 2012, J APPL ECOL, V49, P581, DOI 10.1111/j.1365-2664.2012.02138.x; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; PARKER GR, 1983, CAN J ZOOL, V61, P770, DOI 10.1139/z83-102; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Russell AJM, 2004, EUR J WILDLIFE RES, V50, P53, DOI 10.1007/s10344-004-0037-0; Simkova A, 2006, EVOLUTION, V60, P1023, DOI 10.1111/j.0014-3820.2006.tb01180.x; Stiling P.D, 1999, ECOLOGY THEORIES APP; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WERDELIN L, 1981, ANN ZOOL FENN, V18, P37; WITMER GW, 1986, CAN J ZOOL, V64, P2333, DOI 10.1139/z86-347	57	59	60	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51488	10.1371/journal.pone.0051488	http://dx.doi.org/10.1371/journal.pone.0051488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236508	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100124
J	Schlender, A; Alperin, PE; Grossman, HL; Sutherland, ER				Schlender, Amory; Alperin, Peter E.; Grossman, Helene L.; Sutherland, E. Rand			Modeling the Impact of Increased Adherence to Asthma Therapy	PLOS ONE			English	Article							PERSISTENT ASTHMA; EXACERBATIONS; OUTCOMES; FAILURE; TRIALS	Background: Nonadherence to medications occurs in up to 70% of patients with asthma. The effect of improving adherence is not well quantified. We developed a mathematical model with which to assess the population-level effects of improving medication prescribing and adherence for asthma. Methods: A mathematical model, calibrated to clinical trial data from the U. S. NHLBI-funded SOCS trial and validated using data from the NHLBI SLIC trial, was used to model the effects of increased prescribing and adherence to asthma controllers. The simulated population consisted of 4,930 individuals with asthma, derived from a sample the National Asthma Survey. Main outcomes were controller use, reliever use, unscheduled doctor visits, emergency department (ED) visits, and hospitalizations. Results: For the calibration, simulated outcomes agreed closely with SOCS trial outcomes, with treatment failure hazard ratios [95% confidence interval] of 0.92 [0.58-1.26], 0.97 [0.49-1.45], and 1.01 [0-1.87] for simulation vs. trial in the in placebo, salmeterol, and triamcinolone arms, respectively. For validation, simulated outcomes predicted mid-and end-point treatment failure rates, hazard ratios 1.21 [0.08-2.34] and 0.83 [0.60-1.07], respectively, for patients treated with salmeterol/triamcinolone during the first half of the SLIC study and salmeterol monotherapy during the second half. The model performed less well for patients treated with salmeterol/triamcinolone during the entire study duration, with mid-and end-point hazard ratios 0.83 [0.00-2.12] and 0.37 [0.10-0.65], respectively. Simulation of optimal adherence and prescribing indicated that closing adherence and prescription gaps could prevent as many as nine million unscheduled doctor visits, four million emergency department visits, and one million asthma-related hospitalizations each year in the U. S. Conclusions: Improvements in medication adherence and prescribing could have a substantial impact on asthma morbidity and healthcare utilization.	[Sutherland, E. Rand] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Sutherland, E. Rand] Univ Colorado, Dept Med, Denver, CO USA; [Schlender, Amory; Alperin, Peter E.; Grossman, Helene L.] Archimedes Inc, San Francisco, CA USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Sutherland, ER (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	sutherlande@njhealth.org			Archimedes Incorporated	Archimedes Incorporated	This study was funded by Archimedes Incorporated (http://archimedesmodel.com/). Three authors (AS, PEA, HLG) are employees of the funder and were jointly involved in the study design and analysis. The decision to publish and preparation of the manuscript were participated in equally by all authors. Data utilized in this study were obtained from publicly-available datasets and were not collected by the funder.	[Anonymous], 2003, NAT ASTHM SURV 2003; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Gamble J, 2009, AM J RESP CRIT CARE, V180, P817, DOI 10.1164/rccm.200902-0166OC; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Hall Margaret Jean, 2010, Natl Health Stat Report, P1; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; MARTIN TG, 1982, ANN EMERG MED, V11, P466, DOI 10.1016/S0196-0644(82)80063-2; Milgrom H, 1996, J ALLERGY CLIN IMMUN, V98, P1051, DOI 10.1016/S0091-6749(96)80190-4; National Center for Health Statistics, NAT HOSP DISCH SURV; Price D, 2011, NEW ENGL J MED, V364, P1695, DOI 10.1056/NEJMoa1010846; Schappert Susan M, 2011, Vital Health Stat 13, P1; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Tattersfield AE, 1999, AM J RESP CRIT CARE, V160, P594, DOI 10.1164/ajrccm.160.2.9811100; Ward BW, 2010, VITAL HLTH STAT, V10, P1; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; Williams LK, 2011, J ALLERGY CLIN IMMUN, V128, P1185, DOI 10.1016/j.jaci.2011.09.011; Wilson SR, 2010, AM J RESP CRIT CARE, V181, P566, DOI 10.1164/rccm.200906-0907OC	20	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51139	10.1371/journal.pone.0051139	http://dx.doi.org/10.1371/journal.pone.0051139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236442	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100070
J	Buckberry, S; Bianco-Miotto, T; Hiendleder, S; Roberts, CT				Buckberry, Sam; Bianco-Miotto, Tina; Hiendleder, Stefan; Roberts, Claire T.			Quantitative Allele-Specific Expression and DNA Methylation Analysis of H19, IGF2 and IGF2R in the Human Placenta across Gestation Reveals H19 Imprinting Plasticity	PLOS ONE			English	Article							DIFFUSIONAL EXCHANGE CHARACTERISTICS; NONCODING RNA; EPIGENETIC ASYMMETRY; GENETIC CONFLICTS; ANTISENSE RNA; CTCF-BINDING; GROWTH; RECEPTOR; MOUSE; LINEAGE	Imprinted genes play important roles in placental differentiation, growth and function, with profound effects on fetal development. In humans, H19 and IGF2 are imprinted, but imprinting of IGF2R remains controversial. The H19 non-coding RNA is a negative regulator of placental growth and altered placental imprinting of H19-IGF2 has been associated with pregnancy complications such as preeclampsia, which have been attributed to abnormal first trimester placentation. This suggests that changes in imprinting during the first trimester may precede aberrant placental morphogenesis. To better understand imprinting in the human placenta during early gestation, we quantified allele-specific expression for H19, IGF2 and IGF2R in first trimester (6-12 weeks gestation) and term placentae (37-42 weeks gestation) using pyrosequencing. Expression of IGF2R was biallelic, with a mean expression ratio of 49:51 (SD = 0.07), making transient imprinting unlikely. Expression from the repressed H19 alleles ranged from 1-25% and was higher (P<0.001) in first trimester (13.5 +/- 8.2%) compared to term (3.4 +/- 2.1%) placentae. Surprisingly, despite the known co-regulation of H19 and IGF2, little variation in expression of the repressed IGF2 alleles was observed (2.7 +/- 2.0%). To identify regulatory regions that may be responsible for variation in H19 allelic expression, we quantified DNA methylation in the H19-IGF2 imprinting control region and H19 transcription start site (TSS). Unexpectedly, we found positive correlations (P<0.01) between DNA methylation levels and expression of the repressed H19 allele at 5 CpG's 2000 bp upstream of the H19 TSS. Additionally, DNA methylation was significantly higher (P<0.05) in first trimester compared with term placentae at 5 CpG's 39-523 bp upstream of the TSS, but was not correlated with H19 repressed allele expression. Our data suggest that variation in H19 imprinting may contribute to early programming of placental phenotype and illustrate the need for quantitative and robust methodologies to further elucidate the role of imprinted genes in normal and pathological placental development.	[Buckberry, Sam; Bianco-Miotto, Tina; Hiendleder, Stefan; Roberts, Claire T.] Univ Adelaide, Robinson Inst, Res Ctr Reprod Hlth, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Bianco-Miotto, Tina] Univ Adelaide, Robinson Inst, Res Ctr Early Origins Hlth & Dis, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Hiendleder, Stefan] Univ Adelaide, JS Davies Epigenet & Genet Grp, Sch Anim & Vet Sci, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide	Roberts, CT (corresponding author), Univ Adelaide, Robinson Inst, Res Ctr Reprod Hlth, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia.	claire.roberts@adelaide.edu.au	Bianco-Miotto, Tina/C-4808-2008; Buckberry, Sam/H-5774-2019	Bianco-Miotto, Tina/0000-0002-8431-5338; Buckberry, Sam/0000-0003-2388-6046; Roberts, Claire/0000-0002-9250-2192	Australian Postgraduate Award; Healthy Development Adelaide and Channel 7 Children's Research Foundation PhD scholarship; W. Bruce Hall Cancer Council of South Australia Fellowship; National Health and Medical Research Council (NHMRC) [APP1020749, 565320]	Australian Postgraduate Award(Australian Government); Healthy Development Adelaide and Channel 7 Children's Research Foundation PhD scholarship; W. Bruce Hall Cancer Council of South Australia Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	SB is supported by Australian Postgraduate Award and a Healthy Development Adelaide and Channel 7 Children's Research Foundation PhD scholarship. TBM is supported by a W. Bruce Hall Cancer Council of South Australia Fellowship. SH is a JS Davies Fellow. CTR is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship APP1020749. The research described herein was funded by NHMRC Research Project #565320 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam GIR, 1996, DEVELOPMENT, V122, P839; Andraweera PH, 2012, REPROD SCI, V19, P547, DOI 10.1177/1933719111428520; Arney KL, 2003, TRENDS GENET, V19, P17, DOI 10.1016/S0168-9525(02)00004-5; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Coan PM, 2008, J PHYSIOL-LONDON, V586, P5023, DOI 10.1113/jphysiol.2008.157313; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Diplas AI, 2009, NUCLEIC ACIDS RES, V37, P7039, DOI 10.1093/nar/gkp749; Ergaz Z, 2005, REPROD TOXICOL, V20, P301, DOI 10.1016/j.reprotox.2005.04.007; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gao WL, 2011, HYPERTENS RES, V34, P655, DOI 10.1038/hr.2011.9; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haig D, 1996, AM J REPROD IMMUNOL, V35, P226; Harris LK, 2011, BIOL REPROD, V84, P440, DOI 10.1095/biolreprod.110.088195; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Hirasawa R, 2010, ESSAYS BIOCHEM, V48, P187, DOI [10.1042/bse0480187, 10.1042/BSE0480187]; Hu JF, 1999, BIOCHEM BIOPH RES CO, V257, P604, DOI 10.1006/bbrc.1999.0380; JINNO Y, 1995, NAT GENET, V10, P318, DOI 10.1038/ng0795-318; Kaffer CR, 2000, GENE DEV, V14, P1908; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lambertini L, 2008, EPIGENETICS-US, V3, P261, DOI 10.4161/epi.3.5.6755; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohammad F, 2012, DEVELOPMENT, V139, P2792, DOI 10.1242/dev.079566; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Monk D, 2008, GENOME RES, V18, P1270, DOI 10.1101/gr.077115.108; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; OGAWA O, 1993, HUM MOL GENET, V2, P2163, DOI 10.1093/hmg/2.12.2163; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Oudejans CBM, 2001, GENOMICS, V73, P331, DOI 10.1006/geno.2001.6522; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pozharny Y, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.039; Qiu XW, 2008, MOL ENDOCRINOL, V22, P1476, DOI 10.1210/me.2007-0474; Reik W, 2003, PHILOS T R SOC B, V358, P1403, DOI 10.1098/rstb.2003.1326; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Roberts CT, 2010, PLACENTA, V31, pS47, DOI 10.1016/j.placenta.2010.01.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Steck E, 2012, J MOL MED, V90, P1185, DOI 10.1007/s00109-012-0895-y; Tabano S, 2010, EPIGENETICS-US, V5, P313, DOI 10.4161/epi.5.4.11637; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Thorvaldsen JL, 2000, SCIENCE, V288, P2145, DOI 10.1126/science.288.5474.2145; Wang Y, 2010, J GENET, V89, P213; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011	59	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51210	10.1371/journal.pone.0051210	http://dx.doi.org/10.1371/journal.pone.0051210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227253	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200112
J	Dmitriew, C; Blanckenhorn, WU				Dmitriew, Caitlin; Blanckenhorn, Wolf U.			The Role of Sexual Selection and Conflict in Mediating Among-Population Variation in Mating Strategies and Sexually Dimorphic Traits in Sepsis punctum	PLOS ONE			English	Article							FEMALE MATE CHOICE; BODY-SIZE; SEAWEED FLY; EVOLUTION; SPECIATION; DIPTERA; COSTS; COEVOLUTION; ADAPTATION; ALLOMETRY	The black scavenger fly Sepsis punctum exhibits striking among-population variation in the direction and magnitude of sexual size dimorphism, modification to the male forelimb and pre-copulatory behaviour. In some populations, male-biased sexual size dimorphism is observed; in other, less dimorphic, populations males court prior to mating. Such variation in reproductive traits is of interest to evolutionary biologists because it has the potential to limit gene flow among populations, contributing to speciation. Here, we investigate whether large male body size and modified forefemur are associated with higher male mating success within populations, whether these traits are associated with higher mating success among populations, and if these traits carry viability costs that could constrain their response to sexual selection. Flies from five distinct populations were reared at high or low food, generating high and low quality males. The expression of body size, forelimb morphology and courtship rate were each greater at high food, but high food males experienced higher mating success or reduced latency to first copulation in only one of the populations. Among populations, overall mating success increased with the degree of male-bias in overall body size and forelimb modification, suggesting that these traits have evolved as a means of increasing male mating rate. The increased mating success observed in large-male populations raises the question of why variation in magnitude of dimorphism persists among populations. One reason may be that costs of producing a large size constrain the evolution of ever-larger males. We found no evidence that juvenile mortality under food stress was greater for large-male populations, but development time was considerably longer and may represent an important constraint in an ephemeral and competitive growth environment. Citation: Dmitriew C, Blanckenhorn WU (2012) The Role of Sexual Selection and Conflict in Mediating Among-Population Variation in Mating Strategies and Sexually Dimorphic Traits in Sepsis punctum. PLoS ONE 7(12): e49511. doi:10.1371/journal.pone.0049511	[Dmitriew, Caitlin] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Blanckenhorn, Wolf U.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Colorado System; University of Colorado Boulder; University of Zurich	Dmitriew, C (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	c.dmitriew@utoronto.ca			Swiss National Fund Grant	Swiss National Fund Grant	Swiss National Fund Grant to W.U. Blanckenhorn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2002, EVOLUTION, V56, P936; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; Arnqvist Goran, 2005, pUnpaginated; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Blanckenhorn WU, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.1101; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Blanckenhorn WU, 2002, EVOL ECOL RES, V4, P1201; Blanckenhorn WU, 2000, ETHOLOGY, V106, P577, DOI 10.1046/j.1439-0310.2000.00573.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Crean CS, 1998, ANIM BEHAV, V56, P1405, DOI 10.1006/anbe.1998.0932; Crean CS, 2000, ANIM BEHAV, V59, P121, DOI 10.1006/anbe.1999.1268; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Eberhard WG, 2001, ZOOL J LINN SOC-LOND, V133, P335, DOI [10.1006/zjls.2000.0285, 10.1111/j.1096-3642.2001.tb00630.x]; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Gage MJG, 2002, P ROY SOC B-BIOL SCI, V269, P2309, DOI 10.1098/rspb.2002.2154; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jann P, 2000, J EVOLUTION BIOL, V13, P927, DOI 10.1046/j.1420-9101.2000.00230.x; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Kraushaar U, 2002, EVOLUTION, V56, P307, DOI 10.1111/j.0014-3820.2002.tb01341.x; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V255, P31, DOI 10.1098/rspb.1994.0005; Matute DR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000341; Mayhew PJ, 2007, BIOL REV, V82, P425, DOI 10.1111/j.1469-185X.2007.00018.x; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Millar NP, 2006, OIKOS, V113, P1; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Ortigosa A, 2003, ANIM BEHAV, V65, P851, DOI 10.1006/anbe.2003.2112; Ortigosa A, 2002, ANIM BEHAV, V64, P369, DOI 10.1006/anbe.2002.3065; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Parker G.A., 1979, P123; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Perry JC, 2012, EVOLUTION, V66, P544, DOI 10.1111/j.1558-5646.2011.01464.x; Pont Adrian C., 2002, Fauna Entomologica Scandinavica, V37, P1; Puniamoorthy N, 2012, ONLINE EARLY VIEW, DOI [10.1111/j.1558-5646.2012.01599.x, DOI 10.1111/J.1558-5646.2012.01599.X]; Puniamoorthy N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-155; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; Rowe L, 2002, EVOLUTION, V56, P754; RYAN MJ, 1993, PHILOS T ROY SOC B, V340, P187, DOI 10.1098/rstb.1993.0057; SCHULZ K, 1999, THESIS U ARIZONA TUC; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Servedio MR, 2004, EVOLUTION, V58, P913, DOI 10.1111/j.0014-3820.2004.tb00425.x; Stearns S.C., 1992, pi; Teder T, 2005, ECOL ENTOMOL, V30, P342, DOI 10.1111/j.0307-6946.2005.00693.x; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Teuschl Y, 2007, J EVOLUTION BIOL, V20, P87, DOI 10.1111/j.1420-9101.2006.01225.x; Zerbe F, 1993, THESIS U WURZBURG WU	55	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49511	10.1371/journal.pone.0049511	http://dx.doi.org/10.1371/journal.pone.0049511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227145	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000312588200008
J	Wang, SK; Chan, HC; Makovey, I; Simmer, JP; Hu, JCC				Wang, Shih-Kai; Chan, Hui-Chen; Makovey, Igor; Simmer, James P.; Hu, Jan C-C.			Novel PAX9 and COL1A2 Missense Mutations Causing Tooth Agenesis and OI/DGI without Skeletal Abnormalities	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPODONTIA; IMPERFECTA TYPE-II; OSTEOGENESIS IMPERFECTA; PAIRED DOMAIN; DENTINOGENESIS IMPERFECTA; DENTIN PHOSPHOPROTEIN; CAUSES OLIGODONTIA; MOLAR OLIGODONTIA; NONSENSE MUTATION; HELICAL DOMAIN	Inherited dentin defects are classified into three types of dentinogenesis imperfecta (DGI) and two types of dentin dysplasia (DD). The genetic etiology of DD-I is unknown. Defects in dentin sialophosphoprotein (DSPP) cause DD type II and DGI types II and III. DGI type I is the oral manifestation of osteogenesis imperfecta (OI), a systemic disease typically caused by defects in COL1A1 or COL1A2. Mutations in MSX1, PAX9, AXIN2, EDA and WNT10A can cause non-syndromic familial tooth agenesis. In this study a simplex pattern of clinical dentinogenesis imperfecta juxtaposed with a dominant pattern of hypodontia (mild tooth agenesis) was evaluated, and available family members were recruited. Mutational analyses of the candidate genes for DGI and hypodontia were performed and the results validated. A spontaneous novel mutation in COL1A2 (c.1171G>A; p.Gly391Ser) causing only dentin defects and a novel mutation in PAX9 (c.43T>A; p.Phe15Ile) causing hypodontia were identified and correlated with the phenotypic presentations in the family. Bone radiographs of the proband's dominant leg and foot were within normal limits. We conclude that when no DSPP mutation is identified in clinically determined isolated DGI cases, COL1A1 and COL1A2 should be considered as candidate genes. PAX9 mutation p.Phe15Ile within the N-terminal beta-hairpin structure of the PAX9 paired domain causes tooth agenesis.	[Wang, Shih-Kai; Chan, Hui-Chen; Makovey, Igor; Simmer, James P.; Hu, Jan C-C.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hu, JCC (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	janhu@umich.edu	Wang, Shih-Kai/AAB-5562-2022; Wang, Shih-Kai/P-3644-2019; Hu, Jan C-C./F-5679-2015	Wang, Shih-Kai/0000-0002-8378-5880; Hu, Jan C-C./0000-0002-9294-0248; Simmer, James/0000-0002-7192-6105	NIDCR National Institute of Dental and Craniofacial Research /NIH [DE015846]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015846] Funding Source: NIH RePORTER	NIDCR National Institute of Dental and Craniofacial Research /NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIDCR National Institute of Dental and Craniofacial Research /NIH research grant DE015846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Basel D, 2009, GENET MED, V11, P375, DOI 10.1097/GIM.0b013e3181a1ff7b; Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k; Bodian DL, 2009, HUM MOL GENET, V18, P463, DOI 10.1093/hmg/ddn374; Boeira Junior BR, 2012, J ORAL PATHOL MED, V2, P1600; Chan TF, 2008, GENOMICS, V91, P307, DOI 10.1016/j.ygeno.2007.12.008; Das P, 2003, AM J MED GENET A, V118A, P35, DOI 10.1002/ajmg.a.10011; Das P, 2002, HUM GENET, V110, P371, DOI 10.1007/s00439-002-0699-1; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; Han D, 2008, EUR J MED GENET, V51, P536, DOI 10.1016/j.ejmg.2008.06.002; Hansen L, 2007, EUR J ORAL SCI, V115, P330, DOI 10.1111/j.1600-0722.2007.00457.x; Jumlongras D, 2004, HUM GENET, V114, P242, DOI 10.1007/s00439-003-1066-6; Kapadia H, 2006, EUR J HUM GENET, V14, P403, DOI 10.1038/sj.ejhg.5201574; Kim JW, 2006, J DENT RES, V85, P267, DOI 10.1177/154405910608500312; Klein ML, 2005, J DENT RES, V84, P43, DOI 10.1177/154405910508400107; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lammi L, 2003, EUR J HUM GENET, V11, P866, DOI 10.1038/sj.ejhg.5201060; Lee KE, 2011, CLIN GENET, V79, P378, DOI 10.1111/j.1399-0004.2010.01483.x; Liang CL, 2007, J HUM GENET, V52, P374, DOI 10.1007/s10038-007-0117-6; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; Mostowska A, 2003, EUR J ORAL SCI, V111, P272, DOI 10.1034/j.1600-0722.2003.00036.x; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Pallos D, 2001, ARCH ORAL BIOL, V46, P459, DOI 10.1016/S0003-9969(00)00130-8; Rauch F, 2010, EUR J HUM GENET, V18, P642, DOI 10.1038/ejhg.2009.242; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Tallon-Walton V, 2007, EUR J ORAL SCI, V115, P427, DOI 10.1111/j.1600-0722.2007.00492.x; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Wang SK, 2011, EUR J ORAL SCI, V119, P158, DOI 10.1111/j.1600-0722.2011.00874.x; Wang Y, 2009, CELLS TISSUES ORGANS, V189, P80, DOI 10.1159/000151448; Wang Y, 2009, HUM MOL GENET, V18, P2863, DOI 10.1093/hmg/ddp221; Zhao Ji-lin, 2005, Zhonghua Kou Qiang Yi Xue Za Zhi, V40, P266; Zhao JL, 2007, AM J MED GENET A, V143A, P2592, DOI 10.1002/ajmg.a.31993	38	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51533	10.1371/journal.pone.0051533	http://dx.doi.org/10.1371/journal.pone.0051533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227268	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200127
J	Bergholz, J; Zhang, Y; Wu, J; Meng, L; Walsh, EM; Rai, A; Sherman, MY; Xiao, ZXJ				Bergholz, J.; Zhang, Y.; Wu, J.; Meng, L.; Walsh, E. M.; Rai, A.; Sherman, M. Y.; Xiao, Z-X Jim			Delta Np63 alpha regulates Erk signaling via MKP3 to inhibit cancer metastasis	ONCOGENE			English	Article						p63; MKP3; Erk; metastasis; cancer	SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; LUNG-CANCER; BREAST-CANCER; UP-REGULATION; P53 HOMOLOG; EPITHELIAL DEVELOPMENT; PANCREATIC-CANCER; DOWN-REGULATION; GROWTH-FACTOR	Reduced expression of the p53 family member p63 has been suggested to play a causative role in cancer metastasis. Here, we show that Delta Np63 alpha, the predominant p63 isoform, plays a major role in regulation of cell migration, invasion and cancer metastasis. We identified mitogen-activated protein (MAP) kinase phosphatase 3 (MKP3) as a downstream target of Delta Np63 alpha that is required for mediating these effects. We show that Delta Np63 alpha regulates extracellular signal-regulated protein kinases 1 and 2 (Erk1/2) activity via MKP3 in both cancer and non-transformed cells. We further show that exogenous Delta Np63 alpha inhibits cell invasion and is dependent on MKP3 upregulation for repression. Conversely, endogenous pan-p63 ablation results in increased cell migration and invasion, which can be reverted by reintroducing the Delta Np63 alpha isoform alone, but not by other isoforms. Interestingly, these effects require Erk2, but not Erk1 expression, and can be rescued by enforced MKP3 expression. Moreover, MKP3 expression is reduced in invasive cancers, and reduced p63 expression increases metastatic frequency in vivo. Taken together, these results suggest an important role for Delta Np63 alpha in preventing cancer metastasis by inhibition of Erk2 signaling via MKP3.	[Bergholz, J.; Wu, J.; Meng, L.; Walsh, E. M.; Rai, A.; Sherman, M. Y.; Xiao, Z-X Jim] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Bergholz, J.; Zhang, Y.; Xiao, Z-X Jim] Sichuan Univ, Ctr Growth Metab & Aging, Coll Life Sci, Chengdu 610014, Sichuan, Peoples R China; [Bergholz, J.; Zhang, Y.; Xiao, Z-X Jim] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610014, Sichuan, Peoples R China	Boston University; Sichuan University; Sichuan University	Xiao, ZXJ (corresponding author), Sichuan Univ, Ctr Growth Metab & Aging, Coll Life Sci, 29 Wangjiang Rd, Chengdu 610014, Sichuan, Peoples R China.	jimzx@scu.edu.cn			NIH [CA79804, GM70017]; National Key Basic Research Program (973 Program) of China [2012CB910700]; United States Department of Defense [W81XWH-10-1-0161]; NATIONAL CANCER INSTITUTE [R01CA079804] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Basic Research Program (973 Program) of China(National Basic Research Program of China); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Frank McKeon (Harvard Medical School, Boston, MA, USA) for providing the myc-tagged murine pcDNA3-Delta Np63 alpha, pcDNA3-Delta Np63 gamma, pcDNA3-TAp63 alpha and pcDNA3-TAp63 gamma expression plasmids, and Dr Tyler Jacks (Massachusetts Institute of Technology, Cambridge, MA, USA) for providing a plasmid encoding shRNA against human MKP3. We also thank Dr Xixi Cao (Baylor College of Medicine) for help with Oncomine bioinformatics analysis. This work was supported by NIH grants (CA79804 and GM70017) and by the National Key Basic Research Program (973 Program) of China (2012CB910700) to Z-XJX, and United States Department of Defense Congressionally Directed Medical Research Programs grant (W81XWH-10-1-0161) to JB.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; DeYoung MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Eicheler W, 2002, J HISTOCHEM CYTOCHEM, V50, P197, DOI 10.1177/002215540205000207; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Fu SW, 2003, BREAST CANCER RES, V5, pR82, DOI 10.1186/bcr602; Fukushima H, 2009, CANCER RES, V69, P9263, DOI 10.1158/0008-5472.CAN-09-1188; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Higashikawa K, 2007, CANCER RES, V67, P9207, DOI 10.1158/0008-5472.CAN-07-0932; Higashikawa K, 2009, INT J CANCER, V124, P2837, DOI 10.1002/ijc.24280; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Karlsson M, 2004, J BIOL CHEM, V279, P41882, DOI 10.1074/jbc.M406720200; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kommagani R, 2009, J CELL SCI, V122, P2828, DOI 10.1242/jcs.049619; Krueger JS, 2001, ONCOGENE, V20, P4209, DOI 10.1038/sj.onc.1204541; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Liu J, 2006, MOL CANCER RES, V4, P803, DOI 10.1158/1541-7786.MCR-06-0201; Liu SY, 2005, CELL PHYSIOL BIOCHEM, V16, P207, DOI 10.1159/000089846; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Massion PP, 2003, CANCER RES, V63, P7113; McCawley LJ, 1999, J BIOL CHEM, V274, P4347, DOI 10.1074/jbc.274.7.4347; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Shalom-Feuerstein R, 2011, CELL DEATH DIFFER, V18, P887, DOI 10.1038/cdd.2010.159; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Su H, 2003, CANCER RES, V63, P3872; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Thanos CD, 1999, PROTEIN SCI, V8, P1708, DOI 10.1110/ps.8.8.1708; Vanaja DK, 2003, CANCER RES, V63, P3877; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Webb CP, 1998, P NATL ACAD SCI USA, V95, P8773, DOI 10.1073/pnas.95.15.8773; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weber A, 2002, INT J CANCER, V99, P22, DOI 10.1002/ijc.10296; Xu SH, 2005, J HUM GENET, V50, P159, DOI 10.1007/s10038-005-0235-y; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Ying HQ, 2005, MOL CELL BIOL, V25, P6154, DOI 10.1128/MCB.25.14.6154-6164.2005; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	69	35	36	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					212	224		10.1038/onc.2012.564	http://dx.doi.org/10.1038/onc.2012.564			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23246965	Green Accepted			2022-12-25	WOS:000329440700009
J	Todd, JR; Scurr, LL; Becker, TM; Kefford, RF; Rizos, H				Todd, J. R.; Scurr, L. L.; Becker, T. M.; Kefford, R. F.; Rizos, H.			The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma	ONCOGENE			English	Article						c-Kit; stem cell factor; melanoma; melanocytes; MAPK; PI3K	GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE; METASTATIC MELANOMA; PROTEIN EXPRESSION; IMATINIB MESYLATE; HUMAN MELANOCYTES; MUCOSAL MELANOMA; MAJOR RESPONSE; RESISTANCE; MUTATIONS	Stimulation of the c-Kit receptor tyrosine kinase has a critical role in the development and migration of melanocytes, and oncogenic c-Kit mutants contribute to the progression of some melanomas. c-Kit signalling activates the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways and their relative contribution to the activities of oncogenic and ligand-dependent c-Kit remains uncertain. We show that PI3K is a major regulator of MAPK activation in response to c-Kit activity and the dominant effector of c-Kit-driven melanocyte proliferation and melanoma survival. Nevertheless, inhibition of the PI3K pathway in c-Kit mutant melanoma cells did not replicate the apoptotic efficacy of the c-Kit inhibitor, imatinib mesylate. Instead, the simultaneous suppression of the PI3K and MAPK pathways promoted a strong synergistic apoptotic effect. These data indicate that MAPK functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma. Thus, the concurrent inhibition of PI3K and MAPK signalling is required to suppress oncogenic c-Kit activity and may provide an effective therapeutic strategy in c-Kit mutant melanomas.	[Todd, J. R.; Scurr, L. L.; Becker, T. M.; Kefford, R. F.; Rizos, H.] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead Hosp, Westmead, NSW 2145, Australia; [Kefford, R. F.] Melanoma Inst Australia, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia	Rizos, H (corresponding author), Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead Hosp, Darcy Rd, Westmead, NSW 2145, Australia.	helen.rizos@sydney.edu.au		Becker, Therese/0000-0002-5636-9902; Kefford, Richard/0000-0001-9251-9229; Rizos, Helen/0000-0002-2094-9198	National Health and Medical Research Council of Australia (NHMRC) [633004]; Health Department of NSW through Sydney West Area Health Service; Australian Cancer Research Foundation; Cancer Institute New South Wales; NHMRC; Australian Postgraduate Award; Westmead Medical Research Foundation; Melanoma Foundation of the University of Sydney	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Health Department of NSW through Sydney West Area Health Service; Australian Cancer Research Foundation; Cancer Institute New South Wales; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Westmead Medical Research Foundation; Melanoma Foundation of the University of Sydney(University of Sydney)	We are grateful to Antoni Ribas, Peter Hersey and Meenhard Herlyn for providing c-Kit mutant melanoma cells lines. This work is supported by Programme Grant 633004 and project grants of the National Health and Medical Research Council of Australia (NHMRC) and an infrastructure grant to Westmead Millennium Institute by the Health Department of NSW through Sydney West Area Health Service. Westmead Institute for Cancer Research is the recipient of capital grant funding from the Australian Cancer Research Foundation. HR is a recipient of a Cancer Institute New South Wales, Research Fellowship and a NHMRC Senior Research Fellowship. JT is supported by an Australian Postgraduate Award and a Westmead Medical Research Foundation Top-up Award. The support of the Melanoma Foundation of the University of Sydney and colleagues from Melanoma Institute Australia and the Department of Anatomical Pathology at the Royal Prince Alfred Hospital are also gratefully acknowledged.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; Antonescu CR, 2007, INT J CANCER, V121, P257, DOI 10.1002/ijc.22681; Atefi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028973; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Garrido MC, 2010, J INVEST DERMATOL, V130, P20, DOI 10.1038/jid.2009.334; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Gounder MM, 2011, CANCER CHEMOTH PHARM, V67, P25, DOI 10.1007/s00280-010-1526-3; Guo J, 2011, J CLIN ONCOL, V29, P2904, DOI 10.1200/JCO.2010.33.9275; HALABAN R, 1986, J INVEST DERMATOL, V87, P95, DOI 10.1111/1523-1747.ep12523594; Handolias D, 2010, PIGM CELL MELANOMA R, V23, P210, DOI 10.1111/j.1755-148X.2010.00671.x; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Jeon S, 2009, PIGM CELL MELANOMA R, V22, P77, DOI 10.1111/j.1755-148X.2008.00519.x; Jiang XF, 2008, CLIN CANCER RES, V14, P7726, DOI 10.1158/1078-0432.CCR-08-1144; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kontogianni-Katsarou K, 2008, WORLD J GASTROENTERO, V14, P1891, DOI 10.3748/wjg.14.1891; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Larribere L, 2004, CELL DEATH DIFFER, V11, P1084, DOI 10.1038/sj.cdd.4401475; Lefevre G, 2004, J BIOL CHEM, V279, P31769, DOI 10.1074/jbc.M403907200; Liang RX, 2011, PIGM CELL MELANOMA R, V24, P714, DOI 10.1111/j.1755-148X.2011.00870.x; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Martin J, 2005, J CLIN ONCOL, V23, P6190, DOI 10.1200/JCO.2005.19.554; Monsel G, 2010, ONCOGENE, V29, P227, DOI 10.1038/onc.2009.320; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Omholt K, 2011, CLIN CANCER RES, V17, P3933, DOI 10.1158/1078-0432.CCR-10-2917; Rivera RS, 2008, VIRCHOWS ARCH, V452, P27, DOI 10.1007/s00428-007-0524-2; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Si L, 2012, J CLIN ONCOL, V30, pE37, DOI 10.1200/JCO.2011.37.9644; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Takayama Y, 2008, CANCER LETT, V264, P241, DOI 10.1016/j.canlet.2008.01.035; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wardelmann E, 2002, MODERN PATHOL, V15, P125, DOI 10.1038/modpathol.3880504; Woodman SE, 2009, MOL CANCER THER, V8, P2079, DOI 10.1158/1535-7163.MCT-09-0459; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x	41	40	41	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					236	245		10.1038/onc.2012.562	http://dx.doi.org/10.1038/onc.2012.562			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23246970	Bronze			2022-12-25	WOS:000329440700011
J	Moore, SF; van den Bosch, MTJ; Hunter, RW; Sakamoto, K; Poole, AW; Hers, I				Moore, Samantha F.; van den Bosch, Marion T. J.; Hunter, Roger W.; Sakamoto, Kei; Poole, Alastair W.; Hers, Ingeborg			Dual Regulation of Glycogen Synthase Kinase 3 (GSK3)alpha/beta by Protein Kinase C (PKC)alpha and Akt Promotes Thrombin-mediated Integrin alpha(IIb)beta(3) Activation and Granule Secretion in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; PHOSPHOINOSITIDE 3-KINASE; PHOSPHORYLATION; INHIBITORS; AGGREGATION; COLLAGEN	Glycogen synthase kinase-3 is a Ser/Thr kinase, tonically active in resting cells but inhibited by phosphorylation of an N-terminal Ser residue (Ser(21) in GSK3 alpha and Ser(9) in GSK3 beta) in response to varied external stimuli. Recent work suggests that GSK3 functions as a negative regulator of platelet function, but how GSK3 is regulated in platelets has not been examined in detail. Here, we show that early thrombin-mediated GSK3 phosphorylation (0-30 s) was blocked by PKC inhibitors and largely absent in platelets from PKC alpha knock-out mice. In contrast, late (2-5 min) GSK3 phosphorylation was dependent on the PI3K/Akt pathway. Similarly, early thrombin-mediated inhibition of GSK3 activity was blocked in PKC alpha knock-out platelets, whereas the Akt inhibitor MK2206 reduced late thrombin-mediated GSK3 inhibition and largely prevented GSK3 inhibition in PKC alpha knock-out platelets. More importantly, GSK3 phosphorylation contributes to platelet function as knock-in mice where GSK3 alpha Ser(21) and GSK3 beta Ser(9) were mutated to Ala showed a significant reduction in PAR4-mediated platelet aggregation, fibrinogen binding, and P-selectin expression, whereas the GSK3 inhibitor CHIR99021 enhanced these responses. Together, these results demonstrate that PKC alpha and Akt modulate platelet function by phosphorylating and inhibiting GSK3 alpha/beta, thereby relieving the negative effect of GSK3 alpha/beta on thrombin-mediated platelet activation.	[Moore, Samantha F.; van den Bosch, Marion T. J.; Poole, Alastair W.; Hers, Ingeborg] Univ Bristol, Sch Med Sci, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Hunter, Roger W.; Sakamoto, Kei] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Hunter, Roger W.; Sakamoto, Kei] Nestle Inst Hlth Sci SA, CH-1015 Lausanne, Switzerland	University of Bristol; University of Dundee; Nestle SA	Hers, I (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	i.hers@bris.ac.uk	sakamoto, kei/C-8806-2019; Hers, Ingeborg/ABG-3357-2020	sakamoto, kei/0000-0001-8839-5980; Hers, Ingeborg/0000-0002-6467-5715; Hunter, Roger/0000-0003-0177-1512; van den Bosch, Marion/0000-0002-4635-4416; Poole, Alastair/0000-0002-0868-297X; Moore, Samantha/0000-0003-0944-7055	British Heart Foundation [PG/08/056, PG/09/059, PG/10/100, RG/10/006, FS/11/62]; British Medical Research Council; British Heart Foundation [FS/11/62/28934, PG/10/100/28658, FS/12/22/29510, PG/08/056/25325, RG/10/006/28299] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants PG/08/056, PG/09/059, PG/10/100, RG/10/006, and FS/11/62.; Supported by the British Medical Research Council.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Cosemans JMEM, 2010, J THROMB HAEMOST, V8, P1797, DOI 10.1111/j.1538-7836.2010.03935.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Mesquita DD, 2001, FEBS LETT, V502, P84, DOI 10.1016/S0014-5793(01)02669-2; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; GOODE N, 1992, J BIOL CHEM, V267, P16878; Harper MT, 2010, CELL CALCIUM, V48, P333, DOI 10.1016/j.ceca.2010.10.006; Hers I, 1999, FEBS LETT, V460, P433, DOI 10.1016/S0014-5793(99)01389-7; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hunter RW, 2008, J THROMB HAEMOST, V6, P1923, DOI 10.1111/j.1538-7836.2008.03140.x; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; Pasquet JM, 2000, BLOOD, V95, P3429, DOI 10.1182/blood.V95.11.3429.011k22_3429_3434; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Xia Z, 1996, BRIT J HAEMATOL, V93, P204, DOI 10.1046/j.1365-2141.1996.445980.x; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522	39	103	111	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3918	3928		10.1074/jbc.M112.429936	http://dx.doi.org/10.1074/jbc.M112.429936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23239877	Green Published, hybrid			2022-12-25	WOS:000314845000022
J	Bao, H; Duong, F				Bao, Huan; Duong, Franck			ATP Alone Triggers the Outward Facing Conformation of the Maltose ATP-binding Cassette Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRENE EXCIMER FLUORESCENCE; CHEMICAL CROSS-LINKING; ABC-TRANSPORTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; PROTEIN; MECHANISM; HYDROLYSIS; NANODISCS	The maltose transporter MalFGK(2) is a study prototype for ABC importers. During catalysis, the MalFG membrane domain alternates between inward and outward facing conformations when the MalK dimer closes and hydrolyzes ATP. Because a rapid ATP hydrolysis depends on MalE and maltose, it has been proposed that closed liganded MalE facilitates the transition to the outward facing conformation. Here we find that, in contrast to the expected, ATP is sufficient for the closure of MalK and for the conversion of MalFG to the outward facing state. The outward facing transporter binds MalE with nanomolar affinity, yet neither MalE nor maltose is necessary or facilitates the transition. Thus, the rapid hydrolysis of ATP observed in the presence of MalE and maltose is not because closed liganded MalE accelerates the formation of the outward facing conformation. These findings have fundamental implications for the description of the transport reaction.	[Bao, Huan; Duong, Franck] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124; Bao, Huan/0000-0002-4301-4627	Canadian Foundation for Innovation; University of British Columbia; Chaires de Recherche du Canada	Canadian Foundation for Innovation(Canada Foundation for Innovation); University of British Columbia; Chaires de Recherche du Canada	This work was supported by an infrastructure grant from the Canadian Foundation for Innovation.; Supported by a Four Year Fellowship (FYF) from the University of British Columbia.; Supported by Chaires de Recherche du Canada. To whom correspondence should be addressed: Dept. of Biochemistry & Molecular Biology, Life Sciences Institute, Faculty of Medicine, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada. Tel.: 604-822-5975; Fax: 604-822-522; E-mail: fduong@mail.ubc.ca.	Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; Daus ML, 2007, MOL MICROBIOL, V66, P1107, DOI 10.1111/j.1365-2958.2007.05982.x; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hunke S, 2000, J BIOL CHEM, V275, P15526, DOI 10.1074/jbc.275.20.15526; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lehrer S S, 1995, Subcell Biochem, V24, P115; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reich-Slotky R, 2000, J BACTERIOL, V182, P993, DOI 10.1128/JB.182.4.993-1000.2000; Sahoo D, 2000, BIOCHEMISTRY-US, V39, P6594, DOI 10.1021/bi992609m; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shilton BH, 2008, BBA-BIOMEMBRANES, V1778, P1772, DOI 10.1016/j.bbamem.2007.09.005; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956	34	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3439	3448		10.1074/jbc.M112.431932	http://dx.doi.org/10.1074/jbc.M112.431932			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23243313	Green Published, hybrid			2022-12-25	WOS:000314397900048
J	Bao, XF; Beatty, WL; Fan, HZ				Bao, Xiaofeng; Beatty, Wandy L.; Fan, Huizhou			Exploration of Chlamydial Type III Secretion System Reconstitution in Escherichia coli	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SMALL-MOLECULE INHIBITORS; HOST-CELL CYTOPLASM; PEPTIDE DEFORMYLASE; SURFACE PROJECTIONS; EPITHELIAL-CELLS; INC PROTEINS; TRACHOMATIS; IDENTIFICATION; PNEUMONIAE	Background: Type III secretion system is a virulent factor for many pathogens, and is thought to play multiple roles in the development cycle and pathogenesis of chlamydia, an important human pathogen. However, due to the obligate intracellular parasitical nature of chlamydiae and a lack of convenient genetic methodology for the organisms, very limited approaches are available to study the chlamydial type III secretion system. In this study, we explored the reconstitution of a chlamydial type III secretion in Escherichia coli. Results: We successfully cloned all 6 genomic DNA clusters of the chlamydial type III secretion system into three bacterial plasmids. 5 of the 6 clusters were found to direct mRNA synthesis from their own promoters in Escherichia coli transformed with the three plasmids. Cluster 5 failed to express mRNA using its own promoters. However, fusion of cluster 5 to cluster 6 resulted in the expression of cluster 5 mRNA. Although only two of the type III secretion system proteins were detected transformed E. coli due to limited antibody availability, type III secretion system-like structures were detected in ultrathin sections in a small proportion of transformed E. coli. Conclusions: We have successfully generated E. coli expressing all genes of the chlamydial type III secretion system. This serves as a foundation for optimal expression and assembly of the recombinant chlamydial type III secretion system, which may be extremely useful for the characterization of the chlamydial type III secretion system and for studying its role in chlamydial pathogenicity.	[Bao, Xiaofeng; Fan, Huizhou] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Bao, Xiaofeng] Nantong Univ, Sch Med, Dept Pharmacol, Nantong, Peoples R China; [Beatty, Wandy L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Nantong University; Washington University (WUSTL)	Fan, HZ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	fanhu@umdnj.edu		FAN, HUIZHOU/0000-0002-4903-926X	National Institutes of Health [AI071954]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071954, R33AI071954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI071954 to HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey L, 2007, FEBS LETT, V581, P587, DOI 10.1016/j.febslet.2007.01.013; Balakrishnan A, 2006, J BIOL CHEM, V281, P16691, DOI 10.1074/jbc.M513648200; Bao XF, 2012, P NATL ACAD SCI USA, V109, P16870, DOI 10.1073/pnas.1207300109; Bao XF, 2011, MICROBIOL-SGM, V157, P2569, DOI 10.1099/mic.0.049668-0; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Chellas-Gery B, 2011, INFECT IMMUN, V79, P3036, DOI 10.1128/IAI.00159-11; Clifton DR, 2005, INFECT IMMUN, V73, P3860, DOI 10.1128/IAI.73.7.3860-3868.2005; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Fields KA, 2007, CHLAMYDIA GENOMICS P, P219; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; GINOCCHIO C, 1992, P NATL ACAD SCI USA, V89, P5976, DOI 10.1073/pnas.89.13.5976; Gopal V, 1997, EUR J BIOCHEM, V244, P613, DOI 10.1111/j.1432-1033.1997.00613.x; GREGORY WW, 1979, J BACTERIOL, V138, P241, DOI 10.1128/JB.138.1.241-244.1979; Hefty PS, 2007, J BACTERIOL, V189, P198, DOI 10.1128/JB.01034-06; Ho TD, 2005, INFECT IMMUN, V73, P905, DOI 10.1128/IAI.73.2.905-911.2005; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Hybiske K, 2007, INFECT IMMUN, V75, P3925, DOI 10.1128/IAI.00106-07; Jamison WP, 2008, MICROB PATHOGENESIS, V45, P435, DOI 10.1016/j.micpath.2008.10.002; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Lei L, 2011, MICROB PATHOGENESIS, V51, P101, DOI 10.1016/j.micpath.2011.05.002; Li XJ, 2007, CELL RES, V17, P985, DOI 10.1038/cr.2007.98; MATSUMOTO A, 1982, J BACTERIOL, V150, P358, DOI 10.1128/JB.150.1.358-364.1982; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Peters J, 2007, TRENDS MICROBIOL; Qi ML, 2011, J BACTERIOL, V193, P2498, DOI 10.1128/JB.01301-10; Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021; Schachter J, 1999, CHLAMYDIA, P139; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Subtil A, 2000, MICROBES INFECT, V2, P367, DOI 10.1016/S1286-4579(00)00335-X; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x	44	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50833	10.1371/journal.pone.0050833	http://dx.doi.org/10.1371/journal.pone.0050833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239989	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800026
J	Au, HHT; Jan, E				Au, Hilda H. T.; Jan, Eric			Insights into Factorless Translational Initiation by the tRNA-Like Pseudoknot Domain of a Viral IRES	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; METHIONINE-INDEPENDENT INITIATION; INTERNAL RIBOSOME; HEPATITIS-C; VIRUS-RNA; DICISTROVIRIDAE; BINDING; PROTEIN; CODON; REGION	The intergenic region internal ribosome entry site (IGR IRES) of the Dicistroviridae family adopts an overlapping triple pseudoknot structure to directly recruit the 80S ribosome in the absence of initiation factors. The pseudoknot I (PKI) domain of the IRES mimics a tRNA-like codon: anticodon interaction in the ribosomal P site to direct translation initiation from a non-AUG initiation codon in the A site. In this study, we have performed a comprehensive mutational analysis of this region to delineate the molecular parameters that drive IRES translation. We demonstrate that IRES-mediated translation can initiate at an alternate adjacent and overlapping start site, provided that basepairing interactions within PKI remain intact. Consistent with this, IGR IRES translation tolerates increases in the variable loop region that connects the anticodon- and codon-like elements within the PKI domain, as IRES activity remains relatively robust up to a 4-nucleotide insertion in this region. Finally, elements from an authentic tRNA anticodon stem-loop can functionally supplant corresponding regions within PKI. These results verify the importance of the codon: anticodon interaction of the PKI domain and further define the specific elements within the tRNA-like domain that contribute to optimal initiator Met-tRNAi-independent IRES translation.	[Au, Hilda H. T.; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Jan, E (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	ej@mail.ubc.ca	Jan, Eric/O-1923-2019		Canadian Institute for Health Research [MOPS-81244]; National Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 341459-07]; NSERC CGS M fellowship	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS M fellowship	This work was supported by a Canadian Institute for Health Research grant (MOPS-81244) and a National Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (RGPIN 341459-07) to EJ. EJ is a Michael Smith Foundation for Health Research Scholar and a Canadian Institutes of Health Research New Investigator. HA is supported by an NSERC CGS M fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Carrasco L, 1974, Methods Enzymol, V30, P282; CHANG YN, 1986, GENE, V48, P165; Costantino D, 2005, RNA, V11, P332, DOI 10.1261/rna.7184705; Costantino DA, 2008, NAT STRUCT MOL BIOL, V15, P57, DOI 10.1038/nsmb1351; Doudna J.A., 2007, COLD SPRING HARB MON, V48, P129; Dreher TW, 2009, VIRUS RES, V139, P217, DOI 10.1016/j.virusres.2008.06.010; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hertz MI, 2011, NUCLEIC ACIDS RES, V39, P7276, DOI 10.1093/nar/gkr427; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Jang CJ, 2010, RNA, V16, P1182, DOI 10.1261/rna.2044610; Jang CJ, 2009, J MOL BIOL, V387, P42, DOI 10.1016/j.jmb.2009.01.042; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Nakashima N, 2009, VIRUS RES, V139, P137, DOI 10.1016/j.virusres.2008.06.006; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pfingsten JS, 2007, J MOL BIOL, V370, P856, DOI 10.1016/j.jmb.2007.04.076; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Pfingsten JS, 2010, J MOL BIOL, V395, P205, DOI 10.1016/j.jmb.2009.10.047; Ren Q, 2012, P NATL ACAD SCI USA, V109, pE630, DOI 10.1073/pnas.1111303109; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; SZER W, 1970, Biochimica et Biophysica Acta, V224, P477, DOI 10.1016/0005-2787(70)90580-0; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yamamoto H, 2007, J BIOL CHEM, V282, P7770, DOI 10.1074/jbc.M610887200; Zhu JY, 2011, P NATL ACAD SCI USA, V108, P1839, DOI 10.1073/pnas.1018582108	37	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51477	10.1371/journal.pone.0051477	http://dx.doi.org/10.1371/journal.pone.0051477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236506	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100122
J	Yokoo, H; Chiba, S; Tomita, K; Takashina, M; Sagara, H; Yagisita, S; Takano, Y; Hattori, Y				Yokoo, Hiroki; Chiba, Seiichi; Tomita, Kengo; Takashina, Michinori; Sagara, Hiroshi; Yagisita, Saburo; Takano, Yasuo; Hattori, Yuichi			Neurodegenerative Evidence in Mice Brains with Cecal Ligation and Puncture-Induced Sepsis: Preventive Effect of the Free Radical Scavenger Edaravone	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE LUNG INJURY; SEPTIC ENCEPHALOPATHY; BARRIER BREAKDOWN; PEROXYNITRITE SCAVENGER; PERMEABILITY CHANGES; ANIMAL-MODELS; URIC-ACID; EXPRESSION; NITROTYROSINE	Sepsis is a major clinical challenge and septic encephalopathy is its nasty complication. The pathogenesis and underlying mechanisms of septic encephalopathy are not well understood. This study sought to fully characterize sepsis-associated biochemical and histopathological changes in brains of mice after cecal ligation and puncture, regarded as a highly clinically relevant animal model of polymicrobial sepsis. Real-time PCR analysis showed that gene expression levels of proinflammatory cytokines, including tumor necrosis factor-alpha and interleukin-1 beta, were significantly up-regulated in brain tissues from septic mice, but to a much lesser extent when compared with those in peripheral tissues such as lungs. Blood-brain barrier (BBB) permeability was significantly increased in septic mice, as determined by the measurement of sodium fluorescein and Evans blue content. Sepsis resulted in increases in NADPH oxidase activity and expression of p47(phox) and p67(phox) and up-regulation of inducible nitric oxide (NO) synthase in brains, indicating that superoxide, produced by NADPH oxidase, reacts with NO to form peroxynitrite, that maybe lead to the loss of BBB integrity. Light and electron microscopic examination of septic mouse brain showed serious neuronal degeneration, as indicated by hyperchromatic, shrunken, pyknotic, and electron-dense neurons. These histopathogical changes were prevented by treatment with the free radical scavenger edaravone. Together, these results suggest that sepsis can lead to rapid neurodegenerative changes in brains via free radical species production and possibly subsequent injury to the BBB. We may also provide a potentially useful therapeutic tool for treating septic encephalopathy.	[Yokoo, Hiroki; Tomita, Kengo; Takashina, Michinori; Hattori, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 930, Japan; [Chiba, Seiichi] Oita Univ, Fac Med, Dept Internal Med, Yufu, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo, Japan; [Yagisita, Saburo] Kanagawa Rehabil Ctr, Sect Pathol, Atsugi, Kanagawa, Japan; [Takano, Yasuo] Kanagawa Canc Res Inst, Yokohama, Kanagawa, Japan	University of Toyama; Oita University; University of Tokyo; Kanagawa Prefectural Cancer Center	Yokoo, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 930, Japan.	hyokoo@med.u-toyama.ac.jp	Sagara, Hiroshi/GRX-7740-2022	Sagara, Hiroshi/0000-0001-8456-8362; Tomita, Kengo/0000-0002-7310-8093	Ministry of Education, Culture, Sports, Science and Technology of Japan [21590271, 24590315]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21590271, 24590315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Gawad HM, 2001, PHARMACOL RES, V43, P257, DOI 10.1006/phrs.2000.0781; Ahmad A, 2012, MOL CELL BIOCHEM, V367, P215, DOI 10.1007/s11010-012-1335-6; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Berg RMG, 2011, J CEREBR BLOOD F MET, V31, P1532, DOI 10.1038/jcbfm.2011.48; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Candolfi M, 2004, NEUROENDOCRINOLOGY, V80, P83, DOI 10.1159/000081313; Chang CC, 2011, TOXICOL APPL PHARM, V257, P137, DOI 10.1016/j.taap.2011.08.027; CLAWSON CC, 1966, J COMP NEUROL, V127, P183; Dal-Pizzol F, 2010, NEUROCHEM RES, V35, P1, DOI 10.1007/s11064-009-0043-4; Davies DC, 2002, J ANAT, V200, P639, DOI 10.1046/j.1469-7580.2002.00065.x; Davies NWS, 2006, J NEUROL, V253, P833, DOI 10.1007/s00415-006-0092-4; DENG XM, 1995, J APPL PHYSIOL, V78, P2052, DOI 10.1152/jappl.1995.78.6.2052; Ebersoldt M, 2007, INTENS CARE MED, V33, P941, DOI 10.1007/s00134-007-0622-2; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Ganopolsky JG, 2004, AM J PATHOL, V165, P1433, DOI 10.1016/S0002-9440(10)63401-3; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Houkin K, 1998, J Stroke Cerebrovasc Dis, V7, P315, DOI 10.1016/S1052-3057(98)80049-9; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Jacob A, 2011, NEUROCHEM INT, V58, P472, DOI 10.1016/j.neuint.2011.01.004; JEPPSSON B, 1981, AM J SURG, V141, P136, DOI 10.1016/0002-9610(81)90026-X; Jiao L, 2011, NEUROSCIENCE, V182, P177, DOI 10.1016/j.neuroscience.2011.01.017; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kean RB, 2000, J IMMUNOL, V165, P6511, DOI 10.4049/jimmunol.165.11.6511; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Lagrange P, 1999, FREE RADICAL BIO MED, V27, P667, DOI 10.1016/S0891-5849(99)00112-4; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu JSH, 2001, AM J PATHOL, V158, P2057, DOI 10.1016/S0002-9440(10)64677-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcus JS, 2003, GLIA, V41, P152, DOI 10.1002/glia.10168; Matsuda N, 2008, BIOCHEM PHARMACOL, V75, P1065, DOI 10.1016/j.bcp.2007.10.036; Matsuda N, 2010, AM J PHYSIOL-HEART C, V298, pH92, DOI 10.1152/ajpheart.00069.2009; Matsuda N, 2009, CRIT CARE MED, V37, P2791, DOI 10.1097/CCM.0b013e3181ab844d; Nag S, 2001, LAB INVEST, V81, P41, DOI 10.1038/labinvest.3780210; Otani H, 2005, EUR J PHARMACOL, V512, P129, DOI 10.1016/j.ejphar.2005.01.050; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Piazza O, 2009, NEUROCHEM RES, V34, P1289, DOI 10.1007/s11064-008-9907-2; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Siami S, 2008, CRIT CARE CLIN, V24, P67, DOI 10.1016/j.ccc.2007.10.001; Streck EL, 2008, NEUROCHEM RES, V33, P2171, DOI 10.1007/s11064-008-9671-3; Takano K, 2011, J PHARMACOL EXP THER, V336, P381, DOI 10.1124/jpet.110.171462; Toklu HZ, 2009, J SURG RES, V152, P238, DOI 10.1016/j.jss.2008.03.013; Tsujimoto I, 2005, HYPERTENSION, V45, P921, DOI 10.1161/01.HYP.0000163461.71943.e9; Vincent JL, 2007, CONTRIB NEPHROL, V156, P64; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Wilson JX, 2003, CAN J NEUROL SCI, V30, P98, DOI 10.1017/S031716710005335X; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016; Zhang XH, 2003, EUR J PHARMACOL, V476, P131, DOI 10.1016/S0014-2999(03)02151-4	51	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51539	10.1371/journal.pone.0051539	http://dx.doi.org/10.1371/journal.pone.0051539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236515	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100131
J	Eldem, V; Akcay, UC; Ozhuner, E; Bakir, Y; Uranbey, S; Unver, T				Eldem, Vahap; Akcay, Ufuk Celikkol; Ozhuner, Esma; Bakir, Yakup; Uranbey, Serkan; Unver, Turgay			Genome-Wide Identification of miRNAs Responsive to Drought in Peach (Prunus persica) by High-Throughput Deep Sequencing	PLOS ONE			English	Article							MICROARRAY-BASED ANALYSIS; PLANT MICRORNA; SMALL RNAS; MEDICAGO-TRUNCATULA; STRESS; ARABIDOPSIS; BIOGENESIS; TARGETS; GENES; ANNOTATION	Peach (Prunus persica L.) is one of the most important worldwide fresh fruits. Since fruit growth largely depends on adequate water supply, drought stress is considered as the most important abiotic stress limiting fleshy fruit production and quality in peach. Plant responses to drought stress are regulated both at transcriptional and post-transcriptional level. As post-transcriptional gene regulators, miRNAs (miRNAs) are small (19-25 nucleotides in length), endogenous, non-coding RNAs. Recent studies indicate that miRNAs are involved in plant responses to drought. Therefore, Illumina deep sequencing technology was used for genome-wide identification of miRNAs and their expression profile in response to drought in peach. In this study, four sRNA libraries were constructed from leaf control (LC), leaf stress (LS), root control (RC) and root stress (RS) samples. We identified a total of 531, 471, 535 and 487 known mature miRNAs in LC, LS, RC and RS libraries, respectively. The expression level of 262 (104 up-regulated, 158 down-regulated) of the 453 miRNAs changed significantly in leaf tissue, whereas 368 (221 up-regulated, 147 down-regulated) of the 465 miRNAs had expression levels that changed significantly in root tissue upon drought stress. Additionally, a total of 197, 221, 238 and 265 novel miRNA precursor candidates were identified from LC, LS, RC and RS libraries, respectively. Target transcripts (137 for LC, 133 for LS, 148 for RC and 153 for RS) generated significant Gene Ontology (GO) terms related to DNA binding and catalytic activites. Genome-wide miRNA expression analysis of peach by deep sequencing approach helped to expand our understanding of miRNA function in response to drought stress in peach and Rosaceae. A set of differentially expressed miRNAs could pave the way for developing new strategies to alleviate the adverse effects of drought stress on plant growth and development. Citation: Eldem V, Celikkol Akcay U, Ozhuner E, Bakir Y, Uranbey S, et al. (2012) Genome-Wide Identification of miRNAs Responsive to Drought in Peach (Prunus persica) by High-Throughput Deep Sequencing. PLoS ONE 7(12): e50298. doi:10.1371/journal.pone.0050298	[Eldem, Vahap; Ozhuner, Esma; Uranbey, Serkan; Unver, Turgay] Cankiri Karatekin Univ, Fac Sci, Dept Biol, Cankiri, Turkey; [Eldem, Vahap] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey; [Akcay, Ufuk Celikkol] Suleyman Demirel Univ, Fac Agr, Dept Agr Biotechnol, TR-32200 Isparta, Turkey; [Bakir, Yakup] Marmara Univ, Fac Arts & Sci, Dept Biol, Istanbul, Turkey	Cankiri Karatekin University; Istanbul University; Suleyman Demirel University; Marmara University	Unver, T (corresponding author), Cankiri Karatekin Univ, Fac Sci, Dept Biol, Cankiri, Turkey.	turgayunver@gmail.com	Eldem, Vahap/A-9160-2018; Celikkol Akcay, Ufuk/A-1402-2011; Unver, Turgay/B-4819-2009; Uranbey, Serkan/AAF-2939-2020	Eldem, Vahap/0000-0003-3767-5661; Unver, Turgay/0000-0001-6760-443X; Celikkol Akcay, Ufuk/0000-0003-1260-3813; OZHUNER, ESMA/0000-0002-5456-3496	State Planning Organization of Turkey [DPT2010K120720]	State Planning Organization of Turkey(Turkiye Cumhuriyeti Kalkinma Bakanligi)	The study was supported by State Planning Organization of Turkey with grant no. DPT2010K120720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros Victor, 2004, Methods Mol Biol, V265, P131; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; BAIRD WV, 1994, J AM SOC HORTIC SCI, V119, P1312, DOI 10.21273/JASHS.119.6.1312; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buxdorf K, 2010, PLANTA, V232, P1009, DOI 10.1007/s00425-010-1231-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; CHALMERS DJ, 1978, ANN BOT-LONDON, V42, P285, DOI 10.1093/oxfordjournals.aob.a085459; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; De Paola D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-41; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gonzalez-Ibeas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-393; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jia XY, 2009, J PLANT PHYSIOL, V166, P2046, DOI 10.1016/j.jplph.2009.06.011; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li HY, 2011, PLANTA, V233, P611, DOI 10.1007/s00425-010-1327-2; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Lin SL, 2005, GENE, V356, P32, DOI 10.1016/j.gene.2005.04.036; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; MANTE S, 1989, PLANT CELL TISS ORG, V19, P1, DOI 10.1007/BF00037771; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nielsen Boye Schnack, 2012, Methods Mol Biol, V822, P67, DOI 10.1007/978-1-61779-427-8_5; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pennisi E, 2008, SCIENCE, V320, P171, DOI 10.1126/science.320.5873.171; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; RIEGER M, 1992, TREE PHYSIOL, V11, P369, DOI 10.1093/treephys/11.4.369; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Sunkar R., 2012, MICRORNAS PLANT DEV, P109, DOI [10.1007/978-3-642-27384-1_6, DOI 10.1007/978-3-642-27384-1_6]; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Takhtadzhian A.L., 1997, DIVERSITY CLASSIFICA; Tani E, 2011, PLANT PHYSIOL BIOCH, V49, P654, DOI 10.1016/j.plaphy.2011.01.020; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Unver T, 2010, MOL GENET GENOMICS, V283, P397, DOI 10.1007/s00438-010-0526-7; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-122; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P403, DOI 10.1007/s11295-007-0119-8; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zoltan H, 2010, METHODS MOL BIOL, V592, P127, DOI 10.1007/978-1-60327-005-2_9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	87	123	135	4	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50298	10.1371/journal.pone.0050298	http://dx.doi.org/10.1371/journal.pone.0050298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227166	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200027
J	Karanth, KK; Gopalaswamy, AM; DeFries, R; Ballal, N				Karanth, Krithi K.; Gopalaswamy, Arjun M.; DeFries, Ruth; Ballal, Natasha			Assessing Patterns of Human-Wildlife Conflicts and Compensation around a Central Indian Protected Area	PLOS ONE			English	Article							LARGE CARNIVORES; NATIONAL-PARK; LIVESTOCK; CROP; RESERVE; RISK; DEPREDATION; MANAGEMENT; ELEPHANTS; FARMS	Mitigating crop and livestock loss to wildlife and improving compensation distribution are important for conservation efforts in landscapes where people and wildlife co-occur outside protected areas. The lack of rigorously collected spatial data poses a challenge to management efforts to minimize loss and mitigate conflicts. We surveyed 735 households from 347 villages in a 5154 km 2 area surrounding Kanha Tiger Reserve in India. We modeled self-reported household crop and livestock loss as a function of agricultural, demographic and environmental factors, and mitigation measures. We also modeled self-reported compensation received by households as a function of demographic factors, conflict type, reporting to authorities, and wildlife species involved. Seventy-three percent of households reported crop loss and 33% livestock loss in the previous year, but less than 8% reported human injury or death. Crop loss was associated with greater number of cropping months per year and proximity to the park. Livestock loss was associated with grazing animals inside the park and proximity to the park. Among mitigation measures only use of protective physical structures were associated with reduced livestock loss. Compensation distribution was more likely for tiger related incidents, and households reporting loss and located in the buffer. Average estimated probability of crop loss was 0.93 and livestock loss was 0.60 for surveyed households. Estimated crop and livestock loss and compensation distribution were higher for households located inside the buffer. Our approach modeled conflict data to aid managers in identifying potential conflict hotspots, influential factors, and spatially maps risk probability of crop and livestock loss. This approach could help focus allocation of conservation efforts and funds directed at conflict prevention and mitigation where high densities of people and wildlife co-occur. Citation: Karanth KK, Gopalaswamy AM, DeFries R, Ballal N (2012) Assessing Patterns of Human-Wildlife Conflicts and Compensation around a Central Indian Protected Area. PLoS ONE 7(12): e50433. doi:10.1371/journal.pone.0050433	[Karanth, Krithi K.; DeFries, Ruth] Columbia Univ, New York, NY 10027 USA; [Karanth, Krithi K.; Gopalaswamy, Arjun M.; Ballal, Natasha] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Karanth, Krithi K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Gopalaswamy, Arjun M.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, England; [Gopalaswamy, Arjun M.] Wildlife Conservat Soc India Program, Bangalore, Karnataka, India	Columbia University; Duke University; University of Oxford	Karanth, KK (corresponding author), Columbia Univ, New York, NY 10027 USA.	krithi.karanth@gmail.com			National Science Foundation Grant [1029219]; Centre for Wildlife Studies; Wildlife Conservation Society-India program	National Science Foundation Grant(National Science Foundation (NSF)); Centre for Wildlife Studies; Wildlife Conservation Society-India program	National Science Foundation Grant Number 1029219 supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Centre for Wildlife Studies and Wildlife Conservation Society-India program for support. We are grateful to the Madhya Pradesh forest department especially H. S. Pabla, J. S. Chauhan, H. S. Mohanta and R. Shukla for their support. We thank S. Dasgupta, R. Jhaveri, S. Kotian and N. Patil. We thank volunteers A. Sur, A. Dhanpal, A. Joshi, A. Kerketta, N. Kumar, A. Bade, A. Kodilkar, A. Mendis, C. V. Casiker, D. Prasad, D. Dixit, I. Majhgaonkar, K. P. Kothari, Mythri. S, N. Surve, N. Shitole, P. Ghaskadbi, P. Baro, P. Thatte, P.R. Khambe, P. D. Kamble, R. Chakravarty, R. Jha, S. Sawat, Shashank K, S. Yadav, V. Kumar, Vatsaraj, V. Shinde, and Y. S. Patil. Columbia University IRB approved all survey protocols.	Akkala A., 2010, ENV PROGR SUSTAINABL, V29, P134, DOI DOI 10.1002/EP.10455; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Baruch-Mordo S., 2009, Human Dimensions of Wildlife, V14, P219, DOI 10.1080/10871200902839324; Boeringa M, 2003, KRIGING INTERPOLATOR; Boitani L, 2010, WILDLIFE RES, V37, P722, DOI 10.1071/WR10029; Bulte EH, 2005, J WILDLIFE MANAGE, V69, P14, DOI 10.2193/0022-541X(2005)069&lt;0014:WCWDMB&gt;2.0.CO;2; Campbell-Smith G, 2012, J APPL ECOL, V49, P367, DOI 10.1111/j.1365-2664.2012.02109.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cressie NAC, 1991, STAT SPATIAL DATA, P900; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Gehring TM, 2010, WILDLIFE RES, V37, P715, DOI 10.1071/WR10023; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Graham MD, 2008, ORYX, V42, P76, DOI 10.1017/S0030605308000677; Jarynowski A., 2010, LIFE TIME CORRELATIO, V1; Karanth KK, 2012, ENVIRON MANAGE, V49, P372, DOI 10.1007/s00267-011-9778-1; Karanth KU, 2002, MAKING PARKS WORK: STRATEGIES FOR PRESERVING TROPICAL NATURE, P250; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Mateo-Tomas P, 2012, J APPL ECOL, V49, P376, DOI 10.1111/j.1365-2664.2012.02119.x; McDonald-Madden E, 2008, J APPL ECOL, V45, P1630, DOI 10.1111/j.1365-2664.2008.01553.x; Mitas L., 1999, GEOGRAPHICAL INFORM, V8, P481; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Sekhar NU, 1998, ENVIRON CONSERV, V25, P160, DOI 10.1017/S0376892998000204; Sitati NW, 2005, J APPL ECOL, V42, P1175, DOI 10.1111/j.1365-2664.2005.01091.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 2005, CONSERV BIOL SER, V9, P86; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; Webber AD, 2007, ORYX, V41, P177, DOI 10.1017/S0030605307001792; White PCL, 2010, WILDLIFE RES, V37, P623, DOI 10.1071/WR10191; Woodroffe R., 2005, PEOPLE WILDLIFE CONF	39	88	92	3	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50433	10.1371/journal.pone.0050433	http://dx.doi.org/10.1371/journal.pone.0050433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227173	Green Published, gold			2022-12-25	WOS:000312588200034
J	Mason, B; Schmale, M; Gibbs, P; Miller, MW; Wang, Q; Levay, K; Shestopalov, V; Slepak, VZ				Mason, Benjamin; Schmale, Michael; Gibbs, Patrick; Miller, Margaret W.; Wang, Qiang; Levay, Konstantin; Shestopalov, Valery; Slepak, Vladlen Z.			Evidence for Multiple Phototransduction Pathways in a Reef-Building Coral	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; VISUAL PIGMENTS; LIGHT; EVOLUTION; COUNTERION; RHODOPSIN; ROD; PHOTORECEPTORS; MELANOPSIN; EXPRESSION	Photosensitive behaviors and circadian rhythms are well documented in reef-building corals and their larvae, but the mechanisms responsible for photoreception have not been described in these organisms. Here we report the cloning, immunolocalization, and partial biochemical characterization of three opsins and four G proteins expressed in planulae of the Caribbean elkhorn coral, Acropora palmata. All three opsins (acropsins 1-3) possess conserved seven-pass transmembrane structure, and localize to distinct regions of coral planulae. Acropsin 1 was localized in the larval endoderm, while acropsin 2 was localized in solitary cells of the ectoderm. These rod-like cells displayed a remarkably polarized distribution, concentrated in the aboral end. We also cloned four A. palmata G protein alpha subunits. Three were homologs of vertebrate Gi, Go, and Gq. The fourth is presumably a novel G protein, which displays only 40% identity with the nearest known G protein, and we termed it Gc for "cnidarian''. We show that Gc and Gq can be activated by acropsins in a light-dependent manner in vitro. This indicates that at least acropsins 1 and 3 can form functional photoreceptors and potentially may play a role in color preference during settlement, vertical positioning and other light-guided behaviors observed in coral larvae. Citation: Mason B, Schmale M, Gibbs P, Miller MW, Wang Q, et al. (2012) Evidence for Multiple Phototransduction Pathways in a Reef-Building Coral. PLoS ONE 7(12): e50371. doi:10.1371/journal.pone.0050371	[Mason, Benjamin; Wang, Qiang; Levay, Konstantin; Slepak, Vladlen Z.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Mason, Benjamin; Schmale, Michael; Gibbs, Patrick] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Miller, Margaret W.] Natl Marine Fisheries Serv, SE Fisheries Sci Ctr, Miami, FL USA; [Shestopalov, Valery] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA	University of Miami; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami	Mason, B (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	ben.mason@jcu.edu.au; VSlepak@med.miami.edu	Shestopalov, Valery/AAE-9838-2020	Shestopalov, Valery/0000-0002-1568-6637	Florida Keys National Marine Sanctuary; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program; Henry Foundation; Ocean Foundation; University of Miami SAC award; National Institutes of Health (NIH) [RO1EY018666, RO1GM060019, EY017991, EY021517]; NIH center grant [P30 EY014801]; Research to Prevent Blindness (RPB) grant; NATIONAL EYE INSTITUTE [R21EY017991, P30EY014801, R01EY018666, R01EY021517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060019] Funding Source: NIH RePORTER	Florida Keys National Marine Sanctuary; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Henry Foundation; Ocean Foundation; University of Miami SAC award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB) grant(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge D. Williams, L. Johnston, and others for their assistance with fieldwork and larval culture, M. Medina for supplying larval RNA, I. Baums and N. Polato for sharing unpublished A. palmata transcriptome data, G. Gaidosh for help with confocal microscopy and imaging, R. Crouch (Medical University of South Carolina and NEI, National Institutes of Health) for providing 11-cis-retinal, D. Farrens for helpful discussions, and R. Albright for advice during preparation of this manuscript. This project was facilitated by permits FKNMS-2006-026, FKNMS-2009-022, FKNMS-2010-055, and support from the Florida Keys National Marine Sanctuary.; Funding was provided by the National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program, the Henry Foundation, and the Ocean Foundation. The project was also supported by University of Miami SAC award and National Institutes of Health (NIH) grants RO1EY018666 and RO1GM060019 (VZS) and EY017991 and EY021517 (VIS), NIH center grant P30 EY014801 and an unrestricted Research to Prevent Blindness (RPB) grant to the Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady AK, 2009, CORAL REEFS, V28, P677, DOI 10.1007/s00338-009-0498-4; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P107, DOI 10.1007/978-94-007-0114-4_8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gleason DF, 2006, MAR BIOL, V148, P503, DOI 10.1007/s00227-005-0098-y; Gorbunov MY, 2002, LIMNOL OCEANOGR, V47, P309, DOI 10.4319/lo.2002.47.1.0309; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Jones JC, 2010, SIGNAL COMMUN PLANTS, P1, DOI 10.1007/978-3-642-03524-1_1; Kawaguti S., 1941, Palao Tropical Biological Station Studies, V2, P319; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Koyanagi M, 1998, FEBS LETT, V439, P66, DOI 10.1016/S0014-5793(98)01339-8; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Land MF, 2002, OXFORD ANIMAL BIOLOG; LASKER HR, 1979, BIOL BULL, V156, P196, DOI 10.2307/1541043; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Mason B, 2011, CORAL REEFS, V30, P667, DOI 10.1007/s00338-011-0739-1; Mason BM, 2012, BIOL BULL-US, V222, P88, DOI 10.1086/BBLv222n2p88; Miller Margaret W., 2006, P219; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NAVON SE, 1987, J BIOL CHEM, V262, P15746; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Plachetzki DC, 2010, P ROY SOC B-BIOL SCI, V277, P1963, DOI 10.1098/rspb.2009.1797; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Rozen S, 2000, Methods Mol Biol, V132, P365; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SINGLA CL, 1974, CELL TISSUE RES, V149, P413; Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059; Sweeney AM, 2011, J EXP BIOL, V214, P770, DOI 10.1242/jeb.043406; Szmant A. M., 2006, P 10 INT COR REEF S, P431; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; VANDERMEULEN JH, 1974, MAR BIOL, V27, P239, DOI 10.1007/BF00391949; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westfall JA, 1998, INVERTEBR BIOL, V117, P186, DOI 10.2307/3226984; Wolken J., 1995, LIGHT DETECTORS PHOT; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; YOKOYAMA S, 1995, MOL BIOL EVOL, V12, P53, DOI 10.1093/oxfordjournals.molbev.a040190	51	30	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50371	10.1371/journal.pone.0050371	http://dx.doi.org/10.1371/journal.pone.0050371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227169	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200030
J	Moreira, B; Pausas, JG				Moreira, Bruno; Pausas, Juli G.			Tanned or Burned: The Role of Fire in Shaping Physical Seed Dormancy	PLOS ONE			English	Article							HEAT-SHOCK; POSTFIRE SUCCESSION; GERMINATION; FLAMMABILITY; SMOKE; INTENSITY; CISTACEAE; DYNAMICS; HISTORY; TRAITS	Plant species with physical seed dormancy are common in mediterranean fire-prone ecosystems. Because fire breaks seed dormancy and enhances the recruitment of many species, this trait might be considered adaptive in fire-prone environments. However, to what extent the temperature thresholds that break physical seed dormancy have been shaped by fire (i.e., for post-fire recruitment) or by summer temperatures in the bare soil (i.e., for recruitment in fire-independent gaps) remains unknown. Our hypothesis is that the temperature thresholds that break physical seed dormancy have been shaped by fire and thus we predict higher dormancy lost in response to fire than in response to summer temperatures. We tested this hypothesis in six woody species with physical seed dormancy occurring in fire-prone areas across the Mediterranean Basin. Seeds from different populations of each species were subject to heat treatments simulating fire (i.e., a single high temperature peak of 100 degrees C, 120 degrees C or 150 degrees C for 5 minutes) and heat treatments simulating summer (i.e., temperature fluctuations; 30 daily cycles of 3 hours at 31 degrees C, 4 hours at 43 degrees C, 3 hours at 33 degrees C and 14 hours at 18 degrees C). Fire treatments broke dormancy and stimulated germination in all populations of all species. In contrast, summer treatments had no effect over the seed dormancy for most species and only enhanced the germination in Ulex parviflorus, although less than the fire treatments. Our results suggest that in Mediterranean species with physical dormancy, the temperature thresholds necessary to trigger seed germination are better explained as a response to fire than as a response to summer temperatures. The high level of dormancy release by the heat produced by fire might enforce most recruitment to be capitalized into a single post-fire pulse when the most favorable conditions occur. This supports the important role of fire in shaping seed traits.	[Moreira, Bruno; Pausas, Juli G.] Ctr Invest Desertificac CIDE CSIC, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Pausas, JG (corresponding author), Ctr Invest Desertificac CIDE CSIC, Valencia, Spain.	juli.g.pausas@uv.es	Moreira, Bruno/G-6080-2011; Pausas, Juli/C-5794-2008	Moreira, Bruno/0000-0002-7319-2555; Pausas, Juli/0000-0003-3533-5786	Spanish Government (VIRRA) [CGL2009-12048/BOS]; Fundacao para a Ciencia e Tecnologia grant (Portugal) [SFRH/BD/41343/2007]	Spanish Government (VIRRA); Fundacao para a Ciencia e Tecnologia grant (Portugal)	The work has been financed by the Spanish Government (VIRRA, CGL2009-12048/BOS). B.M. is supported by the Fundacao para a Ciencia e Tecnologia grant (SFRH/BD/41343/2007, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULD TD, 1991, AUST J ECOL, V16, P53, DOI 10.1111/j.1442-9993.1991.tb01481.x; Auld TD, 1996, AUST J ECOL, V21, P106, DOI 10.1111/j.1442-9993.1996.tb00589.x; Baeza MJ, 2011, J VEG SCI, V22, P467, DOI 10.1111/j.1654-1103.2011.01262.x; Baeza MJ, 2008, FOREST ECOL MANAG, V256, P685, DOI 10.1016/j.foreco.2008.05.014; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; Bell DT, 1998, AUST J BOT, V46, P221, DOI 10.1071/BT97010; BELL DT, 1993, BOT REV, V59, P24, DOI 10.1007/BF02856612; Benjamini Y, 2001, ANN STAT, V29, P1165; Bond WJ, 2010, NEW PHYTOL, V188, P1137, DOI 10.1111/j.1469-8137.2010.03418.x; BOND WJ, 1990, S AFR J BOT, V56, P326, DOI 10.1016/S0254-6299(16)31060-2; BRADSHAW SD, 2011, TRENDS PLANT SCI, V16, P69, DOI DOI 10.1016/j.tplants.2010.10.007; Buhk C, 2006, J ARID ENVIRON, V66, P193, DOI 10.1016/j.jaridenv.2005.11.007; Clemente AS, 2007, PLANT ECOL, V190, P175, DOI 10.1007/s11258-006-9199-z; Fenner M., 2005, ECOLOGY SEEDS; Segarra-Moragues JG, 2010, EVOLUTION, V64, P3511, DOI 10.1111/j.1558-5646.2010.01064.x; Gomez-Gonzalez S, 2011, P NATL ACAD SCI USA, V108, P18743, DOI 10.1073/pnas.1108863108; Gomez-Gonzalez S, 2011, DIVERS DISTRIB, V17, P58, DOI 10.1111/j.1472-4642.2010.00728.x; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; He TH, 2011, NEW PHYTOL, V191, P184, DOI 10.1111/j.1469-8137.2011.03663.x; Herranz JM, 1998, PLANT ECOL, V136, P95, DOI 10.1023/A:1009702318641; Herranz JM, 1999, INT J WILDLAND FIRE, V9, P173, DOI 10.1071/WF00014; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Keeley J. E., 2012, FIRE MEDITERRANEAN E; KEELEY JE, 1991, BOT REV, V57, P81, DOI 10.1007/BF02858766; Keeley JE, 1986, RESILIENCE MEDITERRA, P95, DOI DOI 10.1007/978-94-009-4822-8_7; Keeley JE, 1995, ECOLOGY BIOGEOGRAPHY, V108, P239; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keith DA, 1997, OECOLOGIA, V112, P340, DOI 10.1007/s004420050318; LLORET F, 1993, J VEG SCI, V4, P367, DOI 10.2307/3235595; Luna B, 2007, ENVIRON EXP BOT, V60, P324, DOI 10.1016/j.envexpbot.2006.12.014; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Moreira B, 2012, OECOLOGIA, V168, P671, DOI 10.1007/s00442-011-2127-5; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; MORENO JM, 1991, ECOLOGY, V72, P1993, DOI 10.2307/1941554; MORENO JM, 1991, OECOLOGIA, V85, P429, DOI 10.1007/BF00320621; Morrison DA, 1998, ANN BOT-LONDON, V82, P35, DOI 10.1006/anbo.1998.0640; Ooi MKJ, 2012, PLANT SOIL, V353, P289, DOI 10.1007/s11104-011-1032-3; Paula S, 2008, J ECOL, V96, P543, DOI 10.1111/j.1365-2745.2008.01359.x; Paula S., 2009, ECOLOGY, V90, P1420, DOI DOI 10.1890/08-1309.1; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Pausas JG, 2012, NEW PHYTOL, V194, P610, DOI 10.1111/j.1469-8137.2012.04132.x; Pausas JG, 2012, NEW PHYTOL, V193, P301, DOI 10.1111/j.1469-8137.2011.04010.x; Pausas JG, 2012, NEW PHYTOL, V193, P18, DOI 10.1111/j.1469-8137.2011.03945.x; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Santana VM, 2012, ACTA OECOL, V39, P51, DOI 10.1016/j.actao.2011.12.001; Santana VM, 2010, AUST J BOT, V58, P539, DOI 10.1071/BT10144; Saura-Mas S, 2010, INT J WILDLAND FIRE, V19, P783, DOI 10.1071/WF09066; Schwilk DW, 2003, AM NAT, V162, P725, DOI 10.1086/379351; THANOS CA, 1991, ANN BOT-LONDON, V68, P469, DOI 10.1093/oxfordjournals.aob.a088280; THANOS CA, 1992, ISRAEL J BOT, V41, P251; Thomas PB, 2003, AUSTRAL ECOL, V28, P674, DOI 10.1046/j.1442-9993.2003.1330.doc.x; Thompson K, 2010, SEED SCI RES, V20, P209, DOI 10.1017/S0960258510000267; Tieu A, 2001, ANN BOT-LONDON, V88, P259, DOI 10.1006/anbo.2001.1451; TRABAUD L, 1979, ANN SCI FOREST, V36, P13, DOI 10.1051/forest/19790102; Vesk PA, 2004, OIKOS, V107, P72, DOI 10.1111/j.0030-1299.2004.13122.x; [No title captured]	57	100	109	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51523	10.1371/journal.pone.0051523	http://dx.doi.org/10.1371/journal.pone.0051523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227267	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200126
J	Schaevitz, LR; Nicolai, R; Lopez, CM; D'Iddio, S; Iannoni, E; Berger-Sweeney, JE				Schaevitz, Laura R.; Nicolai, Raffaella; Lopez, Carla M.; D'Iddio, Stefania; Iannoni, Emerenziana; Berger-Sweeney, Joanne E.			Acetyl-L-Carnitine Improves Behavior and Dendritic Morphology in a Mouse Model of Rett Syndrome	PLOS ONE			English	Article							DIETARY CHOLINE SUPPLEMENTATION; NEUROTROPHIC FACTOR EXPRESSION; MECP2 MUTANT MICE; CEREBRAL-CORTEX; IN-VIVO; RESPIRATORY-FUNCTION; NEURONAL MATURATION; MOLECULAR-GENETICS; MENTAL-RETARDATION; PYRAMIDAL NEURONS	Rett syndrome (RTT) is a devastating neurodevelopmental disorder affecting 1 in 10,000 girls. Approximately 90% of cases are caused by spontaneous mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2). Girls with RTT suffer from severe motor, respiratory, cognitive and social abnomalities attributed to early deficits in synaptic connectivity which manifest in the adult as a myriad of physiological and anatomical abnormalities including, but not limited to, dimished dendritic complexity. Supplementation with acetyl-L-carnitine (ALC), an acetyl group donor, ameliorates motor and cognitive deficits in other disease models through a variety of mechanisms including altering patterns of histone acetylation resulting in changes in gene expression, and stimulating biosynthetic pathways such as acetylcholine. We hypothesized ALC treatment during critical periods in cortical development would promote normal synaptic maturation, and continuing treatment would improve behavioral deficits in the Mecp2(1lox) mouse model of RTT. In this study, wildtype and Mecp2(1lox) mutant mice received daily injections of ALC from birth until death (postnatal day 47). General health, motor, respiratory, and cognitive functions were assessed at several time points during symptom progression. ALC improved weight gain, grip strength, activity levels, prevented metabolic abnormalities and modestly improved cognitive function in Mecp2 null mice early in the course of treatment, but did not significantly improve motor or cognitive functions assessed later in life. ALC treatment from birth was associated with an almost complete rescue of hippocampal dendritic morphology abnormalities with no discernable side effects in the mutant mice. Therefore, ALC appears to be a promising therapeutic approach to treating early RTT symptoms and may be useful in combination with other therapies.	[Schaevitz, Laura R.; Lopez, Carla M.; Berger-Sweeney, Joanne E.] Wellesley Coll, Dept Biol, Wellesley, MA 02181 USA; [Nicolai, Raffaella; D'Iddio, Stefania; Iannoni, Emerenziana] Sigma Tau Pharmaceut Co, Pomezia, Italy	Wellesley College; Leadiant Biosciences	Schaevitz, LR (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	Laura.Schaevitz@tufts.edu			Sigma-Tau SpA	Sigma-Tau SpA	These studies were sponsored by Sigma-Tau SpA. The funders played a role in the study design, analysis of samples for carnitine measurements, the decision to publish, and reviewed the manuscript prior to submission for publication. The funders played no role in collection or analysis of the behavioral, neuroanatomical, or growth factor analysis data.	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; BELICHENKO PV, 1995, J NEUROSCI METH, V57, P55, DOI 10.1016/0165-0270(94)00125-Z; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Berger-Sweeney J, 2011, NEUROBIOL LEARN MEM, V96, P637, DOI 10.1016/j.nlm.2011.05.006; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Blue ME, 1999, EXP NEUROL, V156, P345, DOI 10.1006/exnr.1999.7030; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; CASTORINA M, 1993, EXP GERONTOL, V28, P537, DOI 10.1016/0531-5565(93)90042-C; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Cobb S, 2010, BIOCHEM SOC T, V38, P498, DOI 10.1042/BST0380498; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; DAVIS S, 1993, NEUROBIOL AGING, V14, P107, DOI 10.1016/0197-4580(93)90030-F; DAY J, 1991, PHARMACOL BIOCHEM BE, V38, P723, DOI 10.1016/0091-3057(91)90233-R; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dunn HG, 2001, CAN J NEUROL SCI, V28, P16; Ellaway C, 1999, J CHILD NEUROL, V14, P162, DOI 10.1177/088307389901400306; Ellaway CJ, 2001, BRAIN DEV-JPN, V23, pS85, DOI 10.1016/S0387-7604(01)00346-1; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Goulart BK, 2010, NEUROSCIENCE, V167, P969, DOI 10.1016/j.neuroscience.2010.03.032; Guideri F, 2005, PEDIATR CARDIOL, V26, P574, DOI 10.1007/s00246-005-0784-z; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P372, DOI 10.1016/S0387-7604(85)80048-6; Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562; Halbach NSJ, 2008, AM J MED GENET A, V146A, P1925, DOI 10.1002/ajmg.a.32361; HAMBERGER A, 1992, NEUROPEDIATRICS, V23, P212, DOI 10.1055/s-2008-1071344; Hohmann CF, 1998, PERSPECT DEV NEUROBI, V5, P401; IMPERATO A, 1989, NEUROSCI LETT, V107, P251, DOI 10.1016/0304-3940(89)90826-4; Inano A, 2003, BIOPHARM DRUG DISPOS, V24, P357, DOI 10.1002/bdd.371; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kishi N, 2010, EXP NEUROL, V222, P51, DOI 10.1016/j.expneurol.2009.12.007; Le Gouill E, 2007, DIABETES, V56, P2690, DOI 10.2337/db06-1228; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x; McFarlane S, 2000, MOL NEUROBIOL, V22, P1, DOI 10.1385/MN:22:1-3:001; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Meng H, 2007, BRAIN RES, V1160, P47, DOI 10.1016/j.brainres.2007.05.048; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nag N, 2008, BRAIN RES, V1237, P101, DOI 10.1016/j.brainres.2008.08.042; Nag N, 2007, NEUROBIOL DIS, V26, P473, DOI 10.1016/j.nbd.2007.02.003; Naidu S, 2001, BRAIN DEV-JPN, V23, pS62, DOI 10.1016/S0387-7604(01)00381-3; Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007; Pepeu G, 2004, LEARN MEMORY, V11, P21, DOI 10.1101/lm.68104; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Rezvani A. H., 2006, ANIMAL MODELS COGNIT; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; Robinson L, 2012, BRAIN J NEUROLOGY; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Roux JC, 2007, EUR J NEUROSCI, V25, P1915, DOI 10.1111/j.1460-9568.2007.05466.x; Scafidi S, 2010, J NEUROCHEM, V114, P820, DOI 10.1111/j.1471-4159.2010.06807.x; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schaevitz LR, 2010, PHYSIOL BEHAV, V100, P255, DOI 10.1016/j.physbeh.2009.12.025; Schmid DA, 2012, J NEUROSCI, V32, P1803, DOI 10.1523/JNEUROSCI.0865-11.2012; SERESS L, 1981, J ANAT, V133, P181; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Taglialatela G, 1996, EXP GERONTOL, V31, P577, DOI 10.1016/0531-5565(96)00052-6; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; TOTH E, 1993, NEUROCHEM RES, V18, P573, DOI 10.1007/BF00966933; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006; Ward BC, 2009, J NEUROCHEM, V108, P361, DOI 10.1111/j.1471-4159.2008.05768.x; WAWRZENCZYK A, 1995, NEUROCHEM INT, V26, P635, DOI 10.1016/0197-0186(94)00162-N; WAWRZENCZYK A, 1995, BIOCHEM BIOPH RES CO, V213, P383, DOI 10.1006/bbrc.1995.2143; Wawrzenczyk A, 2001, EUR J BIOCHEM, V268, P2091, DOI 10.1046/j.1432-1327.2001.02087.x; Wenk GL, 1999, NEUROPEDIATRICS, V30, P125, DOI 10.1055/s-2007-973476; Wu GY, 1999, J NEUROSCI, V19, P4472; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; ZOGHBI HY, 1989, ANN NEUROL, V25, P56, DOI 10.1002/ana.410250109	80	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51586	10.1371/journal.pone.0051586	http://dx.doi.org/10.1371/journal.pone.0051586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227269	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200128
J	Ertelt, D; Witt, K; Reetz, K; Frank, W; Junghanns, K; Backhaus, J; Tadic, V; Pellicano, A; Born, J; Binkofski, F				Ertelt, Denis; Witt, Karsten; Reetz, Kathrin; Frank, Wolfgang; Junghanns, Klaus; Backhaus, Jutta; Tadic, Vera; Pellicano, Antonello; Born, Jan; Binkofski, Ferdinand			Skill Memory Escaping from Distraction by Sleep-Evidence from Dual-Task Performance	PLOS ONE			English	Article							MOTOR MEMORY; TIME-COURSE; SEQUENCE; CONSOLIDATION; ACQUISITION; ATTENTION	Background: Sleep facilitates off-line consolidation of memories, as shown for learning of motor skills in the absence of concomitant distractors. We often perform complex tasks focusing our attention mostly on one single part of them. However, we are equally able to skillfully perform other concurrent tasks. One may even improve performance on disregarded parts of complex tasks, which were learned implicitly. In the present study we investigated the role of sleep in the off-line consolidation of procedural skills when attention is diverted from the procedural task because of interference from a concurrent task. Methodology/Principal Findings: We used a dual-task paradigm containing (i) procedural serial reaction time task (SRTT), which was labeled as subordinate and unimportant and (ii) declarative word-pair association task (WPAT), performed concomitantly. The WPAT served as a masked distractor to SRTT and was strongly reinforced by the instructions. One experimental and three control groups were tested. The experimental group was re-tested after two nights of sleep (sleep group, SG). The first control group had sleep deprivation on the first post-learning night (nighttime-awake group, NA), the second control group was tested in the morning and then re-tested after 12-hours (daytime-awake group, DA); the third one had the same assignments as DA but with a subsequent, instead of a concomitant, WPAT (daytime-awake-subsequent-WPAT group, DAs). We found SRTT performance gains in SG but not in NA and DA groups. Furthermore, SG reached similar learning gains in SRTT as the DAs group, which gained in SRTT performance because of post-training interference from the declarative task. Conclusions/Significance: The results demonstrate that sleep allows off-line consolidation, which is resistant to deteriorating effects of a reinforced distractor on the implicit procedural learning and allowing for gains which are consistent with those produced when inhibited declarative memories of SRTT do not compete with procedural ones. Citation: Ertelt D, Witt K, Reetz K, Frank W, Junghanns K, et al. (2012) Skill Memory Escaping from Distraction by Sleep-Evidence from Dual-Task Performance. PLoS ONE 7(12): e50983. doi:10.1371/journal.pone.0050983	[Reetz, Kathrin; Binkofski, Ferdinand] Res Ctr Julich, Inst Neurosci & Med, Julich, Germany; [Ertelt, Denis; Tadic, Vera] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Witt, Karsten] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany; [Reetz, Kathrin] Rhein Westfal TH Aachen Univ, Dept Neurol, Aachen, Germany; [Reetz, Kathrin; Binkofski, Ferdinand] Rhein Westfal TH Aachen Univ, JARA BRAIN Translat Brain Med, Aachen, Germany; [Junghanns, Klaus; Backhaus, Jutta] Med Univ Lubeck, Dept Psychiat, D-23538 Lubeck, Germany; [Born, Jan] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Pellicano, Antonello; Binkofski, Ferdinand] Rhein Westfal TH Aachen, Dept Neurol, Fac Med, Div Clin & Cognit Neurosci, Aachen, Germany	Helmholtz Association; Research Center Julich; University of Lubeck; University of Kiel; RWTH Aachen University; RWTH Aachen University; University of Lubeck; University of Lubeck; RWTH Aachen University	Binkofski, F (corresponding author), Res Ctr Julich, Inst Neurosci & Med, Julich, Germany.	fbinkofski@ukaachen.de	Binkofski, Ferdinand/S-6997-2017; Born, Jan/K-2596-2016; Reetz, Kathrin/H-9510-2012; Pellicano, Antonello/C-7638-2017	Binkofski, Ferdinand/0000-0002-6750-943X; Born, Jan/0000-0002-1847-6248; Reetz, Kathrin/0000-0002-9730-9228; Pellicano, Antonello/0000-0003-1517-1323	German Research Council (Sonderforschungsbereich) [SFB 654, A2, A11]	German Research Council (Sonderforschungsbereich)(German Research Foundation (DFG))	This study was supported by the German Research Council (Sonderforschungsbereich SFB 654, Projects A2 and A11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; Ebbinghaus, 1885, GEDACHTNIS; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Graves EA, 1936, J EXP PSYCHOL, V19, P316, DOI 10.1037/h0057827; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Janke W, 2003, J EXPT PSYCHOL LEARN, V22, P948; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; KNOPMAN DS, 1987, NEUROLOGY, V37, P784, DOI 10.1212/WNL.37.5.784; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Newman EB, 1939, AM J PSYCHOL, V52, P65, DOI 10.2307/1416661; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Robertson EM, 2004, CURR BIOL, V14, pR1061, DOI 10.1016/j.cub.2004.11.048; Seidler RD, 2002, SCIENCE, V296, P2043, DOI 10.1126/science.1068524; SMITH C, 1994, J SLEEP RES, V3, P206, DOI 10.1111/j.1365-2869.1994.tb00133.x; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Van Ormer EB, 1933, PSYCHOL BULL, V30, P415, DOI 10.1037/h0071478; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047	39	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e50983	10.1371/journal.pone.0050983	http://dx.doi.org/10.1371/journal.pone.0050983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	051EQ	23226554	Green Submitted, Green Published, gold			2022-12-25	WOS:000312108500038
J	Adachi, E; Nakajima, H; Mizuguchi, C; Dhanasekaran, P; Kawashima, H; Nagao, K; Akaji, K; Lund-Katz, S; Phillips, MC; Saito, H				Adachi, Emi; Nakajima, Hiroyuki; Mizuguchi, Chiharu; Dhanasekaran, Padmaja; Kawashima, Hiroyuki; Nagao, Kohjiro; Akaji, Kenichi; Lund-Katz, Sissel; Phillips, Michael C.; Saito, Hiroyuki			Dual Role of an N-terminal Amyloidogenic Mutation in Apolipoprotein A-I DESTABILIZATION OF HELIX BUNDLE AND ENHANCEMENT OF FIBRIL FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID INTERACTION; CRYSTAL-STRUCTURE; DOMAIN; MECHANISM; OLIGOMERS; HDL; ORGANIZATION; KINETICS; REVEALS; BINDING	A number of naturally occurring mutations of apolipoprotein (apo) A-I, the major protein of HDL, are known to be associated with hereditary amyloidosis and atherosclerosis. Here, we examined the effects of the G26R point mutation in apoA-I (apoA-I-Iowa) on the structure, stability, and aggregation propensity to form amyloid fibril of full-length apoA-I and the N-terminal fragment of apoA-I. Circular dichroism and fluorescence measurements demonstrated that the G26R mutation destabilizes the N-terminal helix bundle domain of full-length protein, leading to increased hydrophobic surface exposure, whereas it has no effect on the initial structure of the N-terminal 1-83 fragment, which is predominantly a random coil structure. Upon incubation for extended periods at neutral pH, the N-terminal 1-83 variants undergo a conformational change to beta-sheet-rich structure with a great increase in thioflavin T fluorescence, whereas no structural change is observed in full-length proteins. Comparison of fibril-forming propensity among substituted mutants at Gly-26 position of 1-83 fragments demonstrated that the G26R mutation enhances the nucleation step of fibril formation, whereas G26K and G26E mutations have small or inhibiting effects on the formation of fibrils. These fibrils of the 1-83 variants have long and straight morphology as revealed by atomic force microscopy and exhibited significant toxicity with HEK293 cells. Our results indicate dual critical roles of the arginine residue at position 26 in apoA-I-Iowa: destabilization of the N-terminal helix bundle structure in full-length protein and enhancement of amyloid fibril formation by the N-terminal 1-83 fragment.	[Nagao, Kohjiro; Saito, Hiroyuki] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708505, Japan; [Nagao, Kohjiro; Saito, Hiroyuki] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Kawashima, Hiroyuki; Akaji, Kenichi] Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan; [Dhanasekaran, Padmaja; Lund-Katz, Sissel; Phillips, Michael C.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Lipid Res Grp,Gastroenterol Hepatol & Nutr Div, Philadelphia, PA 19104 USA	Tokushima University; Tokushima University; Kyoto Pharmaceutical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Saito, H (corresponding author), Univ Tokushima, Inst Hlth Biosci, 1-78-1 Shomachi, Tokushima 7708505, Japan.	hsaito@tokushima-u.ac.jp		Phillips, Michael/0000-0002-7147-8007	National Institutes of Health [HL22633]; Japan Society for the Promotion of Science [22590046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL22633 (to M. C. P.). This work was also supported by Grant-in-Aid for Scientific Research 22590046 (to H. S.) from the Japan Society for the Promotion of Science.	Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Chetty PS, 2012, BIOCHEMISTRY-US, V51, P8993, DOI 10.1021/bi300926j; Crespo R, 2012, J BIOL CHEM, V287, P30585, DOI 10.1074/jbc.M112.375345; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Di Gaetano S, 2006, BIOCHEM BIOPH RES CO, V351, P223, DOI 10.1016/j.bbrc.2006.10.026; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fang YL, 2003, BIOCHEMISTRY-US, V42, P13260, DOI 10.1021/bi0354031; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; Genschel J, 1998, FEBS LETT, V430, P145, DOI 10.1016/S0014-5793(98)00668-1; Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014; Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; Hristova K, 2011, J MEMBRANE BIOL, V239, P49, DOI 10.1007/s00232-010-9323-9; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kono M, 2010, J LIPID RES, V51, P809, DOI 10.1194/jlr.M002113; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; RADER DJ, 1992, J LIPID RES, V33, P755; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Ramella NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043755; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; SEGREST JP, 1992, J LIPID RES, V33, P141; Shukla D, 2010, J PHYS CHEM B, V114, P13426, DOI 10.1021/jp108399g; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Teoh CL, 2011, PROTEIN CELL, V2, P116, DOI 10.1007/s13238-011-1013-6; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vacca RA, 1997, J BIOL CHEM, V272, P21932, DOI 10.1074/jbc.272.35.21932; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wong YQ, 2012, FEBS LETT, V586, P1754, DOI 10.1016/j.febslet.2012.05.007; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688; Zaiou M, 2000, J LIPID RES, V41, P1087; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832	54	33	33	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2848	2856		10.1074/jbc.M112.428052	http://dx.doi.org/10.1074/jbc.M112.428052			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233678	hybrid, Green Published			2022-12-25	WOS:000314211500067
J	Alsterberg, C; Sundback, K; Hulth, S				Alsterberg, Christian; Sundback, Kristina; Hulth, Stefan			Functioning of a Shallow-Water Sediment System during Experimental Warming and Nutrient Enrichment	PLOS ONE			English	Article							PHYTOPLANKTON GROWTH; SEAGRASS ECOSYSTEMS; NITROGEN FLUXES; DENITRIFICATION; TEMPERATURE; MICROPHYTOBENTHOS; EUTROPHICATION; RESPIRATION; BACTERIA; CHLOROPHYLL	Effects of warming and nutrient enrichment on intact unvegetated shallow-water sediment were investigated for 5 weeks in the autumn under simulated natural field conditions, with a main focus on trophic state and benthic nitrogen cycling. In a flow-through system, sediment was exposed to either seawater at ambient temperature or seawater heated 4 degrees C above ambient, with either natural or nutrient enriched water. Sediment-water fluxes of oxygen and inorganic nutrients, nitrogen mineralization, and denitrification were measured. Warming resulted in an earlier shift to net heterotrophy due to increased community respiration; primary production was not affected by temperature but (slightly) by nutrient enrichment. The heterotrophic state was, however, not further strengthened by warming, but was rather weakened, probably because increased mineralization induced a shortage of labile organic matter. Climate-related warming of seawater during autumn could therefore, in contrast to previous predictions, induce shorter but more intensive heterotrophic periods in shallow-water sediments, followed by longer autotrophic periods. Increased nitrogen mineralization and subsequent effluxes of ammonium during warming suggested a preferential response of organisms driving nitrogen mineralization when compared to sinks of ammonium such as nitrification and algal assimilation. Warming and nutrient enrichment resulted in non-additive effects on nitrogen mineralization and denitrification (synergism), as well as on benthic fluxes of phosphate (antagonism). The mode of interaction appears to be related to the trophic level of the organisms that are the main drivers of the affected processes. Despite the weak response of benthic microalgae to both warming and nutrient enrichment, the assimilation of nitrogen by microalgae was similar in magnitude to rates of nitrogen mineralization. This implies a sustained filter function and retention capacity of nutrients by the sediment.	[Alsterberg, Christian; Sundback, Kristina] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Hulth, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Alsterberg, C (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	christian.alsterberg@bioenv.gu.se	Hulth, Stefan/D-1875-2009		Swedish Research Council for Environment, Agricultural Science and Special Planning (FORMAS); Memorial Fund of Birgit and Birger Wahlstrom; Royal Society of Arts and Sciences in Gothenburg; Sven Loven Centre of Marine Research, University of Gothenburg	Swedish Research Council for Environment, Agricultural Science and Special Planning (FORMAS)(Swedish Research Council Formas); Memorial Fund of Birgit and Birger Wahlstrom; Royal Society of Arts and Sciences in Gothenburg; Sven Loven Centre of Marine Research, University of Gothenburg	Financial support was received from the Swedish Research Council for Environment, Agricultural Science and Special Planning (FORMAS), the Memorial Fund of Birgit and Birger Wahlstrom, the Royal Society of Arts and Sciences in Gothenburg, and the Sven Loven Centre of Marine Research, University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal W, 1984, ECOLOGY ESTUARINE SE; Alsterberg C, 2011, LIMNOL OCEANOGR, V56, P2147, DOI 10.4319/lo.2011.56.6.2147; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1972, B FISHERIES RES BOAR; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; ASMUS RM, 1994, HELGOLANDER MEERESUN, V48, P257, DOI 10.1007/BF02367040; Baden S, 2010, LIMNOL OCEANOGR, V55, P1435, DOI 10.4319/lo.2010.55.3.1435; Baulch HM, 2005, LIMNOL OCEANOGR, V50, P1377, DOI 10.4319/lo.2005.50.5.1377; Bintz JC, 2003, ESTUARIES, V26, P765, DOI 10.1007/BF02711987; BLACKBURN TH, 1983, LIMNOL OCEANOGR, V28, P477, DOI 10.4319/lo.1983.28.3.0477; Boros G, 2011, HYDROBIOLOGIA, V665, P117, DOI 10.1007/s10750-011-0609-4; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Christensen MR, 2006, GLOBAL CHANGE BIOL, V12, P2316, DOI 10.1111/j.1365-2486.2006.01257.x; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Cook PLM, 2007, AQUAT MICROB ECOL, V49, P165, DOI 10.3354/ame01142; Cook PLM, 2009, MAR ECOL PROG SER, V394, P35, DOI 10.3354/meps08270; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DELIA CF, 1986, CAN J FISH AQUAT SCI, V43, P397, DOI 10.1139/f86-050; Development Core Team R, 2010, LANG ENV STAT COMP; Doyle SA, 2005, LIMNOL OCEANOGR, V50, P1362, DOI 10.4319/lo.2005.50.5.1362; Dueri S, 2009, ECOL MODEL, V220, P2060, DOI 10.1016/j.ecolmodel.2009.04.052; Engelsen A, 2008, ESTUAR COAST SHELF S, V78, P783, DOI 10.1016/j.ecss.2008.02.018; Eyre BD, 2002, MAR ECOL PROG SER, V229, P43, DOI 10.3354/meps229043; Feuchtmayr H, 2009, J APPL ECOL, V46, P713, DOI 10.1111/j.1365-2664.2009.01644.x; Fitch JE, 2011, J EXP MAR BIOL ECOL, V400, P257, DOI 10.1016/j.jembe.2011.02.005; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Gameiro C, 2004, HYDROBIOLOGIA, V525, P113, DOI 10.1023/B:HYDR.0000038858.29164.31; Garcia-Ruiz R, 1998, APPL ENVIRON MICROB, V64, P2533; Glud RN, 2002, MAR ECOL PROG SER, V238, P15, DOI 10.3354/meps238015; Gudmundsdottir R, 2011, FRESHWATER BIOL, V56, P2045, DOI 10.1111/j.1365-2427.2011.02636.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hancke K, 2004, AQUAT MICROB ECOL, V37, P265, DOI 10.3354/ame037265; Heck KL, 2000, LIMNOL OCEANOGR, V45, P1041, DOI 10.4319/lo.2000.45.5.1041; Hillebrand H, 2011, ECOL RES, V26, P533, DOI 10.1007/s11284-011-0810-y; Hochard S, 2010, ECOL MODEL, V221, P1687, DOI 10.1016/j.ecolmodel.2010.04.002; Hulth S, 2005, MAR CHEM, V94, P125, DOI 10.1016/j.marchem.2004.07.013; JONSSON B, 1993, NETH J SEA RES, V31, P83, DOI 10.1016/0077-7579(93)90020-S; Lewandowska A, 2010, MAR ECOL PROG SER, V405, P101, DOI 10.3354/meps08520; Liboriussen L, 2011, FRESHWATER BIOL, V56, P437, DOI 10.1111/j.1365-2427.2010.02510.x; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lotze HK, 2002, LIMNOL OCEANOGR, V47, P1734, DOI 10.4319/lo.2002.47.6.1734; MACKIN JE, 1984, LIMNOL OCEANOGR, V29, P250, DOI 10.4319/lo.1984.29.2.0250; MARINELLI RL, 1994, LIMNOL OCEANOGR, V39, P303, DOI 10.4319/lo.1994.39.2.0303; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; NILSSON P, 1991, MAR ECOL PROG SER, V71, P275, DOI 10.3354/meps071275; Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006; Ogilvie BG, 1997, FEMS MICROBIOL ECOL, V23, P11, DOI 10.1016/S0168-6496(97)00004-4; Ouellette D, 2004, MAR ECOL PROG SER, V266, P185, DOI 10.3354/meps266185; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petersen DG, 2007, ECOTOXICOLOGY, V16, P371, DOI 10.1007/s10646-007-0139-z; RiveraMonroy VH, 1996, LIMNOL OCEANOGR, V41, P284, DOI 10.4319/lo.1996.41.2.0284; Rysgaard S, 2004, LIMNOL OCEANOGR, V49, P1493, DOI 10.4319/lo.2004.49.5.1493; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; Scholz B, 2012, DIATOM RES, V27, P65, DOI 10.1080/0269249X.2012.660875; SEITZINGER SP, 1985, LIMNOL OCEANOGR, V30, P1332, DOI 10.4319/lo.1985.30.6.1332; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Sundback K, 2005, COAST ESTUAR STUD, V60, P7; Sundback K, 2000, MAR ECOL PROG SER, V200, P59, DOI 10.3354/meps200059; Sundback K, 2004, LIMNOL OCEANOGR, V49, P1095, DOI 10.4319/lo.2004.49.4.1095; SUNDBACK K, 1991, BOT MAR, V34, P341, DOI 10.1515/botm.1991.34.4.341; Sundback K, 2006, ESTUAR COAST, V29, P1196, DOI 10.1007/BF02781820; Sundback K, 2007, MAR ECOL PROG SER, V330, P13, DOI 10.3354/meps330013; Sundback K, 2010, J EXP MAR BIOL ECOL, V388, P39, DOI 10.1016/j.jembe.2010.03.007; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 1998, AQUAT MICROB ECOL, V15, P191, DOI 10.3354/ame015191; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Vouve F, 2000, OCEANOL ACTA, V23, P575, DOI 10.1016/S0399-1784(00)01104-X; Worm B, 2000, INT REV HYDROBIOL, V85, P359; Yvon-Durocher G, 2012, NATURE; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	74	23	23	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51503	10.1371/journal.pone.0051503	http://dx.doi.org/10.1371/journal.pone.0051503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240032	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800068
J	Berard, AR; Cortens, JP; Krokhin, O; Wilkins, JA; Severini, A; Coombs, KM				Berard, Alicia R.; Cortens, John P.; Krokhin, Oleg; Wilkins, John A.; Severini, Alberto; Coombs, Kevin M.			Quantification of the Host Response Proteome after Mammalian Reovirus T1L Infection	PLOS ONE			English	Article							ONCOLYTIC VIRAL THERAPY; NILE VIRUS-INFECTION; LARGE GENE LISTS; INDUCED APOPTOSIS; ANTIVIRAL PROPERTIES; HEPATITIS-C; DNA-REPAIR; CELLS; EXPRESSION; PROTEINS	All viruses are dependent upon host cells for replication. Infection can induce profound changes within cells, including apoptosis, morphological changes, and activation of signaling pathways. Many of these alterations have been analyzed by gene arrays to measure the cellular "transcriptome." We used SILAC (stable isotope labeling by amino acids in cell culture), combined with high-throughput 2-D HPLC/mass spectrometry, to determine relative quantitative differences in host proteins at 6 and 24 hours after infecting HEK293 cells with reovirus serotype 1 Lang (T1L). 3,076 host proteins were detected at 6hpi, of which 132 and 68 proteins were significantly up or down regulated, respectively. 2,992 cellular proteins, of which 104 and 49 were up or down regulated, respectively, were identified at 24hpi. IPA and DAVID analyses indicated proteins involved in cell death, cell growth factors, oxygen transport, cell structure organization and inflammatory defense response to virus were up-regulated, whereas proteins involved in apoptosis, isomerase activity, and metabolism were down-regulated. These proteins and pathways may be suitable targets for intervention to either attenuate virus infection or enhance oncolytic potential. Citation: Berard AR, Cortens JP, Krokhin O, Wilkins JA, Severini A, et al. (2012) Quantification of the Host Response Proteome after Mammalian Reovirus T1L Infection. PLoS ONE 7(12): e51939. doi: 10.1371/journal.pone.0051939	[Berard, Alicia R.; Wilkins, John A.; Severini, Alberto; Coombs, Kevin M.] Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB, Canada; [Berard, Alicia R.; Cortens, John P.; Krokhin, Oleg; Wilkins, John A.; Coombs, Kevin M.] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada; [Severini, Alberto] Natl Microbiol Lab, Winnipeg, MB, Canada; [Coombs, Kevin M.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Coombs, KM (corresponding author), Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB, Canada.	kcoombs@cc.umanitoba.ca		Coombs, Kevin/0000-0001-7667-8430; Berard, Alicia/0000-0002-2210-0577	Canadian Institutes of Health Research [MT-11630]; Manitoba Health Research Council Studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council Studentship	This work was supported by grant MT-11630 from the Canadian Institutes of Health Research to K.M.C. A.R.B. was the recipient of a Manitoba Health Research Council Studentship. The authors thank Kolawole Opanubi for expert technical assistance, and members of the laboratory for reviewing the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Alloussi SH, 2011, ONCOL REP, V26, P645, DOI 10.3892/or.2011.1331; Barkhash AV, 2010, J INFECT DIS, V202, P1813, DOI 10.1086/657418; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Berard Alicia, 2009, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15c01s14; Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Clarke P, 2000, J VIROL, V74, P8135, DOI 10.1128/JVI.74.17.8135-8139.2000; Clarke P, 2003, APOPTOSIS, V8, P141, DOI 10.1023/A:1022966508671; Coombs KM, 2006, CURR TOP MICROBIOL, V309, P117; Coombs KM, 2011, EXPERT REV PROTEOMIC, V8, P659, DOI [10.1586/EPR.11.55, 10.1586/epr.11.55]; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; COOMBS KM, 1994, J VIROL, V68, P177, DOI 10.1128/JVI.68.1.177-186.1994; Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468; DeBiasi RL, 2003, J VIROL, V77, P8934, DOI 10.1128/JVI.77.16.8934-8947.2003; Dwivedi RC, 2008, ANAL CHEM, V80, P7036, DOI 10.1021/ac800984n; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; Golden JW, 2004, J BIOL CHEM, V279, P8547, DOI 10.1074/jbc.M309758200; Goody RJ, 2007, J NEUROVIROL, V13, P373, DOI 10.1080/13550280701344983; Guergnon J, 2011, BBA-MOL BASIS DIS, V1812, P1498, DOI 10.1016/j.bbadis.2011.07.001; Harrington KJ, 2010, CYTOKINE GROWTH F R, V21, P91, DOI 10.1016/j.cytogfr.2010.02.006; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Lang QL, 2011, J ZHEJIANG UNIV-SC B, V12, P116, DOI 10.1631/jzus.B1000278; Lenschow DJ, 2010, VIRUSES-BASEL, V2, P2154, DOI 10.3390/v2102154; Li LN, 2010, J PROTEOME RES, V9, P2460, DOI 10.1021/pr901151k; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Lolkema MP, 2011, CLIN CANCER RES, V17, P581, DOI 10.1158/1078-0432.CCR-10-2159; Mertens P, 2004, VIRUS RES, V101, P3, DOI 10.1016/j.virusres.2003.12.002; Morgan KL, 2005, NEUROSCI LETT, V382, P259, DOI 10.1016/j.neulet.2005.03.044; Munday DC, 2010, PROTEOMICS, V10, P4320, DOI 10.1002/pmic.201000228; Nag A, 2004, CANCER RES, V64, P8152, DOI 10.1158/0008-5472.CAN-04-2598; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; O'Donnell SM, 2006, J VIROL, V80, P1077, DOI 10.1128/JVI.80.3.1077-1086.2006; Ohtani N, 2003, J CELL BIOL, V162, P173, DOI 10.1083/jcb.200302085; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ooms LS, 2010, J BIOL CHEM, V285, P41604, DOI 10.1074/jbc.M110.176255; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205; Petit A, 2010, LEUKEMIA, V24, P654, DOI 10.1038/leu.2009.241; Plesca D, 2007, CELL CYCLE, V6, P1147, DOI 10.4161/cc.6.10.4259; Poggioli GJ, 2002, J VIROL, V76, P2585, DOI 10.1128/JVI.76.6.2585-2594.2002; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Salgado M, 2011, VIROLOGY, V411, P103, DOI 10.1016/j.virol.2010.12.037; Schiff L.A., 2007, FIELDS VIROLOGY, V2, P1853; SILVERSTEIN SC, 1968, J CELL BIOL, V36, P197, DOI 10.1083/jcb.36.1.197; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Thirukkumaran Chandini, 2009, V542, P607, DOI 10.1007/978-1-59745-561-9_31; Thirukkumaran CM, 2010, CANCER RES, V70, P2435, DOI 10.1158/0008-5472.CAN-09-2408; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809; Villa-Moruzzi E, 2011, ANAL CELL PATHOL, V34, P101, DOI [10.1155/2011/870459, 10.3233/ACP-2011-0008]; Vogels MW, 2011, PROTEOMICS, V11, P64, DOI 10.1002/pmic.201000309; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Yan W, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r54	65	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51939	10.1371/journal.pone.0051939	http://dx.doi.org/10.1371/journal.pone.0051939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240068	gold, Green Submitted, Green Published			2022-12-25	WOS:000312290800104
J	Hartwich, K; Poehlein, A; Daniel, R				Hartwich, Katrin; Poehlein, Anja; Daniel, Rolf			The Purine-Utilizing Bacterium Clostridium acidurici 9a: A Genome-Guided Metabolic Reconsideration	PLOS ONE			English	Article							AMINO-ACID DEGRADATION; GENUS CLOSTRIDIUM; VANCOMYCIN RESISTANCE; GLYCINE METABOLISM; SEQUENCE; FERMENTATION; IDENTIFICATION; CYLINDROSPORUM; PERSPECTIVE; MECHANISM	Clostridium acidurici is an anaerobic, homoacetogenic bacterium, which is able to use purines such as uric acid as sole carbon, nitrogen, and energy source. Together with the two other known purinolytic clostridia C. cylindrosporum and C. purinilyticum, C. acidurici serves as a model organism for investigation of purine fermentation. Here, we present the first complete sequence and analysis of a genome derived from a purinolytic Clostridium. The genome of C. acidurici 9a consists of one chromosome (3,105,335 bp) and one small circular plasmid (2,913 bp). The lack of candidate genes encoding glycine reductase indicates that C. acidurici 9a uses the energetically less favorable glycine-serine-pyruvate pathway for glycine degradation. In accordance with the specialized lifestyle and the corresponding narrow substrate spectrum of C. acidurici 9a, the number of genes involved in carbohydrate transport and metabolism is significantly lower than in other clostridia such as C. acetobutylicum, C. saccharolyticum, and C. beijerinckii. The only amino acid that can be degraded by C. acidurici is glycine but growth on glycine only occurs in the presence of a fermentable purine. Nevertheless, the addition of glycine resulted in increased transcription levels of genes encoding enzymes involved in the glycine-serine-pyruvate pathway such as serine hydroxymethyltransferase and acetate kinase, whereas the transcription levels of formate dehydrogenase-encoding genes decreased. Sugars could not be utilized by C. acidurici but the full genetic repertoire for glycolysis was detected. In addition, genes encoding enzymes that mediate resistance against several antimicrobials and metals were identified. High resistance of C. acidurici towards bacitracin, acriflavine and azaleucine was experimentally confirmed.	[Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany; Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, Gottingen, Germany	University of Gottingen; University of Gottingen	Daniel, R (corresponding author), Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany.	rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Poehlein, Anja/0000-0002-2473-6202	Bundesministerium fur Bildung und Forschung (BMBF); Niedersachsisches Ministerium fur Wissenschaft und Kultur	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Niedersachsisches Ministerium fur Wissenschaft und Kultur	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) and the Niedersachsisches Ministerium fur Wissenschaft und Kultur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN JR, 1994, ANTON LEEUW INT J G, V66, P223, DOI 10.1007/BF00871641; Andreesen JR, 1994, ACETOGENESIS, P568, DOI DOI 10.1007/978-1-4615-1777-1_23; Barker HA, 1942, J BACTERIOL, V43, P291, DOI 10.1128/JB.43.3.291-304.1942; Barker HA, 1941, J BIOL CHEM, V141, P3; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; *BIOCYC, BIOCYC DAT COLL; BREHM JK, 1992, PLASMID, V28, P1, DOI 10.1016/0147-619X(92)90031-5; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; DURRE P, 1983, J BACTERIOL, V154, P192; DURRE P, 1981, INT J SYST BACTERIOL, V31, P184, DOI 10.1099/00207713-31-2-184; DURRE P, 1982, J GEN MICROBIOL, V128, P1457; DURRE P, 1982, FEMS MICROBIOL LETT, V15, P51; DYKE KGH, 1989, FEMS MICROBIOL LETT, V58, P209; ExPASy, SIB BIOINF RES PORT; Fonknechten N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-555; FRIEDMANN HC, 1970, ANNU REV MICROBIOL, V24, P159, DOI 10.1146/annurev.mi.24.100170.001111; GOTTSCHALK G, 1968, EUR J BIOCHEM, V5, P346, DOI 10.1111/j.1432-1033.1968.tb00376.x; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P285, DOI 10.1099/ijs.0.001792-0; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hui EKW, 1998, CELL MOL LIFE SCI, V54, P1403, DOI 10.1007/s000180050262; Kalhoefer D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-324; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; McKessar SJ, 2000, ANTIMICROB AGENTS CH, V44, P3224, DOI 10.1128/AAC.44.11.3224-3228.2000; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; RABINOWITZ JC, 1956, J BIOL CHEM, V222, P537; RABINOWITZ JC, 1959, ANNU REV MICROBIOL, V13, P441, DOI 10.1146/annurev.mi.13.100159.002301; RABINOWITZ JC, 1956, J BIOL CHEM, V218, P189; Rabinowitz JG, 1963, METHOD ENZYMOL, P703; Rahlfs S, 1999, FEBS LETT, V453, P35, DOI 10.1016/S0014-5793(99)00576-1; RAKOSKY JOSEPH, 1955, JOUR BACT, V69, P563; SAGERS RD, 1961, J BACTERIOL, V81, P541, DOI 10.1128/JB.81.4.541-549.1961; Sanger F, 1992, Biotechnology, V24, P104; SCHIEFERULLRICH H, 1984, ARCH MICROBIOL, V138, P345, DOI 10.1007/BF00410902; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Self WT, 2000, P NATL ACAD SCI USA, V97, P7208, DOI 10.1073/pnas.97.13.7208; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Staden R, 2000, Methods Mol Biol, V132, P115; Steiner E, 2011, MOL MICROBIOL, V80, P641, DOI 10.1111/j.1365-2958.2011.07608.x; Stickland LH, 1934, BIOCHEM J, V28, P1746, DOI 10.1042/bj0281746; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tech Maike, 2003, In Silico Biology, V3, P441; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; WABER LJ, 1979, J BACTERIOL, V140, P468, DOI 10.1128/JB.140.2.468-478.1979; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	63	31	31	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51662	10.1371/journal.pone.0051662	http://dx.doi.org/10.1371/journal.pone.0051662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240052	Green Published, Green Submitted			2022-12-25	WOS:000312290800088
J	Hu, J; Luo, CX; Chu, WH; Shan, YA; Qian, ZM; Zhu, G; Yu, YB; Feng, H				Hu, Jun; Luo, Chun Xia; Chu, Wei Hua; Shan, You An; Qian, Zhong-Ming; Zhu, Gang; Yu, Yan Bing; Feng, Hua			20-Hydroxyecdysone Protects against Oxidative Stress-Induced Neuronal Injury by Scavenging Free Radicals and Modulating NF-kappa B and JNK Pathways	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; NITRIC-OXIDE SYNTHASE; CELL-DEATH; CEREBRAL-ISCHEMIA; REACTIVE OXYGEN; SIGNALING PATHWAY; MICE LACKING; PC12 CELLS; MITOCHONDRIA	Oxidative stress plays an important role in the pathological processes of ischemic brain damage. Many antioxidants have been shown to protect against cerebral ischemia injury by inhibiting oxidative stress both in vitro and in vivo. 20-Hydroxyecdysone (20E), an ecdysteroid hormone, exhibits antioxidative effects. For the work described in this paper, we used an in vitro oxidative damage model and an in vivo ischemic model of middle cerebral artery occlusion (MCAO) to investigate the neuroprotective effects of 20E and the mechanisms related to these effects. Treatment of cells with H2O2 led to neuronal injury, intracellular ROS/RNS generation, mitochondrial membrane potential dissipation, cellular antioxidant potential descent, an increase in malondialdehyde (MDA) and an elevation of intracellular [Ca2+], all of which were markedly attenuated by 20E. Inhibition of the activation of the ASK1-MKK4/7-JNK stress signaling pathway and cleaved caspase-3 induced by oxidative stress were involved in the neuroprotection afforded by 20E. In addition, 20E reduced the expression of iNOS protein by inhibition of NF-kappa B activation. The neuroprotective effect of 20E was also confirmed in vivo. 20E significantly decreased infarct volume and the neurological deficit score, restored antioxidant potential and inhibited the increase in MDA and TUNEL-positive and cleaved caspase-3-positive cells in the cerebral cortex in MCAO rats. Together, these results support that 20E protects against cerebral ischemia injury by inhibiting ROS/RNS production and modulating oxidative stress-induced signal transduction pathways. Citation: Hu J, Luo CX, Chu WH, Shan YA, Qian Z-M, et al. (2012) 20-Hydroxyecdysone Protects against Oxidative Stress-Induced Neuronal Injury by Scavenging Free Radicals and Modulating NF-kappa B and JNK Pathways. PLoS ONE 7(12): e50764. doi:10.1371/journal.pone.0050764	[Yu, Yan Bing] China Japan Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China; [Hu, Jun; Luo, Chun Xia; Chu, Wei Hua; Shan, You An; Qian, Zhong-Ming; Zhu, Gang; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China	China-Japan Friendship Hospital; Army Medical University	Yu, YB (corresponding author), China Japan Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China.	zllnd00@yahoo.cn; fenghua88888@yahoo.cn	Qian, Zhong Ming/E-8884-2016; Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217; Hu, Jun/0000-0002-3038-0206	Natural Science Foundation of Chong-Qing, China [2007BA5010]; National Natural Science Foundation of China [304803920, 81070929]	Natural Science Foundation of Chong-Qing, China(Natural Science Foundation of Chongqing); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of Chong-Qing, China (2007BA5010) and from the National Natural Science Foundation of China (304803920, 81070929). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Benedi J, 2004, LIFE SCI, V75, P1263, DOI 10.1016/j.lfs.2004.05.001; Cai YJ, 2002, CAN J PHYSIOL PHARM, V80, P1187, DOI [10.1139/y02-152, 10.1139/Y02-152]; CATALAN RE, 1985, COMP BIOCHEM PHYS B, V81, P771, DOI 10.1016/0305-0491(85)90403-1; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Z, 2004, CHIN J CLIN PHARM TH, V9, P540; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Feng Chun-Yan, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P76; Frantz MC, 2010, ENV MOL MUTAGEN; Friberg H, 2002, NEUROSCI LETT, V334, P111, DOI 10.1016/S0304-3940(02)01116-3; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Hu J, 2010, J CELL BIOCHEM, V111, P1512, DOI 10.1002/jcb.22877; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Iadecola C, 1997, J NEUROSCI, V17, P9157; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kholodova Iu D, 1997, Ukr Biokhim Zh (1978), V69, P3; Kuzmenko A. I., 1999, Ukrainskii Biokhimicheskii Zhurnal, V71, P35; Kuzmenko A. I., 2001, Ukrainskii Biokhimicheskii Zhurnal, V73, P44; Kuzmenko AI, 1997, BIOCHEMISTRY-MOSCOW+, V62, P609; Lafont R, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.7; Le Bras M, 2005, HISTOL HISTOPATHOL, V20, P205, DOI 10.14670/HH-20.205; LI X, 2011, BRAIN RES; Liu Z, 2008, ACTA NEUROCHIR SUPPL, V104, P297; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Love S, 1999, BRAIN PATHOL, V9, P119; Matsuda H, 1970, Nihon Yakurigaku Zasshi, V66, P551; Murin R, 2001, GEN PHYSIOL BIOPHYS, V20, P431; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; Oehme I, 2006, CELL DEATH DIFFER, V13, P189, DOI 10.1038/sj.cdd.4401730; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Schaller B, 2005, FREE RADICAL BIO MED, V38, P411, DOI 10.1016/j.freeradbiomed.2004.10.032; Schild L, 2005, FEBS J, V272, P3593, DOI 10.1111/j.1742-4658.2005.04781.x; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SLAMA K, 1995, EUR J ENTOMOL, V92, P355; Somayajulu M, 2005, NEUROBIOL DIS, V18, P618, DOI 10.1016/j.nbd.2004.10.021; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tang WH, 2008, NEUROL RES, V30, P571, DOI 10.1179/174313208X297986; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Toth N, 2008, PHYTOMEDICINE, V15, P691, DOI 10.1016/j.phymed.2008.04.015; Vosler PS, 2009, STROKE, V40, pS119, DOI 10.1161/STROKEAHA.108.533109; Wang R, 2006, J NEUROCHEM, V99, P1543, DOI 10.1111/j.1471-4159.2006.04201.x; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Wang XD, 2001, GENE DEV, V15, P2922; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; Zhang JJ, 2010, MOL HUM REPROD; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhao XR, 2000, BRAIN RES, V872, P215, DOI 10.1016/S0006-8993(00)02459-8	62	40	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50764	10.1371/journal.pone.0050764	http://dx.doi.org/10.1371/journal.pone.0050764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239983	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800021
J	Ishizawa, M; Ogura, M; Kato, S; Makishima, M				Ishizawa, Michiyasu; Ogura, Michitaka; Kato, Shigeaki; Makishima, Makoto			Impairment of Bilirubin Clearance and Intestinal Interleukin-6 Expression in Bile Duct-Ligated Vitamin D Receptor Null Mice	PLOS ONE			English	Article							NF-KAPPA-B; CONSTITUTIVE ANDROSTANE RECEPTOR; FARNESOID-X-RECEPTOR; NUCLEAR RECEPTORS; IN-VIVO; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; ACID; TRANSPORTERS; LACKING	The vitamin D receptor (VDR) mediates the physiological and pharmacological actions of 1 alpha,25-dihydroxyvitamin D-3 in bone and calcium metabolism, cellular growth and differentiation, and immunity. VDR also responds to secondary bile acids and belongs to the NR1I subfamily of the nuclear receptor superfamily, which regulates expression of xenobiotic metabolism genes. When compared to knockout mouse investigations of the other NR1I nuclear receptors, pregnane X receptor and constitutive androstane receptor, an understanding of the role of VDR in xenobiotic metabolism remains limited. We examined the effect of VDR deletion in a mouse model of cholestasis. We performed bile duct ligation (BDL) on VDR-null mice and compared blood biochemistry, mRNA expression of genes involved in bile acid and bilirubin metabolism, cytokine production, and expression of inflammatory regulators with those of wild-type mice. VDR-null mice had elevated plasma conjugated bilirubin levels three days after BDL compared with wild-type mice. Urine bilirubin levels and renal mRNA and/or protein expression of multidrug resistance-associated proteins 2 and 4 were decreased in VDR-null mice, suggesting impaired excretion of conjugated bilirubin into urine. While VDR-null kidney showed mRNA expression of interleukin-6 (IL-6) after BDL and VDR-null macrophages had higher IL-6 protein levels after lipopolysaccharide stimulation, the induction of intestinal Il6 mRNA expression and plasma IL-6 protein levels after BDL was impaired in VDR-null mice. Immunoblotting analysis showed that expression of an immune regulator, I kappa B alpha, was elevated in the jejunum of VDR-null mice, a possible mechanism for the attenuated induction of Il6 expression in the intestine after BDL. Increased expression of I kappa B alpha may be a consequence of compensatory mechanisms for VDR deletion. These results reveal a role of VDR in bilirubin clearance during cholestasis. VDR is also suggested to contribute to tissue-selective immune regulation.	[Ishizawa, Michiyasu; Ogura, Michitaka; Makishima, Makoto] Nihon Univ, Sch Med, Div Biochem, Dept Biomed Sci, Tokyo, Japan; [Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	Nihon University; University of Tokyo	Makishima, M (corresponding author), Nihon Univ, Sch Med, Div Biochem, Dept Biomed Sci, Tokyo, Japan.	makishima.makoto@nihon-u.ac.jp			Japan Society for the Promotion of Science [22590294]; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (C) 22590294] (to MM) and Strategic Research Base Development Program for Private Universities subsidized by the Ministry of Education, Culture, Sports, Science and Technology, Japan (since 2010) (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2005, J LIPID RES, V46, P46, DOI 10.1194/jlr.M400294-JLR200; Aleksunes LM, 2008, TOXICOLOGY, V250, P82, DOI 10.1016/j.tox.2008.06.009; Belinsky MG, 2005, MOL PHARMACOL, V68, P160, DOI 10.1124/mol.104.010587; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Choi M, 2011, MOL PHARMACOL, V80, P1147, DOI 10.1124/mol.111.074138; Choi M, 2009, EXPERT OPIN THER PAT, V19, P593, DOI 10.1517/13543770902877717; Chow ECY, 2010, BIOPHARM DRUG DISPOS, V31, P91, DOI 10.1002/bdd.694; Chu XY, 2006, J PHARMACOL EXP THER, V317, P579, DOI 10.1124/jpet.105.098665; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Echchgadda I, 2004, MOL PHARMACOL, V65, P720, DOI 10.1124/mol.65.3.720; Fan JH, 2009, J PHARMACOL EXP THER, V330, P389, DOI 10.1124/jpet.108.149815; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Gao J, 2010, DRUG METAB DISPOS, V38, P2091, DOI 10.1124/dmd.110.035568; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Hartmann G, 2002, J PHARMACOL EXP THER, V303, P273, DOI 10.1124/jpet.102.039404; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Ishizawa M, 2008, J LIPID RES, V49, P763, DOI 10.1194/jlr.M700293-JLR200; Ishizawa M, 2009, AM J PHYSIOL-ENDOC M, V297, pE728, DOI 10.1152/ajpendo.00168.2009; Iusuf D, 2012, TRENDS PHARMACOL SCI, V33, P100, DOI 10.1016/j.tips.2011.10.005; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Makishima M, 2005, EXPERT OPIN THER PAT, V15, P1133, DOI 10.1517/13543776.15.9.1133; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; Matsubara T, 2008, DRUG METAB DISPOS, V36, P2058, DOI 10.1124/dmd.108.021501; McCarthy TC, 2005, J BIOL CHEM, V280, P23232, DOI 10.1074/jbc.M411520200; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nishida S, 2009, DRUG METAB DISPOS, V37, P2037, DOI 10.1124/dmd.109.027334; Ogura M, 2009, J PHARMACOL EXP THER, V328, P564, DOI 10.1124/jpet.108.145987; Ozeki J, 2011, TOXICOLOGY, V280, P10, DOI 10.1016/j.tox.2010.11.003; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sawada N, 2004, BIOCHEMISTRY-US, V43, P4530, DOI 10.1021/bi030207f; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Soroka CJ, 2010, HEPATOLOGY, V51, P181, DOI 10.1002/hep.23265; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stedman C, 2004, J BIOL CHEM, V279, P11336, DOI 10.1074/jbc.M310258200; Stedman CAM, 2005, P NATL ACAD SCI USA, V102, P2063, DOI 10.1073/pnas.0409794102; Stedman C, 2006, P NATL ACAD SCI USA, V103, P11323, DOI 10.1073/pnas.0604772103; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; TANABE O, 1988, J IMMUNOL, V141, P3875; Thummel KE, 2001, MOL PHARMACOL, V60, P1399, DOI 10.1124/mol.60.6.1399; Uno S, 2009, BIOCHEM PHARMACOL, V77, P186, DOI 10.1016/j.bcp.2008.10.007; Vlaming MLH, 2006, J PHARMACOL EXP THER, V318, P319, DOI 10.1124/jpet.106.101774; Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784; Wagner M, 2003, GASTROENTEROLOGY, V125, P825, DOI 10.1016/S0016-5085(03)01068-0; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Wu SP, 2010, INT J BIOCHEM CELL B, V42, P329, DOI 10.1016/j.biocel.2009.11.012; Xie W, 2001, J BIOL CHEM, V276, P37739, DOI 10.1074/jbc.R100033200; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Xu Y, 2006, MOL PHARMACOL, V69, P56, DOI 10.1124/mol.105.017392; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zelcer N, 2006, J HEPATOL, V44, P768, DOI 10.1016/j.jhep.2005.07.022; Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200; Zhang YC, 2012, TOXICOL SCI, V127, P451, DOI 10.1093/toxsci/kfs123; Zollner G, 2002, AM J PHYSIOL-GASTR L, V282, pG184, DOI 10.1152/ajpgi.00215.2001; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s	71	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51664	10.1371/journal.pone.0051664	http://dx.doi.org/10.1371/journal.pone.0051664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240054	Green Submitted, gold, Green Published			2022-12-25	WOS:000312290800090
J	Nikolin, VM; Osterrieder, K; von Messling, V; Hofer, H; Anderson, D; Dubovi, E; Brunner, E; East, ML				Nikolin, Veljko M.; Osterrieder, Klaus; von Messling, Veronika; Hofer, Heribert; Anderson, Danielle; Dubovi, Edward; Brunner, Edgar; East, Marion L.			Antagonistic Pleiotropy and Fitness Trade-Offs Reveal Specialist and Generalist Traits in Strains of Canine Distemper Virus	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; HOST-RANGE; EVOLUTION; HEMAGGLUTININ; SERENGETI; RESIDUES; SLAM; IDENTIFICATION; DIVERSITY; EPIDEMIC	Theoretically, homogeneous environments favor the evolution of specialists whereas heterogeneous environments favor generalists. Canine distemper is a multi-host carnivore disease caused by canine distemper virus (CDV). The described cell receptor of CDV is SLAM (CD150). Attachment of CDV hemagglutinin protein (CDV-H) to this receptor facilitates fusion and virus entry in cooperation with the fusion protein (CDV-F). We investigated whether CDV strains co-evolved in the large, homogeneous domestic dog population exhibited specialist traits, and strains adapted to the heterogeneous environment of smaller populations of different carnivores exhibited generalist traits. Comparison of amino acid sequences of the SLAM binding region revealed higher similarity between sequences from Canidae species than to sequences from other carnivore families. Using an in vitro assay, we quantified syncytia formation mediated by CDV-H proteins from dog and non-dog CDV strains in cells expressing dog, lion or cat SLAM. CDV-H proteins from dog strains produced significantly higher values with cells expressing dog SLAM than with cells expressing lion or cat SLAM. CDV-H proteins from strains of non-dog species produced similar values in all three cell types, but lower values in cells expressing dog SLAM than the values obtained for CDV-H proteins from dog strains. By experimentally changing one amino acid (Y549H) in the CDV-H protein of one dog strain we decreased expression of specialist traits and increased expression of generalist traits, thereby confirming its functional importance. A virus titer assay demonstrated that dog strains produced higher titers in cells expressing dog SLAM than cells expressing SLAM of non-dog hosts, which suggested possible fitness benefits of specialization post-cell entry. We provide in vitro evidence for the expression of specialist and generalist traits by CDV strains, and fitness trade-offs across carnivore host environments caused by antagonistic pleiotropy. These findings extend knowledge on CDV molecular epidemiology of particular relevance to wild carnivores.	[Nikolin, Veljko M.; Hofer, Heribert; East, Marion L.] Leibniz Inst Zoo & Wildlife Res Berlin, Berlin, Germany; [von Messling, Veronika; Anderson, Danielle] INRS Inst Armand Frappier, Quebec City, PQ, Canada; [Nikolin, Veljko M.; Osterrieder, Klaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [von Messling, Veronika; Anderson, Danielle] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore; [Dubovi, Edward] Cornell Univ, Anim Hlth Diagnost Ctr, Ithaca, NY USA; [Brunner, Edgar] Univ Gottingen, Dept Med Stat, Gottingen, Germany	Leibniz Institut fur Zoo und Wildtierforschung; University of Quebec; Institut national de la recherche scientifique (INRS); Free University of Berlin; National University of Singapore; Cornell University; University of Gottingen	Nikolin, VM (corresponding author), Leibniz Inst Zoo & Wildlife Res Berlin, Berlin, Germany.	Nikolin@izw-berlin.de	Anderson, Danielle/HCH-2004-2022; Nikolin, Veljko/ABC-6034-2020; Hofer, Heribert/AAF-7854-2021	Hofer, Heribert/0000-0002-2813-7442; Osterrieder, Nikolaus/0000-0002-5313-2176; Anderson, Danielle/0000-0003-4791-5024	Deutsche Forschungsgemeinschaft (DFG) through (Genetic and Immunologic Determinants of Pathogen-Host Interactions) at the Centre of Infection Biology and Immunity (ZIBI) of the Humboldt University Berlin [GRAKO 1121]; Leibniz Institute for Zoo and Wildlife Research Berlin	Deutsche Forschungsgemeinschaft (DFG) through (Genetic and Immunologic Determinants of Pathogen-Host Interactions) at the Centre of Infection Biology and Immunity (ZIBI) of the Humboldt University Berlin(German Research Foundation (DFG)); Leibniz Institute for Zoo and Wildlife Research Berlin	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) through the GRAKO 1121 (Genetic and Immunologic Determinants of Pathogen-Host Interactions) at the Centre of Infection Biology and Immunity (ZIBI) of the Humboldt University Berlin, and the Leibniz Institute for Zoo and Wildlife Research Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; Alto BW, 2010, EVOL ECOL, V24, P299, DOI 10.1007/s10682-009-9307-3; ANDERSON R M, 1991; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; APPEL M, 1974, AM J VET RES, V35, P803; APPEL MJG, 1995, VET MICROBIOL, V44, P187, DOI 10.1016/0378-1135(95)00011-X; Aversa G, 1997, IMMUNOL CELL BIOL, V75, P202, DOI 10.1038/icb.1997.30; Benetka V, 2011, VET REC, V168, P376, DOI 10.1136/vr.c6404; Bianco S, 2011, B MATH BIOL, V73, P248, DOI 10.1007/s11538-010-9541-4; Biek R, 2003, J VIROL, V77, P9578, DOI 10.1128/JVI.77.17.9578-9589.2003; Brunner E., 2002, NICHTPARAMETRISCHE D; Brunner E, 2002, NONPARAMETRIC ANAL L; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Carpenter MA, 1998, VET IMMUNOL IMMUNOP, V65, P259, DOI 10.1016/S0165-2427(98)00159-7; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Craft ME, 2009, P ROY SOC B-BIOL SCI, V276, P1777, DOI 10.1098/rspb.2008.1636; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; DIETZ K, 1979, J MATH BIOL, V8, P291, DOI 10.1007/BF00276314; Dimcheff DE, 2000, J VIROL, V74, P3984, DOI 10.1128/JVI.74.9.3984-3995.2000; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Eizirik E, 2010, MOL PHYLOGENET EVOL, V56, P49, DOI 10.1016/j.ympev.2010.01.033; Elena Santiago F, 2009, Open Virol J, V3, P1, DOI 10.2174/1874357900903010001; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gandon S, 2004, EVOLUTION, V58, P455, DOI 10.1111/j.0014-3820.2004.tb01669.x; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Goller KV, 2010, VET MICROBIOL, V146, P245, DOI 10.1016/j.vetmic.2010.05.018; Guiserix M, 2007, J R SOC INTERFACE, V4, P1127, DOI 10.1098/rsif.2007.0235; Haas L, 1996, VET MICROBIOL, V49, P147, DOI 10.1016/0378-1135(95)00180-8; Hueffer K, 2003, J VIROL, V77, P1718, DOI 10.1128/JVI.77.3.1718-1726.2003; Ikeda Y, 2001, CLIN DIAGN LAB IMMUN, V8, P641, DOI 10.1128/CDLI.8.3.641-644.2001; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kaelber JT, 2012, PLOS PATHOG, V8, P5; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Lajeunesse MJ, 2002, P ROY SOC B-BIOL SCI, V269, P703, DOI 10.1098/rspb.2001.1943; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; LEVINS R, 1967, GENETICS, V56, P163; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; MAY RM, 1972, P NATL ACAD SCI USA, V69, P1109, DOI 10.1073/pnas.69.5.1109; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Nikolin VM, 2012, VET MICROBIOL, V156, P45, DOI 10.1016/j.vetmic.2011.10.009; Ohishi K, 2010, COMP IMMUNOL MICROB, V33, P227, DOI 10.1016/j.cimid.2008.10.003; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Qu XX, 2005, J BIOL CHEM, V280, P29588, DOI 10.1074/jbc.M500662200; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Sawatsky B, 2010, J VIROL, V84, P2753, DOI 10.1128/JVI.01813-09; Shaw LB, 2007, J MATH BIOL, V55, P1, DOI 10.1007/s00285-007-0074-x; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Slattery JP, 1999, GENOME RES, V9, P525; STERN LBL, 1995, J VIROL, V69, P1661, DOI 10.1128/JVI.69.3.1661-1668.1995; SUMMERS BA, 1984, J COMP PATHOL, V94, P65, DOI 10.1016/0021-9975(84)90009-4; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Truyen U, 1996, VIROLOGY, V215, P186, DOI 10.1006/viro.1996.0021; Turner PE, 2000, GENETICS, V156, P1465; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; von Messling V, 2005, J VIROL, V79, P5857, DOI 10.1128/JVI.79.9.5857-5862.2005; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; Vongpunsawad S, 2004, J VIROL, V78, P302, DOI 10.1128/JVI.78.1.302-313.2004; Wandeler A.I., 1993, Revue Scientifique et Technique Office International des Epizooties, V12, P51; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; WILSON DS, 1994, AM NAT, V144, P692, DOI 10.1086/285702; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zipperle L, 2010, J VIROL, V84, P9618, DOI 10.1128/JVI.01077-10	70	33	36	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50955	10.1371/journal.pone.0050955	http://dx.doi.org/10.1371/journal.pone.0050955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239996	Green Submitted, gold, Green Published			2022-12-25	WOS:000312290800032
J	Polyakova, O; Borman, S; Grimley, R; Vamathevan, J; Hayes, B; Solari, R				Polyakova, Oxana; Borman, Satty; Grimley, Rachel; Vamathevan, Jessica; Hayes, Brian; Solari, Roberto			Identification of Novel Interacting Partners of Sirtuin6	PLOS ONE			English	Article							NF-KAPPA-B; THYMINE-DNA GLYCOSYLASE; DEPENDENT GENE-EXPRESSION; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; POLYACRYLAMIDE-GELS; MASS-SPECTROMETRY; LIGASE PIAS1; HUMAN SIRT6; TRANSCRIPTION	SIRT6 is a member of the Sirtuin family of histone deacetylases that has been implicated in inflammatory, aging and metabolic pathways. Some of its actions have been suggested to be via physical interaction with NF kappa B and HIF1 alpha and transcriptional regulation through its histone deacetylase activity. Our previous studies have investigated the histone deacetylase activity of SIRT6 and explored its ability to regulate the transcriptional responses to an inflammatory stimulus such as TNF alpha. In order to develop a greater understanding of SIRT6 function we have sought to identify SIRT6 interacting proteins by both yeast-2-hybrid and co-immunoprecipitation studies. We report a number of interacting partners which strengthen previous findings that SIRT6 functions in base excision repair (BER), and novel interactors which suggest a role in nucleosome and chromatin remodeling, the cell cycle and NF kappa B biology.	[Hayes, Brian; Solari, Roberto] GlaxoSmithKline, Allerg Inflammat Discovery Performance Unit, Stevenage, Herts, England; [Polyakova, Oxana; Borman, Satty; Grimley, Rachel] GlaxoSmithKline, Platform Technol Sci, Stevenage, Herts, England; [Vamathevan, Jessica] GlaxoSmithKline, Computat Biol, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Solari, R (corresponding author), GlaxoSmithKline, Allerg Inflammat Discovery Performance Unit, Stevenage, Herts, England.	roberto.2.solari@gsk.com		Vamathevan, Jessica/0000-0003-2016-9754	GlaxoSmithKline (GSK)	GlaxoSmithKline (GSK)(GlaxoSmithKline)	This work was fully funded by GlaxoSmithKline (GSK) and the authors were all employees of GSK at the time the work was done. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Aihara T, 1998, CYTOGENET CELL GENET, V81, P191, DOI 10.1159/000015027; Ardestani PM, 2012, NUCLEUS-PHILA, V3, P442, DOI 10.4161/nucl.21134; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cox B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011996; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Grimley R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039847; Holmes-McNary M, 2000, CANCER RES, V60, P3477; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim EJ, 2008, BIOCHEM BIOPH RES CO, V377, P838, DOI 10.1016/j.bbrc.2008.10.058; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Lucey MJ, 2005, NUCLEIC ACIDS RES, V33, P6393, DOI 10.1093/nar/gki940; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mohan RD, 2010, NUCLEIC ACIDS RES, V38, P1135, DOI 10.1093/nar/gkp1097; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Tao KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021602; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Vintermist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019184; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	62	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51555	10.1371/journal.pone.0051555	http://dx.doi.org/10.1371/journal.pone.0051555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240041	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800077
J	Savio, AJ; Lemire, M; Mrkonjic, M; Gallinger, S; Zanke, BW; Hudson, TJ; Bapat, B				Savio, Andrea J.; Lemire, Mathieu; Mrkonjic, Miralem; Gallinger, Steven; Zanke, Brent W.; Hudson, Thomas J.; Bapat, Bharati			MLH1 Region Polymorphisms Show a Significant Association with CpG Island Shore Methylation in a Large Cohort of Healthy Individuals	PLOS ONE			English	Article							COLORECTAL-CANCER; CHROMOSOME 8Q24; COLON-CANCER; GENOME; DNA; HYPERMETHYLATION; EXPRESSION; HMLH1; RISK	Single nucleotide polymorphisms (SNPs) are the most common form of genetic variation. We previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in colorectal cancer (CRC) patients. Recent studies have identified less CpG-dense "shore'' regions flanking many CpG islands. These shores often exhibit distinct methylation profiles between different tissues and matched normal versus tumor cells of patients. To date, most epigenetic studies have focused on somatic methylation events occurring within solid tumors; less is known of the contributions of peripheral blood cell (PBC) methylation to processes such as aging and tumorigenesis. To address whether MLH1 methylation in PBCs is correlated with tumorigenesis we utilized the Illumina 450 K microarrays to measure methylation in PBC DNA of 846 healthy controls and 252 CRC patients from Ontario, Canada. Analysis of a region of chromosome 3p21 spanning the MLH1 locus in healthy controls revealed that a CpG island shore 1 kb upstream of the MLH1 gene exhibits different methylation profiles when stratified by SNP genotypes (rs1800734, rs749072, and rs13098279). Individuals with wild-type genotypes incur significantly higher PBC shore methylation than heterozygous or homozygous variant carriers (p<1.1 x 10(-6); ANOVA). This trend is also seen in CRC cases (p<0.096; ANOVA). Shore methylation also decreases significantly with increasing age in cases and controls. This is the first study of its kind to integrate PBC methylation at a CpG island shore with SNP genotype status in CRC cases and controls. These results indicate that CpG island shore methylation in PBCs may be influenced by genotype as well as the normal aging process. Citation: Savio AJ, Lemire M, Mrkonjic M, Gallinger S, Zanke BW, et al. (2012) MLH1 Region Polymorphisms Show a Significant Association with CpG Island Shore Methylation in a Large Cohort of Healthy Individuals. PLoS ONE 7(12): e51531. doi:10.1371/journal.pone.0051531	[Savio, Andrea J.; Mrkonjic, Miralem; Gallinger, Steven; Bapat, Bharati] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Savio, Andrea J.; Mrkonjic, Miralem; Gallinger, Steven; Bapat, Bharati] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Lemire, Mathieu; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Gallinger, Steven] Canc Care Ontario, Ontario Familial Colorectal Canc Registry, Toronto, ON, Canada; [Gallinger, Steven] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Zanke, Brent W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Bapat, Bharati] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Cancer Care Ontario; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Bapat, B (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	BAPAT@lunenfeld.ca	Bapat, Bharati/B-5839-2014; Gallinger, Steven/E-4575-2013		Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2), ORF-RE [GL2-01-043]; National Cancer Institute, National Institutes of Health under RFA [CA-95-011]; Colon Cancer Familial Registry [U01 CA074783]; Ontario Institute for Cancer Research, through support from the Ontario Ministry of Research and Innovation; Interdisciplinary Health Research Team Program studentship; Canadian Institutes of Health Research; Samuel Lunenfeld Research Institute Studentship at Mount Sinai Hospital; University of Toronto Fellowship award; NATIONAL CANCER INSTITUTE [K22CA095011, U24CA074783, U01CA074783] Funding Source: NIH RePORTER	Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2), ORF-RE; National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colon Cancer Familial Registry; Ontario Institute for Cancer Research, through support from the Ontario Ministry of Research and Innovation; Interdisciplinary Health Research Team Program studentship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Samuel Lunenfeld Research Institute Studentship at Mount Sinai Hospital; University of Toronto Fellowship award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2), ORF-RE File# GL2-01-043 (BWZ, TJH, SG, BB). This work was also supported by the National Cancer Institute, National Institutes of Health under RFA # CA-95-011 and through cooperative agreements with members of the Colon Cancer Family Registry and PIs. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government or the CFR. This work was also supported by funding within the Colon Cancer Familial Registry awarded to the Ontario Registry for Studies of Familial Colorectal Cancer (Grant no. U01 CA074783, Principal Investigator SG). BWZ and TJH are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through support from the Ontario Ministry of Research and Innovation. AJS was supported by the Interdisciplinary Health Research Team Program studentship funded by the Canadian Institutes of Health Research, the Samuel Lunenfeld Research Institute Studentship at Mount Sinai Hospital, and the University of Toronto Fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CR, 2011, J CLIN IMMUNOL, V31, P137, DOI 10.1007/s10875-010-9499-x; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Deng GR, 1999, CANCER RES, V59, P2029; Feber A, 2011, GENOME RES, V21, P515, DOI 10.1101/gr.109678.110; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jiang HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005280; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kane MF, 1997, CANCER RES, V57, P808; Koestler DC, 2012, CANCER EPIDEM BIOMAR, V21, P1293, DOI 10.1158/1055-9965.EPI-12-0361; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Mrkonjic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013314; Muller K, 2001, J BIOL CHEM, V276, P14271; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Perera S, 2011, ONCOL REP, V25, P809, DOI 10.3892/or.2010.1129; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Whiffin N, 2011, CARCINOGENESIS, V32, P1157, DOI 10.1093/carcin/bgr089; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	29	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51531	10.1371/journal.pone.0051531	http://dx.doi.org/10.1371/journal.pone.0051531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240038	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800074
J	Chen, ZJ; Gropler, MC; Mitra, MS; Finck, BN				Chen, Zhouji; Gropler, Matthew C.; Mitra, Mayurranjan S.; Finck, Brian N.			Complex Interplay between the Lipin 1 and the Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) Pathways to Regulate Liver Lipid Metabolism	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; APOLIPOPROTEIN-A-IV; PHOSPHATIDIC-ACID PHOSPHATASE; TRANSCRIPTIONAL REGULATION; SUBCELLULAR-LOCALIZATION; ENERGY-METABOLISM; RESPONSE ELEMENT; SKELETAL-MUSCLE; GENE-EXPRESSION; PROTEIN	Lipin 1 is a bifunctional protein that serves as a metabolic enzyme in the triglyceride synthesis pathway and regulates gene expression through direct protein-protein interactions with DNA-bound transcription factors in liver. Herein, we demonstrate that lipin 1 is a target gene of the hepatocyte nuclear factor 4 alpha (HNF4 alpha), which induces lipin 1 gene expression in cooperation with peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) through a nuclear receptor response element in the first intron of the lipin 1 gene. The results of a series of gain-of-function and loss-of-function studies demonstrate that lipin 1 coactivates HNF4 alpha to activate the expression of a variety of genes encoding enzymes involved in fatty acid catabolism. In contrast, lipin 1 reduces the ability of HNF4 alpha to induce the expression of genes encoding apoproteins A4 and C3. Although the ability of lipin to diminish HNF4 alpha activity on these promoters required a direct physical interaction between the two proteins, lipin 1 did not occupy the promoters of the repressed genes and enhances the intrinsic activity of HNF4 alpha in a promoter-independent context. Thus, the induction of lipin 1 by HNF4 alpha may serve as a mechanism to affect promoter selection to direct HNF4 alpha to promoters of genes encoding fatty acid oxidation enzymes.	[Chen, Zhouji; Gropler, Matthew C.; Mitra, Mayurranjan S.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	bfinck@dom.wustl.edu		Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R01 DK78187]; Digestive Diseases Research Core Center [P30 DK52574]; Nutrition Obesity Research Center (NORC) of Washington University School of Medicine [P30 DK56341]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK052574, R01DK078187, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center; Nutrition Obesity Research Center (NORC) of Washington University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was also supported by the National Institutes of Health grant R01 DK78187 (to BNF) and was also supported, in part, by the Digestive Diseases Research Core Center (P30 DK52574) and the Nutrition Obesity Research Center (NORC) (P30 DK56341) of Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Carrier JC, 2004, J BIOL CHEM, V279, P52052, DOI 10.1074/jbc.M410337200; CARTER ME, 1993, J BIOL CHEM, V268, P13805; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Croce MA, 2007, DIABETES, V56, P2395, DOI 10.2337/db07-0480; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanniman EA, 2006, J LIPID RES, V47, P2503, DOI 10.1194/jlr.M600303-JLR200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hirano T, 2001, AM J PHYSIOL-ENDOC M, V281, pE665, DOI 10.1152/ajpendo.2001.281.4.E665; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; KTISTAKI E, 1994, NUCLEIC ACIDS RES, V22, P4689, DOI 10.1093/nar/22.22.4689; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LEONE TC, 1995, J BIOL CHEM, V270, P24622; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reue K, 2007, FEBS LETT; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sheena V, 2005, J LIPID RES, V46, P328, DOI 10.1194/jlr.M400371-JLR200; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis; Zhang P, 2008, J LIPID RES	46	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51320	10.1371/journal.pone.0051320	http://dx.doi.org/10.1371/journal.pone.0051320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236470	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100094
J	Nagaki, K; Yamamoto, M; Yamaji, N; Mukai, Y; Murata, M				Nagaki, Kiyotaka; Yamamoto, Maki; Yamaji, Naoki; Mukai, Yasuhiko; Murata, Minoru			Chromosome Dynamics Visualized with an Anti-Centromeric Histone H3 Antibody in Allium	PLOS ONE			English	Article							FUNCTIONAL CENTROMERES; TANDEM REPEATS; DNA-SEQUENCES; RETROTRANSPOSONS; IDENTIFICATION; CENH3; ORGANIZATION; SATELLITES; INTERFACE; PROTEINS	Due to the ease with which chromosomes can be observed, the Allium species, and onion in particular, have been familiar materials employed in cytogenetic experiments in biology. In this study, centromeric histone H3 (CENH3)-coding cDNAs were identified in four Allium species (onion, welsh onion, garlic and garlic chives) and cloned. Anti-CENH3 antibody was then raised against a deduced amino acid sequence of CENH3 of welsh onion. The antibody recognized all CENH3 orthologs of the Allium species tested. Immunostaining with the antibody enabled clear visualization of chromosome behavior during mitosis in the species. Furthermore, three-dimensional (3D) observation of mitotic cell division was achieved by subjecting root sections to immunohistochemical techniques. The 3D dynamics of the cells and position of cell-cycle marker proteins (CENH3 and alpha-tubulin) were clearly revealed by immunohistochemical staining with the antibodies. The immunohistochemical analysis made it possible to establish an overview of the location of dividing cells in the root tissues. This breakthrough in technique, in addition to the two centromeric DNA sequences isolated from welsh onion by chromatin immuno-precipitation using the antibody, should lead to a better understanding of plant cell division. A phylogenetic analysis of Allium CENH3s together with the previously reported plant CENH3s showed two separate clades for monocot species tested. One clade was made from CENH3s of the Allium species with those of Poaceae species, and the other from CENH3s of a holocentric species (Luzula nivea). These data may imply functional differences of CENH3s between holocentric and monocentric species. Centromeric localization of DNA sequences isolated from welsh onion by chromatin immunoprecipitation (ChIP) using the antibody was confirmed by fluorescence in situ hybridization and ChIP-quantitative PCR.	[Nagaki, Kiyotaka; Yamaji, Naoki; Murata, Minoru] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Yamamoto, Maki] Kansai Univ Welf Sci, Dept Rehabil Sci, Kashiwara, Japan; [Mukai, Yasuhiko] Osaka Kyoiku Univ, Div Nat Sci, Kashiwara, Japan	Okayama University; Osaka University of Education	Nagaki, K (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan.	nagaki@rib.okayama-u.ac.jp	YAMAJI, Naoki/B-2524-2011	YAMAJI, Naoki/0000-0002-7499-3004	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) as part of the Joint Research Program implemented at the Institute of Plant Science and Resources, Okayama University in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; BARNES SR, 1985, CHROMOSOMA, V92, P185, DOI 10.1007/BF00348692; Do GS, 2001, GENES GENET SYST, V76, P53, DOI 10.1266/ggs.76.53; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Fesenko I. A., 2002, Genetika, V38, P894; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Gong Z, 2012, PLANT CELL; Han YH, 2010, CHROMOSOMA, V119, P89, DOI 10.1007/s00412-009-0239-z; Heckmann S, 2011, CYTOGENET GENOME RES, V134, P220, DOI 10.1159/000327713; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Higaki T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-80; Ho CMK, 2011, PLANT CELL, V23, P2606, DOI 10.1105/tpc.111.086892; Houben A, 2007, CHROMOSOMA, V116, P275, DOI 10.1007/s00412-007-0102-z; Houben A, 2011, CHROMOSOME RES, V19, P471, DOI 10.1007/s10577-011-9207-6; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Kumagai F, 2001, PLANT CELL PHYSIOL, V42, P723, DOI 10.1093/pcp/pce091; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Leme DM, 2009, MUTAT RES-REV MUTAT, V682, P71, DOI 10.1016/j.mrrev.2009.06.002; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Lodish H., 2007, MOL CELL BIOL; Moraes ICR, 2011, PLANT MOL BIOL, V75, P253, DOI 10.1007/s11103-010-9723-3; MUKAI Y, 1993, GENOME, V36, P489, DOI 10.1139/g93-067; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Nagaki K, 2005, CHROMOSOME RES, V13, P195, DOI 10.1007/s10577-005-0847-2; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2012, PLANT CELL REPORTS; Nagaki K, 2011, CHROMOSOME RES, V19, P591, DOI 10.1007/s10577-011-9219-2; Nagaki K, 2009, CHROMOSOMA, V118, P249, DOI 10.1007/s00412-008-0193-1; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Pearce SR, 1996, CHROMOSOME RES, V4, P357, DOI 10.1007/BF02257271; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pich U, 1996, CHROMOSOME RES, V4, P207, DOI 10.1007/BF02254961; Pich U, 1996, PLANT SYST EVOL, V202, P255, DOI 10.1007/BF00983386; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanei M, 2011, P NATL ACAD SCI USA, V108, pE498, DOI 10.1073/pnas.1103190108; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; Shibata F, 2002, CHROMOSOMA, V111, P184, DOI 10.1007/s00412-002-0197-1; Simon EJ, 2010, CAMPBELL ESSENTIAL B; Sugimoto K, 2008, MUTAT RES-GEN TOX EN, V657, P56, DOI 10.1016/j.mrgentox.2008.08.005; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Tek AL, 2011, CHROMOSOME RES, V19, P969, DOI 10.1007/s10577-011-9247-y; Tek AL, 2010, CHROMOSOME RES, V18, P337, DOI 10.1007/s10577-010-9119-x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang GX, 2011, CHROMOSOMA, V120, P353, DOI 10.1007/s00412-011-0315-z; Yamaji N, 2007, PLANT PHYSIOL, V143, P1306, DOI 10.1104/pp.106.093005; Yoneda A, 2005, PLANT CELL PHYSIOL, V46, P531, DOI 10.1093/pcp/pci055; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	50	23	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51315	10.1371/journal.pone.0051315	http://dx.doi.org/10.1371/journal.pone.0051315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236469	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100093
J	Brunelli, M; Bria, E; Nottegar, A; Cingarlini, S; Simionato, F; Calio, A; Eccher, A; Parolini, C; Iannucci, A; Gilioli, E; Pedron, S; Massari, F; Tortora, G; Borze, I; Knuutila, S; Gobbo, S; Santo, A; Tondulli, L; Calabro, F; Martignoni, G; Chilosi, M				Brunelli, Matteo; Bria, Emilio; Nottegar, Alessia; Cingarlini, Sara; Simionato, Francesca; Calio, Anna; Eccher, Albino; Parolini, Claudia; Iannucci, Antonio; Gilioli, Eliana; Pedron, Serena; Massari, Francesco; Tortora, Giampaolo; Borze, Ioana; Knuutila, Sakari; Gobbo, Stefano; Santo, Antonio; Tondulli, Luca; Calabro, Francesco; Martignoni, Guido; Chilosi, Marco			True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; IN-SITU HYBRIDIZATION; COPY NUMBER; CANCER; SOX2; ADENOCARCINOMA; EGFR; CHEMOTHERAPY; EXPRESSION; SURVIVAL	Squamous lung carcinoma lacks specific "ad hoc" therapies. Amplification of chromosome 3q is the most common genomic aberration and this region harbours genes having role as novel targets for therapeutics. There is no standard definition on how to score and report 3q amplification. False versus true 3q chromosomal amplification in squamous cell lung carcinoma may have tremendous impact on trials involving drugs which target DNA zones mapping on 3q. Forty squamous lung carcinomas were analyzed by FISH to assess chromosome 3q amplification. aCGH was performed as gold-standard to avoid false positive amplifications. Three clustered patterns of fluorescent signals were observed. Eight cases out of 40 (20%) showed >= 8 3q signals. Twenty out of 40 (50%) showed from 3 to 7 signals. The remaining showed two fluorescent signals (30%). When corrected by whole chromosome 3 signals, only cases with >= 8 signals maintained a LSI 3q/CEP3 ratio >2. Only the cases showing 3q amplification by aCGH (+3q25.3-3q27.3) showed >= 8 fluorescent signals at FISH evidencing a 3q/3 ratio >2. The remaining cases showed flat genomic portrait at aCGH on chromosome 3. We concluded that: 1) absolute copy number of 3q chromosomal region may harbour false positive interpretation of 3q amplification in squamous cell carcinoma; 2) a case results truly "amplified for chromosome 3q" when showing >= 8 fluorescent 3q signals; 3) trials involving drugs targeting loci on chromosome 3q in squamous lung carcinoma therapy have to consider false versus true 3q chromosomal amplification. Citation: Brunelli M, Bria E, Nottegar A, Cingarlini S, Simionato F, et al. (2012) True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs. PLoS ONE 7(12): e49689. doi:10.1371/journal.pone.0049689	[Brunelli, Matteo; Nottegar, Alessia; Calio, Anna; Parolini, Claudia; Pedron, Serena; Gobbo, Stefano; Martignoni, Guido; Chilosi, Marco] Univ Verona, Azienda Osped Univ Integrata Verona, Dept Pathol & Diagnost, ISH Mol Lab, I-37100 Verona, Italy; [Eccher, Albino; Gilioli, Eliana] Osped Civile, Azienda Osped Univ Integrata Verona, Pathol Unit, I-37126 Verona, Italy; [Borze, Ioana; Knuutila, Sakari] Univ Helsinki, Haartman Insitute, Helsinki, Finland; [Santo, Antonio; Tondulli, Luca] Osped Civile, Azienda Osped Univ Integrata Verona, Oncol Unit, I-37126 Verona, Italy; [Calabro, Francesco] Osped Civile, Azienda Osped Univ Integrata Verona, Thorac Surg Unit, I-37126 Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Helsinki; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Brunelli, M (corresponding author), Univ Verona, Azienda Osped Univ Integrata Verona, Dept Pathol & Diagnost, ISH Mol Lab, I-37100 Verona, Italy.	matteo.brunelli@univr.it	Nottegar, Alessia/Q-4921-2016; cingarlini, sara/ABB-5280-2020; Massari, Francesco/K-7239-2016; Cingarlini, Sara/AAJ-5263-2021; Tortora, Giampaolo/AAA-1252-2019; Brunelli, Matteo/AAA-7679-2019; Tortora, Giampaolo/HGB-6261-2022; Iannucci, Antonio/AAP-9647-2021; Caliò, Anna/Y-1465-2018; Bria, Emilio/A-8574-2019; CHILOSI, MARCO/ABB-8028-2021; Tondulli, Luca/GNP-5039-2022	Nottegar, Alessia/0000-0003-3325-8705; Massari, Francesco/0000-0001-6476-6871; Cingarlini, Sara/0000-0003-4786-4781; Caliò, Anna/0000-0001-7352-6327; Bria, Emilio/0000-0002-2333-704X; eccher, albino/0000-0002-9992-5550; Tortora, Giampaolo/0000-0002-1378-4962; Gobbo, Stefano/0000-0001-5247-5233; BRUNELLI, Matteo/0000-0002-3832-2676	European Union FP7 Health Research Grant [HEALTH-F4-2008-202047]	European Union FP7 Health Research Grant	This study was supported by the European Union FP7 Health Research Grant number HEALTH-F4-2008-202047. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros IM, 2003, J CLIN ONCOL, V21, P2077, DOI 10.1200/JCO.2003.03.025; Balsara BR, 1997, CANCER RES, V57, P2116; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bjorkqvist AM, 1998, BRIT J CANCER, V77, P260, DOI 10.1038/bjc.1998.42; Bjorkqvist AM, 1998, GENE CHROMOSOME CANC, V22, P79; Brass N, 1996, EUR J CANCER, V32A, P1205, DOI 10.1016/0959-8049(96)00016-0; Bria E, 2011, ANN ONCOL, V22, P2277, DOI 10.1093/annonc/mdq742; Bria E, 2009, LUNG CANCER, V63, P50, DOI 10.1016/j.lungcan.2008.05.002; Brunelli M, 2008, PATHOLOGICA, V100, P454; Brunelli M, 2008, MODERN PATHOL, V21, P1, DOI 10.1038/modpathol.3800967; Cai YR, 2011, ONCOL REP, V26, P877, DOI 10.3892/or.2011.1349; Cappuzzo F, 2007, J THORAC ONCOL, V2, P423, DOI 10.1097/01.JTO.0000268676.79872.9b; Chujo M, 2002, LUNG CANCER-J IASLC, V38, P23, DOI 10.1016/S0169-5002(02)00151-4; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gnjatic S, 2009, J IMMUNOL METHODS, V341, P50, DOI 10.1016/j.jim.2008.10.016; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Hussenet T, 2010, CELL CYCLE, V9; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kettunen E, 2000, CANCER GENET CYTOGEN, V117, P66, DOI 10.1016/S0165-4608(99)00146-6; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maddison P, 2010, LUNG CANCER, V70, P335, DOI 10.1016/j.lungcan.2010.03.002; Massion PP, 2002, CANCER RES, V62, P3636; McCaughan F, 2010, AM J RESP CRIT CARE, V182, P83, DOI 10.1164/rccm.201001-0005OC; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Pelosi G, 2007, CLIN CANCER RES, V13, P1995, DOI 10.1158/1078-0432.CCR-06-2483; Petersen I, 1997, CANCER RES, V57, P2331; Qian J, 2008, J THORAC ONCOL, V3, P212, DOI 10.1097/JTO.0b013e3181663544; Racz A, 1999, EUR J CANCER, V35, P641, DOI 10.1016/S0959-8049(98)00419-5; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Singh B, 2001, CANCER RES, V61, P4506; Titulaer MJ, 2009, J CLIN ONCOL, V27, P4260, DOI 10.1200/JCO.2008.20.6169; Tompkins DH, 2011, AM J RESP CELL MOL B; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Varella-Garcia M, 2009, J CLIN PATHOL, V62, P970, DOI 10.1136/jcp.2009.066548; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yokoi S, 2003, CLIN CANCER RES, V9, P4705; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	41	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e49689	10.1371/journal.pone.0049689	http://dx.doi.org/10.1371/journal.pone.0049689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236352	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700005
J	Wan, M; Liang, JC; Xiong, YY; Shi, FT; Zhang, Y; Lu, WS; He, QY; Yang, D; Chen, R; Liu, D; Barton, M; Zhou, SY				Wan, Ma; Liang, Jiancong; Xiong, Yuanyan; Shi, Fengtao; Zhang, Yi; Lu, Weisi; He, Quanyuan; Yang, Dong; Chen, Rui; Liu, Dan; Barton, Michelle; Zhou Songyang			The Trithorax Group Protein Ash2l Is Essential for Pluripotency and Maintaining Open Chromatin in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; H3K4 METHYLATION; TRANSCRIPTIONAL REPRESSION; HISTONE-H3 LYSINE-4; CRYSTAL-STRUCTURE; RECRUITMENT; REVEALS; GENES; DNA; DIFFERENTIATION	Embryonic stem (ES) cells exhibit general characteristics of open chromatin, a state that may be necessary for ES cells to efficiently self-renew while remaining poised for differentiation. Histone H3K4 and H3K9 trimethylation associate as a general rule, with open and silenced chromatin, respectively, for ES cell pluripotency maintenance. However, how histone modifications are regulated to maintain open chromatin in ES cells remains largely unknown. Here, we demonstrate that trithorax protein Ash2l, homologue of the Drosophila Ash2 (absent, small, homeotic-2) protein, is a key regulator of open chromatin in ES cells. Consistent with Ash2l being a core subunit of mixed lineage leukemia methyltransferase complex, RNAiknockdownofAsh2lwassufficienttoreduceH3K4 methylation levels and drive ES cells to a silenced chromatin state with high H3K9 trimethylation. Genome-wide ChIP-seq analysis indicated that Ash2l is recruited to target loci through two distinct modes and enriched at a family of genes implicated in open chromatin regulation, including chromatin remodeler Cdh7, transcription factor c-Myc, and H3K9 demethylase Kdm4c. Our results underscore the importance of Ash2l in open chromatin regulation and provide insight into how the open chromatin landscape is maintained in ES cells.	[Xiong, Yuanyan; Lu, Weisi; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Yuanyan; Lu, Weisi; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Ma; Liang, Jiancong; Shi, Fengtao; Zhang, Yi; He, Quanyuan; Yang, Dong; Liu, Dan; Zhou Songyang] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Barton, Michelle; Zhou Songyang] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Barton, Michelle] Univ Texas MD Anderson Canc Ctr, Univ Texas Houston, Grad Sch Biomed Sci,Dept Biochem & Mol Biol, Ctr Stem Cell & Dev Biol,Grad Program Genes & Dev, Houston, TX 77030 USA	Sun Yat Sen University; Sun Yat Sen University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Zhou, SY (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	songyang@bcm.edu	Liang, Jiancong/AAC-1321-2022; Lu, Weisi/Q-2357-2015	Liang, Jiancong/0000-0002-7215-4346; Lu, Weisi/0000-0001-6039-6009; Barton, Michelle/0000-0002-4042-1374	National Basic Research Program (973 Program) [2010CB945400, 2012CB911201]; National Natural Science Foundation of China [NSFC 91019020]; NIGMS, National Institutes of Health [GM081627]; NCI, National Institutes of Health [CA133249, GM095599]; Welch Foundation [Q-1673]; Leukemia and Lymphoma Society; Dan L. Duncan Cancer Center [P30CA125123]; Administrative and Genome-wide RNAi Screens Cores [IDDRC P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA133249, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095599, P01GM081627] Funding Source: NIH RePORTER	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Dan L. Duncan Cancer Center; Administrative and Genome-wide RNAi Screens Cores; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program (973 Program 2010CB945400 and 2012CB911201); National Natural Science Foundation of China (NSFC 91019020); NIGMS, National Institutes of Health (GM081627), NCI, National Institutes of Health (CA133249 and GM095599); the Welch Foundation (Q-1673), and the Leukemia and Lymphoma Society. This work was also supported by the Dan L. Duncan Cancer Center (P30CA125123) and the Administrative and Genome-wide RNAi Screens Cores (IDDRC P30HD024064).	Ahmed K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010531; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Avdic V, 2011, STRUCTURE, V19, P101, DOI 10.1016/j.str.2010.09.022; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen Y, 2012, CELL RES, V22, P598, DOI 10.1038/cr.2012.9; Chen Y, 2011, EMBO REP, V12, P797, DOI 10.1038/embor.2011.101; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koh FM, 2010, CURR OPIN GENET DEV, V20, P492, DOI 10.1016/j.gde.2010.06.002; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Kubicek S, 2006, E SCHERING RES FDN W, V57, P1; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Loh YH, 2011, ANNU REV GENOM HUM G, V12, P165, DOI 10.1146/annurev-genom-082410-101506; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park SH, 2004, ULTRASTRUCT PATHOL, V28, P229, DOI 10.1080/01913120490515595; Ram EVSR, 2009, GENE DEV, V23, P2793, DOI 10.1101/gad.1881609; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Sarvan S, 2011, NAT STRUCT MOL BIOL, V18, P857, DOI 10.1038/nsmb.2093; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wu H, 2006, PEDIATR RES, V59, p21R, DOI 10.1203/01.pdr.0000203565.76028.2a; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	65	45	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5039	5048		10.1074/jbc.M112.424515	http://dx.doi.org/10.1074/jbc.M112.424515			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23239880	Green Published, hybrid			2022-12-25	WOS:000315340400050
J	Abdian, PL; Caramelo, JJ; Ausmees, N; Zorreguieta, A				Abdian, Patricia L.; Caramelo, Julio J.; Ausmees, Nora; Zorreguieta, Angeles			RapA2 Is a Calcium-binding Lectin Composed of Two Highly Conserved Cadherin-like Domains That Specifically Recognize Rhizobium leguminosarum Acidic Exopolysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-SYMBIONT INTERACTIONS; BIOFILM FORMATION; PROTEIN SECRETION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CELL-SURFACE; I SECRETION; POLYSACCHARIDES; IDENTIFICATION; NODULATION	In silico analyses have revealed a conserved protein domain (CHDL) widely present in bacteria that has significant structural similarity to eukaryotic cadherins. A CHDL domain was shown to be present in RapA, a protein that is involved in autoaggregation of Rhizobium cells, biofilm formation, and adhesion to plant roots as shown by us and others. Structural similarity to cadherins suggested calcium-dependent oligomerization of CHDL domains as a mechanistic basis for RapA action. Here we show by circular dichroism spectroscopy, light scattering, isothermal titration calorimetry, and other methods that RapA2 from Rhizobium leguminosarum indeed exhibits a cadherin-like beta-sheet conformation and that its proper folding and stability are dependent on the binding of one calcium ion per protein molecule. By further in silico analysis we also reveal that RapA2 consists of two CHDL domains and expand the range of CHDL-containing proteins in bacteria and archaea. However, light scattering assays at various concentrations of added calcium revealed that RapA2 formed neither homo-oligomers nor hetero-oligomers with RapB (a distinct CHDL protein), indicating that RapA2 does not mediate cellular interactions through a cadherin-like mechanism. Instead, we demonstrate that RapA2 interacts specifically with the acidic exopolysaccharides (EPSs) produced by R. leguminosarum in a calcium-dependent manner, sustaining a role of these proteins in the development of the biofilm matrix made of EPS. Because EPS binding by RapA2 can only be attributed to its two CHDL domains, we propose that RapA2 is a calcium-dependent lectin and that CHDL domains in various bacterial and archaeal proteins confer carbohydrate binding activity to these proteins.	[Abdian, Patricia L.; Caramelo, Julio J.; Zorreguieta, Angeles] IIBBA Consejo Nacl Invest Cient & Tecnol, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Caramelo, Julio J.; Zorreguieta, Angeles] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Ausmees, Nora] Lund Univ, Dept Biol, S-22362 Lund, Sweden	Leloir Institute; University of Buenos Aires; Lund University	Zorreguieta, A (corresponding author), IIBBA Consejo Nacl Invest Cient & Tecnol, Fdn Inst Leloir, Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	azorreguieta@leloir.org.ar	Abdian, Patricia/AAW-2420-2020	Abdian, Patricia/0000-0002-8366-8115	Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT) [PICT 20334]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 545]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0376]; Swedish Research Council	Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT)(ANPCyTFONCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT, PICT 20334; to A. Z.) a grant (PIP 545) from Consejo Nacional de Investigaciones Cientificas y Tecnologicas (to A. Z.), a grant from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-0376) to J. J. C., and a grant from the Swedish Research Council to N. A.	Abbott DW, 2007, J MOL BIOL, V368, P1215, DOI 10.1016/j.jmb.2007.02.083; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Aravind P, 2009, J MOL BIOL, V385, P163, DOI 10.1016/j.jmb.2008.10.035; Ausmees N, 2001, MICROBIOL-UK, V147, P549, DOI 10.1099/00221287-147-3-549; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Butcher BG, 2007, J BACTERIOL, V189, P8616, DOI 10.1128/JB.01181-07; Cao LH, 2005, FEMS MICROBIOL LETT, V251, P203, DOI 10.1016/j.femsle.2005.08.004; Chen CP, 1998, GLYCOBIOLOGY, V8, P7, DOI 10.1093/glycob/8.1.7; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; DAZZO FB, 1982, APPL ENVIRON MICROB, V44, P478, DOI 10.1128/AEM.44.2.478-490.1982; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Dickens NJ, 2002, CURR BIOL, V12, pR197, DOI 10.1016/S0960-9822(02)00748-0; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; DOWNIE JA, 1983, EMBO J, V2, P947, DOI 10.1002/j.1460-2075.1983.tb01526.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FILISETTICOZZI TMCC, 1991, ANAL BIOCHEM, V197, P157, DOI 10.1016/0003-2697(91)90372-Z; Finnie C, 1997, MOL MICROBIOL, V25, P135, DOI 10.1046/j.1365-2958.1997.4471803.x; Finnie C, 1998, J BACTERIOL, V180, P1691, DOI 10.1128/JB.180.7.1691-1699.1998; Fraiberg M, 2011, J BACTERIOL, V193, P283, DOI 10.1128/JB.00842-10; Fraiberg M, 2010, J BACTERIOL, V192, P1066, DOI 10.1128/JB.01236-09; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Goodstadt L, 2001, BIOINFORMATICS, V17, P845, DOI 10.1093/bioinformatics/17.9.845; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Jefferson K. K., 2006, METHODS MOL BIOL CEL, P119; JOHNSTON AWB, 1975, J GEN MICROBIOL, V87, P343, DOI 10.1099/00221287-87-2-343; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Krehenbrink M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-55; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laus MC, 2004, J BACTERIOL, V186, P6617, DOI 10.1128/JB.186.19.6617-6625.2004; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; LOEWUS MW, 1952, J BIOL CHEM, V199, P857; MCNEIL M, 1986, CARBOHYD RES, V146, P307, DOI 10.1016/0008-6215(86)85048-0; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; MILLER KJ, 1990, J BACTERIOL, V172, P136, DOI 10.1128/JB.172.1.136-142.1990; Mongiardini EJ, 2008, FEMS MICROBIOL ECOL, V65, P279, DOI 10.1111/j.1574-6941.2008.00467.x; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Russo DM, 2006, J BACTERIOL, V188, P4474, DOI 10.1128/JB.00246-06; Sandford P. A., 1977, ACS SYM SER, V45, P192; SHERWOOD MT, 1970, J APPL BACTERIOL, V33, P708, DOI 10.1111/j.1365-2672.1970.tb02253.x; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; WATKINS NJ, 1995, BIOCHEM J, V306, P865, DOI 10.1042/bj3060865; Williams A, 2008, J BACTERIOL, V190, P4706, DOI 10.1128/JB.01694-07; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zeng XQ, 2012, ANAL BIOANAL CHEM, V402, P3161, DOI 10.1007/s00216-011-5594-y; ZEVENHUIZEN LPTM, 1983, CARBOHYD RES, V118, P127, DOI 10.1016/0008-6215(83)88041-0; Zorreguieta A, 2000, J BACTERIOL, V182, P1304, DOI 10.1128/JB.182.5.1304-1312.2000	56	22	23	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2893	2904		10.1074/jbc.M112.411769	http://dx.doi.org/10.1074/jbc.M112.411769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23235153	Green Published, hybrid			2022-12-25	WOS:000314211500071
J	Bae, C; Kalia, J; Song, I; Yu, J; Kim, HH; Swartz, KJ; Kim, JI				Bae, Chanhyung; Kalia, Jeet; Song, Inhye; Yu, JeongHeon; Kim, Ha Hyung; Swartz, Kenton J.; Kim, Jae Il			High Yield Production and Refolding of the Double-Knot Toxin, an Activator of TRPV1 Channels	PLOS ONE			English	Article							FUNNEL-WEB SPIDER; 3-DIMENSIONAL SOLUTION STRUCTURE; CONOTOXIN MVIIA; VENOM; INHIBITOR; PEPTIDES; EXPRESSION; COMPOUND; TYR(13); BLOCKER	A unique peptide toxin, named double-knot toxin (DkTx), was recently purified from the venom of the tarantula Ornithoctonus huwena and was found to stably activate TRPV1 channels by targeting the outer pore domain. DkTx has been shown to consist of two inhibitory cysteine-knot (ICK) motifs, referred to as K1 and K2, each containing six cysteine residues. Beyond this initial characterization, however, the structural and functional details about DkTx remains elusive in large part due to the lack of a high yielding methodology for the synthesis and folding of this cysteine-rich peptide. Here, we overcome this obstacle by generating pure DkTx in quantities sufficient for structural and functional analyses. Our methodology entails expression of DkTx in E. coli followed by oxidative folding of the isolated linear peptide. Upon screening of various oxidative conditions for optimizing the folding yield of the toxin, we observed that detergents were required for efficient folding of the linear peptide. Our synthetic DkTx co-eluted with the native toxin on HPLC, and irreversibly activated TRPV1 in a manner identical to native DkTx. Interestingly, we find that DkTx has two interconvertible conformations present in a 1: 6 ratio at equilibrium. Kinetic analysis of DkTx folding suggests that the K1 and K2 domains influence each other during the folding process. Moreover, the CD spectra of the toxins shows that the secondary structures of K1 and K2 remains intact even after separating the two knots. These findings provide a starting point for detailed studies on the structural and functional characterization of DkTx and utilization of this toxin as a tool to explore the elusive mechanisms underlying the polymodal gating of TRPV1. Citation: Bae C, Kalia J, Song I, Yu J, Kim HH, et al. (2012) High Yield Production and Refolding of the Double-Knot Toxin, an Activator of TRPV1 Channels. PLoS ONE 7(12): e51516. doi:10.1371/journal.pone.0051516	[Bae, Chanhyung; Song, Inhye; Yu, JeongHeon; Kim, Jae Il] Gwangju Inst Sci & Technol GIST, Sch Life Sci, Kwangju, South Korea; [Kalia, Jeet; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Kim, Ha Hyung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Gwangju Institute of Science & Technology (GIST); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Chung Ang University	Kim, JI (corresponding author), Gwangju Inst Sci & Technol GIST, Sch Life Sci, Kwangju, South Korea.	jikim@gist.ac.kr		Bae, Chanhyung/0000-0003-3407-2857	Next-Generation BioGreen 21 Program [PJ008158]; Rural Development Administration, Republic of Korea; National Research Foundation of Korea grant; Korean Government (MEST) [NRF-C1ABA001-2011-0018559]; Brain Research Center of the 21st Century Frontier Research Program [M103KV010005-06K2201-00610]; BioImaging Research Center at the Gwangju Institute of Science and Technology; Basic Research Projects in High-tech Industrial Technology; Gwangju Institute of Science and Technology; Intramural Research Program of the NINDS, NIH; NINDS competitive fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002945] Funding Source: NIH RePORTER	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea grant(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); BioImaging Research Center at the Gwangju Institute of Science and Technology; Basic Research Projects in High-tech Industrial Technology; Gwangju Institute of Science and Technology; Intramural Research Program of the NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS competitive fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the Next-Generation BioGreen 21 Program (PJ008158); the Rural Development Administration, Republic of Korea; a National Research Foundation of Korea grant funded by the Korean Government (MEST) (NRF-C1ABA001-2011-0018559); the Brain Research Center of the 21st Century Frontier Research Program (M103KV010005-06K2201-00610); the BioImaging Research Center at the Gwangju Institute of Science and Technology and Basic Research Projects in High-tech Industrial Technology funded by the Gwangju Institute of Science and Technology in 2011; the Intramural Research Program of the NINDS, NIH, and by an NINDS competitive fellowship to Jeet Kalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ME, 1989, J COMP PHYSIOL A, V164, P333, DOI 10.1007/BF00612993; Adams ME, 2004, TOXICON, V43, P509, DOI 10.1016/j.toxicon.2004.02.004; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Bornstein P, 1977, Methods Enzymol, V47, P132; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; DeLa Cruz R, 2003, J PEPT RES, V61, P202, DOI 10.1034/j.1399-3011.2003.t01-1-00048.x; Escoubas P, 2000, BIOCHIMIE, V82, P893, DOI 10.1016/S0300-9084(00)01166-4; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Gomes PC, 2011, TOXICON, V57, P266, DOI 10.1016/j.toxicon.2010.11.021; HONG SJ, 1995, J PHYSIOL-LONDON, V482, P283, DOI 10.1113/jphysiol.1995.sp020517; Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; KIM JI, 1994, J BIOL CHEM, V269, P23876; KIM JI, 1995, BIOCHEM BIOPH RES CO, V206, P449, DOI 10.1006/bbrc.1995.1063; KIM JI, 1995, J MOL BIOL, V250, P659, DOI 10.1006/jmbi.1995.0406; Kitaguchi T, 2005, BIOCHEMISTRY-US, V44, P15544, DOI 10.1021/bi051494l; Kobayashi K, 2000, BIOCHEMISTRY-US, V39, P14761, DOI 10.1021/bi001506x; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; NICHOLSON GM, 1994, PFLUG ARCH EUR J PHY, V428, P400, DOI 10.1007/BF00724524; Pi CH, 2007, J BIOTECHNOL, V128, P184, DOI 10.1016/j.jbiotec.2006.09.014; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Sasaki T, 1999, BIOCHEMISTRY-US, V38, P12876, DOI 10.1021/bi990731f; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Steiner AM, 2011, J PEPT SCI, V17, P1, DOI 10.1002/psc.1283; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Zhan JB, 2003, BIOCHEM BIOPH RES CO, V311, P495, DOI 10.1016/j.bbrc.2003.09.234; Zhang H, 2005, PROTEIN EXPRES PURIF, V41, P409, DOI 10.1016/j.pep.2005.03.003	34	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51516	10.1371/journal.pone.0051516	http://dx.doi.org/10.1371/journal.pone.0051516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240036	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800072
J	Casanova, V; Naval-Macabuhay, I; Massanella, M; Rodriguez-Garcia, M; Blanco, J; Gatell, JM; Garcia, F; Gallart, T; Lluis, C; Mallol, J; Franco, R; Climent, N; McCormick, PJ				Casanova, Victor; Naval-Macabuhay, Isaac; Massanella, Marta; Rodriguez-Garcia, Marta; Blanco, Julia; Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa; Lluis, Carme; Mallol, Josefa; Franco, Rafael; Climent, Nuria; McCormick, Peter J.			Adenosine Deaminase Enhances the Immunogenicity of Human Dendritic Cells from Healthy and HIV-Infected Individuals	PLOS ONE			English	Article							REGULATORY T-CELLS; CHEMOKINE RECEPTORS; SURFACE EXPRESSION; PEPTIDASE-IV; CD26; ACTIVATION; CYTOKINE; IMMUNITY; BINDING; PROTEIN	ADA is an enzyme implicated in purine metabolism, and is critical to ensure normal immune function. Its congenital deficit leads to severe combined immunodeficiency (SCID). ADA binding to adenosine receptors on dendritic cell surface enables T-cell costimulation through CD26 crosslinking, which enhances T-cell activation and proliferation. Despite a large body of work on the actions of the ecto-enzyme ADA on T-cell activation, questions arise on whether ADA can also modulate dendritic cell maturation. To this end we investigated the effects of ADA on human monocyte derived dendritic cell biology. Our results show that both the enzymatic and non-enzymatic activities of ADA are implicated in the enhancement of CD80, CD83, CD86, CD40 and CCR7 expression on immature dendritic cells from healthy and HIV-infected individuals. These ADA-mediated increases in CD83 and costimulatory molecule expression is concomitant to an enhanced IL-12, IL-6, TNF-alpha, CXCL8(IL-8), CCL3(MIP1-alpha), CCL4(MIP-1 beta) and CCL5(RANTES) cytokine/chemokine secretion both in healthy and HIV-infected individuals and to an altered apoptotic death in cells from HIV-infected individuals. Consistently, ADA-mediated actions on iDCs are able to enhance allogeneic CD4 and CD8-T-cell proliferation, globally yielding increased iDC immunogenicity. Taken together, these findings suggest that ADA would promote enhanced and correctly polarized T-cell responses in strategies targeting asymptomatic HIV-infected individuals.	[Casanova, Victor; Naval-Macabuhay, Isaac; Lluis, Carme; Mallol, Josefa; Franco, Rafael; McCormick, Peter J.] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain; [Massanella, Marta; Blanco, Julia] Fundacio IrsiCaixa HIVACAT, Inst Invest Ciencies Salut Germans Trias & Pujol, Badalona, Spain; [Rodriguez-Garcia, Marta] Dartmouth Med Sch Lebanon, Dept Physiol & Neurobiol, Lebanon, NH USA; [Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa; Climent, Nuria] Inst Invest Biomed August Pi & Sunyer IDIBAPS, AIDS Res Grp, Barcelona, Spain; [Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa; Climent, Nuria] Catalonian Ctr HIV Vaccines HIVACAT, Barcelona, Spain; [Garcia, Felipe] Hosp Clin Barcelona, Infect Dis & AIDS Unit, Barcelona, Spain; [Gallart, Teresa] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain	University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	McCormick, PJ (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain.	pmccormick@ub.edu	Massanella, Marta/P-8619-2016; Climent, Núria/AAF-8161-2021; , Felipe/F-4242-2014; Gatell, Jose M/ABC-3607-2020; Mallol, Josefa/I-4194-2015; Blanco, Julià/A-5347-2008; Franco, Rafael/C-3694-2015; McCormick, Peter/E-7387-2012	Massanella, Marta/0000-0002-3326-151X; Climent, Núria/0000-0002-0791-656X; , Felipe/0000-0001-7658-5832; Mallol, Josefa/0000-0002-2479-4162; Blanco, Julià/0000-0002-2225-0217; Franco, Rafael/0000-0003-2549-4919; McCormick, Peter/0000-0002-2225-5181; Casanova, Victor/0000-0002-4917-260X	FIPSE (Spanish Ministry of Health) [36750/08]; FIPSE (Abbott Laboratories) [36750/08]; FIPSE (Boehringer Ingelheim) [36750/08]; FIPSE (Bristol Myers Squibb) [36750/08]; FIPSE (GlaxoSmithKline) [36750/08]; FIPSE (Merck Sharp and Dohme) [36750/08]; FIPSE (Roche) [36750/08]; FIS (Fondo de Investigacion Sanitaria) [PS09/01297, PI10/02984]; Spanish Ministry of Science [SAF2006-26667-E]; HIVACAT (Catalonian Center for HIV Vaccines)	FIPSE (Spanish Ministry of Health); FIPSE (Abbott Laboratories); FIPSE (Boehringer Ingelheim)(Boehringer Ingelheim); FIPSE (Bristol Myers Squibb); FIPSE (GlaxoSmithKline); FIPSE (Merck Sharp and Dohme); FIPSE (Roche); FIS (Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos III); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); HIVACAT (Catalonian Center for HIV Vaccines)	This study was supported by FIPSE (a non-profit foundation including: Spanish Ministry of Health, Abbott Laboratories, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme and Roche) 36750/08, FIS (Fondo de Investigacion Sanitaria) PS09/01297 and PI10/02984, grant from Spanish Ministry of Science (SAF2006-26667-E) and HIVACAT (Catalonian Center for HIV Vaccines). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo-Vega FX, 1998, AM J HUM GENET, V63, P1049, DOI 10.1086/302054; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Baratelli F, 2005, J LEUKOCYTE BIOL, V78, P555, DOI 10.1189/jlb.1004569; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blackburn MR, 2012, J IMMUNOL, V188, P933, DOI 10.4049/jimmunol.1103519; Blanco J, 2000, FEBS LETT, V477, P123, DOI 10.1016/S0014-5793(00)01751-8; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Cassani B, 2008, BLOOD, V111, P4209, DOI 10.1182/blood-2007-05-092429; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Ciruela F, 1996, FEBS LETT, V380, P219, DOI 10.1016/0014-5793(96)00023-3; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; Climent N, 2009, IMMUNOL CELL BIOL, V87, P634, DOI 10.1038/icb.2009.53; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Cross JL, 2008, J IMMUNOL, V180, P8020, DOI 10.4049/jimmunol.180.12.8020; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; DEMEESTER I, 1994, EUR J IMMUNOL, V24, P566, DOI 10.1002/eji.1830240311; Desrosiers MD, 2007, J IMMUNOL, V179, P1884, DOI 10.4049/jimmunol.179.3.1884; Dong RP, 1996, J IMMUNOL, V156, P1349; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Fan H, 2012, EUR J CELL BIOL, V91, P265, DOI 10.1016/j.ejcb.2011.06.001; FRANCO R, 1986, NEUROCHEM RES, V11, P423, DOI 10.1007/BF00965016; Franco R, 2007, CRIT REV IMMUNOL, V27, P495, DOI 10.1615/CritRevImmunol.v27.i6.10; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Gallois A, 2010, NAT MED, V16, DOI 10.1038/nm0810-854; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gracia E, 2011, BIOCHEM J, V435, P701, DOI 10.1042/BJ20101749; Hashikawa T, 2004, FASEB J, V18, P131, DOI 10.1096/fj.03-0011fje; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Herrera C, 2001, MOL PHARMACOL, V59, P127, DOI 10.1124/mol.59.1.127; Hershfield MS, 2005, EUR J IMMUNOL, V35, P25, DOI 10.1002/eji.200425738; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Klein SA, 1997, AIDS, V11, P1111, DOI 10.1097/00002030-199709000-00005; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Laforge M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002087; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Leon B, 2008, IMMUNOL CELL BIOL, V86, P320, DOI 10.1038/icb.2008.14; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; MARTIN M, 1995, J IMMUNOL, V155, P4630; Martinez-Navio JM, 2011, IMMUNOLOGY CELL BIOL; Martinez-Navio JM, 2011, J LEUKOCYTE BIOL, V89, P127, DOI 10.1189/jlb.1009696; Martinez-Navio JM, 2009, IMMUNOLOGY, V128, P393, DOI 10.1111/j.1365-2567.2009.03121.x; Montoya M, 2006, EUR J IMMUNOL, V36, P2150, DOI 10.1002/eji.200535304; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Panther E, 2001, FASEB J, V15, P1963, DOI 10.1096/fj.01-0169com; Parish ST, 2010, J IMMUNOL, V184, P2847, DOI 10.4049/jimmunol.0903647; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Piercy J, 2006, IMMUNOLOGY, V118, P250, DOI 10.1111/j.1365-2567.2006.02363.x; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Richard E, 2002, J BIOL CHEM, V277, P19720, DOI 10.1074/jbc.M111901200; Rodriguez-Garcia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009436; Rollenhagen C, 2010, JAIDS-J ACQ IMM DEF, V54, P463, DOI 10.1097/QAI.0b013e3181e5e12c; Ryzhov S, 2009, PURINERG SIGNAL, V5, P289, DOI 10.1007/s11302-008-9129-8; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; Shen H, 2009, J AM SOC NEPHROL, V20, P1032, DOI 10.1681/ASN.2008070778; Suchard MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011762; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6	76	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51287	10.1371/journal.pone.0051287	http://dx.doi.org/10.1371/journal.pone.0051287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240012	gold, Green Submitted, Green Published			2022-12-25	WOS:000312290800048
J	Palchesko, RN; Zhang, L; Sun, Y; Feinberg, AW				Palchesko, Rachelle N.; Zhang, Ling; Sun, Yan; Feinberg, Adam W.			Development of Polydimethylsiloxane Substrates with Tunable Elastic Modulus to Study Cell Mechanobiology in Muscle and Nerve	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; MATRIX ELASTICITY; HYDROPHOBIC RECOVERY; PROTEIN ADSORPTION; STIFFNESS; SOFT; RIGIDITY; DIFFERENTIATION; SURFACES; ADHESION	Mechanics is an important component in the regulation of cell shape, proliferation, migration and differentiation during normal homeostasis and disease states. Biomaterials that match the elastic modulus of soft tissues have been effective for studying this cell mechanobiology, but improvements are needed in order to investigate a wider range of physicochemical properties in a controlled manner. We hypothesized that polydimethylsiloxane (PDMS) blends could be used as the basis of a tunable system where the elastic modulus could be adjusted to match most types of soft tissue. To test this we formulated blends of two commercially available PDMS types, Sylgard 527 and Sylgard 184, which enabled us to fabricate substrates with an elastic modulus anywhere from 5 kPa up to 1.72 MPa. This is a three order-of-magnitude range of tunability, exceeding what is possible with other hydrogel and PDMS systems. Uniquely, the elastic modulus can be controlled independently of other materials properties including surface roughness, surface energy and the ability to functionalize the surface by protein adsorption and microcontact printing. For biological validation, PC12 (neuronal inducible-pheochromocytoma cell line) and C2C12 (muscle cell line) were used to demonstrate that these PDMS formulations support cell attachment and growth and that these substrates can be used to probe the mechanosensitivity of various cellular processes including neurite extension and muscle differentiation.	[Palchesko, Rachelle N.; Zhang, Ling; Sun, Yan; Feinberg, Adam W.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Feinberg, Adam W.] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA; [Palchesko, Rachelle N.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Louis J Fox Ctr Vis Restorat, Pittsburgh, PA 15261 USA; [Sun, Yan] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing, Peoples R China	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Beihang University	Feinberg, AW (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	feinberg@andrew.cmu.edu	Feinberg, Adam W/A-7103-2009; Feinberg, Adam W/AAM-8547-2020	Feinberg, Adam W/0000-0003-3338-5456; Feinberg, Adam W/0000-0003-3338-5456; Simko, Rachelle/0000-0001-7101-2496	Louis J. Fox Center for Vision Restoration; Ocular Tissue Engineering and Regenerative Ophthalmology program; China Scholarship Council (CSC) [[2008] 3027]; Pittsburgh Tissue Engineering Initiative Inc.; Advanced Regenerative Medicine program	Louis J. Fox Center for Vision Restoration; Ocular Tissue Engineering and Regenerative Ophthalmology program; China Scholarship Council (CSC)(China Scholarship Council); Pittsburgh Tissue Engineering Initiative Inc.; Advanced Regenerative Medicine program	The authors acknowledge financial support from the Louis J. Fox Center for Vision Restoration, Ocular Tissue Engineering and Regenerative Ophthalmology program to RNP and AWF, China Scholarship Council (CSC) for the Scholarship Fund No. [2008] 3027 program to YS and the Pittsburgh Tissue Engineering Initiative Inc. Advanced Regenerative Medicine program to LZ and AWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2011, SOFT MATTER, V7, P7281, DOI 10.1039/c1sm05483j; Bartalena G, 2011, BIOMED MICRODEVICES, V13, P291, DOI 10.1007/s10544-010-9493-3; Boonen KJM, 2011, J TISSUE ENG REGEN M, V5, P60, DOI 10.1002/term.289; Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816; Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009; Candiello J, 2007, FEBS J, V274, P2897, DOI 10.1111/j.1742-4658.2007.05823.x; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Chandler EM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015008; Charest JM, 2012, MACROMOL BIOSCI, V12, P12, DOI 10.1002/mabi.201100264; Cheng CM, 2009, J BIOMECH, V42, P187, DOI 10.1016/j.jbiomech.2008.10.014; Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Discher DE, 2008, BIORHEOLOGY, V45, P54; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Evans ND, 2009, EUR CELLS MATER, V18, P1; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Feinberg AW, 2010, NANO LETT, V10, P2184, DOI 10.1021/nl100998p; Feinberg AW, 2003, ABSTR PAP AM CHEM S, V225, pU711; Feinberg AW, 2003, ACS SYM SER, V838, P196; Feinberg AW, 2012, BIOMATERIALS; Fioretta ES, 2012, J BIOMECH, V45, P736, DOI 10.1016/j.jbiomech.2011.11.013; FISHER RF, 1976, PROC R SOC SER B-BIO, V193, P335, DOI 10.1098/rspb.1976.0051; Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004; GHISTA DN, 1975, MED BIOL ENG, V13, P151, DOI 10.1007/BF02477722; Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gutierrez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025534; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hiebl B, 2011, J BIOMATER SCI POLYM; Hillborg H, 2004, LANGMUIR, V20, P785, DOI 10.1021/la035552k; Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037; Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim JH, 2010, LANGMUIR, V26, P13015, DOI 10.1021/la1018746; Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003; Lee MH, 2008, BIOMACROMOLECULES, V9, P2315, DOI 10.1021/bm8002094; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Liao QZ, 2010, MECH MATER, V42, P1043, DOI 10.1016/j.mechmat.2010.09.005; Mancini A, 2007, ONCOGENE, V26, P1020, DOI 10.1038/sj.onc.1209853; Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Olah A, 2005, APPL SURF SCI, V239, P410, DOI 10.1016/j.apsusc.2004.06.005; Olson DA, 2006, J AM CHEM SOC, V128, P13625, DOI 10.1021/ja063092m; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Perl A, 2009, ADV MATER, V21, P2257, DOI 10.1002/adma.200801864; RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952; Schneider F, 2009, SENSOR ACTUAT A-PHYS, V151, P95, DOI 10.1016/j.sna.2009.01.026; Shebanova O, 2012, BIOTECHNOL J, V7, P397, DOI 10.1002/biot.201100188; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Stabenfeldt SE, 2011, ACTA BIOMATER, V7, P4102, DOI 10.1016/j.actbio.2011.07.026; Sun YB, 2012, LANGMUIR, V28, P10789, DOI 10.1021/la300978x; Tzvetkova-Chevolleau T, 2008, BIOMATERIALS, V29, P1541, DOI 10.1016/j.biomaterials.2007.12.016; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621; Wang PY, 2012, ACTA BIOMATER, V8, P519, DOI 10.1016/j.actbio.2011.09.030; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Williams C, 2009, ADV MATER, V21, P2161, DOI 10.1002/adma.200801027; Yu HY, 2012, ACTA BIOMATER, V8, P1267, DOI 10.1016/j.actbio.2011.09.006; Yu YH, 2006, J ANIM SCI, V84, P2655, DOI 10.2527/jas.2005-645; Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012	71	350	351	7	184	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51499	10.1371/journal.pone.0051499	http://dx.doi.org/10.1371/journal.pone.0051499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240031	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800067
J	Soldati, C; Cacci, E; Biagioni, S; Carucci, N; Lupo, G; Perrone-Capano, C; Saggio, I; Augusti-Tocco, G				Soldati, Chiara; Cacci, Emanuele; Biagioni, Stefano; Carucci, Nicoletta; Lupo, Giuseppe; Perrone-Capano, Carla; Saggio, Isabella; Augusti-Tocco, Gabriella			Restriction of Neural Precursor Ability to Respond to Nurr1 by Early Regional Specification	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MIDBRAIN DOPAMINERGIC-NEURONS; PROGENITOR CELLS; TRANSCRIPTION FACTOR; FATE SPECIFICATION; HUMAN STRIATUM; IN-VITRO; DIFFERENTIATION; INDUCTION; PITX3	During neural development, spatially regulated expression of specific transcription factors is crucial for central nervous system (CNS) regionalization, generation of neural precursors (NPs) and subsequent differentiation of specific cell types within defined regions. A critical role in dopaminergic differentiation in the midbrain (MB) has been assigned to the transcription factor Nurr1. Nurr1 controls the expression of key genes involved in dopamine (DA) neurotransmission, e. g. tyrosine hydroxylase (TH) and the DA transporter (DAT), and promotes the dopaminergic phenotype in embryonic stem cells. We investigated whether cells derived from different areas of the mouse CNS could be directed to differentiate into dopaminergic neurons in vitro by forced expression of the transcription factor Nurr1. We show that Nurr1 overexpression can promote dopaminergic cell fate specification only in NPs obtained from E13.5 ganglionic eminence (GE) and MB, but not in NPs isolated from E13.5 cortex (CTX) and spinal cord (SC) or from the adult subventricular zone (SVZ). Confirming previous studies, we also show that Nurr1 overexpression can increase the generation of TH-positive neurons in mouse embryonic stem cells. These data show that Nurr1 ability to induce a dopaminergic phenotype becomes restricted during CNS development and is critically dependent on the region of NPs derivation. Our results suggest that the plasticity of NPs and their ability to activate a dopaminergic differentiation program in response to Nurr1 is regulated during early stages of neurogenesis, possibly through mechanisms controlling CNS regionalization. Citation: Soldati C, Cacci E, Biagioni S, Carucci N, Lupo G, et al. (2012) Restriction of Neural Precursor Ability to Respond to Nurr1 by Early Regional Specification. PLoS ONE 7(12): e51798. doi: 10.1371/journal.pone.0051798	[Soldati, Chiara; Cacci, Emanuele; Biagioni, Stefano; Carucci, Nicoletta; Lupo, Giuseppe; Augusti-Tocco, Gabriella] Univ Roma La Sapienza, Dept Biol, Rome, Italy; [Soldati, Chiara; Cacci, Emanuele; Biagioni, Stefano; Carucci, Nicoletta; Lupo, Giuseppe; Augusti-Tocco, Gabriella] Univ Roma La Sapienza, Biotechnol Neurobiol Res Unit, Rome, Italy; [Soldati, Chiara; Cacci, Emanuele; Biagioni, Stefano; Carucci, Nicoletta; Lupo, Giuseppe; Augusti-Tocco, Gabriella] Univ Roma La Sapienza, Daniel Bovet Neurobiol Res Ctr, Rome, Italy; [Soldati, Chiara; Cacci, Emanuele; Carucci, Nicoletta; Lupo, Giuseppe; Saggio, Isabella] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Perrone-Capano, Carla] Univ Naples Federico II, Dept Biol Sci, Naples, Italy; [Perrone-Capano, Carla] IGB A Buzzati Traverso, Naples, Italy; [Saggio, Isabella] Univ Roma La Sapienza, Dept Biol & Biotechnol, Rome, Italy; [Saggio, Isabella] CNR, Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Augusti-Tocco, G (corresponding author), Univ Roma La Sapienza, Dept Biol, Rome, Italy.	gabriella.tocco@uniroma1.it	Biagioni, Stefano/D-4734-2009; Saggio, Isabella/H-2417-2015; Perrone-Capano, Carla/O-7708-2015; Perrone-Capano, Carla/AAX-3217-2020; Lupo, Giuseppe/J-3062-2012	Perrone-Capano, Carla/0000-0002-6327-9753; Perrone-Capano, Carla/0000-0002-6327-9753; Lupo, Giuseppe/0000-0001-7218-4003; saggio, isabella/0000-0002-9497-7415	PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) [20088JEHW3_002]; Facolta and Ateneo "La Sapienza"; MIUR program "Rientro dei Cervell"; Institute Pasteur - Fondazione Cenci Bolognetti; Fondazione Cenci Bolognetti; CNR; MIUR; FP7 braincav; Fondo per gli Investimenti di Ricerca di Base [FIRB-RBIN062YH4]; Medical Research Italy [MERIT-RBNE08LN4P]	PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Facolta and Ateneo "La Sapienza"; MIUR program "Rientro dei Cervell"; Institute Pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); CNR(Consiglio Nazionale delle Ricerche (CNR)); MIUR(Ministry of Education, Universities and Research (MIUR)); FP7 braincav; Fondo per gli Investimenti di Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Medical Research Italy	This work was supported by grants from: PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale progetto no 20088JEHW3_002 "Ruolo dei neurotrasmettitori e di fattori di trascrizione ad essi correlati nel differenziamento neurale") and Facolta and Ateneo "La Sapienza". It was also supported by the MIUR program "Rientro dei Cervell" and a start-up grant from Institute Pasteur - Fondazione Cenci Bolognetti to GL, and by a fellowship from Fondazione Cenci Bolognetti to CS, and funding from Fondazione Cenci Bolognetti to EC. IS received grants from CNR, Fondazione Cenci Bolognetti, MIUR and FP7 braincav funding. This work was supported by "Fondo per gli Investimenti di Ricerca di Base" FIRB-RBIN062YH4 and "Medical Research Italy" MERIT-RBNE08LN4P to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABA ARI, 1992, DEVELOPMENT, V116, P67; Andersson EKI, 2007, EXP CELL RES, V313, P1172, DOI 10.1016/j.yexcr.2006.12.014; Armando S, 2007, NEUROREPORT, V18, P1539, DOI 10.1097/WNR.0b013e3282f03d54; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bithell A, 2008, STEM CELLS, V26, P1565, DOI 10.1634/stemcells.2007-0832; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cossette M, 2003, ANN NY ACAD SCI, V991, P346; Cossette M, 2004, EUR J NEUROSCI, V20, P2089, DOI 10.1111/j.1460-9568.2004.03661.x; Deacon T, 1998, EXP NEUROL, V149, P28, DOI 10.1006/exnr.1997.6674; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Hodges H, 2007, CELL TRANSPLANT, V16, P101; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kelly TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004213; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kim HJ, 2007, EXP NEUROL, V203, P394, DOI 10.1016/j.expneurol.2006.08.029; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim JY, 2003, J NEUROCHEM, V85, P1443, DOI 10.1046/j.1471-4159.2003.01780.x; LENDAHL U, 1990, TRENDS NEUROSCI, V13, P132, DOI 10.1016/0166-2236(90)90004-T; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nakagawa Y, 1996, DEVELOPMENT, V122, P2449; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Onorati M, 2011, CELL MOL LIFE SCI, V68, P1769, DOI 10.1007/s00018-010-0548-7; Park CH, 2008, FEBS LETT, V582, P537, DOI 10.1016/j.febslet.2008.01.018; Perrone-Capano C, 2000, INT J DEV BIOL, V44, P679; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Shim JW, 2007, STEM CELLS, V25, P1252, DOI 10.1634/stemcells.2006-0274; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Sonntag KC, 2004, EUR J NEUROSCI, V19, P1141, DOI 10.1111/j.1460-9568.2004.03204.x; Thompson LH, 2006, EXP NEUROL, V198, P183, DOI 10.1016/j.expneurol.2005.11.025; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Volpicelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030661; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	60	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51798	10.1371/journal.pone.0051798	http://dx.doi.org/10.1371/journal.pone.0051798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240065	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800101
J	Lee, RE; Mama, SK; Adamus-Leach, HJ				Lee, Rebecca E.; Mama, Scherezade K.; Adamus-Leach, Heather J.			Neighborhood Street Scale Elements, Sedentary Time and Cardiometabolic Risk Factors in Inactive Ethnic Minority Women	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL STRESS; BUILT ENVIRONMENT; AFRICAN-AMERICAN; OBESITY; ADULTS; ASSOCIATIONS; ATTRIBUTES	Background: Cardiometabolic risk factors such as obesity, excess percent body fat, high blood pressure, elevated resting heart rate and sedentary behavior have increased in recent decades due to changes in the environment and lifestyle. Neighborhood micro-environmental, street scale elements may contribute to health above and beyond individual characteristics of residents. Purpose: To investigate the relationship between neighborhood street scale elements and cardiometabolic risk factors among inactive ethnic minority women. Method: Women (N = 410) completed measures of BMI, percent body fat, blood pressure, resting heart rate, sedentary behavior and demographics. Trained field assessors completed the Pedestrian Environment Data Scan in participants' neighborhoods. Data were collected from 2006-2008. Multiple regression models were conducted in 2011 to estimate the effect of environmental factors on cardiometabolic risk factors. Results: Adjusted regression models found an inverse association between sidewalk buffers and blood pressure, between traffic control devices and resting heart rate, and a positive association between presence of pedestrian crossing aids and BMI (ps<.05). Neighborhood attractiveness and safety for walking and cycling were related to more time spent in a motor vehicle (ps<.05). Conclusions: Findings suggest complex relationships among micro-environmental, street scale elements that may confer important cardiometabolic benefits and risks for residents. Living in the most attractive and safe neighborhoods for physical activity may be associated with longer times spent sitting in the car.	[Lee, Rebecca E.; Mama, Scherezade K.; Adamus-Leach, Heather J.] Univ Houston, Dept Hlth & Human Performance, Texas Obes Res Ctr, Houston, TX 77030 USA	University of Houston System; University of Houston	Lee, RE (corresponding author), Univ Houston, Dept Hlth & Human Performance, Texas Obes Res Ctr, Houston, TX 77030 USA.	releephd@yahoo.com	Leach, Heather J/F-9317-2017		National Institutes of Health's National Cancer Institute [1R01CA109403]; NATIONAL CANCER INSTITUTE [R01CA109403] Funding Source: NIH RePORTER	National Institutes of Health's National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by a research grant awarded to Dr. Rebecca E. Lee at the University of Houston by the National Institutes of Health's National Cancer Institute (1R01CA109403). The funders had no role in study design, data collection and analysis, decision to publish.	[Anonymous], 2011, REVERSING OBESOGENIC; Block JP, 2009, AM J EPIDEMIOL, V170, P181, DOI 10.1093/aje/kwp104; Booth M, 2000, Res Q Exerc Sport, V71 Suppl 2, P114, DOI 10.1080/02701367.2000.11082794; Brace N, 2009, SPSS PSYCHOL; Brownson RC, 2000, AM J PUBLIC HEALTH, V90, P264, DOI 10.2105/AJPH.90.2.264; Burdette HL, 2004, PREV MED, V38, P57, DOI 10.1016/j.ypmed.2003.09.029; California Department of Public Health, 2010, MAT INF HLTH ASS MIH; Centers for Disease Control and Prevention, 2011, PREGN RISK ASS MON S; Clifton KJ, 2007, LANDSCAPE URBAN PLAN, V80, P95, DOI 10.1016/j.landurbplan.2006.06.008; COOPER KH, 1976, JAMA-J AM MED ASSOC, V236, P166, DOI 10.1001/jama.236.2.166; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; Douglas MJ, 2011, J PUBLIC HEALTH-UK, V33, P160, DOI 10.1093/pubmed/fdr032; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Fung MM, 2011, HYPERTENSION, V58, P596, DOI 10.1161/HYPERTENSIONAHA.111.174409; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Gordon-Larsen P, 2009, ARCH INTERN MED, V169, P1216, DOI 10.1001/archinternmed.2009.163; Heinrich KM, 2008, AM J HEALTH PROMOT, V22, P187, DOI 10.4278/ajhp.22.3.187; Inagami S, 2009, J URBAN HEALTH, V86, P683, DOI 10.1007/s11524-009-9379-y; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kozo J, 2012, HLTH PSYCHOL; Ledoux TA, 2012, J OBESITY IN PRESS; Lee RE, 2011, J COMMUNITY HLTH; Lee Rebecca E, 2005, Int J Behav Nutr Phys Act, V2, P13, DOI 10.1186/1479-5868-2-13; Lee RE, 2010, ENVIRON HEALTH INSIG, V4, P49; Lee RE, 2012, HEALTH PLACE, V18, P63, DOI 10.1016/j.healthplace.2011.08.013; Lee RE, 2011, J PHYS ACT HEALTH, V8, pS83, DOI 10.1123/jpah.8.s1.s83; Lee RE, 2009, EXERC SPORT SCI REV, V37, P10, DOI 10.1097/JES.0b013e318190eb2e; McAlexander KM, 2009, J URBAN HEALTH, V86, P696, DOI 10.1007/s11524-009-9385-0; McMillan TE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-20; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; [National Centers for Chronic Disease Prevention and Health Promotion Translation DoD], 2011, PHYS IN EST; Parmenter B, 2008, J URBAN REG INF SYST, V20, P13; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Sarnoff R, 2005, MATERN CHILD HLTH J, V9, P343, DOI 10.1007/s10995-005-0023-5; Spence JC, 2003, PSYCHOL SPORT EXERC, V4, P7, DOI 10.1016/S1469-0292(02)00014-6; Spruill TM, 2010, CURR HYPERTENS REP, V12, P10, DOI 10.1007/s11906-009-0084-8; Ulijaszek SJ, 2005, ANN HUM BIOL, V32, P326, DOI 10.1080/03014460500087824; Van Dyck D, 2012, SOC SCI MED, V74, P1375, DOI 10.1016/j.socscimed.2012.01.018; Van Dyck D, 2010, AM J PREV MED, V39, P25, DOI 10.1016/j.amepre.2010.03.004; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x	43	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51081	10.1371/journal.pone.0051081	http://dx.doi.org/10.1371/journal.pone.0051081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236434	Green Published, gold			2022-12-25	WOS:000312064100063
J	Liu, ZH; Xiao, HM; Li, HP; Zhao, YH; Lai, SY; Yu, XL; Cai, T; Du, CG; Zhang, WG; Li, JQ				Liu, Zhihong; Xiao, Hongmei; Li, Huipeng; Zhao, Yanhong; Lai, Shuangying; Yu, Xinlei; Cai, Ting; Du, Chenguang; Zhang, Wenguang; Li, Jinquan			Identification of Conserved and Novel microRNAs in Cashmere Goat Skin by Deep Sequencing	PLOS ONE			English	Article							CELL DEVELOPMENT; RNAS; MORPHOGENESIS; BIOGENESIS; GENE	MicroRNAs (miRNAs) are a class of small RNAs that play significant roles in regulating the expression of the post-transcriptional skin and hair follicle gene. In recent years, extensive studies on these microRNAs have been carried out in mammals such as mice, rats, pigs and cattle. By comparison, the number of microRNAs that have been identified in goats is relatively low; and in particular, the miRNAs associated with the processes of skin and hair follicle development remain largely unknown. In this study, areas of skin where the cashmere grows in anagen were sampled. A total of 10,943,292 reads were obtained using Solexa sequencing, a high-throughput sequencing technology. From 10,644,467 reads, we identified 3,381 distinct reads and after applying the classification statistics we obtained 316 miRNAs. Among them, using conservative identification, we found that 68 miRNAs (55 of these are confirmed to match known sheep and goat miRNAs in miRBase) are conserved in goat and have been reported in NCBI; the remaining 248 miRNA were conserved in other species but have not been reported in goat. Furthermore, we identified 22 novel miRNAs. Both the known and novel miRNAs were confirmed by a second sequencing using the same method as was used in the first. This study confirmed the authenticity of 316 known miRNAs and the discovery of 22 novel miRNAs in goat. We found that the miRNAs that were co-expressed in goat and sheep were located in the same region of the respective chromosomes and may play an essential role in skin and follicle development. Identificaton of novel miRNAs resulted in significant enrichment of the repertoire of goat miRNAs.	[Liu, Zhihong; Zhao, Yanhong; Lai, Shuangying; Yu, Xinlei; Cai, Ting; Zhang, Wenguang; Li, Jinquan] Inner Mongolia Agr Univ, Dept Anim Sci, Inner Mongolia Key Lab Anim Genet Breeding & Repr, Hohhot, Inner Mongolia, Peoples R China; [Xiao, Hongmei; Li, Huipeng] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Inner Mongolia, Peoples R China; [Du, Chenguang] Inner Mongolia Agr Univ, Vocat & Tech Coll, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Agricultural University; Inner Mongolia Agricultural University	Li, JQ (corresponding author), Inner Mongolia Agr Univ, Dept Anim Sci, Inner Mongolia Key Lab Anim Genet Breeding & Repr, Hohhot, Inner Mongolia, Peoples R China.	lijinquan_nd@126.com	zhao, yan/GWC-9174-2022		Natural Science Foundation of China [31072005]; earmarked fund for Modern Agro-industry Technology Research System, China [CARS-40-05]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System, China	This work was supported by the Natural Science Foundation of China (Grant No. 31072005) and the earmarked fund for Modern Agro-industry Technology Research System, China (Grant No. CARS-40-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Fan J-B, 2012, NEXT GENERATION MICR, Vxi; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Ford TD, 2009, NEW CANC RES DEV, Vxvi; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gomase Virendra S, 2009, Int J Bioinform Res Appl, V5, P479, DOI 10.1504/IJBRA.2009.028678; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Joyce CE, 2011, HUM MOL GENET; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lannuzzi L, 1997, CHROMOSOME RES, V5, P199, DOI 10.1023/A:1018451131929; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016956; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Mishima Y, 2007, CELL, V129, P247, DOI 10.1016/j.cell.2007.04.008; Pontarotti P, 2011, EVOLUTIONARY BIOL CO, Vxv; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shin KH, 2011, INT J ONCOL, V39, P1205, DOI 10.3892/ijo.2011.1111; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yu Y, 2010, EPIGENETICS-US, V5, P124, DOI 10.4161/epi.5.2.11160; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031; Zhou B, 2011, IRISH J MED SCI, V180, P721, DOI 10.1007/s11845-010-0609-9	38	28	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50001	10.1371/journal.pone.0050001	http://dx.doi.org/10.1371/journal.pone.0050001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236360	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100010
J	Mao, XZ; Chen, X; Zhang, Y; Pangle, S; Xu, Y				Mao, Xizeng; Chen, Xin; Zhang, Yu; Pangle, Spencer; Xu, Ying			CINPER: An Interactive Web System for Pathway Prediction for Prokaryotes	PLOS ONE			English	Article							METABOLIC PATHWAYS; BIOCYC COLLECTION; COMPUTATIONAL PREDICTION; NITROGEN ASSIMILATION; BIOLOGICAL PATHWAYS; GENOME ANNOTATION; METACYC DATABASE; GENES; IRON; NETWORK	We present a web-based network-construction system, CINPER (CSBL INteractive Pathway BuildER), to assist a user to build a user-specified gene network for a prokaryotic organism in an intuitive manner. CINPER builds a network model based on different types of information provided by the user and stored in the system. CINPER's prediction process has four steps: (i) collection of template networks based on (partially) known pathways of related organism(s) from the SEED or BioCyc database and the published literature; (ii) construction of an initial network model based on the template networks using the P-Map program; (iii) expansion of the initial model, based on the association information derived from operons, protein-protein interactions, co-expression modules and phylogenetic profiles; and (iv) computational validation of the predicted models based on gene expression data. To facilitate easy applications, CINPER provides an interactive visualization environment for a user to enter, search and edit relevant data and for the system to display (partial) results and prompt for additional data. Evaluation of CINPER on 17 well-studied pathways in the MetaCyc database shows that the program achieves an average recall rate of 76% and an average precision rate of 90% on the initial models; and a higher average recall rate at 87% and an average precision rate at 28% on the final models. The reduced precision rate in the final models versus the initial models reflects the reality that the final models have large numbers of novel genes that have no experimental evidences and hence are not yet collected in the MetaCyc database. To demonstrate the usefulness of this server, we have predicted an iron homeostasis gene network of Synechocystis sp. PCC6803 using the server. The predicted models along with the server can be accessed at http://csbl.bmb.uga.edu/cinper/.	[Mao, Xizeng; Pangle, Spencer; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Mao, Xizeng; Pangle, Spencer; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Mao, Xizeng; Xu, Ying] Univ Georgia, BESC BioEnergy Sci Ctr, Athens, GA 30602 USA; [Chen, Xin; Zhang, Yu; Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China; [Chen, Xin; Zhang, Yu] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University; Jilin University	Xu, Y (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	xyn@bmb.uga.edu			National Science Foundation [DEB-0830024, DBI-0542119, MCB-0958172]; Chinese National Science Foundation [11001106]; DOE BioEnergy Science Center grant [DE-PS02-06ER64304]; Office of Biological and Environmental Research in the Department of Energy Office of Science	National Science Foundation(National Science Foundation (NSF)); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); DOE BioEnergy Science Center grant; Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported in part by the National Science Foundation (DEB-0830024, DBI-0542119 and MCB-0958172), the Chinese National Science Foundation (11001106) and the DOE BioEnergy Science Center grant (DE-PS02-06ER64304), which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; HANSSON M, 1994, J BACTERIOL, V176, P5962, DOI 10.1128/jb.176.19.5962-5970.1994; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kharchenko P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-177; Kharchenko P, 2004, BIOINFORMATICS, V20, P178, DOI 10.1093/bioinformatics/bth930; Kobayashi M, 2004, PLANT CELL PHYSIOL, V45, P290, DOI 10.1093/pcp/pch034; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mao FL, 2006, P NATL ACAD SCI USA, V103, P129, DOI 10.1073/pnas.0509737102; Mao XZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-291; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morrissey J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00043; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Su ZC, 2006, NUCLEIC ACIDS RES, V34, P1050, DOI 10.1093/nar/gkj496; Su ZC, 2005, NUCLEIC ACIDS RES, V33, P5156, DOI 10.1093/nar/gki817; Su ZC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-156; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Yu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020092	39	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51252	10.1371/journal.pone.0051252	http://dx.doi.org/10.1371/journal.pone.0051252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236458	gold, Green Published			2022-12-25	WOS:000312064100083
J	Arnedo, M; Alonso, E; Eisenberg, N; Ibanez, L; Ferreyra, C; Jaen, A; Flevaud, L; Khamadi, S; Roddy, P; Gatell, JM; Dalmau, D				Arnedo, Mireia; Alonso, Elena; Eisenberg, Nell; Ibanez, Laura; Ferreyra, Cecilia; Jaen, Angels; Flevaud, Laurence; Khamadi, Samuel; Roddy, Paul; Maria Gatell, Jose; Dalmau, David		Busia O R Study Grp	Monitoring HIV Viral Load in Resource Limited Settings: Still a Matter of Debate?	PLOS ONE			English	Article							DRIED BLOOD SPOTS; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; PLASMA PREPARATION TUBES; FIXED-DOSE COMBINATION; DRUG-RESISTANCE; HIV-1-INFECTED ADULTS; INFECTED PATIENTS; LAMIVUDINE; EFAVIRENZ	Introduction: Consequences of lack of viral monitoring in predicting the effects of development of HIV drug resistance mutations during HAART in resource-limited settings (RLS) is still a matter of debate. Design: To assess, among HIV+ patients receiving their first-line HAART, prevalence of virological failure and genotypic resistance mutations pattern in a Medecins Sans Frontieres/Ministry of Health programme in Busia District (Kenya). Methods: Patients with HAART treatment for >= 12 months were eligible for the study and those with HIV-RNA >= 5000 copies/ml underwent genotypic study. Total HIV-1 RNA from Dried Blood Spots was extracted using Nuclisens method. Results: 926 patients were included. Among 274 (29.6%) patients with detectable viral load, 55 (5.9%) experienced treatment failure (viral load >5.000 copies/ml); 61.8% were female and 10 (18.2%) had clinical failure. Median CD4 cell count was 116 cell/mm3 (IQR: 54-189). Median HIV-RNA was 32,000 copies/ml (IQR: 11000-68000). Eighteen out of 55 (33%) samples could be sequenced on PR and RT genes, with resistance associated mutations (RAMs) in 15 out of 18 samples (83%). Among patients carrying RAMs, 12/15 (81%) harboured RAMs associated to thymidine analogues (TAMs). All of them (100%) showed M184V resistance associated mutation to lamivudine as well as NNRTI's RAMS. Conclusions: Virological failure rate in resource-limited settings are similar to those observed in developed countries. Resistance mutation patterns were concordant with HAART received by failing patients. Long term detectable viral load confers greater probability of developing resistance and as a consequence, making difficult to find out a cost-effective subsequent treatment regimen. Citation: Arnedo M, Alonso E, Eisenberg N, Ibanez L, Ferreyra C, et al. (2012) Monitoring HIV Viral Load in Resource Limited Settings: Still a Matter of Debate? PLoS ONE 7(12): e47391. doi:10.1371/journal.pone.0047391	[Dalmau, David] Hosp Univ MutuaTerrassa, Dept Med, Terrassa, Spain; [Alonso, Elena; Eisenberg, Nell; Ferreyra, Cecilia; Flevaud, Laurence; Roddy, Paul] Med Sans Frontieres Operat Ctr Barcelona Athens, Barcelona, Spain; [Arnedo, Mireia; Maria Gatell, Jose] Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain; [Ibanez, Laura; Jaen, Angels; Dalmau, David] Fundacio Docencia & Recerca MutuaTerrassa, Terrassa, Spain; [Khamadi, Samuel] Kenya Med Res Inst KEMRI, Nairobi, Kenya	Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Kenya Medical Research Institute	Dalmau, D (corresponding author), Hosp Univ MutuaTerrassa, Dept Med, Terrassa, Spain.	ddalmau@mutuaterrassa.cat	Jaen, Angeles/J-9780-2013; Gatell, Jose M/ABC-3607-2020	Jaen, Angeles/0000-0002-6815-2022; FERREYRA, CECILIA/0000-0001-5480-7940; Ibanez, Laura/0000-0003-2381-7059	Roche; Boehringer Ingelheim; Abbott; BMS; GSK; Gilead, Janssen; Merck; Pfizer;  [MSF (Medecins Sans Frontieres)]	Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Abbott(Abbott Laboratories); BMS(Bristol-Myers Squibb); GSK(GlaxoSmithKline); Gilead, Janssen; Merck(Merck & Company); Pfizer(Pfizer); 	MSF (Medecins Sans Frontieres) are the sources of funding that have supported the work. There were no funding sources in the writing of the manuscript or the decision to submit it for publication neither to write this article by a pharmaceutical company or other agency. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D Dalmau and JM Gatell have been a consultant on advisory boards, have participated in speakers' bureaus, have received research grants or have conducted clinical trials with Roche, Boehringer Ingelheim, Abbott, BMS, GSK, Gilead, Janssen, Merck and Pfizer. M. Arnedo, E. Alonso, N. Eisenberg, L. Ibanez, C. Ferreyra, A. Jaen, L. Flevaud, S. Khamadi, P. Roddy, J. Mashala, A. Alvarez and E. Velilla report no conflicts of interest relevant to this article. No other potential conflict of interest relevant to this article was reported. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, ANTIRETROVIRAL THERA; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V41, P323; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Bourgeois A, 2005, ANTIVIR THER, V10, P335; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; DART Virology Group and Trial Team, 2006, AIDS, V20, P1291; Elbeik T, 2005, J CLIN MICROBIOL, V43, P3769, DOI 10.1128/JCM.43.8.3769-3771.2005; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Garcia-Bujalance S, 2007, J MICROBIOL METH, V69, P384, DOI 10.1016/j.mimet.2007.01.018; Garcia-Lerma JG, 2009, J ANTIMICROB CHEMOTH, V64, P33, DOI 10.1093/jac/dkp150; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; Morison L, 2001, AIDS, V15, pS109, DOI 10.1097/00002030-200108004-00012; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Phillips A, 2010, 17 C RETR OPP INF FE; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Pieniazek D, 2010, 17 C RETR OPP INF FE; Saag M, 2012, 19 C RETR OPP INF MA; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Squires K, 2004, JAIDS-J ACQ IMM DEF, V36, P1011, DOI 10.1097/00126334-200408150-00003; Stosor V, 2005, CLIN INFECT DIS, V41, P1671, DOI 10.1086/498025; Sung H, 2007, AIDS RES HUM RETROV, V23, P1223, DOI 10.1089/aid.2007.0008; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organisation, 2007, PRIOR 2 LIN ANT DRUG; World Health Organization, 2009, ANT THER HIV INF AD; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100	38	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e47391	10.1371/journal.pone.0047391	http://dx.doi.org/10.1371/journal.pone.0047391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236346	gold, Green Published, Green Submitted			2022-12-25	WOS:000312589700003
J	Boije, H; Harun-Or-Rashid, M; Lee, YJ; Imsland, F; Bruneau, N; Vieaud, A; Gourichon, D; Tixier-Boichard, M; Bed'hom, B; Andersson, L; Hallbook, F				Boije, Henrik; Harun-Or-Rashid, Mohammad; Lee, Yu-Jen; Imsland, Freyja; Bruneau, Nicolas; Vieaud, Agathe; Gourichon, David; Tixier-Boichard, Michele; Bed'hom, Bertrand; Andersson, Leif; Hallbook, Finn			Sonic Hedgehog-Signalling Patterns the Developing Chicken Comb as Revealed by Exploration of the Pea-comb Mutation	PLOS ONE			English	Article							NEURAL CREST; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTORS; CANDIDATE GENE; EXPRESSION; ETS-1; FACE; SOX6; SPECIFICATION	The genetic basis and mechanisms behind the morphological variation observed throughout the animal kingdom is still relatively unknown. In the present work we have focused on the establishment of the chicken comb-morphology by exploring the Pea-comb mutant. The wild-type single-comb is reduced in size and distorted in the Pea-comb mutant. Pea-comb is formed by a lateral expansion of the central comb anlage into three ridges and is caused by a mutation in SOX5, which induces ectopic expression of the SOX5 transcription factor in mesenchyme under the developing comb. Analysis of differential gene expression identified decreased Sonic hedgehog (SHH) receptor expression in Pea-comb mesenchyme. By experimentally blocking SHH with cyclopamine, the wild-type single-comb was transformed into a Pea-comb-like phenotype. The results show that the patterning of the chicken comb is under the control of SHH and suggest that ectopic SOX5 expression in the Pea-comb change the response of mesenchyme to SHH signalling with altered comb morphogenesis as a result. A role for the mesenchyme during comb morphogenesis is further supported by the recent finding that another comb-mutant (Rose-comb), is caused by ectopic expression of a transcription factor in comb mesenchyme. The present study does not only give knowledge about how the chicken comb is formed, it also adds to our understanding how mutations or genetic polymorphisms may contribute to inherited variations in the human face.	[Boije, Henrik; Harun-Or-Rashid, Mohammad; Lee, Yu-Jen; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Imsland, Freyja; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Bruneau, Nicolas; Vieaud, Agathe; Tixier-Boichard, Michele; Bed'hom, Bertrand] AgroParisTech, INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France; [Gourichon, David] INRA, Poultry Expt Platform Tours UE1295, F-37380 Nouzilly, France; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden	Uppsala University; Uppsala University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Swedish University of Agricultural Sciences	Hallbook, F (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	finn.hallbook@neuro.uu.se	Bed'Hom, Bertrand/G-7313-2011	Bed'Hom, Bertrand/0000-0002-0825-0886; Imsland, Freyja/0000-0002-9452-5566; Hallbook, Finn/0000-0001-7552-187X	Swedish Research Council [20859-01-3, 12187-15-3]; FORMAS; Barncancerfonden [PROJ09/038]; Ogonfonden and Kronprinsessan Margaretas arbetsnamnd for synskadade	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas); Barncancerfonden; Ogonfonden and Kronprinsessan Margaretas arbetsnamnd for synskadade	The PTCH1 vector was from Johan Ericson, Karolinska Institute. The work was supported by Swedish Research Council (20859-01-3, 12187-15-3), FORMAS, Barncancerfonden (PROJ09/038), Ogonfonden and Kronprinsessan Margaretas arbetsnamnd for synskadade. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson W., 1902, REP EVOL COMM ROY SO, V1, P87; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Boije H, 2008, GENE EXPR PATTERNS, V8, P117, DOI 10.1016/j.modgep.2007.09.004; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Goodnough LH, 2007, DEV DYNAM, V236, P1918, DOI 10.1002/dvdy.21195; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hu D, 1999, DEVELOPMENT, V126, P4873; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; Hu D, 2012, DEV DYNAM, V241, P732, DOI 10.1002/dvdy.23764; Imsland F, 2012, PLOS GENET IN PRESS; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; LAWRENCE IE, 1968, J EXP ZOOL, V167, P263, DOI 10.1002/jez.1401670302; LAWRENCE IE, 1963, J EXP ZOOL, V152, P205, DOI 10.1002/jez.1401520209; LAWRENCE IE, 1971, J EXP ZOOL, V178, P195, DOI 10.1002/jez.1401780206; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Liu B, 2010, SEMIN CELL DEV BIOL, V21, P309, DOI 10.1016/j.semcdb.2009.09.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Marigo V, 1996, DEVELOPMENT, V122, P1225; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakano T, 1996, J ANAT, V189, P643; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; Pringle N, 2006, NONRADIOACTIVE SITU; Punnett RC, 1905, P CAMB PHILOS SOC, V13, P165; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Remy P, 2000, ONCOGENE, V19, P6417, DOI 10.1038/sj.onc.1204044; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Sato S, 2010, ANIM GENET, V41, P659, DOI 10.1111/j.1365-2052.2010.02048.x; SAUNDERS JOHN WARREN, 1957, J MORPH, V101, P57, DOI 10.1002/jmor.1051010104; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Smits P, 2004, J CELL BIOL, V164, P747, DOI 10.1083/jcb.200312045; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Stephenson JC, 1915, WASHINGTON U STUDI 1, V2, P47; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Theveneau E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001142; Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200	50	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50890	10.1371/journal.pone.0050890	http://dx.doi.org/10.1371/journal.pone.0050890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227218	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200079
J	Byrne, AW; O'Keeffe, J; Green, S; Sleeman, DP; Corner, LAL; Gormley, E; Murphy, D; Martin, SW; Davenport, J				Byrne, Andrew W.; O'Keeffe, James; Green, Stuart; Sleeman, D. Paddy; Corner, Leigh A. L.; Gormley, Eamonn; Murphy, Denise; Martin, S. Wayne; Davenport, John			Population Estimation and Trappability of the European Badger (Meles meles): Implications for Tuberculosis Management	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; BRUSHTAIL POSSUMS; MARK-RECAPTURE; HERD-IMMUNITY; DYNAMICS; VACCINATION; WILDLIFE; DENSITY; OUTBREAK; DISEASES	Estimates of population size and trappability inform vaccine efficacy modelling and are required for adaptive management during prolonged wildlife vaccination campaigns. We present an analysis of mark-recapture data from a badger vaccine (Bacille Calmette-Guerin) study in Ireland. This study is the largest scale (755 km 2) mark-recapture study ever undertaken with this species. The study area was divided into three approximately equal-sized zones, each with similar survey and capture effort. A mean badger population size of 671 (SD: 76) was estimated using a closed-subpopulation model (CSpM) based on data from capturing sessions of the entire area and was consistent with a separate multiplicative model. Minimum number alive estimates calculated from the same data were on average 49-51% smaller than the CSpM estimates, but these are considered severely negatively biased when trappability is low. Population densities derived from the CSpM estimates were 0.82-1.06 badgers km 22, and broadly consistent with previous reports for an adjacent area. Mean trappability was estimated to be 34-35% per session across the population. By the fifth capture session, 79% of the adult badgers caught had been marked previously. Multivariable modelling suggested significant differences in badger trappability depending on zone, season and age-class. There were more putatively trap-wary badgers identified in the population than trap-happy badgers, but wariness was not related to individual's sex, zone or season of capture. Live-trapping efficacy can vary significantly amongst sites, seasons, age, or personality, hence monitoring of trappability is recommended as part of an adaptive management regime during large-scale wildlife vaccination programs to counter biases and to improve efficiencies. Citation: Byrne AW, O'Keeffe J, Green S, Sleeman DP, Corner LAL, et al. (2012) Population Estimation and Trappability of the European Badger (Meles meles): Implications for Tuberculosis Management. PLoS ONE 7(12): e50807. doi:10.1371/journal.pone.0050807	[Byrne, Andrew W.] TEAGASC, Athenry, County Galway, Ireland; [Byrne, Andrew W.; Sleeman, D. Paddy; Davenport, John] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Distillery Fields, Cork, Ireland; [O'Keeffe, James; Corner, Leigh A. L.; Gormley, Eamonn; Murphy, Denise] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Green, Stuart] TEAGASC, Teagasc Rural Econ & Dev Programme Spatial Anal, Dublin, Ireland; [Martin, S. Wayne] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada	Teagasc; University College Cork; University College Dublin; Teagasc; University of Guelph	Byrne, AW (corresponding author), TEAGASC, Mellows Campus, Athenry, County Galway, Ireland.	andrew.byrne@teagasc.ie	Gormley, Eamonn/AAU-6678-2020; Byrne, Andrew/N-3894-2015	Gormley, Eamonn/0000-0003-3900-0393; Byrne, Andrew/0000-0003-0296-4586	Teagasc; Agriculture and Food Development Authority through a Walsh Fellowship; Department of Agriculture, Food and the Marine (DAFM)	Teagasc; Agriculture and Food Development Authority through a Walsh Fellowship; Department of Agriculture, Food and the Marine (DAFM)	AWB was funded by Teagasc, the Agriculture and Food Development Authority (www.teagasc.ie), through a Walsh Fellowship. The vaccine trial was funded by the Department of Agriculture, Food and the Marine (DAFM; www.agriculture.gov.ie). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, PHILOS T R SOC B, V310, P327, DOI 10.1098/rstb.1985.0123; Aznar I, 2012, CENTRE FOR VETERINAR; Aznar I, 2011, VET MICROBIOL, V151, P104, DOI 10.1016/j.vetmic.2011.02.032; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Byrne AW, 2013, PREV VET MED, V109, P128, DOI 10.1016/j.prevetmed.2012.08.016; Byrne AW, 2013, EUR J WILDLIFE RES, V59, P25, DOI 10.1007/s10344-012-0643-1; Byrne AW, 2012, BIOL ENVIRON, V112B, P105, DOI 10.3318/BIOE.2012.02; Caley P, 1999, NEW ZEAL VET J, V47, P133, DOI 10.1080/00480169.1999.36130; Cassidy A, 2012, SOCIOL RURALIS, V52, P192, DOI 10.1111/j.1467-9523.2012.00562.x; CHEESEMAN CL, 1981, J APPL ECOL, V18, P795, DOI 10.2307/2402370; Corner LAL, 2009, J WILDLIFE DIS, V45, P1042, DOI 10.7589/0090-3558-45.4.1042; Courtenay O, 2007, VET REC, V161, P817; Cresswell P, 1990, THE HISTORY DISTRIBU; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Delahay R, 2009, MANAGEMENT OF DISEAS; Do Linh San E, 2003, REV SUISSE ZOOL, V110, P565, DOI 10.5962/bhl.part.80199; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Feore SM, 1994, THESIS; Georgette NT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004168; Gormley E, 2011, VET J, V189, P239, DOI 10.1016/j.tvjl.2011.03.007; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Guerrero A, 1997, LANCET, V350, P1738, DOI 10.1016/S0140-6736(97)07567-3; Hardstaff JL, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-92; HILBORN R, 1976, CAN J ZOOL, V54, P1019, DOI 10.1139/z76-114; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; Knobel DL, 2008, J APPL ECOL, V45, P109, DOI 10.1111/j.1365-2664.2007.01387.x; KREBS CJ, 1984, CAN J ZOOL, V62, P2440, DOI 10.1139/z84-360; KREBS CJ, 1966, ECOL MONOGR, V36, P240, DOI 10.2307/1942418; Lachish S, 2010, CONSERV BIOL, V24, P841, DOI 10.1111/j.1523-1739.2009.01429.x; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; Macdonald DW, 2002, J ZOOL, V256, P121, DOI 10.1017/S0952836902000158; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; Munoz-Igualada J, 2008, J WILDLIFE MANAGE, V72, P830, DOI 10.2193/2007-198; Murphy D, 2010, RES VET SCI, V88, P1, DOI 10.1016/j.rvsc.2009.05.020; O'Brien DJ, 2011, VET MICROBIOL, V151, P179, DOI 10.1016/j.vetmic.2011.02.042; O'Corry-Crowe G., 1993, P35; OTIS DL, 1978, WILDLIFE MONOGR, P1; Palphramand KL, 2011, EUR J WILDLIFE RES, V57, P35, DOI 10.1007/s10344-010-0397-6; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Ramsey DSL, 2010, J APPL ECOL, V47, P911, DOI 10.1111/j.1365-2664.2010.01839.x; Reid N, 2012, WILDLIFE BIOL, V18, P46, DOI 10.2981/11-016; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Sleeman DP, 2009, EUR J WILDLIFE RES, V55, P333, DOI 10.1007/s10344-008-0244-1; Sleeman DP, 1992, WILDLIFE TELEMETRY; Smal C, 1995, THE BADGER AND HABIT; Smith GC, 2007, VET REC, V160, P723, DOI 10.1136/vr.160.21.723; Trinkel M, 2011, J WILDLIFE DIS, V47, P494, DOI 10.7589/0090-3558-47.3.494; Tuyttens FAM, 2000, J ANIM ECOL, V69, P567, DOI 10.1046/j.1365-2656.2000.00419.x; Tuyttens FAM, 1999, J MAMMAL, V80, P950, DOI 10.2307/1383265; Tuyttens FAM, 1999, J APPL ECOL, V36, P1051, DOI 10.1046/j.1365-2664.1999.00462.x; Tuyttens FAM, 2000, CAN J ZOOL, V78, P320, DOI 10.1139/cjz-78-2-320; van Apeldoorn RC, 2006, MAMM BIOL, V71, P25, DOI 10.1016/j.mambio.2005.08.005; Wilkinson D, 2004, J APPL ECOL, V41, P492, DOI 10.1111/j.0021-8901.2004.00898.x	55	36	37	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50807	10.1371/journal.pone.0050807	http://dx.doi.org/10.1371/journal.pone.0050807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227211	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200071
J	Correia, M; Neves-Petersen, MT; Jeppesen, PB; Gregersen, S; Petersen, SB				Correia, Manuel; Neves-Petersen, Maria Teresa; Jeppesen, Per Bendix; Gregersen, Soren; Petersen, Steffen B.			UV-Light Exposure of Insulin: Pharmaceutical Implications upon Covalent Insulin Dityrosine Dimerization and Disulphide Bond Photolysis	PLOS ONE			English	Article							COMPACT FLUORESCENT LAMPS; EXCITED-STATE CHEMISTRY; AROMATIC-AMINO-ACIDS; CROSS-LINKS; DECAY KINETICS; OXIDATION; TYROSINE; PROTEINS; IMMOBILIZATION; PEROXIDASE	In this work we report the effects of continuous UV-light (276 nm, similar to 2.20 W.m(-2)) excitation of human insulin on its absorption and fluorescence properties, structure and functionality. Continuous UV-excitation of the peptide hormone in solution leads to the progressive formation of tyrosine photo-product dityrosine, formed upon tyrosine radical cross-linkage. Absorbance, fluorescence emission and excitation data confirm dityrosine formation, leading to covalent insulin dimerization. Furthermore, UV-excitation of insulin induces disulphide bridge breakage. Near- and far-UV-CD spectroscopy shows that UV-excitation of insulin induces secondary and tertiary structure losses. In native insulin, the A and B chains are held together by two disulphide bridges. Disruption of either of these bonds is likely to affect insulin's structure. The UV-light induced structural changes impair its antibody binding capability and in vitro hormonal function. After 1.5 and 3.5 h of 276 nm excitation there is a 33.7% and 62.1% decrease in concentration of insulin recognized by guinea pig anti-insulin antibodies, respectively. Glucose uptake by human skeletal muscle cells decreases 61.7% when the cells are incubated with pre UV-illuminated insulin during 1.5 h. The observations presented in this work highlight the importance of protecting insulin and other drugs from UV-light exposure, which is of outmost relevance to the pharmaceutical industry. Several drug formulations containing insulin in hexameric, dimeric and monomeric forms can be exposed to natural and artificial UV-light during their production, packaging, storage or administration phases. We can estimate that direct long-term exposure of insulin to sunlight and common light sources for indoors lighting and UV-sterilization in industries can be sufficient to induce irreversible changes to human insulin structure. Routine fluorescence and absorption measurements in laboratory experiments may also induce changes in protein structure. Structural damage includes insulin dimerization via dityrosine cross-linking or disulphide bond disruption, which affects the hormone's structure and bioactivity.	[Neves-Petersen, Maria Teresa; Petersen, Steffen B.] Int Iberian Nanotechnol Lab INL, Braga, Portugal; [Correia, Manuel] Aalborg Univ, Dept Phys & Nanotechnol, Aalborg, Denmark; [Neves-Petersen, Maria Teresa] Aalborg Univ, Dept Biotechnol Chem & Environm Sci, NanoBiotechnol Grp, Aalborg, Denmark; [Jeppesen, Per Bendix; Gregersen, Soren] Aarhus Univ Hosp, Aarhus Sygehus THG, Dept Med & Endocrinol MEA, DK-8000 Aarhus C, Denmark; [Petersen, Steffen B.] Aalborg Univ, Dept Hlth Sci & Technol, NanoBiotechnol Grp, Aalborg, Denmark; [Petersen, Steffen B.] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA	International Iberian Nanotechnology Laboratory; Aalborg University; Aalborg University; Aarhus University; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Neves-Petersen, MT (corresponding author), Int Iberian Nanotechnol Lab INL, Braga, Portugal.	teresa.petersen@inl.int	INL, Citations/K-3436-2015; Petersen, Steffen b/E-8727-2015	INL, Citations/0000-0002-3745-5100; Petersen, Steffen b/0000-0002-0739-2751; Correia, Manuel/0000-0001-7619-2780; Neves-Petersen, Maria Teresa/0000-0003-3178-3709; Gregersen, Soren/0000-0002-1953-8631	"Fundacao para a Ciencia e Tecnologia'' (FCT) [SFRH/BD/61012/2009]; "Programa Operacional Potencial Humano'' (POPH) in the framework of "Quadro de Referencia Estrategico Nacional'' (QREN); European Social Fund ("Fundo Social Europeu'', FSE)	"Fundacao para a Ciencia e Tecnologia'' (FCT)(Portuguese Foundation for Science and Technology); "Programa Operacional Potencial Humano'' (POPH) in the framework of "Quadro de Referencia Estrategico Nacional'' (QREN); European Social Fund ("Fundo Social Europeu'', FSE)(European Social Fund (ESF))	MC acknowledges the support from "Fundacao para a Ciencia e Tecnologia'' (FCT) for the PhD grant (SFRH/BD/61012/2009) supported by "Programa Operacional Potencial Humano'' (POPH) in the framework of "Quadro de Referencia Estrategico Nacional'' (QREN) and co-financed by the European Social Fund ("Fundo Social Europeu'', FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH R, 1976, BIOCHIM BIOPHYS ACTA, V439, P292, DOI 10.1016/0005-2795(76)90064-7; [Anonymous], [No title captured]; Antolikova E, 2011, J BIOL CHEM, V286, P36968, DOI 10.1074/jbc.M111.265249; ASTM, 2003, ANN BOOK ASTM STAND; Attri AK, 2010, BIOPHYS CHEM, V148, P28, DOI 10.1016/j.bpc.2010.02.002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Balasubramanian D, 2002, MOL CELL BIOCHEM, V234, P27, DOI 10.1023/A:1015927907418; Becker RHA, 2007, DIABETES TECHNOL THE, V9, P109, DOI 10.1089/dia.2006.0035; BENT DV, 1975, J AM CHEM SOC, V97, P2599, DOI 10.1021/ja00843a002; BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Brange J, 1993, Pharm Biotechnol, V5, P315; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P563; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; DEREWENDA U, 1989, BRIT MED BULL, V45, P4, DOI 10.1093/oxfordjournals.bmb.a072320; DIAZ JL, 1988, CLIN CHEM, V34, P356; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Duroux M, 2007, PROTEOMICS, V7, P3491, DOI 10.1002/pmic.200700472; FUKADA H, 1982, BIOCHEMISTRY-US, V21, P1570, DOI 10.1021/bi00536a016; GIULIVI C, 1994, METHOD ENZYMOL, V233, P363; Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Hawe A, 2012, J PHARM SCI-US, V101, P895, DOI 10.1002/jps.22812; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; HOFFMAN MZ, 1972, J AM CHEM SOC, V94, P7950, DOI 10.1021/ja00778a002; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Khazova M, 2008, RADIAT PROT DOSIM, V131, P521, DOI 10.1093/rpd/ncn234; Klitgaard S, 2006, J FLUORESC, V16, P595, DOI 10.1007/s10895-006-0081-0; LEHRER SS, 1967, BIOCHEMISTRY-US, V6, P757, DOI 10.1021/bi00855a017; LeRoithn D, 2003, DIABETES MELLITUS FU, P1200; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Malencik DA, 1996, BIOCHEMISTRY-US, V35, P4375, DOI 10.1021/bi9526037; MALENCIK DA, 1991, BIOCHEM BIOPH RES CO, V178, P60, DOI 10.1016/0006-291X(91)91779-C; MALENCIK DA, 1987, BIOCHEMISTRY-US, V26, P695, DOI 10.1021/bi00377a006; MARKUS G, 1964, J BIOL CHEM, V239, P4163; MASON HS, 1948, J BIOL CHEM, V172, P83; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McCormick ML, 1998, J BIOL CHEM, V273, P32030, DOI 10.1074/jbc.273.48.32030; Melmed S, 2005, ENDOCRINOLOGY BASIC, V2, DOI [10.1007/978-1-59259-829-8, DOI 10.1007/978-1-59259-829-8]; Mozziconacci O, 2008, J PHYS CHEM B, V112, P15921, DOI 10.1021/jp8066519; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Nuzum-Keim AD, 2009, LUPUS, V18, P556, DOI 10.1177/0961203309103052; Olivares-Corichi IM, 2005, FRONT BIOSCI-LANDMRK, V10, P3127, DOI 10.2741/1769; Parracino A, 2011, BIOTECHNOL BIOENG, V108, P999, DOI 10.1002/bit.23015; Parracino A, 2010, PROTEIN SCI, V19, P1751, DOI 10.1002/pro.461; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; Potter KN, 2000, DIABETES-METAB RES, V16, P338, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR145>3.0.CO;2-L; Rathore N, 2008, BIOTECHNOL PROGR, V24, P504, DOI 10.1021/bp070462h; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Sayre RM, 2004, PHOTOCHEM PHOTOBIOL, V80, P47, DOI 10.1562/2004-02-03-RA-074.1; Sen Lights Corporation (n.d.) Low-Pressure Mercury Lamps, LOW PRESS MERC LAMPS; Sharma P, 2009, MAPAN-J METROL SOC I, V24, P183, DOI 10.1007/s12647-009-0022-x; Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V85, P79, DOI 10.1016/j.jphotobiol.2006.05.005; Skovsen E, 2009, PROTEOMICS, V9, P3945, DOI 10.1002/pmic.200800960; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; Terryn H, 2006, PHARM RES-DORDR, V23, P2141, DOI 10.1007/s11095-006-9053-y; TEW D, 1988, J BIOL CHEM, V263, P17880; VERWEIJ H, 1982, BIOCHIM BIOPHYS ACTA, V701, P180, DOI 10.1016/0167-4838(82)90111-X; Zhang MG, 2005, ANAL CHEM, V77, P6396, DOI 10.1021/ac0508752; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	67	79	79	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50733	10.1371/journal.pone.0050733	http://dx.doi.org/10.1371/journal.pone.0050733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227203	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200062
J	Fan, Y; Li, CM; Guo, JH; Hu, G; Wu, GY				Fan, Yi; Li, Chunman; Guo, Jianhui; Hu, Gang; Wu, Guangyu			A Single Lys Residue on the First Intracellular Loop Modulates the Endoplasmic Reticulum Export and Cell-Surface Expression of alpha(2A)-Adrenergic Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ANGIOTENSIN-II RECEPTORS; ALPHA(2)-ADRENERGIC RECEPTORS; ANTEROGRADE TRAFFICKING; ADRENERGIC-RECEPTOR; SEROTONIN RECEPTORS; OPIOID RECEPTOR; TRANSPORT; MUTANT; MOTIF	Export from the endoplasmic reticulum (ER) represents an initial step in intracellular trafficking of G protein-coupled receptors (GPCRs). However, the underlying molecular mechanisms remain poorly understood. We have previously demonstrated that a highly conserved Leu residue on the first intracellular loop (ICL1) is required for exit of several GPCRs from the ER. Here we found that, in addition to Leu64 residue in the ICL1, the neighboring positively charged residue Lys65also modulates the cell-surface transport of alpha(2A)-adrenergic receptor (alpha(2A)-AR). Mutation of Lys65 to Ala, Glu and Gln significantly attenuated, whereas mutation of Lys65 to Arg strongly augmented alpha(2A)-AR expression at the cell surface. Consistent with the effects on the cell-surface expression of alpha(2A)-AR, mutation of Lys65 to Ala and Arg produced opposing effects on alpha(2A)-AR-mediated ERK1/2 activation. Furthermore, confocal microscopy revealed that the alpha(2A)-AR mutant K65A displayed a strong intracellular expression pattern and was extensively co-localized with the ER marker DsRed2-ER, suggestive of ER accumulation. These data provide the first evidence indicating an important function for a single Lys residue on the ICL1 in the ER export and cell-surface expression of alpha(2A)-AR. These data also suggest that the ICL1 may possess multiple signals that control the cell-surface targeting of GPCRs via distinct mechanisms. Citation: Fan Y, Li C, Guo J, Hu G, Wu G (2012) A Single Lys Residue on the First Intracellular Loop Modulates the Endoplasmic Reticulum Export and Cell-Surface Expression of alpha(2A)-Adrenergic Receptor. PLoS ONE 7(12): e50416. doi:10.1371/journal.pone.0050416	[Fan, Yi; Li, Chunman; Guo, Jianhui; Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	University System of Georgia; Augusta University; Nanjing Medical University	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA.	guwu@georgiahealth.edu	Fan, Yi/Q-9252-2018; Fan, Yi/AAQ-1874-2021; Guo, Jianhui/AAJ-6220-2020	Fan, Yi/0000-0003-1783-3220; Fan, Yi/0000-0003-1783-3220; 	National Institutes of Health grant [R01GM076167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076167] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant R01GM076167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chen CG, 2011, J BIOL CHEM, V286, P15106, DOI 10.1074/jbc.M111.230896; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Donnellan PD, 2011, BBA-BIOMEMBRANES, V1808, P1202, DOI 10.1016/j.bbamem.2011.01.003; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Ge X, 2009, MOL PHARMACOL, V75, P1307, DOI 10.1124/mol.108.054064; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Hammad MM, 2012, BIOL CHEM, V393, P541, DOI 10.1515/hsz-2011-0284; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hirota N, 2010, J BIOL CHEM, V285, P5931, DOI 10.1074/jbc.M109.066282; Janovick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022784; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; Lu RJ, 2009, J BIOL CHEM, V284, P13233, DOI 10.1074/jbc.M807535200; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; Sawyer GW, 2010, J PHARMACOL EXP THER, V332, P76, DOI 10.1124/jpet.109.160986; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	51	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50416	10.1371/journal.pone.0050416	http://dx.doi.org/10.1371/journal.pone.0050416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227171	gold, Green Published			2022-12-25	WOS:000312588200032
J	Feng, FF; Wu, YM; Zhang, SF; Liu, Y; Qin, LJ; Wu, YJ; Yan, Z; Wu, WD				Feng, Feifei; Wu, Yiming; Zhang, Shaofeng; Liu, Yu; Qin, Lijuan; Wu, Yongjun; Yan, Zhen; Wu, Weidong			Macrophages Facilitate Coal Tar Pitch Extract-Induced Tumorigenic Transformation of Human Bronchial Epithelial Cells Mediated by NF-kappa B	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; LUNG-CANCER; BREAST-CANCER; COLON-CANCER; INFLAMMATION; CARCINOGENESIS; PROGRESSION; METASTASIS; MICROENVIRONMENT; LYMPHANGIOGENESIS	Objective: Chronic respiratory inflammation has been associated with lung cancer. Tumor-associated macrophages (TAMs) play a critical role in the formation of inflammation microenvironment. We sought to characterize the role of TAMs in coal tar pitch extract (CTPE)-induced tumorigenic transformation of human bronchial epithelial cells and the underlying mechanisms. Methods: The expression of TAMs-specific CD68 in lung cancer tissues and paired adjacent tissues from cancer patients was determined using immunostaining. Co-culture of human bronchial epithelial cells (BEAS-2B) and macrophage-like THP-1 cells were conducted to evaluate the promotive effect of macrophages on CTPE-induced tumorigenic transformation of BEAS-2B cells. BEAS-2B cells were first treated with 2.4 mu g/mL CTPE for 72 hours. After removal of CTPE, the cells were continuously cultured either with or without THP-1 cells and passaged using trypsin-EDTA. Alterations of cell cycle, karyotype, colony formation in soft agar and tumor xenograft growth in nude mice of BEAS-2B cells at passages 10, 20 and 30, indicative of tumorigenecity, were determined, respectively. In addition, mRNA and protein levels of NF-kappa B in BEAS-2B cells were measured with RT-PCR and western blot, respectively. B(a)P was used as the positive control. Results: The over-expression of TAMs-specific CD68 around lung tumor tissues was detected and associated with lung cancer progression. The tumorigenic alterations of BEAS-2B cells including increase in cell growth rate, number of cells with aneuploidy, clonogenicity in soft agar, and tumor size in nude mice in vivo occurred at passage 10, becoming significant at passages 20 and 30 of the co-culture following CTPE removal in compared to BEAS-2B cells alone. In addition, the expression levels of NF-kappa B in BEAS-2B cells were positively correlated to the malignancy of BEAS-2B cells under different conditions of treatment. Conclusion: The presence of macrophages facilitated CTPE-induced tumorigenic transformation of BEAS-2B cells, which may be mediated by NF-kappa B.	[Feng, Feifei; Wu, Yiming; Zhang, Shaofeng; Liu, Yu; Yan, Zhen] Zhengzhou Univ, Coll Publ Hlth, Dept Occupat & Environm Hlth, Zhengzhou, Henan, Peoples R China; [Qin, Lijuan; Wu, Yongjun] Zhengzhou Univ, Coll Publ Hlth, Dept Sanit Chem, Zhengzhou, Henan, Peoples R China; [Wu, Weidong] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA	Zhengzhou University; Zhengzhou University; University of North Carolina; University of North Carolina Chapel Hill	Feng, FF (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Occupat & Environm Hlth, Zhengzhou, Henan, Peoples R China.	feifeifeng9@gmail.com			Nature Science Foundation of China [81001240]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the grant from the Nature Science Foundation of China (NO.81001240) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas I, 2011, J APPL TOXICOL; Azambuja D, 2012, ANN ONCOL, V23, P736, DOI 10.1093/annonc/mdr157; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618; Caillou B, 2011, PLOS ONE, P6; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Cho WCS, 2011, EXPERT OPIN THER TAR, V15, P1127, DOI 10.1517/14728222.2011.599801; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Ding JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041942; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gomperts BN, 2011, SEMIN RESP CRIT CARE, V32, P32, DOI 10.1055/s-0031-1272867; Gonda TA, 2009, CELL CYCLE, V8, P2005, DOI 10.4161/cc.8.13.8985; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ju R, 2011, EUR J CANC; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Karabela SP, 2012, CARCINOGENESIS, V33, P859, DOI 10.1093/carcin/bgs024; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Koganti A, 2000, CARCINOGENESIS, V21, P1601, DOI 10.1093/carcin/21.8.1601; Kuramochi J, 2011, RESPIRATION, V82, P263, DOI 10.1159/000327738; Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002; Li ZT, 2011, J HAZARD MATER, V186, P1277, DOI 10.1016/j.jhazmat.2010.11.123; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mizumoto Y, 2011, CLIN CANCER RES, V17, P1341, DOI 10.1158/1078-0432.CCR-10-2291; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; Munari F, 2011, BLOOD, V117, P6612, DOI 10.1182/blood-2010-06-293266; Muscat JE, 2003, CANCER, V97, P1732, DOI 10.1002/cncr.11242; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; Ohno S, 2004, ANTICANCER RES, V24, P3335; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rajagopalan H, 2004, CELL CYCLE, V3, P693; REDDEL RR, 1988, CANCER RES, V48, P1904; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shukla R, 2011, CARCINOGENESIS, V32, P978, DOI 10.1093/carcin/bgr057; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Utrera-Barillas D, 2010, EXP MOL PATHOL, V89, P190, DOI 10.1016/j.yexmp.2010.06.002; Van Dyke AL, 2008, CANCER EPIDEM BIOMAR, V17, P148, DOI 10.1158/1055-9965.EPI-07-0517; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; WEYAND EH, 1995, CHEM RES TOXICOL, V8, P949, DOI 10.1021/tx00049a008; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Wu YM, 2000, J HENAN MED U, V35, P232; Young RP, 2011, RESPIROLOGY, V16, P1047, DOI 10.1111/j.1440-1843.2011.02019.x; Zhou Q, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-13	55	14	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51690	10.1371/journal.pone.0051690	http://dx.doi.org/10.1371/journal.pone.0051690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227270	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200129
J	Song, Y; Xu, JL; Li, YF; Jia, CS; Ma, XW; Zhang, L; Xie, XJ; Zhang, Y; Gao, X; Zhang, YY; Zhu, DH				Song, Yao; Xu, Jialin; Li, Yanfeng; Jia, Chunshi; Ma, Xiaowei; Zhang, Lei; Xie, Xiaojie; Zhang, Yong; Gao, Xiang; Zhang, Youyi; Zhu, Dahai			Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-beta Signaling Pathways	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; PRESSURE-OVERLOAD; DILATED CARDIOMYOPATHY; REGULATED EXPRESSION; INDUCED APOPTOSIS; GENE-EXPRESSION; HEART-FAILURE; ANKRD1; CELLS; TITIN	Aims: It has been reported that cardiac ankyrin repeat protein is associated with heart development and diseases. This study is aimed to investigate the role of CARP in heart hypertrophy in vivo. Methods and Results: We generated a cardiac-specific CARP-overexpressing transgenic mouse. Although such animals did not display any overt physiological abnormality, they developed less cardiac hypertrophy in response to pressure overload than did wildtype mice, as indicated by heart weight/body weight ratios, echocardiographic and histological analyses, and expression of hypertrophic markers. These mice also exhibited less cardiac hypertrophy after infusion of isoproterenol. To gain a molecular insight into how CARP attenuated heart hypertrophy, we examined expression of the mitogen-activated protein kinase cascade and found that the concentrations of phosphorylated ERK1/2 and MEK were markedly reduced in the hearts of transgenic mice subjected to pressure overload. In addition, the expressions of TGF-beta and phosphorylated Smad3 were significantly downregulated in the hearts of CARP Tg mice in response to pressure overload. Furthermore, addition of human TGF-beta 1 could reverse the inhibitory effect of CARP on the hypertrophic response induced by phenylephrine in cardiomyocytes. It was also evidenced that the inhibitory effect of CARP on cardiac hypertrophy was not attributed to apoptosis. Conclusion: CARP attenuates cardiac hypertrophy, in which the ERK and TGF-beta pathways may be involved. Our findings highlight the significance of CARP as an anti-hypertrophic factor in therapy of cardiac hypertrophy. Citation: Song Y, Xu J, Li Y, Jia C, Ma X, et al. (2012) Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-b Signaling Pathways. PLoS ONE 7(12): e50436. doi:10.1371/journal.pone.0050436	[Xu, Jialin; Li, Yanfeng; Jia, Chunshi; Zhang, Lei; Zhang, Yong; Zhu, Dahai] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100730, Peoples R China; [Xu, Jialin; Li, Yanfeng; Jia, Chunshi; Zhang, Lei; Zhang, Yong; Zhu, Dahai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Song, Yao; Ma, Xiaowei; Zhang, Youyi] Peking Univ, Hosp 3, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Inst Vasc Med,Minist Hlth, Beijing 100871, Peoples R China; [Song, Yao; Ma, Xiaowei; Zhang, Youyi] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Gao, Xiang] Nanjing Univ, Natl Resource Ctr Mutant Mice Model Anim Res, Nanjing, Jiangsu, Peoples R China; [Xie, Xiaojie] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; Nanjing University; Zhejiang University	Gao, X (corresponding author), Nanjing Univ, Natl Resource Ctr Mutant Mice Model Anim Res, Nanjing, Jiangsu, Peoples R China.	gaoxiang@nju.edu.cn; zhangyy@bjmu.edu.cn; dhzhu@pumc.edu.cn	li, yan/GTI-4638-2022; xu, jia/GSD-6347-2022; Zhu, Dahai/ABA-5315-2021; Zhang, Yong/AAH-6147-2021		National Basic Research Program of China [2007CB946903, 2005CB522405, 2005CB522507, 2011CB503903]; National Natural Science Foundation of China [30721063, 30971161, 81030001]; Chinese National Programs for High Technology Research and Development [2007AA02Z109]; Project for International Cooperation [30910103902]; Project Exchanges NSFC [30910103902]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); Project for International Cooperation; Project Exchanges NSFC	This work was supported by the National Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx) (grant nos. 2007CB946903, 2005CB522405, 2005CB522507, and 2011CB503903); the National Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) (grant nos. 30721063, 30971161 and 81030001); the Chinese National Programs for High Technology Research and Development (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm) (grant no. 2007AA02Z109); and the Projects for International Cooperation and Exchanges NSFC (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0110.htm) (grant no. 30910103902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Aihara Y, 1999, BBA-GENE STRUCT EXPR, V1447, P318, DOI 10.1016/S0167-4781(99)00171-2; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cinquetti R, 2008, HUM MUTAT, V29, P468, DOI 10.1002/humu.20711; DAHLOF B, 1992, AM J HYPERTENS, V5, P95, DOI 10.1093/ajh/5.2.95; Esposito G, 2001, CIRCULATION, V103, P1453, DOI 10.1161/01.CIR.103.10.1453; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Han XJ, 2005, J BIOL CHEM, V280, P23122, DOI 10.1074/jbc.M501095200; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Lim HW, 2000, CIRCULATION, V101, P2431, DOI 10.1161/01.CIR.101.20.2431; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nakada C, 2003, LAB INVEST, V83, P711, DOI 10.1097/01.LAB.0000067484.35298.1A; Purevjav E, 2012, HUM MOL GENET, V21, P2039, DOI 10.1093/hmg/dds022; Scurr LL, 2008, CLIN CANCER RES, V14, P6924, DOI 10.1158/1078-0432.CCR-07-5189; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Takeda S, 2001, J YONAGO MED ASSOC, V52, P144; Torrado M, 2004, EUR J HEART FAIL, V6, P161, DOI 10.1016/j.ejheart.2003.11.004; Wei YJ, 2009, EUR J HEART FAIL, V11, P559, DOI 10.1093/eurjhf/hfp049; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Xu Q, 2008, ENDOCRINOLOGY, V149, P476, DOI 10.1210/en.2007-1220; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X	31	21	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50436	10.1371/journal.pone.0050436	http://dx.doi.org/10.1371/journal.pone.0050436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227174	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200035
J	Tong, XL; Lindemann, A; Monteiro, A				Tong, Xiaoling; Lindemann, Anna; Monteiro, Antonia			Differential Involvement of Hedgehog Signaling in Butterfly Wing and Eyespot Development	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PSEUDO-ACTIVE-SITE; SONIC HEDGEHOG; EVOLUTION; PROTEIN; ORTHODENTICLE; PROLIFERATION; LEPIDOPTERA; RECRUITMENT; ANTIBODIES	Butterfly eyespots may have evolved from the recruitment of pre-existent gene circuits or regulatory networks into novel locations on the wing. Gene expression data suggests one such circuit, the Hedgehog (Hh) signaling pathway and its target gene engrailed (en), was recruited from a role in patterning the anterior-posterior insect wing axis to a role patterning butterfly eyespots. However, while Junonia coenia expresses hh and en both in the posterior compartment of the wing and in eyespot centers, Bicyclus anynana lacks hh eyespot-specific expression. This suggests that Hh signaling may not be functioning in eyespot development in either species or that it functions in J. coenia but not in B. anynana. In order to test these hypotheses, we performed functional tests of Hh signaling in these species. We investigated the effects of Hh protein sequestration during the larval stage on en expression levels, and on wing size and eyespot size in adults. Hh sequestration led to significantly reduced en expression and to significantly smaller wings and eyespots in both species. But while eyespot size in B. anynana was reduced proportionately to wing size, in J. coenia, eyespots were reduced disproportionately, indicating an independent role of Hh signaling in eyespot development in J. coenia. We conclude that while Hh signaling retains a conserved role in promoting wing growth across nymphalid butterflies, it plays an additional role in eyespot development in some, but not all, lineages of nymphalid butterflies. We discuss our findings in the context of alternative evolutionary scenarios that led to the differential expression of hh and other Hh pathway signaling members across nymphalid species.	[Tong, Xiaoling; Lindemann, Anna; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Tong, Xiaoling] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Yale University; Southwest University - China	Monteiro, A (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	antonia.monteiro@yale.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Tong, Xiaoling/0000-0002-2649-899X	REU [DO 1357]; National Science Foundation (NSF) [IOB-0653399, IOS 1146933]	REU; National Science Foundation (NSF)(National Science Foundation (NSF))	A.L. was supported by an REU DO 1357 supplement to National Science Foundation (NSF) award IOB-0653399 to AM and XT was partly supported by NSF award IOS 1146933 to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bejarano F, 2007, EMBO REP, V8, P778, DOI 10.1038/sj.embor.7401003; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Bossing T, 2006, DEVELOPMENT, V133, P1001, DOI 10.1242/dev.02288; Burglin TR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-241; De Rivoyre M, 2006, J BIOL CHEM, V281, P28584, DOI 10.1074/jbc.M512986200; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fukasawa H, 2004, KIDNEY INT, V65, P63, DOI 10.1111/j.1523-1755.2004.00393.x; Hervold K, 2007, NUCLEIC ACIDS RES, V35, pD595, DOI 10.1093/nar/gkl1012; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McGregor AP, 2006, BIOESSAYS, V28, P683, DOI 10.1002/bies.20429; Monteiro A, 2001, MOL PHYLOGENET EVOL, V18, P264, DOI 10.1006/mpev.2000.0872; Nicholas K.B., 1997, EMBNEW NEWS, V4, P1; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Saenko SV, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-9; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; Shirai LT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-21; Stockwin LH, 2003, EXPERT OPIN BIOL TH, V3, P1133, DOI 10.1517/14712598.3.7.1133; Strigini M, 1997, DEVELOPMENT, V124, P4697; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; VISCHER NOE, 1994, BINARY BIOLINE, V6; Wang XY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001110; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	38	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51087	10.1371/journal.pone.0051087	http://dx.doi.org/10.1371/journal.pone.0051087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227236	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200096
J	Strittmatter, E; Liers, C; Ullrich, R; Wachter, S; Hofrichter, M; Plattner, DA; Piontek, K				Strittmatter, Eric; Liers, Christiane; Ullrich, Rene; Wachter, Sabrina; Hofrichter, Martin; Plattner, Dietmar A.; Piontek, Klaus			First Crystal Structure of a Fungal High-redox Potential Dye-decolorizing Peroxidase SUBSTRATE INTERACTION SITES AND LONG-RANGE ELECTRON TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THANATEPHORUS-CUCUMERIS DEC-1; LIGNIN PEROXIDASE; MOLECULAR-GRAPHICS; BETA; REFINEMENT; MECHANISM; OXIDATION; RESIDUE	Dye-decolorizing peroxidases (DyPs) belong to the large group of heme peroxidases. They utilize hydrogen peroxide to catalyze oxidations of various organic compounds. AauDyPI from Auricularia auricula-judae (fungi) was crystallized, and its crystal structure was determined at 2.1 angstrom resolution. The mostly helical structure also shows a beta-sheet motif typical for DyPs and Cld (chlorite dismutase)-related structures and includes the complete polypeptide chain. At the distal side of the heme molecule, a flexible aspartate residue (Asp-168) plays a key role in catalysis. It guides incoming hydrogen peroxide toward the heme iron and mediates proton rearrangement in the process of Compound I formation. Afterward, its side chain changes its conformation, now pointing toward the protein backbone. We propose an extended functionality of Asp-168, which acts like a gatekeeper by altering the width of the heme cavity access channel. Chemical modifications of potentially redox-active amino acids show that a tyrosine is involved in substrate interaction. Using spin-trapping experiments, a transient radical on the surface-exposed Tyr-337 was identified as the oxidation site for bulky substrates. A possible long-range electron transfer pathway from the surface of the enzyme to the redox cofactor (heme) is discussed.	[Piontek, Klaus] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany; [Liers, Christiane; Ullrich, Rene; Hofrichter, Martin] Int Grad Sch Zittau, Dept Bio & Environm Sci, D-02763 Zittau, Germany	University of Freiburg; Technische Universitat Dresden	Piontek, K (corresponding author), Univ Freiburg, Inst Organ Chem, Albertstr 21, D-79104 Freiburg, Germany.	Klaus.Piontek@ocbc.uni-freiburg.de		Hofrichter, Martin/0000-0001-5174-7604; Liers, Christiane/0000-0002-2000-0820	Commission of the European Communities within the Sixth European Framework Programme (BIORENEW) [NMP2-CT-2006-026456]; International Research Training Group Grant "Catalysts and Catalytic Reactions for Organic Synthesis" (CCROS) of the Deutsche Forschungsgemeinschaft (DFG) [IRTG 1038]	Commission of the European Communities within the Sixth European Framework Programme (BIORENEW); International Research Training Group Grant "Catalysts and Catalytic Reactions for Organic Synthesis" (CCROS) of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was partially financed by a grant from the Commission of the European Communities within the Sixth European Framework Programme (BIORENEW contract NMP2-CT-2006-026456) (to K. P. and M. H.) and by funding from the International Research Training Group Grant IRTG 1038 "Catalysts and Catalytic Reactions for Organic Synthesis" (CCROS) of the Deutsche Forschungsgemeinschaft (DFG) (to D. A. P.).	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Balland V, 2006, BIOCHEMISTRY-US, V45, P2072, DOI 10.1021/bi051696h; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365; Blodig W, 1998, BIOCHEMISTRY-US, V37, P8832, DOI 10.1021/bi9727186; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; INOKUCHI N, 1982, J BIOCHEM-TOKYO, V91, P1661, DOI 10.1093/oxfordjournals.jbchem.a133857; Jones P, 2005, J INORG BIOCHEM, V99, P2292, DOI 10.1016/j.jinorgbio.2005.08.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM SJ, 1995, J FERMENT BIOENG, V79, P601, DOI 10.1016/0922-338X(95)94755-G; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; KLAPPER MH, 1979, Q REV BIOPHYS, V12, P465, DOI 10.1017/S0033583500002791; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; MAURO JM, 1988, BIOCHEMISTRY-US, V27, P6243, DOI 10.1021/bi00417a008; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miki Y, 2011, J BIOL CHEM, V286, P15525, DOI 10.1074/jbc.M111.220996; Piontek K, 2001, BIOCHEM SOC T, V29, P111, DOI 10.1042/BST0290111; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Prytkova TR, 2005, J PHYS CHEM B, V109, P1618, DOI 10.1021/jp0457491; Sato T, 2004, ACTA CRYSTALLOGR D, V60, P149, DOI 10.1107/S0907444903025472; Scheibner M, 2008, APPL MICROBIOL BIOT, V77, P1241, DOI 10.1007/s00253-007-1261-9; Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Smith AT, 2009, P NATL ACAD SCI USA, V106, P16084, DOI 10.1073/pnas.0904535106; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Sugano Y, 2006, APPL MICROBIOL BIOT, V73, P862, DOI 10.1007/s00253-006-0545-9; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x; Welinder KG, 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [DOI 10.1016/0959-440X(92)90230-5, 10.1016/0959-440x(92)90230-5]; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yoshida T, 2011, FEBS J, V278, P2387, DOI 10.1111/j.1742-4658.2011.08161.x; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2; Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200; Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550	49	75	76	0	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4095	4102		10.1074/jbc.M112.400176	http://dx.doi.org/10.1074/jbc.M112.400176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23235158	hybrid, Green Published			2022-12-25	WOS:000314845000038
J	Nurse, P; Marians, KJ				Nurse, Pearl; Marians, Kenneth J.			Purification and Characterization of Escherichia coli MreB Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC CELL-CYCLE; BACTERIAL ACTIN MREB; CHROMOSOME SEGREGATION; BACILLUS-SUBTILIS; DNA SEGREGATION; RNA-POLYMERASE; WALL SYNTHESIS; HOMOLOG MREB; PLASMID DNA; REGION	The actin homolog MreB is required in rod-shaped bacteria for maintenance of cell shape and is intimately connected to the holoenzyme that synthesizes the peptidoglycan layer. The protein has been reported variously to exist in helical loops under the cell surface, to rotate, and to move in patches in both directions around the cell surface. Studies of the Escherichia coli protein in vitro have been hampered by its tendency to aggregate. Here we report the purification and characterization of native E. coli MreB. The protein requires ATP hydrolysis for polymerization, forms bundles with a left-hand twist that can be as long as 4 mu m, forms sheets in the presence of calcium, and has a critical concentration for polymerization of 1.5 mu M.	[Nurse, Pearl; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu			National Institutes of Health Grant [GM34558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34558 (to K. J. M.).	Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaballah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025129; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Karczmarek A, 2007, MOL MICROBIOL, V65, P51, DOI 10.1111/j.1365-2958.2007.05777.x; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Madabhushi R, 2009, MOL CELL, V33, P171, DOI 10.1016/j.molcel.2009.01.001; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Popp D, 2010, J BIOL CHEM, V285, P15858, DOI 10.1074/jbc.M109.095901; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Srinivasan R, 2007, CURR BIOL, V17, P266, DOI 10.1016/j.cub.2006.11.069; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Swulius MT, 2011, BIOCHEM BIOPH RES CO, V407, P650, DOI 10.1016/j.bbrc.2011.03.062; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Vats P, 2007, P NATL ACAD SCI USA, V104, P17795, DOI 10.1073/pnas.0708739104; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; Wang XD, 2010, J BACTERIOL, V192, P6143, DOI 10.1128/JB.00861-10; White CL, 2012, TRENDS MICROBIOL, V20, P74, DOI 10.1016/j.tim.2011.11.004	31	26	26	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3469	3475		10.1074/jbc.M112.413708	http://dx.doi.org/10.1074/jbc.M112.413708			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235161	hybrid, Green Published			2022-12-25	WOS:000314397900051
J	Wang, JD; Leung, JWC; Gong, ZH; Feng, L; Shi, XB; Chen, JJ				Wang, Jiadong; Leung, Justin Wai-chung; Gong, Zihua; Feng, Lin; Shi, Xiaobing; Chen, Junjie			PHF6 Regulates Cell Cycle Progression by Suppressing Ribosomal RNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORSSMAN-LEHMANN-SYNDROME; ACUTE LYMPHOBLASTIC-LEUKEMIA; DEMETHYLASE PHF8; MAMMALIAN-CELLS; MUTATIONS; PROTEIN; TRANSCRIPTION; REPAIR; BINDING; BREAKS	Mutation of PHF6, which results in the X-linked mental retardation disorder Borjeson-Forssman-Lehmann syndrome, is also present in about 38% of adult T-cell acute lymphoblastic leukemias and 3% of adult acute myeloid leukemias. However, it remains to be determined exactly how PHF6 acts in vivo and what functions of PHF6 may be associated with its putative tumor suppressor function. Here, we demonstrate that PHF6 is a nucleolus, ribosomal RNA promoter-associated protein. PHF6 directly interacts with upstream binding factor (UBF) through its PHD1 domain and suppresses ribosomal RNA (rRNA) transcription by affecting the protein level of UBF. Knockdown of PHF6 impairs cell proliferation and arrests cells at G(2)/M phase, which is accompanied by an increased level of phosphorylated H2AX, indicating that PHF6 deficiency leads to the accumulation of DNA damage in the cell. We found that increased DNA damage occurs at the ribosomal DNA (rDNA) locus in PHF6-deficient cells. This effect could be reversed by knocking down UBF or overexpressing RNASE1, which removes RNA-DNA hybrids, suggesting that there is a functional link between rRNA synthesis and genomic stability at the rDNA locus. Together, these results reveal that the key function of PHF6 is involved in regulating rRNA synthesis, which may contribute to its roles in cell cycle control, genomic maintenance, and tumor suppression.	[Wang, Jiadong; Leung, Justin Wai-chung; Gong, Zihua; Feng, Lin; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, 1515 Holcombe Blvd,Rm Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org		Shi, Xiaobing/0000-0001-5242-8189; Leung, Justin Wai Chung/0000-0003-4601-390X	National Institutes of Health [CA089239, CA092312, CA100109, CA016672]; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [R01CA100109, R01CA092312, R01CA089239, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of an Era of Hope Scholar award from the Department of Defense (Grant W81XWH-05-1-0470) and a member of M. D. Anderson Cancer Center (National Institutes of Health Grant CA016672).	ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Chao MM, 2010, PEDIATR BLOOD CANCER, V55, P722, DOI 10.1002/pbc.22574; Donati G, 2011, ONCOGENE, V30, P3274, DOI 10.1038/onc.2011.48; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Turner G, 2004, CLIN GENET, V65, P226, DOI 10.1111/j.0009-9163.2004.00215.x; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Visootsak J, 2004, J PEDIATR-US, V145, P819, DOI 10.1016/j.jpeds.2004.07.041; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017	20	64	66	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3174	3183		10.1074/jbc.M112.414839	http://dx.doi.org/10.1074/jbc.M112.414839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23229552	Green Published, hybrid			2022-12-25	WOS:000314397900025
J	Rodriguez, A; Negro, JJ; Mulero, M; Rodriguez, C; Hernandez-Pliego, J; Bustamante, J				Rodriguez, Airam; Negro, Juan J.; Mulero, Mara; Rodriguez, Carlos; Hernandez-Pliego, Jesus; Bustamante, Javier			The Eye in the Sky: Combined Use of Unmanned Aerial Systems and GPS Data Loggers for Ecological Research and Conservation of Small Birds	PLOS ONE			English	Article							KESTREL FALCO-NAUMANNI; LESSER KESTRELS; FORAGING HABITAT; BREEDING-SEASON; ATTRACTION; DIET	Technological advances for wildlife monitoring have expanded our ability to study behavior and space use of many species. But biotelemetry is limited by size, weight, data memory and battery power of the attached devices, especially in animals with light body masses, such as the majority of bird species. In this study, we describe the combined use of GPS data logger information obtained from free-ranging birds, and environmental information recorded by unmanned aerial systems (UASs). As a case study, we studied habitat selection of a small raptorial bird, the lesser kestrel Falco naumanni, foraging in a highly dynamic landscape. After downloading spatio-temporal information from data loggers attached to the birds, we programmed the UASs to fly and take imagery by means of an onboard digital camera documenting the flight paths of those same birds shortly after their recorded flights. This methodology permitted us to extract environmental information at quasi-real time. We demonstrate that UASs are a useful tool for a wide variety of wildlife studies.	[Rodriguez, Airam; Negro, Juan J.; Mulero, Mara] CSIC, Estn Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Rodriguez, Carlos; Hernandez-Pliego, Jesus; Bustamante, Javier] CSIC, Estn Biol Donana, Dept Wetland Ecol, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Negro, JJ (corresponding author), CSIC, Estn Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain.	negro@ebd.csic.es	Bustamante, Javier/AAA-7273-2019; Bustamante, Javier/C-2735-2008; Negro, Juan Jose/I-2653-2015; Hernández-Pliego, Jesús/M-4067-2015; Rodríguez, Airam/D-5110-2011; Mulero-Pazmany, Margarita/M-5596-2013	Bustamante, Javier/0000-0001-7515-0677; Bustamante, Javier/0000-0001-7515-0677; Negro, Juan Jose/0000-0002-8697-5647; Hernández-Pliego, Jesús/0000-0002-7343-4518; Rodríguez, Airam/0000-0001-7882-135X; Mulero-Pazmany, Margarita/0000-0002-0303-9360	Junta de Andalucia (regional government) [P07-RNM-03246, P09-RNM-04588]; EC [257649]; EU	Junta de Andalucia (regional government)(Junta de Andalucia); EC(European CommissionEuropean Commission Joint Research Centre); EU(European Commission)	Financial support was obtained from the AEROMAB (reference: P07-RNM-03246) and HORUS projects (reference: P09-RNM-04588) funded by Junta de Andalucia (regional government) granted to JJN and JB, respectively, and from the PLANET project (reference: EC 7th FP Grant Agreement 257649) funded by the EU and granted to JJN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, CONSERV GENET, V11, P331, DOI 10.1007/s10592-009-9810-7; Bird Life International, 2011, SPEC FACTSH FALC NAU; BLACKBURN TM, 1994, OIKOS, V70, P127, DOI 10.2307/3545707; Bluff LA, 2008, BIOL LETTERS, V4, P319, DOI 10.1098/rsbl.2008.0075; Chabot D, 2012, WATERBIRDS, V35, P170, DOI 10.1675/063.035.0119; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; DONAZAR JA, 1993, J APPL ECOL, V30, P515, DOI 10.2307/2404191; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Franco AMA, 2004, ANIM CONSERV, V7, P291, DOI 10.1017/S1367943004001465; Gremillet D, 2010, FRONT ECOL ENVIRON, V8, P401, DOI 10.1890/10.WB.020; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kenward RE., 2000, MANUAL WILDLIFE RADI; Millspaugh JJ, 2008, TRENDS ECOL EVOL, V23, P294, DOI 10.1016/j.tree.2008.03.002; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Negro Juan J., 1997, BWP Update, V1, P49; Negro Juan Jose, 2007, P401; Perez-Granados C, 2010, ARDEOLA, V57, P443; Pomarol Manel, 1993, P24; Ribeiro EF, 2007, THESIS U AVEIRO AVEI; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Rodriguez A, 2009, IBIS, V151, P299, DOI 10.1111/j.1474-919X.2009.00925.x; Rodriguez C, 2009, AGR ECOSYST ENVIRON, V129, P361, DOI 10.1016/j.agee.2008.10.010; Rodriguez C, 2010, J RAPTOR RES, V44, P120, DOI 10.3356/JRR-09-34.1; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Rutz C, 2008, TRENDS ECOL EVOL, V23, P292, DOI 10.1016/j.tree.2008.01.011; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007322; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; Ursua E, 2005, BIOL CONSERV, V122, P643, DOI 10.1016/j.biocon.2004.10.002; van Diermen Jan, 2009, Takkeling, V17, P109; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Zavalaga CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019966	39	42	46	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50336	10.1371/journal.pone.0050336	http://dx.doi.org/10.1371/journal.pone.0050336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239979	Green Published, gold			2022-12-25	WOS:000312290800017
J	Brody, MJ; Hacker, TA; Patel, JR; Feng, L; Sadoshima, J; Tevosian, SG; Balijepalli, RC; Moss, RL; Lee, Y				Brody, Matthew J.; Hacker, Timothy A.; Patel, Jitandrakumar R.; Feng, Li; Sadoshima, Junichi; Tevosian, Sergei G.; Balijepalli, Ravi C.; Moss, Richard L.; Lee, Youngsook			Ablation of the Cardiac-Specific Gene Leucine-Rich Repeat Containing 10 (Lrrc10) Results in Dilated Cardiomyopathy	PLOS ONE			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION PATHWAYS; HEART-FAILURE; MUSCLE ACTIN; SEVERE FORM; IN-VIVO; EPSILON; EXPRESSION; MUTATIONS; HYPERTROPHY	Leucine-rich repeat containing 10 (LRRC10) is a cardiac-specific protein exclusively expressed in embryonic and adult cardiomyocytes. However, the role of LRRC10 in mammalian cardiac physiology remains unknown. To determine if LRRC10 is critical for cardiac function, Lrrc10-null (Lrrc10(-/-))mice were analyzed. Lrrc10(-/-) mice exhibit prenatal systolic dysfunction and dilated cardiomyopathy in postnatal life. Importantly, Lrrc10(-/-) mice have diminished cardiac performance in utero, prior to ventricular dilation observed in young adults. We demonstrate that LRRC10 endogenously interacts with alpha-actinin and alpha-actin in the heart and all actin isoforms in vitro. Gene expression profiling of embryonic Lrrc10(-/-) hearts identified pathways and transcripts involved in regulation of the actin cytoskeleton to be significantly upregulated, implicating dysregulation of the actin cytoskeleton as an early defective molecular signal in the absence of LRRC10. In contrast, microarray analyses of adult Lrrc10(-/-) hearts identified upregulation of oxidative phosphorylation and cardiac muscle contraction pathways during the progression of dilated cardiomyopathy. Analyses of hypertrophic signal transduction pathways indicate increased active forms of Akt and PKC epsilon in adult Lrrc10(-/-) hearts. Taken together, our data demonstrate that LRRC10 is essential for proper mammalian cardiac function. We identify Lrrc10 as a novel dilated cardiomyopathy candidate gene and the Lrrc10(-/-) mouse model as a unique system to investigate pediatric cardiomyopathy.	[Brody, Matthew J.; Patel, Jitandrakumar R.; Moss, Richard L.; Lee, Youngsook] Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Brody, Matthew J.; Lee, Youngsook] Univ Wisconsin Madison, Mol & Environm Toxicol Ctr, Madison, WI USA; [Hacker, Timothy A.; Feng, Li; Balijepalli, Ravi C.] Univ Wisconsin Madison, Dept Med, Madison, WI USA; [Sadoshima, Junichi] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Tevosian, Sergei G.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University System of Florida; University of Florida	Lee, Y (corresponding author), Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.	youngsooklee@wisc.edu		Brody, Matthew/0000-0003-4904-7670; Sadoshima, Junichi/0000-0003-3724-4132	National Institutes of Health [HL067050, HD042751, HL097127]; American Heart Association [11PRE5580012]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102738, R01HL112330, R01HL067050, R21HL097127, R01HL105713, R37HL082900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL067050 to YL and HD042751 and HL097127 to SGT. from the National Institutes of Health (http://www.nih.gov/) and predoctoral fellowship 11PRE5580012 to MJB from the American Heart Association (http://www.americanheart.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko II, 2005, DEV DYNAM, V233, P540, DOI 10.1002/dvdy.20368; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Asakura M, 2009, CIRC J, V73, P1568, DOI 10.1253/circj.CJ-09-0465; Babbitt CJ, 2002, HISTOCHEM CELL BIOL, V118, P431, DOI 10.1007/s00418-002-0476-1; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; CHASE PB, 1994, BIOPHYS J, V67, P1994, DOI 10.1016/S0006-3495(94)80682-4; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Colak D, 2009, GENOMICS, V94, P20, DOI 10.1016/j.ygeno.2009.03.003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Duboscq-Bidot L, 2008, CARDIOVASC RES, V77, P118, DOI 10.1093/cvr/cvm015; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Fujita M, 2012, DEV BIOL, V361, P79, DOI 10.1016/j.ydbio.2011.10.008; Goldspink PH, 2004, CIRC RES, V95, P424, DOI 10.1161/01.RES.0000138299.85648.92; Grzeskowiak R, 2003, CARDIOVASC RES, V59, P400, DOI 10.1016/S0008-6363(03)00426-7; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; Hankiewicz JH, 2008, AM J PHYSIOL-HEART C, V294, pH330, DOI 10.1152/ajpheart.01109.2007; Haq S, 2001, CIRCULATION, V103, P670; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Huang XP, 1997, J CELL SCI, V110, P1625; Huang XP, 2004, J CELL SCI, V117, P1971, DOI 10.1242/jcs.01044; Iwata M, 2005, BIOCHEM BIOPH RES CO, V327, P1105, DOI 10.1016/j.bbrc.2004.12.128; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kim KH, 2007, DEV DYNAM, V236, P2225, DOI 10.1002/dvdy.21225; Kim KH, 2007, DEV BIOL, V308, P494, DOI 10.1016/j.ydbio.2007.06.005; Kimura Akinori, 2008, Circ J, V72 Suppl A, pA38, DOI 10.1253/circj.CJ-08-0050; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li R, 2012, AM J PATHOL; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; Manuylov NL, 2008, GENESIS, V46, P441, DOI 10.1002/dvg.20422; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Miyamoto S, 2009, CARDIOVASC RES, V82, P272, DOI 10.1093/cvr/cvp087; Miyamoto T, 2004, BASIC RES CARDIOL, V99, P328, DOI 10.1007/s00395-004-0482-7; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Molkentin JD, 2000, MOL CELL BIOL, V20, P5256, DOI 10.1128/MCB.20.14.5256-5260.2000; Mysliwiec MR, 2012, J BIOL CHEM, V287, P1235, DOI 10.1074/jbc.M111.315945; Mysliwiec MR, 2007, FEBS LETT, V581, P2633, DOI 10.1016/j.febslet.2007.05.006; Mysliwiec MR, 2011, J BIOL CHEM; Nakane T, 2004, BIOCHEM BIOPH RES CO, V314, P1086, DOI 10.1016/j.bbrc.2003.12.202; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; Pepe M, 2010, CIRC RES, V106, P1893, DOI 10.1161/CIRCRESAHA.110.220855; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Robia SL, 2005, AM J PHYSIOL-HEART C, V289, pH1941, DOI 10.1152/ajpheart.01111.2004; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Strait JB, 2001, AM J PHYSIOL-HEART C, V280, pH756, DOI 10.1152/ajpheart.2001.280.2.H756; Takeishi Y, 2000, CIRC RES, V86, P1218, DOI 10.1161/01.RES.86.12.1218; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021767; Wang R, 2010, BIOL CELL, V102, P173, DOI 10.1042/BC20090091; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Will RD, 2010, CIRC RES, V107, P1253, DOI 10.1161/CIRCRESAHA.110.222372; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; Zhou YQ, 2002, PHYSIOL GENOMICS, V10, P113, DOI 10.1152/physiolgenomics.00119.2001	88	24	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51621	10.1371/journal.pone.0051621	http://dx.doi.org/10.1371/journal.pone.0051621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236519	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100135
J	Jin, JH; Zhang, B; Guo, HY; Cui, JY; Jiang, L; Song, SH; Sun, M; Ren, FZ				Jin, Junhua; Zhang, Bing; Guo, Huiyuan; Cui, Jianyun; Jiang, Lu; Song, Shuhui; Sun, Min; Ren, Fazheng			Mechanism Analysis of Acid Tolerance Response of Bifidobacterium longum subsp longum BBMN 68 by Gene Expression Profile Using RNA-Sequencing	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; STREPTOCOCCUS-MUTANS; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; TRANSCRIPTIONAL ANALYSIS; STRESS RESPONSES; BREVE UCC-2003; IN-VIVO; LOW-PH; BACTERIA	To analyze the mechanism of the acid tolerance response (ATR) in Bifidobacterium longum subsp. longum BBMN68, we optimized the acid-adaptation condition to stimulate ATR effectively and analyzed the change of gene expression profile after acid-adaptation using high-throughput RNA-Seq. After acid-adaptation at pH 4.5 for 2 hours, the survival rate of BBMN68 at lethal pH 3.5 for 120 min was increased by 70 fold and the expression of 293 genes were upregulated by more than 2 fold, and 245 genes were downregulated by more than 2 fold. Gene expression profiling of ATR in BBMN68 suggested that, when the bacteria faced acid stress, the cells strengthened the integrity of cell wall and changed the permeability of membrane to keep the H+ from entering. Once the H+ entered the cytoplasm, the cells showed four main responses: First, the F0F1-ATPase system was initiated to discharge H+. Second, the ability to produce NH3 by cysteine-cystathionine-cycle was strengthened to neutralize excess H+. Third, the cells started NER-UVR and NER-VSR systems to minimize the damage to DNA and upregulated HtpX, IbpA, and gamma-glutamylcysteine production to protect proteins against damage. Fourth, the cells initiated global response signals ((p) ppGpp, polyP, and Sec-SRP) to bring the whole cell into a state of response to the stress. The cells also secreted the quorum sensing signal (AI-2) to communicate between intraspecies cells by the cellular signal system, such as two-component systems, to improve the overall survival rate. Besides, the cells varied the pathways of producing energy by shifting to BCAA metabolism and enhanced the ability to utilize sugar to supply sufficient energy for the operation of the mechanism mentioned above. Based on these reults, it was inferred that, during industrial applications, the acid resistance of bifidobacteria could be improved by adding BCAA, gamma-glutamylcysteine, cysteine, and cystathionine into the acid-stress environment.	[Jin, Junhua; Guo, Huiyuan; Cui, Jianyun; Jiang, Lu; Ren, Fazheng] China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Funct Dairy, Beijing 100094, Peoples R China; [Zhang, Bing; Song, Shuhui; Sun, Min] Chinese Acad Sci, Beijing Inst Genom, Core Genom Facil, Beijing, Peoples R China; [Guo, Huiyuan] Beijing Higher Inst, Engn Res Ctr Anim Prod, Beijing, Peoples R China; [Jiang, Lu; Ren, Fazheng] Beijing Key Lab Nutr Hlth & Food Safety, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Ren, FZ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Funct Dairy, Beijing 100094, Peoples R China.	renfazheng@263.net	song, shuhui/D-6015-2014	Zhao, Liang/0000-0001-9244-3121	Ministry of Science and Technology of China [2011AA100903, 2011BAD23B04]; Beijing Science and Technology Project [D101105046010001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Science and Technology Project	1. The Ministry of Science and Technology of China (Grant NO. 2011AA100903, http://www.863.gov.cn/; 2011BAD23B04, http://kjzc.jhgl.org/); 2. The Beijing Science and Technology Project (Grant NO. D101105046010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broadbent JR, 2010, J BACTERIOL, V192, P2445, DOI 10.1128/JB.01618-09; Brockmann-Gretza O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-230; Cappa F, 2005, RES MICROBIOL, V156, P1039, DOI 10.1016/j.resmic.2005.06.003; Champagne CP, 2005, CRIT REV FOOD SCI, V45, P61, DOI 10.1080/10408690590900144; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; De Angelis M, 2001, MICROBIOL-SGM, V147, P1863, DOI 10.1099/00221287-147-7-1863; Even S, 2002, MOL MICROBIOL, V45, P1143, DOI 10.1046/j.1365-2958.2002.03086.x; Gutierrez JA, 1999, MICROBIOL-UK, V145, P357, DOI 10.1099/13500872-145-2-357; HAMILTON IR, 1991, ORAL MICROBIOL IMMUN, V6, P65, DOI 10.1111/j.1399-302X.1991.tb00453.x; Hanna MN, 2001, J BACTERIOL, V183, P5964, DOI 10.1128/JB.183.20.5964-5973.2001; Hao YL, 2011, J BACTERIOL, V193, P787, DOI 10.1128/JB.01213-10; Jayaraman GC, 1997, MOL MICROBIOL, V25, P329, DOI 10.1046/j.1365-2958.1997.4671835.x; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jin JH, 2011, CURR MICROBIOL, V62, P612, DOI 10.1007/s00284-010-9751-x; Kim EK, 2008, BIOCHEM BIOPH RES CO, V369, P1047, DOI 10.1016/j.bbrc.2008.02.139; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Lee YJ, 2009, TETRAHEDRON, V65, P6310, DOI 10.1016/j.tet.2009.06.032; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Masco L, 2005, INT J FOOD MICROBIOL, V102, P221, DOI 10.1016/j.ijfoodmicro.2004.11.018; Matsui R, 2010, FUTURE MICROBIOL, V5, P403, DOI [10.2217/fmb.09.129, 10.2217/FMB.09.129]; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Matuszewska E, 2009, ACTA BIOCHIM POL, V56, P55; Maus JE, 2003, J APPL MICROBIOL, V95, P146, DOI 10.1046/j.1365-2672.2003.01954.x; Moslehi-Jenabian S, 2009, INT J FOOD MICROBIOL, V135, P295, DOI 10.1016/j.ijfoodmicro.2009.08.011; O'May GA, 2005, J CLIN MICROBIOL, V43, P3059, DOI 10.1128/JCM.43.7.3059-3065.2005; Parry-Hanson AA, 2010, MICROBIOL RES, V165, P546, DOI 10.1016/j.micres.2009.11.003; Peng L, 2012, FUTURE MICROBIOL, V7, P411, DOI [10.2217/FMB.12.3, 10.2217/fmb.12.3]; Qian YL, 2011, INT J FOOD MICROBIOL, V145, P320, DOI 10.1016/j.ijfoodmicro.2010.11.026; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Saarela M, 2004, J APPL MICROBIOL, V96, P1205, DOI 10.1111/j.1365-2672.2004.02286.x; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sanchez B, 2007, APPL ENVIRON MICROB, V73, P6450, DOI 10.1128/AEM.00886-07; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Shao HJ, 2010, PERIODONTOL 2000, V52, P53, DOI 10.1111/j.1600-0757.2009.00318.x; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; Thi MHT, 2011, APPL ENVIRON MICROB, V77, P3327, DOI 10.1128/AEM.02518-10; Tonon T, 2000, J APPL MICROBIOL, V89, P526, DOI 10.1046/j.1365-2672.2000.01142.x; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Vandecasteele SJ, 2002, BIOCHEM BIOPH RES CO, V291, P528, DOI 10.1006/bbrc.2002.6465; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; Ventura M, 2005, MICROBIOL-SGM, V151, P2861, DOI 10.1099/mic.0.28176-0; Ventura M, 2004, APPL ENVIRON MICROB, V70, P3110, DOI 10.1128/AEM.70.5.3110-3121.2004; Vercruysse M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r17; Waddington L, 2010, J APPL MICROBIOL, V108, P1408, DOI 10.1111/j.1365-2672.2009.04540.x; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Wu CD, 2012, APPL MICROBIOL BIOT, V93, P707, DOI 10.1007/s00253-011-3757-6; Yang HY, 2009, NUTR RES, V29, P281, DOI 10.1016/j.nutres.2009.03.010; Yang HY, 2009, CURR MICROBIOL, V59, P439, DOI 10.1007/s00284-009-9457-0; Zhang J, 2007, APPL ENVIRON MICROB, V73, P5268, DOI 10.1128/AEM.02787-06; Zhao WM, 2011, BIOINFORMATICS, V27, P3076, DOI 10.1093/bioinformatics/btr504; Zuniga M, 1998, J BACTERIOL, V180, P4154	56	56	59	3	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50777	10.1371/journal.pone.0050777	http://dx.doi.org/10.1371/journal.pone.0050777			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236393	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100034
J	Lim, J; Clements, MA; Dobson, J				Lim, Jenson; Clements, Michael A.; Dobson, Jon			Delivery of Short Interfering Ribonucleic Acid-Complexed Magnetic Nanoparticles in an Oscillating Field Occurs via Caveolae-Mediated Endocytosis	PLOS ONE			English	Article							GENE-TRANSFER; CELL INVASION; ACTIN; INHIBITORS; CHOLESTEROL; DYNAMIN; RNA; INTERNALIZATION; TRANSFECTION; TRAFFICKING	Gene delivery technologies to introduce foreign genes into highly differentiated mammalian cells have improved significantly over the last few decades. Relatively new techniques such as magnetic nanoparticle-based gene transfection technology are showing great promise in terms of its high transfection efficiency and wide-ranging research applications. We have developed a novel gene delivery technique, which uses magnetic nanoparticles moving under the influence of an oscillating magnetic array. Herein we successfully introduced short interfering RNA (siRNA) against green fluorescent protein (GFP) or actin into stably-transfected GFP-HeLa cells or wild-type HeLa and rat aortic smooth muscle cells, respectively. This gene silencing technique occurred in a dose-and cell density-dependent manner, as reflected using fluorescence intensity and adhesion assays. Furthermore, using endocytosis inhibitors, we established that these magnetic nanoparticle-nucleic acid complexes, moving across the cell surface under the influence of an oscillating magnet array, enters into the cells via the caveolae-mediated endocytic pathway.	[Lim, Jenson; Clements, Michael A.] Keele Univ Sci & Business Pk, Med IC4, NanoTher Ltd, Newcastle Under Lyme, Staffs, England; [Lim, Jenson] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Dobson, Jon] Univ Florida, Dept Mat Sci & Engn, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA; [Dobson, Jon] Univ Florida, ICERM, Gainesville, FL 32611 USA; [Dobson, Jon] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England	University of Birmingham; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Keele University	Lim, J (corresponding author), Keele Univ Sci & Business Pk, Med IC4, NanoTher Ltd, Newcastle Under Lyme, Staffs, England.	jenson@nanotherics.com	Dobson, Jon P/C-8323-2009	Dobson, Jon P/0000-0002-8108-5362; Lim, Jenson/0000-0001-7417-356X	nanoTherics Limited	nanoTherics Limited	This research is wholly funded by nanoTherics Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonetta L, 2005, NAT METHODS, V2, P875, DOI 10.1038/nmeth1105-875; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chen Y, 2011, BLOOD, V117, P6392, DOI 10.1182/blood-2010-12-322867; del Pino P, 2010, NANO LETT, V10, P3914, DOI 10.1021/nl102485v; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Ensenauer R, 2011, BIOTECH HISTOCHEM, V86, P226, DOI 10.3109/10520291003675485; Fouriki A, 2012, J TISSUE EN IN PRESS; Govindan S, 2010, BRIT J PHARMACOL, V160, P1953, DOI 10.1111/j.1476-5381.2010.00763.x; Harborth J, 2001, J CELL SCI, V114, P4557; Huth S, 2004, J GENE MED, V6, P923, DOI 10.1002/jgm.577; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jaumouille V, 2011, CURR OPIN CELL BIOL, V23, P22, DOI 10.1016/j.ceb.2010.10.006; Jenkins SI, 2011, ACS NANO, V5, P6527, DOI 10.1021/nn2018717; Kehn-Hall K, 2011, VIROLOGY, V415, P56, DOI 10.1016/j.virol.2011.03.025; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lee S, 2011, NUCLEIC ACID THER, V21, P165, DOI 10.1089/nat.2010.0274; LIAO JF, 1993, MOL PHARMACOL, V44, P364; Lim J, 2012, J GENET, V91, P223, DOI 10.1007/s12041-012-0164-4; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; McBain SC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/40/405102; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nankoe SR, 2006, TRENDS CELL BIOL, V16, P607, DOI 10.1016/j.tcb.2006.10.004; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pickard M, 2010, NANOMEDICINE-UK, V5, P217, DOI [10.2217/nnm.09.109, 10.2217/NNM.09.109]; Pickard MR, 2011, TISSUE ENG PART C-ME, V17, P89, DOI [10.1089/ten.tec.2010.0170, 10.1089/ten.TEC.2010.0170]; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Uriarte SM, 2009, AM J PHYSIOL-CELL PH, V296, pC857, DOI 10.1152/ajpcell.00454.2008; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Visvikis O, 2011, TRAFFIC, V12, P579, DOI 10.1111/j.1600-0854.2011.01174.x; Wattiaux R, 2000, ADV DRUG DELIVER REV, V41, P201, DOI 10.1016/S0169-409X(99)00066-6	35	14	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51350	10.1371/journal.pone.0051350	http://dx.doi.org/10.1371/journal.pone.0051350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236481	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000312064100102
J	McGinley, MP; Aschaffenburg, MD; Pettay, DT; Smith, RT; LaJeunesse, TC; Warner, ME				McGinley, Michael P.; Aschaffenburg, Matthew D.; Pettay, Daniel T.; Smith, Robin T.; LaJeunesse, Todd C.; Warner, Mark E.			Transcriptional Response of Two Core Photosystem Genes in Symbiodinium spp. Exposed to Thermal Stress	PLOS ONE			English	Article							REEF CORALS; CHLOROPLAST TRANSCRIPTS; OXIDATIVE STRESS; CLIMATE-CHANGE; HEAT-STRESS; PHOTOINHIBITION; EXPRESSION; PHOTOSYNTHESIS; DAMAGE; TEMPERATURE	Mutualistic symbioses between scleractinian corals and endosymbiotic dinoflagellates (Symbiodinium spp.) are the foundation of coral reef ecosystems. For many coral-algal symbioses, prolonged episodes of thermal stress damage the symbiont's photosynthetic capability, resulting in its expulsion from the host. Despite the link between photosynthetic competency and symbiont expulsion, little is known about the effect of thermal stress on the expression of photosystem genes in Symbiodinium. This study used real-time PCR to monitor the transcript abundance of two important photosynthetic reaction center genes, psbA (encoding the D1 protein of photosystem II) and psaA (encoding the P-700 protein of photosystem I), in four cultured isolates (representing ITS2-types A13, A20, B1, and F2) and two in hospite Symbiodinium spp. within the coral Pocillopora spp. (ITS2-types C1b-c and D1). Both cultured and in hospite Symbiodinium samples were exposed to elevated temperatures (32 degrees C) over a 7-day period and examined for changes in photochemistry and transcript abundance. Symbiodinium A13 and C1b-c (both thermally sensitive) demonstrated significant declines in both psbA and psaA during the thermal stress treatment, whereas the transcript levels of the other Symbiodinium types remained stable. The downregulation of both core photosystem genes could be the result of several different physiological mechanisms, but may ultimately limit repair rates of photosynthetic proteins, rendering some Symbiodinium spp. especially susceptible to thermal stress.	[McGinley, Michael P.; Aschaffenburg, Matthew D.; Pettay, Daniel T.; Warner, Mark E.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA; [Smith, Robin T.] Florida Int Univ, Dept Biol, Miami, FL 33199 USA; [LaJeunesse, Todd C.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Delaware; State University System of Florida; Florida International University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Warner, ME (corresponding author), Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA.	mwarner@udel.edu	Warner, Mark E/J-6241-2013; LaJeunesse, Todd/B-1720-2009	LaJeunesse, Todd/0000-0001-7607-9358; Warner, Mark/0000-0003-1015-9413	National Science Foundation [IOB 544765, OCE 0825413, IOB 544854]; Directorate For Geosciences [0825413] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by funding from the National Science Foundation (IOB 544765 and OCE 0825413 to MEW and IOB 544854 to TCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles MD, 1967, THESIS, P158; Ambarsari I, 1997, MAR ECOL PROG SER, V159, P303, DOI 10.3354/meps159303; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; BAKER NR, 1991, PHYSIOL PLANTARUM, V81, P563, DOI 10.1111/j.1399-3054.1991.tb05101.x; Bellantuono AJ, 2012, P ROY SOC B-BIOL SCI, V279, P1100, DOI 10.1098/rspb.2011.1780; Bernhardt K, 1999, BBA-BIOENERGETICS, V1409, P125, DOI 10.1016/S0005-2728(98)00149-2; Boldt L., 2009, P 11 ICRS, P118; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 1999, CORAL REEFS, V18, P99; Buxton L, 2012, J PHYCOL, V48, P117, DOI 10.1111/j.1529-8817.2011.01099.x; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Dang Y, 2009, THESIS U BRIT COLUMB, P121; Dang YK, 2010, J BIOL CHEM, V285, P5196, DOI 10.1074/jbc.M109.058545; Diaz-Almeyda E, 2011, CORAL REEFS, V30, P217, DOI 10.1007/s00338-010-0691-5; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAVAUX M, 1991, Z NATURFORSCH C, V46, P1038; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hennige SJ, 2011, MAR BIOL, V158, P2515, DOI 10.1007/s00227-011-1752-1; Hill R, 2011, LIMNOL OCEANOGR, V56, P139, DOI 10.4319/lo.2011.56.1.0139; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoogenboom MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030167; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Ivanov AG, 2012, BIOCHIM BIOPHYS ACTA, V1877, P1374; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; KUSNETSOV VV, 1993, FEBS LETT, V321, P189, DOI 10.1016/0014-5793(93)80105-4; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Leggat W, 2004, SYMBIOSIS, V37, P137; Leggat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026687; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; Muscatine L., 1990, P75; Okamoto OK, 2003, GENE, V321, P73, DOI 10.1016/j.gene.2003.07.003; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Okamoto OK, 2001, J BIOL CHEM, V276, P19989, DOI 10.1074/jbc.M101169200; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; PORTER JW, 1982, P NATL ACAD SCI-BIOL, V79, P1678, DOI 10.1073/pnas.79.5.1678; Ragni M, 2010, MAR ECOL PROG SER, V406, P57, DOI 10.3354/meps08571; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Rosic NN, 2011, CELL STRESS CHAPERON, V16, P69, DOI 10.1007/s12192-010-0222-x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Singh AK, 2001, PHOTOSYNTHETICA, V39, P353, DOI 10.1023/A:1015122124866; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; THOMAS EJ, 1995, PLANT MOL BIOL, V27, P317, DOI 10.1007/BF00020186; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjus SE, 1999, PHOTOSYNTH RES, V60, P75, DOI 10.1023/A:1006283618695; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warner ME, 2006, J EXP MAR BIOL ECOL, V339, P86, DOI 10.1016/j.jembe.2006.07.011; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Warner ME, 1996, PLANT CELL ENVIRON, V19, P291, DOI 10.1111/j.1365-3040.1996.tb00251.x	77	37	38	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50439	10.1371/journal.pone.0050439	http://dx.doi.org/10.1371/journal.pone.0050439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236373	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100016
J	Schneeweis, C; Schnackenburg, B; Stuber, M; Berger, A; Schneider, U; Yu, J; Gebker, R; Weiss, RG; Fleck, E; Kelle, S				Schneeweis, Christopher; Schnackenburg, Bernhard; Stuber, Matthias; Berger, Alexander; Schneider, Udo; Yu, Jing; Gebker, Rolf; Weiss, Robert G.; Fleck, Eckart; Kelle, Sebastian			Delayed Contrast-Enhanced MRI of the Coronary Artery Wall in Takayasu Arteritis	PLOS ONE			English	Article							NATURAL-HISTORY; DIAGNOSIS; DISEASE; CLASSIFICATION; INVOLVEMENT; MECHANISMS; CRITERIA	Background: Takayasu arteritis (TA) is a rare form of chronic inflammatory granulomatous arteritis of the aorta and its major branches. Late gadolinium enhancement (LGE) with magnetic resonance imaging (MRI) has demonstrated its value for the detection of vessel wall alterations in TA. The aim of this study was to assess LGE of the coronary artery wall in patients with TA compared to patients with stable CAD. Methods: We enrolled 9 patients (8 female, average age 46 +/- 13 years) with proven TA. In the CAD group 9 patients participated (8 male, average age 65 +/- 10 years). Studies were performed on a commercial 3T whole-body MR imaging system (Achieva; Philips, Best, The Netherlands) using a 3D inversion prepared navigator gated spoiled gradient-echo sequence, which was repeated 34-45 minutes after low-dose gadolinium administration. Results: No coronary vessel wall enhancement was observed prior to contrast in either group. Post contrast, coronary LGE on IR scans was detected in 28 of 50 segments (56%) seen on T2-Prep scans in TA and in 25 of 57 segments (44%) in CAD patients. LGE quantitative assessment of coronary artery vessel wall CNR post contrast revealed no significant differences between the two groups (CNR in TA: 6.0 +/- 2.4 and 7.3 +/- 2.5 in CAD; p = 0.474). Conclusion: Our findings suggest that LGE of the coronary artery wall seems to be common in patients with TA and similarly pronounced as in CAD patients. The observed coronary LGE seems to be rather unspecific, and differentiation between coronary vessel wall fibrosis and inflammation still remains unclear.	[Schneeweis, Christopher; Berger, Alexander; Gebker, Rolf; Fleck, Eckart; Kelle, Sebastian] Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany; [Schnackenburg, Bernhard] Philips Hlth Care, Hamburg, Germany; [Stuber, Matthias; Yu, Jing; Weiss, Robert G.] Johns Hopkins Univ, Dept Radiol, Div Magnet Resonance Res, Baltimore, MD USA; [Stuber, Matthias] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Stuber, Matthias] CHU Vaudois, Dept Radiol, Ctr Biomed Imaging CIBM, Lausanne, Switzerland; [Stuber, Matthias] Univ Lausanne, Lausanne, Switzerland; [Schneider, Udo] Charite, Dept Rheumatol, D-13353 Berlin, Germany; [Weiss, Robert G.] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD USA	German Heart Center Berlin; Philips; Philips Healthcare; Johns Hopkins University; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johns Hopkins University	Kelle, S (corresponding author), Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany.	kelle@dhzb.de	Kelle, Sebastian/ABH-7348-2020; Stuber, Matthias/B-2949-2010	Stuber, Matthias/0000-0001-9843-2028; Kelle, Sebastian/0000-0001-8105-6599	National Institutes of Health/National Heart, Lung, and Blood Institute [RO1HL084186, ARRA 3R01Hl084186 04S1]; Philips GmbH Healthcare, Clinical Science Hamburg, Germany; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084186] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Philips GmbH Healthcare, Clinical Science Hamburg, Germany; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health/National Heart, Lung, and Blood Institute research grants RO1HL084186 and ARRA 3R01Hl084186 04S1 and Philips GmbH Healthcare, Clinical Science Hamburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Choe YH, 1998, INT J CARDIOL, V66, pS175; CIPRIANO PR, 1977, AM J CARDIOL, V39, P744, DOI 10.1016/S0002-9149(77)80139-2; Desai MY, 2005, AM J ROENTGENOL, V184, P1427, DOI 10.2214/ajr.184.5.01841427; Fischer SE, 1999, MAGN RESON MED, V42, P361, DOI 10.1002/(SICI)1522-2594(199908)42:2<361::AID-MRM18>3.0.CO;2-9; Flamm SD, 1998, INT J CARDIOL, V66, pS151, DOI 10.1016/S0167-5273(98)00163-6; Gerretsen SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012998; Goldschmidt-Clermont PJ, 2005, CIRCULATION, V112, P3348, DOI 10.1161/CIRCULATIONAHA.105.577460; Hamdan A, 2011, JACC-CARDIOVASC IMAG, V4, P50, DOI 10.1016/j.jcmg.2010.10.007; Hoffman GS, 1998, INT J CARDIOL, V66, pS191, DOI 10.1016/S0167-5273(98)00181-8; Ibrahim T, 2009, JACC-CARDIOVASC IMAG, V2, P580, DOI 10.1016/j.jcmg.2008.12.029; ISHIKAWA K, 1978, CIRCULATION, V57, P27, DOI 10.1161/01.CIR.57.1.27; Kelle S, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/856418; Kelle S, 2009, MAGN RESON IMAGING C, V17, P145, DOI 10.1016/j.mric.2008.12.003; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Maintz D, 2006, EUR HEART J, V27, P1732, DOI 10.1093/eurheartj/ehl102; Makowski MR, 2011, NAT MED, V17, P383, DOI 10.1038/nm.2310; Matsubara O, 1992, Heart Vessels Suppl, V7, P26, DOI 10.1007/BF01744540; Nagata S, 1990, MYAKKANGAKU, V30, P1303; Park MC, 2005, SCAND J RHEUMATOL, V34, P284, DOI 10.1080/03009740510026526; Rav-Acha M, 2007, AUTOIMMUN REV, V6, P566, DOI 10.1016/j.autrev.2007.04.001; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saadoun D, 2012, CIRCULATION; Schneeweis C, 2009, KARDIOLOGE, V3, P47, DOI 10.1007/s12181-008-0132-7; SUBRAMANYAN R, 1989, CIRCULATION, V80, P429, DOI 10.1161/01.CIR.80.3.429; Tacke CE, 2011, CIRC CARDIOVASC IMAG; TALWAR KK, 1988, INT J CARDIOL, V21, P323, DOI 10.1016/0167-5273(88)90109-X; Tso E, 2002, ARTHRITIS RHEUM-US, V46, P1634, DOI 10.1002/art.10251; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Yamada I, 2000, JMRI-J MAGN RESON IM, V11, P481, DOI 10.1002/(SICI)1522-2586(200005)11:5<481::AID-JMRI3>3.0.CO;2-4; Yeon SB, 2007, J AM COLL CARDIOL, V50, P441, DOI 10.1016/j.jacc.2007.03.052; Yu J, 2009, MAGN RESON MED, V62, P1211, DOI 10.1002/mrm.22114	32	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50655	10.1371/journal.pone.0050655	http://dx.doi.org/10.1371/journal.pone.0050655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236382	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100024
J	Shea, FF; Rowell, JL; Li, YCW; Chang, TH; Alvarez, CE				Shea, Fortune F.; Rowell, Jennie L.; Li, Yechaowei; Chang, Tien-Hsien; Alvarez, Carlos E.			Mammalian Alpha Arrestins Link Activated Seven Transmembrane Receptors to Nedd4 Family E3 Ubiquitin Ligases and Interact with Beta Arrestins	PLOS ONE			English	Article							MEDIATE UBIQUITINATION; PROTEIN; THIOREDOXIN; TRAFFICKING; BINDING; CANCER; TXNIP; ADIPOGENESIS; ENDOCYTOSIS; GENE	The complement of fungal cell surface proteins is widely regulated by ubiquitination of membrane proteins, which results in their endocytosis and vacuolar degradation. For diverse fungal transporters, the specificity of ubiquitination is conferred by alpha arrestin adaptors, which recruit the Nedd4 family E3 ubiquitin ligase Rsp5. A recent study showed that one mammalian alpha arrestin also mediates ubiquitination and lysosomal trafficking of an activated plasma membrane receptor. Here we first screen all five widely-expressed human alpha arrestins for subcellular localization in ligand-stimulated and -unstimulated cells overexpressing the seven transmembrane receptor vasopressin 2. We then characterize the effects of alpha arrestins ARRDC3 and ARRDC4 upon activation of the seven transmembrane receptors vasopressin 2 and beta adrenergic 2. Using biochemical and imaging approaches, we show that ligand-activated receptors interact with alpha arrestins, and this results in recruitment of Nedd4 family E3 ubiquitin ligases and receptor ubiquitination - which are known to result in lysosomal trafficking. Our time course studies show these effects occur in the first 1-5 minutes after ligand activation, the same time that beta arrestins are known to have roles in receptor endocytic trafficking and kinase signaling. We tested the possibility that alpha and beta arrestins function coordinately and found co-immunoprecipitation and colocalization evidence to support this. Others recently reported that Arrdc3 knockout mice are lean and resistant to obesity. In the course of breeding our own Arrdc3-deficient mice, we observed two novel phenotypes in homozygotes: skin abnormalities, and embryonic lethality on normal chow diet, but not on high fat diet. Our findings suggest that alpha and beta arrestins function coordinately to maintain the optimal complement and function of cell surface proteins according to cellular physiological context and external signals. We discuss the implications of the alpha arrestin functions in fungi having evolved into coordinated alpha/beta arrestin functions in animals.	[Shea, Fortune F.; Rowell, Jennie L.; Li, Yechaowei; Alvarez, Carlos E.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Rowell, Jennie L.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Chang, Tien-Hsien] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Alvarez, Carlos E.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Alvarez, Carlos E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Academia Sinica - Taiwan; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Alvarez, CE (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA.	alvarez.73@osu.edu			Research Institute at Nationwide Children's Hospital	Research Institute at Nationwide Children's Hospital(Ohio State University)	This work was supported by faculty start-up and bridge funds from The Research Institute at Nationwide Children's Hospital (to CEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Andoh T, 2002, FEBS LETT, V525, P131, DOI 10.1016/S0014-5793(02)03104-6; Becuwe M, 2012, J CELL BIOL; Becuwe M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/242764; Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Boase NA, 2004, MOL MICROBIOL, V53, P929, DOI 10.1111/j.1365-2958.2004.04172.x; Chutkow WA, 2011, J BIOL CHEM, V286, P29139, DOI 10.1074/jbc.M111.267666; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; DeFea Kathryn Anne, 2008, Biochem J, V413, pe1, DOI 10.1042/BJ20081009; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Draheim KM, 2010, THESIS U MASSACHUSET; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hislop JN, 2010, TRAFFIC; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang CN, 2011, ANN ONCOL; Jee C, 2012, J MOL BIOL, V417, P165, DOI 10.1016/j.jmb.2012.01.012; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Kulman JD, 2007, P NATL ACAD SCI USA, V104, P8767, DOI 10.1073/pnas.0703195104; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Masutani H, 2012, J CLIN BIOCHEM NUTR, V50, P23, DOI 10.3164/jcbn.11-36SR; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nichols CD, 2004, J NEUROCHEM, V90, P576, DOI 10.1111/j.1471-4159.2004.02515.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Patwari P, 2012, TRENDS ENDOCRIN MET, V23, P216, DOI 10.1016/j.tem.2012.03.003; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Peterson CW, 2012, FRONT BIOSCI, V17, P2206; Polo S, 2008, CELL, V135, P590, DOI 10.1016/j.cell.2008.10.032; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321; Zhou JBA, 2011, INT J BIOCHEM CELL B, V43, P1668, DOI 10.1016/j.biocel.2011.09.005; Zhuang LN, 2011, J BIOL CHEM, V286, P28403, DOI 10.1074/jbc.M111.256099; Zhuang LN, 2011, J BIOL CHEM, V286, P28396, DOI 10.1074/jbc.M111.223206	62	44	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50557	10.1371/journal.pone.0050557	http://dx.doi.org/10.1371/journal.pone.0050557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236378	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100020
J	Strauss, S; Dudziak, S; Hagemann, R; Barcikowski, S; Fliess, M; Israelowitz, M; Kracht, D; Kuhbier, JW; Radtke, C; Reimers, K; Vogt, PM				Strauss, Sarah; Dudziak, Sonja; Hagemann, Ronny; Barcikowski, Stephan; Fliess, Malte; Israelowitz, Meir; Kracht, Dietmar; Kuhbier, Joern W.; Radtke, Christine; Reimers, Kerstin; Vogt, Peter M.			Induction of Osteogenic Differentiation of Adipose Derived Stem Cells by Microstructured Nitinol Actuator-Mediated Mechanical Stress	PLOS ONE			English	Article							HUMAN BONE-MARROW; SHAPE-MEMORY; TISSUE; NICKEL; VASCULARIZATION; FABRICATION; INGROWTH; FRACTURE; FATIGUE; GROWTH	The development of large tissue engineered bone remains a challenge in vitro, therefore the use of hybrid-implants might offer a bridge between tissue engineering and dense metal or ceramic implants. Especially the combination of the pseudoelastic implant material Nitinol (NiTi) with adipose derived stem cells (ASCs) opens new opportunities, as ASCs are able to differentiate osteogenically and therefore enhance osseointegration of implants. Due to limited knowledge about the effects of NiTi-structures manufactured by selective laser melting (SLM) on ASCs the study started with an evaluation of cytocompatibility followed by the investigation of the use of SLM-generated 3-dimensional NiTi-structures preseeded with ASCs as osteoimplant model. In this study we could demonstrate for the first time that osteogenic differentiation of ASCs can be induced by implant-mediated mechanical stimulation without support of osteogenic cell culture media. By use of an innovative implant design and synthesis via SLM-technique we achieved high rates of vital cells, proper osteogenic differentiation and mechanically loadable NiTi-scaffolds could be achieved.	[Strauss, Sarah; Fliess, Malte; Kuhbier, Joern W.; Radtke, Christine; Reimers, Kerstin; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; [Dudziak, Sonja; Hagemann, Ronny; Barcikowski, Stephan; Kracht, Dietmar] Laser Zentrum Hannover eV, Hannover, Germany; [Barcikowski, Stephan] Univ Duisburg Essen, Ctr Nanointegrat, Essen, Germany; [Israelowitz, Meir] Biomimet Technol Inc, Toronto, ON, Canada	Hannover Medical School; University of Duisburg Essen	Strauss, S (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.	strauss.sarah@mh-hannover.de	Vogt, Peter M./AAL-1332-2020; Barcikowski, Stephan/I-4754-2012; Radtke, Christine/M-2927-2013; Radtke, Christine/B-8491-2018	Barcikowski, Stephan/0000-0002-9739-7272; Radtke, Christine/0000-0001-6877-5038; Israelowitz, Meir/0000-0003-3745-7955; Kracht, Dietmar/0000-0003-3473-4814	German Research Foundation within the Collaborative Research Centre [TransRegio 37]	German Research Foundation within the Collaborative Research Centre	German Research Foundation funded this work within the Collaborative Research Centre TransRegio 37 "Micro- and Nanosystems in Medicine - Reconstruction of biologic Functions". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad M, 2003, J BIOMED MATER RES B, V64B, P107, DOI 10.1002/jbm.b.10530; Barcikowski S, 2010, J NANOPART RES, V12, P1733, DOI 10.1007/s11051-009-9834-4; Blackwood DJ, 2003, CORROS REV, V21, P97; BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79; Bram M, 2002, MAT SCI ENG A-STRUCT, V337, P254, DOI 10.1016/S0921-5093(02)00028-X; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Council of the European Communities, 2008, OFF J EUR COMMUN, VL337, P41; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Dudziak S, 2010, PHYSCS PROC, V5, P607, DOI 10.1016/j.phpro.2010.08.088; Dudziak S, 2012, BERICHTE LZH; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; Habijan T, 2009, IFMBE PROC, V22, P2165; Habijan T, 2011, ACTA BIOMATER, V7, P2733, DOI 10.1016/j.actbio.2011.02.022; Habijan T, 2009, THESIS RUHR U BOCHUM; Hahn A, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-011-0686-3; Heintz C, 2001, J ENDOVASC THER, V8, P248, DOI 10.1583/1545-1550(2001)008<0248:CNWIEA>2.0.CO;2; Hollander D, 2003, EUR J TRAUMA, V29, P228; Jeswani S, 2011, J NEUROINTERV SURG, V3, P2, DOI 10.1136/jnis.2010.003657; Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193; Kaveh K, 2011, J ANIM VET ADV, V10, P2317, DOI 10.3923/javaa.2011.2317.2330; Kloos K.-H., 2007, SCHRAUBENVERBINDUNGE; Kohl M, 2009, ADV ENG MATER, V11, P959, DOI 10.1002/adem.200900168; Kuhbier JW, 2010, CHIRURG, V81, P826, DOI 10.1007/s00104-010-1962-y; Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4; Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y; Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012; McKelvey AL, 2001, METALL MATER TRANS A, V32, P731, DOI 10.1007/s11661-001-1008-7; Mischen BT, 2008, PLAST RECONSTR SURG, V122, P725, DOI 10.1097/PRS.0b013e318180ec9f; Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326; Nikanorov A, 2008, J VASC SURG, V48, P435, DOI 10.1016/j.jvs.2008.02.029; Papavasiliou G, 2010, J INVEST MED, V58, P838, DOI 10.231/JIM.0b013e3181f18e38; Peng B, 2005, INT ENDOD J, V38, P550, DOI 10.1111/j.1365-2591.2005.00991.x; Pfeiffer R, 2010, J MAT PROCESS TECH; Pu LLQ, 2012, J PLAST RECONSTR AES, V65, P413, DOI 10.1016/j.bjps.2011.09.033; Robertson SW, 2012, INT MATER REV, V57, P1, DOI 10.1179/1743280411Y.0000000009; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267; Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745; Tjabringa GS, 2006, STEM CELLS, V24, P2262, DOI 10.1634/stemcells.2005-0625; Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032; van Griensven M, 2009, ADV BIOCHEM ENG BIOT, V112, P95, DOI [10.1007/10_2008_14, 10.1007/978-3-540-69357-4_5]; Verein Deutscher Ingeneure, 2003, 2230 VDI GES ENTW KO; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	48	23	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51264	10.1371/journal.pone.0051264	http://dx.doi.org/10.1371/journal.pone.0051264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236461	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100086
J	Treutlein, G; Dorsch, R; Euler, KN; Hauck, SM; Amann, B; Hartmann, K; Deeg, CA				Treutlein, Gudrun; Dorsch, Roswitha; Euler, Kerstin N.; Hauck, Stefanie M.; Amann, Barbara; Hartmann, Katrin; Deeg, Cornelia A.			Novel Potential Interacting Partners of Fibronectin in Spontaneous Animal Model of Interstitial Cystitis	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; IDIOPATHIC CYSTITIS; GENE-EXPRESSION; GROWTH-FACTORS; KAPPA-B; THIOREDOXIN; CELLS; CATS; COMPLEMENT; URINE	Feline idiopathic cystitis (FIC) is the only spontaneous animal model for human interstitial cystitis (IC), as both possess a distinctive chronical and relapsing character. Underlying pathomechanisms of both diseases are not clearly established yet. We recently detected increased urine fibronectin levels in FIC cases. The purpose of this study was to gain further insight into the pathogenesis by assessing interacting partners of fibronectin in urine of FIC affected cats. Several candidate proteins were identified via immunoprecipitation and mass spectrometry. Considerable changes in FIC conditions compared to physiological expression of co-purified proteins were detected by Western blot and immunohistochemistry. Compared to controls, complement C4a and thioredoxin were present in higher levels in urine of FIC patients whereas loss of signal intensity was detected in FIC affected tissue. Galectin-7 was exclusively detected in urine of FIC cats, pointing to an important role of this molecule in FIC pathogenesis. Moderate physiological signal intensity of galectin-7 in transitional epithelium shifted to distinct expression in transitional epithelium under pathophysiological conditions. I-FABP expression was reduced in urine and urinary bladder tissue of FIC cats. Additionally, transduction molecules of thioredoxin, NF-kappa B p65 and p38 MAPK, were examined. In FIC affected tissue, colocalization of thioredoxin and NF-kB p65 could be demonstrated compared to absent coexpression of thioredoxin and p38 MAPK. These considerable changes in expression level and pattern point to an important role for co-purified proteins of fibronectin and thioredoxin-regulated signal transduction pathways in FIC pathogenesis. These results could provide a promising starting point for novel therapeutic approaches in the future.	[Euler, Kerstin N.; Amann, Barbara; Deeg, Cornelia A.] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Treutlein, Gudrun; Dorsch, Roswitha; Hartmann, Katrin] Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Clin Small Anim Med, Munich, Germany; [Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Deeg, CA (corresponding author), Ludwig Maximilians Univ Munchen, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	deeg@tiph.vetmed.uni-muenchen.de	Deeg, Cornelia/U-4216-2019; Hauck, Stefanie/B-3300-2013; Deeg, Cornelia A/G-4940-2010	Hauck, Stefanie/0000-0002-1630-6827; Deeg, Cornelia A/0000-0003-0375-3190; Dorsch, Roswitha/0000-0002-7508-5411; Hartmann, Katrin/0000-0002-5256-863X	Deutsche Forschungsgemeinschaft (DFG) [SFB 571 A5 Deeg]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB 571 A5 Deeg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mageed AB, 2003, UROL RES, V31, P300, DOI 10.1007/s00240-003-0339-9; Abdel-Mageed AB, 1998, J UROLOGY, V160, P2000, DOI 10.1016/S0022-5347(01)62224-9; Bjorling DE, 2011, NEUROUROL URODYNAM, V30, P673, DOI 10.1002/nau.21078; Buffington CAT, 2011, J VET INTERN MED, V25, P784, DOI 10.1111/j.1939-1676.2011.0732.x; Buffington CAT, 1999, J AM VET MED ASSOC, V215, P682; Cao ZY, 2003, ARCH OPHTHALMOL-CHIC, V121, P82; Clemens JQ, 2007, J UROLOGY, V177, P1390, DOI 10.1016/j.juro.2006.11.084; Dasgupta J, 2009, MATURITAS, V64, P212, DOI 10.1016/j.maturitas.2009.09.016; Dvorankova B, 2011, CELLS TISSUES ORGANS, V194, P469, DOI 10.1159/000324864; GOLLIN G, 1993, SURGERY, V113, P545; Gorreta F, 2005, CANCER BIOL THER, V4, P1079, DOI 10.4161/cbt.4.10.1987; Gunn-Moore DA, 2003, J FELINE MED SURG, V5, P133, DOI 10.1016/S1098-612X(02)00129-8; HALLDEN G, 1994, AM J PHYSIOL-GASTR L, V267, pG730, DOI 10.1152/ajpgi.1994.267.4.G730; Hanno P, 2009, NEUROUROL URODYNAM, V28, P274, DOI 10.1002/nau.20687; Hashimoto S, 1999, BIOCHEM BIOPH RES CO, V258, P443, DOI 10.1006/bbrc.1999.0658; HELIN H, 1987, CLIN IMMUNOL IMMUNOP, V43, P88, DOI 10.1016/0090-1229(87)90160-7; Ho CL, 2008, J UROLOGY, V179, P1155, DOI 10.1016/j.juro.2007.10.026; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; HORI K, 1994, BRAIN RES, V652, P304, DOI 10.1016/0006-8993(94)90241-0; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; HUGLI TE, 1984, SPRINGER SEMIN IMMUN, V7, P193; Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Keay S, 1997, J UROLOGY, V158, P1983, DOI 10.1016/S0022-5347(01)64198-3; Kim HJ, 2005, J KOREAN MED SCI, V20, P1000, DOI 10.3346/jkms.2005.20.6.1000; Klima J, 2009, PHYSIOL RES, V58, P873, DOI 10.33549/physiolres.931624; Kruger JM, 2009, VET CLIN N AM-SMALL, V39, P15, DOI 10.1016/j.cvsm.2008.09.008; Kumar B, 2009, INT J ONCOL, V34, P1557, DOI 10.3892/ijo_00000285; Larson J, 2011, J VET INTERN MED, V25, P199, DOI 10.1111/j.1939-1676.2011.0685.x; Lavelle JP, 2000, AM J PHYSIOL-RENAL, V278, pF540, DOI 10.1152/ajprenal.2000.278.4.F540; Lemberger SIK, 2011, AM J VET RES, V72, P1407, DOI 10.2460/ajvr.72.10.1407; Lemberger SIK, 2011, BJU INT, V107, P670, DOI 10.1111/j.1464-410X.2010.09500.x; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; MATTILA J, 1983, EUR UROL, V9, P350; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Nordling J, 2011, WORLD J UROL; Ogawa T, 2010, J UROLOGY, V183, P1206, DOI 10.1016/j.juro.2009.11.007; Palma TF, 2011, ACTAS UROL ESP, V35, P253, DOI [10.1016/j.acuro.2010.05.018, 10.1016/j.acuroe.2011.06.006]; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Rondanino C, 2011, AM J PHYSIOL-RENAL, V301, pF622, DOI 10.1152/ajprenal.00134.2011; Saban R, 2008, AM J PHYSIOL-RENAL, V295, pF1613, DOI 10.1152/ajprenal.90344.2008; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saussez S, 2006, CELL MOL LIFE SCI, V63, P686, DOI 10.1007/s00018-005-5458-8; SCHULTZ G, 1994, EYE, V8, P184, DOI 10.1038/eye.1994.43; STEINERT BW, 1994, J UROLOGY, V151, P350, DOI 10.1016/S0022-5347(17)34946-7; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; Westropp JL, 2002, J UROLOGY, V167, P694, DOI 10.1016/S0022-5347(01)69129-8; Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143; ZHANG K, 1994, AM J PATHOL, V145, P114; Zhou W, 2011, IMMUNOBIOLOGY	50	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51391	10.1371/journal.pone.0051391	http://dx.doi.org/10.1371/journal.pone.0051391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236492	gold, Green Published, Green Submitted			2022-12-25	WOS:000312064100111
J	Bedouch, P; Marra, CA; FitzGerald, JM; Lynd, LD; Sadatsafavi, M				Bedouch, Pierrick; Marra, Carlo A.; FitzGerald, J. Mark; Lynd, Larry D.; Sadatsafavi, Mohsen			Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study	PLOS ONE			English	Article							GLOBAL BURDEN; MANAGED-CARE; PREVALENCE; GUIDELINES; CHILDREN; VISITS; ADULTS	Background: Asthma-related health resource use and costs may be influenced by increasing asthma prevalence, changes to asthma management guidelines, and new medications over the last decade. The objective of this work was to analyze direct asthma-related medical costs, and trends in total and per-patient costs of hospitalizations, physician visits, and medications. Methods: A cohort of asthma patients from British Columbia (BC), Canada, was created. Asthma patients were identified using a validated case definition. Costs for hospitalizations, physician visits, and medications were calculated from billing records (in 2008 Canadian dollars). Trends in total and per-patient costs over the study period were analyzed using Generalized Linear Models. Results: 398,235 patients satisfied the asthma case definition (mid-point prevalence 8.0%). Patients consumed $315.9 million (M) in direct asthma-related health resources between 2002 and 2007. Hospitalizations, physician visits, and medication costs accounted for 16.0%, 15.7% and 68.2% of total costs, respectively. Cost of asthma increased from $49.4 M in 2002 to $54.7 M in 2007. Total annual costs attributable to hospitalizations and physician visits decreased (-39.8% and -25.5%, respectively; p<0.001), while medication costs increased (+38.7%; p<0.001). Interpretation: This population-based analysis shows that the total direct cost of asthma in BC has increased since 2002, mainly due to a rise in asthma prevalence and cost of medication. Combination therapy with inhaled corticosteroids/long-acting beta-agonists has become a significant component of the cost of asthma. Although billing records capture only a fraction of the true burden of asthma, the simultaneous increase in medication costs and reductions in hospitalization and physician visit costs provides valuable insight for policy makers into the shifts in asthma-related resource use.	[Bedouch, Pierrick; Marra, Carlo A.; Lynd, Larry D.; Sadatsafavi, Mohsen] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada; [FitzGerald, J. Mark; Sadatsafavi, Mohsen] Vancouver Coastal Hlth Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [FitzGerald, J. Mark; Sadatsafavi, Mohsen] Univ British Columbia, Fac Med, Div Resp Med, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia	Lynd, LD (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada.	larry.lynd@ubc.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Marra, Carlo/AAE-4904-2021; Bedouch, Pierrick/M-6169-2014	Sadatsafayi, Mohsen/0000-0002-0419-7862; Marra, Carlo/0000-0002-2625-2121; Bedouch, Pierrick/0000-0003-2245-0160; Lynd, Larry/0000-0002-7622-3919	AllerGen National Center of Excellence; Canada Research Chair in Pharmaceutical Outcomes; AllerGen-NCE grant; Sanofi-Aventis France; Grenoble University Hospital; CIHR fellowship award; Grenoble University Hospital, France; Canadian Institutes of Health Research fellowship award	AllerGen National Center of Excellence; Canada Research Chair in Pharmaceutical Outcomes(Canada Research Chairs); AllerGen-NCE grant; Sanofi-Aventis France(Sanofi-Aventis); Grenoble University Hospital; CIHR fellowship award(Canadian Institutes of Health Research (CIHR)); Grenoble University Hospital, France; Canadian Institutes of Health Research fellowship award(Canadian Institutes of Health Research (CIHR))	This study is part of the project "Platform for Outcomes Research and Translation in Asthma and Allergy (PORTAL)'' funded by AllerGen National Center of Excellence. Dr. Lynd is a Michael Smith Foundation for Health Research (MSFHR) Scholar and Canadian Institutes of Health Research (CIHR) New Investigator. Dr. Marra is funded by a Canada Research Chair in Pharmaceutical Outcomes. Dr. Bedouch is a Postdoctoral Fellow funded by an AllerGen-NCE grant, unrestricted grants from Sanofi-Aventis France and the Grenoble University Hospital, France. Dr. Sadatsafavi is a PhD candidate funded by a CIHR fellowship award. None of the sponsors played a role in the study design, data analysis, interpretation or publication of the results.; The content of this article is the sole responsibility of the authors. Dr. FitzGerald has served on advisory boards for GlaxoSmithKline, AstraZeneca, Novartis, Pfizer, Boehringer-Ingelheim, Altana, Merck and Topigen. He has also been a member of speakers' bureaus for Glaxo-SmithKline, AstraZeneca, Boehringer-Ingelheim, Pfizer and Merck. He has received research funding paid directly to the University of British Columbia from the Canadian Institutes of Health Research, AstraZeneca, Glaxo-SmithKline, Boehringer-Ingelheim, Merck, Wyeth, Schering, Genentech and Topigen. Dr. FitzGerald is a member of the Global Initiative for Asthma (GINA) and is chair of the GINA Science Committee. Dr. Bedouch has received financial support for research activities from drug companies including Actelion, Bioprojet, Glaxo-SmithKline. He has had access to unrestricted grants from Sanofi-Aventis France and the Grenoble University Hospital, France. He has also received fees from Actelion for participation in scientific advisory board. Dr. Sadatsafavi was funded by a Canadian Institutes of Health Research fellowship award. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Anis AH, 2001, CAN MED ASSOC J, V164, P625; [Anonymous], 2008, LATEST RELEASE CONSU; Armstrong EP, 2001, DIS MANAG HEALTH OUT, V9, P161, DOI 10.2165/00115677-200109030-00004; Awadh Behbehani N, 1999, Can Respir J, V6, P521; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; BC Ministry of Health (n.d.) Population Data BC, POP DAT BC; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Boulet LP, 1999, CAN MED ASSOC J, V161, pS1; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Canadian Institute for Health Information (CIHI) (n.d.) Canadian MIS Database Hospital Financial Performance Indicators, 2008, CAN MIS DAT HOSP FIN; Chu C, 1994, Healthc Manage Forum, V7, P24; Finlayson G, 1999, HOSP CASE MIX COSTIN; Firoozi F, 2007, THORAX, V62, P581, DOI 10.1136/thx.2006.061572; FitzGerald J Mark, 2006, Can Respir J, V13, P253; Gendo K, 2003, ANN ALLERG ASTHMA IM, V91, P251, DOI 10.1016/S1081-1206(10)63526-0; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Gershon AS, 2010, THORAX, V65, P612, DOI 10.1136/thx.2009.131078; Barcala FJG, 2010, ALLERGOL IMMUNOPATH, V38, P254, DOI 10.1016/j.aller.2009.11.008; Government of Canada SC (n.d.) Population by sex and age group, POP SEX AG GROUP; Klomp H, 2008, CAN MED ASSOC J, V178, P1013, DOI 10.1503/cmaj.070426; Krahn MD, 1996, CAN MED ASSOC J, V154, P821; Lemiere Catherine, 2004, Can Respir J, V11 Suppl A, p9A; Li J, 1995, AM J MANAG CARE, V1, P137; Lougheed AD, 2006, CHEST, V129, P909, DOI 10.1378/chest.129.4.909; Lougheed MD, 2010, CAN RESPIR J, V17, P57, DOI 10.1155/2010/378289; Lougheed MD, 2010, CAN RESPIR J, V17, P15, DOI 10.1155/2010/827281; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Ministry of Health (n.d.) PharmaNet, PHARMANET; Piecoro LT, 2001, HEALTH SERV RES, V36, P357; Poole B, 1998, Healthc Manage Forum, V11, P22; Prosser RJ, 2008, HEALTH SERV RES, V43, P733, DOI 10.1111/j.1475-6773.2007.00775.x; Rowe BH, 2007, CAN RESPIR J, V14, P331, DOI 10.1155/2007/450489; Sapra S, 2005, J ASTHMA, V42, P469, DOI 10.1081/JAS-200067265; Stafford RS, 2003, J ALLERGY CLIN IMMUN, V111, P729, DOI 10.1067/mai.2003.177; Stock S, 2005, EUR RESPIR J, V25, P47, DOI 10.1183/09031936.04.00116203; Stow PJ, 2007, THORAX, V62, P842, DOI 10.1136/thx.2006.075317; Ungar WJ, 2001, PEDIATR PULM, V32, P101, DOI 10.1002/ppul.1095; Yuan Y., 2012, ANAL RISK FACTORS CH	41	54	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50949	10.1371/journal.pone.0050949	http://dx.doi.org/10.1371/journal.pone.0050949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227222	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200083
J	Mesman, AW; de Vries, RD; McQuaid, S; Duprex, WP; de Swart, RL; Geijtenbeek, TBH				Mesman, Annelies W.; de Vries, Rory D.; McQuaid, Stephen; Duprex, W. Paul; de Swart, Rik L.; Geijtenbeek, Teunis B. H.			A Prominent Role for DC-SIGN(+) Dendritic Cells in Initiation and Dissemination of Measles Virus Infection in Non-Human Primates	PLOS ONE			English	Article							LECTIN DC-SIGN; ALVEOLAR MACROPHAGES; IMMUNE-RESPONSES; IN-VITRO; RECEPTOR; MACAQUES; PROTEIN; SLAM; IMMUNOSUPPRESSION; IMMUNIZATION	Measles virus (MV) is a highly contagious virus that is transmitted by aerosols. During systemic infection, CD150(+) T and B lymphocytes in blood and lymphoid tissues are the main cells infected by pathogenic MV. However, it is unclear which cell types are the primary targets for MV in the lungs and how the virus reaches the lymphoid tissues. In vitro studies have shown that dendritic cell (DC) C-type lectin DC-SIGN captures MV, leading to infection of DCs as well as transmission to lymphocytes. However, evidence of DC-SIGN-mediated transmission in vivo has not been established. Here we identified DC-SIGN hi DCs as first target cells in vivo and demonstrate that macaque DC-SIGN functions as an attachment receptor for MV. Notably, DC-SIGN hi cells from macaque broncho-alveolar lavage and lymph nodes transmit MV to B lymphocytes, providing in vivo support for an important role for DCs in both initiation and dissemination of MV infection. Citation: Mesman AW, de Vries RD, McQuaid S, Duprex WP, de Swart RL, et al. (2012) A Prominent Role for DC-SIGN(+) Dendritic Cells in Initiation and Dissemination of Measles Virus Infection in Non-Human Primates. PLoS ONE 7(12): e49573. doi:10.1371/journal.pone.0049573	[Mesman, Annelies W.; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Rory D.; de Swart, Rik L.] Erasmus MC, Virosci Lab, Rotterdam, Netherlands; [McQuaid, Stephen] Queens Univ Belfast, Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Duprex, W. Paul] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Queens University Belfast; Boston University	Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.b.geijtenbeek@amc.uva.nl	de Swart, Rik L./E-6508-2011; de Vries, Rory D/L-2264-2015	de Swart, Rik L./0000-0003-3599-8969; de Vries, Rory D/0000-0003-2817-0127; Duprex, W Paul/0000-0003-1716-6376	ZonMw [9120812]; MRC [G0801001]; Medical Research Council [G0801001] Funding Source: researchfish	ZonMw(Netherlands Organization for Health Research and Development); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were funded by ZonMw (grant 9120812) and MRC (grant G0801001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P129; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baron MD, 2005, J GEN VIROL, V86, P1753, DOI 10.1099/vir.0.80836-0; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Cook Donald N, 2007, Proc Am Thorac Soc, V4, P234, DOI 10.1513/pats.200701-026AW; Cutts FT, 1997, BIOLOGICALS, V25, P323, DOI 10.1006/biol.1997.0103; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; de Swart RL, 2007, VACCINE, V25, P1183, DOI 10.1016/j.vaccine.2006.10.019; de Vries RD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002885; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; de Witte L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000049; Ferreira CSA, 2010, J VIROL, V84, P3033, DOI 10.1128/JVI.01559-09; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Geijtenbeek TBH, 2001, IMMUNOL LETT, V79, P101, DOI 10.1016/S0165-2478(01)00279-6; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Griffin DE, 2010, IMMUNOL REV, V236, P176, DOI 10.1111/j.1600-065X.2010.00925.x; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Hadac EM, 2011, J VIROL METHODS, V176, P78, DOI 10.1016/j.jviromet.2011.06.005; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Kobune F, 1996, LAB ANIM SCI, V46, P315; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Lin WH, 2011, P NATL ACAD SCI USA, V108, P2987, DOI 10.1073/pnas.1017334108; Masten BJ, 2006, J IMMUNOL, V177, P7784, DOI 10.4049/jimmunol.177.11.7784; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Randall TD, 2010, J EXP MED, V207, P451, DOI 10.1084/jem.20100059; Schneider-Schaulies S, 2009, CURR TOP MICROBIOL, V330, P243; Schnorr JJ, 1997, P NATL ACAD SCI USA, V94, P5326, DOI 10.1073/pnas.94.10.5326; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Ten Berge B, 2009, J IMMUNOL METHODS, V351, P13, DOI 10.1016/j.jim.2009.09.009; Valdespino-Gomez JL, 2006, CURR TOP MICROBIOL, V304, P165; VANBINNENDIJK RS, 1994, J INFECT DIS, V170, P443, DOI 10.1093/infdis/170.2.443; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	43	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49573	10.1371/journal.pone.0049573	http://dx.doi.org/10.1371/journal.pone.0049573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227146	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200009
J	Nordberg, J; Mpindi, JP; Iljin, K; Pulliainen, AT; Kallajoki, M; Kallioniemi, O; Elenius, K; Elenius, V				Nordberg, Janne; Mpindi, John Patrick; Iljin, Kristiina; Pulliainen, Arto Tapio; Kallajoki, Markku; Kallioniemi, Olli; Elenius, Klaus; Elenius, Varpu			Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; REFRACTORY SOLID TUMORS; PRECLINICAL TESTING PROGRAM; KINASE INHIBITOR; CLINICAL-FEATURES; EWINGS-SARCOMA; EPH RECEPTORS; PHASE-II; CANCER; CHILDREN	Pediatric sarcomas, including rhabdomyosarcomas, Ewing's sarcoma, and osteosarcoma, are aggressive tumors with poor survival rates. To overcome problems associated with nonselectivity of the current therapeutic approaches, targeted therapeutics have been developed. Currently, an increasing number of such drugs are used for treating malignancies of adult patients but little is known about their effects in pediatric patients. We analyzed expression of 24 clinically approved target genes in a wide variety of pediatric normal and malignant tissues using a novel high-throughput systems biology approach. Analysis of the Genesapiens database of human transcriptomes demonstrated statistically significant upregulation of VEGFC and EPHA2 in Ewing's sarcoma, and ERBB3 in alveolar rhabdomyosarcomas. In silico data for ERBB3 was validated by demonstrating ErbB3 protein expression in pediatric rhabdomyosarcoma in vitro and in vivo. ERBB3 overexpression promoted whereas ERBB3-targeted siRNA suppressed rhabdomyosarcoma cell gowth, indicating a functional role for ErbB3 signaling in rhabdomyosarcoma. These data suggest that drugs targeting ErbB3, EphA2 or VEGF-C could be further tested as therapeutic targets for pediatric sarcomas. Citation: Nordberg J, Mpindi JP, Iljin K, Pulliainen AT, Kallajoki M, et al. (2012) Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma. PLoS ONE 7(12): e50819. doi:10.1371/journal.pone.0050819	[Nordberg, Janne; Pulliainen, Arto Tapio; Elenius, Klaus; Elenius, Varpu] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Mpindi, John Patrick; Iljin, Kristiina; Kallioniemi, Olli] VTT Tech Res Ctr Finland, Turku, Finland; [Kallajoki, Markku] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland; [Kallioniemi, Olli] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Elenius, Klaus] Univ Turku, Med Res Labs, Turku, Finland; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland; [Elenius, Varpu] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland	University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki; University of Turku; University of Turku; University of Turku	Elenius, V (corresponding author), Univ Turku, Dept Med Biochem & Genet, Turku, Finland.	varpu.elenius@utu.fi	Pulliainen, Arto/AAX-2052-2021; Kallioniemi, Olli P/H-5111-2011; Elenius, Klaus/AAI-7594-2021	Kallioniemi, Olli P/0000-0002-3231-0332; Elenius, Klaus/0000-0001-5700-0827; Nordberg, Janne/0000-0002-2917-4341; Iljin, Kristiina/0000-0002-5161-0584; Pulliainen, Arto Tapio/0000-0002-9361-8963	Academy of Finland; Finnish Medical Foundation	Academy of Finland(Academy of Finland); Finnish Medical Foundation	This work was supported by the Academy of Finland and the Finnish Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; Cho J, 2011, BLOOD, V117, P1156, DOI 10.1182/blood-2010-04-279349; Dalal S, 2005, CLIN CANCER RES, V11, P2364, DOI 10.1158/1078-0432.CCR-04-1201; Daw NC, 2005, J CLIN ONCOL, V23, P6172, DOI 10.1200/JCO.2005.11.429; DuBois S, 2007, CANCER-AM CANCER SOC, V109, P813, DOI 10.1002/cncr.22455; Edwards JR, 2008, HUM PATHOL, V39, P49, DOI 10.1016/j.humpath.2007.04.022; Fox E, 2010, J CLIN ONCOL, V28, P5174, DOI 10.1200/JCO.2010.30.9674; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; Funahashi Y, 2009, INT J UROL, V16, P769, DOI 10.1111/j.1442-2042.2009.02339.x; Furman WL, 2009, J CLIN ONCOL, V27, P4599, DOI 10.1200/JCO.2008.19.6642; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Gerber HP, 2005, CANCER RES, V65, P671; Heckman CA, 2008, CANCER RES, V68, P4754, DOI 10.1158/0008-5472.CAN-07-5809; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jakacki RI, 2008, J CLIN ONCOL, V26, P4921, DOI 10.1200/JCO.2007.15.2306; Joensuu H, 2002, MED KLIN, V97, P28; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kolb EA, 2008, PEDIATR BLOOD CANCER, V50, P1198, DOI 10.1002/pbc.21368; Landier W, 2008, ONCOLOGIST, V13, P1181, DOI 10.1634/theoncologist.2008-0104; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Maki RG, 2009, J CLIN ONCOL, V27, P3133, DOI 10.1200/JCO.2008.20.4495; Maris JM, 2008, PEDIATR BLOOD CANCER, V50, P581, DOI 10.1002/pbc.21232; Messahel B, 2005, LANCET ONCOL, V6, P421, DOI 10.1016/S1470-2045(05)70209-6; Mpindi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017259; Noguchi H, 1999, GASTROENTEROLOGY, V117, P1119, DOI 10.1016/S0016-5085(99)70397-5; Paolucci P, 2008, LANCET ONCOL, V9, P176, DOI 10.1016/S1470-2045(08)70030-5; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Sinha G, 2008, J NATL CANCER I, V100, P84, DOI 10.1093/jnci/djm317; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Thompson PA, 2012, CURR ONCOL REP; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; Watson Rory, 2005, BMJ, V330, P1348, DOI 10.1136/bmj.330.7504.1348-c; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50819	10.1371/journal.pone.0050819	http://dx.doi.org/10.1371/journal.pone.0050819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227212	Green Submitted, Green Published, gold			2022-12-25	WOS:000312588200072
J	Scheper, TVO; Mansvelder, HD; van Ooyen, A				Scheper, Tjeerd V. Olde; Mansvelder, Huibert D.; van Ooyen, Arjen			Short Term Depression Unmasks the Ghost Frequency	PLOS ONE			English	Article							COCHLEAR NUCLEUS; NEURAL MECHANISM; AUDITORY-NERVE; SPIKE TRAINS; NEURONS; CELLS; MODEL; PITCH; INFORMATION; SIMULATION	Short Term Plasticity (STP) has been shown to exist extensively in synapses throughout the brain. Its function is more or less clear in the sense that it alters the probability of synaptic transmission at short time scales. However, it is still unclear what effect STP has on the dynamics of neural networks. We show, using a novel dynamic STP model, that Short Term Depression (STD) can affect the phase of frequency coded input such that small networks can perform temporal signal summation and determination with high accuracy. We show that this property of STD can readily solve the problem of the ghost frequency, the perceived pitch of a harmonic complex in absence of the base frequency. Additionally, we demonstrate that this property can explain dynamics in larger networks. By means of two models, one of chopper neurons in the Ventral Cochlear Nucleus and one of a cortical microcircuit with inhibitory Martinotti neurons, it is shown that the dynamics in these microcircuits can reliably be reproduced using STP. Our model of STP gives important insights into the potential roles of STP in self-regulation of cortical activity and long-range afferent input in neuronal microcircuits. Citation: olde Scheper TV, Mansvelder HD, van Ooyen A (2012) Short Term Depression Unmasks the Ghost Frequency. PLoS ONE 7(12): e50189. doi:10.1371/journal.pone.0050189	[Scheper, Tjeerd V. Olde; Mansvelder, Huibert D.; van Ooyen, Arjen] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Scheper, Tjeerd V. Olde] Oxford Brookes Univ, Fac Technol Design & Environm, Dept Comp & Commun Technol, Oxford OX3 0BP, England	Vrije Universiteit Amsterdam; Oxford Brookes University	Scheper, TVO (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands.	tvolde-scheper@brookes.ac.uk	Scheper, Thomas/H-8143-2013; Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340; olde Scheper, Tjeerd/0000-0003-1441-1444	EU BIO-ICT Project SECO [216593]	EU BIO-ICT Project SECO	This work was supported by EU BIO-ICT Project SECO (216593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backoff PM, 1997, HEARING RES, V110, P155, DOI 10.1016/S0378-5955(97)00081-6; Bahmer A, 2006, BIOL CYBERN, V95, P381, DOI 10.1007/s00422-006-0091-7; Bahmer A, 2009, BIOL CYBERN, V100, P21, DOI 10.1007/s00422-008-0276-3; Balaguer-Ballester E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000301; Balenzuela P, 2005, CHAOS, V15, DOI 10.1063/1.1871612; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Cao XJ, 2007, J NEUROPHYSIOL, V97, P3961, DOI 10.1152/jn.00052.2007; Chase SM, 2008, J NEUROPHYSIOL, V99, P1672, DOI 10.1152/jn.00644.2007; Chialvo DR, 2003, CHAOS, V13, P1226, DOI 10.1063/1.1617771; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; de Cheveigne A, 2005, SPR HDB AUD, V24, P169; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Ferragamo MJ, 1998, J NEUROPHYSIOL, V79, P51, DOI 10.1152/jn.1998.79.1.51; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gockel HE, 2007, J ACOUST SOC AM, V121, P373, DOI 10.1121/1.2382476; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Klapuri A, 2006, SIGNAL PROCESSING ME, P229; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Koch Christof, 1999, P1; Larsen E, 2008, J NEUROPHYSIOL, V100, P1301, DOI 10.1152/jn.01361.2007; MacLeod KM, 2007, J NEUROPHYSIOL, V97, P2863, DOI 10.1152/jn.01030.2006; Manjarrez E, 2007, BIOSYSTEMS, V90, P379, DOI 10.1016/j.biosystems.2006.10.002; Mino H, 2007, IEEE T BIO-MED ENG, V54, P360, DOI 10.1109/TBME.2006.890486; Pinto RD, 2000, NEURON, P26; Plack CJ, 2006, J NEUROSCI, V26, P8767, DOI 10.1523/JNEUROSCI.1134-06.2006; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Sayles M, 2008, J NEUROSCI, V28, P11925, DOI 10.1523/JNEUROSCI.3137-08.2008; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Trussell L, 2002, CELLULAR MECH INFORM; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705	37	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50189	10.1371/journal.pone.0050189	http://dx.doi.org/10.1371/journal.pone.0050189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227159	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200021
J	Wang, N; Yang, C; Xie, F; Sun, LH; Su, XL; Wang, Y; Wei, R; Zhang, R; Li, X; Yang, BF; Ai, J				Wang, Ning; Yang, Chao; Xie, Fang; Sun, Lihua; Su, Xiaolin; Wang, Ying; Wei, Ran; Zhang, Rong; Li, Xia; Yang, Baofeng; Ai, Jing			Gadd45 alpha: A Novel Diabetes-Associated Gene Potentially Linking Diabetic Cardiomyopathy and Baroreflex Dysfunction	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ADENOSINE-DEAMINASE; NUCLEUS AMBIGUUS; EXPRESSION; CELLS; IDENTIFICATION; HISTONE; ALPHA; DIFFERENTIATION; HYPERTROPHY	Both diabetic cardiomyopathy (DCM) and baroreflex dysfunction independently contribute to sudden cardiac death (SCD), however the inherent connections between them under diabetic state remains unclear. As microRNAs (miRNAs) have been reported to participate in various physiological and pathological processes, we presume they may also be involved in DCM and DM-induced impairment of baroreflex sensitivity. Two sets of gene expression profiles data from streptozotocin (STZ)-induced diabetic heart and diabetic dorsal root ganglia (DDRG) were retrieved from GEO and ArrayExpress. Co-differentially-expressed genes in diabetic heart and DDRG were identified by t test and intersection analysis. Human Protein Reference Database (HPRD) was applied to find direct interacting proteins of Gadd45 alpha. Differentially-expressed miRNAs in left ventricle from 4-week STZ-induced diabetic rats were screened by miRNA microarray. Expression of miR-499 and its regulating effect on Gadd45 alpha were then verified by quantitative real-time PCR (qRT-PCR), western blot, computational predication, and dual-luciferase reporter analysis. Four co-differentially-expressed genes in DCM and DDRG were identified. Among these genes, Gadd45 alpha has 16 direct interacting proteins and 11 of them are documentedly associated with DM. Accompanied with significantly increased miR-499 expression, Gadd45 alpha expression was increased at mRNA level but decreased at protein level in both diabetic heart and nucleus ambiguous. Furthermore, miR-499 was confirmed negatively regulating Gadd45 alpha by targeting its 3'UTR. Collectively, reduced Gadd45 alpha protein expression by forced miR-499 expression indicated it's a diabetes-associated gene which might potentially be involved in both DCM and DM-induced baroreflex dysfunction.	[Wang, Ning; Yang, Chao; Xie, Fang; Sun, Lihua; Su, Xiaolin; Wang, Ying; Wei, Ran; Zhang, Rong; Yang, Baofeng; Ai, Jing] Harbin Med Univ, Dept Pharmacol, State Prov Key Lab Biomed Pharmaceut China, Harbin, Peoples R China; [Wang, Ning; Sun, Lihua; Zhang, Rong; Yang, Baofeng; Ai, Jing] Minist Educ China, Key Lab Cardiovasc Res, Harbin, Peoples R China; [Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University; Ministry of Education, China; Harbin Medical University	Ai, J (corresponding author), Harbin Med Univ, Dept Pharmacol, State Prov Key Lab Biomed Pharmaceut China, Harbin, Peoples R China.	a.z.hrbmu@gmail.com	li, xia/HHZ-7468-2022		Funds for Natural Science Foundation of China [81271207, 81070882]; Creative Research Groups of the National Natural Science Foundation of China [81121003]; Outstanding Youth Foundation of Heilongjiang Province [JC200904]	Funds for Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Foundation of Heilongjiang Province	This study was supported by the Funds for Natural Science Foundation of China (81271207, 81070882), Creative Research Groups of the National Natural Science Foundation of China (81121003), the Outstanding Youth Foundation of Heilongjiang Province (JC200904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Al-Douahji M, 1999, KIDNEY INT, V56, P1691, DOI 10.1046/j.1523-1755.1999.00728.x; Balkau B, 1999, LANCET, V354, P1968, DOI 10.1016/S0140-6736(99)04383-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brizzi MF, 2002, J CLIN INVEST, V109, P111, DOI 10.1172/JCI13617; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Cresci S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012584; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dimmeler S, 2010, EUR HEART J, V31, P2705, DOI 10.1093/eurheartj/ehq221; Doney Alex S F, 2005, Nucl Recept, V3, P4, DOI 10.1186/1478-1336-3-4; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Feng BA, 2010, DIABETES-METAB RES, V26, P40, DOI 10.1002/dmrr.1054; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Francis G, 2001, HEART, V85, P247, DOI 10.1136/heart.85.3.247; Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417; Garcia-Villegas R, 2009, J NEUROSCI RES, V87, P2509, DOI 10.1002/jnr.22069; Glyn-Jones S, 2007, PHYSIOL GENOMICS, V28, P284, DOI 10.1152/physiolgenomics.00204.2006; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Guttula SV, 2010, INT J DIABETES DEV C, V30, P52, DOI 10.4103/0973-3930.60003; Hamada Yasuhiro, 2007, Kobe J Med Sci, V53, P53; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaneto H, 1999, DIABETOLOGIA, V42, P1093, DOI 10.1007/s001250051276; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Katare R, 2011, CIRC RES, V108, P1238, DOI 10.1161/CIRCRESAHA.110.239111; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kurabe N, 2009, J BIOL CHEM, V284, P5050, DOI 10.1074/jbc.M808598200; Lal A, 2006, CELL CYCLE, V5, P1422, DOI 10.4161/cc.5.13.2902; Lawrence IG, 1997, DIABETIC MED, V14, P82, DOI 10.1002/(SICI)1096-9136(199701)14:1<82::AID-DIA290>3.0.CO;2-3; Lee JG, 2011, DIABETES METAB J, V35, P149, DOI 10.4093/dmj.2011.35.2.149; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Monkemann H, 2002, AMINO ACIDS, V23, P331, DOI 10.1007/s00726-001-0146-y; Moskalev AA, 2012, AGEING RES REV, V11, P51, DOI 10.1016/j.arr.2011.09.003; Oskouie FG, 2011, J IMMUNOL, V186, P6798, DOI 10.4049/jimmunol.1004222; Poirier P, 2003, METABOLISM, V52, P1056, DOI 10.1016/S0026-0495(03)00091-X; Price SA, 2006, J NEUROPATH EXP NEUR, V65, P722, DOI 10.1097/01.jnen.0000228199.89420.90; Salama M, 1998, ARCH ANDROLOGY, V40, P95, DOI 10.3109/01485019808987932; Shi H, 2012, DIABETES TECHNOL THE, V14, P293, DOI 10.1089/dia.2011.0071; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Yan BB, 2009, EXP NEUROL, V220, P34, DOI 10.1016/j.expneurol.2009.07.006; Yan B, 2009, AM J PHYSIOL-REG I, V296, pR299, DOI 10.1152/ajpregu.90412.2008	47	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49077	10.1371/journal.pone.0049077	http://dx.doi.org/10.1371/journal.pone.0049077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227140	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200003
J	Chien, MH; Yang, JS; Chu, YH; Lin, CH; Wei, LH; Yang, SF; Lin, CW				Chien, Ming-Hsien; Yang, Jia-Sin; Chu, Yin-Hung; Lin, Chien-Huang; Wei, Lin-Hung; Yang, Shun-Fa; Lin, Chiao-Wen			Impacts of CA9 Gene Polymorphisms and Environmental Factors on Oral-Cancer Susceptibility and Clinicopathologic Characteristics in Taiwan	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; SQUAMOUS-CELL CARCINOMAS; CLINICAL-RELEVANCE; PREDICTIVE-VALUE; CERVICAL-CANCER; EXPRESSION; HYPOXIA; PROGNOSIS; MICROENVIRONMENT; ASSOCIATION	Background: In Taiwan, oral cancer has causally been associated with environmental carcinogens. Carbonic anhydrase 9 (CA9) is reportedly overexpressed in several types of carcinomas and is generally considered a marker of malignancy. The current study explored the combined effect of CA9 gene polymorphisms and exposure to environmental carcinogens on the susceptibility of developing oral squamous cell carcinoma (OSCC) and the clinicopathological characteristics of the tumors. Methodology and Principal Findings: Four single-nucleotide polymorphisms (SNPs) of the CA9 gene from 462 patients with oral cancer and 519 non-cancer controls were analyzed by a real-time polymerase chain reaction (PCR). While the studied SNPs (CA9 rs2071676, rs3829078, rs1048638 and +376 Del) were not associated with susceptibility to oral cancer, the GAA haplotype of 3 CA9 SNPs (rs2071676, rs3829078, and rs1048638) was related to a higher risk of oral cancer. Moreover, the four CA9 SNPs combined with betel quid chewing and/or tobacco consumption could robustly elevate susceptibility to oral cancer. Finally, patients with oral cancer who had at least one G allele of CA9 rs2071676 were at higher risk for developing lymph-node metastasis (p = 0.022), compared to those patients homozygous for AA. Conclusions: Our results suggest that the haplotype of rs2071676, rs3829078, and rs1048638 combined has potential predictive significance in oral carcinogenesis. Gene-environment interactions of CA9 polymorphisms, smoking, and betel-quid chewing might alter oral cancer susceptibility and metastasis.	[Yang, Jia-Sin; Chu, Yin-Hung; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fan Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Wei, Lin-Hung] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan	Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; cwlin@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Lin, Chien-Huang/0000-0002-0916-8737; Wei, Lin-Hung/0000-0001-8789-0859	Taipei Medical University-Wan Fang Hospital [101swf03]	Taipei Medical University-Wan Fang Hospital	This study was supported by a grant from Taipei Medical University-Wan Fang Hospital (grant no. 101swf03 to Dr. Chien and Dr. Yang). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockton NT, 2012, ORAL ONCOL, V48, P615, DOI 10.1016/j.oraloncology.2012.01.018; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; Chang KW, 2004, BRIT J CANCER, V91, P1551, DOI 10.1038/sj.bjc.6602186; Choi SW, 2008, HUM PATHOL, V39, P1317, DOI 10.1016/j.humpath.2007.10.026; de Martino M, 2009, J UROLOGY, V182, P728, DOI 10.1016/j.juro.2009.03.077; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hedley D, 2003, CLIN CANCER RES, V9, P5666; Hoogsteen IJ, 2007, HEAD NECK-J SCI SPEC, V29, P591, DOI 10.1002/hed.20543; Huang SF, 2009, ORAL ONCOL, V45, P16, DOI 10.1016/j.oraloncology.2008.03.006; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim JY, 2006, J CANCER RES CLIN, V132, P302, DOI 10.1007/s00432-005-0068-2; Kim SJ, 2007, JPN J CLIN ONCOL, V37, P812, DOI 10.1093/jjco/hym121; Kondo Y, 2011, ONCOL REP, V25, P1227, DOI 10.3892/or.2011.1216; Koukourakis MI, 2001, CLIN CANCER RES, V7, P3399; Lai KC, 2006, MUTAT RES-FUND MOL M, V599, P66, DOI 10.1016/j.mrfmmm.2006.01.005; Lee S, 2007, CANCER SCI, V98, P329, DOI 10.1111/j.1349-7006.2007.00396.x; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035078; Lin MH, 2004, ARCH TOXICOL, V78, P167, DOI 10.1007/s00204-003-0524-1; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Liu SY, 2005, J FORMOS MED ASSOC, V104, P113; Nagaraj NS, 2006, TOXICOL LETT, V165, P182, DOI 10.1016/j.toxlet.2006.03.008; Perez-Sayans M., 2012, J ORAL PATHOL MED; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Sorensen BS, 2005, RADIOTHER ONCOL, V76, P187, DOI 10.1016/j.radonc.2005.06.037; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; TOWLE HC, 1995, J BIOL CHEM, V270, P23235, DOI 10.1074/jbc.270.40.23235; VAUPEL P, 1989, CANCER RES, V49, P6449; Weng CJ, 2011, ANN SURG ONCOL, V18, P805, DOI 10.1245/s10434-010-1432-2; Weng CJ, 2010, ORAL ONCOL, V46, P767, DOI 10.1016/j.oraloncology.2010.07.011; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Zavras AI, 2011, ANN SURG ONCOL, V18, P1478, DOI 10.1245/s10434-010-1431-3	39	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51051	10.1371/journal.pone.0051051	http://dx.doi.org/10.1371/journal.pone.0051051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226559	Green Submitted, gold, Green Published			2022-12-25	WOS:000312108500042
J	Jones, DR; Foulger, R; Keune, WJ; Bultsma, Y; Divecha, N				Jones, David R.; Foulger, Rebecca; Keune, Willem-Jan; Bultsma, Yvette; Divecha, Nullin			PtdIns5P is an oxidative stress-induced second messenger that regulates PKB activation	FASEB JOURNAL			English	Article						phosphoinositide; phosphatidylinositol-5-phosphate kinase; lipid kinase	PHOSPHATIDYLINOSITOL 5-PHOSPHATE; TUMOR-SUPPRESSOR; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; MAMMALIAN-CELLS; LIPID KINASE; IN-VIVO; PIKFYVE; INSULIN; IDENTIFICATION	Oxidative stress initiates signaling pathways, which protect from stress-induced cellular damage, initiate apoptosis, or drive cells into senescence or into tumorigenesis. Oxidative stress regulates the activity of the cell survival factor PKB, through the regulation of PtdIns(3,4,5)P-3 synthesis. Whether oxidative stress regulates other phosphoinositides to control PKB activation is not clear. Here we show that PtdIns5P is a redox-regulated second messenger. In response to hydrogen peroxide (H2O2), we measured an increase in PtdIns5P in cells derived from human osteosarcoma, U2OS (5-fold); breast tumors, MDA-MB-468 (2-fold); and fibrosarcoma, HT1080 (3-fold); and in p53-null murine embryonic fibroblasts (8-fold). In U2OS cells, the increase in H2O2-dependent PtdIns5P did not require mTOR, PDK1, PKB, ERK, and p38 signaling or PIKfyve, a lipid kinase that increases PtdIns5P in response to osmotic and oncogenic signaling. A reduction in H2O2-induced PtdIns5P levels by the overexpression of PIP4K revealed its role in PKB activation. Suppression of H2O2-induced PtdIns5P generation reduced PKB activation and, surprisingly, reduced cell sensitivity to growth inhibition by H2O2. These data suggest that inhibition of PIP4K signaling might be useful as a novel strategy to increase the susceptibility of tumor cells to therapeutics that function through increased oxidative stress.-Jones, D. R., Foulger, R., Keune, W.-J., Bultsma, Y., Divecha, N. PtdIns5P is an oxidative stress-induced second messenger that regulates PKB activation. FASEB J. 27, 1644-1656 (2013). www.fasebj.org	[Jones, David R.; Foulger, Rebecca; Keune, Willem-Jan; Bultsma, Yvette; Divecha, Nullin] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Inositide Lab, Manchester M20 4BX, Lancs, England	Paterson Institute for Cancer Research; University of Manchester	Divecha, N (corresponding author), Univ Manchester, Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	ndivecha@picr.man.ac.uk		Keune, Willem-Jan/0000-0001-6607-5898; divecha, nullin/0000-0001-9695-6039	Cancer Research UK	Cancer Research UK(Cancer Research UK)	The authors acknowledge Cancer Research UK for funding. The authors thank members of the Inositide Laboratory for technical support and suggestions.	Bultsma Y, 2010, BIOCHEM J, V430, P223, DOI 10.1042/BJ20100341; Carricaburu V, 2003, P NATL ACAD SCI USA, V100, P9867, DOI 10.1073/pnas.1734038100; Chen QM, 2000, ANN NY ACAD SCI, V908, P111; Clarke JH, 2001, BIOCHEM J, V357, P905, DOI 10.1042/0264-6021:3570905; Coronas S, 2008, BIOCHEM BIOPH RES CO, V372, P351, DOI 10.1016/j.bbrc.2008.05.062; Ding Y, 2012, PLANT J, V70, P866, DOI 10.1111/j.1365-313X.2012.04936.x; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Grainger DL, 2011, PFLUG ARCH EUR J PHY, V462, P723, DOI 10.1007/s00424-011-1008-4; Guittard G, 2009, J IMMUNOL, V182, P3974, DOI 10.4049/jimmunol.0804172; Halstead JR, 2006, CURR BIOL, V16, P1850, DOI 10.1016/j.cub.2006.07.066; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Jones David R., 2009, V462, P75, DOI 10.1007/978-1-60327-115-8_5; Jones DR, 2004, CURR OPIN GENET DEV, V14, P196, DOI 10.1016/j.gde.2004.02.003; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Meijer HJG, 2001, BIOCHEM J, V360, P491, DOI 10.1042/0264-6021:3600491; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Ndamukong I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013396; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Ramel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001619; Roberts HF, 2005, FEBS LETT, V579, P2868, DOI 10.1016/j.febslet.2005.04.027; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sbrissa D, 2002, J BIOL CHEM, V277, P47276, DOI 10.1074/jbc.M207576200; Shimizu T, 2010, GERIATR GERONTOL INT, V10, pS70, DOI 10.1111/j.1447-0594.2010.00604.x; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035; Wilcox A, 2008, FEBS LETT, V582, P1391, DOI 10.1016/j.febslet.2008.03.022; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	40	34	35	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1644	1656		10.1096/fj.12-218842	http://dx.doi.org/10.1096/fj.12-218842			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23241309				2022-12-25	WOS:000316940800034
J	Basu, RS; Murakami, KS				Basu, Ritwika S.; Murakami, Katsuhiko S.			Watching the Bacteriophage N4 RNA Polymerase Transcription by Time-dependent Soak-trigger-freeze X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURES; MECHANISM; INITIATION; PROTEIN; FIDELITY; FRAGMENT	The challenge for structural biology is to understand atomic-level macromolecular motions during enzymatic reaction. X-ray crystallography can reveal high resolution structures; however, one perceived limitation is that it reveals only static views. Here we use time-dependent soak-trigger-freeze X- ray crystallography, namely, soaking nucleotide and divalent metal into the bacteriophage RNA polymerase (RNAP)-promoter DNA complex crystals to trigger the nucleotidyl transfer reaction and freezing crystals at different time points, to capture real-time intermediates in the pathway of transcription. In each crystal structure, different intensities and shapes of electron density maps corresponding to the nucleotide and metal were revealed at the RNAP active site which allow watching the nucleotide and metal bindings and the phosphodiester bond formation in a time perspective. Our study provides the temporal order of substrate assembly and metal co-factor binding at the active site of enzyme which completes our understanding of the two-metal-ion mechanism and fidelity mechanism in single-subunit RNAPs. The nucleotide-binding metal (Me-B) is coordinated at the active site prior to the catalytic metal (Me-A). Me-A coordination is only temporal, established just before and dissociated immediately after phosphodiester bond formation. We captured these elusive intermediates exploiting the slow enzymatic reaction in crystallo. These results demonstrate that the simple time-dependent soak-trigger-freeze X- ray crystallography offers a direct means for monitoring enzymatic reactions.	[Basu, Ritwika S.; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.	kum14@psu.edu		Murakami, Katsuhiko/0000-0003-2244-0501	National Institutes of Health Grant [AI12575]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012575] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI12575.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Chen YY, 2011, J AM CHEM SOC, V133, P12544, DOI 10.1021/ja201557w; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Gleghorn ML, 2011, P NATL ACAD SCI USA, V108, P3566, DOI 10.1073/pnas.1016691108; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RECHINSKY VO, 1995, MOL GEN GENET, V247, P110, DOI 10.1007/BF00425827; Schmidt M., 2008, P201, DOI 10.1007/978-3-540-73566-3_9; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	37	30	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3305	3311		10.1074/jbc.M112.387712	http://dx.doi.org/10.1074/jbc.M112.387712			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235152	hybrid, Green Published			2022-12-25	WOS:000314397900036
J	Zhang, ZC; Gutierrez, D; Li, X; Bidlack, F; Cao, HJ; Wang, JB; Andrade, K; Margolis, HC; Amendt, BA				Zhang, Zichao; Gutierrez, Diana; Li, Xiao; Bidlack, Felicitas; Cao, Huojun; Wang, Jianbo; Andrade, Kelsey; Margolis, Henry C.; Amendt, Brad A.			The LIM Homeodomain Transcription Factor LHX6 A TRANSCRIPTIONAL REPRESSOR THAT INTERACTS WITH PITUITARY HOMEOBOX 2 (PITX2) TO REGULATE ODONTOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTAL EPITHELIUM; FUNCTIONAL INTERACTIONS; CELL-PROLIFERATION; BETA-CATENIN; STEM-CELLS; EXPRESSION; DOMAIN; GENE; TOOTH; PROTEIN	LHX6 is a LIM-homeobox transcription factor expressed during embryogenesis; however, the molecular mechanisms regulating LHX6 transcriptional activities are unknown. LHX6 and the PITX2 homeodomain transcription factor have overlapping expression patterns during tooth and craniofacial development, and in this report, we demonstrate new transcriptional mechanisms for these factors. PITX2 and LHX6 are co-expressed in the oral and dental epithelium and epithelial cell lines. Lhx6 expression is increased in Pitx2c transgenic mice and decreased in Pitx2 null mice. PITX2 activates endogenous Lhx6 expression and the Lhx6 promoter, whereas LHX6 represses its promoter activity. Chromatin immunoprecipitation experiments reveal endogenous PITX2 binding to the Lhx6 promoter. LHX6 directly interacts with PITX2 to inhibit PITX2 transcriptional activities and activation of multiple promoters. Bimolecular fluorescence complementation assays reveal an LHX6.PITX2 nuclear interaction in living cells. LHX6 has a dominant repressive effect on the PITX2 synergistic activation with LEF-1 and beta-catenin co-factors. Thus, LHX6 acts as a transcriptional repressor and represses the expression of several genes involved in odontogenesis. We have identified specific defects in incisor, molar, mandible, bone, and root development and late stage enamel formation in Lhx6 null mice. Amelogenin and ameloblastin expression is reduced and/or delayed in the Lhx6 null mice, potentially resulting from defects in dentin deposition and ameloblast differentiation. Our results demonstrate that LHX6 regulates cell proliferation in the cervical loop and promotes cell differentiation in the anterior region of the incisor. We demonstrate new molecular mechanisms for LHX6 and an interaction with PITX2 for normal craniofacial and tooth development.	[Zhang, Zichao; Gutierrez, Diana; Li, Xiao; Cao, Huojun; Wang, Jianbo; Andrade, Kelsey; Amendt, Brad A.] Texas A&M Univ, Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Bidlack, Felicitas; Margolis, Henry C.] Forsyth Inst, Dept Biomineralizat, Boston, MA 02142 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Forsyth Institute	Amendt, BA (corresponding author), Univ Iowa, Craniofacial Anomalies Res Ctr, 1-675 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu	cao, huojun/M-5431-2017; Li, Xiao/X-3429-2019	Li, Xiao/0000-0001-8527-4438; Bidlack, Felicitas/0000-0001-8105-223X; Amendt, Brad A./0000-0001-6524-1006; Cao, Huojun/0000-0003-4428-8686	National Institutes of Health [DE13941, DE18885, DE016376]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941, R01DE018885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016376, R56DE016376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE13941 and DE18885 (to B. A. A.) and DE016376 (to H. C. M.).	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Cao HJ, 2010, DEV BIOL, V347, P289, DOI 10.1016/j.ydbio.2010.08.031; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Denaxa M, 2009, DEV BIOL, V333, P324, DOI 10.1016/j.ydbio.2009.07.001; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Espinoza HM, 2005, BIOCHEMISTRY-US, V44, P3942, DOI 10.1021/bi048362x; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Granger A, 2006, MOL ENDOCRINOL, V20, P2093, DOI 10.1210/me.2005-0184; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Mucchielli ML, 1996, MOL CELL NEUROSCI, V8, P258, DOI 10.1006/mcne.1996.0062; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Paine ML, 2003, J BIOL CHEM, V278, P19447, DOI 10.1074/jbc.M300445200; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shibaguchi T, 2003, ARCH HISTOL CYTOL, V66, P95, DOI 10.1679/aohc.66.95; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Waite MR, 2011, DEV DYNAM, V240, P333, DOI 10.1002/dvdy.22532; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2004, DEV CELL, V7, P719, DOI 10.1016/j.devcel.2004.09.012; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zhang Y, 2002, Orthod Craniofac Res, V5, P65, DOI 10.1034/j.1600-0544.2002.02198.x; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002	54	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2485	2500		10.1074/jbc.M112.402933	http://dx.doi.org/10.1074/jbc.M112.402933			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229549	Green Published, hybrid			2022-12-25	WOS:000314211500035
J	Porto, WF; Pires, AS; Franco, OL				Porto, William F.; Pires, Allan S.; Franco, Octavio L.			CS-AMPPred: An Updated SVM Model for Antimicrobial Activity Prediction in Cysteine-Stabilized Peptides	PLOS ONE			English	Article							RATIONAL DESIGN; IDENTIFICATION; PROTEIN; CYCLOTIDE; DISCOVERY; DEFENSIN; INSIGHTS; SEEDS	The antimicrobial peptides (AMP) have been proposed as an alternative to control resistant pathogens. However, due to multifunctional properties of several AMP classes, until now there has been no way to perform efficient AMP identification, except through in vitro and in vivo tests. Nevertheless, an indication of activity can be provided by prediction methods. In order to contribute to the AMP prediction field, the CS-AMPPred (Cysteine-Stabilized Antimicrobial Peptides Predictor) is presented here, consisting of an updated version of the Support Vector Machine (SVM) model for antimicrobial activity prediction in cysteine-stabilized peptides. The CS-AMPPred is based on five sequence descriptors: indexes of (i) a-helix and (ii) loop formation; and averages of (iii) net charge, (iv) hydrophobicity and (v) flexibility. CS-AMPPred was based on 310 cysteine-stabilized AMPs and 310 sequences extracted from PDB. The polynomial kernel achieves the best accuracy on 5-fold cross validation (85.81%), while the radial and linear kernels achieve 84.19%. Testing in a blind data set, the polynomial and radial kernels achieve an accuracy of 90.00%, while the linear model achieves 89.33%. The three models reach higher accuracies than previously described methods. A standalone version of CS-AMPPred is available for download at, <http://sourceforge.net/projects/csamppred/> and runs on any Linux machine.	[Porto, William F.; Pires, Allan S.; Franco, Octavio L.] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil	Universidade Catolica de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil.	ocfranco@gmail.com	Franco, Octavio L/T-3020-2017	Porto, William/0000-0002-4739-8250; Franco, Octavio/0000-0001-9546-0525	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPDF (fundacao de Amparo a Pesquisa do Distrito Federal); UCB (Universidade Catolica de Brasilia)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPDF (fundacao de Amparo a Pesquisa do Distrito Federal)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); UCB (Universidade Catolica de Brasilia)	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPDF (fundacao de Amparo a Pesquisa do Distrito Federal) and UCB (Universidade Catolica de Brasilia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Candid  E.S., 2011, SCI MICROBIAL PATHOG, P951; Chen KC, 2002, BOT BULL ACAD SINICA, V43, P251; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; Fernandes FC, 2012, BIOPOLYMERS, V98, P280, DOI 10.1002/bip.22066; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Franco OL, 2011, FEBS LETT, V585, P995, DOI 10.1016/j.febslet.2011.03.008; Fujimura M, 2004, BIOSCI BIOTECH BIOCH, V68, P571, DOI 10.1271/bbb.68.571; Ishikawa C, 2010, J INNATE IMMUN, V2, P66, DOI 10.1159/000242114; Joachims T., 1999, MAKING LARGE SCALE S; Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908; Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912; Lata S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-263; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Mandal SM, 2012, J CELL BIOCHEM, V113, P184, DOI 10.1002/jcb.23343; Mandal SM, 2009, PEPTIDES, V30, P633, DOI 10.1016/j.peptides.2008.12.001; Mulvenna JP, 2006, PLANT CELL, V18, P2134, DOI 10.1105/tpc.106.042812; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pelegrini PB, 2008, PEPTIDES, V29, P1271, DOI 10.1016/j.peptides.2008.03.013; Pinto MFS, 2012, J EVID-BASED INTEGR, V17, P40, DOI 10.1177/2156587211428077; Pinto MFS, 2012, J BIOL CHEM, V287, P134, DOI 10.1074/jbc.M111.294009; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Porto WF, 2012, PEPTIDES, V38, P127, DOI 10.1016/j.peptides.2012.07.025; Porto WF, 2010, LECT N BIOINFORMAT, V6268, P59, DOI 10.1007/978-3-642-15060-9_6; Romagnoli S, 2000, BIOCHEM J, V350, P569, DOI 10.1042/0264-6021:3500569; Silva O. N., 2012, PROTEIN STRUCTURE, P377; Silva ON, 2012, BIOPOLYMERS, V98, P322, DOI 10.1002/bip.22071; Silva ON, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00232; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tavares LS, 2012, PEPTIDES, V37, P294, DOI 10.1016/j.peptides.2012.07.017; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Warren AS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-125; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	43	60	62	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51444	10.1371/journal.pone.0051444	http://dx.doi.org/10.1371/journal.pone.0051444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240023	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800059
J	Singh, P; Agnihotri, SK; Tewari, MC; Kumar, S; Sachdev, M; Tripathi, RK				Singh, Poonam; Agnihotri, Saurabh Kumar; Tewari, Mahesh Chandra; Kumar, Sadan; Sachdev, Monika; Tripathi, Raj Kamal			HIV-1 Nef Breaches Placental Barrier in Rat Model	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD-BRAIN-BARRIER; VERTICAL TRANSMISSION; MOTHER; INFECTION; PREVENTION; PATHOGENICITY; DISRUPTION; MODULATION; EXPRESSION	The vertical transmission of HIV-1 from the mother to fetus is known, but the molecular mechanism regulating this transmission is not fully characterized. The fetus is highly protected by the placenta, which does not permit microbial pathogens to cross the placental barrier. In the present study, a rat model was established to observe the effect of HIV-1 protein Nef on placental barrier. Evans blue dye was used to assay permeability of placental barrier and fourteen day pregnant Sprague Dawley rats were injected intravenously with 2% Evans blue dye along with various concentrations of recombinant Nef. After an hour, animals were sacrificed and dye migration was observed through the assimilation of peripheral blood into fetus. Interestingly, traces of recombinant Nef protein were detected in the embryo as well as amniotic fluid and amniotic membrane along with placenta and uterus. Our study indicates that recombinant HIV-1-Nef protein breaches the placental barrier and allows the migration of Evans blue dye to the growing fetus. Further the concentration of Nef protein in blood is directly proportional to the intensity of dye migration and to the amount of Nef protein detected in uterus, placenta, amniotic membrane, amniotic fluid and embryo. Based on this study, it can be concluded that the HIV-1 Nef protein has a direct effect on breaching of the placental barrier in the model we have established in this study. Our observations will be helpful to understand the molecular mechanisms related to this breach of placental barrier by Nef in humans and may be helpful to identify specific Nef inhibitors. Citation: Singh P, Agnihotri SK, Tewari MC, Kumar S, Sachdev M, et al. (2012) HIV-1 Nef Breaches Placental Barrier in Rat Model. PLoS ONE 7(12): e51518. doi:10.1371/journal.pone.0051518	[Agnihotri, Saurabh Kumar; Tewari, Mahesh Chandra; Sachdev, Monika] Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India; [Singh, Poonam; Kumar, Sadan; Tripathi, Raj Kamal] Cent Drug Res Inst, Div Toxicol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Sachdev, M (corresponding author), Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India.	smonika26@yahoo.com; rk_tripathi@cdri.res.in			Council of Scientific and Industrial Research, New Delhi; Ministry of Health and Alternative Animal Model [NWP034]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Health and Alternative Animal Model	The first author was supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi. This manuscript is an outcome of the research funds provided by the Council of Scientific and Industrial Research, New Delhi, and grants from Ministry of Health and Alternative Animal Model (NWP034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheampong EA, 2009, J VIROL, V6, P10; Al-Husaini AM, 2009, J PERINATOL, V29, P331, DOI 10.1038/jp.2008.187; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P6; Bagasra O, 1995, NAT C HUM RETR REL I, V2, P136; Bai H, 2007, WORLD J GASTROENTERO, V13, P3625, DOI 10.3748/wjg.v13.i26.3625; Cao YZ, 1997, NAT MED, V3, P549, DOI 10.1038/nm0597-549; Cavarelli M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S10; CHANDWANI S, 1991, J INFECT DIS, V163, P1134, DOI 10.1093/infdis/163.5.1134; CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859; D'costa Grace Francis, 2007, Indian J Pathol Microbiol, V50, P515; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Derrien M, 2005, J VIROL, V79, P12304, DOI 10.1128/JVI.79.19.12304-12310.2005; Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294; Foster JL, 2008, RETROVIROL, P5; Frenkel LM, 1997, J INFECT DIS, V175, P971, DOI 10.1086/514003; Greenway AL, 2003, J BIO SCI, V28, P3; GREENWOOD J, 1991, NEURORADIOLOGY, V33, P95, DOI 10.1007/BF00588242; Hahn T, 2003, J BIOMED SCI, V10, P436, DOI 10.1159/000071163; Hanna Z, 2006, VIROLOGY, V346, P40, DOI 10.1016/j.virol.2005.10.010; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Husain M, 2001, AIDS RES HUM RETROV, V17, P765, DOI 10.1089/088922201750237040; Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; LEWIS SH, 1990, LANCET, V335, P565, DOI 10.1016/0140-6736(90)90349-A; MATHUR A, 1992, INT J EXP PATHOL, V73, P603; MCGANN KA, 1994, J INFECT DIS, V169, P746, DOI 10.1093/infdis/169.4.746; Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mordelet E, 2004, FASEB J, V18, P1851, DOI 10.1096/fj.04-2308com; MULDERKAMPINGA GA, 1995, J VIROL, V69, P2285, DOI 10.1128/JVI.69.4.2285-2296.1995; Mullard A, 2008, NAT REV MICROBIOL, V6, P798, DOI 10.1038/nrmicro2025; Nazir A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015312; Patterson BK, 2001, J CLIN INVEST, V107, P287, DOI 10.1172/JCI11481; Pornprasert S, 2006, PLACENTA, V27, P989, DOI 10.1016/j.placenta.2005.10.010; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Sporer B, 2000, J NEUROIMMUNOL, V102, P125, DOI 10.1016/S0165-5728(99)00170-8; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Yedavalli VRK, 2001, AIDS RES HUM RETROV, V17, P911, DOI 10.1089/088922201750290032; Yedavalli VRK, 2001, AIDS RES HUM RETROV, V17, P1089, DOI 10.1089/088922201300343780	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51518	10.1371/journal.pone.0051518	http://dx.doi.org/10.1371/journal.pone.0051518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240037	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800073
J	Guo, SL; Chen, PC; Chen, MS; Cheng, YC; Lin, JM; Lee, HC; Chen, CS				Guo, Shu-Lin; Chen, Po-Chung; Chen, Ming-Shuo; Cheng, Yu-Che; Lin, Jun-Mu; Lee, Hoong-Chien; Chen, Chien-Sheng			A Fast Universal Immobilization of Immunoglobulin G at 4 degrees C for the Development of Array-based Immunoassays	PLOS ONE			English	Article							ANTIBODY MICROARRAYS; ENZYME-IMMUNOASSAY; MASS-SPECTROMETRY; PROTEIN MICROARRAYS; SUBSTANCE-P; SERUM; TECHNOLOGY; PROTEOMICS; PAIN; STRATEGIES	To maintain the antibody activity and enhance performance of array-based immunoassays, protein G was used to allow a shorter duration of immunoglobulin G immobilization at 4 degrees C, with the antibody placed in the appropriate orientation. The multiplexed detection of six pain-related message molecules (PRMMs) was used as examples for the development of array-based immunoassays: substance P, calcitonin gene-related peptide, nerve growth factor, brain-derived neurotrophic factor, tumor necrosis factor-alpha, and beta-endorphin. Protein G- and non-protein G-coated slides were tested. Compared to non-protein G immunoassays, protein G shortened the antibody immobilization time at 4 degrees C from overnight to 2 hours. Only protein G- facilitated immunoassays succeeded in simultaneously detecting all six PRMMs with high specificity. Dose-response curves showed that the limits of detection of the protein G-multiplexed immunoassays for the PRMMs was approximately 164, 167, 120, 60, 80, and 92 pg/ml, respectively. Thus, protein G effectively shortens the duration of antibody immobilization at 4 degrees C, allowing the use of sensitive array-based immunoassays for the simultaneous detection of PRMMs. Citation: Guo S-L, Chen P-C, Chen M-S, Cheng Y-C, Lin J-M, et al. (2012) A Fast Universal Immobilization of Immunoglobulin G at 4 degrees C for the Development of Array-based Immunoassays. PLoS ONE 7(12): e51370. doi: 10.1371/journal.pone.0051370	[Guo, Shu-Lin; Chen, Po-Chung; Chen, Ming-Shuo; Lin, Jun-Mu; Lee, Hoong-Chien; Chen, Chien-Sheng] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Guo, Shu-Lin] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Cheng, Yu-Che] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Cheng, Yu-Che] Natl Cent Univ, Inst Biomed Engn, Jhongli, Taiwan	National Central University; Cathay General Hospital; Cathay General Hospital; National Central University	Lee, HC (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	hclee@sansan.phy.ncu.edu.tw; cchen103@gmail.com	Chen, Chien-Sheng/ACO-7414-2022	Cheng, Yu-Che/0000-0002-5346-3610	National Science Council, Taiwan [97-2311-B-019-001-MY2]; Veterans General Hospitals University System of Taiwan Joint Research Program [VGHUST99-G4-1]; National Central University; Landseed Hospital Program [NCU-LSH-100-A-012]; Cathay General Hospital [CGH-MR-9917, CGH-MR-10019, 99CGH-NCU-A2]; Taipei Medical University Hospital Program [100TMUH-NCU-005]; Center for Dynamical Biomarkers and Translational Medicine (CDBTM); Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Veterans General Hospitals University System of Taiwan Joint Research Program; National Central University; Landseed Hospital Program; Cathay General Hospital; Taipei Medical University Hospital Program; Center for Dynamical Biomarkers and Translational Medicine (CDBTM); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was partially supported by grants from the National Science Council, Taiwan (97-2311-B-019-001-MY2), Veterans General Hospitals University System of Taiwan Joint Research Program (VGHUST99-G4-1), the National Central University and Landseed Hospital Program (NCU-LSH-100-A-012), the Cathay General Hospital (CGH-MR-9917 and CGH-MR-10019), the joint grant from National Central University and Cathay General Hospital (99CGH-NCU-A2), and the National Central University and Taipei Medical University Hospital Program (100TMUH-NCU-005). The authors also thank the Center for Dynamical Biomarkers and Translational Medicine (CDBTM) and the Ministry of Education, Taiwan for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Capelle HH, 2009, CLIN J PAIN, V25, P729, DOI 10.1097/AJP.0b013e3181a776e4; Carlsson A, 2008, EUR J CANCER, V44, P472, DOI 10.1016/j.ejca.2007.11.025; Chen CS, 2006, BIOTECHNIQUES, V40, P423, DOI 10.2144/06404TE01; Chen MS, 2010, CHINESE J PAIN, V20, P18; Choi JW, 2008, ULTRAMICROSCOPY, V108, P1396, DOI 10.1016/j.ultramic.2008.04.050; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Favre-Kontula L, 2006, J IMMUNOL METHODS, V317, P152, DOI 10.1016/j.jim.2006.10.001; Frobert Y, 1999, PEPTIDES, V20, P275, DOI 10.1016/S0196-9781(98)00172-7; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Hamelinck D, 2005, MOL CELL PROTEOMICS, V4, P773, DOI 10.1074/mcp.M400180-MCP200; Herrero M, 2008, ELECTROPHORESIS, V29, P2148, DOI 10.1002/elps.200700404; HOCHHAUS G, 1988, PHARM RES-DORDR, V5, P232, DOI 10.1023/A:1015993713471; Jonkheijm P, 2008, ANGEW CHEM INT EDIT, V47, P9618, DOI 10.1002/anie.200801711; Kim H, 2008, ULTRAMICROSCOPY, V108, P1152, DOI 10.1016/j.ultramic.2008.04.049; Klonisch T, 1996, IMMUNOLOGY, V89, P165, DOI 10.1046/j.1365-2567.1996.d01-722.x; Kusnezow W, 2002, BIOTECHNIQUES, P14; LIABAKK NB, 1990, J IMMUNOL METHODS, V134, P253, DOI 10.1016/0022-1759(90)90387-B; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; McMahon SB, 2004, J NEUROBIOL, V61, P72, DOI 10.1002/neu.20093; Miller JC, 2003, PROTEOMICS, V3, P56, DOI 10.1002/pmic.200390009; NADERDJALAL N, 1995, ANESTH ANALG, V81, P591, DOI 10.1097/00000539-199509000-00030; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; Peluso P, 2003, ANAL BIOCHEM, V312, P113, DOI 10.1016/S0003-2697(02)00442-6; PRINCE WS, 1987, J PHARMACEUT BIOMED, V5, P793, DOI 10.1016/0731-7085(87)80097-3; Seurynck-Servoss SL, 2007, ANAL BIOCHEM, V371, P105, DOI 10.1016/j.ab.2007.07.010; TAKEYAMA M, 1990, CHEM PHARM BULL, V38, P3494, DOI 10.1248/cpb.38.3494; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; WESKAMP G, 1987, J NEUROCHEM, V48, P1779, DOI 10.1111/j.1471-4159.1987.tb05736.x; Wu WW, 2009, MOL CELL PROTEOMICS, V8, P245, DOI 10.1074/mcp.M800171-MCP200; Zheng JY, 2006, INT J PHARM, V308, P46, DOI 10.1016/j.ijpharm.2005.10.024; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	38	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51370	10.1371/journal.pone.0051370	http://dx.doi.org/10.1371/journal.pone.0051370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236488	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100107
J	Memminger, M; Keller, M; Lopuch, M; Pop, N; Bernhardt, G; von Angerer, E; Buschauer, A				Memminger, Martin; Keller, Max; Lopuch, Miroslaw; Pop, Nathalie; Bernhardt, Guenther; von Angerer, Erwin; Buschauer, Armin			The Neuropeptide Y Y-1 Receptor: A Diagnostic Marker? Expression in MCF-7 Breast Cancer Cells Is Down-Regulated by Antiestrogens In Vitro and in Xenografts	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; FUNCTIONAL EXPRESSION; PROGESTERONE-RECEPTOR; ADENYLATE-CYCLASE; ENDOCRINE THERAPY; HIGHLY POTENT; PEPTIDE-YY; ANTAGONIST; ALPHA; TARGETS	The neuropeptide Y (NPY) Y-1 receptor (Y1R) has been suggested as a tumor marker for in vivo imaging and as a therapeutic target. In view of the assumed link between estrogen receptor (ER) and Y1R in mammary carcinoma and with respect to the development of new diagnostic tools, we investigated the Y1R protein expression in human MCF-7 cell variants differing in ER content and sensitivity against antiestrogens. ER and Y1R expression were quantified by radioligand binding using [H-3]-17 beta-estradiol and the Y1R selective antagonist [H-3]-UR-MK114, respectively. The latter was used for cellular binding studies and for autoradiography of MCF-7 xenografts. The fluorescent ligands Cy5-pNPY (universal Y1R, Y2R and Y5R agonist) and UR-MK22 (selective Y1R antagonist), as well as the selective antagonists BIBP3226 (Y1R), BIIE0246 (Y2R) and CGP71683 (Y5R) were used to identify the NPY receptor subtype(s) by confocal microscopy. Y1R functionality was determined by mobilization of intracellular Ca2+. Sensitivity of MCF-7 cells against antiestrogen 4-hydroxytamoxifen correlated directly with the ER content. The exclusive expression of Y(1)Rs was confirmed by confocal microscopy. The Y1R protein was up-regulated (100%) by 17 beta-estradiol (EC50 20 pM) and the predominant role of ER alpha was demonstrated by using the ER alpha-selective agonist "propylpyrazole triol". 17 beta-Estradiol-induced over-expression of functional Y1R protein was reverted by the antiestrogen fulvestrant (IC50 5 nM) in vitro. Furthermore, tamoxifen treatment of nude mice resulted in an almost total loss of Y(1)Rs in MCF-7 xenografts. In conclusion, the value of the Y1R as a target for therapy and imaging in breast cancer patients may be compromised due to Y1R down-regulation induced by hormonal (antiestrogen) treatment.	[Memminger, Martin; Keller, Max; Lopuch, Miroslaw; Pop, Nathalie; Bernhardt, Guenther; von Angerer, Erwin; Buschauer, Armin] Univ Regensburg, Inst Pharm, Dept Pharmaceut Med Chem 2, D-8400 Regensburg, Germany	University of Regensburg	Buschauer, A (corresponding author), Univ Regensburg, Inst Pharm, Dept Pharmaceut Med Chem 2, D-8400 Regensburg, Germany.	armin.buschauer@chemie.uni-regensburg.de			Graduate Training Program (Graduiertenkolleg) of the German Research Foundation (DFG) [GRK760]; DFG	Graduate Training Program (Graduiertenkolleg) of the German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Supported by the Graduate Training Program (Graduiertenkolleg) GRK760, "Medicinal Chemistry: Molecular Recognition - Ligand-Receptor Interactions" of the German Research Foundation (DFG) and by the DFG within the DFG funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAKERLUND L, 1990, FEBS LETT, V260, P73, DOI 10.1016/0014-5793(90)80069-U; Aiglstorfer I, 2000, BIOORG MED CHEM LETT, V10, P1597, DOI 10.1016/S0960-894X(00)00292-4; Allan GF, 2001, STEROIDS, V66, P663, DOI 10.1016/S0039-128X(01)00131-3; Amlal H, 2006, CANCER RES, V66, P3706, DOI 10.1158/0008-5472.CAN-05-2744; Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; BERNHARDT G, 1992, J CANCER RES CLIN, V118, P35, DOI 10.1007/BF01192309; BERNHARDT G, 1992, CONTR ONCOL, V42, P128; BINDAL RD, 1988, J STEROID BIOCHEM, V31, P287, DOI 10.1016/0022-4731(88)90352-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chatenet D, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-21; Criscione L, 1998, J CLIN INVEST, V102, P2136, DOI 10.1172/JCI4188; Doods H, 1999, EUR J PHARMACOL, V384, pR3, DOI 10.1016/S0014-2999(99)00650-0; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; ENTZEROTH M, 1995, EUR J PHARMACOL, V278, P239, DOI 10.1016/0014-2999(95)00161-D; Fowler AM, 2012, J NUCL MED, V53, P1119, DOI 10.2967/jnumed.112.103465; Gilaberte Y, 2012, J AM ACAD DERMATOL, V66, pE201, DOI 10.1016/j.jaad.2011.02.015; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerin B, 2010, B MENS SOC LINN LYON, P1; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HORWITZ KB, 1978, J BIOL CHEM, V253, P2223; Keller M, 2008, J MED CHEM, V51, P8168, DOI 10.1021/jm801018u; Kempna P, 2010, MOL CELL ENDOCRINOL, V314, P101, DOI 10.1016/j.mce.2009.08.010; Khan IU, 2010, ANGEW CHEM INT EDIT, V49, P1155, DOI 10.1002/anie.200905008; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Korner M, 2008, CLIN CANCER RES, V14, P5043, DOI 10.1158/1078-0432.CCR-07-4551; Korner M, 2008, J NEUROPATH EXP NEUR, V67, P741, DOI 10.1097/NEN.0b013e318180e618; Korner M, 2007, PEPTIDES, V28, P419, DOI 10.1016/j.peptides.2006.08.037; Kuang WW, 1998, NUCLEIC ACIDS RES, V26, P1116, DOI 10.1093/nar/26.4.1116; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; Lu C, 2010, ONCOGENE, V29, P5630, DOI 10.1038/onc.2010.301; Magni P, 2001, ANN ONCOL, V12, pS27, DOI 10.1093/annonc/12.suppl_2.S27; Michel MC, 1998, PHARMACOL REV, V50, P143; Moser C, 2000, CAN J PHYSIOL PHARM, V78, P134, DOI 10.1139/cjpp-78-2-134; MOTULSKY HJ, 1988, AM J PHYSIOL, V255, pE880, DOI 10.1152/ajpendo.1988.255.6.E880; Muller M, 1997, ARCH PHARM, V330, P333, DOI 10.1002/ardp.19973301104; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Reubi JC, 2001, CANCER RES, V61, P4636; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Robertson JFR, 2001, BRIT J CANCER, V85, P11, DOI 10.1054/bjoc.2001.1982; RUDOLF K, 1994, EUR J PHARMACOL, V271, pR11, DOI 10.1016/0014-2999(94)90822-2; Schneider E, 2007, CHEMBIOCHEM, V8, P1981, DOI 10.1002/cbic.200700302; Schneider E, 2006, CHEMBIOCHEM, V7, P1400, DOI 10.1002/cbic.200600163; SCHOBERT R, 2007, CHEMMEDCHEM, V2, P333, DOI DOI 10.1002/CMDC.200600173; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Ziemek R, 2006, EUR J PHARMACOL, V551, P10, DOI 10.1016/j.ejphar.2006.08.075; Zimmermann J, 2005, J STEROID BIOCHEM, V94, P57, DOI 10.1016/j.bmcl.2004.10.040; Zwanziger D, 2008, CURR PHARM DESIGN, V14, P2385, DOI 10.2174/138161208785777397; Zwanziger D, 2008, BIOCONJUGATE CHEM, V19, P1430, DOI 10.1021/bc7004297	50	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51032	10.1371/journal.pone.0051032	http://dx.doi.org/10.1371/journal.pone.0051032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236424	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100055
J	Porco, TC; Gao, DZ; Scott, JC; Shim, E; Enanoria, WT; Galvani, AP; Lietman, TM				Porco, Travis C.; Gao, Daozhou; Scott, James C.; Shim, Eunha; Enanoria, Wayne T.; Galvani, Alison P.; Lietman, Thomas M.			When Does Overuse of Antibiotics Become a Tragedy of the Commons?	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; ANTIMICROBIAL RESISTANCE; ANTIRETROVIRAL THERAPY; COMPETITIVE-EXCLUSION; PENICILLIN RESISTANCE; SUSCEPTIBILITY TESTS; MULTIDRUG-RESISTANT; SELF-INTEREST; HIV; AZITHROMYCIN	Background: Over-prescribing of antibiotics is considered to result in increased morbidity and mortality from drug-resistant organisms. A resulting common wisdom is that it would be better for society if physicians would restrain their prescription of antibiotics. In this view, self-interest and societal interest are at odds, making antibiotic use a classic "tragedy of the commons". Methods and Findings: We developed two mathematical models of transmission of antibiotic resistance, featuring de novo development of resistance and transmission of resistant organisms. We analyzed the decision to prescribe antibiotics as a mathematical game, by analyzing individual incentives and community outcomes. Conclusions: A conflict of interest may indeed result, though not in all cases. Increased use of antibiotics by individuals benefits society under certain circumstances, despite the amplification of drug-resistant strains or organisms. In situations where increased use of antibiotics leads to less favorable outcomes for society, antibiotics may be harmful for the individual as well. For other scenarios, where a conflict between self-interest and society exists, restricting antibody use would benefit society. Thus, a case-by-case assessment of appropriate use of antibiotics may be warranted.	[Porco, Travis C.; Gao, Daozhou; Enanoria, Wayne T.; Lietman, Thomas M.] Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; [Porco, Travis C.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Porco, Travis C.; Enanoria, Wayne T.] Univ Calif Berkeley, Ctr Infect Dis & Emergency Readiness, Berkeley, CA 94720 USA; [Scott, James C.] Colby Coll, Dept Math & Stat, Waterville, ME 04901 USA; [Shim, Eunha] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Galvani, Alison P.] Yale Univ, Sch Med, New Haven, CT USA; [Porco, Travis C.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Lietman, Thomas M.] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Colby College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lietman, TM (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA.	tom.lietman@ucsf.edu	Gao, Daozhou/J-3157-2014	Gao, Daozhou/0000-0003-3991-569X	Research to Prevent Blindness and Modeling Infectious Disease Agent Study [NIH UO1 GM08778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087728] Funding Source: NIH RePORTER	Research to Prevent Blindness and Modeling Infectious Disease Agent Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work supported in part by Research to Prevent Blindness and Modeling Infectious Disease Agent Study (NIH UO1 GM08778) and the authors are grateful for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackleh AS, 2005, DISCRETE CONT DYN-B, V5, P175; Allen L.J.S., 2008, MATH EPIDEMIOLOGY; ANDERSON R M, 1991; ANDERSON RM, 1991, NATURE, V350, P356, DOI 10.1038/350356a0; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], SAG MATH SOFTW VERS; Banerjee R, 2008, EXPERT REV ANTI-INFE, V6, P713, DOI 10.1586/14787210.6.5.713; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Baquero F, 2003, Rev Esp Quimioter, V16, P11; Basar T., 1999, DYNAMIC NONCOOPERATI; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Blower S, 1998, INNOV APPL MATH, P51; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Blower SM, 1998, NAT MED, V4, P673, DOI 10.1038/nm0698-673; Castillo-Chavez C, 1999, SIAM J APPL MATH, V59, P1790, DOI 10.1137/S0036139997325862; Chern KC, 1999, BRIT J OPHTHALMOL, V83, P1332, DOI 10.1136/bjo.83.12.1332; Cizman M, 2003, INT J ANTIMICROB AG, V21, P297, DOI 10.1016/S0924-8579(02)00394-1; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; Conly J, 2010, B WORLD HEALTH ORGAN, V88, P805, DOI 10.2471/BLT.10.031110; Evans JR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001860.pub3; Foster KR, 2006, PLOS MED, V3, P177, DOI 10.1371/journal.pmed.0030029; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Fudenberg D., 1991, GAME THEORY; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Garcia-Rey C, 2002, J CLIN MICROBIOL, V40, P159, DOI 10.1128/JCM.40.1.159-164.2002; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; GREENWOOD D, 1981, J INFECT DIS, V144, P380, DOI 10.1093/infdis/144.4.380; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Lamport L, 1994, LATEX DOCUMENT PREPA; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Lipsitch M, 2001, CLIN INFECT DIS, V32, P1044, DOI 10.1086/319604; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3; LORIAN V, 1990, J ANTIMICROB CHEMOTH, V25, P175, DOI 10.1093/jac/25.1.175; Maher MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029407; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Oldfield EC, 2001, GASTROENTEROL CLIN N, V30, P817, DOI 10.1016/S0889-8553(05)70212-0; Ostrom E., 1994, RULES GAMES COMMON P; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; PINSKY P, 1990, MATH BIOSCI, V98, P103, DOI 10.1016/0025-5564(90)90013-O; Porco TC, 2005, J THEOR BIOL, V233, P91, DOI 10.1016/j.jtbi.2004.09.009; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Reluga TC, 2011, MATH BIOSCI, V230, P67, DOI 10.1016/j.mbs.2011.01.003; Shim E, 2010, MED DECIS MAKING, V30, pE64, DOI 10.1177/0272989X10374112; Telalagic S, 2011, OPTIMAL TREATM UNPUB; Toman K, 2004, TOMANS TUBERCULOSIS, P193; TRAVIS J, 1994, SCIENCE, V264, P360, DOI 10.1126/science.8153615; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; Wright TL, 2006, AM J GASTROENTEROL, V101, pS32, DOI 10.1111/j.1572-0241.2006.00376.x	65	53	56	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e46505	10.1371/journal.pone.0046505	http://dx.doi.org/10.1371/journal.pone.0046505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236344	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100001
J	Swadzba, ME; Hauck, SM; Naim, HY; Amann, B; Deeg, CA				Swadzba, Margarete E.; Hauck, Stefanie M.; Naim, Hassan Y.; Amann, Barbara; Deeg, Cornelia A.			Retinal Glycoprotein Enrichment by Concanavalin A Enabled Identification of Novel Membrane Autoantigen Synaptotagmin-1 in Equine Recurrent Uveitis	PLOS ONE			English	Article							EATON MYASTHENIC SYNDROME; NEUROMYELITIS-OPTICA; AQUAPORIN 4; S-ANTIGEN; EXPRESSION; PROTEIN; GLYCOSYLATION; MODEL; IMMUNOPATHOLOGY; AUTOANTIBODIES	Complete knowledge of autoantigen spectra is crucial for understanding pathomechanisms of autoimmune diseases like equine recurrent uveitis (ERU), a spontaneous model for human autoimmune uveitis. While several ERU autoantigens were identified previously, no membrane protein was found so far. As there is a great overlap between glycoproteins and membrane proteins, the aim of this study was to test whether pre-enrichment of retinal glycoproteins by ConA affinity is an effective tool to detect autoantigen candidates among membrane proteins. In 1D Western blots, the glycoprotein preparation allowed detection of IgG reactions to low abundant proteins in sera of ERU patients. Synaptotagmin-1, a Ca2+-sensing protein in synaptic vesicles, was identified as autoantigen candidate from the pre-enriched glycoprotein fraction by mass spectrometry and was validated as a highly prevalent autoantigen by enzyme-linked immunosorbent assay. Analysis of Syt1 expression in retinas of ERU cases showed a downregulation in the majority of ERU affected retinas to 24%. Results pointed to a dysregulation of retinal neurotransmitter release in ERU. Identification of synaptotagmin-1, the first cell membrane associated autoantigen in this spontaneous autoimmune disease, demonstrated that examination of tissue fractions can lead to the discovery of previously undetected novel autoantigens. Further experiments will address its role in ERU pathology.	[Swadzba, Margarete E.; Amann, Barbara; Deeg, Cornelia A.] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Res Unit Prot Sci, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Veterinary Medicine Hannover, Foundation	Deeg, CA (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	deeg@tiph.vetmed.uni-muenchen.de	Deeg, Cornelia/U-4216-2019; Deeg, Cornelia A/G-4940-2010; Hauck, Stefanie/B-3300-2013	Deeg, Cornelia A/0000-0003-0375-3190; Hauck, Stefanie/0000-0002-1630-6827	Deutsche Forschungsgemeinschaft [SFB 571/3 A5 Deeg]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was financially supported by a grant from Deutsche Forschungsgemeinschaft, SFB 571/3 A5 Deeg, http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel P, 2012, PHYSIOLOGY, V27, P15, DOI 10.1152/physiol.00035.2011; BECKER JW, 1975, J BIOL CHEM, V250, P1513; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Bohm S, 2012, SEMIN IMMUNOPATHOL, V34, P443, DOI 10.1007/s00281-012-0308-x; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; COLLIN JP, 1986, NEUROSCIENCE, V19, P657, DOI 10.1016/0306-4522(86)90288-5; DAVID P, 1993, NEUROMUSCULAR DISORD, V3, P451, DOI 10.1016/0960-8966(93)90095-2; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deeg CA, 2006, ANAT HISTOL EMBRYOL, V35, P412, DOI 10.1111/j.1439-0264.2006.00722.x; Deeg CA, 2002, EXP EYE RES, V75, P127, DOI 10.1006/exer.2002.2011; Deeg CA, 2001, INVEST OPHTH VIS SCI, V42, P393; Deeg CA, 2008, VET OPHTHALMOL, V11, P61, DOI 10.1111/j.1463-5224.2008.00625.x; Deeg CA, 2008, OPHTHAL RES, V40, P151, DOI 10.1159/000119867; Deeg CA, 2007, MOL IMMUNOL, V44, P3291, DOI 10.1016/j.molimm.2007.02.027; Deeg CA, 2007, PROTEOMICS, V7, P1540, DOI 10.1002/pmic.200600795; Deeg CA, 2006, MOL CELL PROTEOMICS, V5, P1462, DOI 10.1074/mcp.M500352-MCP200; Degroote RL, 2012, J PROTEOMICS, V75, P4536, DOI 10.1016/j.jprot.2012.01.023; Eberhardt C, 2011, GLIA, V59, P697, DOI 10.1002/glia.21139; Ehrenhofer MCA, 2002, VET OPHTHALMOL, V5, P39, DOI 10.1046/j.1463-5224.2002.00210.x; Gauba V, 2011, P NATL ACAD SCI USA, V108, P12821, DOI 10.1073/pnas.1110042108; Glavan G, 2009, ANAT REC, V292, P1849, DOI 10.1002/ar.21026; Greif KF, 2013, DEV NEUROBIOL, V73, P27, DOI 10.1002/dneu.22033; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Hauck SM, 2007, J PROTEOME RES, V6, P2121, DOI 10.1021/pr060668y; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Josic D, 2007, PROTEOMICS, V7, P3010, DOI 10.1002/pmic.200700139; Kalsow CM, 1999, INVEST OPHTH VIS SCI, V40, P1611; Kiel C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.83; KOONTZ MA, 1993, SYNAPSE, V14, P268, DOI 10.1002/syn.890140405; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levy RA, 2011, CLIN REV ALLERG IMMU, V41, P214, DOI 10.1007/s12016-011-8267-x; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Liu XQ, 2007, MOL VIS, V13, P309; Lux A, 2010, ANN RHEUM DIS, V69, P92, DOI 10.1136/ard.2009.117101; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; MARTINMOUTOT N, 1993, J PHYSIOLOGY-PARIS, V87, P37, DOI 10.1016/0928-4257(93)90022-L; McNeil BD, 2009, NEURON, V63, P419, DOI 10.1016/j.neuron.2009.08.001; MIRSHAHI M, 1984, BIOL CELL, V52, P195; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; NAIM HY, 1992, ARCH VIROL, V122, P45, DOI 10.1007/BF01321117; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Ratelade J, 2012, INT J BIOCHEM CELL B, V44, P1519, DOI 10.1016/j.biocel.2012.06.013; Redecker P, 1996, CELL TISSUE RES, V283, P443, DOI 10.1007/s004410050555; Schubert D, 2004, J IMMUNOL, V172, P4503, DOI 10.4049/jimmunol.172.7.4503; Shamsi KS, 2012, J GERONTOL A-BIOL, DOI [10.1093/gerona/glr1224, DOI 10.1093/GERONA/GLR1224]; Spiess B M, 2010, Equine Vet J Suppl, P50; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Swadzba ME, 2012, INVEST OPHTH VIS SCI, V53, P294, DOI 10.1167/iovs.11-8734; Takamori M, 2000, AM J MED SCI, V319, P204, DOI 10.1097/00000441-200004000-00002; Takamori M, 2004, BIOCHEM BIOPH RES CO, V322, P1347, DOI 10.1016/j.bbrc.2004.08.040; TAKAMORI M, 1994, ANN NEUROL, V35, P74, DOI 10.1002/ana.410350112; Takamori M, 2008, J NEUROIMMUNOL, V201, P145, DOI 10.1016/j.jneuroim.2008.04.040; Troelsen LN, 2012, J RHEUMATOL, V39, P463, DOI 10.3899/jrheum.110584; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Wang YF, 2008, J PROTEOME RES, V7, P4313, DOI 10.1021/pr8002547; WIGGERT B, 1986, INVEST OPHTH VIS SCI, V27, P1041; Zhao M, 2011, INVEST OPHTH VIS SCI, V52, P6340, DOI 10.1167/iovs.11-7675; Zipplies JK, 2012, VET OPHTHALMOL, V15, P57, DOI 10.1111/j.1463-5224.2012.01010.x	63	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50929	10.1371/journal.pone.0050929	http://dx.doi.org/10.1371/journal.pone.0050929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236410	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100046
J	Ameh, C; Msuya, S; Hofman, J; Raven, J; Mathai, M; van den Broek, N				Ameh, Charles; Msuya, Sia; Hofman, Jan; Raven, Joanna; Mathai, Matthews; van den Broek, Nynke			Status of Emergency Obstetric Care in Six Developing Countries Five Years before the MDG Targets for Maternal and Newborn Health	PLOS ONE			English	Article							CHILD HEALTH; SERVICES; AVAILABILITY; MORTALITY; QUALITY; IMPROVEMENT; ASSISTANCE; COUNTDOWN	Background: Ensuring women have access to good quality Emergency Obstetric Care (EOC) is a key strategy to reducing maternal and newborn deaths. Minimum coverage rates are expected to be 1 Comprehensive (CEOC) and 4 Basic EOC (BEOC) facilities per 500,000 population. Methods and Findings: A cross-sectional survey of 378 health facilities was conducted in Kenya, Malawi, Sierra Leone, Nigeria, Bangladesh and India between 2009 and 2011. This included 160 facilities designated to provide CEOC and 218 designated to provide BEOC. Fewer than 1 in 4 facilities aiming to provide CEOC were able to offer the nine required signal functions of CEOC (23.1%) and only 2.3% of health facilities expected to provide BEOC provided all seven signal functions. The two signal functions least likely to be provided included assisted delivery (17.5%) and manual vacuum aspiration (42.3%). Population indicators were assessed for 31 districts (total population = 15.7 million). The total number of available facilities (283) designated to provide EOC for this population exceeded the number required (158) a ratio of 1.8. However, none of the districts assessed met minimum UN coverage rates for EOC. The population based Caesarean Section rate was estimated to be <2%, the maternal Case Fatality Rate (CFR) for obstetric complications ranged from 2.0-9.3% and still birth (SB) rates ranged from 1.9-6.8%. Conclusions: Availability of EOC is well below minimum UN target coverage levels. Health facilities in the surveyed countries do not currently have the capacity to adequately respond to and manage women with obstetric complications. To achieve MDG 5 by 2015, there is a need to ensure that the full range of signal functions are available in health facilities designated to provide CEOC or BEOC and improve the quality of services provided so that CFR and SB rates decline. Citation: Ameh C, Msuya S, Hofman J, Raven J, Mathai M, et al. (2012) Status of Emergency Obstetric Care in Six Developing Countries Five Years before the MDG Targets for Maternal and Newborn Health. PLoS ONE 7(12): e49938. doi:10.1371/journal.pone.0049938	[Ameh, Charles; Msuya, Sia; Hofman, Jan; Raven, Joanna; van den Broek, Nynke] Univ Liverpool, Liverpool Sch Trop Med, Maternal & Newborn Hlth Unit, Liverpool L3 5QA, Merseyside, England; [Mathai, Matthews] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland	Liverpool School of Tropical Medicine; University of Liverpool; World Health Organization	Msuya, S (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Maternal & Newborn Hlth Unit, Liverpool L3 5QA, Merseyside, England.	cehercod@liv.ac.uk	Ameh, Charles Anawo/I-9872-2019	Ameh, Charles Anawo/0000-0002-2341-7605; Raven, Joanna/0000-0002-4112-6959; van den Broek, Nynke/0000-0001-8523-2684	DFID UK (Department of International Development), UNICEF Sierra Leone	DFID UK (Department of International Development), UNICEF Sierra Leone	The project is funded by DFID UK (Department of International Development), UNICEF Sierra Leone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; AMDD working group on indicators, 2002, INT J GYNECOL OBSTET, V78, P277; Bailey P, 2006, INT J GYNECOL OBSTET, V93, P285, DOI 10.1016/j.ijgo.2006.01.028; Bailey PE, 2002, INT J GYNECOL OBSTET, V77, P277; Bradley S, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-14; Cotter AM, 2001, COCHRANE DB SYST REV; Dumont A, 2006, B WORLD HEALTH ORGAN, V84, P218, DOI 10.2471/BLT.05.023903; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Government of India, 2010, FDN COURS REOR BAS E; Grady K, 2011, J OBSTET GYNAECOL, V31, P18, DOI 10.3109/01443615.2010.533218; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Hussein J, 2001, INT J GYNECOL OBSTET, V75, P63, DOI 10.1016/S0020-7292(01)00474-X; Islam MT, 2005, INT J GYNECOL OBSTET, V91, P298, DOI 10.1016/j.ijgo.2005.06.029; Kongnyuy EJ, 2008, BRIT J OBSTET GYNAEC, V116, P7; Kongnyuy EJ, 2009, MATERN CHILD HLTH J, V13, P687, DOI 10.1007/s10995-008-0380-y; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lehmann U, 2008, MIDLEVEL HLTH WORKER, P42; Leigh B, 2008, INT J GYNECOL OBSTET, V101, P107, DOI 10.1016/j.ijgo.2008.01.012; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; More NS, 2009, INT HEALTH, V1, P71, DOI 10.1016/j.inhe.2009.02.004; Oyerinde K, 2011, INT J GYNECOL OBSTET, V114, P168, DOI 10.1016/j.ijgo.2011.05.006; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Pearson L, 2005, INT J GYNECOL OBSTET, V88, P208, DOI 10.1016/j.ijgo.2004.09.027; Pereira C, 2011, INT J GYNECOL OBSTET, V114, P180, DOI 10.1016/j.ijgo.2011.05.004; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Raven J, 2011, INT J GYNECOL OBSTET, V114, P4, DOI 10.1016/j.ijgo.2011.02.007; Ronsmans C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S8; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WHO UNFPA UNICEF, 2009, MON EM OBST CAR HDB; WHO UNICEF UNFPA & Bank T. W, 2010, TRENDS MAT MORT 1990; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization and UNICEF, 2010, COUNTD 2015 DEC REP; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	37	89	89	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e49938	10.1371/journal.pone.0049938	http://dx.doi.org/10.1371/journal.pone.0049938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236357	Green Published, gold, Green Accepted			2022-12-25	WOS:000312589700006
J	Tyagi, RK; Sharma, YD				Tyagi, Rupesh Kumar; Sharma, Yagya Dutta			Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED MUTATIONS; DIHYDROPTEROATE SYNTHASE; IMMUNOLOGICAL RESPONSES; DIHYDROFOLATE-REDUCTASE; MALARIA; FALCIPARUM; PROTEIN; IDENTIFICATION; INVASION; EXPRESSION	Plasmodium vivax is a very common but non-cultivable malaria parasite affecting large human population in tropical world. To develop therapeutic reagents for this malaria, the parasite molecules involved in host-parasite interaction need to be investigated as they form effective vaccine or drug targets. We have investigated here the erythrocyte binding activity of a group of 15 different Plasmodium vivax tryptophan rich antigens (PvTRAgs). Only six of them, named PvTRAg, PvTRAg38, PvTRAg33.5, PvTRAg35.2 PvTRAg69.4 and PvATRAg74, showed binding to host erythrocytes. That the PvTRAgs binding to host erythrocytes was specific was evident from the competitive inhibition and saturation kinetics results. The erythrocyte receptors for these six PvTRAgs were resistant to trypsin and neuraminidase. These receptors were also chymotrypsin resistant except the receptors for PvTRAg38 and PvATRAg74 which were partially sensitive to this enzyme. The cross-competition studies showed that the chymotrypsin resistant RBC receptor for each of these two proteins was different. Altogether, there seems to be three RBC receptors for these six PvTRAgs and each PvTRAg has two RBC receptors. Both RBC receptors for PvTRAg, PvTRAg69.4, PvTRAg33.5, and PvTRAg35.2 were common to all these four proteins. These four PvTRAgs also shared one of their RBC receptors with PvTRAg38 as well as with PvATRAg74. The erythrocyte binding activity of these six PvTRAgs was inhibited by the respective rabbit polyclonal antibodies as well as by the natural antibodies produced by the P. vivax exposed individuals. It is concluded that only selective few PvTRAgs show erythrocyte binding activity involving different receptor molecules which can be blocked by the natural antibodies. Further studies on these receptor and ligands may lead to the development of therapeutic reagents for P. vivax malaria. Citation: Tyagi RK, Sharma YD (2012) Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies. PLoS ONE 7(12): e50754. doi:10.1371/journal.pone.0050754	[Tyagi, Rupesh Kumar; Sharma, Yagya Dutta] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	ydsharma_aiims@yahoo.com		Tyagi, Rupesh/0000-0002-5095-8976	Department of Biotechnology [BT/PR9800/MED/29/44/2007]; Senior Research Fellowships of the Government of India	Department of Biotechnology; Senior Research Fellowships of the Government of India	This work was supported by the Department of Biotechnology (BT/PR9800/MED/29/44/2007 to Y.D.S. and Senior Research Fellowships to R.K.T.) of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2008, PARASITE IMMUNOL, V30, P379, DOI 10.1111/j.1365-3024.2008.01033.x; Alam MT, 2008, VACCINE, V26, P3787, DOI 10.1016/j.vaccine.2008.05.059; Alam MT, 2007, ANTIMICROB AGENTS CH, V51, P857, DOI 10.1128/AAC.01200-06; Barnadas C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-282; Bora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016294; Burns JM, 2000, MOL BIOCHEM PARASIT, V110, P11, DOI 10.1016/S0166-6851(00)00252-8; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chotivanich K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034509; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; Curtidor H, 2004, VACCINE, V22, P1054, DOI 10.1016/j.vaccine.2003.07.019; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Garg S, 2008, MICROBES INFECT, V10, P1097, DOI 10.1016/j.micinf.2008.05.008; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Jasklewicz E, 2010, POSTEP HIG MED DOSW, V64, P617; Jovel IT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-376; Kitagawa Y, 2011, J VIROL, V85, P4606, DOI 10.1128/JVI.02012-10; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Kuesap J, 2011, MEM I OSWALDO CRUZ, V106, P130, DOI 10.1590/S0074-02762011000900017; Kute VB, 2012, EMERG INFECT DIS, V18, P842, DOI 10.3201/eid1805.111442; Li J, 2012, BIOCHEM BIOPH RES CO, V426, P1, DOI 10.1016/j.bbrc.2012.08.055; Lin CH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-85; Lu F, 2010, AM J TROP MED HYG, V83, P474, DOI 10.4269/ajtmh.2010.10-0004; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Mittra P, 2010, MICROBES INFECT, V12, P1019, DOI 10.1016/j.micinf.2010.07.004; Mulky A, 2005, J MOL BIOL, V349, P673, DOI 10.1016/j.jmb.2005.03.057; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; Persson KEM, 2010, ACTA TROP, V114, P138, DOI 10.1016/j.actatropica.2009.05.017; Rodriguez-Morales AJ, 2006, AM J TROP MED HYG, V74, P755, DOI 10.4269/ajtmh.2006.74.755; Rogerson SJ, 2008, PLOS MED, V5, P875, DOI 10.1371/journal.pmed.0050136; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Siddiqui AA, 2008, INFECT IMMUN, V76, P2576, DOI 10.1128/IAI.00677-07; Siddiqui AA, 2007, VACCINE, V26, P96, DOI 10.1016/j.vaccine.2007.10.042; Singh Harpal, 2011, J Infect Public Health, V4, P91, DOI 10.1016/j.jiph.2011.03.002; Smith KJ, 1996, J BIOL CHEM, V271, P16703, DOI 10.1074/jbc.271.28.16703; Tanwar GS, 2011, ANN TROP PAEDIATR, V31, P351, DOI 10.1179/1465328111Y.0000000040; Tanwar GS, 2012, PLATELETS, V23, P211, DOI 10.3109/09537104.2011.607520; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tran TM, 2005, CYTOM PART A, V63A, P59, DOI 10.1002/cyto.a.20098; Udomsangpetch R, 1995, T ROY SOC TROP MED H, V89, P635, DOI 10.1016/0035-9203(95)90422-0; Uhlemann AC, 2001, MOL BIOCHEM PARASIT, V118, P41, DOI 10.1016/S0166-6851(01)00370-X; Wickramarachchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001732; Zeeshan M, 2012, J INFECT DIS	57	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50754	10.1371/journal.pone.0050754	http://dx.doi.org/10.1371/journal.pone.0050754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236392	Green Submitted, gold, Green Published			2022-12-25	WOS:000312589700017
J	Wang, ZF; Chen, ZW; Cheng, JP; Lai, YY; Wang, JF; Bao, YM; Huang, J; Zhang, HS				Wang, Zhoufei; Chen, Zhiwei; Cheng, Jinping; Lai, Yanyan; Wang, Jianfei; Bao, Yongmei; Huang, Ji; Zhang, Hongsheng			QTL Analysis of Na+ and K+ Concentrations in Roots and Shoots under Different Levels of NaCl Stress in Rice (Oryza sativa L.)	PLOS ONE			English	Article							SALT TOLERANCE; QUANTITATIVE TRAITS; SALINITY TOLERANCE; SODIUM; EPISTASIS; TRANSPORT; GENES; IDENTIFICATION; POTASSIUM; LINES	The key to plant survival under NaCl salt stress is maintaining a low Na+ level or Na+/K+ ratio in the cells. A population of recombinant inbred lines (RILs, F-2:9) derived from a cross between the salt-tolerant japonica rice variety Jiucaiqing and the salt-sensitive indica variety IR26, was used to determine Na+ and K+ concentrations in the roots and shoots under three different NaCl stress conditions (0, 100 and 120 mM NaCl). A total of nine additive QTLs were identified by QTL Cartographer program using single-environment phenotypic values, whereas eight additive QTLs were identified by QTL IciMapping program. Among these additive QTLs, five were identified by both programs. Epistatic QTLs and QTL-by-environment interactions were detected by QTLNetwork program in the joint analyses of multi-environment phenotypic values, and one additive QTL and nine epistatic QTLs were identified. There were three epistatic QTLs identified for Na+ in roots (RNC), three additive QTLs and two epistatic QTLs identified for Na+ in shoots (SNC), four additive QTLs identified for K+ in roots (RKC), four additive QTLs and three epistatic QTLs identified for K+ in shoots (SKC) and one additive QTL and one epistatic QTL for salt tolerance rating (STR). The phenotypic variation explained by each additive, epistatic QTL and QTLxenvironment interaction ranged from 8.5 to 18.9%, 0.5 to 5.3% and 0.7 to 7.5%, respectively. By comparing the chromosomal positions of these additive QTLs with those previously identified, five additive QTLs, qSNC9, qSKC1, qSKC9, qRKC4 and qSTR7, might represent novel salt tolerance loci. The identification of salt tolerance in selected RILs showed that a major QTL qSNC11 played a significant role in rice salt tolerance, and could be used to improve salt tolerance of commercial rice varieties with marker-assisted selection (MAS) approach. Citation: Wang Z, Chen Z, Cheng J, Lai Y, Wang J, et al. (2012) QTL Analysis of Na+ and K+ Concentrations in Roots and Shoots under Different Levels of NaCl Stress in Rice (Oryza sativa L.). PLoS ONE 7(12): e51202. doi:10.1371/journal.pone.0051202	[Wang, Zhoufei; Chen, Zhiwei; Cheng, Jinping; Lai, Yanyan; Wang, Jianfei; Bao, Yongmei; Huang, Ji; Zhang, Hongsheng] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Lab Seed Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Huang, J (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Lab Seed Sci & Technol, Nanjing, Jiangsu, Peoples R China.	huangji@njau.edu.cn; hszhang@njau.edu.cn	chen, zhiwei/AAP-5465-2020; chen, zhiwei/G-1305-2013; Huang, Ji/AAY-2852-2020	chen, zhiwei/0000-0002-0478-4880; Huang, Ji/0000-0002-9057-4299	National Natural Science Foundation of China [31000748, 31271806]; Special Fund for Agro-scientific Research in the Public Interest [201203052]; Fundamental Research Funds for the Central Universities [KYZ201202-9]; 111 Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (Grant No. 31000748; 31271806), the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201203052), the Fundamental Research Funds for the Central Universities (Grant No. KYZ201202-9) and the 111 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2011, THEOR APPL GENET, V123, P881, DOI 10.1007/s00122-011-1634-4; Ammar MHM, 2009, J PLANT BIOCHEM BIOT, V18, P139, DOI 10.1007/BF03263312; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Chen X, 1997, GENOMICS, V1, P174; Cheng LR, 2012, GENOME, V55, P45, DOI [10.1139/G11-075, 10.1139/g11-075]; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Feki K, 2011, PLANT MOL BIOL, V76, P545, DOI 10.1007/s11103-011-9787-8; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Gregorio GB, 2002, FIELD CROP RES, V76, P91, DOI 10.1016/S0378-4290(02)00031-X; Gregorio GB, 1995, P 2 ASIAN CROP SCI C; GULATI A, 1993, J PLANT PHYSIOL, V141, P120, DOI 10.1016/S0176-1617(11)80862-X; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kader MA, 2006, J EXP BOT, V57, P4257, DOI 10.1093/jxb/erl199; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Lander ES, 1987, THEOR APPL GENET, V95, P553; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Malmberg RL, 2005, GENETICS, V171, P2013, DOI 10.1534/genetics.105.046078; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Mohan A, 2009, EUPHYTICA, V168, P319, DOI 10.1007/s10681-009-9935-2; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pandit A, 2010, MOL GENET GENOMICS, V284, P121, DOI 10.1007/s00438-010-0551-6; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Sahi Chandan, 2006, Functional & Integrative Genomics, V6, P263, DOI 10.1007/s10142-006-0032-5; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Shen XL, 2006, CROP SCI, V46, P61, DOI 10.2135/cropsci2005.0056; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Wang S, 2007, WINDOW QTL CARTOGRAP; Wang ZF, 2010, SEED SCI TECHNOL, V38, P104, DOI 10.15258/sst.2010.38.1.11; Wang ZF, 2012, THEOR APPL GENET, V125, P807, DOI 10.1007/s00122-012-1873-z; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; Wu YS, 2009, PLANT GROWTH REGUL, V57, P271, DOI 10.1007/s10725-008-9345-9; Wurschum T, 2011, THEOR APPL GENET, V123, P109, DOI 10.1007/s00122-011-1570-3; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Yang J, 2005, QTLNETWORK 2 0; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1; YEO AR, 1982, PHYSIOL PLANTARUM, V56, P343, DOI 10.1111/j.1399-3054.1982.tb00350.x; Yoshida S., 1976, LAB MANUAL PHYSL STU	44	66	77	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51202	10.1371/journal.pone.0051202	http://dx.doi.org/10.1371/journal.pone.0051202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236455	gold, Green Published, Green Submitted			2022-12-25	WOS:000312589700032
J	Rodenburg, G; Kremers, SPJ; Oenema, A; van de Mheen, D				Rodenburg, Gerda; Kremers, Stef P. J.; Oenema, Anke; van de Mheen, Dike			Associations of Children's Appetitive Traits with Weight and Dietary Behaviours in the Context of General Parenting	PLOS ONE			English	Article							EATING BEHAVIOR; SOFT DRINKS; CHILDHOOD OVERWEIGHT; FRUIT; OBESITY; STYLE; QUESTIONNAIRE; VALIDITY; SUSCEPTIBILITY; REPRODUCIBILITY	Background: Individual variations in child weight can be explained by genetic and behavioural susceptibility to obesity. Behavioural susceptibility can be expressed in appetite-related traits, e.g. food responsiveness. Research into such behavioural factors is important, as it can provide starting points for (preventive) interventions. Objectives: To examine associations of children's appetitive traits with weight and with fruit, snack and sugar-sweetened beverage intake, and to examine whether parenting style interacts with appetite in determining child weight/intake. Methods: Data were used from 1275 children participating in the INPACT study in 2009-2010, with a mean age of 9 years in 2009. Their height and weight were measured to calculate body mass index (BMI). Parents completed a questionnaire to measure children's appetitive traits, children's dietary intake and parenting style. Child BMI z-scores, fruit, snack and sugar-sweetened beverage intake were regressed on appetitive traits. Moderation by parenting style was tested by adding interaction terms to the regression analyses. Results: Food-approaching appetitive traits were positively, and food-avoidant appetitive traits were negatively related to child BMI z-scores and to child fruit intake. There were no or less consistent associations for snack and sugar-sweetened beverage intake. Authoritative parenting voided the negative association between food fussiness and fruit intake, while neglecting parenting strengthened the positive association between food-approaching appetitive traits and weight. Conclusions: Early assessment of appetitive traits could be used to identify children at risk for overweight. As parenting style can moderate the associations between appetitive traits and weight/intake in a favourable way, parents are a promising target group for preventive interventions aimed at influencing the effect of appetitive traits on children. Citation: Rodenburg G, Kremers SPJ, Oenema A, van de Mheen D (2012) Associations of Children's Appetitive Traits with Weight and Dietary Behaviours in the Context of General Parenting. PLoS ONE 7(12): e50642. doi:10.1371/journal.pone.0050642	[Rodenburg, Gerda; van de Mheen, Dike] IVO Addict Res Inst, Rotterdam, Netherlands; [Rodenburg, Gerda; van de Mheen, Dike] Erasmus MC, Rotterdam, Netherlands; [Kremers, Stef P. J.; Oenema, Anke] Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Maastricht University	Rodenburg, G (corresponding author), IVO Addict Res Inst, Rotterdam, Netherlands.	rodenburg@ivo.nl	Oenema, Anke/D-7709-2017	Oenema, Anke/0000-0002-4350-5821	ZonMw, The Netherlands Organisation for Health Research and Development [121010011]	ZonMw, The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Financial support for the INPACT study was provided by ZonMw, The Netherlands Organisation for Health Research and Development (grant ID no. 121010011; www.zonmw.nl/en/). ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinia S, 2009, OBES REV, V10, P639, DOI 10.1111/j.1467-789X.2009.00582.x; [Anonymous], 2003, DIET NUTR PREV CHRON; ARCHER LA, 1991, J PEDIATR PSYCHOL, V16, P629, DOI 10.1093/jpepsy/16.5.629; Ashcroft J, 2008, EUR J CLIN NUTR, V62, P985, DOI 10.1038/sj.ejcn.1602855; Baranowski T, 1997, J AM DIET ASSOC, V97, P66, DOI 10.1016/S0002-8223(97)00022-9; Beyers W, 1999, J ADOLESCENCE, V22, P753, DOI 10.1006/jado.1999.0268; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Braet C, 2008, J HEALTH PSYCHOL, V13, P733, DOI 10.1177/1359105308093850; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Carnell S, 2011, APPETITE, V57, P665, DOI 10.1016/j.appet.2011.08.009; Carnell S, 2008, AM J CLIN NUTR, V88, P22, DOI 10.1093/ajcn/88.1.22; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Carnell S, 2009, APPETITE, V53, P260, DOI 10.1016/j.appet.2009.07.014; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527; Croker H, 2011, APPETITE, V57, P525, DOI 10.1016/j.appet.2011.05.320; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; Elfhag K, 2007, PHYSIOL BEHAV, V91, P191, DOI 10.1016/j.physbeh.2007.02.005; Elfhag Kristina, 2008, Eat Behav, V9, P285, DOI 10.1016/j.eatbeh.2007.10.003; Elfhag K, 2008, PUBLIC HEALTH NUTR, V11, P914, DOI 10.1017/S1368980008002371; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Goossens L, 1999, 9 EUR C DEV PSYCH IS; Haraldsdottir J, 2005, ANN NUTR METAB, V49, P221, DOI 10.1159/000087276; Huver RME, 2007, PSYCHOL HEALTH, V22, P575, DOI 10.1080/14768320600976182; Huver RME, 2007, DRUG ALCOHOL DEPEN, V89, P116, DOI 10.1016/j.drugalcdep.2006.12.005; Keij I., 2000, INDEX, V10, P24; Kral TVE, 2010, PHYSIOL BEHAV, V100, P567, DOI 10.1016/j.physbeh.2010.04.031; Kremers SP, 2003, APPETITE, V41, P43, DOI 10.1016/S0195-6663(03)00038-2; LAMBORN SD, 1991, CHILD DEV, V62, P1049, DOI 10.2307/1131151; Pearson N, 2010, PUBLIC HEALTH NUTR, V13, P1245, DOI 10.1017/S1368980009992217; Pinard CA, 2011, PUBLIC HEALTH NUTR, V7, P1; Powers SW, 2006, OBESITY, V14, P2026, DOI 10.1038/oby.2006.237; Rennie KL, 2005, BEST PRACT RES CL EN, V19, P343, DOI 10.1016/j.beem.2005.04.003; Santos JL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-108; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; Spence JC, 2011, INT J PEDIATR OBES, V6, pE501, DOI 10.3109/17477166.2010.512087; STEINBERG L, 1989, CHILD DEV, V60, P1424, DOI 10.1111/j.1467-8624.1989.tb04014.x; Sweetman C, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-60; Van Assema Patricia, 2002, Nutrition and Health (Bicester), V16, P85; van Jaarsveld CHM, 2011, AM J CLIN NUTR, V94, P1562, DOI 10.3945/ajcn.111.015818; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Viana V, 2008, BRIT J NUTR, V100, P445, DOI 10.1017/S0007114508894391; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wardle J, 2009, ANN BEHAV MED, V38, pS25, DOI 10.1007/s12160-009-9116-5; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219; Webber L, 2010, J AM DIET ASSOC, V110, P1718, DOI 10.1016/j.jada.2010.08.007; WHO, 2002, WORLD HLTH REP RED R; Wudy SA, 2005, PEDIATRICS, V116, pE52, DOI 10.1542/peds.2004-1684	55	40	41	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50642	10.1371/journal.pone.0050642	http://dx.doi.org/10.1371/journal.pone.0050642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227194	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200054
J	Barnes, JM; Nauseef, JT; Henry, MD				Barnes, J. Matthew; Nauseef, Jones T.; Henry, Michael D.			Resistance to Fluid Shear Stress Is a Conserved Biophysical Property of Malignant Cells	PLOS ONE			English	Article							TUMOR-CELLS; CANCER-CELLS; EXTRACELLULAR-MATRIX; METASTASIS; FLOW; CYTOSKELETON; ADHESION; MICROCIRCULATION; EXTRAVASATION; HEMOLYSIS	During metastasis, cancer cells enter the circulation in order to gain access to distant tissues, but how this fluid microenvironment influences cancer cell biology is poorly understood. A longstanding view is that circulating cancer cells derived from solid tissues may be susceptible to damage from hemodynamic shear forces, contributing to metastatic inefficiency. Here we report that compared to non-transformed epithelial cells, transformed cells are remarkably resistant to fluid shear stress (FSS) in a microfluidic protocol, exhibiting a biphasic decrease in viability when subjected to a series of millisecond pulses of high FSS. We show that magnitude of FSS resistance is influenced by several oncogenes, is an adaptive and transient response triggered by plasma membrane damage and requires extracellular calcium and actin cytoskeletal dynamics. This novel property of malignant cancer cells may facilitate hematogenous metastasis and indicates, contrary to expectations, that cancer cells are quite resistant to destruction by hemodynamic shear forces. Citation: Barnes JM, Nauseef JT, Henry MD (2012) Resistance to Fluid Shear Stress Is a Conserved Biophysical Property of Malignant Cells. PLoS ONE 7(12): e50973. doi: 10.1371/journal.pone.0050973	[Barnes, J. Matthew; Nauseef, Jones T.; Henry, Michael D.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Nauseef, Jones T.; Henry, Michael D.] Univ Iowa, Med Scientist Training Program, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Henry, Michael D.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Barnes, J. Matthew; Nauseef, Jones T.; Henry, Michael D.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Henry, MD (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-henry@uiowa.edu		Henry, Michael/0000-0002-7871-245X	Department of Defense [W81XWH-10-1-0313, W81XWH-12-1-0163]; Holden Comprehensive Cancer Center [P30 CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Department of Defense pre-doctoral fellowship, W81XWH-10-1-0313 to JMB, pilot funding from the Holden Comprehensive Cancer Center P30 CA086862 and Department of Defense award W81XWH-12-1-0163 to MDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AJ, 2011, CIRCULATING TUMOR CE; Avvisato CL, 2007, J CELL SCI, V120, P2672, DOI 10.1242/jcs.03476; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; BROOKS DE, 1984, BIORHEOLOGY, V21, P85; Chandran KB, 2001, DYNAMIC BEHAV MECH H; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; CLARKE MSF, 1992, J CELL SCI, V102, P533; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; De Giorgi V, 2010, ARCH DERMATOL, V146, P1120, DOI 10.1001/archdermatol.2010.264; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Du GS, 2011, BIOMED MICRODEVICES, V13, P29, DOI 10.1007/s10544-010-9468-4; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; GOLDSMITH H, 1961, NATURE, V190, P1095, DOI 10.1038/1901095a0; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Haier J, 1999, CLIN EXP METASTAS, V17, P377, DOI 10.1023/A:1006658414040; Hur SC, 2011, LAB CHIP, V11, P912, DOI 10.1039/c01c00595a; KOOP S, 1995, CANCER RES, V55, P2520; Korb T, 2004, EXP CELL RES, V299, P236, DOI 10.1016/j.yexcr.2004.06.001; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Miyake K, 2001, J CELL SCI, V114, P3487; OCHALEK T, 1988, CANCER RES, V48, P5124; Okuyama M, 1996, J CELL BIOCHEM, V63, P432; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Reneman RS, 2008, MED BIOL ENG COMPUT, V46, P499, DOI 10.1007/s11517-008-0330-2; ROONEY JA, 1970, SCIENCE, V169, P869, DOI 10.1126/science.169.3948.869; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; STRONY J, 1993, AM J PHYSIOL, V265, pH1787; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Thamilselvan V, 2004, J CELL BIOCHEM, V92, P361, DOI 10.1002/jcb.20072; Truskey GA, 2009, BIOL SYSTEMS; Turgeon M.L., 2005, CLIN HEMATOLOGY THEO; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WEISS L, 1992, INT J CANCER, V50, P103, DOI 10.1002/ijc.2910500121; WILLIAMS AR, 1970, SCIENCE, V169, P871, DOI 10.1126/science.169.3948.871; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; ZEIDMAN I, 1950, CANCER RES, V10, P357	45	106	109	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2012	7	12							e50973	10.1371/journal.pone.0050973	http://dx.doi.org/10.1371/journal.pone.0050973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DH	23226552	Green Submitted, gold, Green Published			2022-12-25	WOS:000312104700028
J	Fujita, M; Takada, YK; Takada, Y				Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu			Insulin-like Growth Factor (IGF) Signaling Requires alpha v beta 3-IGF1-IGF Type 1 Receptor (IGF1R) Ternary Complex Formation in Anchorage Independence, and the Complex Formation Does Not Require IGF1R and Src Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA CELLS; SMOOTH-MUSCLE-CELLS; FACTOR-I RECEPTOR; V BETA 3; INTEGRIN ALPHA-V-BETA-3; DIRECT BINDING; TYROSINE PHOSPHORYLATION; HUMAN SKIN; ALPHA(V)BETA(3); ANGIOGENESIS	Integrin alpha v beta 3 plays a role in insulin-like growth factor 1 (IGF1) signaling (integrin-IGF1 receptor (IGF1R) cross-talk) in non-transformed cells in anchorage-dependent conditions. We reported previously that IGF1 directly binds to alpha v beta 3 and induces alpha v beta 3-IGF1-IGF1R ternary complex formation in these conditions. The integrin-binding defective IGF1 mutant (R36E/R37E) is defective in inducing ternary complex formation and IGF signaling, whereas it still binds to IGF1R. We studied if IGF1 can induce signaling in anchorage-independent conditions in transformed Chinese hamster ovary cells that express alpha v beta 3 (beta 3-CHO) cells. Here we describe that IGF1 signals were more clearly detectable in anchorage-independent conditions (poly-HEMA-coated plates) than in anchorage-dependent conditions. This suggests that IGF signaling is masked by signals from cell-matrix interaction in anchorage-dependent conditions. IGF signaling required alpha v beta 3 expression, and R36E/R37E was defective in inducing signals in polyHEMA-coated plates. These results suggest that alpha v beta 3-IGF1 interaction, not alpha v beta 3-extracellular matrix interaction, is essential for IGF signaling. Inhibitors of IGF1R, Src, AKT, and ERK1/2 did not suppress alpha v beta 3-IGF-IGF1R ternary complex formation, suggesting that activation of these kinases are not required for ternary complex formation. Also, mutations of the beta 3 cytoplasmic tail (Y747F and Y759F) that block beta 3 tyrosine phosphorylation did not affect IGF1R phosphorylation or AKT activation. We propose a model in which IGF1 binding to IGF1R induces recruitment of integrin alpha v beta 3 to the IGF-IGF1R complex and then beta 3 and IGF1R are phosphorylated. It is likely that alpha v beta 3 should be together with the IGF1-IGF1R complex for triggering IGF signaling.	[Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA13015, DOD W81XWH-10-1-0312]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK088752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA13015 and DOD W81XWH-10-1-0312 (to Y. T.).	Akakura N, 2006, CANCER RES, V66, P9691, DOI 10.1158/0008-5472.CAN-06-1686; Blystone SD, 2002, J BIOL CHEM, V277, P46886, DOI 10.1074/jbc.M209506200; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Clemmons DR, 2003, ENDOCRINOLOGY, V144, P1664, DOI 10.1210/en.2002-221102; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Felding-Habermann B, 2002, CLIN EXP METASTAS, V19, P427, DOI 10.1023/A:1016377114119; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; GEHLSEN KR, 1992, CLIN EXP METASTAS, V10, P111, DOI 10.1007/BF00114587; Huveneers S, 2010, THESCIENTIFICWORLDJO, V10, P1100, DOI 10.1100/tsw.2010.114; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200; Ling Y, 2003, MOL ENDOCRINOL, V17, P1824, DOI 10.1210/me.2003-0143; Maile LA, 2001, J CELL SCI, V114, P1417; MITJANS F, 1995, J CELL SCI, V108, P2825; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; NIP J, 1992, J CLIN INVEST, V90, P1406, DOI 10.1172/JCI116007; Petitclerc E, 1999, CANCER RES, V59, P2724; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; STEPHENSON JR, 1971, P NATL ACAD SCI USA, V68, P1542, DOI 10.1073/pnas.68.7.1542; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Xi G, 2008, J CELL PHYSIOL, V214, P306, DOI 10.1002/jcp.21196; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273; Zheng B, 1998, J BIOL CHEM, V273, P8994, DOI 10.1074/jbc.273.15.8994	39	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3059	3069		10.1074/jbc.M112.412536	http://dx.doi.org/10.1074/jbc.M112.412536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23243309	Green Published, hybrid			2022-12-25	WOS:000314397900016
J	Avet, C; Garrel, G; Denoyelle, C; Laverriere, JN; Counis, R; Cohen-Tannoudji, J; Simon, V				Avet, Charlotte; Garrel, Ghislaine; Denoyelle, Chantal; Laverriere, Jean-Noel; Counis, Raymond; Cohen-Tannoudji, Joelle; Simon, Violaine			SET Protein Interacts with Intracellular Domains of the Gonadotropin-releasing Hormone Receptor and Differentially Regulates Receptor Signaling to cAMP and Calcium in Gonadotrope Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR; GNRH RECEPTOR; KINASE-A; LUTEINIZING-HORMONE; PHOSPHATASE 2A; CYCLIC-AMP; FACTOR-I; PITUITARY; GENE; PHOSPHORYLATION	In mammals, the receptor of the neuropeptide gonadotropin-releasing hormone (GnRHR) is unique among the G protein-coupled receptor (GPCR) family because it lacks the carboxyl-terminal tail involved in GPCR desensitization. Therefore, mechanisms involved in the regulation of GnRHR signaling are currently poorly known. Here, using immunoprecipitation and GST pull-down experiments, we demonstrated that SET interacts with GnRHR and targets the first and third intracellular loops. We delineated, by site-directed mutagenesis, SET binding sites to the basic amino acids (KRKK69)-K-66 and (RK247)-R-246, located next to sequences required for receptor signaling. The impact of SET on GnRHR signaling was assessed by decreasing endogenous expression of SET with siRNA in gonadotrope cells. Using cAMP and calcium biosensors in gonadotrope living cells, we showed that SET knockdown specifically decreases GnRHR-mediated mobilization of intracellular cAMP, whereas it increases its intracellular calcium signaling. This suggests that SET influences signal transfer between GnRHR and G proteins to enhance GnRHR signaling to cAMP. Accordingly, complexing endogenous SET by introduction of the first intracellular loop of GnRHR in alpha T3-1 cells significantly reduced GnRHR activation of the cAMP pathway. Furthermore, decreasing SET expression prevented cAMP-mediated GnRH stimulation of Gnrhr promoter activity, highlighting a role of SET in gonadotropin-releasing hormone regulation of gene expression. In conclusion, we identified SET as the first direct interacting partner of mammalian GnRHR and showed that SET contributes to a switch of GnRHR signaling toward the cAMP pathway.	[Avet, Charlotte; Garrel, Ghislaine; Denoyelle, Chantal; Laverriere, Jean-Noel; Counis, Raymond; Cohen-Tannoudji, Joelle; Simon, Violaine] Univ Paris Diderot, Equipe Physiol Axe Gonadotrope, CNRS EAC 4413, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Simon, V (corresponding author), Univ Paris Diderot, Equipe Physiol Axe Gonadotrope, CNRS EAC 4413, Case Courrier 7007,4 Rue MA Lagroua Weill Halle, F-75013 Paris, France.	violaine.simon@univ-paris-diderot.fr	GARREL, Ghislaine/L-2654-2017; Laverriere, Jean-Noel/L-3286-2017	GARREL, Ghislaine/0000-0001-8547-1191; Laverriere, Jean-Noel/0000-0003-0442-1358; simon, violaine/0000-0002-4417-127X	Paris 7 University; CNRS; University Paris 11	Paris 7 University; CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris 11	This work was supported by grants from Paris 7 University and CNRS.; Supported by a fellowship from the University Paris 11.	Arora KK, 1998, J BIOL CHEM, V273, P25581, DOI 10.1074/jbc.273.40.25581; BAUERDANTOIN AC, 1993, ENDOCRINOLOGY, V133, P1911, DOI 10.1210/en.133.4.1911; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Borroto-Escuela DO, 2011, J NEUROSCI METH, V195, P161, DOI 10.1016/j.jneumeth.2010.11.025; Chauvin S, 2000, MOL PHARMACOL, V57, P625, DOI 10.1124/mol.57.3.625; Cohen-Tannoudji Joelle, 2012, Front Endocrinol (Lausanne), V3, P107, DOI 10.3389/fendo.2012.00107; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Counis R, 2005, REPROD NUTR DEV, V45, P243, DOI 10.1051/rnd:2005017; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Garrel G, 2010, BIOL REPROD, V82, P1170, DOI 10.1095/biolreprod.109.082925; Granger A, 2006, MOL ENDOCRINOL, V20, P2093, DOI 10.1210/me.2005-0184; Hamid T, 2008, INT J ONCOL, V33, P1055, DOI 10.3892/ijo_00000094; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Horton CD, 2004, J MOL ENDOCRINOL, V32, P291, DOI 10.1677/jme.0.0320291; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; KIMURA F, 1980, ENDOCRINOLOGY, V106, P631, DOI 10.1210/endo-106-2-631; Krsmanovic LZ, 2003, P NATL ACAD SCI USA, V100, P2969, DOI 10.1073/pnas.0535708100; Lariviere S, 2007, ENDOCRINOLOGY, V148, P1099, DOI 10.1210/en.2006-1473; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; LERRANT Y, 1995, ENDOCRINOLOGY, V136, P2803, DOI 10.1210/en.136.7.2803; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu FJ, 2003, ENDOCRINOLOGY, V144, P4354, DOI 10.1210/en.2003-0204; Luttrell LM, 2002, J CELL SCI, V115, P455; MA QP, 1995, J PHYSIOL-LONDON, V486, P769, DOI 10.1113/jphysiol.1995.sp020852; Matsumoto K, 1999, MOL CELL BIOL, V19, P6940; Maurice P, 2011, ADV PHARMACOL, V62, P349, DOI 10.1016/B978-0-12-385952-5.00001-4; McArdle CA, 1996, J BIOL CHEM, V271, P23711, DOI 10.1074/jbc.271.39.23711; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Myburgh DB, 1998, BIOCHEM J, V331, P893, DOI 10.1042/bj3310893; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; OLSEN SR, 1991, MOL ENDOCRINOL, V5, P1246, DOI 10.1210/mend-5-9-1246; Pantel J, 2011, EUR J PHARMACOL, V660, P139, DOI 10.1016/j.ejphar.2011.01.031; Pincas H, 2001, J BIOL CHEM, V276, P23562, DOI 10.1074/jbc.M100563200; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Sadie H, 2003, ENDOCRINOLOGY, V144, P1958, DOI 10.1210/en.2002-220874; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; SAVOYMOORE RT, 1980, SCIENCE, V209, P942, DOI 10.1126/science.6250218; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shacham S, 2005, J BIOL CHEM, V280, P28981, DOI 10.1074/jbc.M500312200; Shi J, 2007, J PHARMACOL EXP THER, V323, P248, DOI 10.1124/jpet.107.122317; Simon V, 2012, MOL PHARMACOL, V82, P17, DOI 10.1124/mol.111.075523; Simon V, 2006, J BIOL CHEM, V281, P40310, DOI 10.1074/jbc.M603858200; STARZEC A, 1989, MOL ENDOCRINOL, V3, P618, DOI 10.1210/mend-3-4-618; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Vera J, 2007, PROTEOMICS, V7, P578, DOI 10.1002/pmic.200600458; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200	57	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2641	2654		10.1074/jbc.M112.388876	http://dx.doi.org/10.1074/jbc.M112.388876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233674	Green Published, hybrid			2022-12-25	WOS:000314211500049
J	Wong, PY; Chang, CCR; Marx, CE; Caron, MG; Wetsel, WC; Zhang, XD				Wong, Peiyan; Chang, Cecilia Chin Roei; Marx, Christine E.; Caron, Marc G.; Wetsel, William C.; Zhang, Xiaodong			Pregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice	PLOS ONE			English	Article							PREPULSE INHIBITION DEFICITS; CA1 HIPPOCAMPAL REGION; NEUROACTIVE STEROIDS; ALZHEIMERS-DISEASE; NEGATIVE SYMPTOMS; MAJOR DEPRESSION; NMDA ANTAGONIST; RAT HIPPOCAMPUS; OUT MICE; SULFATE	Pregnenolone belongs to a class of endogenous neurosteroids in the central nervous system (CNS), which has been suggested to enhance cognitive functions through GABA(A) receptor signaling by its metabolites. It has been shown that the level of pregnenolone is altered in certain brain areas of schizophrenic patients, and clozapine enhances pregnenolone in the CNS in rats, suggesting that pregnenolone could be used to treat certain symptoms of schizophrenia. In addition, early phase proof-of-concept clinical trials have indicated that pregnenolone is effective in reducing the negative symptoms and cognitive deficits of schizophrenia patients. Here, we evaluate the actions of pregnenolone on a mouse model for schizophrenia, the dopamine transporter knockout mouse (DAT KO). DAT KO mice mirror certain symptoms evident in patients with schizophrenia, such as the psychomotor agitation, stereotypy, deficits of prepulse inhibition and cognitive impairments. Following acute treatment, pregnenolone was found to reduce the hyperlocomotion, stereotypic bouts and pre-pulse inhibition (PPI) deficits in DAT KO mice in a dose-dependent manner. At 60 mg/kg of pregnenolone, there were no significant differences in locomotor activities and stereotypy between wild-type and DAT KO mice. Similarly, acute treatment of 60 mg/kg of pregnenolone fully rescued PPI deficits of DAT KO mice. Following chronic treatment with pregnenolone at 60 mg/kg, the cognitive deficits of DAT KO mice were rescued in the paradigms of novel object recognition test and social transmission of food preference test. Pregnenolone thus holds promise as a therapeutic candidate in schizophrenia.	[Wong, Peiyan; Chang, Cecilia Chin Roei; Zhang, Xiaodong] Duke NUS Grad Med Sch Singapore, Neurosci & Behav Disorders Program, Singapore, Singapore; [Marx, Christine E.] Durham VA Med Ctr, Dept Vet Affairs, Durham, NC USA; [Marx, Christine E.; Wetsel, William C.; Zhang, Xiaodong] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Caron, Marc G.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Zhang, Xiaodong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	National University of Singapore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; Duke University; National University of Singapore	Zhang, XD (corresponding author), Duke NUS Grad Med Sch Singapore, Neurosci & Behav Disorders Program, Singapore, Singapore.	xiaodong.zhang@duke-nus.edu.sg		Wong, Peiyan/0000-0003-3734-2461	Singapore National Medical Research Council Translational and Clinical Research Program [NMRC/TCR/003-GMS/2008]; Singapore Biomedical Research Council [09-MayJGC-139]; Duke-NUS Block Funding	Singapore National Medical Research Council Translational and Clinical Research Program(National Medical Research Council, Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Duke-NUS Block Funding	This research was supported in part by grants from Singapore National Medical Research Council Translational and Clinical Research Program NMRC/TCR/003-GMS/2008 (X.Z., M.G.C., W.C.W.), Singapore Biomedical Research Council 09-MayJGC-139 (X.Z.), and Duke-NUS Block Funding (X.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 2001, P NATL ACAD SCI USA, V98, P14033, DOI 10.1073/pnas.241503698; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bernardi F, 2000, EUR J ENDOCRINOL, V142, P466, DOI 10.1530/eje.0.1420466; Buchanan RW, 2006, AM J PSYCHIAT, V163, P1867, DOI 10.1176/appi.ajp.163.11.1867; Buchanan RW, 2005, AM J PSYCHIAT, V162, P124, DOI 10.1176/appi.ajp.162.1.124; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; Darbra S, 2011, BEHAV BRAIN RES, V216, P705, DOI 10.1016/j.bbr.2010.09.018; Darnaudery M, 2000, BRAIN RES, V852, P173, DOI 10.1016/S0006-8993(99)01964-2; Dong E, 2001, P NATL ACAD SCI USA, V98, P2849, DOI 10.1073/pnas.051628598; Ducharme N, 2010, EUR J PHARMACOL, V641, P128, DOI 10.1016/j.ejphar.2010.05.033; Dzirasa K, 2009, J NEUROSCI, V29, P8215, DOI 10.1523/JNEUROSCI.1773-09.2009; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Eser D, 2008, CURR PHARM DESIGN, V14, P3525, DOI 10.2174/138161208786848838; FARR SA, 1995, PHYSIOL BEHAV, V58, P715, DOI 10.1016/0031-9384(95)00124-2; FLOOD DG, 1991, BRAIN RES, V540, P83, DOI 10.1016/0006-8993(91)90494-G; FLOOD JF, 1988, BRAIN RES, V447, P269, DOI 10.1016/0006-8993(88)91129-8; FLOOD JF, 1995, P NATL ACAD SCI USA, V92, P10806, DOI 10.1073/pnas.92.23.10806; FLOOD JF, 1992, P NATL ACAD SCI USA, V89, P1567, DOI 10.1073/pnas.89.5.1567; Frye CA, 2010, BEHAV BRAIN RES, V209, P59, DOI 10.1016/j.bbr.2010.01.015; Gainetdinov RR, 1999, BIOL PSYCHIAT, V46, P303, DOI 10.1016/S0006-3223(99)00122-5; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; GEORGE MS, 1994, BIOL PSYCHIAT, V35, P775, DOI 10.1016/0006-3223(94)91139-8; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harvey PD, 2004, J CLIN PSYCHIAT, V65, P361; Hashimoto K, 2012, PROG NEUROBIOL; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; ISAACSON RL, 1994, BEHAV NEURAL BIOL, V61, P170, DOI 10.1016/S0163-1047(05)80071-8; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P246, DOI 10.1093/schbul/sbj054; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Marder Stephen R, 2006, J Clin Psychiatry, V67, pe03; Marx CE, 2011, NEUROSCIENCE, V191, P78, DOI 10.1016/j.neuroscience.2011.06.076; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P598, DOI 10.1016/j.pbb.2006.07.026; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P609, DOI 10.1016/j.pbb.2006.07.032; Marx CE, 2006, NEUROPSYCHOPHARMACOL, V31, P1249, DOI 10.1038/sj.npp.1300952; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; Marx CE, 2009, NEUROPSYCHOPHARMACOL, V34, P1885, DOI 10.1038/npp.2009.26; MATHIS C, 1994, PSYCHOPHARMACOLOGY, V116, P201, DOI 10.1007/BF02245063; Mathis C, 1996, NEUROPHARMACOLOGY, V35, P1057, DOI 10.1016/S0028-3908(96)00041-X; Meyer DA, 2002, J BIOL CHEM, V277, P28725, DOI 10.1074/jbc.M202592200; Modol L, 2011, BEHAV BRAIN RES, V222, P223, DOI 10.1016/j.bbr.2011.03.058; Morice E, 2007, NEUROPSYCHOPHARMACOL, V32, P2108, DOI 10.1038/sj.npp.1301354; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; MORLEY JE, 1984, PHYSIOL BEHAV, V33, P237, DOI 10.1016/0031-9384(84)90105-7; MORROW AL, 1987, EUR J PHARMACOL, V142, P483, DOI 10.1016/0014-2999(87)90094-X; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Porton B, 2010, GENES BRAIN BEHAV, V9, P257, DOI 10.1111/j.1601-183X.2009.00555.x; Powell SB, 2008, BEHAV PHARMACOL, V19, P562, DOI 10.1097/FBP.0b013e32830dc110; PURDY RH, 1990, J MED CHEM, V33, P1572, DOI 10.1021/jm00168a008; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ritsner M, 2007, EUR NEUROPSYCHOPHARM, V17, P358, DOI 10.1016/j.euroneuro.2006.10.001; Ritsner MS, 2010, J CLIN PSYCHIAT, V71, P1351, DOI 10.4088/JCP.09m05031yel; Rodriguiz RM, 2008, GENES BRAIN BEHAV, V7, P418, DOI 10.1111/j.1601-183X.2007.00365.x; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Romeo E, 1998, AM J PSYCHIAT, V155, P910, DOI 10.1176/ajp.155.7.910; ROMEO E, 1994, J PHARMACOL EXP THER, V270, P89; Sliwinski A, 2004, J NEUROSCI RES, V78, P691, DOI 10.1002/jnr.20332; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Uzunova V, 1998, P NATL ACAD SCI USA, V95, P3239, DOI 10.1073/pnas.95.6.3239; Vallee M, 2001, BRAIN RES REV, V37, P301, DOI 10.1016/S0165-0173(01)00135-7; Vallee M, 1997, P NATL ACAD SCI USA, V94, P14865, DOI 10.1073/pnas.94.26.14865; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Whittaker MT, 2008, J NEUROCHEM, V107, P510, DOI 10.1111/j.1471-4159.2008.05627.x; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001	70	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51455	10.1371/journal.pone.0051455	http://dx.doi.org/10.1371/journal.pone.0051455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240026	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800062
J	Zamora, E; Lupon, J; de Antonio, M; Vila, J; Galan, A; Gastelurrutia, P; Urrutia, A; Bayes-Genis, A				Zamora, Elisabet; Lupon, Josep; de Antonio, Marta; Vila, Joan; Galan, Amparo; Gastelurrutia, Paloma; Urrutia, Agustin; Bayes-Genis, Antoni			Limited Value of Cystatin-C over Estimated Glomerular Filtration Rate for Heart Failure Risk Stratification	PLOS ONE			English	Article							RENAL-FUNCTION; CARDIOVASCULAR EVENTS; DYSFUNCTION; PROGNOSIS; DEATH; INSUFFICIENCY; PREDICTION; CREATININE; MORTALITY; DISEASE	Background: To compare the prognostic value of estimated glomerular filtration rate, cystatin-C, an alternative renal biomarker, and their combination, in an outpatient population with heart failure. Estimated glomerular filtration rate is routinely used to assess renal function in heart failure patients. We recently demonstrated that the Cockroft-Gault formula is the best among the most commonly used estimated glomerular filtration rate formulas for predicting heart failure prognosis. Methodology/Principal Findings: A total of 879 consecutive patients (72% men, age 70.4 years [P25-75 60.5-77.2]) were studied. The etiology of heart failure was mainly ischemic heart disease (52.7%). The left ventricular ejection fraction was 34% (P25-75 26-43%). Most patients were New York Heart Association class II (65.8%) or III (25.9%). During a median follow-up of 3.46 years (P25-75 1.85-5.05), 312 deaths were recorded. In an adjusted model, estimated glomerular filtration rate and cystatin-C showed similar prognostic value according to the area under the curve (0.763 and 0.765, respectively). In Cox regression, the multivariable analysis hazard ratios were 0.99 (95% CI: 0.98-1, P=0.006) and 1.14 (95% CI: 1.02-1.28, P=0.02) for estimated glomerular filtration rate and cystatin-C, respectively. Reclassification, assessed by the integration discrimination improvement and the net reclassification improvement indices, was poorer with cystatin-C (-0.5 [-1.0; -0.1], P=0.024 and -4.9 [-8.8; -1.0], P=0.013, respectively). The value of cystatin-C over estimated glomerular filtration rate for risk-stratification only emerged in patients with moderate renal dysfunction (eGFR 30-60 ml/min/1.73 m(2), chi-square 12.9, P<0.001). Conclusions/Significance: Taken together, the results indicate that estimated glomerular filtration rate and cystatin-C have similar long-term predictive values in a real-life ambulatory heart failure population. Cystatin-C seems to offer improved prognostication in heart failure patients with moderate renal dysfunction.	[Zamora, Elisabet; Lupon, Josep; de Antonio, Marta; Gastelurrutia, Paloma; Urrutia, Agustin; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain; [Zamora, Elisabet; Lupon, Josep; de Antonio, Marta; Urrutia, Agustin; Bayes-Genis, Antoni] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain; [Vila, Joan] IMIM Hosp Mar Res Inst, Inflammatory & Cardiovasc Dis Programme, Barcelona, Spain; [Vila, Joan] CIBER Epidemiol & Publ Hlth, Barcelona, Spain; [Galan, Amparo] Hosp Badalona Germans Trias & Pujol, Serv Biochem, Badalona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Germans Trias i Pujol	Bayes-Genis, A (corresponding author), Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain.	abayesgenis@gmail.com	de A F, Marta/AAL-3341-2020; Bayes-Genis, Antoni/C-4002-2015; Bayes-Genis, Antonio/AAV-9422-2021	de A F, Marta/0000-0002-4319-797X; Bayes-Genis, Antoni/0000-0002-3044-197X; Bayes-Genis, Antonio/0000-0002-3044-197X; Zamora, Elisabet/0000-0001-5317-7481; Vila-Domenech, Joan Salvador/0000-0002-0413-9291; Lupon, Josep/0000-0002-3981-3020; Lupon, Josep/0000-0002-5601-9611; Gastelurrutia, Paloma/0000-0001-6974-9210	Catalan Society of Cardiology (Barcelona, Spain)	Catalan Society of Cardiology (Barcelona, Spain)	Cystatin-C assays were provided by Radim Iberica (Barcelona, Spain) which had no role in the design of the study or the collection, management, analysis, interpretation or writing of the data. Dr. M. de Antonio received a competitive research grant from the Catalan Society of Cardiology (Barcelona, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2005, J CARD FAIL, V11, P595, DOI 10.1016/j.cardfail.2005.06.001; Bayes-Genis A, 2012, EUR J HEART FAIL, V14, P32, DOI 10.1093/eurjhf/hfr156; Cheng XW, 2006, HYPERTENSION, V48, P979, DOI 10.1161/01.HYP.0000242331.99369.2f; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Damman K, 2012, HEART, V98, P319, DOI 10.1136/heartjnl-2011-300692; De Santo NG, 2005, SEMIN NEPHROL, V25, P404, DOI 10.1016/j.semnephrol.2005.05.010; de Silva R, 2006, EUR HEART J, V27, P569, DOI 10.1093/eurheartj/ehi696; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gao CL, 2011, ARCH CARDIOVASC DIS, V104, P565, DOI 10.1016/j.acvd.2011.08.003; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hoek FJ, 2003, NEPHROL DIAL TRANSPL, V18, P2024, DOI 10.1093/ndt/gfg349; Ix JH, 2007, CIRCULATION, V115, P173, DOI 10.1161/CIRCULATIONAHA.106.644286; Ix JH, 2006, J CARD FAIL, V12, P601, DOI 10.1016/j.cardfail.2006.07.005; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Lassus J, 2007, EUR HEART J, V28, P1841, DOI 10.1093/eurheartj/ehl507; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; McMurray MD, 2009, CIRC-HEART FAIL, V2, P86, DOI 10.1161/CIRCHEARTFAILURE.109.856393; Naruse H, 2009, AM J MED, V122, P566, DOI 10.1016/j.amjmed.2008.10.042; O'Riordan SE, 2003, ANN CLIN BIOCHEM, V40, P648, DOI 10.1258/000456303770367243; Odden MC, 2010, NEPHROL DIAL TRANSPL, V25, P463, DOI 10.1093/ndt/gfp474; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Shlipak MG, 2005, J AM COLL CARDIOL, V45, P268, DOI 10.1016/j.jacc.2004.09.061; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Waheed S, 2012, AM J KIDNEY DIS, V24; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066	32	9	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51234	10.1371/journal.pone.0051234	http://dx.doi.org/10.1371/journal.pone.0051234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240006	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800042
J	Braithwaite, JE; Meeuwig, JJ; Jenner, KCS				Braithwaite, Janelle E.; Meeuwig, Jessica J.; Jenner, K. Curt S.			Estimating Cetacean Carrying Capacity Based on Spacing Behaviour	PLOS ONE			English	Article							ABUNDANCE-OCCUPANCY RELATIONSHIPS; HUMPBACK WHALES; DENSITY; RANGE; SIZE; AGGRESSION; MIGRATION; SUMMER; BIRDS	Conservation of large ocean wildlife requires an understanding of how they use space. In Western Australia, the humpback whale (Megaptera novaeangliae) population is growing at a minimum rate of 10% per year. An important consideration for conservation based management in space-limited environments, such as coastal resting areas, is the potential expansion in area use by humpback whales if the carrying capacity of existing areas is exceeded. Here we determined the theoretical carrying capacity of a known humpback resting area based on the spacing behaviour of pods, where a resting area is defined as a sheltered embayment along the coast. Two separate approaches were taken to estimate this distance. The first used the median nearest neighbour distance between pods in relatively dense areas, giving a spacing distance of 2.16 km (60.94). The second estimated the spacing distance as the radius at which 50% of the population included no other pods, and was calculated as 1.93 km (range: 1.62-2.50 km). Using these values, the maximum number of pods able to fit into the resting area was 698 and 872 pods, respectively. Given an average observed pod size of 1.7 whales, this equates to a carrying capacity estimate of between 1187 and 1482 whales at any given point in time. This study demonstrates that whale pods do maintain a distance from each other, which may determine the number of animals that can occupy aggregation areas where space is limited. This requirement for space has implications when considering boundaries for protected areas or competition for space with the fishing and resources sectors.	[Braithwaite, Janelle E.; Meeuwig, Jessica J.] Univ Western Australia, Fac Nat & Agr Sci, Ctr Marine Futures, UWA Oceans Inst, Perth, WA 6009, Australia; [Jenner, K. Curt S.] Ctr Whale Res, Fremantle, WA, Australia; [Braithwaite, Janelle E.; Meeuwig, Jessica J.] Univ Western Australia, Fac Nat & Agr Sci, Sch Anim Biol, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Braithwaite, JE (corresponding author), Univ Western Australia, Fac Nat & Agr Sci, Ctr Marine Futures, UWA Oceans Inst, Perth, WA 6009, Australia.	janelle.braithwaite@uwa.edu.au		Meeuwig, Jessica/0000-0003-1169-8785	Straits Resources grant	Straits Resources grant	Funding for data collection was provided for by a Straits Resources grant awarded to the Centre for Whale Research, WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JC, 1994, J APPL ECOL, V31, P212, DOI 10.2307/2404537; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Armstrong JD, 2001, J FISH BIOL, V58, P1524, DOI 10.1006/jfbi.2001.1554; BAKER CS, 1985, MAR MAMMAL SCI, V1, P304, DOI 10.1111/j.1748-7692.1985.tb00018.x; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Beck JL, 2006, J WILDLIFE MANAGE, V70, P283, DOI 10.2193/0022-541X(2006)70[283:EOESRN]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Buckland S.T., 2001, pi; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Chittleborough R. G., 1953, Australian Journal of Marine and Freshwater Research, V4, P219; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cowlishaw G, 1999, BEHAV ECOL SOCIOBIOL, V45, P67, DOI 10.1007/s002650050540; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; DAWKINS MS, 1989, BRIT POULTRY SCI, V30, P413, DOI 10.1080/00071668908417163; Dunlop RA, 2010, P ROY SOC B-BIOL SCI, V277, P2521, DOI 10.1098/rspb.2009.2319; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; Frost MT, 2004, ECOGRAPHY, V27, P643; Gaston KJ, 1997, ECOGRAPHY, V20, P569, DOI 10.1111/j.1600-0587.1997.tb00425.x; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Goss-Custard JD, 2002, BIOL CONSERV, V105, P27, DOI 10.1016/S0006-3207(01)00175-6; Goss-Custard JD, 2003, J APPL ECOL, V40, P176, DOI 10.1046/j.1365-2664.2003.00785.x; Hall K, 2010, J MAR BIOL ASSOC UK, V90, P1571, DOI 10.1017/S0025315410000263; Hedley SL, 2009, SC61SH23 INT WHAL CO; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; HOLM JC, 1990, AQUACULTURE, V89, P225, DOI 10.1016/0044-8486(90)90128-A; Jenner K.C.S., 2001, APPEA J, V38, p692?707, DOI DOI 10.1071/aj00044; Jenner KCS, 2010, EFFECTIVE MITIGATION; Jensen MB, 1998, APPL ANIM BEHAV SCI, V56, P97, DOI 10.1016/S0168-1591(97)00106-8; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kent Chandra Salgado, 2012, Journal of Cetacean Research and Management, V12, P29; Krause J, 2002, LIVING GROUPS; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Leopold A., 1933, GAME MANAGEMENT; Li CW, 2007, GEN COMP ENDOCR, V151, P202, DOI 10.1016/j.ygcen.2007.01.014; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Nicol C, 2007, J VET BEHAV, V2, P188, DOI 10.1016/j.jveb.2007.10.002; Noad MJ, 2005, ABSOLUTE RELATIVE AB; Petherick JC, 2009, APPL ANIM BEHAV SCI, V117, P1, DOI 10.1016/j.applanim.2008.09.008; Petherick JC, 2007, J VET BEHAV, V2, P197, DOI 10.1016/j.jveb.2007.10.001; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; SILBER GK, 1986, CAN J ZOOL, V64, P2075, DOI 10.1139/z86-316; Steinhaus H., 1999, MATH SNAPSHOTS; TARRANT PV, 1988, MEAT SCI, V24, P209, DOI 10.1016/0309-1740(88)90079-4; Thomas L., 2009, DISTANCE 6 0 RELEASE; Tilman D., 1982, Monographs in Population Biology, pi; Tiwari M, 2010, MAR ECOL PROG SER, V419, P289, DOI 10.3354/meps08833; TRIPPEL EA, 1991, CAN J FISH AQUAT SCI, V48, P1446, DOI 10.1139/f91-172; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Wedemeyer G.A., 1996, PHYSL FISH INTENSIVE; WEIL CS, 1952, BIOMETRICS, V8, P249, DOI 10.2307/3001557; Western D., 1975, E AFR WILDL J, V13, P265, DOI DOI 10.1111/J.1365-2028.1975.TB00139.X; Zerbini AN, 2010, MAR BIOL, V157, P1225, DOI 10.1007/s00227-010-1403-y	60	12	13	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51347	10.1371/journal.pone.0051347	http://dx.doi.org/10.1371/journal.pone.0051347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236479	gold, Green Published, Green Submitted			2022-12-25	WOS:000312064100101
J	Kaiser, DM; Acharya, M; Leighton, PLA; Wang, H; Daude, N; Wohlgemuth, S; Shi, BP; Allison, WT				Kaiser, Darcy M.; Acharya, Moulinath; Leighton, Patricia L. A.; Wang, Hao; Daude, Nathalie; Wohlgemuth, Serene; Shi, Beipei; Allison, W. Ted			Amyloid Beta Precursor Protein and Prion Protein Have a Conserved Interaction Affecting Cell Adhesion and CNS Development	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; EXPRESSION PATTERNS; SECRETASE CLEAVAGE; ZEBRAFISH; BINDING; GENES; APP; RNA; IDENTIFICATION	Genetic and biochemical mechanisms linking onset or progression of Alzheimer Disease and prion diseases have been lacking and/or controversial, and their etiologies are often considered independent. Here we document a novel, conserved and specific genetic interaction between the proteins that underlie these diseases, amyloid-beta precursor protein and prion protein, APP and PRP, respectively. Knockdown of APP and/or PRNP homologs in the zebrafish (appa, appb, prp1, and prp2) produces a dose-dependent phenotype characterized by systemic morphological defects, reduced cell adhesion and CNS cell death. This genetic interaction is surprisingly exclusive in that prp1 genetically interacts with zebrafish appa, but not with appb, and the zebrafish paralog prp2 fails to interact with appa. Intriguingly, appa & appb are largely redundant in early zebrafish development yet their abilities to rescue CNS cell death are differentially contingent on prp1 abundance. Delivery of human APP or mouse Prnp mRNAs rescue the phenotypes observed in app-prp-depleted zebrafish, highlighting the conserved nature of this interaction. Immunoprecipitation revealed that human APP and PrPC proteins can have a physical interaction. Our study reports a unique in vivo interdependence between APP and PRP loss-of-function, detailing a biochemical interaction that considerably expands the hypothesized roles of PRP in Alzheimer Disease.	[Kaiser, Darcy M.; Acharya, Moulinath; Leighton, Patricia L. A.; Daude, Nathalie; Wohlgemuth, Serene; Shi, Beipei; Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Kaiser, Darcy M.; Acharya, Moulinath; Leighton, Patricia L. A.; Wang, Hao; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/A-2612-2014; Allison, W. Ted/K-5228-2012	Allison, W. Ted/0000-0002-8461-4864; Acharya, Moulinath/0000-0001-8013-7426; Wohlgemuth, Serene/0000-0001-7287-0935	Alberta Innovates Health Solutions; Canadian Institutes for Health Research; Alzheimer Society of Canada; Canadian Foundation for Innovation	Alberta Innovates Health Solutions; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Canadian Foundation for Innovation(Canada Foundation for Innovation)	Alberta Innovates Health Solutions (www.aihealthsolutions.ca) Studentships to DMK and PLAL, Canadian Institutes for Health Research (www.cihr-irsc.gc.ca) Studentship to DMK, and Annie Dakens Research Fund Doctoral Award from the Alzheimer Society of Canada (www.alzheimer.ca) to PLAL. Canadian Foundation for Innovation (www.innovation.ca) NIF grant to WTA and others (D. Westaway Principal Applicant) and LOF grant to WTA. Alzheimer Society of Canada (www.alzheimer.ca) "Great-West Life, London Life & Canada Life Young Investigators Award" to WTA, PrioNet Canada (www.prionetcanada.ca), a Networks of Centres of Excellence (www.nce-rce.gc.ca), and Alberta Prion Research Institute (www.prioninstitute.ca) to WTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamar E, 2008, DEV BIOL, V318, P335, DOI 10.1016/j.ydbio.2008.03.040; Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Alier K, 2011, J NEUROSCI, V31, P16292, DOI 10.1523/JNEUROSCI.4367-11.2011; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bertram L, 2008, CELL, V135, P993, DOI 10.1016/j.cell.2008.11.030; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Broytman O, 2009, NEUROBIOL AGING, V30, P1962, DOI 10.1016/j.neurobiolaging.2008.02.011; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Corley SM, 2008, BIOINFORM BIOL INSIG, V2, P383; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Dermaut B, 2003, ANN NEUROL, V53, P409, DOI 10.1002/ana.10507; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goggin K, 2008, BBA-MOL CELL RES, V1783, P479, DOI 10.1016/j.bbamcr.2007.10.008; Goguel V, 2011, J NEUROSCI, V31, P1032, DOI 10.1523/JNEUROSCI.2896-10.2011; Golanska E, 2009, J ALZHEIMERS DIS, V17, P359, DOI 10.3233/JAD-2009-1055; Gomes MPB, 2012, WIRES RNA, V3, P415, DOI 10.1002/wrna.118; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Griffiths HH, 2012, PRION, V6, P217, DOI 10.4161/pri.18988; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; King OD, 2012, BRAIN RES; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lewis V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031754; Liao HK, 2012, DEV DYNAM, V241, P415, DOI 10.1002/dvdy.23725; Malaga-Trillo E, 2009, PRION, V3, P129, DOI 10.4161/pri.3.3.9651; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mange A, 2002, FEBS LETT, V514, P159, DOI 10.1016/S0014-5793(02)02338-4; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Medina S, 2009, J TOXICOL ENV HEAL A, V72, P1075, DOI 10.1080/15287390903084561; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Musa A, 2001, DEV GENES EVOL, V211, P563, DOI 10.1007/s00427-001-0189-9; NARINDRASORASAK S, 1992, LAB INVEST, V67, P643; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Nicolas O, 2009, BRAIN RES REV, V61, P170, DOI 10.1016/j.brainresrev.2009.06.002; Nik SHM, 2012, J ALZHEIMERS DIS, V28, P515, DOI 10.3233/JAD-2011-110533; Nourizadeh-Lillabadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013573; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Parkin ET, 2000, METH MOLEC MED, V32, P345, DOI 10.1385/1-59259-195-7:345; Perreau VM, 2010, PROTEOMICS, V10, P2377, DOI 10.1002/pmic.200900773; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Reiniger L, 2011, ACTA NEUROPATHOL, V121, P5, DOI 10.1007/s00401-010-0691-0; Riemenschneider M, 2004, NEUROBIOL AGING, V25, P1305, DOI 10.1016/j.neurobiolaging.2004.01.001; Robakis NK, 2011, NEUROBIOL AGING, V32, P372, DOI 10.1016/j.neurobiolaging.2010.05.022; Roucou X, 2009, FRONT BIOSCI-LANDMRK, V14, P5157, DOI 10.2741/3592; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schwarze-Eicker KA, 2005, NEUROBIOL AGING, V26, P1177, DOI 10.1016/j.neurobiolaging.2004.10.004; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Stevens JC, 2011, J NEUROL NEUROSUR PS, V82, P1054, DOI 10.1136/jnnp.2009.199653; Tamayev R, 2012, J NEUROSCI, V32, P5481, DOI 10.1523/JNEUROSCI.5193-11.2012; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Webb TEF, 2008, J NEUROPATH EXP NEUR, V67, P838, DOI 10.1097/NEN.0b013e318182f36e; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Yehiely F, 1997, NEUROBIOL DIS, V3, P339, DOI 10.1006/nbdi.1997.0130; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	82	42	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51305	10.1371/journal.pone.0051305	http://dx.doi.org/10.1371/journal.pone.0051305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236467	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100091
J	Aravena, C; Beltran, AR; Cornejo, M; Torres, V; Diaz, ES; Guzman-Gutierrez, E; Pardo, F; Leiva, A; Sobrevia, L; Ramirez, MA				Aravena, Carmen; Beltran, Ana R.; Cornejo, Marcelo; Torres, Viviana; Diaz, Emilce S.; Guzman-Gutierrez, Enrique; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis; Ramirez, Marco A.			Potential Role of Sodium-Proton Exchangers in the Low Concentration Arsenic Trioxide-Increased Intracellular pH and Cell Proliferation	PLOS ONE			English	Article							EPITHELIAL DOME FORMATION; VEIN ENDOTHELIAL-CELLS; PROTEIN-KINASE-C; NA+/H+ EXCHANGER; CANCER CELLS; NHE3 EXPRESSION; DRINKING-WATER; SMOOTH-MUSCLE; DNA-SYNTHESIS; NITRIC-OXIDE	Arsenic main inorganic compound is arsenic trioxide (ATO) presented in solution mainly as arsenite. ATO increases intracellular pH (pHi), cell proliferation and tumor growth. Sodium-proton exchangers (NHEs) modulate the pHi, with NHE1 playing significant roles. Whether ATO-increased cell proliferation results from altered NHEs expression and activity is unknown. We hypothesize that ATO increases cell proliferation by altering pHi due to increased NHEs-like transport activity. Madin-Darby canine kidney (MDCK) cells grown in 5 mmol/L D-glucose-containing DMEM were exposed to ATO (0.05, 0.5 or 5 mu mol/L, 0-48 hours) in the absence or presence of 5-N, N-hexamethylene amiloride (HMA, 5-100 mu mol/L, NHEs inhibitor), PD-98059 (30 mu mol/L, MAPK1/2 inhibitor), Go6976 (10 mu mol/L, PKC alpha, beta I and mu inhibitor), or Schering 28080 (10 mu mol/L, H+/K(+)ATPase inhibitor) plus concanamycin (0.1 mu mol/L, V type ATPases inhibitor). Incorporation of [H-3]thymidine was used to estimate cell proliferation, and counting cells with a hemocytometer to determine the cell number. The pHi was measured by fluorometry in 2,7-bicarboxyethyl-5,6-carboxyfluorescein loaded cells. The Na+-dependent HMA-sensitive NHEs-like mediated proton transport kinetics, NHE1 protein abundance in the total, cytoplasm and plasma membrane protein fractions, and phosphorylated and total p42/44 mitogen-activated protein kinases (p42/44(mapk)) were also determined. Lowest ATO (0.05 mu mol/L, similar to 0.01 ppm) used in this study increased cell proliferation, pHi, NHEs-like transport and plasma membrane NHE1 protein abundance, effects blocked by HMA, PD-98059 or Go6976. Cell-buffering capacity did not change by ATO. The results show that a low ATO concentration increases MDCK cells proliferation by NHEs (probably NHE1)-like transport dependent-increased pHi requiring p42/44(mapk) and PKC alpha, beta I and/or mu activity. This finding could be crucial in diseases where uncontrolled cell growth occurs, such as tumor growth, and in circumstances where ATO, likely arsenite, is available at the drinking-water at these levels. Citation: Aravena C, Beltran AR, Cornejo M, Torres V, Diaz ES, et al. (2012) Potential Role of Sodium-Proton Exchangers in the Low Concentration Arsenic Trioxide-Increased Intracellular pH and Cell Proliferation. PLoS ONE 7(12): e51451. doi:10.1371/journal.pone.0051451	[Guzman-Gutierrez, Enrique; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis; Ramirez, Marco A.] Pontificia Univ Catolica Chile, Fac Med, Div Obstet & Gynecol, CMPL,Sch Med, Santiago, Chile; [Aravena, Carmen; Beltran, Ana R.; Cornejo, Marcelo; Diaz, Emilce S.; Ramirez, Marco A.] Univ Antofagasta, Fac Hlth Sci, Biomed Dept, Cellular Physiol Lab, Antofagasta, Chile; [Beltran, Ana R.] Univ Antofagasta, Dept Educ, Fac Educ, Antofagasta, Chile; [Torres, Viviana] Univ Concepcion, Fac Biol Sci, Adv Microscopy Ctr CMA Bio Bio, Concepcion, Chile	Pontificia Universidad Catolica de Chile; Universidad de Antofagasta; Universidad de Antofagasta; Universidad de Concepcion	Sobrevia, L (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Div Obstet & Gynecol, CMPL,Sch Med, Alameda 340, Santiago, Chile.	sobrevia@med.puc.cl; biomarco@uantof.cl	Sobrevia, Luis/H-9608-2016; Torres, Viviana/AAC-3329-2019; Cornejo Alaniz, Marcelo Alejandro/AGD-4851-2022; Guzman-Gutierrez, Enrique/H-3536-2016	Cornejo Alaniz, Marcelo Alejandro/0000-0002-1377-0149; Guzman-Gutierrez, Enrique/0000-0001-6589-5667; Sobrevia, Luis/0000-0001-5802-2243; Beltran Gonzalez, Ana Rosa/0000-0001-5068-2132	Direccion de Investigacion [DI-1339-07]; Vicerrectoria Academica, Universidad de Antofagasta (Chile); Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 11110059, 3130583]; Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) (Chile) [Anillos ACT-73]; CONICYT Ayuda de Tesis [CONICYT AT-24120944]	Direccion de Investigacion; Vicerrectoria Academica, Universidad de Antofagasta (Chile); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) (Chile); CONICYT Ayuda de Tesis	This research was supported by Direccion de Investigacion [DI-1339-07] and Vicerrectoria Academica, Universidad de Antofagasta (Chile), Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 11110059, 3130583], Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) [Anillos ACT-73] (Chile) and CONICYT Ayuda de Tesis [CONICYT AT-24120944]. CA and EG-G hold CONICYT-PhD (Chile) fellowships. FP was the recipient of a postdoctoral position (CONICYT PIA Anillos ACT-73 postdoctoral research associate at CMPL, Pontificia Universidad Catolica de Chile). MC is a PhD student at Universidad de Antofagasta (Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RT, 2011, BIOCHEM CELL BIOL, V89, P85, DOI [10.1139/O10-159, 10.1139/o10-159]; Beltran AR, 2008, PFLUG ARCH EUR J PHY, V455, P799, DOI 10.1007/s00424-007-0333-0; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cheung WMW, 2007, CANCER LETT, V246, P122, DOI 10.1016/j.canlet.2006.02.009; Chowdhury R, 2010, TOXICOL LETT, V198, P263, DOI 10.1016/j.toxlet.2010.07.006; Czepan M, 2012, PFLUG ARCH EUR J PHY, V463, P459, DOI 10.1007/s00424-011-1059-6; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Farias M, 2010, CARDIOVASC RES, V86, P45, DOI 10.1093/cvr/cvp410; Fernandez R, 1998, J MEMBRANE BIOL, V163, P137, DOI 10.1007/s002329900378; Gonzalez M, 2004, PFLUG ARCH EUR J PHY, V448, P383; Gumz ML, 2010, AM J PHYSIOL-RENAL, V298, pF12, DOI 10.1152/ajprenal.90723.2008; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; Hodges K, 2006, AM J PHYSIOL-GASTR L, V291, pG959, DOI 10.1152/ajpgi.00274.2005; Huang CY, 2011, J UROLOGY, V185, P2040, DOI 10.1016/j.juro.2011.01.079; Instituto Nacional de Normalizacion Gobierno de Chile, 1984, 4091OF84 I NAC NORM; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Karki P, 2011, J BIOL CHEM, V286, P13096, DOI 10.1074/jbc.M110.165134; KEIZER HG, 1989, J NATL CANCER I, V81, P706, DOI 10.1093/jnci/81.9.706; Lagana A, 2000, J CELL SCI, V113, P3649; Lau ATY, 2004, CARCINOGENESIS, V25, P21, DOI 10.1093/carcin/bgg179; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Liu YH, 2010, J CELL BIOCHEM, V111, P1546, DOI 10.1002/jcb.22886; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; Ministerio de Salud Gobierno de Chile, 2012, PRIM INF REG POBL CA; Pan XY, 2006, BRIT J HAEMATOL, V134, P491, DOI 10.1111/j.1365-2141.2006.06224.x; Rich IN, 2000, BLOOD, V95, P1427, DOI 10.1182/blood.V95.4.1427.004k48_1427_1434; Rigor RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029210; Rios EJ, 2005, AM J PHYSIOL-LUNG C, V289, pL867, DOI 10.1152/ajplung.00455.2004; Rojas S, 2003, EXP PHYSIOL, V88, P209, DOI 10.1113/eph8802515; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Soucy NV, 2003, TOXICOL SCI, V76, P271, DOI 10.1093/toxsci/kfg231; Su HW, 2007, J BIOL CHEM, V282, P9883, DOI 10.1074/jbc.M606754200; Su HW, 2009, AM J PHYSIOL-CELL PH, V296, pC13, DOI 10.1152/ajpcell.00263.2008; Turturro F, 2004, CLIN CANCER RES, V10, P7022, DOI 10.1158/1078-0432.CCR-04-0879; Walker AM, 2010, INT J ENV RES PUB HE, V7, P1996, DOI 10.3390/ijerph7051996; Wang Y, 2009, UROL INT, V82, P214, DOI 10.1159/000200803; WHO, 2011, GUID DRINK WAT QUAL; Wu SJ, 2008, BIOCHEM BIOPH RES CO, V375, P384, DOI 10.1016/j.bbrc.2008.08.008; Xiao YF, 2007, WORLD J GASTROENTERO, V13, P6498, DOI 10.3748/wjg.13.6498; Yang GF, 2010, CHINESE MED J-PEKING, V123, P1768, DOI 10.3760/cma.j.issn.0366-6999.2010.13.028; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; Zhang XY, 2012, CANCER LETT, V318, P93, DOI 10.1016/j.canlet.2011.12.005	45	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51451	10.1371/journal.pone.0051451	http://dx.doi.org/10.1371/journal.pone.0051451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236503	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700041
J	Mancini, G; D'Annessa, I; Coletta, A; Chillemi, G; Pommier, Y; Cushman, M; Desideri, A				Mancini, Giordano; D'Annessa, Ilda; Coletta, Andrea; Chillemi, Giovanni; Pommier, Yves; Cushman, Mark; Desideri, Alessandro			Binding of an Indenoisoquinoline to the Topoisomerase-DNA Complex Induces Reduction of Linker Mobility and Strengthening of Protein-DNA Interaction	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; CATALYTIC MECHANISM; CLEAVAGE COMPLEXES; COVALENT COMPLEX; I INHIBITORS; CAMPTOTHECIN; SIMULATIONS; RESISTANCE; IDENTIFICATION	Long-duration comparative molecular dynamics simulations of the DNA-topoisomerase binary and DNA-topoisomerase-indenoisoquinoline ternary complexes have been carried out. The analyses demonstrated the role of the drug in conformationally stabilizing the protein-DNA interaction. In detail, the protein lips, clamping the DNA substrate, interact more tightly in the ternary complex than in the binary one. The drug also reduces the conformational space sampled by the protein linker domain through an increased interaction with the helix bundle proximal to the active site. A similar alteration of linker domain dynamics has been observed in a precedent work for topotecan but the molecular mechanisms were different if compared to those described in this work. Finally, the indenoisoquinoline keeps Lys532 far from the DNA, making it unable to participate in the religation reaction, indicating that both short- and long-range interactions contribute to the drug poisoning effect. Citation: Mancini G, D'Annessa I, Coletta A, Chillemi G, Pommier Y, et al. (2012) Binding of an Indenoisoquinoline to the Topoisomerase-DNA Complex Induces Reduction of Linker Mobility and Strengthening of Protein-DNA Interaction. PLoS ONE 7(12): e51354. doi:10.1371/journal.pone.0051354	[D'Annessa, Ilda; Coletta, Andrea; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [D'Annessa, Ilda; Coletta, Andrea; Desideri, Alessandro] Univ Roma Tor Vergata, Ctr Bioinformat & Biostat, I-00173 Rome, Italy; [Mancini, Giordano; Chillemi, Giovanni] CASPUR Interuniv Consortium Applicat Super Comp U, Rome, Italy; [Pommier, Yves] NCI, Mol Pharmacol Lab, Bethesda, MD 20892 USA; [Cushman, Mark] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, W Lafayette, IN 47907 USA; [Cushman, Mark] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	University of Rome Tor Vergata; University of Rome Tor Vergata; CINECA, Italy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Desideri, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00173 Rome, Italy.	desideri@uniroma2.it	Coletta, Andrea/H-9856-2012; Chillemi, Giovanni/O-2825-2019; Chillemi, Giovanni/E-5201-2010; Coletta, Andrea/GXF-2972-2022	Coletta, Andrea/0000-0003-4032-394X; Chillemi, Giovanni/0000-0003-3901-6926; Chillemi, Giovanni/0000-0003-3901-6926; D'Annessa, Ilda/0000-0002-6174-6899; desideri, alessandro/0000-0003-1541-4217	Associazione Italiana Ricerca Cancro AIRC [10121]; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	Associazione Italiana Ricerca Cancro AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AD thanks the Associazione Italiana Ricerca Cancro AIRC (www.airc.it), which supported the work with project number 10121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony S, 2003, CANCER RES, V63, P7428; Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Champoux JJ, 2000, ANN NY ACAD SCI, V922, P56; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; CUSHMAN M, 1978, J ORG CHEM, V43, P3781, DOI 10.1021/jo00413a036; DAnnessa I, 2012, J AMINO ACIDS, V2012; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Gongora C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-64; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interthal H, 2004, J BIOL CHEM, V279, P2984, DOI 10.1074/jbc.M309959200; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kohlhagen G, 1998, MOL PHARMACOL, V54, P50, DOI 10.1124/mol.54.1.50; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Liao Z, 2008, MOL PHARMACOL, V73, P490, DOI 10.1124/mol.107.041178; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; Marchand C, 2006, MOL CANCER THER, V5, P287, DOI 10.1158/1535-7163.MCT-05-0456; Meng LH, 2003, CURR TOP MED CHEM, V3, P305; Nagarajan M, 2006, J MED CHEM, V49, P6283, DOI 10.1021/jm060564z; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Scaldaferro S, 2001, CHEM BIOL, V8, P871, DOI 10.1016/S1074-5521(01)00059-X; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; Soret J, 2003, CANCER RES, V63, P8203; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Strumberg D, 1999, J MED CHEM, V42, P446, DOI 10.1021/jm9803323; Taniguchi K, 1996, CANCER RES, V56, P2348; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223	44	13	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51354	10.1371/journal.pone.0051354	http://dx.doi.org/10.1371/journal.pone.0051354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236483	gold, Green Published, Green Submitted			2022-12-25	WOS:000312589700038
J	Birn-Jeffery, AV; Miller, CE; Naish, D; Rayfield, EJ; Hone, DWE				Birn-Jeffery, Aleksandra V.; Miller, Charlotte E.; Naish, Darren; Rayfield, Emily J.; Hone, David W. E.			Pedal Claw Curvature in Birds, Lizards and Mesozoic Dinosaurs - Complicated Categories and Compensating for Mass-Specific and Phylogenetic Control	PLOS ONE			English	Article							KILLING BEHAVIOR; HABITAT USE; MORPHOLOGY; EVOLUTION; PREY; ACCIPITRIDAE; ORIGIN; FLIGHT	Pedal claw geometry can be used to predict behaviour in extant tetrapods and has frequently been used as an indicator of lifestyle and ecology in Mesozoic birds and other fossil reptiles, sometimes without acknowledgement of the caveat that data from other aspects of morphology and proportions also need to be considered. Variation in styles of measurement (both inner and outer claw curvature angles) has made it difficult to compare results across studies, as have over-simplified ecological categories. We sought to increase sample size in a new analysis devised to test claw geometry against ecological niche. We found that taxa from different behavioural categories overlapped extensively in claw geometry. Whilst most taxa plotted as predicted, some fossil taxa were recovered in unexpected positions. Inner and outer claw curvatures were statistically correlated, and both correlated with relative claw robusticity (mid-point claw height). We corrected for mass and phylogeny, as both likely influence claw morphology. We conclude that there is no strong mass-specific effect on claw curvature; furthermore, correlations between claw geometry and behaviour are consistent across disparate clades. By using independent contrasts to correct for phylogeny, we found little significant relationship between claw geometry and behaviour. 'Ground-dweller' claws are less curved and relatively dorsoventrally deep relative to those of other behavioural categories; beyond this it is difficult to assign an explicit category to a claw based purely on geometry.	[Hone, David W. E.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Birn-Jeffery, Aleksandra V.] Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [Birn-Jeffery, Aleksandra V.; Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Miller, Charlotte E.] Duke Univ, Durham, NC USA; [Naish, Darren] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Hone, David W. E.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University of London; Queen Mary University London; University of London; University of London Royal Veterinary College; University of Bristol; Duke University; NERC National Oceanography Centre; University of Southampton; University College Dublin	Hone, DWE (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	dwe_hone@yahoo.com	Rayfield, Emily/F-5038-2010; Benton, Michael J/A-5639-2008; Miller, Charlotte/ABH-5780-2020	Rayfield, Emily/0000-0002-2618-750X; Benton, Michael J/0000-0002-4323-1824; Miller, Charlotte E/0000-0002-8428-8392				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Alibardi L, 2008, ACTA ZOOL-STOCKHOLM, V89, P169, DOI 10.1111/j.1463-6395.2007.00312.x; BADEN HP, 1970, J INVEST DERMATOL, V55, P115, DOI 10.1111/1523-1747.ep12291628; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Bonser RHC, 1996, J AVIAN BIOL, V27, P175, DOI 10.2307/3677149; Bonser RHC, 2000, J MATER SCI LETT, V19, P1039, DOI 10.1023/A:1006786919376; Chatterjee S, 2003, NATURWISSENSCHAFTEN, V90, P27, DOI 10.1007/s00114-002-0385-0; Chiappe Luis M., 1997, Archaeopteryx, V15, P109; Csermely D, 2012, ITAL J ZOOL, V79, P410, DOI 10.1080/11250003.2012.663003; Csermely D, 2006, ITAL J ZOOL, V73, P43, DOI 10.1080/11250000500502368; Dececchi TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022292; Del Hoyo J., 2006, HDB BIRDS WORLD; del Hoyo J., 2005, HDB BIRDS WORLD, V10; Dial KP, 2008, NATURE, V451, P985, DOI 10.1038/nature06517; Dunning J.B., 2007, CRC HDB AVIAN BODY M; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; Elzanowski Andrzej, 2001, Asociacion Paleontologica Argentina Publicacion Especial, V7, P91; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Ethier DM, 2010, CAN J ZOOL, V88, P1043, DOI 10.1139/Z10-073; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; Fowler DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007999; Franck A, 2006, BIOSYST ENG, V93, P459, DOI 10.1016/j.biosystemseng.2006.01.007; Fraser R.D.B., 1980, Symposia of the Society for Experimental Biology, P211; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Glen CL, 2007, CURR BIOL, V17, pR911, DOI 10.1016/j.cub.2007.09.026; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hoyo J., 1997, HDB BIRDS WORLD, V4; Hoyo J, 2007, HDB BIRDS WORLD, V12; Hoyo J., 1996, HDB BIRDS WORLD, V3; Hoyo J., 1999, HDB BIRDS WORLD, V5; Hoyo J, 1992, HDB BIRDS WORLD, V1; Hoyo J.D., 1994, HDB BIRDS WORLD, V2; Hoyo Jd, 2001, HDB BIRDS WORLD, V6; Hoyo Jd, 2008, HDB BIRDS WORLD; Hoyo Jd, 2003, HDB BIRDS WORLD, V8; Hoyo Jd, 2004, HDB BIRDS WORLD, V9; Hoyo Jd, 2002, HDB BIRDS WORLD, V7; LAUDER GV, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Manning PL, 2006, BIOL LETTERS, V2, P110, DOI 10.1098/rsbl.2005.0395; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Naish D, 2000, ARCHAEOPTERYX, V18; Ostrom J.H., 1985, P161; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Peters Dieter Stefan, 1992, Natural History Museum of Los Angeles County Science Series, V36, P29; Pike AVL, 2004, J ZOOL, V262, P73, DOI 10.1017/S0952836903004382; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Renesto Silvio, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V197, P87; Seki Y, 2010, ACTA BIOMATER, V6, P331, DOI 10.1016/j.actbio.2009.08.026; Spielmann JA, 2005, RIV ITAL PALEONTOL S, V111, P395, DOI 10.13130/2039-4942/6328; Sustaita D, 2008, J MORPHOL, V269, P283, DOI 10.1002/jmor.10577; Sustaita D, 2010, J EXP BIOL, V213, P2617, DOI 10.1242/jeb.041731; Team R. D. C, 2011, R LANG ENV STAT COMP; Tulli MJ, 2009, ZOOLOGY, V112, P379, DOI 10.1016/j.zool.2009.02.001; Turner A. K., 1994, HDB SWALLOWS MARTINS; Van Valkenburgh B, 1987, J VERT PALEONTOL, V7, P162, DOI DOI 10.1080/02724634.1987.10011651; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Yalden D .W., 1985, P91; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x; Zhou ZH, 2005, NATURE, V438, pE4, DOI 10.1038/nature04356; Zhou ZH, 2007, FRONTIERS BIOL CHINA, V2, P1, DOI [DOI 10.1007/S11515-007-0001-Y, 10.1007/s11515-007-0001-y]; [No title captured]	70	43	43	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50555	10.1371/journal.pone.0050555	http://dx.doi.org/10.1371/journal.pone.0050555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227184	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200044
J	Harari, O; Wang, JC; Bucholz, K; Edenberg, HJ; Heath, A; Martin, NG; Pergadia, ML; Montgomery, G; Schrage, A; Bierut, LJ; Madden, PF; Goate, AM				Harari, Oscar; Wang, Jen-Chyong; Bucholz, Kathleen; Edenberg, Howard J.; Heath, Andrew; Martin, Nicholas G.; Pergadia, Michele L.; Montgomery, Grant; Schrage, Andrew; Bierut, Laura J.; Madden, Pamela F.; Goate, Alison M.			Pathway Analysis of Smoking Quantity in Multiple GWAS Identifies Cholinergic and Sensory Pathways	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; HEAVY-SMOKING; EUROPEAN-AMERICANS; GENETIC-LINKAGE; VARIANTS; BEHAVIOR; RISK; HERITABILITY; ALLELES	Cigarette smoking is a common addiction that increases the risk for many diseases, including lung cancer and chronic obstructive pulmonary disease. Genome-wide association studies (GWAS) have successfully identified and validated several susceptibility loci for nicotine consumption and dependence. However, the trait variance explained by these genes is only a small fraction of the estimated genetic risk. Pathway analysis complements single marker methods by including biological knowledge into the evaluation of GWAS, under the assumption that causal variants lie in functionally related genes, enabling the evaluation of a broad range of signals. Our approach to the identification of pathways enriched for multiple genes associated with smoking quantity includes the analysis of two studies and the replication of common findings in a third dataset. This study identified pathways for the cholinergic receptors, which included SNPs known to be genome-wide significant; as well as novel pathways, such as genes involved in the sensory perception of smell, that do not contain any single SNP that achieves that stringent threshold.	[Harari, Oscar; Wang, Jen-Chyong; Bucholz, Kathleen; Heath, Andrew; Pergadia, Michele L.; Schrage, Andrew; Bierut, Laura J.; Madden, Pamela F.; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Edenberg, Howard J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Martin, Nicholas G.; Montgomery, Grant] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; QIMR Berghofer Medical Research Institute	Goate, AM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	goatea@psychiatry.wustl.edu	Martin, Nicholas/R-9235-2019; Bierut, Laura Jean/W-6806-2019	Martin, Nicholas/0000-0003-4069-8020; Bierut, Laura Jean/0000-0002-9952-4810; Edenberg, Howard/0000-0003-0344-9690; Goate, Alison/0000-0002-0576-2472	National Institute of Drug Abuse [DA027995]; Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, R37AA007728, K05AA017688, R01AA007728, R01AA013321, P60AA011998, R01AA014041, P50AA011998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019963, R01DA013423, R01DA012854, K08DA019951, R25DA027995, R56DA012854] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	O.H is supported by the National Institute of Drug Abuse (DA027995) and the Barnes-Jewish Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bloom J, 2011, PHARMACOGENET GENOM, V21, P403, DOI 10.1097/FPC.0b013e328346e8c0; Broms U, 2006, TWIN RES HUM GENET, V9, P64, DOI 10.1375/183242706776403046; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Haller G, 2012, HUM MOL GENET, V21, P647, DOI 10.1093/hmg/ddr498; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Hinrichs AL, 2011, PHARMACOGENET GENOM, V21, P397, DOI 10.1097/FPC.0b013e328346886f; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kuehl GE, 2003, DRUG METAB DISPOS, V31, P1361, DOI 10.1124/dmd.31.11.1361; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Malaiyandi V, 2006, MOL PSYCHIATR, V11, P400, DOI 10.1038/sj.mp.4001794; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Osanai M, 2011, CANCER SCI, V102, P1158, DOI 10.1111/j.1349-7006.2011.01920.x; Pergadia ML, 2011, AM J PSYCHIAT, V168, P848, DOI 10.1176/appi.ajp.2011.10091319; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rasmussen-Torvik LJ, 2010, GENET EPIDEMIOL, V34, P665, DOI 10.1002/gepi.20525; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Saccone SF, 2007, AM J HUM GENET, V80, P856, DOI 10.1086/513703; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Sharrett A R, 1992, Ann Epidemiol, V2, P467; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Vink J, 2005, BEHAV GENET, V35, P397, DOI 10.1007/s10519-004-1327-8; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	44	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50913	10.1371/journal.pone.0050913	http://dx.doi.org/10.1371/journal.pone.0050913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227220	Green Published, gold			2022-12-25	WOS:000312588200081
J	Ribeiro, DA; Cota, J; Alvarez, TM; Bruchli, F; Bragato, J; Pereira, BMP; Pauletti, BA; Jackson, G; Pimenta, MTB; Murakami, MT; Camassola, M; Ruller, R; Dillon, AJP; Pradella, JGC; Leme, AFP; Squina, FM				Ribeiro, Daniela A.; Cota, Junio; Alvarez, Thabata M.; Bruechli, Fernanda; Bragato, Juliano; Pereira, Beatriz M. P.; Pauletti, Bianca A.; Jackson, George; Pimenta, Maria T. B.; Murakami, Mario T.; Camassola, Marli; Ruller, Roberto; Dillon, Aldo J. P.; Pradella, Jose G. C.; Paes Leme, Adriana F.; Squina, Fabio M.			The Penicillium echinulatum Secretome on Sugar Cane Bagasse	PLOS ONE			English	Article							TRICHODERMA-REESEI; PHANEROCHAETE-CHRYSOSPORIUM; PROTEOMIC ANALYSIS; LIGNOCELLULOSIC BIOMASS; EXTRACELLULAR PROTEINS; ASPERGILLUS-ORYZAE; CELLULASES; ENZYMES; FERMENTATION; EXPRESSION	Plant feedstocks are at the leading front of the biofuel industry based on the potential to promote economical, social and environmental development worldwide through sustainable scenarios related to energy production. Penicillium echinulatum is a promising strain for the bioethanol industry based on its capacity to produce large amounts of cellulases at low cost. The secretome profile of P. echinulatum after grown on integral sugarcane bagasse, microcrystalline cellulose and three types of pretreated sugarcane bagasse was evaluated using shotgun proteomics. The comprehensive chemical characterization of the biomass used as the source of fungal nutrition, as well as biochemical activity assays using a collection of natural polysaccharides, were also performed. Our study revealed that the enzymatic repertoire of P. echinulatum is geared mainly toward producing enzymes from the cellulose complex (endogluganases, cellobiohydrolases and beta-glucosidases). Glycoside hydrolase (GH) family members, important to biomass-to-biofuels conversion strategies, were identified, including endoglucanases GH5, 7, 6, 12, 17 and 61, beta-glycosidase GH3, xylanases GH10 and GH11, as well as debranching hemicellulases from GH43, GH62 and CE2 and pectinanes from GH28. Collectively, the approach conducted in this study gave new insights on the better comprehension of the composition and degradation capability of an industrial cellulolytic strain, from which a number of applied technologies, such as biofuel production, can be generated.	[Ribeiro, Daniela A.; Cota, Junio; Alvarez, Thabata M.; Bruechli, Fernanda; Bragato, Juliano; Pereira, Beatriz M. P.; Pauletti, Bianca A.; Jackson, George; Pimenta, Maria T. B.; Ruller, Roberto; Pradella, Jose G. C.; Paes Leme, Adriana F.; Squina, Fabio M.] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Murakami, Mario T.] CNPEM, Lab Espectrometria Massas, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Camassola, Marli; Dillon, Aldo J. P.] Univ Caxias do Sul UCS, Inst Biotecnol, Caxias Do Sul, RS, Brazil	Universidade de Caxias do Sul	Squina, FM (corresponding author), CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.	fabio.squina@bioetanol.org.br	Squina, Fabio/J-8130-2012; Dillon, Aldo José Pinheiro/J-4653-2012; Cota, Junio/J-7475-2012; Murakami, Mario T/F-5640-2016; Murakami, Mario T/C-2087-2012; DA CRUZ PRADELLA, JOSE GERALDO/AAA-7022-2019; Leme, Adriana F Paes/C-9679-2012; Büchli, Fernanda/M-8633-2018; Alvarez, Thabata/G-4117-2014; Ruller, ROBERTO/D-1260-2014	Squina, Fabio/0000-0002-8154-7459; Cota, Junio/0000-0002-1547-4087; Murakami, Mario T/0000-0002-0405-8010; DA CRUZ PRADELLA, JOSE GERALDO/0000-0002-2902-0983; Leme, Adriana F Paes/0000-0001-7959-147X; Ruller, ROBERTO/0000-0002-5087-9493; Ruller, Roberto/0000-0001-7501-5176	FAPESP [2008/58037-9, 2010/11499-1]; CNPq [475022/2011-4 e 310177/2011-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from FAPESP (2008/58037-9) and CNPq (475022/2011-4 e 310177/2011-1). TMA received a fellowship from FAPESP (2010/11499-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; Adav SS, 2012, J PROTEOMICS, V75, P1493, DOI 10.1016/j.jprot.2011.11.020; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berlin A, 2005, APPL BIOCHEM BIOTECH, V121, P163, DOI 10.1385/ABAB:121:1-3:0163; Beukes N, 2010, BIORESOURCE TECHNOL, V101, P4472, DOI 10.1016/j.biortech.2010.01.081; Camassola M, 2007, J APPL MICROBIOL, V103, P2196, DOI 10.1111/j.1365-2672.2007.03458.x; Camassola M, 2004, BIOCATAL BIOTRANSFOR, V22, P391, DOI 10.1080/10242420400024532; Camassola M, 2010, APPL BIOCHEM BIOTECH, V162, P1889, DOI 10.1007/s12010-010-8967-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; de Oliveira JMPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020865; DILLON AJP, 1992, REV BRAS GENET, V15, P491; Dillon AJP, 2006, APPL MICROBIOL BIOT, V70, P740, DOI 10.1007/s00253-005-0122-7; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Cairo JPLF, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-50; Gouveia ER, 2009, QUIM NOVA, V32, P1500, DOI 10.1590/S0100-40422009000600026; Grethlein H. E., 1985, NAT BIOTECHNOL, V3, P155, DOI [10.1038/nbt0285-155, DOI 10.1038/NBT0285-155]; Guais O, 2008, J IND MICROBIOL BIOT, V35, P1659, DOI 10.1007/s10295-008-0430-x; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Jami MS, 2010, MOL CELL PROTEOMICS, V9, P2729, DOI 10.1074/mcp.M110.001412; Juhasz T, 2005, PROCESS BIOCHEM, V40, P3519, DOI 10.1016/j.procbio.2005.03.057; Jun H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-68; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Kim KH, 2007, J PROTEOME RES, V6, P4749, DOI 10.1021/pr070355i; Krogh KBR, 2004, APPL BIOCHEM BIOTECH, V113, P389; Mahajan S, 2010, APPL MICROBIOL BIOT, V86, P1903, DOI 10.1007/s00253-010-2516-4; MANDELS M, 1957, J BACTERIOL, V73, P269, DOI 10.1128/JB.73.2.269-278.1957; Martins LF, 2008, BIORESOURCE TECHNOL, V99, P1417, DOI 10.1016/j.biortech.2007.01.060; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moi GP, 2012, CARIES RES, V46, P339, DOI 10.1159/000338246; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Oda K, 2006, APPL ENVIRON MICROB, V72, P3448, DOI 10.1128/AEM.72.5.3448-3457.2006; Otero JM, 2010, BIOTECHNOL BIOENG, V105, P439, DOI 10.1002/bit.22592; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rashid MH, 2008, BIOTECHNOL LETT, V30, P2165, DOI 10.1007/s10529-008-9804-4; Ravalason H, 2008, APPL MICROBIOL BIOT, V80, P719, DOI 10.1007/s00253-008-1596-x; Ravalason H, 2012, BIORESOURCE TECHNOL, V114, P589, DOI 10.1016/j.biortech.2012.03.009; Rubini MR, 2010, J APPL MICROBIOL, V108, P1187, DOI 10.1111/j.1365-2672.2009.04528.x; Sato S, 2007, MICROBIOL-SGM, V153, P3023, DOI 10.1099/mic.0.2006/000513-0; Saykhedkar S, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-52; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Seidl V, 2010, BIOFUELS-UK, V1, P343, DOI 10.4155/BFS.10.1; SMITH DC, 1991, BIOTECHNOL BIOENG, V38, P883, DOI 10.1002/bit.260380810; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Tambor JH, 2012, APPL MICROBIOL BIOT, V93, P203, DOI 10.1007/s00253-011-3419-8; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Wingren A, 2003, BIOTECHNOL PROGR, V19, P1109, DOI 10.1021/bp0340180	52	51	52	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50571	10.1371/journal.pone.0050571	http://dx.doi.org/10.1371/journal.pone.0050571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227186	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200046
J	Torrens, C; Ethirajan, P; Bruce, KD; Cagampang, FRA; Siow, RCM; Hanson, MA; Byrne, CD; Mann, GE; Clough, GF				Torrens, Christopher; Ethirajan, Priya; Bruce, Kimberley D.; Cagampang, Felino R. A.; Siow, Richard C. M.; Hanson, Mark A.; Byrne, Christopher D.; Mann, Giovanni E.; Clough, Geraldine F.			Interaction between Maternal and Offspring Diet to Impair Vascular Function and Oxidative Balance in High Fat Fed Male Mice	PLOS ONE			English	Article							NITRIC-OXIDE BIOAVAILABILITY; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; ANIMAL-MODELS; OBESITY; HYPERTENSION; RESPONSES; STRESS; EDHF; PREGNANCY	Aims: To determine the impact of maternal and post-weaning consumption of a high fat diet on endothelium-dependent vasorelaxation and redox regulation in adult male mouse offspring. Methods: Female C57BL6J mice were fed an obesogenic high fat diet (HF, 45% kcal fat) or standard chow (C, 21% kcal fat) pre-conception and throughout pregnancy and lactation. Post-weaning, male offspring were continued on the same diet as their mothers or placed on the alternative diet to give 4 dietary groups (C/C, HF/C, C/HF and HF/HF) which were studied at 15 or 30 weeks of age. Results: There were significant effects of maternal diet on offspring body weight (p<0.004), systolic blood pressure (p = 0.026) and endothelium-dependent relaxation to ACh (p = 0.004) and NO production (p = 0.005) measured in the femoral artery. With control for maternal diet there was also an effect of offspring post-weaning dietary fat to increase systolic blood pressure (p<0.0001) and reduce endothelium-dependent relaxation (p = 0.022) and ACh-mediated NO production (p = 0.007). There was also a significant impact of age (p, 0.005). Redox balance was perturbed, with altered regulation of vascular enzymes involved in ROS/NO signalling. Conclusions: Maternal consumption of a HF diet is associated with changes in vascular function and oxidative balance in the offspring of similar magnitude to those seen with consumption of a high fat diet post-weaning. Further, this disadvantageous vascular phenotype is exacerbated by age to influence the risk of developing obesity, raised blood pressure and endothelial dysfunction in adult life.	[Torrens, Christopher; Ethirajan, Priya; Bruce, Kimberley D.; Cagampang, Felino R. A.; Hanson, Mark A.; Clough, Geraldine F.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Byrne, Christopher D.] Univ Southampton, Southampton, Hants, England; [Byrne, Christopher D.] Southampton Gen Hosp, Southampton Natl Inst Hlth Res, Biomed Res Ctr, Southampton SO9 4XY, Hants, England; [Siow, Richard C. M.; Mann, Giovanni E.] Kings Coll London, BHF Ctr Res Excellence, Sch Med, Div Cardiovasc, London, England	University of Southampton; University of Southampton; University of Southampton; University of London; King's College London	Clough, GF (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	g.f.clough@southampton.ac.uk	Hanson, Mark/AAE-8236-2019; Cagampang, Felino/AAG-5141-2019; Torrens, Christopher/A-8117-2013	Hanson, Mark/0000-0002-6907-613X; Cagampang, Felino/0000-0003-4404-9853; Torrens, Christopher/0000-0003-4377-0112; Byrne, Christopher D/0000-0001-6322-7753; Mann, Giovanni/0000-0001-7311-2044	Biotechnology and Biological Sciences Research Council [BB/D006133/1]; British Heart Foundation [PG/07/006/22212]; Heart Research United Kingdom [TRP27/09]; RCMS; European Union Cooperation in Science and Technology ACTION [B35]; British Heart Foundation [PG/12/18/29453] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Heart Research United Kingdom; RCMS; European Union Cooperation in Science and Technology ACTION; British Heart Foundation(British Heart Foundation)	This work was supported by Biotechnology and Biological Sciences Research Council (BB/D006133/1); British Heart Foundation (PG/07/006/22212); Heart Research United Kingdom (TRP27/09) to GEM, RCMS; and European Union Cooperation in Science and Technology ACTION B35 to GEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal-Ahmed I, 2007, FREE RADICAL BIO MED, V42, P1781, DOI 10.1016/j.freeradbiomed.2007.02.032; Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Amanso Angelica M, 2012, Front Biosci (Schol Ed), V4, P1044; Ashraf MZ, 2007, INDIAN J EXP BIOL, V45, P505; Bouanane S, 2009, CLIN SCI, V116, P669, DOI 10.1042/CS20080413; Brandes RP, 2010, FREE RADICAL BIO MED, V49, P687, DOI 10.1016/j.freeradbiomed.2010.04.030; Brandes RP, 2010, HYPERTENSION, V56, P17, DOI 10.1161/HYPERTENSIONAHA.108.120295; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; De Boer MP, 2012, MICROCIRCULATION, V19, P5, DOI 10.1111/j.1549-8719.2011.00130.x; Donato AJ, 2007, J PHYSIOL-LONDON, V579, P115, DOI 10.1113/jphysiol.2006.120055; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Feher A, 2010, CARDIOVASC RES, V87, P732, DOI 10.1093/cvr/cvq088; Franco MD, 2002, J CARDIOVASC PHARM, V40, P501, DOI 10.1097/00005344-200210000-00002; Franco MDP, 2004, J PHYSIOL-LONDON, V558, P239, DOI 10.1113/jphysiol.2004.064055; Frisbee JC, 2005, AM J PHYSIOL-REG I, V289, pR307, DOI 10.1152/ajpregu.00114.2005; Georgiou CD, 2008, NAT PROTOC, V3, P1679, DOI 10.1038/nprot.2008.155; Granger DN, 2010, MICROCIRCULATION, V17, P192, DOI 10.1111/j.1549-8719.2009.00015.x; Haddock RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016423; He M, 2011, NUTR METAB CARDIOVAS, V21, P277, DOI 10.1016/j.numecd.2009.12.008; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Jung O, 2004, CIRCULATION, V109, P1795, DOI 10.1161/01.CIR.0000124223.00113.A4; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Leo CH, 2011, BRIT J PHARMACOL, V162, P365, DOI 10.1111/j.1476-5381.2010.01023.x; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Marchesi C, 2009, HYPERTENSION, V54, P1384, DOI 10.1161/HYPERTENSIONAHA.109.138305; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Miller AA, 2010, STROKE, V41, P784, DOI 10.1161/STROKEAHA.109.575365; Morton JS, 2010, AM J PHYSIOL-REG I, V298, pR930, DOI 10.1152/ajpregu.00641.2009; Muller-Delp JM, 2012, MICROCIRCULATION, V19, P19, DOI 10.1111/j.1549-8719.2011.00139.x; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; Ozkor MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/156146; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Poston L, 2011, MICROCIRCULATION, V18, P256, DOI 10.1111/j.1549-8719.2011.00086.x; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rodford JL, 2008, J PHYSIOL-LONDON, V586, P4709, DOI 10.1113/jphysiol.2008.156976; Rowlands DJ, 2011, HYPERTENSION, V57, P833, DOI 10.1161/HYPERTENSIONAHA.110.162198; Saker M, 2008, EUR J OBSTET GYN R B, V141, P95, DOI 10.1016/j.ejogrb.2008.07.013; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; Strakovsky RS, 2012, ANTIOXID REDOX SIGN, V17, P237, DOI 10.1089/ars.2011.4372; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760; Trott DW, 2011, J APPL PHYSIOL, V110, P1171, DOI 10.1152/japplphysiol.01037.2010; Watkins AJ, 2008, J PHYSIOL-LONDON, V586, P2231, DOI 10.1113/jphysiol.2007.149229; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; Zhang LN, 2011, EUR J PHARMACOL, V654, P68, DOI 10.1016/j.ejphar.2010.12.016; Zhang XY, 2011, J NUTR, V141, P1254, DOI 10.3945/jn.111.139576; Zhu JX, 2007, J VASC RES, V44, P382, DOI 10.1159/000102955	60	45	46	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50671	10.1371/journal.pone.0050671	http://dx.doi.org/10.1371/journal.pone.0050671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227196	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000323179700003
J	Vila, L; Roglans, N; Baena, M; Barroso, E; Alegret, M; Merlos, M; Laguna, JC				Vila, Laia; Roglans, Nuria; Baena, Miguel; Barroso, Emma; Alegret, Marta; Merlos, Manuel; Laguna, Juan C.			Metabolic Alterations and Increased Liver mTOR Expression Precede the Development of Autoimmune Disease in a Murine Model of Lupus Erythematosus	PLOS ONE			English	Article							LEPTIN; ATHEROSCLEROSIS; MECHANISMS; STRATEGIES; FRUCTOSE; PATHWAY; OBESITY; IMMUNE	Although metabolic syndrome (MS) and systemic lupus erythematosus (SLE) are often associated, a common link has not been identified. Using the BWF1 mouse, which develops MS and SLE, we sought a molecular connection to explain the prevalence of these two diseases in the same individuals. We determined SLE-markers (plasma anti-ds-DNA antibodies, splenic regulatory T cells (Tregs) and cytokines, proteinuria and renal histology) and MS-markers (plasma glucose, non-esterified fatty acids, triglycerides, insulin and leptin, liver triglycerides, visceral adipose tissue, liver and adipose tissue expression of 86 insulin signaling-related genes) in 8-, 16-, 24-, and 36-week old BWF1 and control New-Zealand-White female mice. Up to week 16, BWF1 mice showed MS-markers (hyperleptinemia, hyperinsulinemia, fatty liver and visceral adipose tissue) that disappeared at week 36, when plasma anti-dsDNA antibodies, lupus nephritis and a pro-autoimmune cytokine profile were detected. BWF1 mice had hyperleptinemia and high splenic Tregs till week 16, thereby pointing to leptin resistance, as confirmed by the lack of increased liver P-Tyr-STAT-3. Hyperinsulinemia was associated with a down-regulation of insulin related-genes only in adipose tissue, whereas expression of liver mammalian target of rapamicyn (mTOR) was increased. Although leptin resistance presented early in BWF1 mice can slow-down the progression of autoimmunity, our results suggest that sustained insulin stimulation of organs, such as liver and probably kidneys, facilitates the over-expression and activity of mTOR and the development of SLE.	[Roglans, Nuria; Alegret, Marta; Merlos, Manuel; Laguna, Juan C.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Roglans, Nuria; Alegret, Marta; Merlos, Manuel; Laguna, Juan C.] CIBER Ctr Invest Biomed Red Physiopathol Obes & N, Barcelona, Spain; [Vila, Laia; Baena, Miguel; Barroso, Emma] Univ Barcelona, Sch Pharm, Dept Pharmacol & Therapeut Chem, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona	Laguna, JC (corresponding author), Univ Barcelona, Inst Biomed, Barcelona, Spain.	jclagunae@ub.edu	Baena, Miguel/L-2263-2017; Laguna, JCLaguna - Juan C./C-5481-2017; Merlos, Manuel/AAC-3064-2021; Alegret, Marta/C-5086-2017; Roglans, Núria/ABH-1242-2020; Fernandez, Emma Barroso/G-9305-2018; Vilà, Laia/ABG-8595-2020	Laguna, JCLaguna - Juan C./0000-0002-7082-0704; Merlos, Manuel/0000-0002-8423-3033; Alegret, Marta/0000-0002-5652-8651; Fernandez, Emma Barroso/0000-0003-4551-4825; Roglans, Nuria/0000-0002-5018-021X; Baena, Miguel/0000-0003-2078-5258; Vila, Laia/0000-0001-7232-2250	Fundacio Privada Catalana de Nutricio i Lipids; Spanish Society of Atherosclerosis; Research and Teaching Grants from the University of Barcelona	Fundacio Privada Catalana de Nutricio i Lipids(Instituto de Salud Carlos III); Spanish Society of Atherosclerosis; Research and Teaching Grants from the University of Barcelona	This study was supported by grants from the Fundacio Privada Catalana de Nutricio i Lipids, project CENIT-GENIUSPHARMA, and the Spanish Society of Atherosclerosis. Laia Vila and Miguel Baena were supported by Research and Teaching Grants from the University of Barcelona. We have been nominated as a Consolidated Research Group by the Autonomous Government of Catalonia (SGR09-00413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovich G, 2007, LUPUS, V16, P18, DOI 10.1177/0961203306073136; Bonelli M, 2010, ANN RHEUM DIS, V69, P65, DOI 10.1136/ard.2009.117135; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiuve SE, 2007, NAT CLIN PRACT CARD, V4, P610, DOI 10.1038/ncpcardio1009; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Feng PH, 2007, ANN NY ACAD SCI, V1108, P114, DOI 10.1196/annals.1422.013; Furukawa F, 2005, AUTOIMMUN REV, V4, P345, DOI 10.1016/j.autrev.2005.01.006; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Haque S, 2005, NAT CLIN PRACT CARD, V2, P423, DOI 10.1038/ncpcardio0270; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Lazarow P B, 1981, Methods Enzymol, V72, P315; Low YL, 2007, MUTAT RES-FUND MOL M, V622, P7, DOI 10.1016/j.mrfmmm.2007.01.015; Manjarrez-Orduno N, 2009, J INVEST DERMATOL, V129, P278, DOI 10.1038/jid.2008.240; Manzi S, 2009, CLEV CLIN J MED, V76, P137, DOI 10.3949/ccjm.76a.gr005; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2008, J LEUKOCYTE BIOL, V84, P893, DOI 10.1189/jlb.0108022; Mok CC, 2006, SCAND J RHEUMATOL, V35, P85, DOI 10.1080/03009740600601526; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ordovas J, 2007, NUTR REV, V65, pS203, DOI [10.1111/j.1753-4887.2007.tb00363.x, 10.1301/nr.2007.dec.S203-S207]; Peter S, 2007, W INDIAN MED J, V56, P264; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rana JS, 2007, DIABETES OBES METAB, V9, P218, DOI 10.1111/j.1463-1326.2006.00594.x; Reddy PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2541; Roglans N, 2007, HEPATOLOGY, V45, P778, DOI 10.1002/hep.21499; Ryan MJ, 2006, HYPERTENSION, V48, P988, DOI 10.1161/01.HYP.0000243612.02929.df; Sherer Y, 2010, AUTOIMMUNITY, V43, P98, DOI 10.3109/08916930903374527; Sigal LH, 2004, JCR-J CLIN RHEUMATOL, V10, P353, DOI 10.1097/01.rhu.0000147138.11053.e4; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Vila L, 2008, HEPATOLOGY, V48, P1506, DOI 10.1002/hep.22523; Westerweel PE, 2007, ARTHRITIS RHEUM-US, V56, P1384, DOI 10.1002/art.22568; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	34	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51118	10.1371/journal.pone.0051118	http://dx.doi.org/10.1371/journal.pone.0051118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226562	Green Published, Green Submitted, gold			2022-12-25	WOS:000312108500045
J	Montero, JC; Esparis-Ogando, A; Re-Louhau, MF; Seoane, S; Abad, M; Calero, R; Ocana, A; Pandiella, A				Montero, J. C.; Esparis-Ogando, A.; Re-Louhau, M. F.; Seoane, S.; Abad, M.; Calero, R.; Ocana, A.; Pandiella, A.			Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer	ONCOGENE			English	Article						mTOR; PI3K; triple-negative breast cancer	PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; ANTITUMOR-ACTIVITY; NVP-BEZ235; GROWTH; CELLS; PHOSPHORYLATION; ACTIVATION; POTENT; PROLIFERATION	Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer. Despite response to chemotherapy, relapses are frequent and resistance to available treatments is often seen in the metastatic setting. Therefore, identification of new therapeutic targets is required. With this aim, we have profiled the activation status of 44 receptor tyrosine kinases (RTKs) and their major signaling pathways in patient-derived TNBC tumors. Frequent co-activation of several RTKs as well as the extracellular signal-regulated protein kinases 1 and 2 (Erk1/2) and mammalian target of rapamycin (mTOR) routes was found. Pharmacologic targeting of the activated kinases indicated that agents that attack the mTOR route are more potent and efficient antitumoral treatments than agents targeting RTKs. mTOR signals through two multiprotein complexes, mTORC1 and mTORC2. We used a genetic approach to explore the contribution of each of the two mTOR branches to the regulation of cell number of TNBC cells. RNA interference experiments indicated that mTORC1 predominated over mTORC2 in the control of TNBC cell proliferation. Moreover, RNA interference of mTOR had a superior antiproliferative action than separately acting on mTORC1 or mTORC2. To analyze the relevance of mTOR targeting in vivo, we used mice with TNBC. Treatment of these mice with BEZ235, a drug that targets mTOR, slowed tumor growth. Mechanistically, BEZ235 delayed cell cycle progression without affecting cell viability. Our results show that TNBCs are particularly sensitive to inhibition of the mTOR pathway, and indicate that mTOR targeting may be a more efficient anti-TNBC therapy than exclusively acting on the mTORC1 branch of the pathway. This is relevant as most mTOR inhibitors used in the clinic act on mTORC1. Collectively with the fact that BEZ235 synergized with drugs commonly used in the treatment of TNBC, our data support the clinical development of agents that act on mTOR as a therapy for this disease.	[Montero, J. C.; Esparis-Ogando, A.; Re-Louhau, M. F.; Seoane, S.; Pandiella, A.] Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain; [Abad, M.] Hosp Clin Univ Salamanca, Pathol Dept, Salamanca, Spain; [Calero, R.; Ocana, A.] Complejo Hosp Univ Albacete, Serv Oncol Med, Albacete, Spain; [Calero, R.; Ocana, A.] AECC Unit, Albacete, Spain; [Ocana, A.] Univ Toronto, Princess Margaret Hosp, Div Med Oncol & Hematol, Toronto, ON, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Pandiella, A (corresponding author), Inst Biol Mol & Celular Canc CIC, Campus Miguel Unamuno,Ave Univ Coimbra, Salamanca 37007, Spain.	atanasio@usal.es	Calero, Raul/F-7867-2016; Seoane, Samuel/H-6299-2015; Seoane, Samuel/L-1309-2014; Esparís-Ogando, Aucena/O-5326-2017; Pandiella, Atanasio/O-5180-2014; Montero, Juan Carlos/AAO-1780-2020	Calero, Raul/0000-0003-1525-1921; Seoane, Samuel/0000-0002-9178-0887; Esparís-Ogando, Aucena/0000-0003-4550-4192; Pandiella, Atanasio/0000-0002-4704-8971; Montero, Juan Carlos/0000-0003-4773-053X; Ocana, Alberto/0000-0002-1067-9630	Ministry of Science and Innovation of Spain [BFU2009-07728/BMC, PS09/00868]; Cancer Center Network Program from the ISCIII [RD06/0020/0041]; European Community through the regional development funding program (FEDER); Fundacion Ramon Areces; FISCAM [PI2010/017]; ISCIII [PS09/02144]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cancer Center Network Program from the ISCIII; European Community through the regional development funding program (FEDER); Fundacion Ramon Areces; FISCAM; ISCIII(Instituto de Salud Carlos III)	This work was supported by grants from the Ministry of Science and Innovation of Spain (BFU2009-07728/BMC to AP, and PS09/00868 to AE-O). JCM and SS were supported by the Cancer Center Network Program from the ISCIII (RD06/0020/0041). The Cancer Research Institute, and the work carried out at AP and AE-O laboratories, receive support from the European Community through the regional development funding program (FEDER), and from the Fundacion Ramon Areces. AO receives research support from the FISCAM (Grant PI2010/017) and from the ISCIII (Grant PS09/02144). We thank Dr J Jonkers (Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands) for the generous gift of the Brca1/p53 conditional mouse model.	Allred DC, 1998, MODERN PATHOL, V11, P155; Barrios CH, 2010, BREAST CANCER RES TR, V121, P121, DOI 10.1007/s10549-010-0788-0; Baselga J, SAN ANT BREAST CANC; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Montero JC, 2012, MOL CANCER THER, V11, P1342, DOI 10.1158/1535-7163.MCT-11-0723; Chen ZM, 2006, MOL PHARMACOL, V69, P1527, DOI 10.1124/mol.105.020172; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Cristofanilli M, 2008, ANN ONCOL, V19, P1713, DOI 10.1093/annonc/mdn352; de Alava E, 2007, J CLIN ONCOL, V25, P2656, DOI 10.1200/JCO.2006.08.6850; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Diaz-Rodriguez E, 1999, EUR J NEUROSCI, V11, P1421, DOI 10.1046/j.1460-9568.1999.00552.x; Diaz-Rodriguez E, 2010, J CELL SCI, V123, P3146, DOI 10.1242/jcs.070516; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hilger R A, 2002, Int J Clin Pharmacol Ther, V40, P567; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Ocana A, 2011, NAT REV CLIN ONCOL, V8, P200, DOI 10.1038/nrclinonc.2010.194; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seoane S, 2010, JNCI-J NATL CANCER I, V102, P1432, DOI 10.1093/jnci/djq315; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yuste L, 2005, CANCER RES, V65, P6801, DOI 10.1158/0008-5472.CAN-04-4023	49	67	71	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					148	156		10.1038/onc.2012.572	http://dx.doi.org/10.1038/onc.2012.572			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23246963				2022-12-25	WOS:000329440700002
J	Qureshi, BM; Hofmann, NE; Arroyo-Olarte, RD; Nickl, B; Hoehne, W; Jungblut, PR; Lucius, R; Scheerer, P; Gupta, N				Qureshi, Bilal M.; Hofmann, Natalie E.; Arroyo-Olarte, Ruben D.; Nickl, Bernadette; Hoehne, Wolfgang; Jungblut, Peter R.; Lucius, Richard; Scheerer, Patrick; Gupta, Nishith			Dynein light chain 8a of Toxoplasma gondii, a unique conoid-localized beta-strand-swapped homodimer, is required for an efficient parasite growth	FASEB JOURNAL			English	Article						Plasmodium falciparum; Eimeria tenella; crystal structure; apical complex; conoid	SELECTABLE MARKER; APICOMPLEXAN; MODEL; LC8; CRYSTALLOGRAPHY; EXPRESSION; SYSTEM; GENE	Dynein light chain 8 (DLC8) is a ubiquitous eukaryotic protein regulating diverse cellular functions. We show that the obligate intracellular parasite Toxoplasma gondii harbors 4 DLC8 proteins (TgDLC8a-d), of which only TgDLC8a clusters in the mainstream LC8 class. TgDLC8b-d proteins form a divergent and alveolate-specific clade. TgDLC8b-d proteins are largely cytosolic, whereas TgDLC8a resides in the conoid at the apical end of T. gondii. The apical location of TgDLC8a is also not shared by its nearly identical Eimeria (EtDLC8a), Plasmodium (PfDLC8), or human (HsDLC8) orthologs. Notwithstanding an exclusive conoid targeting, TgDLC8a exhibits a classical LC8 structure. It forms a homodimer by swapping of the beta(2) strands that interact with the antiparallel beta(1)' strands of the opposing monomers. The TgDLC8a dimer contains two identical binding grooves and appears to be adapted for multitarget recognition. By contrast, the previously reported PfDLC8 homodimer is shaped by binding of the beta(0) strand with the parallel beta(2)' strand and lacks such a distinct binding interface. Our comparisons suggest an unexpected structural and functional divergence of the two otherwise conserved proteins from apicomplexan parasites. Finally, we demonstrate that a phosphomimetic S88E mutation renders the TgDLC8a-S88E mutant monomeric and cytosolic in T. gondii, and its overexpression inhibits the parasite growth in human fibroblasts.-Qureshi, B. M., Hofmann, N. E., Arroyo-Olarte, R. D., Nickl, B., Hoehne, W., Jungblut, P. R., Lucius, R., Scheerer, P., Gupta, N. Dynein light chain 8a of Toxoplasma gondii, a unique conoid-localized beta-strand-swapped homodimer, is required for an efficient parasite growth. FASEB J. 27, 1034-1047 (2013). www.fasebj.org	[Qureshi, Bilal M.; Hofmann, Natalie E.; Arroyo-Olarte, Ruben D.; Nickl, Bernadette; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany; [Qureshi, Bilal M.; Hoehne, Wolfgang; Scheerer, Patrick] Charite, Inst Biochem, D-10098 Berlin, Germany; [Qureshi, Bilal M.; Scheerer, Patrick] Charite, Inst Med Phys & Biophys CC2, D-10098 Berlin, Germany; [Jungblut, Peter R.] Max Planck Inst Infect Biol, Berlin, Germany	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13,House 14, D-10115 Berlin, Germany.	patrick.scheerer@charite.de; gupta.nishith@staff.hu-berlin.de	Arroyo-Olarte, Ruben D/AAW-3127-2021; Arroyo-Olarte, Ruben D/AAH-8939-2020	Arroyo-Olarte, Ruben D/0000-0002-8096-2423; Qureshi, Bilal Muhammad/0000-0002-0153-7729; Gupta, Nishith/0000-0003-1452-5126; Nickl, Bernadette/0000-0002-1998-8157; Scheerer, Patrick/0000-0001-5028-2075	German Research Foundation (DFG) [SFB618, GRK1121]	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors are grateful to Uwe Muller and to the scientific staff of BESSY-MX at beam lines BL14.1 and BL14.2 (Helmholtz Zentrum fur Materialien und Energie, Berlin) for collection of the X-ray diffraction data sets. The authors thank Christa Scholz, Helga Wessner, and Norbert Krauss (Charite-Universitatsmedizin, Berlin) for help with purification, crystallization, and data analyses and Grit Meusel (Humboldt University, Berlin) for transgenic parasite and biochemical work. The authors thank Katja Faelber and Oliver Daumke (Max Delbruck Center of Molecular Medicine, Berlin) for size-exclusion and static light-scattering assays. This work was supported by grants SFB618 (N.G., R.L.) and GRK1121 (N.G.) from the German Research Foundation (DFG). U.S. National Center for Biotechnology Information (NCBI) database accession numbers of the protein and nucleotide sequences derived from the work are as follows: TgDLC8a, ABL74449; TgDLC8b, ADY76967; TgDLC8c, JF815093; TgDLC8d, JF815094; EtDLC8a, JX306039. The atomic coordinates and structure factors for the TgDLC8a crystal structure have been deposited in the Research Collaboratory for Structural Bioinformatics (RCSB) Protein Database (accession code 3RJS).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALLEE RB, 1988, NATURE, V332, P561, DOI 10.1038/332561a0; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Wilkes DE, 2007, CELL MOTIL CYTOSKEL, V64, P82, DOI 10.1002/cm.20165	37	12	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1034	1047		10.1096/fj.11-180992	http://dx.doi.org/10.1096/fj.11-180992			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23233536				2022-12-25	WOS:000315585200018
J	Tohmonda, T; Yoda, M; Mizuochi, H; Morioka, H; Matsumoto, M; Urano, F; Toyama, Y; Horiuchi, K				Tohmonda, Takahide; Yoda, Masaki; Mizuochi, Hiroshi; Morioka, Hideo; Matsumoto, Morio; Urano, Fumihiko; Toyama, Yoshiaki; Horiuchi, Keisuke			The IRE1 alpha-XBP1 Pathway Positively Regulates Parathyroid Hormone (PTH)/PTH-related Peptide Receptor Expression and Is Involved in PTH-induced Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; ER STRESS; TRANSCRIPTION; ACTIVATION; KINASE; DECISIONS; OSTERIX	To address the "endoplasmic reticulum stress" triggered by the burden of protein synthesis, the unfolded protein response is induced during osteoblast differentiation. In this study, we show that the transcription of parathyroid hormone (PTH)/PTH-related peptide receptor (PTH1R) is regulated by one of the endoplasmic reticulum-stress mediators, the IRE1 alpha-XBP1 pathway, in osteoblasts. We found that the increase in Pth1r transcription upon BMP2 treatment is significantly suppressed in mouse embryonic fibroblasts lacking IRE1 alpha. As expected, gene silencing of Ire1 alpha and Xbp1 resulted in a decrease in Pth1r transcripts in BMP2-treated embryonic fibroblasts. We identified two potential binding sites for XBP1 in the promoter region of Pth1r and found that XBP1 promotes the transcription of Pth1r by directly binding to those sites. Moreover, we confirmed that the gene silencing of Xbp1 suppresses PTH-induced Rankl expression in primary osteoblasts and thereby abolishes osteoclast formation in an in vitro model of osteoclastogenesis. Thus, the present study reveals potential involvement of the IRE1 alpha-XBP1 pathway in PTH-induced osteoclastogenesis through the regulation of PTH1R expression.	[Tohmonda, Takahide; Yoda, Masaki; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo 1608582, Japan; [Horiuchi, Keisuke] Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Urano, Fumihiko] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63110 USA	Keio University; Keio University; Washington University (WUSTL)	Horiuchi, K (corresponding author), Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	horiuchi@z3.keio.jp	Matsumoto, Morio M/L-6227-2013; Urano, Fumihiko/AAF-4492-2020; Horiuchi, Keisuke/L-2277-2013; Toyama, Yoshiaki/K-5743-2013	Horiuchi, Keisuke/0000-0001-7063-9609; 	Keio University; MEXT KAKENHI [24390358, 24791566]	Keio University; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Keio University Kanrinmaru Project (to K. H.) and MEXT KAKENHI Grants 24390358 (to K. H.) and 24791566 (to T. T.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; McCauley LK, 2012, J BONE MINER RES, V27, P1231, DOI 10.1002/jbmr.1617; MCCUAIG KA, 1995, NUCLEIC ACIDS RES, V23, P1948, DOI 10.1093/nar/23.11.1948; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Oikawa D, 2010, FEBS LETT, V584, P1066, DOI 10.1016/j.febslet.2010.02.012; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Reimold AM, 2000, GENE DEV, V14, P152; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	26	13	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1691	1695		10.1074/jbc.C112.424606	http://dx.doi.org/10.1074/jbc.C112.424606			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23235147	Green Published, hybrid			2022-12-25	WOS:000313751400025
J	Daliento, L; Dal Bianco, L; Bagato, F; Secco, E; Sarubbi, B; Mazzotti, E; Bauce, B; Rizzoli, G				Daliento, Luciano; Dal Bianco, Lucia; Bagato, Francesco; Secco, Eleonora; Sarubbi, Berardo; Mazzotti, Elisa; Bauce, Barbara; Rizzoli, Giulio			Gender Differences and Role of Pregnancy in the History of Post-Surgical Women Affected by Tetralogy of Fallot	PLOS ONE			English	Article							REPAIR	Background: The aim of this study was to describe gender differences in patients operated on for TOF and to define the impact of pregnancy in late post-surgical follow-up in women. Methods: In this research, we studied 145 patients after correction of TOF: 66 male, 79 women, 41 of which reported history of 68 pregnancies, means age 37 +/- 10 years, age at operation 7 +/- 8 years, mean duration of post-surgical follow-up 30 +/- 7 years. Selected variables were compared according to sex and according to history of pregnancy with statistical tests. Results: Men had more severe hemodynamic impairment and a higher number of cardiac reoperations than females. 41% of patients had at least one complication during pregnancy; there were 16 (67%) abortions and 39 (74%) Caesarian delivers; the recurrence of congenital heart defect was 10%. After pregnancy, there was a shift from first to second functional class: unique pregnancy determined no differences in term of morpho-functional ventricular features compared to nulliparous, but they complained fatigue and palpitation and echocardiographyc dysfunction. Left ventricular dysfunction and QRS duration at ECG were independent predictors of ventricular arrhythmias in all patients. Conclusions: There were no gender-specific differences in patients operated on for TOF using ventriculotomy. Pregnancy is an event in these patients at risk for the newborn, in terms of miscarriage, prematurity, and recurrence of birth defects, and for the mother in terms of ventricular dysfunction and electrical instability. At least a single pregnancy does not appear to significantly modify the natural history of post-surgical patients operated on for TOF.	[Daliento, Luciano; Dal Bianco, Lucia; Bagato, Francesco; Secco, Eleonora; Mazzotti, Elisa; Bauce, Barbara] Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Surg, Cardiol Unit, Padua, Italy; [Sarubbi, Berardo] Univ Naples Federico II, Sch Med, Cardiol Unit, Naples, Italy; [Rizzoli, Giulio] Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Surg, Adult Cardiac Surg Unit, Padua, Italy	University of Padua; University of Naples Federico II; University of Padua	Dal Bianco, L (corresponding author), Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Surg, Cardiol Unit, Padua, Italy.	lucia_db@libero.it	Sarubbi, Berardo/AAL-1439-2021	Sarubbi, Berardo/0000-0001-9941-8500				Balci A, 2011, AM HEART J, V161, P307, DOI 10.1016/j.ahj.2010.10.027; Broberg CS, 2011, AM J CARDIOL, V107, P1215, DOI 10.1016/j.amjcard.2010.12.026; Daliento L, 2005, HEART, V91, P213, DOI 10.1136/hrt.2003.029280; Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LILLEHEI CW, 1955, ANN SURG, V142, P418, DOI 10.1097/00000658-195509000-00010; Naguib MA, 2010, INT J OBSTET ANESTH, V19, P306, DOI 10.1016/j.ijoa.2009.10.009; Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5; Sarikouch S, 2011, CIRC CARDIOVASC IMAG, DOI CIRCIMAGING.111.963637; Shinebourne EA., 2002, PAEDIAT CARDIOLOGY, P1213; Somerville J, 1998, EUR HEART J, V19, P1766, DOI 10.1053/euhj.1998.1204; STATA, 2009, STATA STAT CORP 2009; Uebing A, 2010, INT J CARDIOL, V139, P50, DOI 10.1016/j.ijcard.2008.09.001; UNGER RK, 1979, AM PSYCHOL, V34, P1085, DOI 10.1037/0003-066X.34.11.1085; Veldtman GR, 2004, J AM COLL CARDIOL, V44, P174, DOI 10.1016/j.jacc.2003.11.067; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4	16	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49729	10.1371/journal.pone.0049729	http://dx.doi.org/10.1371/journal.pone.0049729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239969	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800007
J	Mellert, DJ; Robinett, CC; Baker, BS				Mellert, David J.; Robinett, Carmen C.; Baker, Bruce S.			doublesex Functions Early and Late in Gustatory Sense Organ Development	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; SOMATIC SEXUAL-DIFFERENTIATION; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; PERIPHERAL NEUROGENESIS; DETERMINATION PATHWAY; NEURAL PRECURSORS; FEMALE PHEROMONES; SEGMENT NUMBER; POX-NEURO	Somatic sexual dimorphisms outside of the nervous system in Drosophila melanogaster are largely controlled by the male- and female-specific Doublesex transcription factors (DSXM and DSXF, respectively). The DSX proteins must act at the right times and places in development to regulate the diverse array of genes that sculpt male and female characteristics across a variety of tissues. To explore how cellular and developmental contexts integrate with doublesex (dsx) gene function, we focused on the sexually dimorphic number of gustatory sense organs (GSOs) in the foreleg. We show that DSXM and DSXF promote and repress GSO formation, respectively, and that their relative contribution to this dimorphism varies along the proximodistal axis of the foreleg. Our results suggest that the DSX proteins impact specification of the gustatory sensory organ precursors (SOPs). DSXF then acts later in the foreleg to regulate gustatory receptor neuron axon guidance. These results suggest that the foreleg provides a unique opportunity for examining the context-dependent functions of DSX.	[Mellert, David J.; Robinett, Carmen C.; Baker, Bruce S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Mellert, David J.; Baker, Bruce S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Robinett, CC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	robinettc@janelia.hhmi.org	Robinett, Carmen/AAH-3177-2019	Mellert, David/0000-0001-6606-0274	National Institutes of Health; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the National Institutes of Health and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN WQ, 1995, GENE DEV, V9, P256, DOI 10.1101/gad.9.2.256; Arbeitman MN, 2004, DEVELOPMENT, V131, P2007, DOI 10.1242/dev.01077; Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Awasaki T, 2001, DEV GENES EVOL, V211, P20, DOI 10.1007/s004270000119; BAKER BS, 1980, GENETICS, V94, P383; Barmina O, 2005, DEV BIOL, V288, P528, DOI 10.1016/j.ydbio.2005.09.052; BELOTE JM, 1982, P NATL ACAD SCI-BIOL, V79, P1568, DOI 10.1073/pnas.79.5.1568; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; BOWNES M, 1994, BIOESSAYS, V16, P745, DOI 10.1002/bies.950161009; BOWNES M, 1981, MOL GEN GENET, V182, P222, DOI 10.1007/BF00269661; BRAND M, 1993, DEVELOPMENT, V119, P1; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; Camara N, 2008, CURR TOP DEV BIOL, V83, P65, DOI 10.1016/S0070-2153(08)00403-1; Campuzano S, 2001, ONCOGENE, V20, P8299, DOI 10.1038/sj.onc.1205162; Chatterjee SS, 2011, DEVELOPMENT, V138, P1099, DOI 10.1242/dev.055731; Christiansen AE, 2002, TRENDS GENET, V18, P510, DOI 10.1016/S0168-9525(02)02769-5; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Culi J, 2001, DEVELOPMENT, V128, P299; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Erdman SE, 1996, GENETICS, V144, P1639; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Furman DP, 2008, CURR GENOMICS, V9, P312, DOI 10.2174/138920208785133271; Gehring WJ, 1996, GENES CELLS, V1, P11, DOI 10.1046/j.1365-2443.1996.11011.x; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; Gomez-Skarmeta J, 2003, NAT REV NEUROSCI, V4, P587, DOI 10.1038/nrn1142; GRABOWSKI CT, 1954, J MORPHOL, V94, P1, DOI 10.1002/jmor.1050940102; HANNAH-ALAVA ALOHA, 1958, J MORPH, V103, P281, DOI 10.1002/jmor.1051030205; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Hempel LU, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-113; HILDRETH PE, 1965, GENETICS, V51, P659; HUANG F, 1991, DEVELOPMENT, V111, P1087; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; JALLON JM, 1988, GENET RES, V51, P17, DOI 10.1017/S0016672300023892; JARMAN AP, 1993, DEVELOPMENT, V119, P19; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lebo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-80; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; Luo SZD, 2011, DEVELOPMENT, V138, P2761, DOI 10.1242/dev.065227; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Miller A., 1950, BIOL DROSOPHILA, P420; NAGOSHI RN, 1990, GENE DEV, V4, P89, DOI 10.1101/gad.4.1.89; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NOTTEBOHM E, 1994, J PHYSIOL-PARIS, V88, P141, DOI 10.1016/0928-4257(94)90024-8; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; ORENIC TV, 1993, DEVELOPMENT, V118, P9; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Sanchez L, 2001, BIOESSAYS, V23, P698, DOI 10.1002/bies.1099; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Shirangi TR, 2007, DEV BIOL, V306, P10, DOI 10.1016/j.ydbio.2007.03.022; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Simpson P, 1999, DEVELOPMENT, V126, P1349; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Starostina E, 2012, J NEUROSCI, V32, P4665, DOI 10.1523/JNEUROSCI.6178-11.2012; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; TAYLOR BJ, 1992, DEVELOPMENT, V114, P625; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371; Venard R, 1989, DROSOPHILA CHEMORECE; Wang W, 2011, P NATL ACAD SCI USA, V108, P11139, DOI 10.1073/pnas.1108431108; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4	82	23	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51489	10.1371/journal.pone.0051489	http://dx.doi.org/10.1371/journal.pone.0051489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240029	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800065
J	Dawson, LF; Valiente, E; Faulds-Pain, A; Donahue, EH; Wren, BW				Dawson, Lisa F.; Valiente, Esmeralda; Faulds-Pain, Alexandra; Donahue, Elizabeth H.; Wren, Brendan W.			Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MICROBIAL BIOFILMS; MASTER REGULATOR; EPIDEMIOLOGY; BACTERIA; INCREASE; GENOME; MATRIX	Clostridium difficile is a Gram-positive anaerobic, spore-forming bacillus that is the leading cause of nosocomial diarrhoea worldwide. We demonstrate that C. difficile aggregates and forms biofilms in vitro on abiotic surfaces. These polymicrobial aggregates are attached to each other and to an abiotic surface by an extracellular polymeric substance (EPS). The EPS matrix provides the scaffold bonding together vegetative cells and spores, as well as forming a protective barrier for vegetative cells against oxygen stress. The master regulator of sporulation, Spo0A, may play a key role in biofilm formation, as genetic inactivation of spo0A in strain R20291 exhibits decreased biofilm formation. Our findings highlight an important attribute of C. difficile pathogenesis, which may have significant implications for infection, treatment and relapse.	[Dawson, Lisa F.; Valiente, Esmeralda; Faulds-Pain, Alexandra; Donahue, Elizabeth H.; Wren, Brendan W.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Wren, BW (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	Brendan.wren@lshtm.ac.uk			Wellcome Trust [086418/Z/]; MRC [94717]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-252207]; Medical Research Council [G1000214] Funding Source: researchfish; MRC [G1000214] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Intra-European Fellowship(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Wellcome Trust grant number 086418/Z/and MRC grant number 94717. A Marie Curie Intra-European Fellowship (PIEF-GA-2009-252207) also provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Julio Carlos, 2010, P1; Barbut F, 2000, J CLIN MICROBIOL, V38, P2386; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Colledge VL, 2011, J MOL BIOL, V411, P597, DOI 10.1016/j.jmb.2011.06.004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Dawson LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025754; Dawson LF, 2009, INFECT GENET EVOL, V9, P1410, DOI 10.1016/j.meegid.2009.06.005; Deakin LJ, 2012, INFECT IMMU IN PRESS; Donelli G, 2012, FEMS IMMUNOL MED MIC, V65, P318, DOI 10.1111/j.1574-695X.2012.00962.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Schneider EE, 2011, WATER SCI TECHNOL, V63, P143, DOI 10.2166/wst.2011.024; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Worthington RJ, 2012, ORG BIOMOL CHEM; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813; Zandri G, 2012, CLIN MICROBIOL INFEC, V18, pE259, DOI 10.1111/j.1469-0691.2012.03893.x; ZOTTOLA EA, 1994, INT J FOOD MICROBIOL, V23, P125, DOI 10.1016/0168-1605(94)90047-7	39	81	83	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50527	10.1371/journal.pone.0050527	http://dx.doi.org/10.1371/journal.pone.0050527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236376	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000312064100018
J	Griese, M; Heinrich, S; Ratjen, F; Kabesch, M; Paul, K; Ballmann, M; Rietschel, E; Kappler, M				Griese, Matthias; Heinrich, Stephanie; Ratjen, Felix; Kabesch, Michael; Paul, Karl; Ballmann, Manfred; Rietschel, Ernst; Kappler, Matthias			Surfactant Protein A in Cystic Fibrosis: Supratrimeric Structure and Pulmonary Outcome	PLOS ONE			English	Article							AIRWAY INFLAMMATION; PSEUDOMONAS-AERUGINOSA; YOUNG-CHILDREN; LUNG-FUNCTION; HOST-DEFENSE; DISEASE; OLIGOMERIZATION; PHAGOCYTOSIS; BINDING; SP-A1	Background: The state of oligomerization of surfactant associated protein-A (SP-A) monomers differs between individuals. This likely affects SP-A's functional properties and could thereby influence clinical status in patients with lung diseases. In this study we focus on SP-A structure in cystic fibrosis (CF) compared to both healthy subjects and disease controls. Methods: SP-A composition and function were assessed in both bronchoalveolar lavage (BAL) fluid and serum of 46 CF patients with mild disease, 25 patients with chronic bronchitis and 22 healthy subjects by gel chromatography and a functional agglutination assay. Relation of SP-A agglutination ability to disease severity of the subjects was explored. Results: SP-A was present in seven major oligomeric forms with the majority of SP-A being structurally organized as complex oligomeric forms. More complex oligomeric forms were associated with better SP-A function with regard to its agglutination ability. These forms were more frequently observed in BAL than in serum, but there were no differences between disease groups. In CF patients, more complex forms of SP-A were associated with better lung function. Conclusions: Organizational structure of SP-A affects its functional activity and is linked to disease severity in CF.	[Griese, Matthias; Heinrich, Stephanie; Kappler, Matthias] Univ Munich, Dr von Haunersches Kinderspital, Munich, Germany; [Ratjen, Felix] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Kabesch, Michael] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, D-3000 Hannover, Germany; [Paul, Karl] Lungenpraxis, Berlin, Germany; [Ballmann, Manfred] St Josefs Hosp, Klin Kinder & Jugendmed, Bochum, Germany; [Rietschel, Ernst] Univ Cologne, Klin & Poliklin Kinder & Jugendmed, D-50931 Cologne, Germany	University of Munich; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Hannover Medical School; Ruhr University Bochum; University of Cologne	Griese, M (corresponding author), Univ Munich, Dr von Haunersches Kinderspital, Munich, Germany.	Matthias.griese@med.uni-muenchen.de	Kabesch, Michael/GZM-1583-2022; Ballmann, Manfred/AAE-3730-2019; Kabesch, Michael/AAB-5701-2020	Ratjen, Felix/0000-0003-4057-6592	Mukoviszidose e.V.; Vaincre la Mucoviscidose	Mukoviszidose e.V.; Vaincre la Mucoviscidose	This work was supported by a grant from the Mukoviszidose e.V. and Vaincre la Mucoviscidose. Dr. von Haunersches Kinderspital, University of Munich, Munich, Germany is a Member of the German Center for Lung Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bufler P, 2004, EXP LUNG RES, V30, P163, DOI 10.1080/01902140490276294; Bufler P, 2003, AM J RESP CELL MOL, V28, P249, DOI 10.1165/rcmb.4896; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; Dobbie JW, 1996, PERITON DIALYSIS INT, V16, P574; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; GEERTSMA MF, 1994, AM J PHYSIOL-LUNG C, V267, pL578, DOI 10.1152/ajplung.1994.267.5.L578; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Griese M, 2008, EUR RESPIR J, V32, P783, DOI 10.1183/09031936.00146807; Griese M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-133; Griese M, 2007, EUR RESPIR J, V29, P240, DOI 10.1183/09031936.00047306; Griese M, 2004, AM J RESP CRIT CARE, V170, P1000, DOI 10.1164/rccm.200405-575oc; Griese M, 2002, AM J RESP CRIT CARE, V165, P1546, DOI 10.1164/rccm.2107147; Griese M, 1997, EUR RESPIR J, V10, P1983, DOI 10.1183/09031936.97.10091983; Griese M, 2001, ELECTROPHORESIS, V22, P165, DOI 10.1002/1522-2683(200101)22:1<165::AID-ELPS165>3.0.CO;2-H; Heinrich S, 2006, CURR MED CHEM, V13, P3239, DOI 10.2174/092986706778773112; Heinrich SM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-59; Hickling TP, 1998, MOL MED, V4, P266, DOI 10.1007/BF03401923; Hull J, 1997, AM J RESP CRIT CARE, V156, P161, DOI 10.1164/ajrccm.156.1.9609090; Khubchandani KR, 2001, PEDIATR PATHOL MOL M, V20, P349, DOI 10.1080/15513810109168620; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Meyer KC, 2000, CHEST, V118, P164, DOI 10.1378/chest.118.1.164; Noah TL, 2003, AM J RESP CRIT CARE, V168, P685, DOI 10.1164/rccm.200301-005OC; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; Peterson-Carmichael SL, 2009, PEDIATR PULM, V44, P503, DOI 10.1002/ppul.21044; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Sanchez-Barbero F, 2007, BIOCHEM J, V406, P479, DOI 10.1042/BJ20070275; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; Uemura T, 2006, BIOCHEMISTRY-US, V45, P14543, DOI 10.1021/bi061338u; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200	30	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51050	10.1371/journal.pone.0051050	http://dx.doi.org/10.1371/journal.pone.0051050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236429	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100059
J	Song, XJ; Jin, P; Qin, S; Chen, LM; Ma, F				Song, Xiaojun; Jin, Ping; Qin, Sheng; Chen, Liming; Ma, Fei			The Evolution and Origin of Animal Toll-Like Receptor Signaling Pathway Revealed by Network-Level Molecular Evolutionary Analyses	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN LENGTH; GENOME; DROSOPHILA; RATES; REPERTOIRE; CENTRALITY; PATTERNS; HISTORY; MUSCLE	Genes carry out their biological functions through pathways in complex networks consisting of many interacting molecules. Studies on the effect of network architecture on the evolution of individual proteins will provide valuable information for understanding the origin and evolution as well as functional conservation of signaling pathways. However, the relationship between the network architecture and the individual protein sequence evolution is yet little known. In current study, we carried out network-level molecular evolution analysis on TLR (Toll-like receptor) signaling pathway, which plays an important role in innate immunity in insects and mammals, and we found that: 1) The selection constraint of genes was negatively correlated with its position along TLR signaling pathway; 2) all genes in TLR signaling pathway were highly conserved and underwent strong purifying selection; 3) the distribution of selective pressure along the pathway was driven by differential nonsynonymous substitution levels; 4) The TLR signaling pathway might present in a common ancestor of sponges and eumetazoa, and evolve via the TLR, IKK, I kappa B and NF-kappa B genes underwent duplication events as well as adaptor molecular enlargement, and gene structure and conservation motif of NF-kappa B genes shifted in their evolutionary history. Our results will improve our understanding on the evolutionary history of animal TLR signaling pathway as well as the relationship between the network architecture and the sequences evolution of individual protein.	[Song, Xiaojun; Jin, Ping; Qin, Sheng; Ma, Fei] Nanjing Normal Univ, Coll Life Sci, Lab Comparat Genom & Bioinformat, Nanjing, Jiangsu, Peoples R China; [Song, Xiaojun; Jin, Ping; Qin, Sheng; Ma, Fei] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Chen, Liming] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Southeast University - China	Ma, F (corresponding author), Nanjing Normal Univ, Coll Life Sci, Lab Comparat Genom & Bioinformat, Nanjing, Jiangsu, Peoples R China.	mafei01@tsinghua.org.cn	Qin, Sheng/HCH-0856-2022		National Natural Science Foundation of China [30970348]; Major Program of Natural Science Research of Jiangsu Higher Education Institutions [12KJA180005]; Ph.D. Programs Foundation of Ministry of Education of China [20113207110009]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Natural Science Research of Jiangsu Higher Education Institutions; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was jointly supported by grants from the National Natural Science Foundation of China (30970348), the Major Program of Natural Science Research of Jiangsu Higher Education Institutions (12KJA180005), the Ph.D. Programs Foundation of Ministry of Education of China (20113207110009) and a grant from Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ponce D, 2011, GENOME BIOL EVOL, V3, P87, DOI 10.1093/gbe/evq084; Alvarez-Ponce D, 2009, GENOME RES, V19, P234, DOI 10.1101/gr.084038.108; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Cui QH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-21; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gauthier MEA, 2010, EVOL DEV, V12, P519, DOI 10.1111/j.1525-142X.2010.00436.x; Gerdol M, 2011, DEV COMP IMMUNOL, V35, P635, DOI 10.1016/j.dci.2011.01.018; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Jovelin R, 2011, GENOME BIOL EVOL, V3, P715, DOI 10.1093/gbe/evr071; Jovelin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r35; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livingstone K, 2009, J HERED, V100, P754, DOI 10.1093/jhered/esp026; Lu CQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-407; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Montanucci L, 2011, MOL BIOL EVOL, V28, P813, DOI 10.1093/molbev/msq259; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Pal C, 2001, GENETICS, V158, P927; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2008, J MOL EVOL, V67, P137, DOI 10.1007/s00239-008-9105-5; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Song XJ, 2012, GENOMICS, V99, P361, DOI 10.1016/j.ygeno.2012.03.002; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Vij S, 2008, FUNCT INTEGR GENOMIC, V8, P301, DOI 10.1007/s10142-008-0078-7; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wang YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007456; Wiens M, 2007, MOL BIOL EVOL, V24, P792, DOI 10.1093/molbev/msl208; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wu XC, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-46; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu HS, 2011, MOL BIOL EVOL, V28, P1785, DOI 10.1093/molbev/msr002	56	37	38	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51657	10.1371/journal.pone.0051657	http://dx.doi.org/10.1371/journal.pone.0051657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236523	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100139
J	Kim, J; Keay, SK; You, S; Loda, M; Freeman, MR				Kim, Jayoung; Keay, Susan K.; You, Sungyong; Loda, Massimo; Freeman, Michael R.			A Synthetic Form of Frizzled 8-Associated Antiproliferative Factor Enhances p53 Stability through USP2a and MDM2	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; BLADDER EPITHELIAL-CELLS; INTERSTITIAL-CYSTITIS; TUMOR-SUPPRESSOR; URINE MARKERS; CYCLIN D1; PATHWAY; EXPRESSION; PROLIFERATION; CKAP4/P63	Frizzled 8-associated Antiproliferative Factor (APF) is a sialoglycopeptide urinary biomarker of interstitial cystitis/painful bladder syndrome (IC/PBS), a chronic condition of unknown etiology with variable symptoms that generally include pelvic and/or perineal pain, urinary frequency, and urgency. We previously reported that native human APF suppresses the proliferation of normal bladder epithelial cells through a mechanism that involves increased levels of p53. The goal of this study was to delineate the regulatory mechanism whereby p53 expression is regulated by APF. Two APF-responsive cell lines (T24 bladder carcinoma cells and the immortalized human bladder epithelial cell line, TRT-HU1) were treated with asialo-APF (as-APF), a chemically synthesized form of APF. Biochemical analysis revealed that as-APF increased p53 levels in two ways: by decreasing ubiquitin specific protease 2a (USP2a) expression leading to enhanced ubiquitination of murine double minute 2 E3 ubiquitin ligase (MDM2), and by suppressing association of p53 with MDM2, thus impairing p53 ubiquitination. Biological responses to as-APF were suppressed by increased expression of wild type, but not mutant USP2a, which enhanced cell growth via upregulation of a cell cycle mediator, cyclin D1, at both transcription and protein levels. Consistent with this, gene silencing of USP2a with siRNA arrested cell proliferation. Our findings suggest that APF upregulates cellular p53 levels via functional attenuation of the USP2a-MDM2 pathway, resulting in p53 accumulation and growth arrest. These data also imply that targeting USP2a, MDM2, p53 and/or complex formation by these molecules may be relevant in the development of novel therapeutic approaches to IC/PBS. Citation: Kim J, Keay SK, You S, Loda M, Freeman MR (2012) A Synthetic Form of Frizzled 8-Associated Antiproliferative Factor Enhances p53 Stability through USP2a and MDM2. PLoS ONE 7(12): e50392. doi:10.1371/journal.pone.0050392	[Kim, Jayoung; You, Sungyong; Freeman, Michael R.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Surg, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA; [Kim, Jayoung; You, Sungyong; Freeman, Michael R.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Kim, Jayoung; Freeman, Michael R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Kim, Jayoung; Freeman, Michael R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kim, Jayoung; Freeman, Michael R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Keay, Susan K.] Univ Maryland, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21201 USA; [Keay, Susan K.] VA Maryland Hlth Care Ctr, Baltimore, MD USA; [Loda, Massimo] Harvard Univ, Sch Med, Dept Med Oncol, Boston, MA USA; [Loda, Massimo] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Loda, Massimo] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kim, J (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Surg, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA.	Jayoung.Kim@cshs.org	You, Sungyong/AAJ-7372-2020	You, Sungyong/0000-0003-3513-1783	NIH [R37 DK47556, R01 DK57691, P50 DK65298, R01 CA131945, R01 DK52596]; Fishbein Family IC Research Foundation/Interstitial Cystitis Association; New York Academy of Medicine; Children's Hospital Boston Faculty Development; NATIONAL CANCER INSTITUTE [R01CA131945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087806, R37DK047556, R01DK052596, P50DK065298, R01DK057691] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fishbein Family IC Research Foundation/Interstitial Cystitis Association; New York Academy of Medicine; Children's Hospital Boston Faculty Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by: NIH grants R37 DK47556, R01 DK57691, P50 DK65298 (to MRF); R01 CA131945 (to ML); R01 DK52596 (to SKK); and the Fishbein Family IC Research Foundation/Interstitial Cystitis Association; New York Academy of Medicine; and Children's Hospital Boston Faculty Development (to JK); JK is an American Urological Association Foundation Research Scholar and an Eleanor and Miles Shore Scholar of Harvard Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Benassi B, 2012, CANCER DISCOV, V2, P236, DOI 10.1158/2159-8290.CD-11-0219; Bogart LM, 2007, J UROLOGY, V177, P450, DOI 10.1016/j.juro.2006.09.032; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chai TC, 2000, J UROLOGY, V163, P1440, DOI 10.1016/S0022-5347(05)67638-0; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Clemens JQ, 2009, NEUROUROL URODYNAM, V28, P907; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Deb SP, 2002, FRONT BIOSCI, V7, pD235, DOI 10.2741/deb; Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; HANNO P, 1990, J UROLOGY, V143, P278, DOI 10.1016/S0022-5347(17)39933-0; Hanno Philip, 2005, Int Urogynecol J Pelvic Floor Dysfunct, V16 Suppl 1, pS2, DOI 10.1007/s00192-005-1301-x; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; Hanno PM, 1997, UROLOGY, V49, P93, DOI 10.1016/S0090-4295(97)00179-9; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Keay S, 2000, J UROLOGY, V164, P2112, DOI 10.1016/S0022-5347(05)66980-7; Keay S, 2001, Urology, V57, P104, DOI 10.1016/S0090-4295(01)01028-7; Keay S, 1998, UROLOGY, V52, P974, DOI 10.1016/S0090-4295(98)00488-9; Keay S, 2003, UROLOGY, V61, P1278, DOI 10.1016/S0090-4295(03)00005-0; Keay SK, 2004, P NATL ACAD SCI USA, V101, P11803, DOI 10.1073/pnas.0404509101; Keay SK, 2001, UROLOGY, V57, P9, DOI 10.1016/S0090-4295(01)01127-X; Keay S, 2011, CHEM BIOL DRUG DES, V77, P421, DOI 10.1111/j.1747-0285.2011.01108.x; Keay S, 2008, CELL SIGNAL, V20, P2174, DOI 10.1016/j.cellsig.2008.06.004; Kim J, 2007, FEBS LETT, V581, P3795, DOI 10.1016/j.febslet.2007.06.058; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Kim JY, 2009, BJU INT, V103, P541, DOI 10.1111/j.1464-410X.2008.08097.x; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lane DP, 2005, COLD SH Q B, V70, P489, DOI 10.1101/sqb.2005.70.049; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Moutzouris DA, 2009, CLIN J AM SOC NEPHRO, V4, P1844, DOI 10.2215/CJN.02000309; Ness TJ, 2005, J UROLOGY, V173, P1983, DOI 10.1097/01.ju.0000158452.15915.e2; Nordling J, 2004, EUR UROL, V45, P662, DOI 10.1016/j.eururo.2003.11.021; Persu C, 2010, J Med Life, V3, P167; Phatak S, 2006, NAT CLIN PRACT UROL, V3, P45, DOI 10.1038/ncpuro0385; Planey SL, 2009, MOL BIOL CELL, V20, P1454, DOI 10.1091/mbc.E08-08-0849; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sant GR, 2001, UROLOGY, V57, P82, DOI 10.1016/S0090-4295(01)01131-1; Shahjee HM, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-160; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shi Y, 2011, J BIOL CHEM; Slobodov G, 2004, J UROLOGY, V171, P1554, DOI 10.1097/01.ju.0000118938.09119.a5; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Warren John W, 2002, Curr Opin Urol, V12, P69, DOI 10.1097/00042307-200201000-00013; Yang W, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007492; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200	54	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50392	10.1371/journal.pone.0050392	http://dx.doi.org/10.1371/journal.pone.0050392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236372	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700014
J	Lukats, O; Vizkelety, T; Markella, Z; Maka, E; Kiss, M; Dobai, A; Bujtar, P; Szucs, A; Barabas, J				Lukats, Olga; Vizkelety, Tamas; Markella, Zsolt; Maka, Erika; Kiss, Maria; Dobai, Adrienn; Bujtar, Peter; Szucs, Attila; Barabas, Jozsef			Measurement of Orbital Volume after Enucleation and Orbital Implantation	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY	Introduction: This article reports experience relating to the measurement of orbital volume by means of cone beam computed tomography (CBCT) and Cranioviewer program software in patients who have undergone enucleation and orbital implantation. Patients and Methods: CBCT scans were made in 30 cases, 10 of which were later excluded because of various technical problems. The study group therefore consisted of 20 patients (8 men and 12 women). The longest follow-up time was 7 years, and the shortest was 1 year. In all 20 cases, the orbital volume was measured with Cranioviewer orbital program software. Slices were made in the ventrodorsal direction at 4.8 mm intervals in the frontal plane, in both bony orbits (both that containing the orbital implant and the healthy one). Similar measurements were made in 20 patients with various dental problems. CBCT scans were recorded for the facial region of the skull, containing the orbital region. The Cranioviewer program can colour the area of the slices red, and it automatically measures the area in mm. Results: In 5 of the 20 cases, the first 4 or all 5 slices revealed that the volume of the operated orbit was significantly smaller than that of the healthy orbit, in 12 cases only from 1 to 3 of the slices indicated such a significant difference, and in 3 cases no differences were observed between the orbits. In the control group of patients with various dental problems, there was no significant difference between the two healthy orbits. The accuracy of the volume measurements was assessed statistically by means of the paired samples t-test. Summary: To date, no appropriate method is avaliable for exact measurement of the bony orbital volume, which would be of particular importance in orbital injury reconstruction. However, the use of CBCT scans and Cranioviewer orbital program software appears to offer a reliable method for the measurement of changes in orbital volume. Citation: Lukats O, Vizkelety T, Markella Z, Maka E, Kiss M, et al. (2012) Measurement of Orbital Volume after Enucleation and Orbital Implantation. PLoS ONE 7(12): e50333. doi:10.1371/journal.pone.0050333	[Lukats, Olga; Maka, Erika] Semmelweis Univ, Fac Med, Dept Opthalmol, Budapest, Hungary; [Vizkelety, Tamas; Dobai, Adrienn; Szucs, Attila; Barabas, Jozsef] Semmelweis Univ, Fac Dent, Dept Oral & Maxillofacial Surg & Dent, Budapest, Hungary; [Markella, Zsolt] Obuda Univ, Kalman Kando Fac Elect Engn, Budapest, Hungary; [Kiss, Maria] Dunaujvaros Coll, Dunaujvaros, Hungary; [Bujtar, Peter] Univ Hosp, Dept Oral & Maxillofacial Surg, Leicester, Leics, England	Semmelweis University; Semmelweis University; Obuda University; University Hospitals of Leicester NHS Trust	Lukats, O (corresponding author), Semmelweis Univ, Fac Med, Dept Opthalmol, Budapest, Hungary.	lukatsolga@gmail.com			scientific application TAMOP (Tarsadalmi Megujulas Operativ Program) [4.2.1./B-09/1KMR 2010-001]	scientific application TAMOP (Tarsadalmi Megujulas Operativ Program)	The authors' work was part of a study which was supported by a scientific application TAMOP (Tarsadalmi Megujulas Operativ Program) 4.2.1./B-09/1KMR 2010-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv RI, 2005, CLIN RADIOL, V60, P279, DOI 10.1016/j.crad.2004.05.017; Bryant JA, 2008, DENTOMAXILLOFAC RAD, V37, P365, DOI 10.1259/dmfr/13227258; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; FORBES G, 1985, AM J ROENTGENOL, V145, P149, DOI 10.2214/ajr.145.1.149; Hintschich C, 2001, BRIT J OPHTHALMOL, V85, P205, DOI 10.1136/bjo.85.2.205; Hintschich C, 2001, OPER TECH OCULOPLAST, V4, P3; HOWARD GM, 1965, ARCH OPHTHALMOL-CHIC, V73, P80; Ji YR, 2010, J ANAT, V217, P501, DOI 10.1111/j.1469-7580.2010.01286.x; Koppel DA, 2003, J CRANIO MAXILL SURG, V31, P88, DOI 10.1016/S1010-5182(02)00170-1; Kwon J, 2010, OPHTHAL PLAST RECONS, V26, P26, DOI 10.1097/IOP.0b013e3181b80c6a; Kwon J, 2009, ARCH FACIAL PLAST S, V11, P395, DOI 10.1001/archfacial.2009.77; Nout E, 2012, J CRANIO MAXILL SURG, V40, P223, DOI 10.1016/j.jcms.2011.04.005; O'Connor EJF, 2009, PLAST RECONSTR SURG, V123, P1570, DOI 10.1097/PRS.0b013e3181a07625	13	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50333	10.1371/journal.pone.0050333	http://dx.doi.org/10.1371/journal.pone.0050333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236368	Green Published, gold, Green Submitted			2022-12-25	WOS:000312589700011
J	Posel, C; Moller, K; Frohlich, W; Schulz, I; Boltze, J; Wagner, DC				Poesel, Claudia; Moeller, Karoline; Froehlich, Wenke; Schulz, Isabell; Boltze, Johannes; Wagner, Daniel-Christoph			Density Gradient Centrifugation Compromises Bone Marrow Mononuclear Cell Yield	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FICOLL-HYPAQUE SEPARATION; BLOOD LYSIS TECHNIQUE; STEM-CELLS; PROGENITOR CELLS; THERAPEUTIC ANGIOGENESIS; VENTRICULAR-FUNCTION; FLOW-CYTOMETRY; NORMAL ADULTS; TRANSPLANTATION	Bone marrow mononuclear cells (BMNCs) are widely used in regenerative medicine, but recent data suggests that the isolation of BMNCs by commonly used Ficoll-Paque density gradient centrifugation (DGC) causes significant cell loss and influences graft function. The objective of this study was to determine in an animal study whether and how Ficoll-Paque DGC affects the yield and composition of BMNCs compared to alternative isolation methods such as adjusted Percoll DGC or immunomagnetic separation of polymorphonuclear cells (PMNs). Each isolation procedure was confounded by a significant loss of BMNCs that was maximal after Ficoll-Paque DGC, moderate after adjusted Percoll DGC and least after immunomagnetic PMN depletion (25.6 +/- 5.8%, 51.5 +/- 2.3 and 72.3 +/- 6.7% recovery of total BMNCs in lysed bone marrow). Interestingly, proportions of BMNC subpopulations resembled those of lysed bone marrow indicating symmetric BMNC loss independent from the isolation protocol. Hematopoietic stem cell (HSC) content, determined by colony-forming units for granulocytes-macrophages (CFU-GM), was significantly reduced after Ficoll-Paque DGC compared to Percoll DGC and immunomagnetic PMN depletion. Finally, in a proof-of-concept study, we successfully applied the protocol for BMNC isolation by immunodepletion to fresh human bone marrow aspirates. Our findings indicate that the common method to isolate BMNCs in both preclinical and clinical research can be considerably improved by replacing Ficoll-Paque DGC with adapted Percoll DGC, or particularly by immunodepletion of PMNs. Citation: Posel C, Moller K, Frohlich W, Schulz I, Boltze J, et al. (2012) Density Gradient Centrifugation Compromises Bone Marrow Mononuclear Cell Yield. PLoS ONE 7(12): e50293. doi:10.1371/journal.pone.0050293	[Poesel, Claudia; Moeller, Karoline; Froehlich, Wenke; Schulz, Isabell; Boltze, Johannes; Wagner, Daniel-Christoph] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Froehlich, Wenke; Boltze, Johannes; Wagner, Daniel-Christoph] Translat Ctr Regenerat Med, Leipzig, Germany	Fraunhofer Gesellschaft	Posel, C (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany.	claudia.poesel@izi.fraunhofer.de		Boltze, Johannes/0000-0003-3956-4164	German Federal Ministry of Education and Research (BMBF) [01GN0981]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF), http://www.bmbf.de/en/index.php, grant number 01GN0981. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Ahmadbeigi N, 2012, CYTOTHERAPY, V14, P917, DOI 10.3109/14653249.2012.689426; Aktas M, 2008, CYTOTHERAPY, V10, P203, DOI 10.1080/14653240701851324; Assmus B, 2010, J AM COLL CARDIOL, V55, P1385, DOI 10.1016/j.jacc.2009.10.059; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bhartiya D, 2012, STEM CELLS DEV, V21, P1, DOI 10.1089/scd.2011.0311; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Federmann B, 2012, HAEMATOL-HEMATOL J, V97, P1523, DOI 10.3324/haematol.2011.059378; Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512; Ghodsizad A, 2004, CYTOTHERAPY, V6, P523, DOI 10.1080/14653240410005014; Goodchild TT, 2009, JACC-CARDIOVASC INTE, V2, P1005, DOI 10.1016/j.jcin.2009.08.010; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; Koskenvuo JW, 2012, ANN MED; Lachtermacher S, 2012, STEM CELL REV REP, V8, P251, DOI 10.1007/s12015-011-9282-2; Lannert H, 2008, BONE MARROW TRANSPL, V42, P443, DOI 10.1038/bmt.2008.196; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Luttmann W, 2006, IMMUNOLOGY; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Medina RJ, 2006, INT J MOL MED, V17, P721; Mouquet F, 2011, CELL TRANSPLANT, V20, P1087, DOI 10.3727/096368910X544924; Naranbhai V, 2011, J IMMUNOL METHODS, V366, P28, DOI 10.1016/j.jim.2011.01.001; Nieto JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031297; Preobrazhensky SN, 2009, CRYOBIOLOGY, V59, P366, DOI 10.1016/j.cryobiol.2009.09.008; RENZI P, 1987, J IMMUNOL METHODS, V98, P53, DOI 10.1016/0022-1759(87)90434-0; ROMEU MA, 1992, J IMMUNOL METHODS, V154, P7; Rosca AM, 2010, BIOTECHNOL APPL BIOC, V55, P199, DOI 10.1042/BA20090356; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Seeger FH, 2007, EUR HEART J, V28, P766, DOI 10.1093/eurheartj/ehl509; Stelzer GT, 1997, CYTOMETRY, V30, P214, DOI 10.1002/(SICI)1097-0320(19971015)30:5<214::AID-CYTO2>3.0.CO;2-H; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tendera M, 2009, EUR HEART J, V30, P1313, DOI 10.1093/eurheartj/ehp073; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; van Beem Rachel T, 2008, EuroIntervention, V4, P133; Yerebakan C, 2011, J THORAC CARDIOV SUR, V142, P1530, DOI 10.1016/j.jtcvs.2011.05.002	41	84	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50293	10.1371/journal.pone.0050293	http://dx.doi.org/10.1371/journal.pone.0050293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236366	gold, Green Submitted, Green Published			2022-12-25	WOS:000312589700010
J	Zahn, R; Gillisen, G; Roos, A; Koning, M; van der Helm, E; Spek, D; Weijtens, M; Pau, MG; Radosevic, K; Weverling, GJ; Custers, J; Vellinga, J; Schuitemaker, H; Goudsmit, J; Rodriguez, A				Zahn, Roland; Gillisen, Gert; Roos, Anna; Koning, Marina; van der Helm, Esmeralda; Spek, Dirk; Weijtens, Mo; Pau, Maria Grazia; Radosevic, Katarina; Weverling, Gerrit Jan; Custers, Jerome; Vellinga, Jort; Schuitemaker, Hanneke; Goudsmit, Jaap; Rodriguez, Ariane			Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species	PLOS ONE			English	Article							PROTECTS NONHUMAN-PRIMATES; ATTENUATED RECOMBINANT VACCINE; EBOLA-VIRUS INFECTION; HEMORRHAGIC-FEVER; MARBURG VIRUS; ADENOVIRUS VECTORS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; RHESUS-MONKEYS; POPULATIONS	Filoviruses cause sporadic but highly lethal outbreaks of hemorrhagic fever in Africa in the human population. Currently, no drug or vaccine is available for treatment or prevention. A previous study with a vaccine candidate based on the low seroprevalent adenoviruses 26 and 35 (Ad26 and Ad35) was shown to provide protection against homologous Ebola Zaire challenge in non human primates (NHP) if applied in a prime-boost regimen. Here we have aimed to expand this principle to construct and evaluate Ad26 and Ad35 vectors for development of a vaccine to provide universal filovirus protection against all highly lethal strains that have caused major outbreaks in the past. We have therefore performed a phylogenetic analysis of filovirus glycoproteins to select the glycoproteins from two Ebola species (Ebola Zaire and Ebola Sudan/Gulu,), two Marburg strains (Marburg Angola and Marburg Ravn) and added the more distant non-lethal Ebola Ivory Coast species for broadest coverage. Ad26 and Ad35 vectors expressing these five filovirus glycoproteins were evaluated to induce a potent cellular and humoral immune response in mice. All adenoviral vectors induced a humoral immune response after single vaccination in a dose dependent manner that was cross-reactive within the Ebola and Marburg lineages. In addition, both strain-specific as well as cross-reactive T cell responses could be detected. A heterologous Ad26-Ad35 prime-boost regime enhanced mainly the humoral and to a lower extend the cellular immune response against the transgene. Combination of the five selected filovirus glycoproteins in one multivalent vaccine potentially elicits protective immunity in man against all major filovirus strains that have caused lethal outbreaks in the last 20 years. Citation: Zahn R, Gillisen G, Roos A, Koning M, van der Helm E, et al. (2012) Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species. PLoS ONE 7(12): e44115. doi:10.1371/journal.pone.0044115	[Zahn, Roland; Gillisen, Gert; Roos, Anna; Koning, Marina; van der Helm, Esmeralda; Spek, Dirk; Weijtens, Mo; Pau, Maria Grazia; Radosevic, Katarina; Weverling, Gerrit Jan; Custers, Jerome; Vellinga, Jort; Schuitemaker, Hanneke; Goudsmit, Jaap; Rodriguez, Ariane] Crucell Holland BV, Leiden, Netherlands	Johnson & Johnson	Rodriguez, A (corresponding author), Crucell Holland BV, Leiden, Netherlands.	Ariane.Rodriquez@crucell.com			Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800056C]	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200800056C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Alazard-Dany N, 2006, J GEN VIROL, V87, P1247, DOI 10.1099/vir.0.81361-0; Bannister B, 2010, BRIT MED BULL, V95, P193, DOI 10.1093/bmb/ldq022; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Bradfute SB, 2011, HUM VACCINES, V7, P701, DOI 10.4161/hv.7.6.15398; Busico KM, 1999, J INFECT DIS, V179, pS102, DOI 10.1086/514309; Daddario-DiCaprio KM, 2006, J VIROL, V80, P9659, DOI 10.1128/JVI.00959-06; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Francois Jerome, 2010, Proceedings 2010 IEEE International Workshop on Information Forensics and Security (WIFS 2010), DOI 10.1109/WIFS.2010.5711450; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Geisbert TW, 2010, REV MED VIROL, V20, P344, DOI 10.1002/rmv.661; Geisbert TW, 2010, J VIROL, V84, P10386, DOI 10.1128/JVI.00594-10; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Gonzalez JP, 2000, MICROBES INFECT, V2, P39, DOI 10.1016/S1286-4579(00)00287-2; GONZALEZ JP, 1989, RES VIROLOGY, V140, P319, DOI 10.1016/S0923-2516(89)80112-8; Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001; Havenga M, 2006, J GEN VIROL, V87, P2135, DOI 10.1099/vir.0.81956-0; Hayman DTS, 2010, PLOS ONE, V5; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Holmes EC, 2009, EVOLUTION EMERGENCE, P254; Honeyman MC, 1998, NAT BIOTECHNOL, V16, P966, DOI 10.1038/nbt1098-966; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jahrling PB, 1996, ARCH VIROL, P135; Jahrling PB, 2007, J INFECT DIS, V196, pS400, DOI 10.1086/520587; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Kuhn JH, 2010, ARCH VIROLOGY; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Ophorst OJAE, 2007, VACCINE, V25, P6501, DOI 10.1016/j.vaccine.2007.06.019; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Pratt WD, 2010, CLIN VACCINE IMMUNOL, V17, P572, DOI 10.1128/CVI.00467-09; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI 10.1586/ERV.09.14; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reed DS, 2007, VACCINE, V25, P1923, DOI 10.1016/j.vaccine.2006.11.037; Rhee EG, 2010, J VIROL, V84, P10413, DOI 10.1128/JVI.00928-10; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Shott JP, 2008, VACCINE, V26, P2818, DOI 10.1016/j.vaccine.2008.03.080; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2011, NATURE MED; Swenson DL, 2008, CLIN VACCINE IMMUNOL, V15, P460, DOI 10.1128/CVI.00431-07; Swenson DL, 2008, EXPERT REV VACCINES, V7, P417, DOI 10.1586/14760584.7.4.417; Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536	66	43	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e44115	10.1371/journal.pone.0044115	http://dx.doi.org/10.1371/journal.pone.0044115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236343	Green Published, gold, Green Submitted			2022-12-25	WOS:000312589700001
J	Bonilla, C; Lawlor, DA; Taylor, AE; Gunnell, DJ; Ben-Shlomo, Y; Ness, AR; Timpson, NJ; St Pourcain, B; Ring, SM; Emmett, PM; Smith, AD; Refsum, H; Pennell, CE; Brion, MJ; Smith, GD; Lewis, SJ				Bonilla, Carolina; Lawlor, Debbie A.; Taylor, Amy E.; Gunnell, David J.; Ben-Shlomo, Yoav; Ness, Andrew R.; Timpson, Nicholas J.; St Pourcain, Beate; Ring, Susan M.; Emmett, Pauline M.; Smith, A. David; Refsum, Helga; Pennell, Craig E.; Brion, Marie-Jo; Smith, George Davey; Lewis, Sarah J.			Vitamin B-12 Status during Pregnancy and Child's IQ at Age 8: A Mendelian Randomization Study in the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COGNITIVE FUNCTION; COBALAMIN STATUS; GENETIC EPIDEMIOLOGY; TRANSCOBALAMIN GENE; HOMOCYSTEINE; POLYMORPHISM; PLASMA; POPULATION; FOLATE	Vitamin B-12 is essential for the development and maintenance of a healthy nervous system. Brain development occurs primarily in utero and early infancy, but the role of maternal vitamin B-12 status during pregnancy on offspring cognitive function is unclear. In this study we assessed the effect of vitamin B-12 status in well-nourished pregnant women on the cognitive ability of their offspring in a UK birth cohort (ALSPAC). We then examined the association of SNPs in maternal genes FUT2 (rs492602) and TCN2 (rs1801198, rs9606756) that are related to plasma vitamin B-12, with offspring IQ. Observationally, there was a positive association between maternal vitamin B-12 intake and child's IQ that was markedly attenuated after adjustment for potential confounders (mean difference in offspring IQ score per doubling of maternal B-12 intake, before adjustment: 2.0 (95% CI 1.3, 2.8); after adjustment: 0.7 (95% CI -0.04, 1.4)). Maternal FUT2 was weakly associated with offspring IQ: mean difference in IQ per allele was 0.9 (95% CI 0.1, 1.6). The expected effect of maternal vitamin B-12 on offspring IQ, given the relationships between SNPs and vitamin B-12, and SNPs and IQ was consistent with the observational result. Our findings suggest that maternal vitamin B-12 may not have an important effect on offspring cognitive ability. However, further examination of this issue is warranted.	[Bonilla, Carolina; Lawlor, Debbie A.; Taylor, Amy E.; Timpson, Nicholas J.; Brion, Marie-Jo; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Ness, Andrew R.] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [Smith, A. David; Refsum, Helga] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Pennell, Craig E.; Brion, Marie-Jo] Univ Western Australia, Sch Womens & Infants Hlth, Nedlands, WA 6009, Australia	University of Bristol; University of Bristol; University of Oxford; University of Oslo; University of Western Australia	Bonilla, C (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	C.Bonilla@bristol.ac.uk	Refsum, Helga/A-4073-2010; Davey Smith, George/A-7407-2013; Berryman, Katie/J-4236-2014; Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Attrill, Lauren/V-1688-2018; Ness, Andy R/M-7612-2013; Gunnell, David/ABE-6653-2020; Bonilla, Carolina/U-9263-2018; Brion, Marie-Jo A/O-6825-2014; Study, Raine/G-9547-2015; Smith, Anthony D./A-4233-2010; Pennell, Craig/ABD-6902-2020; Emmett, Pauline/AAL-6815-2021; Ben-Shlomo, Yoav/ABD-2004-2021	Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Ness, Andy R/0000-0003-3548-9523; Gunnell, David/0000-0002-0829-6470; Bonilla, Carolina/0000-0002-9972-6383; Brion, Marie-Jo A/0000-0002-9030-2103; Smith, Anthony D./0000-0002-1095-6722; Pennell, Craig/0000-0002-0937-6165; Ben-Shlomo, Yoav/0000-0001-6648-3007; St Pourcain, Beate/0000-0002-4680-3517; Lewis, Sarah/0000-0003-4311-6890; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Emmett, Pauline/0000-0003-1076-4779	Wellcome Trust [WT084668MA, 076467]; UK Medical Research Council [G0600705, 74882]; University of Bristol; MRC (Medical Research Council); Arthritic Association; Sir Henry Wellcome Postdoctoral Fellowship [085515]; University of Western Australia (UWA); Telethon Institute for Child Health Research; Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Women and Infants Research Foundation; Australian National Health and Medical Research Council; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705, G9815508] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritic Association; Sir Henry Wellcome Postdoctoral Fellowship; University of Western Australia (UWA); Telethon Institute for Child Health Research; Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Women and Infants Research Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by a Wellcome Trust grant (grant ref: WT084668MA), which funds CB. AET is funded by a Wellcome Trust PhD studentship and DAL, NJT and GDS work in an MRC Centre that is supported by the UK Medical Research Council (G0600705) and the University of Bristol; the MRC (Medical Research Council) contribution to this centre funds NJT's salary. DJG is an NIHR Senior Investigator (National Institute for Health Research), the work of PME is partly supported by the Arthritic Association. The UK Medical Research Council (grant ref: 74882), the Wellcome Trust (grant ref: 076467) and the University of Bristol provide core support for ALSPAC. MJB is funded by a Sir Henry Wellcome Postdoctoral Fellowship (grant ref: 085515). Core management for the Raine study is funded by The University of Western Australia (UWA), Telethon Institute for Child Health Research, Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences and the Women and Infants Research Foundation. Collection, extraction and genotyping of maternal and child DNA in Raine was funded by the Australian National Health and Medical Research Council and the Women and Infants Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman LA, 2002, EUR J HUM GENET, V10, P433, DOI 10.1038/sj.ejhg.5200830; Akcam M, 2010, INDIAN PEDIATR, V47, P119, DOI 10.1007/s13312-010-0017-2; Benton D, 2008, EUR J NUTR, V47, P38, DOI 10.1007/s00394-008-3004-9; Bhate V, 2008, FOOD NUTR BULL, V29, P249, DOI 10.1177/156482650802900401; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Castro R, 2010, CLIN BIOCHEM, V43, P645, DOI 10.1016/j.clinbiochem.2010.01.015; Davey Smith G, PLOS MED, V4, pe352; Garcia CD, 2009, NUTR NEUROSCI, V12, P13, DOI 10.1179/147683009X388913; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Hay G, 2010, J NUTR, V140, P557, DOI 10.3945/jn.109.117424; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Joinson C, 2007, PEDIATRICS, V120, pE308, DOI 10.1542/peds.2006-2891; Jones RW, 2000, EUR J HUM GENET, V8, P653, DOI 10.1038/sj.ejhg.5200502; KELLEHER BP, 1987, CLIN CHEM, V33, P52; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lievers KJA, 2002, CLIN CHEM, V48, P1383; Louwman MWJ, 2000, AM J CLIN NUTR, V72, P762; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Morkbak AL, 2007, HAEMATOLOGICA, V92, P1711, DOI 10.3324/haematol.11636; Murphy MM, 2007, J NUTR, V137, P1863, DOI 10.1093/jn/137.8.1863; Namour F, 2001, BLOOD, V97, P1092, DOI 10.1182/blood.V97.4.1092; Obeid R, 2005, CLIN CHEM LAB MED, V43, P1052, DOI 10.1515/CCLM.2005.184; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Refsum H, 2006, CLIN CHEM, V52, P129, DOI 10.1373/clinchem.2005.054619; Riedel BM, 2011, J NUTR, V141, P1784, DOI 10.3945/jn.111.141960; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Silla Y, 2011, BIOCHEMISTRY-US, V50, P1396, DOI 10.1021/bi101095g; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Verduijn M, 2010, NEPHROL DIAL TRANSPL, V25, P1394, DOI 10.1093/ndt/gfq098; Vogiatzoglou A, 2009, AM J CLIN NUTR, V89, P1078, DOI 10.3945/ajcn.2008.26598; von Castel-Dunwoody KM, 2005, AM J CLIN NUTR, V81, P1436; vonSchenck U, 1997, ARCH DIS CHILD, V77, P137, DOI 10.1136/adc.77.2.137; Wechsler D., 1991, MANUAL WECHSLER INTE	41	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51084	10.1371/journal.pone.0051084	http://dx.doi.org/10.1371/journal.pone.0051084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227234	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200094
J	Feliciano, L; Li, JR; Lee, J; Pascall, MA				Feliciano, Lizanel; Li, Jianrong; Lee, Jaesung; Pascall, Melvin A.			Efficacies of Sodium Hypochlorite and Quaternary Ammonium Sanitizers for Reduction of Norovirus and Selected Bacteria during Ware-Washing Operations	PLOS ONE			English	Article							STAINLESS-STEEL; FOODBORNE PATHOGENS; FELINE CALICIVIRUS; MURINE NOROVIRUS; INACTIVATION; SURFACE; FOOD; SURROGATES; OUTBREAK; SURVIVAL	Cross-contamination of ready-to-eat (RTE) foods with pathogens on contaminated tableware and food preparation utensils is an important factor associated with foodborne illnesses. To prevent this, restaurants and food service establishments are required to achieve a minimum microbial reduction of 5 logs from these surfaces. This study evaluated the sanitization efficacies of ware-washing protocols (manual and mechanical) used in restaurants to clean tableware items. Ceramic plates, drinking glasses and stainless steel forks were used as the food contact surfaces. These were contaminated with cream cheese and reduced-fat milk inoculated with murine norovirus (MNV-1), Escherichia coli K-12 and Listeria innocua. The sanitizing solutions tested were sodium hypochlorite (chlorine), quaternary ammonium (QAC) and tap water (control). During the study, the survivability and response to the experimental conditions of the bacterial species was compared with that of MNV-1. The results showed that current ware-washing protocols used to remove bacteria from tableware items were not sufficient to achieve a 5 log reduction in MNV-1 titer. After washing, a maximum of 3 log reduction in the virus were obtained. It was concluded that MNV-1 appeared to be more resistant to both the washing process and the sanitizers when compared with E. coli K-12 and L. innocua. Citation: Feliciano L, Li J, Lee J, Pascall MA (2012) Efficacies of Sodium Hypochlorite and Quaternary Ammonium Sanitizers for Reduction of Norovirus and Selected Bacteria during Ware-Washing Operations. PLoS ONE 7(12): e50273. doi:10.1371/journal.pone.0050273	[Feliciano, Lizanel; Li, Jianrong; Lee, Jaesung; Pascall, Melvin A.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Li, JR (corresponding author), Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA.	li.926@osu.edu; pascall.1@osu.edu		Pascall, Melvin/0000-0002-3601-4012	National Center for Research Resources [UL1RR025755]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by award number UL1RR025755 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean Nancy H., 1996, Morbidity and Mortality Weekly Report, V45, P1; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Cords BR, 2005, FOOD SCI, V143, P507; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; FDA, 2012, SAFE PRACTICE FOR FO; Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2008, MICROBIOLOGICAL RISK, V13; Food and Drug Administration (FDA), 2009, REPORT ON THE OCCURR; Gibson KE, 2011, FOOD ENVIRON VIROL, V3, P74, DOI 10.1007/s12560-011-9059-4; Goodgame Richard, 2007, Curr Infect Dis Rep, V9, P102, DOI 10.1007/s11908-007-0004-5; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Handojo A, 2009, J FOOD PROTECT, V72, P1315, DOI 10.4315/0362-028X-72.6.1315; Hedberg CW, 2006, J FOOD PROTECT, V69, P2697, DOI 10.4315/0362-028X-69.11.2697; Ioannou CJ, 2007, ANTIMICROB AGENTS CH, V51, P296, DOI 10.1128/AAC.00375-06; Koopmans M, 2004, INT J FOOD MICROBIOL, V90, P23, DOI 10.1016/S0168-1605(03)00169-7; Kreske AC, 2006, J FOOD PROTECT, V69, P1892, DOI 10.4315/0362-028X-69.8.1892; Kuda T, 2008, LWT-FOOD SCI TECHNOL, V41, P988, DOI 10.1016/j.lwt.2007.06.016; Kusumaningrum HD, 2003, INT J FOOD MICROBIOL, V85, P227, DOI 10.1016/S0168-1605(02)00540-8; Kusumaningrum HD, 2002, J FOOD PROTECT, V65, P61, DOI 10.4315/0362-028X-65.1.61; Lee J, 2007, J FOOD ENG, V80, P885, DOI 10.1016/j.jfoodeng.2006.08.003; LINE JE, 1991, J FOOD PROTECT, V54, P762, DOI 10.4315/0362-028X-54.10.762; Lou FF, 2011, APPL ENVIRON MICROB, V77, P1862, DOI 10.1128/AEM.01918-10; Malik YS, 2006, INT J FOOD MICROBIOL, V109, P160, DOI 10.1016/j.ijfoodmicro.2005.08.033; Moe Christine L, 2009, Clin Infect Dis, V48, P38, DOI 10.1086/594119; Nowak P, 2011, J VIROL METHODS, V174, P7, DOI 10.1016/j.jviromet.2011.03.004; Sanglay GC, 2011, J FOOD PROTECT, V74, P1155, DOI 10.4315/0362-028X.JFP-10-405; Takahashi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021951; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Trudy CP, 1996, APPL MICROBIOLOGY, V14, P769; Verhoef LPB, 2009, EMERG INFECT DIS, V15, P31, DOI 10.3201/eid1501.080673; Virto R, 2005, APPL ENVIRON MICROB, V71, P5022, DOI 10.1128/AEM.71.9.5022-5028.2005; Whitehead K, 2010, AM J INFECT CONTROL, V38, P26, DOI 10.1016/j.ajic.2009.03.015; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05	33	24	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50273	10.1371/journal.pone.0050273	http://dx.doi.org/10.1371/journal.pone.0050273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227163	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200024
J	Gray, SM; Akob, DM; Green, SJ; Kostka, JE				Gray, Sarah M.; Akob, Denise M.; Green, Stefan J.; Kostka, Joel E.			The Bacterial Composition within the Sarracenia purpurea Model System: Local Scale Differences and the Relationship with the Other Members of the Food Web	PLOS ONE			English	Article							PITCHER-PLANT; COMMUNITY STRUCTURE; DIVERSITY; RICHNESS; DISTINCT	The leaves of the carnivorous pitcher plant, Sarracenia purpurea, contain a microscopic aquatic food web that is considered a model system in ecological research. The species identity of the intermediate and top trophic level of this food web, as well the detritivore midge, are highly similar across the native geographic range of S. purpurea and, in some cases, appear to have co-evolved with the plant. However, until recently, the identity, geographic variation, and diversity of the bacteria in the bottom trophic level of this food web have remained largely unknown. This study investigated bacterial community composition inside the leaves of S. purpurea to address: 1) variation in bacterial communities at the beginning of succession at the local scale in different areas of the plant's native geographic range (southern and mid-regional sites) and 2) the impacts of bacterial consumers and other members of the aquatic food web (i. e., insects) on bacterial community structure. Communities from six leaves (one leaf per plant) from New York and Florida study sites were analyzed using 16S ribosomal RNA gene cloning. Each pitcher within each site had a distinct community; however, there was more overlap in bacterial composition within each site than when communities were compared across sites. In contrast, the identity of protozoans and metazoans in this community were similar in species identity both within a site and between the two sites, but abundances differed. Our results indicate that, at least during the beginning of succession, there is no strong selection for bacterial taxa and that there is no core group of bacteria required by the plant to start the decomposition of trapped insects. Co-evolution between the plant and bacteria appears to not have occurred as it has for other members of this community.	[Gray, Sarah M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Gray, Sarah M.] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland; [Akob, Denise M.] Univ Jena, Inst Ecol, Jena, Germany; [Green, Stefan J.] Univ Illinois, Res Resources Ctr, DNA Serv Facil, Chicago, IL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Fribourg; Friedrich Schiller University of Jena; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Gray, SM (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	sarahmarie.gray@unifr.ch	Akob, Denise/D-9478-2013	Akob, Denise/0000-0003-1534-3025; Green, Stefan/0000-0003-2781-359X	United States Department of Energy [ER65245]; United States National Institutes of Health [GM060731]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060731] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Office of Biological and Environmental Research, Terrestrial Ecosystem Science (TES) Program, under the United States Department of Energy contract #ER65245 (J. Kostka as PI) and by United States National Institutes of Health Grant # GM060731 (D. Dykuizen as PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; Akob DM, 2007, FEMS MICROBIOL ECOL, V59, P95, DOI 10.1111/j.1574-6941.2006.00203.x; BRADSHAW WE, 1984, AM MIDL NAT, V112, P294, DOI 10.2307/2425436; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Buckley HL, 2010, GLOBAL ECOL BIOGEOGR, V19, P711, DOI 10.1111/j.1466-8238.2010.00554.x; Buckley HL, 2003, ECOL LETT, V6, P825, DOI 10.1046/j.1461-0248.2003.00504.x; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; Godt MJW, 1998, SYST BOT, V23, P427, DOI 10.2307/2419375; Gray SM, 2006, HYDROBIOLOGIA, V573, P173, DOI 10.1007/s10750-006-0265-2; Gray SM, 2012, AQUAT ECOL, V46, P487, DOI 10.1007/s10452-012-9417-9; Gray SM, 2011, THESIS STONY BROOK U; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; Hegner RW, 1926, BIOL BULL-US, V50, P271, DOI 10.2307/1536674; Johnson John L., 1994, P683; Juniper B.E., 1989, CARNIVOROUS PLANTS; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; Koopman MM, 2011, MICROB ECOL, V61, P750, DOI 10.1007/s00248-011-9832-9; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Krieger JR, 2012, FEMS MICROBIOL ECOL, V79, P555, DOI 10.1111/j.1574-6941.2011.01240.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ludwig W., 2001, BERGEYS MANUAL SYSTE, P49; Miller TE, 2002, ECOLOGY, V83, P898, DOI 10.1890/0012-9658(2002)083[0898:EOCSOI]2.0.CO;2; Miller TE, 2012, OECOLOGIA, V170, P243, DOI 10.1007/s00442-012-2292-1; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990	33	20	20	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50969	10.1371/journal.pone.0050969	http://dx.doi.org/10.1371/journal.pone.0050969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227224	Green Published, gold			2022-12-25	WOS:000312588200085
J	Zhang, L; Ye, R; Yu, FQ; Cao, ZL; Zhu, CY; Cai, Z; Hu, PP; Pu, H; Wang, K				Zhang, Lei; Ye, Rong; Yu, Fengqiong; Cao, Zhaolun; Zhu, Chunyan; Cai, Zhu; Hu, Panpan; Pu, Hui; Wang, Kai			How Does Emotional Context Modulate Response Inhibition in Alexithymia: Electrophysiological Evidence from an ERP Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EVENT-RELATED POTENTIALS; SCALE; CONFLICT; TASK; ASSOCIATION; PREVALENCE; ACTIVATION; STABILITY; PARADIGM	Background: Alexithymia, characterized by difficulties in identifying and describing feelings, is highly indicative of a broad range of psychiatric disorders. Several studies have also discovered the response inhibition ability impairment in alexithymia. However, few studies on alexithymic individuals have specifically examined how emotional context modulates response inhibition procedure. In order to investigate emotion cognition interaction in alexithymia, we analyzed the spatiao-temporal features of such emotional response inhibition by the approaches of event-related potentials and neural source-localization. Method: The study participants included 15 subjects with high alexithymia scores on the 20-item Toronto Alexithymia Scale (alexithymic group) and 15 matched subjects with low alexithymia scores (control group). Subjects were instructed to perform a modified emotional Go/Nogo task while their continuous electroencephalography activities were synchronously recorded. The task includes 3 categories of emotional contexts (positive, negative and neutral) and 2 letters ("M'' and "W'') centered in the screen. Participants were told to complete go and nogo actions based on the letters. We tested the influence of alexithymia in this emotional Go/Nogo task both in behavioral level and related neural activities of N2 and P3 ERP components. Results: We found that negatively valenced context elicited larger central P3 amplitudes of the Nogo-Go difference wave in the alexithymic group than in the control group. Furthermore, source-localization analyses implicated the anterior cingulate cortex (ACC) as the neural generator of the Nogo-P3. Conclusion: These findings suggest that difficulties in identifying feelings, particularly in negative emotions, is a major feature of alexithymia, and the ACC plays a critical role in emotion-modulated response inhibition related to alexithymia.	[Zhang, Lei; Ye, Rong; Yu, Fengqiong; Cao, Zhaolun; Zhu, Chunyan; Cai, Zhu; Wang, Kai] Anhui Med Univ, Lab Cognit Neuropsychol, Dept Med Psychol, Hefei, Anhui, Peoples R China; [Hu, Panpan; Pu, Hui; Wang, Kai] Anhui Med Univ, Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Wang, K (corresponding author), Anhui Med Univ, Lab Cognit Neuropsychol, Dept Med Psychol, Hefei, Anhui, Peoples R China.	wangkai1964@126.com	hu, panpan/ABD-5695-2021	Ye, Rong/0000-0003-2529-7755	Natural Science Foundation of China [81171273, 31100812, 31000503]; Special Research Fund for Doctoral Program of Higher Education [20113420110001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Fund for Doctoral Program of Higher Education	This research was supported by the Natural Science Foundation of China (81171273, 31100812, and 31000503), Special Research Fund for Doctoral Program of Higher Education (20113420110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chiu PH, 2008, NEUROIMAGE, V42, P988, DOI 10.1016/j.neuroimage.2008.04.248; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delplanque S, 2004, NEUROSCI LETT, V356, P1, DOI 10.1016/j.neulet.2003.10.014; Delplanque S, 2007, J NEUROSCI METH, V165, P144, DOI 10.1016/j.jneumeth.2007.05.030; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Freitas AL, 2009, PSYCHOPHYSIOLOGY, V46, P1226, DOI 10.1111/j.1469-8986.2009.00864.x; GLENN SW, 1993, ALCOHOL, V10, P89, DOI 10.1016/0741-8329(93)90086-4; Goldstein M, 2007, NEUROIMAGE, V36, P1026, DOI 10.1016/j.neuroimage.2007.01.056; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; JODO E, 1990, ELECTROEN CLIN NEURO, V76, P249, DOI 10.1016/0013-4694(90)90019-G; Joukamaa M, 2007, J PSYCHOSOM RES, V63, P373, DOI 10.1016/j.jpsychores.2007.01.018; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kamarajan C, 2005, CLIN NEUROPHYSIOL, V116, P1049, DOI 10.1016/j.clinph.2004.12.015; Karlsson H, 2008, BRIT J PSYCHIAT, V192, P32, DOI 10.1192/bjp.bp.106.034728; Kugel H, 2008, NEUROSCI LETT, V435, P40, DOI 10.1016/j.neulet.2008.02.005; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lemogne C, 2012, J AFFECT DISORDERS, V136, pE1, DOI 10.1016/j.jad.2010.11.034; Loas G, 2001, J PSYCHOSOM RES, V50, P255, DOI 10.1016/S0022-3999(01)00197-0; Luminet O, 2007, J PSYCHOSOM RES, V62, P641, DOI 10.1016/j.jpsychores.2007.01.003; Machin GC, 2009, PERS INDIV DIFFER, V46, P412, DOI 10.1016/j.paid.2008.11.010; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Nemiah J.C., 1976, MODERN TRENDS PSYCHO, P430, DOI DOI 10.1016/J.IJNURSTU.2009.03.014; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Shafritz KM, 2006, NEUROIMAGE, V31, P468, DOI 10.1016/j.neuroimage.2005.11.053; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith JL, 2006, INT J PSYCHOPHYSIOL, V61, P121, DOI 10.1016/j.ijpsycho.2005.07.013; Stadler C, 2007, J PSYCHIATR RES, V41, P410, DOI 10.1016/j.jpsychires.2006.01.006; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; TAYLOR GJ, 1991, PSYCHOSOMATICS, V32, P153, DOI 10.1016/S0033-3182(91)72086-0; TAYLOR GJ, 1988, PSYCHIAT CLIN N AM, V11, P351; Tolmunen T, 2011, COMPR PSYCHIAT, V52, P536, DOI 10.1016/j.comppsych.2010.09.007; WISE TN, 1995, PSYCHOPATHOLOGY, V28, P173, DOI 10.1159/000284919; [蚁金瑶 Yi Jinyao], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P763; Zech E, 1999, EUR J PERSONALITY, V13, P511; Zhang L, 2008, CHIN J NERV MENT DIS, V2, P103; Zhang L, 2011, NEUROSCI LETT, V504, P261, DOI 10.1016/j.neulet.2011.09.043	52	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51110	10.1371/journal.pone.0051110	http://dx.doi.org/10.1371/journal.pone.0051110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227242	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200101
J	Pazos, M; Natale, P; Vicente, M				Pazos, Manuel; Natale, Paolo; Vicente, Miguel			A Specific Role for the ZipA Protein in Cell Division STABILIZATION OF THE FtsZ PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL TAIL; ESCHERICHIA-COLI; SEPTAL RING; SELF-INTERACTION; BINDING; CLPA; MEMBRANE; DYNAMICS; DOMAIN; ACTIN	In Escherichia coli, the cell division protein FtsZ is anchored to the cytoplasmic membrane by the action of the bitopic membrane protein ZipA and the cytoplasmic protein FtsA. Although the presence of both ZipA and FtsA is strictly indispensable for cell division, an FtsA gain-of-function mutant FtsA* (R286W) can bypass the ZipA requirement for cell division. This observation casts doubts on the role of ZipA and its need for cell division. Maxicells are nucleoid-free bacterial cells used as a whole cell in vitro system to probe protein-protein interactions without the need of protein purification. We show that ZipA protects FtsZ from the ClpXP-directed degradation observed in E. coli maxicells and that ZipA-stabilized FtsZ forms membrane-attached spiral-like structures in the bacterial cytoplasm. The overproduction of the FtsZ-binding ZipA domain is sufficient to protect FtsZ from degradation, whereas other C-terminal ZipA partial deletions lacking it are not. Individual overproduction of the proto-ring component FtsA or its gain-of-function mutant FtsA* does not result in FtsZ protection. Overproduction of FtsA or FtsA* together with ZipA does not interfere with the FtsZ protection. Moreover, neither FtsA nor FtsA* protects FtsZ when overproduced together with ZipA mutants lacking the FZB domain. We propose that ZipA protects FtsZ from degradation by ClpP by making the FtsZ site of interaction unavailable to the ClpX moiety of the ClpXP protease. This role cannot be replaced by either FtsA or FtsA*, suggesting a unique function for ZipA in proto-ring stability.	[Pazos, Manuel; Natale, Paolo; Vicente, Miguel] CSIC, CNB, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Vicente, M (corresponding author), CSIC, CNB, C Darwin 3, Madrid 28049, Spain.	mvicente@cnb.csic.es	Pazos, Manuel/AAH-7922-2019; Natale, Paolo/E-9326-2012	Pazos, Manuel/0000-0002-8774-4453; Natale, Paolo/0000-0002-4759-0816	Human Frontier Science Program [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Ministerio de Ciencia e Innovacion [BIO2008-04478-C03-01, BIO2011-28941-C03-01]; program Formacion de Personal Investigador Ministerio de Educacion y Ciencia; Juan de la Cierva program Ministerio de Educacion y Ciencia	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); program Formacion de Personal Investigador Ministerio de Educacion y Ciencia; Juan de la Cierva program Ministerio de Educacion y Ciencia(German Research Foundation (DFG))	This work was supported by the Human Frontier Science Program though Grant RGP0050/2010, the European Commission through Contract HEALTH-F3-2009-223431 (DIVINOCELL), and Grants BIO2008-04478-C03-01 and BIO2011-28941-C03-01 from Ministerio de Ciencia e Innovacion (all to M. V.).; Supported by a fellowship from program Formacion de Personal Investigador Ministerio de Educacion y Ciencia.; Supported by a fellowship from Juan de la Cierva program Ministerio de Educacion y Ciencia.	Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Geissler B, 2005, MOL MICROBIOL, V58, P596, DOI 10.1111/j.1365-2958.2005.04858.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 1999, J BACTERIOL, V181, P167, DOI 10.1128/JB.181.1.167-176.1999; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2004, MOLECULES IN TIME AND SPACE: BACTERIAL SHAPE, DIVISON AND PHYLOGENY, P79, DOI 10.1007/0-306-48579-6_5; Miller J. H., 1972, EXPT MOL GENETICS, P268; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Ohashi T, 2002, J BACTERIOL, V184, P4313, DOI 10.1128/JB.184.15.4313-4315.2002; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sambrook J., 2001, MOL CLONING LAB MANU, P81; SANCAR A, 1979, J BACTERIOL, V137, P692, DOI 10.1128/JB.137.1.692-693.1979; SANCAR A, 1978, GENE, V4, P295, DOI 10.1016/0378-1119(78)90047-1; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	45	41	42	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3219	3226		10.1074/jbc.M112.434944	http://dx.doi.org/10.1074/jbc.M112.434944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23233671	hybrid, Green Published			2022-12-25	WOS:000314397900029
J	An, XH; Xiong, W; Yang, Y; Li, FH; Zhou, XF; Wang, ZJ; Deng, ZX; Liang, JD				An, Xianhui; Xiong, Wei; Yang, Yan; Li, Fuhou; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin; Liang, Jingdan			A Novel Target of IscS in Escherichia coli: Participating in DNA Phosphorothioation	PLOS ONE			English	Article							STREPTOMYCES-LIVIDANS; SELENOCYSTEINE LYASE; S-MODIFICATION; GENE CLONING; TRANSFER-RNA; SULFUR; PURIFICATION; BACTERIA; BACKBONE; SEQUENCE	Many bacterial species modify their DNA with the addition of sulfur to phosphate groups, a modification known as DNA phosphorothioation. DndA is known to act as a cysteine desulfurase, catalyzing a key biochemical step in phosphorothioation. However, bioinformatic analysis revealed that 19 out of the 31 known dnd gene clusters, contain only four genes (dndB-E), lacking a key cysteine desulfurase corresponding gene. There are multiple cysteine desulfurase genes in Escherichia coli, but which one of them participates into DNA phosphorothioation is unknown. Here, by employing heterologous expression of the Salmonella enterica dnd gene cluster named dptBCDE in three E. coli mutants, each of which lacked a different cysteine desulfurase gene, we show that IscS is the only cysteine desulfurase that collaborates with dptB-E, resulting in DNA phosphorothioation. Using a bacterial two-hybrid system, protein interactions between IscS and DptC, and IscS and DptE were identified. Our findings revealed IscS as a key participant in DNA phosphorothioation and lay the basis for in-depth analysis of the DNA phosphorothioation biochemical pathway.	[An, Xianhui; Xiong, Wei; Yang, Yan; Li, Fuhou; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin; Liang, Jingdan] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [An, Xianhui; Xiong, Wei; Yang, Yan; Li, Fuhou; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin; Liang, Jingdan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [An, Xianhui; Li, Fuhou] Ocean Coll, HuaiHai Inst Technol, Lianyungang, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Jiangsu Ocean University	Deng, ZX (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	zxdeng@sjtu.edu.cn; jdliang@sjtu.edu.cn	Yang, Sophie/GQB-2082-2022		National Science Foundation of China; Ministry of Science and Technology (973 program); Ministry of Science and Technology (863 program); Ministry of Education of China; Shanghai Municipal Council of Science and Technology and Shanghai Leading Academic Discipline Project [B203]; State Key Laboratory of Bio-Organic and Natural Products Chemistry (CAS); National Program of Development of Transgenic New Species of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (973 program)(National Basic Research Program of China); Ministry of Science and Technology (863 program); Ministry of Education of China(Ministry of Education, China); Shanghai Municipal Council of Science and Technology and Shanghai Leading Academic Discipline Project; State Key Laboratory of Bio-Organic and Natural Products Chemistry (CAS)(Chinese Academy of Sciences); National Program of Development of Transgenic New Species of China	The authors wish to thank the National Science Foundation of China, the Ministry of Science and Technology (973 and 863 programs), the Ministry of Education of China, the Shanghai Municipal Council of Science and Technology and Shanghai Leading Academic Discipline Project B203, the State Key Laboratory of Bio-Organic and Natural Products Chemistry (CAS) and the National Program of Development of Transgenic New Species of China for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BJORK GR, 1995, PROG NUCLEIC ACID RE, V50, P263, DOI 10.1016/S0079-6603(08)60817-X; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Liang JD, 2007, NUCLEIC ACIDS RES, V35, P2944, DOI 10.1093/nar/gkm176; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Ray T, 1992, FEDERATION EUROPEAN, V96, P6; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Stratagene, 2008, BACTERIOMATCH 2 2 HY; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Xu TG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-41; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	19	35	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51265	10.1371/journal.pone.0051265	http://dx.doi.org/10.1371/journal.pone.0051265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240007	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800043
J	Millen, AM; Horvath, P; Boyaval, P; Romero, DA				Millen, Anne M.; Horvath, Philippe; Boyaval, Patrick; Romero, Dennis A.			Mobile CRISPR/Cas-Mediated Bacteriophage Resistance in Lactococcus lactis	PLOS ONE			English	Article							SHORT PALINDROMIC REPEATS; STREPTOCOCCUS-LACTIS; ESCHERICHIA-COLI; IMMUNE-SYSTEM; SEQUENCE-ANALYSIS; CONJUGAL TRANSFER; CELL-AGGREGATION; GENOME ANALYSIS; SEED SEQUENCE; DNA ELEMENTS	Lactococcus lactis is a biotechnological workhorse for food fermentations and potentially therapeutic products and is therefore widely consumed by humans. It is predominantly used as a starter microbe for fermented dairy products, and specialized strains have adapted from a plant environment through reductive evolution and horizontal gene transfer as evidenced by the association of adventitious traits with mobile elements. Specifically, L. lactis has armed itself with a myriad of plasmid-encoded bacteriophage defensive systems to protect against viral predation. This known arsenal had not included CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins), which forms a remarkable microbial immunity system against invading DNA. Although CRISPR/Cas systems are common in the genomes of closely related lactic acid bacteria (LAB), none was identified within the eight published lactococcal genomes. Furthermore, a PCR-based search of the common LAB CRISPR/Cas systems (Types I and II) in 383 industrial L. lactis strains proved unsuccessful. Here we describe a novel, Type III, self-transmissible, plasmid-encoded, phage-interfering CRISPR/Cas discovered in L. lactis. The native CRISPR spacers confer resistance based on sequence identity to corresponding lactococcal phage. The interference is directed at phages problematic to the dairy industry, indicative of a responsive system. Moreover, targeting could be modified by engineering the spacer content. The 62.8-kb plasmid was shown to be conjugally transferrable to various strains. Its mobility should facilitate dissemination within microbial communities and provide a readily applicable system to naturally introduce CRISPR/Cas to industrially relevant strains for enhanced phage resistance and prevention against acquisition of undesirable genes.	[Millen, Anne M.; Romero, Dennis A.] DuPont Nutr & Hlth, Madison, WI 55431 USA; [Horvath, Philippe; Boyaval, Patrick] DuPont Nutr & Hlth, Dange St Romain, France	DuPont	Romero, DA (corresponding author), DuPont Nutr & Hlth, Madison, WI 55431 USA.	dennis.romero@dupont.com	HORVATH, Philippe/K-5266-2015	HORVATH, Philippe/0000-0003-2015-8123				Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; ANDERSON DG, 1984, J BACTERIOL, V158, P954, DOI 10.1128/JB.158.3.954-962.1984; ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Coffey A, 2002, ANTON LEEUW INT J G, V82, P303, DOI 10.1023/A:1020639717181; Crutz-Le Coq AM, 2002, MICROBIOL-SGM, V148, P985, DOI 10.1099/00221287-148-4-985; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dougherty BA, 1998, MOL MICROBIOL, V29, P1029, DOI 10.1046/j.1365-2958.1998.00988.x; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garrett RA, 2011, TRENDS MICROBIOL, V19, P549, DOI 10.1016/j.tim.2011.08.002; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Hayes F, 1998, J BACTERIOL, V180, P6415; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kelly WJ, 2010, GENOME BIOL EVOL, V2, P729, DOI 10.1093/gbe/evq056; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; Labrie SJ, 2008, APPL ENVIRON MICROB, V74, P4636, DOI 10.1128/AEM.00118-08; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Mahanivong C, 2001, APPL ENVIRON MICROB, V67, P3564, DOI 10.1128/AEM.67.8.3564-3576.2001; Mahony J, 2006, FEMS MICROBIOL LETT, V261, P253, DOI 10.1111/j.1574-6968.2006.00372.x; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MCKAY LL, 1980, APPL ENVIRON MICROB, V40, P84, DOI 10.1128/AEM.40.1.84-91.1980; MCKAY LL, 1972, APPL MICROBIOL, V23, P1090, DOI 10.1128/AEM.23.6.1090-1096.1972; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; Samson JE, 2010, APPL ENVIRON MICROB, V76, P6843, DOI 10.1128/AEM.00796-10; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; SCHOULER C, 1994, MICROBIOL-UK, V140, P3061, DOI 10.1099/13500872-140-11-3061; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Trotter M, 2006, GENE, V366, P189, DOI 10.1016/j.gene.2005.09.022; WALSH PM, 1981, J BACTERIOL, V146, P937, DOI 10.1128/JB.146.3.937-944.1981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	48	54	59	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51663	10.1371/journal.pone.0051663	http://dx.doi.org/10.1371/journal.pone.0051663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240053	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800089
J	Rather, GM; Mukherjee, J; Halling, PJ; Gupta, MN				Rather, Gulam Mohmad; Mukherjee, Joyeeta; Halling, Peter James; Gupta, Munishwar Nath			Activation of Alpha Chymotrypsin by Three Phase Partitioning Is Accompanied by Aggregation	PLOS ONE			English	Article							BACTERIAL INCLUSION-BODIES; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ORGANIC-SOLVENTS; PROTEIN; PURIFICATION; FLUORESCENCE; ENZYMES; HYDROPHOBICITY; SUBTILISIN	Precipitation of alpha chymotrypsin in the simultaneous presence of ammonium sulphate and t-butanol (three phase partitioning) resulted in preparations which showed self aggregation of the enzyme molecules. Precipitation with increasing amounts of ammonium sulphate led to increasing size of aggregates. While light scattering estimated the hydrodynamic diameter of these aggregates in the range of 242-1124 nm; Nanoparticle tracking analysis (NTA) gave the value as 130-462 nm. Scanning electron microscopy and gel filtration on Sephadex G-200 showed extensive aggregation in these preparations. Transmission electron microscopy showed that the aggregates had irregular shapes. All the aggregates had about 3 x higher catalytic activity than the native enzyme. These aggregates did not differ in lambda(max) of fluorescence emission which was around 340 nm. However, all the aggregates showed higher fluorescence emission intensity. Far-UV and near-UV circular dichroism also showed no significant structural changes as compared to the native molecule. Interestingly, HPLC gel filtration (on a hydroxylated silica column) gave 14 nm as the diameter for all preparations. Light scattering of preparations in the presence of 10% ethylene glycol also dissociated the aggregates to monomers of 14 nm. Both these results indicated that hydrophobic interactions were the driving force behind this aggregation. These results indicate: (1) Even without any major structural change, three phase partitioning led to protein molecules becoming highly prone to aggregation. (2) Different methods gave widely different estimates of sizes of aggregates. It was however possible to reconcile the data obtained with various approaches. (3) The nature of the gel filtration column is crucial and use of this technique for refolding and studying aggregation needs a rethink. Citation: Rather GM, Mukherjee J, Halling PJ, Gupta MN (2012) Activation of Alpha Chymotrypsin by Three Phase Partitioning Is Accompanied by Aggregation. PLoS ONE 7(12): e49241. doi: 10.1371/journal.pone.0049241	[Rather, Gulam Mohmad; Mukherjee, Joyeeta; Gupta, Munishwar Nath] Indian Inst Technol Delhi, Dept Chem, New Delhi, India; [Halling, Peter James] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow, Lanark, Scotland	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Strathclyde	Gupta, MN (corresponding author), Indian Inst Technol Delhi, Dept Chem, New Delhi, India.	appliedbiocat@yahoo.co.in			Department of Science and Technology (DST) core group, Government of India; Department of Biotechnology (DBT), Government of India; United Kingdom India Education and Research Initiative (UKIERI); University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR)	Department of Science and Technology (DST) core group, Government of India; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); United Kingdom India Education and Research Initiative (UKIERI); University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Partial financial support was provided by the Department of Science and Technology (DST) core group funding for "applied biocatalysis" and Department of Biotechnology (DBT), both Government of India organizations. Support was also provided by the United Kingdom India Education and Research Initiative (UKIERI) for funding the collaboration between MNG and PJH. Financial support was provided by University Grants Commission (UGC) to GMR and Council of Scientific and Industrial Research (CSIR) to JM, in the form of Senior and Junior Research Fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ P, 1990, ANN NY ACAD SCI, V613, P517, DOI 10.1111/j.1749-6632.1990.tb18211.x; Bemporad F, 2009, FEBS LETT, V583, P2630, DOI 10.1016/j.febslet.2009.07.013; Celej MS, 2004, BIOCHEM J, V378, P1059, DOI 10.1042/BJ20031536; CHAUDHURI TK, 1993, J BIOCHEM, V113, P729, DOI 10.1093/oxfordjournals.jbchem.a124111; Clark DS, 2004, PHILOS T ROY SOC B, V359, P1299, DOI 10.1098/rstb.2004.1506; De Diego T, 2004, BIOTECHNOL BIOENG, V88, P916, DOI 10.1002/bit.20330; Dennison C, 1997, PROTEIN EXPRES PURIF, V11, P149, DOI 10.1006/prep.1997.0779; DESIE G, 1986, BIOCHEMISTRY-US, V25, P8301, DOI 10.1021/bi00373a026; Desnuelle P, 1960, 118, P93; Elshereef R, 2006, BIOTECHNOL BIOENG, V95, P863, DOI 10.1002/bit.21039; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Flores-Fernandez GM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-57; Freydell EJ, 2010, J CHROMATOGR A, V1217, P7723, DOI 10.1016/j.chroma.2010.10.038; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Garcia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65, DOI 10.1016/j.tibtech.2011.09.003; Ghaouar N, 2010, INT J BIOL MACROMOL, V47, P425, DOI 10.1016/j.ijbiomac.2010.08.001; Hames BD, 1986, GEL ELECTROPHORESIS, P1; HAYNES CA, 1992, J PHYS CHEM-US, V96, P905, DOI 10.1021/j100181a069; HEINITZ ML, 1988, J CHROMATOGR, V443, P173, DOI 10.1016/S0021-9673(00)94791-5; Jain S, 2004, J CHROMATOGR A, V1035, P83, DOI 10.1016/j.chroma.2004.01.007; KATO A, 1980, BIOCHIM BIOPHYS ACTA, V624, P13, DOI 10.1016/0005-2795(80)90220-2; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kobayashi T, 2007, APPL MICROBIOL BIOT, V75, P71, DOI 10.1007/s00253-006-0800-0; Lovrein R., 1987, PROTEIN PURIFICATION, P131; Lovrein R.E., 1995, PROTEIN SOLVENT INTE, P521; Marcon G, 2006, METHOD ENZYMOL, V413, P75, DOI 10.1016/S0076-6879(06)13004-9; Pallares I, 2004, J MOL BIOL, V342, P321, DOI 10.1016/j.jmb.2004.06.089; Petsko G., 2004, PROTEIN STRUCTURE FU; PIKE RN, 1989, BIOTECHNOL BIOENG, V33, P221, DOI 10.1002/bit.260330213; PORATH J, 1973, NATURE, V245, P465, DOI 10.1038/245465a0; Przybycien TM, 2004, CURR OPIN BIOTECH, V15, P469, DOI 10.1016/j.copbio.2004.08.008; Raghava S, 2008, PROTEIN SCI, V17, P1987, DOI 10.1110/ps.036939.108; RAJPUT YS, 1987, ENZYME MICROB TECH, V9, P161, DOI 10.1016/0141-0229(87)90071-8; Rezaei-Ghaleh N, 2008, BIOPHYS J, V95, P4139, DOI 10.1529/biophysj.108.132407; Roy I, 2005, ENZYME MICROB TECH, V37, P113, DOI 10.1016/j.enzmictec.2005.02.007; Roy I, 2004, BIOCATAL BIOTRANSFOR, V22, P261, DOI 10.1080/10242420400010523; Shah S, 2007, BBA-GEN SUBJECTS, V1770, P94, DOI 10.1016/j.bbagen.2006.10.004; Sharma S, 2001, PROTEIN EXPRES PURIF, V21, P310, DOI 10.1006/prep.2000.1357; Singh N, 2005, FEBS J, V272, P562, DOI 10.1111/j.1742-4658.2004.04499.x; Singh RK, 2001, PROTEIN ENG, V14, P307, DOI 10.1093/protein/14.5.307; Solanki K, 2012, BIORESOURCE TECHNOL, V115, P147, DOI 10.1016/j.biortech.2011.12.066; Vallejo LF, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-11	43	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49241	10.1371/journal.pone.0049241	http://dx.doi.org/10.1371/journal.pone.0049241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239966	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800004
J	Shringi, S; Schmidt, C; Katherine, K; Brayton, KA; Hancock, DD; Besser, TE				Shringi, Smriti; Schmidt, Carrie; Katherine, Kaya; Brayton, Kelly A.; Hancock, Dale D.; Besser, Thomas E.			Carriage of stx2a Differentiates Clinical and Bovine-Biased Strains of Escherichia coli O157	PLOS ONE			English	Article							SHIGA TOXIN; NUCLEOTIDE-SEQUENCE; VIRULENCE FACTORS; GENETIC-STRUCTURE; INTEGRATION SITE; GENOME; PHAGE; IDENTIFICATION; GENOTYPES; VARIANTS	Background: Shiga toxin (Stx) are cardinal virulence factors of enterohemorrhagic E. coli O157:H7 (EHEC O157). The gene content and genomic insertion sites of Stx-associated bacteriophages differentiate clinical genotypes of EHEC O157 (CG, typical of clinical isolates) from bovine-biased genotypes (BBG, rarely identified among clinical isolates). This project was designed to identify bacteriophage-mediated differences that may affect the virulence of CG and BBG. Methods: Stx-associated bacteriophage differences were identified by whole genome optical scans and characterized among >400 EHEC O157 clinical and cattle isolates by PCR. Results: Optical restriction maps of BBG strains consistently differed from those of CG strains only in the chromosomal insertion sites of Stx2-associated bacteriophages. Multiplex PCRs (stx1, stx2a, and stx2c as well as Stx-associated bacteriophage - chromosomal insertion site junctions) revealed four CG and three BBG that accounted for >90% of isolates. All BBG contained stx2c and Stx2c-associated bacteriophage - sbcB junctions. All CG contained stx2a and Stx2a-associated bacteriophage junctions in wrbA or argW. Conclusions: Presence or absence of stx2a (or another product encoded by the Stx2a-associated bacteriophage) is a parsimonious explanation for differential virulence of BBG and CG, as reflected in the distributions of these genotypes in humans and in the cattle reservoir.	[Shringi, Smriti; Schmidt, Carrie; Katherine, Kaya; Brayton, Kelly A.; Besser, Thomas E.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Hancock, Dale D.] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA	Washington State University; Washington State University	Besser, TE (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbesser@vetmed.wsu.edu	Shringi, Smriti/AAC-9789-2020	Shringi, Smriti/0000-0001-9212-9175	National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-30055]; United States Department of Agriculture, Agriculture and Food Research Initiative [2009-04248]; Poncin fellowship Fund; Agricultural Animal Health Program, Washington State University College of Veterinary Medicine, Pullman, WA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Agriculture, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); Poncin fellowship Fund; Agricultural Animal Health Program, Washington State University College of Veterinary Medicine, Pullman, WA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institute of Allergy and Infectious Diseases, National Institutes of Health [contract N01-AI-30055]; United States Department of Agriculture, Agriculture and Food Research Initiative [grant 2009-04248]; Poncin fellowship Fund and the Agricultural Animal Health Program, Washington State University College of Veterinary Medicine, Pullman, WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Besser RE, 1999, ANNU REV MED, V50, P355, DOI 10.1146/annurev.med.50.1.355; Besser TE, 2007, APPL ENVIRON MICROB, V73, P671, DOI 10.1128/AEM.01035-06; Bono JL, 2012, MOL BIOL EVOL, V29, P2047, DOI 10.1093/molbev/mss072; BORCZYK AA, 1987, LANCET, V1, P98; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; Creuzburg K, 2005, MICROBIOL-SGM, V151, P941, DOI 10.1099/mic.0.27632-0; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Fogg PCM, 2007, MICROBIOL-SGM, V153, P4098, DOI 10.1099/mic.0.2007/011205-0; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gannon VPJ, 1997, J CLIN MICROBIOL, V35, P656, DOI 10.1128/JCM.35.3.656-662.1997; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Kawano K, 2008, EUR J CLIN MICROBIOL, V27, P227, DOI 10.1007/s10096-007-0420-3; Kawano K, 2012, EUR J CLIN MICROBIOL, V31, P119, DOI 10.1007/s10096-011-1283-1; Kim J, 1999, P NATL ACAD SCI USA, V96, P13288, DOI 10.1073/pnas.96.23.13288; Kim JY, 2001, J BACTERIOL, V183, P6885, DOI 10.1128/JB.183.23.6885-6897.2001; Koch C, 2003, J BACTERIOL, V185, P6463, DOI 10.1128/JB.185.21.6463-6466.2003; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Kotewicz ML, 2008, MICROBIOL-SGM, V154, P3518, DOI 10.1099/mic.0.2008/019026-0; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Law D, 2000, J APPL MICROBIOL, V88, P729, DOI 10.1046/j.1365-2672.2000.01031.x; Lee K, 2012, APPL ENVIRON MICROB, V78, P3361, DOI 10.1128/AEM.06646-11; Lee K, 2011, J CLIN MICROBIOL, V49, P1495, DOI 10.1128/JCM.02640-10; Lefebvre B, 2009, FOODBORNE PATHOG DIS, V6, P357, DOI 10.1089/fpd.2008.0188; Makino K, 1999, GENES GENET SYST, V74, P227, DOI 10.1266/ggs.74.227; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Nakamura H, 2008, JPN J INFECT DIS, V61, P251; Nishikawa Y, 2000, J CLIN MICROBIOL, V38, P2440; Ohnishi M, 2002, P NATL ACAD SCI USA, V99, P17043, DOI 10.1073/pnas.262441699; OLSVIK O, 1991, MOL CELL PROBE, V5, P429, DOI 10.1016/S0890-8508(05)80014-3; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Recktenwald J, 2002, INFECT IMMUN, V70, P1896, DOI 10.1128/IAI.70.4.1896-1908.2002; Rivas M, 2008, EMERG INFECT DIS, V14, P763, DOI 10.3201/eid1405.071050; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Shringi S, 2012, INFECT IMMUN, V80, P369, DOI 10.1128/IAI.05470-11; Strauch E, 2008, INFECT IMMUN, V76, P5466, DOI 10.1128/IAI.00875-08; Vanaja SK, 2010, APPL ENVIRON MICROB, V76, P60, DOI 10.1128/AEM.01666-09; Whitworth J, 2010, APPL ENVIRON MICROB, V76, P361, DOI 10.1128/AEM.01761-09; Whitworth JH, 2008, APPL ENVIRON MICROB, V74, P7447, DOI 10.1128/AEM.01190-08; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; Yang Z, 2004, APPL ENVIRON MICROB, V70, P6846, DOI 10.1128/AEM.70.11.6846-6854.2004; Zhang YX, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-121; Zhang YX, 2010, APPL ENVIRON MICROB, V76, P474, DOI 10.1128/AEM.01288-09; Zhou S, 2004, J BACTERIOL, V186, P7773, DOI 10.1128/JB.186.22.7773-7782.2004; Ziebell K, 2008, APPL ENVIRON MICROB, V74, P4314, DOI 10.1128/AEM.02821-07	50	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51572	10.1371/journal.pone.0051572	http://dx.doi.org/10.1371/journal.pone.0051572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240045	Green Submitted, gold, Green Published			2022-12-25	WOS:000312290800081
J	aan den Toorn, M; Huijbers, MME; de Vries, SC; van Mierlo, CPM				aan den Toorn, Marije; Huijbers, Mieke M. E.; de Vries, Sacco C.; van Mierlo, Carlo P. M.			The Arabidopsis thaliana SERK1 Kinase Domain Spontaneously Refolds to an Active State In Vitro	PLOS ONE			English	Article							INTRINSICALLY DISORDERED PROTEINS; RECEPTOR-LIKE KINASES; TO-ORDER TRANSITION; STRUCTURAL BASIS; ACTIVATION LOOP; GRAS PROTEINS; PHOSPHORYLATION; COMPLEX; PERCEPTION; PREDICTION	Auto-phosphorylating kinase activity of plant leucine-rich-repeat receptor-like kinases (LRR-RLK's) needs to be under tight negative control to avoid unscheduled activation. One way to achieve this would be to keep these kinase domains as intrinsically disordered protein (IDP) during synthesis and transport to its final location. Subsequent folding, which may depend on chaperone activity or presence of interaction partners, is then required for full activation of the kinase domain. Bacterially produced SERK1 kinase domain was previously shown to be an active Ser/Thr kinase. SERK1 is predicted to contain a disordered region in kinase domains X and XI. Here, we show that loss of structure of the SERK1 kinase domain during unfolding is intimately linked to loss of activity. Phosphorylation of the SERK1 kinase domain neither changes its structure nor its stability. Unfolded SERK1 kinase has no autophosphorylation activity and upon removal of denaturant about one half of the protein population spontaneously refolds to an active protein in vitro. Thus, neither chaperones nor interaction partners are required during folding of this protein to its catalytically active state.	[aan den Toorn, Marije; Huijbers, Mieke M. E.; de Vries, Sacco C.; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands; [aan den Toorn, Marije] Ctr Biosyst Gen, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	aan den Toorn, M (corresponding author), Wageningen Univ, Biochem Lab, Wageningen, Netherlands.	marije.aandentoorn@wur.nl	vanMierlo, Carlo p/B-4491-2016	vanMierlo, Carlo p/0000-0002-5358-8392	Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project was (co)financed by the Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.1	Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Cheng W, 2011, CELL HOST MICROBE, V10, P616, DOI 10.1016/j.chom.2011.10.013; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Espinoza-Fonseca LM, 2007, BIOPHYS J, V93, P2083, DOI 10.1529/biophysj.106.095802; Espinoza-Fonseca LM, 2008, J AM CHEM SOC, V130, P12208, DOI 10.1021/ja803143g; Fong JH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000316; Ganguly D, 2009, J AM CHEM SOC, V131, P5214, DOI 10.1021/ja808999m; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kwaaitaal MACJ, 2005, PROTOPLASMA, V226, P55, DOI 10.1007/s00709-005-0111-9; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Marin M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00086; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Rienties IM, 2005, PLANTA, V221, P394, DOI 10.1007/s00425-004-1447-7; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Su W, 2011, P NATL ACAD SCI USA, V108, P870, DOI 10.1073/pnas.1013251108; Sun XL, 2012, BIOCHEM J, V442, P1, DOI 10.1042/BJ20111766; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001258; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	64	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50907	10.1371/journal.pone.0050907	http://dx.doi.org/10.1371/journal.pone.0050907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236403	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100041
J	Dorion, C; Hunter, PR; Van den Bergh, R; Roure, C; Delchevalerie, P; Reid, T; Maes, P				Dorion, Claire; Hunter, Paul R.; Van den Bergh, Rafael; Roure, Carme; Delchevalerie, Pascale; Reid, Tony; Maes, Peter			Does Village Water Supply Affect Children's Length of Stay in a Therapeutic Feeding Program in Niger? Lessons from a Medecins Sans Frontieres Program	PLOS ONE			English	Article							INFECTION; MALNUTRITION	Objective: With an increasing move towards outpatient therapeutic feeding for moderately and severely malnourished children, the home environment has become an increasingly important factor in achieving good program outcomes. Infections, including those water-borne, may significantly delay weight gain in a therapeutic feeding program. This study examined the relationship between adequacy of water supply and children's length of stay in a therapeutic feeding program in Niger. Methods: The length of stay in a therapeutic feeding program of Medecins Sans Frontieres in Niger was registered for 1518 children from 20 villages in the region. In parallel, the quality and quantity of the water source in each village were documented, and the association between adequacy of the water supply and length of stay in the program was assessed through Generalized Estimating Equation analysis. Results: 36% of the children presented with a secondary infection, 69% of which were water-related. When stratified by the adequacy of the quantity and/or quality of the water supply in their village of origin, non-adequacy of the water supply was clearly associated with a higher prevalence of secondary water-related infections and with much longer lengths of stay of malnourished children in the therapeutic feeding program. Conclusion: This study suggests that therapeutic feeding programs using an outpatient model should routinely evaluate the water supply in their target children's villages if they are to provide optimal care.	[Van den Bergh, Rafael; Delchevalerie, Pascale; Reid, Tony; Maes, Peter] Med Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium; [Dorion, Claire; Roure, Carme] Med Sans Frontieres, Operat Ctr Barcelona, Barcelona, Spain; [Hunter, Paul R.] Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England	Doctors Without Borders; Doctors Without Borders; University of East Anglia	Maes, P (corresponding author), Med Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium.	peter.maes@brussels.msf.org	Hunter, Paul/A-7172-2008; Hunter, Paul/N-9021-2019	Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144; Van den Bergh, Rafael/0000-0001-6277-8713				Braghetta A, 2006, J AM WATER WORKS ASS, V98, P97; CAIRNCROSS AM, 1990, J INST WATER ENV MAN, V4, P571; Cairncross S., 1993, ENV HLTH ENG TROPICS, V2nd; Chen LC, 1983, DIARRHEA MALNUTRITIO; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Faim ACL, 2005, HERMANN EDITEURS CHA, P3; Hunter PR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000361; KEUSCH GT, 1986, REV INFECT DIS, V8, P273; Khara T, 2004, COMMUNITY BASED THER; Lutter Chessa K., 1992, Food and Nutrition Bulletin, V14, P36; MARTORELL R, 1980, AM J CLIN NUTR, V33, P345, DOI 10.1093/ajcn/33.2.345; PELLETIER DL, 1994, NUTR REV, V52, P409, DOI 10.1111/j.1753-4887.1994.tb01376.x; Rudert C, 2007, PLUMPYNUT MALNOURISH; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; WHO (World Health Organization), 2002, JOINT MON PROGR WAT	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50982	10.1371/journal.pone.0050982	http://dx.doi.org/10.1371/journal.pone.0050982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236416	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100049
J	Yang, XY; Forier, K; Steukers, L; Van Vlierberghe, S; Dubruel, P; Braeckmans, K; Glorieux, S; Nauwynck, HJ				Yang, Xiaoyun; Forier, Katrien; Steukers, Lennert; Van Vlierberghe, Sandra; Dubruel, Peter; Braeckmans, Kevin; Glorieux, Sarah; Nauwynck, Hans J.			Immobilization of Pseudorabies Virus in Porcine Tracheal Respiratory Mucus Revealed by Single Particle Tracking	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CYSTIC-FIBROSIS SPUTUM; BASEMENT-MEMBRANE; DIFFUSION; SULFATE; TRANSLOCATION; INFECTIONS; PEGYLATION; INVASION; PIGS	Pseudorabies virus (PRV) initially replicates in the porcine upper respiratory tract. It easily invades the mucosae and submucosae for subsequent spread throughout the body via blood vessels and nervous system. In this context, PRV developed ingenious processes to overcome different barriers such as epithelial cells and the basement membrane. Another important but often overlooked barrier is the substantial mucus layer which coats the mucosae. However, little is known about how PRV particles interact with porcine respiratory mucus. We therefore measured the barrier properties of porcine tracheal respiratory mucus, and investigated the mobility of nanoparticles including PRV in this mucus. We developed an in vitro model utilizing single particle tracking microscopy. Firstly, the mucus pore size was evaluated with polyethylene glycol coupled (PEGylated) nanoparticles and atomic force microscope. Secondly, the mobility of PRV in porcine tracheal respiratory mucus was examined and compared with that of negative, positive and PEGylated nanoparticles. The pore size of porcine tracheal respiratory mucus ranged from 80 to 1500 nm, with an average diameter of 455 +/- 240 nm. PRV (zeta potential: -31.8 +/- 1.5 mV) experienced a severe obstruction in porcine tracheal respiratory mucus, diffusing 59-fold more slowly than in water. Similarly, the highly negatively (-49.8 +/- 0.6 mV) and positively (36.7 +/- 1.1 mV) charged nanoparticles were significantly trapped. In contrast, the nearly neutral, hydrophilic PEGylated nanoparticles (-9.6 +/- 0.8 mV) diffused rapidly, with the majority of particles moving 50-fold faster than PRV. The mobility of the particles measured was found to be related but not correlated to their surface charge. Furthermore, PEGylated PRV (-13.8 +/- 0.9 mV) was observed to diffuse 13-fold faster than native PRV. These findings clearly show that the mobility of PRV was significantly hindered in porcine tracheal respiratory mucus, and that the obstruction of PRV was due to complex mucoadhesive interactions including charge interactions rather than size exclusion.	[Yang, Xiaoyun; Steukers, Lennert; Glorieux, Sarah; Nauwynck, Hans J.] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Merelbeke, Belgium; [Forier, Katrien; Braeckmans, Kevin] Univ Ghent, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium; [Forier, Katrien; Braeckmans, Kevin] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium; [Van Vlierberghe, Sandra; Dubruel, Peter] Polymer Chem & Biomat Grp, Ghent, Belgium	Ghent University; Ghent University; Ghent University	Nauwynck, HJ (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Salisburylaan, Merelbeke, Belgium.	hans.nauwynck@ugent.be	Van Vlierberghe, Sandra./AAN-7863-2021; Braeckmans, Kevin/HCH-3119-2022	Braeckmans, Kevin/0000-0002-7993-6295; Nauwynck, Hans/0000-0001-5470-0713; Forier, Katrien/0000-0002-7003-3612; Van Vlierberghe, Sandra/0000-0001-7688-1682; Dubruel, Peter/0000-0002-5928-7726	Ghent University	Ghent University(Ghent University)	This work was supported by Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; AGARWAL M, 1994, BIORHEOLOGY, V31, P11; Braeckmans K, 2010, NANOSCOPY AND MULTIDIMENSIONAL OPTICAL FLUORESCENCE MICROSCOPY; Broughton-Head VJ, 2007, PULM PHARMACOL THER, V20, P708, DOI 10.1016/j.pupt.2006.08.008; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Croyle MA, 2004, J VIROL, V78, P912, DOI 10.1128/JVI.78.2.912-921.2004; Croyle MA, 2000, HUM GENE THER, V11, P1713, DOI 10.1089/10430340050111368; EMERY N, 1995, AM J RESP CELL MOL, V12, P130, DOI 10.1165/ajrcmb.12.2.7865212; Forier K, 2012, NANOMEDICIN IN PRESS; Gadegaard N, 2006, BIOTECH HISTOCHEM, V81, P87, DOI 10.1080/10520290600783143; GIBSON JS, 1992, ARCH VIROL, V123, P351, DOI 10.1007/BF01317269; Glorieux S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-58; Glorieux S, 2009, VET MICROBIOL, V136, P341, DOI 10.1016/j.vetmic.2008.11.005; HAMPSON IN, 1984, BIOCHIM BIOPHYS ACTA, V801, P306, DOI 10.1016/0304-4165(84)90081-3; Hida K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019919; Khutoryanskiy VV, 2011, MACROMOL BIOSCI, V11, P748, DOI 10.1002/mabi.201000388; KING M, 1980, FED PROC, V39, P3080; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lieleg O, 2010, BIOPHYS J, V98, P1782, DOI 10.1016/j.bpj.2010.01.012; Lieleg O, 2009, BIOPHYS J, V97, P1569, DOI 10.1016/j.bpj.2009.07.009; Maeda K, 1998, J VET MED SCI, V60, P881, DOI 10.1292/jvms.60.881; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; McGrane SJ, 2004, STARCH-STARKE, V56, P122, DOI 10.1002/star.200300242; MORTAZAVI SA, 1995, INT J PHARM, V124, P173, DOI 10.1016/0378-5173(95)00073-R; Murphy JA, 2003, J VIROL, V77, P9337, DOI 10.1128/JVI.77.17.9337-9345.2003; Nauwynck H, 2007, VET RES, V38, P229, DOI 10.1051/vetres:200661; Nauwynck HJ, 1997, VET MICROBIOL, V55, P3, DOI 10.1016/S0378-1135(96)01299-0; Norris DA, 1997, J APPL POLYM SCI, V63, P1481, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1481::AID-APP10>3.0.CO;2-5; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Ramachandran S, 2011, WIRES SYST BIOL MED, V3, P702, DOI 10.1002/wsbm.154; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Sims DE, 1997, AM J PHYSIOL-LUNG C, V273, pL1036; Steukers L, 2012, TRENDS MICROBIOL, V20, P147, DOI 10.1016/j.tim.2012.01.001; Steukers L, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-33; Suh J, 2005, ADV DRUG DELIVER REV, V57, P1551, DOI 10.1016/j.addr.2005.05.003; Symens N, 2011, MOL PHARMACEUT, V8, P1757, DOI 10.1021/mp200120v; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Trybala E, 1998, J BIOL CHEM, V273, P5047, DOI 10.1074/jbc.273.9.5047; Trybala E, 1996, VIROLOGY, V218, P35, DOI 10.1006/viro.1996.0163; Vandekerckhove AP, 2010, J GEN VIROL, V91, P2019, DOI 10.1099/vir.0.019257-0; Varum FJO, 2012, J PHARM PHARMACOL, V64, P218, DOI 10.1111/j.2042-7158.2011.01399.x; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; WITTMANN G, 1980, ARCH VIROL, V66, P227, DOI 10.1007/BF01314736; Xie H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215301	49	27	27	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51054	10.1371/journal.pone.0051054	http://dx.doi.org/10.1371/journal.pone.0051054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236432	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100061
J	Cuthbertson, DJ; Irwin, A; Gardner, CJ; Daousi, C; Purewal, T; Furlong, N; Goenka, N; Thomas, EL; Adams, VL; Pushpakom, SP; Pirmohamed, M; Kemp, GJ				Cuthbertson, Daniel J.; Irwin, Andrew; Gardner, Chris J.; Daousi, Christina; Purewal, Tej; Furlong, Niall; Goenka, Niru; Thomas, E. Louise; Adams, Valerie L.; Pushpakom, Sudeep P.; Pirmohamed, Munir; Kemp, Graham J.			Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; MAGNETIC-RESONANCE-SPECTROSCOPY; NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR-DISEASE; INCREASED PREVALENCE; TRIGLYCERIDE CONTENT; PLASMA ADIPONECTIN; CONTROLLED-TRIAL; ADIPOSE-TISSUE; OPEN-LABEL	Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with type 2 diabetes mellitus (T2DM) because they concomitantly target obesity and dysglycaemia. Considering the high prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with T2DM, we determined the impact of 6 months' GLP-1 RA therapy on intrahepatic lipid (IHL) in obese, T2DM patients with hepatic steatosis, and evaluated the inter-relationship between changes in IHL with those in glycosylated haemoglobin (HbA(1)c), body weight, and volume of abdominal visceral and subcutaneous adipose tissue (VAT and SAT). We prospectively studied 25 (12 male) patients, age 50 +/- 10 years, BMI 38.4 +/- 5.6 kg/m(2) (mean +/- SD) with baseline IHL of 28.2% (16.5 to 43.1%) and HbA(1)c of 9.6% (7.9 to 10.7%) (median and interquartile range). Patients treated with metformin and sulphonylureas/DPP-IV inhibitors were given 6 months GLP-1 RA (exenatide, n = 19; liraglutide, n = 6). IHL was quantified by liver proton magnetic resonance spectroscopy (H-1 MRS) and VAT and SAT by whole body magnetic resonance imaging (MRI). Treatment was associated with mean weight loss of 5.0 kg (95% CI 3.5,6.5 kg), mean HbA(1c) reduction of 1.6% (17 mmol/mol) (0.8, 2.4%) and a 42% relative reduction in IHL (-59.3, -16.5%). The relative reduction in IHL correlated with that in HbA(1)c (rho = 0.49; p = 0.01) but was not significantly correlated with that in total body weight, VAT or SAT. The greatest IHL reduction occurred in individuals with highest pre-treatment levels. Mechanistic studies are needed to determine potential direct effects of GLP-1 RA on human liver lipid metabolism. Citation: Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, et al. (2012) Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists. PLoS ONE 7(12): e50117. doi:10.1371/journal.pone.0050117	[Cuthbertson, Daniel J.; Irwin, Andrew; Gardner, Chris J.; Daousi, Christina] Aintree Univ Hosp NHS Fdn Trust, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England; [Cuthbertson, Daniel J.; Daousi, Christina] Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Liverpool L69 3BX, Merseyside, England; [Purewal, Tej] Royal Liverpool Univ Hosp, Dept Endocrinol & Diabet, Liverpool, Merseyside, England; [Furlong, Niall] St Helens & Knowsley, Dept Endocrinol & Diabet, Whiston, Merseyside, England; [Goenka, Niru] Countess Chester Hosp, Dept Endocrinol & Diabet, Chester, Cheshire, England; [Thomas, E. Louise] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Metab & Mol Imaging Grp, London, England; [Adams, Valerie L.; Kemp, Graham J.] Univ Liverpool, Magnet Resonance & Image Anal Res Ctr, Liverpool L69 3BX, Merseyside, England; [Pushpakom, Sudeep P.; Pirmohamed, Munir] Univ Liverpool, Wolfson Ctr Personalised Med, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Kemp, Graham J.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England	Aintree University Hospitals NHS Foundation Trust; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Imperial College London; University of Liverpool; University of Liverpool; University of Liverpool	Cuthbertson, DJ (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England.	daniel.cuthbertson@liverpool.ac.uk	Thomas, Elizabeth Louise/AIF-0055-2022; Pirmohamed, Munir/H-6004-2011; Pushpakom, Sudeep/AAK-3281-2020; Kemp, Graham J/A-7540-2008	Pirmohamed, Munir/0000-0002-7534-7266; Kemp, Graham J/0000-0002-8324-9666; Thomas, Elizabeth/0000-0003-4235-4694; Cuthbertson, Daniel/0000-0002-6128-0822	medical charity Weight Matters; European Federation for the Study of Diabetes (EFSD)	medical charity Weight Matters; European Federation for the Study of Diabetes (EFSD)	Funding from medical charity Weight Matters was for 2500 pound. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please note this charity is a local charity set up by the investigators and the volunteers within the authors' hospital and they contributed 2500 pound towards cost of MRI scanning.; We would like to acknowledge the support of the European Federation for the Study of Diabetes (EFSD) in establishing the magnetic resonance spectroscopy methodologies. We would also like to thank Dan Lythgoe, Department of Molecular and Clinical Cancer Medicine, University of Liverpool for his help with the statistical analysis.	Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240; Bunck MC, 2010, DIABETES CARE, V33, P1734, DOI 10.2337/dc09-2361; Buse JB, 2007, CLIN THER, V29, P139, DOI 10.1016/j.clinthera.2007.01.015; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Centre for Clinical Practice at NICE (UK), 2009, TYP 2 DIAB NEW AG BL; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Gardner CJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7199; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094; Hattersley JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039029; Jendle J, 2009, DIABETES OBES METAB, V11, P1163, DOI 10.1111/j.1463-1326.2009.01158.x; Kenny PR, 2010, AM J GASTROENTEROL, V105, P2707, DOI 10.1038/ajg.2010.363; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463; Lazo M, 2010, DIABETES CARE, V33, P2156, DOI 10.2337/dc10-0856; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Ratziu V, 2010, HEPATOLOGY, V52, P2206, DOI 10.1002/hep.24042; Sathyanarayana P, 2011, OBESITY SILVER SPRIN; Shlomo SB, 2010, J HEPATOL; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Targher G, 2008, DIABETOLOGIA, V51, P1947, DOI 10.1007/s00125-008-1135-4; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2006, DIABETIC MED, V23, P403, DOI 10.1111/j.1464-5491.2006.01817.x; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; Tiikkainen M, 2004, DIABETES, V53, P2169, DOI 10.2337/diabetes.53.8.2169; Tushuizen ME, 2006, LIVER INT, V26, P1015, DOI 10.1111/j.1478-3231.2006.01315.x; Williamson RM, 2011, DIABETES CARE, V34, P1139, DOI 10.2337/dc10-2229	38	166	181	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50117	10.1371/journal.pone.0050117	http://dx.doi.org/10.1371/journal.pone.0050117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236362	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000312589700008
J	Jaeschke, A; Bittner, T; Jentsch, A; Reineking, B; Schlumprecht, H; Beierkuhnlein, C				Jaeschke, Anja; Bittner, Torsten; Jentsch, Anke; Reineking, Bjoern; Schlumprecht, Helmut; Beierkuhnlein, Carl			Biotic Interactions in the Face of Climate Change: A Comparison of Three Modelling Approaches	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DRAGONFLY AESHNA-VIRIDIS; STRATIOTES-ALOIDES; HABITAT MODELS; THRESHOLD CRITERIA; RANGE EXPANSION; DISTRIBUTIONS; SHIFTS; BIODIVERSITY; PREDICTION	Climate change is expected to alter biotic interactions, and may lead to temporal and spatial mismatches of interacting species. Although the importance of interactions for climate change risk assessments is increasingly acknowledged in observational and experimental studies, biotic interactions are still rarely incorporated in species distribution models. We assessed the potential impacts of climate change on the obligate interaction between Aeshna viridis and its egg-laying plant Stratiotes aloides in Europe, based on an ensemble modelling technique. We compared three different approaches for incorporating biotic interactions in distribution models: (1) We separately modelled each species based on climatic information, and intersected the future range overlap ('overlap approach'). (2) We modelled the potential future distribution of A. viridis with the projected occurrence probability of S. aloides as further predictor in addition to climate ('explanatory variable approach'). (3) We calibrated the model of A. viridis in the current range of S. aloides and multiplied the future occurrence probabilities of both species ('reference area approach'). Subsequently, all approaches were compared to a single species model of A. viridis without interactions. All approaches projected a range expansion for A. viridis. Model performance on test data and amount of range gain differed depending on the biotic interaction approach. All interaction approaches yielded lower range gains (up to 667% lower) than the model without interaction. Regarding the contribution of algorithm and approach to the overall uncertainty, the main part of explained variation stems from the modelling algorithm, and only a small part is attributed to the modelling approach. The comparison of the no-interaction model with the three interaction approaches emphasizes the importance of including obligate biotic interactions in projective species distribution modelling. We recommend the use of the 'reference area approach' as this method allows a separation of the effect of climate and occurrence of host plant. Citation: Jaeschke A, Bittner T, Jentsch A, Reineking B, Schlumprecht H, et al. (2012) Biotic Interactions in the Face of Climate Change: A Comparison of Three Modelling Approaches. PLoS ONE 7(12): e51472. doi:10.1371/journal.pone.0051472	[Jaeschke, Anja; Beierkuhnlein, Carl] Univ Bayreuth, BayCEER, Dept Biogeog, Bayreuth, Germany; [Bittner, Torsten] LUBW Landesanstalt Umwelt Messungen & Nat Schutz, Karlsruhe, Germany; [Jentsch, Anke] Univ Bayreuth, BayCEER, Dept Disturbance Ecol, Bayreuth, Germany; [Schlumprecht, Helmut] Buro Okol Studien, Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Jaeschke, A (corresponding author), Univ Bayreuth, BayCEER, Dept Biogeog, Bayreuth, Germany.	anja.jaeschke@uni-bayreuth.de	Beierkuhnlein, Carl/ABF-8797-2021; Beierkuhnlein, Carl/ABF-9693-2021	Beierkuhnlein, Carl/0000-0002-6456-4628; Reineking, Bjorn/0000-0001-5277-9181	Federal Agency for Nature Conservation Germany [FKZ 3508 85 0600]; German Research Foundation; Federal Agency for Nature Conservation Germany for the coordination of the project "Impacts of climate change on fauna, flora and habitats as well as adaptation strategies of nature conservation'' [FKZ 3508 85 0600]	Federal Agency for Nature Conservation Germany; German Research Foundation(German Research Foundation (DFG)); Federal Agency for Nature Conservation Germany for the coordination of the project "Impacts of climate change on fauna, flora and habitats as well as adaptation strategies of nature conservation''	The work was funded by the Federal Agency for Nature Conservation Germany (FKZ 3508 85 0600) (www.bfn.de). This publication was funded by the German Research Foundation (www.dfg.de) and the University of Bayreuth (www.uni-bayreuth.de) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Federal Agency for Nature Conservation Germany for the coordination of the project "Impacts of climate change on fauna, flora and habitats as well as adaptation strategies of nature conservation'' (FKZ 3508 85 0600). Further, we thank two anonymous reviewers for their helpful comments on an earlier version of this manuscript.	Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Bittner T, 2011, J VEG SCI, V22, P699, DOI 10.1111/j.1654-1103.2011.01266.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dijkstra K.-D.-B., 2006, FIELD GUIDE DRAGONFL; Dormann CF, 2008, ECOLOGY, V89, P3371, DOI 10.1890/07-1772.1; EIONET, 2009, CENTR DAT REP CDR; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hassall C, 2008, INT J ODONATOL, V11, P131, DOI 10.1080/13887890.2008.9748319; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu YZ, 2011, ECOLOGY, V92, P1201, DOI 10.1890/10-2060.1; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Pagel J, 2012, GLOBAL ECOL BIOGEOGR, V21, P293, DOI 10.1111/j.1466-8238.2011.00663.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Preston CD, 1997, AQUATIC PLANTS BRIT; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; Rantala MJ, 2004, AQUAT ECOL, V38, P77; Reineking B, 2006, ECOL MODEL, V193, P675, DOI 10.1016/j.ecolmodel.2005.10.003; Ruete A, 2012, P ROY SOC B-BIOL SCI, V279, P3098, DOI 10.1098/rspb.2012.0428; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Settele J, 2005, GAIA, V14, P69, DOI 10.14512/gaia.14.1.20; Smolders AJP, 1996, ARCH HYDROBIOL, V136, P327; Spangenberg JH, 2007, SUSTAIN DEV, V15, P343, DOI 10.1002/sd.320; Sugier P, 2010, HYDROBIOLOGIA, V656, P43, DOI 10.1007/s10750-010-0433-2; Suutari E, 2004, OECOLOGIA, V140, P135, DOI 10.1007/s00442-004-1559-6; Suutari E, 2009, J INSECT CONSERV, V13, P413, DOI 10.1007/s10841-008-9188-8; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W., 2009, BIOMOD SPECIES CLIMA; Thuiller W., 2010, BIOMOD SPECIES CLIMA; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Walsh C., 2008, HIER PART HIERARCHIC	59	20	20	4	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51472	10.1371/journal.pone.0051472	http://dx.doi.org/10.1371/journal.pone.0051472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236505	Green Submitted, gold, Green Published			2022-12-25	WOS:000312589700042
J	Oxaran, V; Ledue-Clier, F; Dieye, Y; Herry, JM; Pechoux, C; Meylheuc, T; Briandet, R; Juillard, V; Piard, JC				Oxaran, Virginie; Ledue-Clier, Florence; Dieye, Yakhya; Herry, Jean-Marie; Pechoux, Christine; Meylheuc, Thierry; Briandet, Romain; Juillard, Vincent; Piard, Jean-Christophe			Pilus Biogenesis in Lactococcus lactis: Molecular Characterization and Role in Aggregation and Biofilm Formation	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; LACTOBACILLUS-RHAMNOSUS GG; STAPHYLOCOCCUS-AUREUS SORTASE; GROUP-B STREPTOCOCCUS; CELL-WALL ANCHOR; SURFACE-PROTEINS; ACTINOMYCES-NAESLUNDII; GENE INACTIVATION; ACID BACTERIA; CORYNEBACTERIUM-DIPHTHERIAE	The genome of Lactococcus lactis strain IL1403 harbors a putative pilus biogenesis cluster consisting of a sortase C gene flanked by 3 LPxTG protein encoding genes (yhgD, yhgE, and yhhB), called here pil. However, pili were not detected under standard growth conditions. Over-expression of the pil operon resulted in production and display of pili on the surface of lactococci. Functional analysis of the pilus biogenesis machinery indicated that the pilus shaft is formed by oligomers of the YhgE pilin, that the pilus cap is formed by the YhgD pilin and that YhhB is the basal pilin allowing the tethering of the pilus fibers to the cell wall. Oligomerization of pilin subunits was catalyzed by sortase C while anchoring of pili to the cell wall was mediated by sortase A. Piliated L. lactis cells exhibited an auto-aggregation phenotype in liquid cultures, which was attributed to the polymerization of major pilin, YhgE. The piliated lactococci formed thicker, more aerial biofilms compared to those produced by non-piliated bacteria. This phenotype was attributed to oligomers of YhgE. This study provides the first dissection of the pilus biogenesis machinery in a non-pathogenic Gram-positive bacterium. Analysis of natural lactococci isolates from clinical and vegetal environments showed pili production under standard growth conditions. The identification of functional pili in lactococci suggests that the changes they promote in aggregation and biofilm formation may be important for the natural lifestyle as well as for applications in which these bacteria are used. Citation: Oxaran V, Ledue-Clier F, Dieye Y, Herry J-M, Pechoux C, et al. (2012) Pilus Biogenesis in Lactococcus lactis: Molecular Characterization and Role in Aggregation and Biofilm Formation. PLoS ONE 7(12): e50989. doi:10.1371/journal.pone.0050989	[Oxaran, Virginie; Ledue-Clier, Florence; Dieye, Yakhya; Herry, Jean-Marie; Meylheuc, Thierry; Briandet, Romain; Juillard, Vincent; Piard, Jean-Christophe] INRA, Micalis UMR1319, Jouy En Josas, France; [Oxaran, Virginie; Ledue-Clier, Florence; Dieye, Yakhya; Herry, Jean-Marie; Meylheuc, Thierry; Briandet, Romain; Juillard, Vincent; Piard, Jean-Christophe] Agro ParisTech, Micalis UMR1319, Jouy En Josas, France; [Pechoux, Christine] INRA, GPL UR1196, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Piard, JC (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	jean-christophe.piard@jouy.inra.fr	Briandet, Romain/AAD-2102-2020; Dieye, Yakhya/P-9086-2019; Dieye, Yakhya/A-5175-2012	Briandet, Romain/0000-0002-8123-3492; Dieye, Yakhya/0000-0003-2461-6558; Oxaran, Virginie/0000-0001-6766-6497; HERRY, Jean-Marie/0000-0001-8627-9994	French government through the doctoral school ABIES; INRA; Fondation pour la Recherche Medicale	French government through the doctoral school ABIES; INRA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	V.O. was the recipient of a doctoral grant from the French government through the doctoral school ABIES (http://www.agroparistech.fr/abies/) and INRA (http://www.inra.fr/); Y.D. was the recipient of a joint grant from INRA and Fondation pour la Recherche Medicale (http://www.frm.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Becherelli M, 2012, MOL MICROBIOL, V83, P1035, DOI 10.1111/j.1365-2958.2012.07987.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bermudez-Humaran LG, 2005, J IMMUNOL, V175, P7297, DOI 10.4049/jimmunol.175.11.7297; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; DeDent AC, 2007, J BACTERIOL, V189, P4473, DOI 10.1128/JB.00227-07; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; DELORME C, 1993, J BACTERIOL, V175, P4391, DOI 10.1128/JB.175.14.4391-4399.1993; deRuyter PGGA, 1997, NAT BIOTECHNOL, V15, P976, DOI 10.1038/nbt1097-976; Dieye Y, 2003, APPL ENVIRON MICROB, V69, P7281, DOI 10.1128/AEM.69.12.7281-7288.2003; Dieye Y, 2010, APPL ENVIRON MICROB, V76, P7332, DOI 10.1128/AEM.00928-10; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; ELLIOTT JA, 1991, J CLIN MICROBIOL, V29, P2731, DOI 10.1128/JCM.29.12.2731-2734.1991; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Fittipaldi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008426; Foroni E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S16; Gaeng S, 2000, APPL ENVIRON MICROB, V66, P2951, DOI 10.1128/AEM.66.7.2951-2958.2000; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Gilad O, 2011, PROTEOMICS, V11, P2503, DOI 10.1002/pmic.201000716; GODON JJ, 1993, J BACTERIOL, V175, P4383, DOI 10.1128/JB.175.14.4383-4390.1993; Habimana O, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-36; Habimana O, 2009, APPL ENVIRON MICROB, V75, P7814, DOI 10.1128/AEM.01333-09; Hanniffy SB, 2007, J INFECT DIS, V195, P185, DOI 10.1086/509807; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hugenholtz J, 2002, ANTON LEEUW INT J G, V82, P217, DOI 10.1023/A:1020608304886; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Igarashi T, 2003, ORAL MICROBIOL IMMUN, V18, P266, DOI 10.1034/j.1399-302X.2003.00076.x; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kelly WJ, 1998, INT J FOOD MICROBIOL, V45, P85, DOI 10.1016/S0168-1605(98)00135-4; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; LANGELLA P, 1993, J BACTERIOL, V175, P5806, DOI 10.1128/JB.175.18.5806-5813.1993; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; Mandlik A, 2008, P NATL ACAD SCI US; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mercenier A, 2000, Curr Issues Mol Biol, V2, P17; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nelson AL, 2007, MOL MICROBIOL; Nobbs AH, 2007, MICROBIOL-SGM, V153, P4088, DOI 10.1099/mic.0.2007/007252-0; O'Callaghan J, 2012, APPL ENVIRON MICROB, V78, P5196, DOI 10.1128/AEM.00507-12; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Piard JC, 1997, J BACTERIOL, V179, P3068, DOI 10.1128/jb.179.9.3068-3072.1997; Ping H, 2008, ARCH ORAL BIOL, V53, P150; Price CE, 2012, FEMS MICROBIOL REV, V36, P949, DOI 10.1111/j.1574-6976.2011.00323.x; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Raz A, 2008, P NATL ACAD SCI US; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; Ross RP, 1999, ANTON LEEUW INT J G, V76, P337, DOI 10.1023/A:1002069416067; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Siciliano RA, 2012, CURR OPIN M IN PRESS; Sillapaa J, 2008, MICROBIOL-SGM, V154, P3199, DOI 10.1099/mic.0.2008/017319-0; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stentz R, 2004, MICROBIOL-SGM, V150, P2503, DOI 10.1099/mic.0.27149-0; Sulavik MC, 1996, J BACTERIOL, V178, P5826, DOI 10.1128/jb.178.19.5826-5830.1996; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Yeung MK, 1998, INFECT IMMUN, V66, P1482, DOI 10.1128/IAI.66.4.1482-1491.1998; Yeung MK, 1997, INFECT IMMUN, V65, P2629, DOI 10.1128/IAI.65.7.2629-2639.1997; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	112	47	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50989	10.1371/journal.pone.0050989	http://dx.doi.org/10.1371/journal.pone.0050989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236417	Green Submitted, gold, Green Published			2022-12-25	WOS:000312589700026
J	Aikio, M; Alahuhta, I; Nurmenniemi, S; Suojanen, J; Palovuori, R; Teppo, S; Sorsa, T; Lopez-Otin, C; Pihlajaniemi, T; Salo, T; Heljasvaara, R; Nyberg, P				Aikio, Mari; Alahuhta, Ilkka; Nurmenniemi, Sini; Suojanen, Juho; Palovuori, Riitta; Teppo, Susanna; Sorsa, Timo; Lopez-Otin, Carlos; Pihlajaniemi, Taina; Salo, Tuula; Heljasvaara, Ritva; Nyberg, Pia			Arresten, a Collagen-Derived Angiogenesis Inhibitor, Suppresses Invasion of Squamous Cell Carcinoma	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; IV COLLAGEN; E-CADHERIN; IN-VIVO; TUMOR MICROENVIRONMENT; BASEMENT-MEMBRANE; ALPHA-1-BETA-1 INTEGRIN; ALPHA-3 CHAIN; CANCER CELLS; NC1 DOMAIN	The turnover of extracellular matrix liberates various cryptic molecules with novel biological activity. Among these are the collagen-derived anti-angiogenic fragments, some of which are suggested to affect carcinoma cells also directly. Arresten is an endogenous angiogenesis inhibitor that is derived from the non-collagenous domain of the basement membrane collagen IV alpha 1 chain. As the mere prevention of tumor angiogenesis leads to hypoxia that can result in selection of more aggressive cell types and reduces the efficacy of chemotherapy, we aimed here to elucidate how arresten influences the aggressive human carcinoma cells. Arresten efficiently inhibited migration and invasion of HSC-3 tongue carcinoma cells in culture and in an organotypic model. Subcutaneous Arr-HSC xenografts grew markedly more slowly in nude mice and showed reduced tumor cell proliferation, vessel density and local invasiveness. In the organotypic assay, HSC-3 cells overproducing arresten (Arr-HSC) showed induction of cell death. In monolayer culture the Arr-HSC cells grew in aggregated cobblestone-like clusters and, relative to the control cells, showed increased expression and localization of epithelial marker E-cadherin in cell-cell contacts. Application of electric cell-substrate impedance sensing (ECIS) further supported our observations on altered morphology and motility of the Arr-HSC cells. Administration of a function-blocking alpha 1 integrin antibody abolished the impedance difference between the Arr-HSC and control cells suggesting that the effect of arresten on promotion of HSC-3 cell-cell contacts and cell spreading is at least partly mediated by alpha 1 beta 1 integrin. Collectively, our data suggest novel roles for arresten in the regulation of oral squamous carcinoma cell proliferation, survival, motility and invasion through the modulation of cell differentiation state and integrin signaling.	[Aikio, Mari; Alahuhta, Ilkka; Nurmenniemi, Sini; Palovuori, Riitta; Teppo, Susanna; Pihlajaniemi, Taina; Salo, Tuula; Heljasvaara, Ritva; Nyberg, Pia] Univ Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland; [Aikio, Mari; Palovuori, Riitta; Pihlajaniemi, Taina; Heljasvaara, Ritva] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Aikio, Mari; Palovuori, Riitta; Pihlajaniemi, Taina; Heljasvaara, Ritva] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu, Finland; [Alahuhta, Ilkka; Nurmenniemi, Sini; Teppo, Susanna; Salo, Tuula; Nyberg, Pia] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Suojanen, Juho; Sorsa, Timo] Univ Helsinki, Inst Dent, Helsinki, Finland; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; [Salo, Tuula; Nyberg, Pia] Oulu Univ Hosp, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oulu	Nyberg, P (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland.	pia.nyberg@oulu.fi	, tuula/ABG-2051-2021; Suojanen, Juho/D-5448-2013; López-Otín, Carlos/AAB-2106-2020	López-Otín, Carlos/0000-0001-6964-1904; Suojanen, Juho/0000-0002-2361-5134; Salo, Tuula/0000-0001-6039-0088; Pihlajaniemi, Taina/0000-0002-1664-9045; Heljasvaara, Ritva/0000-0003-4763-3844	Academy of Finland [1126783, 1130140, 115256, 128259, 132051, 138866]; Centre of Excellence of Academy of Finland [251314]; Finnish Cancer Organizations; Cancer Foundation of Northern Finland; Sigrid Juselius Foundation; Oulu and Helsinki University Hospital KEVO-support; Oulu University Scholarship Foundation; Finnish Dental Society Apollonia; Cancer Foundation Finland sr [110111, 100130] Funding Source: researchfish	Academy of Finland(Academy of Finland); Centre of Excellence of Academy of Finland; Finnish Cancer Organizations; Cancer Foundation of Northern Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Oulu and Helsinki University Hospital KEVO-support; Oulu University Scholarship Foundation; Finnish Dental Society Apollonia; Cancer Foundation Finland sr	This study was financially supported by Academy of Finland (1126783, 1130140, 115256, 128259, 132051, 138866), Centre of Excellence of Academy of Finland Grant 2012-2017 (251314, Finnish Cancer Organizations, Cancer Foundation of Northern Finland, Sigrid Juselius Foundation, Oulu and Helsinki University Hospital KEVO-support, Oulu University Scholarship Foundation, and Finnish Dental Society Apollonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadian S, 2012, CANCER RES, V72, P1270, DOI 10.1158/0008-5472.CAN-11-2348; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boosani CS, 2009, INVEST OPHTH VIS SCI, V50, P4567, DOI 10.1167/iovs.09-3473; Boosani CS, 2006, PROTEIN EXPRES PURIF, V49, P211, DOI 10.1016/j.pep.2006.03.007; Brassart-Pasco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029587; Brideau G, 2007, CANCER RES, V67, P11528, DOI 10.1158/0008-5472.CAN-07-1458; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Canel M, 2010, CANCER RES, V70, P9413, DOI 10.1158/0008-5472.CAN-10-1454; Celik I, 2005, CANCER RES, V65, P11044, DOI 10.1158/0008-5472.CAN-05-2617; Colorado PC, 2000, CANCER RES, V60, P2520; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kylmaniemi M, 1996, J DENT RES, V75, P919, DOI 10.1177/00220345960750030901; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Mundel TM, 2008, INT J CANCER, V122, P1738, DOI 10.1002/ijc.23269; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; Pasco S, 2004, EXP CELL RES, V301, P251, DOI 10.1016/j.yexcr.2004.07.036; Pedchenko V, 2004, J BIOL CHEM, V279, P2772, DOI 10.1074/jbc.M311901200; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Ramazani M, 2011, EUR J VASC ENDOVASC, V42, P484, DOI 10.1016/j.ejvs.2011.05.021; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Schuh JoAnn C L, 2004, Toxicol Pathol, V32 Suppl 1, P53, DOI 10.1080/01926230490424770; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Sudhakar A, 2005, J CLIN INVEST, V115, P2801, DOI 10.1172/JCI24813; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Wang XQ, 1999, J CELL BIOL, V147, P389, DOI 10.1083/jcb.147.2.389; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zhang WT, 2006, J CELL SCI, V119, P283, DOI 10.1242/jcs.02738	57	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51044	10.1371/journal.pone.0051044	http://dx.doi.org/10.1371/journal.pone.0051044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227231	gold, Green Submitted, Green Published			2022-12-25	WOS:000312588200091
J	Bennett, VA; Doerr, VAJ; Doerr, ED; Manning, AD; Lindenmayer, DB; Yoon, HJ				Bennett, Victoria A.; Doerr, Veronica A. J.; Doerr, Erik D.; Manning, Adrian D.; Lindenmayer, David B.; Yoon, Hwan-Jin			Habitat Selection and Post-Release Movement of Reintroduced Brown Treecreeper Individuals in Restored Temperate Woodland	PLOS ONE			English	Article							HOME-RANGE SIZE; REPRODUCTIVE SUCCESS; NATAL DISPERSAL; MULLIGANS FLAT; SURVIVAL; TRANSLOCATION; BIRDS; ESTABLISHMENT; CONSERVATION; RESTORATION	It is essential to choose suitable habitat when reintroducing a species into its former range. Habitat quality may influence an individual's dispersal decisions and also ultimately where they choose to settle. We examined whether variation in habitat quality (quantified by the level of ground vegetation cover and the installation of nest boxes) influenced the movement, habitat choice and survival of a reintroduced bird species. We experimentally reintroduced seven social groups (43 individuals) of the brown treecreeper (Climacteris picumnus) into two nature reserves in south-eastern Australia. We radio-tracked 18 brown treecreepers from release in November 2009 until February 2010. We observed extensive movements by individuals irrespective of the release environment or an individual's gender. This indicated that individuals were capable of dispersing and actively selecting optimum habitat. This may alleviate pressure on wildlife planners to accurately select the most optimum release sites, so long as the species' requirements are met. There was significant variation in movement between social groups, suggesting that social factors may be a more important influence on movement than habitat characteristics. We found a significant effect of ground vegetation cover on the likelihood of settlement by social groups, with high rates of settlement and survival in dry forests, rather than woodland (where the species typically resides), which has implications for the success of woodland restoration. However, overall the effects of variation in habitat quality were not as strong as we had expected, and resulted in some unpredicted effects such as low survival and settlement in woodland areas with medium levels of ground vegetation cover. The extensive movement by individuals and unforeseen effects of habitat characteristics make it difficult to predict the outcome of reintroductions, the movement behaviour and habitat selection of reintroduced individuals, particularly when based on current knowledge of a species' ecology. Citation: Bennett VA, Doerr VAJ, Doerr ED, Manning AD, Lindenmayer DB, et al. (2012) Habitat Selection and Post-Release Movement of Reintroduced Brown Treecreeper Individuals in Restored Temperate Woodland. PLoS ONE 7(12): e50612. doi:10.1371/journal.pone. 0050612	[Bennett, Victoria A.; Manning, Adrian D.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Doerr, Veronica A. J.; Doerr, Erik D.] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia; [Doerr, Veronica A. J.; Doerr, Erik D.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Yoon, Hwan-Jin] Australian Natl Univ, Sch Math Sci, Stat Consulting Unit, Canberra, ACT, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Australian National University	Bennett, VA (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	victoria.bennett325@gmail.com	Lindenmayer, David B/P-7183-2017; Doerr, Erik/A-9797-2011; Manning, Adrian/AAG-2949-2019; Doerr, Veronica/A-2150-2011; Manning, Adrian/AAX-7288-2021	Lindenmayer, David B/0000-0002-4766-4088; Doerr, Erik/0000-0003-4511-9972; Doerr, Veronica/0000-0003-4330-4576; Manning, Adrian/0000-0003-0989-9203; Yoon, Hwan-Jin/0000-0003-1772-7911	Birding NSW; Birdlife Australia - Stuart Leslie Bird Research Award; Canberra Ornithologists Group; Canberra Birds Conservation Fund; Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University; Fenner School of Environment and Society at The Australian National University; Foundation for National Parks and Wildlife; Gould League of NSW Centenary Year Cayley Memorial Scholarship; Mulligans Flat-Goorooyarroo Woodland Experiment (ARC Linkage Project) [LP0561817]; Norman Wettenhall Foundation [20108002]; Conservation and Landscape Ecology Group; Mulligans Flat-Goorooyarroo Woodland Experiment; Mulligans Flat Woodland Sanctuary Species Management Panel; Mulligans Flat-Goorooyarroo Research Committee; Hume Livestock Health and Pest Authority	Birding NSW; Birdlife Australia - Stuart Leslie Bird Research Award; Canberra Ornithologists Group; Canberra Birds Conservation Fund; Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University; Fenner School of Environment and Society at The Australian National University; Foundation for National Parks and Wildlife; Gould League of NSW Centenary Year Cayley Memorial Scholarship; Mulligans Flat-Goorooyarroo Woodland Experiment (ARC Linkage Project)(Australian Research Council); Norman Wettenhall Foundation; Conservation and Landscape Ecology Group; Mulligans Flat-Goorooyarroo Woodland Experiment; Mulligans Flat Woodland Sanctuary Species Management Panel; Mulligans Flat-Goorooyarroo Research Committee; Hume Livestock Health and Pest Authority	The project has been made possible by funding from: Birding NSW (www.birdingnsw.org.au), Birdlife Australia - Stuart Leslie Bird Research Award (www.birdlife.org.au), Canberra Ornithologists Group, Canberra Birds Conservation Fund (www.canberrabirds.org.au), The Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University (http://fennerschool-research.anu.edu.au/cle/), The Fenner School of Environment and Society at The Australian National University (http://fennerschool.anu.edu.au/), The Foundation for National Parks and Wildlife (www.fnpw.org.au), Gould League of NSW 2010 Centenary Year Cayley Memorial Scholarship (www.gould.edu.au), The Mulligans Flat-Goorooyarroo Woodland Experiment (ARC Linkage Project LP0561817) (http://www.mfgowoodlandexperiment.org.au/), The Norman Wettenhall Foundation (reference 20108002) (www.nwf.org.au), In-kind contribution was greatly appreciated from CSIRO Ecosystem Sciences (http://www.csiro.au/Organisation-Structure/Divisions/EcosystemSciences.aspx) and The Parks and Conservation Service within the Australian Capital Territory Government Department of Territory and Municipal Services (http://www.tams.act.gov.au/play/pcl). One field assistant was employed (Jenny Newport) using funds from Conservation and Landscape Ecology Group and the Mulligans Flat-Goorooyarroo Woodland Experiment to assist in collecting data obtained through radio-tracking reintroduced brown treecreepers. Otherwise, individuals that were employed or contracted by the funders (other than the named authors) did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the invaluable help and support of the Mulligans Flat Woodland Sanctuary Species Management Panel, the Mulligans Flat-Goorooyarroo Research Committee, Sanctuary rangers Peter Mills and Grant Woodbridge, the Hume Livestock Health and Pest Authority, research assistant Jenny Newport, volunteers and the landowners in Wagga Wagga.	Antos MJ, 2006, EMU, V106, P29, DOI 10.1071/MU05039; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Armstrong DP, 1999, BIOL CONSERV, V89, P329, DOI 10.1016/S0006-3207(99)00012-9; ARMSTRONG DP, 1995, BIOL CONSERV, V71, P281, DOI 10.1016/0006-3207(94)00038-R; Bajomi B, 2010, ORYX, V44, P358, DOI 10.1017/S0030605310000281; Baker MB, 2004, ECOLOGY, V85, P1039, DOI 10.1890/02-0507; Banks PB, 2002, BIOL CONSERV, V103, P133, DOI 10.1016/S0006-3207(01)00110-0; Bennett VA, 2012, EMU, V112, P298, DOI 10.1071/MU11048; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Clarke MF, 1997, BIOL CONSERV, V80, P161, DOI 10.1016/S0006-3207(96)00075-4; Clarke Rohan H., 2003, Pacific Conservation Biology, V8, P223; Cooper CB, 2002, BIOL CONSERV, V105, P1, DOI 10.1016/S0006-3207(01)00172-0; Cooper CB, 2002, CONSERV BIOL, V16, P471, DOI 10.1046/j.1523-1739.2002.00346.x; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Doerr ED, 2005, OECOLOGIA, V142, P1, DOI 10.1007/s00442-004-1707-z; Doerr ED, 2007, J ANIM ECOL, V76, P966, DOI 10.1111/j.1365-2656.2007.01280.x; Doerr ED, 2006, ANIM BEHAV, V72, P147, DOI 10.1016/j.anbehav.2005.10.017; Doerr VAJ, 2006, EMU, V106, P93, DOI 10.1071/MU05020; Doerr VAJ, 2004, ECOLOGY, V85, P1428, DOI 10.1890/03-0015; Doerr VAJ, 2003, ALTERNATIVE DISPERSA; Doerr VAJ, 2011, EMU, V111, P71, DOI 10.1071/MU09118; Enfjall K, 2009, OIKOS, V118, P291, DOI 10.1111/j.1600-0706.2008.16863.x; Ewen JG, 2007, ECOSCIENCE, V14, P401, DOI 10.2980/1195-6860(2007)14[401:SMORIE]2.0.CO;2; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Ford HA, 2011, EMU, V111, P1, DOI 10.1071/MU09115; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Germano JM, 2009, CONSERV BIOL, V23, P7, DOI 10.1111/j.1523-1739.2008.01123.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Haughland DL, 2004, J ANIM ECOL, V73, P1024, DOI 10.1111/j.0021-8790.2004.00884.x; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Heidinger IMM, 2009, BEHAV PROCESS, V82, P12, DOI 10.1016/j.beproc.2009.03.001; Hester JM, 2008, J WILDLIFE MANAGE, V72, P772, DOI 10.2193/2007-049; Higgins P.J., 2001, HDB AUSTR NZ ANTARCT; Ims Rolf A., 2001, P203; IUCN, 1998, IUCN GUID REINTR; Le Gouar P, 2008, ECOL APPL, V18, P859, DOI 10.1890/07-0854.1; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Lin YK, 2006, J MAMMAL, V87, P446, DOI 10.1644/05-MAMM-A-201R1.1; Lindsay EA, 2009, FOREST ECOL MANAG, V258, P178, DOI 10.1016/j.foreco.2009.04.005; Luck GW, 2003, BIOL CONSERV, V109, P1, DOI 10.1016/S0006-3207(02)00085-X; Lurz PWW, 2000, J ZOOL, V251, P167, DOI 10.1111/j.1469-7998.2000.tb00601.x; Manning A.D., 2011, Australian Zoologist, V35, P633; Maron M, 2005, BIOL CONSERV, V124, P439, DOI 10.1016/j.biocon.2005.02.002; Martin CA, 2008, J ANIM ECOL, V77, P326, DOI 10.1111/j.1365-2656.2007.01349.x; McCullagh P, 1989, GEN LINEAR MODELS; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McIntyre S., 2010, Cunninghamia, V11, P319; Meek WR, 2003, BIOL CONSERV, V109, P271, DOI 10.1016/S0006-3207(02)00155-6; Moehrenschlager A, 2003, ANIM CONSERV, V6, P199, DOI 10.1017/S1367943003251; Moorhouse TP, 2009, BIOL CONSERV, V142, P53, DOI 10.1016/j.biocon.2008.09.023; MUSIL DD, 1993, J WILDLIFE MANAGE, V57, P85, DOI 10.2307/3809004; Noske R. A., 1982, AUSTR NATURAL HIST, V20, P419; NOSKE RA, 1991, EMU, V91, P73, DOI 10.1071/MU9910073; NOSKE RA, 1979, EMU, V79, P120, DOI 10.1071/MU9790120; Noske RA, 1982, COMP BEHAV ECOLOGY S; Pinheiro J, 2001, MIXED EFFECTS MODELS; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Remy A, 2011, J ANIM ECOL, V80, P929, DOI 10.1111/j.1365-2656.2011.01849.x; Rittenhouse CD, 2007, J HERPETOL, V41, P115, DOI 10.1670/0022-1511(2007)41[115:MOTART]2.0.CO;2; Sakai HF, 1997, J WILDLIFE MANAGE, V61, P343, DOI 10.2307/3802590; SCANLAN JC, 1990, AUST J ECOL, V15, P191, DOI 10.1111/j.1442-9993.1990.tb01527.x; Schradin C, 2010, ANIM BEHAV, V79, P195, DOI 10.1016/j.anbehav.2009.10.027; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Sheean VA, 2012, AUSTRAL ECOL, V37, P204, DOI 10.1111/j.1442-9993.2011.02264.x; Shorthouse David J., 2012, Ecological Management & Restoration, V13, P112, DOI 10.1111/j.1442-8903.2012.00654.x; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Stamps JA, 2006, ANIM BEHAV, V72, P1279, DOI 10.1016/j.anbehav.2006.03.010; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; Tweed EJ, 2003, BIOL CONSERV, V111, P1, DOI 10.1016/S0006-3207(02)00175-1; van Heezik Y, 2009, ORYX, V43, P639, DOI 10.1017/S0030605309990081; Van Zant JL, 2003, BIOL CONSERV, V112, P405, DOI 10.1016/S0006-3207(02)00338-5; Vandenberghe C, 2009, BASIC APPL ECOL, V10, P662, DOI 10.1016/j.baae.2009.03.009; VEITCH CR, 1995, REINTRODUCTION BIOLOGY OF AUSTRALIAN AND NEW ZEALAND FAUNA, P97; WALKER J, 1986, AUST J ECOL, V11, P135, DOI 10.1111/j.1442-9993.1986.tb01384.x; Walters JR, 1999, BIOL CONSERV, V90, P13, DOI 10.1016/S0006-3207(99)00016-6; Watson DM, 2011, EMU, V111, P10, DOI 10.1071/MU09109; Wiens John A., 2001, P96; Wolf CM, 1998, BIOL CONSERV, V86, P243; Yoder JM, 2004, BEHAV ECOL, V15, P469, DOI 10.1093/beheco/arh037; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x	84	20	20	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50612	10.1371/journal.pone.0050612	http://dx.doi.org/10.1371/journal.pone.0050612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227192	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200052
J	Parlee, SD; McNeil, JO; Muruganandan, S; Sinal, CJ; Goralski, KB				Parlee, Sebastian D.; McNeil, Jenna O.; Muruganandan, Shanmugam; Sinal, Christopher J.; Goralski, Kerry B.			Elastase and Tryptase Govern TNF alpha-Mediated Production of Active Chemerin by Adipocytes	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; CORONARY-ARTERY-DISEASE; NECROSIS-FACTOR-ALPHA; METABOLIC SYNDROME; CATHEPSIN-S; SERINE PROTEASES; DENDRITIC CELLS; INFLAMMATION; EXPRESSION; RECEPTOR	Chemerin is a leukocyte chemoattractant and adipokine with important immune and metabolic roles. Chemerin, secreted in an inactive form prochemerin, undergoes C-terminal proteolytic cleavage to generate active chemerin, a ligand for the chemokine-like receptor-1 (CMKLR1). We previously identified that adipocytes secrete and activate chemerin. Following treatment with the obesity-associated inflammatory mediator TNF alpha, unknown adipocyte mechanisms are altered resulting in an increased ratio of active to total chemerin production. Based on these findings we hypothesized adipocytes produce proteases capable of modifying chemerin and its ability to activate CMKRL1. 3T3-L1 adipocytes expressed mRNA of immunocyte and fibrinolytic proteases known to activate chemerin in vitro. Following treatment with a general protease inhibitor cocktail (PIC), the TNF alpha-stimulated increase in apparent active chemerin concentration in adipocyte media was amplified 10-fold, as measured by CMKLR1 activation. When the components of the PIC were investigated individually, aprotinin, a serine protease inhibitor, blocked 90% of the TNF alpha-associated increase in active chemerin. The serine proteases, elastase and tryptase were elevated in adipocyte media following treatment with TNF alpha and their targeted neutralization recapitulated the aprotinin-mediated effects. In contrast, bestatin, an aminopeptidase inhibitor, further elevated the TNF alpha-associated increase in active chemerin. Our results support that adipocytes regulate chemerin by serine protease-mediated activation pathways and aminopeptidase deactivation pathways. Following TNF alpha treatment, increased elastase and tryptase modify the balance between activation and deactivation, elevating active chemerin concentration in adipocyte media and subsequent CMKLR1 activation.	[McNeil, Jenna O.; Goralski, Kerry B.] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 3J5, Canada; [Parlee, Sebastian D.; Muruganandan, Shanmugam; Sinal, Christopher J.; Goralski, Kerry B.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	Goralski, KB (corresponding author), Dalhousie Univ, Coll Pharm, Halifax, NS B3H 3J5, Canada.	kerry.goralski@dal.ca	Muruganandan, Shanmugam/H-5673-2019	Goralski, Kerry/0000-0003-0040-5879; Shanmugam, Muruganandan/0000-0001-9552-2175; Sinal, Christopher/0000-0001-8301-3349	Canadian Foundation for Innovation; Canadian Institutes of Health Research; Nova Scotia Health Research Foundation; Dalhousie Pharmacy Endowment; Dalhousie Medical Research Foundation	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Dalhousie Pharmacy Endowment; Dalhousie Medical Research Foundation	The research project was funded by grants from the Canadian Foundation for Innovation (to KBG), the Canadian Institutes of Health Research (to KBG and CJS), the Nova Scotia Health Research Foundation (to KBG), the Dalhousie Pharmacy Endowment (to KBG) and the Dalhousie Medical Research Foundation (to KBG). SDP received scholarship support from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Buxbaum E, 2007, FUNDAMENTALS PROTEIN, Vxi; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; CATALAN V, 2011, SURG OBES RELAT DIS; Chakaroun R, 2011, METABOLISM; CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; Du XY, 2009, ACTA BIOCH BIOPH SIN, V41, P973, DOI 10.1093/abbs/gmp091; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; El-Mesallamy HO, 2011, DIABET MED; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479; Gao XY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-87; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Hah YJ, 2011, DIABETES METAB J, V35, P248, DOI 10.4093/dmj.2011.35.3.248; HEYMANN E, 1986, BIOMED BIOCHIM ACTA, V45, P575; Hou WS, 2002, ARTHRITIS RHEUM, V46, P663, DOI 10.1002/art.10114; HUET G, 1993, ARTHRITIS RHEUM-US, V36, P772, DOI 10.1002/art.1780360606; HUI KS, 1983, BIOCHEMISTRY-US, V22, P1062, DOI 10.1021/bi00274a010; Issa ME, 2012, AM J PHYSL CELL PHYS; John H, 2007, ANAL BIOCHEM, V362, P117, DOI 10.1016/j.ab.2006.12.001; KANAYAMA N, 1995, J LEUKOCYTE BIOL, V57, P129, DOI 10.1002/jlb.57.1.129; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Le QT, 2011, J IMMUNOL, V186, P7136, DOI 10.4049/jimmunol.1001804; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Lehr S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010504; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Lemaire R, 1997, BRIT J RHEUMATOL, V36, P735; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Mikhail N, 2011, CURR DRUG SAF, V6, P304, DOI 10.2174/157488611798918700; Mussig K, 2009, METABOLISM, V58, P519, DOI 10.1016/j.metabol.2008.11.011; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Ramirez M, 2008, HEART FAIL REV, V13, P339, DOI 10.1007/s10741-007-9066-6; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Ress C, 2010, EUR J CLIN INVEST, V40, P277, DOI 10.1111/j.1365-2362.2010.02255.x; Seki T, 2001, J CELL PHYSIOL, V189, P72, DOI 10.1002/jcp.1140; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Song SH, 2010, DOMEST ANIM ENDOCRIN, V39, P97, DOI 10.1016/j.domaniend.2010.02.007; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Taggart C, 2000, AM J PHYSIOL-LUNG C, V278, pL33, DOI 10.1152/ajplung.2000.278.1.L33; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; Tan BK, 2009, DIABETES, V58, P1971, DOI 10.2337/db08-1528; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yan Q, 2012, ENDOCRINE, V41, P281, DOI 10.1007/s12020-011-9550-6; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Yoo HJ, 2012, J ATHEROSCLER THROMB, V19, P59, DOI 10.5551/jat.9647; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954; Zollner H., 1993, HDB ENZYME INHIBITOR, P1065	77	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51072	10.1371/journal.pone.0051072	http://dx.doi.org/10.1371/journal.pone.0051072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227233	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200093
J	Ploemen, IHJ; Croes, HJ; van Gemert, GJJ; Wijers-Rouw, M; Hermsen, CC; Sauerwein, RW				Ploemen, Ivo H. J.; Croes, Huib J.; van Gemert, Geert-Jan J.; Wijers-Rouw, Mietske; Hermsen, Cornelus C.; Sauerwein, Robert W.			Plasmodium berghei Delta p52&p36 Parasites Develop Independent of a Parasitophorous Vacuole Membrane in Huh-7 Liver Cells	PLOS ONE			English	Article							VACCINE CANDIDATES; SPOROZOITES; INFECTION; APOPTOSIS; IMMUNITY; STAGE	The proteins P52 and P36 are expressed in the sporozoite stage of the murine malaria parasite Plasmodium berghei. Delta p52&p36 sporozoites lacking expression of both proteins are severely compromised in their capability to develop into liver stage parasites and abort development soon after invasion; presumably due to the absence of a parasitophorous vacuole membrane (PVM). However, a small proportion of P. berghei Delta p52&p36 parasites is capable to fully mature in hepatocytes causing breakthrough blood stage infections. We have studied the maturation of replicating Delta p52&p36 parasites in cultured Huh-7 hepatocytes. Approximately 50% of Delta p52&p36 parasites developed inside the nucleus of the hepatocyte but did not complete maturation and failed to produce merosomes. In contrast cytosolic Delta p52&p36 parasites were able to fully mature and produced infectious merozoites. These Delta p52&p36 parasites developed into mature schizonts in the absence of an apparent parasitophorous vacuole membrane as shown by immunofluorescence and electron microscopy. Merozoites derived from these maturing Delta p52&p36 liver stages were infectious for C57BL/6 mice.	[Ploemen, Ivo H. J.; van Gemert, Geert-Jan J.; Hermsen, Cornelus C.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Croes, Huib J.; Wijers-Rouw, Mietske] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Sauerwein, RW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	R.Sauerwein@mmb.umcn.nl	Croes, Huib JE/G-4012-2016; Wijers-Rouw, Mietske/G-4456-2016; Sauerwein, Robert/C-8519-2013; Hermsen, C.C./L-4368-2015					Annoura T, 2012, VACCINE, V30, P2662, DOI 10.1016/j.vaccine.2012.02.010; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; MEIS JFGM, 1984, CELL BIOL INT REP, V8, P1016, DOI 10.1016/0309-1651(84)90088-2; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Rennenberg A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000825; Silvie O, 2004, TRENDS MOL MED, V10, P97, DOI 10.1016/j.molmed.2004.01.004; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vera IM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002197	14	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50772	10.1371/journal.pone.0050772	http://dx.doi.org/10.1371/journal.pone.0050772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227206	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200065
J	Ribot, RFH; Buchanan, KL; Endler, JA; Joseph, L; Bennett, ATD; Berg, ML				Ribot, Raoul F. H.; Buchanan, Katherine L.; Endler, John A.; Joseph, Leo; Bennett, Andrew T. D.; Berg, Mathew L.			Learned Vocal Variation Is Associated with Abrupt Cryptic Genetic Change in a Parrot Species Complex	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; RETINAL OIL DROPLETS; SEX-BIASED DISPERSAL; POPULATION-STRUCTURE; SONG VARIATION; CONTACT CALL; EVOLUTION; DIALECTS; SPECIATION; BUDGERIGARS	Contact zones between subspecies or closely related species offer valuable insights into speciation processes. A typical feature of such zones is the presence of clinal variation in multiple traits. The nature of these traits and the concordance among clines are expected to influence whether and how quickly speciation will proceed. Learned signals, such as vocalizations in species having vocal learning (e.g. humans, many birds, bats and cetaceans), can exhibit rapid change and may accelerate reproductive isolation between populations. Therefore, particularly strong concordance among clines in learned signals and population genetic structure may be expected, even among continuous populations in the early stages of speciation. However, empirical evidence for this pattern is often limited because differences in vocalisations between populations are driven by habitat differences or have evolved in allopatry. We tested for this pattern in a unique system where we may be able to separate effects of habitat and evolutionary history. We studied geographic variation in the vocalizations of the crimson rosella (Platycercus elegans) parrot species complex. Parrots are well known for their life-long vocal learning and cognitive abilities. We analysed contact calls across a ca 1300 km transect encompassing populations that differed in neutral genetic markers and plumage colour. We found steep clinal changes in two acoustic variables (fundamental frequency and peak frequency position). The positions of the two clines in vocal traits were concordant with a steep cline in microsatellite-based genetic variation, but were discordant with the steep clines in mtDNA, plumage and habitat. Our study provides new evidence that vocal variation, in a species with vocal learning, can coincide with areas of restricted gene flow across geographically continuous populations. Our results suggest that traits that evolve culturally can be strongly associated with reduced gene flow between populations, and therefore may promote speciation, even in the absence of other barriers.	[Ribot, Raoul F. H.; Buchanan, Katherine L.; Endler, John A.; Bennett, Andrew T. D.; Berg, Mathew L.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic 3217, Australia; [Ribot, Raoul F. H.; Bennett, Andrew T. D.; Berg, Mathew L.] Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol, Avon, England; [Joseph, Leo] Commonwealth Sci & Ind Res Org Ecosyst Sci, Australian Natl Wildlife Collect, Canberra, ACT, Australia; [Bennett, Andrew T. D.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	Deakin University; University of Bristol; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide	Berg, ML (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic 3217, Australia.	mathew.berg@deakin.edu.au	Buchanan, Kate/A-8178-2012; Endler, John A/B-6659-2009; Bennett, Andrew T.D. T.D./P-2670-2016	Buchanan, Kate/0000-0002-6648-5819; Endler, John A/0000-0002-7557-7627; Bennett, Andrew T.D. T.D./0000-0001-8512-2805	Biotechnology and Biological Sciences Research Council [B01568]; Leverhulme Fellowship; Lady Emily Smyth Agricultural Research Station; University of Bristol postgraduate scholarship; Deakin University	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Fellowship(Leverhulme Trust); Lady Emily Smyth Agricultural Research Station; University of Bristol postgraduate scholarship; Deakin University	This work was funded by the Biotechnology and Biological Sciences Research Council (grant B01568 to ATDB, KLB and MLB), a Leverhulme Fellowship (ATDB), the Lady Emily Smyth Agricultural Research Station (RFHR and ATDB), a University of Bristol postgraduate scholarship (RFHR), and Deakin University. All work conformed to the laws of Australia and the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C., 2004, MOL MARKERS NATURAL; BAKER MC, 1975, EVOLUTION, V29, P226, DOI 10.1111/j.1558-5646.1975.tb00203.x; BALABAN E, 1988, BEHAVIOUR, V105, P250, DOI 10.1163/156853988X00043; Balsby TJS, 2011, ANIM BEHAV, V81, P983, DOI 10.1016/j.anbehav.2011.01.034; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Barton NH, 1979, HEREDITY, V43, P1; Behr O, 2004, BEHAV ECOL SOCIOBIOL, V56, P106, DOI 10.1007/s00265-004-0768-7; Berg KS, 2012, P ROY SOC B-BIOL SCI, V279, P585, DOI 10.1098/rspb.2011.0932; Berg KS, 2011, ANIM BEHAV, V81, P241, DOI 10.1016/j.anbehav.2010.10.012; Berg ML, 2010, EMU, V110, P10, DOI 10.1071/MU09076; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bradbury JW, 2003, ANIMAL SOCIAL COMPLEXITY, P293; Brumfield RT, 2001, EVOLUTION, V55, P2070; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Coyne JA, 2004, SPECIATION, V37; Derryberry EP, 2009, AM NAT, V174, P24, DOI 10.1086/599298; Eda-Fujiwara H, 2011, ANIM BEHAV, V82, P971, DOI 10.1016/j.anbehav.2011.07.030; Edwards SV, 2005, P NATL ACAD SCI USA, V102, P6550, DOI 10.1073/pnas.0501846102; Endler J.A., 1977, Monographs in Population Biology, pi; Forshaw JM, 2002, AUSTR PARROTS; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Higgins PJ, 1999, HDB AUSTR NZ ANTARTI, V4; Hile AG, 2000, ANIM BEHAV, V59, P1209, DOI 10.1006/anbe.1999.1438; Holland J, 1996, J AVIAN BIOL, V27, P47, DOI 10.2307/3676960; Hunley K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000239; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin DE, 2001, GENETICA, V112, P223, DOI 10.1023/A:1013319217703; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Janik Vincent M., 1999, Symposia of the Zoological Society of London, V72, P308; Joseph L, 2008, P ROY SOC B-BIOL SCI, V275, P2431, DOI 10.1098/rspb.2008.0765; Knott B, 2012, J COMP PHYSIOL A, V198, P43, DOI 10.1007/s00359-011-0684-z; Knott B, 2010, P ROY SOC B-BIOL SCI, V277, P953, DOI 10.1098/rspb.2009.1805; LOUGHEED SC, 1992, EVOLUTION, V46, P1443, DOI 10.1111/j.1558-5646.1992.tb01135.x; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; Marler P., 2004, NATURES MUSIC SCI BI; McCracken KG, 1997, P NATL ACAD SCI USA, V94, P3833, DOI 10.1073/pnas.94.8.3833; Moravec ML, 2006, ETHOLOGY, V112, P1108, DOI 10.1111/j.1439-0310.2006.01267.x; Moravec ML, 2010, ETHOLOGY, V116, P961, DOI 10.1111/j.1439-0310.2010.01809.x; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Nicholls JA, 2006, EVOLUTION, V60, P1279; Patten MA, 2004, EVOLUTION, V58, P2144; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Price T, 2008, SPECIATION BIRDS; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Ribot RFH, 2011, EMU, V111, P360, DOI 10.1071/MU10080; Ribot RFH, 2009, ANIM BEHAV, V77, P581, DOI 10.1016/j.anbehav.2008.10.029; SAUNDERS DA, 1983, AUST WILDLIFE RES, V10, P527, DOI 10.1071/WR9830527; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Soha JA, 2004, BEHAV ECOL, V15, P636, DOI 10.1093/beheco/arh055; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wanker R, 2005, ANIM BEHAV, V70, P111, DOI 10.1016/j.anbehav.2004.09.022; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x; Wright TF, 1996, P ROY SOC B-BIOL SCI, V263, P867, DOI 10.1098/rspb.1996.0128; Wright TF, 2001, P ROY SOC B-BIOL SCI, V268, P609, DOI 10.1098/rspb.2000.1403	60	25	25	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50484	10.1371/journal.pone.0050484	http://dx.doi.org/10.1371/journal.pone.0050484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227179	Green Published, gold			2022-12-25	WOS:000312588200039
J	Roy, S; Javed, S; Jain, SK; Majumdar, SS; Mukhopadhyay, A				Roy, Sushmita; Javed, Saleem; Jain, Swatantra K.; Majumdar, Subeer S.; Mukhopadhyay, Asok			Donor Hematopoietic Stem Cells Confer Long-Term Marrow Reconstitution by Self-Renewal Divisions Exceeding to That of Host Cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BONE-MARROW; PROGENITOR CELLS; DNA-REPLICATION; RICH SOURCE; CYCLIN-A; EX-VIVO; PROLIFERATION; MICE; ENGRAFTMENT	Dormant hematopoietic stem cells (HSCs) are activated by microenvironmental cues of the niche in response to the injury of bone marrow (BM). It is not clearly understood how engrafted cells respond to these cues and are involved in marrow regeneration. The purpose of this study was to decipher this cellular response in competitive environment. BM cells of CD45.2 mice were transplanted in sub-lethally irradiated CD45.1 mice. The status of the donor and recipient stem cells (LSK: Lin(-)Sca-1(+)c-Kit(+)) were determined by flowcytometry using CD45 alleles specific antibodies. The presence of long-term engraftable stem cells was confirmed by marrow repopulation assay in secondary hosts, and cell cycle status was determined by staining with Ho33342 and pyronin Y, and BrdU retention assay. The expressions of different hematopoietic growth factor genes in stromal compartment (CD45(-) cells) were assessed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). The presence of donor cells initially stimulated the proliferation of host LSK cells compared with control mice without transplantation. This was expected due to pro-mitotic and anti-apoptotic factors secreted by the donor hematopoietic cells. Upon transplantation, a majority of the donor LSK cells entered into cell cycle, and later they maintained cell cycle status similar to that in the normal mouse. Donor-derived LSK cells showed 1000-fold expansion within 15 days of transplantation. Donor-derived cells not only regenerated BM in the primary irradiated host for long-term, they were also found to be significantly involved in marrow regeneration after the second cycle of irradiation. The proliferation of LSK cells was associated with the onset of colossal expression of different hematopoietic growth factor genes in non-hematopoietic cellular compartment. Activation of donor LSK cells was found to be dynamically controlled by BM cellularity. Long-term study showed that a high level of hematopoietic reconstitution could be possible by donor cells in a sub-lethally irradiated host.	[Roy, Sushmita; Majumdar, Subeer S.; Mukhopadhyay, Asok] Natl Inst Immunol, New Delhi 110067, India; [Roy, Sushmita; Javed, Saleem] Jamia Hamdard, Dept Biochem, New Delhi, India; [Jain, Swatantra K.] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Hamdard University; Jamia Hamdard University	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	ashok@nii.ac.in	Javed, Saleem/ABA-3845-2020	Majumdar, Subeer/0000-0003-1724-7483	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The last author is thankful to the Director, National Institute of Immunology for providing infrastructural support to conduct this work. A part of the research fund has been provided by Department of Science and Technology, Government of India, for which the last author is indebted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1176, P36; Bodine DM, 1996, BLOOD, V88, P89; BRANDT J, 1992, BLOOD, V79, P634; Chen TC, 2007, EXP HEMATOL, V35, P203, DOI 10.1016/j.exphem.2006.10.002; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Cui JS, 1999, BRIT J HAEMATOL, V107, P895, DOI 10.1046/j.1365-2141.1999.01779.x; DEAN PN, 1984, CELL TISSUE KINET, V17, P427, DOI 10.1111/j.1365-2184.1984.tb00601.x; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Hiraoka A, 2001, Hematol J, V2, P307, DOI 10.1038/sj.thj.6200118; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobayashi M, 1996, BLOOD, V88, P429, DOI 10.1182/blood.V88.2.429.bloodjournal882429; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; LEMOLI RM, 1993, EXP HEMATOL, V21, P1668; Liu LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031300; Madhusudhan T, 2004, STEM CELLS DEV, V13, P173, DOI 10.1089/154732804323046774; Mio H, 1998, BIOCHEM BIOPH RES CO, V249, P124, DOI 10.1006/bbrc.1998.9073; MISHELL BB, 1980, SELECTED METHODS CEL, P3; Moore MAS, 1997, STEM CELLS, V15, P239, DOI 10.1002/stem.5530150832; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Mukhopadhyay A, 2004, ADV BIOCHEM ENG BIOT, V86, P215; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; QUESENBERRY PJ, 1994, BLOOD CELLS, V20, P348; Shah AJ, 1996, BLOOD, V87, P3563, DOI 10.1182/blood.V87.9.3563.bloodjournal8793563; SHAPIRO HM, 1981, CYTOMETRY, V2, P143, DOI 10.1002/cyto.990020302; SHIROTA T, 1992, BLOOD CELLS, V18, P197; Stewart FM, 1998, BLOOD, V91, P3681; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Veiby P, 1996, J IMMUNOL, V157, P2953; WALKER DH, 1991, NATURE, V354, P314, DOI 10.1038/354314a0; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004	42	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50693	10.1371/journal.pone.0050693	http://dx.doi.org/10.1371/journal.pone.0050693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227199	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200058
J	Yokoya, M; Shimizu, H; Higuchi, Y				Yokoya, Masana; Shimizu, Hideyasu; Higuchi, Yukito			Geographical Distribution of Adolescent Body Height with Respect to Effective Day Length in Japan: An Ecological Analysis	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; LUTEINIZING-HORMONE; SEASONAL-VARIATION; HUMAN ILLUMINATION; CIRCADIAN-RHYTHMS; SOLAR-RADIATION; ACTION SPECTRUM; SECULAR TRENDS; MELATONIN; SLEEP	The height of Japanese youth raised in the northern region tends to be greater than that of youth raised in the southern region; therefore, a geographical gradient in youth body height exists. Although this gradient has existed for about 100 years, the reasons for it remain unclear. Consideration of the nutritional improvement, economic growth, and intense migration that has occurred in this period indicates that it is probably the result of environmental rather than nutritional or genetic factors. To identify possible environmental factors, ecological analysis of prefecture-level data on the body size of 8-to 17-year-old youth averaged over a 13-year period (1996 to 2008) and Japanese mesh climatic data on the climatic variables of temperature, solar radiation, and effective day length (duration of photoperiod exceeding the threshold of light intensity) was performed. The geographical distribution of the standardized height of Japanese adolescents was found to be inversely correlated to a great extent with the distribution of effective day length at a light intensity greater than 4000 lx. The results of multiple regression analysis of effective day length, temperature, and weight (as an index of food intake) indicated that a combination of effective day length and weight was statistically significant as predictors of height in early adolescence; however, only effective day length was statistically significant as a predictor of height in late adolescence. Day length may affect height by affecting the secretion of melatonin, a hormone that inhibits sexual and skeletal maturation, which in turn induces increases in height. By affecting melatonin production, regional differences in the duration of the photoperiod may lead to regional differences in height. Exposure to light intensity greater than 4000 lx appears to be the threshold at which light intensity begins to affect the melatonin secretion of humans who spend much of their time indoors. Citation: Yokoya M, Shimizu H, Higuchi Y (2012) Geographical Distribution of Adolescent Body Height with Respect to Effective Day Length in Japan: An Ecological Analysis. PLoS ONE 7(12): e50994. doi:10.1371/journal.pone.0050994	[Yokoya, Masana] Shimonoseki Jr Coll, Shimonoseki, Yamaguchi, Japan; [Shimizu, Hideyasu] Toshiwa Kai Hosp, Naka Ku, Nagoya, Aichi, Japan; [Higuchi, Yukito] Kyushu Kyoritsu Univ, Yahatanishi Ku, Kitakyushu, Fukuoka, Japan		Yokoya, M (corresponding author), Shimonoseki Jr Coll, 1-1 Sakurayama Cho, Shimonoseki, Yamaguchi, Japan.	m.yokoya@shimonoseki-jc.ac.jp		Yokoya, Masana/0000-0002-1122-9500				Agyemang C, 2005, J HYPERTENS, V23, P913, DOI 10.1097/01.hjh.0000166827.94699.f9; Alfonzo-Gonzalez G, 2004, EUR J CLIN NUTR, V58, P1125, DOI 10.1038/sj.ejcn.1601940; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; [Anonymous], TRANSF US GUID REF M; Arble DM, 2010, BEST PRACT RES CL EN, V24, P785, DOI 10.1016/j.beem.2010.08.003; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Baggs JE, 2010, CURR OPIN GENET DEV, V20, P581, DOI 10.1016/j.gde.2010.08.009; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Boivin DB, 1996, NATURE, V379, P540, DOI 10.1038/379540a0; BOJLEN K, 1964, Bibl Laeger, V156, P109; Brainard GC, 2001, J NEUROSCI, V21, P6405; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Case A, 2008, AM ECON REV, V98, P463, DOI 10.1257/aer.98.2.463; Central Intelligence Agency, 2008, CIA WORLD FACT BOOK; Cole RJ, 1995, J BIOL RHYTHM, V10, P324, DOI 10.1177/074873049501000406; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; ENDO A, 1993, AM J PHYS ANTHROPOL, V91, P299, DOI 10.1002/ajpa.1330910305; ESQUIFINO AI, 1987, J STEROID BIOCHEM, V27, P1089; GEIST V, 1987, CAN J ZOOL, V65, P1035, DOI 10.1139/z87-164; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Grivas TB, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-9; Hebert M, 1998, CHRONOBIOL INT, V15, P59; Hermanussen M, 2007, ANTHROPOL ANZ, V65, P275, DOI 10.1127/anthranz/65/2007/275; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; HONMA KI, 1992, AM J PHYSIOL, V262, pR885, DOI 10.1152/ajpregu.1992.262.5.R885; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Japan Meteorological Agency, AMEDAS DAT; Japan Meteorological Agency, 2000, EXPL MESH CLIM DAT 2; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Kouchi M, 1983, B U MUSEUM U TOKYO, V22, P1; Lesgards JF, 2002, ENVIRON HEALTH PERSP, V110, P479, DOI 10.1289/ehp.02110479; LINCOLN GA, 1982, J ENDOCRINOL, V92, P237, DOI 10.1677/joe.0.0920237; MCNAB BK, 1971, ECOLOGY, V52, P845, DOI 10.2307/1936032; Ministry of Education Culture Sports Science and Technology, 2010, SCH HLTH EX SURV REP; Ministry of Health and Welfare, 2006, INF NUTR SURV 2006; Ministry of Health and Welfare, 2011, REP NAT NUTR SURV 20; Ministry of Health and Welfare, 2010, DIET REF INT JAP 201; Ministry of Internal Affairs and Communications, 2010, FIN REP 2005 POP CEN; Nole Gregory, 2004, Dermatol Ther, V17 Suppl 1, P57, DOI 10.1111/j.1396-0296.2004.04S1007.x; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Parker JE, 2002, AM J VET RES, V63, P948, DOI 10.2460/ajvr.2002.63.948; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; Roberts DF, 1953, AM J PHYS ANTHROP-NE, V11, P533, DOI 10.1002/ajpa.1330110404; Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S; Rozman B, 2003, COLLEGIUM ANTROPOL, V27, P285; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; Smith MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006014; Steckel RH, 1995, J ECON LIT, V33, P1903; Steegmann AT, 2007, AM J HUM BIOL, V19, P218, DOI 10.1002/ajhb.20614; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thornthwaite C. W., 1957, DREXEL I TECHNOLOGY, V10, P185, DOI DOI 10.1007/S10584-011-0148-Z; TOUITOU Y, 1981, J ENDOCRINOL, V91, P467, DOI 10.1677/joe.0.0910467; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Van Cauter E, 1998, HORM RES, V49, P147, DOI 10.1159/000023162; Wehr TA, 1997, J BIOL RHYTHM, V12, P518, DOI 10.1177/074873049701200605; Yokoya M., 2010, Japanese Journal of Nutrition and Dietetics, V68, P263, DOI 10.5264/eiyogakuzashi.68.263; Yokoya M, 2011, INT J ENV RES PUB HE, V8, P4272, DOI 10.3390/ijerph8114272; YOUNG IM, 1988, J PINEAL RES, V5, P71, DOI 10.1111/j.1600-079X.1988.tb00770.x; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	64	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50994	10.1371/journal.pone.0050994	http://dx.doi.org/10.1371/journal.pone.0050994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227226	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200087
J	Wang, MH; Zhou, WB; Zhao, YC; Xia, TS; Zha, XM; Ding, Q; Liu, XA; Zhao, Y; Ling, LJ; Chen, L; Wang, S				Wang, Minghai; Zhou, Wenbin; Zhao, Yingchun; Xia, Tiansong; Zha, Xiaoming; Ding, Qiang; Liu, Xiaoan; Zhao, Yi; Ling, Lijun; Chen, Lin; Wang, Shui			A Novel Finding of Sentinel Lymphatic Channels in Early Stage Breast Cancer Patients: Which May Influence Detection Rate and False-Negative Rate of Sentinel Lymph Node Biopsy	PLOS ONE			English	Article							SUBAREOLAR INJECTION; BLUE-DYE; DISSECTION; ANATOMY; TRIAL; MULTICENTER; SURGERY	Background: The exact lymphatic drainage pattern of the breast hasn't been explained clearly. The aim of this study was to investigate the sentinel lymphatic channels (SLCs) in the cancerous breast. Whether the type of SLCs influenced the detection rate and false-negative rate of SLNB was also assessed. Methodology and Principal Findings: Mimic SLNB was performed in 110 early-stage breast cancer patients with subareolar injection of blue methylene dye intraoperatively. Postoperatively, 110 specimens of modified radical mastectomy were examined for all blue SLCs after additional injection of methylene dye in peritumoral parenchyma. Interestingly, three types of SLCs, including superficial sentinel lymphatic channel (SSLC), deep sentinel lymphatic channel (DSLC), and penetrating sentinel lymphatic channel (PSLC) were found in 107 patients. Six lymphatic drainage patterns based on the three types of SLCs were observed in these 107 patients. The proportions of the drainage pattern SSLC, DSLC, PSLC, SSLC+DSLC, SSLC+PSLC, and DSLC+PSLC in the breast were 43%, 0.9%, 15.9%, 33.6%, 3.7% and 2.8%, respectively. The lymphatic drainage pattern in the breast was a significant risk factor for unsuccessful identification of sentinel lymph nodes (P<0.001) and false-negatives in SLNB (P = 0.034) with the subareolar injection technique. Conclusions: Three kinds of SLCs are the basis of six lymphatic drainage patterns from the breast to the axilla. The type of SLCs is the factor influencing the detection rate and false-negative rate of SLNB. These findings suggest the optimal injection technique of the combination of superficial and deep injection in SLNB procedures. Future clinical studies are needed to confirm our novel findings.	[Wang, Minghai; Zhou, Wenbin; Zhao, Yingchun; Xia, Tiansong; Zha, Xiaoming; Ding, Qiang; Liu, Xiaoan; Zhao, Yi; Ling, Lijun; Chen, Lin; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Minghai] Wannan Med Coll, Affiliated Yijishan Hosp 1, Dept Gen Surg, Wuhu, Anhui, Peoples R China	Nanjing Medical University; Wannan Medical College	Wang, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	ws0801@hotmail.com			National Natural Science Foundation of China [81071753, 81172502]; Science and Education for Health Foundation of Jiangsu Province [RC2007054]; Natural Science Foundation of Jiangsu Province [BK2009438, BK2010581, BK2011853, BK2011855]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education for Health Foundation of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by the National Natural Science Foundation of China (81071753 and 81172502), the Science and Education for Health Foundation of Jiangsu Province (RC2007054), the Natural Science Foundation of Jiangsu Province (BK2009438, BK2010581, BK2011853 and BK2011855), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajen MT, 2006, EUR J NUCL MED MOL I, V33, P338, DOI 10.1007/s00259-005-1931-8; Bezu C, 2011, SURG ONCOL, V20, pE55, DOI 10.1016/j.suronc.2010.10.002; Cheng G, 2011, EUR J NUCL MED MOL I, V38, P562, DOI 10.1007/s00259-010-1577-z; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Kaklamanos IG, 2011, J SURG ONCOL, V104, P37, DOI 10.1002/jso.21897; Kargozaran H, 2007, J SURG RES, V143, P126, DOI 10.1016/j.jss.2007.02.054; Kern KA, 1999, J AM COLL SURGEONS, V189, P539, DOI 10.1016/S1072-7515(99)00200-8; Kern KA, 2000, J AM COLL SURGEONS, V191, P479, DOI 10.1016/S1072-7515(00)00720-1; Kern KA, 2001, J AM COLL SURGEONS, V193, P601, DOI 10.1016/S1072-7515(01)01068-7; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Langer I, 2007, ANN SURG, V245, P452, DOI 10.1097/01.sla.0000245472.47748.ec; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Mudun A, 2008, CLIN NUCL MED, V33, P262, DOI 10.1097/RLU.0b013e3181662fc7; Noguchi M, 2009, J SURG ONCOL, V100, P100, DOI 10.1002/jso.21308; Purushotham AD, 2005, EJSO-EUR J SURG ONC, V31, P929, DOI 10.1016/j.ejso.2005.07.008; Sappey MPC, 1874, ANATOMIE PHYSL PATHO; Straver ME, 2010, ANN SURG ONCOL, V17, P1854, DOI 10.1245/s10434-010-0945-z; Suami H, 2008, ANN SURG ONCOL, V15, P863, DOI 10.1245/s10434-007-9709-9; Tanis PJ, 2001, J AM COLL SURGEONS, V192, P399, DOI 10.1016/S1072-7515(00)00776-6; TURNERWARWICK RT, 1959, BRIT J SURG, V46, P574, DOI 10.1002/bjs.18004620004; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Zavagno G, 2008, EJSO-EUR J SURG ONC, V34, P620, DOI 10.1016/j.ejso.2007.07.003; Zavagno G, 2008, ANN SURG, V247, P207, DOI 10.1097/SLA.0b013e31812e6a73	24	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51226	10.1371/journal.pone.0051226	http://dx.doi.org/10.1371/journal.pone.0051226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226569	Green Submitted, Green Published, gold			2022-12-25	WOS:000312108500052
J	Yuji, K; Imoto, S; Yamaguchi, R; Matsumura, T; Murashige, N; Kodama, Y; Minayo, S; Imai, K; Kami, M				Yuji, Koichiro; Imoto, Seiya; Yamaguchi, Rui; Matsumura, Tomoko; Murashige, Naoko; Kodama, Yuko; Minayo, Satoru; Imai, Kohzoh; Kami, Masahiro			Forecasting Japan's Physician Shortage in 2035 as the First Full-Fledged Aged Society	PLOS ONE			English	Article							WORKFORCE; DOCTORS; HOSPITALS; IMPACT	Introduction: Japan is rapidly becoming a full-fledged aged society, and physician shortage is a significant concern. The Japanese government has increased the number of medical school enrollments since 2008, but some researchers warn that this increase could lead to physician surplus in the future. It is unknown how many physicians will be required to accommodate future healthcare needs. Materials and Methods: We simulated changes in age/sex composition of the population, fatalities (the number of fatalities for the consecutive five years), and number of physicians from 2010 to 2035. Two indicators were defined: fatalities per physician and fatalities by physician working hour, based on the data of the working hours of physicians for each tuple of sex and age groups. We estimated the necessary number of physicians in 2035 and the number of new physicians to maintain the indicator levels in 2010. Results: The number of physicians per 1,000 population is predicted to rise from 2.00 in 2010 to 3.14 in 2035. The number of physicians aged 60 years or older is expected to increase from 55,375 (20% of physicians) to 141,711 (36%). In 2010 and 2035, fatalities per physician were 23.1 and 24.0 for the total population, and 13.9 and 19.2 for 75 years or older, respectively. Fatalities per physician working hour are predicted to rise from 0.128 to 0.138. If working hours are limited to 48 hours per week in 2035, the number of fatalities per physician working hour is expected to be 0.196, and the number of new physicians must be increased by 53% over the current pace. Discussion: The number of physicians per population continues to rise, but the estimated supply will not fulfill the demand for healthcare in the aging society. Strategies to increase the number of physicians and improve working conditions are urgently needed. Citation: Yuji K, Imoto S, Yamaguchi R, Matsumura T, Murashige N, et al. (2012) Forecasting Japan's Physician Shortage in 2035 as the First Full-Fledged Aged Society. PLoS ONE 7(11): e50410. doi:10.1371/journal.pone.0050410	[Yuji, Koichiro; Imai, Kohzoh] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Internal Med,Minato Ku, Tokyo, Japan; [Imoto, Seiya; Yamaguchi, Rui; Minayo, Satoru] Univ Tokyo, Lab DNA Informat Anal, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo, Japan; [Imoto, Seiya; Yamaguchi, Rui; Minayo, Satoru] Univ Tokyo, Lab Sequence Anal, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo, Japan; [Matsumura, Tomoko; Murashige, Naoko; Kodama, Yuko; Kami, Masahiro] Univ Tokyo, Div Social Commun Syst Adv Clin Res, Inst Med Sci, Minato Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Yuji, K (corresponding author), Univ Tokyo, Res Hosp, Inst Med Sci, Dept Internal Med,Minato Ku, Tokyo, Japan.	yuji-tky@umin.ac.jp						[Anonymous], 2011, JAPAN TIMES     1128; [Anonymous], 2008, AGENCE FRANCE P 0315; [Anonymous], 2007, JAPAN TIMES     1001; [Anonymous], 2001, CONDITION NEED LONG, P30; [Anonymous], 2008, JAPAN TIMES     0412; [Anonymous], 2009, JAPAN TIMES     0423; [Anonymous], 2006, JAPAN TIMES     0412; Campbell JL, 2004, OXFORD TXB PRIMARY M, P65; Charles J, 2004, MED J AUSTRALIA, V181, P85, DOI 10.5694/j.1326-5377.2004.tb06181.x; Gray S, 2005, BRIT MED J, V331, P696, DOI 10.1136/bmj.331.7518.696; Hiyama T, 2008, OCCUP ENVIRON MED, V65, P428, DOI 10.1136/oem.2007.037473; Horev T, 2004, HEALTH POLICY, V68, P223, DOI 10.1016/j.healthpol.2003.09.011; Izumi M, 2008, IGAKU KYOIKU, V39, pS15; Jackson DB, 2011, NAT REV CLIN ONCOL, V8, P735, DOI 10.1038/nrclinonc.2011.151; Kaneto C, 2009, HEALTH POLICY, V89, P115, DOI 10.1016/j.healthpol.2008.05.010; KOBAYASHI Y, 1992, LANCET, V340, P1391, DOI 10.1016/0140-6736(92)92569-2; Koike S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-180; Koike S, 2009, HEALTH POLICY, V92, P244, DOI 10.1016/j.healthpol.2009.04.005; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Matsumoto K., 2010, J JAPAN SOC HLTH CAR, V10, P575; Matsumoto M, 2010, HEALTH POLICY, V95, P129, DOI 10.1016/j.healthpol.2009.11.012; McMurray Julia E, 2002, J Am Med Womens Assoc (1972), V57, P185; Ministry of Health Labor and Welfare, 2009, VIT STAT JAP; Ministry of Health Labor and Welfare, 2009, ANN REG NUMB TABL GU; Ministry of Health Labour and Welfare Japan, 2008, SURV MED CAR ACT PUB; Moonesinghe SR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1580; Moore W, 2002, BRIT MED J, V324, P754; Nagamatsu S, 2009, CURR OPIN ANESTHESIO, V22, P199, DOI 10.1097/ACO.0b013e328323f7aa; National Institute of Population and Social Security, 2011, POP PROJ JAP 2001 20; Organization for Economic Co-operation and Development, 2010, PRACT PHYS PER 1000; Prunier-Poulmaire S, 2001, J Hum Ergol (Tokyo), V30, P41; Takata H, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-14; The Association of American Medical Colleges, 2012, 2011 STAT PHYS WORKF; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Whitcomb ME, 2010, NEW ENGL J MED, V362, P1255, DOI 10.1056/NEJMp0912179; Working Group on the new post-graduate clinical training system Ministry of Health Labor and Welfare, 2012, REG IMP INTR NEW POS; World Health Organization, 2010, HLTH LIF EXP HALE BI; Yazaki Y, 2006, REPORT STUDY GROUP P	38	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50410	10.1371/journal.pone.0050410	http://dx.doi.org/10.1371/journal.pone.0050410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23233868	Green Published, Green Submitted, gold			2022-12-25	WOS:000312376100090
J	Yang, Q; Jie, Z; Ye, S; Li, Z; Han, Z; Wu, J; Yang, C; Jiang, Y				Yang, Q.; Jie, Z.; Ye, S.; Li, Z.; Han, Z.; Wu, J.; Yang, C.; Jiang, Y.			Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility	ONCOGENE			English	Article						gastric tumorigenesis; microRNA; miR-27a; single-nucleotide polymorphisms	HOX GENES; DROSHA-DGCR8 COMPLEX; MICRORNA NETWORKS; EXPRESSION; RISK; TARGET; CELLS; MIRNA; TRANSFORMATION; TUMORIGENESIS	MicroRNAs (miRNAs) are noncoding RNAs that function as post-transcriptional regulators of tumor oncogenes and suppressors. Single-nucleotide polymorphisms (SNPs) in miRNA genes are a novel class of genetic variations in the human genome that are currently being identified and investigated in human cancers. In this study, we aimed to investigate whether SNPs in the miR-27a gene affect miR-27a expression and alter susceptibility to gastric cancer. Therefore, we conducted a case-control population study and the allele and genotype frequencies for polymorphism rs11671784 in miR-27a gene were examined in the study population. As a result, we found that the G/A polymorphism in the miR-27a gene exhibited a significant effect on gastric cancer risk. Compared with GG homozygotes, subjects who were GA heterozygotes or AA homozygotes exhibited a decreased risk of gastric cancer. The G/A polymorphism impaired the processing of pre-miR-27a to mature miR-27a, resulting in significantly reduced expression of mature miR-27a and an increased level of its target HOXA10. Furthermore, we confirmed these findings in in vitro studies by overexpressing pre-miR-27a carrying G or A allele. It provided further evidence demonstrating that allelic difference of rs11671784 is linked to gastric tumorigenesis. In summary, our results indicate that the G/A polymorphism in miR-27a gene (rs11671784) decreases miR-27a expression, reduces gastric cancer risk and plays a role in gastric tumorigenesis. This is the first study to address the role and function of miR-27a polymorphism rs11671784 in gastric cancer. These results could be useful to assess individual susceptibility of gastric cancer and will improve our understanding of the potential contribution of miRNA SNPs to cancer pathogenesis.	[Yang, Q.; Han, Z.; Wu, J.; Jiang, Y.] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou 510182, Guangdong, Peoples R China; [Jie, Z.; Li, Z.] Nanchang Univ, Dept Gen Surg, Affiliated Hosp 1, Nanchang, Peoples R China; [Ye, S.] Sun Yat Sen Univ, Dept Med Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Yang, C.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Yang, C.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Nanchang University; Sun Yat Sen University; Michigan State University; Michigan State University	Jiang, Y (corresponding author), Guangzhou Med Univ, Inst Chem Carcinogenesis, 195 Dongfeng Rd West, Guangzhou 510182, Guangdong, Peoples R China.	jiangyiguo@yahoo.com		Jiang, Yiguo/0000-0002-9499-2594	National Natural Science Foundation of China [30771780, 30972443, 81102099]; Natural Science Foundation of Guangdong Province [9251018201000004]; University Talent Program of Guangdong [2010-79]; University Talent Program of Guangzhou [10A003D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); University Talent Program of Guangdong; University Talent Program of Guangzhou	We thank Xin Zhou and Wei Li (Department of General Surgery, First Affiliated Hospital of Nanchang University) for collecting the clinicopathologic information utilized in this study. We thank Chengjie Liang (Laboratory Animal Center, Guangzhou Medical University) for assistance with the nude mice assays. This work was supported by the National Natural Science Foundation of China (30771780, 30972443 to YJ and 81102099 to QY), the Natural Science Foundation of Guangdong Province (9251018201000004 to YJ), the University Talent Program of Guangdong (2010-79 to YJ) and the University Talent Program of Guangzhou (10A003D to YJ).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bornschein J, 2011, HELICOBACTER, V16, P45, DOI 10.1111/j.1523-5378.2011.00880.x; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cantile M, 2011, CURR MED CHEM, V18, P4872, DOI 10.2174/092986711797535182; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Catucci I, 2012, BREAST CANCER RES TR, V133, P805, DOI 10.1007/s10549-012-2011-y; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Cillo C, 2011, INT J CANCER, V129, P2577, DOI 10.1002/ijc.25941; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gonzalez CA, 2012, INT J CANCER, V130, P745, DOI 10.1002/ijc.26430; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nunes Fabio Daumas, 2003, Pesqui Odontol Bras, V17, P94; Plowright L, 2009, BRIT J CANCER, V100, P470, DOI 10.1038/sj.bjc.6604857; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Wang Q, 2011, ONCOGENE, V30, P3875, DOI 10.1038/onc.2011.103; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang QY, 2011, CARCINOGENESIS, V32, P713, DOI 10.1093/carcin/bgr035; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhou Y, 2012, J CANCER RES CLIN, V138, P939, DOI 10.1007/s00432-012-1164-8	44	61	63	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					193	202		10.1038/onc.2012.569	http://dx.doi.org/10.1038/onc.2012.569			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23246964				2022-12-25	WOS:000329440700007
J	Luis, AS; Venditto, I; Temple, MJ; Rogowski, A; Basle, A; Xue, J; Knox, JP; Prates, JAM; Ferreira, LMA; Fontes, CMGA; Najmudin, S; Gilbert, HJ				Luis, Ana S.; Venditto, Immacolata; Temple, Max J.; Rogowski, Artur; Basle, Arnaud; Xue, Jie; Knox, J. Paul; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir; Gilbert, Harry J.			Understanding How Noncatalytic Carbohydrate Binding Modules Can Display Specificity for Xyloglucan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-CELL WALLS; CELLULOMONAS-FIMI; LIGAND-BINDING; EUBACTERIUM-CELLULOSOLVENS; CLOSTRIDIUM-THERMOCELLUM; ENDOGLUCANASE CEL5A; RECOGNITION; FAMILY; XYLANASE; DOMAIN	Plant biomass is central to the carbon cycle and to environmentally sustainable industries exemplified by the biofuel sector. Plant cell wall degrading enzymes generally contain noncatalytic carbohydrate binding modules (CBMs) that fulfil a targeting function, which enhances catalysis. CBMs that bind beta-glucan chains often display broad specificity recognizing beta 1,4-glucans (cellulose), beta 1,3-beta 1,4-mixed linked glucans and xyloglucan, a beta 1,4-glucan decorated with beta 1,6-xylose residues, by targeting structures common to the three polysaccharides. Thus, CBMs that recognize xyloglucan target the beta 1,4-glucan backbone and only accommodate the xylose decorations. Here we show that two closely related CBMs, CBM65A and CBM65B, derived from EcCel5A, a Eubacterium cellulosolvens endoglucanase, bind to a range of beta-glucans but, uniquely, display significant preference for xyloglucan. The structures of the two CBMs reveal a beta-sandwich fold. The ligand binding site comprises the beta-sheet that forms the concave surface of the proteins. Binding to the backbone chains of beta-glucans is mediated primarily by five aromatic residues that also make hydrophobic interactions with the xylose side chains of xyloglucan, conferring the distinctive specificity of the CBMs for the decorated polysaccharide. Significantly, and in contrast to other CBMs that recognize beta-glucans, CBM65A utilizes different polar residues to bind cellulose and mixed linked glucans. Thus, Gln(106) is central to cellulose recognition, but is not required for binding to mixed linked glucans. This report reveals the mechanism by which beta-glucan-specific CBMs can distinguish between linear and mixed linked glucans, and show how these CBMs can exploit an extensive hydrophobic platform to target the side chains of decorated beta-glucans.	[Luis, Ana S.; Venditto, Immacolata; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir] Univ Tecn Lisboa, Fac Med Vet, CIISA, P-1300477 Lisbon, Portugal; [Temple, Max J.; Rogowski, Artur; Basle, Arnaud; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE 4HH, Tyne & Wear, England; [Xue, Jie; Knox, J. Paul] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England	Universidade de Lisboa; Newcastle University - UK; University of Leeds	Fontes, CMGA (corresponding author), Univ Tecn Lisboa, Fac Med Vet, CIISA, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.utl.pt; h.j.gilbert@ncl.ac.uk	Luis, Ana/ABE-5158-2020; Prates, José A M/K-9934-2013; Knox, Paul/H-4577-2012	Luis, Ana/0000-0002-5086-7353; Prates, José A M/0000-0003-1032-5987; Knox, Paul/0000-0002-9231-6891; VENDITTO, IMMACOLATA/0000-0003-0392-2871; Ferreira, Luis/0000-0002-3543-9166; Basle, Arnaud/0000-0002-4899-3086; Najmudin, Shabir/0000-0002-0429-5454; Temple, Max/0000-0003-4678-9396; Fontes, Carlos/0000-0002-1219-9753	Biochemical and Biotechnological Research Council [BB/K001949/1]; Wellcome Research Trust [WT097907MA]; Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-PRO/103980/2008, PTDC/BIA-PRO/69732/2006]; European Union Seventh Framework Programme under the WallTraC project [263916]; BBSRC [BB/E015190/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E015190/1, BB/C005074/1] Funding Source: researchfish	Biochemical and Biotechnological Research Council; Wellcome Research Trust(Wellcome Trust); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union Seventh Framework Programme under the WallTraC project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the Biochemical and Biotechnological Research Council (BB/K001949/1), Wellcome Research Trust (WT097907MA), Fundacao para a Ciencia e a Tecnologia (PTDC/BIA-PRO/103980/2008 and PTDC/BIA-PRO/69732/2006), and from the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (Grant Agreement no. 263916). We also acknowledge the Synchrotron Radiation Facilities at SOLEIL (PROXIMA-1) and DIAMOND (beamlines IO2 and IO4).	Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Bolam DN, 2001, BIOCHEMISTRY-US, V40, P2468, DOI 10.1021/bi002564l; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Flint J, 2004, J MOL BIOL, V337, P417, DOI 10.1016/j.jmb.2003.12.081; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Luis AS, 2011, ACTA CRYSTALLOGR F, V67, P491, DOI 10.1107/S1744309111004246; MACKIE RI, 1990, J DAIRY SCI, V73, P2971, DOI 10.3168/jds.S0022-0302(90)78986-2; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Money VA, 2008, ORG BIOMOL CHEM, V6, P851, DOI 10.1039/b719288f; Montanier CY, 2011, J BIOL CHEM, V286, P22499, DOI 10.1074/jbc.M110.217372; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Najmudin S, 2005, ACTA CRYSTALLOGR F, V61, P1043, DOI 10.1107/S1744309105035670; NIEDUSZYNSKI IA, 1972, BIOPOLYMERS, V11, P1335, DOI 10.1002/bip.1972.360110703; Simpson PJ, 1999, STRUCTURE, V7, P853, DOI 10.1016/S0969-2126(99)80108-7; Simpson PJ, 2002, BIOCHEMISTRY-US, V41, P5712, DOI 10.1021/bi012093i; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoda K, 2005, APPL ENVIRON MICROB, V71, P5787, DOI 10.1128/AEM.71.10.5787-5793.2005	44	28	31	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4799	4809		10.1074/jbc.M112.432781	http://dx.doi.org/10.1074/jbc.M112.432781			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23229556	Green Published, hybrid			2022-12-25	WOS:000315340400029
J	Fargue, S; Lewin, J; Rumsby, G; Danpure, CJ				Fargue, Sonia; Lewin, Jackie; Rumsby, Gill; Danpure, Christopher J.			Four of the Most Common Mutations in Primary Hyperoxaluria Type 1 Unmask the Cryptic Mitochondrial Targeting Sequence of Alanine:glyoxylate Aminotransferase Encoded by the Polymorphic Minor Allele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; ENZYME TRAFFICKING DEFECT; ALANINEGLYOXYLATE AMINOTRANSFERASE; SACCHAROMYCES-CEREVISIAE; PEROXISOMAL ALANINE; IMPORT; PHENOTYPE; DIMERIZATION; GENOTYPE; DISEASE	The gene encoding the liver-specific peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT, EC. 2.6.1.44) exists as two common polymorphic variants termed the "major" and "minor" alleles. The P11L amino acid replacement encoded by the minor allele creates a hidden N-terminal mitochondrial targeting sequence, the unmasking of which occurs in the hereditary calcium oxalate kidney stone disease primary hyperoxaluria type 1 (PH1). This unmasking is due to the additional presence of a common disease-specific G170R mutation, which is encoded by about one third of PH1 alleles. The P11L and G170R replacements interact synergistically to reroute AGT to the mitochondria where it cannot fulfill its metabolic role (i.e. glyoxylate detoxification) effectively. In the present study, we have reinvestigated the consequences of the interaction between P11L and G170R in stably transformed CHO cells and have studied for the first time whether a similar synergism exists between P11L and three other mutations that segregate with the minor allele (i.e. I244T, F152I, and G41R). Our investigations show that the latter three mutants are all able to unmask the cryptic P11L-generated mitochondrial targeting sequence and, as a result, all are mistargeted to the mitochondria. However, whereas the G170R, I244T, and F152I mutants are able to form dimers and are catalytically active, the G41R mutant aggregates and is inactive. These studies open up the possibility that all PH1 mutations, which segregate with the minor allele, might also lead to the peroxisome-to-mitochondrion mistargeting of AGT, a suggestion that has important implications for the development of treatment strategies for PH1.	[Danpure, Christopher J.] UCL, Dept Cell & Dev Biol, Div Biosci, London WC1E 6BT, England; [Lewin, Jackie] Royal Free & Univ Coll Med Sch, Electron Microscopy Unit, London NW3 2PF, England; [Rumsby, Gill] Univ Coll London Hosp, Dept Clin Biochem, London W1T 4EU, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Danpure, CJ (corresponding author), UCL, Dept Cell & Dev Biol, Div Biosci, Gower St, London WC1E 6BT, England.	c.danpure@ucl.ac.uk	Fargue, Sonia/J-1706-2019	Fargue, Sonia/0000-0001-7451-7481	Oxalosis and Hyperoxaluria Foundation; Societe Francaise de Nephrologie	Oxalosis and Hyperoxaluria Foundation; Societe Francaise de Nephrologie	This work was supported by grants from the Oxalosis and Hyperoxaluria Foundation (to C. J. D.) and the Societe Francaise de Nephrologie (to S. F.).	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Behnam JI, 2006, BIOCHEM J, V394, P409, DOI 10.1042/BJ20051397; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; Cellini B, 2010, BIOCHIMIE, V92, P1801, DOI 10.1016/j.biochi.2010.08.005; Cellini B, 2010, P NATL ACAD SCI USA, V107, P2896, DOI 10.1073/pnas.0908565107; Cellini B, 2009, J BIOL CHEM, V284, P8349, DOI 10.1074/jbc.M808965200; Coulter-Mackie MB, 2006, MOL GENET METAB, V89, P349, DOI 10.1016/j.ymgme.2006.07.013; Coulter-Mackie MB, 2008, CLIN BIOCHEM, V41, P598, DOI 10.1016/j.clinbiochem.2008.01.018; Coulter-Mackie MB, 2005, PROTEIN EXPRES PURIF, V41, P18, DOI 10.1016/j.pep.2004.11.004; Danpure C. J., 2001, METABOLIC MOL BASES, V2, P3323; Danpure CJ, 2006, BBA-MOL CELL RES, V1763, P1776, DOI 10.1016/j.bbamcr.2006.08.021; DANPURE CJ, 1993, BIOCHIMIE, V75, P309, DOI 10.1016/0300-9084(93)90091-6; DANPURE CJ, 1993, AM J HUM GENET, V53, P417; DANPURE CJ, 1986, FEBS LETT, V201, P20, DOI 10.1016/0014-5793(86)80563-4; DANPURE CJ, 1989, J CELL BIOL, V108, P1345, DOI 10.1083/jcb.108.4.1345; Djordjevic S, 2010, ACTA CRYSTALLOGR F, V66, P233, DOI 10.1107/S1744309109054645; EILERS M, 1988, CELL, V52, P481, DOI 10.1016/0092-8674(88)90458-8; ELGERSMA Y, 1995, EMBO J, V14, P3472, DOI 10.1002/j.1460-2075.1995.tb07353.x; Fan JQ, 2007, FEBS J, V274, P4962, DOI 10.1111/j.1742-4658.2007.06041.x; Harambat J, 2010, KIDNEY INT, V77, P443, DOI 10.1038/ki.2009.435; Hopper ED, 2008, J BIOL CHEM, V283, P30493, DOI 10.1074/jbc.M803525200; Knott TG, 2000, BIOCHEM J, V352, P409, DOI 10.1042/0264-6021:3520409; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Lee JG, 2000, J BIOCHEM-TOKYO, V128, P1059, DOI 10.1093/oxfordjournals.jbchem.a022834; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; Lumb MJ, 1999, J BIOL CHEM, V274, P20587, DOI 10.1074/jbc.274.29.20587; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; Monico CG, 2005, AM J NEPHROL, V25, P183, DOI 10.1159/000085411; Montioli R, 2012, INT J BIOCHEM CELL B, V44, P536, DOI 10.1016/j.biocel.2011.12.007; MOTLEY A, 1995, J CELL BIOL, V131, P95, DOI 10.1083/jcb.131.1.95; Oatey PB, 1996, EUR J BIOCHEM, V241, P374, DOI 10.1111/j.1432-1033.1996.00374.x; Obita T, 2003, J MOL BIOL, V328, P495, DOI 10.1016/S0022-2836(03)00288-2; Petrova VY, 2004, BIOCHEM J, V380, P393, DOI 10.1042/BJ20040042; PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900; PURDUE PE, 1992, GENOMICS, V13, P215, DOI 10.1016/0888-7543(92)90225-H; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; Rumsby G, 1997, ANN CLIN BIOCHEM, V34, P400, DOI 10.1177/000456329703400411; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Siekierska A, 2012, J BIOL CHEM, V287, P28386, DOI 10.1074/jbc.M112.351056; Strobel G, 2002, MOL BIOL CELL, V13, P1439, DOI 10.1091/mbc.01-08-0396; Tarn AC, 1997, J INHERIT METAB DIS, V20, P689, DOI 10.1023/A:1005326510239; van Woerden CS, 2004, KIDNEY INT, V66, P746, DOI 10.1111/j.1523-1755.2004.00796.x; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Williams E, 2007, CLIN CHEM, V53, P1216, DOI 10.1373/clinchem.2006.084434; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	50	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2475	2484		10.1074/jbc.M112.432617	http://dx.doi.org/10.1074/jbc.M112.432617			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23229545	Green Published, hybrid			2022-12-25	WOS:000314211500034
J	Baumstarck, K; Reuter, F; Boucekine, M; Aghababian, V; Klemina, I; Loundou, A; Pelletier, J; Auquier, P				Baumstarck, Karine; Reuter, Francoise; Boucekine, Mohamed; Aghababian, Valerie; Klemina, Irina; Loundou, Anderson; Pelletier, Jean; Auquier, Pascal			Relevance of Quality of Life Assessment for Multiple Sclerosis Patients with Memory Impairment	PLOS ONE			English	Article							NOTTINGHAM HEALTH PROFILE; COGNITIVE IMPAIRMENT; VALIDITY; RELIABILITY; VALIDATION; ACQUISITION; DEMENTIA; STORAGE	Background: Memory disturbances, in particular episodic verbal memory dysfunction, are the most frequent cognitive impairment observed in multiple sclerosis (MS) patients. The use of self-reported outcomes for evaluating treatment and managing care of these subjects has been questioned. The aim of this study was to provide new evidence about the suitability of self-reported outcomes for use in this impaired population by exploring the internal structure, reliability and external validity of a specific quality of life (QoL) instrument, the Multiple Sclerosis International Quality of Life questionnaire (MusiQoL). Methods: Design: cross-sectional study. Inclusion criteria: MS patients of any disease subtype. Data collection: sociodemographic (age, gender, marital status, education level, and occupational activity) and clinical data (MS subtype, Expanded Disability Status Scale, disease duration); QoL (MusiQoL and SF36); and memory performance (Grober and Buschke test). In accordance with the French norms of the memory test, non-impaired and impaired populations were defined for short- and long-delay free composites and for short- and long-delay total composites. For the 8 populations, psychometric properties were compared to those reported from the reference population assessed in the validation study. Principal Findings: One hundred and twenty-four consecutive patients were enrolled. The analysis performed in the impaired populations showed that the questionnaire structure adequately matched the initial structure of the MusiQoL. The unidimensionality of the dimensions was preserved, and the internal/external validity indices were close to those of the reference population. Conclusions/Significance: Our study suggests that memory dysfunction did not compromise the reliability or validity of the self-reported QoL questionnaires. Citation: Baumstarck K, Reuter F, Boucekine M, Aghababian V, Klemina I, et al. (2012) Relevance of Quality of Life Assessment for Multiple Sclerosis Patients with Memory Impairment. PLoS ONE 7(12): e50056. doi:10.1371/journal.pone.0050056	[Baumstarck, Karine; Boucekine, Mohamed; Loundou, Anderson; Auquier, Pascal] Timone Univ, APHM, Self Perceived Hlth Assessment Res Unit EA3279, Dept Publ Hlth, Marseille, France; [Reuter, Francoise; Klemina, Irina; Pelletier, Jean] Timone Univ Hosp, APHM, Dept Neurol, Marseille, France; [Reuter, Francoise; Klemina, Irina; Pelletier, Jean] Timone Univ Hosp, APHM, CRMBM CNRS6612, Marseille, France; [Aghababian, Valerie] Aix Marseille Univ, Dept Psychol, Psychol Cognit Language & Emot Res Ctr EA 3273, Aix En Provence, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Baumstarck, K (corresponding author), Timone Univ, APHM, Self Perceived Hlth Assessment Res Unit EA3279, Dept Publ Hlth, Marseille, France.	karine.baumstarck@univmed.fr		Baumstarck, Karine/0000-0003-3602-6766	French Programme Hospitalier Recherche Clinique; French Institut de Recherche en Sante Publique (CUD-QV, Concepts, Usages et Determinants en Qualite de Vie); Assistance Publique, Hopitaux de Marseille (Marseille, France)	French Programme Hospitalier Recherche Clinique; French Institut de Recherche en Sante Publique (CUD-QV, Concepts, Usages et Determinants en Qualite de Vie); Assistance Publique, Hopitaux de Marseille (Marseille, France)	This work was supported by institutional grants from the French 2004 Programme Hospitalier Recherche Clinique and the French 2009 Institut de Recherche en Sante Publique (CUD-QV, Concepts, Usages et Determinants en Qualite de Vie). The sponsor was represented by Assistance Publique, Hopitaux de Marseille (Marseille, France). The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2004, J NEUROL, V251, P1472, DOI 10.1007/s00415-004-0567-0; Auquier P, 2003, SCHIZOPHR RES, V63, P137, DOI 10.1016/S0920-9964(02)00355-9; Baro E, 2006, QUAL LIFE RES, V15, P575, DOI 10.1007/s11136-005-3691-0; Baumstarck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030627; Baumstarck-Barrau K, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-17; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2004, MULT SCLER J, V10, P675, DOI 10.1191/1352458504ms1098oa; Benito-Leon J, 2002, EUR J NEUROL, V9, P497, DOI 10.1046/j.1468-1331.2002.00450.x; Bureau-Chalot F, 2002, GERONTOLOGY, V48, P220, DOI 10.1159/000058354; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; FEINSTEIN A, 1992, J NEUROL NEUROSUR PS, V55, P869, DOI 10.1136/jnnp.55.10.869; Feuillet L, 2007, MULT SCLER, V13, P124, DOI 10.1177/1352458506071196; Gold SM, 2003, MULT SCLER J, V9, P404, DOI 10.1191/1352458503ms927oa; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; GRAFMAN J, 1991, ARCH NEUROL-CHICAGO, V48, P1072, DOI 10.1001/archneur.1991.00530220094025; GRANT I, 1984, J NEUROL NEUROSUR PS, V47, P250, DOI 10.1136/jnnp.47.3.250; Hoe J, 2005, AGE AGEING, V34, P130, DOI 10.1093/ageing/afi030; Juniper E.F., 1996, QUAL LIFE PHARAMACOE, P49; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Marrie RA, 2007, MULT SCLER J, V13, P1176, DOI 10.1177/1352458507078388; Marrie RA, 2003, MULT SCLER, V9, P621, DOI 10.1191/1352458503ms971oa; Nishiyama T, 2010, QUAL LIFE RES, V19, P25, DOI 10.1007/s11136-009-9556-1; Nunnaly JC, 1994, PSYCHOMETRIC THEORY; Orley J, 1998, BRIT J PSYCHIAT, V172, P291, DOI 10.1192/bjp.172.4.291; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Polman CH, 2005, MULT SCLER, V11, P5, DOI 10.1191/1352458505ms1135oa; RAO SM, 1995, CURR OPIN NEUROL, V8, P216, DOI 10.1097/00019052-199506000-00010; Rectem D, 2004, EVALUATION TROUBLES; Riemsma R P, 2001, Health Technol Assess, V5, P1; Simeoni MC, 2008, MULT SCLER J, V14, P219, DOI 10.1177/1352458507080733; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Ware J. E., 1997, MAP R WINDOWS MULTIT; Wong JGWS, 2005, QUAL LIFE RES, V14, P687, DOI 10.1007/s11136-004-1215-y; Wright BD, 1979, BEST TEST DESIGN RAS	41	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50056	10.1371/journal.pone.0050056	http://dx.doi.org/10.1371/journal.pone.0050056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23239975	Green Published, gold			2022-12-25	WOS:000312290800013
J	Giesecke, T; Wolters, S; Jahns, S; Brande, A				Giesecke, Thomas; Wolters, Steffen; Jahns, Susanne; Brande, Arthur			Exploring Holocene Changes in Palynological Richness in Northern Europe - Did Postglacial Immigration Matter?	PLOS ONE			English	Article							LATE-QUATERNARY VEGETATION; CLIMATE-CHANGE; PLANT DIVERSITY; FOSSIL POLLEN; DISPERSAL; TIME; DYNAMICS; HISTORY; FOREST; RANGE	In mid to high latitudes glacial and interglacial cycles have repeatedly changed the area available for plant growth. The speed at which plants are able to colonize areas at the onset of an interglacial is hypothesized to limit their distribution ranges even today (migrational lag). If the spread of plants would have been generally slow then plant diversity in previously glaciated areas would be expected to increase over time. We explore this hypothesis using results from six palynological investigations from two previously glaciated regions: central Sweden and north-eastern Germany. Rarefaction, slope of rank order abundance, and taxa accumulation plots were used to evaluate richness and evenness in pollen data in an attempt to separate richness from evenness. These analyses show little change in palynological richness for the northern sites throughout the Holocene. In contrast, the southern sites show an increase in richness and evenness during the early Holocene; this may be explained by the different initial conditions at the onset of the Holocene. A strong rise in palynological richness around 6000 and 1000 years ago at the southern sites can be attributed to the regional initiation of agriculture and major opening of the forest, respectively. For the northern sites there is no evidence for increased taxonomic diversity through time that could be due to delayed immigration of species.	[Giesecke, Thomas] Univ Gottingen, Dept Palynol & Climate Dynam, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Wolters, Steffen] Lower Saxony Inst Hist Coastal Res, Wilhelmshaven, Germany; [Jahns, Susanne] Brandenburg Dept Cultural Heritage, Zossen, Germany; [Jahns, Susanne] Archaeol State Museum, Zossen, Germany; [Brande, Arthur] Tech Univ Berlin, Dept Ecol, Berlin, Germany	University of Gottingen; Technical University of Berlin	Giesecke, T (corresponding author), Univ Gottingen, Dept Palynol & Climate Dynam, Albrecht von Haller Inst Plant Sci, Gottingen, Germany.	thomas.giesecke@biologie.uni-goettingen.de	Giesecke, Thomas/A-2450-2013; Giesecke, Thomas/N-6395-2019	Giesecke, Thomas/0000-0002-5132-1061; Giesecke, Thomas/0000-0002-5132-1061; Wolters, Steffen/0000-0003-3727-1982	German Research Foundation (DFG) [GI 732/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the the German Research Foundation (DFG), project GI 732/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2003, ECOL LETT, V6, P749, DOI 10.1046/j.1461-0248.2003.00497.x; [Anonymous], PALAEOECOLOGICAL EVE; Berglund BE, 2008, QUATERN INT, V184, P187, DOI 10.1016/j.quaint.2007.09.018; Beug H.-J., 2004, LEITFADEN POLLENBEST; Birks HJB, 2008, HOLOCENE, V18, P19, DOI 10.1177/0959683607085572; Birks HJB, 1992, HOLOCENE, V2, P1, DOI 10.1177/095968369200200101; Birks H.J.B., 1973, PRESENT VEGETATION I; BIRKS HJB, 1988, CULTURAL LANDSCAPE P, P229; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Davis M., 1976, GEOSCIENCE MAN, V13, P13; DAVIS MB, 1986, VEGETATIO, V67, P93, DOI 10.1007/BF00037360; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Firbas F., 1949, SPAT NACHEISZEITLICH; Giesecke T, 2005, HOLOCENE, V15, P858, DOI 10.1191/0959683605hl859ra; Giesecke T, 2005, VEG HIST ARCHAEOBOT, V14, P133, DOI 10.1007/s00334-005-0070-2; Giesecke T, 2007, J BIOGEOGR, V34, P118, DOI 10.1111/j.1365-2699.2006.01580.x; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; HUNTLEY B, 1993, J BIOGEOGR, V20, P163, DOI 10.2307/2845669; Huntley B., 1983, ATLAS PRESENT POLLEN; Iversen J., 1973, Danmarks geol Unders (Raekke 5), VNo. 7C, P1; Jahns S, 2000, VEG HIST ARCHAEOBOT, V9, P111, DOI 10.1007/BF01300061; Jaramillo C, 2010, SCIENCE, V330, P957, DOI 10.1126/science.1193833; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lisitsyna OV, 2011, REV PALAEOBOT PALYNO, V166, P311, DOI 10.1016/j.revpalbo.2011.06.004; McKinney ML, 1999, EVOL ECOL RES, V1, P641; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Nielsen AB, 2012, QUATERNARY SCI REV, V47, P131, DOI 10.1016/j.quascirev.2012.05.011; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Odgaard B.V, 1994, OPERA BOT, V123, P3; Odgaard B.V, 2008, TERRA NOSTRA, V2, P209; Odgaard Bent Vad, 2001, Diversity and Distributions, V7, P197, DOI 10.1111/j.1472-4642.2001.00110.x; Odgaard BV, 1999, J BIOGEOGR, V26, P7, DOI 10.1046/j.1365-2699.1999.00280.x; Oksanen J., 2016, R PACKAG; Peros MC, 2008, J PALEOLIMNOL, V40, P357, DOI 10.1007/s10933-007-9166-2; Poska A, 2002, VEG HIST ARCHAEOBOT, V11, P191, DOI 10.1007/s003340200022; PRENTICE IC, 1991, ECOLOGY, V72, P2038, DOI 10.2307/1941558; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; R Development Core Team, 2012, R LANG ENV STAT COMP; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rull V, 1987, POLLEN SPORES, V29, P471; Seppa H, 1998, HOLOCENE, V8, P43, DOI 10.1191/095968398674096317; Seppa H, 2009, J ECOL, V97, P629, DOI 10.1111/j.1365-2745.2009.01505.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; SOBERON J, 1993, CONSERV BIOL, V7, P480, DOI 10.1046/j.1523-1739.1993.07030480.x; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2008, ECOGRAPHY, V31, P316, DOI 10.1111/j.0906-7590.2008.05206.x; Theuerkauf M, 2012, BOREAS, V41, P391, DOI 10.1111/j.1502-3885.2011.00240.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; van der Knaap WO, 2009, HOLOCENE, V19, P159, DOI 10.1177/0959683608098962; WEBB T, 1986, VEGETATIO, V67, P75, DOI 10.1007/BF00037359; Weng CY, 2006, DIVERS DISTRIB, V12, P310, DOI 10.1111/j.1366-9516.2006.00230.x; White EP, 2006, OIKOS, V112, P185; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Williams JW, 2001, ECOLOGY, V82, P3346; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wolters S., 2002, DISSERTATIONES BOT, V366, P1; Zerbe S, 2003, PHYTOCOENOLOGIA, V33, P683, DOI 10.1127/0340-269X/2003/0033-0683	64	40	43	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51624	10.1371/journal.pone.0051624	http://dx.doi.org/10.1371/journal.pone.0051624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240048	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800084
J	Lopez-Alvarez, D; Lopez-Herranz, ML; Betekhtin, A; Catalan, P				Lopez-Alvarez, Diana; Luisa Lopez-Herranz, Maria; Betekhtin, Alexander; Catalan, Pilar			A DNA Barcoding Method to Discriminate between the Model Plant Brachypodium distachyon and Its Close Relatives B. stacei and B. hybridum (Poaceae)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; GENETIC DIVERSITY; GRASS; MARKERS; IDENTIFICATION; PHYLOGENETICS; EVOLUTIONARY; POPULATIONS; GENOMES	Background: Brachypodium distachyon s. l. has been widely investigated across the world as a model plant for temperate cereals and biofuel grasses. However, this annual plant shows three cytotypes that have been recently recognized as three independent species, the diploids B. distachyon (2n = 10) and B. stacei (2n = 20) and their derived allotetraploid B. hybridum (2n = 30). Methodology/Principal Findings: We propose a DNA barcoding approach that consists of a rapid, accurate and automatable species identification method using the standard DNA sequences of complementary plastid (trnLF) and nuclear (ITS, GI) loci. The highly homogenous but largely divergent B. distachyon and B. stacei diploids could be easily distinguished (100% identification success) using direct trnLF (2.4%), ITS (5.5%) or GI (3.8%) sequence divergence. By contrast, B. hybridum could only be unambiguously identified through the use of combined trnLF+ITS sequences (90% of identification success) or by cloned GI sequences (96.7%) that showed 5.4% (ITS) and 4% (GI) rate divergence between the two parental sequences found in the allopolyploid. Conclusion/Significance: Our data provide an unbiased and effective barcode to differentiate these three closely-related species from one another. This procedure overcomes the taxonomic uncertainty generated from methods based on morphology or flow cytometry identifications that have resulted in some misclassifications of the model plant and its allies. Our study also demonstrates that the allotetraploid B. hybridum has resulted from bi-directional crosses of B. distachyon and B. stacei plants acting either as maternal or paternal parents. Citation: Lopez-Alvarez D, Lopez-Herranz ML, Betekhtin A, Catalan P (2012) A DNA Barcoding Method to Discriminate between the Model Plant Brachypodium distachyon and Its Close Relatives B. stacei and B. hybridum (Poaceae). PLoS ONE 7(12): e51058. doi:10.1371/journal.pone.0051058	[Lopez-Alvarez, Diana; Luisa Lopez-Herranz, Maria; Betekhtin, Alexander; Catalan, Pilar] Univ Zaragoza, Dept Agr & Environm Sci, Huesca, Spain; [Betekhtin, Alexander] Univ Silesia, Dept Plant Anat & Cytol, Katowice, Poland	University of Zaragoza; University of Silesia in Katowice	Catalan, P (corresponding author), Univ Zaragoza, Dept Agr & Environm Sci, Huesca, Spain.	pcatalan@unizar.es	López-Alvarez, Diana Carolina/AAW-5358-2021; Catalan, Pilar/AAL-8833-2020; Catalan, Pilar/N-7641-2014; Betekhtin, Alexander/O-4619-2018	López-Alvarez, Diana Carolina/0000-0002-7734-8481; Betekhtin, Alexander/0000-0001-6146-1669; Catalan Rodriguez, Maria Pilar/0000-0001-7793-5259	Spanish Ministry of Science and Innovation grant [CGL2009-12955-C02-01]; Bioflora research grant; Spanish Aragon government; European Social Fund; Spanish Ministry of Science and Innovation PhD FPI grant; European Erasmus; UPGOW project	Spanish Ministry of Science and Innovation grant(Spanish Government); Bioflora research grant; Spanish Aragon government(Gobierno de Aragon); European Social Fund(European Social Fund (ESF)); Spanish Ministry of Science and Innovation PhD FPI grant; European Erasmus; UPGOW project	This work was financed by the Spanish Ministry of Science and Innovation grant project CGL2009-12955-C02-01 and partially supported by the Bioflora research grant co-funded by the Spanish Aragon government and the European Social Fund. DL-A was funded by a Spanish Ministry of Science and Innovation PhD FPI grant. AB was funded by a European Erasmus visiting stay grant at the University of Zaragoza and by the UPGOW project co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Casiraghi M, 2011, BIOINFORM, V4, P440; Catalan P, 2000, PLANT SYST EVOL, V220, P1, DOI 10.1007/BF00985367; Catalan P, 2012, ANN BOT-LONDON, V109, P385, DOI 10.1093/aob/mcr294; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dentinger BTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025081; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Ennos RA, 2005, TRENDS ECOL EVOL, V20, P164, DOI 10.1016/j.tree.2005.01.012; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Filiz E, 2009, GENOME, V52, P876, DOI [10.1139/g09-062, 10.1139/G09-062]; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Giraldo P, 2012, GENOME, V55, P523, DOI [10.1139/g2012-039, 10.1139/G2012-039]; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Griffin PC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-19; Hammami R, 2011, PLANT SYST EVOL, V297, P99, DOI 10.1007/s00606-011-0502-7; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hasterok R, 2004, CHROMOSOME RES, V12, P397, DOI 10.1023/B:CHRO.0000034130.35983.99; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hong SY, 2010, PLANT MOL BIOL, V72, P485, DOI 10.1007/s11103-009-9586-7; HSIAO C, 1995, GENOME, V38, P211, DOI 10.1139/g95-026; Idziak D, 2008, GENOME, V51, P387, DOI 10.1139/G08-017; Idziak D, 2011, CHROMOSOMA, V120, P469, DOI 10.1007/s00412-011-0326-9; Jenkins G, 2003, BUILDING MOL INFRAST; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Madisson WP, 2000, ANAL PHYLOGENY CHARA; Manzaneda AJ, 2012, NEW PHYTOL, V193, P797, DOI 10.1111/j.1469-8137.2011.03988.x; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Paun O, 2009, NEW PHYTOL, V182, P507, DOI 10.1111/j.1469-8137.2009.02767.x; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; ROBERTSON IH, 1981, GENETICA, V56, P55, DOI 10.1007/BF00126930; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Steele PR, 2011, AM J BOT, V98, P415, DOI 10.3732/ajb.1000296; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vain P, 2011, J CEREAL SCI, V54, P1, DOI 10.1016/j.jcs.2011.04.002; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vanhaecke D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032939; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Wang Q, 2011, J SYST EVOL, V49, P182, DOI 10.1111/j.1759-6831.2011.00135.x; Wolny E, 2011, CHROMOSOMA, V120, P199, DOI 10.1007/s00412-010-0303-8; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455	62	47	50	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51058	10.1371/journal.pone.0051058	http://dx.doi.org/10.1371/journal.pone.0051058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240000	Green Submitted, gold, Green Published			2022-12-25	WOS:000312290800036
J	Penas-Steinhardt, A; Barcos, LS; Belforte, FS; de Sereday, M; Vilarino, J; Gonzalez, CD; Martinez-Larrad, MT; Tellechea, ML; Serrano-Rios, M; Poskus, E; Frechtel, GD; Leskow, FC				Penas-Steinhardt, Alberto; Soledad Barcos, Lucia; Sabrina Belforte, Fiorella; de Sereday, Martha; Vilarino, Jorge; Daniel Gonzalez, Claudio; Teresa Martinez-Larrad, Maria; Lorena Tellechea, Mariana; Serrano-Rios, Manuel; Poskus, Edgardo; Daniel Frechtel, Gustavo; Coluccio Leskow, Federico			Functional Characterization of TLR4+3725 G/C Polymorphism and Association with Protection against Overweight	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; SYSTEMIC INFLAMMATION; METABOLIC SYNDROME; DIABETES-MELLITUS; OBESITY; TOLL-LIKE-RECEPTOR-4; SMOKING; POPULATION; ACTIVATION	Subclinical low-grade systemic inflammation has been associated with obesity, insulin resistance and metabolic syndrome (MS). Recent studies have highlighted the role of gut microbiota in these disorders. The toll-like receptor 4 (TLR4) plays a key role in the innate immune response activation. We studied two polymorphisms (+3725G/C and 11350G/C) in the 3' untranslated region (3'UTR) of the TLR4 gene that may alter its expression and their association with metabolic disorders related to systemic inflammation. We cloned the 3'UTR into a luciferase reporter system and compared wild-type 3'UTR (WT) and +3725C variant (MUT) constructs luciferase activities. MUT construct reduced the reporter gene activity by 30% compared to WT (P = 0.0001). To evaluate the association between these polymorphisms with biochemical and clinical overweight related variables, we conducted a population cross-sectional study in 966 men of Argentine general population. Considering smoking as a confounding variable that causes systemic inflammation, we studied these possible effects in both, smokers and nonsmokers. The 11350G/C polymorphism was not detected in our sample whereas the CC genotype of +3725 polymorphism was associated with lean subjects (p = 0.011) and higher Adiponectin levels (p = 0.021). Subjects without any NCEP/ATP III MS component were associated with this genotype as well (p = 0.001). These results were strengthened in nonsmokers, in which CC genotype was associated with lean subjects (p = 0.003) and compared with G carriers showed significantly lower BMI (25.53 vs. 28.60 kg/m2; p = 0.023) and waist circumference (89.27 vs. 97.51 cm; p = 0.025). None of these associations were found in smokers. These results showed that +3725C variant has a functional effect down-regulating gene expression and it could be considered as a predictive factor against overweight, particularly in nonsmokers. Considering the role of TLR4 in inflammation, these findings would suggest that the presence of +3725C variant could predict a lower prevalence of chronic metabolic disorders.	[Penas-Steinhardt, Alberto; Lorena Tellechea, Mariana; Poskus, Edgardo] Univ Buenos Aires, CONICET, Inst Estudios Inmunidad Humoral IDEHU, Buenos Aires, DF, Argentina; [Penas-Steinhardt, Alberto; Lorena Tellechea, Mariana; Poskus, Edgardo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina; [Penas-Steinhardt, Alberto] Univ Buenos Aires, Hosp Clin, Div Endocrinol, Buenos Aires, DF, Argentina; [Soledad Barcos, Lucia; Coluccio Leskow, Federico] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Dept Quim Biol,IQUIBICEN, Buenos Aires, DF, Argentina; [Soledad Barcos, Lucia; Coluccio Leskow, Federico] Univ Nacl Lujan, Dept Ciencias Basicas, Buenos Aires, DF, Argentina; [Sabrina Belforte, Fiorella] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Genet & Biol Mol, Mol Biol Lab, RA-1113 Buenos Aires, DF, Argentina; [de Sereday, Martha] Hosp Fiorito, Serv Endocrinol, Buenos Aires, DF, Argentina; [Vilarino, Jorge] Inst FLENI, Cardiol Clin, Buenos Aires, DF, Argentina; [Daniel Gonzalez, Claudio] Univ Buenos Aires, Fac Med, Dept Farmacol, Buenos Aires, DF, Argentina; [Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Daniel Frechtel, Gustavo] Univ Buenos Aires, Hosp Clin, Div Genet, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Nacional de Lujan; University of Buenos Aires; University of Buenos Aires; Hospital Clinico San Carlos; University of Buenos Aires	Penas-Steinhardt, A (corresponding author), Univ Buenos Aires, CONICET, Inst Estudios Inmunidad Humoral IDEHU, Buenos Aires, DF, Argentina.	pufetin@gmail.com	TELLECHEA, MARIANA L/AAM-6673-2021	TELLECHEA, MARIANA L/0000-0002-1194-8433; Penas-Steinhardt, Alberto/0000-0002-6164-8842; Gonzalez, Claudio/0000-0002-3772-8850; Belforte, Fiorella S./0000-0002-3437-1454	ANCyP-Argentina [PICT 38343, PICT-2008-260]; UBACyT [B118 - B104, 20020090200714]; CONICET-Argentina [PIP 0697]; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-RETIC, Madrid, Spain [RD06/0015/0012]	ANCyP-Argentina; UBACyT; CONICET-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-RETIC, Madrid, Spain(Instituto de Salud Carlos III)	This work was supported by the following grants: PICT 38343 and PICT-2008-260 (ANCyP-Argentina, http://www.agencia.mincyt.gov.ar/), UBACyT B118 - B104 and 20020090200714 (UBA-Argentina, http://www.uba.ar/), PIP 0697 (CONICET-Argentina, http://www.conicet.gov.ar/), and by a grant from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-RETIC http://www.isciii.es/(RD06/0015/0012), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Cornier M-A, ENDOCRINE REV, V29, P777; Duncan BB, 2006, DIABETES TECHNOL THE, V8, P7, DOI 10.1089/dia.2006.8.7; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; Fukusaki T, 2007, J PERIODONTAL RES, V42, P541, DOI 10.1111/j.1600-0765.2007.00979.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grundy SM, CRITICAL PATHWAYS CA, V4, P198; Hishida A, 2009, HELICOBACTER, V14, P47, DOI 10.1111/j.1523-5378.2009.00659.x; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikonomidis I, 2005, AM HEART J, V149, P832, DOI 10.1016/j.ahj.2004.08.030; JOHNSON GB, 2004, FASEB J, V4, P1; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kissebah AH, 1997, DIABETES REV, V5, P8; Kolek MJ, 2004, AM HEART J, V148, P1034, DOI 10.1016/j.ahj.2004.05.049; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Liu PY, 2007, ATHEROSCLEROSIS, V195, P199, DOI 10.1016/j.atherosclerosis.2006.11.001; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; NEEL JV, 1962, AM J HUM GENET, V14, P353; Steinhardt AP, 2010, METABOLISM, V59, P711, DOI 10.1016/j.metabol.2009.09.015; Pesole G, 1999, TRENDS GENET, V15, P378, DOI 10.1016/S0168-9525(99)01795-3; Petruzzelli M, 2010, CELL METAB, V11, P345, DOI 10.1016/j.cmet.2010.04.012; Sam S, 2009, DIABETES CARE, V32, P1916, DOI 10.2337/dc09-0412; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Song C, 2006, CANCER BIOL THER, V5, P1285, DOI 10.4161/cbt.5.10.3304; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50992	10.1371/journal.pone.0050992	http://dx.doi.org/10.1371/journal.pone.0050992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239997	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800033
J	You, S; Cho, CS; Lee, I; Hood, L; Hwang, D; Kim, WU				You, Sungyong; Cho, Chul-Soo; Lee, Inyoul; Hood, Leroy; Hwang, Daehee; Kim, Wan-Uk			A Systems Approach to Rheumatoid Arthritis	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; TUMOR-SUPPRESSOR GENE; SYNOVIAL TISSUE HETEROGENEITY; TRANSCRIPTION FACTOR; T-CELLS; SOMATIC MUTATIONS; TARGET GENES; DATABASE; EXPRESSION; DISEASE	Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily attacks synovial joints. Despite the advances in diagnosis and treatment of RA, novel molecular targets are still needed to improve the accuracy of diagnosis and the therapeutic outcomes. Here, we present a systems approach that can effectively 1) identify core RA-associated genes (RAGs), 2) reconstruct RA-perturbed networks, and 3) select potential targets for diagnosis and treatments of RA. By integrating multiple gene expression datasets previously reported, we first identified 983 core RAGs that show RA dominant differential expression, compared to osteoarthritis (OA), in the multiple datasets. Using the core RAGs, we then reconstructed RA-perturbed networks that delineate key RA associated cellular processes and transcriptional regulation. The networks revealed that synovial fibroblasts play major roles in defining RA-perturbed processes, anti-TNF-alpha therapy restored many RA-perturbed processes, and 19 transcription factors (TFs) have major contribution to deregulation of the core RAGs in the RA-perturbed networks. Finally, we selected a list of potential molecular targets that can act as metrics or modulators of the RA-perturbed networks. Therefore, these network models identify a panel of potential targets that will serve as an important resource for the discovery of therapeutic targets and diagnostic markers, as well as providing novel insights into RA pathogenesis.	[You, Sungyong; Hwang, Daehee] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Cho, Chul-Soo; Kim, Wan-Uk] Catholic Res Inst Med Sci, Res Inst Immunobiol, Seoul, South Korea; [Cho, Chul-Soo; Kim, Wan-Uk] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea; [Lee, Inyoul; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Hwang, Daehee] POSTECH, Dept Chem Engn, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Catholic University of Korea; Institute for Systems Biology (ISB); Pohang University of Science & Technology (POSTECH)	Hwang, D (corresponding author), POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	dhhwang@postech.ac.kr; wan725@catholic.ac.kr	Kim, Wan-Uk/AAO-8502-2020; You, Sungyong/AAJ-7372-2020	You, Sungyong/0000-0003-3513-1783; Kim, Wan-Uk/0000-0001-8224-8496	Korean MEST from the Global Frontier Project [NRF-M1AXA002-2011-0028392]; WCU program [R31-2008-000-10105-0]; Converging Research Center Program [2011K000896]; National Research Foundation of Korea [R31-2008-000-10105-0, 20090080087]; ISB-University of Luxembourg program [NS41997]	Korean MEST from the Global Frontier Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); WCU program; Converging Research Center Program; National Research Foundation of Korea(National Research Foundation of Korea); ISB-University of Luxembourg program	This study was supported by Korean MEST grants from the Global Frontier Project grant (NRF-M1AXA002-2011-0028392), WCU program (R31-2008-000-10105-0), the Converging Research Center Program (2011K000896 to D. Hwang), National Research Foundation of Korea (R31-2008-000-10105-0 and 20090080087), and ISB-University of Luxembourg program (NS41997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buch MH, 2004, ARTHRITIS RHEUM-US, V50, P725, DOI 10.1002/art.20115; CASH JM, 1994, NEW ENGL J MED, V330, P1368; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Firestein GS, 1997, ARTHRITIS RHEUM, V40, P255; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2485; Imamura F, 1998, ARTHRITIS RHEUM, V41, P1979; Inazuka M, 2000, RHEUMATOLOGY, V39, P262, DOI 10.1093/rheumatology/39.3.262; JANOSSY G, 1981, LANCET, V2, P839; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kasperkovitz PV, 2005, ARTHRITIS RHEUM-US, V52, P430, DOI 10.1002/art.20811; Keystone E, 2009, ANN RHEUM DIS, V68, P216, DOI 10.1136/ard.2007.085787; Keystone E, 2008, ARTHRIT RHEUM-ARTHR, V59, P785, DOI 10.1002/art.23715; Kim Y, 2011, BIOINFORMATICS, V27, P391, DOI 10.1093/bioinformatics/btq670; KINNE RW, 1995, SCAND J RHEUMATOL, P121; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Kremer JM, 2006, ANN RHEUM DIS, V65, P326; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; Meyer LH, 2006, BEST PRACT RES CL RH, V20, P969, DOI 10.1016/j.berh.2006.06.005; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Nakazato T, 2009, NUCLEIC ACIDS RES, V37, pW166, DOI 10.1093/nar/gkp483; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Reme T, 1998, CLIN EXP IMMUNOL, V111, P353; Ryu T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-136; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Sanders M, 2000, J RHEUMATOL, V27, P523; Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39; Shiozawa S, 1997, J CLIN INVEST, V99, P1210, DOI 10.1172/JCI119277; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Tamamura H, 2007, CURR MED CHEM, V14, P93, DOI 10.2174/092986707779313499; Tedder TF, 2009, NAT REV RHEUMATOL, V5, P572, DOI 10.1038/nrrheum.2009.184; Tolboom TCA, 2006, CLIN EXP RHEUMATOL, V24, P142; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P1602, DOI 10.1002/art.27415; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199; Yoon HJ, 2011, ARTHRITIS RHEUM-US, V63, P1843, DOI 10.1002/art.30229; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	57	21	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51508	10.1371/journal.pone.0051508	http://dx.doi.org/10.1371/journal.pone.0051508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240033	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800069
J	Hwang, E; Kim, S; Han, K; Choi, JH				Hwang, Eunjin; Kim, Seunghwan; Han, Kyungreem; Choi, Jee Hyun			Characterization of Phase Transition in the Thalamocortical System during Anesthesia-Induced Loss of Consciousness	PLOS ONE			English	Article							CORTICAL EFFECTIVE CONNECTIVITY; GENERAL-ANESTHESIA; SPECTRAL EDGE; BREAKDOWN; PROPOFOL; BRAIN; STATE	The thalamocortical system plays a key role in the breakdown or emergence of consciousness, providing bottom-up information delivery from sensory afferents and integrating top-down intracortical and thalamocortical reciprocal signaling. A fundamental and so far unanswered question for cognitive neuroscience remains whether the thalamocortical switch for consciousness works in a discontinuous manner or not. To unveil the nature of thalamocortical system phase transition in conjunction with consciousness transition, ketamine/xylazine was administered unobtrusively to ten mice under a forced working test with motion tracker, and field potentials in the sensory and motor-related cortex and thalamic nuclei were concomitantly collected. Sensory and motor-related thalamocortical networks were found to behave continuously at anesthesia induction and emergence, as evidenced by a sigmoidal response function with respect to anesthetic concentration. Hyperpolarizing and depolarizing susceptibility diverged, and a non-discrete change of transitional probability occurred at transitional regimes, which are hallmarks of continuous phase transition. The hyperpolarization curve as a function of anesthetic concentration demonstrated a hysteresis loop, with a significantly higher anesthetic level for transition to the down state compared to transition to the up state. Together, our findings concerning the nature of phase transition in the thalamocortical system during consciousness transition further elucidate the underlying basis for the ambiguous borderlines between conscious and unconscious brains. Moreover, our novel analysis method can be applied to systematic and quantitative handling of subjective concepts in cognitive neuroscience.	[Hwang, Eunjin; Choi, Jee Hyun] Korea Inst Sci & Technol, Ctr Neurosci, Seoul, South Korea; [Hwang, Eunjin; Kim, Seunghwan] Pohang Univ Sci & Technol, Dept Phys, Nonlinear Complex Syst Lab, Pohang, South Korea; [Han, Kyungreem] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Choi, Jee Hyun] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea; [Hwang, Eunjin; Kim, Seunghwan] Pohang Univ Sci & Technol, Asia Pacific Ctr Theoret Phys, Pohang, South Korea	Korea Institute of Science & Technology (KIST); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH)	Choi, JH (corresponding author), Korea Inst Sci & Technol, Ctr Neurosci, Seoul, South Korea.	jeechoi@kist.re.kr		Ward, Lawrence/0000-0003-4431-5015; KIM, Seunghwan/0000-0002-0563-3902	National Research Foundation; Ministry of Education, Science and Technology of South Korea [2012-0001414, 2012-0005805]	National Research Foundation; Ministry of Education, Science and Technology of South Korea	This research was supported by the Brain Research Program and Basic Science Research Program through the National Research Foundation funded by the Ministry of Education, Science and Technology of South Korea (2012-0001414; 2012-0005805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2010, SUPPRESSING THE MIND: ANESTHETIC MODULATION OF MEMORY AND CONSCIOUSNESS, P127, DOI 10.1007/978-1-60761-462-3_6; Billard V, 1997, CLIN PHARMACOL THER, V61, P45, DOI 10.1016/S0009-9236(97)90181-8; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; FOSSE RT, 1987, AM J VET RES, V48, P211; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Gandomani MJ, 2011, VET SCAN, V6, P81; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Hwang E, 2010, J NEUROSCI METH, V188, P14, DOI 10.1016/j.jneumeth.2010.01.028; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Liley DTJ, 2005, J CLIN NEUROPHYSIOL, V22, P300; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Molaee-Ardekani B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041911; Paxinos G., 2001, MOUSE BRAIN STEREOTA; SCHUTTLER J, 1987, J PHARMACOKINET BIOP, V15, P241, DOI 10.1007/BF01066320; Schwender D, 1996, BRIT J ANAESTH, V77, P179, DOI 10.1093/bja/77.2.179; Sleigh J, 2010, SUPPRESSING THE MIND: ANESTHETIC MODULATION OF MEMORY AND CONSCIOUSNESS, P139, DOI 10.1007/978-1-60761-462-3_7; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001	22	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50580	10.1371/journal.pone.0050580	http://dx.doi.org/10.1371/journal.pone.0050580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236379	gold, Green Submitted, Green Published			2022-12-25	WOS:000312064100021
J	Rostovskaya, M; Anastassiadis, K				Rostovskaya, Maria; Anastassiadis, Konstantinos			Differential Expression of Surface Markers in Mouse Bone Marrow Mesenchymal Stromal Cell Subpopulations with Distinct Lineage Commitment	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; OSTEOGENESIS IMPERFECTA; CLONAL HETEROGENEITY; FIBROUS DYSPLASIA; IN-VITRO; MSCS; GENE; IDENTIFICATION; PROLIFERATION; MAINTENANCE	Bone marrow mesenchymal stromal cells (BM MSCs) represent a heterogeneous population of progenitors with potential for generation of skeletal tissues. However the identity of BM MSC subpopulations is poorly defined mainly due to the absence of specific markers allowing in situ localization of those cells and isolation of pure cell types. Here, we aimed at characterization of surface markers in mouse BM MSCs and in their subsets with distinct differentiation potential. Using conditionally immortalized BM MSCs we performed a screening with 176 antibodies and high-throughput flow cytometry, and found 33 markers expressed in MSCs, and among them 3 were novel for MSCs and 13 have not been reported for MSCs from mice. Furthermore, we obtained clonally derived MSC subpopulations and identified bipotential progenitors capable for osteo-and adipogenic differentiation, as well as monopotential osteogenic and adipogenic clones, and thus confirmed heterogeneity of MSCs. We found that expression of CD200 was characteristic for the clones with osteogenic potential, whereas SSEA4 marked adipogenic progenitors lacking osteogenic capacity, and CD140a was expressed in adipogenic cells independently of their efficiency for osteogenesis. We confirmed our observations in cell sorting experiments and further investigated the expression of those markers during the course of differentiation. Thus, our findings provide to our knowledge the most comprehensive characterization of surface antigens expression in mouse BM MSCs to date, and suggest CD200, SSEA4 and CD140a as markers differentially expressed in distinct types of MSC progenitors.	[Rostovskaya, Maria; Anastassiadis, Konstantinos] Tech Univ Dresden, BIOTEC, D-01062 Dresden, Germany	Technische Universitat Dresden	Anastassiadis, K (corresponding author), Tech Univ Dresden, BIOTEC, D-01062 Dresden, Germany.	konstantinos.anastassiadis@biotec.tu-dresden.de	Anastassiadis, Konstantinos/A-8944-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft grant Collaborative Research Center 655 "Cells into tissues: Stem cell and progenitor commitment and interactions during tissue formation" (Project B1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; Anastassiadis K, 2010, GENESIS, V48, P220, DOI 10.1002/dvg.20605; Artemenko Y, 2005, J CELL PHYSIOL, V204, P646, DOI 10.1002/jcp.20314; Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592; Baer PC, 2012, STEM CELLS DEV; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bianco P, 2000, J BONE MINER RES, V15, P120, DOI 10.1359/jbmr.2000.15.1.120; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Fitter S, 2012, J MOL ENDOCRINOL, V48, P229, DOI 10.1530/JME-12-0003; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Fukiage K, 2008, BIOCHEM BIOPH RES CO, V365, P406, DOI 10.1016/j.bbrc.2007.10.149; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gioia R, 2012, STEM CELLS, V30, P1465, DOI 10.1002/stem.1107; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Kaltz N, 2010, EXP CELL RES, V316, P2609, DOI 10.1016/j.yexcr.2010.06.002; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401; Lee L, 2006, IMMUNOL LETT, V105, P150, DOI 10.1016/j.imlet.2006.02.002; Lin Y, 2011, ADV HEMATOL, V2011, DOI DOI 10.1155/2011/427863; Mareddy S, 2009, J CELL BIOCHEM, V106, P776, DOI 10.1002/jcb.22088; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Muraglia A, 2000, J CELL SCI, V113, P1161; Niehage C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020399; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pelekanos RA, 2012, STEM CELL RES, V8, P58, DOI 10.1016/j.scr.2011.08.003; Pochampally RR, 2005, GENE THER, V12, P1119, DOI 10.1038/sj.gt.3302514; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rosu-Myles M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038954; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; van den Berk LCJ, 2010, J LEUKOCYTE BIOL, V87, P283, DOI 10.1189/jlb.0709467; Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205; Vogel W, 2003, HAEMATOLOGICA, V88, P126; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wu Y, 2008, CELL BIOL INT, V32, P748, DOI 10.1016/j.cellbi.2008.02.006; Yanagisawa M, 2011, NEUROCHEM RES, V36, P1623, DOI 10.1007/s11064-010-0358-1	56	46	47	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51221	10.1371/journal.pone.0051221	http://dx.doi.org/10.1371/journal.pone.0051221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236457	Green Published, gold			2022-12-25	WOS:000312064100082
J	Wibom, C; Ghasimi, S; Van Loo, P; Brannstrom, T; Trygg, J; Lau, C; Henriksson, R; Bergenheim, T; Andersson, U; Ryden, P; Melin, B				Wibom, Carl; Ghasimi, Soma; Van Loo, Peter; Brannstrom, Thomas; Trygg, Johan; Lau, Ching; Henriksson, Roger; Bergenheim, Tommy; Andersson, Ulrika; Ryden, Patrik; Melin, Beatrice			EGFR Gene Variants Are Associated with Specific Somatic Aberrations in Glioma	PLOS ONE			English	Article							GENOMIC STABILITY; RISK; GLIOBLASTOMA; RECEPTOR; SUSCEPTIBILITY; MUTATIONS; PATHWAYS	A number of gene variants have been associated with an increased risk of developing glioma. We hypothesized that the reported risk variants may be associated with tumor genomic instability. To explore potential correlations between germline risk variants and somatic genetic events, we analyzed matched tumor and blood samples from 95 glioma patients by means of SNP genotyping. The generated genotype data was used to calculate genome-wide allele-specific copy number profiles of the tumor samples. We compared the copy number profiles across samples and found two EGFR gene variants (rs17172430 and rs11979158) that were associated with homozygous deletion at the CDKN2A/B locus. One of the EGFR variants (rs17172430) was also associated with loss of heterozygosity at the EGFR locus. Our findings were confirmed in a separate dataset consisting of matched blood and tumor samples from 300 glioblastoma patients, compiled from publically available TCGA data. These results imply there is a functional effect of germline EGFR variants on tumor progression.	[Wibom, Carl] Umea Univ, Computat Life Sci Cluster CLiC, Dept Radiat Sci, Umea, Sweden; [Ghasimi, Soma; Andersson, Ulrika; Melin, Beatrice] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Van Loo, Peter] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; [Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Umea, Sweden; [Trygg, Johan] Umea Univ, Computat Life Sci Cluster CLiC, Dept Chem, Umea, Sweden; [Lau, Ching] Baylor Coll Med, Dept Pediat & Hematol, Houston, TX 77030 USA; [Henriksson, Roger] Karolinska Inst, Dept Oncol, Umea, Sweden; [Ryden, Patrik] Umea Univ, Computat Life Sci Cluster CLiC, Dept Math & Math Stat, Umea, Sweden; [Van Loo, Peter] VIB, Dept Human Genet, Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Louvain, Belgium	Umea University; Umea University; Wellcome Trust Sanger Institute; Umea University; Umea University; Baylor College of Medicine; Karolinska Institutet; Umea University; Flanders Institute for Biotechnology (VIB); KU Leuven	Wibom, C (corresponding author), Umea Univ, Computat Life Sci Cluster CLiC, Dept Radiat Sci, Umea, Sweden.	carl.wibom@onkologi.umu.se	Henriksson, Roger/AAI-8608-2020	Van Loo, Peter/0000-0003-0292-1949	Umea University Hospital Cutting Edge Grant; Umea University; Acta Oncologica through the Royal Swedish Academy of Science; Swedish Cancer Foundation; Swedish Research Council; Northern Sweden Research Foundation; FWO	Umea University Hospital Cutting Edge Grant; Umea University; Acta Oncologica through the Royal Swedish Academy of Science; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Northern Sweden Research Foundation; FWO(FWO)	The study was supported by the following grants; Umea University Hospital Cutting Edge Grant, Young Investigator Award by Umea University, Acta Oncologica through the Royal Swedish Academy of Science, The Swedish Cancer Foundation, The Swedish Research Council, and the Northern Sweden Research Foundation. PVL is a postdoctoral researcher of the Research Foundation - Flanders (FWO) and is as a visiting scientist at the Wellcome Trust Sanger Institute supported by a travel grant from the FWO. The SNP&SEQ Technology Platform is part of Science for Life Laboratory at Uppsala University and supported as a national infrastructure by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2010, ACTA ONCOL, V49, P767, DOI 10.3109/0284186X.2010.480980; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; Feng JJ, 2012, CANCER-AM CANCER SOC, V118, P232, DOI 10.1002/cncr.26250; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Lystig TC, 2003, GENETICS, V164, P1683; Melin B, 2011, CURR OPIN ONCOL, V23, P643, DOI 10.1097/CCO.0b013e32834a6f61; Saavedra HI, 1999, J BIOL CHEM, V274, P38083, DOI 10.1074/jbc.274.53.38083; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Schwartzbaum JA, 2010, CARCINOGENESIS, V31, P1770, DOI 10.1093/carcin/bgq152; Sharma GG, 2003, ONCOGENE, V22, P131, DOI 10.1038/sj.onc.1206063; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Simon M, 2010, CLIN CANCER RES, V16, P5252, DOI 10.1158/1078-0432.CCR-10-1502; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	22	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e47929	10.1371/journal.pone.0047929	http://dx.doi.org/10.1371/journal.pone.0047929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236348	gold, Green Published, Green Submitted			2022-12-25	WOS:000312064100003
J	Zhang, XF; Sobue, T; Isshiki, M; Makino, S; Inoue, M; Kato, K; Shioda, T; Ohashi, T; Sato, H; Komano, J; Hanabusa, H; Shida, H				Zhang, Xianfeng; Sobue, Tomoyoshi; Isshiki, Mao; Makino, Shun-ichi; Inoue, Makoto; Kato, Kazunori; Shioda, Tatsuo; Ohashi, Takashi; Sato, Hirotaka; Komano, Jun; Hanabusa, Hideji; Shida, Hisatoshi			Elicitation of Both Anti HIV-1 Env Humoral and Cellular Immunities by Replicating Vaccinia Prime Sendai Virus Boost Regimen and Boosting by CD40Lm	PLOS ONE			English	Article							IMMUNE-RESPONSES; GENE-TRANSFER; DNA VACCINE; T-CELLS; INFECTION; TYPE-1; CD154; GAG; ANTIBODIES; LIGAND	For protection from HIV-1 infection, a vaccine should elicit both humoral and cell-mediated immune responses. A novel vaccine regimen and adjuvant that induce high levels of HIV-1 Env-specific T cell and antibody (Ab) responses was developed in this study. The prime-boost regimen that used combinations of replication-competent vaccinia LC16m8 Delta (m8 Delta) and Sendai virus (SeV) vectors expressing HIV-1 Env efficiently produced both Env-specific CD8(+) T cells and anti-Env antibodies, including neutralizing antibodies (nAbs). These results sharply contrast with vaccine regimens that prime with an Env expressing plasmid and boost with the m8 Delta or SeV vector that mainly elicited cellular immunities. Moreover, co-priming with combinations of m8 Delta s expressing Env or a membrane-bound human CD40 ligand mutant (CD40Lm) enhanced Env-specific CD8(+) T cell production, but not anti-Env antibody production. In contrast, priming with an m8 Delta that coexpresses CD40Lm and Env elicited more anti-Env Abs with higher avidity, but did not promote T cell responses. These results suggest that the m8 Delta prime/SeV boost regimen in conjunction with CD40Lm expression could be used as an immunization platform for driving both potent cellular and humoral immunities against pathogens such as HIV-1.	[Zhang, Xianfeng; Sobue, Tomoyoshi; Isshiki, Mao; Makino, Shun-ichi; Ohashi, Takashi; Sato, Hirotaka; Shida, Hisatoshi] Hokkaido Univ, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan; [Inoue, Makoto] DNAVEC Corp, Tsukuba, Ibaraki, Japan; [Kato, Kazunori] Toyo Univ, Dept BioMed Engn, Kawagoe, Saitama, Japan; [Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka, Japan; [Komano, Jun] Osaka Prefectural Inst Publ Hlth, Div Virol, Dept Infect Dis, Nakamichi Higashinari Ku, Osaka 537, Japan; [Hanabusa, Hideji] Ogikubo Hosp, Tokyo, Tokyo, Japan	Hokkaido University; DNAVEC Corporation; Toyo University; Osaka University; Osaka Prefectural Institute of Public Health	Shida, H (corresponding author), Hokkaido Univ, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan.	hshida@igm.hokudai.ac.jp	Ohashi, Takashi/C-4671-2012; zhang, xian/GYA-0290-2022	Ohashi, Takashi/0000-0002-3769-4224; Inoue, Makoto/0000-0003-0804-7439; Sato, Hirotaka/0000-0002-8321-9731	Ministry of Sports and Culture (Japan) [21390135]; Ministry of Health and Welfare (Japan); Health Science Foundation; Ministry of Education, Culture, Sports, Science and Technology [21390135]; Human Health Foundation [SAB4861]; Grants-in-Aid for Scientific Research [22390118] Funding Source: KAKEN	Ministry of Sports and Culture (Japan); Ministry of Health and Welfare (Japan)(Ministry of Health, Labour and Welfare, Japan); Health Science Foundation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Health Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Sports and Culture (Japan) (21390135), the Ministry of Health and Welfare (Japan), and the Health Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare one author, M. Inoue, has an affiliation in DNAVEC Corporation. Although DNAVEC, a profit company, has developed and is preparing for marketing the Sendai Virus Vector (SeV Vector), it has not financially supported this study at all. This study has been exclusively supported by the grants (No: 21390135) of Ministry of Education, Culture, Sports, Science and Technology and that (No: SAB4861) of Human Health Foundation. Thus, participation of Makoto Inoue, a member of DNAVEC, does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brown SA, 2010, VIRUSES-BASEL, V2, P435, DOI 10.3390/v2020435; Carter D, 2010, CURR OPIN HIV AIDS, V5, P409, DOI 10.1097/COH.0b013e32833d2cdb; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Garcin D, 1995, EMBO J, V14, P6087, DOI 10.1002/j.1460-2075.1995.tb00299.x; Gares SL, 2006, CLIN VACCINE IMMUNOL, V13, P958, DOI 10.1128/CVI.00080-06; GAUCHAT JF, 1994, RES IMMUNOL, V145, P240, DOI 10.1016/S0923-2494(94)80191-6; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Gordon SN, 2011, J INFECT DIS, V203, P1043, DOI 10.1093/infdis/jiq162; Gurunathan S, 1998, J IMMUNOL, V161, P4563; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Hashizume S, 1985, VACCINIA VIRUSES VEC, P421; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; JIN NY, 1994, ARCH VIROL, V138, P315, DOI 10.1007/BF01379134; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kato A, 1997, J VIROL, V71, P7266, DOI 10.1128/JVI.71.10.7266-7272.1997; Kawada M, 2006, J VIROL, V80, P1949, DOI 10.1128/JVI.80.4.1949-1958.2006; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu J, 2008, VACCINE, V26, P4062, DOI 10.1016/j.vaccine.2008.05.018; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; Manoj S, 2003, J IMMUNOL, V170, P989, DOI 10.4049/jimmunol.170.2.989; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Masuta Y, 2007, J IMMUNOTHER, V30, P694, DOI 10.1097/CJI.0b013e31811a5c51; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McElrath MJ, 1995, SEMIN CANCER BIOL, V6, P375, DOI 10.1016/1044-579X(95)90007-1; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mendoza RB, 1997, J IMMUNOL, V159, P5777; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saito T, 2009, JAMA-J AM MED ASSOC, V301, P1025, DOI 10.1001/jama.2009.289; Sakurai A, 2004, MICROBES INFECT, V6, P150, DOI 10.1016/j.micinf.2003.10.011; SHIDA H, 1983, CELL, V33, P423, DOI 10.1016/0092-8674(83)90424-5; SHIDA H, 1987, EMBO J, V6, P3379, DOI 10.1002/j.1460-2075.1987.tb02660.x; SHIDA H, 1986, VIROLOGY, V150, P451, DOI 10.1016/0042-6822(86)90309-0; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Suzuki Hajime, 2009, Vaccine, V27, P966, DOI 10.1016/j.vaccine.2008.12.015; Tokui M, 1997, BIOCHEM BIOPH RES CO, V233, P527, DOI 10.1006/bbrc.1997.6485; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu SQ, 2008, VACCINE, V26, P6124, DOI 10.1016/j.vaccine.2008.09.017	59	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51633	10.1371/journal.pone.0051633	http://dx.doi.org/10.1371/journal.pone.0051633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236521	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100137
J	Aurich, MK; Thiele, I				Aurich, Maike K.; Thiele, Ines			Contextualization Procedure and Modeling of Monocyte Specific TLR Signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NOD-LIKE RECEPTOR; NF-KAPPA-B; GENE-EXPRESSION; BINDING-PROTEIN; MESSENGER-RNAS; NETWORK; ACTIVATION; CELL; INTEGRATION	Innate immunity is the first line of defense against invasion of pathogens. Toll-like receptor (TLR) signaling is involved in a variety of human diseases extending far beyond immune system-related diseases, affecting a number of different tissues and cell-types. Computational models often do not account for cell-type specific differences in signaling networks. Investigation of these differences and its phenotypic implications could increase understanding of cell signaling and processes such as inflammation. The wealth of knowledge for TLR signaling has been recently summarized in a stoichiometric signaling network applicable for constraint-based modeling and analysis (COBRA). COBRA methods have been applied to investigate tissue-specific metabolism using omics data integration. Comparable approaches have not been conducted using signaling networks. In this study, we present ihsTLRv2, an updated TLR signaling network accounting for the association of 314 genes with 558 network reactions. We present a mapping procedure for transcriptomic data onto signaling networks and demonstrate the generation of a monocyte-specific TLR network. The generated monocyte network is characterized through expression of a specific set of isozymes rather than reduction of pathway contents. While further tailoring the network to a specific stimulation condition, we observed that the quantitative changes in gene expression due to LPS stimulation affected the tightly connected set of genes. Differential expression influenced about one third of the entire TLR signaling network, in particular, NF-kappa B activation. Thus, a cell-type and condition-specific signaling network can provide functional insight into signaling cascades. Furthermore, we demonstrate the energy dependence of TLR signaling pathways in monocytes. Citation: Aurich MK, Thiele I (2012) Contextualization Procedure and Modeling of Monocyte Specific TLR Signaling. PLoS ONE 7(12): e49978. doi:10.1371/journal.pone.0049978	[Aurich, Maike K.; Thiele, Ines] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Thiele, Ines] Univ Iceland, Fac Ind Engn Mech Engn & Comp Sci, Reykjavik, Iceland	University of Iceland; University of Iceland	Thiele, I (corresponding author), Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland.	ines.thiele@gmail.com	Thiele, Ines/A-7629-2014	Thiele, Ines/0000-0002-8071-7110	European Research Council Advanced Grant [N 232816]; Marie Curie International Reintegration Grant within the 7th European Community Framework Program [N 249261]	European Research Council Advanced Grant(European Research Council (ERC)); Marie Curie International Reintegration Grant within the 7th European Community Framework Program	This work was supported by a European Research Council Advanced Grant (N 232816), and by a Marie Curie International Reintegration Grant awarded to IT (N 249261) within the 7th European Community Framework Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bajikar SS, 2012, ANN BIOMEDICAL ENG; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Cachia O, 1998, J BIOL CHEM, V273, P32801, DOI 10.1074/jbc.273.49.32801; COHN ZA, 1965, J EXP MED, V121, P153, DOI 10.1084/jem.121.1.153; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dasika MS, 2006, BIOPHYS J, V91, P382, DOI 10.1529/biophysj.105.069724; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Dunne A, 2011, CURR OPIN PHARMACOL, V11, P404, DOI 10.1016/j.coph.2011.03.004; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gianchandani EP, 2006, PLOS COMPUT BIOL, V2, P902, DOI 10.1371/journal.pcbi.0020101; Gianchandani EP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000403; GRUBE BJ, 1994, J BIOL CHEM, V269, P8477; Gudmundsson S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-489; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jensen PA, 2011, BIOINFORMATICS, V27, P541, DOI 10.1093/bioinformatics/btq702; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; KAVITA U, 1995, J BIOL CHEM, V270, P27758, DOI 10.1074/jbc.270.46.27758; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kostromins A, 2012, BIOSYSTEMS, V109, P233, DOI 10.1016/j.biosystems.2012.03.002; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lee JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000086; Li F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000292; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Ospelt C, 2010, INT J BIOCHEM CELL B, V42, P495, DOI 10.1016/j.biocel.2009.10.010; Palsson B, 2006, SYSTEMS BIOL PROPERT, pxii; Papin JA, 2004, BIOPHYS J, V87, P37, DOI 10.1529/biophysj.103.029884; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Richard G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031341; Richard G, 2011, IEEE DECIS CONTR P, P2227, DOI 10.1109/CDC.2011.6160954; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; Thiele I, 2012, PLOS ONE IN PRESS; Thiele I, 2010, BIOPHYS J, V98, P2072, DOI 10.1016/j.bpj.2010.01.060; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; Thorleifsson SG, 2011, BIOINFORMATICS, V27, P2009, DOI 10.1093/bioinformatics/btr308; Vardi L, 2012, J COMPUT BIOL, V19, P232, DOI 10.1089/cmb.2011.0277; Warren P, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P108; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	66	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e49978	10.1371/journal.pone.0049978	http://dx.doi.org/10.1371/journal.pone.0049978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236359	Green Published, Green Submitted, gold			2022-12-25	WOS:000312589700007
J	Kaur, H; Mao, SH; Li, QW; Sameni, M; Krawetz, SA; Sloane, BF; Mattingly, RR				Kaur, Hitchintan; Mao, Shihong; Li, Quanwen; Sameni, Mansoureh; Krawetz, Stephen A.; Sloane, Bonnie F.; Mattingly, Raymond R.			RNA-Seq of Human Breast Ductal Carcinoma In Situ Models Reveals Aldehyde Dehydrogenase Isoform 5A1 as a Novel Potential Target	PLOS ONE			English	Article							CANCER CELL-LINES; GENE-EXPRESSION; HISTONE DEACETYLASE; LOCAL RECURRENCE; GASTRIC-CANCER; VALPROIC ACID; TUMOR-CELLS; MCF10 MODEL; PROGRESSION; INHIBITORS	Breast ductal carcinoma in situ (DCIS) is being found in great numbers of women due to the widespread use of mammography. To increase knowledge of DCIS, we determined the expression changes that are common among three DCIS models (MCF10.DCIS, SUM102 and SUM225) compared to the MCF10A model of non-tumorigenic mammary epithelial cells in three dimensional (3D) overlay culture with reconstituted basement membrane (rBM). Extracted mRNA was subjected to 76 cycles of deep sequencing (RNA-Seq) using Illumina Genome Analyzer GAIIx. Analysis of RNA-Seq results showed 295 consistently differentially expressed transcripts in the DCIS models. These differentially expressed genes encode proteins that are associated with a number of signaling pathways such as integrin, fibroblast growth factor and TGF beta signaling, show association with cell-cell signaling, cell-cell adhesion and cell proliferation, and have a notable bias toward localization in the extracellular and plasma membrane compartments. RNA-Seq data was validated by quantitative real-time PCR of selected differentially expressed genes. Aldehyde dehydrogenase 5A1 (ALDH5A1) which is an enzyme that is involved in mitochondrial glutamate metabolism, was over-expressed in all three DCIS models at both the mRNA and protein levels. Disulfiram and valproic acid are known to inhibit ALDH5A1 and are safe for chronic use in humans for other disorders. Both of these drugs significantly inhibited net proliferation of the DCIS 3D rBM overlay models, but had minimal effect on MCF10A 3D rBM overlay models. These results suggest that ALDH5A1 may play an important role in DCIS and potentially serve as a novel molecular therapeutic target. Citation: Kaur H, Mao S, Li Q, Sameni M, Krawetz SA, et al. (2012) RNA-Seq of Human Breast Ductal Carcinoma In Situ Models Reveals Aldehyde Dehydrogenase Isoform 5A1 as a Novel Potential Target. PLoS ONE 7(12): e50249. doi:10.1371/journal.pone.0050249	[Kaur, Hitchintan; Li, Quanwen; Sameni, Mansoureh; Sloane, Bonnie F.; Mattingly, Raymond R.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Mao, Shihong; Krawetz, Stephen A.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Li, Quanwen; Krawetz, Stephen A.; Sloane, Bonnie F.; Mattingly, Raymond R.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Mattingly, RR (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	r.mattingly@wayne.edu	krawetz, stephen/GQQ-3308-2022		National Institute of Health [R01 CA131990]; The Genomics and Microscopic Imaging and Cytometry Resources Cores [NIH P30 CA22453]; NATIONAL CANCER INSTITUTE [P30CA022453, R01CA131990] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Genomics and Microscopic Imaging and Cytometry Resources Cores; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institute of Health R01 CA131990 (BFS and RRM). The Genomics and Microscopic Imaging and Cytometry Resources Cores are supported by NIH P30 CA22453. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Adeyinka A, 2002, CLIN CANCER RES, V8, P3788; Allred DC, 2012, J CLIN ONCOL, V30, P1268, DOI 10.1200/JCO.2010.34.0141; ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barnes NLP, 2005, BRIT J SURG, V92, P429, DOI 10.1002/bjs.4878; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; Calaf GM, 2008, INT J MOL MED, V21, P561; Cardiff RD, 2010, TOXICOL PATHOL, V38, P171, DOI 10.1177/0192623309356447; Castellana B, 2012, J CANCER, V3, P175, DOI 10.7150/jca.4120; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chen JL, 2010, WORLD J GASTROENTERO, V16, P5874, DOI 10.3748/wjg.v16.i46.5874; Clark SE, 2011, BRIT J CANCER, V104, P120, DOI 10.1038/sj.bjc.6606021; Claus EB, 2001, EXP MOL PATHOL, V70, P303, DOI 10.1006/exmp.2001.2366; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DeCensi A, 2011, CANCER PREV RES, V4, P1181, DOI 10.1158/1940-6207.CAPR-10-0337; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Emery LA, 2009, AM J PATHOL, V175, P1292, DOI 10.2353/ajpath.2009.090115; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Gao J, 2009, GLIA, V57, P989, DOI 10.1002/glia.20823; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Griffith OL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2923; Han K, 2012, CLIN ONCOL-UK, V24, P183, DOI 10.1016/j.clon.2011.09.008; Hannemann J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1613; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Heiser LM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r31; HELLSTROM E, 1982, BIOCHEM PHARMACOL, V31, P3899, DOI 10.1016/0006-2952(82)90308-2; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Hrstka R, 2010, ONCOGENE, V29, P4838, DOI 10.1038/onc.2010.228; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Jeevan R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4505; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; Koike H, 2011, INT J CANC; Kuerer HM, 2009, J CLIN ONCOL, V27, P279, DOI 10.1200/JCO.2008.18.3103; Kulka J, 2009, PATHOL ONCOL RES, V15, P59, DOI 10.1007/s12253-008-9089-x; Kumar AS, 2005, BREAST CANCER RES, V7, P271, DOI 10.1186/bcr1346; Lari SA, 2011, J CANCER, V2, P232, DOI 10.7150/jca.2.232; Lee LY, 2008, HISTOL HISTOPATHOL, V23, P515, DOI 10.14670/HH-23.515; Lee SH, 2012, CURR CANCER RES, P45, DOI 10.1007/978-1-4614-0016-5_3; Li QW, 2008, NEOPLASIA, V10, P314, DOI 10.1593/neo.07970; Li QW, 2010, J PHARMACOL EXP THER, V332, P821, DOI 10.1124/jpet.109.160390; Li XR, 2009, BIOCHEMISTRY-MOSCOW+, V74, P979, DOI 10.1134/S0006297909090053; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; Nan HM, 2011, HUM MOL GENET, V20, P2673, DOI 10.1093/hmg/ddr154; Pearce DJ, 2005, STEM CELLS, V23, P752, DOI 10.1634/stemcells.2004-0292; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pleijhuis RG, 2009, ANN SURG ONCOL, V16, P2717, DOI 10.1245/s10434-009-0609-z; Porter D, 2003, MOL CANCER RES, V1, P362; Provenzano E, 2003, EUR J CANCER, V39, P622, DOI 10.1016/S0959-8049(02)00666-4; Raveh S, 2009, J CELL BIOCHEM, V108, P326, DOI 10.1002/jcb.22258; Rhee DK, 2008, GENOMICS, V92, P419, DOI 10.1016/j.ygeno.2008.08.005; Ringberg A, 2001, EUR J CANCER, V37, P1514, DOI 10.1016/S0959-8049(01)00165-4; Sakorafas GH, 2008, CANCER TREAT REV, V34, P483, DOI 10.1016/j.ctrv.2008.03.001; Sameni M, 2009, CLIN EXP METASTAS, V26, P299, DOI 10.1007/s10585-008-9218-7; Sartor CI, 1997, CANCER RES, V57, P978; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Seth A, 2003, ANTICANCER RES, V23, P2043; Ulazzi L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-17; VANDERLAAN JW, 1979, J NEUROCHEM, V32, P1769, DOI 10.1111/j.1471-4159.1979.tb02290.x; Vargas AC, 2012, BREAST CANC RES TREA; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Virnig Beth A., 2010, Journal of the National Cancer Institute Monographs, P113, DOI 10.1093/jncimonographs/lgq024; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039446; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; WHITTLE SR, 1981, BIOCHIM BIOPHYS ACTA, V657, P94, DOI 10.1016/0005-2744(81)90133-9; Wickstrom M, 2007, BIOCHEM PHARMACOL, V73, P25, DOI 10.1016/j.bcp.2006.08.016; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yang ZQ, 2004, CANCER GENET CYTOGEN, V155, P57, DOI 10.1016/j.cancergencyto.2004.03.013	80	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50249	10.1371/journal.pone.0050249	http://dx.doi.org/10.1371/journal.pone.0050249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236365	Green Published, gold, Green Submitted			2022-12-25	WOS:000312589700009
J	Guiller, A; Martin, MC; Hiraux, C; Madec, L				Guiller, Annie; Martin, Marie-Claire; Hiraux, Celine; Madec, Luc			Tracing the Invasion of the Mediterranean Land Snail Cornu aspersum aspersum Becoming an Agricultural and Garden Pest in Areas Recently Introduced	PLOS ONE			English	Article							ADDITIVE GENETIC VARIANCE; HELIX-ASPERSA; MITOCHONDRIAL-DNA; LIFE-HISTORY; POPULATION BOTTLENECKS; BIOLOGICAL INVASION; ADAPTIVE EVOLUTION; NORTH-AFRICA; MOLLUSCA; DIFFERENTIATION	This study is the first on the genetics of invasive populations of one of the most widely spread land mollusc species known in the world, the "Brown Snail'' Cornu aspersum aspersum. Deliberately or accidentally imported, the species has become recently a notorious pest outside its native Mediterranean range. We compared the spatial structure and genetic variability of invasive (America, Oceania, South Africa) versus native populations using five microsatellite loci and mitochondrial (Cyt b and 16S rRNA) genes as a first step towards (i) the detection of potential source populations, and (ii) a better understanding of mechanisms governing evolutionary changes involved in the invasion process. Results based on multivariate analysis (Discriminant Analysis of Principal Components), Bayesian statistical inference (Clustering, Approximate Bayesian Computation) and demographic tests allowed a construction of the introduction pathways of the species over recent centuries. While emigrants originated from only one of the two native lineages, the West one, the most likely scenario involved several introduction events and "source switching'' comprising (i) an early stage (around 1660) of simultaneous introductions from Europe (France, Spain) towards Oceania (New Zealand) and California, (ii) from the early 18 th century, a second colonization wave from bridgehead populations successfully established in California, (iii) genetic admixture in invasive areas where highly divergent populations came into contact as in New Zealand. Although these man-made pathways are consistent with historical data, introduction time estimates suggest that the two putative waves of invasion would have occurred long before the first field observations recorded, both in America and in Oceania. A prolonged lag period as the use of an incorrect generation time could explain such 100-150 years discrepancy. Lastly, the contrasting patterns of neutral genetic signal left in invasive populations are discussed in light of possible ways of facing novel environments (standing genetic variation versus new mutation).	[Guiller, Annie; Martin, Marie-Claire; Hiraux, Celine; Madec, Luc] Univ Rennes, CNRS, UMR 6553, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Guiller, A (corresponding author), Univ Rennes, CNRS, UMR 6553, Rennes, France.	annie.guiller@univ-rennes1.fr		Guiller, Annie/0000-0002-9047-9777	Centre national de la recherche scientifique	Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS))	This research was funded by the Centre national de la recherche scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Ansart A., 2009, CABI INVASIVE SPECIE; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barker G. M., 2002, MOLLUSCS CROP PESTS; Barker GM, 1999, FAUNA NZ, V38; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Basinger AJ, 1931, AGRIC EXP STA BERKEL, V515, P1; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brook FJ, 2000, J ROY SOC NEW ZEAL, V30, P209, DOI 10.1080/03014223.2000.9517618; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cowie Robert H., 1997, Bishop Museum Occasional Papers, V0, P1; Davis M. A., 2009, INVASION BIOL; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Fearnley R, 1993, THESIS U MANCHESTER; Frankham R, 2005, HEREDITY, V94, P385, DOI 10.1038/sj.hdy.6800634; Fu YX, 1997, GENETICS, V147, P915; Gargominy O, 1996, REV ECOL-TERRE VIE, V51, P375; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillemaud T, 2011, CR BIOL, V334, P237, DOI 10.1016/j.crvi.2010.12.008; Guiller A, 2001, MOL ECOL, V10, P81, DOI 10.1046/j.1365-294X.2001.01145.x; Guiller A, 1998, SYST BIOL, V47, P208, DOI 10.1080/106351598260888; Guiller A, 2000, MOL ECOL, V9, P1191, DOI 10.1046/j.1365-294x.2000.00954-13.x; GUILLER A, 1994, J MOLLUS STUD, V60, P205, DOI 10.1093/mollus/60.3.205; GUILLER A, 1994, THESIS U RENNES FRAN; Guiller A, 2006, GENET RES, V88, P27, DOI 10.1017/S0016672306008305; Guiller A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-18; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; GUTELL RR, 1988, NUCLEIC ACIDS RES, V16, pR175, DOI 10.1093/nar/16.suppl.r175; Hanfling B, 2002, MAR ECOL PROG SER, V238, P307, DOI 10.3354/meps238307; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jenkins C, 2011, BIOL INVASIONS, V13, P1471, DOI 10.1007/s10530-010-9907-4; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Knopp T, 2007, CONSERV GENET, V8, P45, DOI 10.1007/s10592-006-9147-4; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; KOWARIK I, 1995, PLANT INVASIONS, P15; Le Roux JJ, 2011, DIVERS DISTRIB, V17, P861, DOI 10.1111/j.1472-4642.2011.00784.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Lopez DP, 2011, THESIS FLORIDA INT U; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MADEC L, 1994, J ZOOL, V233, P215, DOI 10.1111/j.1469-7998.1994.tb08585.x; Madec L, 2003, HEREDITY, V91, P224, DOI 10.1038/sj.hdy.6800301; Madec L, 2000, BIOL J LINN SOC, V69, P25, DOI 10.1111/j.1095-8312.2000.tb01667.x; Madec L, 1996, CR ACAD SCI III-VIE, V319, P225; Marsico TD, 2010, EVOL APPL, V3, P203, DOI 10.1111/j.1752-4571.2009.00101.x; Meimberg H, 2006, BIOL INVASIONS, V8, P1355, DOI 10.1007/s10530-005-2463-7; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Muller J, 2001, ZOOL-ANAL COMPLEX SY, V104, P346, DOI 10.1078/0944-2006-00040; Naciri-Graven Y, 2003, EVOLUTION, V57, P706, DOI 10.1111/j.0014-3820.2003.tb00284.x; Neiman M, 2006, HEREDITY, V96, P111, DOI 10.1038/sj.hdy.6800772; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Nylander J. A. A., 2004, MRAIC PL PROGRAM DIS; Oliver MK, 2012, MOL BIOL EVOL, V29, P1713, DOI 10.1093/molbev/mss063; Oosterhoff LM, 1976, NETH J ZOOL, V27, P1; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ricciardi A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P225; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanders NJ, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P239; Simon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018560; Slade RW, 1998, P ROY SOC B-BIOL SCI, V265, P769, DOI 10.1098/rspb.1998.0359; SLATKIN M, 1991, GENETICS, V129, P555; Stearns R. E. C., 1900, Science, Vxi, P655, DOI 10.1126/science.11.278.655; Taylor J. W., 1913, MONOGRAPH LAND FRESH, P236; Thomaz D, 1996, P ROY SOC B-BIOL SCI, V263, P363, DOI 10.1098/rspb.1996.0056; Turelli M, 2006, EVOLUTION, V60, P1763; van Heerwaarden B, 2008, GENETICS, V179, P2135, DOI 10.1534/genetics.107.082768	89	38	39	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e49674	10.1371/journal.pone.0049674	http://dx.doi.org/10.1371/journal.pone.0049674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227148	Green Published, gold			2022-12-25	WOS:000323179700006
J	Koishi, AC; Zanello, PR; Bianco, EM; Bordignon, J; dos Santos, CND				Koishi, Andrea Cristine; Zanello, Paula Rodrigues; Bianco, Everson Miguel; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes			Screening of Dengue Virus Antiviral Activity of Marine Seaweeds by an In Situ Enzyme-Linked Immunosorbent Assay	PLOS ONE			English	Article							MOSQUITO CELLS; NEUTRAL RED; BROWN-ALGAE; OPTIMIZATION; IMMUNOASSAY; INHIBITION; VALIDATION; MONOLAYERS	Dengue is a significant public health problem worldwide. Despite the important social and clinical impact, there is no vaccine or specific antiviral therapy for prevention and treatment of dengue virus (DENV) infection. Considering the above, drug discovery research for dengue is of utmost importance; in addition natural marine products provide diverse and novel chemical structures with potent biological activities that must be evaluated. In this study we propose a target-free approach for dengue drug discovery based on a novel, rapid, and economic in situ enzyme-linked immunosorbent assay and the screening of a panel of marine seaweed extracts. The in situ ELISA was standardized and validated for Huh7.5 cell line infected with all four serotypes of DENV, among them clinical isolates and a laboratory strain. Statistical analysis showed an average S/B of 7.2 and Z-factor of 0.62, demonstrating assay consistency and reliability. A panel of fifteen seaweed extracts was then screened at the maximum non-toxic dose previously determined by the MTT and Neutral Red cytotoxic assays. Eight seaweed extracts were able to reduce DENV infection of at least one serotype tested. Four extracts (Phaeophyta: Canistrocarpus cervicornis, Padina gymnospora; Rhodophyta: Palisada perforate; Chlorophyta: Caulerpa racemosa) were chosen for further evaluation, and time of addition studies point that they might act at an early stage of the viral infection cycle, such as binding or internalization.	[Koishi, Andrea Cristine; Zanello, Paula Rodrigues; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes] Inst Carlos Chagas ICC FIOCRUZ PR, Mol Virol Lab, Curitiba, Parana, Brazil; [Koishi, Andrea Cristine] Univ Fed Parana UFPR, Programa Posgrad Biol Celular & Mol, Curitiba, Parana, Brazil; [Bianco, Everson Miguel] Univ Fed Pernambuco UFPE, Programa Posgrad Quim, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Parana; Universidade Federal de Pernambuco	Bordignon, J (corresponding author), Inst Carlos Chagas ICC FIOCRUZ PR, Mol Virol Lab, Curitiba, Parana, Brazil.	jbordig@tecpar.br; clsantos@tecpar.br	dos Santos, Claudia Nunes Duarte/E-1857-2018; Bordignon, Juliano/Z-6268-2019; dos Santos, Claudia Duarte/P-4868-2019; P, CM/B-1358-2013; Koishi, Andrea/N-2484-2013; Publica, Inct Saude/J-9544-2013	dos Santos, Claudia Nunes Duarte/0000-0001-8707-6638; Bordignon, Juliano/0000-0002-1965-6152; dos Santos, Claudia Duarte/0000-0001-8707-6638; Koishi, Andrea/0000-0002-3542-1353; 	CNPq; Fundacao Araucaria; Fiocruz EMB; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Fiocruz EMB; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by CNPq, Fundacao Araucaria and Fiocruz EMB (post-doctoral fellowship PRODOC/DQF/UFPE jan2009-april2010) and PRZ are supported by fellowships from CAPES. ACK and CNDS are CNPq fellowship recipients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliya R, 2003, PAKISTAN J BOT, V35, P659; BERKOWITZ FE, 1985, ANTIMICROB AGENTS CH, V28, P207, DOI 10.1128/AAC.28.2.207; BIO Ventures for Global Health, 2007, DENGUE FEVER; BORENFREUND E, 1988, TOXICOL IN VITRO, V2, P1, DOI 10.1016/0887-2333(88)90030-6; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Che PL, 2009, INT J CLIN EXP MED, V2, P363; Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P3255, DOI 10.1128/AAC.00397-10; Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10; Chiba K, 1998, TOXICOL IN VITRO, V12, P251, DOI 10.1016/S0887-2333(97)00107-0; Clercq ED, 2009, MED RES REV, V29; Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7; De Burghgraeve T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037244; de Oliveira AS, 2008, NAT PROD COMMUN, V3, P1469; DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469; Ferreira LD, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/431954; FIGUEIREDO LTM, 1989, T ROY SOC TROP MED H, V83, P702, DOI 10.1016/0035-9203(89)90403-3; FIGUEIREDO LTM, 1987, J VIROL METHODS, V17, P191, DOI 10.1016/0166-0934(87)90129-7; Fujii MT, 2011, REV BRAS FARMACOGN, V21, P268, DOI 10.1590/S0102-695X2011005000064; Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Harden EA, 2009, ANTIVIR RES, V83, P282, DOI 10.1016/j.antiviral.2009.06.007; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hidari KIPJ, 2008, BIOCHEM BIOPH RES CO, V376, P91, DOI 10.1016/j.bbrc.2008.08.100; Hong JY, 2011, CURR OPIN CHEM BIOL, V15, P350, DOI 10.1016/j.cbpa.2011.03.004; Jamur MC, 2010, METHODS MOL BIOL, V588, P55, DOI 10.1007/978-1-59745-324-0_8; Khanavi M, 2010, BIOL RES, V43, P31, DOI [10.4067/S0716-97602010000100005, /S0716-97602010000100005]; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Marques CT, 2012, REV BRAS FARMACOGN, V22, P115, DOI 10.1590/S0102-695X2011005000206; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myc A, 1999, J VIROL METHODS, V77, P165, DOI 10.1016/S0166-0934(98)00150-5; Nielsen DG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-211; Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; Sayce AC, 2010, TRENDS MICROBIOL, V18, P323, DOI 10.1016/j.tim.2010.04.003; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321; Stahle EL, 1998, ANTIVIR RES, V40, P105; Stengel DB, 2011, BIOTECHNOL ADV, V29, P483, DOI 10.1016/j.biotechadv.2011.05.016; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08; WHO, 2009, DENGUE GUIDELINES FO; Yasuhara-Bell J, 2010, ANTIVIR RES, V86, P231, DOI 10.1016/j.antiviral.2010.03.009; Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XCG, 2009, ANTIVIR RES, V83, P21, DOI 10.1016/j.antiviral.2009.02.204	51	26	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51089	10.1371/journal.pone.0051089	http://dx.doi.org/10.1371/journal.pone.0051089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227238	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200098
J	Simioni, S; Schluep, M; Bault, N; Coricelli, G; Kleeberg, J; Du Pasquier, RA; Gschwind, M; Vuilleumier, P; Annoni, JM				Simioni, Samanta; Schluep, Myriam; Bault, Nadege; Coricelli, Giorgio; Kleeberg, Joerg; Du Pasquier, Renaud A.; Gschwind, Markus; Vuilleumier, Patrik; Annoni, Jean-Marie			Multiple Sclerosis Decreases Explicit Counterfactual Processing and Risk Taking in Decision Making	PLOS ONE			English	Article							PREFRONTAL CORTEX; EMOTIONAL REACTIVITY; DIAGNOSTIC-CRITERIA; COGNITIVE DEFICITS; LESION LOAD; ALEXITHYMIA; DEPRESSION; ANXIETY; IMPAIRMENT; REGRET	Introduction: Deficits in decision making (DM) are commonly associated with prefrontal cortical damage, but may occur with multiple sclerosis (MS). There are no data concerning the impact of MS on tasks evaluating DM under explicit risk, where different emotional and cognitive components can be distinguished. Methods: We assessed 72 relapsing-remitting MS (RRMS) patients with mild to moderate disease and 38 healthy controls in two DM tasks involving risk with explicit rules: (1) The Wheel of Fortune (WOF), which probes the anticipated affects of decisions outcomes on future choices; and (2) The Cambridge Gamble Task (CGT) which measures risk taking. Participants also underwent a neuropsychological and emotional assessment, and skin conductance responses (SCRs) were recorded. Results: In the WOF, RRMS patients showed deficits in integrating positive counterfactual information (p < 0.005) and greater risk aversion (p < 0.001). They reported less negative affect than controls (disappointment: p = 0.007; regret: p = 0.01), although their implicit emotional reactions as measured by post-choice SCRs did not differ. In the CGT, RRMS patients differed from controls in quality of DM (p = 0.01) and deliberation time (p = 0.0002), the latter difference being correlated with attention scores. Such changes did not result in overall decreases in performance (total gains). Conclusions: The quality of DM under risk was modified by MS in both tasks. The reduction in the expression of disappointment coexisted with an increased risk aversion in the WOF and alexithymia features. These concomitant emotional alterations may have implications for better understanding the components of explicit DM and for the clinical support of MS patients.	[Simioni, Samanta; Schluep, Myriam; Kleeberg, Joerg; Du Pasquier, Renaud A.; Annoni, Jean-Marie] Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland; [Simioni, Samanta; Schluep, Myriam; Kleeberg, Joerg; Du Pasquier, Renaud A.; Annoni, Jean-Marie] Univ Lausanne, Lausanne, Switzerland; [Bault, Nadege; Coricelli, Giorgio] CNRS, Inst Cognit Sci, Ctr Neurosci Cognit, Bron, France; [Gschwind, Markus; Vuilleumier, Patrik; Annoni, Jean-Marie] Univ Geneva, Univ Med Ctr CMU, Dept Neurosci, Geneva, Switzerland; [Annoni, Jean-Marie] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre National de la Recherche Scientifique (CNRS); University of Geneva; University of Fribourg	Annoni, JM (corresponding author), Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland.	jean-marie.annoni@unifr.ch	Bault, Nadège/L-9907-2019; Du Pasquier, Renaud/O-8588-2016; Gschwind, Markus/N-7215-2015; Vuilleumier, Patrik/AAJ-1839-2021	Bault, Nadège/0000-0001-8244-6062; Du Pasquier, Renaud/0000-0002-2786-3434; Gschwind, Markus/0000-0002-5623-1313; Vuilleumier, Patrik/0000-0002-8198-9214	Swiss MS Society; Swiss National Science Foundation [3200BO-118206]; Societe Academique de Geneve	Swiss MS Society; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Societe Academique de Geneve	This work was supported by the Swiss MS Society (Forname Fund to Myriam Schluep), the Swiss National Science Foundation (Grant 3200BO-118206) and the Societe Academique de Geneve (Foremane Fund to Patrik Vuilleumier). The grants were used for the salaries of SS and MG and for the reimbursments of patients' travel and controls' time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bodini B, 2008, ACTA NEUROL SCAND, V118, P18, DOI 10.1111/j.1600-0404.2007.00969.x; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Burnett S, 2010, COGNITIVE DEV, V25, P183, DOI 10.1016/j.cogdev.2009.11.003; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Camille N, 2010, COGN AFFECT BEHAV NE, V10, P460, DOI 10.3758/CABN.10.4.460; Chahraoui K, 2008, REV NEUROL-FRANCE, V164, P242, DOI 10.1016/j.neurol.2007.09.006; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Costa A, 2006, EUR J NEUROL, V13, P836, DOI 10.1111/j.1468-1331.2006.01216.x; Damasio A.R., 1994, DESCARTES ERROR EMOT; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Di Bitonto L, 2011, REV NEUROL-FRANCE, V167, P820, DOI 10.1016/j.neurol.2011.01.024; Fulton JC, 1999, AM J NEURORADIOL, V20, P1951; Garcia-Molina A, 2009, NEUROLOGIA, V24, P94; Giorgetta C, 2012, EMOTION; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Heinzel A, 2010, PSYCHOTHER PSYCHOSOM, V79, P363, DOI 10.1159/000320121; Kincses ZT, 2011, MULT SCLER J, V17, P681, DOI 10.1177/1352458510391342; Kleeberg J, 2004, ANN NEUROL, V56, P787, DOI 10.1002/ana.20277; Korostil M, 2007, MULT SCLER, V13, P67, DOI 10.1177/1352458506071161; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lima FS, 2007, BEHAV NEUROL, V18, P81, DOI 10.1155/2007/674075; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Mavaddat N, 2000, BRAIN, V123, P2109, DOI 10.1093/brain/123.10.2109; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Nagy H, 2006, J INT NEUROPSYCH SOC, V12, P559, DOI 10.1017/S1355617706060644; Passamonti L, 2009, BRAIN, V132, P3380, DOI 10.1093/brain/awp095; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pouga L, 2010, HUM BRAIN MAPP, V31, P1469, DOI 10.1002/hbm.20953; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Prochnow D, 2011, J NEUROL, V258, P1683, DOI 10.1007/s00415-011-6002-4; Ptak R, 2001, BEHAV NEUROSCI, V115, P993, DOI 10.1037//0735-7044.115.5.993; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Rao S, 1990, MANUAL BRIEF REPEATA; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Roca M, 2008, MULT SCLER, V14, P364, DOI 10.1177/1352458507084270; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Simioni S, 2009, J INT NEUROPSYCH SOC, V15, P291, DOI 10.1017/S1355617709090262; Simioni S, 2008, J NEUROL, V255, P1762, DOI 10.1007/s00415-008-0025-5; Spalletta G, 2001, PSYCHOSOM MED, V63, P944, DOI 10.1097/00006842-200111000-00013; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; WISE TN, 1994, HEADACHE, V34, P362, DOI 10.1111/j.1526-4610.1994.hed3406362.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zorzon M, 2001, J NEUROL, V248, P416, DOI 10.1007/s004150170184	55	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50718	10.1371/journal.pone.0050718	http://dx.doi.org/10.1371/journal.pone.0050718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227201	Green Published, gold, Green Submitted			2022-12-25	WOS:000312588200060
J	Wu, JX; Du, J; Liu, LG; Li, Q; Rong, WQ; Wang, LM; Wang, Y; Zang, MY; Wu, ZY; Zhang, YW; Qu, CF				Wu, Jianxiong; Du, Jun; Liu, Liguo; Li, Qian; Rong, Weiqi; Wang, Liming; Wang, Ying; Zang, Mengya; Wu, Zhiyuan; Zhang, Yawei; Qu, Chunfeng			Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy	PLOS ONE			English	Article							HEPATITIS-B VIRUS; HELPER 17 CELLS; GENE-EXPRESSION; TUMOR-DEVELOPMENT; T-CELLS; SURVIVAL; MICROENVIRONMENT; DIFFERENTIATION; PREDICTION; SIGNATURE	Background and Aims: Primary hepatocellular carcinoma (HCC) is usually presented in inflamed fibrotic/cirrhotic liver with extensive lymphocyte infiltration. We examined the associations between the HCC early recurrence and alterations in serum levels of inflammatory cytokines. Methods: A cohort of 105 HCC patients with chronic hepatitis B virus infection were included. Pre-therapy, we quantified their serum concentrations of Th1-, Th2-, Th17-, Treg-related, and other cytokines that have been reported to be associated with poor prognosis in human cancers. IL17-producing T-cells were generated in vitro from HCC patients and co-cultured with HCC cell lines separated by a 0.4 mu M transwell. Results: All the 105 cases of HCC patients had liver cirrhosis. The patients who suffered from HCC early recurrence had higher pre-therapy serum levels of IL17 and lower levels of IL10 than those who did not suffer from recurrence after curative hepatectomy. After adjustment for general tumor clinicopathological factors, elevated serum levels of IL17 (>= 0.9 pg/ml) was found to be an independent risk factor for HCC early recurrence with a hazard ratio of 2.46 (95%CI 1.34-4.51). Patients with bigger tumors (>5 cm in diameter) and elevated serum levels of IL17 had the highest risk of early recurrence as compared to those with only one of these factors (P = 0.009) or without any (P<0.001). These factors showed similar effects on the HCC patient overall survival. Intrahepatic infiltrated T-cells in HCC patients were identified as the major IL17-producing cells. Proliferation of HCC cells, QGY-7703, was augmented QGY-7703, was augmented in the presence of IL17-producing T-cells. This effect diminished after neutralizing antibody against human IL17A or TNF alpha was included. Conclusion: Both tumors and IL17 from liver infiltrated T-cells contributed to HCC early recurrence and progression after curative resection. Pre-therapy serum IL17 levels may serve as an additional indicator for predicting high-risk patients.	[Du, Jun; Liu, Liguo; Wang, Ying; Zang, Mengya; Wu, Zhiyuan; Qu, Chunfeng] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China; [Wu, Jianxiong; Liu, Liguo; Rong, Weiqi; Wang, Liming] Chinese Acad Med Sci, Canc Inst Hosp, Dept Surg, Beijing 100730, Peoples R China; [Li, Qian] Chinese Acad Med Sci, Canc Inst Hosp, Natl Off Canc Prevent & Control, Beijing 100730, Peoples R China; [Li, Qian; Zhang, Yawei] Yale Univ, Sch Publ Hlth, Environm Hlth Sci Div, New Haven, CT USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Yale University	Qu, CF (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China.	quchf@cicams.ac.cn	Wang, Liming/AAD-7697-2020		Natural Science Foundation of China [30973387]; "973'' project [2011CB504205]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973'' project(National Basic Research Program of China)	This work was supported by the Natural Science Foundation of China (#30973387) and "973'' project: 2011CB504205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chew V, 2010, J HEPATOL, V52, P370, DOI 10.1016/j.jhep.2009.07.013; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Dahiya D, 2010, SURGERY, V147, P676, DOI 10.1016/j.surg.2009.10.043; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P215, DOI 10.1158/1055-9965.EPI-08-0705; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; He DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032126; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huang RM, 2003, CANCER RES, V63, P3775; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kirshberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024856; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Marin-Hargreaves G, 2003, CRIT REV ONCOL HEMAT, V47, P13, DOI 10.1016/S1040-8428(02)00213-5; MING L, 2002, HEPATOLOGY, V36, P1214, DOI DOI 10.1053/jhep.2002.36366; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pandey D, 2007, ANN SURG ONCOL, V14, P2817, DOI 10.1245/s10434-007-9518-1; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Qu CF, 2003, J IMMUNOL, V170, P1010, DOI 10.4049/jimmunol.170.2.1010; Seike M, 2007, JNCI-J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu M, 2010, LIVER CANCER, P327; Yan J, 2004, ONCOGENE, V23, P1939, DOI 10.1038/sj.onc.1207306; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	34	31	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50035	10.1371/journal.pone.0050035	http://dx.doi.org/10.1371/journal.pone.0050035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227158	gold, Green Submitted, Green Published			2022-12-25	WOS:000312588200020
J	Yu, PL; Wild, DJ				Yu, Pulan; Wild, David J.			Discovering Associations in Biomedical Datasets by Link-based Associative Classifier (LAC)	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; GENE-EXPRESSION DATA; STOCHASTIC APPROACH; RULES; PAGERANK; SALSA; INHIBITOR; DATABASES; CELLS; AKT	Associative classification mining (ACM) can be used to provide predictive models with high accuracy as well as interpretability. However, traditional ACM ignores the difference of significances among the features used for mining. Although weighted associative classification mining (WACM) addresses this issue by assigning different weights to features, most implementations can only be utilized when pre-assigned weights are available. In this paper, we propose a link-based approach to automatically derive weight information from a dataset using link-based models which treat the dataset as a bipartite model. By combining this link-based feature weighting method with a traditional ACM method-classification based on associations (CBA), a Link-based Associative Classifier (LAC) is developed. We then demonstrate the application of LAC to biomedical datasets for association discovery between chemical compounds and bioactivities or diseases. The results indicate that the novel link-based weighting method is comparable to support vector machine (SVM) and RELIEF method, and is capable of capturing significant features. Additionally, LAC is shown to produce models with high accuracies and discover interesting associations which may otherwise remain unrevealed by traditional ACM. Citation: Yu P, Wild DJ (2012) Discovering Associations in Biomedical Datasets by Link-based Associative Classifier (LAC). PLoS ONE 7(12): e51018. doi:10.1371/journal.pone.0051018	[Yu, Pulan; Wild, David J.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Wild, DJ (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	djwild@indiana.edu						Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Bauckhage C, 2008, LECT NOTES COMPUT SC, V5096, P426, DOI 10.1007/978-3-540-69321-5_43; Becquet C, 2002, GENOME BIOL, V3; Bingzheng Wang, 2011, 2011 IEEE 3rd International Conference on Communication Software and Networks (ICCSN 2011), P145, DOI 10.1109/ICCSN.2011.6014692; Bouzouita I, 2006, LECT NOTES COMPUT SC, V4081, P554; Cai CH, 1998, IDEAS 98 - INTERNATIONAL DATABASE ENGINEERING AND APPLICATIONS SYMPOSIUM, PROCEEDINGS, P68, DOI 10.1109/IDEAS.1998.694360; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-54; Chen Z, 2002, WISE 2002: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS ENGINEERING, P63, DOI 10.1109/WISE.2002.1181644; Cheng TJ, 2011, J CHEM INF MODEL, V51, P2440, DOI 10.1021/ci200192v; Cheng TJ, 2011, J CHEM INF MODEL, V51, P229, DOI 10.1021/ci100364a; Creighton C, 2003, BIOINFORMATICS, V19, P79, DOI 10.1093/bioinformatics/19.1.79; Ding C., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P353; Evangelisti C, 2011, J CELL PHYSIOL, V226, P822, DOI 10.1002/jcp.22407; Farahat A, 2006, SIAM J SCI COMPUT, V27, P1181, DOI 10.1137/S1064827502412875; Fliri AF, 2005, J MED CHEM, V48, P6918, DOI 10.1021/jm050494g; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Garrett CR, 2011, INVEST NEW DRUG, V29, P1381, DOI 10.1007/s10637-010-9479-2; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hansen K, 2009, J CHEM INF MODEL, V49, P2077, DOI 10.1021/ci900161g; Jankowski N, 2011, LECT NOTES COMPUT SC, V7063, P238, DOI 10.1007/978-3-642-24958-7_28; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kazius J, 2005, J MED CHEM, V48, P312, DOI 10.1021/jm040835a; Khan MS, 2008, LECT NOTES ARTIF INT, V5077, P200, DOI 10.1007/978-3-540-70720-2_16; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kumar P, 2010, INT CONF COMPUT AUTO, P718, DOI 10.1109/ICCAE.2010.5451339; Lempel R, 2001, ACM T INFORM SYST, V19, P131, DOI 10.1145/382979.383041; Lempel R, 2000, COMPUT NETW, V33, P387, DOI 10.1016/S1389-1286(00)00034-7; Leung KS, 2010, NUCLEIC ACIDS RES, V38, P6324, DOI 10.1093/nar/gkq500; Li GJ, 2011, INFORMATION SCIENCE AND TECHNOLOGY IN CHINA: A ROADMAP TO 2050, P1; Li WM, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P369, DOI 10.1109/ICDM.2001.989541; Liu B, 1998, KNOWLEDGE DISCOVERY, P80, DOI DOI 10.5555/3000292.3000305; MacDonald NJ, 2010, BIOINFORMATICS, V26, P1834, DOI 10.1093/bioinformatics/btq305; Martinez R, 2008, BIOINFORMATICS, V24, P2643, DOI 10.1093/bioinformatics/btn490; Marx KA, 2003, J CHEM INF COMP SCI, V43, P1652, DOI 10.1021/ci034050+; Meghabghab G, 2008, STUD COMPUT INTELL, V99, P69; Muyeba M, 2009, LECT NOTES ARTIF INT, V5433, P49; Page L, 1999, PAGERANK CITATION RA; Park SH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-36; Qian-Cheng Wang, 2010, 2010 International Conference on Machine Learning and Cybernetics (ICMLC 2010), P220, DOI 10.1109/ICMLC.2010.5581062; Ramkumar G.D., 1998, P 4 ACM INT C KNOWL; Ross DD, 2000, BLOOD, V96, P365, DOI 10.1182/blood.V96.1.365.013k46_365_368; Soni S, 2009, NAT BIOL INSP COMP 2, P1492; Soni S, 2011, PERFORM EVALUATION, P224; Sun K, 2008, IEEE T KNOWL DATA EN, V20, P489, DOI 10.1109/TKDE.2007.190723; Tao F., 2003, P 9 ACM SIGKDD INT C, P661, DOI DOI 10.1145/956750.956836; Thabtah F.A., 2005, P 3 ACSIEEE INT C CO, P127; Thabtah F, 2007, KNOWL ENG REV, V22, P37, DOI 10.1017/S0269888907001026; Tseng VS, 2010, KDD, P253; van der Kolk DM, 2002, BLOOD, V99, P3763, DOI 10.1182/blood.V99.10.3763; Wang W, 2004, KNOWL INF SYST, V6, P203, DOI 10.1007/s10115-003-0108-7; Weill N, 2009, J CHEM INF MODEL, V49, P1049, DOI 10.1021/ci800447g; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yin XX, 2003, SIAM PROC S, P331; Yu P, 2013, J CHEMINFOR IN PRESS; Zuo J, 2002, MINING PREDICATE ASS, P281	55	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51018	10.1371/journal.pone.0051018	http://dx.doi.org/10.1371/journal.pone.0051018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227228	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200089
J	Ho, L; Ali, SA; Al-Jazrawe, M; Kandel, R; Wunder, JS; Alman, BA				Ho, L.; Ali, S. A.; Al-Jazrawe, M.; Kandel, R.; Wunder, J. S.; Alman, B. A.			Primary cilia attenuate hedgehog signalling in neoplastic chondrocytes	ONCOGENE			English	Article						chondrosarcoma; primary cilia; hedgehog pathway; enchondroma; cartilage	RENAL-CELL CARCINOMA; INTRAFLAGELLAR TRANSPORT; GROWTH-PLATE; CARTILAGE HISTOPATHOLOGY; REPRESSOR FUNCTIONS; EXPRESSION; ACTIVATOR; DEFECTS; PATHWAY; CANCER	Primary cilia can act as either a negative or positive regulator of the hedgehog (Hh) signaling pathway. Many cartilage tumors are characterized by abnormal activation of the Hh pathway. Here, we report that the presence of primary cilia occurs at a low frequency (12.4%) in neoplastic chondrocytes from malignant human chondrosarcomas, compared with chondrocytes from normal articular cartilage (67.7%). To determine the function of primary cilia in cartilaginous neoplasia, we studied benign cartilage tumors that are formed in mice by chondrocyte-specific overexpression of Gli2, a downstream transcriptional activator of the Hh pathway. Col2A1-Gli2 mice were crossed with Ift88+/- mice, which display a partial loss of ciliogenesis. Surprisingly, cartilage tumors developed in Ift88+/- mice that were phenotypically similar to those that arise in Col2A1-Gli2 mice. Further activation of the Hh pathway was observed in Col2A1-Gli2; Ift88+/- mice compared with either Col2A1-Gli2 or Ift88+/- mice, which was associated with an increased incidence of cartilage tumors. Chondrosarcomas were established in explant cultures, and treated with choral hydrate, which disrupts the functional primary cilia. Thus, treatment resulted in hyperactivity of the Hh signaling pathway, as well as cellular changes that could promote tumor growth. Primary cilia functions to inhibit Hh signaling in neoplastic chondrocytes. The activation of Hh signaling is sufficient to induce benign cartilage tumors without another oncogenic initiating event. Moreover, as primary cilia suppress Hh pathway activation in chondrosarcoma, cellular mechanisms inhibiting proper cilia function may be important in maintaining the neoplastic phenotype.	[Ho, L.; Ali, S. A.; Al-Jazrawe, M.; Alman, B. A.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Ho, L.; Al-Jazrawe, M.; Kandel, R.; Alman, B. A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ali, S. A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kandel, R.; Wunder, J. S.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wunder, J. S.; Alman, B. A.] Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Alman, BA (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	benjamin.alman@sickkids.ca	Kandel, Rita/E-2149-2017; Kandel, Rita/AAU-9908-2021	Kandel, Rita/0000-0003-4047-3913; Kandel, Rita/0000-0003-4047-3913; Ali, Shabana/0000-0002-4339-9467	Canadian Institutes of Health Research [MOP- 37913]; University of Toronto Fellowship; Hospital for Sick Children (RESTRACOMP); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Fellowship(University of Toronto); Hospital for Sick Children (RESTRACOMP); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Wewould like to acknowledge the Canadian Institutes of Health Research for supporting this research project through operating grant no, MOP- 37913. Funding by the University of Toronto Fellowship and Hospital for Sick Children (RESTRACOMP) is also gratefully acknowledged.	Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; de Andrea CE, 2010, LAB INVEST, V90, P1091, DOI 10.1038/labinvest.2010.81; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Ho L, 2009, CANCER CELL, V16, P126, DOI 10.1016/j.ccr.2009.05.013; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Hsu SHC, 2011, DEVELOPMENT, V138, P3791, DOI 10.1242/dev.069492; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027410; LEE GM, 1987, J CELL SCI, V88, P603; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McGlashan SR, 2008, DEV DYNAM, V237, P2013, DOI 10.1002/dvdy.21501; McGlashan SR, 2007, MATRIX BIOL, V26, P234, DOI 10.1016/j.matbio.2006.12.003; Moser JJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-448; Pansuriya TC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-2; Pauli C, 2012, OSTEOARTHR CARTILAGE, V20, P476, DOI 10.1016/j.joca.2011.12.018; Poon R, 2001, ONCOGENE, V20, P451, DOI 10.1038/sj.onc.1204107; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Serra R, 2008, ANAT REC, V291, P1049, DOI 10.1002/ar.20634; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yan TQ, 2008, CLIN ORTHOP RELAT R, V466, P2184, DOI 10.1007/s11999-008-0332-2; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856	36	40	44	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 21	2013	32	47					5388	5396		10.1038/onc.2012.588	http://dx.doi.org/10.1038/onc.2012.588			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	254PM	23246966	Green Published, hybrid			2022-12-25	WOS:000327177600002
J	Ishii, T; Asai, T; Oyama, D; Agato, Y; Yasuda, N; Fukuta, T; Shimizu, K; Minamino, T; Oku, N				Ishii, Takayuki; Asai, Tomohiro; Oyama, Dai; Agato, Yurika; Yasuda, Nodoka; Fukuta, Tatsuya; Shimizu, Kosuke; Minamino, Tetsuo; Oku, Naoto			Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506	FASEB JOURNAL			English	Article						neuroprotectant; tacrolimus; apoptosis; inflammation; motor function	TACROLIMUS FK506; BRAIN-DAMAGE; PHOSPHORYLATION; ACCUMULATION; CALCINEURIN; APOPTOSIS; PROTECTS; SYSTEM; AGENT; MICE	FK506 (Tacrolimus) has the potential to decrease cerebral ischemia-reperfusion injury. However, the clinical trial of FK506 as a neuroprotectant failed due to adverse side effects. This present study aimed to conduct the selective delivery of FK506 to damaged regions, while at the same time reducing the dosage of FK506, by using a liposomal drug delivery system. First, the cytoprotective effect of polyethylene glycol-modified liposomes encapsulating FK506 (FK506-liposomes) on neuron-like pheochromocytoma PC12 cells was examined. FK506-liposomes protected these cells from H2O2-induced toxicity in a dose-dependent manner. Next, we investigated the usefulness of FK506-liposomes in transient middle cerebral artery occlusion (t-MCAO) rats. FK506-liposomes accumulated in the brain parenchyma by passing through the disrupted blood-brain barrier at an early stage after reperfusion had been initiated. Histological analysis showed that FK506-liposomes strongly suppressed neutrophil invasion and apoptotic cell death, events that lead to a poor stroke outcome. Corresponding to these results, a single injection of FK506-liposomes at a low dosage significantly reduced cerebral cell death and ameliorated motor function deficits in t-MCAO rats. These results suggest that liposomalization of FK506 could reduce the administration dose by enhancing the therapeutic efficacy; hence, FK506-liposomes should be a promising neuroprotectant after cerebral stroke.-Ishii, T., Asai, T., Oyama, D., Agato, Y., Yasuda, N., Fukuta, T., Shimizu, K., Minamino, T., Oku, N. Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506. FASEB J. 27, 1362-1370 (2013). www.fasebj.org	[Ishii, Takayuki; Asai, Tomohiro; Oyama, Dai; Agato, Yurika; Yasuda, Nodoka; Fukuta, Tatsuya; Shimizu, Kosuke; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan; [Minamino, Tetsuo] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan	University of Shizuoka; Osaka University	Oku, N (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	oku@u-shizuoka-ken.ac.jp		Fukuta, Tatsuya/0000-0001-8878-8602; Shimizu, Kosuke/0000-0003-3789-2447	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24790047] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Astellas Pharmaceutical Co., Ltd. (Tokyo, Japan) for the gift of the FK506. This research was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science.	Asai T, 2011, BIOCONJUGATE CHEM, V22, P429, DOI 10.1021/bc1004697; Chuang YC, 2011, NEUROUROL URODYNAM, V30, P421, DOI 10.1002/nau.20981; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9808, DOI 10.1073/pnas.90.21.9808; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Duzgunes N, 1999, ADV DRUG DELIVER REV, V40, P3, DOI 10.1016/S0169-409X(99)00037-X; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Furuichi Y, 2003, J CEREBR BLOOD F MET, V23, P1183, DOI 10.1097/01.WCB.0000088761.02615.EB; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Hashiguchi A, 2003, NEUROSCIENCE, V121, P379, DOI 10.1016/S0306-4522(03)00490-1; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Ishii T, 2012, J CONTROL RELEASE, V160, P81, DOI 10.1016/j.jconrel.2012.02.004; Ishii T, 2010, BRAIN RES, V1321, P164, DOI 10.1016/j.brainres.2010.01.039; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Li JY, 2006, NEUROSCIENCE, V142, P789, DOI 10.1016/j.neuroscience.2006.06.064; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Micheli Maria-Rita, 2012, Recent Pat CNS Drug Discov, V7, P71; Moffatt SD, 1999, TRANSPLANTATION, V67, P1205, DOI 10.1097/00007890-199905150-00001; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; Noto T, 2007, BIOL PHARM BULL, V30, P313, DOI 10.1248/bpb.30.313; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Shichinohe H, 2004, BRAIN RES, V1001, P51, DOI 10.1016/j.brainres.2003.11.054; SHIRAGA T, 1994, BIOCHEM PHARMACOL, V47, P727, DOI 10.1016/0006-2952(94)90136-8; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Tan ML, 2010, PEPTIDES, V31, P184, DOI 10.1016/j.peptides.2009.10.002; Torres E, 2011, J CONTROL RELEASE, V154, P196, DOI 10.1016/j.jconrel.2011.05.017; Toung TJ, 1999, STROKE, V30, P1279, DOI 10.1161/01.STR.30.6.1279; Tuma RF, 2012, CURR PHARM BIOTECHNO, V13, P46; VertutDoi A, 1996, BBA-BIOMEMBRANES, V1278, P19, DOI 10.1016/0005-2736(95)00185-9; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wong CHY, 2008, CURR MED CHEM, V15, P1; Yura H, 1999, J CONTROL RELEASE, V57, P87, DOI 10.1016/S0168-3659(98)00150-3; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06	34	54	59	2	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1362	1370		10.1096/fj.12-221325	http://dx.doi.org/10.1096/fj.12-221325			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23241312				2022-12-25	WOS:000316940800009
J	Gugusheff, JR; Ong, ZY; Muhlhausler, BS				Gugusheff, Jessica R.; Ong, Zhi Yi; Muhlhausler, Beverly S.			A maternal "junk-food" diet reduces sensitivity to the opioid antagonist naloxone in offspring postweaning	FASEB JOURNAL			English	Article						fetal programming; high-fat diet; reward	HIGH-FAT DIET; VENTRAL TEGMENTAL AREA; LOW-BIRTH-WEIGHT; NUTRIENT SELECTION; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; CAFETERIA DIET; PROTEIN-DIET; BREAST-MILK; RAT-BRAIN	Perinatal exposure to a maternal "junk-food" diet has been demonstrated to increase the preference for palatable diets in adult offspring. We aimed to determine whether this increased preference could be attributed to changes in mu-opioid receptor expression within the mesolimbic reward pathway. We report here that mRNA expression of the mu-opioid receptor in the ventral tegmental area (VTA) at weaning was 1.4-fold (males) and 1.9-fold (females) lower in offspring of junk-food (JF)-fed rat dams than in offspring of dams fed a standard rodent diet (control) (P<0.05). Administration of the opioid antagonist naloxone to offspring given a palatable diet postweaning significantly reduced fat intake in control offspring (males: 7.7 +/- 0.7 vs. 5.4 +/- 0.6 g/kg/d; females: 6.9 +/- 0.3 vs. 3.9 +/- 0.5g/kg/d; P<0.05), but not in male JF offspring (8.6 +/- 0.6 vs. 7.1 +/- 0.5g/kg/d) and was less effective at reducing fat intake in JF females (42.2 +/- 6.0 vs. 23.1 +/- 4.1% reduction, P<0.05). Similar findings were observed for total energy intake. Naloxone treatment did not affect intake of standard rodent feed in control or JF offspring. These findings suggest that exposure to a maternal junk-food diet results in early desensitization of the opioid system which may explain the increased preference for junk food in these offspring.-Gugusheff, J. R., Ong, Z. Y., Muhlhausler, B. S. A maternal " junk-food" diet reduces sensitivity to the opioid antagonist naloxone in offspring postweaning. FASEB J. 27, 1275-1284 (2013). www.fasebj.org	[Gugusheff, Jessica R.; Ong, Zhi Yi; Muhlhausler, Beverly S.] Univ Adelaide, Sch Agr Food & Wine, FOODplus Res Ctr, Adelaide, SA 5064, Australia; [Ong, Zhi Yi; Muhlhausler, Beverly S.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	University of Adelaide; University of South Australia	Muhlhausler, BS (corresponding author), Univ Adelaide, Sch Agr Food & Wine, FOODplus Res Ctr, Adelaide, SA 5064, Australia.	beverly.muhlhausler@adelaide.edu.au	Ong, Zhi Yi/AFP-0699-2022	Gugusheff, Jessica/0000-0003-2327-8403; Ong, Zhi Yi/0000-0002-8300-6955; Muhlhausler, Beverly/0000-0002-9021-6790	National Health and Medical Research Council of Australia; Australian Postgraduate Award; University of South Australia; Healthy Development Adelaide	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); University of South Australia; Healthy Development Adelaide	B. M. is supported by a Career Development Award from the National Health and Medical Research Council of Australia. J.G. is supported by an Australian Postgraduate Award. Z.O. is supported by a President's Scholarship from the University of South Australia. Both Z.O. and J.G. are the recipients of top-up scholarships from Healthy Development Adelaide. The authors acknowledge the expert assistance of Pamela Sim with animal protocols. The authors also thank John Carragher for editorial assistance.	Acosta-Martinez M, 2002, NEUROENDOCRINOLOGY, V76, P235, DOI 10.1159/000065953; BAKSHI VP, 1993, J PHARMACOL EXP THER, V265, P1253; BARDO MT, 1983, NEUROPHARMACOLOGY, V22, P453, DOI 10.1016/0028-3908(83)90163-6; BARDO MT, 1981, DEV BRAIN RES, V1, P487, DOI 10.1016/0165-3806(81)90003-1; Bayol SA, 2008, J PHYSIOL-LONDON, V586, P3219, DOI 10.1113/jphysiol.2008.153817; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bergevin A, 2002, NEUROPHARMACOLOGY, V42, P1065, DOI 10.1016/S0028-3908(02)00061-8; BERKOWITZ BA, 1975, J PHARMACOL EXP THER, V195, P499; BRANDS B, 1979, LIFE SCI, V24, P1773, DOI 10.1016/0024-3205(79)90066-3; Chandorkar GA, 1999, ADV DRUG DELIVER REV, V38, P59, DOI 10.1016/S0169-409X(99)00006-X; CHILDERS SR, 1979, EUR J PHARMACOL, V55, P11, DOI 10.1016/0014-2999(79)90142-0; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; COOPER SJ, 1980, PSYCHOPHARMACOLOGY, V71, P1, DOI 10.1007/BF00433244; GIRAUDO SQ, 1993, PHARMACOL BIOCHEM BE, V46, P917, DOI 10.1016/0091-3057(93)90222-F; Glass MJ, 1996, AM J PHYSIOL-REG I, V271, pR217, DOI 10.1152/ajpregu.1996.271.1.R217; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; Kelley AE, 2003, EUR J NEUROSCI, V18, P2592, DOI 10.1046/j.1460-9568.2003.02991.x; Kelley AE, 2002, PHYSIOL BEHAV, V76, P365, DOI 10.1016/S0031-9384(02)00751-5; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Le Saux M, 2005, PSYCHONEUROENDOCRINO, V30, P251, DOI 10.1016/j.psyneuen.2004.08.002; Lindemalm S, 2009, J HUM LACT, V25, P199, DOI 10.1177/0890334408328295; MARKSKAUFMAN R, 1985, PSYCHOPHARMACOLOGY, V85, P414, DOI 10.1007/BF00429656; MARKSKAUFMAN R, 1981, PSYCHOPHARMACOLOGY, V74, P321, DOI 10.1007/BF00432739; Naef L, 2011, NEUROSCIENCE, V176, P225, DOI 10.1016/j.neuroscience.2010.12.037; Naef L, 2008, PSYCHOPHARMACOLOGY, V197, P83, DOI 10.1007/s00213-007-1008-4; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; REPKE JT, 1991, AM J CLIN NUTR, V54, pS237, DOI 10.1093/ajcn/54.1.237S; ROBIEUX I, 1990, J TOXICOL-CLIN TOXIC, V28, P365, DOI 10.3109/15563659008994437; Roca P, 1999, PFLUG ARCH EUR J PHY, V438, P628, DOI 10.1007/s004240051086; SAKAGUCHI T, 1988, J CLIN INVEST, V82, P282, DOI 10.1172/JCI113584; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; Takaya J, 2006, MAGNESIUM RES, V19, P63; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Van Ree JM, 2000, EUR J PHARMACOL, V405, P89, DOI 10.1016/S0014-2999(00)00544-6; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Zhu YX, 1998, J NEUROSCI, V18, P2538	40	23	23	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					1275	1284		10.1096/fj.12-217653	http://dx.doi.org/10.1096/fj.12-217653			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23233534	Green Submitted			2022-12-25	WOS:000315585200039
J	Sundaresan, S; Shahid, R; Riehl, TE; Chandra, R; Nassir, F; Stenson, WF; Liddle, RA; Abumrad, NA				Sundaresan, Sinju; Shahid, Rafiq; Riehl, Terrence E.; Chandra, Rashmi; Nassir, Fatiha; Stenson, William F.; Liddle, Rodger A.; Abumrad, Nada A.			CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin	FASEB JOURNAL			English	Article						CCK; cAMP; calcium	PROTEIN-COUPLED RECEPTORS; IMMUNOFLUORESCENT LOCALIZATION; GASTROINTESTINAL-TRACT; CHOLESTEROL UPTAKE; DIETARY LIPIDS; CD36; ACTIVATION; INTESTINE; APPETITE; FOOD	Genetic variants in the fatty acid (FA) translocase FAT/CD36 associate with abnormal postprandial lipids and influence risk for the metabolic syndrome. CD36 is abundant on apical enterocyte membranes in the proximal small intestine, where it facilitates FA uptake and FA-initiated signaling. We explored whether CD36 signaling influences FA-mediated secretion of cholecystokinin (CCK) and secretin, peptides released by enteroendocrine cells (EECs) in the duodenum/jejunum, which regulate events important for fat digestion and homeostasis. CD36 was immunodetected on apical membranes of secretin- and CCK-positive EECs and colocalized with cytosolic granules. Intragastric lipid administration to CD36(-/-) mice released less secretin (-60%) and CCK (-50%) compared with wild-type mice. Likewise, diminished secretin and CCK responses to FA were observed with CD36(-/-) intestinal segments in vitro, arguing against influence of alterations in fat absorption. Signaling mechanisms underlying peptide release were examined in STC-1 cells stably expressing human CD36 or a signaling-impaired mutant (CD36K/A). FA stimulation of cells expressing CD36 (vs. vector or CD36K/A) released more secretin (3.5- to 4-fold) and CCK (2- to 3-fold), generated more cAMP (2- to 2.5-fold), and enhanced protein kinase A activation. Protein kinase A inhibition (H-89) blunted secretin (80%) but not CCK release, which was reduced (50%) by blocking of calmodulin kinase II (KN-62). Coculture of STC-1 cells with Caco- 2 cells stably expressing CD36 did not alter secretin or CCK release, consistent with a minimal effect of adjacent enterocytes. In summary, CD36 is a major mediator of FA-induced release of CCK and secretin. These peptides contribute to the role of CD36 in fat absorption and to its pleiotropic metabolic effects.-Sundaresan, S., Shahid, R., Riehl, T. E., Chandra, R., Nassir, F., Stenson, W. F., Liddle, R. A., Abumrad, N. A. CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin. FASEB J. 27, 1191-1202 (2013). www.fasebj.org	[Sundaresan, Sinju; Nassir, Fatiha; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Riehl, Terrence E.; Stenson, William F.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Shahid, Rafiq; Chandra, Rashmi; Liddle, Rodger A.] Duke Univ, Dept Med, Div Gastroenterol, Durham, NC 27706 USA	Washington University (WUSTL); Washington University (WUSTL); Duke University	Abumrad, NA (corresponding author), Ctr Human Nutr, Dept Med, 660 S Euclid Ave,Campus Box 8031, St Louis, MO 63110 USA.	nabumrad@dom.wustl.edu		Nassir, Fatiha/0000-0002-3653-3621	U. S. National Institutes of Health [DK033301, DK60022, DK33165, DK55753, DK091946]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, R37DK033165, R01DK098796, R01DK055753, R01DK060022, R01DK091946, R01DK033165, P30DK056341] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge valuable assistance by Terri Pietka (Adipocyte Biology and Molecular Nutrition Core, Nutrition and Obesity Research Center, Washington University School of Medicine; P30-DK056341) and are grateful to Dr. Ondrej Kuda for help with the calcium flux studies and to Dr. Doug Hanahan for the permission to obtain STC-1 cells from American Type Culture Collection (Manassas, VA, USA). This work was supported by funding from U. S. National Institutes of Health grants DK033301, DK60022 (to N. A. A.), DK33165, DK55753 (to W. F. S.), and DK091946 (to R. A. L.). R. S., T. E. R., R. C., and F. N. assisted in data acquisition and reviewed the manuscript; W. F. S. and R. A. L. critically reviewed the manuscript; S. S. obtained and analyzed data; and S. S. and N. A. A. were involved in development of the study concept and design, data analysis and interpretation, and manuscript preparation.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Beglinger C, 2004, PHYSIOL BEHAV, V83, P617, DOI 10.1016/j.physbeh.2004.07.031; Berna MJ, 2007, CURR TOP MED CHEM, V7, P1211; BUCHAN AMJ, 1978, GUT, V19, P403, DOI 10.1136/gut.19.5.403; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chandra R, 2010, CELL TISSUE RES, V341, P289, DOI 10.1007/s00441-010-0997-1; Chang CH, 1998, AM J PHYSIOL-GASTR L, V275, pG192, DOI 10.1152/ajpgi.1998.275.2.G192; Cheng CYY, 2011, NEUROPSYCHOPHARMACOL, V36, P459, DOI 10.1038/npp.2010.178; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; Chey WY, 2003, J GASTROENTEROL, V38, P1025, DOI 10.1007/s00535-003-1235-3; Dockray GJ, 2012, CURR OPIN ENDOCRINOL, V19, P8, DOI 10.1097/MED.0b013e32834eb77d; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hsieh J, 2009, GASTROENTEROLOGY, V137, P997, DOI 10.1053/j.gastro.2009.05.051; Hussain MM, 2000, ATHEROSCLEROSIS, V148, P1; Khan NA, 2009, BBA-MOL CELL BIOL L, V1791, P149, DOI 10.1016/j.bbalip.2009.01.001; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Lam IPY, 2008, INT REV CYTOL, V265, P159, DOI 10.1016/S0074-7696(07)65004-9; Lam IPY, 2006, ANN NY ACAD SCI, V1070, P371, DOI 10.1196/annals.1317.047; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Levy E, 2000, MICROSC RES TECHNIQ, V49, P374, DOI 10.1002/(SICI)1097-0029(20000515)49:4<374::AID-JEMT6>3.0.CO;2-W; LIDDLE RA, 1984, GASTROENTEROLOGY, V87, P542; Liddle RA, 2000, J GASTROENTEROL, V35, P181, DOI 10.1007/s005350050328; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Lipsky RH, 1997, RECEPT SIGNAL TRANS, V7, P1; Little TJ, 2011, PHYSIOL BEHAV, V104, P613, DOI 10.1016/j.physbeh.2011.04.038; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Mathias A, 2010, J BIOL CHEM, V285, P33906, DOI 10.1074/jbc.M110.135111; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Parker HE, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239940900132X; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; POLAK JM, 1971, GUT, V12, P605, DOI 10.1136/gut.12.8.605; POLAK JM, 1971, SCAND J GASTROENTERO, V6, P739, DOI 10.3109/00365527109179946; PortelaGomes GM, 1997, J HISTOCHEM CYTOCHEM, V45, P815, DOI 10.1177/002215549704500606; PRPIC V, 1994, BIOCHEM BIOPH RES CO, V201, P1483, DOI 10.1006/bbrc.1994.1871; Rehfeld JF, 1998, CLIN CHEM, V44, P991; RINDI G, 1990, AM J PATHOL, V136, P1349; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Scott L, 1996, AM J PHYSIOL-GASTR L, V270, pG291, DOI 10.1152/ajpgi.1996.270.2.G291; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Sidhu S. S., 2000, J PHYSL 1, V528, P165; Silverstein RL, 2009, CLIN LIPIDOL, V4, P767, DOI 10.2217/CLP.09.57; Smith J, 2008, WESTERN HUM REV, V62, P36; Suzuki S, 2010, NEUROGASTROENT MOTIL, V22, P585, DOI 10.1111/j.1365-2982.2009.01444.x; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Tashiro M, 2004, AM J PHYSIOL-GASTR L, V286, pG784, DOI 10.1152/ajpgi.00446.2003; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; VARNDELL IM, 1985, HISTOCHEM J, V17, P981, DOI 10.1007/BF01417947; Vinolo MAR, 2012, CURR OPIN CLIN NUTR, V15, P112, DOI 10.1097/MCO.0b013e32834f4598	60	69	70	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1191	1202		10.1096/fj.12-217703	http://dx.doi.org/10.1096/fj.12-217703			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23233532	Green Published			2022-12-25	WOS:000315585200031
J	Watanabe, S; Kaneko, K; Yamanaka, K				Watanabe, Shoji; Kaneko, Kumi; Yamanaka, Koji			Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TARDBP GENE-MUTATIONS; MOTOR DEFICITS; RNA DEPLETION; ALS; AGGREGATION; EXPRESSION; NEURONS; IDENTIFICATION; INSTABILITY	Abnormal protein accumulation is a pathological hallmark of neurodegenerative diseases, including accumulation of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis (ALS). Dominant mutations in the TDP-43 gene are causative for familial ALS; however, the relationship between mutant protein biochemical phenotypes and disease course and their significance to disease pathomechanism are not known. Here, we found that longer half-lives of mutant proteins correlated with accelerated disease onset. Based on our findings, we established a cell model in which chronic stabilization of wildtype TDP-43 protein provoked cytotoxicity and recapitulated pathogenic protein cleavage and insolubility to the detergent Sarkosyl, TDP-43 properties that have been observed in sporadic ALS lesions. Furthermore, these cells showed proteasomal impairment and dysregulation of their own mRNA levels. These results suggest that chronically increased stability of mutant or wild-type TDP-43 proteins results in a gain of toxicity through abnormal proteostasis.	[Watanabe, Shoji; Kaneko, Kumi; Yamanaka, Koji] RIKEN, Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan; [Watanabe, Shoji] Doshisha Univ, Grad Sch Brain Sci, Kyoto 6190225, Japan; [Yamanaka, Koji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Koji] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Yamanaka, Koji] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan	RIKEN; Doshisha University; Japan Science & Technology Agency (JST); Saitama University; Kyoto University	Yamanaka, K (corresponding author), RIKEN, Brain Sci Inst, Lab Motor Neuron Dis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kyamanaka@brain.riken.jp	Yamanaka, Koji/ABD-1034-2020; Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035	Ministry for Education, Culture, and Sports, Science and Technology of Japan [23111006, 23110523, 22700404]; Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour, and Welfare of Japan; Takeda Science Foundation; Naito Foundation	Ministry for Education, Culture, and Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-aid for Scientific Research on Innovative Areas 23111006 and 23110523 (to K. Y.) and 22700404 (to S. W.) for Young Scientists (B) from the Ministry for Education, Culture, and Sports, Science and Technology of Japan, grants-in-aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour, and Welfare of Japan, The Takeda Science Foundation, and The Naito Foundation (to K. Y.).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Del Bo R, 2009, EUR J NEUROL, V16, P727, DOI 10.1111/j.1468-1331.2009.02574.x; Fujita Y, 2011, NEUROLOGY, V77, P1427, DOI 10.1212/WNL.0b013e318232ab87; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kamada M, 2009, J NEUROL SCI, V284, P69, DOI 10.1016/j.jns.2009.04.017; Kirby J, 2010, NEUROGENETICS, V11, P217, DOI 10.1007/s10048-009-0218-9; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lemmens R, 2009, J NEUROL NEUROSUR PS, V80, P354, DOI 10.1136/jnnp.2008.157677; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nozaki I, 2010, INTERNAL MED, V49, P1209, DOI 10.2169/internalmedicine.49.3300; Origone P, 2010, AMYOTROPH LATERAL SC, V11, P223, DOI 10.3109/17482960903165039; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tamaoka A, 2010, INTERNAL MED, V49, P331, DOI 10.2169/internalmedicine.49.2915; Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Tsai CP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.009; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Williams KL, 2009, J NEUROL NEUROSUR PS, V80, P1286, DOI 10.1136/jnnp.2008.163261; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xiong HL, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-8; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	60	80	80	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3641	3654		10.1074/jbc.M112.433615	http://dx.doi.org/10.1074/jbc.M112.433615			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23235148	Green Published, hybrid			2022-12-25	WOS:000314397900068
J	Yeo, YS; Nybo, SE; Chittiboyina, AG; Weerasooriya, AD; Wang, YH; Gongora-Castillo, E; Vaillancourt, B; Buell, CR; DellaPenna, D; Celiz, MD; Jones, AD; Wurtele, ES; Ransom, N; Dudareva, N; Shaaban, KA; Tibrewal, N; Chandra, S; Smillie, T; Khan, IA; Coates, RM; Watt, DS; Chappell, J				Yeo, Yun-Soo; Nybo, S. Eric; Chittiboyina, Amar G.; Weerasooriya, Aruna D.; Wang, Yan-Hong; Gongora-Castillo, Elsa; Vaillancourt, Brieanne; Buell, C. Robin; DellaPenna, Dean; Celiz, Mary Dawn; Jones, A. Daniel; Wurtele, Eve Syrkin; Ransom, Nick; Dudareva, Natalia; Shaaban, Khaled A.; Tibrewal, Nidhi; Chandra, Suman; Smillie, Troy; Khan, Ikhlas A.; Coates, Robert M.; Watt, David S.; Chappell, Joe			Functional Identification of Valerena-1,10-diene Synthase, a Terpene Synthase Catalyzing a Unique Chemical Cascade in the Biosynthesis of Biologically Active Sesquiterpenes in Valeriana officinalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALERENA-4,7(11)-DIENE; EXPRESSION; EXTRACTS; ALCOHOL; PATHWAY; TOPHAT; PLANTS; ACID	Valerian is an herbal preparation from the roots of Valeriana officinalis used as an anxiolytic and sedative and in the treatment of insomnia. The biological activities of valerian are attributed to valerenic acid and its putative biosynthetic precursor valerenadiene, sesquiterpenes, found in V. officinalis roots. These sesquiterpenes retain an isobutenyl side chain whose origin has been long recognized as enigmatic because a chemical rationalization for their biosynthesis has not been obvious. Using recently developed metabolomic and transcriptomic resources, we identified seven V. officinalis terpene synthase genes (VoTPSs), two that were functionally characterized as monoterpene synthases and three that preferred farnesyl diphosphate, the substrate for sesquiterpene synthases. The reaction products for two of the sesquiterpene synthases exhibiting root-specific expression were characterized by a combination of GC-MS and NMR in comparison to the terpenes accumulating in planta. VoTPS7 encodes for a synthase that biosynthesizes predominately germacrene C, whereas VoTPS1 catalyzes the conversion of farnesyl diphosphate to valerena-1,10-diene. Using a yeast expression system, specific labeled [C-13] acetate, and NMR, we investigated the catalytic mechanism for VoTPS1 and provide evidence for the involvement of a caryophyllenyl carbocation, a cyclobutyl intermediate, in the biosynthesis of valerena-1,10-diene. We suggest a similar mechanism for the biosynthesis of several other biologically related isobutenyl-containing sesquiterpenes.	[Yeo, Yun-Soo; Nybo, S. Eric; Chappell, Joe] Univ Kentucky, Plant Biol Program, Lexington, KY 40503 USA; [Chittiboyina, Amar G.; Weerasooriya, Aruna D.; Wang, Yan-Hong; Chandra, Suman; Smillie, Troy; Khan, Ikhlas A.] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Gongora-Castillo, Elsa; Vaillancourt, Brieanne; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [DellaPenna, Dean; Celiz, Mary Dawn; Jones, A. Daniel] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Jones, A. Daniel] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Wurtele, Eve Syrkin; Ransom, Nick] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Dudareva, Natalia] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Shaaban, Khaled A.; Tibrewal, Nidhi] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Watt, David S.] Univ Kentucky, Dept Cellular & Mol Biochem, Lexington, KY 40536 USA; [Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Kentucky; University of Mississippi; Michigan State University; Michigan State University; Michigan State University; Iowa State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Kentucky; University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign	Chappell, J (corresponding author), Univ Kentucky, Plant Biol Program, Lexington, KY 40503 USA.	chappell@uky.edu	Khan, Ikhlas/AAA-1829-2020; Khan, Ikhlas/AAA-1490-2020; Jones, Arthur D/C-2670-2013; Góngora-Castillo, Elsa B/R-8854-2016; Dudareva, Natalia/S-8710-2017; Chittiboyina, Amar G/F-4898-2016; Shaaban, Khaled A./AAN-3108-2021	Góngora-Castillo, Elsa B/0000-0001-6327-6993; Dudareva, Natalia/0000-0003-0777-7763; Chittiboyina, Amar G/0000-0002-7047-5373; Shaaban, Khaled A./0000-0001-7638-4942; Jones, A. Daniel/0000-0002-7408-6690; Vaillancourt, Brieanne/0000-0002-6795-5173; Weerasooriya, Aruna/0000-0002-2001-6101; Wurtele, Eve/0000-0003-1552-9495; Buell, C Robin/0000-0002-6727-4677	National Institutes of Health [1RC2GM092521]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RC2GM092521 (to the Medicinal Plant Consortium).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BACK K, 1995, J BIOL CHEM, V270, P7375, DOI 10.1074/jbc.270.13.7375; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bent S, 2006, AM J MED, V119, P1005, DOI 10.1016/j.amjmed.2006.02.026; Bos R, 1996, PHYTOCHEM ANALYSIS, V7, P143, DOI 10.1002/(SICI)1099-1565(199605)7:3<143::AID-PCA284>3.0.CO;2-1; BOS R, 1986, PHYTOCHEMISTRY, V25, P1234, DOI 10.1016/S0031-9422(00)81590-3; BOWERS WS, 1977, SCIENCE, V196, P680, DOI 10.1126/science.558651; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Chappell J, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P609; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; CONNOLLY JD, 1984, TETRAHEDRON LETT, V25, P1401, DOI 10.1016/S0040-4039(01)80169-6; Disch A, 1998, FEMS MICROBIOL LETT, V168, P201, DOI 10.1016/S0378-1097(98)00442-X; Gongora-Castillo E, 2012, METHOD ENZYMOL, V517, P139, DOI 10.1016/B978-0-12-404634-4.00007-3; Grieve M., 1974, MODERN HERBAL, P824; Gu LP, 2010, PLANT J, V61, P579, DOI 10.1111/j.1365-313X.2009.04083.x; Hirai N, 2000, BIOSCI BIOTECH BIOCH, V64, P1448, DOI 10.1271/bbb.64.1448; Houghton P., 1997, VALERIAN GENUS VALER; Houghton PJ, 1999, J PHARM PHARMACOL, V51, P505, DOI 10.1211/0022357991772772; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; IZAC RR, 1982, TETRAHEDRON LETT, V23, P3743, DOI 10.1016/S0040-4039(00)87695-9; Kitayama T, 2010, BIOSCI BIOTECH BIOCH, V74, P1963, DOI 10.1271/bbb.100297; Lefebvre T, 2004, J PHARM PHARM SCI, V7, P265; Murphy K, 2010, PHYTOMEDICINE, V17, P674, DOI 10.1016/j.phymed.2009.10.020; Paul C, 2001, PHYTOCHEMISTRY, V57, P307, DOI 10.1016/S0031-9422(01)00018-8; Pyle BW, 2012, FEBS J, V279, P3136, DOI 10.1111/j.1742-4658.2012.08692.x; Rising KA, 2000, J AM CHEM SOC, V122, P6526, DOI 10.1021/ja004652z; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; TAKAHASHI K, 1983, J ANTIBIOT, V36, P1531, DOI 10.7164/antibiotics.36.1531; Takahashi S, 2007, BIOTECHNOL BIOENG, V97, P170, DOI 10.1002/bit.21216; Takemoto H, 2009, J NAT MED-TOKYO, V63, P380, DOI 10.1007/s11418-009-0340-x; Tanaka K, 2008, J NAT MED, V62, P112, DOI 10.1007/s11418-007-0199-7; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weeks BS, 2009, MED SCI MONITOR, V15, pRA256; WEINHEIMER A J, 1970, Tetrahedron Letters, V7, P497; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251	36	30	32	2	81	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3163	3173		10.1074/jbc.M112.415836	http://dx.doi.org/10.1074/jbc.M112.415836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23243312	Green Published, hybrid			2022-12-25	WOS:000314397900024
J	Stupka, N; Kintakas, C; White, JD; Fraser, FW; Hanciu, M; Aramaki-Hattori, N; Martin, S; Coles, C; Collier, F; Ward, AC; Apte, SS; McCulloch, DR				Stupka, Nicole; Kintakas, Christopher; White, Jason D.; Fraser, Fiona W.; Hanciu, Michael; Aramaki-Hattori, Noriko; Martin, Sheree; Coles, Chantal; Collier, Fiona; Ward, Alister C.; Apte, Suneel S.; McCulloch, Daniel R.			Versican Processing by a Disintegrin-like and Metalloproteinase Domain with Thrombospondin-1 Repeats Proteinases-5 and-15 Facilitates Myoblast Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; ADAMTS METALLOPROTEASES; MUSCLE GROWTH; IN-VIVO; CELL; EXPRESSION; DIFFERENTIATION; CARTILAGE; MYOGENESIS; MICE	Skeletal muscle development and regeneration requires the fusion of myoblasts into multinucleated myotubes. Because the enzymatic proteolysis of a hyaluronan and versican-rich matrix by ADAMTS versicanases is required for developmental morphogenesis, we hypothesized that the clearance of versican may facilitate the fusion of myoblasts during myogenesis. Here, we used transgenic mice and an in vitro model of myoblast fusion, C2C12 cells, to determine a potential role for ADAMTS versicanases. Versican processing was observed during in vivo myogenesis at the time when myoblasts were fusing to form multinucleated myotubes. Relevant ADAMTS genes, chief among them Adamts5 and Adamts15, were expressed both in developing embryonic muscle and differentiating C2C12 cells. Reducing the levels of Adamts5 mRNA in vitro impaired myoblast fusion, which could be rescued with catalytically active but not the inactive forms of ADAMTS5 or ADAMTS15. The addition of inactive ADAMTS5, ADAMTS15, or full-length V1 versican effectively impaired myoblast fusion. Finally, the expansion of a hyaluronan and versican-rich matrix was observed upon reducing the levels of Adamts5 mRNA in myoblasts. These data indicate that these ADAMTS proteinases contribute to the formation of multinucleated myotubes such as is necessary for both skeletal muscle development and during regeneration, by remodeling a versican-rich pericellular matrix of myoblasts. Our study identifies a possible pathway to target for the improvement of myogenesis in a plethora of diseases including cancer cachexia, sarcopenia, and muscular dystrophy.	[Stupka, Nicole; Kintakas, Christopher; Fraser, Fiona W.; Hanciu, Michael; Martin, Sheree; Ward, Alister C.; McCulloch, Daniel R.] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia; [Stupka, Nicole; Kintakas, Christopher; Fraser, Fiona W.; Hanciu, Michael; Martin, Sheree; Ward, Alister C.; McCulloch, Daniel R.] Deakin Univ, Mol & Med Res SRC, Geelong, Vic 3216, Australia; [Kintakas, Christopher; White, Jason D.; Coles, Chantal] Murdoch Childrens Res Inst, Muscular Dystrophy Res Grp, Parkville, Vic 3052, Australia; [White, Jason D.; Coles, Chantal] Univ Melbourne, Sch Vet, Parkville, Vic 3010, Australia; [Aramaki-Hattori, Noriko; Apte, Suneel S.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Collier, Fiona] Geelong Hosp, Barwon Hlth, Geelong, Vic 3220, Australia	Deakin University; Deakin University; Murdoch Children's Research Institute; University of Melbourne; Cleveland Clinic Foundation; Geelong Hospital	McCulloch, DR (corresponding author), 75 Pigdons Rd, Geelong, Vic 3216, Australia.	daniel.mcculloch@deakin.edu.au	White, Jason/AAF-8712-2020; McCulloch, Daniel/N-9142-2013	White, Jason/0000-0002-0557-392X; McCulloch, Daniel/0000-0003-0269-5857; Apte, Suneel/0000-0001-8441-1226; Stupka, Nicole/0000-0002-1000-1707; Ward, Alister/0000-0001-7945-7975	National Institutes of Health [PO1-HL107147]; Financial Markets Foundation for Children Grant [162-2010]; National Health and Medical Research Council; Molecular and Medical Research SRC, Deakin University; Muscular Dystrophy Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Financial Markets Foundation for Children Grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Molecular and Medical Research SRC, Deakin University; Muscular Dystrophy Australia(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1-HL107147 (to S. A.) and The Financial Markets Foundation for Children Grant 162-2010 (to D. McC., N. S. and A. W.).; Supported in part by a National Health and Medical Research Council Peter Doherty Fellowship.; Supported by Postgraduate Scholarships from the Molecular and Medical Research SRC, Deakin University, and Muscular Dystrophy Australia.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Brown HM, 2006, DEV BIOL, V300, P699, DOI 10.1016/j.ydbio.2006.10.012; Calve S, 2012, FASEB J, V26, P2538, DOI 10.1096/fj.11-200162; Carrino DA, 1999, POULTRY SCI, V78, P769, DOI 10.1093/ps/78.5.769; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Ermakova II, 2011, BIOCHEMISTRY-MOSCOW+, V76, P359, DOI 10.1134/S0006297911030102; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; GOLDSPINK G, 1979, J PHYSIOL-LONDON, V296, P453, DOI 10.1113/jphysiol.1979.sp013016; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kintakas C, 2011, MATRIX BIOL, V30, P311, DOI 10.1016/j.matbio.2011.05.004; KNUDSON CB, 1987, DEV BIOL, V124, P82, DOI 10.1016/0012-1606(87)90462-3; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; McCulloch DR, 2010, OSTEOARTHR CARTILAGE, V18, P455, DOI 10.1016/j.joca.2009.10.014; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; ORKIN RW, 1985, DEV BIOL, V107, P527, DOI 10.1016/0012-1606(85)90333-1; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; RAGANATHAN S, 1995, CELL BIOL INT, V19, P161, DOI 10.1006/cbir.1995.1057; Reed UC, 2009, ARQ NEURO-PSIQUIAT, V67, P144, DOI 10.1590/S0004-282X2009000100038; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stewart MC, 2006, OSTEOARTHR CARTILAGE, V14, P392, DOI 10.1016/j.joca.2005.11.009; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Velasco J, 2011, J BIOL CHEM, V286, P26016, DOI 10.1074/jbc.M110.208694; Velleman SG, 2012, POULTRY SCI, V91, P1964, DOI 10.3382/ps.2012-02147; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318	48	48	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1907	1917		10.1074/jbc.M112.429647	http://dx.doi.org/10.1074/jbc.M112.429647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23233679	hybrid, Green Published			2022-12-25	WOS:000313751400044
J	Ohkura, M; Sasaki, T; Sadakari, J; Gengyo-Ando, K; Kagawa-Nagamura, Y; Kobayashi, C; Ikegaya, Y; Nakai, J				Ohkura, Masamichi; Sasaki, Takuya; Sadakari, Junko; Gengyo-Ando, Keiko; Kagawa-Nagamura, Yuko; Kobayashi, Chiaki; Ikegaya, Yuji; Nakai, Junichi			Genetically Encoded Green Fluorescent Ca2+ Indicators with Improved Detectability for Neuronal Ca2+ Signals	PLOS ONE			English	Article							GCAMP CALCIUM INDICATOR; IN-VIVO; NEURAL ACTIVITY; ELECTROPORATION; ACTIVATION; REPORTER; SPINES; MOUSE	Imaging the activities of individual neurons with genetically encoded Ca2+ indicators (GECIs) is a promising method for understanding neuronal network functions. Here, we report GECIs with improved neuronal Ca2+ signal detectability, termed G-CaMP6 and G-CaMP8. Compared to a series of existing G-CaMPs, G-CaMP6 showed fairly high sensitivity and rapid kinetics, both of which are suitable properties for detecting subtle and fast neuronal activities. G-CaMP8 showed a greater signal (F-max/F-min = 38) than G-CaMP6 and demonstrated kinetics similar to those of G-CaMP6. Both GECIs could detect individual spikes from pyramidal neurons of cultured hippocampal slices or acute cortical slices with 100% detection rates, demonstrating their superior performance to existing GECIs. Because G-CaMP6 showed a higher sensitivity and brighter baseline fluorescence than G-CaMP8 in a cellular environment, we applied G-CaMP6 for Ca2+ imaging of dendritic spines, the putative postsynaptic sites. By expressing a G-CaMP6-actin fusion protein for the spines in hippocampal CA3 pyramidal neurons and electrically stimulating the granule cells of the dentate gyrus, which innervate CA3 pyramidal neurons, we found that sub-threshold stimulation triggered small Ca2+ responses in a limited number of spines with a low response rate in active spines, whereas supra-threshold stimulation triggered large fluorescence responses in virtually all of the spines with a 100% activity rate.	[Ohkura, Masamichi; Sasaki, Takuya; Sadakari, Junko; Gengyo-Ando, Keiko; Kagawa-Nagamura, Yuko; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Kobayashi, Chiaki; Ikegaya, Yuji] Univ Tokyo, Chem Pharmacol Lab, Grad Sch Pharmaceut Sci, Tokyo, Japan	Saitama University; University of Tokyo	Ohkura, M (corresponding author), Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan.	mohkura@mail.saitama-u.ac.jp; ikegaya@mol.f.u-tokyo.ac.jp; jnakai@mail.saitama-u.ac.jp	Sasaki, Takuya/J-3283-2015; Ohkura, Masamichi/J-6976-2012; Nakai, Junichi/GQZ-6415-2022; Gengyo-Ando, Keiko/AAC-4504-2019	Ikegaya, Yuji/0000-0003-2260-8191; Ohkura, Masamichi/0000-0002-3659-7780	Regional Innovation Cluster Program (City Area Type, Central Saitama Area); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22500285, 24111509, 10J05408, 22500353, 21500379]	Regional Innovation Cluster Program (City Area Type, Central Saitama Area); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by the Regional Innovation Cluster Program (City Area Type, Central Saitama Area) and by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to M.O. (nos. 22500285 and 24111509), T.S. (no. 10J05408), K.G.-A. (no. 22500353) and J.N. (no. 21500379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; BRENNER S, 1974, GENETICS, V77, P71; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Edwards RA, 1998, BIOCHEM J, V331, P149, DOI 10.1042/bj3310149; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mittmann W, 2011, NAT NEUROSCI, V14, P1089, DOI 10.1038/nn.2879; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Peled ES, 2011, NAT NEUROSCI, V14, P519, DOI 10.1038/nn.2767; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Yamada Y, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00018; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	33	136	141	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51286	10.1371/journal.pone.0051286	http://dx.doi.org/10.1371/journal.pone.0051286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240011	gold, Green Submitted, Green Published			2022-12-25	WOS:000312290800047
J	Sullivan, C; Liu, YH; Shen, JJ; Curtis, A; Newman, C; Hock, JM; Li, X				Sullivan, Con; Liu, Youhong; Shen, Jingjing; Curtis, Adam; Newman, Christina; Hock, Janet M.; Li, Xiong			Novel Interactions between FOXM1 and CDC25A Regulate the Cell Cycle	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; G(1)/S TRANSITION; TYROSINE PHOSPHATASE; MITOTIC PROGRESSION; ACTIVATES P34CDC2; FORKHEAD; CANCER; EXPRESSION; BINDING; MITOSIS	FOXM1 is a critical regulator of the G1/S and G2/M cell cycle transitions, as well as of the mitotic spindle assembly. Previous studies have suggested that FOXM1 regulates CDC25A gene transcription, but the mechanism remains unknown. Here, we provide evidence that FOXM1 directly regulates CDC25A gene transcription via direct promoter binding and indirect activation of E2F-dependent pathways. Prior literature reported that CDC25B and CDC25C activate CDK1/cyclinB complexes in order to enable phosphorylation of FOXM1. It was unknown if CDC25A functions in a similar manner. We report that FOXM1 transcriptional activity is synergistically enhanced when co-expressed with CDC25A. The increase is dependent upon CDK1 phosphorylation of FOXM1 at T600, T611 and T620 residues. We also report a novel protein interaction between FOXM1 and CDC25A via the C-terminus of FOXM1. We demonstrate that the phosphorylation of Thr 600 and Thr 611 residues of FOXM1 enhanced this interaction, and that the interaction is dependent upon CDC25A phosphatase activity. Our work provides novel insight into the underlying mechanisms by which FOXM1 controls the cell cycle through its association with CDC25A.	[Sullivan, Con; Liu, Youhong; Shen, Jingjing; Curtis, Adam; Newman, Christina; Hock, Janet M.; Li, Xiong] Maine Inst Human Genet & Hlth, Brewer, ME 04412 USA; [Liu, Youhong; Li, Xiong] Cent S Univ, Xiangya Hosp, Ctr Mol Med, Changsha, Hunan, Peoples R China; [Sullivan, Con] Univ Maine, Orono, ME USA	Central South University; University of Maine System; University of Maine Orono	Li, X (corresponding author), Maine Inst Human Genet & Hlth, Brewer, ME 04412 USA.	xiolijob@gmail.com		Hock, Janet/0000-0001-8873-2545	United States Army Medical Research and Materiel Command [USAMRMC 617 0704400]; Maine Institute for Human Genetics and Health, United States of America; "Shenghua Scholar Professorship", Central South University, People's Republic of China	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Maine Institute for Human Genetics and Health, United States of America; "Shenghua Scholar Professorship", Central South University, People's Republic of China	This work was supported by United States Army Medical Research and Materiel Command (USAMRMC 617 0704400), the Maine Institute for Human Genetics and Health, United States of America, and the "Shenghua Scholar Professorship", Central South University, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chen X, 1999, MOL CELL BIOL, V19, P4695; Chen YJ, 2009, J BIOL CHEM, V284, P30695, DOI 10.1074/jbc.M109.007997; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li X, 2005, CANCER RES, V65, P1941, DOI 10.1158/0008-5472.CAN-04-3666; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu YH, 2010, J CELL BIOCHEM, V111, P1546, DOI 10.1002/jcb.22886; Loffler H, 2003, ONCOGENE, V22, P8063, DOI 10.1038/sj.onc.1206976; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; McCain DF, 2002, J BIOL CHEM, V277, P11190, DOI 10.1074/jbc.M109636200; MILLAR JBA, 1991, EMBO J, V10, P4301, DOI 10.1002/j.1460-2075.1991.tb05008.x; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Rudolph J, 2007, NAT REV CANCER, V7, P202, DOI 10.1038/nrc2087; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang ZW, 2010, PHARM RES-DORDR, V27, P1159, DOI 10.1007/s11095-010-0106-x; Wierstra I, 2006, BIOCHEM BIOPH RES CO, V348, P99, DOI 10.1016/j.bbrc.2006.07.008; Wierstra I, 2006, BIOL CHEM, V387, P949, DOI 10.1515/BC.2006.119; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xu X, 1996, J BIOL CHEM, V271, P5118; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827	50	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51277	10.1371/journal.pone.0051277	http://dx.doi.org/10.1371/journal.pone.0051277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240008	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800044
J	Wootton, EC; Woolmer, AP; Vogan, CL; Pope, EC; Hamilton, KM; Rowley, AF				Wootton, Emma C.; Woolmer, Andrew P.; Vogan, Claire L.; Pope, Edward C.; Hamilton, Kristina M.; Rowley, Andrew F.			Increased Disease Calls for a Cost-Benefits Review of Marine Reserves	PLOS ONE			English	Article							PROTECTED AREAS; SHELL DISEASE; ECOLOGICAL CONSEQUENCES; DECAPOD CRUSTACEANS; HOMARUS-AMERICANUS; TROPHIC CASCADES; LOBSTER; POPULATION; ABUNDANCE; RECOGNITION	Marine reserves (or No-Take Zones) are implemented to protect species and habitats, with the aim of restoring a balanced ecosystem. Although the benefits of marine reserves are commonly monitored, there is a lack of insight into the potential detriments of such highly protected waters. High population densities attained within reserves may induce negative impacts such as unfavourable trophic cascades and disease outbreaks. Hence, we investigated the health of lobster populations in the UK's Marine Conservation Zone (MCZ) at Lundy Island. Comparisons were made between the fished, Refuge Zone (RZ) and the un-fished, No-Take Zone (NTZ; marine reserve). We show ostensibly positive effects such as increased lobster abundance and size within the NTZ; however, we also demonstrate apparent negative effects such as increased injury and shell disease. Our findings suggest that robust cost-benefit analyses of marine reserves could improve marine reserve efficacy and subsequent management strategies.	[Wootton, Emma C.; Pope, Edward C.; Hamilton, Kristina M.; Rowley, Andrew F.] Swansea Univ, Dept Biosci, Swansea, W Glam, Wales; [Woolmer, Andrew P.] Salacia Marine, Swansea, W Glam, Wales; [Vogan, Claire L.] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Swansea University; Swansea University	Rowley, AF (corresponding author), Swansea Univ, Dept Biosci, Swansea, W Glam, Wales.	a.f.rowley@swansea.ac.uk	Pope, Edward/G-5665-2011	Pope, Edward/0000-0001-5781-5575	Interreg 4A Ireland-Wales 2007-3013 Programme	Interreg 4A Ireland-Wales 2007-3013 Programme	This work was funded by Interreg 4A Ireland-Wales 2007-3013 Programme (Grant entitled SUSFISH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Agardy T, 2011, UNEP REGIONAL SEAS R; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Beamish RJ, 2006, PROG OCEANOGR, V68, P289, DOI 10.1016/j.pocean.2006.02.005; Beukers-Stewart BD, 2005, MAR ECOL PROG SER, V298, P189, DOI 10.3354/meps298189; Caveen AJ, 2013, MAR POLICY, V37, P3, DOI 10.1016/j.marpol.2012.04.005; Cawthorn RJ, 2011, J INVERTEBR PATHOL, V106, P71, DOI 10.1016/j.jip.2010.09.010; Childress Michael J., 2006, P78, DOI 10.1002/9780470995969.ch3; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Debuse VJ, 1999, ANIM BEHAV, V58, P973, DOI 10.1006/anbe.1999.1213; DOBSON AP, 1987, INT J PARASITOL, V17, P363, DOI 10.1016/0020-7519(87)90111-1; Ehler C., 2009, IOC MANUAL GUIDES, V53; Freeman DJ, 2009, MAR FRESHWATER RES, V60, P140, DOI 10.1071/MF08091; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; GETCHELL R G, 1989, Journal of Shellfish Research, V8, P1; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hoskin MG, 2011, CAN J FISH AQUAT SCI, V68, P185, DOI 10.1139/F10-143; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; Jury SH, 2001, MAR FRESHWATER RES, V52, P1125, DOI 10.1071/MF01096; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; Kelly S, 2002, COAST MANAGE, V30, P153, DOI 10.1080/089207502753504689; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Lebarbenchon C, 2006, ECOHEALTH, V3, P303, DOI 10.1007/s10393-006-0067-z; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lubchenco J, 2003, ECOL APPL, V13, pS3; McCallum H, 2005, J APPL ECOL, V42, P688, DOI 10.1111/j.1365-2664.2005.01043.x; Moland E, 2010, MAR ECOL PROG SER, V400, P165, DOI 10.3354/meps08397; O'Sullivan D, 2011, MAR ECOL PROG SER, V440, P115, DOI 10.3354/meps09294; Page CA, 2009, DIS AQUAT ORGAN, V87, P135, DOI 10.3354/dao02112; Pande A, 2008, MAR ECOL PROG SER, V366, P147, DOI 10.3354/meps07494; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rowe S, 2002, FISH RES, V56, P167, DOI 10.1016/S0165-7836(01)00321-6; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sasal P, 2004, J FISH BIOL, V64, P370, DOI 10.1111/j.0022-1112.2004.00297.x; Skog M, 2009, BEHAVIOUR, V146, P1071, DOI 10.1163/156853909X406437; SMOLOWITZ RM, 1992, BIOL BULL, V183, P99, DOI 10.2307/1542411; Stokesbury KDE, 2007, MAR ECOL PROG SER, V349, P151, DOI 10.3354/meps07113; Vogan CL, 2001, DIS AQUAT ORGAN, V47, P209, DOI 10.3354/dao047209; Vogan CL, 2008, ENVIRON MICROBIOL, V10, P826, DOI 10.1111/j.1462-2920.2007.01514.x	51	25	26	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51615	10.1371/journal.pone.0051615	http://dx.doi.org/10.1371/journal.pone.0051615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240047	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800083
J	Long, GW; Wang, F; Duan, QL; Yang, SL; Chen, FQ; Gong, W; Yang, X; Wang, Y; Chen, C; Wang, DW				Long, Guangwen; Wang, Feng; Duan, Quanlu; Yang, Shenglan; Chen, Fuqiong; Gong, Wei; Yang, Xu; Wang, Yan; Chen, Chen; Wang, Dao Wen			Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial Infarction	PLOS ONE			English	Article							DOWN-REGULATION; HEART-FAILURE; MICRORNAS; BIOGENESIS; DISEASE; ANGIOGENESIS; EXPRESSION; BIOMARKERS; APOPTOSIS; PATHWAY	Background: MicroRNAs (miRNAs) play key roles in diverse biological and pathological processes, including the regulation of proliferation, apoptosis, angiogenesis and cellular differentiation. Recently, circulating miRNAs have been reported as potential biomarkers for various pathologic conditions. This study investigated miR-30a, miR-195 and let-7b as potential of biomarker for acute myocardial infarction (AMI). Methods and Results: Plasma samples from 18 patients with AMI and 30 healthy adults were collected. Total RNA was extracted from plasma with TRIzol LS Reagent. MiRNA levels and plasma cardiac troponin I (cTnI) concentrations were measured by quantitative real-time PCR and ELISA assay, respectively. Results showed that circulating miR-30a in AMI patients was highly expressed at 4 h, 8 h and 12 h after onset of AMI, and miR-195 was highly expressed at 8 h and 12 h. However, let-7b was lower in AMI patients than in controls throughout the whole time points. Interestingly, in these patients, circulating miR-30a, miR-195 and let-7b all reached their expression peak at 8 h. By the receiver operating characteristic (ROC) curve analyses, these plasma miRNAs were of significant diagnostic value for AMI. The combined ROC analysis revealed the an AUC value of 0.93 with 94% sensitivity and 90% specificity at 8 h after onset, and an AUC value of 0.92 with 90% sensitivity and 90% specificity at 12 h after onset, in discriminating the AMI patients from healthy controls. Conclusions: Our results imply that the plasma concentration of miR-30a, miR-195 and let-7b can be potential indicators for AMI.	[Chen, Chen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Inst Hypertens, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, C (corresponding author), Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	chenchen@tjh.tjmu.edu.cn	, Chen/R-4321-2019	, Chen/0000-0001-5080-9383	National Natural Science Foundation of China [30770882, 81070236, 31200594]; Ministry of Health of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of the People's Republic of China	This work was supported by grant from the National Natural Science Foundation of China (No. 30770882, 81070236 and 31200594) and Key Project of Ministry of Health of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Condorelli G, 2010, EUR HEART J, V31, P649, DOI 10.1093/eurheartj/ehp573; Cordes KR, 2010, PEDIATR CARDIOL, V31, P349, DOI 10.1007/s00246-010-9639-3; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Fu J, 2012, ENVIRON TOXICOL PHAR, V33, P312, DOI 10.1016/j.etap.2011.12.023; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; Guo R, 2012, AUTOPHAGY, P8; Ha Tai-You, 2011, Immune Netw, V11, P227, DOI 10.4110/in.2011.11.5.227; He JF, 2011, J BIOCHEM MOL TOXIC, V25, P404, DOI 10.1002/jbt.20396; Kim CW, 2012, NUCLEIC ACIDS RES, V40, P3856, DOI 10.1093/nar/gkr1302; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morrow David A, 2007, Circulation, V115, pe356; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Olivieri F., 2012, INT J CARDIOL; Qin SS, 2011, J CARDIOVASC PHARM, V57, P8, DOI 10.1097/FJC.0b013e318203759b; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437; Yasui N, 2007, HYPERTENS RES, V30, P185, DOI 10.1291/hypres.30.185; Yu ML, 2011, CIRC J, V75, P703, DOI 10.1253/circj.CJ-10-0393; Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145	36	106	118	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50926	10.1371/journal.pone.0050926	http://dx.doi.org/10.1371/journal.pone.0050926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236408	gold, Green Submitted, Green Published			2022-12-25	WOS:000312064100045
J	Pin, C; Hansen, T; Munoz-Cuevas, M; de Jonge, R; Rosenkrantz, JT; Lofstrom, C; Aarts, H; Olsen, JE				Pin, Carmen; Hansen, Trine; Munoz-Cuevas, Marina; de Jonge, Rob; Rosenkrantz, Jesper T.; Lofstrom, Charlotta; Aarts, Henk; Olsen, John E.			The Transcriptional Heat Shock Response of Salmonella Typhimurium Shows Hysteresis and Heated Cells Show Increased Resistance to Heat and Acid Stress	PLOS ONE			English	Article							ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; EXPONENTIAL-GROWTH; OSMOTIC SHIFTS; GENE NETWORKS; SINGLE-CELL; BISTABILITY; PHASE; FOOD; BOUNDARIES	We investigated if the transcriptional response of Salmonella Typhimurium to temperature and acid variations was hysteretic, i.e. whether the transcriptional regulation caused by environmental stimuli showed memory and remained after the stimuli ceased. The transcriptional activity of non-replicating stationary phase cells of S. Typhimurium caused by the exposure to 45 degrees C and to pH 5 for 30 min was monitored by microarray hybridizations at the end of the treatment period as well as immediately and 30 minutes after conditions were set back to their initial values, 25 degrees C and pH 7. One hundred and two out of 120 up-regulated genes during the heat shock remained up-regulated 30 minutes after the temperature was set back to 25 degrees C, while only 86 out of 293 down regulated genes remained down regulated 30 minutes after the heat shock ceased. Thus, the majority of the induced genes exhibited hysteresis, i.e., they remained up-regulated after the environmental stress ceased. At 25 degrees C the transcriptional regulation of genes encoding for heat shock proteins was determined by the previous environment. Gene networks constructed with up-regulated genes were significantly more modular than those of down-regulated genes, implying that down-regulation was significantly less synchronized than up-regulation. The hysteretic transcriptional response to heat shock was accompanied by higher resistance to inactivation at 50 degrees C as well as cross-resistance to inactivation at pH 3; however, growth rates and lag times at 43 degrees C and at pH 4.5 were not affected. The exposure to pH 5 only caused up-regulation of 12 genes and this response was neither hysteretic nor accompanied of increased resistance to inactivation conditions. Cellular memory at the transcriptional level may represent a mechanism of adaptation to the environment and a deterministic source of variability in gene regulation.	[Pin, Carmen; Munoz-Cuevas, Marina] AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Hansen, Trine; Lofstrom, Charlotta] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [de Jonge, Rob; Aarts, Henk] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Rosenkrantz, Jesper T.; Olsen, John E.] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia; Technical University of Denmark; Netherlands National Institute for Public Health & the Environment; University of Copenhagen	Pin, C (corresponding author), AFRC, Inst Food Res, Colney Lane, Norwich NR4 7UA, Norfolk, England.	carmen.pin@bbsrc.ac.uk	Olsen, John Elmerdahl/N-9271-2019; Löfström, Charlotta/F-2217-2011; pin, carmen/C-8959-2014	Löfström, Charlotta/0000-0001-6492-1245; Olsen, John Elmerdahl/0000-0001-6225-6587	European Union [FP6-2006-FOOD-036272]; BBSRC [BBS/E/F/00044406] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044406] Funding Source: researchfish	European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been supported by the European Union integrated project BIOTRACER (FP6-2006-FOOD-036272) under the 6th RTD Framework (http://cordis.europa.eu/fp6/dc/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ordonez A, 2009, FOODBORNE PATHOG DIS, V6, P1147, DOI 10.1089/fpd.2009.0313; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; ANDERSON KL, 2009, INT J MICROBIOL; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Baranyi J, 2004, J FOOD PROTECT, V67, P1967, DOI 10.4315/0362-028X-67.9.1967; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Belessi CIA, 2011, J FOOD PROTECT, V74, P78, DOI 10.4315/0362-028X.JFP-10-117; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hoorfar J, 2011, INT J FOOD MICROBIOL, V145, pS1, DOI 10.1016/j.ijfoodmicro.2010.04.028; Jovanovic G, 2006, J BIOL CHEM, V281, P21147, DOI 10.1074/jbc.M602323200; Laurent M, 2005, CELL MOL BIOL, V51, P583, DOI 10.1170/T667; Le Marc Y, 2010, APPL ENVIRON MICROB, V76, P6555, DOI 10.1128/AEM.00847-10; MACKEY BM, 1990, J APPL BACTERIOL, V69, P373, DOI 10.1111/j.1365-2672.1990.tb01527.x; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Munoz-Cuevas M, 2010, APPL ENVIRON MICROB, V76, P2908, DOI 10.1128/AEM.02572-09; Ou KL, 2005, J BACTERIOL, V187, P4276, DOI 10.1128/JB.187.12.4276-4285.2005; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pin C, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-108; Pin C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-455; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Samelis J, 2003, J APPL MICROBIOL, V95, P563, DOI 10.1046/j.1365-2672.2003.02013.x; SELKOV E, 1975, EUR J BIOCHEM, V59, P151, DOI 10.1111/j.1432-1033.1975.tb02436.x; Shachrai I, 2010, MOL CELL, V38, P758, DOI 10.1016/j.molcel.2010.04.015; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Zhang DL, 2010, INT J FOOD MICROBIOL, V141, P177, DOI 10.1016/j.ijfoodmicro.2010.05.015	32	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51196	10.1371/journal.pone.0051196	http://dx.doi.org/10.1371/journal.pone.0051196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236453	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100081
J	Scheibner, KA; Teaboldt, B; Hauer, MC; Chen, XC; Cherukuri, S; Guo, Y; Kelley, SM; Liu, ZQ; Baer, MR; Heimfeld, S; Civin, CI				Scheibner, Kara A.; Teaboldt, Brianne; Hauer, Mary Claire; Chen, Xiaochun; Cherukuri, Srujana; Guo, Yin; Kelley, Shannon M.; Liu, Zhenqiu; Baer, Maria R.; Heimfeld, Shelly; Civin, Curt I.			MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3 theta	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; STEM-CELL DIFFERENTIATION; C-MYC; MIR-23A-SIMILAR-TO-27A-SIMILAR-TO-24-2 CLUSTER; MICRORNA EXPRESSION; APOPTOSIS; REPRESSION; MIRNAS; CANCER	MicroRNAs (miRs) play major roles in normal hematopoietic differentiation and hematopoietic malignancies. In this work, we report that miR-27a, and its coordinately expressed cluster (miR-23a similar to miR-27a similar to miR-24-2), was down-regulated in acute leukemia cell lines and primary samples compared to hematopoietic stem-progenitor cells (HSPCs). Decreased miR-23a cluster expression in some acute leukemia cell lines was mediated by c-MYC. Replacement of miR-27a in acute leukemia cell lines inhibited cell growth due, at least in part, to increased cellular apoptosis. We identified a member of the anti-apoptotic 14-3-3 family of proteins, which support cell survival by interacting with and negatively regulating pro-apoptotic proteins such as Bax and Bad, as a target of miR-27a. Specifically, miR-27a regulated 14-3-3 theta at both the mRNA and protein levels. These data indicate that miR-27a contributes a tumor suppressor-like activity in acute leukemia cells via regulation of apoptosis, and that miR-27a and 14-3-3 theta may be potential therapeutic targets.	[Scheibner, Kara A.; Teaboldt, Brianne; Hauer, Mary Claire; Chen, Xiaochun; Cherukuri, Srujana; Guo, Yin; Kelley, Shannon M.; Civin, Curt I.] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Scheibner, Kara A.; Chen, Xiaochun; Cherukuri, Srujana; Civin, Curt I.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Liu, Zhenqiu] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Baer, Maria R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Heimfeld, Shelly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Fred Hutchinson Cancer Center	Scheibner, KA (corresponding author), Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA.	KScheibner@som.umaryland.edu			National Foundation for Cancer Research; National Institutes of Health [PO1CA70970, RO1DK080750]; Maryland Stem Cell Research Foundation/TEDCO [2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065-00, 2010-MSCRFE-0067-00]; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080750, P30DK056465] Funding Source: NIH RePORTER	National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation/TEDCO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Foundation for Cancer Research, the National Institutes of Health (PO1CA70970 and RO1DK080750) (http://www.nih.gov/) and the Maryland Stem Cell Research Foundation/TEDCO (2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065-00, and 2010-MSCRFE-0067-00) (http://www.mscrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjappala BS, 2009, J IMMUNOL, V182, P1050, DOI 10.4049/jimmunol.182.2.1050; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Feng DD, 2011, J CELL MOL MED, V15, P2164, DOI 10.1111/j.1582-4934.2010.01213.x; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Gomez-Curet I, 2006, J PEDIATR SURG, V41, P207, DOI 10.1016/j.jpedsurg.2005.10.025; Han BW, 2011, HUM MOL GENET, V20, P4903, DOI 10.1093/hmg/ddr428; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jordan CT, 2002, LEUKEMIA, V16, P559, DOI 10.1038/sj.leu.2402446; Kong KY, 2010, EXP HEMATOL, V38, P629, DOI 10.1016/j.exphem.2010.04.004; Kong Y, 2008, LEUKEMIA, V22, P1207, DOI 10.1038/leu.2008.83; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuzelova K, 2009, J CELL BIOCHEM, V106, P673, DOI 10.1002/jcb.22061; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Merkel O, 2010, CELL CYCLE, V9, P2764, DOI 10.4161/cc.9.14.12267; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morisot S, 2010, LEUKEMIA, V24, P1859, DOI 10.1038/leu.2010.184; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Sakamaki J, 2011, P NATL ACAD SCI USA, V108, P6085, DOI 10.1073/pnas.1015328108; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Saumet A, 2009, BLOOD, V113, P412, DOI 10.1182/blood-2008-05-158139; Singh R, 2012, J CELL SCI, V125, P1568, DOI 10.1242/jcs.095976; Srivastava N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2861; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006849	55	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50895	10.1371/journal.pone.0050895	http://dx.doi.org/10.1371/journal.pone.0050895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236401	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100039
J	Sol, EM; Wagner, SA; Weinert, BT; Kumar, A; Kim, HS; Deng, CX; Choudhary, C				Sol, Eri Maria; Wagner, Sebastian A.; Weinert, Brian T.; Kumar, Amit; Kim, Hyun-Seok; Deng, Chu-Xia; Choudhary, Chunaram			Proteomic Investigations of Lysine Acetylation Identify Diverse Substrates of Mitochondrial Deacetylase Sirt3	PLOS ONE			English	Article							FATTY-ACID OXIDATION; MASS SPECTROMETRY; FRACTIONATION; PHOSPHORYLATION; IDENTIFICATION; METABOLISM; PHYSIOLOGY; EFFICIENT; DISEASE	Lysine acetylation is a posttranslational modification that is dynamically regulated by the activity of acetyltransferases and deacetylases. The human and mouse genomes encode 18 different lysine deacetylases (KDACs) which are key regulators of many cellular processes. Identifying substrates of KDACs and pinpointing the regulated acetylation sites on target proteins may provide important information about the molecular basis of their functions. Here we apply quantitative proteomics to identify endogenous substrates of the mitochondrial deacetylase Sirtuin 3 (Sirt3) by comparing site-specific acetylation in wild-type murine embryonic fibroblasts to Sirt3 knockout cells. We confirm Sirt3-regulated acetylation of several mitochondrial proteins in human cells by comparing acetylation in U2OS cells overexpressing Sirt3 to U2OS cells in which Sirt3 expression was reduced by shRNA. Our data demonstrate that ablation of Sirt3 significantly increases acetylation at dozens of sites on mitochondrial proteins. Substrates of Sirt3 are implicated in various metabolic pathways, including fatty acid metabolism and the tricarboxylic acid cycle. These results imply broader regulatory roles of Sirt3 in the mitochondria by modulating acetylation on diverse substrates. The experimental strategy described here is generic and can be applied to identify endogenous substrates of other lysine deacetylases.	[Sol, Eri Maria; Wagner, Sebastian A.; Weinert, Brian T.; Kumar, Amit; Choudhary, Chunaram] Univ Copenhagen, Dept Prote, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Copenhagen, Denmark; [Kim, Hyun-Seok; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA; [Kim, Hyun-Seok] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Coll Nat Sci, Seoul, South Korea	University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Ewha Womans University	Choudhary, C (corresponding author), Univ Copenhagen, Dept Prote, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Copenhagen, Denmark.	chuna.choudhary@cpr.ku.dk	choudhary, chunaram/ABE-6634-2020; deng, chuxia/N-6713-2016; Imhof, Axel/O-8905-2018	choudhary, chunaram/0000-0002-9863-433X; Imhof, Axel/0000-0003-2993-8249; Weinert, Brian/0000-0002-1335-9915	European Commission [INFRASTRUCTURES-F7-2010-262067/PRIME-XS]; Lundbeck Foundation [R48-A4649]; Novo Nordisk Foundation; Swedish Research Council [20097387]; Danish Council for Independent Research [FSS: 10-085134]	European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work is supported in part by the European Commission's 7th Framework Programme grant Proteomics Research Infrastructure Maximising knowledge EXchange and access (XS) (INFRASTRUCTURES-F7-2010-262067/PRIME-XS), and the Lundbeck Foundation (R48-A4649). The Center for Protein Research is funded by a generous grant from the Novo Nordisk Foundation. EMS is supported by a postdoctoral fellowship from Swedish Research Council (20097387). SAW is supported by a postdoctoral grant from Danish Council for Independent Research (FSS: 10-085134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Gnad F, 2010, MOL CELL PROTEOMICS, V9, P2642, DOI 10.1074/mcp.M110.001594; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Hubner NC, 2008, PROTEOMICS, V8, P4862, DOI 10.1002/pmic.200800351; Kelstrup C. D, 2012, J PROTEOME RES; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim JY, 2002, ANAL CHEM, V74, P5443, DOI 10.1021/ac0256080; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	51	112	114	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50545	10.1371/journal.pone.0050545	http://dx.doi.org/10.1371/journal.pone.0050545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236377	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100019
J	Strand, LB; Laugsand, LE; Skaug, EA; Ellingsen, O; Madssen, E; Wisloff, U; Vatten, L; Janszky, I				Strand, Linn B.; Laugsand, Lars E.; Skaug, Eli-Anne; Ellingsen, Oyvind; Madssen, Erik; Wisloff, Ulrik; Vatten, Lars; Janszky, Imre			Insomnia and Endothelial Function - The HUNT 3 Fitness Study	PLOS ONE			English	Article							SHORT-SLEEP DURATION; ACUTE MYOCARDIAL-INFARCTION; FLOW-MEDIATED DILATION; BRACHIAL-ARTERY; HOSPITAL ANXIETY; RISK; DYSFUNCTION; DEPRESSION; DEPRIVATION; DISTURBANCE	Background: Insomnia is associated with increased risk of coronary heart disease (CHD), but the underlying mechanisms are not understood. To our knowledge, no previous studies have examined insomnia in relation to endothelial function, an indicator of preclinical atherosclerosis. Our aim was to assess the association of insomnia with endothelial function in a large population based study of healthy individuals. Methods: A total of 4 739 participants free from known cardiovascular or pulmonary diseases, cancer, and sarcoidosis, and who were not using antihypertensive medication were included in the study. They reported how often they had experienced difficulties falling asleep at night, repeated awakenings during the night, early awakenings without being able to go back to sleep, and daytime sleepiness. Endothelial function was measured by flow mediated dilation (FMD) derived from the brachial artery. Results: We found no consistent association between the insomnia symptoms and endothelial function in multiadjusted models, but individual insomnia symptoms may be related to endothelial function. Among women who reported early awakenings, endothelial function may be lower than in women without this symptom (p = 0.03). Conclusions: This study provided no evidence that endothelial function, an early indicator of atherosclerosis, is an important linking factor between insomnia and CHD. Further studies are needed to explore the complex interrelation between sleep and cardiovascular pathology. Citation: Strand LB, Laugsand LE, Skaug E-A, Ellingsen O, Madssen E, et al. (2012) Insomnia and Endothelial Function - The HUNT 3 Fitness Study. PLoS ONE 7(12): e50933. doi:10.1371/journal.pone.0050933	[Strand, Linn B.; Laugsand, Lars E.; Vatten, Lars; Janszky, Imre] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Skaug, Eli-Anne; Ellingsen, Oyvind; Madssen, Erik; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Janszky, Imre] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Ellingsen, Oyvind; Madssen, Erik] St Olavs Hosp, Dept Cardiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Norwegian University of Science & Technology (NTNU)	Strand, LB (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	linn.b.strand@ntnu.no	Wisloff, Ulrik/K-2899-2012; Vatten, Lars/AFK-2073-2022; Vatten, Lars/AAF-9380-2022	Wisloff, Ulrik/0000-0002-7211-3587; Skaug, Eli-Anne/0000-0001-8472-3916	Liaison Committee between the Central Norway Regional Health Authority; Norwegian University of Science and Technology; Swedish Research Council; Swedish Council of Working Life and Social Research; Norwegian Council on Cardiovascular Disease; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Norwegian Research Council Grant for Outstanding Young Investigators; K.G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease	Liaison Committee between the Central Norway Regional Health Authority; Norwegian University of Science and Technology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council of Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Norwegian Council on Cardiovascular Disease; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Norwegian Research Council Grant for Outstanding Young Investigators; K.G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease	This work was supported by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (LBS, IJ, LEL), the Swedish Research Council and by the Swedish Council of Working Life and Social Research (IJ). FMD-data was collected in the Fitness - study and this work was supported by grants from the Norwegian Council on Cardiovascular Disease, the Foundation for Cardiovascular Research at St. Olav's Hospital; the Norwegian State Railways; and Roche Norway Incorporated, and a Norwegian Research Council Grant for Outstanding Young Investigators (UW) and the K.G. Jebsen Foundation, Norwegian Council of Cardiovascular Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Amir O, 2004, AM J CARDIOL, V93, P947, DOI 10.1016/j.amjcard.2003.12.032; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Behrendt D, 2002, AM J CARDIOL, V90, p40L, DOI 10.1016/S0002-9149(02)02963-6; BENOIT O, 1981, CHRONOBIOLOGIA, V8, P341; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Carney CE, 2010, SER ANXIETY RELAT DI, P1, DOI 10.1007/978-1-4419-1434-7; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Drexler H, 1997, PROG CARDIOVASC DIS, V39, P287, DOI 10.1016/S0033-0620(97)80030-8; Egashira K, 2002, CIRC J, V66, P529, DOI 10.1253/circj.66.529; Elwood P, 2006, J EPIDEMIOL COMMUN H, V60, P69, DOI 10.1136/jech.2005.039057; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hattori M, 2001, J Hum Ergol (Tokyo), V30, P321; Irwin MR, 2008, BIOL PSYCHIAT, V64, P538, DOI 10.1016/j.biopsych.2008.05.004; Janszky I, 2010, EUR J EPIDEMIOL, V25, P361, DOI 10.1007/s10654-010-9462-4; Janszky I, 2010, J AM COLL CARDIOL, V56, P31, DOI 10.1016/j.jacc.2010.03.033; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Kuvin JT, 2001, J AM COLL CARDIOL, V38, P1843, DOI 10.1016/S0735-1097(01)01657-6; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Littner M, 2003, SLEEP, V26, P754, DOI 10.1093/sleep/26.6.754; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miller MA, 2010, ARTERIOSCL THROM VAS, V30, P2032, DOI 10.1161/ATVBAHA.110.206987; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Peretz Alon, 2007, BMC Cardiovasc Disord, V7, P11, DOI 10.1186/1471-2261-7-11; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Schillaci G, 2001, AM J CARDIOL, V87, P1323, DOI 10.1016/S0002-9149(01)01535-1; Skaug E-A, 2012, EUROPEAN J PREVENTIV; Spiegelhalder K, 2010, NAT SCI SLEEP, V2, P71; Takase B, 2004, CLIN CARDIOL, V27, P223, DOI 10.1002/clc.4960270411; Taylor DJ, 2008, SLEEP, V31, P447, DOI 10.1093/sleep/31.4.447; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; Van Dongen HPA, 2005, SLEEP, V28, P479, DOI 10.1093/sleep/28.4.479; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Weil BR, 2010, CAN J PHYSIOL PHARM, V88, P777, DOI 10.1139/Y10-046; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391; Zigmond A. S., 1994, HADS HOSP ANXIETY DE	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50933	10.1371/journal.pone.0050933	http://dx.doi.org/10.1371/journal.pone.0050933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236412	Green Published, gold			2022-12-25	WOS:000312589700024
J	Heise, CE; Murray, J; Augustyn, KE; Bravo, B; Chugha, P; Cohen, F; Giannetti, AM; Gibbons, P; Hannoush, RN; Hearn, BR; Jaishankar, P; Ly, CQ; Shah, K; Stanger, K; Steffek, M; Tang, YY; Zhao, XR; Lewcock, JW; Renslo, AR; Flygare, J; Arkin, MR				Heise, Christopher E.; Murray, Jeremy; Augustyn, Katherine E.; Bravo, Brandon; Chugha, Preeti; Cohen, Frederick; Giannetti, Anthony M.; Gibbons, Paul; Hannoush, Rami N.; Hearn, Brian R.; Jaishankar, Priyadarshini; Ly, Cuong Q.; Shah, Kinjalkumar; Stanger, Karen; Steffek, Micah; Tang, Yinyan; Zhao, Xianrui; Lewcock, Joseph W.; Renslo, Adam R.; Flygare, John; Arkin, Michelle R.			Mechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6	PLOS ONE			English	Article							SUBSTRATE RECOGNITION; PROTEOLYTIC CLEAVAGE; ALLOSTERIC SITE; ACTIVATION; PROTEIN; IDENTIFICATION; BINDING; DEHYDROGENASE; RESVERATROL; SPECIFICITY	Inhibition of caspase-6 is a potential therapeutic strategy for some neurodegenerative diseases, but it has been difficult to develop selective inhibitors against caspases. We report the discovery and characterization of a potent inhibitor of caspase-6 that acts by an uncompetitive binding mode that is an unprecedented mechanism of inhibition against this target class. Biochemical assays demonstrate that, while exquisitely selective for caspase-6 over caspase-3 and -7, the compound's inhibitory activity is also dependent on the amino acid sequence and P1' character of the peptide substrate. The crystal structure of the ternary complex of caspase-6, substrate-mimetic and an 11 nM inhibitor reveals the molecular basis of inhibition. The general strategy to develop uncompetitive inhibitors together with the unique mechanism described herein provides a rationale for engineering caspase selectivity.	[Heise, Christopher E.; Bravo, Brandon; Giannetti, Anthony M.; Shah, Kinjalkumar] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Murray, Jeremy; Steffek, Micah] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Augustyn, Katherine E.; Chugha, Preeti; Hearn, Brian R.; Jaishankar, Priyadarshini; Tang, Yinyan; Renslo, Adam R.; Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Cohen, Frederick; Gibbons, Paul; Ly, Cuong Q.; Zhao, Xianrui; Flygare, John] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Hannoush, Rami N.; Stanger, Karen] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Lewcock, Joseph W.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Heise, CE (corresponding author), Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA.	heise.christopher@gene.com; michelle.arkin@ucsf.edu	arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	arkin, michelle/0000-0002-9366-6770; Renslo, Adam/0000-0002-1240-2846; Hearn, Brian/0000-0002-2078-5728				Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Giannetti AM, 2011, METHOD ENZYMOL, V493, P169, DOI 10.1016/B978-0-12-381274-2.00008-X; Graham RK, 2011, TRENDS NEUROSCI; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Groebe DR, 2009, DRUG DISCOV TODAY, V14, P41, DOI 10.1016/j.drudis.2008.09.011; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; HEDSTROM L, 1990, BIOCHEMISTRY-US, V29, P849, DOI 10.1021/bi00456a001; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Leyva MJ, 2010, CHEM BIOL, V17, P1189, DOI 10.1016/j.chembiol.2010.08.014; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mintzer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030376; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Panigrahi SK, 2007, PROTEINS, V67, P128, DOI 10.1002/prot.21253; Pereira NA, 2008, BIOCHEM BIOPH RES CO, V377, P873, DOI 10.1016/j.bbrc.2008.10.101; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schmidt MF, 2009, ANGEW CHEM INT EDIT, V48, P6346, DOI 10.1002/anie.200901647; Schneck JL, 2008, BIOCHEMISTRY-US, V47, P8697, DOI 10.1021/bi8007627; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Tang YY, 2011, J BIOL CHEM, V286, P34147, DOI 10.1074/jbc.M111.247627; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; VanScyoc WS, 2008, BIOCHEMISTRY-US, V47, P5017, DOI 10.1021/bi701811x; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141	40	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50864	10.1371/journal.pone.0050864	http://dx.doi.org/10.1371/journal.pone.0050864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227217	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200078
J	Kundu, D; Kumar, AMV; Satyanarayana, S; Dewan, PK; Nair, SA; Khaparde, K; Nayak, P; Van den Bergh, R; Manzi, M; Enarson, DA; Deshpande, MR; Chandraker, S				Kundu, Debashish; Kumar, Ajay M. V.; Satyanarayana, Srinath; Dewan, Puneet Kumar; Nair, Sreenivas Achuthan; Khaparde, Kshitij; Nayak, Priyakanta; Van den Bergh, Rafael; Manzi, Marcel; Enarson, Donald A.; Deshpande, Madhav Rao; Chandraker, Sachin			Can Follow-Up Examination of Tuberculosis Patients Be Simplified? A Study in Chhattisgarh, India	PLOS ONE			English	Article								Background: Each follow-up during the course of tuberculosis treatment currently requires two sputum examinations. However, the incremental yield of the second sputum sample during follow-up of different types of tuberculosis patients has never been determined precisely. Objectives: To assess the incremental yield of the second sputum sample in the follow-up of tuberculosis patients under the Revised National Tuberculosis Control Programme (RNTCP) in Chhattisgarh, India. Methodology: A record review of tuberculosis (TB) patients registered in 2009 using a structured proforma from two sources, Tuberculosis and Laboratory Register, was undertaken in the six districts of Chhattisgarh, India. Results: In smear positive cases, of 10,048 follow-up examinations, 45 (0.5%) were found to be smear positive only on the second sputum when the result of the first sample was negative. In smear negative pulmonary and extra pulmonary TB patients, of 6,206 follow-up smear examinations, 11(0.2%) were found to be smear positive. Conclusions: The incremental yield of a second smear examination was very low, indicating that examination of one sputum sample is enough during follow-up among TB patients. There is insufficient yield to support sputum smear microscopy for monitoring smear negative pulmonary TB and extra pulmonary TB patients. These results indicate that the follow-up smear microscopy can be substantially simplified with favourable resource implications.	[Kundu, Debashish; Dewan, Puneet Kumar; Nair, Sreenivas Achuthan; Khaparde, Kshitij; Nayak, Priyakanta] WHO Country Off, Off World Hlth Org WHO Representat India, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath; Enarson, Donald A.] South East Asia Off, Int Union TB & Lung Dis Union, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath; Enarson, Donald A.] South East Asia Off, Int Union TB & Lung Dis Union, Paris, France; [Van den Bergh, Rafael; Manzi, Marcel] OCB, Luxembourg, Luxembourg; [Deshpande, Madhav Rao] Directorate Hlth Serv, Raipur, Chhattisgarh, India; [Chandraker, Sachin] Intermediate Reference Lab, Raipur, Chhattisgarh, India	World Health Organization	Kundu, D (corresponding author), WHO Country Off, Off World Hlth Org WHO Representat India, New Delhi, India.	debashishkundu@yahoo.com		Nair, Sreenivas/0000-0002-2586-6797; Van den Bergh, Rafael/0000-0001-6277-8713; Satyanarayana, Srinath/0000-0002-5420-2551	Department for International Development, United Kingdom; Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg	Department for International Development, United Kingdom; Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg	This research was supported through an operational research course, which was jointly developed and run by the Center for Operational Research, International Union Against Tuberculosis and Lung Disease, France, and the Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg. Funding for the course was from an anonymous donor and the Department for International Development, United Kingdom. Additional support for running the course was provided by the Center for International Health, University of Bergen, Norway. This study itself was not funded. However, the publication fee is being funded by the Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central TB Division, 2011, MAN RNTCP YOUR AR TR; Nataraj Gita, 2011, Indian J Tuberc, V58, P60; Shivakumar M, 2006, INT J TUBERC LUNG D, V10, P1296; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	4	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51038	10.1371/journal.pone.0051038	http://dx.doi.org/10.1371/journal.pone.0051038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227230	gold, Green Published, Green Submitted			2022-12-25	WOS:000323179700002
J	Liu, P; Xia, JH; Lin, G; Sun, F; Liu, F; Lim, HS; Pang, HY; Yue, GH				Liu, Peng; Xia, Jun Hong; Lin, Grace; Sun, Fei; Liu, Feng; Lim, Huan Sein; Pang, Hong Yan; Yue, Gen Hua			Molecular Parentage Analysis Is Essential in Breeding Asian Seabass	PLOS ONE			English	Article							BARRAMUNDI LATES-CALCARIFER; GROWTH-RELATED TRAITS; LINKAGE MAP; MICROSATELLITE MARKERS; SPERM COMPETITION; DNA MARKER; HERITABILITY; AQUACULTURE; GENETICS; PROGRAM	In aquaculture species, maintaining pedigree information and genetic variation in each generation is essential, but very difficult. In this study, we used nine microsatellites to genotype 2,520 offspring from four independent full-factorial crosses (10 males x 10 females) of Asian seabass to reconstruct pedigree and monitor the change of genetic variations. In all four crosses, over 96.8% of the offspring could be assigned to their parents, indicating the high power of the nine microsatellites for parentage assignment. This study revealed several interesting results: (1). In all four crosses, the contribution of parents to offspring was significantly uneven, and some dominant breeding fishes (i.e. brooders) were found; (2). In two mass crosses where the brooders were carefully checked for reproductive status, a majority (>= 90%) of brooders contributed to offspring, whereas in another two crosses, where the brooders were randomly picked without checking reproductive status, only a few brooders (40.0-45.0%) produced offspring; (3). Females had more problems in successful spawning compared to males; and (4). In the two crosses where a few brooders produced offspring, there was a substantial loss in allelic (24.1-34.3%) and gene (20.5-25.7%) diversities in offspring, while in the other two crosses, the majority of allelic (96.8-97.0%) and gene diversities (94.8-97.1%) were maintained. These observations suggest that a routine molecular parentage analysis is required to maintain both allelic and gene diversity in breeding Asian seabass.	[Liu, Peng; Xia, Jun Hong; Lin, Grace; Sun, Fei; Liu, Feng; Pang, Hong Yan; Yue, Gen Hua] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore; [Lim, Huan Sein] Agri Food & Vet Author Singapore, Marine Aquaculture Ctr, Singapore, Singapore	National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	AVA, Singapore	AVA, Singapore	This study is part of the project "To ensure self-sufficiency of safe seafood for Singapore through the development of aquaculture genomic tools for marker-assisted selective breeding of tropical marine foodfish'' funded by AVA, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Duchesne P, 2002, MOL ECOL NOTES, V2, P191, DOI 10.1046/j.1471-8286.2002.00164.x; *FAO, 2008, FOOD AGR ORG UN STAT; Frost LA, 2006, AQUACULTURE, V261, P1056, DOI 10.1016/j.aquaculture.2006.09.004; GARCIA LMB, 1990, AQUACULTURE, V86, P333, DOI 10.1016/0044-8486(90)90124-6; Gjedrem T, 2009, REV-METHODS TECHNOL, V10, P1, DOI 10.1007/978-90-481-2773-3_1; Gjedrem T, 2010, REV AQUACULT, V2, P2, DOI 10.1111/j.1753-5131.2010.01011.x; Hara M, 2003, AQUACULTURE, V217, P107, DOI 10.1016/S0044-8486(02)00069-8; Herbinger CM, 1995, AQUACULTURE, V137, P245, DOI 10.1016/0044-8486(95)01109-9; Jerry DR, 2006, AQUACULTURE, V254, P171, DOI 10.1016/j.aquaculture.2005.10.035; Jerry DR, 2004, AQUACULTURE, V235, P237, DOI 10.1016/j.aquaculture.2004.01.019; Lewis PO, 2000, GENETIC DATA ANAL; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Nelson JS, 1984, FISHES WORLD; Norris AT, 2000, AQUACULTURE, V182, P73, DOI 10.1016/S0044-8486(99)00247-1; PALMER PJ, 1993, REPROD FERT DEVELOP, V5, P285, DOI 10.1071/RD9930285; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; Schuster SC, 2008, NATURE, V5, P15; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Vandeputte M, 2004, AQUACULTURE, V235, P223, DOI 10.1016/j.aquaculture.2003.12.019; Wang CM, 2008, ANIM GENET, V39, P34, DOI 10.1111/j.1365-2052.2007.01672.x; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-139; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Xia JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011974; Xu YX, 2006, ANIM GENET, V37, P266, DOI 10.1111/j.1365-2052.2006.01423.x; Yue GH, 2009, AQUACULTURE, V293, P22, DOI 10.1016/j.aquaculture.2009.03.053; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Yue GH, 2002, MAR BIOTECHNOL, V4, P503, DOI 10.1007/s10126-002-0037-6; Zhu ZY, 2010, ANIM GENET, V41, P208, DOI 10.1111/j.1365-2052.2009.01973.x; Zhu ZY, 2006, AQUACULTURE, V256, P167, DOI 10.1016/j.aquaculture.2006.02.033	34	22	22	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51142	10.1371/journal.pone.0051142	http://dx.doi.org/10.1371/journal.pone.0051142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227245	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200104
J	Mologni, L; Brussolo, S; Ceccon, M; Gambacorti-Passerini, C				Mologni, Luca; Brussolo, Stefania; Ceccon, Monica; Gambacorti-Passerini, Carlo			Synergistic Effects of Combined Wnt/KRAS Inhibition in Colorectal Cancer Cells	PLOS ONE			English	Article							PANCREATIC TUMOR-GROWTH; BETA-CATENIN; K-RAS; COLON-CANCER; PYRVINIUM PAMOATE; CARCINOMA-CELLS; IN-VITRO; FARNESYLTHIOSALICYLIC ACID; PROMOTES APOPTOSIS; THYROID CARCINOMAS	Activation of Wnt signalling due to inability to degrade beta-catenin is found in >85% of colorectal cancers. Approximately half of colon cancers express a constitutively active KRAS protein. A significant fraction of patients show both abnormalities. We previously reported that simultaneous down-regulation of both beta-catenin and KRAS was necessary to induce significant cell death and tumor growth inhibition of colorectal cancer cells. Although attractive, an RNAi-based therapeutic approach is still far from being employed in the clinical setting. Therefore, we sought to recapitulate our previous findings by the use of small-molecule inhibitors of beta-catenin and KRAS. We show here that the beta-catenin inhibitors PKF115-584 and pyrvinium pamoate block beta-catenin-dependent transcriptional activity and synergize with the KRAS inhibitor S-trans, transfarnesylthiosalicylic acid (FTS, salirasib) in colon cancer cells driven by Wnt and KRAS oncogenic signals, but not in cells carrying BRAF mutations. The combined use of these compounds was superior to the use of any drug alone in inducing cell growth arrest, cell death, MYC and survivin down-modulation, and inhibition of anchorage-independent growth. Expression analysis of selected cancer-relevant genes revealed down-regulation of CD44 as a common response to the combined treatments. These data provide a proof of principle for a combination therapeutic strategy in colorectal cancer.	[Mologni, Luca; Ceccon, Monica; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Brussolo, Stefania] Univ Ca Foscari, Dept Environm Sci, Venice, Italy	University of Milano-Bicocca; Universita Ca Foscari Venezia	Mologni, L (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	luca.mologni@unimib.it	Mologni, Luca/AAC-1065-2022	Mologni, Luca/0000-0002-6365-5149; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X	Italian Association for Cancer Research (AIRC), Cariplo Foundation; Italian Ministry of Health and Lombardy Regional Government	Italian Association for Cancer Research (AIRC), Cariplo Foundation(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health and Lombardy Regional Government	This work was supported by the Italian Association for Cancer Research (AIRC), Cariplo Foundation, the Italian Ministry of Health and Lombardy Regional Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Balmanno K, 2009, INT J CANCER, V125, P2332, DOI 10.1002/ijc.24604; Biankin AV, 2011, HUM GENET, V130, P79, DOI 10.1007/s00439-011-1010-0; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Doghman M, 2008, J CLIN ENDOCR METAB, V93, P3222, DOI 10.1210/jc.2008-0247; Downey AS, 2008, ANTIMICROB AGENTS CH, V52, P3106, DOI 10.1128/AAC.00207-08; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Elad G, 1999, BBA-MOL CELL RES, V1452, P228, DOI 10.1016/S0167-4889(99)00144-5; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; FABIEN N, 1992, BRIT J CANCER, V66, P1094, DOI 10.1038/bjc.1992.416; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Frattini M, 2004, CLIN CANCER RES, V10, P4015, DOI 10.1158/1078-0432.CCR-04-0031; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gorospe M, 1996, MOL CELL BIOL, V16, P6654; Haklai R, 2008, CANCER CHEMOTH PHARM, V61, P89, DOI 10.1007/s00280-007-0451-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Kaneko R, 2007, J BIOL CHEM, V282, P19273, DOI 10.1074/jbc.M610350200; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Kucherlapati R, 2012, AACR ANN M; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Levy R, 2010, MOL CANCER THER, V9, P2208, DOI 10.1158/1535-7163.MCT-10-0262; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; MARCIANO D, 1995, J MED CHEM, V38, P1267, DOI 10.1021/jm00008a004; Mariadason JM, 2001, CANCER RES, V61, P3465; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Migliardi G, 2012, CLIN CANCER RES, V2012, P12; Misra S, 1944, FEBS J, V278, P1429; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Mologni L, 2009, INT J CANCER, V124, P1990, DOI 10.1002/ijc.24158; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oxnard GR, 2010, ONCOLOGY-NY, V24, P392; Poluha W, 1996, MOL CELL BIOL, V16, P1335; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sarthy AV, 2007, MOL CANCER THER, V6, P269, DOI 10.1158/1535-7163.MCT-06-0560; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smakman N, 2006, CANCER RES, V66, P5403, DOI 10.1158/0008-5472.CAN-05-4108; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Tan YH, 2008, PATHOLOGY, V40, P295, DOI 10.1080/00313020801911512; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vasovcak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024114; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Weis B, 1999, ONCOGENE, V18, P2579, DOI 10.1038/sj.onc.1202602; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zhang T, 2001, CANCER RES, V61, P8664; Zundelevich A, 2007, MOL CANCER THER, V6, P1765, DOI 10.1158/1535-7163.MCT-06-0706	63	35	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51449	10.1371/journal.pone.0051449	http://dx.doi.org/10.1371/journal.pone.0051449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227266	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200125
J	Zheng, M; Wu, JN; Huang, YX; Liu, GX; Zhou, Y; Zhou, CG				Zheng, Ming; Wu, Jia-nan; Huang, Yan-xin; Liu, Gui-xia; Zhou, You; Zhou, Chun-guang			Inferring Gene Regulatory Networks by Singular Value Decomposition and Gravitation Field Algorithm	PLOS ONE			English	Article								Reconstruction of gene regulatory networks (GRNs) is of utmost interest and has become a challenge computational problem in system biology. However, every existing inference algorithm from gene expression profiles has its own advantages and disadvantages. In particular, the effectiveness and efficiency of every previous algorithm is not high enough. In this work, we proposed a novel inference algorithm from gene expression data based on differential equation model. In this algorithm, two methods were included for inferring GRNs. Before reconstructing GRNs, singular value decomposition method was used to decompose gene expression data, determine the algorithm solution space, and get all candidate solutions of GRNs. In these generated family of candidate solutions, gravitation field algorithm was modified to infer GRNs, used to optimize the criteria of differential equation model, and search the best network structure result. The proposed algorithm is validated on both the simulated scale-free network and real benchmark gene regulatory network in networks database. Both the Bayesian method and the traditional differential equation model were also used to infer GRNs, and the results were used to compare with the proposed algorithm in our work. And genetic algorithm and simulated annealing were also used to evaluate gravitation field algorithm. The cross-validation results confirmed the effectiveness of our algorithm, which outperforms significantly other previous algorithms.	[Zheng, Ming; Wu, Jia-nan; Huang, Yan-xin; Liu, Gui-xia; Zhou, You; Zhou, Chun-guang] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Wu, Jia-nan] Changchun Univ, Coll Comp Sci & Technol, Changchun, Peoples R China; [Huang, Yan-xin] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China	Jilin University; Changchun University; Northeast Normal University - China	Zhou, Y (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	zyou@jlu.edu.cn			National Natural Science Foundation of China [60873146, 60973092, 60903097, 61172183]; Hi-Tech Research and Development Program of China [2009AA02Z307]; Project of Science and Technology Innovation Platform of Computing and Software Science [985]; Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Science-Technology Development Research Project from Jilin Province of China [20101589, 201201139, 20101503]; Graduate Innovation Fund of Jilin University [20121109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Project of Science and Technology Innovation Platform of Computing and Software Science; Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Science-Technology Development Research Project from Jilin Province of China; Graduate Innovation Fund of Jilin University(Jilin University)	This work was supported by grants from The National Natural Science Foundation of China (60873146,60973092, 60903097, 61172183), Hi-Tech Research and Development Program of China (2009AA02Z307), Project of Science and Technology Innovation Platform of Computing and Software Science (985 En-gineering), the Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China, Graduate Innovation Fund of Jilin University (20121109). The Science-Technology Development Research Project from Jilin Province of China (20101589,201201139, 20101503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank M, 2012, ADV ENG SOFTW, V47, P1, DOI 10.1016/j.advengsoft.2011.12.001; Barrett T, 2008, NAT METHODS, V5, P117, DOI 10.1038/nmeth0208-117b; Bowden J, 2009, T AM MATH SOC, V361, P5457, DOI 10.1090/S0002-9947-09-04721-7; Chuang LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021036; Darabos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025110; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katsikis VN, 2011, ELECTRON J LINEAR AL, V22, P1156; Kuwahara H, 2012, J R SOC INTERFACE, V9, P1589, DOI 10.1098/rsif.2011.0757; Liu GX, 2011, J BIONIC ENG, V8, P98, DOI 10.1016/S1672-6529(11)60008-5; Ou RQ, 2012, PHYSICA A, V391, P887, DOI 10.1016/j.physa.2011.08.056; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Safronov V., 1972, EVOLUTION PROTOPLANE; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Whelan C, 2012, BIOINFORMATICS, V28, P290, DOI 10.1093/bioinformatics/btr637; Zaki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021821; Zheng M, 2012, PROG BIOCHEM BIOPHYS, V39, P581, DOI 10.3724/SP.J.1206.2011.00311; Zheng M, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-32; Zhu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052393	19	3	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51141	10.1371/journal.pone.0051141	http://dx.doi.org/10.1371/journal.pone.0051141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226565	Green Published, gold, Green Submitted			2022-12-25	WOS:000312108500047
J	Singh, SK; Boyle, AL; Main, ERG				Singh, Sunny K.; Boyle, Aimee L.; Main, Ewan R. G.			LcrH, a Class II Chaperone from the Type Three Secretion System, Has a Highly Flexible Native Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATOR PROTEIN IPAB; FLY-CASTING MECHANISM; KAPPA-B-ALPHA; REPEAT PROTEINS; TETRATRICOPEPTIDE REPEATS; MOLECULAR RECOGNITION; QUATERNARY STRUCTURE; DIMERIC PROTEINS; BINDING; STABILITY	The type three secretion system is a large and complex protein nano-machine that many Gram-negative pathogens employ to infect host cells. A key structure of this machine is a proteinaceous pore that inserts into the target membrane and forms a channel for bacterial toxins to flow from bacteria into the host cell. The pore is mainly formed from two large membrane proteins called "translocators." Importantly, effective secretion and thus pore formation of the translocators depend on their binding to and being transported by small specialized chaperones after synthesis in the bacterial cytosol. Recent crystal structures have shown these chaperones are formed from modular tetratricopeptide repeats. However, each crystal structure produced different homodimeric structures, suggesting flexibility in their topology that may be of importance to function. Given the crucial role of the translocator chaperones, we investigated the conformational stability of the chaperone LcrH (Yersinia pestis). Mutational analysis coupled with analytical ultracentrifugation and equilibrium denaturations showed that LcrH is a weak and thermodynamically unstable dimer (K-D approximate to 15 mu M, Delta G(H2O) = 7.4 kcal mol(-1)). The modular tetratricopeptide repeat structure of the dimer allows it to readily unfold in a noncooperative manner to a one-third unfolded dimeric intermediate (Delta G(H2O) = 1.7 kcal mol(-1)), before cooperatively unfolding to a monomeric denatured state (Delta G(H2O) = 5.7 kcal mol(-1)). Thus, under physiological conditions, the chaperone is able to populate C-terminally unraveled partially folded states, while being held together by its dimeric interface. Such ability suggests a "fly-casting" mechanism as a route to binding their far larger translocator cargo.	[Singh, Sunny K.; Main, Ewan R. G.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Singh, Sunny K.] Univ Sussex, Sch Life Sci, Falmer BN1 9QJ, Near Brighton, England; [Boyle, Aimee L.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of London; University of Sussex; University of Bristol	Main, ERG (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	e.main@qmul.ac.uk	Singh, Sunny/B-1442-2017	Singh, Sunny/0000-0002-2306-4096; Boyle, Aimee/0000-0003-4176-6080; Main, Ewan/0000-0001-6087-9000	Queen Mary, University of London; Sussex Universities; Sussex University studentship; Biotechnology and Biological Sciences Research Council	Queen Mary, University of London; Sussex Universities; Sussex University studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Queen Mary, University of London, and Sussex Universities.; Supported by a Sussex University studentship.; Supported by a Biotechnology and Biological Sciences Research Council studentship with Prof. Dek Woolfson.	Adam PR, 2012, BIOCHEMISTRY-US, V51, P4062, DOI 10.1021/bi300243z; Barta ML, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-21; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Deu E, 2007, BIOCHEMISTRY-US, V46, P5810, DOI 10.1021/bi602621t; Doyle SM, 2000, BIOCHEMISTRY-US, V39, P11667, DOI 10.1021/bi000299y; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Grimsley JK, 1997, BIOCHEMISTRY-US, V36, P14366, DOI 10.1021/bi971596e; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hayes D. B., 1998, SEDNTERP; Javadi Y, 2009, P NATL ACAD SCI USA, V106, P17383, DOI 10.1073/pnas.0907455106; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; Lamboy JA, 2011, P NATL ACAD SCI USA, V108, P10178, DOI 10.1073/pnas.1102226108; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; Lokareddy RK, 2010, J BIOL CHEM, V285, P39965, DOI 10.1074/jbc.M110.135616; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003; Main ERG, 2005, P NATL ACAD SCI USA, V102, P5721, DOI 10.1073/pnas.0404530102; Main ERG, 2003, CURR OPIN STRUC BIOL, V13, P482, DOI 10.1016/S0959-440X(03)00105-2; Marlovits TC, 2010, CURR OPIN MICROBIOL, V13, P47, DOI 10.1016/j.mib.2009.11.001; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Mei G, 1997, BIOCHEMISTRY-US, V36, P10917, DOI 10.1021/bi970614p; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Perham M, 2005, J AM CHEM SOC, V127, P16402, DOI 10.1021/ja055574o; Phillips JJ, 2012, PROTEIN SCI, V21, P327, DOI 10.1002/pro.2018; Riley PW, 2007, J MOL BIOL, V367, P558, DOI 10.1016/j.jmb.2006.12.066; Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004; Schreiner M, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-13; Scott D. J., 2005, ULTRASCAN COMPREHENS; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Tan YW, 2009, PROTEIN SCI, V18, P1724, DOI 10.1002/pro.187; Truhlar SME, 2006, P NATL ACAD SCI USA, V103, P18951, DOI 10.1073/pnas.0605794103; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320	35	7	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4048	4055		10.1074/jbc.M112.395889	http://dx.doi.org/10.1074/jbc.M112.395889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23233673	Green Published, hybrid			2022-12-25	WOS:000314845000033
J	Hou, ZH; Yu, X				Hou, Zai-Hua; Yu, Xiang			Activity-regulated Somatostatin Expression Reduces Dendritic Spine Density and Lowers Excitatory Synaptic Transmission via Postsynaptic Somatostatin Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; DISYNAPTIC INHIBITION; ELECTRICAL-ACTIVITY; KAINIC ACID; PLASTICITY; INTERNEURONS; NEUROTRANSMISSION; HIPPOCAMPUS; SEIZURES; INCREASE	Neuronal activity regulates multiple aspects of the morphological and functional development of neural circuits. One mechanism by which it achieves this is through regulation of gene expression. In a screen for activity-induced genes, we identified somatostatin (SST), a neuropeptide secreted by the SST subtype of interneurons. Using real time quantitative PCR and ELISA, we showed that persistent elevation of neuronal activity increased both the gene expression and protein secretion of SST over a relatively prolonged time course of 48 h. Using primary hippocampal neuronal cultures, we found that SST treatment for 1 day significantly reduced the density of dendritic spines, the morphological bases of excitatory synapses. Furthermore, the density of pre- and postsynaptic markers of excitatory synapses was significantly lowered following SST treatment, whereas that of inhibitory synapses was not affected. Consistently, SST treatment reduced the frequency of miniature excitatory postsynaptic currents, without affecting inhibition. Finally, lowering the endogenous level of SST receptor subtype 4 in individual hippocampal pyramidal neurons significantly blocked the effect of SST in reducing spine density and excitatory synaptic transmission in a cell autonomous fashion, suggesting that the effect of SST in regulating excitatory synaptic transmission is mainly mediated by SST receptor subtype 4. Together, our results demonstrated that activity-dependent release of SST reduced the density of dendritic spines and the number of excitatory synapses through postsynaptic activation of SST receptor subtype 4 in pyramidal neurons. To our knowledge, this is the first demonstration of the long term effect of SST on neuronal morphology.	[Hou, Zai-Hua; Yu, Xiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Hou, Zai-Hua; Yu, Xiang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Hou, Zai-Hua] Univ Chinese Acad Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yuxiang@ion.ac.cn		Yu, Xiang/0000-0003-1225-7666	Ministry of Science and Technology [2011CBA00400]; National Natural Science Foundation of China [31125015, 31021063]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology Grant 2011CBA00400 and National Natural Science Foundation of China Grants 31125015 and 31021063.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Applied Biosystems, 2001, APP BIOS US B; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Boehm S, 1997, J NEUROSCI, V17, P4066; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Buckmaster PS, 2002, EPILEPSY RES, V48, P43, DOI 10.1016/S0920-1211(01)00318-7; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Csaba Z, 2001, NEUROPEPTIDES, V35, P1, DOI 10.1054/npep.2001.0848; EPELBAUM J, 1986, PROG NEUROBIOL, V27, P63, DOI 10.1016/0301-0082(86)90012-2; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gastambide F, 2010, HIPPOCAMPUS, V20, P745, DOI 10.1002/hipo.20680; HASHIMOTO T, 1991, NEUROSCI RES, V12, P514, DOI 10.1016/S0168-0102(09)80004-7; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Jinno S, 2006, NEUROSCI RES, V56, P229, DOI 10.1016/j.neures.2006.07.007; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kumar U, 2010, RESULTS PROBL CELL D, V50, P137, DOI 10.1007/400_2009_29; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030803; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; MANFRIDI A, 1991, NEUROSCIENCE, V41, P127, DOI 10.1016/0306-4522(91)90203-Z; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MAZARATI AM, 1992, NEUROPHARMACOLOGY, V31, P793, DOI 10.1016/0028-3908(92)90043-O; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Qiu C, 2008, J NEUROSCI, V28, P3567, DOI 10.1523/JNEUROSCI.4679-07.2008; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Schreff M, 2000, J NEUROSCI, V20, P3785, DOI 10.1523/JNEUROSCI.20-10-03785.2000; SCHWEITZER P, 1990, NATURE, V346, P464, DOI 10.1038/346464a0; Schweitzer P, 1998, J NEUROPHYSIOL, V79, P1230, DOI 10.1152/jn.1998.79.3.1230; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Tallent MK, 2008, MOL CELL ENDOCRINOL, V286, P96, DOI 10.1016/j.mce.2007.12.004; Tallent MK, 1999, J NEUROPHYSIOL, V81, P1626, DOI 10.1152/jn.1999.81.4.1626; Tallent MK, 1997, J NEUROPHYSIOL, V78, P3008, DOI 10.1152/jn.1997.78.6.3008; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Vezzani A, 1999, EUR J NEUROSCI, V11, P3767, DOI 10.1046/j.1460-9568.1999.00838.x; Viollet C, 2008, MOL CELL ENDOCRINOL, V286, P75, DOI 10.1016/j.mce.2007.09.007; WANSCHER B, 1990, NEUROSCI LETT, V118, P33, DOI 10.1016/0304-3940(90)90242-2; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	53	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2501	2509		10.1074/jbc.M112.419051	http://dx.doi.org/10.1074/jbc.M112.419051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233668	hybrid, Green Published			2022-12-25	WOS:000314211500036
J	Walsh, CM; Suchanek, AL; Cyphert, TJ; Kohan, AB; Szeszel-Fedorowicz, W; Salati, LM				Walsh, Callee M.; Suchanek, Amanda L.; Cyphert, Travis J.; Kohan, Alison B.; Szeszel-Fedorowicz, Wioletta; Salati, Lisa M.			Serine Arginine Splicing Factor 3 Is Involved in Enhanced Splicing of Glucose-6-phosphate Dehydrogenase RNA in Response to Nutrients and Hormones in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR MESSENGER-RNA; SR PROTEINS; NUTRITIONAL REGULATION; ARACHIDONIC-ACID; GLOBAL ANALYSIS; POLYMERASE-II; IN-VIVO; INSULIN; GENE; TRANSCRIPTION	Expression of G6PD is controlled by changes in the degree of splicing of the G6PD mRNA in response to nutrients in the diet. This regulation involves an exonic splicing enhancer (ESE) in exon 12 of the mRNA. Using the G6PD model, we demonstrate that nutrients and hormones control the activity of serine-arginine-rich (SR) proteins, a family of splicing co-activators, and thereby regulate the splicing of G6PD mRNA. In primary rat hepatocyte cultures, insulin increased the amount of phosphorylated SR proteins, and this effect was counteracted by arachidonic acid. The results of RNA affinity analysis with nuclear extracts from intact liver demonstrated that the SR splicing factor proteins SRSF3 and SRSF4 bound to the G6PD ESE. Consequently, siRNA-mediated depletion of SRSF3, but not SRSF4, in liver cells inhibited accumulation of both mRNA expressed from a minigene containing exon 12 and the endogenous G6PD mRNA. Consistent with the functional role of SRSF3 in regulating splicing, SRSF3 was observed to bind to the ESE in both intact cells and in animals using RNA immunoprecipitation analysis. Furthermore, refeeding significantly increased the binding of SRSF3 coincident with increased splicing and expression of G6PD. Together, these data establish that nutritional regulation of SRSF3 activity is involved in the differential splicing of the G6PD transcript in response to nutrients. Nutritional regulation of other SR proteins presents a regulatory mechanism that could cause widespread changes in mRNA splicing. Nutrients are therefore novel regulators of mRNA splicing.	[Salati, Lisa M.] W Virginia Univ, Hlth Sci Ctr, Dept Biochem, Morgantown, WV 26506 USA	West Virginia University	Salati, LM (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Biochem, 1 Med Ctr Dr,POB 9142, Morgantown, WV 26506 USA.	Lsalati@hsc.wvu.edu	Suchanek, Amanda/HCI-3855-2022	Kohan, Alison/0000-0003-3127-7283; Walsh, Callee/0000-0002-3368-9209	National Institutes of Health [DK46897, T32 HL090610]; West Virginia Graduate Student Fellowships in Science, Technology, Engineering and Math Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL090610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046897, R29DK046897, R01DK046897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia Graduate Student Fellowships in Science, Technology, Engineering and Math Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK46897 (to L. M. S.) and T32 HL090610 (to A. B. K.). This work was also supported by a grant from the West Virginia Graduate Student Fellowships in Science, Technology, Engineering and Math Program (to C. M. W.).	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Anko ML, 2010, NAT STRUCT MOL BIOL, V17, P962, DOI 10.1038/nsmb.1862; Amir-Ahmady B, 2001, J BIOL CHEM, V276, P10514, DOI 10.1074/jbc.M010535200; Apostolatos A, 2012, J BIOL CHEM, V287, P9299, DOI 10.1074/jbc.M111.313080; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Chalfant CE, 1998, J BIOL CHEM, V273, P910, DOI 10.1074/jbc.273.2.910; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doyle O, 2002, J STRUCT BIOL, V140, P154, DOI 10.1016/S1047-8477(02)00547-6; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Friedman JR, 2004, P NATL ACAD SCI USA, V101, P12986, DOI 10.1073/pnas.0402875101; Griffith BN, 2006, BBA-GENE STRUCT EXPR, V1759, P552, DOI 10.1016/j.bbaexp.2006.10.001; Hartmann B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r11; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Motta-Mena LB, 2011, J BIOL CHEM, V286, P20043, DOI 10.1074/jbc.M111.218727; NEUGEBAUER KM, 1995, J CELL BIOL, V129, P899, DOI 10.1083/jcb.129.4.899; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Salati LM, 2004, J NUTR, V134, p2437S, DOI 10.1093/jn/134.9.2437S; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Selth LA, 2009, COLD SPRING HARB PRO, V2009, DOI 10.1101/pdb.prot5234; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Setzer DA, 1999, METH MOL B, V118, P115; Stabile LP, 1998, J LIPID RES, V39, P1951; Stabile LP, 1996, ARCH BIOCHEM BIOPHYS, V332, P269, DOI 10.1006/abbi.1996.0342; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Szeszel-Fedorowicz W, 2006, J BIOL CHEM, V281, P34146, DOI 10.1074/jbc.M603825200; Talukdar I, 2005, J BIOL CHEM, V280, P40660, DOI 10.1074/jbc.M505531200; Tao HM, 2002, J BIOL CHEM, V277, P31270, DOI 10.1074/jbc.M203196200; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yeakley JM, 1999, J CELL BIOL, V145, P447, DOI 10.1083/jcb.145.3.447; Yin LY, 2005, MOL CELL ENDOCRINOL, V245, P43, DOI 10.1016/j.mce.2005.10.002; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	50	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2816	2828		10.1074/jbc.M112.410803	http://dx.doi.org/10.1074/jbc.M112.410803			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23233666	Green Published, hybrid			2022-12-25	WOS:000314211500064
J	Ibitokou, S; Oesterholt, M; Brutus, L; Borgella, S; Agbowai, C; Ezinmegnon, S; Lusingu, J; Schmiegelow, C; Massougbodji, A; Deloron, P; Troye-Blomberg, M; Varani, S; Luty, AJF; Fievet, N				Ibitokou, Samad; Oesterholt, Mayke; Brutus, Laurent; Borgella, Sophie; Agbowai, Carine; Ezinmegnon, Sem; Lusingu, John; Schmiegelow, Christentze; Massougbodji, Achille; Deloron, Philippe; Troye-Blomberg, Marita; Varani, Stefania; Luty, Adrian J. F.; Fievet, Nadine			Peripheral Blood Cell Signatures of Plasmodium falciparum Infection during Pregnancy	PLOS ONE			English	Article							REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; PLACENTAL MALARIA; INTERVILLOUS BLOOD; UP-REGULATION; CC-CHEMOKINE; ACTIVATION; IMMUNITY; CHILDREN; PATHOGENESIS	Sequestration of Plasmodium falciparum-infected erythrocytes in placental intervillous spaces causes inflammation and pathology. Knowledge of the profiles of immune cells associated with the physiopathology of pregnancy-associated malaria (PAM) is scarce. We conducted a longitudinal, prospective study, both in Benin and Tanzania, including similar to 1000 pregnant women in each site with systematic follow-up at scheduled antenatal visits until delivery. We used ex vivo flow cytometry to identify peripheral blood mononuclear cell (PBMC) profiles that are associated with PAM and anaemia, determining the phenotypic composition and activation status of PBMC in selected sub-groups with and without PAM both at inclusion and at delivery in a total of 302 women. Both at inclusion and at delivery PAM was associated with significantly increased frequencies both of B cells overall and of activated B cells. Infection-related profiles were otherwise quite distinct at the two different time-points. At inclusion, PAM was associated with anaemia, with an increased frequency of immature monocytes and with a decreased frequency of regulatory T cells (Treg). At delivery, infected women presented with significantly fewer plasmacytoid dendritic cells (DC), more myeloid DC expressing low levels of HLA-DR, and more effector T cells (Teff) compared to uninfected women. Independent associations with an increased risk of anaemia were found for altered antigen-presenting cell frequencies at inclusion, but for an increased frequency of Teff at delivery. Our findings emphasize the prominent role played by B cells during PAM whenever it arises during pregnancy, whilst also revealing signature changes in other circulating cell types that, we conclude, primarily reflect the relative duration of the infections. Thus, the acute, recently-acquired infections present at delivery were marked by changes in DC and Teff frequencies, contrasting with infections at inclusion, considered chronic in nature, that were characterized by an abundance of immature monocytes and a paucity of Treg in PBMC. Citation: Ibitokou S, Oesterholt M, Brutus L, Borgella S, Agbowai C, et al. (2012) Peripheral Blood Cell Signatures of Plasmodium falciparum Infection during Pregnancy. PLoS ONE 7(12): e49621. doi: 10.1371/journal.pone.0049621	[Ibitokou, Samad; Brutus, Laurent; Deloron, Philippe; Luty, Adrian J. F.; Fievet, Nadine] Inst Rech Dev, UMR 216, Paris, France; [Ibitokou, Samad; Borgella, Sophie; Agbowai, Carine; Ezinmegnon, Sem; Massougbodji, Achille] Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Ibitokou, Samad; Brutus, Laurent; Deloron, Philippe; Luty, Adrian J. F.; Fievet, Nadine] Univ Paris 05, Fac Pharm, PRES Sorbonne Paris Cite, Paris, France; [Oesterholt, Mayke; Luty, Adrian J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Lusingu, John] Natl Inst Med Res, Tanga, Tanzania; [Schmiegelow, Christentze] Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Schmiegelow, Christentze] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Varani, Stefania] Univ Bologna, Dept Hematol & Oncol, Microbiol Unit, Bologna, Italy	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; University of Copenhagen; University of Copenhagen; Stockholm University; University of Bologna	Luty, AJF (corresponding author), Inst Rech Dev, UMR 216, Paris, France.	adrian.luty@ird.fr	Lusingu, John P. A./GSJ-3228-2022; Troye-Blomberg, Marita/B-9210-2016; Brutus, Laurent/A-7430-2011; Deloron, Philippe/G-6305-2010; Varani, Stefania/AAZ-1856-2021; Luty, Adrian/CAH-2547-2022	Troye-Blomberg, Marita/0000-0002-2804-0325; Brutus, Laurent/0000-0002-9967-0666; Deloron, Philippe/0000-0003-4705-2484; Luty, Adrian John Frederick/0000-0001-8830-3425; shmiegelow, christentze/0000-0002-9360-9741; Lusingu, John P. A./0000-0002-9407-0602; VARANI, STEFANIA/0000-0003-0862-4937; Fievet, Nadine/0000-0003-2272-9794	European Union Framework 7 [200889]; AIRD-DPF	European Union Framework 7; AIRD-DPF	This work was supported by the European Union Framework 7 contract number 200889, and by a PhD scholarship awarded by AIRD-DPF to S. Ibitokou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Bachy V, 2008, J REPROD IMMUNOL, V78, P11, DOI 10.1016/j.jri.2007.09.004; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bouyou-Akotet MK, 2004, CLIN INFECT DIS, V38, P342, DOI 10.1086/380646; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322; Chaisavaneeyakorn S, 2002, J INFECT DIS, V185, P127, DOI 10.1086/338013; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Darmochwal-Kolarz D, 2003, J REPROD IMMUNOL, V59, P193, DOI 10.1016/S0165-0378(03)00047-0; Della Bella S, 2011, CLIN EXP IMMUNOL, V164, P180, DOI 10.1111/j.1365-2249.2011.04330.x; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Diallo M, 2008, INT J PARASITOL, V38, P1557, DOI 10.1016/j.ijpara.2008.04.013; Diouf I, 2004, J INFECT DIS, V189, P2235, DOI 10.1086/420791; Diouf I, 2007, J REPROD IMMUNOL, V74, P152, DOI 10.1016/j.jri.2006.10.001; Donati D, 2006, J IMMUNOL, V177, P3035, DOI 10.4049/jimmunol.177.5.3035; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x; Holloway JA, 2009, PEDIAT ALLERG IMM-UK, V20, P119, DOI 10.1111/j.1399-3038.2008.00771.x; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kolte L, 2011, BLOOD, V117, P1861, DOI 10.1182/blood-2010-07-298992; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Leber A, 2010, AM J REPROD IMMUNOL, V63, P445, DOI 10.1111/j.1600-0897.2010.00821.x; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Morva A, 2012, BLOOD, V119, P106, DOI 10.1182/blood-2011-06-360768; Muehlenbachs A, 2007, J IMMUNOL, V179, P557, DOI 10.4049/jimmunol.179.1.557; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Nduati E, 2011, J INFECT DIS, V204, P962, DOI 10.1093/infdis/jir438; Ordi J, 2001, J INFECT DIS, V183, P1100, DOI 10.1086/319295; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Sato K, 1999, J IMMUNOL, V162, P3865; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Tkachuk AN, 2001, J INFECT DIS, V183, P967, DOI 10.1086/319248; Urban BC, 2001, BLOOD, V98, P2859, DOI 10.1182/blood.V98.9.2859; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wykes MN, 2012, TRENDS PARASITOL, V28, P182, DOI 10.1016/j.pt.2012.01.007	50	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49621	10.1371/journal.pone.0049621	http://dx.doi.org/10.1371/journal.pone.0049621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239967	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800005
J	Liu, J; Eischeid, AN; Chen, XM				Liu, Jun; Eischeid, Alex N.; Chen, Xian-Ming			Col1A1 Production and Apoptotic Resistance in TGF-beta 1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells	PLOS ONE			English	Article							BILE-DUCT LIGATION; LIVER FIBROSIS; TGF-BETA; TRANSCRIPTION FACTORS; HEPATIC FIBROGENESIS; BILIARY FIBROSIS; HEPATOCYTES; CHOLANGIOCYTES; DISEASE; MICE	Recent studies have suggested that proliferating cholangiocytes have an important role in the induction of fibrosis, either directly via epithelial-to-mesenchymal transition (EMT), or indirectly via activation of other liver cell types. Transforming growth factor beta 1 (TGF-beta 1), a critical fibrotic cytokine for hepatic fibrosis, is a potent EMT inducer. This study aimed to clarify the potential contributions of TGF-beta 1-induced EMT-like cholangiocyte phenotype to collagen production and cell survival of cholangiocytes in vitro. Mouse cholangiocytes (603B cells) were treated with TGF-beta 1 and EMT-like phenotype alterations were monitored by morphological changes and expression of EMT-associated genes. Alterations in Col1A1 gene, Col1A1-associated miR-29s, and pro-apoptotic genes were measured in TGF-beta 1-treated 603B cells. Snail1 knockdown was achieved using shRNA to evaluate the contribution of EMT-associated changes to Col1A1 production and cell survival. We found TGF-beta 1 treatment induced partial EMT-like phenotype transition in 603B cells in a Snail1-dependent manner. TGF-beta 1 also stimulated collagen alpha 1(I) expression in 603B cells. However, this induction was not parallel to the EMT-like alterations and independent of Snail1 or miR-29 expression. Cells undergoing EMT-like changes showed a modest down-regulation of multiple pro-apoptotic genes and displayed resistance to TNF-alpha-induced apoptosis. TGF-beta 1-induced apoptosis resistance was attenuated in Snail1 knockdown 603B cells. TGF-beta 1-induced Col1A1 production seems to be independent of EMT-like transition and miR-29 expression. Nevertheless, TGF-beta 1-induced EMT may contribute to the increased survival capacity of cholangiocytes via modulating the expression of pro-apoptotic genes. Citation: Liu J, Eischeid AN, Chen X-M (2012) Col1A1 Production and Apoptotic Resistance in TGF-beta 1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells. PLoS ONE 7(12): e51371. doi: 10.1371/journal.pone.0051371	[Liu, Jun; Eischeid, Alex N.; Chen, Xian-Ming] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68102 USA	Creighton University	Chen, XM (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68102 USA.	xianmingchen@creighton.edu			Nebraska Tobacco Settlement Biomedical Research Program [LB506, LB692, LB595]	Nebraska Tobacco Settlement Biomedical Research Program	This study was supported by the Nebraska Tobacco Settlement Biomedical Research Program (LB506, LB692 and LB595) (to X-MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beaussier M, 2007, LAB INVEST, V87, P292, DOI 10.1038/labinvest.3700513; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Decker P, 2000, J BIOL CHEM, V275, P9043, DOI 10.1074/jbc.275.12.9043; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Glaser SS, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000994; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Hanada S, 2003, LIVER INT, V23, P3; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Popov Y, 2010, GASTROENTEROLOGY, V139, P722, DOI 10.1053/j.gastro.2010.07.015; Priester Sally, 2010, World J Gastrointest Pathophysiol, V1, P30, DOI 10.4291/wjgp.v1.i2.30; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Sato Y, 2007, AM J PATHOL, V171, P1859, DOI 10.2353/ajpath.2007.070337; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valdes F, 2004, EXP CELL RES, V292, P209, DOI 10.1016/j.yexcr.2003.08.015; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wells RG, 2008, CLIN LIVER DIS, V12, P759, DOI 10.1016/j.cld.2008.07.008; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	38	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51371	10.1371/journal.pone.0051371	http://dx.doi.org/10.1371/journal.pone.0051371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236489	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100108
J	Singh, G; Dal Grande, F; Cornejo, C; Schmitt, I; Scheidegger, C				Singh, Garima; Dal Grande, Francesco; Cornejo, Carolina; Schmitt, Imke; Scheidegger, Christoph			Genetic Basis of Self-Incompatibility in the Lichen-Forming Fungus Lobaria pulmonaria and Skewed Frequency Distribution of Mating-Type Idiomorphs: Implications for Conservation	PLOS ONE			English	Article							EPIPHYTIC LICHEN; MICROSATELLITE MARKERS; GENUS XANTHORIA; POPULATION; SEX; RECOMBINATION; SYSTEMS; DISPERSAL; PCR; AMPLIFICATION	Fungal populations that reproduce sexually are likely to be genetically more diverse and have a higher adaptive potential than asexually reproducing populations. Mating systems of fungal species can be self-incompatible, requiring the presence of isolates of different mating-type genes for sexual reproduction to occur, or self-compatible, requiring only one. Understanding the distribution of mating-type genes in populations can help to assess the potential of self-incompatible species to reproduce sexually. In the locally threatened epiphytic lichen-forming fungus Lobaria pulmonaria (L.) Hoffm., low frequency of sexual reproduction is likely to limit the potential of populations to adapt to changing environmental conditions. Our study provides direct evidence of self-incompatibility (heterothallism) in L. pulmonaria. It can thus be hypothesized that sexual reproduction in small populations might be limited by an unbalanced distribution of mating-type genes. We therefore assessed neutral genetic diversity (using microsatellites) and mating-type ratio in 27 lichen populations (933 individuals). We found significant differences in the frequency of the two mating types in 13 populations, indicating a lower likelihood of sexual reproduction in these populations. This suggests that conservation translocation activities aiming at maximizing genetic heterogeneity in threatened and declining populations should take into account not only presence of fruiting bodies in transplanted individuals, but also the identity and balanced representation of mating-type genes.	[Singh, Garima; Dal Grande, Francesco; Cornejo, Carolina; Scheidegger, Christoph] WSL Swiss Fed Res Inst, Birmensdorf, Switzerland; [Dal Grande, Francesco; Schmitt, Imke] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Schmitt, Imke] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Singh, G (corresponding author), WSL Swiss Fed Res Inst, Birmensdorf, Switzerland.	garima.singh@stud.uni-frankfurt.de	Dal Grande, Francesco/K-1914-2016; Scheidegger, Christoph/C-6547-2011; Singh, Garima/ABF-5659-2021; Singh, Garima/P-1518-2017; Cornejo, Carolina/ADX-6219-2022	Dal Grande, Francesco/0000-0002-1865-6281; Scheidegger, Christoph/0000-0003-3713-5331; Singh, Garima/0000-0003-3753-5431; Singh, Garima/0000-0003-3753-5431; 	Swiss National Science Foundation [31003A-105830, 31003A-127346]; 'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts	This study was supported by the Swiss National Science Foundation (projects 31003A-105830 and 31003A-127346 to CS), and by 'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; AnalystSoft Inc, STATPLUS MAC STAT AN; Arie T, 2000, MOL PLANT MICROBE IN, V13, P1330, DOI 10.1094/MPMI.2000.13.12.1330; Arie T, 1997, FUNGAL GENET BIOL, V21, P118, DOI 10.1006/fgbi.1997.0961; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G., 1982, MASTERPIECE NATURE E; Brown Dennis H., 1992, P259; Budel B, 2008, LICHEN BIOLOGY, 2ND EDITION, P40, DOI 10.1017/CBO9780511790478.005; CHARLESWORTH B, 1980, J THEOR BIOL, V84, P655, DOI 10.1016/S0022-5193(80)80026-9; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Consolo VF, 2005, MYCOPATHOLOGIA, V160, P285, DOI 10.1007/s11046-005-4333-3; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Dal Grande F, 2012, MOL ECOL, V21, P3159, DOI 10.1111/j.1365-294X.2012.05482.x; Dal Grande F, 2011, THESIS U BERN BERN; Dal Grande F, 2010, CONSERV GENET, V11, P1147, DOI 10.1007/s10592-009-9904-2; Denison WC, 2003, MYCOLOGIA, V95, P513, DOI 10.2307/3761894; Dyer PS, 2005, MED MYCOL, V43, pS7, DOI 10.1080/13693780400029015; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foster SJ, 2003, CURR GENET, V44, P277, DOI 10.1007/s00294-003-0445-9; Gauslaa Y, 2009, NEW PHYTOL, V181, P683, DOI 10.1111/j.1469-8137.2008.02690.x; Genkai-Kato M, 1999, THEOR POPUL BIOL, V55, P309, DOI 10.1006/tpbi.1998.1407; Grube M, 2012, MOL ECOL, V21, P3098, DOI 10.1111/j.1365-294X.2012.05647.x; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hawksworth D., 1990, EARTH TRANSITION PAT, P45; Hawksworth D.L., 1973, AIR POLLUTION LICHEN, P330; Heitman J., 2007, SEX FUNGI MOL DETERM; Hilmo O, 2012, MOL ECOL, V21, P3250, DOI 10.1111/j.1365-294X.2012.05605.x; Hoistad F, 2011, LICHENOLOGIST, V43, P495, DOI 10.1017/S0024282911000429; Honegger R, 2004, MYCOL RES, V108, P480, DOI 10.1017/s0953756204009682; Honegger R, 2008, LICHEN BIOLOGY, 2ND EDITION, P27, DOI 10.1017/CBO9780511790478.004; Honegger R, 2008, LICHEN BIOLOGY, 2ND EDITION, P94, DOI 10.1017/CBO9780511790478.007; Honegger R, 2007, MYCOL RES, V111, P424, DOI 10.1016/j.mycres.2007.02.005; KOELLA JC, 1988, J EVOLUTION BIOL, V1, P95, DOI 10.1046/j.1420-9101.1988.1020095.x; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Kueck Ulrich, 2009, Fungal Biology Reviews, V23, P86, DOI 10.1016/j.fbr.2009.10.004; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; Mikryukov VS, 2011, THESIS RUSSIAN ACAD; Murtagh GJ, 2000, NATURE, V404, P564, DOI 10.1038/35007142; Nelson MA, 1996, TRENDS GENET, V12, P69, DOI 10.1016/0168-9525(96)81403-X; OCHMAN H, 1988, GENETICS, V120, P621; Olarte RA, 2012, MOL ECOL, V21, P1453, DOI 10.1111/j.1365-294X.2011.05398.x; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Pentecost A, 2011, ROYAL IRISH ACAD, V111, P1; Pringle A, 2003, BRYOLOGIST, V106, P221, DOI 10.1639/0007-2745(2003)106[0221:SFICTS]2.0.CO;2; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Saleh D, 2012, MOL ECOL, V21, P1330, DOI 10.1111/j.1365-294X.2012.05469.x; Scarascia-Mugnozza G. T., 2002, P1, DOI 10.1079/9780851995229.0001; Schei FH, 2012, J VEG SCI, V23, P459, DOI 10.1111/j.1654-1103.2011.01368.x; Scheidegger C, 2002, NATO SCI S SS IV EAR, V7, P163; SCHEIDEGGER C, 1995, LICHENOLOGIST, V27, P361, DOI 10.1017/S0024282995000478; Scheidegger C., 1995, MITTEILUNGEN EIDGEN, V70, P41; Scheidegger C, 2012, ECOL EVOL, V2, P2223, DOI 10.1002/ece3.341; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Scherrer S, 2005, FUNGAL GENET BIOL, V42, P976, DOI 10.1016/j.fgb.2005.09.002; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Seymour FA, 2005, FUNGAL GENET BIOL, V42, P554, DOI 10.1016/j.fgb.2005.03.006; Singer T, 2003, METH MOL B, V236, P241; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stofer S, 2006, LICHENOLOGIST, V38, P331, DOI 10.1017/S0024282906006207; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tomiuk J, 1998, GENETICA, V102-3, P545, DOI 10.1023/A:1017080119277; TURGEON BG, 1993, MOL GEN GENET, V238, P270; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Walser JC, 2004, HEREDITY, V93, P322, DOI 10.1038/sj.hdy.6800505; Walser JC, 2004, AM J BOT, V91, P1273, DOI 10.3732/ajb.91.8.1273; Walser JC, 2003, FUNGAL GENET BIOL, V40, P72, DOI 10.1016/S1087-1845(03)00080-X; Wang LQ, 2011, FUNGAL GENET BIOL, V48, P651, DOI 10.1016/j.fgb.2011.02.001; Werth S, 2007, MOL ECOL, V16, P2807, DOI 10.1111/j.1365-294X.2007.03344.x; Werth S, 2006, ECOLOGY, V87, P2037, DOI 10.1890/0012-9658(2006)87[2037:QDAELI]2.0.CO;2; Whittle CA, 2011, FUNGAL GENET BIOL, V48, P661, DOI 10.1016/j.fgb.2011.02.005; Widmer I, 2012, MOL ECOL, V21, P5827, DOI 10.1111/mec.12051; Widmer I, 2010, FUNGAL BIOL-UK, V114, P538, DOI 10.1016/j.funbio.2010.04.003; Wirth V., 1996, SCHRIFTENREIHE VEGET, V28, P307; Zoller S, 1999, MOL ECOL, V8, P2049, DOI 10.1046/j.1365-294x.1999.00820.x	80	25	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51402	10.1371/journal.pone.0051402	http://dx.doi.org/10.1371/journal.pone.0051402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236495	Green Published, gold			2022-12-25	WOS:000312064100114
J	Audouard, E; Schakman, O; Rene, F; Huettl, RE; Huber, AB; Loeffler, JP; Gailly, P; Clotman, F				Audouard, Emilie; Schakman, Olivier; Rene, Frederique; Huettl, Rosa-Eva; Huber, Andrea B.; Loeffler, Jean-Philippe; Gailly, Philippe; Clotman, Frederic			The Onecut Transcription Factor HNF-6 Regulates in Motor Neurons the Formation of the Neuromuscular Junctions	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-6; PROTEIN-KINASE-C; SCHWANN-CELLS; TGF-BETA; ACETYLCHOLINE-RECEPTORS; MAMMALIAN MEMBER; NERVOUS-SYSTEM; GAIT ANALYSIS; MUTANT MICE; IN-VITRO	The neuromuscular junctions are the specialized synapses whereby spinal motor neurons control the contraction of skeletal muscles. The formation of the neuromuscular junctions is controlled by a complex interplay of multiple mechanisms coordinately activated in motor nerve terminals and in their target myotubes. However, the transcriptional regulators that control in motor neurons the genetic programs involved in neuromuscular junction development remain unknown. Here, we provide evidence that the Onecut transcription factor HNF-6 regulates in motor neurons the formation of the neuromuscular junctions. Indeed, adult Hnf6 mutant mice exhibit hindlimb muscle weakness and abnormal locomotion. This results from defects of hindlimb neuromuscular junctions characterized by an abnormal morphology and defective localization of the synaptic vesicle protein synaptophysin at the motor nerve terminals. These defects are consequences of altered and delayed formation of the neuromuscular junctions in newborn mutant animals. Furthermore, we show that the expression level of numerous regulators of neuromuscular junction formation, namely agrin, neuregulin-2 and TGF-beta receptor II, is downregulated in the spinal motor neurons of Hnf6 mutant newborn animals. Finally, altered formation of neuromuscular junction-like structures in a co-culture model of wildtype myotubes with mutant embryonic spinal cord slices is rescued by recombinant agrin and neuregulin, indicating that depletion in these factors contributes to defective neuromuscular junction development in the absence of HNF-6. Thus, HNF-6 controls in spinal motor neurons a genetic program that coordinates the formation of hindlimb neuromuscular junctions.	[Audouard, Emilie; Clotman, Frederic] Catholic Univ Louvain, Inst Neurosci, Lab Neural Differentiat, B-1200 Brussels, Belgium; [Schakman, Olivier; Gailly, Philippe] Catholic Univ Louvain, Inst Neurosci, Lab Cell Physiol, B-1200 Brussels, Belgium; [Rene, Frederique; Loeffler, Jean-Philippe] Univ Strasbourg, Fac Med, INSERM, U692,Lab Signalisat Mol & Neurodegenerescence, Strasbourg, France; [Huettl, Rosa-Eva; Huber, Andrea B.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany	Universite Catholique Louvain; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Clotman, F (corresponding author), Catholic Univ Louvain, Inst Neurosci, Lab Neural Differentiat, B-1200 Brussels, Belgium.	frederic.clotman@uclouvain.be	LOEFFLER, Jean-Philippe/AAS-4401-2020		"Fonds speciaux de recherche'' (FSR) of the Universite catholique de Louvain; Fonds de la Recherche Scientifique [1.5.085.10.F]; Fund for Scientific Medical Research [3.4.538.10.F]; Actions de Recherche Concertees grant [10/15-026]; Association Belge contre les Maladies neuro-Musculaires (ABMM asbl); Walloon Region's Marshall Programme of Excellence (DIANE convention); Association pour la recherche sur la SLA et les autres maladies du motoneurone (ARSIa); Association pour la recherche et le developpment des moyens de lutte contre les maladies neurodegeneratives (AREMANE); F.R.I.A. (Belgium)	"Fonds speciaux de recherche'' (FSR) of the Universite catholique de Louvain; Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fund for Scientific Medical Research; Actions de Recherche Concertees grant; Association Belge contre les Maladies neuro-Musculaires (ABMM asbl); Walloon Region's Marshall Programme of Excellence (DIANE convention); Association pour la recherche sur la SLA et les autres maladies du motoneurone (ARSIa); Association pour la recherche et le developpment des moyens de lutte contre les maladies neurodegeneratives (AREMANE); F.R.I.A. (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the "Fonds speciaux de recherche'' (FSR) of the Universite catholique de Louvain, by the Fonds de la Recherche Scientifique (F.R.S.-FNRS) including a Credit au chercheur #1.5.085.10.F and a grant from the Fund for Scientific Medical Research #3.4.538.10.F (Belgium), by the Actions de Recherche Concertees grant #10/15-026 (Communaute francaise de Belgique and Academie Louvain) and by the Association Belge contre les Maladies neuro-Musculaires (ABMM asbl) (F.C.), by the Walloon Region's Marshall Programme of Excellence (DIANE convention) (P.G.), and by the Association pour la recherche sur la SLA et les autres maladies du motoneurone (ARSIa) and the Association pour la recherche et le developpment des moyens de lutte contre les maladies neurodegeneratives (AREMANE) (F.R., J.P.L.). E.A. holds a specialization grant from the F.R.I.A. (Belgium). F.C. is a Research Associate of the F.R.S.-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Baudet C, 2008, J NEUROSCI, V28, P963, DOI 10.1523/JNEUROSCI.4489-07.2008; Becher A, 1999, EUR J CELL BIOL, V78, P650, DOI 10.1016/S0171-9335(99)80050-8; Besalduch N, 2010, J COMP NEUROL, V518, P211, DOI 10.1002/cne.22220; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bonanomi D, 2007, BIOCHEM J, V404, P525, DOI 10.1042/BJ20061907; Britto JM, 2004, MOL CELL BIOL, V24, P8221, DOI 10.1128/MCB.24.18.8221-8226.2004; Burau K, 2004, EUR J NEUROSCI, V20, P353, DOI 10.1111/j.1460-9568.2004.03500.x; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Clotman F, 2002, DEVELOPMENT, V129, P1819; Court FA, 2008, J CELL SCI, V121, P3901, DOI 10.1242/jcs.031047; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Ellis JE, 2010, DEV BIOL, V342, P121, DOI 10.1016/j.ydbio.2010.03.012; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Espana A, 2012, MOL CELL NEUROSCI, V50, P93, DOI 10.1016/j.mcn.2012.04.002; Espana A, 2012, J COMP NEUROL, V520, P1424, DOI 10.1002/cne.22803; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Feng Z, 2008, ANN NY ACAD SCI, V1132, P19, DOI 10.1196/annals.1405.016; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Francius C, 2010, NEUROSCIENCE, V165, P116, DOI 10.1016/j.neuroscience.2009.09.076; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Henriquez JP, 2012, ACTA PHYSIOL, V204, P128, DOI 10.1111/j.1748-1716.2011.02295.x; Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665; Jevsek M, 2004, EUR J NEUROSCI, V20, P2865, DOI 10.1111/j.1460-9568.2004.03752.x; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Landry C, 1997, DEV BIOL, V192, P247, DOI 10.1006/dbio.1997.8757; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; Lanuza MA, 2000, J NEUROSCI RES, V61, P616, DOI 10.1002/1097-4547(20000915)61:6<616::AID-JNR5>3.0.CO;2-N; Lanuza MA, 2002, J NEUROSCI RES, V67, P607, DOI 10.1002/jnr.10122; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; LEONG SK, 1990, J NEUROSCI METH, V32, P15, DOI 10.1016/0165-0270(90)90067-P; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Margagliotti S, 2007, DEV BIOL, V311, P579, DOI 10.1016/j.ydbio.2007.09.013; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mignion L., 2012, MAGN RESON MED; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Plumb-Rudewiez N, 2004, HEPATOLOGY, V40, P1266, DOI 10.1002/hep.20459; Ravassard P, 1997, J NEUROSCI RES, V48, P146, DOI 10.1002/(SICI)1097-4547(19970415)48:2<146::AID-JNR7>3.0.CO;2-C; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rimer M, 2004, MOL CELL NEUROSCI, V26, P271, DOI 10.1016/j.mcn.2004.02.002; Roy A, 2012, DEVELOPMENT, V139, P3109, DOI 10.1242/dev.078501; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Schafer S, 2011, BEHAV BRAIN RES; Schmidt N, 2011, J CELL BIOL, V195, P1171, DOI 10.1083/jcb.201107083; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134; Sugiura Y, 2011, BIOSCIENCE REP, V31, P295, DOI 10.1042/BSR20100107; Todd KJ, 2010, J NEUROSCI, V30, P11870, DOI 10.1523/JNEUROSCI.3165-10.2010; Vanhorenbeeck V, 2002, BIOCHEM BIOPH RES CO, V292, P848, DOI 10.1006/bbrc.2002.6760; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Yang JF, 2001, J NEUROSCI, V21, P9572, DOI 10.1523/JNEUROSCI.21-24-09572.2001	66	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50509	10.1371/journal.pone.0050509	http://dx.doi.org/10.1371/journal.pone.0050509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227180	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200040
J	Kozlitina, J; Garcia, CK				Kozlitina, Julia; Garcia, Christine Kim			Red Blood Cell Size Is Inversely Associated with Leukocyte Telomere Length in a Large Multi-Ethnic Population	PLOS ONE			English	Article							MEAN CORPUSCULAR VOLUME; PULMONARY-FIBROSIS; MYELODYSPLASTIC SYNDROME; DYSKERATOSIS-CONGENITA; TRANSFERASE-ACTIVITY; ALCOHOL-CONSUMPTION; AFRICAN-AMERICANS; APLASTIC-ANEMIA; HUMAN OBESITY; MACROCYTOSIS	Although mutations in the genes encoding either the protein or RNA component of telomerase have been found in patients with various blood disorders, the impact of telomere length on hematopoiesis is less well understood for subjects from the general population. Here we have measured telomere lengths of genomic DNA isolated from circulating leukocytes of 3157 subjects, ranging from 18 to 85 years of age, enrolled in a large multiethnic population based study, the Dallas Heart Study 2. Shorter telomere lengths are marginally associated with lower red blood cell counts in this cohort, but are significantly associated with larger mean red blood cell size (as measured by the MCV), increased red blood cell distribution width (RDW), higher hemoglobin levels and lower platelet counts, even after correction for age, gender and ethnicity (p-values of <0.0001, <0.0001, 0.0009 and 0.0016, respectively). In a multiple regression model we find that telomere length is a significant covariate of MCV (p = 7.6x10(-8)), independent of age, ethnicity, BMI, current smoking, alcohol consumption, iron or homocysteine levels. The effect of telomere length on MCV variation is comparable to the effect of smoking or alcohol consumption and is more significant in older individuals (p = 9.2x10(-7) for >50 years vs. p = 0.0006 for <50 years of age). To our knowledge, this is the first report of an association between telomere length and red cell size in a large urban US population and suggests a biologic mechanism for macrocytosis of aging.	[Kozlitina, Julia; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Pulm & Crit Care Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, CK (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	christine.garcia@utsouthwestern.edu		Kozlitina, Julia/0000-0001-7720-2290	National Institutes of Health [R01 HL093096]; Doris Duke Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (R01 HL093096) and the Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; BEGUINOT F, 1985, J CLIN ENDOCR METAB, V60, P1226, DOI 10.1210/jcem-60-6-1226; Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; CHALMERS DM, 1979, BRIT J HAEMATOL, V43, P631, DOI 10.1111/j.1365-2141.1979.tb03796.x; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; DAVIDSON RJL, 1978, J CLIN PATHOL, V31, P493, DOI 10.1136/jcp.31.5.493; de Leon AD, 2011, CHEST, V140, P753, DOI 10.1378/chest.10-2865; de Leon AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010680; De Meyer T, 2008, AGING CELL, V7, P700, DOI 10.1111/j.1474-9726.2008.00419.x; Den Elzen WPJ, 2011, AGE AGEING, V40, P494, DOI 10.1093/ageing/afr048; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; ESCHWEGE E, 1978, J CLIN PATHOL, V31, P654, DOI 10.1136/jcp.31.7.654; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; KLIPPEL JH, 1974, JAMA-J AM MED ASSOC, V229, P180, DOI 10.1001/jama.229.2.180; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Liangpunsakul S, 2010, J STUD ALCOHOL DRUGS, V71, P249, DOI 10.15288/jsad.2010.71.249; Mahmoud MY, 1996, AGE AGEING, V25, P310, DOI 10.1093/ageing/25.4.310; MARSH JCW, 1992, BLOOD, V79, P3138; McClintock B, 1941, GENETICS, V26, P234; MCGRATH BP, 1975, Q J MED, V44, P57; Mollica L, 2009, J GERONTOL A-BIOL, V64, P965, DOI 10.1093/gerona/glp065; Myojo M, 2012, ATHEROSCLEROSIS, V221, P148, DOI 10.1016/j.atherosclerosis.2011.11.044; Njajou OT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013048; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donovan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019687; OKUNO T, 1972, BRIT MED J, V1, P569, DOI 10.1136/bmj.1.5799.569-c; PAPOZ L, 1981, Journal of the American Medical Association, V245, P1748, DOI 10.1001/jama.245.17.1748; Rauw J, 2011, LEUKEMIA RES, V35, P1335, DOI 10.1016/j.leukres.2011.05.001; RILLAERTS E, 1989, INT J OBESITY, V13, P739; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Schuller CE, 2007, LEUKEMIA, V21, P983, DOI 10.1038/sj.leu.2404631; Schweiger C, 2010, OBES SURG, V20, P193, DOI 10.1007/s11695-009-0008-3; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VALDES AM, 2007, OSTEOPOROS INT; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wright WE, 1996, DEV GENET, V18, P173; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	61	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51046	10.1371/journal.pone.0051046	http://dx.doi.org/10.1371/journal.pone.0051046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23226558	Green Submitted, gold, Green Published			2022-12-25	WOS:000312108500041
J	Jansen, M; Wang, W; Greco, D; Bellenchi, GC; di Porzio, U; Brown, AJ; Ikonen, E				Jansen, Maurice; Wang, Wei; Greco, Dario; Bellenchi, Gian Carlo; di Porzio, Umberto; Brown, Andrew J.; Ikonen, Elina			What dictates the accumulation of desmosterol in the developing brain?	FASEB JOURNAL			English	Article						progesterone; 3 beta-hydroxysterol 24-reductase; liver X receptor; cholesterol precursor; central nervous system	CHOLESTEROL-SYNTHESIS; ALZHEIMERS-DISEASE; RAT-BRAIN; STEROL BIOSYNTHESIS; REDUCTASE-ACTIVITY; NERVOUS-SYSTEM; LIPID RAFTS; METABOLISM; LIVER; PROGESTERONE	The brain is the most cholesterol-enriched tissue in the body. During brain development, desmosterol, an immediate precursor of cholesterol, transiently accumulates up to 30% of total brain sterols. This massive desmosterol deposition appears to be present in all mammalian species reported so far, including humans, but how it is achieved is not well understood. Here, we propose that desmosterol accumulation in the developing brain may be primarily caused by post-transcriptional repression of 3 beta-hydroxysterol 24-reductase (DHCR24) by progesterone. Furthermore, distinct properties of desmosterol may serve to increase the membrane active pool of sterols in the brain: desmosterol cannot be hydroxylated to generate 24S-hydroxycholesterol, a brain derived secretory sterol, desmosterol has a reduced propensity to be esterified as compared to cholesterol, and desmosterol may activate LXR to stimulate astrocyte sterol secretion. This regulated accumulation of desmosterol by progesterone-induced suppression of DHCR24 may facilitate the rapid enrichment and distribution of membrane sterols in the developing brain.-Jansen, M., Wang, W., Greco, D., Bellenchi, G. C., di Porzio, U., Brown, A. J., and Ikonen, E. What dictates the accumulation of desmosterol in the developing brain? FASEB J. 27, 865- 870 ( 2013). www.fasebj.org	[Jansen, Maurice; Wang, Wei; Ikonen, Elina] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Greco, Dario] Univ Helsinki, Res Unit Mol Med, Helsinki, Finland; [Jansen, Maurice; Wang, Wei; Ikonen, Elina] Minerva Fdn, Helsinki, Finland; [Greco, Dario] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Bellenchi, Gian Carlo; di Porzio, Umberto] Inst Genet & Biophys, Naples, Italy; [Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Helsinki; University of Helsinki; Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of New South Wales Sydney	Ikonen, E (corresponding author), Haartmaninkatu 8, Helsinki 00290, Finland.	elina.ikonen@helsinki.fi	Greco, Dario/T-7113-2019	Greco, Dario/0000-0001-9195-9003; Ikonen, Elina/0000-0001-8382-1135; di Porzio, Umberto/0000-0002-2139-8754; BELLENCHI, GIANCARLO/0000-0002-9302-0021	Academy of Finland [131489]; EU FP7 LipidomicNet [202272]; National Health and Medical Research Council [1008081]; National Heart Foundation of Australia [G11S 5757]; Fondo per gli Investimenti i Ricerca di Base [FIRB-RBIN062YH4]; Medical Research Italy [MERIT-RBNE08LN4P]; Progetti di Ricerca di Interesse Nazionale [PRIN-2009TBCZJB_003]	Academy of Finland(Academy of Finland); EU FP7 LipidomicNet; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Fondo per gli Investimenti i Ricerca di Base; Medical Research Italy; Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The authors thank Eser J. Zerenturk for performing the experiments in DHCR24-overexpressing cells, Valerio Piscopo for the RT-PCR experiments, and Pipsa Kaipainen for technical assistance. This work was financially supported by the Academy of Finland (grant 131489 to E.I.), EU FP7 LipidomicNet (grant 202272 to E.I.), the National Health and Medical Research Council (grant 1008081 to A.J.B.), the National Heart Foundation of Australia (G11S 5757 to A.J.B.), Fondo per gli Investimenti i Ricerca di Base (FIRB-RBIN062YH4 to U.D.P.), Medical Research Italy (MERIT-RBNE08LN4P to U.D.P.), and Progetti di Ricerca di Interesse Nazionale (PRIN-2009TBCZJB_003 to U.D.P.).	ARTHUR JR, 1976, BIOCHEM J, V158, P47, DOI 10.1042/bj1580047; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogan RL, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096347; CONNOR WE, 1969, J LIPID RES, V10, P388; DENNICK RG, 1973, J NEUROCHEM, V20, P1293, DOI 10.1111/j.1471-4159.1973.tb00102.x; Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105; FitzPatrick DR, 1998, AM J MED GENET, V75, P145, DOI 10.1002/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S; FUMAGALLI R, 1963, LIFE SCI, P291; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Greeve I, 2000, J NEUROSCI, V20, P7345; Heverin M, 2007, ARTERIOSCL THROM VAS, V27, P2191, DOI 10.1161/ATVBAHA.107.149823; HINSE CH, 1971, J NEUROCHEM, V18, P1989, DOI 10.1111/j.1471-4159.1971.tb09604.x; Ibanez C, 2003, ENDOCRINOLOGY, V144, P2902, DOI 10.1210/en.2002-0073; Iivonen S, 2002, NEUROSCIENCE, V113, P301, DOI 10.1016/S0306-4522(02)00180-X; Jansen M, 2008, J BIOL CHEM, V283, P14610, DOI 10.1074/jbc.M710355200; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Konkle ATM, 2011, ENDOCRINOLOGY, V152, P223, DOI 10.1210/en.2010-0607; KRITCHEVSKY D, 1962, BIOCHEM BIOPH RES CO, V7, P128, DOI 10.1016/0006-291X(62)90160-2; Lindenthal B, 2001, FASEB J, V15, P775, DOI 10.1096/fj.00-0214com; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lutjohann D, 2002, J LIPID RES, V43, P1078, DOI 10.1194/jlr.M200071-JLR200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; Mutka AL, 2004, J BIOL CHEM, V279, P48654, DOI 10.1074/jbc.M405345200; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; PANINI SR, 1987, J BIOL CHEM, V262, P14435; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Quan G, 2003, DEV BRAIN RES, V146, P87, DOI 10.1016/j.devbrainres.2003.09.015; Ruan BF, 1996, P NATL ACAD SCI USA, V93, P11603, DOI 10.1073/pnas.93.21.11603; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Sharpe LJ, 2012, J ALZHEIMERS DIS, V30, P35, DOI 10.3233/JAD-2012-111955; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; TAVANI DM, 1982, J LIPID RES, V23, P774; Vainio S, 2006, J BIOL CHEM, V281, P348, DOI 10.1074/jbc.M509530200; Volpicelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030661; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Zerenturk E. J., 2011, BIOCHIM BIOPHYS ACTA, V1821, P1269	43	27	28	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					865	870		10.1096/fj.12-211235	http://dx.doi.org/10.1096/fj.12-211235			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23230282	Green Submitted			2022-12-25	WOS:000315585200003
J	Spender, LC; Carter, MJ; O'Brien, DI; Clark, LJ; Yu, J; Michalak, EM; Happo, L; Cragg, MS; Inman, GJ				Spender, Lindsay C.; Carter, Matthew J.; O'Brien, Darren I.; Clark, Louise J.; Yu, Jian; Michalak, Ewa M.; Happo, Lina; Cragg, Mark S.; Inman, Gareth J.			Transforming Growth Factor-beta Directly Induces p53-up-regulated Modulator of Apoptosis (PUMA) during the Rapid Induction of Apoptosis in Myc-driven B-cell Lymphomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEIN PUMA; BCL-2 FAMILY-MEMBERS; UP-REGULATION; CANCER CELLS; GENE-EXPRESSION; BAX ACTIVATION; X-L; RESPONSES; BH3; P53	c-Myc transformed human Burkitt's lymphoma (BL) cells are highly sensitive to TGF-beta-induced apoptosis. Previously we demonstrated that TGF-beta-mediated cell death in BL cells is regulated via the mitochondrial intrinsic apoptosis pathway, which is dependent on the activation of BAX and/or BAK. TGF-beta directly induces transcription of the BH3-only protein BIK and represses expression of the pro-survival factor BCL-X-L but has no effect on the direct BAX/BAK "activators" BIM or BID (tBID). Here we show that TGF-beta induces the BH3-only activator PUMA to aid induction of the intrinsic cell death pathway. TGF-beta also induced PUMA in normal germinal center CD77-positive centroblasts isolated from human tonsil tissue. PUMA was a direct TGF-beta target gene in B-cells, and we identify a putative Smad-binding region within the human PUMA promoter that recruits Smad3 and Smad4 in cells in response to TGF-beta signaling. Constitutive activity of the isolated Smadbinding region in luciferase reporter assays was dependent on Smad consensus sequences and was partially dependent on endogenous TGF-beta signaling and Smad4. Knockdown ofPUMA in BL cells using lentiviral shRNA resulted in slower kinetics of the TGF-beta -mediated apoptotic response. Analysis of E mu-Myc cell lines demonstrated that c-myc-driven murine lymphomas are also sensitive to TGF-beta-mediated apoptosis. Moreover, Puma(-/-) E mu-Myc lines demonstrated significantly delayed kinetics of the apoptotic response when compared with wild type lymphomas. TGF-beta therefore induces a polygenic response in Myc-driven lymphomas involving transcription of PUMA, which is necessary for the rapid induction of cell death.	[Spender, Lindsay C.; Inman, Gareth J.] Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res,Med Res Inst, Dundee DD1 9SY, Scotland; [Carter, Matthew J.; Cragg, Mark S.] Univ Southampton, Southampton Gen Hosp, Canc Sci Unit, Southampton SO16 6YD, Hants, England; [O'Brien, Darren I.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Clark, Louise J.] So Gen Hosp, Dept Otolaryngol, Glasgow G51 4TF, Lanark, Scotland; [Yu, Jian] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Yu, Jian] Inst Canc Res, Pittsburgh, PA 15213 USA; [Michalak, Ewa M.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Happo, Lina] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Happo, Lina] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	University of Dundee; University of Southampton; Beatson Institute; University of Glasgow; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Netherlands Cancer Institute; Walter & Eliza Hall Institute; University of Melbourne	Inman, GJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res,Med Res Inst, James Arrott Dr, Dundee DD1 9SY, Scotland.	g.j.inman@dundee.ac.uk	Cragg, Mark S/E-5965-2010; Yu, Jian/A-8301-2009	Cragg, Mark S/0000-0003-2077-089X; Yu, Jian/0000-0002-4021-1000; Inman, Gareth/0000-0002-6264-4253; Carter, Matthew/0000-0002-5198-5933; Michalak, Ewa/0000-0002-5772-2122	National Institutes of Health [CA129829, U01-DK085570]; Cancer Research UK; Association for International Cancer Research; Medical Research Council; American Cancer Society [RGS-10-124-01-CCE]; NATIONAL CANCER INSTITUTE [R01CA129829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085570] Funding Source: NIH RePORTER; Worldwide Cancer Research [11-0788] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Worldwide Cancer Research	This work was supported, in whole or in part, by National Institutes of Health Grants CA129829 and U01-DK085570 (to J. Y.).; 1 Supported by Cancer Research UK and the Association for International Cancer Research.; 2 Supported by a Medical Research Council studentship.; 3 Supported by American Cancer Society Grant RGS-10-124-01-CCE.	Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clybouw C, 2011, BLOOD, V118, P4120, DOI 10.1182/blood-2011-04-347096; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; FARRELL PJ, 1991, EMBO J, V10, P2879, DOI 10.1002/j.1460-2075.1991.tb07837.x; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gros MJ, 2008, J IMMUNOL, V180, P8153, DOI 10.4049/jimmunol.180.12.8153; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Inman GJ, 2000, J IMMUNOL, V165, P2500, DOI 10.4049/jimmunol.165.5.2500; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Luo X, 2005, CELL DEATH DIFFER, V12, P1310, DOI 10.1038/sj.cdd.4401659; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Schulz R, 2008, CELL TISSUE RES, V334, P327, DOI 10.1007/s00441-008-0714-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SNAPPER CM, 1993, J IMMUNOL, V151, P4625; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Spender LC, 2001, J VIROL, V75, P3537, DOI 10.1128/JVI.75.8.3537-3546.2001; Spender LC, 2012, MOL CANCER RES, V10, P347, DOI 10.1158/1541-7786.MCR-11-0394; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yamamura Y, 2008, FEBS LETT, V582, P2663, DOI 10.1016/j.febslet.2008.06.046; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	46	30	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5198	5209		10.1074/jbc.M112.410274	http://dx.doi.org/10.1074/jbc.M112.410274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23243310	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000315340400067
J	Kost, A; Laderach, P; Fisher, M; Cook, S; Gomez, L				Kost, Andre; Laederach, Peter; Fisher, Myles; Cook, Simon; Gomez, Lorena			Improving Index-Based Drought Insurance in Varying Topography: Evaluating Basis Risk Based on Perceptions of Nicaraguan Hillside Farmers	PLOS ONE			English	Article							WEATHER GENERATORS; AGRICULTURE; VARIABILITY; INNOVATIONS; AMERICA; AFRICA; AREAS; MODEL	This paper discusses a methodology to model precipitation indices and premium prices for index-based drought insurance for smallholders. Spatial basis risk, which is borne by the insured, is a problem, especially in variable topography. Also, site-specific drought risk needs to be estimated accurately in order to offer effective insurance cover and ensure financial sustainability of the insurance scheme. We explore farmers' perceptions on drought and spatial climate variability and draw conclusions concerning basis risk with regards to the proposed methodology. There are technically many options to represent natural heterogeneity in index insurance contracts while serving the customer adequately and keeping transaction costs low.	[Kost, Andre] Univ Bonn, Dept Geog, Bonn, Germany; [Laederach, Peter; Gomez, Lorena] Ctr Int Agr Trop, Managua, Nicaragua; [Fisher, Myles] Ctr Int Agr Trop, Cali, Colombia; [Cook, Simon] Int Water Management Inst, Pelawatte, Battaramulla, Sri Lanka	University of Bonn; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Water Management Institute (IWMI)	Kost, A (corresponding author), Univ Bonn, Dept Geog, Bonn, Germany.	andre.kost@arcor.de	; Cook, Simon/R-7762-2017	Laderach, Peter/0000-0001-8708-6318; Cook, Simon/0000-0003-0902-1476	Gesellschaft fur Internationale Zusammenarbeit; Deutsche Gesellschaft fur Internationale Zusammenarbeit, Beratungsgruppe Entwicklungsorientierte Agrarforschung (GIZ-BEAF); Nicaraguan Ministerio Agropecuario y Forestal (MAGFOR); Instituto Nicaraguense de Technologia Agropecuaria (INTA)	Gesellschaft fur Internationale Zusammenarbeit; Deutsche Gesellschaft fur Internationale Zusammenarbeit, Beratungsgruppe Entwicklungsorientierte Agrarforschung (GIZ-BEAF); Nicaraguan Ministerio Agropecuario y Forestal (MAGFOR); Instituto Nicaraguense de Technologia Agropecuaria (INTA)	Research was partially financed by Gesellschaft fur Internationale Zusammenarbeit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This research was conducted under the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) with additional funding from Deutsche Gesellschaft fur Internationale Zusammenarbeit, Beratungsgruppe Entwicklungsorientierte Agrarforschung (GIZ-BEAF). Many thanks also to Lesbia Rizo, Dr. Carlos Zelaya, Narisoki Castro and Armando Martinez from CIAT as well as to the Nicaraguan Ministerio Agropecuario y Forestal (MAGFOR) and the Instituto Nicaraguense de Technologia Agropecuaria (INTA), for supporting this study.	Anderson JR, 2003, AGR SYST, V75, P161, DOI 10.1016/S0308-521X(02)00064-1; [Anonymous], 2007, AGR DEV; [Anonymous], 2009, LA PRENSA; [Anonymous], 2004, COPING RISK AGR; Baethgen W, 2008, CONTRIBUTIONS AGR SY; Balzer N, 2010, POTENTIAL SCALE SUST; Barnett BJ, 2007, AM J AGR ECON, V89, P1241, DOI 10.1111/j.1467-8276.2007.01091.x; Barrett C.B., 2007, POVERTY TRAPS CLIMAT; Carter M.R., 2008, INSURING NEVER INSUR; Churchill C, 2006, PROTECTING POOR MICR, P13; Dercon S, 2004, J DEV ECON, V74, P309, DOI 10.1016/j.jdeveco.2004.01.001; DEWALT BR, 1994, HUM ORGAN, V53, P123, DOI 10.17730/humo.53.2.ku60563817m03n73; Diaz Nieto J, 2006, SYSTEM DROUGHT INSUR; Diaz Nieto J, 2004, 11 CIAT; Diaz Nieto J, 2004, 4 CIAT; El Nuevo Diario, 2010, AMPL COB SEG AGR; El Nuevo Diario, 2009, LAF LANZ SEG AGR ANT; Ericksen PJ, 2003, GEODERMA, V111, P233, DOI 10.1016/S0016-7061(02)00266-5; FAO, 2011, PROM GROWTH DEV SMAL; FUJISAKA S, 1994, AGR SYST, V46, P409, DOI 10.1016/0308-521X(94)90104-N; Gabler Wirtschaftslexikon, 2011, BAS; Giannini A, 2009, 0901 IRI; Gine X., 2010, 5459 WORLD BANK; Gold J. R, 1980, INTRO BEHAV GEOGRAPH; Golledge RG., 1997, SPATIAL BEHAV GEOGRA; GUDGER M, 1991, RISK IN AGRICULTURE, P143; Hartkamp AD, 2003, AGR SYST, V76, P539, DOI 10.1016/S0308-521X(01)00108-1; Hellmuth ME, 2009, INDEX INSURANCE CLIM, V2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ingram KT, 2002, AGR SYST, V74, P331, DOI 10.1016/S0308-521X(02)00044-6; Instituto Nicaragu ense de Estudios Territoriales (INETER), 2005, CAR CLIM NIC MAN ATL; Instituto Nicaraguense de Estudios Territoriales (INETER), 2010, BOL CLIM MENS; Instituto Nicaraguense de Estudios Territoriales (INETER), 2005, FEN NIN; Instituto Nicaraguense de Tecnologia Agropecuaria (INTA), 2004, CULT FRIJ CON MEN RI; JASANOFF S, 1993, RISK ANAL, V13, P123, DOI 10.1111/j.1539-6924.1993.tb01057.x; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Jones P. G., 2002, MARKSIM COMPUTER TOO; JONES PG, 1993, AGR FOREST METEOROL, V63, P1, DOI 10.1016/0168-1923(93)90019-E; Jones PG, 1997, AGR FOREST METEOROL, V86, P127, DOI 10.1016/S0168-1923(96)02399-4; Jones PG, 2000, AGRON J, V92, P445, DOI 10.2134/agronj2000.923445x; Kitchin R., 2002, COGNITION GEOGRAPHIC; Kluge S., 2010, EINZELFALL TYPUS FAL; Magana V, 1999, J CLIMATE, V12, P1577, DOI 10.1175/1520-0442(1999)012<1577:TMDOMA>2.0.CO;2; Mavromatis T, 2001, AGR FOREST METEOROL, V109, P283, DOI 10.1016/S0168-1923(01)00272-6; Mayring P., 2021, QUALITATIVE CONTENT; Miranda M, 2001, AM J AGR ECON, V83, P650, DOI 10.1111/0002-9092.00185; MIRANDA MJ, 1991, AM J AGR ECON, V73, P233, DOI 10.2307/1242708; Nieto JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038281; Nieto JD, 2010, CLIM DEV, V2, P233, DOI 10.3763/cdev.2010.0050; NIEUWOLT S, 1982, AGR ENVIRON, V7, P135, DOI 10.1016/0304-1131(82)90003-0; Osgood DE, 2007, 0702 IRI WORLD BANK; Renn O., 2017, RISK GOVERNANCE COPI; Skees J, 1999, IFPRI DISCUSSION PAP; Skees J. R., 2008, Agricultural and Resource Economics Review, V37, P1; The World Bank, 2005, MAN AGR PROD RISK IN; Wilhite D. A., 1985, Water International, V10, P111, DOI 10.1080/02508068508686328; Witzel A., 2000, FORUM QUALITATIVE SO, V1, P26	57	6	6	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51412	10.1371/journal.pone.0051412	http://dx.doi.org/10.1371/journal.pone.0051412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23240020	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800056
J	Kuo, SY; Tu, CH; Hsu, YT; Wang, HD; Wen, RK; Lin, CT; Wu, CL; Huang, YT; Huang, GS; Lan, TH; Fu, TF				Kuo, Shu-Yun; Tu, Chiao-Hui; Hsu, Ya-Ting; Wang, Horng-Dar; Wen, Rong-Kun; Lin, Chen-Ta; Wu, Chia-Lin; Huang, Yu-Ting; Huang, Guan-Shieng; Lan, Tsuo-Hung; Fu, Tsai-Feng			A Hormone Receptor-Based Transactivator Bridges Different Binary Systems to Precisely Control Spatial-Temporal Gene Expression in Drosophila	PLOS ONE			English	Article							TRANSGENE EXPRESSION; DISRUPTION PROJECT; LIFE-SPAN; TEMPERATURE; LONGEVITY; SLEEP; ENTRAINMENT; RESISTANCE; NEURONS; RESCUE	The GAL4/UAS gene expression system is a precise means of targeted gene expression employed to study biological phenomena in Drosophila. A modified GAL4/UAS system can be conditionally regulated using a temporal and regional gene expression targeting (TARGET) system that responds to heat shock induction. However heat shock-related temperature shifts sometimes cause unexpected physiological responses that confound behavioral analyses. We describe here the construction of a drug-inducible version of this system that takes advantage of tissue-specific GAL4 driver lines to yield either RU486-activated LexA-progesterone receptor chimeras (LexPR) or beta-estradiol-activated LexA-estrogen receptor chimeras (XVE). Upon induction, these chimeras bind to a LexA operator (LexAop) and activate transgene expression. Using GFP expression as a marker for induction in fly brain cells, both approaches are capable of tightly and precisely modulating transgene expression in a temporal and dosage-dependent manner. Additionally, tissue-specific GAL4 drivers resulted in target gene expression that was restricted to those specific tissues. Constitutive expression of the active PKA catalytic subunit using these systems altered the sleep pattern of flies, demonstrating that both systems can regulate transgene expression that precisely mimics regulation that was previously engineered using the GeneSwitch/UAS system. Unlike the limited number of GeneSwitch drivers, this approach allows for the usage of the multitudinous, tissue-specific GAL4 lines for studying temporal gene regulation and tissue-specific gene expression. Together, these new inducible systems provide additional, highly valuable tools available to study gene function in Drosophila.	[Kuo, Shu-Yun; Hsu, Ya-Ting; Lin, Chen-Ta; Fu, Tsai-Feng] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou, Taiwan; [Kuo, Shu-Yun; Tu, Chiao-Hui; Wen, Rong-Kun; Lin, Chen-Ta; Huang, Yu-Ting; Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Coll Med, Dept Biochem, Tao Yuan, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Huang, Guan-Shieng] Natl Chi Nan Univ, Dept Comp Sci & Informat Engn, Nantou, Taiwan; [Lan, Tsuo-Hung] Natl Yang Ming Univ, Sch Med, Dept Psychiat, Taipei 112, Taiwan; [Lan, Tsuo-Hung] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan	National Chi Nan University; National Chi Nan University; National Tsing Hua University; National Tsing Hua University; Chang Gung University; Chang Gung University; National Chi Nan University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Fu, TF (corresponding author), Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou, Taiwan.	tffu@ncnu.edu.tw		Wu, Chia-Lin/0000-0002-7906-2364; Wang, Horng-Dar/0000-0001-9570-3611; Lan, Tsuo-Hung/0000-0002-2796-1026; Fu, Tsai-Feng/0000-0002-0343-3018	National Science Council [101-2311-B-260-002, 101-2627-M-260-001-, 98-2311-B-260-001-MY3]; Taichung Veterans General Hospital/National Chi Nan University Joint Research Program [TCVGH-NCNU1017904]	National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital/National Chi Nan University Joint Research Program	This work was supported by National Science Council Grant 101-2311-B-260-002, 101-2627-M-260-001- and 98-2311-B-260-001-MY3 (to T.-F. F.) and a grant from the Taichung Veterans General Hospital/National Chi Nan University Joint Research Program TCVGH-NCNU1017904 (also to T.-F. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Bello B, 1998, DEVELOPMENT, V125, P2193; Bieschke ET, 1998, MOL GEN GENET, V258, P571, DOI 10.1007/s004380050770; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Burcin Mark M., 1998, Frontiers in Bioscience, V3, pC1; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Folguera G, 2010, J INSECT PHYSIOL, V56, P1679, DOI 10.1016/j.jinsphys.2010.06.015; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; Han DD, 2000, DEVELOPMENT, V127, P573; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Howlader G, 2006, J BIOL RHYTHM, V21, P13, DOI 10.1177/0748730405282882; Huckesfeld S, 2011, J INSECT PHYSIOL, V57, P136, DOI 10.1016/j.jinsphys.2010.10.002; Ito C, 2011, J BIOL RHYTHM, V26, P14, DOI 10.1177/0748730410391640; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Le Bourg E, 2007, BIOGERONTOLOGY, V8, P431, DOI 10.1007/s10522-007-9086-6; Madalan A, 2012, LEARN MEMORY, V19, P26, DOI 10.1101/lm.024802.111; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, SCI STKE, P16, DOI DOI 10.1126/28822202004P16; Mizuguchi H, 2002, J GENE MED, V4, P240, DOI 10.1002/jgm.261; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Peng IF, 2007, J NEUROSCI, V27, P12611, DOI 10.1523/JNEUROSCI.2179-07.2007; Riveron J, 2009, J INSECT PHYSIOL, V55, P943, DOI 10.1016/j.jinsphys.2009.06.009; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Shih CT, 2011, COMPUT PHYS COMMUN, V182, P195, DOI 10.1016/j.cpc.2010.07.021; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; Stebbins MJ, 2001, GENE, V270, P103, DOI 10.1016/S0378-1119(01)00447-4; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Viktorinova I, 2007, INSECT BIOCHEM MOLEC, V37, P246, DOI 10.1016/j.ibmb.2006.11.010; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Wang X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001125; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zars M, 2006, J COMP PHYSIOL A, V192, P727, DOI 10.1007/s00359-006-0109-6; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	46	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50855	10.1371/journal.pone.0050855	http://dx.doi.org/10.1371/journal.pone.0050855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239992	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800028
J	Walkey, CJ; Luo, ZL; Madilao, LL; van Vuuren, HJJ				Walkey, Christopher J.; Luo, Zongli; Madilao, Lufiani L.; van Vuuren, Hennie J. J.			The Fermentation Stress Response Protein Aaf1p/Yml081Wp Regulates Acetate Production in Saccharomyces cerevisiae	PLOS ONE			English	Article							ACETALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASES; GENE DISRUPTION; BUDDING YEAST; ALD3 GENES; GLUCOSE; CASSETTE; GROWTH; ENZYME; WINE	The production of acetic acid during wine fermentation is a critical issue for wineries since the sensory quality of a wine can be affected by the amount of acetic acid it contains. We found that the C2H2-type zinc-finger transcription factor YML081Wp regulated the mRNA levels of ALD4 and ALD6, which encode a cytosolic acetaldehyde dehydrogenase (ACDH) and a mitochondrial ACDH, respectively. These enzymes produce acetate from acetaldehyde as part of the pyruvate dehydrogenase bypass. This regulation was also reflected in the protein levels of Ald4p and Ald6p, as well as total ACDH activity. In the absence of ALD6, YML081W had no effect on acetic acid levels, suggesting that this transcription factor's effects are mediated primarily through this gene. lacZ reporter assays revealed that Yml081wp stimulates ALD6 transcription, in large part from a GAGGGG element 590 base pairs upstream of the translation start site. The non-annotated ORF YML081W therefore encodes a transcription factor that regulates acetate production in Saccharomyces cerevisiae. We propose AAF1 as a gene name for the YML081W ORF.	[Walkey, Christopher J.; Luo, Zongli; Madilao, Lufiani L.; van Vuuren, Hennie J. J.] Univ British Columbia, Wine Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	van Vuuren, HJJ (corresponding author), Univ British Columbia, Wine Res Ctr, Vancouver, BC V5Z 1M9, Canada.	hjjvv@mail.ubc.ca			Genome Canada/Genome BC [WIN151]; NSERC [217271-09]	Genome Canada/Genome BC(Genome Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by Genome Canada/Genome BC grant WIN151 and NSERC grant 217271-09 to HJJvV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2010, AM J ENOL VITICULT, V61, P125; Deed NK, 2011, APPL MICROBIOL BIOT, V89, P1537, DOI 10.1007/s00253-011-3084-y; Flikweert MT, 1996, YEAST, V12, P247, DOI 10.1002/(SICI)1097-0061(19960315)12:3<247::AID-YEA911>3.0.CO;2-I; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grabowska D, 2003, J BIOL CHEM, V278, P13984, DOI 10.1074/jbc.M210076200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hansen J, 2003, FEMS YEAST RES, V4, P323, DOI 10.1016/S1567-1356(03)00178-8; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KISPAL G, 1991, BIOCHIM BIOPHYS ACTA, V1085, P217, DOI 10.1016/0005-2760(91)90097-2; Kurita O, 1999, FEMS MICROBIOL LETT, V181, P281, DOI 10.1111/j.1574-6968.1999.tb08856.x; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; Meaden PG, 1997, YEAST, V13, P1319, DOI 10.1002/(SICI)1097-0061(199711)13:14<1319::AID-YEA183>3.0.CO;2-T; Melcher K, 2000, GENE, V247, P53, DOI 10.1016/S0378-1119(00)00124-4; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Remize F, 2000, APPL ENVIRON MICROB, V66, P3151, DOI 10.1128/AEM.66.8.3151-3159.2000; Richards KD, 2009, ANTON LEEUW INT J G, V96, P355, DOI 10.1007/s10482-009-9346-3; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; SEEGMILLER JE, 1953, J BIOL CHEM, V201, P629; Tessier WD, 1998, FEMS MICROBIOL LETT, V164, P29, DOI 10.1111/j.1574-6968.1998.tb13063.x; Volschenk H, 1997, NAT BIOTECHNOL, V15, P253, DOI 10.1038/nbt0397-253; Walkey CJ, 2011, FEMS YEAST RES, V11, P499, DOI 10.1111/j.1567-1364.2011.00740.x; White WH, 2003, GENETICS, V163, P69; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893	27	18	20	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51551	10.1371/journal.pone.0051551	http://dx.doi.org/10.1371/journal.pone.0051551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240040	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800076
J	Burgos-Rivera, B; Dawe, RK				Burgos-Rivera, Brunilis; Dawe, R. Kelly			An Arabidopsis Tissue-Specific RNAi Method for Studying Genes Essential to Mitosis	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CENP-C; INNER KINETOCHORE; MAIZE HOMOLOG; THALIANA; CENTROMERE; PLANTS; TRANSFORMATION; TRANSCRIPTION; ORGANIZATION	A large fraction of the genes in plants can be considered essential in the sense that when absent the plant fails to develop past the first few cell divisions. The fact that angiosperms pass through a haploid gametophyte stage can make it challenging to propagate such mutants even in the heterozygous condition. Here we describe a tissue-specific RNAi method that allows us to visualize cell division phenotypes in petals, which are large dispensable organs. Portions of the APETALA (AP3) and PISTILLATA (PI) promoters confer early petal-specific expression. We show that when either promoter is used to drive the expression of a beta-glucuronidase (GUS) RNAi transgene in plants uniformly expressing GUS, GUS expression is knocked down specifically in petals. We further tested the system by targeting the essential kinetochore protein CENPC and two different components of the Spindle Assembly Checkpoint (MAD2 and BUBR1). Plant lines expressing petal-specific RNAi hairpins targeting these genes exhibited an array of petal phenotypes. Cytological analyses of the affected flower buds confirmed that CENPC knockdown causes cell cycle arrest but provided no evidence that either MAD2 or BUBR1 are required for mitosis (although both genes are required for petal growth by this assay). A key benefit of the petal-specific RNAi method is that the phenotypes are not expressed in the lineages leading to germ cells, and the phenotypes are faithfully transmitted for at least four generations despite their pronounced effects on growth. Citation: Burgos-Rivera B, Dawe RK (2012) An Arabidopsis Tissue-Specific RNAi Method for Studying Genes Essential to Mitosis. PLoS ONE 7(12): e51388. doi: 10.1371/journal.pone.0051388	[Burgos-Rivera, Brunilis; Dawe, R. Kelly] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Dawe, R. Kelly] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dawe, RK (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	kelly@plantbio.uga.edu			National Science Foundation grant [0922703]; SREB-State Doctoral Scholars Program; National Institutes of Health training grant; Direct For Biological Sciences [0922703] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	National Science Foundation grant(National Science Foundation (NSF)); SREB-State Doctoral Scholars Program; National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant 0922703, a fellowship from the SREB-State Doctoral Scholars Program, and funds from an National Institutes of Health training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Byzova M, 2004, PLANTA, V218, P379, DOI 10.1007/s00425-003-1117-1; Caillaud MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006757; CASTLE LA, 1993, MOL GEN GENET, V241, P504, DOI 10.1007/BF00279892; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Dawe RK, 1999, PLANT CELL, V11, P1227, DOI 10.1105/tpc.11.7.1227; Ding DF, 2012, PLANT MOL BIOL, V79, P203, DOI 10.1007/s11103-012-9903-4; Du YQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000835; ERRAMPALLI D, 1991, PLANT CELL, V3, P149, DOI 10.1105/tpc.3.2.149; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 1997, HUM MOL GENET, V6, P2301, DOI 10.1093/hmg/6.13.2301; Hill TA, 1998, DEVELOPMENT, V125, P1711; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Honma T, 2000, DEVELOPMENT, V127, P2021; JEFFERSON RA, 1987, EMBO J, V6, P3901; JURGENS G, 1991, DEVELOPMENT, P27; Kalantidis K, 2008, BIOL CELL, V100, P13, DOI 10.1042/BC20070079; Kimbara J, 2004, CHROMOSOME RES, V12, P703, DOI 10.1023/B:CHRO.0000045760.42880.8c; Krizek BA, 1996, DEVELOPMENT, V122, P11; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Meinke David W., 1994, V27, P253; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Ogura Y, 2004, GENES GENET SYST, V79, P139, DOI 10.1266/ggs.79.139; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Rao MK, 2006, NAT PROTOC, V1, P1494, DOI 10.1038/nprot.2006.260; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Salinas J, 2006, ARABIDOPSIS PROTOCOL; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Yu HG, 1999, J CELL BIOL, V145, P425, DOI 10.1083/jcb.145.3.425; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	47	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51388	10.1371/journal.pone.0051388	http://dx.doi.org/10.1371/journal.pone.0051388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236491	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100110
J	Narasimhan, M; Patel, D; Vedpathak, D; Rathinam, M; Henderson, G; Mahimainathan, L				Narasimhan, Madhusudhanan; Patel, Dhyanesh; Vedpathak, Dhanashree; Rathinam, Marylatha; Henderson, George; Mahimainathan, Lenin			Identification of Novel microRNAs in Post-Transcriptional Control of Nrf2 Expression and Redox Homeostasis in Neuronal, SH-SY5Y Cells	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; MESSENGER-RNA DEGRADATION; CUL3-BASED E3 LIGASE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; NEUROBLASTOMA-CELLS; SIGNALING PATHWAY; GENE-EXPRESSION; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR-2	Nuclear factor-erythroid 2-related factor 2 (Nrf2/NFE2L2), a redox-sensitive transcription factor plays a critical role in adaptation to cellular stress and affords cellular defense by initiating transcription of antioxidative and detoxification genes. While a protein can be regulated at multiple levels, control of Nrf2 has been largely studied at post-translational regulation points by Keap1. Importantly, post-transcriptional/translational based regulation of Nrf2 is less understood and to date there are no reports on such mechanisms in neuronal systems. In this context, studies involving the role of microRNAs (miRs) which are normally considered as fine tuning regulators of protein production through translation repression and/or post-transcriptional alterations, are in place. In the current study, based on in-silico analysis followed by immunoblotting and real time analysis, we have identified and validated for the first time that human NFE2L2 could be targeted by miR153/miR27a/miR142-5p/miR144 in neuronal, SH-SY5Y cells. Co-transfection studies with individual miR mimics along with either WT 3' UTR of human Nrf2 or mutated miRNA targeting seed sequence within Nrf2 3' UTR, demonstrated that Nrf2 is a direct regulatory target of these miRs. In addition, ectopic expression of miR153/miR27a/miR142-5p/miR144 affected Nrf2 mRNA abundance and nucleo-cytoplasmic concentration of Nrf2 in a Keap1 independent manner resulting in inefficient transactivating ability of Nrf2. Furthermore, forced expression of miRs diminished GCLC and GSR expression resulting in alteration of Nrf2 dependent redox homeostasis. Finally, bioinformatics based miRNA-disease network analysis (MDN) along with extended computational network analysis of Nrf2 associated pathologic processes suggests that if in a particular cellular scenario where any of these miR153/miR27a/miR142-5p/miR144 either individually or as a group is altered, it could affect Nrf2 thus triggering and/or determining the fate of wide range of disease outcomes.	[Narasimhan, Madhusudhanan; Patel, Dhyanesh; Vedpathak, Dhanashree; Rathinam, Marylatha; Henderson, George; Mahimainathan, Lenin] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Narasimhan, Madhusudhanan; Henderson, George; Mahimainathan, Lenin] Texas Tech Univ, Hlth Sci Ctr, S Plains Alcohol & Addict Res Ctr, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Narasimhan, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA.	madhu.narasimhan@ttuhsc.edu; lenin.mahimainathan@ttuhsc.edu		/0000-0001-5077-3552	National Institutes of Health Research Project Grant Program [RO1 AA010114]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010114] Funding Source: NIH RePORTER	National Institutes of Health Research Project Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by RO1 AA010114 (National Institutes of Health Research Project Grant Program) to George I. Henderson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Aleksunes LM, 2012, DRUG METABOLISM DISP; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bartuma H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-36; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Burton NC, 2006, NEUROTOXICOLOGY, V27, P1094, DOI 10.1016/j.neuro.2006.07.019; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chumanov RS, 2010, PROTEIN EXPRES PURIF, V74, P280, DOI 10.1016/j.pep.2010.06.017; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dunckley T, 2006, BRAIN RES, V1116, P39, DOI 10.1016/j.brainres.2006.07.111; Fujimori K, 2012, J NEUROCHEM, V120, P279, DOI 10.1111/j.1471-4159.2011.07570.x; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grudt TJ, 1996, MOL BRAIN RES, V36, P93, DOI 10.1016/0169-328X(95)00248-Q; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Ho PWL, 2006, J NEUROSCI RES, V84, P1358, DOI 10.1002/jnr.21034; Hota KB, 2012, J CEREBRAL BLOOD FLO; Im JY, 2012, HUMAN MOL GENETICS; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Janssen HL, 2011, HEPATOLOGY, V54, p1430A; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kocerha J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-527; Kokot A, 2009, ENDOCRINOLOGY, V150, P3197, DOI 10.1210/en.2008-1315; Lau A, 2012, ANTIOXIDANT IN PRESS; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004; Li WG, 2010, NUCLEIC ACIDS RES, V38, P778, DOI 10.1093/nar/gkp1048; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; McGinnis KM, 1999, J NEUROCHEM, V72, P1853, DOI 10.1046/j.1471-4159.1999.0721853.x; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Narasimhan M, 2011, MOL PHARMACOL, V80, P988, DOI 10.1124/mol.111.073262; Nath R, 1997, BIOCHEM MOL BIOL INT, V43, P197; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nguyen HN, 2002, BRAIN RES, V924, P159, DOI 10.1016/S0006-8993(01)03229-2; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Ragusa M, 2010, MOL CANCER THER, V9, P3396, DOI 10.1158/1535-7163.MCT-10-0137; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shin JH, 2012, NEUROCHEMISTRY INT; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Silveira LR, 2003, FREE RADICAL BIO MED, V35, P455, DOI 10.1016/S0891-5849(03)00271-5; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	70	145	154	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51111	10.1371/journal.pone.0051111	http://dx.doi.org/10.1371/journal.pone.0051111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236440	gold, Green Submitted, Green Published			2022-12-25	WOS:000312064100069
J	Odunsi, K; Mhawech-Fauceglia, P; Andrews, C; Beck, A; Amuwo, O; Lele, S; Black, JD; Huang, RY				Odunsi, Kunle; Mhawech-Fauceglia, Paulette; Andrews, Christopher; Beck, Amy; Amuwo, Olajumoke; Lele, Shashikant; Black, Jennifer D.; Huang, Ruea-Yea			Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro	PLOS ONE			English	Article							SPLICING FACTORS; SACCHAROMYCES-CEREVISIAE; SR PROTEINS; CELL-CYCLE; NUCLEAR; INACTIVATION; RESISTANCE; DEPHOSPHORYLATION; PHOSPHORYLATION; VARIANTS	Alternatively spliced variants of several oncogenes and tumor suppressors have been shown to be important for their tumorigenicity. In the present study we have tested whether serine-arginine protein kinase 1 (SRPK1), a major regulator of splicing factors, is involved in ovarian cancer progression and plays a role in chemo-sensitivity. By Western blot analyses, SRPK1 protein was found to be overexpressed in 4 out of 6 ovarian cancer cell lines as compared with an immortalized ovarian surface epithelial cell line; and in 55% of ovarian tumor samples as compared with non-neoplastic ovarian tissue samples. Reduction of SRPK1 expression using small interfering RNA (siRNA) encoding small hairpin RNA in ovarian cancer cells led to (i) reduced cell proliferation rate, slower cell cycle progression and compromised anchorage-independent growth and migration ability in vitro, (ii) decreased level of phosphorylation of multiple serine-arginine proteins, and P44/42MAPK and AKT proteins, and (iii) enhanced sensitivity to cisplatin. Together, these results suggest that elevated SRPK1 expression may play a role in ovarian tumorigenesis and SRPK1 may be a potential target for ovarian cancer therapy.	[Odunsi, Kunle; Amuwo, Olajumoke; Lele, Shashikant; Huang, Ruea-Yea] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Mhawech-Fauceglia, Paulette] Roswell Pk Canc Inst, Dept Pathol & Lab Med, Buffalo, NY 14263 USA; [Andrews, Christopher] SUNY Buffalo, Dept Biostatist, Buffalo, NY 14260 USA; [Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Odunsi, Kunle; Beck, Amy] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Huang, RY (corresponding author), Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA.	raya.huang@roswellpark.org		Andrews, Chris/0000-0001-5130-6374	National Institutes of Health [CA 107303]; Gynecologic Cancer Foundation [DK60632, CA16056]; Cancer Research Institute/Ludwig Institute for Cancer Research Cancer Vaccine Collaborative Grant; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016056, R21CA107303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK060632, R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gynecologic Cancer Foundation; Cancer Research Institute/Ludwig Institute for Cancer Research Cancer Vaccine Collaborative Grant; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants CA 107303 (RH), Gynecologic Cancer Foundation (RH), DK60632 (JDB), and CA16056 (RPCI Core Grant); Cancer Research Institute/Ludwig Institute for Cancer Research Cancer Vaccine Collaborative Grant (KO); and Hilton-Ludwig Cancer Metastasis Grant of the Ludwig Institute for Cancer Research (KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; ANDREWS PA, 1985, CANCER RES, V45, P6250; ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; AUERSPERG N, 1994, LAB INVEST, V71, P510; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Cao WH, 1997, RNA, V3, P1456; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; FU XD, 1995, RNA, V1, P663; Ghigna C, 1998, CANCER RES, V58, P5818; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; He X, 2007, ONCOGENE; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Hishizawa M, 2005, BRIT J HAEMATOL, V130, P382, DOI 10.1111/j.1365-2141.2005.05619.x; Huang RY, 1996, NUCLEIC ACIDS RES, V24, P816, DOI 10.1093/nar/24.5.816; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Krishnakumar S, 2008, PEDIATR BLOOD CANCER, V50, P402, DOI 10.1002/pbc.21088; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Mhawech P, 2005, MODERN PATHOL, V18, P340, DOI 10.1038/modpathol.3800240; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Papoutsopoulou S, 1999, NUCLEIC ACIDS RES, V27, P2972, DOI 10.1093/nar/27.14.2972; Pelisch F, 2005, J BIOL CHEM, V280, P25461, DOI 10.1074/jbc.M412007200; Plasencia C, 2006, INT J ONCOL, V29, P225; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; Salesse S, 2004, LEUKEMIA, V18, P727, DOI 10.1038/sj.leu.2403310; Schenk PW, 2002, MOL PHARMACOL, V61, P659, DOI 10.1124/mol.61.3.659; Schenk PW, 2001, CANCER RES, V61, P6982; Thorsen K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002998; Tockman MS, 1997, CLIN CANCER RES, V3, P2237; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang ZN, 2003, CANCER RES, V63, P655; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I	43	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51030	10.1371/journal.pone.0051030	http://dx.doi.org/10.1371/journal.pone.0051030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236423	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100054
J	Preissner, S; Dunkel, M; Hoffmann, MF; Preissner, SC; Genov, N; Rong, WW; Preissner, R; Seeger, K				Preissner, Saskia; Dunkel, Mathias; Hoffmann, Michael F.; Preissner, Sarah C.; Genov, Nikolai; Rong, Wen Wei; Preissner, Robert; Seeger, Karlheinz			Drug Cocktail Optimization in Chemotherapy of Cancer	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN LIVER-MICROSOMES; HUMAN HEPATOCYTES; IFOSFAMIDE ACTIVATION; METABOLIZING-ENZYMES; HEPG2 CELLS; IN-VITRO; CYTOCHROME-P450; DEXAMETHASONE; CYCLOPHOSPHAMIDE	Background: In general, drug metabolism has to be considered to avoid adverse effects and ineffective therapy. In particular, chemotherapeutic drug cocktails strain drug metabolizing enzymes especially the cytochrome P450 family (CYP). Furthermore, a number of important chemotherapeutic drugs such as cyclophosphamide, ifosfamide, tamoxifen or procarbazine are administered as prodrugs and have to be activated by CYP. Therefore, the genetic variability of these enzymes should be taken into account to design appropriate therapeutic regimens to avoid inadequate drug administration, toxicity and inefficiency. Objective: The aim of this work was to find drug interactions and to avoid side effects or ineffective therapy in chemotherapy. Data sources and methods: Information on drug administration in the therapy of leukemia and their drug metabolism was collected from scientific literature and various web resources. We carried out an automated textmining approach. Abstracts of PubMed were filtered for relevant articles using specific keywords. Abstracts were automatically screened for antineoplastic drugs and their synonyms in combination with a set of human CYPs in title or abstract. Results: We present a comprehensive analysis of over 100 common cancer treatment regimens regarding drug-drug interactions and present alternatives avoiding CYP overload. Typical concomitant medication, e. g. antiemetics or antibiotics is a preferred subject to improvement. A webtool, which allows drug cocktail optimization was developed and is publicly available on http://bioinformatics.charite.de/chemotherapy.	[Seeger, Karlheinz] Charite Univ Med Berlin, Dept Pediat, Div Hematol & Oncol, CC17, Berlin, Germany; [Preissner, Saskia] Charite Univ Med Berlin, Dept Operat & Prevent Dent, CC3, Berlin, Germany; [Dunkel, Mathias; Hoffmann, Michael F.; Preissner, Sarah C.; Genov, Nikolai; Rong, Wen Wei; Preissner, Robert] Charite Univ Med Berlin, Inst Physiol, CC2, Struct Bioinformat Grp, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Seeger, K (corresponding author), Charite Univ Med Berlin, Dept Pediat, Div Hematol & Oncol, CC17, Berlin, Germany.	karl.seeger@charite.de	Genov, Nikolai/F-1197-2017	Genov, Nikolai/0000-0002-0443-9841; Dunkel, Mathias/0000-0002-6642-483X; preissner, robert/0000-0002-2407-1087	Berliner Krebsgeselleschaft; DFG Graduate School 1776; BMBF MedSys; EU SynSys	Berliner Krebsgeselleschaft; DFG Graduate School 1776; BMBF MedSys(Federal Ministry of Education & Research (BMBF)); EU SynSys	This work was supported by Berliner Krebsgeselleschaft, DFG Graduate School 1776, BMBF MedSys, EU SynSys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angalakuditi M, 2011, CLINICOECONOMIC OUTC, V3, P105, DOI 10.2147/CEOR.S21789; Araya Z, 2003, BIOCHEM J, V372, P529, DOI 10.1042/BJ20021651; Bates S, 2010, DRUG DISCOV TODAY, V15, P115, DOI 10.1016/j.drudis.2009.11.001; Baumhakel M, 2001, INT J CLIN PHARM TH, V39, P517; Bazargan A, 2012, EXPERT REV ANTICANC, V12, P393, DOI [10.1586/era.12.2, 10.1586/ERA.12.2]; Bell EC, 2007, ANN PHARMACOTHER, V41, P1819, DOI 10.1345/aph.1K316; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Berners-Lee T, 2006, SCIENCE, V313, P769, DOI 10.1126/science.1126902; Bosch TM, 2006, CLIN PHARMACOKINET, V45, P253, DOI 10.2165/00003088-200645030-00003; CHANG TKH, 1993, CANCER RES, V53, P5629; Chang TKH, 1997, CANCER RES, V57, P1946; Colburn Dawn E, 2004, Hematology, V9, P217, DOI 10.1080/10245330410001701585; Davidsen ML, 2008, J PEDIAT HEMATOL ONC, V30, P831, DOI 10.1097/MPH.0b013e3181868570; Dennison JB, 2006, DRUG METAB DISPOS, V34, P1317, DOI 10.1124/dmd.106.009902; Egbelakin A, 2011, PEDIATR BLOOD CANCER, V56, P361, DOI 10.1002/pbc.22845; Engelhardt MB, 2008, BLAUE BUCH; Ferron GM, 1999, J PHARMACOKINET BIOP, V27, P1, DOI 10.1023/A:1020626611479; Flockhart DA., 2007, DRUG INTERACTIONS CY; Gardiner SJ, 2006, PHARMACOL REV, V58, P521, DOI 10.1124/pr.58.3.6; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gentile DM, 1996, J PHARMACOL EXP THER, V277, P105; Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242; Gor PP, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2570; Grishanova A. Y., 2003, Biomeditsinskaya Khimiya, V49, P27; Hukkanen J, 2000, AM J RESP CELL MOL, V22, P360, DOI 10.1165/ajrcmb.22.3.3845; Ingelman-Sundberg Magnus, 2005, Toxicol Appl Pharmacol, V207, P52; Kanou M, 2004, MOL BIOL REP, V31, P151, DOI 10.1023/B:MOLE.0000043582.35335.ff; Krusekopf S, 2003, EUR J PHARMACOL, V466, P7, DOI 10.1016/S0014-2999(03)01481-X; Lampen A, 1995, DRUG METAB DISPOS, V23, P1315; Lindley C, 2002, DRUG METAB DISPOS, V30, P814, DOI 10.1124/dmd.30.7.814; Lund B, 2011, PEDIATR BLOOD CANCER, V56, P551, DOI 10.1002/pbc.22719; May-Manke A, 1999, CANCER CHEMOTH PHARM, V44, P327, DOI 10.1007/s002800050985; Mehta PA, 2004, CURR OPIN HEMATOL, V11, P434, DOI 10.1097/01.moh.0000145671.04385.4f; Miranda SR, 2007, FOOD CHEM TOXICOL, V45, P871, DOI 10.1016/j.fct.2006.11.011; Morrow PK, 2011, CANCER; Nelson David R, 2006, Methods Mol Biol, V320, P1; Niwa T, 2011, CURR DRUG METAB, V12, P549; OERTLE M, 1993, MOL CELL ENDOCRINOL, V91, P201, DOI 10.1016/0303-7207(93)90273-M; Patterson LH, 2002, CURR PHARM DESIGN, V8, P1335, DOI 10.2174/1381612023394502; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Roy P, 1999, DRUG METAB DISPOS, V27, P655; Savas U, 2003, ARCH BIOCHEM BIOPHYS, V409, P212, DOI 10.1016/S0003-9861(02)00499-X; TRZECIAK WH, 1993, MOL ENDOCRINOL, V7, P206, DOI 10.1210/me.7.2.206; Usui T, 2003, BIOL PHARM BULL, V26, P510; Villikka K, 1999, CLIN PHARMACOL THER, V66, P589, DOI 10.1016/S0009-9236(99)90067-X; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035; Xia XY, 2002, ACTA PHARMACOL SIN, V23, P471; ZHOU XJ, 1993, BIOCHEM PHARMACOL, V45, P853, DOI 10.1016/0006-2952(93)90169-W; ZHOUPAN XR, 1993, CANCER RES, V53, P5121	50	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51020	10.1371/journal.pone.0051020	http://dx.doi.org/10.1371/journal.pone.0051020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236419	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100051
J	Lauxmann, MA; Brun, B; Borsani, J; Bustamante, CA; Budde, CO; Lara, MV; Drincovich, MF				Lauxmann, Martin A.; Brun, Bianca; Borsani, Julia; Bustamante, Claudia A.; Budde, Claudio O.; Lara, Maria V.; Drincovich, Maria F.			Transcriptomic Profiling during the Post-Harvest of Heat-Treated Dixiland Prunus persica Fruits: Common and Distinct Response to Heat and Cold	PLOS ONE			English	Article							PEACH FRUIT; CHILLING INJURY; SHOCK PROTEINS; PROTEOMIC ANALYSIS; GENES; ACID; EXPRESSION; IDENTIFICATION; ACCUMULATION; WOOLLINESS	Cold storage is extensively used to slow the rapid deterioration of peach (Prunus persica L. Batsch) fruit after harvest. However, peach fruit subjected to long periods of cold storage develop chilling injury (CI) symptoms. Post-harvest heat treatment (HT) of peach fruit prior to cold storage is effective in reducing some CI symptoms, maintaining fruit quality, preventing softening and controlling post-harvest diseases. To identify the molecular changes induced by HT, which may be associated to CI protection, the differential transcriptome of peach fruit subjected to HT was characterized by the differential display technique. A total of 127 differentially expressed unigenes (DEUs), with a presence-absence pattern, were identified comparing peach fruit ripening at 20 degrees C with those exposed to a 39 degrees C-HT for 3 days. The 127 DEUs were divided into four expression profile clusters, among which the heat-induced (47%) and heat-repressed (36%) groups resulted the most represented, including genes with unknown function, or involved in protein modification, transcription or RNA metabolism. Considering the CI-protection induced by HT, 23-heat-responsive genes were selected and analyzed during and after short-term cold storage of peach fruit. More than 90% of the genes selected resulted modified by cold, from which nearly 60% followed the same and nearly 40% opposite response to heat and cold. Moreover, by using available Arabidopsis microarray data, it was found that nearly 70% of the peach-heat responsive genes also respond to cold in Arabidopsis, either following the same trend or showing an opposite response. Overall, the high number of common responsive genes to heat and cold identified in the present work indicates that HT of peach fruit after harvest induces a cold response involving complex cellular processes; identifying genes that are involved in the better preparation of peach fruit for cold-storage and unraveling the basis for the CI protection induced by HT. Citation: Lauxmann MA, Brun B, Borsani J, Bustamante CA, Budde CO, et al. (2012) Transcriptomic Profiling during the Post-Harvest of Heat-Treated Dixiland Prunus persica Fruits: Common and Distinct Response to Heat and Cold. PLoS ONE 7(12): e51052. doi:10.1371/journal.pone.0051052	[Lauxmann, Martin A.; Brun, Bianca; Borsani, Julia; Bustamante, Claudia A.; Lara, Maria V.; Drincovich, Maria F.] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim CEFOBI, RA-2000 Rosario, Santa Fe, Argentina; [Budde, Claudio O.] INTA, Estn Expt San Pedro, San Pedro, Argentina	National University of Rosario; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Drincovich, MF (corresponding author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim CEFOBI, RA-2000 Rosario, Santa Fe, Argentina.	drincovich@cefobi-conicet.gov.ar	Drincovich, Maria F/Q-4195-2019; Drincovich, Maria F/F-3902-2017	Drincovich, Maria F/0000-0003-4897-3285; Drincovich, Maria F/0000-0003-4897-3285; Bustamante, Claudia/0000-0003-4113-4219; Lauxmann, Martin Alexander/0000-0003-1162-4858	Agencia Nacional de Promocion de Actividades Cientificas y Tecnicas (Argentina); CONICET (Argentina) [PIP 0679]	Agencia Nacional de Promocion de Actividades Cientificas y Tecnicas (Argentina); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Agencia Nacional de Promocion de Actividades Cientificas y Tecnicas (Argentina) and by CONICET (PIP 0679; Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borsani J, 2009, J EXP BOT, V60, P1823, DOI 10.1093/jxb/erp055; Brummell DA, 2004, J EXP BOT, V55, P2041, DOI 10.1093/jxb/erh228; Cao SF, 2010, POSTHARVEST BIOL TEC, V58, P93, DOI 10.1016/j.postharvbio.2010.05.010; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dagar A, 2013, TREE GENET GENOMES, V9, P223, DOI 10.1007/s11295-012-0549-9; Dagar A, 2011, POSTHARVEST BIOL TEC, V60, P1, DOI 10.1016/j.postharvbio.2010.11.002; Dagar A, 2010, POSTHARVEST BIOL TEC, V57, P77, DOI 10.1016/j.postharvbio.2010.03.009; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Falara V, 2011, FUNCT INTEGR GENOMIC, V11, P357, DOI 10.1007/s10142-010-0204-1; Ferguson IB, 2000, POSTHARVEST BIOL TEC, V21, P1, DOI 10.1016/S0925-5214(00)00160-5; Gonzalez-Aguero M, 2008, J EXP BOT, V59, P1973, DOI 10.1093/jxb/em69; Jin P, 2009, POSTHARVEST BIOL TEC, V52, P24, DOI 10.1016/j.postharvbio.2008.09.011; Jung S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-81; Lara MV, 2011, PLANT CELL PHYSIOL, V52, P392, DOI 10.1093/pcp/pcq200; Lara MV, 2009, J EXP BOT, V60, P4315, DOI 10.1093/jxb/erp267; Lazzari B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S9; Liang P, 1998, MOL BIOTECHNOL, V10, P261, DOI 10.1007/BF02740847; Liu J, 2012, POSTHARVEST BIOL TEC, V65, P61, DOI 10.1016/j.postharvbio.2011.11.002; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurie S, 2006, ACTA HORTIC, P165, DOI 10.17660/ActaHortic.2006.712.16; Lurie S, 2005, POSTHARVEST BIOL TEC, V37, P195, DOI 10.1016/j.postharvbio.2005.04.012; Lurie S, 1998, POSTHARVEST BIOL TEC, V14, P257, DOI 10.1016/S0925-5214(98)00045-3; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Nilo R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-43; Ogundiwin EA, 2008, PLANT MOL BIOL, V68, P379, DOI 10.1007/s11103-008-9378-5; Paull RE, 2000, POSTHARVEST BIOL TEC, V21, P21, DOI 10.1016/S0925-5214(00)00162-9; Pegoraro C, 2011, PLANT GROWTH REGUL, V65, P231, DOI 10.1007/s10725-011-9591-0; Pegoraro C, 2010, POSTHARVEST BIOL TEC, V57, P19, DOI 10.1016/j.postharvbio.2010.02.003; Polenta GA, 2007, FEBS J, V274, P6447, DOI 10.1111/j.1742-4658.2007.06162.x; Rugkong A, 2011, POSTHARVEST BIOL TEC, V61, P1, DOI 10.1016/j.postharvbio.2011.02.009; Sabehat A, 1996, PLANT PHYSIOL, V110, P531, DOI 10.1104/pp.110.2.531; Sabehat A, 1998, PLANT PHYSIOL, V117, P651, DOI 10.1104/pp.117.2.651; Sanchez-Ballesta MT, 2003, PLANTA, V218, P65, DOI 10.1007/s00425-003-1086-4; Sapitnitskaya M, 2006, J EXP BOT, V57, P2943, DOI 10.1093/jxb/erl055; Tittarelli A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-121; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Vizoso P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-423; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang LJ, 2006, POSTHARVEST BIOL TEC, V41, P244, DOI 10.1016/j.postharvbio.2006.04.010; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang AP, 2011, FOOD CHEM, V129, P1619, DOI 10.1016/j.foodchem.2011.06.018; Yang ZF, 2012, J AGR FOOD CHEM, V60, P1209, DOI 10.1021/jf2041164; Zhang CF, 2010, AMINO ACIDS, V39, P181, DOI 10.1007/s00726-009-0397-6; Zhang CF, 2010, FOOD CHEM, V120, P864, DOI 10.1016/j.foodchem.2009.11.029; Zhang CF, 2009, FOOD CHEM, V115, P405, DOI 10.1016/j.foodchem.2008.12.021; Zhang L, 2011, J PROTEOMICS, V74, P1135, DOI 10.1016/j.jprot.2011.04.012	50	29	29	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51052	10.1371/journal.pone.0051052	http://dx.doi.org/10.1371/journal.pone.0051052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236430	Green Published, gold, Green Submitted			2022-12-25	WOS:000312589700029
J	Mura, M; Cappato, S; Giacopelli, F; Ravazzolo, R; Bocciardi, R				Mura, Marzia; Cappato, Serena; Giacopelli, Francesca; Ravazzolo, Roberto; Bocciardi, Renata			The Role of the 3 ' UTR Region in the Regulation of the ACVR1/Alk-2 Gene Expression	PLOS ONE			English	Article							MESSENGER-RNA; UP-REGULATION; ALK2; MICRORNAS; DIFFERENTIATION; MIR-365; GROWTH; CELLS; REPRESSION; RECEPTORS	Background: The ACVR1/Alk-2 gene, encoding a BMP type I receptor, is mutated in Fibrodysplasia Ossificans Progressiva, a severe form of heterotopic ossification. Regulation of ACVR1/Alk-2 expression, still poorly understood, is likely to be controlled by transcriptional and post-transcriptional mechanisms. In our work, we focused on the functional role of the 3'UTR region of the gene and on microRNAs as possible modulators of the ACVR1/Alk-2 expression. Results: The ACVR1/Alk-2 3'UTR region consists of a 1.1 kb sequence harboring several putative, well-conserved binding sites for miRNAs in its proximal half, and AU-rich elements in the distal one, as assessed by bioinformatic analysis. The functional role of this region was tested in presence of transcription inhibitors and in transfection experiments in different cell lines, with a ACVR1/Alk-2-3'UTR reporter construct. By this transfection-based approach, we have also verified that three microRNAs, among those predicted to target ACVR1/Alk-2 gene by in silico analysis, can bind its 3'UTR sequence thereby modulating its expression. Conclusion: In this work we demonstrated that the ACVR1/Alk-2 transcript is unstable in presence of inhibitors of transcription. Functional analysis of the 3'UTR region by Luciferase reporter assays showed that it plays an inhibitory role on ACVR1/Alk-2 gene expression. Moreover, we found that specific miRNAs are involved in modulating ACVR1/Alk-2 gene expression as suggested by binding sites prediction in its 3'UTR sequence. In particular, we found that mir148b and mir365 were able to down-regulate ACVR1/Alk-2 expression, whereas mir26a showed a positive effect on its mRNA. Our data contribute to elucidate some of the mechanisms intervening in the modulation of ACVR1/Alk-2 expression. Considering that no specific and effective treatment of FOP is available, clarifying the basic mechanisms of the ACVR1/Alk-2 gene biology may provide means to develop innovative therapeutics approaches.	[Mura, Marzia; Ravazzolo, Roberto; Bocciardi, Renata] G Gaslini Inst Children, Mol Genet Lab, Genoa, Italy; [Cappato, Serena; Giacopelli, Francesca; Ravazzolo, Roberto; Bocciardi, Renata] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy; [Cappato, Serena; Giacopelli, Francesca; Ravazzolo, Roberto; Bocciardi, Renata] CEBR, Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Bocciardi, R (corresponding author), G Gaslini Inst Children, Mol Genet Lab, Genoa, Italy.	bocciardi@unige.it	Cappato, Serena/J-8605-2016; Cappato, Serena/AAB-3972-2021; Bocciardi, Renata/J-8577-2016	Cappato, Serena/0000-0002-1745-5410; Cappato, Serena/0000-0002-1745-5410; Bocciardi, Renata/0000-0001-8415-3802	FOP Italia Association; Italian Ministry of Health [RFPS-2007-4-631972]	FOP Italia Association; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by FOP Italia Association and by the Strategic grant RFPS-2007-4-631972 of the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTUS MS, 1991, J BIOL CHEM, V266, P21190; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Harradine KA, 2006, ANN MED, V38, P403, DOI 10.1080/07853890600919911; Herrera B, 2009, CANCER RES, V69, P9254, DOI 10.1158/0008-5472.CAN-09-2912; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Karbiener M, 2011, RNA BIOL, V1; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Qin B, 2011, BIOCHEM BIOPH RES CO, V410, P127, DOI 10.1016/j.bbrc.2011.05.118; Romero D, 2010, CARCINOGENESIS, V31, P359, DOI 10.1093/carcin/bgp217; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Song YX, 2012, INT J CANCER, V131, P1042, DOI 10.1002/ijc.26485; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Yamazaki S, 2008, BBA-GENE REGUL MECH, V1779, P108, DOI 10.1016/j.bbagmi.2007.11.001; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209	36	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50958	10.1371/journal.pone.0050958	http://dx.doi.org/10.1371/journal.pone.0050958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227223	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200084
J	Vyazovskiy, VV; Tobler, I				Vyazovskiy, Vladyslav V.; Tobler, Irene			The Temporal Structure of Behaviour and Sleep Homeostasis	PLOS ONE			English	Article							REM-SLEEP; BIOCHEMICAL REGULATION; ULTRADIAN RHYTHMS; TIME-COURSE; RAT; EEG; DEPRIVATION; WAKING; MICE; WAKEFULNESS	The amount and architecture of vigilance states are governed by two distinct processes, which occur at different time scales. The first, a slow one, is related to a wake/sleep dependent homeostatic Process S, which occurs on a time scale of hours, and is reflected in the dynamics of NREM sleep EEG slow-wave activity. The second, a fast one, is manifested in a regular alternation of two sleep states - NREM and REM sleep, which occur, in rodents, on a time scale of similar to 5-10 minutes. Neither the mechanisms underlying the time constants of these two processes - the slow one and the fast one, nor their functional significance are understood. Notably, both processes are primarily apparent during sleep, while their potential manifestation during wakefulness is obscured by ongoing behaviour. Here, we find, in mice provided with running wheels, that the two sleep processes become clearly apparent also during waking at the level of behavior and brain activity. Specifically, the slow process was manifested in the total duration of waking periods starting from dark onset, while the fast process was apparent in a regular occurrence of running bouts during the waking periods. The dynamics of both processes were stable within individual animals, but showed large interindividual variability. Importantly, the two processes were not independent: the periodic structure of waking behaviour (fast process) appeared to be a strong predictor of the capacity to sustain continuous wakefulness (slow process). The data indicate that the temporal organization of vigilance states on both the fast and the slow time scales may arise from a common neurophysiologic mechanism.	[Vyazovskiy, Vladyslav V.; Tobler, Irene] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Vyazovskiy, Vladyslav V.] Univ Surrey, Dept Biochem & Physiol, Guildford GU2 5XH, Surrey, England	University of Zurich; University of Surrey	Vyazovskiy, VV (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	vyazovskiy@gmail.com		Vyazovskiy, Vladyslav/0000-0002-4336-6681	Swiss National Science Foundation [3100-053005.97, 3100A0-100567]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation grants 3100-053005.97 and 3100A0-100567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; Aeschbach D, 1996, AM J PHYSIOL-REG I, V270, pR41, DOI 10.1152/ajpregu.1996.270.1.R41; [Anonymous], 2005, PRINCIPLES PRACTICE; Bassi A, 2009, SLEEP, V32, P655, DOI 10.1093/sleep/32.5.655; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; Borbely A. A., 2005, PRINCIPLES PRACTICE, P405; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Clinton JM, 2011, J CLIN SLEEP MED, V7, pS38, DOI 10.5664/JCSM.1360; CONTE S, 1994, PHYSIOL BEHAV, V55, P287, DOI 10.1016/0031-9384(94)90135-X; Endo T, 1998, AM J PHYSIOL-REG I, V274, pR1186, DOI 10.1152/ajpregu.1998.274.4.R1186; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; Franken P, 2002, J SLEEP RES, V11, P17, DOI 10.1046/j.1365-2869.2002.00275.x; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; FRANKEN P, 1991, NEUROSCI LETT, V130, P141, DOI 10.1016/0304-3940(91)90382-4; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; MAZZUCCHELLI A, 1995, BEHAV BRAIN RES, V67, P81, DOI 10.1016/0166-4328(94)00107-Q; MCCORMICK DA, 1992, J CLIN NEUROPHYSIOL, V9, P212, DOI 10.1097/00004691-199204010-00004; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Obal F, 2003, FRONT BIOSCI-LANDMRK, V8, pD520, DOI 10.2741/1033; OTHMER E, 1969, SCIENCE, V164, P447, DOI 10.1126/science.164.3878.447; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petit JM, 2002, EUR J NEUROSCI, V16, P1163, DOI 10.1046/j.1460-9568.2002.02145.x; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rusterholz T, 2010, SLEEP, V33, P491, DOI 10.1093/sleep/33.4.491; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TRACHSEL L, 1991, PHYSIOL BEHAV, V49, P575, DOI 10.1016/0031-9384(91)90283-T; Van Dongen HPA, 2005, SLEEP, V28, P479, DOI 10.1093/sleep/28.4.479; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Vyazovskiy V, 2007, BRAIN RES BULL, V74, P37, DOI 10.1016/j.brainresbull.2007.05.001; Vyazovskiy VV, 2006, J NEUROENDOCRINOL, V18, P567, DOI 10.1111/j.1365-2826.2006.01452.x; Vyazovskiy VV, 2011, PROG BRAIN RES, V193, P17, DOI 10.1016/B978-0-444-53839-0.00002-8; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyazovskiy VV, 2006, CEREB CORTEX, V16, P328, DOI 10.1093/cercorbhi110; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022	43	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50677	10.1371/journal.pone.0050677	http://dx.doi.org/10.1371/journal.pone.0050677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227197	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200056
J	Walsh, BH; Broadhurst, DI; Mandal, R; Wishart, DS; Boylan, GB; Kenny, LC; Murray, DM				Walsh, Brian H.; Broadhurst, David I.; Mandal, Rupasri; Wishart, David S.; Boylan, Geraldine B.; Kenny, Louise C.; Murray, Deirdre M.			The Metabolomic Profile of Umbilical Cord Blood in Neonatal Hypoxic Ischaemic Encephalopathy	PLOS ONE			English	Article							CEREBRAL FUNCTION MONITOR; PERINATAL ASPHYXIA; CARNITINE LEVELS; PROGNOSTIC VALUE; NEWBORN-INFANTS; BRAIN-INJURY; EEG; SERUM; SPECTROSCOPY; PROTEIN	Background: Hypoxic ischaemic encephalopathy (HIE) in newborns can cause significant long-term neurological disability. The insult is a complex injury characterised by energy failure and disruption of cellular homeostasis, leading to mitochondrial damage. The importance of individual metabolic pathways, and their interaction in the disease process is not fully understood. The aim of this study was to describe and quantify the metabolomic profile of umbilical cord blood samples in a carefully defined population of full-term infants with HIE. Methods and Findings: The injury severity was defined using both the modified Sarnat score and continuous multichannel electroencephalogram. Using these classification systems, our population was divided into those with confirmed HIE (n = 31), asphyxiated infants without encephalopathy (n = 40) and matched controls (n = 71). All had umbilical cord blood drawn and biobanked at -80 degrees C within 3 hours of delivery. A combined direct injection and LC-MS/MS assay (AbsolutIDQ p180 kit, Biocrates Life Sciences AG, Innsbruck, Austria) was used for the metabolomic analyses of the samples. Targeted metabolomic analysis showed a significant alteration between study groups in 29 metabolites from 3 distinct classes (Amino Acids, Acylcarnitines, and Glycerophospholipids). 9 of these metabolites were only significantly altered between neonates with Hypoxic ischaemic encephalopathy and matched controls, while 14 were significantly altered in both study groups. Multivariate Discriminant Analysis models developed showed clear multifactorial metabolite associations with both asphyxia and HIE. A logistic regression model using 5 metabolites clearly delineates severity of asphyxia and classifies HIE infants with AUC = 0.92. These data describe wide-spread disruption to not only energy pathways, but also nitrogen and lipid metabolism in both asphyxia and HIE. Conclusion: This study shows that a multi-platform targeted approach to metabolomic analyses using accurately phenotyped and meticulously biobanked samples provides insight into the pathogenesis of perinatal asphyxia. It highlights the potential for metabolomic technology to develop a diagnostic test for HIE.	[Walsh, Brian H.; Boylan, Geraldine B.; Murray, Deirdre M.] Cork Univ, Matern Hosp, Dept Paediat & Child Hlth, Neonatal Brain Res Grp, Cork, Ireland; [Broadhurst, David I.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Mandal, Rupasri; Wishart, David S.] Univ Alberta, Dept Biol, Edmonton, AB, Canada; [Mandal, Rupasri; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Kenny, Louise C.] Natl Univ Ireland Univ Coll Cork, Dept Obstet & Gynaecol, Cork, Ireland	University College Cork; University of Alberta; University of Alberta; University of Alberta; University College Cork	Walsh, BH (corresponding author), Cork Univ, Matern Hosp, Dept Paediat & Child Hlth, Neonatal Brain Res Grp, Cork, Ireland.	Bh.walsh@ucc.ie	Walsh, Brian/AAA-6421-2020; Kenny, Louise/X-6329-2019; Walsh, Brian/HGA-7649-2022; Kenny, Louise C/G-1112-2011; Wishart, David Scott/ABI-3181-2020	Kenny, Louise/0000-0002-9011-759X; Walsh, Brian/0000-0003-4665-6884; Kenny, Louise C/0000-0002-9011-759X; Murray, Deirdre/0000-0002-2201-9912; Boylan, Geraldine/0000-0003-0920-5291; Wishart, David S/0000-0002-3207-2434; Broadhurst, David/0000-0003-0775-9581	Molecular Medicine Ireland [PRTLI cycle 4 of the Higher Education Authority of Ireland]; National Children's Research Centre, Dublin, Ireland [NCT01498965]; Wellcome Trust [085249/Z/08/Z]; Health Research Board [CSA/2007/2]; Science Foundation Ireland [08/IN.1/B2083]	Molecular Medicine Ireland [PRTLI cycle 4 of the Higher Education Authority of Ireland]; National Children's Research Centre, Dublin, Ireland; Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Molecular Medicine Ireland [PRTLI cycle 4 of the Higher Education Authority of Ireland to BW]; the National Children's Research Centre, Dublin, Ireland [www.baselinestudy.net, www.clinicaltrials.gov NCT01498965: DM, and LK]; the Wellcome Trust [grant number 085249/Z/08/Z to GB]; Health Research Board [grant number CSA/2007/2 to LK]; Science Foundation Ireland [grant number 08/IN.1/B2083 to LK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel-Tison C, 2002, PEDIATR NEUROL, V27, P196, DOI 10.1016/S0887-8994(02)00436-8; Atzori L, 2010, J MATERN-FETAL NEO M, V23, P134, DOI 10.3109/14767058.2010.517033; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Bayes R, 2001, EARLY HUM DEV, V65, pS103, DOI 10.1016/S0378-3782(01)00212-2; Beckstrom AC, 2011, J CHROMATOGR A, V1218, P1899, DOI 10.1016/j.chroma.2011.01.086; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Boylan GB, 2010, ACTA PAEDIATR, V99, P1150, DOI 10.1111/j.1651-2227.2010.01809.x; Cam H, 2005, J TROP PEDIATRICS, V51, P106, DOI 10.1093/tropej/fmh089; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Chu CY, 2006, CLIN BIOCHEM, V39, P203, DOI 10.1016/j.clinbiochem.2006.01.006; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; ED Deigner H, 2010, ESPACENENT; El-Ayouty M, 2007, AM J PERINAT, V24, P467, DOI 10.1055/s-2007-986686; Engidawork E, 1997, EXP NEUROL, V145, P390, DOI 10.1006/exnr.1997.6482; Eriksson L., 2001, MULTI MEGAVARIATE DA; Ezgu FS, 2004, NUTR NEUROSCI, V7, P351, DOI 10.1080/10284150400017280; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Helton E, 2000, PEDIATRICS, V105, P1260; HOLMES G, 1982, ELECTROEN CLIN NEURO, V53, P60, DOI 10.1016/0013-4694(82)90106-7; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huang CC, 1999, NEW ENGL J MED, V341, P328, DOI 10.1056/NEJM199907293410504; Kaukola T, 2004, ANN NEUROL, V55, P186, DOI 10.1002/ana.10809; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Kumar A, 2008, PEDIATRICS, V122, pE722, DOI 10.1542/peds.2008-0269; Laforgia N, 2001, ACTA PAEDIATR, V90, P351, DOI 10.1080/080352501300067811; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LEMONS JA, 1976, J CLIN INVEST, V58, P1428, DOI 10.1172/JCI108598; LEVENE MI, 1986, LANCET, V1, P67, DOI 10.1016/S0140-6736(86)90718-X; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; MartinAncel A, 1997, PEDIATRICS, V100, P789, DOI 10.1542/peds.100.5.789; Meyburg J, 2001, PEDIATR RES, V49, P125, DOI 10.1203/00006450-200101000-00024; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF183, DOI 10.1136/adc.2006.100800; Murray DM, 2006, PEDIATRICS, V118, P41, DOI 10.1542/peds.2005-1524; Murray DM, 2009, PEDIATRICS, V124, pE459, DOI 10.1542/peds.2008-2190; Nagdyman N, 2003, PEDIATR RES, V54, P270, DOI 10.1203/01.PDR.0000072518.98189.A0; Pepe MS, 2004, STAT EVALUATION MED; Perlman JM, 2004, SEMIN PERINATOL, V28, P415, DOI 10.1053/j.semperi.2004.10.003; Pressler RM, 2001, CLIN NEUROPHYSIOL, V112, P31, DOI 10.1016/S1388-2457(00)00517-4; Rennie JM, 2004, ARCH DIS CHILD-FETAL, V89, pF37, DOI 10.1136/fn.89.1.F37; ROBERTSON CMT, 1993, CLIN PERINATOL, V20, P483, DOI 10.1016/S0095-5108(18)30405-6; Roth SC, 1997, DEV MED CHILD NEUROL, V39, P718; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Signorini C, 2008, PEDIATR RES, V63, P287, DOI 10.1203/PDR.0b013e318163a1fd; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; SOLTESZ G, 1978, PEDIATRICS, V61, P77; Speed TP, 2003, STAT ANAL GENE EXPRE, Vxiii; Sunagawa S, 2009, BRAIN DEV-JPN, V31, P588, DOI 10.1016/j.braindev.2008.09.001; Tekgul H, 2004, PEDIATR NEUROL, V31, P326, DOI 10.1016/j.pediatrneurol.2004.05.004; THORNBERG E, 1995, ARCH DIS CHILD-FETAL, V72, pF39, DOI 10.1136/fn.72.1.F39; Thorngren-Jerneck K, 2004, PEDIATR RES, V55, P406, DOI 10.1203/01.PDR.0000106806.75086.D3; Trollmann R, 2002, EUR J ENDOCRINOL, V147, P711, DOI 10.1530/eje.0.1470711; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van Walsum AMV, 2001, PEDIATR RES, V49, P698; VANLIESHOUT HBM, 1995, ACTA NEUROL SCAND, V91, P203; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Wainwright MS, 2006, STROKE, V37, P524, DOI 10.1161/01.STR.0000198892.15269.f7; Wainwright MS, 2003, PEDIATR RES, V54, P688, DOI 10.1203/01.PDR.0000085036.07561.9C; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; White CR, 2012, J MATERN FETAL NEONA; WHITMER JT, 1978, J BIOL CHEM, V253, P4305; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3	65	72	73	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50520	10.1371/journal.pone.0050520	http://dx.doi.org/10.1371/journal.pone.0050520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227182	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200042
J	Xi, Y; Wei, Y; Sennino, B; Ulsamer, A; Kwan, I; Brumwell, AN; Tan, K; Aghi, MK; McDonald, DM; Jablons, DM; Chapman, HA				Xi, Y.; Wei, Y.; Sennino, B.; Ulsamer, A.; Kwan, I.; Brumwell, A. N.; Tan, K.; Aghi, M. K.; McDonald, D. M.; Jablons, D. M.; Chapman, H. A.			Identification of pY654-beta-catenin as a critical co-factor in hypoxia-inducible factor-1 alpha signaling and tumor responses to hypoxia	ONCOGENE			English	Article						hypoxia; signaling; transcription; tumor; epithelial	EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN; ANTIANGIOGENIC THERAPY; GENE-EXPRESSION; CELL INVASION; C-SRC; ACTIVATION; METASTASIS; MET; MECHANISMS	Hypoxia is linked to epithelial-mesenchymal transition (EMT) and tumor progression in numerous carcinomas. Responses to hypoxia are thought to operate via hypoxia-inducible factors (HIFs), but the importance of co-factors that regulate HIF signaling within tumors is not well understood. Here, we elucidate a signaling pathway that physically and functionally couples tyrosine phosphorylation of beta-catenin to HIF1 alpha signaling and HIF1 alpha-mediated tumor EMT. Primary human lung adenocarcinomas accumulate pY654-beta-catenin and HIF1 alpha. All pY654-beta-catenin, and only the tyrosine phosphorylated form, was found complexed with HIF1 alpha and active Src, both within the human tumors and in lung tumor cell lines exposed to hypoxia. Phosphorylation of Y654, generated by hypoxia mediated, reactive oxygen species (ROS)-dependent Src kinase activation, was required for beta-catenin to interact with HIF1 alpha and Src, to promote HIF1 alpha transcriptional activity, and for hypoxia-induced EMT. Mice bearing hypoxic pancreatic islet adenomas, generated by treatment with anti-vascular endothelial growth factor antibodies, accumulate HIF1 alpha/pY654-beta-catenin complexes and develop an invasive phenotype. Concurrent administration of the ROS inhibitor N-acetylcysteine abrogated beta-catenin/HIF pathway activity and restored adenoma architecture. Collectively, the findings implicate accumulation of pY654-beta-catenin specifically complexed to HIF1 alpha and Src kinase as critically involved in HIF1 alpha signaling and tumor invasion. The findings also suggest that targeting ROS-dependent aspects of the pY654-beta-catenin/HIF1 alpha pathway may attenuate untoward biological effects of anti-angiogenic agents and tumor hypoxia.	[Xi, Y.; Wei, Y.; Ulsamer, A.; Kwan, I.; Brumwell, A. N.; Tan, K.; Chapman, H. A.] Univ Calif San Francisco, Div Pulm & Crit Care, Dept Med, San Francisco, CA 94143 USA; [Sennino, B.; McDonald, D. M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Sennino, B.; McDonald, D. M.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Aghi, M. K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Aghi, M. K.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; [Jablons, D. M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wei, Y (corresponding author), Univ Calif San Francisco, Div Pulm & Crit Care, 513 Parnassus Ave, San Francisco, CA 94143 USA.	ying.wei@ucsf.edu; hal.chapman@ucsf.edu	Ulsamer, A/H-7994-2014	Ulsamer, A/0000-0001-7808-1005	NIH [HL-44712, CA-125564]; NATIONAL CANCER INSTITUTE [R01CA125564] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059157, P01HL024136, R01HL044712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079697, K02NS064167] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Roshni Ray, Mazen Sidani, Toshina Ishiguro-Oonuma, Casey W Williamson, Thomas Kim, Yonghyun Kim, Yang Gao and Ronald Tsang for technical assistance; and Drs Miguel Ramalho Santos and Martin Brown for generous gifts of reagents. This work was supported by NIH Grants to HL-44712 and CA-125564 (HAC).	Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Grepin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/835680; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Jiang BH, 1997, CANCER RES, V57, P5328; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kaluz S, 2008, CLIN CHIM ACTA, V395, P6, DOI 10.1016/j.cca.2008.05.002; Karni R, 2002, J BIOL CHEM, V277, P42919, DOI 10.1074/jbc.M206141200; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Luo DC, 2011, MOL CANCER RES, V9, P234, DOI 10.1158/1541-7786.MCR-10-0214; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pham NA, 2009, INT J CANCER, V124, P280, DOI 10.1002/ijc.23912; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Ulsamer A, 2012, J BIOL CHEM, V287, P5164, DOI 10.1074/jbc.M111.322123; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zeng G, 2006, EXP CELL RES, V312, P3620, DOI 10.1016/j.yexcr.2006.08.003; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009	45	28	28	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5048	5057		10.1038/onc.2012.530	http://dx.doi.org/10.1038/onc.2012.530			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23246962	Green Accepted			2022-12-25	WOS:000325937900006
J	Zhang, SF; Zhou, YJ; Sarkeshik, A; Yates, JR; Thomson, TM; Zhang, ZT; Lee, EYC; Lee, MYWT				Zhang, Sufang; Zhou, Yajing; Sarkeshik, Ali; Yates, John R., III; Thomson, Timothy M.; Zhang, Zhongtao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.			Identification of RNF8 as a Ubiquitin Ligase Involved in Targeting the p12 Subunit of DNA Polymerase delta for Degradation in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; STRAND BREAK REPAIR; CALF THYMUS; HUMAN-CELLS; PROTEIN; PCNA; RECRUITMENT; TOLERANCE; FAMILY; SITES	DNA polymerase delta consists of four subunits, one of which, p12, is degraded in response to DNA damage through the ubiquitin-proteasome pathway. However, the identities of the ubiquitin ligase(s) that are responsible for the proximal biochemical events in triggering proteasomal degradation of p12 are unknown. We employed a classical approach to identifying a ubiquitin ligase that is involved in p12 degradation. Using UbcH5c as ubiquitin-conjugating enzyme, a ubiquitin ligase activity that polyubiquitinates p12 was purified from HeLa cells. Proteomic analysis revealed that RNF8, a RING finger ubiquitin ligase that plays an important role in the DNA damage response, was the only ubiquitin ligase present in the purified preparation. In vivo, DNA damage-induced p12 degradation was significantly reduced by shRNA knockdown of RNF8 in cultured human cells and in RNF8(-/-) mouse epithelial cells. These studies provide the first identification of a ubiquitin ligase activity that is involved in the DNA damage-induced destruction of p12. The identification of RNF8 allows new insights into the integration of the control of p12 degradation by different DNA damage signaling pathways.	[Zhang, Sufang; Zhou, Yajing; Zhang, Zhongtao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Sarkeshik, Ali; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Thomson, Timothy M.] CSIC, Dept Cell Biol, Inst Mol Biol Barcelona, Barcelona 08028, Spain	New York Medical College; Scripps Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC)	Lee, MYWT (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	marietta_lee@NYMC.edu	Thomson, Timothy/Z-6271-2019	Thomson, Timothy/0000-0002-4670-9440; zhang, zhongtao/0000-0002-1910-4753; Zhang, Sufang/0000-0003-3883-023X	National Institutes of Health [GM31973, ES14737, P41 GM103533]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973, P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31973 and ES14737 (to M. Y. W. T. L.) and P41 GM103533 (to J. R. Y.).	Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonner MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020489; Brooks L, 2008, CELL MOL LIFE SCI, V65, P3458, DOI 10.1007/s00018-008-8220-1; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Chea J, 2012, CELL CYCLE, V11, P2885, DOI 10.4161/cc.21280; Chen JJ, 2011, CELL BIOCHEM BIOPHYS, V60, P47, DOI 10.1007/s12013-011-9187-3; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Kim HT, 2008, MOL CELLS, V25, P457; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Lee MYWT, 2012, ENVIRON MOL MUTAGEN, V53, P683, DOI 10.1002/em.21743; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1980, BIOCHEMISTRY-US, V19, P2096, DOI 10.1021/bi00551a015; Lehmann AR, 2011, DNA REPAIR, V10, P730, DOI 10.1016/j.dnarep.2011.04.023; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Lorick KL, 2005, METHOD ENZYMOL, V398, P54, DOI 10.1016/S0076-6879(05)98006-3; Luijsterburg MS, 2012, CURR OPIN CELL BIOL, V24, P439, DOI 10.1016/j.ceb.2012.03.008; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10; Plans V, 2008, ONCOGENE, V27, P1355, DOI 10.1038/sj.onc.1210782; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; PLON SE, 1993, P NATL ACAD SCI USA, V90, P10484, DOI 10.1073/pnas.90.22.10484; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Seki N, 1998, J HUM GENET, V43, P272, DOI 10.1007/s100380050088; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224	54	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2941	2950		10.1074/jbc.M112.423392	http://dx.doi.org/10.1074/jbc.M112.423392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23233665	Green Published, hybrid			2022-12-25	WOS:000314397900005
J	Higueruelo, AP; Schreyer, A; Bickerton, GRJ; Blundell, TL; Pitt, WR				Higueruelo, Alicia P.; Schreyer, Adrian; Bickerton, G. Richard J.; Blundell, Tom L.; Pitt, Will R.			What Can We Learn from the Evolution of Protein-Ligand Interactions to Aid the Design of New Therapeutics?	PLOS ONE			English	Article							X-RAY CRYSTALLOGRAPHY; DRUG DISCOVERY; BINDING; DATABASE; ANTAGONISTS; DOMAIN; ALPHA; P53; THERMODYNAMICS; CLASSIFICATION	Efforts to increase affinity in the design of new therapeutic molecules have tended to lead to greater lipophilicity, a factor that is generally agreed to be contributing to the low success rate of new drug candidates. Our aim is to provide a structural perspective to the study of lipophilic efficiency and to compare molecular interactions created over evolutionary time with those designed by humans. We show that natural complexes typically engage in more polar contacts than synthetic molecules bound to proteins. The synthetic molecules also have a higher proportion of unmatched heteroatoms at the interface than the natural sets. These observations suggest that there are lessons to be learnt from Nature, which could help us to improve the characteristics of man-made molecules. In particular, it is possible to increase the density of polar contacts without increasing lipophilicity and this is best achieved early in discovery while molecules remain relatively small.	[Higueruelo, Alicia P.; Schreyer, Adrian; Bickerton, G. Richard J.; Blundell, Tom L.; Pitt, Will R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Pitt, Will R.] UCB Pharma, Slough, Berks, England	University of Cambridge; UCB Pharma SA	Higueruelo, AP (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	alicia@cryst.bioc.cam.ac.uk		Schreyer, Adrian/0000-0001-5270-3742; Pitt, William/0000-0001-8164-4550; Higueruelo, Alicia/0000-0001-5616-6593; /0000-0001-6426-0598	BBSRC; Wellcome Trust; UCB Pharma; University of Cambridge	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); UCB Pharma(UCB Pharma SA); University of Cambridge(University of Cambridge)	Funding was provided by the BBSRC, Wellcome Trust, UCB Pharma, and the University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bickerton GR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-313; Charpentier TH, 2009, BIOCHEMISTRY-US, V48, P6202, DOI 10.1021/bi9005754; Cochran AG, 2000, CHEM BIOL, V7, pR85, DOI 10.1016/S1074-5521(00)00106-X; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deu E, 2012, NAT STRUCT MOL BIOL, V19, P9, DOI 10.1038/nsmb.2203; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Ferenczy GG, 2010, DRUG DISCOV TODAY, V15, P919, DOI 10.1016/j.drudis.2010.08.013; Garnier JP, 2008, HARVARD BUS REV, V86, P68; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Hann MM, 2011, MEDCHEMCOMM, V2, P349, DOI 10.1039/c1md00017a; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Keseru GM, 2009, NAT REV DRUG DISCOV, V8, P203, DOI 10.1038/nrd2796; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Leeson PD, 2011, NAT REV DRUG DISCOV, V10, P749, DOI 10.1038/nrd3552; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Schreyer A, 2009, CHEM BIOL DRUG DES, V73, P157, DOI 10.1111/j.1747-0285.2008.00762.x; Sugano K, 2010, NAT REV DRUG DISCOV, V9, P597, DOI 10.1038/nrd3187; Thanos CD, 2003, J AM CHEM SOC, V125, P15280, DOI 10.1021/ja0382617; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	39	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51742	10.1371/journal.pone.0051742	http://dx.doi.org/10.1371/journal.pone.0051742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240060	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800096
J	Li, DS; Dong, BL; Tong, ZS; Wang, QN; Liu, WH; Wang, Y; Liu, W; Chen, JB; Xu, L; Chen, LQ; Duan, YQ				Li, Dongsheng; Dong, Bilin; Tong, Zhongsheng; Wang, Qinning; Liu, Weihuang; Wang, Yan; Liu, Wei; Chen, Jinbo; Xu, Li; Chen, Liuqing; Duan, Yiqun			MBL-Mediated Opsonophagocytosis of Candida albicans by Human Neutrophils Is Coupled with Intracellular Dectin-1-Triggered ROS Production	PLOS ONE			English	Article							BINDING LECTIN MBL; DECTIN-1; RECOGNITION; RECEPTOR; MANNOSE; ACTIVATION; YEAST	Mannan-binding lectin (MBL), a lectin homologous to C1q, greatly facilitates C3/C4-mediated opsonophagocytosis of Candida albicans (C. albicans) by human neutrophils, and has the capacity to bind to CR1 (CD35) expressed on circulating neutrophils. The intracellular pool of neutrophil Dectin-1 plays a critical role in stimulating the reactive oxygen species (ROS) generation through recognition of beta-1,3-glucan component of phagocytized zymosan or yeasts. However, little is known about whether MBL can mediate the opsonophagocytosis of Candida albicans by neutrophils independent of complement activation, and whether MBL-mediated opsonophagocytosis influence the intracellular expression of Dectin-1 and ROS production. Here we showed that the inhibited phagocytic efficiency of neutrophils as a result of blockage of Dectin-1 was compensated by exogenous MBL alone in a dose-dependent manner. Furthermore, the expressions of Dectin-1 at mRNA and intracellular protein levels were significantly up-regulated in neutrophils stimulated by MBL-pre-incubated C. albicans, while the expression of surface Dectin-1 remained almost unchanged. Nevertheless, the stimulated ROS production in neutrophils was partly and irreversibly inhibited by blockage of Dectin-1 in the presence of exogenous MBL. Confocal microscopy examination showed that intracellular Dectin-1 was recruited and co-distributed with ROS on the surface of some phagocytized yeasts. The beta-1,3-glucanase digestion test further suggested that the specific recognition and binding site of human Dectin-1 is just the beta-1,3-glucan moiety on the cell wall of C. albicans. These data demonstrate that MBL has an ability to mediate the opsonophagocytosis of Candida albicans by human neutrophils independent of complement activation, which is coupled with intracellular Dectin-1-triggered ROS production.	[Li, Dongsheng; Dong, Bilin; Tong, Zhongsheng; Chen, Jinbo; Xu, Li; Chen, Liuqing; Duan, Yiqun] 1 Hosp Wuhan, Dept Dermatol, Ctr Infect Skin Dis, Wuhan, Peoples R China; [Wang, Qinning] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia; [Liu, Weihuang] Wuhan Univ, Med Res Ctr, Wuhan 430072, Peoples R China; [Wang, Yan; Liu, Wei] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China	University of Sydney; Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Chen, LQ (corresponding author), 1 Hosp Wuhan, Dept Dermatol, Ctr Infect Skin Dis, Wuhan, Peoples R China.	chlq35@yahoo.com.cn; augustusdong@126.com		Chen, Jinbo/0000-0002-9665-8506	Wuhan Health Bureau [[2011] 99]; Hubei Health Department, China [JX3A25]	Wuhan Health Bureau; Hubei Health Department, China	This study is supported by the grants from Wuhan Health Bureau (NO: [2011] 99) and Hubei Health Department (NO: JX3A25), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alangaden GJ, 2011, INFECT DIS CLIN N AM, V25, P201, DOI 10.1016/j.idc.2010.11.003; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chen LY, 2011, J HOSP INFECT, V78, P50, DOI 10.1016/j.jhin.2010.12.007; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Han X, 2011, PLOS ONE; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Lillegard JB, 2006, J INFECT DIS, V193, P1589, DOI 10.1086/503804; Linden JR, 2010, MED MYCOL, V48, P355, DOI [10.1080/13693780903164566, 10.3109/13693780903164566]; McGreal E, 2002, BIOCHEM SOC T, V30, P1010, DOI 10.1042/BST0301010; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Sealy PI, 2008, MED MYCOL, V46, P531, DOI 10.1080/13693780801961329; Skrzypek F, 2009, MICROBES INFECT, V11, P661, DOI 10.1016/j.micinf.2009.03.010; Van Asbeck EC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-229; Yang Z, 2009, ZYMOSAN TREATMENT MO	19	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50589	10.1371/journal.pone.0050589	http://dx.doi.org/10.1371/journal.pone.0050589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239982	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800020
J	Olsson, J; Drott, JB; Laurantzon, L; Laurantzon, O; Bergh, A; Elgh, F				Olsson, Jan; Drott, Johanna Bergh; Laurantzon, Lovisa; Laurantzon, Oscar; Bergh, Anders; Elgh, Fredrik			Chronic Prostatic Infection and Inflammation by Propionibacterium acnes in a Rat Prostate Infection Model	PLOS ONE			English	Article							BACTERIAL INFLAMMATION; MOUSE PROSTATE; CANCER; HYPERPLASIA; CARCINOGENESIS; PATHOGENESIS; CASTRATION; SPECIMENS; PROTEINS; CELLS	Chronic inflammation in the prostate, seen as infiltration of inflammatory cells into the prostate gland in histological samples, affects approximately half the male population without indication of prostate disease, and is almost ubiquitous in patients diagnosed with benign prostate hyperplasia and cancer. Several studies have demonstrated the Gram-positive bacterium Propionibacterium acnes to be frequently present in prostate tissue from men suffering from prostate disease. P. acnes has been shown to be associated with histological inflammation in human prostatectomy specimens, and also to induce strong inflammatory response in prostate-derived tissue culture models. The present paper describes a rat model for assessment of the pathogenic potential of P. acnes in prostate. Prostate glands of Sprague Dawley rats (n = 98) were exposed via an abdominal incision and live P. acnes or, in control rats, saline were injected into the ventral and dorso-lateral lobes. Rats were sacrificed 5 days, 3 weeks, 3 months and 6 months post infection, and prostate tissue was analyzed for bacterial content and histological inflammation. Rat sera were assessed for levels of CRP and anti-P. acnes IgG. Live P. acnes could be recovered from the dorso-lateral lobes up to 3 months post infection, while the ventral lobes were cleared from bacteria at that time. In samples up to 3 months post infection, the dorso-lateral lobes exhibited intense focal inflammation. CRP and IgG levels were elevated throughout the span of the experiment, and reached maximum levels 3 weeks and 3 months post infection, respectively. We show that P. acnes have the potential to cause chronic infection in previously healthy prostate, and that the infection has potential to cause chronic histological inflammation in the infected tissue. The high prevalence of P. acnes in human prostate tissue calls for resolution of pathogenic details. The present rat model suggests that complications such as chronic inflammation may be induced by P. acnes infection.	[Olsson, Jan; Drott, Johanna Bergh; Laurantzon, Lovisa; Laurantzon, Oscar; Elgh, Fredrik] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University	Olsson, J (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	jan.olsson@climi.umu.se		Olsson, Jan/0000-0001-9094-319X	County Council of Vasterbotten (ALF); Medical Faculty of Umea University; Lions Cancer Research Foundation; Cancerforskningsfonden Norrland; Percy Falks Stiftelse for forskning betraffande prostatacancer och brostcancer; Svenska Lakaresallskapet [SLS-173871, SLS-248771]	County Council of Vasterbotten (ALF); Medical Faculty of Umea University; Lions Cancer Research Foundation; Cancerforskningsfonden Norrland; Percy Falks Stiftelse for forskning betraffande prostatacancer och brostcancer; Svenska Lakaresallskapet	This study was funded by grants from the County Council of Vasterbotten (ALF), (FE), the Medical Faculty of Umea University (FE), the Lions Cancer Research Foundation and Cancerforskningsfonden Norrland (JO, FE), Percy Falks Stiftelse for forskning betraffande prostatacancer och brostcancer (JO), and Svenska Lakaresallskapet (SLS-173871, SLS-248771) (JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev O, 2006, CANCER CAUSE CONTROL, V17, P1127, DOI 10.1007/s10552-006-0054-2; Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433; Cheng I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008736; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; DEBEER FC, 1982, IMMUNOLOGY, V45, P55; Delongchamps NB, 2008, J UROLOGY, V179, P1736, DOI 10.1016/j.juro.2008.01.034; Drott JB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-126; Elkahwaji JE, 2009, BRIT J CANCER, V101, P1740, DOI 10.1038/sj.bjc.6605370; Elkahwaji JE, 2005, UROLOGY, V66, P883, DOI 10.1016/j.urology.2005.04.013; Fassi Fehri L, 2010, INT J MED MICROBIOL; Goldschmidt P, 2009, BRIT J OPHTHALMOL, V93, P258, DOI 10.1136/bjo.2008.146639; Good PI, 2005, PERMUTATION PARAMETR, Vxix; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Hochreiter WW, 2000, J UROLOGY, V163, P127, DOI 10.1016/S0022-5347(05)67987-6; KAPLAN L, 1983, PROSTATE, V4, P625, DOI 10.1002/pros.2990040608; Khalili M, 2010, AM J PATHOL; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; NASLUND MJ, 1988, J UROLOGY, V140, P1049, DOI 10.1016/S0022-5347(17)41924-0; Nickel JC, 2008, J UROLOGY, V179, P1391, DOI 10.1016/j.juro.2007.11.081; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Olsson J, 2012, APMIS, V120, P778, DOI 10.1111/j.1600-0463.2012.02905.x; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Sfanos KS, 2009, P NATL ACAD SCI USA, V106, P3443, DOI 10.1073/pnas.0810473106; Shannon BA, 2008, BJU INT, V101, P429, DOI 10.1111/j.1464-410X.2007.07214.x; SHARMA OP, 1992, J STEROID BIOCHEM, V43, P557, DOI 10.1016/0960-0760(92)90244-D; Sutcliffe Siobhan, 2008, Curr Urol Rep, V9, P243, DOI 10.1007/s11934-008-0042-z; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562	32	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51434	10.1371/journal.pone.0051434	http://dx.doi.org/10.1371/journal.pone.0051434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240022	Green Published, gold			2022-12-25	WOS:000312290800058
J	Pine, MK; Jeffs, AG; Radford, CA				Pine, Matthew K.; Jeffs, Andrew G.; Radford, Craig A.			Turbine Sound May Influence the Metamorphosis Behaviour of Estuarine Crab Megalopae	PLOS ONE			English	Article							MUD CRAB; CHASMAGNATHUS-GRANULATA; DELAYED METAMORPHOSIS; SWIMMING BEHAVIOR; CLIMATE-CHANGE; HELICE-CRASSA; REEF SOUND; CUES; INDUCTION; LARVAE	It is now widely accepted that a shift towards renewable energy production is needed in order to avoid further anthropogenically induced climate change. The ocean provides a largely untapped source of renewable energy. As a result, harvesting electrical power from the wind and tides has sparked immense government and commercial interest but with relatively little detailed understanding of the potential environmental impacts. This study investigated how the sound emitted from an underwater tidal turbine and an offshore wind turbine would influence the settlement and metamorphosis of the pelagic larvae of estuarine brachyuran crabs which are ubiquitous in most coastal habitats. In a laboratory experiment the median time to metamorphosis (TTM) for the megalopae of the crabs Austrohelice crassa and Hemigrapsus crenulatus was significantly increased by at least 18 h when exposed to either tidal turbine or sea-based wind turbine sound, compared to silent control treatments. Contrastingly, when either species were subjected to natural habitat sound, observed median TTM decreased by approximately 21-31% compared to silent control treatments, 38-47% compared to tidal turbine sound treatments, and 46-60% compared to wind turbine sound treatments. A lack of difference in median TTM in A. crassa between two different source levels of tidal turbine sound suggests the frequency composition of turbine sound is more relevant in explaining such responses rather than sound intensity. These results show that estuarine mudflat sound mediates natural metamorphosis behaviour in two common species of estuarine crabs, and that exposure to continuous turbine sound interferes with this natural process. These results raise concerns about the potential ecological impacts of sound generated by renewable energy generation systems placed in the nearshore environment.	[Pine, Matthew K.; Jeffs, Andrew G.; Radford, Craig A.] Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand	University of Auckland	Pine, MK (corresponding author), Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand.	matt.pine@auckland.ac.nz	Jeffs, Andrew G/D-9474-2012	Jeffs, Andrew/0000-0002-8504-1949; Radford, Craig/0000-0001-7949-9497	Marsden Fast-Start Grant; University of Auckland, Faculty of Science, Research and Development Fund	Marsden Fast-Start Grant(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland, Faculty of Science, Research and Development Fund	This research was funded by a Marsden Fast-Start Grant to CAR, and the University of Auckland, Faculty of Science, Research and Development Fund to CAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cada G, 2007, FISHERIES, V32, P174, DOI 10.1577/1548-8446(2007)32[174:PIOHAW]2.0.CO;2; Ferro B.D., 2006, REFOCUS, V7, P46, DOI [10.1016/S1471-0846(06)70574-1, DOI 10.1016/S1471-0846(06)70574-1]; Forward RB, 2001, AM ZOOL, V41, P1108, DOI 10.1668/0003-1569(2001)041[1108:CFMOBC]2.0.CO;2; Forward RB, 2000, J EXP MAR BIOL ECOL, V245, P277, DOI 10.1016/S0022-0981(99)00169-0; Forward RB, 1996, MAR ECOL PROG SER, V131, P165, DOI 10.3354/meps131165; Gebauer P, 2004, J EXP MAR BIOL ECOL, V311, P25, DOI 10.1016/j.jembe.2004.04.014; Gebauer P, 1999, J EXP MAR BIOL ECOL, V238, P271, DOI 10.1016/S0022-0981(98)00219-6; Gunson D, 1993, GUIDE NZ SEASHORE; Herbert GMJ, 2007, RENEW SUST ENERG REV, V11, P1117, DOI 10.1016/j.rser.2005.08.004; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Jeffs AG, 2000, CRUSTACEANA, V73, P847, DOI 10.1163/156854000504859; JONES MB, 1983, B MAR SCI, V33, P656; King DA, 2004, SCIENCE, V303, P176, DOI 10.1126/science.1094329; Lloyd TP, 2011, MODELLING TECHNIQUES, P777; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Medina JM, 2010, CURR ZOOL, V56, P618, DOI 10.1093/czoolo/56.5.618; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Morrisey DJ, 1999, MAR ECOL PROG SER, V182, P231, DOI 10.3354/meps182231; O'Connor NJ, 1998, J CRUSTACEAN BIOL, V18, P700, DOI 10.2307/1549146; OCONNOR NJ, 1991, MAR ECOL PROG SER, V68, P243; Parvin S, 2005, ASSESSMENT TIDAL CUR; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PECHENIK JA, 1990, OPHELIA, V32, P63, DOI 10.1080/00785236.1990.10422025; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Radford CA, 2007, B MAR SCI, V80, P369; Richards S, 2007, UNDERWATER NOISE STU; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016625; Sivaguru K, 2000, THESIS U AUCKLAND; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Steinberg MK, 2008, ESTUAR COAST, V31, P738, DOI 10.1007/s12237-008-9063-6; Thomas G, 2009, OVERVIEW IMPACTS ANT; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660; Wahlberg M, 2005, MAR ECOL PROG SER, V288, P295, DOI 10.3354/meps288295; Weber JC, 1996, MAR BIOL, V126, P655, DOI 10.1007/BF00351332; Wilkens SL, 2012, BIOFOULING, V28, P65, DOI 10.1080/08927014.2011.651717; Wright A. J, 2008, INT WORKSH SHIPP NOI, V15	42	34	35	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51790	10.1371/journal.pone.0051790	http://dx.doi.org/10.1371/journal.pone.0051790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240063	Green Published, Green Submitted, gold			2022-12-25	WOS:000312290800099
J	Witty, CF; Foster, TC; Semple-Rowland, SL; Daniel, JM				Witty, Christine F.; Foster, Thomas C.; Semple-Rowland, Susan L.; Daniel, Jill M.			Increasing Hippocampal Estrogen Receptor Alpha Levels via Viral Vectors Increases MAP Kinase Activation and Enhances Memory in Aging Rats in the Absence of Ovarian Estrogens	PLOS ONE			English	Article							MIDDLE-AGED RATS; ESTRADIOL REPLACEMENT; WORKING-MEMORY; REPRODUCTIVE EXPERIENCE; SYNAPTIC PLASTICITY; LENTIVIRAL VECTORS; PREFRONTAL CORTEX; PROTEIN-LEVELS; BETA; PERFORMANCE	We previously demonstrated that aged ovariectomized rats that had received prior estradiol treatment in middle-age exhibited increased levels of estrogen receptor alpha (ER alpha) in the hippocampus as well as enhanced hippocampal dependent memory as compared to aged rats that had not received mid-life estradiol treatment. These effects persisted long after the estradiol treatment had been terminated. The goal of the current experiment was to determine if increased expression of ER alpha in the hippocampus, in the absence of exogenously administered estrogens, can impact the hippocampus and cognitive function in aging ovariectomized rats. Middle-aged rats were trained for 24 days on an eightarm radial maze spatial memory task. All rats were then ovariectomized. Forty days later, rats received either lentiviral delivery to the hippocampus of the gene encoding ER alpha (lenti-ER alpha) or a control virus. Rats were tested on delay trials in the radial-maze in which delays of varying lengths were imposed between the fourth and fifth arm choices. Following behavior testing, hippocampi were immunostained using western blotting for ER alpha, the ER alpha-regulated protein choline acetyltransferase, and phosphorylation of the ER alpha-regulated kinases, ERK/MAPK and Akt. Results revealed that aging ovariectomized rats that received delivery of lenti-ER alpha to the hippocampus exhibited enhanced spatial memory as indicated by increased arm-choice accuracy across delays as compared to ovariectomized rats that received control virus. Western blot data revealed that lenti-ER alpha delivery significantly increased levels of ER alpha and phosphorylated ERK/MAPK and had no impact on levels of ChAT or phosphorylation of Akt. Results indicate that increasing hippocampal levels of ER alpha in aging females in the absence of ovarian or exogenously administered estrogens leads to increases in phosphorylation of ERK/MAPK as well as in enhanced memory.	[Witty, Christine F.; Daniel, Jill M.] Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA; [Foster, Thomas C.; Semple-Rowland, Susan L.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Daniel, Jill M.] Tulane Univ, Dept Psychol, New Orleans, LA 70118 USA	Tulane University; State University System of Florida; University of Florida; Tulane University	Daniel, JM (corresponding author), Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA.	jmdaniel@tulane.edu		Daniel, Jill/0000-0002-0383-2414	National Science Foundation [0951008]; National Institute of Aging [R01AG041374, AG014979, AG037984, AG036800]; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE ON AGING [R01AG037984, P30AG028740, R01AG014979, R56AG037984, R37AG036800, R01AG041374] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0951008] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 0951008 and National Institute of Aging Grant R01AG041374 to JMD and National Institute of Aging Grants AG014979, AG037984, AG036800, and the Evelyn F. McKnight Brain Research Foundation to TCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2002, J NEUROSCI, V22, P3608; Bimonte HA, 1999, PSYCHONEUROENDOCRINO, V24, P161, DOI 10.1016/S0306-4530(98)00068-7; Bimonte-Nelson HA, 2010, MOLECULES, V15, P6050, DOI 10.3390/molecules15096050; Bohacek J, 2008, J NEUROENDOCRINOL, V20, P1023, DOI 10.1111/j.1365-2826.2008.01752.x; Bohacek J, 2009, J NEUROENDOCRINOL, V21, P640, DOI 10.1111/j.1365-2826.2009.01882.x; Bohacek J, 2010, PSYCHONEUROENDOCRINO, V35, P694, DOI 10.1016/j.psyneuen.2009.10.010; Bora SH, 2005, EXP NEUROL, V194, P506, DOI 10.1016/j.expneurol.2005.03.015; CHROBAK JJ, 1995, BEHAV NEUROSCI, V109, P241; Coleman JE, 2003, PHYSIOL GENOMICS, V12, P221, DOI 10.1152/physiolgenomics.00135.2002; Daniel JM, 2006, J NEUROENDOCRINOL, V18, P787, DOI 10.1111/j.1365-2826.2006.01471.x; Daniel JM, 2010, BBA-GEN SUBJECTS, V1800, P1068, DOI 10.1016/j.bbagen.2010.01.007; Daniel JM, 2006, ENDOCRINOLOGY, V147, P607, DOI 10.1210/en.2005-0998; Daniel JM, 2001, J NEUROSCI, V21, P6949, DOI 10.1523/JNEUROSCI.21-17-06949.2001; Dohanich G, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P539; Fan L, 2010, J NEUROSCI, V30, P4390, DOI 10.1523/JNEUROSCI.4333-09.2010; Foster TC, 2003, NEUROBIOL AGING, V24, P839, DOI 10.1016/S0197-4580(03)00014-9; FOSTER TC, 2011, HIPPOCAMPUS, DOI DOI 10.1002/HIPO.20935; Foster TC, 2008, MOL THER, V16, P1587, DOI 10.1038/mt.2008.140; Ghosh S, 2009, NEUROSCI LETT, V464, P218, DOI 10.1016/j.neulet.2009.08.054; Gibbs RB, 2009, HORM BEHAV, V56, P73, DOI 10.1016/j.yhbeh.2009.03.003; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hyder SM, 1999, BIOCHEM PHARMACOL, V57, P597, DOI 10.1016/S0006-2952(98)00355-4; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kelly JF, 2008, CURR ALZHEIMER RES, V5, P45, DOI 10.2174/156720508783884611; Korol DL, 2004, NEUROBIOL LEARN MEM, V82, P309, DOI 10.1016/j.nlm.2004.07.006; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; Luine VN, 2008, J NEUROENDOCRINOL, V20, P866, DOI 10.1111/j.1365-2826.2008.01710.x; Luine VN, 1998, HORM BEHAV, V34, P149, DOI 10.1006/hbeh.1998.1473; Maki PM, 2011, BRAIN RES, V1379, P232, DOI 10.1016/j.brainres.2010.11.030; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Mehra RD, 2005, BRAIN RES, V1056, P22, DOI 10.1016/j.brainres.2005.06.073; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Mukai H, 2010, BBA-GEN SUBJECTS, V1800, P1030, DOI 10.1016/j.bbagen.2009.11.002; Ogiue-Ikeda M, 2008, BRAIN RES REV, V57, P363, DOI 10.1016/j.brainresrev.2007.06.010; OOISHI Y, 2011, J STEROID BIOCHEM, DOI DOI 10.1016/J.JSBMB.2011.10.004; Pawluski JL, 2006, HORM BEHAV, V49, P143, DOI 10.1016/j.yhbeh.2005.05.016; Pawluski JL, 2006, J NEUROBIOL, V66, P71, DOI 10.1002/neu.20194; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PAXINOS G, 1995, RAT NERVOUS SYSTEM, DOI DOI 10.1016/J.BRAINRESREV.2007.06.010; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; Resnick SM, 2002, JAMA-J AM MED ASSOC, V288, P2170, DOI 10.1001/jama.288.17.2170; Rodgers SP, 2010, ENDOCRINOLOGY, V151, P1194, DOI 10.1210/en.2009-1245; Semple-Rowland SL, 2010, MOL VIS, V16, P916; Smith CC, 2010, P NATL ACAD SCI USA, V107, P19543, DOI 10.1073/pnas.1009307107; Smith CL, 1998, BIOL REPROD, V58, P627, DOI 10.1095/biolreprod58.3.627; Spencer-Segal JL, 2012, NEUROSCIENCE, V202, P131, DOI 10.1016/j.neuroscience.2011.11.035; Towart LA, 2003, J COMP NEUROL, V463, P390, DOI 10.1002/cne.10753; Waters EM, 2011, BRAIN RES, V1379, P86, DOI 10.1016/j.brainres.2010.09.069; Wu TW, 2011, BRAIN RES, V1379, P34, DOI 10.1016/j.brainres.2011.01.034; Yaffe K, 2002, BIOL PSYCHIAT, V51, P677, DOI 10.1016/S0006-3223(01)01289-6; Yaffe K, 2009, NEUROBIOL AGING, V30, P607, DOI 10.1016/j.neurobiolaging.2007.08.003; Zhang QG, 2011, P NATL ACAD SCI USA, V108, pE617, DOI 10.1073/pnas.1104391108; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhou LP, 2007, EXP NEUROL, V203, P72, DOI 10.1016/j.expneurol.2006.07.020	58	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51385	10.1371/journal.pone.0051385	http://dx.doi.org/10.1371/journal.pone.0051385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240018	Green Submitted, Green Published, gold			2022-12-25	WOS:000312290800054
J	Brauer, A; Kurz, A; Stockwell, T; Baden-Tillson, H; Heidler, J; Wittig, I; Kauferstein, S; Mebs, D; Stocklin, R; Remm, M				Brauer, Age; Kurz, Alexander; Stockwell, Tim; Baden-Tillson, Holly; Heidler, Juliana; Wittig, Ilka; Kauferstein, Silke; Mebs, Dietrich; Stoecklin, Reto; Remm, Maido			The Mitochondrial Genome of the Venomous Cone Snail Conus consors	PLOS ONE			English	Article							TRANSFER-RNA GENES; DNA CONTROL REGION; COMPLETE SEQUENCE; NUCLEOTIDE-SEQUENCES; EVOLUTION; ORGANIZATION; GASTROPOD; REARRANGEMENT; TEREBRIDAE; PHYLOGENY	Cone snails are venomous predatory marine neogastropods that belong to the species-rich superfamily of the Conoidea. So far, the mitochondrial genomes of two cone snail species (Conus textile and Conus borgesi) have been described, and these feed on snails and worms, respectively. Here, we report the mitochondrial genome sequence of the fish-hunting cone snail Conus consors and describe a novel putative control region (CR) which seems to be absent in the mitochondrial DNA (mtDNA) of other cone snail species. This possible CR spans about 700 base pairs (bp) and is located between the genes encoding the transfer RNA for phenylalanine (tRNA-Phe, trnF) and cytochrome c oxidase subunit III (cox3). The novel putative CR contains several sequence motifs that suggest a role in mitochondrial replication and transcription.	[Brauer, Age; Remm, Maido] Estonian Bioctr, Tartu, Estonia; [Brauer, Age; Remm, Maido] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Kurz, Alexander; Kauferstein, Silke; Mebs, Dietrich] Goethe Univ Frankfurt, Sch Med, Inst Forens Med, Frankfurt, Germany; [Stockwell, Tim; Baden-Tillson, Holly] J Craig Venter Inst, Rockville, MD USA; [Heidler, Juliana] Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, Frankfurt, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, Frankfurt, Germany; [Mebs, Dietrich] Toxin Fdn, Geneva, Switzerland; [Stoecklin, Reto] Atheris Labs, Geneva, Switzerland	Estonian Biocentre; University of Tartu; Goethe University Frankfurt; J. Craig Venter Institute; Goethe University Frankfurt; Goethe University Frankfurt	Brauer, A (corresponding author), Estonian Bioctr, Tartu, Estonia.	age.brauer@ut.ee	Kauferstein, Silke/AFK-4350-2022; Brauer, Age/ABI-7540-2020; Brauer, Age/AAO-6064-2021; Remm, Maido/L-9072-2019; Kauferstein, Silke/AAG-3102-2022	Brauer, Age/0000-0003-4779-2458; Remm, Maido/0000-0003-3966-8422; Stockwell, Timothy/0000-0002-3595-4539	European Commission [037592]; Estonian Ministry of Education and Research [SF0180026s09]; European Union European Regional Development Fund through the Estonian Centre of Excellence in Genomics; German Network for Mitochondrial Disorders mitoNET of the Bundesministerium fur Bildung und Forschung [01GM1113B]	European Commission(European CommissionEuropean Commission Joint Research Centre); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union European Regional Development Fund through the Estonian Centre of Excellence in Genomics; German Network for Mitochondrial Disorders mitoNET of the Bundesministerium fur Bildung und Forschung	This study has been performed as part of the CONCO cone snail genome project for health (www.conco.eu) funded by the European Commission within the 6th Framework Program (LIFESCIHEALTH-6 Integrated Project LSHB-CT-2007, contract number 037592) with Dr Torbjorn Ingemansson as scientific officer. AB and MR were partially supported by SF0180026s09 from the Estonian Ministry of Education and Research and by the European Union European Regional Development Fund through the Estonian Centre of Excellence in Genomics. IW was supported by the German Network for Mitochondrial Disorders mitoNET 01GM1113B of the Bundesministerium fur Bildung und Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUADRO CF, 1983, GENETICS, V103, P287; Arndt A, 1998, MOL BIOL EVOL, V15, P1009, DOI 10.1093/oxfordjournals.molbev.a025999; Bandyopadhyay PK, 2008, MOL PHYLOGENET EVOL, V46, P215, DOI 10.1016/j.ympev.2007.08.002; Bandyopadhyay PK, 2006, TOXICON, V48, P29, DOI 10.1016/j.toxicon.2006.04.013; BERNARDI G, 1965, NATURE, V206, P779, DOI 10.1038/206779a0; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2004, MOL BIOL EVOL, V21, P1492, DOI 10.1093/molbev/msh090; BOORE JL, 1994, GENETICS, V138, P423; Brehm A, 2003, J MOL EVOL, V56, P46, DOI 10.1007/s00239-002-2379-0; CANN RL, 1984, GENETICS, V106, P479; Cao LQ, 2004, GENETICS, V167, P835, DOI 10.1534/genetics.103.026187; Castelin M, 2012, MOL PHYLOGENET EVOL, V64, P21, DOI 10.1016/j.ympev.2012.03.001; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; DeGiorgi C, 1996, MOL PHYLOGENET EVOL, V5, P323, DOI 10.1006/mpev.1996.0027; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez-Silva P, 2001, NUCLEIC ACIDS RES, V29, P4736, DOI 10.1093/nar/29.22.4736; GJETVAJ B, 1992, MOL BIOL EVOL, V9, P106; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; Holford M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007667; Hu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-60; Jiang L, 1995, MOL MAR BIOL BIOTECH, V4, P353; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Machida RJ, 2004, MAR BIOTECHNOL, V6, P238, DOI 10.1007/s10126-003-0016-6; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maynard BT, 2005, MAR BIOTECHNOL, V7, P645, DOI 10.1007/s10126-005-0013-z; McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029; Menez A, 2006, TOXICON, V47, P255, DOI 10.1016/j.toxicon.2005.12.010; Milbury CA, 2005, MAR BIOTECHNOL, V7, P697, DOI 10.1007/s10126-005-0004-0; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mueller RL, 2005, MOL BIOL EVOL, V22, P2104, DOI 10.1093/molbev/msi204; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Roberti M, 1999, CURR GENET, V34, P449, DOI 10.1007/s002940050419; Sambrook J., 2002, MOL CLONING LAB MANU; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Simison WB, 2006, MOL PHYLOGENET EVOL, V39, P562, DOI 10.1016/j.ympev.2005.11.006; SNYDER M, 1987, P NATL ACAD SCI USA, V84, P7595, DOI 10.1073/pnas.84.21.7595; Stockwell T, 2010, ADV NEW TECHNOLOGIES, P11; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yuan Y, 2012, MOL BIOL REP, V39, P1287, DOI 10.1007/s11033-011-0861-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	14	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51528	10.1371/journal.pone.0051528	http://dx.doi.org/10.1371/journal.pone.0051528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236512	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100128
J	Chamontin, C; Yu, B; Racine, PJ; Darlix, JL; Mougel, M				Chamontin, Celia; Yu, Bing; Racine, Pierre-Jean; Darlix, Jena-Luc; Mougel, Marylene			MoMuLV and HIV-1 Nucleocapsid Proteins Have a Common Role in Genomic RNA Packaging but Different in Late Reverse Transcription	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; ZINC-FINGER; HUMAN-IMMUNODEFICIENCY; VIRAL-RNA; BASIC RESIDUES; GAG; MUTATIONS; VIRIONS; ENCAPSIDATION; REPLICATION	Retroviral nucleocapsid proteins harbor nucleic acid chaperoning activities that mostly rely on the N-terminal basic residues and the CCHC zinc finger motif. Such chaperoning is essential for virus replication, notably for genomic RNA selection and packaging in virions, and for reverse transcription of genomic RNA into DNA. Recent data revealed that HIV-1 nucleocapsid restricts reverse transcription during virus assembly - a process called late reverse transcription - suggesting a regulation between RNA packaging and late reverse transcription. Indeed, mutating the HIV-1 nucleocapsid basic residues or the two zinc fingers caused a reduction in RNA incorporated and an increase in newly made viral DNA in the mutant virions. MoMuLV nucleocapsid has an N-terminal basic region similar to HIV-1 nucleocapsid but a unique zinc finger. This prompted us to investigate whether the N-terminal basic residues and the zinc finger of MoMuLV and HIV-1 nucleocapsids play a similar role in genomic RNA packaging and late reverse transcription. To this end, we analyzed the genomic RNA and viral DNA contents of virions produced by cells transfected with MoMuLV molecular clones where the zinc finger was mutated or completely deleted or with a deletion of the N-terminal basic residues of nucleocapsid. All mutant virions showed a strong defect in genomic RNA content indicating that the basic residues and zinc finger are important for genomic RNA packaging. In contrast to HIV-1 nucleocapsid-mutants, the level of viral DNA in mutant MoMuLV virions was only slightly increased. These results confirm that the N-terminal basic residues and zinc finger of MoMuLV nucleocapsid are critical for genomic RNA packaging but, in contrast to HIV-1 nucleocapsid, they most probably do not play a role in the control of late reverse transcription. In addition, these results suggest that virus formation and late reverse transcription proceed according to distinct mechanisms for MuLV and HIV-1.	[Chamontin, Celia; Yu, Bing; Racine, Pierre-Jean; Mougel, Marylene] UM2, UM1, CNRS UMR5236, CPBS, Montpellier, France; [Darlix, Jena-Luc] Fac Pharm, UMR CNRS 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mougel, M (corresponding author), UM2, UM1, CNRS UMR5236, CPBS, Montpellier, France.	marylene.mougel@cpbs.cnrs.fr	LUC, DARLIX JEAN/AAE-9268-2020; Mougel, Marylene/K-7958-2013	Mougel, Marylene/0000-0002-0345-1427; CHAMONTIN, CELIA/0000-0001-7760-373X; RACINE, pierre-jean/0000-0003-1747-6737	Infectiopole Sud; ANRS; UMI; CNRS;  [ANRS2009-2]	Infectiopole Sud; ANRS(ANRSFrench National Research Agency (ANR)); UMI; CNRS(Centre National de la Recherche Scientifique (CNRS)); 	YB was supported by Infectiopole Sud, PJR by ANRS, CC by UMI and MM by CNRS. YB was supported by Infectiopole Sud and PJR by ANRS2009-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; Bowzard JB, 1998, J VIROL, V72, P9034, DOI 10.1128/JVI.72.11.9034-9044.1998; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; Darlix J L, 2000, Adv Pharmacol, V48, P345; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; DARLIX JL, 1977, J VIROL, V22, P118, DOI 10.1128/JVI.22.1.118-129.1977; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; Datta SAK, 2011, J VIROL, V85, P12733, DOI 10.1128/JVI.05889-11; DEROCQUIGNY H, 1993, NUCLEIC ACIDS RES, V21, P823; Dey A, 2005, BIOCHEMISTRY-US, V44, P3735, DOI 10.1021/bi047639q; Didierlaurent L, 2011, NUCL ACIDS RES; Didierlaurent L, 2008, NUCLEIC ACIDS RES, V36, P4745, DOI 10.1093/nar/gkn474; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; GORELICK RJ, 1988, P NATL ACAD SCI USA, V85, P8420, DOI 10.1073/pnas.85.22.8420; Grigorov B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-54; Grohmann D, 2008, BIOCHEMISTRY-US, V47, P12230, DOI 10.1021/bi801386r; Heldsinger A, 2001, ARCH VIROL, V146, P2385, DOI 10.1007/s007050170010; HOUSSET V, 1993, J VIROL, V67, P2537, DOI 10.1128/JVI.67.5.2537-2545.1993; Housset V, 1996, CR ACAD SCI III-VIE, V319, P81; Houzet L, 2003, EMBO J, V22, P4866, DOI 10.1093/emboj/cdg450; Houzet L, 2008, NUCLEIC ACIDS RES, V36, P2311, DOI 10.1093/nar/gkn069; Houzet L, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-30; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Jouvenet N, 2011, RNA BIOL, V8, P572, DOI 10.4161/rna.8.4.16030; Lener D, 1998, J BIOL CHEM, V273, P33781, DOI 10.1074/jbc.273.50.33781; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; LORI F, 1992, J VIROL, V66, P5067, DOI 10.1128/JVI.66.8.5067-5074.1992; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; MELY Y, 1991, BIOPOLYMERS, V31, P899, DOI 10.1002/bip.360310709; MERIC C, 1989, J VIROL, V63, P1558; Mirambeau G, 2010, RNA BIOL, V7, P724, DOI 10.4161/rna.7.6.13777; Mougel M, 1996, J VIROL, V70, P5043, DOI 10.1128/JVI.70.8.5043-5050.1996; Mougel M, 2010, VIRUSES-BASEL, V2, P939, DOI 10.3390/v2040939; Mougel M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-24; Muriaux D, 2004, J VIROL, V78, P12378, DOI 10.1128/JVI.78.22.12378-12385.2004; Muriaux D, 2002, J VIROL, V76, P11405, DOI 10.1128/JVI.76.22.11405-11413.2002; Muriaux D, 2010, RNA BIOL, V7, P744, DOI 10.4161/rna.7.6.14065; Ott DE, 1998, VIROLOGY, V243, P283, DOI 10.1006/viro.1998.9062; PRATS AC, 1988, EMBO J, V7, P1777, DOI 10.1002/j.1460-2075.1988.tb03008.x; REIN A, 1994, J VIROL, V68, P6124, DOI 10.1128/JVI.68.9.6124-6129.1994; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Rein Alan, 1997, Leukemia (Basingstoke), V11, P106; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; Smagulova F, 2005, J MOL BIOL, V354, P1118, DOI 10.1016/j.jmb.2005.10.021; Stewart-Maynard KM, 2008, J VIROL, V82, P10129, DOI 10.1128/JVI.01169-08; Still A, 2011, VIRUS RES, V155, P181, DOI 10.1016/j.virusres.2010.10.001; Swanstrom R., 1997, P263; Thomas JA, 2008, J VIROL, V82, P9318, DOI 10.1128/JVI.00583-08; TOUNEKTI N, 1992, J MOL BIOL, V223, P205, DOI 10.1016/0022-2836(92)90726-Z; TRONO D, 1992, J VIROL, V66, P4893, DOI 10.1128/JVI.66.8.4893-4900.1992; Yu QA, 1996, J VIROL, V70, P5791, DOI 10.1128/JVI.70.9.5791-5798.1996; ZHANG H, 1993, AIDS RES HUM RETROV, V9, P1287, DOI 10.1089/aid.1993.9.1287; Zhang WH, 2002, J VIROL, V76, P7473, DOI 10.1128/JVI.76.15.7473-7484.2002; ZHANG YQ, 1995, J VIROL, V69, P5716, DOI 10.1128/JVI.69.9.5716-5722.1995	56	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51534	10.1371/journal.pone.0051534	http://dx.doi.org/10.1371/journal.pone.0051534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236513	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100129
J	Conner, OL; Siegle, GJ; McFarland, AM; Silk, JS; Ladouceur, CD; Dahl, RE; Coan, JA; Ryan, ND				Conner, Olivia L.; Siegle, Greg J.; McFarland, Ashley M.; Silk, Jennifer S.; Ladouceur, Cecile D.; Dahl, Ronald E.; Coan, James A.; Ryan, Neal D.			Mom-It Helps When You're Right Here! Attenuation of Neural Stress Markers in Anxious Youths Whose Caregivers Are Present during fMRI	PLOS ONE			English	Article							PREFRONTAL CORTEX ACTIVATION; EMOTIONAL INFORMATION; ATTENTIONAL BIAS; ANGRY FACES; ANXIETY; ADOLESCENTS; AMYGDALA; CHILDREN	Close proximity to an attachment figure, such as a caregiver, has been shown to attenuate threat-related activity in limbic regions such as the hypothalamus in healthy individuals. We hypothesized that such features might be similarly attenuated by proximity during a potentially stressful situation in a clinically anxious population of youths. Confirmation of this hypothesis could support the role of attachment figures in the management of anxiety among children and adolescents. Three groups were analyzed: anxious children and adolescents who requested that their caregiver accompany them in the scanner room, anxious children and adolescents without their caregiver in the scanner room and healthy controls (each of N = 10). The groups were matched for age and, among the two anxious groups, for diagnosis (mean age 9.5). The children and adolescents were exposed to physical threat words during an fMRI assessment. Results indicate that activity in the hypothalamus, ventromedial, and ventrolateral prefrontal cortex were significantly reduced in anxious children and adolescents who requested that their caregiver accompany them in the scanner room compared to those without their caregiver in the scanner room. Mean activity in these regions in anxious children and adolescents with their caregiver in the scanner room was comparable to that of healthy controls. These data suggest links between social contact and neural mechanisms of emotional reactivity; specifically, presence of caregivers moderates the increase in anxiety seen with stressful stimuli. Capitalizing on the ability of anxious youths to manifest low levels of anxiety-like information processing in the presence of a caregiver could help in modeling adaptive function in behavioral treatments.	[Conner, Olivia L.; McFarland, Ashley M.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Siegle, Greg J.; Silk, Jennifer S.; Ladouceur, Cecile D.; Ryan, Neal D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Dahl, Ronald E.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Coan, James A.] Univ Virginia, Charlottesville, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Berkeley; University of Virginia	Conner, OL (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.	connerol@upmc.edu	Dahl, Ronald/AAW-8714-2021; Ladouceur, Cecile D/H-3124-2016	Silk, Jennifer/0000-0002-8638-4337; dahl, ronald/0000-0002-1794-7132	National Institutes of Health [P50 MH080215, MH082998, MH083001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH080215, K02MH082998, K01MH083001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by P50 MH080215, the National Institutes of Health MH082998 and MH083001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, DIAGN STAT MAN DIS; Barrett PM, 1996, J CONSULT CLIN PSYCH, V64, P333, DOI 10.1037/0022-006X.64.2.333; Beckes L, 2011, SOC PERSONAL PSYCHOL, V5, P976, DOI 10.1111/j.1751-9004.2011.00400.x; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bowlby J., 1982, ATTACHMENT LOSS, V2nd; Cacioppo JT, 1999, CURR DIR PSYCHOL SCI, V8, P133, DOI 10.1111/1467-8721.00031; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kemeny ME, 2003, CURR DIR PSYCHOL SCI, V12, P124, DOI 10.1111/1467-8721.01246; MACLEOD C, 1992, BEHAV RES THER, V30, P479, DOI 10.1016/0005-7967(92)90032-C; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Neshat-Doost HT, 2000, J CHILD PSYCHOL PSYC, V41, P363, DOI 10.1111/1469-7610.00620; Riddle MA, 2002, J AM ACAD CHILD PSY, V41, P1061, DOI 10.1097/01.CHI.0000020259.43550.F4; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Silk JS, 2007, AM J PSYCHIAT, V164, P1873, DOI 10.1176/appi.ajp.2007.06111816; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wechsler D., 1999, WECHSLER ABBREVIATED; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	20	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50680	10.1371/journal.pone.0050680	http://dx.doi.org/10.1371/journal.pone.0050680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236383	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100025
J	Pan, XB; Han, JC; Cong, X; Wei, L				Pan, Xiao-Ben; Han, Jin-Chao; Cong, Xu; Wei, Lai			BST2/Tetherin Inhibits Dengue Virus Release from Human Hepatoma Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; WEST NILE VIRUS; INTERFERON-ALPHA; INFECTION; TETHERIN; PROTEIN; INNATE; IDENTIFICATION; LOCALIZATION; REPLICATION	Type I interferons (IFN) have been shown to play an important role for inhibiting Dengue virus (DENV) infection. Identifying IFN-induced cellular proteins are essential for understanding its mechanisms against DENV. Here we established stable Huh7-derived cell lines expressing the IFN-induced cell membrane protein BST2 (Huh7-BST2) or its variant bearing a V5 tag at the C-terminal (Huh7-BST5CV5). These cell lines were infected with DENV to determine proteins modulating their anti-DENV response. We found that expression of BST2 did not affect the efficiency of DENV infection and intracellular replication. Rather, it significantly reduced the virion yield of the infected cells, particularly at low MOI infection. In addition, BST2 also decreased the foci formation and the size of infectious foci in cultured Huh7 monolayers with media containing methocellulose. The addition of the V5 tag at C-terminal inhibited the GPI modification of BST2 and blocked its shift from endoplasm to cytoplastic membrane. BST2CV5 did not affect DENV infection and foci formation in Huh7 cells but reduced virion yield by 1 log at low MOI infection. Interestingly, intracellular BST2CV5 expression was reduced by high level of DENV production. Conclusion: Our results imply that BST2 is a functional mediator of the IFN response against DENV infection. BST2 inhibits the release of DENV virions from Huh7 cells and limits viral cell-to-cell transmission. BST2CV5 variant is unable to inhibit DENV release but impairs viral infection in cells.	[Pan, Xiao-Ben; Han, Jin-Chao; Cong, Xu; Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China; [Wei, Lai] Peking Univ, Peoples Hosp, Dept Infect Dis, Beijing 100871, Peoples R China	Peking University; Peking University	Pan, XB (corresponding author), Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China.	Panxiaoben@pkuph.edu.cn; weilai@pkuph.edu.cn		Pan, Xiao-Ben/0000-0002-7795-8159	National Natural Science Foundation of China [30972605, 30700697]; Program for New Century Excellent Talents in University (NCET) [BMU20110272]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (30972605 and 30700697) and Program for New Century Excellent Talents in University (NCET, BMU20110272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Barrett BS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002596; Beatty M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001450; Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Dafa-Berger A, 2012, VIROLOGY, V428, P98, DOI 10.1016/j.virol.2012.03.011; Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468; de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; GOTO T, 1994, BLOOD, V84, P1922; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Janvier K, 2012, CURR HIV RES, V10, P315, DOI 10.2174/157016212800792414; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-10; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kuhl BD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-115; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Tortorec A, 2011, VIRUSES-BASEL, V3, P520, DOI 10.3390/v3050520; Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346; Lu MY, 2011, CELL DEATH DIFFER, V18, P925, DOI 10.1038/cdd.2010.160; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297; Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09; Pichyangkul S, 2003, J IMMUNOL, V171, P5571, DOI 10.4049/jimmunol.171.10.5571; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Ruiz A, 2010, VIROLOGY, V406, P312, DOI 10.1016/j.virol.2010.07.021; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; St John AL, 2011, P NATL ACAD SCI USA, V108, P9190, DOI 10.1073/pnas.1105079108; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985; Viswanathan K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002332; Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10	50	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51033	10.1371/journal.pone.0051033	http://dx.doi.org/10.1371/journal.pone.0051033			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236425	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100056
J	Stewart, P; Campbell, L; Skogtvedt, S; Griffin, KA; Arnemo, JM; Tryland, M; Girling, S; Miller, MW; Tranulis, MA; Goldmann, W				Stewart, Paula; Campbell, Lauren; Skogtvedt, Susan; Griffin, Karen A.; Arnemo, Jon M.; Tryland, Morten; Girling, Simon; Miller, Michael W.; Tranulis, Michael A.; Goldmann, Wilfred			Genetic Predictions of Prion Disease Susceptibility in Carnivore Species Based on Variability of the Prion Gene Coding Region	PLOS ONE			English	Article							FELINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; TRANSMISSIBLE MINK ENCEPHALOPATHY; PROTEIN GENE; SCRAPIE; PRP; SHEEP; CATS; MICE; CONSERVATION	Mammalian species vary widely in their apparent susceptibility to prion diseases. For example, several felid species developed prion disease (feline spongiform encephalopathy or FSE) during the bovine spongiform encephalopathy (BSE) epidemic in the United Kingdom, whereas no canine BSE cases were detected. Whether either of these or other groups of carnivore species can contract other prion diseases (e. g. chronic wasting disease or CWD) remains an open question. Variation in the host-encoded prion protein (PrP C) largely explains observed disease susceptibility patterns within ruminant species, and may explain interspecies differences in susceptibility as well. We sequenced and compared the open reading frame of the PRNP gene encoding PrP C protein from 609 animal samples comprising 29 species from 22 genera of the Order Carnivora; amongst these samples were 15 FSE cases. Our analysis revealed that FSE cases did not encode an identifiable disease-associated PrP polymorphism. However, all canid PrPs contained aspartic acid or glutamic acid at codon 163 which we propose provides a genetic basis for observed susceptibility differences between canids and felids. Among other carnivores studied, wolverine (Gulo gulo) and pine marten (Martes martes) were the only non-canid species to also express PrP-Asp163, which may impact on their prion diseases susceptibility. Populations of black bear (Ursus americanus) and mountain lion (Puma concolor) from Colorado showed little genetic variation in the PrP protein and no variants likely to be highly resistant to prions in general, suggesting that strain differences between BSE and CWD prions also may contribute to the limited apparent host range of the latter.	[Stewart, Paula; Campbell, Lauren; Goldmann, Wilfred] Univ Edinburgh, Roslin Inst, Div Neurobiol, Roslin, Midlothian, Scotland; [Skogtvedt, Susan; Tranulis, Michael A.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Griffin, Karen A.; Miller, Michael W.] Colorado Div Pk & Wildlife, Wildlife Res Ctr, Ft Collins, CO USA; [Arnemo, Jon M.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Elverum, Norway; [Arnemo, Jon M.] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Fac Forest Sci, S-90183 Umea, Sweden; [Tryland, Morten] Norwegian Sch Vet Sci, Sect Arctic Vet Med, Tromso, Norway; [Tryland, Morten] GenOk Ctr Biosafety, Tromso, Norway; [Girling, Simon] Royal Zool Soc Scotland, Edinburgh Zoo, Edinburgh, Midlothian, Scotland; [Stewart, Paula; Campbell, Lauren; Goldmann, Wilfred] Univ Edinburgh, R D SVS, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; Swedish University of Agricultural Sciences; Norwegian University of Life Sciences; University of Edinburgh	Goldmann, W (corresponding author), Univ Edinburgh, Roslin Inst, Div Neurobiol, Roslin, Midlothian, Scotland.	wilfred.goldmann@roslin.ed.ac.uk		Tryland, Morten/0000-0001-5394-5196; Girling, Simon/0000-0001-9927-9491	Roslin Institute; Biotechnology and Biological Sciences Research Council, United Kingdom; BBSRC [BBS/E/D/20251967, BBS/E/D/20251968, BBS/E/D/05241340, BBS/E/A/00001652] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251968, BBS/E/D/20251967, BBS/E/D/05241340, BBS/E/A/00001652] Funding Source: researchfish	Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	PS, LC and WG were supported by Roslin Institute Strategic Grant funding from the Biotechnology and Biological Sciences Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; B-Rao C, 2001, HUM HERED, V52, P191, DOI 10.1159/000053376; Baron T, 1997, VET REC, V141, P270, DOI 10.1136/vr.141.11.270; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; Bencsik A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006929; BRATBERG B, 1995, VET REC, V136, P444, DOI 10.1136/vr.136.17.444; Brun A, 2004, NEUROSCI RES, V48, P75, DOI 10.1016/j.neures.2003.09.004; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chase-Topping ME, 2005, J GEN VIROL, V86, P1229, DOI 10.1099/vir.0.80277-0; Eiden M, 2010, J GEN VIROL, V91, P2874, DOI 10.1099/vir.0.022103-0; Fernandez-Borges N, 2012, PRION S, V6, P47; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Goldmann W, 1998, J GEN VIROL, V79, P3173, DOI 10.1099/0022-1317-79-12-3173; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Hamir AN, 2005, VET PATHOL, V42, P844, DOI 10.1354/vp.42-6-844; Hamir AN, 2004, J VET DIAGN INVEST, V16, P57, DOI 10.1177/104063870401600110; Harrington RD, 2008, J GEN VIROL, V89, P1086, DOI 10.1099/vir.0.83422-0; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Hewicker-Trautwein M, 2007, PRIONS IN HUMANS AND ANIMALS, P271; Hilbe MM, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-11; Iulini B, 2008, VET PATHOL, V45, P626, DOI 10.1354/vp.45-5-626; Jennelle CS, 2009, J TOXICOL ENV HEAL A, V72, P1018, DOI 10.1080/15287390903084249; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kirkwood JK, 2007, PRIONS IN HUMANS AND ANIMALS, P250; Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; LEGGETT MM, 1990, VET REC, V127, P586; Lezmi S, 2003, HISTOCHEM CELL BIOL, V119, P415, DOI 10.1007/s00418-003-0524-5; Liberski PP, 2009, FOLIA NEUROPATHOL, V47, P195; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Lysek DA, 2004, GENE, V341, P249, DOI 10.1016/j.gene.2004.07.002; Maj A, 2008, VIRUS GENES, V36, P433, DOI 10.1007/s11262-008-0208-2; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; MENOTTIRAYMOND MA, 1995, J HERED, V86, P319, DOI 10.1093/oxfordjournals.jhered.a111594; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Nalls AH, 2011, PRION, V5, P1; O'Brien SJ, 2005, ANNU REV GENOM HUM G, V6, P407, DOI 10.1146/annurev.genom.6.080604.162151; PEARSON GR, 1991, VET REC, V128, P532, DOI 10.1136/vr.128.22.532-b; Peletto S, 2009, J VET SCI, V10, P115, DOI 10.4142/jvs.2009.10.2.115; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; Polymenidou M, 2008, VACCINE, V26, P2601, DOI 10.1016/j.vaccine.2008.03.035; Robinson PJ, 2009, BIOCHEMISTRY-US, V48, P8551, DOI 10.1021/bi901070t; Schatzl HM, 1997, J MOL BIOL, V265, P257, DOI 10.1006/jmbi.1996.0791; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Slate J, 2005, P ROY SOC B-BIOL SCI, V272, P2371, DOI 10.1098/rspb.2005.3259; Sweeting B, 2010, BIOCHEM CELL BIOL, V88, P195, DOI [10.1139/o09-172, 10.1139/O09-172]; Vorberg I, 1999, VIROLOGY, V255, P26, DOI 10.1006/viro.1998.9561; Wan JY, 2009, MOL BIOL REP, V36, P1299, DOI 10.1007/s11033-008-9312-6; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wik L, 2012, PRION, V6, P1; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Young S, 2003, AUST VET J, V81, P295, DOI 10.1111/j.1751-0813.2003.tb12579.x	57	26	28	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50623	10.1371/journal.pone.0050623	http://dx.doi.org/10.1371/journal.pone.0050623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236380	Green Published, gold, Green Submitted			2022-12-25	WOS:000312064100022
J	Tennant, BR; Islam, R; Kramer, MM; Merkulova, Y; Kiang, RL; Whiting, CJ; Hoffman, BG				Tennant, Bryan R.; Islam, Ratib; Kramer, Marabeth M.; Merkulova, Yulia; Kiang, Roger L.; Whiting, Cheryl J.; Hoffman, Brad G.			The Transcription Factor Myt3 Acts as a Pro-Survival Factor in beta-cells	PLOS ONE			English	Article							INSULIN GENE-EXPRESSION; ZINC-FINGER; OLIGODENDROCYTE LINEAGE; MAFA EXPRESSION; DIFFERENTIATION; FAMILY; ENHANCERS; APOPTOSIS; IDENTIFICATION; MUTATION	Aims/Hypothesis: We previously identified the transcription factor Myt3 as specifically expressed in pancreatic islets. Here, we sought to determine the expression and regulation of Myt3 in islets and to determine its significance in regulating islet function and survival. Methods: Myt3 expression was determined in embryonic pancreas and adult islets by qPCR and immunohistochemistry. ChIP-seq, ChIP-qPCR and luciferase assays were used to evaluate regulation of Myt3 expression. Suppression of Myt3 was used to evaluate gene expression, insulin secretion and apoptosis in islets. Results: We show that Myt3 is the most abundant MYT family member in adult islets and that it is expressed in all the major endocrine cell types in the pancreas after E18.5. We demonstrate that Myt3 expression is directly regulated by Foxa2, Pdx1, and Neurod1, which are critical to normal beta-cell development and function, and that Ngn3 induces Myt3 expression through alterations in the Myt3 promoter chromatin state. Further, we show that Myt3 expression is sensitive to both glucose and cytokine exposure. Of specific interest, suppressing Myt3 expression reduces insulin content and increases beta-cell apoptosis, at least in part, due to reduced Pdx1, Mafa, Il-6, Bcl-xl, c-Iap2 and Igfr1 levels, while over-expression of Myt3 protects islets from cytokine induced apoptosis. Conclusion/Interpretation: We have identified Myt3 as a novel transcriptional regulator with a critical role in beta-cell survival. These data are an important step in clarifying the regulatory networks responsible for beta-cell survival, and point to Myt3 as a potential therapeutic target for improving functional beta-cell mass.	[Tennant, Bryan R.; Islam, Ratib; Kramer, Marabeth M.; Merkulova, Yulia; Kiang, Roger L.; Whiting, Cheryl J.; Hoffman, Brad G.] British Columbia Childrens Hosp, Child & Family Res Inst, Vancouver, BC V6H 3V4, Canada; [Tennant, Bryan R.; Islam, Ratib; Kramer, Marabeth M.; Merkulova, Yulia; Kiang, Roger L.; Whiting, Cheryl J.; Hoffman, Brad G.] Sunny Hill Hlth Ctr, Vancouver, BC, Canada; [Hoffman, Brad G.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; University of British Columbia	Hoffman, BG (corresponding author), British Columbia Childrens Hosp, Child & Family Res Inst, Vancouver, BC V6H 3V4, Canada.	brad.hoffman@ubc.ca			Child and Family Research Institute (CFRI); Canadian Institutes for Health Research (CIHR); BC Knowledge Development fund	Child and Family Research Institute (CFRI); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Knowledge Development fund(General Electric)	Funding was provided by the Child and Family Research Institute (CFRI, www.cfri.ca) and the Canadian Institutes for Health Research (CIHR, www.cihr.ca). Infrastructure support was provided by the Canadian Foundation for Innovation (www.innovation.ca), the BC Knowledge Development fund (www.jti.gov.bc.ca/researchandinnovation/Funding/BCKDF/index.htm), Commonwealth Insurance (http://www.nbfc.com), and the CFRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Cai T, 2011, ENDOCRINOLOGY, V152, P1961, DOI 10.1210/en.2010-1065; Carbone I, 2002, DIABETOLOGIA, V45, P153; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; Cockburn B N, 2005, Hum Genet, V116, P538; Cornu M, 2009, ISLETS, V1, P280, DOI 10.4161/isl.1.3.9932; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ehses Jan A., 2009, Archives of Physiology and Biochemistry, V115, P240, DOI 10.1080/13813450903025879; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Furuta H, 1997, DIABETES, V46, P1652, DOI 10.2337/diabetes.46.10.1652; Gamsjaeger R, 2008, J BIOL CHEM, V283, P5158, DOI 10.1074/jbc.M703772200; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu C, CELL METAB, V11, P298; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; Klusmann JH, GENES DEV, V24, P478; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Leibiger B, 2000, J BIOL CHEM, V275, P30153, DOI 10.1074/jbc.M005216200; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liu LM, 2007, MOL CELL BIOCHEM, V303, P115, DOI 10.1007/s11010-007-9463-0; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Macfarlane WM, 2000, J BIOL CHEM, V275, P15330, DOI 10.1074/jbc.M908045199; Matsushita F, 2002, MECH DEVELOP, V118, P209, DOI 10.1016/S0925-4773(02)00250-2; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; van Belle TL, PHYSL REV, V91, P79; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Yang JL, 2008, FASEB J, V22, P3956, DOI 10.1096/fj.08-111013; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	73	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51501	10.1371/journal.pone.0051501	http://dx.doi.org/10.1371/journal.pone.0051501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236509	Green Submitted, Green Published, gold			2022-12-25	WOS:000312064100125
J	Mracek, P; Santoriello, C; Idda, ML; Pagano, C; Ben-Moshe, Z; Gothilf, Y; Vallone, D; Foulkes, NS				Mracek, Philipp; Santoriello, Cristina; Idda, M. Laura; Pagano, Cristina; Ben-Moshe, Zohar; Gothilf, Yoav; Vallone, Daniela; Foulkes, Nicholas S.			Regulation of per and cry Genes Reveals a Central Role for the D-Box Enhancer in Light-Dependent Gene Expression	PLOS ONE			English	Article							CIRCADIAN CLOCK; TRANSCRIPTION; INDUCTION; SYSTEM; AP-1; JUN	Light serves as a key environmental signal for synchronizing the circadian clock with the day night cycle. The zebrafish represents an attractive model for exploring how light influences the vertebrate clock mechanism. Direct illumination of most fish tissues and cell lines induces expression of a broad range of genes including DNA repair, stress response and key clock genes. We have previously identified D- and E-box elements within the promoter of the zebrafish per2 gene that together direct light-induced gene expression. However, is the combined regulation by E- and D-boxes a general feature for all light-induced gene expression? We have tackled this question by examining the regulation of additional light-inducible genes. Our results demonstrate that with the exception of per2, all other genes tested are not induced by light upon blocking of de novo protein synthesis. We reveal that a single D-box serves as the principal light responsive element within the cry1a promoter. Furthermore, upon inhibition of protein synthesis D-box mediated gene expression is abolished while the E-box confers light driven activation as observed in the per2 gene. Given the existence of different photoreceptors in fish cells, our results implicate the D-box enhancer as a general convergence point for light driven signaling. Citation: Mracek P, Santoriello C, Idda ML, Pagano C, Ben-Moshe Z, et al. (2012) Regulation of per and cry Genes Reveals a Central Role for the D- Box Enhancer in Light-Dependent Gene Expression. PLoS ONE 7(12): e51278. doi:10.1371/journal.pone.0051278	[Mracek, Philipp; Idda, M. Laura; Pagano, Cristina; Vallone, Daniela; Foulkes, Nicholas S.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Santoriello, Cristina] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ben-Moshe, Zohar; Gothilf, Yoav] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Helmholtz Association; Karlsruhe Institute of Technology; Harvard University; Tel Aviv University	Vallone, D (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	Daniela.Vallone@kit.edu; nicholas.foulkes@kit.edu	Foulkes, Nicholas S/K-7003-2013; Vallone, Daniela/S-2244-2019	Foulkes, Nicholas S/0000-0002-1794-9891; Pagano, Cristina/0000-0002-9181-6595; Gothilf, Yoav/0000-0002-6054-4128	Max-Planck-Institute for Developmental Biology, Tubingen; BioInterfaces programme of Karlsruhe Institute of Technology (KIT, Germany); CNRS (France)	Max-Planck-Institute for Developmental Biology, Tubingen; BioInterfaces programme of Karlsruhe Institute of Technology (KIT, Germany); CNRS (France)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by funding from the Max-Planck-Institute for Developmental Biology, Tubingen, the BioInterfaces programme of Karlsruhe Institute of Technology (KIT, Germany) and the CNRS (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; Ben-Moshe Z, 2010, CHRONOBIOL INT, V27, P1509, DOI 10.3109/07420528.2010.510229; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; Gachon F, 2007, ANN MED, V39, P562, DOI 10.1080/07853890701491034; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Pando MP, 2001, P NATL ACAD SCI USA, V98, P10178, DOI 10.1073/pnas.181228598; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Uchida Y, 2010, BIOL PHARM BULL, V33, P535, DOI 10.1248/bpb.33.535; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone Daniela, 2007, Methods Mol Biol, V362, P429; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	33	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51278	10.1371/journal.pone.0051278	http://dx.doi.org/10.1371/journal.pone.0051278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236462	gold, Green Published, Green Submitted			2022-12-25	WOS:000312589700034
J	Chen, J; Wang, LL; Li, Y; Cai, B; Fu, Y; Liao, Y; Zhang, JL				Chen, Jie; Wang, Lanlan; Li, Yi; Cai, Bei; Fu, Yang; Liao, Yun; Zhang, Junlong			Association Analysis between SNPs in IL-28B Gene and the Progress of Hepatitis B Infection in Han Chinese	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; VIRUS; PROMOTER	Objective: As a candidate gene association study, we investigated the genetic association of SNPs in IL-28B genes with different outcomes of HBV infection, including LC and HCC occurrence. Methods: Chinese Han subjects were categorized into two groups: 406 LC caused by CHB and 406 HCC caused by CHB. Genomic DNA was isolated from whole blood samples, SNPs were detected using high resolution melting curve (HRM) method. PCR amplification was carried out under the same conditions in a 96-well plate in Real-Time PCR System. Then 341 LC and 356 HCC patients caused by HBV infection were analyzed as a verification by independent sample. 393 CHB patients and 244 health subjects were included as control. Results: CHB patients who progress to LC or HCC showed a significant different frequency in rs12979860 (p = 0.046). Patients with HCC carried more frequently the T alleles in rs12979860 comparison to LC. Same results were found in the independent sample. Conclusion: IL-28B rs12979860 C/T polymorphism T allele appears to be more prevalent in patients with HCC than in LC. Carriage of this allele seems to enhance the risk for developing HCC. Gene polymorphism of IL-28B may confer symptomatic specificity in progress and extent of hepatitis B infection.	[Chen, Jie; Wang, Lanlan; Li, Yi; Cai, Bei; Fu, Yang; Liao, Yun; Zhang, Junlong] Sichuan Univ, W China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China	Sichuan University	Wang, LL (corresponding author), Sichuan Univ, W China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China.	wangll1019@163.com						Chui SH, 2011, BRIT J BIOMED SCI, V68, P143; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Domagalski K, 2010, POSTEP HIG MED DOSW, V64, P522; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146; Michielsen P, 2011, ACTA GASTRO-ENT BELG, V74, P4; Migita K, 2009, TRANSL RES, V153, P91, DOI 10.1016/j.trsl.2008.11.008; Pearlman Brian L, 2011, Curr Gastroenterol Rep, V13, P78, DOI 10.1007/s11894-010-0161-9; Ren S, 2012, CANCER IMMUNOL IMMUN, V61, P1433, DOI 10.1007/s00262-012-1203-y; Ruiz-Extremera A, 2011, HEPATOLOGY, V53, P1830, DOI 10.1002/hep.24298; Shimomura S, 2012, HEPATOL RES, V42, P22, DOI 10.1111/j.1872-034X.2011.00889.x; Thursz M, 2011, SEMIN LIVER DIS, V31, P115, DOI 10.1055/s-0031-1276642; Yan J, 2011, HEPAT MON, V11, P358	15	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50787	10.1371/journal.pone.0050787	http://dx.doi.org/10.1371/journal.pone.0050787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227209	Green Submitted, gold, Green Published			2022-12-25	WOS:000312588200069
J	Hanaoka, M; Droma, Y; Basnyat, B; Ito, M; Kobayashi, N; Katsuyama, Y; Kubo, K; Ota, M				Hanaoka, Masayuki; Droma, Yunden; Basnyat, Buddha; Ito, Michiko; Kobayashi, Nobumitsu; Katsuyama, Yoshihiko; Kubo, Keishi; Ota, Masao			Genetic Variants in EPAS1 Contribute to Adaptation to High-Altitude Hypoxia in Sherpas	PLOS ONE			English	Article							OXIDE SYNTHASE GENE; HEMOGLOBIN CONCENTRATION; TIBETAN; POLYMORPHISMS; ASSOCIATION; POPULATION; METABOLISM; SELECTION; GLUCOSE; ROLES	Sherpas comprise a population of Tibetan ancestry in the Himalayan region that is renowned for its mountaineering prowess. The very small amount of available genetic information for Sherpas is insufficient to explain their physiological ability to adapt to high-altitude hypoxia. Recent genetic evidence has indicated that natural selection on the endothelial PAS domain protein 1 (EPAS1) gene was occurred in the Tibetan population during their occupation in the Tibetan Plateau for millennia. Tibetan-specific variations in EPAS1 may regulate the physiological responses to high-altitude hypoxia via a hypoxia-inducible transcription factor pathway. We examined three significant tag single-nucleotide polymorphisms (SNPs, rs13419896, rs4953354, and rs4953388) in the EPAS1 gene in Sherpas, and compared these variants with Tibetan highlanders on the Tibetan Plateau as well as with non-Sherpa lowlanders. We found that Sherpas and Tibetans on the Tibetan Plateau exhibit similar patterns in three EPAS1 significant tag SNPs, but these patterns are the reverse of those in non-Sherpa lowlanders. The three SNPs were in strong linkage in Sherpas, but in weak linkage in non-Sherpas. Importantly, the haplotype structured by the Sherpa-dominant alleles was present in Sherpas but rarely present in non-Sherpas. Surprisingly, the average level of serum erythropoietin in Sherpas at 3440 m was equal to that in non-Sherpas at 1300 m, indicating a resistant response of erythropoietin to high-altitude hypoxia in Sherpas. These observations strongly suggest that EPAS1 is under selection for adaptation to the high-altitude life of Tibetan populations, including Sherpas. Understanding of the mechanism of hypoxia tolerance in Tibetans is expected to provide lights to the therapeutic solutions of some hypoxia-related human diseases, such as cardiovascular disease and cancer.	[Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Hanaoka, Masayuki; Droma, Yunden; Ito, Michiko; Kobayashi, Nobumitsu; Kubo, Keishi] Shinshu Univ, Sch Med, Dept Med 1, Matsumoto, Nagano 390, Japan; [Basnyat, Buddha] Nepal Int Clin, Kathmandu, Nepal; [Katsuyama, Yoshihiko] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University	Ota, M (corresponding author), Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan.	otamasao@shinshu-u.ac.jp		Ota, Masao/0000-0002-6400-5658	Japan Society for the Promotion of Science [22590853]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Grant-in-Aid for Scientific Research (C), No. 22590853, from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], SHERP HIST; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beall CM, 1997, HUM BIOL, V69, P597; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beall CM, 2000, ADV EXP MED BIOL, V475, P63; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham Abigail W., 2009, Human Genomics, V4, P79; Droma Y, 2002, CIRCULATION, V106, P826, DOI 10.1161/01.CIR.0000024409.30143.70; Droma Y, 2008, WILD ENVIRON MED, V19, P22, DOI 10.1580/06-WEME-OR-073.1; Droma Y, 2006, HIGH ALT MED BIOL, V7, P209, DOI 10.1089/ham.2006.7.209; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garruto RM, 2003, AM J PHYS ANTHROPOL, V122, P171, DOI 10.1002/ajpa.10283; HACKETT PH, 1980, J APPL PHYSIOL, V49, P374, DOI 10.1152/jappl.1980.49.3.374; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Hochachka PW, 1996, J APPL PHYSIOL, V81, P1355, DOI 10.1152/jappl.1996.81.3.1355; HOLDEN JE, 1995, J APPL PHYSIOL, V79, P222, DOI 10.1152/jappl.1995.79.1.222; Hotta J, 2004, CHEST, V126, P825, DOI 10.1378/chest.126.3.825; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Luo YJ, 2012, RESPIRATION, V84, P155, DOI 10.1159/000336625; MORPURGO G, 1972, EXPERIENTIA, V28, P1280, DOI 10.1007/BF01965295; MORPURGO G, 1976, P NATL ACAD SCI USA, V73, P747, DOI 10.1073/pnas.73.3.747; Ohneda O, 2007, METHOD ENZYMOL, V435, P199, DOI 10.1016/S0076-6879(07)35011-8; Ou LC, 1998, J APPL PHYSIOL, V84, P1242, DOI 10.1152/jappl.1998.84.4.1242; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; SAMAJA M, 1979, J APPL PHYSIOL, V47, P337, DOI 10.1152/jappl.1979.47.2.337; SANTACHIARABENERECETTI AS, 1976, HUM HERED, V26, P351, DOI 10.1159/000152827; Sherpa LN, 2008, SHERPA WINDOW ILLUST; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; SLOAN AW, 1978, ANN HUM BIOL, V5, P453, DOI 10.1080/03014467800003101; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	40	49	51	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50566	10.1371/journal.pone.0050566	http://dx.doi.org/10.1371/journal.pone.0050566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227185	gold, Green Published, Green Submitted			2022-12-25	WOS:000312588200045
J	Ma, WN; Lu, S; Pan, P; Sadatmousavi, P; Yuan, YF; Chen, P				Ma, Weina; Lu, Sheng; Pan, Pei; Sadatmousavi, Parisa; Yuan, Yongfang; Chen, P.			Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine	PLOS ONE			English	Article							INDUCED APOPTOSIS; CANCER-CELLS	The amino acid pairing peptide EAK16-II (EAK) has shown the ability to stabilize the hydrophobic anticancer agent ellipticine (EPT) in aqueous solution. In this study, we investigate pharmacokinetics of the formulation of EAK-EPT complexes in vivo. The developed formulation can achieve a sufficiently high drug concentration required in vivo animal models. The nanostructure and surface properties of EAK-EPT complexes or nanoparticle were characterized by transmission electron microscopy (TEM) and zeta potential measurements, respectively. 12 healthy male SD rats were divided into EPT group and EAK-EPT group randomly. Rats in EPT group were tail intravenously injected with the EPT (20 mg/kg); rats in EAK-EPT group were injected with EAK-EPT complexes (EPT's concentration is 20 mg/kg). EPT was extracted from rat plasma with dexamethasone sodium phosphate as internal standards (IS). The pharmacokinetic parameters were obtained using high pressure liquid chromatography (HPLC). Significant differences in main pharmacokinetic parameters between EPT and EAK-EPT complexes were observed, demonstrating that the complexation with EAK prolongs the residence time of the drug and enlarges the area under the concentration-time curve (AUC). This means that EAK can serve as a suitable carrier to increase the bioavailability of EPT.	[Ma, Weina; Pan, Pei; Yuan, Yongfang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Pharm, Shanghai 200030, Peoples R China; [Lu, Sheng; Sadatmousavi, Parisa; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	Shanghai Jiao Tong University; University of Waterloo	Ma, WN (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Pharm, Shanghai 200030, Peoples R China.	nmxyyf@yahoo.cn			Shanghai Committee of Science and Technology, China [10410711300]; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canada Research Chairs Program	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs)	This project was supported by the Shanghai Committee of Science and Technology, China (Grant No. 10410711300). This research was financially supported by the Natural Sciences and Engineering Research Council of Canada, Canadian Foundation for Innovation and the Canada Research Chairs Program for one of the co-authors (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawa R, 2011, NANOMEDICIN IN PRESS; Fang K, 2009, LUNG CANCER, V63, P227, DOI 10.1016/j.lungcan.2008.05.026; Fung SY, 2006, J PHYS CHEM A, V110, P11446, DOI 10.1021/jp062778y; Fung SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001956; Fung SY, 2011, BIOMATERIALS, V32, P4000, DOI 10.1016/j.biomaterials.2011.02.005; FUNG SY, 2005, HDB NANOSTRUCTURED B, P1; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Kuo PL, 2005, CANCER LETT, V223, P293, DOI 10.1016/j.canlet.2004.09.046; Kuo YC, 2006, LIFE SCI, V78, P2550, DOI 10.1016/j.lfs.2005.10.041; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Stiborova M, 2006, GEN PHYSIOL BIOPHYS, V25, P245; Stiborova Marie, 2006, Biomedical Papers (Olomouc), V150, P13; SUREAU F, 1993, BIOPHYS J, V65, P1767, DOI 10.1016/S0006-3495(93)81273-6; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	14	44	44	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43684	10.1371/journal.pone.0043684	http://dx.doi.org/10.1371/journal.pone.0043684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	23236514	Green Published, gold, Green Submitted			2022-12-25	WOS:000308221300022
J	IJssennagger, N; de Wit, N; Muller, M; van der Meer, R				IJssennagger, Noortje; de Wit, Nicole; Muller, Michael; van der Meer, Roelof			Dietary Heme-Mediated PPAR alpha Activation Does Not Affect the Heme-Induced Epithelial Hyperproliferation and Hyperplasia in Mouse Colon	PLOS ONE			English	Article							ACID-BINDING PROTEIN; RED MEAT; OXIDATIVE STRESS; CANCER; GENE; MICE; CARCINOGENESIS; EXPRESSION; RISK; NRF1	Red meat consumption is associated with an increased colon cancer risk. Heme, present in red meat, injures the colon surface epithelium by luminal cytotoxicity and reactive oxygen species. This surface injury is overcompensated by hyperproliferation and hyperplasia of crypt cells. Transcriptome analysis of mucosa of heme-fed mice showed, besides stress-and proliferation-related genes, many upregulated lipid metabolism-related PPAR alpha target genes. The aim of this study was to investigate the role of PPAR alpha in heme-induced hyperproliferation and hyperplasia. Male PPAR alpha KO and WT mice received a purified diet with or without heme. As PPAR alpha is proposed to protect against oxidative stress and lipid peroxidation, we hypothesized that the absence of PPAR alpha leads to more surface injury and crypt hyperproliferation in the colon upon heme-feeding. Heme induced luminal cytotoxicity and lipid peroxidation and colonic hyperproliferation and hyperplasia to the same extent in WT and KO mice. Transcriptome analysis of colonic mucosa confirmed similar heme-induced hyperproliferation in WT and KO mice. Stainings for alkaline phosphatase activity and expression levels of Vanin-1 and Nrf2-targets indicated a compromised antioxidant defense in heme-fed KO mice. Our results suggest that the protective role of PPAR alpha in antioxidant defense involves the Nrf2-inhibitor Fosl1, which is upregulated by heme in PPAR alpha KO mice. We conclude that PPAR alpha plays a protective role in colon against oxidative stress, but PPAR alpha does not mediate heme-induced hyperproliferation. This implies that oxidative stress of surface cells is not the main determinant of heme-induced hyperproliferation and hyperplasia.	[IJssennagger, Noortje; de Wit, Nicole; Muller, Michael; van der Meer, Roelof] Top Inst Food & Nutr, Wageningen, Netherlands; [IJssennagger, Noortje; Muller, Michael; van der Meer, Roelof] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [de Wit, Nicole; Muller, Michael] Netherlands Nutrigen Ctr, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	IJssennagger, N (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	noortje.ijssennagger@wur.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Kleerebezem, Michiel/AAT-2078-2021; Derrien, Muriel/AAS-6845-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235	program council of TIFN [A-1001]	program council of TIFN	This study was funded by the program council of TIFN (grant A-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Anton PM, 2002, DIGEST DIS SCI, V47, P1308, DOI 10.1023/A:1015322514547; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; IJssennagger N, 2012, GUT, V61, P1041, DOI 10.1136/gutjnl-2011-300239; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee SJ, 2010, TOXICOL APPL PHARM, V242, P191, DOI 10.1016/j.taap.2009.10.007; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Pouyet L, 2010, INFLAMM BOWEL DIS, V16, P96, DOI 10.1002/ibd.21031; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Sesink ALA, 1999, CANCER RES, V59, P5704; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang GQ, 2005, HEPATOLOGY, V42, P871, DOI 10.1002/hep.20857; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	38	74	75	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43260	10.1371/journal.pone.0043260	http://dx.doi.org/10.1371/journal.pone.0043260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	23239972	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500800068
J	Borges, JC; Seraphim, TV; Mokry, DZ; Almeida, FCL; Cyr, DM; Ramos, CHI				Borges, Julio C.; Seraphim, Thiago V.; Mokry, David Z.; Almeida, Fabio C. L.; Cyr, Douglas M.; Ramos, Carlos H. I.			Identification of Regions Involved in Substrate Binding and Dimer Stabilization within the Central Domains of Yeast Hsp40 Sis1	PLOS ONE			English	Article							MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; DNAK CHAPERONE; HSP70; PROTEIN; YDJ1; ULTRACENTRIFUGATION; SPECTROSCOPY; AGGREGATION; SPECIFICITY	Protein folding, refolding and degradation are essential for cellular life and are regulated by protein homeostatic processes such those that involve the molecular chaperone DnaK/Hsp70 and its co-chaperone DnaJ. Hsp70 action is initiated when proteins from the DnaJ family bind an unfolded protein for delivery purposes. In eukaryotes, the DnaJ family can be divided into two main groups, Type I and Type II, represented by yeast cytosolic Ydj1 and Sis1, respectively. Although sharing some unique features both members of the DnaJ family, Ydj1 and Sis1 are structurally and functionally distinct as deemed by previous studies, including the observation that their central domains carry the structural and functional information even in switched chimeras. In this study, we combined several biophysical tools for evaluating the stability of Sis1 and mutants that had the central domains (named Gly/Met rich domain and C-terminal Domain I) deleted or switched to those of Ydj1 to gain insight into the role of these regions in the structure and function of Sis1. The mutants retained some functions similar to full length wild-type Sis1, however they were defective in others. We found that: 1) Sis1 unfolds in at least two steps as follows: folded dimer to partially folded monomer and then to an unfolded monomer. 2) The Gly/Met rich domain had intrinsically disordered characteristics and its deletion had no effect on the conformational stability of the protein. 3) The deletion of the C-terminal Domain I perturbed the stability of the dimer. 4) Exchanging the central domains perturbed the conformational stability of the protein. Altogether, our results suggest the existence of two similar subdomains in the C-terminal domain of DnaJ that could be important for stabilizing each other in order to maintain a folded substrate-binding site as well as the dimeric state of the protein.	[Seraphim, Thiago V.; Mokry, David Z.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil; [Borges, Julio C.; Seraphim, Thiago V.] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil; [Seraphim, Thiago V.] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil; [Almeida, Fabio C. L.] Natl Ctr Nucl Magnet Resonance Macromol UFRJ, Inst Med Biochem, Rio De Janeiro, Brazil; [Almeida, Fabio C. L.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Cyr, Douglas M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of North Carolina; University of North Carolina Chapel Hill	Ramos, CHI (corresponding author), Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil.	cramos@iqm.unicamp.br	Ramos, CH/C-1571-2012; Almeida, Fabio/O-4989-2018; Borges, Julio C/C-6160-2008; Seraphim, Thiago V/J-9949-2013; Portes Santos, Claudia/D-5093-2009	Ramos, CH/0000-0002-7246-9081; Almeida, Fabio/0000-0001-6046-7006; Borges, Julio C/0000-0003-4856-748X; Santos, Helena/0000-0002-5240-5662; Monteiro-Neto, Cassiano/0000-0001-9342-8089; Cyr, Douglas/0000-0002-4928-3414; Vargas Seraphim, Thiago/0000-0002-8682-8962; Portes Santos, Claudia/0000-0001-5165-0853	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981, R01GM067785] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the agencies that funded this work through grants, namely, the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - www.fapesp.br) and Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq - www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges JC, 2011, CURR MED CHEM, V18, P1276; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; da Silva KP, 2011, PROTEIN PEPTIDE LETT, V18, P132; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Ramos CHI, 2005, PROTEIN PEPTIDE LETT, V12, P213, DOI 10.2174/0929866053587156; Ramos CHI, 1999, BIOCHEMISTRY-US, V38, P9783, DOI 10.1021/bi9828627; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40; Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]	31	41	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50927	10.1371/journal.pone.0050927	http://dx.doi.org/10.1371/journal.pone.0050927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	22792329	Green Published, Green Submitted, gold			2022-12-25	WOS:000312588200082
J	Bourgeois, FT; Murthy, S; Mandl, KD				Bourgeois, Florence T.; Murthy, Srinivas; Mandl, Kenneth D.			Comparative Effectiveness Research: An Empirical Study of Trials Registered in ClinicalTrials.gov	PLOS ONE			English	Article							CLINICAL-TRIALS; COMPARATIVE EFFICACY; COST-EFFECTIVENESS; HEALTH; INFORMATION; COMPANIES; BRITAIN; SERVICE; CANADA; NICE	Background: The $1.1 billion investment in comparative effectiveness research will reshape the evidence-base supporting decisions about treatment effectiveness, safety, and cost. Defining the current prevalence and characteristics of comparative effectiveness (CE) research will enable future assessments of the impact of this program. Methods: We conducted an observational study of clinical trials addressing priority research topics defined by the Institute of Medicine and conducted in the US between 2007 and 2010. Trials were identified in ClinicalTrials.gov. Main outcome measures were the prevalence of comparative effectiveness research, nature of comparators selected, funding sources, and impact of these factors on results. Results: 231 (22.3%; 95% CI 19.8%-24.9%) studies were CE studies and 804 (77.7%; 95% CI, 75.1%-80.2%) were non-CE studies, with 379 (36.6%; 95% CI, 33.7%-39.6%) employing a placebo control and 425 (41.1%; 95% CI, 38.1%-44.1%) no control. The most common treatments examined in CE studies were drug interventions (37.2%), behavioral interventions (28.6%), and procedures (15.6%). Study findings were favorable for the experimental treatment in 34.8% of CE studies and greater than twice as many (78.6%) non-CE studies (P < 0.001). CE studies were more likely to receive government funding (P = 0.003) and less likely to receive industry funding (P = 0.01), with 71.8% of CE studies primarily funded by a noncommercial source. The types of interventions studied differed based on funding source, with 95.4% of industry trials studying a drug or device. In addition, industry-funded CE studies were associated with the fewest pediatric subjects (P < 0.001), the largest anticipated sample size (P < 0.001), and the shortest study duration (P < 0.001). Conclusions: In this sample of studies examining high priority areas for CE research, less than a quarter are CE studies and the majority is supported by government and nonprofits. The low prevalence of CE research exists across CE studies with a broad array of interventions and characteristics.	[Bourgeois, Florence T.; Mandl, Kenneth D.] Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Bourgeois, Florence T.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Murthy, Srinivas] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Mandl, Kenneth D.] Childrens Hosp, Harvard MIT Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital	Bourgeois, FT (corresponding author), Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	florence.bourgeois@childrens.harvard.edu	Bourgeois, Florence/H-6710-2016; Murthy, Srinivas/AAS-7243-2020; BERTRAND, Joris/C-1812-2014; Mila, Borja/L-4867-2014; Bourgeois, Yann/D-9938-2012	Bourgeois, Florence/0000-0001-7798-4560; BERTRAND, Joris/0000-0002-3379-1019; Mila, Borja/0000-0002-6446-0079; Bourgeois, Yann/0000-0002-1809-387X; Murthy, Srinivas/0000-0002-9476-839X; Thebaud, Christophe/0000-0002-8586-1234	National Institute of Child Health and Human Development [5T32HD040128]; National Library of Medicine, National Institutes of Health [5G08LM009778]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040128] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM009778] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr. Bourgeois was supported by a training grant (5T32HD040128) from the National Institute of Child Health and Human Development, and Dr. Mandl by a grant from the National Library of Medicine (5G08LM009778), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; Baicker K, 2004, HLTH AFF MILLWOOD S, pVAR33; Berger E, 2008, ANN EMERG MED, V52, P137, DOI 10.1016/j.annemergmed.2008.06.009; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; De Angelis C, 2004, MED J AUSTRALIA, V181, P293, DOI 10.5694/j.1326-5377.2004.tb06290.x; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Henry DA, 2005, JAMA-J AM MED ASSOC, V294, P2630, DOI 10.1001/jama.294.20.2630; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; Mittler JN, 2010, HEALTH SERV RES, V45, P647, DOI 10.1111/j.1475-6773.2010.01108.x; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; Rawlins MD, 2004, NEW ENGL J MED, V351, P1383, DOI 10.1056/NEJMp048221; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Sorenson C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4849; Sox HC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000269; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Tierney M, 2008, CAN MED ASSOC J, V178, P432, DOI 10.1503/cmaj.070713; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	30	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e28820	10.1371/journal.pone.0028820	http://dx.doi.org/10.1371/journal.pone.0028820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253698	gold, Green Submitted, Green Published			2022-12-25	WOS:000301352400001
J	Li, XB; Yan, WG; Agrama, H; Jia, LM; Jackson, A; Moldenhauer, K; Yeater, K; McClung, A; Wu, DX				Li, Xiaobai; Yan, Wengui; Agrama, Hesham; Jia, Limeng; Jackson, Aaron; Moldenhauer, Karen; Yeater, Kathleen; McClung, Anna; Wu, Dianxing			Unraveling the Complex Trait of Harvest Index with Association Mapping in Rice (Oryza sativa L.)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; YIELD-RELATED TRAITS; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; QUANTITATIVE TRAITS; GENETIC DIVERSITY; GRAIN-YIELD; CORE SUBSET; QUALITY; MODEL	Harvest index is a measure of success in partitioning assimilated photosynthate. An improvement of harvest index means an increase in the economic portion of the plant. Our objective was to identify genetic markers associated with harvest index traits using 203 O. sativa accessions. The phenotyping for 14 traits was conducted in both temperate (Arkansas) and subtropical (Texas) climates and the genotyping used 154 SSRs and an indel marker. Heading, plant height and weight, and panicle length had negative correlations, while seed set and grain weight/panicle had positive correlations with harvest index across both locations. Subsequent genetic diversity and population structure analyses identified five groups in this collection, which corresponded to their geographic origins. Model comparisons revealed that different dimensions of principal components analysis (PCA) affected harvest index traits for mapping accuracy, and kinship did not help. In total, 36 markers in Arkansas and 28 markers in Texas were identified to be significantly associated with harvest index traits. Seven and two markers were consistently associated with two or more harvest index correlated traits in Arkansas and Texas, respectively. Additionally, four markers were constitutively identified at both locations, while 32 and 24 markers were identified specifically in Arkansas and Texas, respectively. Allelic analysis of four constitutive markers demonstrated that allele 253 bp of RM431 had significantly greater effect on decreasing plant height, and 390 bp of RM24011 had the greatest effect on decreasing panicle length across both locations. Many of these identified markers are located either nearby or flanking the regions where the QTLs for harvest index have been reported. Thus, the results from this association mapping study complement and enrich the information from linkage-based QTL studies and will be the basis for improving harvest index directly and indirectly in rice.	[Li, Xiaobai; Jia, Limeng; Wu, Dianxing] Zhejiang Univ, State Key Lab Rice Biol, Int Atom Energy Agcy, Collaborating Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Yan, Wengui; Jia, Limeng; Jackson, Aaron; McClung, Anna] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Li, Xiaobai] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China; [Agrama, Hesham; Jia, Limeng; Moldenhauer, Karen] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA; [Yeater, Kathleen] ARS, USDA, So Plains Area, College Stn, TX USA	Zhejiang University; United States Department of Agriculture (USDA); Zhejiang Academy of Agricultural Sciences; University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA)	Li, XB (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Int Atom Energy Agcy, Collaborating Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	Wengui.Yan@ars.usda.gov; dxwu@zju.edu.cn	Li, Xiaobai/AAB-7604-2021; Yin, Minghao/E-9611-2015	Li, Xiaobai/0000-0001-9615-3543; Jackson, Aaron/0000-0002-5540-9255; Yin, Minghao/0000-0002-6226-2394	United States Department of Agriculture-Agricultural Research Service	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by the United States Department of Agriculture-Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Ando T, 2008, THEOR APPL GENET, V116, P881, DOI 10.1007/s00122-008-0722-6; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; BORBA TCO, 2005, CROP BREED APPL BIOT, V2, P157; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brondani C, 2006, GENET MOL BIOL, V29, P676, DOI 10.1590/S1415-47572006000400017; Can N. D., 1999, Plant Production Science, V2, P67; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Dalling M. J., 1985, EXPLOITATION PHYSL G, P55; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; Din K., 2005, SAIC NEWSLETTER, V15, P4; Din RU, 2010, WHEAT PAK J BOT, V42, P899; DONALD CM, 1976, ADV AGRON, V28, P361, DOI 10.1016/S0065-2113(08)60559-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Franco J, 2006, CROP SCI, V46, P854, DOI 10.2135/cropsci2005.07-0201; Fu Q, 2010, J GENET GENOMICS, V37, P147, DOI 10.1016/S1673-8527(09)60033-3; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Hao ZF, 2010, EUPHYTICA, V174, P165, DOI 10.1007/s10681-009-0091-5; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HAY RKM, 1995, ANN APPL BIOL, V126, P197, DOI 10.1111/j.1744-7348.1995.tb05015.x; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Homma K, 2004, FIELD CROP RES, V88, P11, DOI 10.1016/j.fcr.2003.08.010; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jun F, 1997, CROP RES, V2, P1; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kim S, 2006, GENETICS, V173, P1125, DOI 10.1534/genetics.105.052720; Koutroubas SD, 2003, FIELD CROP RES, V83, P251, DOI 10.1016/S0378-4290(03)00067-4; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Li Xiaobai, 2010, Genetica, V138, P1221, DOI 10.1007/s10709-010-9521-5; Li XB, 2011, PLANTA, V234, P347, DOI 10.1007/s00425-011-1405-0; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mao Bei-Bei, 2003, Acta Genetica Sinica, V30, P1118; Marri PR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-33; Matsumoto TK, 2006, HORTSCIENCE, V41, P131, DOI 10.21273/HORTSCI.41.1.131; MOHAMMAD D, 1993, INDIAN J AGR SCI, V63, P92; Nei M., 1983, P 5 WORLD C GEN APPL, V21, P405; Parisseaux B, 2004, THEOR APPL GENET, V109, P508, DOI 10.1007/S00122-004-1666-0; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Raes D, 2009, AGRON J, V101, P438, DOI 10.2134/agronj2008.0140s; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rohlf F, 2000, FNTSYS PC NUMERICAL; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Sabouri H, 2009, AUST J CROP SCI, V3, P155; Saxton AM, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1243; Shao YF, 2011, THEOR APPL GENET, V122, P1005, DOI 10.1007/s00122-010-1505-4; SHPILER L, 1990, EUPHYTICA, V51, P257, DOI 10.1007/BF00039727; Shrotria PK, 1988, SORGHUM NEWSLETTER U, V31, P4; Sial MA, 2005, PAKISTAN J BOT, V37, P575; Sinclair TR, 1998, CROP SCI, V38, P638, DOI 10.2135/cropsci1998.0011183X003800030002x; Soltani A., 2001, Journal of Science and Technology of Agriculture and Natural Resources, V5, P127; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang T, 2006, PLOS GENET, V2, P1824, DOI 10.1371/journal.pgen.0020199; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Thomson MJ, 2007, THEOR APPL GENET, V114, P559, DOI 10.1007/s00122-006-0457-1; Thomson MJ, 2009, RICE, V2, P80, DOI 10.1007/s12284-009-9023-1; Tyagi AK, 2004, J GENET, V83, P79, DOI 10.1007/BF02715832; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; Xu YB, 2004, CROP SCI, V44, P1947, DOI 10.2135/cropsci2004.1947; XUE W, 2008, NAT GENET, V143, P1; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yan WG, 2005, U AR AGRI EXP STA RE, P63; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; Yoshida S., 1981, Fundamentals of rice crop science.; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863; Zou JiangShi, 2003, Acta Agronomica Sinica, V29, P652	84	189	201	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29350	10.1371/journal.pone.0029350	http://dx.doi.org/10.1371/journal.pone.0029350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	23240004	Green Published, gold			2022-12-25	WOS:000301570600005
J	Yang, HS; Fu, DZ; Shao, H; Kong, XF; Wang, W; Yang, XJ; Nyachoti, CM; Yin, YL				Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yang, Xiaojian; Nyachoti, Charles M.; Yin, Yulong			Impacts of Birth Weight on Plasma, Liver and Skeletal Muscle Neutral Amino Acid Profiles and Intestinal Amino Acid Transporters in Suckling Huanjiang Mini-Piglets	PLOS ONE			English	Article							ULTRA-FINE POWDER; GROWTH-PERFORMANCE; ADIPOSE-TISSUE; SUPPLEMENTATION; DIGESTIBILITY; METABOLISM; CAPACITY; ILEAL; GAIN; PIGS	Genetic selection strategies towards increased prolificacy have resulted in more and more increased littler size and incidences of impaired fetal development. Low birth weight (LBW) piglets, with long-term alterations in structure, physiology and metabolism, have lower survival rates and poor growth performance. The aim of the study was to compare the plasma, liver and skeletal muscle contents of neutral amino acids (NAA) and the intestinal expression of NAA transporters between LBW and high birth weight (HBW) suckling Huanjiang mini-piglets. Forty piglets with either LBW or HBW (20 piglets per group) were sampled on day 0, 7, 14 and 21 of age to give 5 observations per day per group. The contents of NAA in plasma, liver and skeletal muscle were measured, and jejunal expression of transporters for NAA, including Slc6a19 (B(0)AT1) and Slc1a5 (ASCT2), were determined by real-time RT-PCR and Western Blot, respectively. Results showed that the suckling piglets with LBW had higher contents of Thr, Ser, Gly, Ala, Val, Met, Ile, Leu, Tyr, Phe and Pro in liver, and Gly in skeletal muscle, whereas lower contents of Met, Ser and Ala in plasma when compared with the HBW littermates. Consistent with the content differences in plasma NAA, the jejunal expression profiles of both Slc6a19 (B(0)AT1) and Slc1a5 (ASCT2) in the LBW piglets were lower in compared with the HBW littermates during the early suckling period. These findings suggested that intestinal dysfunction in the LBW piglets may be one of the reasons in altered physiology and metabolism states of other organs, which result in lower survival and growth rate.	[Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yin, Yulong] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yin, Yulong] Chinese Acad Sci, Res Ctr Hlth Breeding Livestock & Poultry, Inst Subtrop Agr, Changsha, Hunan, Peoples R China; [Kong, Xiangfeng] Chinese Acad Sci, Huanjiang Observat & Res Stn Karst Ecosyst, Huanjiang, Guangxi, Peoples R China; [Yang, Xiaojian] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Nyachoti, Charles M.] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Shao, Hua] Univ Ottawa, Res Inst, Ottawa Hosp, Ottawa, ON, Canada; [Yang, Huansheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; University of Guelph; University of Manitoba; University of Ottawa; Ottawa Hospital Research Institute; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kong, XF (corresponding author), Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	nnkxf@isa.ac.cn; yinyulong@isa.ac.cn	Wentzensen, Nicolas/AAG-8522-2019; Yang, Huansheng/AAA-1380-2020; Schiffman, Mark/B-9766-2015	WANG, SOPHIA/0000-0003-2597-9393	National Basic Research Program of China [2012CB124704]; National Natural Science Foundation of China [31110103909, 30901040, 30928018, 31101729]; National Scientific and Technology Support Project [2011BAD26B002-5]; Chinese Academy of Sciences [2011T2S15]; NATIONAL CANCER INSTITUTE [ZIACP010124] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific and Technology Support Project; Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was jointly supported by the National Basic Research Program of China (2012CB124704), National Natural Science Foundation of China (No. 31110103909, 30901040, 30928018, and 31101729), National Scientific and Technology Support Project (2011BAD26B002-5) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant No. 2011T2S15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bauer R, 1998, EXP TOXICOL PATHOL, V50, P59, DOI 10.1016/S0940-2993(98)80071-7; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Deng D, 2009, J NUTR BIOCHEM, V20, P544, DOI 10.1016/j.jnutbio.2008.05.014; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Gondret F, 2005, LIVEST PROD SCI, V93, P137, DOI 10.1016/j.livprodsci.2004.09.009; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAUSSINGER D, 1992, ENZYME, V46, P72; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kong XF, 2007, LIVEST SCI, V108, P272, DOI 10.1016/j.livsci.2007.01.079; Kong XF, 2007, LIVEST SCI, V108, P94, DOI 10.1016/j.livsci.2007.01.002; Kong XF, 2009, LIVEST SCI, V123, P261, DOI 10.1016/j.livsci.2008.11.015; Kong XF, 2009, AMINO ACIDS, V37, P573, DOI 10.1007/s00726-008-0176-9; Milligan BN, 2002, PREV VET MED, V56, P119, DOI 10.1016/S0167-5877(02)00157-5; Milligan BN, 2002, LIVEST PROD SCI, V76, P181, DOI 10.1016/S0301-6226(02)00012-X; Morise A, 2008, ANIMAL, V2, P73, DOI 10.1017/S175173110700095X; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; Rehfeldt C, 2008, MEAT SCI, V78, P170, DOI 10.1016/j.meatsci.2007.05.029; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Ritacco G, 1997, J ANIM SCI, V75, P1237; Sangild PT, 2002, BIOL GROW ANIM, V1, P111, DOI 10.1016/S1877-1823(09)70119-5; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Tan B, 2011, J NUTR BIOCHEM, V22, P441, DOI 10.1016/j.jnutbio.2010.03.012; Thorn SR, 2009, ENDOCRINOLOGY, V150, P3021, DOI 10.1210/en.2008-1789; THORNBURY JC, 1993, PEDIATR PATHOL, V13, P59, DOI 10.3109/15513819309048193; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; XU RJ, 1994, J PEDIATR GASTR NUTR, V18, P231, DOI 10.1097/00005176-199402000-00018; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin YL, 2000, LIVEST PROD SCI, V62, P119, DOI 10.1016/S0301-6226(99)00129-3; Zhang M, 1996, SWINE PROD, V2, P30; Zhao DS, 2008, LIVEST POULTRY HUSBA, V3, P16	31	72	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50921	10.1371/journal.pone.0050921	http://dx.doi.org/10.1371/journal.pone.0050921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	22253702	Green Published, Green Submitted, gold			2022-12-25	WOS:000312064100044
J	Yu, Q; Wu, HH; He, NP; Lu, XT; Wang, ZP; Elser, JJ; Wu, JG; Han, XG				Yu, Qiang; Wu, Honghui; He, Nianpeng; Lue, Xiaotao; Wang, Zhiping; Elser, James J.; Wu, Jianguo; Han, Xingguo			Testing the Growth Rate Hypothesis in Vascular Plants with Above- and Below-Ground Biomass	PLOS ONE			English	Article							N-P STOICHIOMETRY; BIOLOGICAL STOICHIOMETRY; LEAF NITROGEN; NUTRIENT LIMITATION; MINERAL-NUTRITION; PHOSPHORUS; RATIOS; RNA; HOMEOSTASIS; AUTOTROPHS	The growth rate hypothesis (GRH) proposes that higher growth rate (the rate of change in biomass per unit biomass, mu) is associated with higher P concentration and lower C: P and N:P ratios. However, the applicability of the GRH to vascular plants is not well-studied and few studies have been done on belowground biomass. Here we showed that, for aboveground, belowground and total biomass of three study species, mu was positively correlated with N: C under N limitation and positively correlated with P: C under P limitation. However, the N: P ratio was a unimodal function of mu, increasing for small values of mu, reaching a maximum, and then decreasing. The range of variations in mu was positively correlated with variation in C: N: P stoichiometry. Furthermore, mu and C: N: P ranges for aboveground biomass were negatively correlated with those for belowground. Our results confirm the well-known association of growth rate with tissue concentration of the limiting nutrient and provide empirical support for recent theoretical formulations.	[Yu, Qiang; Wu, Honghui; Lue, Xiaotao; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yu, Qiang; Wu, Honghui; Lue, Xiaotao; Wang, Zhiping; Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Elser, James J.; Wu, Jianguo] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Inner Mongolia Univ, SUCCESS, Hohhot, Inner Mongolia, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Arizona State University; Arizona State University-Tempe; Inner Mongolia University	Yu, Q (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	turfyu@gmail.com; xghan@ibcas.ac.cn	Elser, James/A-7082-2008; Han, Xingguo/K-7552-2016; Wu, Jianguo/G-6267-2010; Yu, Qiang/E-2097-2011; Lu (ü), Xiao-Tao/B-3905-2008; Elser, James J/AAL-6199-2020; Wu, Honghui/AAF-5696-2019	Elser, James/0000-0002-1460-2155; Han, Xingguo/0000-0002-1836-975X; Wu, Jianguo/0000-0002-1182-3024; Yu, Qiang/0000-0002-5480-0623; Lu (ü), Xiao-Tao/0000-0001-5571-1895; Elser, James J/0000-0002-1460-2155; he, nianpeng/0000-0002-0458-5953	National Natural Science Foundation of China (NSFC) [31170434]; NSFC [30830026]; Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering [K0802]; National Science Foundation [DEB-0618193]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering; National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Natural Science Foundation of China (NSFC, 31170434) and the Key Project of NSFC (30830026). N. He acknowledges support from the Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering (K0802). J. Elser and J. Wu acknowledge support from the National Science Foundation (DEB-0618193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2004, LIMNOL OCEANOGR, V49, P656, DOI 10.4319/lo.2004.49.3.0656; Agren GI, 2004, ECOL LETT, V7, P185, DOI 10.1111/j.1461-0248.2004.00567.x; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Cernusak LA, 2010, NEW PHYTOL, V185, P770, DOI 10.1111/j.1469-8137.2009.03106.x; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; ELRIFI IR, 1985, J PHYCOL, V21, P592, DOI 10.1111/j.0022-3646.1985.00592.x; Elser JJ, 2006, FUNCT ECOL, V20, P846, DOI 10.1111/j.1365-2435.2006.01165.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 1998, ECOSYSTEMS, V1, P120, DOI 10.1007/s100219900009; ERICSSON T, 1995, PLANT SOIL, V168, P205, DOI 10.1007/BF00029330; Gorokhova E, 2002, P ROY SOC B-BIOL SCI, V269, P2373, DOI 10.1098/rspb.2002.2145; Gusewell S, 2009, FUNCT ECOL, V23, P211, DOI 10.1111/j.1365-2435.2008.01478.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hessen DO, 2007, FUNCT ECOL, V21, P956, DOI 10.1111/j.1365-2435.2007.01306.x; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hoagland R, 347 U CAL COLL AGR C; INGESTAD T, 1982, PLANT CELL ENVIRON, V5, P443, DOI 10.1111/1365-3040.ep11611714; Ingestad T, 1986, SCAND J FOREST RES, V1, P439, DOI 10.1080/02827588609382436; Jensen M. H., 1985, Horticultural Reviews, V7, P483, DOI 10.1002/9781118060735.ch10; Johnson NC, 2008, ECOLOGY, V89, P2868, DOI 10.1890/07-1394.1; Kerkhoff AJ, 2006, ECOL LETT, V9, P419, DOI 10.1111/j.1461-0248.2006.00888.x; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Limpens J, 2003, NEW PHYTOL, V157, P339, DOI 10.1046/j.1469-8137.2003.00667.x; Loladze I, 2000, B MATH BIOL, V62, P1137, DOI 10.1006/bulm.2000.0201; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; MCJANNET CL, 1995, FUNCT ECOL, V9, P231, DOI 10.2307/2390569; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Niklas KJ, 2006, ANN BOT-LONDON, V97, P155, DOI 10.1093/aob/mcj021; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; POORTER H, 1992, PLANT CELL ENVIRON, V15, P221, DOI 10.1111/j.1365-3040.1992.tb01476.x; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; STERNER RW, 1992, BIOGEOCHEMISTRY, V17, P49; TILMAN D, 1988; Tomassen HBM, 2004, J APPL ECOL, V41, P139, DOI 10.1111/j.1365-2664.2004.00870.x; Venterink HO, 2010, FUNCT ECOL, V24, P877, DOI 10.1111/j.1365-2435.2010.01692.x; Watts T, 2006, J INSECT PHYSIOL, V52, P187, DOI 10.1016/j.jinsphys.2005.09.012; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Yu QA, 2011, OECOLOGIA, V166, P1, DOI 10.1007/s00442-010-1902-z; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x	52	52	78	8	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32162	10.1371/journal.pone.0032162	http://dx.doi.org/10.1371/journal.pone.0032162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427823	Green Published, gold			2022-12-25	WOS:000303129700007
J	Yang, HP; Zuna, RE; Schiffman, M; Walker, JL; Sherman, ME; Landrum, LM; Moxley, K; Gold, MA; Dunn, ST; Allen, RA; Zhang, R; Long, R; Wang, SS; Wentzensen, N				Yang, Hannah P.; Zuna, Rosemary E.; Schiffman, Mark; Walker, Joan L.; Sherman, Mark E.; Landrum, Lisa M.; Moxley, Katherine; Gold, Michael A.; Dunn, S. Terence; Allen, Richard A.; Zhang, Roy; Long, Rodney; Wang, Sophia S.; Wentzensen, Nicolas			Clinical and Pathological Heterogeneity of Cervical Intraepithelial Neoplasia Grade 3	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; EARLY END-POINTS; NATURAL-HISTORY; LOOP EXCISION; CANCER; LESIONS; WOMEN; DETERMINANTS; METAANALYSIS; PROGRESSION	Objective: Cervical intraepithelial neoplasia grade 3 (CIN3), the immediate cervical cancer precursor, is a target of cervical cancer prevention. However, less than half of CIN3s will progress to cancer. Routine treatment of all CIN3s and the majority of CIN2s may lead to overtreatment of many lesions that would not progress. To improve our understanding of CIN3 natural history, we performed a detailed characterization of CIN3 heterogeneity in a large referral population in the US. Methods: We examined 309 CIN3 cases in the SUCCEED, a large population-based study of women with abnormal cervical cancer screening results. Histology information for 12 individual loop electrosurgical excision procedure (LEEP) segments was evaluated for each woman. We performed case-case comparisons of CIN3s to analyze determinants of heterogeneity and screening test performance. Results: CIN3 cases varied substantially by size (1-10 LEEP segments) and by presentation with concomitant CIN2 and CIN1. All grades of CINs were equally distributed over the cervical surface. In half of the women, CIN3 lesions were found as multiple distinct lesions on the cervix. Women with large and solitary CIN3 lesions were more likely to be older, have longer sexual activity span, and have fewer multiple high risk HPV infections. Screening frequency, but not HPV16 positivity, was an important predictor of CIN3 size. Large CIN3 lesions were also characterized by high-grade clinical test results. Conclusions: We demonstrate substantial heterogeneity in clinical and pathological presentation of CIN3 in a US population. Time since sexual debut and participation in screening were predictors of CIN3 size. We did not observe a preferential site of CIN3 on the cervical surface that could serve as a target for cervical biopsy. Cervical cancer screening procedures were more likely to detect larger CIN3s, suggesting that CIN3s detected by multiple independent diagnostic tests may represent cases with increased risk of invasion.	[Yang, Hannah P.; Schiffman, Mark; Sherman, Mark E.; Wentzensen, Nicolas] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Zuna, Rosemary E.; Dunn, S. Terence; Allen, Richard A.; Zhang, Roy] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Walker, Joan L.; Landrum, Lisa M.; Moxley, Katherine] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Gold, Michael A.] Vanderbilt Univ, Dept Obstet & Gynecol, Nashville, TN USA; [Long, Rodney] Natl Lib Med, Bethesda, MD USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Beckman Res Inst, Div Canc Etiol, Duarte, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); City of Hope; Beckman Research Institute of City of Hope	Yang, HP (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	yanghan@mail.nih.gov	Wentzensen, Nicolas/AAG-8522-2019; Yang, Huansheng/AAA-1380-2020; Schiffman, Mark/B-9766-2015	WANG, SOPHIA/0000-0003-2597-9393	US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch; NATIONAL CANCER INSTITUTE [ZIACP010124] Funding Source: NIH RePORTER	US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program at the US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard Jay E, 2005, J Low Genit Tract Dis, V9, P36, DOI 10.1097/00128360-200501000-00008; Cardenas-Turanzas M, 2005, LANCET ONCOL, V6, P43; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Guido RS, 2005, AM J OBSTET GYNECOL, V193, P1331, DOI 10.1016/j.ajog.2005.05.008; HEATLEY M, 1995, J CLIN PATHOL, V48, P323, DOI 10.1136/jcp.48.4.323; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lurie S, 2007, AM J OBSTET GYNECOL, V125, pe121; Massad LS, 1996, GYNECOL ONCOL, V60, P400, DOI 10.1006/gyno.1996.0062; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Mitchell M F, 1996, J Natl Cancer Inst Monogr, P17; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P45, DOI 10.1097/01.lgt.0000192697.31291.42; RICHART RM, 1965, CANCER, V18, P950, DOI 10.1002/1097-0142(196508)18:8<950::AID-CNCR2820180805>3.0.CO;2-T; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schiffman M, 2010, OBSTET GYNECOL, V116, P177, DOI 10.1097/AOG.0b013e3181e4629f; Sherman ME, 2003, CANCER EPIDEM BIOMAR, V12, P372; Shiffman M, 2008, LANCET ONCOL, V9, P404, DOI 10.1016/S1470-2045(08)70110-4; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Szurkus DC, 2003, AM J OBSTET GYNECOL, V188, P1180, DOI 10.1067/mob.2003.282; TIDBURY P, 1992, BRIT J OBSTET GYNAEC, V99, P583, DOI 10.1111/j.1471-0528.1992.tb13825.x; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Wang SS, 2009, CANCER EPIDEM BIOMAR, V18, P113, DOI 10.1158/1055-9965.EPI-08-0591; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Wheeler CM, 2008, OBSTET GYN CLIN N AM, V35, P519, DOI 10.1016/j.ogc.2008.09.006; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050	27	72	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29051	10.1371/journal.pone.0029051	http://dx.doi.org/10.1371/journal.pone.0029051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253702	gold, Green Published, Green Submitted			2022-12-25	WOS:000301361500005
J	IJssennagger, N; Derrien, M; van Doorn, GM; Rijnierse, A; van den Bogert, B; Muller, M; Dekker, J; Kleerebezem, M; van der Meer, R				IJssennagger, Noortje; Derrien, Muriel; van Doorn, Gerdien M.; Rijnierse, Anneke; van den Bogert, Bartholomeus; Muller, Michael; Dekker, Jan; Kleerebezem, Michiel; van der Meer, Roelof			Dietary Heme Alters Microbiota and Mucosa of Mouse Colon without Functional Changes in Host-Microbe Cross-Talk	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; RED MEAT; COLORECTAL-CANCER; HYDROGEN-SULFIDE; RISK; GUT; INHIBITOR; SHOCK; CONSUMPTION; MODULATION	Colon cancer is a major cause of cancer deaths in Western countries and is associated with diets high in red meat. Heme, the iron-porphyrin pigment of red meat, induces cytotoxicity of gut contents which injures surface cells leading to compensatory hyperproliferation of crypt cells. This hyperproliferation results in epithelial hyperplasia which increases the risk of colon cancer. In humans, a high red-meat diet increases Bacteroides spp in feces. Therefore, we simultaneously investigated the effects of dietary heme on colonic microbiota and on the host mucosa of mice. Whole genome microarrays showed that heme injured the colonic surface epithelium and induced hyperproliferation by changing the surface to crypt signaling. Using 16S rRNA phylogenetic microarrays, we investigated whether bacteria play a role in this changed signaling. Heme increased Bacteroidetes and decreased Firmicutes in colonic contents. This shift was most likely caused by a selective susceptibility of Gram-positive bacteria to heme cytotoxic fecal water, which is not observed for Gram-negative bacteria, allowing expansion of the Gram-negative community. The increased amount of Gram-negative bacteria most probably increased LPS exposure to colonocytes, however, there is no appreciable immune response detected in the heme-fed mice. There was no functional change in the sensing of the bacteria by the mucosa, as changes in inflammation pathways and Toll-like receptor signaling were not detected. This unaltered host-microbe cross-talk indicates that the changes in microbiota did not play a causal role in the observed hyperproliferation and hyperplasia.	[IJssennagger, Noortje; Derrien, Muriel; van Doorn, Gerdien M.; Rijnierse, Anneke; van den Bogert, Bartholomeus; Muller, Michael; Dekker, Jan; Kleerebezem, Michiel; van der Meer, Roelof] Top Inst Food & Nutr, Wageningen, Netherlands; [IJssennagger, Noortje; Rijnierse, Anneke; Muller, Michael; van der Meer, Roelof] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Derrien, Muriel; van Doorn, Gerdien M.; van den Bogert, Bartholomeus; Kleerebezem, Michiel] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; NIZO Food Research	Muller, M (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	michiel.kleerebezem@nizo.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Kleerebezem, Michiel/AAT-2078-2021; Derrien, Muriel/AAS-6845-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235	program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands [A-1001]	program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands	This study was funded only by the program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands (grant A-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ALJALILI TAR, 1988, CURR MICROBIOL, V17, P13, DOI 10.1007/BF01568812; Attene-Ramos MS, 2010, ENVIRON MOL MUTAGEN, V51, P304, DOI 10.1002/em.20546; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Bovee-Oudenhoven IM, 1999, J NUTR, V129, P607, DOI 10.1093/jn/129.3.607; CARTER RL, 1989, PSYCHOMETRIKA, V54, P9, DOI 10.1007/BF02294446; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Fund WCR Research AIfC, 2007, FOOD NUTR PHYS ACT P, V1; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; IJssennagger N, 2011, GUT; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; LAPRE JA, 1992, AM J PHYSIOL, V263, pG333, DOI 10.1152/ajpgi.1992.263.3.G333; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee DH, 2004, JNCI-J NATL CANCER I, V96, P403, DOI 10.1093/jnci/djh047; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; MAIER BR, 1974, AM J CLIN NUTR, V27, P1470, DOI 10.1093/ajcn/27.12.1470; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Nakamura A, 2003, J EXP MED, V197, P669, DOI 10.1084/jem.20021824; NITZAN Y, 1994, CURR MICROBIOL, V29, P125, DOI 10.1007/BF01570752; Nobles CL, 2011, METALLOMICS, V3, P788, DOI 10.1039/c1mt00047k; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Parham NJ, 2000, FEMS MICROBIOL ECOL, V31, P21, DOI 10.1111/j.1574-6941.2000.tb00667.x; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Poelstra K, 1997, AM J PATHOL, V151, P1163; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schepens MAA, 2011, NUTRITION, V27, P590, DOI 10.1016/j.nut.2010.05.002; SCHWARTZ S, 1985, GASTROENTEROLOGY, V89, P19, DOI 10.1016/0016-5085(85)90740-1; Sesink ALA, 1999, CANCER RES, V59, P5704; Si-Tahar M, 2000, GASTROENTEROLOGY, V118, P1061, DOI 10.1016/S0016-5085(00)70359-3; Vaishnava S, 2007, CELL HOST MICROBE, V2, P365, DOI 10.1016/j.chom.2007.11.004; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; YOUNG GP, 1989, J GASTROEN HEPATOL, V4, P537, DOI 10.1111/j.1440-1746.1989.tb00858.x; Zhang XH, 2011, CANCER CAUSE CONTROL, V22, P1627, DOI 10.1007/s10552-011-9839-z; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	57	74	75	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49868	10.1371/journal.pone.0049868	http://dx.doi.org/10.1371/journal.pone.0049868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239972	Green Published, gold, Green Submitted			2022-12-25	WOS:000312290800010
J	Wang, GY; Zhang, JW; Liu, LY; Sharma, S; Dong, QH				Wang, Guanyu; Zhang, Jiawei; Liu, Luying; Sharma, Sherven; Dong, Qinghua			Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl	PLOS ONE			English	Article							INDUCED APOPTOSIS; P-GLYCOPROTEIN; HEPATOCELLULAR-CARCINOMA; CELLS; EXPRESSION; FLAVONOIDS; CARDIOTOXICITY; MITOCHONDRIA; ADRIAMYCIN; TOXICITY	Background: The dose-dependent toxicities of doxorubicin (DOX) limit its clinical applications, particularly in drug-resistant cancers, such as liver cancer. In this study, we investigated the role of quercetin on the antitumor effects of DOX on liver cancer cells and its ability to provide protection against DOX-mediated liver damage in mice. Methodology and Results: The MTT and Annexin V/PI staining assay demonstrated that quercetin selectively sensitized DOX-induced cytotoxicity against liver cancer cells while protecting normal liver cells. The increase in DOX-mediated apoptosis in hepatoma cells by quercetin was p53-dependent and occurred by downregulating Bcl-xl expression. Z-VAD-fmk (caspase inhibitor), pifithrin-alpha (p53 inhibitor), or overexpressed Bcl-xl decreased the effects of quercetin on DOX-mediated apoptosis. The combined treatment of quercetin and DOX significantly reduced the growth of liver cancer xenografts in mice. Moreover, quercetin decreased the serum levels of alanine aminotransferase and aspartate aminotransferase that were increased in DOX-treated mice. Quercetin also reversed the DOX-induced pathological changes in mice livers. Conclusion and Significance: These results indicate that quercetin potentiated the antitumor effects of DOX on liver cancer cells while protecting normal liver cells. Therefore, the development of quercetin may be beneficial in a combined treatment with DOX for increased therapeutic efficacy against liver cancer.	[Dong, Qinghua] Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Guanyu] Zhejiang Univ, Sch Med, Dept Gen Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jiawei] Zhejiang Univ, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Luying] Zhejiang Canc Hosp, Dept Radiotherapy, Hangzhou, Zhejiang, Peoples R China; [Sharma, Sherven] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sharma, Sherven] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; [Dong, Qinghua] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Canc Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Dong, QH (corresponding author), Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	dongqinghua@zju.edu.cn	Yu, Hengyong/AAH-5726-2019; Vannier, Michael W/AAI-6951-2021; Wang, Ge/AAH-8592-2020	Yu, Hengyong/0000-0002-5852-0813; Wang, Ge/0000-0002-2656-7705; Vannier, Michael/0000-0001-9898-384X	National Natural Science Foundation of China [30400521]; Science Technology Department of Zhejiang Province [2012R10047, 2012C33116]; Education Department of Zhejiang Province [Y201224108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province; Education Department of Zhejiang Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Natural Science Foundation of China (No.: 30400521), the Science Technology Department of Zhejiang Province (No.: 2012R10047 to QD and No.: 2012C33116 to GW) and the Education Department of Zhejiang Province (No.: Y201224108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshabanah OA, 2010, OXID MED CELL LONGEV, V3, P428, DOI 10.4161/oxim.3.6.14416; BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M; Bulucu F, 2009, BIOL TRACE ELEM RES, V132, P184, DOI 10.1007/s12011-009-8377-y; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Choi KC, 2010, FOOD CHEM TOXICOL, V48, P2747, DOI 10.1016/j.fct.2010.07.001; de David C, 2011, TOXICOL PATHOL, V39, P949, DOI 10.1177/0192623311418680; Donmez Y, 2011, CANCER CHEMOTH PHARM, V67, P823, DOI 10.1007/s00280-010-1385-y; Du GJ, 2010, INT IMMUNOPHARMACOL, V10, P819, DOI 10.1016/j.intimp.2010.04.018; Du GJ, 2010, CANCER CHEMOTH PHARM, V65, P277, DOI 10.1007/s00280-009-1032-7; Dudka J, 2005, BASIC CLIN PHARMACOL, V97, P74, DOI 10.1111/j.1742-7843.2005.pto_98.x; Duraj J, 2005, NEOPLASMA, V52, P273; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fotsis T, 1997, CANCER RES, V57, P2916; Gibellini L, 2011, EVID BASED COMPLEMEN; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hovorka O, 2010, EUR J PHARM BIOPHARM, V76, P514, DOI 10.1016/j.ejpb.2010.07.008; Jing S, 2008, INT J HYPERTHER, V24, P151, DOI 10.1080/02656730701843109; Kahraman A, 2012, MOL BIOL REP, V39, P2789, DOI 10.1007/s11033-011-1037-2; Kaiserova H, 2007, BBA-MOL BASIS DIS, V1772, P1065, DOI 10.1016/j.bbadis.2007.05.002; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; Kebieche M, 2009, EXP TOXICOL PATHOL, V61, P161, DOI 10.1016/j.etp.2008.06.002; King PD, 2001, ONCOLOGIST, V6, P162, DOI 10.1634/theoncologist.6-2-162; Krizkova Jitka, 2009, Interdiscip Toxicol, V2, P201, DOI 10.2478/v10102-009-0018-y; Li L, 2006, BIOCHEM PHARMACOL, V71, P584, DOI 10.1016/j.bcp.2005.11.026; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nessa MU, 2011, ANTICANCER RES, V31, P3789; Nowak AK, 2004, EUR J CANCER, V40, P1474, DOI 10.1016/j.ejca.2004.02.027; Odbayar TO, 2009, MOL CELL BIOCHEM, V325, P121, DOI 10.1007/s11010-009-0026-4; Park MH, 2011, BIOCHEM BIOPH RES CO, V412, P710, DOI 10.1016/j.bbrc.2011.08.037; Pei Tian-xian, 2007, Yaoxue Xuebao, V42, P1029; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; SCAMBIA G, 1994, CANCER CHEMOTH PHARM, V34, P459, DOI 10.1007/BF00685655; SILBER JH, 1995, NEW ENGL J MED, V333, P1359; Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x; Suematsu N, 2011, NEUROSCI LETT, V504, P223, DOI 10.1016/j.neulet.2011.09.028; Szanto M, 2011, CARDIOVASC RES, V92, P430, DOI 10.1093/cvr/cvr246; Tiong KH, 2010, XENOBIOTICA, V40, P458, DOI 10.3109/00498251003786749; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Walia V, 2011, FRONT BIOSCI-LANDMRK, V16, P749, DOI 10.2741/3717; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang YA, 2008, INT J CANCER, V123, P1536, DOI 10.1002/ijc.23671; Wiegand H, 2009, NUTR CANCER, V61, P717, DOI 10.1080/01635580902825621; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; Zordoky BNM, 2011, DRUG METAB DISPOS, V39, P1440, DOI 10.1124/dmd.111.039123	50	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51764	10.1371/journal.pone.0051764	http://dx.doi.org/10.1371/journal.pone.0051764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240061	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800097
J	Wang, G; Zhang, J; Gao, H; Weir, V; Yu, HY; Cong, WX; Xu, XC; Shen, HO; Bennett, J; Furth, M; Wang, Y; Vannier, M				Wang, Ge; Zhang, Jie; Gao, Hao; Weir, Victor; Yu, Hengyong; Cong, Wenxiang; Xu, Xiaochen; Shen, Haiou; Bennett, James; Furth, Mark; Wang, Yue; Vannier, Michael			Towards Omni-Tomography-Grand Fusion of Multiple Modalities for Simultaneous Interior Tomography	PLOS ONE			English	Article							NANOPARTICLE-LOADED OBJECTS; LINEAR INVERSE PROBLEMS; COMPUTED-TOMOGRAPHY; PHYSIOME PROJECT; PET/CT; SPECT/CT; RECONSTRUCTION; MRI; INTEGRATION; PROTEINS	We recently elevated interior tomography from its origin in computed tomography (CT) to a general tomographic principle, and proved its validity for other tomographic modalities including SPECT, MRI, and others. Here we propose "omni-tomography", a novel concept for the grand fusion of multiple tomographic modalities for simultaneous data acquisition in a region of interest (ROI). Omni-tomography can be instrumental when physiological processes under investigation are multi-dimensional, multi-scale, multi-temporal and multi-parametric. Both preclinical and clinical studies now depend on in vivo tomography, often requiring separate evaluations by different imaging modalities. Over the past decade, two approaches have been used for multimodality fusion: Software based image registration and hybrid scanners such as PET-CT, PET-MRI, and SPECT-CT among others. While there are intrinsic limitations with both approaches, the main obstacle to the seamless fusion of multiple imaging modalities has been the bulkiness of each individual imager and the conflict of their physical (especially spatial) requirements. To address this challenge, omni-tomography is now unveiled as an emerging direction for biomedical imaging and systems biomedicine.	[Wang, Ge; Cong, Wenxiang; Shen, Haiou; Bennett, James] Virginia Tech, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Blacksburg, VA 24061 USA; [Zhang, Jie] Univ Kentucky, Dept Radiol, Lexington, KY USA; [Gao, Hao] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Weir, Victor] Baylor Hlth Care Syst, Dept Med Phys & Radiat Safety, Dallas, TX USA; [Wang, Ge; Yu, Hengyong] Wake Forest Univ Hlth Sci, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Winston Salem, NC USA; [Xu, Xiaochen] Texas Instruments Inc, Med Business Unit, Dallas, TX USA; [Furth, Mark] Wake Forest Univ Hlth Sci, Ctr Comprehens Canc, Winston Salem, NC USA; [Wang, Yue] Virginia Tech, Dept Elect & Comp Engn, Blacksburg, VA USA; [Vannier, Michael] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Virginia Polytechnic Institute & State University; University of Kentucky; University of California System; University of California Los Angeles; Baylor Health Care System; Wake Forest University; Wake Forest University School of Medicine; Texas Instruments; Wake Forest University; Wake Forest University School of Medicine; Virginia Polytechnic Institute & State University; University of Chicago	Wang, G (corresponding author), Virginia Tech, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Blacksburg, VA 24061 USA.	ge-wang@ieee.org	Yu, Hengyong/AAH-5726-2019; Vannier, Michael W/AAI-6951-2021; Wang, Ge/AAH-8592-2020	Yu, Hengyong/0000-0002-5852-0813; Wang, Ge/0000-0002-2656-7705; Vannier, Michael/0000-0001-9898-384X	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) [EB011785]; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI) [HL098912]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) grant EB011785 and National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI) grant HL098912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn PH, 2008, SEMIN NUCL MED, V38, P141, DOI 10.1053/j.semnuclmed.2007.11.002; Annie M, 2007, 29 ANN INT C IEEE EN; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bieri O, 2005, MAGNET RESON MED, V54, P129, DOI 10.1002/mrm.20527; Bockisch A, 2009, SEMIN NUCL MED, V39, P276, DOI 10.1053/j.semnuclmed.2009.03.003; Boles CD, 1998, IEEE J SOLID-ST CIRC, V33, P733, DOI 10.1109/4.668988; Boss A, 2011, EUR RADIOL, V21, P1439, DOI 10.1007/s00330-011-2072-z; Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773; Chen XY, 2011, NANOPLATFORM-BASED MOLECULAR IMAGING, pIX; Cheong SK, 2010, PHYS MED BIOL, V55, P647, DOI 10.1088/0031-9155/55/3/007; Cherry SR, 2009, SEMIN NUCL MED, V39, P348, DOI 10.1053/j.semnuclmed.2009.03.001; Cong WX, 2012, PHYS MED BIOL, V57, P2905, DOI 10.1088/0031-9155/57/10/2905; Cong WX, 2012, J OPTICAL S IN PRESS; Courdurier M, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/6/065001; Daubechies I, 2008, J FOURIER ANAL APPL, V14, P764, DOI 10.1007/s00041-008-9039-8; Delbeke D, 2009, SEMIN NUCL MED, V39, P308, DOI 10.1053/j.semnuclmed.2009.03.002; Even-Sapir E, 2009, SEMIN NUCL MED, V39, P264, DOI 10.1053/j.semnuclmed.2009.03.004; Fessler JA, 2010, IEEE SIGNAL PROC MAG, V27, P81, DOI 10.1109/MSP.2010.936726; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Gao H, 2011, PHYS MED BIOL, V56, P3181, DOI 10.1088/0031-9155/56/11/002; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Han WM, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/125871; Hunter P, 2005, MECH AGEING DEV, V126, P187, DOI 10.1016/j.mad.2004.09.025; Hunter P, 2002, PFLUG ARCH EUR J PHY, V445, P1, DOI 10.1007/s00424-002-0890-1; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Jin YD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1042; Jones BL, 2011, PHYS MED BIOL, V56, P3719, DOI 10.1088/0031-9155/56/12/017; Katsevich E, 2012, INVERSE PRO IN PRESS; Kaufmann PA, 2009, SEMIN NUCL MED, V39, P341, DOI 10.1053/j.semnuclmed.2009.03.007; Kudo H, 2008, PHYS MED BIOL, V53, P2207, DOI 10.1088/0031-9155/53/9/001; Laskaris ET, 1995, OPEN MRI MAGNET WTH; Mah D, 2008, SEMIN NUCL MED, V38, P114, DOI 10.1053/j.semnuclmed.2007.11.003; Moon CH, 2000, MEAS SCI TECHNOL, V11, pN89, DOI 10.1088/0957-0233/11/8/401; Patton JA, 2009, SEMIN NUCL MED, V39, P247, DOI 10.1053/j.semnuclmed.2009.03.005; Pichler BJ, 2008, SEMIN NUCL MED, V38, P199, DOI 10.1053/j.semnuclmed.2008.02.001; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Tumer TO, 2006, IEEE NUCL SCI CONF R, P384, DOI 10.1109/NSSMIC.2006.356181; van Houten VMM, 2000, CLIN CANCER RES, V6, P3803; Wang G, 2011, ARXIV11062124PHYSICS; Wang G, 2010, P NATL ACAD SCI USA, V107, pE92, DOI 10.1073/pnas.1002473107; Wang G, 2009, MED PHYS, V36, P3575, DOI 10.1118/1.3157103; While PT, 2010, J MAGN RESON, V207, P124, DOI 10.1016/j.jmr.2010.08.017; Xu Q, 2012, IEEE T BIOM IN PRESS; Yang J., 2011, INVERSE PROBL, V28; Yang JS, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/3/035013; Ye YB, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/63634; Yu HY, 2011, J COMPUT ASSIST TOMO, V35, P762, DOI 10.1097/RCT.0b013e318231c578; Yu HY, 2009, PHYS MED BIOL, V54, pN425, DOI 10.1088/0031-9155/54/18/N04; Yu HY, 2009, COMMUN NUMER METH EN, V25, P693, DOI 10.1002/cnm.1206; Yu HY, 2008, J X-RAY SCI TECHNOL, V16, P243; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Yu HY, 2012, J XRAY SCI TECHNOLOG	52	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39700	10.1371/journal.pone.0039700	http://dx.doi.org/10.1371/journal.pone.0039700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	23240061	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100078
J	Wang, G; Li, CX; Guo, XX; Xing, D; Dong, YD; Wang, ZM; Zhang, YM; Liu, MD; Zheng, Z; Zhang, HD; Zhu, XJ; Wu, ZM; Zhao, TY				Wang, Gang; Li, Chunxiao; Guo, Xiaoxia; Xing, Dan; Dong, Yande; Wang, Zhongming; Zhang, Yingmei; Liu, Meide; Zheng, Zhong; Zhang, Hengduan; Zhu, Xiaojuan; Wu, Zhiming; Zhao, Tongyan			Identifying the Main Mosquito Species in China Based on DNA Barcoding	PLOS ONE			English	Article							CODON USAGE; SPARIDAE; TAXONOMY; DIPTERA	Mosquitoes are insects of the Diptera, Nematocera, and Culicidae families, some species of which are important disease vectors. Identifying mosquito species based on morphological characteristics is difficult, particularly the identification of specimens collected in the field as part of disease surveillance programs. Because of this difficulty, we constructed DNA barcodes of the cytochrome c oxidase subunit 1, the COI gene, for the more common mosquito species in China, including the major disease vectors. A total of 404 mosquito specimens were collected and assigned to 15 genera and 122 species and subspecies on the basis of morphological characteristics. Individuals of the same species grouped closely together in a Neighborhood- Joining tree based on COI sequence similarity, regardless of collection site. COI gene sequence divergence was approximately 30 times higher for species in the same genus than for members of the same species. Divergence in over 98% of congeneric species ranged from 2.3% to 21.8%, whereas divergence in conspecific individuals ranged from 0% to 1.67%. Cryptic species may be common and a few pseudogenes were detected.	[Wang, Gang; Li, Chunxiao; Guo, Xiaoxia; Xing, Dan; Dong, Yande; Wang, Zhongming; Zhang, Yingmei; Liu, Meide; Zheng, Zhong; Zhang, Hengduan; Zhu, Xiaojuan; Wu, Zhiming; Zhao, Tongyan] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Zheng, Zhong] Mil Area Command, Ctr Dis Control & Prevent, Xinjiang, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Zhao, TY (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China.	aedes@263.net	Yu, Hengyong/AAH-5726-2019; Vannier, Michael W/AAI-6951-2021; Wang, Ge/AAH-8592-2020	Yu, Hengyong/0000-0002-5852-0813; Wang, Ge/0000-0002-2656-7705; Vannier, Michael/0000-0001-9898-384X	Infective Diseases Prevention and Cure Project of China [2008ZX10402, 2012ZX10004219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	Infective Diseases Prevention and Cure Project of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Infective Diseases Prevention and Cure Project of China (NO: 2008ZX10402) and (NO: 2012ZX10004219).	AKASHI H, 1994, GENETICS, V136, P927; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Baolin L, 1997, FAUNA SINICA INSECTA, V9; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brown JW, 2003, P ENTOMOL SOC WASH, V105, P1043; Burns JM, 2007, PNAS, V105, p6 350; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; Edwards FW, 1932, GENERA INSECTORUM DI; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FENG Lan-chou, 1938, Peking Natural History Bulletin, V12, P285; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gao Q, 2004, J MED ENTOMOL, V41, P5, DOI 10.1603/0022-2585-41.1.5; Hanel R, 2000, J MOL EVOL, V50, P276, DOI 10.1007/s002399910032; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Marko PB, 2002, EVOLUTION, V56, P1303; Moftah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027001; Monaghan M, 2005, PHIL TRAMS R SOCB, V360; Moriyama EN, 1997, J MOL EVOL, V45, P514, DOI 10.1007/PL00006256; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Phuc HK, 2003, MED VET ENTOMOL, V17, P423, DOI 10.1111/j.1365-2915.2003.00462.x; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sirivanakarn S., 1976, Contributions Am ent Inst, V12, P1; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	35	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47051	10.1371/journal.pone.0047051	http://dx.doi.org/10.1371/journal.pone.0047051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23240061	gold, Green Published, Green Submitted			2022-12-25	WOS:000312385200072
